PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Christianson, SJ; Brand, CL; Wilkinson, GS				Christianson, Sarah J.; Brand, Cara L.; Wilkinson, Gerald S.			Reduced Polymorphism Associated with X Chromosome Meiotic Drive in the Stalk-Eyed Fly Teleopsis dalmanni	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; SEX-RATIO POLYMORPHISM; DROSOPHILA-SIMULANS; NATURAL-POPULATIONS; SEGREGATION DISTORTION; REPRODUCTIVE ISOLATION; GENETIC-VARIATION; DNA POLYMORPHISM; BACKGROUND SELECTION; CENTROMERIC REGION	Sex chromosome meiotic drive has been suggested as a cause of several evolutionary genetic phenomena, including genomic conflicts that give rise to reproductive isolation between new species. In this paper we present a population genetic analysis of X chromosome drive in the stalk-eyed fly, Teleopsis dalmanni, to determine how this natural polymorphism influences genetic diversity. We analyzed patterns of DNA sequence variation at two X-linked regions (comprising 1325 bp) approximately 50 cM apart and one autosomal region (comprising 921 bp) for 50 males, half of which were collected in the field from one of two allopatric locations and the other half were derived from lab-reared individuals with known brood sex ratios. These two populations are recently diverged but exhibit partial postzygotic reproductive isolation, i.e. crosses produce sterile hybrid males and fertile females. We find no nucleotide or microsatellite variation on the drive X chromosome, whereas the same individuals show levels of variation at autosomal regions that are similar to field-collected flies. Furthermore, one field-caught individual collected 10 years previously had a nearly identical X haplotype to the drive X, and is over 2% divergent from other haplotypes sampled from the field. These results are consistent with a selective sweep that has removed genetic variation from much of the drive X chromosome. We discuss how this finding may relate to the rapid evolution of postzygotic reproductive isolation that has been documented for these flies.	[Christianson, Sarah J.; Brand, Cara L.; Wilkinson, Gerald S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Christianson, SJ (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	wilkinso@umd.edu	Wilkinson, Gerald S./E-4424-2011	Wilkinson, Gerald S./0000-0001-7799-8444	NSF [DEB-0077878, DEB-0343617, DEB-0444886]; University of Maryland; Division Of Environmental Biology [0952260] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Maryland; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by NSF (http://www.nsf.gov/) grants DEB-0077878, DEB-0343617, and DEB-0444886 to GSW. Additional financial support came from an NSF predoctoral fellowship, a University of Maryland Graduate School Fellowship and a University of Maryland Dissertation Fellowship to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUADE M, 1994, P NATL ACAD SCI USA, V91, P4658, DOI 10.1073/pnas.91.11.4658; AGUADE M, 1989, GENETICS, V122, P607; Andolfatto P, 2001, GENETICS, V158, P657; Babcock CS, 1996, MOL BIOL EVOL, V13, P297, DOI 10.1093/oxfordjournals.molbev.a025589; Baker RH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001121; Baker RH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-361; Bastide H, 2011, MOL BIOL EVOL, V28, P2461, DOI 10.1093/molbev/msr074; Beckenbach AT, 1996, EVOLUTION, V50, P787, DOI 10.1111/j.1558-5646.1996.tb03888.x; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Birge LM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-227; Capillon C, 1999, EVOLUTION, V53, P506, DOI [10.2307/2640786, 10.1111/j.1558-5646.1999.tb03785.x]; Carvalho AB, 1999, HEREDITY, V83, P221, DOI 10.1038/sj.hdy.6886100; Carvalho AB, 1997, GENETICS, V146, P891; Cazemajor M, 1997, GENETICS, V147, P635; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Christianson SJ, 2005, EVOLUTION, V59, P849, DOI 10.1554/04-291; CURTSINGER JW, 1980, GENETICS, V94, P445; DECARVALHO AB, 1989, HEREDITY, V62, P425, DOI 10.1038/hdy.1989.58; DECARVALHO AB, 1993, HEREDITY, V71, P546, DOI 10.1038/hdy.1993.174; Dermitzakis ET, 2000, GENETICS, V154, P687; Derome N, 2008, MOL BIOL EVOL, V25, P409, DOI 10.1093/molbev/msm269; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; EDWARDS AW, 1961, HEREDITY, V16, P291, DOI 10.1038/hdy.1961.35; Fay JC, 2000, GENETICS, V155, P1405; Fisher, 1958, GENETICAL THEORY NAT; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; FU YX, 1993, GENETICS, V133, P693; Gershenson S, 1928, GENETICS, V13, P488; Glinka S, 2003, GENETICS, V165, P1269; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall DW, 2004, EVOLUTION, V58, P925; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HAUSCHTECKJUNGEN E, 1990, GENETICA, V83, P31; HUDSON RR, 1987, GENETICS, V116, P153; HURST LD, 1991, GENETICS, V128, P841; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Jaenike J, 1996, AM NAT, V148, P237, DOI 10.1086/285923; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; JAMES AC, 1990, GENETICS, V126, P651; Jensen MA, 2002, GENETICS, V160, P493; Johns PM, 2005, P ROY SOC B-BIOL SCI, V272, P2097, DOI 10.1098/rspb.2005.3183; KAPLAN NL, 1989, GENETICS, V123, P887; Kim Y, 2000, GENETICS, V155, P1415; Kingan SB, 2010, GENETICS, V184, P253, DOI 10.1534/genetics.109.109587; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI [10.2307/2406613, 10.1111/j.1558-5646.1967.tb03408.x]; Lande R, 1999, GENET RES, V74, P245, DOI 10.1017/S0016672399004218; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARTINCAMPOS JM, 1992, GENETICS, V130, P805; McDermott SR, 2010, PHILOS T R SOC B, V365, P1265, DOI 10.1098/rstb.2009.0264; MERCOT H, 1995, J EVOLUTION BIOL, V8, P283, DOI 10.1046/j.1420-9101.1995.8030283.x; MIYASHITA NT, 1990, GENETICS, V125, P407; Montchamp-Moreau C, 2002, GENETICS, V162, P1221; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Palopoli MF, 1996, GENETICS, V143, P1675; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000463; Presgraves DC, 1997, GENETICS, V147, P1169; Quesada H, 2003, GENETICS, V165, P895; Reed FA, 2005, EVOLUTION, V59, P1280, DOI 10.1111/j.0014-3820.2005.tb01778.x; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STALKER HD, 1961, GENETICS, V46, P177; STEPHAN W, 1992, GENETICS, V132, P1039, DOI 10.1093/genetics/132.4.1039; STEPHAN W, 1989, GENETICS, V121, P89, DOI 10.1093/genetics/121.1.89; Sturtevant AH, 1936, GENETICS, V21, P473; TAJIMA F, 1989, GENETICS, V123, P585; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Tao Y, 2007, PLOS BIOL, V5, P2560, DOI 10.1371/journal.pbio.0050292; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilkinson GS, 2006, J EVOLUTION BIOL, V19, P1851, DOI 10.1111/j.1420-9101.2006.01169.x; Wilkinson GS, 2003, GENETICA, V117, P37, DOI 10.1023/A:1022360531703; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Wilkinson GS, 1998, NATURE, V391, P276, DOI 10.1038/34640; Wolfenbarger LL, 2001, EVOLUTION, V55, P103; Wright TF, 2004, GENET RES, V84, P27, DOI 10.1017/S0016672304006986	81	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27254	10.1371/journal.pone.0027254	http://dx.doi.org/10.1371/journal.pone.0027254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087274	gold, Green Published			2022-12-27	WOS:000297349700024
J	Wolting, CD; Griffiths, EK; Sarao, R; Prevost, BC; Wybenga-Groot, LE; McGlade, CJ				Wolting, Cheryl D.; Griffiths, Emily K.; Sarao, Renu; Prevost, Brittany C.; Wybenga-Groot, Leanne E.; McGlade, C. Jane			Biochemical and Computational Analysis Of LNX1 Interacting Proteins	PLOS ONE			English	Article							ADENOVIRUS RECEPTOR CAR; E3 UBIQUITIN LIGASE; JUNCTIONAL CELL-ADHESION; PDZ-DOMAIN; BINDING DOMAIN; ACTIVE ZONE; P21-ACTIVATED KINASES; FINGER STRUCTURE; PTP-BL; NUMB	PDZ (Post-synaptic density, 95 kDa, Discs large, Zona Occludens-1) domains are protein interaction domains that bind to the carboxy-terminal amino acids of binding partners, heterodimerize with other PDZ domains, and also bind phosphoinositides. PDZ domain containing proteins are frequently involved in the assembly of multi-protein complexes and clustering of transmembrane proteins. LNX1 (Ligand of Numb, protein X 1) is a RING (Really Interesting New Gene) domain-containing E3 ubiquitin ligase that also includes four PDZ domains suggesting it functions as a scaffold for a multiprotein complex. Here we use a human protein array to identify direct LNX1 PDZ domain binding partners. Screening of 8,000 human proteins with isolated PDZ domains identified 53 potential LNX1 binding partners. We combined this set with LNX1 interacting proteins identified by other methods to assemble a list of 220 LNX1 interacting proteins. Bioinformatic analysis of this protein list was used to select interactions of interest for future studies. Using this approach we identify and confirm six novel LNX1 binding partners: KCNA4, PAK6, PLEKHG5, PKC-alpha1, TYK2 and PBK, and suggest that LNX1 functions as a signalling scaffold.	[Wolting, Cheryl D.; Prevost, Brittany C.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wolting, Cheryl D.; Griffiths, Emily K.; Sarao, Renu; Prevost, Brittany C.; Wybenga-Groot, Leanne E.; McGlade, C. Jane] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wolting, CD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	jmcglade@sickkids.ca			Canadian Institutes of Health Research [MOP-121669]; Canadian Cancer Society [020228]; National Cancer Institute of Canada; Terry Fox Foundation; NSERC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Terry Fox Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Canadian Institutes of Health Research (MOP-121669) and the Canadian Cancer Society (#020228) to Dr. McGlade. Dr. Wolting was supported by a studentship from the National Cancer Institute of Canada, and Dr. Griffiths was supported by a Terry Fox Foundation Fellowship with funds from the Canadian Cancer Society, Dr. Wybeng-Groot was supported by a fellowship from the Canadian Institutes of Health Research, and Dr. Prevost by an NSERC PGSM studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruester V, 2004, J VIROL, V78, P10310, DOI 10.1128/JVI.78.19.10310-10319.2004; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bork P, 2002, BIOINFORMATICS, V18, pS64, DOI 10.1093/bioinformatics/18.suppl_2.S64; Borrell-Pages M, 2000, MOL BIOL CELL; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817; Chen JX, 2005, INT J BIOCHEM CELL B, V37, P2273, DOI 10.1016/j.biocel.2005.02.028; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gross C, 2001, FEBS LETT, V496, P101, DOI 10.1016/S0014-5793(01)02401-2; Higa S, 2007, BIOCHEM BIOPH RES CO, V354, P686, DOI 10.1016/j.bbrc.2007.01.036; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; KLOCKE R, 1993, GENOMICS, V18, P568, DOI 10.1016/S0888-7543(05)80358-1; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Mori H, 2004, GENES CELLS, V9, P811, DOI 10.1111/j.1365-2443.2004.00765.x; Nie J, 2004, J BIOL CHEM, V279, P20807, DOI 10.1074/jbc.M311396200; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; PHILIPSON LH, 1993, GENOMICS, V15, P463, DOI 10.1006/geno.1993.1094; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Song E, 2006, MOL CELL PROTEOMICS, V5, P1368, DOI 10.1074/mcp.M600072-MCP200; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tajima M, 2003, GENES CELLS, V8, P759, DOI 10.1046/j.1365-2443.2003.00673.x; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; van den Berk LCJ, 2007, BIOCHEMISTRY-US, V46, P13629, DOI 10.1021/bi700954e; Wang P, 2000, EUR J BIOCHEM, V267, P3116, DOI 10.1046/j.1432-1327.2000.01318.x; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Wolting C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-338; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xie Y, 2001, BIOCHEM GENET, V39, P117, DOI 10.1023/A:1010269908398; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zegers M, 2008, INT REV CEL MOL BIO, V267, P253, DOI 10.1016/S1937-6448(08)00606-0; Zheng D, 2010, MOL BIOL REP, V37, P2431, DOI 10.1007/s11033-009-9754-5; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Zimmermann P, 2006, BBA-MOL CELL BIOL L, V1761, P947, DOI 10.1016/j.bbalip.2006.04.003	61	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26248	10.1371/journal.pone.0026248	http://dx.doi.org/10.1371/journal.pone.0026248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087225	Green Submitted, gold, Green Published			2022-12-27	WOS:000297349700006
J	Chen, MH; Yang, WLR; Lin, KT; Liu, CH; Liu, YW; Huang, KW; Chang, PMH; Lai, JM; Hsu, CN; Chao, KM; Kao, CY; Huang, CYF				Chen, Ming-Huang; Yang, Wu-Lung R.; Lin, Kuan-Ting; Liu, Chia-Hung; Liu, Yu-Wen; Huang, Kai-Wen; Chang, Peter Mu-Hsin; Lai, Jin-Mei; Hsu, Chun-Nan; Chao, Kun-Mao; Kao, Cheng-Yan; Huang, Chi-Ying F.			Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma	PLOS ONE			English	Article							INTERACTION NETWORK; TARGETED THERAPIES; SMALL MOLECULES; CANCER; GROWTH; CELLS; HEPATOMA; PHENOTHIAZINES; CHLORPROMAZINE; TRANSCRIPTION	Hepatocellular carcinoma (HCC) is an aggressive tumor with a poor prognosis. Currently, only sorafenib is approved by the FDA for advanced HCC treatment; therefore, there is an urgent need to discover candidate therapeutic drugs for HCC. We hypothesized that if a drug signature could reverse, at least in part, the gene expression signature of HCC, it might have the potential to inhibit HCC-related pathways and thereby treat HCC. To test this hypothesis, we first built an integrative platform, the "Encyclopedia of Hepatocellular Carcinoma genes Online 2", dubbed EHCO2, to systematically collect, organize and compare the publicly available data from HCC studies. The resulting collection includes a total of 4,020 genes. To systematically query the Connectivity Map (CMap), which includes 6,100 drug-mediated expression profiles, we further designed various gene signature selection and enrichment methods, including a randomization technique, majority vote, and clique analysis. Subsequently, 28 out of 50 prioritized drugs, including tanespimycin, trichostatin A, thioguanosine, and several anti-psychotic drugs with anti-tumor activities, were validated via MTT cell viability assays and clonogenic assays in HCC cell lines. To accelerate their future clinical use, possibly through drug-repurposing, we selected two well-established drugs to test in mice, chlorpromazine and trifluoperazine. Both drugs inhibited orthotopic liver tumor growth. In conclusion, we successfully discovered and validated existing drugs for potential HCC therapeutic use with the pipeline of Connectivity Map analysis and lab verification, thereby suggesting the usefulness of this procedure to accelerate drug repurposing for HCC treatment.	[Chen, Ming-Huang; Liu, Yu-Wen; Chang, Peter Mu-Hsin; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Wu-Lung R.; Chao, Kun-Mao; Kao, Cheng-Yan] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Lin, Kuan-Ting; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Lin, Kuan-Ting; Liu, Chia-Hung; Hsu, Chun-Nan] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Liu, Chia-Hung; Chao, Kun-Mao; Kao, Cheng-Yan] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Dept Surg, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Hepatitis Res Ctr, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City, Taiwan; [Hsu, Chun-Nan] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; University of Southern California; National Yang Ming Chiao Tung University	Chen, MH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; CHAO, KUN-MA0/0000-0003-2837-1279; HUANG, KAI-WEN/0000-0001-6375-8714	National Science Council (NSC) [NSC99-3112-B-010-005-CC1, NSC100-2627-B-010-005-, 100-2325 -B-182 -006]; Taipei Veterans General Hospital [V100E2-010, V100E2-005]; National Health Research Institutes [NHRI-EX100-10029BI]; Ministry of Economic Affairs [99-EC-17-A-17-S1-152]; Ministry of Education, Aim for the Top University Plan (National Yang Ming University)	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Economic Affairs; Ministry of Education, Aim for the Top University Plan (National Yang Ming University)	This research was supported by grants from the National Science Council (NSC99-3112-B-010-005-CC1 and NSC100-2627-B-010-005-), Taipei Veterans General Hospital (V100E2-010), the National Health Research Institutes (NHRI-EX100-10029BI), Ministry of Economic Affairs (99-EC-17-A-17-S1-152) and the Ministry of Education, Aim for the Top University Plan (National Yang Ming University) to C. Huang and Taipei Veterans General Hospital (V100E2-005) to M. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sheng-An Lee for conducting Clique Analysis. We would also like to thank Taiwan Liver Cancer Network (TLCN) for providing the hepatocellular carcinoma tissue samples and related clinical data (all are anonymous) for our research work. This network currently includes five major medical centers (National Taiwan University Hospital, Chang-Gung Memorial Hospital-Linko, Veteran General Hospital-Taichung, Chang-Gung Memorial Hospital -Kaohsiung, and Veteran General Hospital - Kaohsiung). TLCN is supported by grants from National Science Council since 2005 till now (NSC 100-2325 -B-182 -006) and National Health Research Institutes, Taiwan.	Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Chen TC, 2009, PROTEOMICS, V9, P4048, DOI 10.1002/pmic.200900231; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dourado Marilia, 2007, Pathophysiology, V14, P3, DOI 10.1016/j.pathophys.2006.09.003; Duensing S, 2010, BIOCHEM PHARMACOL, V80, P575, DOI 10.1016/j.bcp.2010.04.006; Finn RS, 2010, CLIN CANCER RES, V16, P390, DOI 10.1158/1078-0432.CCR-09-2084; Galle Peter R, 2008, J Hepatol, V49, P871, DOI 10.1016/j.jhep.2008.09.001; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil-Ad I, 2006, ONCOL REP, V15, P107; Gray SG, 2000, INT J MOL MED, V5, P33; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Hsu C, 2003, P IJCAI 2003 WORKSH; Hsu CN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-66; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kast RE, 2007, MED HYPOTHESES, V69, P1074, DOI 10.1016/j.mehy.2006.08.048; Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lan MY, 2010, MOL CANCER THER, V9, P2511, DOI 10.1158/1535-7163.MCT-09-0966; Lee JS, 2002, HEPATOLOGY, V35, P1134, DOI 10.1053/jhep.2002.33165; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lee SA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-114; Liu C-H, 2011, ICONCEPT T COMPUTATI; Manghisi G, 1998, HEPATOLOGY, V28, P751; Neo SY, 2004, HEPATOLOGY, V39, P944, DOI 10.1002/hep.20105; Platta CS, 2007, J SURG RES, V142, P219, DOI 10.1016/j.jss.2006.12.555; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Shin SY, 2010, EXP MOL MED, V42, P395, DOI 10.3858/emm.2010.42.5.041; Shirota Y, 2001, HEPATOLOGY, V33, P832, DOI 10.1053/jhep.2001.23003; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; WEISS JW, 1974, CANCER RES, V34, P581; Wiklund ED, 2010, INT J CANCER, V126, P28, DOI 10.1002/ijc.24813; Yoo DR, 2009, CANCER LETT, V282, P48, DOI 10.1016/j.canlet.2009.02.051	40	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27186	10.1371/journal.pone.0027186	http://dx.doi.org/10.1371/journal.pone.0027186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087264	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700028
J	Chung, U; Mack, L; Yun, JI; Kim, SH				Chung, Uran; Mack, Liz; Yun, Jin I.; Kim, Soo-Hyung			Predicting the Timing of Cherry Blossoms in Washington, DC and Mid-Atlantic States in Response to Climate Change	PLOS ONE			English	Article							BUD-BURST; DORMANCY INDUCTION; TREE PHENOLOGY; TEMPERATURE; GROWTH; MODELS; PHOTOPERIOD; RESOLUTION; BUDBURST; EARLIER	Cherry blossoms, an icon of spring, are celebrated in many cultures of the temperate region. For its sensitivity to winter and early spring temperatures, the timing of cherry blossoms is an ideal indicator of the impacts of climate change on tree phenology. Here, we applied a process-based phenology model for temperate deciduous trees to predict peak bloom dates (PBD) of flowering cherry trees (Prunus x yedoensis 'Yoshino' and Prunus serrulata 'Kwanzan') in the Tidal Basin, Washington, DC and the surrounding Mid-Atlantic States in response to climate change. We parameterized the model with observed PBD data from 1991 to 2010. The calibrated model was tested against independent datasets of the past PBD data from 1951 to 1970 in the Tidal Basin and more recent PBD data from other locations (e.g., Seattle, WA). The model performance against these independent data was satisfactory (Yoshino: r(2) = 0.57, RMSE = 6.6 days, bias = 0.9 days and Kwanzan: r(2) = 0.76, RMSE = 5.5 days, bias = -2.0 days). We then applied the model to forecast future PBD for the region using downscaled climate projections based on IPCC's A1B and A2 emissions scenarios. Our results indicate that PBD at the Tidal Basin are likely to be accelerated by an average of five days by 2050 s and 10 days by 2080 s for these cultivars under a mid-range (A1B) emissions scenario projected by ECHAM5 general circulation model. The acceleration is likely to be much greater (13 days for 2050 s and 29 days for 2080s) under a higher (A2) emissions scenario projected by CGCM2 general circulation model. Our results demonstrate the potential impacts of climate change on the timing of cherry blossoms and illustrate the utility of a simple process-based phenology model for developing adaptation strategies to climate change in horticulture, conservation planning, restoration and other related disciplines.	[Chung, Uran; Mack, Liz; Kim, Soo-Hyung] Univ Washington, Ctr Urban Hort, Sch Forest Resources, Coll Environm, Seattle, WA 98195 USA; [Yun, Jin I.] Kyung Hee Univ, Dept Ecosyst Engn, Yongin, South Korea; [Chung, Uran] Seoul Natl Univ, Natl Ctr Agrometeorol, Seoul, South Korea	University of Washington; University of Washington Seattle; Kyung Hee University; Seoul National University (SNU)	Chung, U (corresponding author), Univ Washington, Ctr Urban Hort, Sch Forest Resources, Coll Environm, Seattle, WA 98195 USA.	soohkim@u.washington.edu	Kim, Soo-Hyung/A-3012-2009	Kim, Soo-Hyung/0000-0003-3879-4080	Rural Development Administration, Republic of Korea [PJ006403]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Cooperative Research Program for Agricultural Science & Technology Development (Project No. PJ006403), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; CANNELL MGR, 1985, J APPL ECOL, V22, P931, DOI 10.2307/2403241; Cesaraccio C, 2004, AGR FOREST METEOROL, V126, P1, DOI 10.1016/j.agrformet.2004.03.002; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chung U, 2009, CLIMATIC CHANGE, V93, P447, DOI 10.1007/s10584-008-9504-z; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Granhus A, 2009, TREE PHYSIOL, V29, P497, DOI 10.1093/treephys/tpn039; Havens K, 2008, USING PHENOLOGY ENGA; Heide OM, 2008, SCI HORTIC-AMSTERDAM, V115, P309, DOI 10.1016/j.scienta.2007.10.005; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Heide OM, 2003, TREE PHYSIOL, V23, P931, DOI 10.1093/treephys/23.13.931; Henebry GM, 2010, EOS, V91, P3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Jefferson RM, 1977, JAPANESE FLOWERING C; Linkosalo T, 2006, TREE PHYSIOL, V26, P1165, DOI 10.1093/treephys/26.9.1165; McClellan A., 2005, CHERRY BLOSSOM FESTI; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2007, AM J BOT, V94, P1470, DOI 10.3732/ajb.94.9.1470; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; Oh S. D., 2004, FRUIT TREE PHYSL REL; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pooler Margaret R., 1999, Journal of Environmental Horticulture, V17, P189; Primack RB, 2009, BIOL CONSERV, V142, P1943, DOI 10.1016/j.biocon.2009.03.016; Ramirez J, 2010, 1 CIATCGIAR; RETTA A, 1991, AGRON J, V83, P757, DOI 10.2134/agronj1991.00021962008300040021x; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Roh MS, 2007, SCI HORTIC-AMSTERDAM, V114, P121, DOI 10.1016/j.scienta.2007.06.005; Rutishauser T, 2003, THESIS U BERN; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Seeley SD, 1996, MODELLING CLIMATIC R, P361; Seino H., 1993, J AGR METEOROL, V48, P379, DOI DOI 10.2480/AGRMET.48.379; Thompson R, 2008, HOLOCENE, V18, P95, DOI 10.1177/0959683607085599; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; WMO, 1989, 10 WMO WCDP, P1011; 정재은, 2005, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V7, P148; Yun Jin, 2006, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V8, P68; Zavalloni C, 2006, J AM SOC HORTIC SCI, V131, P601, DOI 10.21273/JASHS.131.5.601	44	47	50	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27439	10.1371/journal.pone.0027439	http://dx.doi.org/10.1371/journal.pone.0027439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087317	gold, Green Published			2022-12-27	WOS:000297347700054
J	Fritz, H; Kennedy, D; Fergusson, D; Fernandes, R; Cooley, K; Seely, A; Sagar, S; Wong, R; Seely, D				Fritz, Heidi; Kennedy, Deborah; Fergusson, Dean; Fernandes, Rochelle; Cooley, Kieran; Seely, Andrew; Sagar, Stephen; Wong, Raimond; Seely, Dugald			Selenium and Lung Cancer: A Systematic Review and Meta Analysis	PLOS ONE			English	Review							GYNECOLOGIC RADIATION ONCOLOGY; A/J MOUSE LUNG; SODIUM SELENITE; PROSTATE-CANCER; METHYLSELENINIC ACID; ORGANOSELENIUM COMPOUND; NUTRITIONAL PREVENTION; DIETARY SUPPLEMENTATION; MELANOMA-CELLS; SOLID TUMORS	Background: Selenium is a natural health product widely used in the treatment and prevention of lung cancers, but large chemoprevention trials have yielded conflicting results. We conducted a systematic review of selenium for lung cancers, and assessed potential interactions with conventional therapies. Methods and Findings: Two independent reviewers searched six databases from inception to March 2009 for evidence pertaining to the safety and efficacy of selenium for lung cancers. Pubmed and EMBASE were searched to October 2009 for evidence on interactions with chemo- or radiation-therapy. In the efficacy analysis there were nine reports of five RCTs and two biomarker-based studies, 29 reports of 26 observational studies, and 41 preclinical studies. Fifteen human studies, one case report, and 36 preclinical studies were included in the interactions analysis. Based on available evidence, there appears to be a different chemopreventive effect dependent on baseline selenium status, such that selenium supplementation may reduce risk of lung cancers in populations with lower baseline selenium status (serum, <106 ng/mL), but increase risk of lung cancers in those with higher selenium (>= 121.6 ng/mL). Pooling data from two trials yielded no impact to odds of lung cancer, OR 0.93 (95% confidence interval 0.61-1.43); other cancers that were the primary endpoints of these trials, OR 1.51 (95%CI 0.70-3.24); and all-cause-death, OR 0.93 (95%CI 0.79-1.10). In the treatment of lung cancers, selenium may reduce cisplatin-induced nephrotoxicity and side effects associated with radiation therapy. Conclusions: Selenium may be effective for lung cancer prevention among individuals with lower selenium status, but at present should not be used as a general strategy for lung cancer prevention. Although promising, more evidence on the ability of selenium to reduce cisplatin and radiation therapy toxicity is required to ensure that therapeutic efficacy is maintained before any broad clinical recommendations can be made in this context.	[Fritz, Heidi; Kennedy, Deborah; Fernandes, Rochelle; Cooley, Kieran; Seely, Dugald] Canadian Coll Naturopath Med, Dept Res & Epidemiol, Toronto, ON, Canada; [Kennedy, Deborah; Cooley, Kieran] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Fernandes, Rochelle] Univ Toronto, Lab Med & Pathobiol LMP, Toronto, ON, Canada; [Seely, Andrew] Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada; [Sagar, Stephen; Wong, Raimond] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada; [Sagar, Stephen; Wong, Raimond] McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; McMaster University; McMaster University	Fritz, H (corresponding author), Canadian Coll Naturopath Med, Dept Res & Epidemiol, Toronto, ON, Canada.	dseely@ccnm.edu	Cooley, Kieran/L-3080-2019	Cooley, Kieran/0000-0001-7960-6504; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research (CIHR); SickKids Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); SickKids Foundation	This project was supported by a knowledge synthesis grant from the Canadian Institutes of Health Research (CIHR). DAK is supported by a career training award from the SickKids Foundation. No additional sources of funding were accessed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R, 2005, J TRACE ELEM MED BIO, V19, P141, DOI 10.1016/j.jtemb.2005.09.003; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; *AM CANC SOC, 2010, CANC REF INF WHAT AR; Asfour IA, 2007, BIOL TRACE ELEM RES, V120, P1, DOI 10.1007/s12011-007-0029-5; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Azrak RG, 2008, CANCER BIOL THER, V7, P1901, DOI 10.4161/cbt.7.12.6939; BALDEW GS, 1989, CANCER RES, V49, P3020; Becker-Witt C, 2003, J ALTERN COMPLEM MED, V9, P113, DOI 10.1089/107555303321222991; Bruns F, 2004, MED PRIN PRACT, V13, P185, DOI 10.1159/000078313; Buntzel J, 2006, TRACE ELEM ELECTROLY, V23, P178; Buntzel J, 2005, TRACE ELEM ELECTROLY, V22, P211; Buntzel J, 2002, TRACE ELEM ELECTROLY, V19, P33; Caffrey PB, 2000, CANCER CHEMOTH PHARM, V46, P74, DOI 10.1007/s002800000127; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Combs G F Jr, 1997, Med Klin (Munich), V92 Suppl 3, P42; Combs GF, 1997, BIOMED ENVIRON SCI, V10, P227; Das A, 2003, NUTR CANCER, V46, P179, DOI 10.1207/S15327914NC4602_11; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; El-Bayoumy K, 2002, INT J ONCOL, V20, P557; El-Bayoumy K, 2006, CARCINOGENESIS, V27, P1369, DOI 10.1093/carcin/bgi328; Elango N, 2006, CLIN CHIM ACTA, V373, P92, DOI 10.1016/j.cca.2006.05.021; ELBAYOUMY K, 1993, CARCINOGENESIS, V14, P1111, DOI 10.1093/carcin/14.6.1111; ElBayoumy K, 1996, ANTICANCER RES, V16, P2709; Fakih MG, 2008, CANCER CHEMOTH PHARM, V62, P499, DOI 10.1007/s00280-007-0631-4; Fakih MG, 2006, CLIN CANCER RES, V12, P1237, DOI 10.1158/1078-0432.CCR-05-2004; Finley JW, 2006, NUTR REV, V64, P146, DOI 10.1301/nr.2006.mar.146-151; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Ganther HE, 2001, ADV EXP MED BIOL, V492, P119; GARLAND M, 1995, J NATL CANCER I, V87, P497, DOI 10.1093/jnci/87.7.497; Gonzalez-Moreno O, 2007, INT J CANCER, V121, P1197, DOI 10.1002/ijc.22764; Goodman GE, 2001, CANCER EPIDEM BIOMAR, V10, P1069; Hu GZ, 2000, AM J EPIDEMIOL, V151, P975, DOI 10.1093/oxfordjournals.aje.a010141; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Hu H, 2008, CLIN CANCER RES, V14, P1150, DOI 10.1158/1078-0432.CCR-07-4037; Hu YJ, 1997, BIOL TRACE ELEM RES, V56, P331, DOI 10.1007/BF02785304; Institute. OHR The Newcastle-Ottawa Scale (NOS), OHR NEWC OTT SCAL NO; Ip C, 2002, CANCER METAST REV, V21, P281, DOI 10.1023/A:1021263027659; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kamangar F, 2006, CANCER EPIDEM BIOMAR, V15, P1562, DOI 10.1158/1055-9965.EPI-06-0316; Karp DD, 2010, J CLIN ONCOLOGY S, V28; Khan MAK, 2009, ENVIRON TOXICOL CHEM, V28, P1567, DOI 10.1897/08-375.1; Knizhnikov VA, 1996, NUTR RES, V16, P505, DOI 10.1016/0271-5317(96)00031-0; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Larsen EH, 2004, J AOAC INT, V87, P225; Li DH, 2004, J NUTR, V134, P1536, DOI 10.1093/jn/134.6.1536; Li L, 2005, J BIOCHEM MOL TOXIC, V19, P396, DOI 10.1002/jbt.20105; Li S, 2007, ANTICANCER RES, V27, P3075; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MENKES MS, 1986, NEW ENGL J MED, V315, P1250, DOI 10.1056/NEJM198611133152003; Micke O, 2000, TRACE ELEM ELECTROLY, V17, P206; Micke O, 2003, INT J RADIAT ONCOL, V56, P40, DOI 10.1016/S0360-3016(02)04390-0; Micke O, 2010, FRONT RADIAT THER ON, V42, P198, DOI 10.1159/000262477; Mucke R, 2004, TRACE ELEM ELECTROLY, V21, P78; Mucke R, 2006, TRACE ELEM ELECTROLY, V23, P173; Muecke R, 2010, INT J RAD ONCOL BIOL; Mueller AS, 2009, FREE RADICAL RES, P1; OHKAWA K, 1988, BRIT J CANCER, V58, P38, DOI 10.1038/bjc.1988.157; Prokopczyk B, 1997, CARCINOGENESIS, V18, P1855, DOI 10.1093/carcin/18.9.1855; Prokopczyk B, 2000, CANCER LETT, V161, P35, DOI 10.1016/S0304-3835(00)00590-5; Rao M, 1998, J PHARM PHARMACOL, V50, P687, DOI 10.1111/j.2042-7158.1998.tb06906.x; Ratnasinghe D, 2000, CANCER CAUSE CONTROL, V11, P129, DOI 10.1023/A:1008977320811; Rayman MP, 2008, BRIT J NUTR, V100, P238, DOI 10.1017/S0007114508922522; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Reid ME, 2008, NUTR CANCER, V60, P155, DOI 10.1080/01635580701684856; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Reid ME, 2004, J TRACE ELEM MED BIO, V18, P69, DOI 10.1016/j.jtemb.2004.03.004; SATOH M, 1992, CANCER CHEMOTH PHARM, V30, P439, DOI 10.1007/BF00685594; Schonberg SA, 1997, CARCINOGENESIS, V18, P1897, DOI 10.1093/carcin/18.10.1897; Schrauzer GN, 2009, CRIT REV BIOTECHNOL, V29, P10, DOI 10.1080/07388550802658048; Schrauzer GN, 2009, CRIT REV BIOTECHNOL, V29, P2, DOI 10.1080/07388550902728261; Schroeder CP, 2004, BIOL TRACE ELEM RES, V99, P17, DOI 10.1385/BTER:99:1-3:017; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Smith ML, 2004, ANTICANCER RES, V24, P1401; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Swede H, 2003, CANCER EPIDEM BIOMAR, V12, P1248; Tanaka T, 2000, CANCER RES, V60, P3713; Thomson CD, 2008, AM J CLIN NUTR, V87, P379, DOI 10.1093/ajcn/87.2.379; Vadgama JV, 2000, ANTICANCER RES, V20, P1391; VERMEULEN NPE, 1993, DRUG METAB DISPOS, V21, P30; Vinceti Marco, 2009, Reviews on Environmental Health, V24, P231; Witschi H, 2002, CARCINOGENESIS, V23, P289, DOI 10.1093/carcin/23.2.289; Witschi H, 2000, EXP LUNG RES, V26, P743, DOI 10.1080/01902140150216792; Witschi H, 2000, CARCINOGENESIS, V21, P977, DOI 10.1093/carcin/21.5.977; Xu H, STUDY OXIDATIVE META; Yamamoto N, 2003, CANCER GENE THER, V10, P445, DOI 10.1038/sj.cgt.7700587; YU SY, 1990, BIOL TRACE ELEM RES, V24, P105, DOI 10.1007/BF02917199; Zhang Q., 2009, J NANJING MED U, V23, P111; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771; Zimmermann T, 2005, BIOL TRACE ELEM RES, V106, P193, DOI 10.1385/BTER:106:3:193	92	51	53	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26259	10.1371/journal.pone.0026259	http://dx.doi.org/10.1371/journal.pone.0026259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073154	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200006
J	Tio, M; Toh, J; Fang, WR; Blanco, J; Udolph, G				Tio, Murni; Toh, Joanne; Fang, Wanru; Blanco, Jorge; Udolph, Gerald			Asymmetric Cell Division and Notch Signaling Specify Dopaminergic Neurons in Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; LATERAL INHIBITION; GENE-EXPRESSION; MOSAIC ANALYSIS; FATE DECISIONS; NUMB; NEUROGENESIS; SPECIFICATION; MELANOGASTER	In Drosophila, dopaminergic (DA) neurons can be found from mid embryonic stages of development till adulthood. Despite their functional involvement in learning and memory, not much is known about the developmental as well as molecular mechanisms involved in the events of DA neuronal specification, differentiation and maturation. In this report we demonstrate that most larval DA neurons are generated during embryonic development. Furthermore, we show that loss of function (l-o-f) mutations of genes of the apical complex proteins in the asymmetric cell division (ACD) machinery, such as inscuteable and bazooka result in supernumerary DA neurons, whereas l-o-f mutations of genes of the basal complex proteins such as numb result in loss or reduction of DA neurons. In addition, when Notch signaling is reduced or abolished, additional DA neurons are formed and conversely, when Notch signaling is activated, less DA neurons are generated. Our data demonstrate that both ACD and Notch signaling are crucial mechanisms for DA neuronal specification. We propose a model in which ACD results in differential Notch activation in direct siblings and in this context Notch acts as a repressor for DA neuronal specification in the sibling that receives active Notch signaling. Our study provides the first link of ACD and Notch signaling in the specification of a neurotransmitter phenotype in Drosophila. Given the high degree of conservation between Drosophila and vertebrate systems, this study could be of significance to mechanisms of DA neuronal differentiation not limited to flies.	[Tio, Murni; Toh, Joanne; Fang, Wanru; Blanco, Jorge; Udolph, Gerald] Inst Med Biol, Singapore, Singapore; [Blanco, Jorge; Udolph, Gerald] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Tio, M (corresponding author), Inst Med Biol, Singapore, Singapore.	gerald.udolph@imb.a-star.edu.sg			NICHD	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Buescher and X. H. Yang for advice and critical comments on the manuscript. We are very grateful to M. Rosbash (Per), B.W. Lu (dTH) and Lee C. Y. for sharing antibodies and fly stocks. We thank the Bloomington Drosophila stock center and VDRC for providing the fly stocks. We used monoclonal antibodies obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Babaoglan AB, 2009, DEVELOPMENT, V136, P4089, DOI 10.1242/dev.040386; Binor E, 2005, DEV NEUROSCI-BASEL, V27, P306, DOI 10.1159/000086710; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BOSSING T, 1994, DEVELOPMENT, V120, P1895; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; CABRERA CV, 1990, DEVELOPMENT, V110, P733; CamposOrtega JA, 1996, NEURON, V17, P1, DOI 10.1016/S0896-6273(00)80274-3; Cardona A, 2010, J NEUROSCI, V30, P7538, DOI 10.1523/JNEUROSCI.0186-10.2010; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; DOE CQ, 1992, DEVELOPMENT, V116, P855; Dye CA, 1998, DEVELOPMENT, V125, P1845; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HARTENSTEIN V, 1994, DEV BIOL, V165, P480, DOI 10.1006/dbio.1994.1269; HORNYKIEWICZ O, 1992, CLIN NEUROL NEUROSUR, V94, pS9; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lacin H, 2009, DEVELOPMENT, V136, P3257, DOI 10.1242/dev.037242; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LIU X, 1992, J NEUROSCI, V12, P2735; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Mahler J, 2010, J NEUROSCI, V30, P16621, DOI 10.1523/JNEUROSCI.4769-10.2010; Matsuzaki F, 2000, CURR OPIN NEUROBIOL, V10, P38, DOI 10.1016/S0959-4388(99)00052-5; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Rath P, 2002, EMBO REP, V3, P660, DOI 10.1093/embo-reports/kvf134; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stagg SB, 2011, DEVELOPMENT, V138, P2171, DOI 10.1242/dev.056507; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Udolph G, 2010, NOTCH SIGNALING GENE; Udolph G, 2009, DEV BIOL, V336, P156, DOI 10.1016/j.ydbio.2009.09.030; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; Xiao H, 1996, MECH DEVELOP, V58, P65, DOI 10.1016/S0925-4773(96)00559-X; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	62	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26879	10.1371/journal.pone.0026879	http://dx.doi.org/10.1371/journal.pone.0026879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073214	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200021
J	Worodria, W; Anderson, J; Cattamanchi, A; Davis, JL; den Boon, S; Andama, A; Yoo, SD; Joloba, M; Huang, L; Kato-Maeda, M				Worodria, William; Anderson, Jillian; Cattamanchi, Adithya; Davis, J. Lucian; den Boon, Saskia; Andama, Alfred; Yoo, Samuel D.; Joloba, Moses; Huang, Laurence; Kato-Maeda, Midori			The Role of Speciation in Positive Lowenstein-Jensen Culture Isolates from a High Tuberculosis Burden Country	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM COMPLEX; POLYMERASE GENE RPOB; NONTUBERCULOUS MYCOBACTERIA; PCR ASSAY; IDENTIFICATION; DISEASE; DIFFERENTIATION; BACTEREMIA; INFECTION; DIAGNOSIS	Objective: To determine the need for routine speciation of positive Lowenstein-Jensen mycobacterial cultures in HIV-infected patients suspected of having pulmonary tuberculosis at Mulago Hospital in Kampala, Uganda. Methods: Sputum and bronchoalveolar lavage Lowenstein-Jensen mycobacterial culture isolates from consecutive, HIV-infected patients admitted to Mulago Hospital with 2 weeks or more of cough were subjected to IS6110 PCR and rpoB genetic analysis to determine the presence of Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM). Results: Eighty (100%) mycobacterial cultures from 65 patients were confirmed to be members of MTBC. Subsequent analysis of the cultures from 54 patients by PCR and sequence analyses to identify co-infection with NTM confirmed the presence of MTBC as well as the presence of Micrococcus luteus (n = 4), Janibacter spp. (n = 1) and six cultures had organisms that could not be identified. Conclusions: Presumptive diagnosis of tuberculosis on the basis of a positive Lowenstein-Jensen culture is sufficient in HIV-infected Ugandans suspected of having tuberculosis. Routine molecular confirmation of positive Lowenstein-Jensen cultures is unnecessary in this low resource setting.	[Worodria, William; Andama, Alfred; Yoo, Samuel D.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Worodria, William; Andama, Alfred; Yoo, Samuel D.] Mulago Natl Referral & Teaching Hosp, Dept Med, Kampala, Uganda; [Worodria, William; Cattamanchi, Adithya; Davis, J. Lucian; den Boon, Saskia; Andama, Alfred; Yoo, Samuel D.; Huang, Laurence] Univ Calif San Francisco, Makerere Univ, San Francisco Res Collaborat, Kampala, Uganda; [Anderson, Jillian; Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence; Kato-Maeda, Midori] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA; [Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence; Kato-Maeda, Midori] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Curry Int TB Ctr, San Francisco, CA USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA USA; [Joloba, Moses] Makerere Univ, Sch Biomed Sci, Dept Microbiol, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University	Worodria, W (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	worodria@yahoo.com	Huang, Laurence/AAZ-7120-2021; Huang, Laurence/AAE-1590-2019; Davis, J. Lucian/AAC-8376-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Joloba, Moses/0000-0002-0334-9983	National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases at the National Institutes of Health; Netherlands-African Partnership for Capacity Development and Clinical Interventions Against Poverty-Related Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands-African Partnership for Capacity Development and Clinical Interventions Against Poverty-Related Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants from the National Heart, Lung, and Blood Institute and from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; and was also funded by the Netherlands-African Partnership for Capacity Development and Clinical Interventions Against Poverty-Related Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afghani B, 1996, BIOCHEM MOL MED, V57, P14, DOI 10.1006/bmme.1996.0003; Buijtels PCAM, 2009, EMERG INFECT DIS, V15, P242, DOI 10.3201/eid1502.080006; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P15, DOI 10.1164/ajrccm.160.1.9812080; Corbett EL, 1999, AM J RESP CRIT CARE, V159, P94, DOI 10.1164/ajrccm.159.1.9803048; Eaton T, 1995, TUBERCLE LUNG DIS, V76, P570, DOI 10.1016/0962-8479(95)90536-7; GILKS CF, 1995, J ACQ IMMUN DEF SYND, V8, P195; Gopinath K, 2009, J APPL MICROBIOL, V107, P425, DOI 10.1111/j.1365-2672.2009.04218.x; Kim BJ, 2004, J CLIN MICROBIOL, V42, P1308, DOI 10.1128/JCM.42.3.1308-1312.2004; Kim BJ, 2001, J CLIN MICROBIOL, V39, P2102, DOI 10.1128/JCM.39.6.2102-2109.2001; Loubinoux J, 2005, J CLIN MICROBIOL, V43, P3564, DOI 10.1128/JCM.43.7.3564-3566.2005; Mawak Jd, 2006, Ghana Med J, V40, P132; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Ngamlert K, 2009, TROP MED INT HEALTH, V14, P748, DOI 10.1111/j.1365-3156.2009.02284.x; Nunes Elizabete Abrantes, 2008, J. bras. pneumol., V34, P822, DOI 10.1590/S1806-37132008001000011; OKELLO DO, 1990, J INFECT DIS, V162, P208, DOI 10.1093/infdis/162.1.208; Pettipher CA, 2001, CLIN INFECT DIS, V33, P2068, DOI 10.1086/323979; Shenai S, 2010, INT J TUBERC LUNG D, V14, P1001; Smith KJ, 1999, BRIT J DERMATOL, V141, P558; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; Thrash JC, 2011, J BACTERIOL, V193, P584, DOI 10.1128/JB.01298-10; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; *WHO, 2007, WHOHTMSTB200740; WILSON ML, 1995, J CLIN MICROBIOL, V33, P2516, DOI 10.1128/JCM.33.9.2516-2518.1995	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27017	10.1371/journal.pone.0027017	http://dx.doi.org/10.1371/journal.pone.0027017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073241	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200029
J	Yabas, M; Godfrey, DI; Goodnow, CC; Hoyne, GF				Yabas, Mehmet; Godfrey, Dale I.; Goodnow, Christopher C.; Hoyne, Gerard F.			Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and Conventional T Cells	PLOS ONE			English	Article							NATURAL-KILLER; FUNCTIONALLY DISTINCT; CYTOKINE PRODUCTION; HOMEOSTASIS; CD1D; RIBONUCLEOPROTEIN; IDENTIFICATION; ACTIVATION; MATURATION; PRECURSOR	Natural killer T (NKT) cells represent an important regulatory T cell subset that develops in the thymus and contains immature (NK1.1(lo)) and mature (NK1.1(hi)) cell subsets. Here we show in mice that an inherited mutation in heterogeneous ribonucleoprotein L-like protein (hnRNPLL(thunder)), that shortens the survival of conventional T cells, has no discernible effect on NKT cell development, homeostasis or effector function. Thus, Hnrpll deficiency effectively increases the NKT:T cell ratio in the periphery. However, Hnrpll mutation disrupts CD45RA, RB and RC exon silencing of the Ptprc mRNA in both NKT and conventional T cells, and leads to a comparably dramatic shift to high molecular weight CD45 isoforms. In addition, Hnrpll mutation has a cell intrinsic effect on the expression of the developmentally regulated cell surface marker NK1.1 on NKT cells in the thymus and periphery but does not affect cell numbers. Therefore our results highlight both overlapping and divergent roles for hnRNPLL between conventional T cells and NKT cells. In both cell subsets it is required as a trans-acting factor to regulate alternative splicing of the Ptprc mRNA, but it is only required for survival of conventional T cells.	[Yabas, Mehmet; Goodnow, Christopher C.; Hoyne, Gerard F.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia; [Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Australian National University; John Curtin School of Medical Research; University of Melbourne	Yabas, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia.	Chris.Goodnow@anu.edu.au; Gerard.Hoyne@nd.edu.au	Yabas, Mehmet/D-9513-2012; Goodnow, Christopher C/V-8108-2018; Hoyne, Gerard/M-5406-2013	Yabas, Mehmet/0000-0002-3462-5389; Goodnow, Christopher C/0000-0001-5296-6155; Hoyne, Gerard/0000-0002-7370-9139; Godfrey, Dale/0000-0002-3009-5472	National Institutes of Health (NIH) [BAA NIAID-DAIT-07-35]; Juvenile Diabetes Research Foundation/National Health and Medical Research Council (JDRF/NHMRC) [219167]; JDRF [7-2006-327]; Ministry of National Education, Republic of Turkey; NHMRC; Australian Research Council (ARC)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation/National Health and Medical Research Council (JDRF/NHMRC)(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); JDRF(Juvenile Diabetes Research Foundation); Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This work was supported by the National Institutes of Health (NIH) contract BAA NIAID-DAIT-07-35; Juvenile Diabetes Research Foundation/National Health and Medical Research Council (JDRF/NHMRC) Special Program Grant 219167 and JDRF Program Grant 7-2006-327. Dr. Yabas was supported by a postgraduate award from the Ministry of National Education, Republic of Turkey, Dr. Godfrey by an NHMRC Principal Research Fellowship and Dr. Goodnow by an Australian Research Council (ARC) Federation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mcnab FW, 2007, J IMMUNOL, V179, P6630, DOI 10.4049/jimmunol.179.10.6630; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wu ZP, 2010, J IMMUNOL, V185, P231, DOI 10.4049/jimmunol.0903625; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004	33	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26440	10.1371/journal.pone.0026440	http://dx.doi.org/10.1371/journal.pone.0026440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073166	Green Published, gold			2022-12-27	WOS:000297198200013
J	Zhu, YG; Ji, F; Shang, H; Zhu, Q; Wang, PX; Xu, CC; Deng, Y; Peng, DH; Ruan, LF; Sun, M				Zhu, Yiguang; Ji, Fang; Shang, Hui; Zhu, Qian; Wang, Pengxia; Xu, Chengchen; Deng, Yun; Peng, Donghai; Ruan, Lifang; Sun, Ming			Gene Clusters Located on Two Large Plasmids Determine Spore Crystal Association (SCA) in Bacillus thuringiensis Subsp finitimus Strain YBT-020	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TOXIN-CODING PLASMID; PROTEIN GENES; EXOSPORIUM; ISRAELENSIS; GERMINATION; PBTOXIS; CLONING	Crystals in Bacillus thuringiensis are usually formed in the mother cell compartment during sporulation and are separated from the spores after mother cell lysis. In a few strains, crystals are produced inside the exosporium and are associated with the spores after sporulation. This special phenotype, named 'spore crystal association' (SCA), typically occurs in B. thuringiensis subsp. finitimus. Our aim was to identify genes determining the SCA phenotype in B. thuringiensis subsp. finitimus strain YBT-020. Plasmid conjugation experiments indicated that the SCA phenotype in this strain was tightly linked with two large plasmids (pBMB26 and pBMB28). A shuttle bacterial artificial chromosome (BAC) library of strain YBT-020 was constructed. Six fragments from BAC clones were screened from this library and discovered to cover the full length of pBMB26; four others were found to cover pBMB28. Using fragment complementation testing, two fragments, each of approximately 35 kb and located on pBMB26 and pBMB28, were observed to recover the SCA phenotype in an acrystalliferous mutant, B. thuringiensis strain BMB171. Furthermore, deletion analysis indicated that the crystal protein gene cry26Aa from pBMB26, along with five genes from pBMB28, were indispensable to the SCA phenotype. Gene disruption and frame-shift mutation analyses revealed that two of the five genes from pBMB28, which showed low similarity to crystal proteins, determined the location of crystals inside the exosporium. Gene disruption revealed that the three remaining genes, similar to spore germination genes, contributed to the stability of the SCA phenotype in strain YBT-020. Our results thus identified the genes determining the SCA phenotype in B. thuringiensis subsp. finitimus.	[Zhu, Yiguang; Shang, Hui; Zhu, Qian; Wang, Pengxia; Xu, Chengchen; Deng, Yun; Peng, Donghai; Ruan, Lifang; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Beijing, Peoples R China; [Ji, Fang] Jianghan Univ, Sch Med, Wuhan, Peoples R China	Huazhong Agricultural University; Jianghan University	Zhu, YG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Beijing, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983	National Natural Science Foundation of China [30870066, 30470026]; National High Technology Research and Development Program (863 Program) of China [2011AA10A203, 2006AA02Z174]; National Basic Research Program (973) of China [2009CB118902]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; Ministry of Agriculture; Ministry of Forestry [2006-4-41]; China National Fundamental Fund of Personnel Training [J0730649]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); Genetically Modified Organisms Breeding Major Projects of China; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Forestry; China National Fundamental Fund of Personnel Training	This study was supported by the National Natural Science Foundation of China (30870066 and 30470026), National High Technology Research and Development Program (863 Program) of China grants 2011AA10A203 and 2006AA02Z174, the National Basic Research Program (973) of China (2009CB118902), Genetically Modified Organisms Breeding Major Projects of China grant 2009ZX08009-032B, and China 948 Program of Ministry of Agriculture (2011) and Ministry of Forestry (2006-4-41), and China National Fundamental Fund of Personnel Training (J0730649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoarrahem MM, 2009, APPL ENVIRON MICROB, V75, P6410, DOI 10.1128/AEM.00962-09; ANDRUP L, 1993, J BACTERIOL, V175, P6530, DOI 10.1128/jb.175.20.6530-6536.1993; Andrup L, 1998, PLASMID, V40, P30, DOI 10.1006/plas.1998.1346; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Aronson A, 2002, CELL MOL LIFE SCI, V59, P417, DOI 10.1007/s00018-002-8434-6; Bailey-Smith K, 2005, J BACTERIOL, V187, P3800, DOI 10.1128/JB.187.11.3800-3806.2005; BAUM JA, 1994, J BACTERIOL, V176, P2835, DOI 10.1128/JB.176.10.2835-2845.1994; BAUM JA, 1991, J BACTERIOL, V173, P5280, DOI 10.1128/jb.173.17.5280-5289.1991; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; DEBRO L, 1986, J BACTERIOL, V165, P258, DOI 10.1128/jb.165.1.258-268.1986; Fang SL, 2009, APPL ENVIRON MICROB, V75, P5237, DOI 10.1128/AEM.00532-09; GERHARDT P, 1964, J BACTERIOL, V88, P1774, DOI 10.1128/JB.88.6.1774-1789.1964; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; HANNAY CL, 1961, J BIOPHYS BIOCHEM CY, V9, P285, DOI 10.1083/jcb.9.2.285; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hernandez-Soto A, 2009, APPL ENVIRON MICROB, V75, P4661, DOI 10.1128/AEM.00409-09; Ji F, 2009, FEMS MICROBIOL LETT, V300, P11, DOI 10.1111/j.1574-6968.2009.01743.x; Jv Shou-yong, 2007, Weishengwu Xuebao, V47, P88; Kim HS, 2003, CURR MICROBIOL, V46, P33, DOI 10.1007/s00284-002-3801-y; Liu XY, 2010, J BIOL CHEM, V285, P39191, DOI 10.1074/jbc.M110.148387; Liu XY, 2009, APPL MICROBIOL BIOT, V82, P765, DOI 10.1007/s00253-008-1854-y; LopezMeza JE, 1996, APPL ENVIRON MICROB, V62, P1306, DOI 10.1128/AEM.62.4.1306-1310.1996; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shao ZZ, 2001, APPL ENVIRON MICROB, V67, P5362, DOI 10.1128/AEM.67.12.5362-5369.2001; SHORT JA, 1974, J GEN MICROBIOL, V84, P261, DOI 10.1099/00221287-84-2-261; Steichen CT, 2007, MOL MICROBIOL, V64, P359, DOI 10.1111/j.1365-2958.2007.05658.x; Stein C, 2006, APPL ENVIRON MICROB, V72, P1771, DOI 10.1128/AEM.72.3.1771-1776.2006; Vidal-Quist JC, 2009, J MICROBIOL BIOTECHN, V19, P749, DOI 10.4014/jmb.0810.595; Wojciechowska JA, 1999, FEBS LETT, V453, P46, DOI 10.1016/S0014-5793(99)00650-X; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025; Zhu YG, 2011, J BACTERIOL, V193, P2379, DOI 10.1128/JB.00267-11	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27164	10.1371/journal.pone.0027164	http://dx.doi.org/10.1371/journal.pone.0027164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076131	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200043
J	Sawides, L; de Gracia, P; Dorronsoro, C; Webster, MA; Marcos, S				Sawides, Lucie; de Gracia, Pablo; Dorronsoro, Carlos; Webster, Michael A.; Marcos, Susana			Vision Is Adapted to the Natural Level of Blur Present in the Retinal Image	PLOS ONE			English	Article							NEURAL COMPENSATION; ADAPTATION	Background: The image formed by the eye's optics is inherently blurred by aberrations specific to an individual's eyes. We examined how visual coding is adapted to the optical quality of the eye. Methods and Findings: We assessed the relationship between perceived blur and the retinal image blur resulting from high order aberrations in an individual's optics. Observers judged perceptual blur in a psychophysical two-alternative forced choice paradigm, on stimuli viewed through perfectly corrected optics (using a deformable mirror to compensate for the individual's aberrations). Realistic blur of different amounts and forms was computer simulated using real aberrations from a population. The blur levels perceived as best focused were close to the levels predicted by an individual's high order aberrations over a wide range of blur magnitudes, and were systematically biased when observers were instead adapted to the blur reproduced from a different observer's eye. Conclusions: Our results provide strong evidence that spatial vision is calibrated for the specific blur levels present in each individual's retinal image and that this adaptation at least partly reflects how spatial sensitivity is normalized in the neural coding of blur.	[Sawides, Lucie; de Gracia, Pablo; Dorronsoro, Carlos; Marcos, Susana] CSIC, Inst Opt, E-28006 Madrid, Spain; [Webster, Michael A.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes); Nevada System of Higher Education (NSHE); University of Nevada Reno	Sawides, L (corresponding author), CSIC, Inst Opt, Serrano 121, E-28006 Madrid, Spain.	lucie@io.cfmac.csic.es	Sawides, Lucie/O-1431-2016; Dorronsoro, Carlos/AAC-8003-2019; Dorronsoro, Carlos/A-2297-2011; De Gracia, Pablo/B-2786-2017	Sawides, Lucie/0000-0002-8918-8753; Dorronsoro, Carlos/0000-0001-5968-1128; Dorronsoro, Carlos/0000-0001-5968-1128; Webster, Michael/0000-0001-8262-7525; De Gracia, Pablo/0000-0003-4319-2797	Ministerio de Ciencia e Innovacion (MICINN) [FIS2008-02065]; Consejo Superior de Investigaciones Cientificas (CSIC); European Heads of Research Councils-European Science Foundation EUROHORCs-ESF [EURYI-05-102-ES];  [EY-10834]; NATIONAL EYE INSTITUTE [R29EY010834, R01EY010834] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); European Heads of Research Councils-European Science Foundation EUROHORCs-ESF; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the following: Ministerio de Ciencia e Innovacion (MICINN), Formacion de Personal Investigador (FPI) Predoctoral Fellowship to LS; Consejo Superior de Investigaciones Cientificas (CSIC) I3P Predoctoral Fellowship to PdG; EY-10834 to MW; MICINN FIS2008-02065 and EURYI-05-102-ES (European Heads of Research Councils-European Science Foundation EUROHORCs-ESF) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Chen L, 2007, J VISION, V7, DOI 10.1167/7.10.9; DEGRACIA P, 2010, VISION RES, V15; Delahunt PB, 2004, VISUAL NEUROSCI, V21, P301, DOI 10.1017/S0952523804213025; Elliott SL, 2011, J VISION, V11, DOI 10.1167/11.2.7; Goodman J. W., 1996, INTRO FOURIER OPTICS; Jung GH, 2010, J VISION, V10, DOI 10.1167/10.5.7; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marcos S, 2009, J MOD OPTIC, V56, P2181, DOI 10.1080/09500340902927074; Marcos S, 2008, J VISION, V8, DOI 10.1167/8.13.1; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; Pesudovs K, 2005, J REFRACT SURG, V21, P144; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Rossi EA, 2010, J VISION, V10, DOI 10.1167/10.12.11; Sabesan R, 2010, INVEST OPHTH VIS SCI, V51, P3835, DOI 10.1167/iovs.09-4558; Sawides L, 2011, J VISION, V11, DOI 10.1167/11.7.21; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Webster MA, 2008, J OPT SOC AM A, V25, P2817, DOI 10.1364/JOSAA.25.002817	20	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27031	10.1371/journal.pone.0027031	http://dx.doi.org/10.1371/journal.pone.0027031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073247	Green Published, gold			2022-12-27	WOS:000297154900067
J	Arvidsson, L; Fagerlund, M; Jaff, N; Ossoinak, A; Jansson, K; Hagerstrand, A; Johansson, CB; Brundin, L; Svensson, M				Arvidsson, Lisa; Fagerlund, Michael; Jaff, Nasren; Ossoinak, Amina; Jansson, Katarina; Hagerstrand, Anders; Johansson, Clas B.; Brundin, Lou; Svensson, Mikael			Distribution and Characterization of Progenitor Cells within the Human Filum Terminale	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ADULT HUMAN BRAIN; SPINAL-CORD; DIFFERENTIATION; NEURONS; RAT; NEUROGENESIS; HIPPOCAMPUS; GENERATION	Background: Filum terminale (FT) is a structure that is intimately associated with conus medullaris, the most caudal part of the spinal cord. It is well documented that certain regions of the adult human central nervous system contains undifferentiated, progenitor cells or multipotent precursors. The primary objective of this study was to describe the distribution and progenitor features of this cell population in humans, and to confirm their ability to differentiate within the neuroectodermal lineage. Methodology/Principal Findings: We demonstrate that neural stem/progenitor cells are present in FT obtained from patients treated for tethered cord. When human or rat FT-derived cells were cultured in defined medium, they proliferated and formed neurospheres in 13 out of 21 individuals. Cells expressing Sox2 and Musashi-1 were found to outline the central canal, and also to be distributed in islets throughout the whole FT. Following plating, the cells developed antigen profiles characteristic of astrocytes (GFAP) and neurons (beta-III-tubulin). Addition of PDGF-BB directed the cells towards a neuronal fate. Moreover, the cells obtained from young donors shows higher capacity for proliferation and are easier to expand than cells derived from older donors. Conclusion/Significance: The identification of bona fide neural progenitor cells in FT suggests a possible role for progenitor cells in this extension of conus medullaris and may provide an additional source of such cells for possible therapeutic purposes. Filum terminale, human, progenitor cells, neuron, astrocytes, spinal cord.	[Arvidsson, Lisa; Fagerlund, Michael; Jaff, Nasren; Brundin, Lou; Svensson, Mikael] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Dept Neurosurg & Neurol, Stockholm, Sweden; [Ossoinak, Amina; Jansson, Katarina; Hagerstrand, Anders] NeuroNova, Stockholm, Sweden; [Johansson, Clas B.] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Arvidsson, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Dept Neurosurg & Neurol, Stockholm, Sweden.	lou.brundin@karolinska.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003; Brundin, Lou/0000-0003-4408-7817; Arvidsson, Lisa/0000-0003-2129-5357	Torsten and Ragnar Soderberg Foundation; Swedish medical research council; Karolinska Institutet	Torsten and Ragnar Soderberg Foundation; Swedish medical research council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet)	This work was supported by Torsten and Ragnar Soderberg Foundation(www.soderbergsstiftelser.se), the Swedish medical research council (www.vr.se) and Karolinska Institutet (www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ND, 2005, DEV BIOL, V279, P356, DOI 10.1016/j.ydbio.2004.12.026; Al-Omari MH, 2011, J MED IMAG RADIAT ON, V55, P286, DOI 10.1111/j.1754-9485.2011.02266.x; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chen J, 2006, NEUROSCIENCE, V140, P377, DOI 10.1016/j.neuroscience.2006.02.064; CHESLER M, 1985, J COMP NEUROL, V239, P431, DOI 10.1002/cne.902390409; CHOI BH, 1992, HUM PATHOL, V23, P916, DOI 10.1016/0046-8177(92)90405-R; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; Gomes FC, 2002, NEUROSURGERY, V51, P725, DOI 10.1227/01.NEU.0000023605.47661.EA; Hansasuta A, 1999, PEDIATR NEUROSURG, V30, P176, DOI 10.1159/000028790; Harmeier JW, 1933, ARCH NEURO PSYCHIATR, V29, P308, DOI 10.1001/archneurpsyc.1933.02240080098008; Iskandar B J, 2001, Neurosurg Focus, V10, pe7; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; KUNIMOTO K, 1918, CONTRIBUTIONS EMBRYO, P161; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Okano H, 2002, J CELL SCI, V115, P1355; Rethelyi M, 2004, BRAIN RES, V1028, P133, DOI 10.1016/j.brainres.2004.08.069; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; Shum ASW, 2010, DEV DYNAM, V239, P3192, DOI 10.1002/dvdy.22457; SONNELAND PRL, 1985, CANCER, V56, P883, DOI 10.1002/1097-0142(19850815)56:4<883::AID-CNCR2820560431>3.0.CO;2-6; STANDRING S, 2005, GRAYS ANATOMY, P775; Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1; Varghese M, 2009, STEM CELLS DEV, V18, P603, DOI 10.1089/scd.2008.0144; Weiss S, 1996, J NEUROSCI, V16, P7599; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4	36	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27393	10.1371/journal.pone.0027393	http://dx.doi.org/10.1371/journal.pone.0027393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096566	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900040
J	Greenberg, E; Rechavi, G; Amariglio, N; Solomon, O; Schachter, J; Markel, G; Eyal, E				Greenberg, Eyal; Rechavi, Gideon; Amariglio, Ninette; Solomon, Oz; Schachter, Jacob; Markel, Gal; Eyal, Eran			Mutagen-Specific Mutation Signature Determines Global microRNA Binding	PLOS ONE			English	Article							MYELOID-LEUKEMIA GENOME; MALIGNANT-MELANOMA; HUMAN CANCER; TARGET RECOGNITION; EXPRESSION; PROGRESSION; CELLS; GENE; TRANSFORMATION; MELANOCYTES	Micro-RNAs (miRNAs) are small non-coding RNAs that regulate gene products at the post-transcriptional level. It is thought that loss of cell regulation by miRNAs supports cancer development. Based on whole genome sequencing of a melanoma tumor, we predict, using three different computational algorithms, that the melanoma somatic mutations globally reduce binding of miRNAs to the mutated 3'UTRs. This phenomenon reflects the nature of the characteristic UV-induced mutation, C-to-T. Furthermore, we show that seed regions are enriched with Guanine, thus rendering miRNAs prone to reduced binding to UV-mutated 3'UTRs. Accordingly, mutation patterns in non UV-induced malignancies e.g. lung cancer and leukemia do not yield similar predictions. It is suggested that UV-induced disruption of miRNA-mediated gene regulation plays a carcinogenic role. Remarkably, dark-skinned populations have significantly higher GC content in 3'UTR SNPs than light-skinned populations, which implies on evolutionary pressure to preserve regulation by trans-acting oligonucleotides under conditions with excess UV radiation.	[Greenberg, Eyal; Schachter, Jacob; Markel, Gal] Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel; [Greenberg, Eyal; Markel, Gal] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Rechavi, Gideon; Amariglio, Ninette; Solomon, Oz; Eyal, Eran] Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Solomon, Oz] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Markel, Gal] Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Bar Ilan University; Chaim Sheba Medical Center	Greenberg, E (corresponding author), Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel.	Markel@post.tau.ac.il; eran.eyal@sheba.health.gov.il			Flight Attendants Medical Research Institute (FAMRI); Recanati Foundation for Medical Research [6713]	Flight Attendants Medical Research Institute (FAMRI); Recanati Foundation for Medical Research	This work was supported by the Flight Attendants Medical Research Institute (FAMRI) and the Recanati Foundation for Medical Research (#6713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Blake J, 2003, HISTOL HISTOPATHOL, V18, P529, DOI 10.14670/HH-18.529; Bradford Porcia T, 2009, Dermatol Nurs, V21, P170; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Calin GA, 2009, GENOME MED, V1, DOI 10.1186/gm78; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; DROBETSKY EA, 1987, P NATL ACAD SCI USA, V84, P9103, DOI 10.1073/pnas.84.24.9103; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giehl A, 2007, J CUTAN PATHOL, V34, P7, DOI 10.1111/j.1600-0560.2006.00569.x; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Howlader N, 2011, SEER CANC STAT REV 1; Israel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006045; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Ottaiano A, 2005, ANTICANCER RES, V25, P4519; Patino Willmar D, 2008, Adv Dermatol, V24, P59, DOI 10.1016/j.yadr.2008.09.003; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sobolewski AL, 2005, P NATL ACAD SCI USA, V102, P17903, DOI 10.1073/pnas.0504087102; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	56	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27400	10.1371/journal.pone.0027400	http://dx.doi.org/10.1371/journal.pone.0027400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096567	gold, Green Published, Green Submitted			2022-12-27	WOS:000297350800051
J	Hill-Burns, EM; Factor, SA; Zabetian, CP; Thomson, G; Payami, H				Hill-Burns, Erin M.; Factor, Stewart A.; Zabetian, Cyrus P.; Thomson, Glenys; Payami, Haydeh			Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region	PLOS ONE			English	Article							HAPLOTYPES; METAANALYSIS; IMPUTATION; GENETICS; SNCA	Parkinson's disease (PD) was recently found to be associated with HLA in a genome-wide association study (GWAS). Followup GWAS's replicated the PD-HLA association but their top hits differ. Do the different hits tag the same locus or is there more than one PD-associated variant within HLA? We show that the top GWAS hits are not correlated with each other (0.00 <= r(2)<= 0.15). Using our GWAS (2000 cases, 1986 controls) we conducted step-wise conditional analysis on 107 SNPs with P, 10 23 for PD-association; 103 dropped-out, four remained significant. Each SNP, when conditioned on the other three, yielded P-SNP1 = 5610 24, P-SNP2 = 5610 24, P-SNP3 = 4610 23 and P-SNP4 = 0.025. The four SNPs were not correlated (0.01 <= r(2)<= 0.20). Haplotype analysis (excluding rare SNP2) revealed increasing PD risk with increasing risk alleles from OR = 1.27, P = 5610 23 for one risk allele to OR = 1.65, P = 4610 28 for three. Using additional 843 cases and 856 controls we replicated the independent effects of SNP1 (Pconditioned-on-SNP4 = 0.04) and SNP4 (Pconditioned-on-SNP1 = 0.04); SNP2 and SNP3 could not be replicated. In pooled GWAS and replication, SNP1 had ORconditioned-on-SNP4 = 1.23, Pconditioned-on-SNP4 = 6610 27; SNP4 had ORconditioned-on-SNP1 = 1.18, Pconditioned-on-SNP1 = 3610 23; and the haplotype with both risk alleles had OR = 1.48, P = 2x10(-12). Genotypic OR increased with the number of risk alleles an individual possessed up to OR = 1.94, P = 2610 211 for individuals who were homozygous for the risk allele at both SNP1 and SNP4. SNP1 is a variant in HLA-DRA and is associated with HLA-DRA, DRB5 and DQA2 gene expression. SNP4 is correlated (r(2) = 0.95) with variants that are associated with HLA-DQA2 expression, and with the top HLA SNP from the IPDGC GWAS (r(2) = 0.60). Our findings suggest more than one PD-HLA association; either different alleles of the same gene, or separate loci.	[Hill-Burns, Erin M.; Payami, Haydeh] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Factor, Stewart A.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Zabetian, Cyrus P.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Zabetian, Cyrus P.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Thomson, Glenys] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	State University of New York (SUNY) System; Wadsworth Center; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of California System; University of California Berkeley	Hill-Burns, EM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	hpayami@wadsworth.org	Payami, Haydeh/ABE-1944-2020	Payami, Haydeh/0000-0001-9084-5338; Zabetian, Cyrus/0000-0002-7739-4306	National Institute of Neurological Disorders And Stroke (NINDS) [R01 NS36960, R01 NS067469]; Edmond J. Safra Michael J. Fox Foundation Global Genetic Consortium Initiative; Department of Veterans Affairs [I01BX000531]; Close to a Cure Foundation: A Fund for Parkinson's Research of Foundation for the Carolinas; National Institute of Allergy and Infectious Disease [AI40076]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067469, R01NS036960] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000531] Funding Source: NIH RePORTER	National Institute of Neurological Disorders And Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Edmond J. Safra Michael J. Fox Foundation Global Genetic Consortium Initiative; Department of Veterans Affairs(US Department of Veterans Affairs); Close to a Cure Foundation: A Fund for Parkinson's Research of Foundation for the Carolinas; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Study was supported by grants from the National Institute of Neurological Disorders And Stroke (NINDS R01 NS36960 and R01 NS067469 to HP), the Edmond J. Safra Michael J. Fox Foundation Global Genetic Consortium Initiative (HP), the Department of Veterans Affairs ('I01BX000531 to CZ), The Close to a Cure Foundation: A Fund for Parkinson's Research of Foundation for the Carolinas (SF), and the National Institute of Allergy and Infectious Disease (AI40076, GT). Funding support for the replication dataset was provided by the National Institute of Neurological Disorders and Stroke (Foroud/Myers, PI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benkler M, 2009, INT J NEUROSCI, V119, P2133, DOI 10.3109/00207450903178786; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hughes AJ, 1997, EUR NEUROL, V38, P13, DOI 10.1159/000113471; Lin DY, 2007, AM J HUM GENET, V80, P577, DOI 10.1086/512201; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Menon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018660; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neter J, 1996, APPL LINEAR STAT MOD, P52; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; PAYAMI H, 1989, AM J HUM GENET, V45, P541; PAYAMI H, 1987, AM J HUM GENET, V41, P331; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puschmann A, 2011, PARKINSONISM RELAT D, V17, P376, DOI 10.1016/j.parkreldis.2011.03.008; Rohn TT, 2010, PLOS ONE, V6; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x	29	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27109	10.1371/journal.pone.0027109	http://dx.doi.org/10.1371/journal.pone.0027109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096524	Green Submitted, gold, Green Published			2022-12-27	WOS:000297350800027
J	Macas, J; Kejnovsky, E; Neumann, P; Novak, P; Koblizkova, A; Vyskot, B				Macas, Jiri; Kejnovsky, Eduard; Neumann, Pavel; Novak, Petr; Koblizkova, Andrea; Vyskot, Boris			Next Generation Sequencing-Based Analysis of Repetitive DNA in the Model Dioceous Plant Silene latifolia	PLOS ONE			English	Article							GENOME SIZE VARIATION; DIOECIOUS PLANT; Y-CHROMOSOME; SATELLITE REPEATS; AMPLIFICATION; ACCUMULATION; EVOLUTION; ALIGNMENT; ELEMENTS; SUBFAMILIES	Background: Silene latifolia is a dioceous plant with well distinguished X and Y chromosomes that is used as a model to study sex determination and sex chromosome evolution in plants. However, efficient utilization of this species has been hampered by the lack of large-scale sequencing resources and detailed analysis of its genome composition, especially with respect to repetitive DNA, which makes up the majority of the genome. Methodology/Principal Findings: We performed low-pass 454 sequencing followed by similarity-based clustering of 454 reads in order to identify and characterize sequences of all major groups of S. latifolia repeats. Illumina sequencing data from male and female genomes were also generated and employed to quantify the genomic proportions of individual repeat families. The majority of identified repeats belonged to LTR-retrotransposons, constituting about 50% of genomic DNA, with Ty3/gypsy elements being more frequent than Ty1/copia. While there were differences between the male and female genome in the abundance of several repeat families, their overall repeat composition was highly similar. Specific localization patterns on sex chromosomes were found for several satellite repeats using in situ hybridization with probes based on k-mer frequency analysis of Illumina sequencing data. Conclusions/Significance: This study provides comprehensive information about the sequence composition and abundance of repeats representing over 60% of the S. latifolia genome. The results revealed generally low divergence in repeat composition between the sex chromosomes, which is consistent with their relatively recent origin. In addition, the study generated various data resources that are available for future exploration of the S. latifolia genome.	[Macas, Jiri; Neumann, Pavel; Novak, Petr; Koblizkova, Andrea] Acad Sci Czech Republ, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Kejnovsky, Eduard; Vyskot, Boris] Acad Sci Czech Republ, Inst Biophys, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Macas, J (corresponding author), Acad Sci Czech Republ, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic.	macas@umbr.cas.cz	Vyskot, Boris/H-1962-2014; Macas, Jiri/G-8618-2014; Neumann, Pavel/H-7345-2013; Kejnovsky, Eduard/D-8878-2012; Novak, Petr/A-3059-2013	Macas, Jiri/0000-0003-0829-1570; Neumann, Pavel/0000-0001-6711-6639; Novak, Petr/0000-0002-5068-9681	Ministry of Education, Youth and Sports [OC10037, LC06004, LH11058]; Czech Science Foundation [P305/10/0930, P501/10/0102]; Academy of Sciences of the Czech Republic [AVOZ50510513]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The work was funded by projects OC10037, LC06004 and LH11058 from the Ministry of Education, Youth and Sports, P305/10/0930 and P501/10/0102 from the Czech Science Foundation and AVOZ50510513 from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buzek J, 1997, CHROMOSOME RES, V5, P57, DOI 10.1023/A:1011693603279; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CIUPERCESCU DD, 1990, GENOME, V33, P556, DOI 10.1139/g90-082; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dong H, 2011, ACTA BIOCH BIOPH SIN, V43, P496, DOI 10.1093/abbs/gmr030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filatov DA, 2009, GENETICS, V181, P811, DOI 10.1534/genetics.108.099267; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Ishii K, 2008, GENOME, V51, P251, DOI 10.1139/G08-005; Kazama Y, 2006, GENOME, V49, P520, DOI 10.1139/G05-130; Kejnovsky E, 2010, CYTOGENET GENOME RES, V129, P250, DOI 10.1159/000314285; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Lengerova M, 2004, THEOR APPL GENET, V108, P1193, DOI 10.1007/s00122-003-1568-6; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Macas J, 2003, CHROMOSOMA, V112, P152, DOI 10.1007/s00412-003-0255-3; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2007, GENE, V390, P108, DOI 10.1016/j.gene.2006.08.007; Macas J, 2010, BIOINFORMATICS, V26, P2101, DOI 10.1093/bioinformatics/btq343; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Siroky J, 2001, CHROMOSOME RES, V9, P387, DOI 10.1023/A:1016783501674; Song JQ, 2001, GENOME, V44, P463, DOI 10.1139/gen-44-3-463; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Sykorova E, 2003, MOL GENET GENOMICS, V269, P13, DOI 10.1007/s00438-003-0811-9; Sykorova E, 2001, CHROMOSOME RES, V9, P309, DOI 10.1023/A:1016698713959; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Torres GA, 2011, G3-GENES GENOM GENET, V1, P85, DOI 10.1534/g3.111.000125; Uchida W, 2002, CHROMOSOMA, V111, P313, DOI 10.1007/s00412-002-0213-5; VAGERA J, 1994, ANN BOT-LONDON, V73, P455, DOI 10.1006/anbo.1994.1056; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Wicker T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-518; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	48	83	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27335	10.1371/journal.pone.0027335	http://dx.doi.org/10.1371/journal.pone.0027335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096552	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800044
J	Wang, XL; Xu, HB; Alvarez, X; Pahar, B; Moroney-Rasmussen, T; Lackner, AA; Veazey, RS				Wang, Xiaolei; Xu, Huanbin; Alvarez, Xavier; Pahar, Bapi; Moroney-Rasmussen, Terri; Lackner, Andrew A.; Veazey, Ronald S.			Distinct Expression Patterns of CD69 in Mucosal and Systemic Lymphoid Tissues in Primary SIV Infection of Rhesus Macaques	PLOS ONE			English	Article							CD4(+) T-CELLS; SIMIAN-IMMUNODEFICIENCY-VIRUS; GASTROINTESTINAL-TRACT; IMMUNE ACTIVATION; HIV-INFECTION; IN-VIVO; DEPLETION; SELECTION; PATHOGENESIS; REPLICATION	Although the intestinal tract plays a major role in early human immunodeficiency virus (HIV) infection, the role of immune activation and viral replication in intestinal tissues is not completely understood. Further, increasing evidence suggests the early leukocyte activation antigen CD69 may be involved in the development or regulation of important T cell subsets, as well as a major regulatory molecule of immune responses. Using the simian immunodeficiency virus (SIV) rhesus macaque model, we compared expression of CD69 on T cells from the intestine, spleen, lymph nodes, and blood of normal and SIV-infected macaques throughout infection. In uninfected macaques, the majority of intestinal lamina propria CD4+ T cells had a memory (CD95+) phenotype and co-expressed CD69, and essentially all intestinal CCR5+ cells co-expressed CD69. In contrast, systemic lymphoid tissues had far fewer CD69+ T cells, and many had a naive phenotype. Further, marked, selective depletion of intestinal CD4+ CD69+ T cells occurred in early SIV infection, and this depletion persisted throughout infection. Markedly increased levels of CD8+CD69+ T cells were detected after SIV infection in virtually all tissues, including the intestine. Further, confocal microscopy demonstrated selective, productive infection of CD3+CD69+ T cells in the intestine in early infection. Combined, these results indicate CD69+CD4+ T cells are a major early target for viral infection, and their rapid loss by direct infection may have profound effects on intestinal immune regulation in HIV infected patients.	[Wang, Xiaolei; Xu, Huanbin; Alvarez, Xavier; Pahar, Bapi; Moroney-Rasmussen, Terri; Lackner, Andrew A.; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA	Tulane University	Wang, XL (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA.	rveazey@tulane.edu	Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X	National Institutes of Health [AI49080, AI084793, RR000164]; Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049080, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants AI49080, AI084793, and RR000164, and a Faculty Enhancement Grant from Tulane University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Borda JT, 2004, AM J PATHOL, V165, P2111, DOI 10.1016/S0002-9440(10)63261-0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Douek Daniel, 2007, Top HIV Med, V15, P114; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hare KJ, 1999, J IMMUNOL, V162, P3978; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Veazey Ronald, 2003, AIDS Rev, V5, P245; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 2001, TRENDS IMMUNOL, V22, P626, DOI 10.1016/S1471-4906(01)02039-7; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2007, FUTURE HIV THERAPY, V1, P103; Vega-Ramos J, 2010, IMMUNOL CELL BIOL, V88, P707, DOI 10.1038/icb.2010.62; Zeigler SF, 1994, STEM CELLS, V12, P456	32	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27207	10.1371/journal.pone.0027207	http://dx.doi.org/10.1371/journal.pone.0027207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096538	gold, Green Published, Green Submitted			2022-12-27	WOS:000297350800038
J	Fullwood, MJ; Lee, J; Lin, LF; Li, GL; Huss, M; Ng, P; Sung, WK; Shenolikar, S				Fullwood, Melissa J.; Lee, Joanne; Lin, Lifang; Li, Guoliang; Huss, Mikael; Ng, Patrick; Sung, Wing-Kin; Shenolikar, Shirish			Next-Generation Sequencing of Apoptotic DNA Breakpoints Reveals Association with Actively Transcribed Genes and Gene Translocations	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; DOUBLE-STRAND BREAKS; FRAGMENTATION FACTOR; CLUSTER REGION; HORIZONTAL TRANSFER; ACTINOMYCIN-D; NUCLEAR-DNA; CLEAVAGE; IDENTIFICATION; BIOLOGY	DNA fragmentation is a well-recognized hallmark of apoptosis. However, the precise DNA sequences cleaved during apoptosis triggered by distinct mechanisms remain unclear. We used next-generation sequencing of DNA fragments generated in Actinomycin D-treated human HL-60 leukemic cells to generate a high-throughput, global map of apoptotic DNA breakpoints. These data highlighted that DNA breaks are non-random and show a significant association with active genes and open chromatin regions. We noted that transcription factor binding sites were also enriched within a fraction of the apoptotic breakpoints. Interestingly, extensive apoptotic cleavage was noted within genes that are frequently translocated in human cancers. We speculate that the non-random fragmentation of DNA during apoptosis may contribute to gene translocations and the development of human cancers.	[Fullwood, Melissa J.; Lin, Lifang] Duke NUS Grad Med Sch Singapore, A STAR Duke NUS Neurosci Partnership, Singapore, Singapore; [Fullwood, Melissa J.; Lee, Joanne; Li, Guoliang; Sung, Wing-Kin] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Fullwood, Melissa J.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Huss, Mikael; Ng, Patrick] 1st Base Pte Ltd, Singapore, Singapore; [Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Dis, Singapore, Singapore; [Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, Singapore, Singapore; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore; Duke University	Fullwood, MJ (corresponding author), Duke NUS Grad Med Sch Singapore, A STAR Duke NUS Neurosci Partnership, Singapore, Singapore.	Shirish.shenolikar@duke-nus.edu.sg	Li, Guoliang/D-8014-2012; Fullwood, Melissa/G-5713-2011	Li, Guoliang/0000-0003-1601-6640; Fullwood, Melissa/0000-0003-0321-7865; Sung, Wing-Kin/0000-0001-7806-7086; Huss, Mikael/0000-0003-0839-2451	Duke-NUS; Singapore Ministry of Education [T1]; Lee Kwan Yew Postdoctoral Fellowship; L'Oreal for Women in Science Fellowship	Duke-NUS; Singapore Ministry of Education(Ministry of Education, Singapore); Lee Kwan Yew Postdoctoral Fellowship; L'Oreal for Women in Science Fellowship	This study was supported by Duke-NUS funds to S.S. and a Singapore Ministry of Education grant (T1) to M.J.F. M.J.F. is supported by a Lee Kwan Yew Postdoctoral Fellowship and a L'Oreal for Women in Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Boyle AP, 2011, GENOME RES; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Di Filippo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005010; Didenko VV, 1996, J CELL BIOL, V135, P1369, DOI 10.1083/jcb.135.5.1369; Dullea RG, 1999, CANCER RES, V59, P3712; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Futami T, 2005, J BIOL CHEM, V280, P826, DOI 10.1074/jbc.M409948200; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gogusev J, 2002, CANCER GENET CYTOGEN, V138, P95, DOI 10.1016/S0165-4608(02)00589-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Holmgren L, 2010, BIOCHEM BIOPH RES CO, V396, P147, DOI 10.1016/j.bbrc.2010.04.026; Hsieh SY, 2003, BRIT J CANCER, V88, P210, DOI 10.1038/sj.bjc.6600695; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huebner K, 1998, ANNU REV GENET, V32, P7, DOI 10.1146/annurev.genet.32.1.7; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Liu HS, 2009, BIOCHEM J, V422, P543, DOI 10.1042/BJ20090342; Liu QY, 2003, CELL DEATH DIFFER, V10, P278, DOI 10.1038/sj.cdd.4401146; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Mirault ME, 2006, AM J HUM GENET, V79, P779, DOI 10.1086/507791; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; MIYASHITA T, 1995, CELL, V80, P293; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sim SP, 2001, J BIOL CHEM, V276, P31590, DOI 10.1074/jbc.M103962200; Stanulla M, 1997, LEUKEMIA, V11, P490, DOI 10.1038/sj.leu.2400632; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Stanulla M, 2001, HUM MOL GENET, V10, P2481, DOI 10.1093/hmg/10.22.2481; Stenman G, 2010, CELL CYCLE, V9, P2986, DOI 10.4161/cc.9.15.12515; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Turan T, 2006, INT J GYNECOL CANCER, V16, P1432, DOI 10.1111/j.1525-1438.2006.00606.x; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Winter DB, 1998, NUCLEIC ACIDS RES, V26, P4422, DOI 10.1093/nar/26.19.4422; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yan B, 2006, ONCOGENE, V25, P5370, DOI 10.1038/sj.onc.1209535; Yan B, 2006, P NATL ACAD SCI USA, V103, P1504, DOI 10.1073/pnas.0507779103; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2011, NUCL ACIDS RES	69	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26054	10.1371/journal.pone.0026054	http://dx.doi.org/10.1371/journal.pone.0026054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087219	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700002
J	Jourdan, M; Deutz, NEP; Cynober, L; Aussel, C				Jourdan, Marion; Deutz, Nicolaas E. P.; Cynober, Luc; Aussel, Christian			Features, Causes and Consequences of Splanchnic Sequestration of Amino Acid in Old Rats	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; WHOLE-BODY; ADIPOSE-TISSUE; DIETARY RESTRICTION; ISOTOPE ENRICHMENT; DRAINED VISCERA; METABOLIC FLUX; ELDERLY-MEN; IN-VIVO; LEUCINE	Rationale: In elderly subjects, splanchnic extraction of amino acids (AA) increases during meals in a process known as splanchnic sequestration of amino acids (SSAA). This process potentially contributes to the age-related progressive decline in muscle mass via reduced peripheral availability of dietary AA. SSAA mechanisms are unknown but may involve an increased net utilization of ingested AA in the splanchnic area. Objectives: Using stable isotope methodology in fed adult and old rats to provide insight into age-related SSAA using three hypotheses: 1) an increase in protein synthesis in the gut and/or the liver, 2) an increase in AA oxidation related to an increased ureagenesis, and 3) Kupffer cell (KC) activation consequently to age-related low-grade inflammation. Findings: Splanchnic extraction of Leu (SPELeu) was doubled in old rats compared to adult rats and was not changed after KC inactivation. No age-related effects on gut and liver protein synthesis were observed, but urea synthesis was lower in old rats and negatively correlated to liver Arg utilization. Net whole-body protein synthesis and arterial AA levels were lower in old rats and correlated negatively with SPELeu. Conclusion: SSAA is not the consequence of age-related alterations in ureagenesis, gut or liver protein synthesis or of KC activity. However, SSAA may be related to reduced net whole-body protein synthesis and consequently to the reduced lean body mass that occurs during aging.	[Jourdan, Marion; Cynober, Luc; Aussel, Christian] Paris Descartes Univ, Lab Biol Nutr EA 4466, Paris, France; [Deutz, Nicolaas E. P.] Maastricht Univ, Dept Surg, Maastricht, Netherlands; [Cynober, Luc] Cochin Hosp APHP, Paris, France; [Cynober, Luc] Hotel Dieu Hosp APHP, Paris, France; [Aussel, Christian] Henri Mondor Hosp APHP, PUI, Nutr Unit, Creteil, France	UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Jourdan, M (corresponding author), Paris Descartes Univ, Lab Biol Nutr EA 4466, Paris, France.	christian.aussel@erx.aphp.fr	Cynober, Luc/ABB-2368-2020; Deutz, Nicolaas E/J-5200-2012	Deutz, Nicolaas/0000-0001-5845-6447	French Ministry of Research and Technology [EA 2498]; Ajinomoto Inc.; ESPEN-ABBOTT	French Ministry of Research and Technology; Ajinomoto Inc.; ESPEN-ABBOTT	This program was supported by a grant from the French Ministry of Research and Technology (2002-2005 four-year contract/EA 2498) and an unrestricted grant from Ajinomoto Inc. Marion Jourdan was supported by an ESPEN-ABBOTT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2009, AGE, V31, P155, DOI 10.1007/s11357-009-9092-5; BARRETT EJ, 1987, BIOCHEM J, V245, P223, DOI 10.1042/bj2450223; Beliveau CG, 1993, BIOCHEM J, V292, P241; Boirie Y, 1997, AM J CLIN NUTR, V65, P489; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; BORKAN GA, 1977, HUM BIOL, V49, P495; Bruins MJ, 2000, J NUTR, V130, P3003, DOI 10.1093/jn/130.12.3003; BRUN C, 1951, J LAB CLIN MED, V37, P955; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; CYNOBER L, 2004, ENCY BIOL CHEM, P90; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Dardevet D, 2000, J NUTR, V130, P2630, DOI 10.1093/jn/130.11.2630; Felgines C, 1999, JPEN-PARENTER ENTER, V23, P32, DOI 10.1177/014860719902300132; FLEURY P, 1951, Ann Biol Clin (Paris), V9, P453; FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4; FRICK GP, 1981, J BIOL CHEM, V256, P2618; FRICK GP, 1988, J BIOL CHEM, V263, P3245; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507; Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Jefferson LS, 2001, J NUTR, V131, p2460S, DOI 10.1093/jn/131.9.2460S; Jourdan M, 2008, AM J PHYSIOL-REG I, V294, pR748, DOI 10.1152/ajpregu.00291.2007; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kumagai K, 2007, TOXICOLOGY, V241, P106, DOI 10.1016/j.tox.2007.08.090; Lochs H, 1987, Beitr Infusionther Klin Ernahr, V17, P167; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X; MERRY BJ, 1992, EXP GERONTOL, V27, P191, DOI 10.1016/0531-5565(92)90043-Y; Morais JA, 1997, AM J CLIN NUTR, V66, P880, DOI 10.1093/ajcn/66.4.880; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; NAIR KS, 1992, AM J PHYSIOL, V263, pE928, DOI 10.1152/ajpendo.1992.263.5.E928; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Pailla K, 2001, CLIN NUTR, V20, P313, DOI 10.1054/clnu.2001.0421; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rai RM, 1996, AM J PHYSIOL-GASTR L, V270, pG909, DOI 10.1152/ajpgi.1996.270.6.G909; RAO TI, 1982, J NEUROSCI RES, V7, P387, DOI 10.1002/jnr.490070404; ROSENBLATT J, 1992, AM J PHYSIOL, V263, pE584, DOI 10.1152/ajpendo.1992.263.3.E584; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; SCHAUDER P, 1987, SCAND J CLIN LAB INV, V47, P447; SHINNICK FL, 1976, BIOCHIM BIOPHYS ACTA, V437, P477, DOI 10.1016/0304-4165(76)90016-7; Tenhave GAM, 1996, LAB ANIM-UK, V30, P347, DOI 10.1258/002367796780739862; Timmerman KL, 2008, CURR OPIN CLIN NUTR, V11, P45, DOI 10.1097/MCO.0b013e3282f2a592; TOURIAN A, 1969, J CELL PHYSIOL, V73, P159, DOI 10.1002/jcp.1040730210; Van Eijk HMH, 2007, J CHROMATOGR B, V856, P48, DOI 10.1016/j.jchromb.2007.05.020; van Eijk HMH, 1999, ANAL BIOCHEM, V271, P8, DOI 10.1006/abio.1999.4112; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693	54	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27002	10.1371/journal.pone.0027002	http://dx.doi.org/10.1371/journal.pone.0027002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087243	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700013
J	Riegel, AK; Busch, R; Segal, S; Fox, JA; Eltzschig, HK; Shernan, SK				Riegel, Ann K.; Busch, Raila; Segal, Scott; Fox, John A.; Eltzschig, Holger K.; Shernan, Stanton K.			Evaluation of Transmitral Pressure Gradients in the Intraoperative Echocardiographic Diagnosis of Mitral Stenosis after Mitral Valve Repair	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HALF-TIME; PULMONARY EMBOLECTOMY; 3D ECHOCARDIOGRAPHY; REGURGITATION; AREA; EMBOLISM; RECURRENCE; ANESTHESIA; SURGERY	Objective: Acute mitral stenosis (MS) following mitral valve (MV) repair is a rare but severe complication. We hypothesize that intraoperative echocardiography can be utilized to diagnose iatrogenic MS immediately after MV repair. Methods: The medical records of 552 consecutive patients undergoing MV repair at a single institution were reviewed. Post-cardiopulmonary bypass peak and mean transmitral pressure gradients (TMPG), and pressure half time (PHT) were obtained from intraoperative transesophageal echocardiographic (TEE) examinations in each patient. Results: Nine patients (9/552 = 1.6%) received a reoperation for primary MS, prior to hospital discharge. Interestingly, all of these patients already showed intraoperative post-CPB mean and peak TMPGs that were significantly higher compared to values for those who did not: 10.7 +/- 4.8 mmHg vs 2.9 +/- 1.6 mmHg; p<0.0001 and 22.9 +/- 7.9 mmHg vs 7.6 +/- 3.7 mmHg; p<0.0001, respectively. However, PHT varied considerably (87 +/- 37 ms; range: 20-439 ms) within the entire population, and only weakly predicted the requirement for reoperation (113 +/- 56 vs. 87 +/- 37 ms, p = 0.034). Receiver operating characteristic curves showed strong discriminating ability for mean gradients (AUC = 0.993) and peak gradients (area under the curve, AUC = 0.996), but poor performance for PHT (AUC = 0.640). A value of >= 7 mmHg for mean, and >= 17 mmHg for peak TMPG, best separated patients who required reoperation for MS from those who did not. Conclusions: Intraoperative TEE diagnosis of a peak TMPG >= 17 mmHg or mean TMPG >= 7 mmHg immediately following CPB are suggestive of clinically relevant MS after MV repair.	[Riegel, Ann K.; Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA; [Busch, Raila] Univ Hosp Greifswald, Dept Cardiol Angiol Pneumol & Intens Care Med, Greifswald, Germany; [Segal, Scott] Tufts Med Ctr, Dept Anesthesiol, Boston, MA USA; [Fox, John A.; Shernan, Stanton K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	University of Colorado System; University of Colorado Denver; Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Riegel, AK (corresponding author), Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA.	holger.eltzschig@ucdenver.edu; sshernan@partners.org	Segal, Scott/S-4157-2019	Segal, Scott/0000-0002-7647-6422	Brigham and Women's Hospital, Boston, MA	Brigham and Women's Hospital, Boston, MA	Departmental funding, Brigham and Women's Hospital, Boston, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Chu JW, 2008, J AM SOC ECHOCARDIOG, V21, P1006, DOI 10.1016/j.echo.2008.05.010; Cohn LH, 2002, ADV CARDIOL, V39, P153; Eltzschig HK, 2004, NEW ENGL J MED, V350, P2424, DOI 10.1056/NEJM200406033502323; Eltzschig HK, 2003, J CARDIOTHOR VASC AN, V17, P422, DOI 10.1016/S1053-0770(03)00145-9; Eltzschig HK, 2003, NEW ENGL J MED, V348, P319, DOI 10.1056/NEJMra021276; Eltzschig HK, 2002, ANESTHESIOLOGY, V97, P1627, DOI 10.1097/00000542-200212000-00041; Eltzschig HK, 2002, ANAESTHESIST, V51, P81; Eltzschig HK, 2008, ANN THORAC SURG, V85, P845, DOI 10.1016/j.athoracsur.2007.11.015; Eltzschig Holger K, 2005, J Am Soc Echocardiogr, V18, P1221; Felbinger TW, 2003, CAN J ANAESTH, V50, P480, DOI 10.1007/BF03021060; FERNANDEZ J, 1992, ANN THORAC SURG, V54, P440, DOI 10.1016/0003-4975(92)90433-5; Firstenberg MS, 2001, J HEART VALVE DIS, V10, P49; Flameng W, 2003, CIRCULATION, V107, P1609, DOI 10.1161/01.CIR.0000058703.26715.9D; HATLE L, 1979, CIRCULATION, V60, P1096, DOI 10.1161/01.CIR.60.5.1096; Ibrahim MF, 2002, ANN THORAC SURG, V73, P34, DOI 10.1016/S0003-4975(01)03305-7; Kouris Nikos, 2005, Eur J Echocardiogr, V6, P435; Mannaerts HFJ, 2004, EUR HEART J, V25, P2073, DOI 10.1016/j.ehj.2004.10.001; Maslow A, 2011, J CARDIOTHOR VASC AN, V25, P486, DOI 10.1053/j.jvca.2010.04.006; Maslow A, 2011, J CARDIOTHOR VASC AN, V25, P221, DOI 10.1053/j.jvca.2010.11.022; Memtsoudis SG, 2006, ANESTH ANALG, V102, P1653, DOI 10.1213/01.ane.0000216412.83790.29; Mergner D, 2005, ANAESTHESIST, V54, P427, DOI 10.1007/s00101-005-0846-x; Mohan JC, 2004, AM HEART J, V148, P703, DOI 10.1016/j.ahj.2003.12.043; Mohan JC, 2002, J AM COLL CARDIOL, V40, P1809, DOI 10.1016/S0735-1097(02)02487-7; Muehrcke DD, 1997, ANN THORAC SURG, V63, P1718, DOI 10.1016/S0003-4975(97)00271-3; Muratori M, 2001, J HEART VALVE DIS, V10, P65; Nowak M, 2006, ANAESTHESIST, V55, P337, DOI 10.1007/s00101-006-0992-9; Nowak M, 2005, ECHOCARDIOGRAP UNPUB; Nowak M, 2008, J CLIN ANESTH, V20, P136, DOI 10.1016/j.jclinane.2007.06.026; Nowak M, 2006, ANESTHESIOLOGY, V104, P1346, DOI 10.1097/00000542-200606000-00042; Poh KK, 2006, INT J CARDIOL, V108, P177, DOI 10.1016/j.ijcard.2005.04.027; RIFKIN RD, 1995, J AM COLL CARDIOL, V26, P458, DOI 10.1016/0735-1097(95)80023-A; Rosenberger P, 2005, J CLIN ANESTH, V17, P146, DOI 10.1016/j.jclinane.2004.12.009; Rosenberger P, 2005, ANN THORAC SURG, V79, P1092, DOI 10.1016/j.athoracsur.2004.04.103; Rosenberger P, 2005, ANESTH ANALG, V100, P292, DOI 10.1213/01.ANE.0000141274.42848.40; Rosenberger P, 2004, ANN THORAC SURG, V78, P862, DOI 10.1016/j.athoracsur.2004.02.069; Rosenberger P, 2004, ANESTH ANALG, V99, P12, DOI 10.1213/01.ANE.0000117284.25696.64; Russo A, 2008, J AM COLL CARDIOL, V51, P1203, DOI 10.1016/j.jacc.2007.10.058; Schlosshan D, 2011, JACC-CARDIOVASC IMAG, V4, P580, DOI 10.1016/j.jcmg.2010.12.009; Shernan SK, 2007, CRIT CARE MED, V35, pS372, DOI 10.1097/01.CCM.0000270248.34274.AB; Singh P, 2009, ECHOCARDIOGR-J CARD, V26, P980, DOI 10.1111/j.1540-8175.2009.01022.x; Tanaka K, 2003, J CARDIOVASC SURG, V44, P59; THOMAS JD, 1988, CIRCULATION, V78, P980, DOI 10.1161/01.CIR.78.4.980; Umana JP, 1998, ANN THORAC SURG, V66, P1640, DOI 10.1016/S0003-4975(98)00828-5; Williams ML, 2009, ANN THORAC SURG, V88, P1197, DOI 10.1016/j.athoracsur.2009.06.022; Zamorano J, 2004, EUR HEART J, V25, P2086, DOI 10.1016/j.ehj.2004.09.041; Zhao LP, 2007, J THORAC CARDIOV SUR, V133, P1257, DOI 10.1016/j.jtcvs.2006.12.048	48	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26559	10.1371/journal.pone.0026559	http://dx.doi.org/10.1371/journal.pone.0026559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087230	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700007
J	Shepard, ELC; Lambertucci, SA; Vallmitjana, D; Wilson, RP				Shepard, Emily L. C.; Lambertucci, Sergio A.; Vallmitjana, Diego; Wilson, Rory P.			Energy Beyond Food: Foraging Theory Informs Time Spent in Thermals by a Large Soaring Bird	PLOS ONE			English	Article							MARGINAL VALUE THEOREM; ANDEAN CONDOR; MIGRATION; FLIGHT; PERFORMANCE; MOVEMENT; PATTERNS; BEHAVIOR; SEA	Current understanding of how animals search for and exploit food resources is based on microeconomic models. Although widely used to examine feeding, such constructs should inform other energy-harvesting situations where theoretical assumptions are met. In fact, some animals extract non-food forms of energy from the environment, such as birds that soar in updraughts. This study examined whether the gains in potential energy (altitude) followed efficiency-maximising predictions in the world's heaviest soaring bird, the Andean condor (Vultur gryphus). Animal-attached technology was used to record condor flight paths in three-dimensions. Tracks showed that time spent in patchy thermals was broadly consistent with a strategy to maximise the rate of potential energy gain. However, the rate of climb just prior to leaving a thermal increased with thermal strength and exit altitude. This suggests higher rates of energetic gain may not be advantageous where the resulting gain in altitude would lead to a reduction in the ability to search the ground for food. Consequently, soaring behaviour appeared to be modulated by the need to reconcile differing potential energy and food energy distributions. We suggest that foraging constructs may provide insight into the exploitation of non-food energy forms, and that non-food energy distributions may be more important in informing patterns of movement and residency over a range of scales than previously considered.	[Shepard, Emily L. C.; Vallmitjana, Diego; Wilson, Rory P.] Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales; [Lambertucci, Sergio A.; Vallmitjana, Diego] Univ Nacl Comahue, INIBIOMA, CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina	Swansea University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Shepard, ELC (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales.	e.l.c.shepard@swansea.ac.uk		Shepard, Emily/0000-0001-7325-6398; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Leverhulme Early Career Fellowship; National Geographic Society [W133-10]; Wingate scholarship; Fundacion Banco Bilbao Vizcaya Argentaria [BIOCON-08-126]	Leverhulme Early Career Fellowship(Leverhulme Trust); National Geographic Society(National Geographic Society); Wingate scholarship; Fundacion Banco Bilbao Vizcaya Argentaria	Funding was provided through a Leverhulme Early Career Fellowship (to ES) and a National Geographic Society/Waitt Grant (W133-10), with additional support from a Wingate scholarship (to ES). Fieldwork was conducted in collaboration with Fundacion Banco Bilbao Vizcaya Argentaria project BIOCON-08-126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akos Z, 2008, P NATL ACAD SCI USA, V105, P4139, DOI 10.1073/pnas.0707711105; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Bradbury T., 2000, METEOROLOGY FLIGHT P; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Houston DC, 1974, AFR J ECOL, V12, P63, DOI [10.1111/j.1365-2028.1974.tb00107.x, DOI 10.1111/J.1365-2028.1974.TB00107.X]; JONES FRH, 1979, J CONSEIL, V38, P331; Lambertucci SA, 2009, ANIM CONSERV, V12, P338, DOI 10.1111/j.1469-1795.2009.00258.x; Leshem Y, 1998, IBIS, V140, P41, DOI 10.1111/j.1474-919X.1998.tb04539.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; MCGAHAN J, 1973, J EXP BIOL, V58, P225; MCNAIR JN, 1982, AM NAT, V119, P511, DOI 10.1086/283929; PALADINES OL, 1964, J NUTR, V82, P145, DOI 10.1093/jn/82.1.145; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Stephens D., 2007, FORAGING BEHAV ECOLO; Tsoar A, 2011, P NATL ACAD SCI US; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; White C.M., 1994, NEW WORLD VULTURES G; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Wilson RP, 2011, P ROY SOC B IN PRESS	31	56	56	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27375	10.1371/journal.pone.0027375	http://dx.doi.org/10.1371/journal.pone.0027375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087301	Green Published, gold			2022-12-27	WOS:000297349700036
J	Zhao, RM; Dai, H; Qiu, S; Li, T; He, YW; Ma, YB; Chen, ZY; Wu, YL; Li, WX; Cao, ZJ				Zhao, Ruiming; Dai, Hui; Qiu, Su; Li, Tian; He, Yawen; Ma, Yibao; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian			SdPI, The First Functionally Characterized Kunitz-Type Trypsin Inhibitor from Scorpion Venom	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; TRANSCRIPTOME ANALYSIS; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; LYCHAS-MUCRONATUS; TOXIN SEQUENCES; NEUROTOXIN; CLONING; CONKUNITZIN-S1; PANCREATITIS	Background: Kunitz-type venom peptides have been isolated from a wide variety of venomous animals. They usually have protease inhibitory activity or potassium channel blocking activity, which by virtue of the effects on predator animals are essential for the survival of venomous animals. However, no Kunitz-type peptides from scorpion venom have been functionally characterized. Principal Findings: A new Kunitz-type venom peptide gene precursor, SdPI, was cloned and characterized from a venom gland cDNA library of the scorpion Lychas mucronatus. It codes for a signal peptide of 21 residues and a mature peptide of 59 residues. The mature SdPI peptide possesses a unique cysteine framework reticulated by three disulfide bridges, different from all reported Kunitz-type proteins. The recombinant SdPI peptide was functionally expressed. It showed trypsin inhibitory activity with high potency (K(i) = 1.6 x 10(-7) M) and thermostability. Conclusions: The results illustrated that SdPI is a potent and stable serine protease inhibitor. Further mutagenesis and molecular dynamics simulation revealed that SdPI possesses a serine protease inhibitory active site similar to other Kunitz-type venom peptides. To our knowledge, SdPI is the first functionally characterized Kunitz-type trypsin inhibitor derived from scorpion venom, and it represents a new class of Kunitz-type venom peptides.	[Zhao, Ruiming; Dai, Hui; Qiu, Su; Li, Tian; He, Yawen; Ma, Yibao; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Zhao, RM (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; zjcao@whu.edu.cn	Zhao, Ruiming/C-1817-2017; Ma, Yibao/H-3849-2016	Ma, Yibao/0000-0002-3270-8893	National Natural Sciences Foundation of China [30971500, 31071942]; Major State Basic Research Development Program of China [2010CB529800, 2010CB530100]; China Specific Project for Developing New Drugs [2009ZX09103-612]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); China Specific Project for Developing New Drugs	This work was supported by grants from the National Natural Sciences Foundation of China (Nos. 30971500 and 31071942) and the Major State Basic Research Development Program of China (Nos. 2010CB529800 and 2010CB530100), and the China Specific Project for Developing New Drugs (No. 2009ZX09103-612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Barbar E, 2001, BIOCHEMISTRY-US, V40, P9734, DOI 10.1021/bi010483z; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Brillard-Bourdet M, 2006, BIOCHEM J, V400, P467, DOI 10.1042/BJ20060437; Cao ZJ, 2005, IUBMB LIFE, V57, P513, DOI 10.1080/15216540500149870; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Hansen KK, 2008, N-S ARCH PHARMACOL, V377, P377, DOI 10.1007/s00210-007-0194-2; Hoogerwerf WA, 2005, CURR OPIN PHARMACOL, V5, P578, DOI 10.1016/j.coph.2005.06.007; Kozlov S A, 2009, Bioorg Khim, V35, P789; Lewis R. J., 2009, V46, P45, DOI 10.1007/978-3-540-87895-7_2; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Minagawa S, 2008, COMP BIOCHEM PHYS B, V150, P240, DOI 10.1016/j.cbpb.2008.03.010; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; SOKOLOVSKY M, 1992, J NEUROCHEM, V59, P809, DOI 10.1111/j.1471-4159.1992.tb08318.x; STRYDOM DJ, 1973, NATURE-NEW BIOL, V243, P88; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; VINCENT JP, 1974, EUR J BIOCHEM, V42, P505, DOI 10.1111/j.1432-1033.1974.tb03365.x; Wang GJ, 2009, WORLD J GASTROENTERO, V15, P1427, DOI 10.3748/wjg.15.1427; Wu WL, 2007, PEPTIDES, V28, P2306, DOI 10.1016/j.peptides.2007.10.009; YI H, BMC STRUCT BIOL, V11, P3; You DW, 2009, J BIOL CHEM, V284, P22079, DOI 10.1074/jbc.M109.013276; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	35	35	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27548	10.1371/journal.pone.0027548	http://dx.doi.org/10.1371/journal.pone.0027548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087336	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700058
J	Ellis, L; Lehet, K; Ramakrishnan, S; Adelaiye, R; Miles, KM; Wang, D; Liu, S; Atadja, P; Carducci, MA; Pili, R				Ellis, Leigh; Lehet, Kristin; Ramakrishnan, Swathi; Adelaiye, Remi; Miles, Kiersten M.; Wang, Dan; Liu, Song; Atadja, Peter; Carducci, Michael A.; Pili, Roberto			Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PROSTATE-CANCER; MAMMALIAN TARGET; C-MYC; ANGIOGENESIS; COMBINATION; VORINOSTAT; CARCINOMA; RAPAMYCIN; PROTEINS	Specific inhibitors towards Histone Deacetylases (HDACs) and Mammalian Target of Rapamycin Complex 1 (mTORC1) have been developed and demonstrate potential as treatments for patients with advanced and/or metastatic and castrate resistant prostate cancer (PCa). Further, deregulation of HDAC expression and mTORC1 activity are documented in PCa and provide rational targets to create new therapeutic strategies to treat PCa. Here we report the use of the c-Myc adenocarcinoma cell line from the c-Myc transgenic mouse with prostate cancer to evaluate the in vitro and in vivo antitumor activity of the combination of the HDAC inhibitor panobinostat with the mTORC1 inhibitor everolimus. Panobinostat/everolimus combination treatment resulted in significantly greater antitumor activity in mice bearing androgen sensitive Myc-CaP and castrate resistant Myc-CaP tumors compared to single treatments. We identified that panobinostat/everolimus combination resulted in enhanced anti-tumor activity mediated by decreased tumor growth concurrent with augmentation of p21 and p27 expression and the attenuation of angiogenesis and tumor proliferation via androgen receptor, c-Myc and HIF-1 alpha signaling. Also, we observed altered expression of microRNAs associated with these three transcription factors. Overall, our results demonstrate that low dose concurrent panobinostat/everolimus combination therapy is well tolerated and results in greater anti-tumor activity compared to single treatments in tumor bearing immuno-competent mice. Finally, our results suggest that response of selected miRs could be utilized to monitor panobinostat/everolimus in vivo activity.	[Ellis, Leigh; Lehet, Kristin; Ramakrishnan, Swathi; Adelaiye, Remi; Miles, Kiersten M.; Pili, Roberto] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Genitourinary Program, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Bioinformat, Buffalo, NY 14263 USA; [Atadja, Peter] Novartis Biomed Res Inst, Shanghai, Peoples R China; [Carducci, Michael A.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Johns Hopkins University; Johns Hopkins Medicine	Ellis, L (corresponding author), Roswell Pk Canc Inst, Grace Canc Drug Ctr, Genitourinary Program, Buffalo, NY 14263 USA.	Roberto.pili@roswellpark.org	Ramakrishnan, Swathi/O-5054-2019; Carducci, Michael/R-8164-2019	Adelaiye-Ogala, Remi/0000-0002-6581-7359	Department of Defense [PC040800]; National Cancer Institute [P50CA58236]; NCI [P30CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056, P50CA058236, P30CA006973] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the Department of Defense-PC040800 (to LE) and the National Cancer Institute-P50CA58236 (to RP and MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In vivo bioluminescence imaging studies were performed through the Shared Tumor imaging Resource at Roswell Park Cancer Institute supported by NCI P30CA16056 (Trump, DL). We kindly thank past and present members of the Pili laboratory for insightful discussions.	Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273; Atadja P, 2004, CANCER RES, V64, P689, DOI 10.1158/0008-5472.CAN-03-2043; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradley D, 2009, CANCER-AM CANCER SOC, V115, P5541, DOI 10.1002/cncr.24597; Chiong E, 2011, CLIN CANCER RES, V17, P2863, DOI 10.1158/1078-0432.CCR-09-3202; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Ellis L, 2011, PROSTATE; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Ellis L, 2010, PHARMACEUTICALS, V3, P2441, DOI 10.3390/ph3082441; Ellis L, 2009, BLOOD, V114, P380, DOI 10.1182/blood-2008-10-182758; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Emmenegger U, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.tps246; Evren S, 2010, PROSTATE, V70, P1429, DOI 10.1002/pros.21178; Garcia JA, 2008, MOL CANCER THER, V7, P1347, DOI 10.1158/1535-7163.MCT-07-2408; Glaser KB, 2003, MOL CANCER THER, V2, P151; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gurel B, 2008, ADV ANAT PATHOL, V15, P319, DOI 10.1097/PAP.0b013e31818a5c19; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hao Y, 2011, CANC INVEST; Hwang JJ, 2010, J UROLOGY, V184, P2557, DOI 10.1016/j.juro.2010.07.035; Iacopino F, 2008, INT J ONCOL, V32, P1293; Jans J, 2010, UROLOGY, V75, P786, DOI 10.1016/j.urology.2009.08.024; Kaarbo M, 2010, CELL ONCOL, V32, P11, DOI 10.3233/CLO-2009-0487; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Nguyen DM, 2004, CLIN CANCER RES, V10, P1813, DOI 10.1158/1078-0432.CCR-0901-3; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pesta M, 2010, ANTICANCER RES, V30, P3579; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qian DZ, 2004, CANCER RES, V64, P6626, DOI 10.1158/0008-5472.CAN-04-0540; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rai JS, 2010, UROL ONCOL-SEMIN ORI, V28, P134, DOI 10.1016/j.urolonc.2009.03.023; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Schayowitz A, 2010, BRIT J CANCER, V103, P1001, DOI 10.1038/sj.bjc.6605882; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Tessel MA, 2010, CURR OPIN ONCOL, V22, P592, DOI 10.1097/CCO.0b013e32833ea80c; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Wang LG, 2008, INT J ONCOL, V33, P375, DOI 10.3892/ijo_00000018; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Wedel S, 2011, LIFE SCI, V88, P418, DOI 10.1016/j.lfs.2010.12.017; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Wu Y, 2010, ANTICANCER RES, V30, P3895; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246	59	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27178	10.1371/journal.pone.0027178	http://dx.doi.org/10.1371/journal.pone.0027178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087262	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700026
J	Huttmann, EM; Greulich, T; Hattesohl, A; Schmid, S; Noeske, S; Herr, C; John, G; Jorres, RA; Muller, B; Vogelmeier, C; Koczulla, AR				Huettmann, Eva-Maria; Greulich, Timm; Hattesohl, Akira; Schmid, Severin; Noeske, Sarah; Herr, Christian; John, Gerrit; Joerres, Rudolf A.; Mueller, Bernd; Vogelmeier, Claus; Koczulla, Andreas Rembert			Comparison of Two Devices and Two Breathing Patterns for Exhaled Breath Condensate Sampling	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PH; ASTHMA; INTERLEUKIN-6; TEMPERATURE; BIOMARKERS; CHILDREN	Introduction: Analysis of exhaled breath condensate (EBC) is a noninvasive method to access the epithelial lining fluid of the lungs. Due to standardization problems the method has not entered clinical practice. The aim of the study was to assess the comparability for two commercially available devices in healthy controls. In addition, we assessed different breathing patterns in healthy controls with protein markers to analyze the source of the EBC. Methods: EBC was collected from ten subjects using the RTube and ECoScreen Turbo in a randomized crossover design, twice with every device - once in tidal breathing and once in hyperventilation. EBC conductivity, pH, surfactant protein A, Clara cell secretory protein and total protein were assessed. Bland-Altman plots were constructed to display the influence of different devices or breathing patterns and the intra-class correlation coefficient (ICC) was calculated. The volatile organic compound profile was measured using the electronic nose Cyranose 320. For the analysis of these data, the linear discriminant analysis, the Mahalanobis distances and the cross-validation values (CVV) were calculated. Results: Neither the device nor the breathing pattern significantly altered EBC pH or conductivity. ICCs ranged from 0.61 to 0.92 demonstrating moderate to very good agreement. Protein measurements were greatly influenced by breathing pattern, the device used, and the way in which the results were reported. The electronic nose could distinguish between different breathing patterns and devices, resulting in Mahalanobis distances greater than 2 and CVVs ranging from 64% to 87%. Conclusion: EBC pH and (to a lesser extent) EBC conductivity are stable parameters that are not influenced by either the device or the breathing patterns. Protein measurements remain uncertain due to problems of standardization. We conclude that the influence of the breathing maneuver translates into the necessity to keep the volume of ventilated air constant in further studies.	[Huettmann, Eva-Maria; Greulich, Timm; Hattesohl, Akira; Schmid, Severin; Noeske, Sarah; Herr, Christian; Mueller, Bernd; Vogelmeier, Claus; Koczulla, Andreas Rembert] Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany; [John, Gerrit] Helmholtz Zentrum Munich, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Neuherberg, Germany; [Joerres, Rudolf A.] Univ Munich, Inst Occupat Social & Environm Med, Munich, Germany; [Joerres, Rudolf A.] Univ Munich, Outpatient Clin Occupat Social & Environm Med, Munich, Germany	Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Huttmann, EM (corresponding author), Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany.	koczulla@med.uni-marburg.de	Herr, Christian/AAH-5291-2021; Hattesohl, Akira/AAB-1341-2022	Schmid, Severin/0000-0001-8077-082X; Herr, Christian/0000-0001-9422-6569	German Research Foundation (DFG) [SFB/TR22, TP A19]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was partially funded by the German Research Foundation (DFG, SFB/TR22, TP A19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antczak Adam, 2002, Int J Occup Med Environ Health, V15, P317; Baraldi E, 2003, CHEST, V124, P25, DOI 10.1378/chest.124.1.25; Bondesson E, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/1/016005; Bucchioni E, 2003, RESP MED, V97, P1299, DOI 10.1016/j.rmed.2003.07.008; Carpagnano GE, 2004, CHEST, V125, P2005, DOI 10.1378/chest.125.6.2005; Carpagnano GE, 2003, AM J RESP CRIT CARE, V167, P1109, DOI 10.1164/rccm.200203-179OC; Czebe K, 2008, RESP MED, V102, P720, DOI 10.1016/j.rmed.2007.12.013; DAVIS JM, 1989, J APPL PHYSIOL, V67, P1007, DOI 10.1152/jappl.1989.67.3.1007; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Ferrazzoni S, 2009, CHEST, V136, P155, DOI 10.1378/chest.08-2338; Garey KW, 2004, CHEST, V125, P22, DOI 10.1378/chest.125.1.22; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Hunt John, 2006, Cough, V2, P3, DOI 10.1186/1745-9974-2-3; Jackson AS, 2007, AM J RESP CRIT CARE, V175, P222, DOI 10.1164/rccm.200601-107OC; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Kane B, 2009, RESPIROLOGY, V14, P419, DOI 10.1111/j.1440-1843.2009.01492.x; Koczulla AR, 2010, RESPIRATION, V79, P61, DOI 10.1159/000245325; Koczulla AR, 2010, RESPIROLOGY, V15, P155, DOI 10.1111/j.1440-1843.2009.01664.x; Koczulla R, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-78; McRae K., 2001, Journal of Heart and Lung Transplantation, V20, P184, DOI 10.1016/S1053-2498(00)00379-X; Prieto L, 2007, RESP MED, V101, P1715, DOI 10.1016/j.rmed.2007.02.023; Rosias PP, 2006, EUR RESPIR J, V28, P1036, DOI 10.1183/09031936.06.00110305; Shahid SK, 2002, AM J RESP CRIT CARE, V165, P1290, DOI 10.1164/rccm.2108082; SIDORENKO GI, 1980, TERAPEVT ARKH, V52, P65; Soyer OU, 2006, ALLERGY, V61, P1016, DOI 10.1111/j.1398-9995.2006.01064.x; Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926; Thorevska Natalya Y, 2004, Respir Care, V49, P1326; Vaughan J, 2003, EUR RESPIR J, V22, P889, DOI 10.1183/09031936.03.00038803	28	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27467	10.1371/journal.pone.0027467	http://dx.doi.org/10.1371/journal.pone.0027467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087323	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700056
J	Juneja, J; Cushman, I; Casey, PJ				Juneja, Juhi; Cushman, Ian; Casey, Patrick J.			G12 Signaling through c-Jun NH2-Terminal Kinase Promotes Breast Cancer Cell Invasion	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; LEUCINE-ZIPPER PROTEIN; STRESS FIBER FORMATION; SERUM RESPONSE FACTOR; TERMINAL KINASE; COUPLED RECEPTORS; REGULATED KINASE; LYSOPHOSPHATIDIC ACID; TRANSCRIPTION FACTORS; SCAFFOLDING PROTEIN	Signaling through the heterotrimeric G protein, G12, via Rho induces a striking increase in breast cancer cell invasion. In this study, evidence is provided that the c-Jun NH2-terminal kinase (JNK) is a key downstream effector of G12 on this pathway. Expression of constitutively-active G alpha 12 or activation of G12 signaling by thrombin leads to increased JNK and c-Jun phosphorylation. Pharmacologic inhibition of JNK or knockdown of JNK expression by siRNA significantly decreases G12-induced JNK activation as well as the ability of breast cancer cells to invade a reconstituted basement membrane. Furthermore, expression of dominant-negative Rho or treatment of cells with an inhibitor of the Rho kinase, ROCK, reduces G12-induced JNK and c-Jun activation, and ROCK inhibitor treatment also inhibits G12-induced cellular invasion. JNK knockdown or ROCK inhibitor treatment has no effect on activation of Rho by G12. Taken together, our data indicate that JNK activation is required for G12-induced invasion of breast cancer cells and that JNK is downstream of Rho and ROCK on this pathway. This study implicates a G12-stimulated mitogen-activated protein kinase cascade in cancer cell invasion, and supports a role for JNK in cancer progression.	[Juneja, Juhi; Cushman, Ian; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Cushman, Ian; Casey, Patrick J.] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore	Duke University; National University of Singapore	Juneja, J (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	patrick.casey@duke.edu		Casey, Patrick/0000-0002-7366-9309	National Institutes of Health (USA); National Medical Research Council (Singapore); Human Frontier Science Program Fellowship	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council (Singapore)(National Medical Research Council, Singapore); Human Frontier Science Program Fellowship(Human Frontier Science Program)	This work was supported by grants from the National Institutes of Health (USA) and National Medical Research Council (Singapore) (to P.J.C.) and a Human Frontier Science Program Fellowship (to J.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Dermott JM, 2004, ONCOGENE, V23, P226, DOI 10.1038/sj.onc.1207009; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jho EH, 1997, J BIOL CHEM, V272, P24468, DOI 10.1074/jbc.272.39.24468; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kashef K, 2005, BIOCHEMISTRY-US, V44, P14090, DOI 10.1021/bi050604l; Kashef K, 2011, NEOPLASIA, V13, P358, DOI 10.1593/neo.101622; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Malchinkhuu E, 2005, ONCOGENE, V24, P6676, DOI 10.1038/sj.onc.1208805; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Meigs TE, 2005, J BIOL CHEM, V280, P18049, DOI 10.1074/jbc.M500445200; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Shimada K, 2007, AM J PATHOL, V171, P1003, DOI 10.2353/ajpath.2007.070010; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Tabu K, 2007, MOL CANCER RES, V5, P1099, DOI 10.1158/1541-7786.MCR-07-0096; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26085	10.1371/journal.pone.0026085	http://dx.doi.org/10.1371/journal.pone.0026085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087220	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700003
J	Andersson, EA; Harder, MN; Pilgaard, K; Pisinger, C; Stancakova, A; Kuusisto, J; Grarup, N; Faerch, K; Poulsen, P; Witte, DR; Jorgensen, T; Vaag, A; Laakso, M; Pedersen, O; Hansen, T				Andersson, Ehm A.; Harder, Marie N.; Pilgaard, Kasper; Pisinger, Charlotta; Stancakova, Alena; Kuusisto, Johanna; Grarup, Niels; Faerch, Kristine; Poulsen, Pernille; Witte, Daniel R.; Jorgensen, Torben; Vaag, Allan; Laakso, Markku; Pedersen, Oluf; Hansen, Torben			The Birth Weight Lowering C-Allele of rs900400 Near LEKR1 and CCNL1 Associates with Elevated Insulin Release following an Oral Glucose Challenge	PLOS ONE			English	Article							RISK GENOTYPES; TYPE-2	Background and Aim: The first genome-wide association study on birth weight was recently published and the most significant associated birth weight lowering variant was the rs900400 C-allele located near LEKR1 and CCNL1. We aimed to replicate the association with birth weight in the Danish Inter99 study and furthermore to evaluate associations between rs900400 and indices of insulin secretion and insulin sensitivity obtained by oral glucose tolerance tests in adults from the Danish Inter99 study and the Finnish, Metabolic Syndrome in Men (METSIM) sample. Methods: For 4,744 of 6,784 Inter99 participants, midwife journals were traced through the Danish State Archives and association of rs900400 with birth weight was examined. Associations between rs900400 and fasting serum insulin, fasting plasma glucose, insulinogenic index, homeostasis model assessment of insulin resistance (HOMA-IR) and disposition index were studied in 5,484 Danish and 6,915 Finnish non-diabetic individuals and combined in meta-analyses. Results: The C-allele of rs900400 was associated with a 22.1 g lower birth weight ([-41.3; -3.0], P = 0.024) per allele. Moreover, in combined analyses of the Danish Inter99 study and the Finnish METSIM study we found that the birth weight lowering allele was associated with increased insulin release measured by the insulinogenic index (beta = 2.25% [0.59; 3.91], P = 0.008) and with an increased disposition index (beta = 1.76% [0.04; 3.49], P = 0.05). Conclusion: The birth weight lowering effect of the C-allele of rs900400 located near LEKR1 and CCNL1 was replicated in the Danish population. Furthermore the C-allele was associated with increased insulin response following oral glucose stimulation in a meta-analysis based on Danish and Finnish non-diabetic individuals.	[Andersson, Ehm A.; Harder, Marie N.; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Pilgaard, Kasper; Faerch, Kristine; Poulsen, Pernille; Witte, Daniel R.; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pisinger, Charlotta; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, Copenhagen, Denmark; [Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; University of Southern Denmark	Andersson, EA (corresponding author), Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	marie.harder@sund.ku.dk	Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Stancakova, Alena/AAN-6723-2020; Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Stancakova, Alena/0000-0002-1375-0252; Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830; Vaag, Allan Arthur/0000-0002-3690-2191; Pilgaard, Kasper Ascanius/0000-0003-2079-5229; Pisinger, Charlotta/0000-0002-7970-3168; Faerch, Kristine/0000-0002-6127-0448	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Strategic Research Council, Hagedorn Research Institute; Novo Nordisk Foundation Center for Basic Metabolic Research; PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health Sciences	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Strategic Research Council, Hagedorn Research Institute(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health Sciences	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP). The Inter99 was initiated by T. Jorgensen (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T. F. Thomsen. The Steering Committee comprises the former two and C. Pisinger. The study was financially supported by research grants from the Danish Strategic Research Council, Hagedorn Research Institute, the Novo Nordisk Foundation Center for Basic Metabolic Research, the PhD School of Molecular Metabolism University of Southern Denmark and the Copenhagen Graduate School of Health Sciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Dusatkova P, 2011, J PEDIATR ENDOCR MET, V24, P187, DOI 10.1515/JPEM.2011.083; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Freathy RM, NAT GENET; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; Pilgaard K, 2010, DIABETOLOGIA, V53, P2526, DOI 10.1007/s00125-010-1917-3; Pilgaard K, J DEV ORIGINS HLTH D, P1; Pulizzi N, 2009, DIABETOLOGIA, V52, P825, DOI 10.1007/s00125-009-1291-1; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Who, 1999, TECH REP SER WHO; Zhao JH, 2009, DIABETES, V58, P2414, DOI 10.2337/db09-0506	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27096	10.1371/journal.pone.0027096	http://dx.doi.org/10.1371/journal.pone.0027096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073261	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200033
J	Vizcaychipi, MP; Lloyd, DG; Wan, YJ; Palazzo, MG; Maze, M; Ma, DQ				Vizcaychipi, Marcela P.; Lloyd, Dafydd G.; Wan, Yanjie; Palazzo, Mark G.; Maze, Mervyn; Ma, Daqing			Xenon Pretreatment May Prevent Early Memory Decline after Isoflurane Anesthesia and Surgery in Mice	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; HEAT-SHOCK-PROTEIN; CARDIOPULMONARY BYPASS; PERIPHERAL INFECTION; DORSAL HIPPOCAMPUS; CEREBRAL-ISCHEMIA; NEONATAL ASPHYXIA; RATS; BRAIN; INJURY	Postoperative cognitive decline (POCD) is a common complication following surgery, but its aetiology remains unclear. We hypothesized that xenon pretreatment prevents POCD by suppressing the systemic inflammatory response or through an associated protective signaling pathway involving heat shock protein 72 (Hsp72) and PI3-kinase. Twenty-four hours after establishing long-term memory using fear conditioning training, C57BL/6 adult male mice (n = 12/group) received one of the following treatments: 1) no treatment group (control); 2) 1.8% isoflurane anesthesia; 3) 70% xenon anesthesia; 4) 1.8% isoflurane anesthesia with surgery of the right hind leg tibia that was pinned and fractured; or 5) pretreatment with 70% xenon for 20 minutes followed immediately by 1.8% isoflurane anesthesia with the surgery described above. Assessments of hippocampal-dependent memory were performed on days 1 and 7 after treatment. Hsp72 and PI3-kinase in hippocampus, and plasma IL-1 beta, were measured using western blotting and ELISA respectively, from different cohorts on day 1 after surgery. Isoflurane induced memory deficit after surgery was attenuated by xenon pretreatment. Xenon pretreatment prevented the memory deficit typically seen on day 1 (P = 0.04) but not on day 7 (P = 0.69) after surgery under isoflurane anesthesia, when compared with animals that underwent surgery without pretreatment. Xenon pretreatment modulated the expression of Hsp72 (P = 0.054) but had no significant effect on PI3-kinase (P = 0.54), when compared to control. Xenon pretreatment also reduced the plasma level increase of IL-1 beta induced by surgery (P = 0.028). Our data indicated that surgery and/or Isoflurane induced memory deficit was attenuated by xenon pretreatment. This was associated with a reduction in the plasma level of IL-1 beta and an upregulation of Hsp72 in the hippocampus.	[Vizcaychipi, Marcela P.; Lloyd, Dafydd G.; Palazzo, Mark G.; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Surg & Canc, London, England; [Wan, Yanjie] Gongli Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA	Imperial College London; University of California System; University of California San Francisco	Vizcaychipi, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Surg & Canc, London, England.	d.ma@imperial.ac.uk	Ma, Daqing/GLT-2735-2022; Vizcaychipi, Marcela/H-5487-2011	Ma, Daqing/0000-0003-1235-0537; Vizcaychipi, Marcela/0000-0001-7894-873X; Ma, Daqing/0000-0002-0688-2097	Joint Research Committee of Chelsea; Westminster Medical School; Chelsea and Westminster Hospital NHS Foundation Trust; Charing Cross Hospital; Imperial College Healthcare NHS Trust	Joint Research Committee of Chelsea; Westminster Medical School; Chelsea and Westminster Hospital NHS Foundation Trust; Charing Cross Hospital; Imperial College Healthcare NHS Trust	This work was supported in part by grants from the Joint Research Committee of Chelsea and Westminster Medical School, the Chelsea and Westminster Hospital NHS Foundation Trust and the Charing Cross Hospital, Imperial College Healthcare NHS Trust to Marcela P. Vizcaychipi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adori C, 2005, NEUROBIOL DIS, V19, P427, DOI 10.1016/j.nbd.2005.01.015; Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Boodhwani M, 2006, CIRCULATION, V114, pI461, DOI 10.1161/CIRCULATIONAHA.105.001354; Cattano D, 2008, CAN J ANAESTH, V55, P429, DOI 10.1007/BF03016309; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clark JA, 2005, J CARDIOTHOR VASC AN, V19, P488, DOI 10.1053/j.jvca.2005.05.007; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Fahlenkamp AV, 2011, J MOL NEUROSCI, V45, P48, DOI 10.1007/s12031-010-9432-z; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Harry LE, 2008, J ORTHOP RES, V26, P1238, DOI 10.1002/jor.20649; Hein M, 2008, ACTA ANAESTH SCAND, V52, P1194, DOI 10.1111/j.1399-6576.2008.01757.x; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Kang MJ, 2008, FEBS J, V275, P5969, DOI 10.1111/j.1742-4658.2008.06725.x; Kelly S, 2002, ANN NEUROL, V52, P160, DOI 10.1002/ana.10264; Kitahata H, 2008, ANESTH ANALG, V107, P755, DOI 10.1213/ane.0b013e31817f0e61; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Ma DQ, 2007, ANESTHESIOLOGY, V106, P746, DOI 10.1097/01.anes.0000264762.48920.80; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Saravanan P, 2009, BRIT J ANAESTH, V103, P805, DOI 10.1093/bja/aep297; Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011; Sun YJ, 2006, J CEREBR BLOOD F MET, V26, P937, DOI 10.1038/sj.jcbfm.9600246; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Valentim AM, 2008, BRIT J ANAESTH, V101, P434, DOI 10.1093/bja/aen228; Vizcaychipi MP, 2011, ANESTHESIOLOGY, V114, P891, DOI 10.1097/ALN.0b013e31820ad3ce; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xu X, 2008, NEUROSCIENCE, V154, P1002, DOI 10.1016/j.neuroscience.2008.04.013; Yang YL, 1999, AM J PHYSIOL-HEART C, V276, pH1961, DOI 10.1152/ajpheart.1999.276.6.H1961; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	42	32	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26394	10.1371/journal.pone.0026394	http://dx.doi.org/10.1371/journal.pone.0026394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073162	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000009
J	Dang, CW; Wang, Y; Zhang, DB; Yao, Q; Chen, KP				Dang, Chunwang; Wang, Yong; Zhang, Debao; Yao, Qin; Chen, Keping			A Genome-Wide Survey on Basic Helix-Loop-Helix Transcription Factors in Giant Panda	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; FACTOR FAMILY; DNA	The giant panda (Ailuropoda melanoleuca) is a critically endangered mammalian species. Studies on functions of regulatory proteins involved in developmental processes would facilitate understanding of specific behavior in giant panda. The basic helix-loop-helix (bHLH) proteins play essential roles in a wide range of developmental processes in higher organisms. bHLH family members have been identified in over 20 organisms, including fruit fly, zebrafish, mouse and human. Our present study identified 107 bHLH family members being encoded in giant panda genome. Phylogenetic analyses revealed that they belong to 44 bHLH families with 46, 25, 15, 4, 11 and 3 members in group A, B, C, D, E and F, respectively, while the remaining 3 members were assigned into "orphan''. Compared to mouse, the giant panda does not encode seven bHLH proteins namely Beta3a, Mesp2, Sclerax, S-Myc, Hes5 (or Hes6), EBF4 and Orphan 1. These results provide useful background information for future studies on structure and function of bHLH proteins in the regulation of giant panda development.	[Dang, Chunwang; Zhang, Debao; Yao, Qin; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Provinc, Peoples R China; [Wang, Yong] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu Provinc, Peoples R China	Jiangsu University; Jiangsu University	Dang, CW (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Provinc, Peoples R China.	ywang@ujs.edu.cn			Scientific Research Promotion Fund for the Talents of Jiangsu University [09JDG029]; Jiangsu Sci-Tech Support Project - Agriculture [BE2008379]	Scientific Research Promotion Fund for the Talents of Jiangsu University; Jiangsu Sci-Tech Support Project - Agriculture	This work was supported by Scientific Research Promotion Fund for the Talents of Jiangsu University (No. 09JDG029) and Jiangsu Sci-Tech Support Project - Agriculture (No. BE2008379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; LEDENT V, 2002, GENOME BIOL, V3, pR30; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liu WY, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/682095; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Satou Y, 2003, DEV GENES EVOL, V213, P213, DOI 10.1007/s00427-003-0319-7; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao YQ, 2010, DNA CELL BIOL, V29, P41, DOI 10.1089/dna.2009.0909; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wan QH, 2003, ELECTROPHORESIS, V24, P1353, DOI 10.1002/elps.200390174; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; Wang Y, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4001; Wang Y, 2007, DEV GENES EVOL, V217, P715, DOI 10.1007/s00427-007-0184-x; Wang Yong, 2010, Yichuan, V32, P307, DOI 10.3724/SP.J.1005.2010.00307; Wang Y, 2009, J MOL EVOL, V68, P629, DOI 10.1007/s00239-009-9232-7; Zheng X, 2009, MAMM GENOME, V20, P236, DOI 10.1007/s00335-009-9176-7	25	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26878	10.1371/journal.pone.0026878	http://dx.doi.org/10.1371/journal.pone.0026878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096504	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800015
J	Mattia, K; Puffer, BA; Williams, KL; Gonzalez, R; Murray, M; Sluzas, E; Pagano, D; Ajith, S; Bower, M; Berdougo, E; Harris, E; Doranz, BJ				Mattia, Kimberly; Puffer, Bridget A.; Williams, Katherine L.; Gonzalez, Ritela; Murray, Meredith; Sluzas, Emily; Pagano, Dan; Ajith, Sandya; Bower, Megan; Berdougo, Eli; Harris, Eva; Doranz, Benjamin J.			Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes	PLOS ONE			English	Article							WEST-NILE-VIRUS; PACKAGING CELL-LINE; DC-SIGN; MONOCLONAL-ANTIBODIES; INFECTION; DETERMINANTS; ASSAY; IDENTIFICATION; ENCEPHALITIS; PATHOGENESIS	The lack of reliable, high-throughput tools for characterizing anti-dengue virus (DENV) antibodies in large numbers of serum samples has been an obstacle in understanding the impact of neutralizing antibodies on disease progression and vaccine efficacy. A reporter system using pseudoinfectious DENV reporter virus particles (RVPs) was previously developed by others to facilitate the genetic manipulation and biological characterization of DENV virions. In the current study, we demonstrate the diagnostic utility of DENV RVPs for measuring neutralizing antibodies in human serum samples against all four DENV serotypes, with attention to the suitability of DENV RVPs for large-scale, long-term studies. DENV RVPs used against human sera yielded serotype-specific responses and reproducible neutralization titers that were in statistical agreement with Plaque Reduction Neutralization Test (PRNT) results. DENV RVPs were also used to measure neutralization titers against the four DENV serotypes in a panel of human sera from a clinical study of dengue patients. The high-throughput capability, stability, rapidity, and reproducibility of assays using DENV RVPs offer advantages for detecting immune responses that can be applied to large-scale clinical studies of DENV infection and vaccination.	[Mattia, Kimberly; Puffer, Bridget A.; Murray, Meredith; Sluzas, Emily; Pagano, Dan; Ajith, Sandya; Bower, Megan; Berdougo, Eli; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA; [Williams, Katherine L.; Gonzalez, Ritela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mattia, K (corresponding author), Integral Mol Inc, Philadelphia, PA USA.	bdoranz@integralmolecular.com		Pagano, Daniel/0000-0002-6513-3870	National Institutes of Health [AI062100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI062100, R42AI062100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health, Grant # AI062100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Dowd KA, PLOS PATHOG, V7; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.1.531-538.2004; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Lai CY, 2008, J BIOMED SCI, V15, P15, DOI 10.1007/s11373-007-9204-0; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Martin NC, 2006, J VIROL METHODS, V134, P74, DOI 10.1016/j.jviromet.2005.12.002; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Puffer BA, 2010, [Flavivirus reporter virus and methods of making and using the same, US Pat #], Patent No. [12/942,632, 12942632]; Putnak JR, 2008, AM J TROP MED HYG, V79, P115, DOI 10.4269/ajtmh.2008.79.115; Rocha C, 2009, AM J TROP MED HYG, V81, P287, DOI 10.4269/ajtmh.2009.81.287; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Shanaka W. W., 2009, American Journal of Tropical Medicine and Hygiene, V80, P61; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; WHO, 2005, REP COLL STUD ASS SU	34	51	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27252	10.1371/journal.pone.0027252	http://dx.doi.org/10.1371/journal.pone.0027252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096543	Green Submitted, gold, Green Published			2022-12-27	WOS:000297350800040
J	Wu, HY; Chen, LH; Zhou, QL; Zhang, WZ				Wu, Hongyu; Chen, Lihe; Zhou, Qiaoling; Zhang, Wenzheng			AF17 Facilitates Dot1a Nuclear Export and Upregulates ENaC-Mediated Na plus Transport in Renal Collecting Duct Cells	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; HISTONE H3; MINERALOCORTICOID RECEPTOR; SUBCELLULAR-LOCALIZATION; NONCOORDINATE REGULATION; MEMBRANE TOPOLOGY; SUBUNIT PROTEINS; ALDOSTERONE; ALPHA; KIDNEY	Our previous work in 293T cells and AF17(-/-) mice suggests that AF17 upregulates expression and activity of the epithelial Na(+) channel (ENaC), possibly by relieving Dot1a-AF9-mediated repression. However, whether and how AF17 directly regulates Dot1a cellular distribution and ENaC function in renal collecting duct cells remain unaddressed. Here, we report our findings in mouse cortical collecting duct M-1 cells that overexpression of AF17 led to preferential distribution of Dot1a in the cytoplasm. This effect could be blocked by nuclear export inhibitor leptomycin B. siRNA-mediated depletion of AF17 caused nuclear accumulation of Dot1a. AF17 overexpression elicited multiple effects that are reminiscent of aldosterone action. These effects include 1) increased mRNA and protein expression of the three ENaC subunits (alpha, beta and gamma) and serum- and glucocorticoid inducible kinase 1, as revealed by real-time RT-qPCR and immunoblotting analyses; 2) impaired Dot1a-AF9 interaction and H3 K79 methylation at the alpha ENaC promoter without affecting AF9 binding to the promoter, as evidenced by chromatin immunoprecipitation; and 3) elevated ENaC-mediated Na+ transport, as analyzed by measurement of benzamil-sensitive intracellular [Na(+)] and equivalent short circuit current using single-cell fluorescence imaging and an epithelial Volt-ohmmeter, respectively. Knockdown of AF17 elicited opposite effects. However, combination of AF17 overexpression or depletion with aldosterone treatment did not cause an additive effect on mRNA expression of the ENaC subunits. Taken together, we conclude that AF17 promotes Dot1a nuclear export and upregulates basal, but not aldosterone-stimulated ENaC expression, leading to an increase in ENaC-mediated Na(+) transport in renal collecting duct cells.	[Wu, Hongyu; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA; [Chen, Lihe; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA; [Zhou, Qiaoling] Cent S Univ, Xiangya Hosp, Dept Internal Med, Changsha, Hunan, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University	Wu, HY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA.	wenzheng.zhang@uth.tmc.edu	Chen, Lihe/N-3186-2018	Chen, Lihe/0000-0002-6207-6364	American Heart Association [0865271F]; American Society of Nephrology; National Institutes of Health [R01 DK080236]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080236] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Nephrology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Heart Association Beginning Grant-in-Aid 0865271F (to WZ), American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (to WZ), and National Institutes of Health grants R01 DK080236 (to WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Akkiprik M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-103; Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chang CT, 2007, NEPHROL DIAL TRANSPL, V22, P722, DOI 10.1093/ndt/gfl668; CHEN L, J AM SOC NEPHROL, V22, P1076; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Escoubet B, 1997, AM J PHYSIOL-CELL PH, V272, pC1482, DOI 10.1152/ajpcell.1997.272.5.C1482; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; May A, 1997, J AM SOC NEPHROL, V8, P1813; MCENEANEY V, MOL CELL ENDOCRINOL, V325, P8; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nishi M, 2001, MOL ENDOCRINOL, V15, P1077, DOI 10.1210/me.15.7.1077; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; PAN YJ, 1982, HYPERTENSION, V4, P279, DOI 10.1161/01.HYP.4.2.279; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; PERLEWITZ A, NUCL ACIDS RES, V38, P5746; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; POINDEXTER BJ, 2005, J BURNS WOUNDS, V4, P128; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; RENARD S, 1994, J BIOL CHEM, V269, P12981; RENARD S, 1995, PFLUG ARCH EUR J PHY, V430, P299, DOI 10.1007/BF00373903; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; SCHNERMANN JB, 1998, KIDNEY PHYSL; Sheldon C, 2004, PFLUG ARCH EUR J PHY, V449, P307, DOI 10.1007/s00424-004-1344-8; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang S, 2009, J MEMBRANE BIOL, V227, P77, DOI 10.1007/s00232-008-9145-1; Waseem TV, 2007, BRAIN RES BULL, V73, P135, DOI 10.1016/j.brainresbull.2007.03.002; Weisz OA, 2003, AM J PHYSIOL-RENAL, V285, pF833, DOI 10.1152/ajprenal.00088.2003; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2004, AM J PHYSIOL-RENAL, V286, pF1171, DOI 10.1152/ajprenal.00043.2003; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27429	10.1371/journal.pone.0027429	http://dx.doi.org/10.1371/journal.pone.0027429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087315	Green Submitted, gold, Green Published			2022-12-27	WOS:000297349700044
J	Aachoui, Y; Ghosh, SK				Aachoui, Youssef; Ghosh, Swapan K.			Extracellular Matrix from Porcine Small Intestinal Submucosa (SIS) as Immune Adjuvants	PLOS ONE			English	Article							INFLAMMATORY DENDRITIC CELLS; VACCINE; ACTIVATION; GENERATION; BIOLOGY; PROTEIN; DANGER; GROWTH; REPAIR	Porcine small intestinal submucosa (SIS) of Cook Biotech is licensed and widely used for tissue remodeling in humans. SIS was shown to be highly effective as an adjuvant in model studies with prostate and ovarian cancer vaccines. However, SIS adjuvanticity relative to alum, another important human-licensed adjuvant, has not yet been delineated in terms of activation of innate immunity via inflammasomes and boosting of antibody responses to soluble proteins and hapten-protein conjugates. We used ovalbumin, and a hapten-protein conjugate, phthalate-keyhole limpet hemocyanin. The evaluation of SIS was conducted in BALB/c and C57BL/6 mice using both intraperitoneal and subcutaneous routes. Inflammatory responses were studied by microarray profiling of chemokines and cytokines and by qPCR of inflammasomes-related genes. Results showed that SIS affected cytokine and chemokines microenvironments such as up-regulation of IL-4 and CD30-ligand and activation of chemotactic factors LIX and KC (neutrophil chemotactic factors), MCP-1 (monocytes chemotactic factors), MIP 1-alpha (macrophage chemotactic factor) and lymphotactin, as well as, growth factors like M-CSF. SIS also promoted gene expression of Nod-like receptors (NLR) and associated downstream effectors. However, in contrast to alum, SIS had no effects on pro-inflammatory cytokines (IL-6, IL-1 beta, TNF-alpha) or NLRP3, but it appeared to promote both Th1 and Th2 responses under different conditions. Lastly, it was as effective as alum in engendering a lasting and specific antibody response, primarily of IgG1 type.	[Aachoui, Youssef; Ghosh, Swapan K.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University	Ghosh, SK (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	sghosh@indstate.edu			Cook Biotech; Fraternal Order of Eagles; graduate school of Indiana State University	Cook Biotech; Fraternal Order of Eagles; graduate school of Indiana State University	The work was supported by grants from Cook Biotech, and the Fraternal Order of Eagles and the graduate school of Indiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachoui Y, 2011, CELL IMMUNOL; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054; Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Badylak, 1996, Patent No. 5516533; Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349; Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032; Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071; Conti L, 2008, EUR J IMMUNOL, V38, P750, DOI 10.1002/eji.200737395; Coombe D, 1998, IMMUNOL CELL BIOL, V76, P114; Crapo PM, 2010, ACTA BIOMATER, V6, P2091, DOI 10.1016/j.actbio.2009.10.048; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; GHOSH SK, 1984, J IMMUNOL, V133, P1677; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; KNOPP BP, 1995, UROLOGY, V46, P396, DOI 10.1016/S0090-4295(99)80227-1; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kuroda Y, 2004, BIOMED PHARMACOTHER, V58, P325, DOI 10.1016/j.biopha.2004.04.009; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lim So-Yon, 2006, J Immune Based Ther Vaccines, V4, P6, DOI 10.1186/1476-8518-4-6; Lim SY, 2003, IMMUNOLOGY, V110, P482, DOI 10.1111/j.1365-2567.2003.01765.x; Mathews RJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2525; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reiter R, 2002, IMMUNOLOGY, V106, P222, DOI 10.1046/j.1365-2567.2002.01405.x; Rosen Michael, 2005, Surg Innov, V12, P227, DOI 10.1177/155335060501200307; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; STANLEY ER, 1994, STEM CELLS, V12, P15; Suckow MA, 2008, ANTICANCER RES, V28, P2529; Suckow MA, 2007, CANCER IMMUNOL IMMUN, V56, P1275, DOI 10.1007/s00262-006-0278-8; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Wang HB, 2008, J LEUKOCYTE BIOL, V83, P817, DOI 10.1189/jlb.0607392; Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	45	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27083	10.1371/journal.pone.0027083	http://dx.doi.org/10.1371/journal.pone.0027083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087247	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700015
J	Trinko, R; Gan, GL; Gao, XB; Sears, RM; Guarnieri, DJ; DiLeone, RJ				Trinko, Richard; Gan, Geliang; Gao, Xiao-Bing; Sears, Robert M.; Guarnieri, Douglas J.; DiLeone, Ralph J.			Erk1/2 Mediates Leptin Receptor Signaling in the Ventral Tegmental Area	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; PROOPIOMELANOCORTIN NEURONS; INDUCED ANOREXIA; ARCUATE NUCLEUS; FOOD-INTAKE; INSULIN; HYPOTHALAMUS; EXPRESSION; RAT; TRANSCRIPTION-3	Leptin acts on the ventral tegmental area (VTA) to modulate neuronal function and feeding behavior in rats and mice. To identify the intracellular effectors of the leptin receptor (Lepr), downstream signal transduction events were assessed for regulation by direct leptin infusion. Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) and phosphorylated extracellular signal-regulated kinase-1 and -2 (pERK1/2) were increased in the VTA while phospho-AKT (pAKT) was unaffected. Pretreatment of brain slices with the mitogen-activated protein kinase kinase -1 and -2 (MEK1/2) inhibitor U0126 blocked the leptin-mediated decrease in firing frequency of VTA dopamine neurons. The anorexigenic effects of VTA-administered leptin were also blocked by pretreatment with U0126, which effectively blocked phosphorylation of ERK1/2 but not STAT3. These data demonstrate that pERK1/2 may have a critical role in mediating both the electrophysiogical and behavioral effects of leptin receptor signaling in the VTA.	[Trinko, Richard; Sears, Robert M.; Guarnieri, Douglas J.; DiLeone, Ralph J.] Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat,Ribicoff Res Facil, New Haven, CT 06520 USA; [Gan, Geliang; Gao, Xiao-Bing] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA	Yale University; Yale University	Trinko, R (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat,Ribicoff Res Facil, New Haven, CT 06520 USA.	ralph.dileone@yale.edu	Gao, Xiao-Bing/C-3121-2011	Gao, Xiao-Bing/0000-0002-2035-4936; , robert/0000-0001-5688-1853; DiLeone, Ralph/0000-0002-4770-2590	National Institutes of Health (NIH) [DK076964]; State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076964] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (NIH) grant DK076964 to R.J.D. and the State of Connecticut, Department of Mental Health and Addiction Services (R.J.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Baskin DG, 2000, REGUL PEPTIDES, V92, P9, DOI 10.1016/S0167-0115(00)00143-9; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Carvalheira JBC, 2005, OBES RES, V13, P48, DOI 10.1038/oby.2005.7; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Johansson A, 2008, PEPTIDES, V29, P1588, DOI 10.1016/j.peptides.2008.04.018; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Lindblom J, 2005, MOL BRAIN RES, V133, P37, DOI 10.1016/j.molbrainres.2004.09.025; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Morton GJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE202, DOI 10.1152/ajpendo.90865.2008; Muroya S, 2004, EUR J NEUROSCI, V19, P1524, DOI 10.1111/j.1460-9568.2004.03255.x; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Numan S, 1999, MOL BRAIN RES, V72, P97, DOI 10.1016/S0169-328X(99)00160-6; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Robertson SA, 2008, PHYSIOL BEHAV, V94, P637, DOI 10.1016/j.physbeh.2008.04.005; Wang JH, 2008, NEUROSCIENCE, V156, P89, DOI 10.1016/j.neuroscience.2008.04.079; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301	32	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27180	10.1371/journal.pone.0027180	http://dx.doi.org/10.1371/journal.pone.0027180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076135	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200047
J	Yu, RJ; Zhao, LY; Lu, L				Yu, Rongjun; Zhao, Liyan; Lu, Lin			Regional Grey and White Matter Changes in Heavy Male Smokers	PLOS ONE			English	Article							QUALITY-OF-LIFE; NICOTINE DEPENDENCE; CIGARETTE-SMOKING; BRAIN; ADDICTION; RECEPTORS; MRI; ABSTINENCE; RESPONSES; VOLUMES	Cigarette smoking is highly prevalent in the general population but the effects of chronic smoking on brain structures are still unclear. Previous studies have found mixed results regarding regional grey matter abnormalities in smokers. To characterize both grey and white matter changes in heavy male smokers, we investigated 16 heavy smokers and 16 matched healthy controls, using both univariate voxel-based morphometry (VBM) and multivariate pattern classification analysis. Compared with controls, heavy smokers exhibited smaller grey matter volume in cerebellum, as well as larger white matter volume in putamen, anterior and middle cingulate cortex. Further, the spatial patterns of grey matter or white matter both discriminated smokers from controls in these regions as well as in other brain regions. Our findings demonstrated volume abnormalities not only in the grey matter but also in the white matter in heavy male smokers. The multivariate analysis suggests that chronic smoking may be associated with volume alternations in broader brain regions than those identified in VBM analysis. These results may better our understanding of the neurobiological consequence of smoking and inform smoking treatment.	[Yu, Rongjun] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England; [Zhao, Liyan; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	South China Normal University; University of Cambridge; Peking University	Yu, RJ (corresponding author), S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	zgywyls2006@bjmu.edu.cn	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524	National Basic Research Program of China (973 Program) [2009CB522000, 2011CB707800]; Natural Science Foundation of China [30725016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Basic Research Program of China (973 Program 2009CB522000 and 2011CB707800) - http://program.most.gov.cn/; Natural Science Foundation of China (No. 30725016) - http://www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Gazdzinski S, 2005, ALCOHOL CLIN EXP RES, V29, P1484, DOI 10.1097/01.alc.0000175018.72488.61; GONG Q, 2010, NEUROIMAGE; Hoeft F, 2008, ARCH GEN PSYCHIAT, V65, P1087, DOI 10.1001/archpsyc.65.9.1087; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Jarraya B, 2010, J NEUROSURG, V113, P1219, DOI 10.3171/2010.6.JNS10346; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Liao Y, 2010, ADDICT BIOL; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; McClernon FJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1940, DOI 10.1038/sj.npp.1300780; Naha N, 2009, SYNAPSE, V63, P847, DOI 10.1002/syn.20662; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Schmitz N, 2003, AM J PSYCHIAT, V160, P1670, DOI 10.1176/appi.ajp.160.9.1670; Sim ME, 2007, NEUROPSYCHOPHARMACOL, V32, P2229, DOI 10.1038/sj.npp.1301346; Tamagaki C, 2005, AM J PSYCHIAT, V162, P2315, DOI 10.1176/appi.ajp.162.12.2315; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volkow ND, 2003, J NEUROSCI, V23, P11461; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Wilson D, 1999, PREV MED, V29, P139, DOI 10.1006/pmed.1999.0523; Wullner U, 2008, NEUROSCI LETT, V430, P34, DOI 10.1016/j.neulet.2007.10.011; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	34	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27440	10.1371/journal.pone.0027440	http://dx.doi.org/10.1371/journal.pone.0027440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076160	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200074
J	Fernandez-Martos, CM; Gonzalez-Fernandez, C; Gonzalez, P; Maqueda, A; Arenas, E; Rodriguez, FJ				Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Gonzalez, Pau; Maqueda, Alfredo; Arenas, Ernest; Javier Rodriguez, Francisco			Differential Expression of Wnts after Spinal Cord Contusion Injury in Adult Rats	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SIGNALING CONTROLS; INFLAMMATORY RESPONSES; ALZHEIMERS-DISEASE; STEM-CELLS; BRAIN; LITHIUM; REGENERATION; ACTIVATION	Background: Spinal cord injury is a major cause of disability that has no clinically accepted treatment. Functional decline following spinal cord injury is caused by mechanical damage, secondary cell death, reactive gliosis and a poor regenerative capacity of damaged axons. Wnt proteins are a family of secreted glycoproteins that play key roles in different developmental processes although little is known of the expression patterns and functions of Wnts in the adult central nervous system in normal or diseased states. Findings: Using qRT-PCR analysis, we demonstrate that mRNA encoding most Wnt ligands and soluble inhibitors are constitutively expressed in the healthy adult spinal cord. Strikingly, contusion spinal cord injury induced a time-dependent increase in Wnt mRNA expression from 6 hours until 28 days post-injury, and a narrow peak in the expression of soluble Wnt inhibitors between 1 and 3 days post-injury. These results are consistent with the increase in the migration shift, from day 1 to 7, of the intracellular Wnt signalling component, Dishevelled-3. Moreover, after an initial decrease by 1 day, we also found an increase in phosphorylation of the Wnt co-receptor, low-density lipoprotein receptor-related protein 6, and an increase in active beta-catenin protein, both of which suffer a dramatic change, from a homogeneous expression pattern in the grey matter to a disorganized injury-induced pattern. Conclusions: Our results suggest a role for Wnts in spinal cord homeostasis and injury. We demonstrate that after injury Wnt signalling is activated via the Wnt/beta-catenin and possibly other pathways. These findings provide an important foundation to further address the function of individual Wnt proteins in vivo and the pathophysiology of spinal cord injury.	[Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Gonzalez, Pau; Maqueda, Alfredo; Javier Rodriguez, Francisco] HNP, Lab Neurol Mol, Toledo, Spain; [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Unit, MBB, Stockholm, Sweden	Karolinska Institutet	Fernandez-Martos, CM (corresponding author), HNP, Lab Neurol Mol, Toledo, Spain.	fjrodriguez@sescam.jccm.es	González, Carlos/AAG-9659-2019; Fernandez-Martos, Carmen/J-7770-2014; Sanchez, Pau Gonzalez/J-2530-2019; Rodríguez Muñoz, Francisco Javier/GZM-5286-2022; Arenas, Ernest/AAO-5231-2020	González, Carlos/0000-0002-3415-0723; Fernandez-Martos, Carmen/0000-0002-6387-4456; Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodríguez Muñoz, Francisco Javier/0000-0001-5902-7556; Arenas, Ernest/0000-0003-0197-6577; Maqueda Fernandez, Alfredo/0000-0002-0117-5422	Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM) [PI2008-39]; Fondode Investigaciones Sanitarias (FIS) [PI08-1475]; Fondo Europeo de Desarrollo Regional (FEDER); FISCAM [MOV-2009_JI-06]	Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM); Fondode Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); FISCAM	This work was supported by: Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM; Grant PI2008-39) and Fondode Investigaciones Sanitarias (FIS; Grant PI08-1475 with Fondo Europeo de Desarrollo Regional (FEDER) co-funding). Carlos Gonzalez-Fernandez was supported by FISCAM (MOV-2009_JI-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam SY, 2007, CURR ALZHEIMER RES, V4, P21; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bian QM, 2007, BRAIN RES, V1184, P270, DOI 10.1016/j.brainres.2007.09.054; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Chen RW, 2003, J NEUROCHEM, V84, P566, DOI 10.1046/j.1471-4159.2003.01548.x; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P153, DOI 10.4161/oxim.3.2.11758; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V318, P79, DOI 10.1124/jpet.106.102863; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18; Eto M, 2005, CIRCULATION, V112, P1316, DOI 10.1161/CIRCULATIONAHA.105.564112; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fernandez CM, 2009, BIOCHIM BIOPHYS ACTA, V1803, P1131; Fradkin LG, 2010, TRENDS NEUROSCI, V33, P84, DOI 10.1016/j.tins.2009.11.005; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Goodwin AM, 2007, GROWTH FACTORS, V25, P25, DOI 10.1080/08977190701272933; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim H, 2010, NEUROBIOL A IN PRESS; Knafo S, 2008, BRIT J NEUROSURG, V22, P3, DOI 10.1080/02688690701593595; Komiya Yuko, 2008, Organogenesis, V4, P68; Kubo F, 2008, DEV GROWTH DIFFER, V50, P245, DOI [10.1111/j.1440-169X.2008.01033.x, 10.1111/j.1440-169x.2008.01033.x]; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; Lei ZN, 2008, NEUROSCI LETT, V435, P108, DOI 10.1016/j.neulet.2008.02.031; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Pishvaian Michael J., 2007, Cancer Biomarkers, V3, P263; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Preston E, 2001, J NEUROTRAUM, V18, P83, DOI 10.1089/089771501750055794; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Rosenberg SS, 2009, GENE DEV, V23, P1487, DOI 10.1101/gad.1824009; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Suh HI, 2011, ACTA NEUROC IN PRESS; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wong YW, 2011, SPINAL CORD, V49, P94, DOI 10.1038/sc.2010.69; Yick LW, 2004, J NEUROTRAUM, V21, P932, DOI 10.1089/neu.2004.21.932; Yin Zong-Sheng, 2007, Neurol Res, V29, P847, DOI 10.1179/016164107X223539; Yin ZS, 2008, NEUROL RES, V30, P480, DOI 10.1179/174313208X284133; Zenzmaier C, 2009, J NEUROCHEM, V110, P653, DOI 10.1111/j.1471-4159.2009.06158.x; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	100	66	79	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27000	10.1371/journal.pone.0027000	http://dx.doi.org/10.1371/journal.pone.0027000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073235	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900059
J	Tonione, MA; Reeder, N; Moritz, CC				Tonione, Maria A.; Reeder, Natalie; Moritz, Craig C.			High Genetic Diversity Despite the Potential for Stepping-Stone Colonizations in an Invasive Species of Gecko on Moorea, French Polynesia	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; HEMIDACTYLUS GECKOS; MITOCHONDRIAL-DNA; HOUSE GECKOS; BIOLOGICAL INVASION; GUINEA ISLANDS; CANE TOAD; EVOLUTION; GEKKONIDAE; BIOGEOGRAPHY	Invasive species often have reduced genetic diversity, but the opposite can be true if there have been multiple introductions and genetic admixture. Reduced diversity is most likely soon after establishment, in remote locations, when there is lower propagule pressure and with stepping-stone colonizations. The common house gecko (Hemidactylus frenatus) was introduced to Moorea, French Polynesia in the remote eastern Pacific within the last two decades and accordingly is expected to exhibit low diversity. In contrast, we show that H. frenatus on Moorea has exceptionally high genetic diversity, similar to that near the native range in Asia and much higher than reported for other Pacific island reptiles. The high diversity in this recently founded population likely reflects extensive genetic admixture in source population(s) and a life history that promotes retention of diversity. These observations point to the importance of understanding range-wide dynamics of genetic admixture in highly invasive species.	[Tonione, Maria A.; Moritz, Craig C.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Reeder, Natalie] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California Berkeley; California State University System; San Francisco State University	Tonione, MA (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	riatoni@berkeley.edu	Tonione, Maria/ABB-8483-2021	Tonione, Maria/0000-0001-7447-213X	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research is a component of the Moorea Biocode Project, supported by the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Arnold EN, 2008, ZOOL SCR, V37, P619, DOI 10.1111/j.1463-6409.2008.00351.x; Austin CC, 1999, NATURE, V397, P113, DOI 10.1038/16365; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Bansal R, 2010, MOL PHYLOGENET EVOL, V57, P459, DOI 10.1016/j.ympev.2010.06.008; Bauer AM, 2010, MOL PHYLOGENET EVOL, V57, P343, DOI 10.1016/j.ympev.2010.06.014; Brown W. C., 1957, Copeia, V1957, P39, DOI 10.2307/1440508; Bruna EM, 1996, P ROY SOC B-BIOL SCI, V263, P681, DOI 10.1098/rspb.1996.0102; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Carranza S, 2006, MOL PHYLOGENET EVOL, V38, P531, DOI 10.1016/j.ympev.2005.07.012; Case Ted J., 1992, P91; CASE TJ, 1991, EVOL ECOL, V5, P272, DOI 10.1007/BF02214232; CASE TJ, 1994, ECOLOGY, V75, P464, DOI 10.2307/1939550; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cole NC, 2005, BIOL CONSERV, V125, P467, DOI 10.1016/j.biocon.2005.04.017; Dame EA, 2006, ANIM BEHAV, V71, P1165, DOI 10.1016/j.anbehav.2005.10.009; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Estoup A, 2010, MOL ECOL RESOUR, V10, P886, DOI 10.1111/j.1755-0998.2010.02882.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feng J, 2007, ZOOL SCI, V24, P656, DOI 10.2108/zsj.24.656; Fisher RN, 1997, EVOLUTION, V51, P906, DOI 10.1111/j.1558-5646.1997.tb03672.x; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Harris DJ, 2004, AMPHIBIA-REPTILIA, V25, P451; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoskin C, 2010, AUSTRAL ECOLOGY; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; INEICH I, 1988, Atoll Research Bulletin, P1; Jesus J, 2005, MOL PHYLOGENET EVOL, V34, P480, DOI 10.1016/j.ympev.2004.11.006; Jesus J, 2006, HERPETOL J, V16, P291; Joly S, 2006, SYST BIOL, V55, P623, DOI 10.1080/10635150600863109; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; McKeown S, 1996, FIELD GUIDE REPTILES; Meyer CP, 2004, MALACOLOGIA, V46, P127; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1006/bijl.1993.1010; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA, 2004, MRMODELTEST 2 0; Ota Hidetoshi, 2006, Current Herpetology, V25, P97, DOI 10.3105/1345-5834(2006)25[97:COTGDD]2.0.CO;2; Peacock MM, 2009, MOL ECOL, V18, P3603, DOI 10.1111/j.1365-294X.2009.04308.x; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Pritchard JK, 2000, GENETICS, V155, P945; Rato C, 2011, MOL PHYLOGENET EVOL, V58, P365, DOI 10.1016/j.ympev.2010.12.004; Rato C, 2010, MOL PHYLOGENET EVOL, V56, P962, DOI 10.1016/j.ympev.2010.04.033; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thulin CG, 2006, MOL ECOL, V15, P3947, DOI 10.1111/j.1365-294X.2006.03084.x; Tinghitella RM, 2011, J EVOLUTION BIOL, V24, P1199, DOI 10.1111/j.1420-9101.2011.02255.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vences M, 2004, BIOL J LINN SOC, V83, P115, DOI 10.1111/j.1095-8312.2004.00370.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8; Yamamoto Yurie, 2006, Current Herpetology, V25, P39, DOI 10.3105/1345-5834(2006)25[39:LFSSBA]2.0.CO;2; Zalewski A, 2010, BIOL CONSERV, V143, P1355, DOI 10.1016/j.biocon.2010.03.009; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	73	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26874	10.1371/journal.pone.0026874	http://dx.doi.org/10.1371/journal.pone.0026874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073211	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900048
J	Hirahatake, KM; Meissen, JK; Fiehn, O; Adams, SH				Hirahatake, Kristin M.; Meissen, John K.; Fiehn, Oliver; Adams, Sean H.			Comparative Effects of Fructose and Glucose on Lipogenic Gene Expression and Intermediary Metabolism in HepG2 Liver Cells	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; HEXOSAMINE BIOSYNTHESIS; INSULIN-RESISTANCE; DIETARY FRUCTOSE; HEPATIC LIPOGENESIS; RAT HEPATOCYTES; MESSENGER-RNA; HEALTHY-MEN; CARBOHYDRATE; DISEASE	Consumption of large amounts of fructose or sucrose increases lipogenesis and circulating triglycerides in humans. Although the underlying molecular mechanisms responsible for this effect are not completely understood, it is possible that as reported for rodents, high fructose exposure increases expression of the lipogenic enzymes fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC-1) in human liver. Since activation of the hexosamine biosynthesis pathway (HBP) is associated with increases in the expression of FAS and ACC-1, it raises the possibility that HBP-related metabolites would contribute to any increase in hepatic expression of these enzymes following fructose exposure. Thus, we compared lipogenic gene expression in human-derived HepG2 cells after incubation in culture medium containing glucose alone or glucose plus 5 mM fructose, using the HBP precursor 10 mM glucosamine (GlcN) as a positive control. Cellular metabolite profiling was conducted to analyze differences between glucose and fructose metabolism. Despite evidence for the active uptake and metabolism of fructose by HepG2 cells, expression of FAS or ACC-1 did not increase in these cells compared with those incubated with glucose alone. Levels of UDP-N-acetylglucosamine (UDP-GlcNAc), the end-product of the HBP, did not differ significantly between the glucose and fructose conditions. Exposure to 10 mM GlcN for 10 minutes to 24 hours resulted in 8-fold elevated levels of intracellular UDP-GlcNAc (P<0.001), as well as a 74-126% increase in FAS (P<0.05) and 49-95% increase in ACC-1 (P<0.01) expression above controls. It is concluded that in HepG2 liver cells cultured under standard conditions, sustained exposure to fructose does not result in an activation of the HBP or increased lipogenic gene expression. Should this scenario manifest in human liver in vivo, it would suggest that high fructose consumption promotes triglyceride synthesis primarily through its action to provide lipid precursor carbon and not by activating lipogenic gene expression.	[Hirahatake, Kristin M.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Meissen, John K.; Fiehn, Oliver] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Meissen, John K.; Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Adams, Sean H.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Hirahatake, KM (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	sean.h.adams@ars.usda.gov	ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319	United States Department of Agriculture (USDA)-Agricultural Research Service [5306-51530-016-00D, 5306-51530-019-00]; Diabetes Action and Research Education Fund	United States Department of Agriculture (USDA)-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Diabetes Action and Research Education Fund	This work was funded in part by the following: intramural United States Department of Agriculture (USDA)-Agricultural Research Service Projects 5306-51530-016-00D and 5306-51530-019-00 and a pilot grant from the Diabetes Action and Research Education Fund (to SHA). USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Adams SH, 2008, ENDOCRINOLOGY, V149, P3002, DOI 10.1210/en.2007-1812; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bray GA, 2004, AM J CLIN NUTR, V79, P537; BRUCKDORFER KR, 1972, BIOCHEM J, V129, P439, DOI 10.1042/bj1290439; Collison KS, 2009, OBESITY, V17, P2003, DOI 10.1038/oby.2009.58; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; DeHaven JE, 2001, DIABETES, V50, P2419, DOI 10.2337/diabetes.50.11.2419; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; HERS HG, 1952, BIOCHIM BIOPHYS ACTA, V8, P416, DOI 10.1016/0006-3002(52)90067-X; HERZBERG GR, 1982, CAN J PHYSIOL PHARM, V60, P912, DOI 10.1139/y82-128; Jijakli H, 2003, J BIOL CHEM, V278, P4531, DOI 10.1074/jbc.M206730200; KATZEN HM, 1965, P NATL ACAD SCI USA, V54, P1218, DOI 10.1073/pnas.54.4.1218; Kazumi T, 1997, ENDOCR J, V44, P239, DOI 10.1507/endocrj.44.239; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Le KA, 2008, DIABETES METAB, V34, P82, DOI 10.1016/j.diabet.2007.08.004; Malaisse WJ, 2002, MOL CELL BIOCHEM, V241, P103, DOI 10.1023/A:1020818810935; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; MENDELOFF AI, 1953, METABOLISM, V2, P450; Moreno-Aliaga MJ, 2007, J MOL ENDOCRINOL, V38, P537, DOI 10.1677/JME-06-0034; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Nagata R, 2004, J BIOL CHEM, V279, P29031, DOI 10.1074/jbc.M309449200; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Rumberger JM, 2003, J BIOL CHEM, V278, P28547, DOI 10.1074/jbc.M302793200; Sage AT, 2010, AM J PHYSIOL-ENDOC M, V298, pE499, DOI 10.1152/ajpendo.00507.2009; Scruel O, 1997, MOL CELL BIOCHEM, V175, P263, DOI 10.1023/A:1006834010660; SHAFRIR E, 1975, ISRAEL J MED SCI, V11, P738; SPENCE JT, 1982, EUR J BIOCHEM, V128, P15; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; WINDER WW, 1975, P SOC EXP BIOL MED, V148, P1150, DOI 10.3181/00379727-148-38706	40	35	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26583	10.1371/journal.pone.0026583	http://dx.doi.org/10.1371/journal.pone.0026583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096489	gold, Green Submitted, Green Published			2022-12-27	WOS:000297553900005
J	Pope, BD; Tsumagari, K; Battaglia, D; Ryba, T; Hiratani, I; Ehrlich, M; Gilbert, DM				Pope, Benjamin D.; Tsumagari, Koji; Battaglia, Dana; Ryba, Tyrone; Hiratani, Ichiro; Ehrlich, Melanie; Gilbert, David M.			DNA Replication Timing Is Maintained Genome-Wide in Primary Human Myoblasts Independent of D4Z4 Contraction in FSH Muscular Dystrophy	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; FACIOSCAPULOHUMERAL DYSTROPHY; SMOOTH-MUSCLE; CHROMATIN; GENE; EXPRESSION; LOCUS; DIFFERENTIATION; REPEAT; MOUSE	Facioscapulohumeral muscular dystrophy (FSHD) is linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.2 from 11-100 copies to 1-10 copies. The extent to which D4Z4 contraction at 4q35.2 affects overall 4q35.2 chromatin organization remains unclear. Because DNA replication timing is highly predictive of long-range chromatin interactions, we generated genome-wide replication-timing profiles for FSHD and control myogenic precursor cells. We compared non-immortalized myoblasts from four FSHD patients and three control individuals to each other and to a variety of other human cell types. This study also represents the first genome- wide comparison of replication timing profiles in non-immortalized human cell cultures. Myoblasts from both control and FSHD individuals all shared a myoblast-specific replication profile. In contrast, male and female individuals were readily distinguished by monoallelic differences in replication timing at DXZ4 and other regions across the X chromosome affected by X inactivation. We conclude that replication timing is a robust cell-type specific feature that is unaffected by FSHD-related D4Z4 contraction.	[Pope, Benjamin D.; Battaglia, Dana; Ryba, Tyrone; Hiratani, Ichiro; Gilbert, David M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Tsumagari, Koji; Ehrlich, Melanie] Dept Biochem, Human Genet Program, New Orleans, LA USA; [Tsumagari, Koji; Ehrlich, Melanie] Tulane Canc Ctr, Tulane Med Sch, New Orleans, LA USA	State University System of Florida; Florida State University; Tulane University	Pope, BD (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	ehrlich@tulane.edu; gilbert@bio.fsu.edu	Pope, Ben/Y-4326-2019; Hiratani, Ichiro/AAH-6330-2020; Hiratani, Ichiro/N-6424-2015	Pope, Ben/0000-0003-1847-9163; Hiratani, Ichiro/0000-0003-3710-3540; Hiratani, Ichiro/0000-0003-3710-3540	National Institutes of Health [GM083337, AA3768G2]; FSHD Global Research Foundation; Grants-in-Aid for Scientific Research [23770235] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSHD Global Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grants GM083337 to DMG and AA3768G2 to ME, and a grant from the FSHD Global Research Foundation to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Chadwick BP, 2009, CHROMOSOMA, V118, P675, DOI 10.1007/s00412-009-0233-5; CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Desprat R, 2009, GENOME RES, V19, P2288, DOI 10.1101/gr.094060.109; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Pope BD, 2010, CHROMOSOME RES, V18, P127, DOI 10.1007/s10577-009-9100-8; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; RYBA T, 2011, PLOS COMPUT IN PRESS; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Stevens Troy, 2008, Proc Am Thorac Soc, V5, P783, DOI 10.1513/pats.200803-027HR; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; TSUMAGARI K, 2011, BMC MED GEN IN PRESS; Tsumagari K, 2008, NUCLEIC ACIDS RES, V36, P2196, DOI 10.1093/nar/gkn055; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wu R, 2006, J CELL BIOL, V174, P185, DOI 10.1083/jcb.200601113; Xu XQ, 2009, NUCLEIC ACIDS RES, V37, P7381, DOI 10.1093/nar/gkp833; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Yang F, 2004, CHROMOSOMA, V112, P350, DOI 10.1007/s00412-004-0280-x; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	51	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27413	10.1371/journal.pone.0027413	http://dx.doi.org/10.1371/journal.pone.0027413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096571	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900043
J	Yamauchi, Y; Izumi, Y; Kawamura, M; Nakatsuka, S; Yashiro, H; Tsukada, N; Inoue, M; Asakura, K; Nomori, H				Yamauchi, Yoshikane; Izumi, Yotaro; Kawamura, Masafumi; Nakatsuka, Seishi; Yashiro, Hideki; Tsukada, Norimasa; Inoue, Masanori; Asakura, Keisuke; Nomori, Hiroaki			Percutaneous Cryoablation of Pulmonary Metastases from Colorectal Cancer	PLOS ONE			English	Article							ACUTE LUNG INJURY; RADIOFREQUENCY ABLATION; SURGICAL-TREATMENT; RESECTION; TUMORS; CRYOTHERAPY; EXPERIENCE; MODEL; PNEUMOTHORAX; CANDIDATES	Objective: To evaluate the safety and efficacy of cryoablation for metastatic lung tumors from colorectal cancer. Methods: The procedures were performed on 24 patients (36-82 years of age, with a median age of 62; 17 male patients, 7 female patients) for 55 metastatic tumors in the lung, during 30 sessions. The procedural safety, local progression free interval, and overall survival were assessed by follow-up computed tomographic scanning performed every 3-4 months. Results: The major complications were pneumothorax, 19 sessions (63%), pleural effusion, 21 sessions (70%), transient and self-limiting hemoptysis, 13 sessions (43%) and tract seeding, 1 session (3%). The 1- and 3-year local progression free intervals were 90.8% and 59%, respectively. The 3-years local progression free intervals of tumors <= 15 mm in diameter was 79.8% and that of tumors >15 mm was 28.6% (p = 0.001; log-rank test). The 1- and 3-year overall survival rates were 91% and 59.6%, respectively. Conclusion: The results indicated that percutaneous cryoablation is a feasible treatment option. The local progression free interval was satisfactory at least for tumors that were <= 15 mm in diameter.	[Yamauchi, Yoshikane; Izumi, Yotaro; Tsukada, Norimasa; Asakura, Keisuke; Nomori, Hiroaki] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Nakatsuka, Seishi; Yashiro, Hideki; Inoue, Masanori] Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Kawamura, Masafumi] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan	Keio University; Keio University; Teikyo University	Yamauchi, Y (corresponding author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	yoshikaney@2004.jukuin.keio.ac.jp	Yamauchi, Yoshikane/I-1952-2019	Yamauchi, Yoshikane/0000-0002-3374-2399; Asakura, Keisuke/0000-0002-4491-3456	Japanese Ministry of Education, Culture, Sports, Science and Technology [21591823, 22591374]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants (#21591823 and #22591374) to MK and to SN respectively, from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge BK, 2006, J ENDOUROL, V20, P1101, DOI 10.1089/end.2006.20.1101; Bahn DK, 2002, UROLOGY, V60, P3, DOI 10.1016/S0090-4295(02)01678-3; Chapman WC, 2000, ARCH SURG-CHICAGO, V135, P667, DOI 10.1001/archsurg.135.6.667; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; Deygas N, 2001, CHEST, V120, P26, DOI 10.1378/chest.120.1.26; Dupuy DE, 2000, AM J ROENTGENOL, V174, P57, DOI 10.2214/ajr.174.1.1740057; Fernando HC, 2005, J THORAC CARDIOV SUR, V129, P639, DOI 10.1016/j.jtcvs.2004.10.019; Girard P, 1996, J CLIN ONCOL, V14, P2047, DOI 10.1200/JCO.1996.14.7.2047; Goldberg SN, 2005, J VASC INTERV RADIOL, V16, P765, DOI 10.1097/01.RVI.0000170858.46668.65; Hiraki T, 2007, J VASC INTERV RADIOL, V18, P1264, DOI 10.1016/j.jvir.2007.06.027; Hruby G, 2008, BJU INT, V102, P723, DOI 10.1111/j.1464-410X.2008.07735.x; Izumi Y, 2005, ANN THORAC SURG, V79, P318, DOI 10.1016/j.athoracsur.2003.09.082; Kawamura M, 2006, J THORAC CARDIOV SUR, V131, P1007, DOI 10.1016/j.jtcvs.2005.12.051; Kelly H, 2005, J CLIN ONCOL, V23, P4553, DOI 10.1200/JCO.2005.17.749; Lee FT, 1997, RADIOLOGY, V202, P624, DOI 10.1148/radiology.202.3.9051005; MCAFEE MK, 1992, ANN THORAC SURG, V53, P780, DOI 10.1016/0003-4975(92)91435-C; MCCORMACK PM, 1992, ARCH SURG-CHICAGO, V127, P1403; Moorjani V, 2001, EUR J CARDIO-THORAC, V20, P502, DOI 10.1016/S1010-7940(01)00815-6; Nakatsuka S, 2010, CRYOBIOLOGY, V61, P317, DOI 10.1016/j.cryobiol.2010.10.157; Okumura S, 1996, J THORAC CARDIOV SUR, V112, P867, DOI 10.1016/S0022-5223(96)70085-5; Permpongkosol S, 2007, J VASC INTERV RADIOL, V18, P283, DOI 10.1016/j.jvir.2006.12.008; Regnard JF, 1998, ANN THORAC SURG, V66, P214, DOI 10.1016/S0003-4975(98)00269-0; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Sakurai J, 2007, J VASC INTERV RADIOL, V18, P141, DOI 10.1016/j.jvir.2006.10.011; Seifert JK, 1999, WORLD J SURG, V23, P1019, DOI 10.1007/s002689900617; Shiono S, 2005, ANN THORAC SURG, V80, P1040, DOI 10.1016/j.athoracsur.2004.12.033; SHIROUZU K, 1995, CANCER, V76, P393, DOI 10.1002/1097-0142(19950801)76:3<393::AID-CNCR2820760308>3.0.CO;2-8; THOMFORD NR, 1965, J THORAC CARDIOV SUR, V49, P357, DOI 10.1016/S0022-5223(19)33271-4; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Wang HW, 2005, RADIOLOGY, V235, P289, DOI 10.1148/radiol.2351030747; Washington K, 2001, J SURG RES, V95, P1, DOI 10.1006/jsre.2000.5976; Yamagami T, 2006, J VASC INTERV RADIOL, V17, P1625, DOI 10.1097/01.RVI.0000236607.05698.4A; Yamakado K, 2009, ONCOL REP, V22, P885, DOI 10.3892/or_00000513	33	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27086	10.1371/journal.pone.0027086	http://dx.doi.org/10.1371/journal.pone.0027086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096520	gold, Green Published, Green Submitted			2022-12-27	WOS:000297350800025
J	Boras-Granic, K; VanHouten, J; Hiremath, M; Wysolmerski, J				Boras-Granic, Kata; VanHouten, Joshua; Hiremath, Minoti; Wysolmerski, John			Parathyroid Hormone-Related Protein Is Not Required for Normal Ductal or Alveolar Development in the Post-Natal Mammary Gland	PLOS ONE			English	Article							BREAST-CANCER; BRANCHING MORPHOGENESIS; TRANSGENIC MICE; SIGNALING PATHWAYS; LACZ EXPRESSION; CELL FATE; OVEREXPRESSION; DIFFERENTIATION; COMMITMENT; MAINTAINS	PTHrP is necessary for the formation of the embryonic mammary gland and, in its absence, the embryonic mammary bud fails to form the neonatal duct system. In addition, PTHrP is produced by the breast during lactation and contributes to the regulation of maternal calcium homeostasis during milk production. In this study, we examined the role of PTHrP during post-natal mammary development. Using a PTHrP-lacZ transgenic mouse, we surveyed the expression of PTHrP in the developing post-natal mouse mammary gland. We found that PTHrP expression is restricted to the basal cells of the gland during pubertal development and becomes expressed in milk secreting alveolar cells during pregnancy and lactation. Based on the previous findings that overexpression of PTHrP in cap and myoepithelial cells inhibited ductal elongation during puberty, we predicted that ablation of native PTHrP expression in the post-natal gland would result in accelerated ductal development. To address this hypothesis, we generated two conditional models of PTHrP-deficiency specifically targeted to the postnatal mammary gland. We used the MMTV-Cre transgene to ablate the floxed PTHrP gene in both luminal and myoepithelial cells and a tetracycline-regulated K14-tTA;tetO-Cre transgene to target PTHrP expression in just myoepithelial and cap cells. In both models of PTHrP ablation, we found that mammary development proceeds normally despite the absence of PTHrP. We conclude that PTHrP signaling is not required for normal ductal or alveolar development.	[Boras-Granic, Kata; VanHouten, Joshua; Wysolmerski, John] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Hiremath, Minoti] Boise State Univ, Dept Biol, Boise, ID 83725 USA	Yale University; Idaho; Boise State University	Boras-Granic, K (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	john.wysolmerski@yale.edu			National Institutes of Health [DK05501, DK077565, CA153702]; Yale Diabetes and Endocrine Research Center (NIH) [P30DK45735]; Yale Core Center for Musculoskeletal Disease (NIH) [P30AR46032]; NATIONAL CANCER INSTITUTE [R01CA153702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK055501, R01DK077565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Diabetes and Endocrine Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Core Center for Musculoskeletal Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following grants: DK05501, DK077565 and CA153702 from the National Institutes of Health. Support was also provided by core facilities funded by the Yale Diabetes and Endocrine Research Center (NIH P30DK45735) and the Yale Core Center for Musculoskeletal Disease (NIH P30AR46032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtari M, 2008, CANCER BIOL THER, V7, P3, DOI 10.4161/cbt.7.1.5163; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chen XS, 2006, J BONE MINER RES, V21, P113, DOI 10.1359/JBMR.051005; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; Dewar R, 2011, ARCH PATHOL LAB MED, V135, P422, DOI 10.1043/2010-0336-CP.1; Dunbar ME, 1998, DEV BIOL, V203, P75, DOI 10.1006/dbio.1998.9029; Dunbar ME, 2001, J ENDOCRINOL, V171, P403, DOI 10.1677/joe.0.1710403; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; EDWARDS RC, 1995, EUR J CANCER, V31A, P334, DOI 10.1016/0959-8049(94)00451-A; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; Fleming NI, 2009, CANCER RES, V69, P7473, DOI 10.1158/0008-5472.CAN-09-0194; Foley J, 2001, DEVELOPMENT, V128, P513; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; LI J, 2008, J BONE MINER RES, pS1016; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Shen XL, 2004, EXP CELL RES, V294, P420, DOI 10.1016/j.yexcr.2003.11.028; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; Vanhouten JN, 2003, ENDOCRINOLOGY, V144, P5521, DOI 10.1210/en.2003-0892; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; Visvader JE, 2011, COLD SPRING HARB PER, V3; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; WYSOLMERSKI JJ, 1995, DEVELOPMENT, V121, P3539; WYSOLMERSKI JJ, 1994, P NATL ACAD SCI USA, V91, P1133, DOI 10.1073/pnas.91.3.1133; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; WYSOLMERSKI JJ, 2008, PRIMER METABOLIC BON, P127	35	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27278	10.1371/journal.pone.0027278	http://dx.doi.org/10.1371/journal.pone.0027278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087279	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700026
J	Bulut, G; Fallen, S; Beauchamp, EM; Drebing, LE; Sun, JF; Berry, DL; Kallakury, B; Crum, CP; Toretsky, JA; Schlegel, R; Uren, A				Bulut, Guelay; Fallen, Shannon; Beauchamp, Elspeth M.; Drebing, Lauren E.; Sun, Junfeng; Berry, Deborah L.; Kallakury, Bhaskar; Crum, Christopher P.; Toretsky, Jeffrey A.; Schlegel, Richard; Ueren, Aykut			Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice	PLOS ONE			English	Article							EPIGENETIC INACTIVATION; SQUAMOUS CARCINOGENESIS; UTERINE CERVIX; RODENT DIETS; WNT PATHWAY; SFRP GENES; CANCER; CARCINOMA; TRANSFORMATION; E6	Human papilloma virus (HPV) is the principal etiological agent of cervical cancer in women, and its DNA is present in virtually all of these tumors. However, exposure to the high-risk HPV types alone is insufficient for tumor development. Identifying specific collaborating factors that will lead to cervical cancer remains an unanswered question, especially because millions of women are exposed to HPV. Our earlier work using an in vitro model indicated that activation of the canonical Wnt pathway in HPV-positive epithelial cells was sufficient to induce anchorage independent growth. We therefore hypothesized that constitutive activation of this pathway might function as the "second hit." To address this possibility, we developed two double-transgenic (DT) mouse models, K14-E7/Delta N87 beta cat and K14-HPV16/Delta N87 beta cat that express either the proteins encoded by the E7 oncogene or the HPV16 early region along with constitutively active beta-catenin, which was expressed by linking it to the keratin-14 (K14) promoter. We initiated tumor formation by treating all groups with estrogen for six months. Invasive cervical cancer was observed in 11% of the K14-Delta N87 beta cat mice, expressing activated beta-catenin and in 50% of the animals expressing the HPV16 E7 oncogene. In double-transgenic mice, coexpression of beta-catenin and HPV16 E7 induced invasive cervical cancer at about 7 months in 94% of the cases. We did not observe cervical cancer in any group unless the mice were treated with estrogen. In the second model, K14-HPV16 mice suffered cervical dysplasias, but this phenotype was not augmented in HPV16/Delta N87 beta cat mice. In summary, the phenotypes of the K14-E7/Delta N87 beta cat mice support the hypothesis that activation of the Wnt/beta-catenin pathway in HPV-associated premalignant lesions plays a functional role in accelerating cervical carcinogenesis.	[Bulut, Guelay; Fallen, Shannon; Beauchamp, Elspeth M.; Drebing, Lauren E.; Toretsky, Jeffrey A.; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Sun, Junfeng] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Kallakury, Bhaskar; Schlegel, Richard] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Crum, Christopher P.] Harvard Univ, Dept Pathol, Boston, MA 02115 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Georgetown University; Harvard University	Fallen, S (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	au26@georgetown.edu	BULUT, GULAY/J-3180-2012		National Institutes of Health (NIH) [CA108641]; Cancer Center [P30 CA051008]; NIH ARRA [1G20 RR025828-01]; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008, R01CA108641] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR025828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NIH ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants from the National Institutes of Health (NIH) CA108641 (to AU), Cancer Center Support Grant P30 CA051008 for use of Shared Resources (H&E and IHC stainings) and NIH ARRA Grant 1G20 RR025828-01 for use of Rodent Barrier Facility Equipment (between 7/20/2009 to 7/19/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Barcroft JD, 2002, THEORY PRACTICE HIST; Brake T, 2003, CANCER RES, V63, P8173; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Elson DA, 2000, CANCER RES, V60, P1267; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Jensen MN, 2007, LAB ANIM-UK, V41, P1, DOI 10.1258/002367707779399428; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; LAMBERT PF, 1993, P NATL ACAD SCI USA, V90, P5583, DOI 10.1073/pnas.90.12.5583; Lee J, 2008, GYNECOL ONCOL, V109, P270, DOI 10.1016/j.ygyno.2008.01.034; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Polakis P, 2000, GENE DEV, V14, P1837; Rampias T, 2010, MOL CANCER RES, V8, P433, DOI 10.1158/1541-7786.MCR-09-0345; Riley RR, 2003, CANCER RES, V63, P4862; Rodriguez-Sastre MA, 2005, GYNECOL ONCOL, V97, P330, DOI 10.1016/j.ygyno.2004.12.062; Shinohara A, 2001, GYNECOL ONCOL, V82, P450, DOI 10.1006/gyno.2001.6298; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Uren A, 2004, PEDIATR BLOOD CANCER, V43, P243, DOI 10.1002/pbc.20124; Wang HB, 2005, P NATL ACAD SCI USA, V102, P9960, DOI 10.1073/pnas.0501632102; Wolf JK, 2003, CANCER-AM CANCER SOC, V98, P2064, DOI 10.1002/cncr.11682	31	48	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27243	10.1371/journal.pone.0027243	http://dx.doi.org/10.1371/journal.pone.0027243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087269	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700030
J	Galbo, T; Olsen, GS; Quistorff, B; Nishimura, E				Galbo, Thomas; Olsen, Grith Skytte; Quistorff, Bjorn; Nishimura, Erica			Free Fatty Acid-Induced PP2A Hyperactivity Selectively Impairs Hepatic Insulin Action on Glucose Metabolism	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHATASE 2A; RESISTANCE; INHIBITION; AKT; PHOSPHORYLATION; ACTIVATION; CELLS; LIVER; OBESE	In type 2 Diabetes (T2D) free fatty acids (FFAs) in plasma are increased and hepatic insulin resistance is "selective", in the sense that the insulin-mediated decrease of glucose production is blunted while insulin's effect on stimulating lipogenesis is maintained. We investigated the molecular mechanisms underlying this pathogenic paradox. Primary rat hepatocytes were exposed to palmitate for twenty hours. To establish the physiological relevance of the in vitro findings, we also studied insulin-resistant Zucker Diabetic Fatty (ZDF) rats. While insulin-receptor phosphorylation was unaffected, activation of Akt and inactivation of the downstream targets Glycogen synthase kinase 3 alpha (Gsk3 alpha and Forkhead box O1 (FoxO1) was inhibited in palmitate-exposed cells. Accordingly, dose-response curves for insulin-mediated suppression of the FoxO1-induced gluconeogenic genes and for de novo glucose production were right shifted, and insulin-stimulated glucose oxidation and glycogen synthesis were impaired. In contrast, similar to findings in human T2D, the ability of insulin to induce triglyceride (TG) accumulation and transcription of the enzymes that catalyze de novo lipogenesis and TG assembly was unaffected. Insulin-induction of these genes could, however, be blocked by inhibition of the atypical PKCs (aPKCs). The activity of the Akt-inactivating Protein Phosphatase 2A (PP2A) was increased in the insulin-resistant cells. Furthermore, inhibition of PP2A by specific inhibitors increased insulin-stimulated activation of Akt and phosphorylation of FoxO1 and Gsk3 alpha. Finally, PP2A mRNA levels were increased in liver, muscle and adipose tissue, while PP2A activity was increased in liver and muscle tissue in insulin-resistant ZDF rats. In conclusion, our findings indicate that FFAs may cause a selective impairment of insulin action upon hepatic glucose metabolism by increasing PP2A activity.	[Galbo, Thomas; Olsen, Grith Skytte; Nishimura, Erica] Novo Nordisk AS, Dept Insulin Biol, Diabet Res Unit, Malov, Denmark; [Galbo, Thomas; Quistorff, Bjorn] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark	Novo Nordisk; University of Copenhagen	Galbo, T (corresponding author), Novo Nordisk AS, Dept Insulin Biol, Diabet Res Unit, Malov, Denmark.	tgbo@novonordisk.com		Nishimura, Erica/0000-0001-5741-3648	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation	TG is funded by a grant from Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation. BQ is employed by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Basu R, 2004, AM J PHYSIOL-ENDOC M, V287, pE55, DOI 10.1152/ajpendo.00549.2003; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Federici M, 2004, CIRCULATION, V109, P399, DOI 10.1161/01.CIR.0000109498.77895.6F; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fernandez JJ, 2002, CURR MED CHEM, V9, P229, DOI 10.2174/0929867023371247; Guenin S, 2008, INT J ONCOL, V32, P49; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mistafa O, 2010, J BIOL CHEM, V285, P27900, DOI 10.1074/jbc.M110.117093; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; NORDLIE RC, 1968, J BIOL CHEM, V243, P1140; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Passonneau Lowry, 1972, FLEXIBLE SYSTEM ENZY; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Sajan MP, 2009, J LIPID RES, V50, P1133, DOI 10.1194/jlr.M800520-JLR200; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TERRETTAZ J, 1983, ENDOCRINOLOGY, V112, P1346, DOI 10.1210/endo-112-4-1346; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	41	36	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27424	10.1371/journal.pone.0027424	http://dx.doi.org/10.1371/journal.pone.0027424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087313	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700052
J	Karlocai, MR; Toth, K; Watanabe, M; Ledent, C; Juhasz, G; Freund, TF; Magloczky, Z				Karlocai, Maria R.; Toth, Kinga; Watanabe, Masahiko; Ledent, Catherine; Juhasz, Gabor; Freund, Tamas F.; Magloczky, Zsofia			Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy	PLOS ONE			English	Article							PERISOMATIC INHIBITORY INPUT; TEMPORAL-LOBE EPILEPSY; ENDOCANNABINOID SYSTEM; DENTATE GYRUS; IMMUNOREACTIVE INTERNEURONS; SYNAPTIC REORGANIZATION; MEDIATED INHIBITION; GRANULE CELLS; MODEL; GABA	The endocannabinoid system plays a central role in retrograde synaptic communication and may control the spread of activity in an epileptic network. Using the pilocarpine model of temporal lobe epilepsy we examined the expression pattern of the Type 1 cannabinoid receptor (CB1-R) in the hippocampi of CD1 mice at survival times of 2 hours, 1 day, 3 days and 2 months (acute, latent and chronic phases). Based on the behavioral signs of the acute seizures, animals were classified as "weakly'' or "strongly'' epileptic using the modified Racine scale. Mice of the weak group had mild seizures, whereas seizures in the strong group were frequent with intense motor symptoms and the majority of these animals developed sclerosis in the chronic phase. In control samples the most intense staining of CB1-R-positive fibers was found in the molecular layer of the dentate gyrus and in str. pyramidale of the cornu Ammonis. In weak animals no significant changes were seen at any survival time compared to controls. In strong animals, however, in the acute phase, a massive reduction in CB1-R-stained terminals occurred in the hippocampus. In the latent phase CB1-R immunoreactivity gradually recovered. In the chronic phase, CB1-immunostaining in sclerotic samples was stronger throughout the hippocampus. Quantitative electron microscopic analysis showed an increase in the number of CB1-R-positive terminals in the dentate gyrus. Moreover, the number of immunogold particles significantly increased in GABAergic terminals. Our results suggest a proconvulsive downregulation of CB1 receptors in the acute phase most probably due to receptor internalization, followed by compensatory upregulation and sprouting in the chronic phase of epilepsy. In conclusion, the changes in CB1 receptor expression pattern revealed in this study are associated with the severity of hippocampal injury initiated by acute seizures that ultimately leads to sclerosis in the vulnerable regions in the chronic phase.	[Karlocai, Maria R.; Toth, Kinga; Freund, Tamas F.; Magloczky, Zsofia] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Ledent, Catherine] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Juhasz, Gabor] Eotvos Lorand Univ, Inst Biol, Res Grp Prote, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hokkaido University; Universite Libre de Bruxelles; Eotvos Lorand University	Karlocai, MR (corresponding author), Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary.	karlocai.rita@koki.hu	WATANABE, Masahiko/A-4055-2012; Juhász, Gábor/I-7781-2017; Karlocai, Rita/ABD-9391-2021; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Juhász, Gábor/0000-0002-0849-6931; Karlocai, Rita/0000-0002-2110-8825; Watanabe, Masahiko/0000-0001-5037-7138	EC [LSH-CT-2006-037315, NS030549]; Hungarian Scientific Research Fund [NKTH-OTKA CNK 77793]; National Development Agency [TAMOP 4.2.1./B-09/1/KMR.2010.0003]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN	EC(European CommissionEuropean Commission Joint Research Centre); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the following: EPICURE FP6 EC LSH-CT-2006-037315, NS030549, and Hungarian Scientific Research Fund (NKTH-OTKA CNK 77793) and National Development Plan of the National Development Agency (TAMOP 4.2.1./B-09/1/KMR.2010.0003) for G.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskaran MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010683; Cadas H, 1996, J NEUROSCI, V16, P3934; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Corsellis JAN, 1976, GREENFIELDS NEUROPAT, P771; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Coutts AA, 2001, J NEUROSCI, V21, P2425; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; da Costa NM, 2009, J NEUROSCI METH, V180, P77, DOI 10.1016/j.jneumeth.2009.03.001; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Engel J, 1996, CAN J NEUROL SCI, V23, P167, DOI 10.1017/S0317167100038464; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 2003, NEURON, V38, P362, DOI 10.1016/S0896-6273(03)00262-9; Fujiwara-Tsukamoto Y, 2003, NEUROSCIENCE, V119, P265, DOI 10.1016/S0306-4522(03)00102-7; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; GALLYAS F, 1980, STAIN TECHNOL, V55, P299, DOI 10.3109/10520298009067258; GASS P, 1995, NEUROSCIENCE, V65, P27, DOI 10.1016/0306-4522(95)92049-P; Goffin K, 2011, BRAIN, V134, P1033, DOI 10.1093/brain/awq385; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Green RC, 1991, EPILEPSY BEHAV, P345; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Haller J, 2007, EUR J NEUROSCI, V25, P2445, DOI 10.1111/j.1460-9568.2007.05476.x; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kathmann M, 1999, N-S ARCH PHARMACOL, V359, P466, DOI 10.1007/PL00005377; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; KEELER MH, 1967, DIS NERV SYST, V28, P474; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Lourenco J, 2011, J NEUROSCI, V31, P3243, DOI 10.1523/JNEUROSCI.3512-10.2011; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Lutz B, 2002, PROSTAG LEUKOTR ESS, V66, P123, DOI 10.1054/plef.2001.0342; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Magloczky Z, 1997, NEUROSCIENCE, V76, P377, DOI 10.1016/S0306-4522(96)00440-X; MAGLOCZKY Z, 1995, NEUROSCIENCE, V66, P847, DOI 10.1016/0306-4522(94)00613-A; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matyas F, 2004, HIPPOCAMPUS, V14, P460, DOI 10.1002/hipo.10191; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; NADLER JV, 1980, BRAIN RES, V182, P1; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Stein V, 2003, NEURON, V37, P375, DOI 10.1016/S0896-6273(03)00056-4; Sullivan JM, 1999, J NEUROPHYSIOL, V82, P1286, DOI 10.1152/jn.1999.82.3.1286; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Toth K, 2007, NEUROSCIENCE, V144, P495, DOI 10.1016/j.neuroscience.2006.09.039; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wittner L, 2005, BRAIN, V128, P138, DOI 10.1093/brain/awh339; Wittner L, 2002, NEUROSCIENCE, V115, P961, DOI 10.1016/S0306-4522(02)00264-6; Wittner L, 2001, NEUROSCIENCE, V108, P587, DOI 10.1016/S0306-4522(01)00446-8; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010	87	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27196	10.1371/journal.pone.0027196	http://dx.doi.org/10.1371/journal.pone.0027196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076136	Green Submitted, gold, Green Published			2022-12-27	WOS:000297198200048
J	Wright, H; Cohen, A; Sonmez, K; Yochum, G; McWeeney, S				Wright, Hollis; Cohen, Aaron; Soenmez, Kemal; Yochum, Gregory; McWeeney, Shannon			Occupancy Classification of Position Weight Matrix-Inferred Transcription Factor Binding Sites	PLOS ONE			English	Article							NETWORKS	Background: Computational prediction of Transcription Factor Binding Sites (TFBS) from sequence data alone is difficult and error-prone. Machine learning techniques utilizing additional environmental information about a predicted binding site (such as distances from the site to particular chromatin features) to determine its occupancy/functionality class show promise as methods to achieve more accurate prediction of true TFBS in silico. We evaluate the Bayesian Network (BN) and Support Vector Machine (SVM) machine learning techniques on four distinct TFBS data sets and analyze their performance. We describe the features that are most useful for classification and contrast and compare these feature sets between the factors. Results: Our results demonstrate good performance of classifiers both on TFBS for transcription factors used for initial training and for TFBS for other factors in cross-classification experiments. We find that distances to chromatin modifications (specifically, histone modification islands) as well as distances between such modifications to be effective predictors of TFBS occupancy, though the impact of individual predictors is largely TF specific. In our experiments, Bayesian network classifiers outperform SVM classifiers. Conclusions: Our results demonstrate good performance of machine learning techniques on the problem of occupancy classification, and demonstrate that effective classification can be achieved using distances to chromatin features. We additionally demonstrate that cross-classification of TFBS is possible, suggesting the possibility of constructing a generalizable occupancy classifier capable of handling TFBS for many different transcription factors.	[Wright, Hollis; Cohen, Aaron; Soenmez, Kemal; McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Yochum, Gregory] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Biostat, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Wright, H (corresponding author), Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	wrighth@ohsu.edu	Sonmez, Kemal/ABF-3992-2020	Sonmez, Kemal/0000-0002-2816-6438; McWeeney, Shannon/0000-0001-8333-6607	National Library of Medicine [T15 LM007088]; National Institutes of Health, National Center for Research Resources [5UL1RR024140]; National Institutes of Health, National Cancer Institute [5 P30 CA069533-13]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was primarily supported by a National Library of Medicine pre-doctoral fellowship (T15 LM007088) to Dr. Wright, and National Institutes of Health, National Center for Research Resources (5UL1RR024140 to Dr. McWeeney); National Institutes of Health, National Cancer Institute (5 P30 CA069533-13 to Dr. McWeeney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen Y, 2007, PLOS COMPUT BIOL, V3; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins PJ, 2007, PLOS GENET, V3, P2247, DOI 10.1371/journal.pgen.0030208; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Hall M., 1998, THESIS U WAIKATO HAM; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jensen F. V., 2007, BAYESIAN NETWORKS DE, DOI DOI 10.1007/978-0-387-68282-2; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; R Core Team, 2021, R LANGUAGE ENV STAT; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roulet E, 1998, In Silico Biol, V1, P21; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Witten I. H., 2005, DATA MINING PRACTICA; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Won KJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r7; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26160	10.1371/journal.pone.0026160	http://dx.doi.org/10.1371/journal.pone.0026160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073148	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200005
J	Munro, JB; Heraty, JM; Burks, RA; Hawks, D; Mottern, J; Cruaud, A; Rasplus, JY; Jansta, P				Munro, James B.; Heraty, John M.; Burks, Roger A.; Hawks, David; Mottern, Jason; Cruaud, Astrid; Rasplus, Jean-Yves; Jansta, Petr			A Molecular Phylogeny of the Chalcidoidea (Hymenoptera)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; PERILAMPIDAE HYMENOPTERA; SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; WASPS HYMENOPTERA; CLASSIFICATION; INSECTA; GENUS; 28S; EVOLUTION	Chalcidoidea (Hymenoptera) are extremely diverse with more than 23,000 species described and over 500,000 species estimated to exist. This is the first comprehensive phylogenetic analysis of the superfamily based on a molecular analysis of 18S and 28S ribosomal gene regions for 19 families, 72 subfamilies, 343 genera and 649 species. The 56 outgroups are comprised of Ceraphronoidea and most proctotrupomorph families, including Mymarommatidae. Data alignment and the impact of ambiguous regions are explored using a secondary structure analysis and automated (MAFFT) alignments of the core and pairing regions and regions of ambiguous alignment. Both likelihood and parsimony approaches are used to analyze the data. Overall there is no impact of alignment method, and few but substantial differences between likelihood and parsimony approaches. Monophyly of Chalcidoidea and a sister group relationship between Mymaridae and the remaining Chalcidoidea is strongly supported in all analyses. Either Mymarommatoidea or Diaprioidea are the sister group of Chalcidoidea depending on the analysis. Likelihood analyses place Rotoitidae as the sister group of the remaining Chalcidoidea after Mymaridae, whereas parsimony nests them within Chalcidoidea. Some traditional family groups are supported as monophyletic (Agaonidae, Eucharitidae, Encyrtidae, Eulophidae, Leucospidae, Mymaridae, Ormyridae, Signiphoridae, Tanaostigmatidae and Trichogrammatidae). Several other families are paraphyletic (Perilampidae) or polyphyletic (Aphelinidae, Chalcididae, Eupelmidae, Eurytomidae, Pteromalidae, Tetracampidae and Torymidae). Evolutionary scenarios discussed for Chalcidoidea include the evolution of phytophagy, egg parasitism, sternorrhynchan parasitism, hypermetamorphic development and heteronomy.	[Munro, James B.; Heraty, John M.; Burks, Roger A.; Hawks, David; Mottern, Jason; Cruaud, Astrid] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Rasplus, Jean-Yves] INRA, Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Jansta, Petr] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	University of California System; University of California Riverside; INRAE; Institut de Recherche pour le Developpement (IRD); Charles University Prague	Munro, JB (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	john.heraty@ucr.edu	Munro, James B./C-5489-2009; Rasplus, Jean-Yves/O-2873-2017; Jansta, Petr/R-9124-2017	Munro, James B./0000-0003-3067-6434; Rasplus, Jean-Yves/0000-0001-8614-6665; Jansta, Petr/0000-0001-6409-3603	National Science Foundation [TOL EF-0341149, PEET DEB-0730616]; @-Speed-Id; ANR BioFigs;  [MSM0021620828]	National Science Foundation(National Science Foundation (NSF)); @-Speed-Id; ANR BioFigs(French National Research Agency (ANR)); 	Funding was provided by National Science Foundation grants TOL EF-0341149 and PEET DEB-0730616 to JMH, @-Speed-Id and ANR BioFigs to JYR, and MSM0021620828 to PJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annecke DP, 1961, DEP AGR TECHNICAL SE, V5, P1; Ashmead W.H., 1904, MEM CARNEGIE MUS, V1, P225, DOI DOI 10.5962/BHL.TITLE.10341; Banks JC, 2006, MOL PHYLOGENET EVOL, V41, P690, DOI 10.1016/j.ympev.2006.06.001; Boucek Z., 1988, P11; BOUCEK Z, 1981, Tijdschrift voor Entomologie, V124, P149; BOUCEK Z, 1987, SYST ENTOMOL, V12, P407, DOI 10.1111/j.1365-3113.1987.tb00212.x; BOUCEK Z, 1974, ENTOMOLOGY S, V23, P1; Boucek Z, 1997, ANNOTATED KEYS GENER; BOUCEK Z, 1988, AUSTR CHALCIDOIDEA H; Boucek Z, 1997, ANNOTATED KEYS GENER; Burks BD, 1979, ORMYRIDAE CATALOG HY, P1198; Burks RA, 2011, CLADISTICS, V27, P581, DOI 10.1111/j.1096-0031.2011.00358.x; CAMPBELL B, 2000, HYMENOPTERA EVOLUTIO, P57; Castro LR, 2006, INVERTEBR SYST, V20, P603, DOI 10.1071/IS06002; Chen Y, 2004, MOL PHYLOGENET EVOL, V31, P300, DOI 10.1016/S1055-7903(03)00282-3; COMPERE HAROLD, 1961, JOUR ENT SOC SOUTHERN AFRICA, V24, P17; COPLAND MJW, 1973, J ENTOMOL SER A, V48, P25; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; DARLING DC, 1992, SYST ENTOMOL, V17, P331, DOI 10.1111/j.1365-3113.1992.tb00554.x; Darling DC, 1997, ANNOTATED KEYS GENER, P794; Deans AR, 2006, SYST ENTOMOL, V31, P517, DOI 10.1111/j.1365-3113.2006.00327.x; Delucchi V, 1962, SCI ZOOLOGIQUE, V110, P363; DELVARE G., 1992, MEM AM ENTOMOL INST, V53, P119; Delvare G., 1992, MEM AM ENTOMOL I, V53, P1; DESANTIS L, 1946, REV MUSEO PLATA, V5, P1; Desjardins CA, 2007, MOL PHYLOGENET EVOL, V45, P454, DOI 10.1016/j.ympev.2007.08.004; Domenichini G., 1954, Bollettino di Zoologia Agraria e Bachicoltura Parma, V20, P95; Erdos J, 1964, FAUNA HUNG, V73, P1; FERRIERE C, 1965, HYMENOPTERA APHELINI; Gates M, 2008, U CALIFORNIA PUBLICA, V127, P1; Gauld ID, 1995, HYMENOPTERA COSTA RI, P185; Gauthier N, 2000, SYST ENTOMOL, V25, P521, DOI 10.1046/j.1365-3113.2000.00134.x; Ghesquiere J., 1955, Memoires de la Societe Entomologique de Belgique, V27, P217; Gibson G., 1990, Chalcid Forum, P7; Gibson G. A. P., 2003, Phylogenetics and classification of Cleonyminae (Hymenoptera: Chalcidoidea: Pteromalidae); Gibson G. A. P, 1989, MEMOIRS ENTOMOLOGICA, V149, P1, DOI [10.4039/entm121149fv, DOI 10.4039/ENTM121149FV]; GIBSON GAP, 1986, CAN ENTOMOL, V118, P205, DOI 10.4039/Ent118205-3; Gibson GAP, 1999, ZOOL SCR, V28, P125, DOI 10.1046/j.1463-6409.1999.00015.x; Gibson GAP, 2000, J NAT HIST, V34, P2293, DOI 10.1080/002229300750037901; Gibson GAP, 1999, ZOOL SCR, V28, P87, DOI 10.1046/j.1463-6409.1999.00016.x; Gibson GAP, 1993, HYMENOPTERA WORLD ID; Gibson Gary A.P., 2008, Zootaxa, V1730, P1; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; Gillespie JJ, 2005, J MOL EVOL, V61, P114, DOI 10.1007/s00239-004-0246-x; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Girault A. A., 1915, Memoirs of the Queensland Museum, V4; Goloboff PA, 2003, TREE ANAL USING NEW; Goloboff P, 2008, CLADISTICS, V24, P91; Gordh G, 1979, ENCYRTIDAE CATALOG H; Graham M. W. R. de V., 1969, Bull. Br. Mus. nat. Hist. Ent., V16, P1; Grimaldi David, 2005, pi; Grissell E.E., 1995, Memoirs on Entomology International, V2, P1; Grissell EE, 1997, ANNOTATED KEYS GENER; Gumovsky Alex V., 2005, Entomological Problems, V35, P123; Gumovsky AV, 2002, PARASITIC WASPS EVOL; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; HANSON P, 1992, J NAT HIST, V26, P1333, DOI 10.1080/00222939200770761; Hanson P, 1997, ANNOTATED KEYS GENER; HAYAT M, 1994, ORIENT INSECTS, V28, P81; HAYAT M, 1983, SYST ENTOMOL, V8, P63, DOI 10.1111/j.1365-3113.1983.tb00467.x; Hayat M., 1998, MEM ENTOMOL INT, V13, P1; Hayat M, 1985, ORIENT INSECTS, V19, p[226, 163]; HEDQVIST K-J, 1971, Entomologisk Tidskrift, V92, P237; Heraty J, 2004, SYST ENTOMOL, V29, P544, DOI 10.1111/j.0307-6970.2004.00267.x; Heraty J. M., 2007, Journal of the Entomological Society of Ontario, V138, P33; Heraty J. M., 2003, P 21 S PLANT BIOL LO, P277; Heraty J. M, 2002, MEM AM ENTOMOL I, V68, P1; HERATY JM, 1984, SYST ENTOMOL, V9, P309, DOI 10.1111/j.1365-3113.1984.tb00056.x; Heraty JM, 1997, SYST ENTOMOL, V22, P45, DOI 10.1046/j.1365-3113.1997.d01-26.x; Heraty J, 2011, MOL PHYLOGENET EVOL, V60, P73, DOI 10.1016/j.ympev.2011.04.003; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Heraty JM, 2009, ZOOTAXA, P1; HUBER J T, 1986, Entomography, V4, P185; Huber JT, 2008, J HYMENOPT RES, V17, P175; Huber JT, 2006, J NAT HIST, V40, P1909, DOI 10.1080/00222930601046428; Huber JT, 1997, ANNOTATED KEYS GENER; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khan MY, 1980, SCI ENV ALIGARH, V2, P59; LaSalle J, 1997, SYST ENTOMOL, V22, P131, DOI 10.1046/j.1365-3113.1997.d01-38.x; LASALLE J, 1985, J NEW YORK ENTOMOL S, V93, P1261; LASALLE J, 1987, CONTRIBUTIONS AM ENT, V23, P1; Letsch HO, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-146; LINARES AR, 1991, J MOL BIOL, V219, P381, DOI 10.1016/0022-2836(91)90178-9; Lotfalizadeh H, 2007, ZOOL J LINN SOC-LOND, V151, P441, DOI 10.1111/j.1096-3642.2007.00308.x; Masner L, 1995, PROCTOTRUPOID FAMILI, P209; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; MERCET RICARDO GARCIA, 1929, EOS, V5, P111; Miller M, 2010, CIPRES PORTALS, P2009; Mottern JL, 2011, SYST ENTOMOL, V36, P267, DOI 10.1111/j.1365-3113.2010.00557.x; Muesebeck CFW, 1951, AGR MONOGRAPH; Narendran T. C, 1989, ORIENTAL CHALCIDIDAE; NIKOLSKAYA MN, 1966, OPREDELITELI FAUNE S, V91, P1; Noyes J.S., 1990, Chalcid Forum, P6; Noyes John S., 2000, Memoirs of the American Entomological Institute (Gainesville), V62, P1; Noyes JS, 2011, UNIVERSAL CHALCIDOID; Noyes JS, 1997, ANNOTATED KEYS GENER; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Owen AK, 2007, SYST ENTOMOL, V32, P227, DOI 10.1111/j.1365-3113.2006.00361.x; Parker HL, 1924, ANN SOC ENTOMOLOGIQU, V93, P1; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pedata P.A., 1991, Redia, V74, P343; Pfeiffer W, 2010, 9 IEEE INT WORKSH HI; Pinto J, 2003, ENCY INSECTS, P546; Poinar G, 2011, ZOOKEYS, P461, DOI 10.3897/zookeys.130.1241; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rosen D., 1990, ARMORED SCALE INSECT; Schauff M.E., 1984, Memoirs of the Entomological Society of Washington, P1; Schauff ME, 1997, ANNOTATED KEYS GENER; Schmidt AR, 2010, P NATL ACAD SCI USA, V107, P7329, DOI 10.1073/pnas.1000948107; Schulmeister S, 2003, BIOL J LINN SOC, V79, P245, DOI 10.1046/j.1095-8312.2003.00233.x; SHAFEE S A, 1978, Journal of Zoological Research (Aligarh), V2, P42; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; STAGE G I, 1986, Contributions in Science (Los Angeles), P1; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L., 1990, MOL SYSTEMATICS; Swofford DL, 2002, PAUP VERSION 4 0 U 1; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Triapitzin VA, 1973, ENTOMOLOGICAL REV, V57, P287; Trjapitzin V.A., 1989, Opredeliteli po Faune SSSR, V158, P1; Trjapitzin V.A, 1973, ENTOMOL REV, V52, P118; VIGGIANI G, 1984, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V41, P149; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wijesekara G. A. W., 1997, Contributions of the American Entomological Institute, V29, P1; WOOLLEY JB, 1988, SYST ENTOMOL, V13, P465, DOI 10.1111/j.1365-3113.1988.tb00256.x; Woolley JB, 1997, ANNOTATED KEYS GENER; Woolley JB, 1997, ANNOTATED KEYS GENER; YASNOSH V A, 1976, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V55, P114; YOSHIMOTO CM, 1975, CAN ENTOMOL, V107, P499, DOI 10.4039/Ent107499-5	134	116	124	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27023	10.1371/journal.pone.0027023	http://dx.doi.org/10.1371/journal.pone.0027023			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22087244	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000022
J	Sulmon, C; Gouesbet, G; Ramel, F; Cabello-Hurtado, F; Penno, C; Bechtold, N; Couee, I; El Amrani, A				Sulmon, Cecile; Gouesbet, Gwenola; Ramel, Fanny; Cabello-Hurtado, Francisco; Penno, Christophe; Bechtold, Nicole; Couee, Ivan; El Amrani, Abdelhak			Carbon Dynamics, Development and Stress Responses in Arabidopsis: Involvement of the APL4 Subunit of ADP-Glucose Pyrophosphorylase (Starch Synthesis)	PLOS ONE			English	Article							SUGAR-INDUCED TOLERANCE; SUCROSE-INDUCED TOLERANCE; GENOME-WIDE ANALYSIS; GENE-EXPRESSION MAP; OXIDATIVE STRESS; HERBICIDE ATRAZINE; SINGLET OXYGEN; SOLUBLE SUGARS; THALIANA; PLANTS	An Arabidopsis thaliana T-DNA insertional mutant was identified and characterized for enhanced tolerance to the singlet-oxygen-generating herbicide atrazine in comparison to wild-type. This enhanced atrazine tolerance mutant was shown to be affected in the promoter structure and in the regulation of expression of the APL4 isoform of ADP-glucose pyrophosphorylase, a key enzyme of the starch biosynthesis pathway, thus resulting in decrease of APL4 mRNA levels. The impact of this regulatory mutation was confirmed by the analysis of an independent T-DNA insertional mutant also affected in the promoter of the APL4 gene. The resulting tissue-specific modifications of carbon partitioning in plantlets and the effects on plantlet growth and stress tolerance point out to specific and non-redundant roles of APL4 in root carbon dynamics, shoot-root relationships and sink regulations of photosynthesis. Given the effects of exogenous sugar treatments and of endogenous sugar levels on atrazine tolerance in wild-type Arabidopsis plantlets, atrazine tolerance of this apl4 mutant is discussed in terms of perception of carbon status and of investment of sugar allocation in xenobiotic and oxidative stress responses.	[Sulmon, Cecile; Gouesbet, Gwenola; Ramel, Fanny; Cabello-Hurtado, Francisco; Penno, Christophe; Couee, Ivan; El Amrani, Abdelhak] Univ Rennes 1, Ctr Natl Rech Sci, ECOBIO, UMR 6553, Rennes, France; [Bechtold, Nicole] Ctr Versailles Grignon, Inst Natl Rech Agron, Unite Genet & Ameliorat Plantes, Versailles, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; INRAE	Sulmon, C (corresponding author), Univ Rennes 1, Ctr Natl Rech Sci, ECOBIO, UMR 6553, Rennes, France.	cecile.sulmon-maisonneuve@univ-rennes1.fr	Sulmon, Cécile/AAC-3611-2019; Gouesbet, Gwenola/C-4790-2009; Couee, Ivan/D-9201-2012	Sulmon, Cécile/0000-0003-3989-9853; Gouesbet, Gwenola/0000-0002-5223-7240; Couee, Ivan/0000-0002-1117-0043; penno, christophe/0000-0002-7698-5278	Ministere de l'Enseignement Superieur et de la Recherche (France); Centre National de la Recherche Scientifique, France; Rennes Metropole (France) local council	Ministere de l'Enseignement Superieur et de la Recherche (France); Centre National de la Recherche Scientifique, France(Centre National de la Recherche Scientifique (CNRS)); Rennes Metropole (France) local council	This work was supported in part by fellowships (to F.R. and to C.S.) from the Ministere de l'Enseignement Superieur et de la Recherche (France, www.recherche.gouv.fr) and by grants from the Environnement-Vie-Societe and Ingenierie Ecologique programmes (Centre National de la Recherche Scientifique, France; www.cnrs.fr) and from Rennes Metropole (France; www.rennes-metropole.fr) local council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbacher RA, 2000, P 9 SWISS PLANT CELL, P51; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; De Prado R, 2000, PESTIC BIOCHEM PHYS, V67, P114, DOI 10.1006/pest.2000.2484; Devic M, 1997, PLANT PHYSIOL BIOCH, V35, P331; FREAR DS, 1970, PHYTOCHEMISTRY, V9, P2123, DOI 10.1016/S0031-9422(00)85377-7; Fritzius T, 2001, PLANT PHYSIOL, V126, P883, DOI 10.1104/pp.126.2.883; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Hummel I, 2004, GENE, V342, P199, DOI 10.1016/j.gene.2004.08.024; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; LIN TP, 1988, PLANT PHYSIOL, V88, P1175, DOI 10.1104/pp.88.4.1175; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; NEUHAUS HE, 1990, PLANTA, V182, P445, DOI [10.1007/BF02411398, 10.1007/BF00197565]; Ohkama-Ohtsu N, 2004, PLANT PHYSIOL, V136, P3209, DOI 10.1104/pp.104.047068; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Owen W.J., 2000, METABOLISM AGROCHEMI, P211; Paul MJ, 2010, PLANT SIGNAL BEHAV, V5, P386, DOI 10.4161/psb.5.4.10792; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; PREISS J, 1982, ANNU REV PLANT PHYS, V33, P431, DOI 10.1146/annurev.pp.33.060182.002243; PREISS J, 1997, MOL APPROACH PRIMARY, P81; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Ramel F, 2009, ANN BOT-LONDON, V104, P1323, DOI 10.1093/aob/mcp243; Ramel F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-450; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Sahrawy M, 2004, J EXP BOT, V55, P2495, DOI 10.1093/jxb/erh257; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Sulmon C, 2006, PLANT CELL REP, V25, P489, DOI 10.1007/s00299-005-0062-9; Sulmon C, 2004, PLANT SCI, V167, P913, DOI 10.1016/j.plantsci.2004.05.036; Sulmon C, 2007, J PLANT PHYSIOL, V164, P1083, DOI 10.1016/j.jplph.2006.11.005; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Sun JD, 1999, PLANT PHYSIOL, V119, P267, DOI 10.1104/pp.119.1.267; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tsai HL, 2009, PLANT PHYSIOL, V151, P1582, DOI 10.1104/pp.109.144196; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Wang SM, 1997, PLANT J, V11, P1121, DOI 10.1046/j.1365-313X.1997.11051121.x; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Windsor B, 2003, NAT BIOTECHNOL, V21, P428, DOI 10.1038/nbt809; Wingler A, 2000, PLANT PHYSIOL, V124, P105, DOI 10.1104/pp.124.1.105; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393	63	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26855	10.1371/journal.pone.0026855	http://dx.doi.org/10.1371/journal.pone.0026855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073207	gold, Green Published			2022-12-27	WOS:000297197000002
J	Green, TC; Black, R; Serrano, JMG; Budman, SH; Butler, SF				Green, Traci C.; Black, Ryan; Serrano, Jill M. Grimes; Budman, Simon H.; Butler, Stephen F.			Typologies of Prescription Opioid Use in a Large Sample of Adults Assessed for Substance Abuse Treatment	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; HUMAN-IMMUNODEFICIENCY-VIRUS; ADDICTION SEVERITY INDEX; LATENT CLASS ANALYSIS; NONMEDICAL USE; DRUG-USE; ILLICIT USE; SELF-REPORTS; SEEKING TREATMENT; COLLEGE-STUDENTS	Background: As a population, non-medical prescription opioid users are not well-defined. We aimed to derive and describe typologies of prescription opioid use and nonmedical use using latent class analysis in an adult population being assessed for substance abuse treatment. Methods: Latent class analysis was applied to data from 26,314 unique respondents, aged 18-70, self-reporting past month use of a prescription opioid out of a total of 138,928 cases (18.9%) collected by the Addiction Severity Index-Multimedia Version (ASI-MV (R)), a national database for near real-time prescription opioid abuse surveillance. Data were obtained from November 2005 through December 2009. Substance abuse treatment, criminal justice, and public assistance programs in the United States submitted data to the ASI-MV database (n = 538). Six indicators of the latent classes derived from responses to the ASI-MV, a version of the ASI modified to collect prescription opioid abuse and chronic pain experience. The latent class analysis included respondent home ZIP code random effects to account for nesting of respondents within ZIP code. Results: A four-class adjusted latent class model fit best and defined clinically interpretable and relevant subgroups: Use as prescribed, Prescribed misusers, Medically healthy abusers, and Illicit users. Classes varied on key variables, including race/ethnicity, gender, concurrent substance abuse, duration of prescription opioid abuse, mental health problems, and ASI composite scores. Three of the four classes (81% of respondents) exhibited high potential risk for fatal opioid overdose; 18.4% exhibited risk factors for blood-borne infections. Conclusions: Multiple and distinct profiles of prescription opioid use were detected, suggesting a range of use typologies at differing risk for adverse events. Results may help clinicians and policy makers better focus overdose and blood-borne infection prevention efforts and intervention strategies for prescription opioid abuse reduction.	[Green, Traci C.] Brown Med Sch, Providence, RI USA; [Green, Traci C.] Rhode Isl Hosp, Providence, RI USA; [Black, Ryan; Serrano, Jill M. Grimes; Budman, Simon H.; Butler, Stephen F.] Inflexxion Inc, Needham, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Green, TC (corresponding author), Brown Med Sch, Providence, RI USA.	traci.c.green@gmail.com	Butler, Stephen/AAK-7902-2020	Butler, Stephen/0000-0002-6132-5883	National Research Service from the National Institute on Drug Abuse [5F31DA023862]; Lifespan/Tufts/Brown Center for AIDS Research [NIAID P30AI042853]; King Pharmaceuticals(R), Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA023862] Funding Source: NIH RePORTER	National Research Service from the National Institute on Drug Abuse; Lifespan/Tufts/Brown Center for AIDS Research; King Pharmaceuticals(R), Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a National Research Service Award grant (TCG) from the National Institute on Drug Abuse (5F31DA023862) and by a 2009 Developmental grant to TCG from Lifespan/Tufts/Brown Center for AIDS Research (NIAID P30AI042853). The writing of this paper was funded in part by an unrestricted grant to Inflexxion, Inc. from King Pharmaceuticals, Inc., which was acquired by Pfizer, Inc. in March 2011. JGS and SFB, who are employees of Inflexxion, were paid consultants to King Pharmaceuticals, Inc., in connection with the development of this manuscript. The views expressed in this paper are those of the authors and do not necessarily represent the views of Pfizer Pharmaceuticals, Inc. The funding sources had no part in the conception, design, data analysis, interpretation, writing, editing, or decision to publish this manuscript.	Agrawal A, 2007, ADDICTION, V102, P94, DOI 10.1111/j.1360-0443.2006.01630.x; Back SE, 2010, ADDICT BEHAV, V35, P1001, DOI 10.1016/j.addbeh.2010.06.018; Boyd CJ, 2006, DRUG ALCOHOL DEPEN, V81, P37, DOI 10.1016/j.drugalcdep.2005.05.017; Butler SF, 2004, PAIN, V112, P65, DOI 10.1016/j.pain.2004.07.026; Butler SF, 2008, J PAIN, V9, P360, DOI 10.1016/j.jpain.2007.11.014; Butler SF, 2008, PHARMACOEPIDEM DR S, V17, P1142, DOI 10.1002/pds.1659; Carise D, 2007, AM J PSYCHIAT, V164, P1750, DOI 10.1176/appi.ajp.2007.07050252; CHAISSON RE, 1987, AM J PUBLIC HEALTH, V77, P169, DOI 10.2105/AJPH.77.2.169; Chitwood DD, 2003, J PSYCHOACTIVE DRUGS, V35, P445, DOI 10.1080/02791072.2003.10400491; Connors GJ, 2003, ADDICTION, V98, P21, DOI 10.1046/j.1359-6357.2003.00585.x; Daniulaityte R, 2006, J DRUG ISSUES, V36, P787, DOI 10.1177/002204260603600402; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dasgupta N, 2010, AM J LIFESTYLE MED, V4, P32, DOI 10.1177/1559827609348462; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Delucchi KL, 2004, DRUG ALCOHOL DEPEN, V74, P235, DOI 10.1016/j.drugalcdep.2003.12.014; Des Jarlais DC, 2007, ADDICTION, V102, P778, DOI 10.1111/j.1360-0443.2007.01764.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Draus PJ, 2006, SUBST USE MISUSE, V41, P1111, DOI 10.1080/10826080500411577; FDA, 2011, QUEST ANSW FDA REQ R; Ghandour LA, 2008, INT J METH PSYCH RES, V17, P89, DOI 10.1002/mpr.232; Girion L, 2011, DRUG DEATHS NOW OUTN; Goodman FDC, 2005, AM J HEALTH-SYST PH, V62, P2604, DOI 10.2146/ajhp040618; GOSSOP M, 1992, J ROY SOC MED, V85, P469; Gossop M, 1992, BR J ADDICT, V87; Grau LE, 2007, AM J ADDICTION, V16, P166, DOI 10.1080/10550490701375293; Green TC, 2008, DISTINGUISHING SIGNS, P979; Green TC, 2009, DRUG ALCOHOL DEPEN, V103, P65, DOI 10.1016/j.drugalcdep.2009.03.014; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Havens JR, 2011, DRUG ALCOHOL DEPEN, V115, P107, DOI 10.1016/j.drugalcdep.2010.11.003; Havens Jennifer R, 2008, J Opioid Manag, V4, P63; Havens JR, 2008, CHARACTERIZING OPIOI; HENDRIKS VM, 1989, J SUBST ABUSE TREAT, V6, P133, DOI 10.1016/0740-5472(89)90041-X; Hickman M, 2008, ADDICTION, V103, P1060, DOI 10.1111/j.1360-0443.2008.02134.x; Huang BJ, 2006, J CLIN PSYCHIAT, V67, P1062, DOI 10.4088/JCP.v67n0708; Jamison RN, 2000, J PAIN SYMPTOM MANAG, V19, P53, DOI 10.1016/S0885-3924(99)00144-X; Kochanek KD, 2011, DEATHS PRELIMINARY D; Latkin CA, 2001, J SUBST ABUSE, V13, P89, DOI 10.1016/S0899-3289(01)00070-0; Lord S, 2003, J AM PHARM ASSOC, V49, P519, DOI DOI 10.1331/JAPHA.2009.08027; Magidson J, 2004, HDB QUANTITATIVE MET, P175, DOI DOI 10.4135/9781412986311.N19; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P215; MARMOR M, 1987, AIDS, V1, P39; McCabe SE, 2005, J SUBST ABUSE TREAT, V28, P225, DOI 10.1016/j.jsat.2004.12.009; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; McCabe SE, 2005, DRUG ALCOHOL DEPEN, V77, P37, DOI 10.1016/j.drugalcdep.2004.07.005; McCabe SE, 2005, ADDICT BEHAV, V30, P789, DOI 10.1016/j.addbeh.2004.08.024; McCabe SE, 2007, ADDICT BEHAV, V32, P562, DOI 10.1016/j.addbeh.2006.05.022; McCabe SE, 2007, J ADOLESCENT HEALTH, V40, P76, DOI 10.1016/j.jadohealth.2006.07.016; McCabe SE, 2009, ARCH PEDIAT ADOL MED, V163, P739, DOI 10.1001/archpediatrics.2009.120; McCabe SE, 2009, DRUG ALCOHOL DEPEN, V102, P63, DOI 10.1016/j.drugalcdep.2009.01.007; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; McNees E, 2008, EXPLORATORY PROFILE; Monga N, 2007, DRUG ALCOHOL DEPEN, V88, P1, DOI 10.1016/j.drugalcdep.2006.08.029; Morasco BJ, 2011, PAIN, V152, P488, DOI 10.1016/j.pain.2010.10.009; Muthen L.K., 2012, MPLUS USERS GUIDE ST, DOI DOI 10.1111/J.1532-5415.2004.52225.X; Neale J, 2003, DRUG ALCOHOL DEPEN, V71, P57, DOI 10.1016/S0376-8716(03)00053-X; NSDUH, 2007, 2007 NAT SURV DRUG U; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Office of Applied Studies, 2004, RES 2003 NAT SURV DR; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Passik Steven D, 2006, J Pain Palliat Care Pharmacother, V20, P5; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2007, TRENDS UNINTENTIONAL; Paulozzi LJ, 2008, TRENDS UNINTENTIONAL; Potter JS, 2004, DRUG ALCOHOL DEPEN, V76, P213, DOI 10.1016/j.drugalcdep.2004.05.001; Razak MH, 2003, JAIDS-J ACQ IMM DEF, V33, P259, DOI 10.1097/00126334-200306010-00023; Secades-Villa R, 2003, ADDICT BEHAV, V28, P1175, DOI 10.1016/S0306-4603(02)00219-8; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; Simoni-Wastila L, 2004, SUBST USE MISUSE, V39, P1, DOI 10.1081/JA-120027764; Simoni-Wastila Linda, 2006, Am J Geriatr Pharmacother, V4, P380, DOI 10.1016/j.amjopharm.2006.10.002; Solbergsdottir E, 2004, J ADDICT DIS, V23, P29, DOI 10.1300/J069v23n01_03; Stohler R, 2000, EUR ADDICT RES, V6, P154, DOI 10.1159/000019019; Substance Abuse and Mental Health Services Administration, 2008, TREATM EP DAT SET TE; Teter CJ, 2005, J AM COLL HEALTH, V53, P253, DOI 10.3200/JACH.53.6.253-262; Tetrault JM, 2008, ADDICTION, V103, P258, DOI 10.1111/j.1360-0443.2007.02056.x; [United States Department of Health and Human Services Substance Abuse and Mental Health Services Administration OoAS], 2009, ICPSR30462V1 US DEP; Wang CL, 2005, AIDS, V19, P935, DOI 10.1097/01.aids.0000171407.30866.22; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; Wisniewski AM, 2008, J ADDICT DIS, V27, P1, DOI 10.1300/J069v27n01_01; Wu LT, 2010, DRUG ALCOHOL DEPEN, V112, P69, DOI 10.1016/j.drugalcdep.2010.05.013; Yacoubian GS, 2002, J DRUG EDUC, V32, P261, DOI 10.2190/FAW4-6GNP-Q6N7-V5MB	82	49	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27244	10.1371/journal.pone.0027244	http://dx.doi.org/10.1371/journal.pone.0027244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22087270	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900094
J	Hornstra, HM; Priestley, RA; Georgia, SM; Kachur, S; Birdsell, DN; Hilsabeck, R; Gates, LT; Samuel, JE; Heinzen, RA; Kersh, GJ; Keim, P; Massung, RF; Pearson, T				Hornstra, Heidie M.; Priestley, Rachael A.; Georgia, Shalamar M.; Kachur, Sergey; Birdsell, Dawn N.; Hilsabeck, Remy; Gates, Lauren T.; Samuel, James E.; Heinzen, Robert A.; Kersh, Gilbert J.; Keim, Paul; Massung, Robert F.; Pearson, Talima			Rapid Typing of Coxiella burnetii	PLOS ONE			English	Article							AMPLIFICATION MUTATION ASSAY; PCR; GENE	Coxiella burnetii has the potential to cause serious disease and is highly prevalent in the environment. Despite this, epidemiological data are sparse and isolate collections are typically small, rare, and difficult to share among laboratories as this pathogen is governed by select agent rules and fastidious to culture. With the advent of whole genome sequencing, some of this knowledge gap has been overcome by the development of genotyping schemes, however many of these methods are cumbersome and not readily transferable between institutions. As comparisons of the few existing collections can dramatically increase our knowledge of the evolution and phylogeography of the species, we aimed to facilitate such comparisons by extracting SNP signatures from past genotyping efforts and then incorporated these signatures into assays that quickly and easily define genotypes and phylogenetic groups. We found 91 polymorphisms (SNPs and indels) among multispacer sequence typing (MST) loci and designed 14 SNP-based assays that could be used to type samples based on previously established phylogenetic groups. These assays are rapid, inexpensive, real-time PCR assays whose results are unambiguous. Data from these assays allowed us to assign 43 previously untyped isolates to established genotypes and genomic groups. Furthermore, genotyping results based on assays from the signatures provided here are easily transferred between institutions, readily interpreted phylogenetically and simple to adapt to new genotyping technologies.	[Hornstra, Heidie M.; Georgia, Shalamar M.; Kachur, Sergey; Birdsell, Dawn N.; Hilsabeck, Remy; Gates, Lauren T.; Keim, Paul; Pearson, Talima] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Priestley, Rachael A.; Kersh, Gilbert J.; Massung, Robert F.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA USA; [Samuel, James E.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA; [Heinzen, Robert A.] NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA	Northern Arizona University; Centers for Disease Control & Prevention - USA; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Translational Genomics Research Institute	Hornstra, HM (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	rfm2@cdc.gov; talima.pearson@nau.edu	Pearson, Talima/O-7840-2019	Pearson, Talima/0000-0003-3696-041X	U.S. Department of Homeland Security ST CB Division	U.S. Department of Homeland Security ST CB Division	This work was supported by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EURO SURVEILL; Archie James W., 1996, P153, DOI 10.1016/B978-012618030-5/50008-3; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Cha R S, 1992, PCR Methods Appl, V2, P14; Cruz RE, 2010, J CLIN MICROBIOL, V48, P3081, DOI 10.1128/JCM.00634-10; DERRICK E. H., 1937, Medical Journal of Australia, V2, P281; Easterday WR, 2005, BIOTECHNIQUES, V38, P731, DOI 10.2144/05385ST03; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; HENDRIX LR, 1991, J GEN MICROBIOL, V137, P269, DOI 10.1099/00221287-137-2-269; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; WAAG DM, 2007, Q FEVER MED ASPECTS	21	65	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26201	10.1371/journal.pone.0026201	http://dx.doi.org/10.1371/journal.pone.0026201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073151	gold, Green Submitted, Green Published			2022-12-27	WOS:000297154900015
J	Nauta, ST; Deckers, JW; Akkerhuis, M; Lenzen, M; Simoons, ML; van Domburg, RT				Nauta, Sjoerd T.; Deckers, Jaap W.; Akkerhuis, Martijn; Lenzen, Mattie; Simoons, Maarten L.; van Domburg, Ron T.			Changes in Clinical Profile, Treatment, and Mortality in Patients Hospitalised for Acute Myocardial Infarction between 1985 and 2008	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; RANDOMIZED-TRIAL; THROMBOLYTIC THERAPY; HEART-FAILURE; TRENDS; SURVIVAL; OUTCOMES; DISEASE; DEATH	Objectives: To quantify the impact of the implementation of treatment modalities into clinical practice since 1985, on outcome of patients with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Methods: All consecutive patients admitted for STEMI or NSTEMI at the Thoraxcenter between 1985 and 2008 were included. Baseline characteristics, pharmacological and invasive treatment modalities, and survival status were collected. The study population was categorised in three groups of patients: those hospitalised between 1985-1990, 1990-2000, and 2000-2008. Results: We identified 14,434 patients hospitalised for myocardial infarction (MI). Both STEMI and NSTEMI patients were increasingly treated with the current guideline based therapy. In STEMI, at 30 days following admission, cumulative mortality rate decreased from 17% in 1985-1990 to 13% in 1990-2000, and to 6% in 2000-2008. Adjusted 30-day and three-year mortality in the last period was 80% and 68% lower than in 1985, respectively. In NSTEMI, at 30 days following admission, cumulative mortality rate decreased from 6% in 1985-1990 to 4% in 1990-2000, and to 2% in 2000-2008. Adjusted 30-day and three-year mortality in the last period was 78% and 49% lower than in 1985, respectively. For patients admitted between 2000 and 2008, 3 year survival of STEMI and NSTEMI patients was 87% and 88%, respectively. Conclusions: Our results indicate substantial improvements in acute-and long-term survival in patients hospitalised for MI, related to improved acute-as well as long-term treatment. Early medical evaluation in suspected MI and intensive early hospital treatment both remain warranted in the future.	[Nauta, Sjoerd T.; Deckers, Jaap W.; Akkerhuis, Martijn; Lenzen, Mattie; Simoons, Maarten L.; van Domburg, Ron T.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Nauta, ST (corresponding author), Erasmus MC, Dept Cardiol, Rotterdam, Netherlands.	j.deckers@erasmusmc.nl			Erasmus Medical Center, Rotterdam	Erasmus Medical Center, Rotterdam	The Erasmus Medical Center, Rotterdam, was the only source of funding for the present study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Arciero TJ, 2004, AM J MED, V117, P228, DOI 10.1016/j.amjmed.2004.04.008; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Chew DP, 2010, HEART, V96, P1201, DOI 10.1136/hrt.2009.184853; Cleland JGF, 1997, EUR HEART J, V18, P41; Floyd KC, 2009, CIRC-CARDIOVASC QUAL, V2, P88, DOI 10.1161/CIRCOUTCOMES.108.811828; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; GRIJSEELS EWM, 1995, EUR HEART J, V16, P325; Grijseels EWM, 1996, EUR HEART J, V17, P89; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Hirsch A, 2007, LANCET, V369, P827, DOI 10.1016/S0140-6736(07)60410-3; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; PEDERSEN TR, 1994, LANCET, V344, P1383; Reiner JS, 1996, CIRCULATION, V94, P2441, DOI 10.1161/01.CIR.94.10.2441; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; SIMOONS ML, 1993, LANCET, V342, P1523, DOI 10.1016/S0140-6736(05)80089-3; SIMOONS ML, 1985, LANCET, V2, P578; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	29	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26917	10.1371/journal.pone.0026917	http://dx.doi.org/10.1371/journal.pone.0026917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073220	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900053
J	Ni, L; Zhou, CQ; Duan, QL; Lv, JG; Fu, XN; Xia, Y; Wang, DW				Ni, Li; Zhou, Changqing; Duan, Quanlu; Lv, Jiagao; Fu, Xiangning; Xia, Yong; Wang, Dao Wen			beta-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CHANNEL RYANODINE RECEPTOR; CELL-DEATH; BETA(1)-ADRENERGIC STIMULATION; PKA PHOSPHORYLATION; APOPTOSIS; DYSFUNCTION; ACTIVATION; DISEASE	Background: Long-term beta-adrenergic receptor (beta-AR) blockade reduces mortality in patients with heart failure. Chronic sympathetic hyperactivity in heart failure causes sustained beta-AR activation, and this can deplete Ca(2+) in endoplasmic reticulum (ER) leading to ER stress and subsequent apoptosis. We tested the effect of beta-AR blockers on ER stress pathway in experimental model of heart failure. Methods and Results: ER chaperones were markedly increased in failing hearts of patients with end-stage heart failure. In Sprague-Dawley rats, cardiac hypertrophy and heart failure was induced by abdominal aortic constriction or isoproterenol subcutaneous injection. Oral beta-AR blockers treatment was performed in therapy groups. Cardiac remodeling and left ventricular function were analyzed in rats failing hearts. After 4 or 8 weeks of banding, rats developed cardiac hypertrophy and failure. Cardiac expression of ER chaperones was significantly increased. Similar to the findings above, sustained isoproterenol infusion for 2 weeks induced cardiac hypertrophy and failure with increased ER chaperones and apoptosis in hearts. beta-AR blockers treatment markedly attenuated these pathological changes and reduced ER stress and apoptosis in failing hearts. On the other hand, beta-AR agonist isoproterenol induced ER stress and apoptosis in cultured cardiomyocytes. beta-AR blockers largely prevented ER stress and protected myocytes against apoptosis. And beta-AR blockade significantly suppressed the overactivation of CaMKII in isoproterenol-stimulated cardiomyocytes and failing hearts in rats. Conclusions: Our results demonstrated that ER stress occurred in failing hearts and this could be reversed by beta-AR blockade. Alleviation of ER stress may be an important mechanism underlying the therapeutic effect of beta-AR blockers on heart failure.	[Ni, Li; Zhou, Changqing; Duan, Quanlu; Lv, Jiagao; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Fu, Xiangning] Huazhong Univ Sci & Technol, Dept Cardiothorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xia, Yong] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med,Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Ohio State University	Ni, L (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	yong.xia@osumc.edu; dwwang@tjh.tjmu.edu.cn		Wang, Dao Wen/0000-0002-9774-3980	National Basic Research Program (973) of China [2007CB512004]; National Natural Science Foundation of China [30770882, 81000097]; National Institutes of Health [HL77575, HL86965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077575, R01HL086965] Funding Source: NIH RePORTER	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a National Basic Research Program (973) of China (2007CB512004) and National Natural Science Foundation of China (30770882 and 81000097). Y.X. was supported by National Institutes of Health Grants HL77575 and HL86965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH1689, DOI 10.1152/ajpheart.00538.2007; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; Bristow M, 2003, CIRCULATION, V107, P1100, DOI 10.1161/01.CIR.0000054530.87613.36; BRISTOW MR, 1997, AM J CARDIOL, V80, P26; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Marano G, 2002, J HYPERTENS, V20, P763, DOI 10.1097/00004872-200204000-00036; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vatner DE, 2001, CIRC RES, V88, P645, DOI 10.1161/hh0701.089951; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2003, TRENDS BIOCHEM SCI, V28, P671, DOI 10.1016/j.tibs.2003.10.003; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yaoita H, 2002, CIRCULATION, V105, P975, DOI 10.1161/hc0802.104503; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; [No title captured]	37	51	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27294	10.1371/journal.pone.0027294	http://dx.doi.org/10.1371/journal.pone.0027294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073308	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900097
J	Tauber, JM; Vanlandingham, PA; Zhang, B				Tauber, John M.; Vanlandingham, Phillip A.; Zhang, Bing			Elevated Levels of the Vesicular Monoamine Transporter and a Novel Repetitive Behavior in the Drosophila Model of Fragile X Syndrome	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; LONGITUDINAL IQ CHANGES; MOUSE MODEL; MESSENGER-RNA; SYNAPTIC PLASTICITY; COURTSHIP BEHAVIOR; AUTISTIC BEHAVIOR; GENE; IDENTIFICATION; FMRP	Fragile X Syndrome (FXS) is characterized by mental impairment and autism in humans, and it often features hyperactivity and repetitive behaviors. The mechanisms for the disease, however, remain poorly understood. Here we report that the dfmr1 mutant in the Drosophila model of FXS grooms excessively, which may be regulated differentially by two signaling pathways. Blocking metabotropic glutamate receptor signaling enhances grooming in dfmr1 mutant flies, whereas blocking the vesicular monoamine transporter (VMAT) suppresses excessive grooming. dfmr1 mutant flies also exhibit elevated levels of VMAT mRNA and protein. These results suggest that enhanced monoamine signaling correlates with repetitive behaviors and hyperactivity associated with FXS.	[Tauber, John M.; Vanlandingham, Phillip A.; Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Tauber, JM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	bing@ou.edu			University of Oklahoma; NIH [RO1 NS060878]; Vad Foundation Award for Outstanding Undergraduate Thesis; Division Of Integrative Organismal Systems [0822236, 1025556] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060878] Funding Source: NIH RePORTER	University of Oklahoma; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vad Foundation Award for Outstanding Undergraduate Thesis; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by internal funds from the University of Oklahoma (to B.Z.) and in part by an NIH grant (RO1 NS060878 to B.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Yong Q. Zhang and Kendal Broadie for providing the w; dfmr1<SUP>83M</SUP>/TM6B, Tb stock, and Dr. Thomas Jongens for providing the w; dfmr1<SUP>3</SUP>/TM6C, Sb, wild-type rescue (Control) and frameshift rescue (FS) stocks. We also thank Dr. David Krantz for his advice on the use of acetic acid in dissolving reserpine and for providing the antibody to dVMAT, Drs. Michael Tranfaglia, Randy Hewes, Rosemary Knapp, and David McCauley for constructive comments on the manuscript, Dr. Lauren Ritterhouse for assistance in the statistical analysis of the data, Logan Cox for assistance on fly husbandry, and Emily Kumimoto, Rod Kumimoto, and Sunetra Das for their instruction and assistance with RNA isolation and real-time PCR. The MPEP drug was a generous gift of Dr. Michael Tranfaglia from the FRAXA Research Foundation. J.M.T. received the inaugural Vad Foundation Award for Outstanding Undergraduate Thesis for this research. We wish to thank Dr. Vijay Vad and his Foundation for his support.	Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Boyle L, 2010, AM J MED GENET C, V154C, P469, DOI 10.1002/ajmg.c.30277; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Choi CH, 2011, BRAIN RES, V1380, P106, DOI 10.1016/j.brainres.2010.11.032; Choi CH, 2010, BIOGERONTOLOGY, V11, P347, DOI 10.1007/s10522-009-9259-6; Coffee B, 2009, AM J HUM GENET, V85, P503, DOI 10.1016/j.ajhg.2009.09.007; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Cook D, 2010, J NEUROSCI, V30, P7121, DOI 10.1523/JNEUROSCI.1298-10.2010; Cordeiro L, 2011, J NEURODEV DISORD, V3, P57, DOI 10.1007/s11689-010-9067-y; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Gabis LV, 2011, J CHILD NEUROL; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; HAGERMAN RJ, 1989, AM J MED GENET, V33, P513, DOI 10.1002/ajmg.1320330422; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hall SS, 2008, AM J MENT RETARD, V113, P44, DOI 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2; Harris SW, 2008, AM J MENT RETARD, V113, P427, DOI 10.1352/2008.113:427-438; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Hong A, 2011, J MOL NEUROSCI; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Inoue SB, 2002, CURR BIOL, V12, P1331, DOI 10.1016/S0960-9822(02)01036-9; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Larson J, 2005, J NEUROSCI, V25, P9460, DOI 10.1523/JNEUROSCI.2638-05.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Moon J, 2006, BEHAV NEUROSCI, V120, P1367, DOI 10.1037/0735-7044.120.6.1367; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Moss J, 2009, J AUTISM DEV DISORD, V39, P572, DOI 10.1007/s10803-008-0655-6; Pan L, 2008, MOL CELL NEUROSCI, V37, P747, DOI 10.1016/j.mcn.2008.01.003; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; REISS AL, 1992, AM J MED GENET, V43, P35, DOI 10.1002/ajmg.1320430106; Repicky S, 2009, J NEUROPHYSIOL, V101, P672, DOI 10.1152/jn.90953.2008; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; WrightTalamante C, 1996, AM J MED GENET, V64, P350, DOI 10.1002/(SICI)1096-8628(19960809)64:2<350::AID-AJMG23>3.0.CO;2-D; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	59	41	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27100	10.1371/journal.pone.0027100	http://dx.doi.org/10.1371/journal.pone.0027100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22087250	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900077
J	Ramos, I; Gomes, F; Koeller, CM; Saito, K; Heise, N; Masuda, H; Docampo, R; de Souza, W; Machado, EA; Miranda, K				Ramos, Isabela; Gomes, Fabio; Koeller, Carolina M.; Saito, Katsuharu; Heise, Norton; Masuda, Hatisaburo; Docampo, Roberto; de Souza, Wanderley; Machado, Ednildo A.; Miranda, Kildare			Acidocalcisomes as Calcium- and Polyphosphate-Storage Compartments during Embryogenesis of the Insect Rhodnius prolixus Stahl	PLOS ONE			English	Article							PROTON-PUMPING PYROPHOSPHATASE; VACUOLAR H+-PYROPHOSPHATASE; YOLK GRANULES; INORGANIC POLYPHOSPHATE; PERIPLANETA-AMERICANA; TRYPANOSOMA-CRUZI; UNICELLULAR EUKARYOTES; ENDOPLASMIC-RETICULUM; MALARIA PARASITES; ESCHERICHIA-COLI	Background: The yolk of insect eggs is a cellular domain specialized in the storage of reserve components for embryo development. The reserve macromolecules are stored in different organelles and their interactions with the embryo cells are mostly unknown. Acidocalcisomes are lysosome-related organelles characterized by their acidic nature, high electron density and large content of polyphosphate bound to several cations. In this work, we report the presence of acidocalcisome-like organelles in eggs of the insect vector Rhodnius prolixus. Methodology/Principal findings: Characterization of the elemental composition of electron-dense vesicles by electron probe X-ray microanalysis revealed a composition similar to that previously described for acidocalcisomes. Following subcellular fractionation experiments, fractions enriched in acidocalcisomes were obtained and characterized. Immunofluorescence showed that polyphosphate polymers and the vacuolar proton translocating pyrophosphatase (V-H+-PPase, considered as a marker for acidocalcisomes) are found in the same vesicles and that these organelles are mainly localized in the egg cortex. Polyphosphate quantification showed that acidocalcisomes contain a significant amount of polyphosphate detected at day-0 eggs. Elemental analyses of the egg fractions showed that 24.5 +/- 0.65% of the egg calcium are also stored in such organelles. During embryogenesis, incubation of acidocalcisomes with acridine orange showed that these organelles are acidified at day-3 (coinciding with the period of yolk mobilization) and polyphosphate quantification showed that the levels of polyphosphate tend to decrease during early embryogenesis, being approximately 30% lower at day-3 compared to day-0 eggs. Conclusions: We found that acidocalcisomes are present in the eggs and are the main storage compartments of polyphosphate and calcium in the egg yolk. As such components have been shown to be involved in a series of dynamic events that may control embryo growth, results reveal the potential involvement of a novel organelle in the storage and mobilization of inorganic elements to the embryo cells.	[Ramos, Isabela; Gomes, Fabio; Koeller, Carolina M.; Heise, Norton; de Souza, Wanderley; Machado, Ednildo A.; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Ramos, Isabela; Masuda, Hatisaburo] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [de Souza, Wanderley; Machado, Ednildo A.; Miranda, Kildare] Inst Nacl Metrol Normalizacao & Qualidade Ind, Diretoria Programas, Xerem, Brazil; [Saito, Katsuharu] Shinshu Univ, Fac Agr, Nagano, Japan; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Shinshu University; University System of Georgia; University of Georgia	Ramos, I (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	ednildo@biof.ufrj.br; kmiranda@biof.ufrj.br	Koeller, Carolina/ABB-1968-2021; Ramos, Isabela B/N-7091-2017; Heise, Norton/I-4098-2013; Saito, Katsuharu/I-9304-2014; Machado, Ednildo A/G-9725-2013	Koeller, Carolina/0000-0002-1919-7582; Ramos, Isabela B/0000-0003-0874-7902; Saito, Katsuharu/0000-0003-2557-1726; Heise, Norton/0000-0003-0154-7406; Machado, Ednildo/0000-0002-4428-3829; Gomes, Fabio/0000-0001-8439-8762	Conselho Nacional de Desenvolvimento CientUfico e Tccnoloegico (CNPq/Brazil); Programa Jovens Pesquisadores (CNPq/Brazil); Grupos Emergentes of Fundaca Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Barbara and Sanford Orkin/Georgia Research Alliance Chair; Grants-in-Aid for Scientific Research [23780062] Funding Source: KAKEN	Conselho Nacional de Desenvolvimento CientUfico e Tccnoloegico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Jovens Pesquisadores (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Grupos Emergentes of Fundaca Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Barbara and Sanford Orkin/Georgia Research Alliance Chair; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Conselho Nacional de Desenvolvimento CientUfico e Tccnoloegico (CNPq/Brazil). Programa Jovens Pesquisadores (CNPq/Brazil) (to K.M.) and Grupos Emergentes of Fundaca Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). R.D. was funded by the Barbara and Sanford Orkin/Georgia Research Alliance Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu LA, 2004, INSECT BIOCHEM MOLEC, V34, P443, DOI 10.1016/j.ibmb.2004.01.006; Andersen S.O., 1985, COMPREHENSIVE INSECT, V3, P59, DOI 10.1016/0020-711X(85)90033-3; ANDERSON RGW, 1988, J CELL BIOL, V106, P539, DOI 10.1083/jcb.106.3.539; Atella GC, 2005, AN ACAD BRAS CIENC, V77, P405, DOI 10.1590/S0001-37652005000300005; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Briano MVM, 1995, ARCH LATINOAM NUTR, V45, P172; Campos E, 2007, INSECT BIOCHEM MOLEC, V37, P1103, DOI 10.1016/j.ibmb.2007.06.003; Chestkov VV, 1998, J BIOL CHEM, V273, P2445, DOI 10.1074/jbc.273.4.2445; COLMAN A, 1976, EUR J BIOCHEM, V61, P387, DOI 10.1111/j.1432-1033.1976.tb10032.x; DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Docampo R, 2010, PHILOS T R SOC B, V365, P775, DOI 10.1098/rstb.2009.0179; FAGOTTO F, 1995, J CELL SCI, V108, P3645; FAGOTTO F, 1991, DEV GROWTH DIFFER, V33, P57; Fausto AM, 2001, CELL TISSUE RES, V305, P433, DOI 10.1007/s004410100392; Fialho E, 2002, INSECT BIOCHEM MOLEC, V32, P871, DOI 10.1016/S0965-1748(01)00175-8; Fiske CH, 1925, J BIOL CHEM, V66, P375; Garcia CRS, 1998, EUR J CELL BIOL, V76, P133, DOI 10.1016/S0171-9335(98)80026-5; Gomes FM, 2010, J CELL PHYSIOL, V222, P606, DOI 10.1002/jcp.21975; Gomes FM, 2008, J INSECT PHYSIOL, V54, P1459, DOI 10.1016/j.jinsphys.2008.07.018; HEMING BS, 1994, CAN J ZOOL, V72, P1100, DOI 10.1139/z94-148; Kornberg A, 1999, Prog Mol Subcell Biol, V23, P1; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marchesini N, 2000, BIOCHEM J, V347, P243, DOI 10.1042/0264-6021:3470243; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; McNeil PL, 2000, J CELL SCI, V113, P1891; Miranda K, 2004, PROTIST, V155, P395, DOI 10.1078/1434461042650361; Miranda K, 2004, HISTOCHEM CELL BIOL, V121, P407, DOI 10.1007/s00418-004-0646-4; Miranda K, 2000, PARASITOL RES, V86, P373, DOI 10.1007/s004360050682; Miranda K, 2008, EXP PARASITOL, V118, P2, DOI 10.1016/j.exppara.2007.07.009; Motta LS, 2004, INSECT BIOCHEM MOLEC, V34, P19, DOI 10.1016/j.ibmb.2003.07.002; Motta LS, 2009, INSECT BIOCHEM MOLEC, V39, P198, DOI 10.1016/j.ibmb.2008.11.003; NORDIN JH, 1991, ARCH INSECT BIOCHEM, V18, P177, DOI 10.1002/arch.940180306; OLIVEIRA PL, 1986, J INSECT PHYSIOL, V32, P859, DOI 10.1016/0022-1910(86)90101-0; OLIVEIRA PL, 1989, INSECT BIOCHEM, V19, P489; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Ramos IB, 2007, J EXP BIOL, V210, P138, DOI 10.1242/jeb.02652; Ramos IB, 2006, MOL REPROD DEV, V73, P1247, DOI 10.1002/mrd.20560; Ramos IB, 2011, MOL BIOL REP, V38, P1757, DOI 10.1007/s11033-010-0290-0; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Ramos IB, 2010, BIOL CELL, V102, P421, DOI 10.1042/BC20100011; REIMER CL, 1995, DEV BIOL, V167, P439, DOI 10.1006/dbio.1995.1040; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saito K, 2005, APPL ENVIRON MICROB, V71, P5692, DOI 10.1128/AEM.71.10.5692-5701.2005; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Seufferheld M, 2004, J BIOL CHEM, V279, P51193, DOI 10.1074/jbc.M406099200; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; Singla PN, 1998, J TROP PEDIATRICS, V44, P117, DOI 10.1093/tropej/44.2.117; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; TERASAKI M, 1991, DEV BIOL, V148, P398, DOI 10.1016/0012-1606(91)90348-7; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; *WHO, 2008, REP EXP COMM CONTR C, V905; Yamahama Y, 2003, J INSECT PHYSIOL, V49, P131, DOI 10.1016/S0022-1910(02)00257-3; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153	68	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27276	10.1371/journal.pone.0027276	http://dx.doi.org/10.1371/journal.pone.0027276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096545	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900029
J	Veselkin, E; Kondratyev, M; Lurie, Y; Ron, E; Santo, M; Reif, S; Elashvili, I; Bar, L; Lederkremer, GZ				Veselkin, Elena; Kondratyev, Maria; Lurie, Yoav; Ron, Efrat; Santo, Moshe; Reif, Shimon; Elashvili, Irma; Bar, Lana; Lederkremer, Gerardo Z.			A Secreted Form of the Asialoglycoprotein Receptor, sH2a, as a Novel Potential Noninvasive Marker for Liver Fibrosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; DIAGNOSTIC-ACCURACY; VIRAL-HEPATITIS; EXPRESSION; MECHANISMS; PREDICTION; BIOMARKERS; DISEASE; TESTS; INDEX	Background and Aim: The human asialoglycoprotein receptor is a membrane heterooligomer expressed exclusively in hepatocytes. A soluble secreted form, sH2a, arises, not by shedding at the cell surface, but by intracellular cleavage of its membrane-bound precursor, which is encoded by an alternatively spliced form of the receptor H2 subunit. Here we determined and report that sH2a, present at constant levels in serum from healthy individuals is altered upon liver fibrosis, reflecting the status of hepatocyte function. Methods: We measured sH2a levels in serum using a monoclonal antibody and an ELISA assay that we developed, comparing with routine liver function markers. We compared blindly pretreatment serum samples from a cohort of 44 hepatitis C patients, which had METAVIR-scored biopsies, with 28 healthy individuals. Results: sH2a levels varied minimally for the healthy individuals (150 +/- 21 ng/ml), whereas the levels deviated from this normal range increasingly in correlation with fibrosis stage. A simple algorithm combining sH2a levels with those of alanine aminotransferase allowed prediction of fibrosis stage, with a very high area under the ROC curve of 0.86. Conclusions: sH2a has the potential to be a uniquely sensitive and specific novel marker for liver fibrosis and function.	[Veselkin, Elena; Kondratyev, Maria; Ron, Efrat; Lederkremer, Gerardo Z.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Lurie, Yoav; Santo, Moshe; Reif, Shimon; Elashvili, Irma; Bar, Lana] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, Liver Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Veselkin, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il		Lederkremer, Gerardo/0000-0002-9857-7152	Israel Science Foundation; Israel Cancer Association; Israeli Ministry of Health	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israeli Ministry of Health	GZL received financial support from the Ramot research fund, the Israel Science Foundation, the Israel Cancer Association and the Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BENYAIR R, 2011, WORLD J GAS IN PRESS; Bissell DM, 2004, GASTROENTEROLOGY, V127, P1847, DOI 10.1053/j.gastro.2004.10.012; BURGESS JB, 1992, HEPATOLOGY, V15, P702, DOI 10.1002/hep.1840150425; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; DRICKAMER K, 1991, CELL, V67, P1029, DOI 10.1016/0092-8674(91)90278-7; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; Higuchi H, 2003, CURR MOL MED, V3, P483, DOI 10.2174/1566524033479528; Ishii H, 1998, J GASTROENTEROL, V33, P920, DOI 10.1007/s005350050203; Jarcuska P, 2010, CLIN CHIM ACTA, V411, P1009, DOI 10.1016/j.cca.2010.04.009; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Kokudo N, 2002, WORLD J SURG, V26, P1342, DOI 10.1007/s00268-002-6262-3; KUDO M, 1991, J NUCL MED, V32, P1177; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; PIMSTONE NR, 1994, HEPATOLOGY, V20, P917, DOI 10.1002/hep.1840200421; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Rossi Enrico, 2007, Clin Biochem Rev, V28, P3; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Takemoto R, 2009, J DIGEST DIS, V10, P145, DOI 10.1111/j.1751-2980.2009.00377.x; Thuluvath PJ, 2006, AM J GASTROENTEROL, V101, P1497, DOI 10.1111/j.1572-0241.2005.00304.x; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Trere D, 1999, BRIT J CANCER, V81, P404, DOI 10.1038/sj.bjc.6690708	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							se27210	10.1371/journal.pone.0027210	http://dx.doi.org/10.1371/journal.pone.0027210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096539	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900025
J	Baskaran, P; Heckler, EJ; van den Akker, F; Beuve, A				Baskaran, Padmamalini; Heckler, Erin J.; van den Akker, Focco; Beuve, Annie			Identification of Residues in the Heme Domain of Soluble Guanylyl Cyclase that are Important for Basal and Stimulated Catalytic Activity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; NITRIC-OXIDE; ACTIVATION; BINDING; NO; MECHANISM; SENSITIVITY; INSIGHTS; MOIETY; SENSOR	Nitric oxide signals through activation of soluble guanylyl cyclase (sGC), a heme-containing heterodimer. NO binds to the heme domain located in the N-terminal part of the beta subunit of sGC resulting in increased production of cGMP in the catalytic domain located at the C-terminal part of sGC. Little is known about the mechanism by which the NO signaling is propagated from the receptor domain (heme domain) to the effector domain (catalytic domain), in particular events subsequent to the breakage of the bond between the heme iron and Histidine 105 (H105) of the b subunit. Our modeling of the heme-binding domain as well as previous homologous heme domain structures in different states point to two regions that could be critical for propagation of the NO activation signal. Structure-based mutational analysis of these regions revealed that residues T110 and R116 in the alpha F helix-beta 1 strand, and residues I41 and R40 in the alpha B-alpha C loop mediate propagation of activation between the heme domain and the catalytic domain. Biochemical analysis of these heme mutants allows refinement of the map of the residues that are critical for heme stability and propagation of the NO/YC-1 activation signal in sGC.	[Baskaran, Padmamalini; Heckler, Erin J.; Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University	Baskaran, P (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	focco.vandenakker@case.edu; annie.beuve@umdnj.edu		Heckler, Erin/0000-0002-9156-1318	National Institutes of Health [GM067640, HL075329]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM067640 (to AB) and HL075329 (to FvdA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskaran P, 2011, BIOCHEMISTRY-US, V50, P4291, DOI 10.1021/bi2004087; Capece L, 2008, BIOCHEMISTRY-US, V47, P9416, DOI 10.1021/bi800682k; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Knipp M, 2011, J INORG BIOCHEM, V105, P1405, DOI 10.1016/j.jinorgbio.2011.07.009; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin F, 2010, J BIOL CHEM; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Mergia Evanthia, 2009, V191, P33, DOI 10.1007/978-3-540-68964-5_3; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olea C, 2010, PROTEIN SCI, V19, P881, DOI 10.1002/pro.357; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Schmidt PM, 2005, EUR J PHARMACOL, V513, P67, DOI 10.1016/j.ejphar.2005.02.046; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; YUEN PST, 1994, J BIOL CHEM, V269, P791	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26976	10.1371/journal.pone.0026976	http://dx.doi.org/10.1371/journal.pone.0026976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096512	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800020
J	Comeau, AM; Li, WKW; Tremblay, JE; Carmack, EC; Lovejoy, C				Comeau, Andre M.; Li, William K. W.; Tremblay, Jean-Eric; Carmack, Eddy C.; Lovejoy, Connie			Arctic Ocean Microbial Community Structure before and after the 2007 Record Sea Ice Minimum	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; BEAUFORT SEA; DIVERSITY; BACTERIAL; GROWTH; PICOPHYTOPLANKTON; PHYSIOLOGY; ECOLOGY; RIVER	Increasing global temperatures are having a profound impact in the Arctic, including the dramatic loss of multiyear sea ice in 2007 that has continued to the present. The majority of life in the Arctic is microbial and the consequences of climate-mediated changes on microbial marine food webs, which are responsible for biogeochemical cycling and support higher trophic levels, are unknown. We examined microbial communities over time by using high-throughput sequencing of microbial DNA collected between 2003 and 2010 from the subsurface chlorophyll maximum (SCM) layer of the Beaufort Sea (Canadian Arctic). We found that overall this layer has freshened and concentrations of nitrate, the limiting nutrient for photosynthetic production in Arctic seas, have decreased. We compared microbial communities from before and after the record September 2007 sea ice minimum and detected significant differences in communities from all three domains of life. In particular, there were significant changes in species composition of Eukarya, with ciliates becoming more common and heterotrophic marine stramenopiles (MASTs) accounting for a smaller proportion of sequences retrieved after 2007. Within the Archaea, Marine Group I Thaumarchaeota, which earlier represented up to 60% of the Archaea sequences in this layer, have declined to <10%. Bacterial communities overall were less diverse after 2007, with a significant decrease of the Bacteroidetes. These significant shifts suggest that the microbial food webs are sensitive to physical oceanographic changes such as those occurring in the Canadian Arctic over the past decade.	[Comeau, Andre M.; Tremblay, Jean-Eric; Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Comeau, Andre M.; Tremblay, Jean-Eric; Lovejoy, Connie] Univ Laval, IBIS, Quebec City, PQ G1K 7P4, Canada; [Li, William K. W.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Carmack, Eddy C.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	Laval University; Laval University; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Comeau, AM (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	andre.comeu@ibis.ulaval.ca; connie.lovejoy@bio.ulaval.ca	Lovejoy, Connie/A-3756-2008; Comeau, André/E-7461-2012	Lovejoy, Connie/0000-0001-8027-2281; 	Natural Science and Engineering Research Council of Canada (NSERC); Canadian Healthy Oceans Network	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Healthy Oceans Network	C.L.'s multiple cruise participations were funded by ongoing Natural Science and Engineering Research Council of Canada (NSERC) Discovery grants and the Canadian Healthy Oceans Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2008, ENVIRON MICROBIOL, V10, P2444, DOI 10.1111/j.1462-2920.2008.01674.x; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bachy C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00106; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Brugel S, 2009, MAR ECOL PROG SER, V377, P63, DOI 10.3354/meps07808; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Falk-Petersen S, 2009, DEEP-SEA RES PT II, V56, P2080, DOI 10.1016/j.dsr2.2008.11.020; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Forest A, 2010, DEEP-SEA RES PT I, V57, P125, DOI 10.1016/j.dsr.2009.10.002; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Garneau ME, 2006, AQUAT MICROB ECOL, V42, P27, DOI 10.3354/ame042027; Gosink JJ, 1998, INT J SYST BACTERIOL, V48, P223, DOI 10.1099/00207713-48-1-223; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Guo JP, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015140; Hansen PJ, 1999, J EUKARYOT MICROBIOL, V46, P382, DOI 10.1111/j.1550-7408.1999.tb04617.x; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jackson JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005265; Jeong HJ, 1999, J EUKARYOT MICROBIOL, V46, P390, DOI 10.1111/j.1550-7408.1999.tb04618.x; Kalanetra KM, 2009, ENVIRON MICROBIOL, V11, P2434, DOI 10.1111/j.1462-2920.2009.01974.x; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Kwok R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044678; Lavoie D, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005493; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lo Giudice A, 2012, MICROB ECOL, V63, P210, DOI 10.1007/s00248-011-9904-x; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Lovejoy C., 2010, MAR BIODIVERS, V41, P5, DOI DOI 10.1007/s12526-010-0062-z; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Lovejoy C, 2011, J PLANKTON RES, V33, P431, DOI 10.1093/plankt/fbq124; Marie D, 2006, FEMS MICROBIOL ECOL, V55, P403, DOI 10.1111/j.1574-6941.2005.00058.x; Martin J, 2010, MAR ECOL PROG SER, V412, P69, DOI 10.3354/meps08666; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; McLaughlin FA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045459; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Nicol GW, 2006, TRENDS MICROBIOL, V14, P207, DOI 10.1016/j.tim.2006.03.004; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Piquet AMT, 2011, FEMS MICROBIOL ECOL, V76, P413, DOI 10.1111/j.1574-6941.2011.01062.x; Proshutinsky A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005162; Purcell JE, 2010, DEEP-SEA RES PT II, V57, P127, DOI 10.1016/j.dsr2.2009.08.011; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rainville L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041291; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; STOLTE W, 1995, MICROBIOL-SGM, V141, P1221, DOI 10.1099/13500872-141-5-1221; STREY ST, 2010, J GEOPHYS RES, V115, P1; Terrado R, 2011, POLAR BIOL, V34, P1901, DOI 10.1007/s00300-011-1039-5; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Tremblay JE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004547; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006; Vincent WF, 2010, ISME J, V4, P1089, DOI 10.1038/ismej.2010.108; Zeder M, 2009, ENVIRON MICROBIOL, V11, P2676, DOI 10.1111/j.1462-2920.2009.01994.x	64	254	258	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27492	10.1371/journal.pone.0027492	http://dx.doi.org/10.1371/journal.pone.0027492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096583	gold, Green Published, Green Submitted			2022-12-27	WOS:000297350800055
J	Kasera, R; Singh, BP; Lavasa, S; Prasad, KN; Sahoo, RC; Singh, AB				Kasera, Ramkrashan; Singh, Bhanu Pratap; Lavasa, Sakuntala; Prasad, Komerla N.; Sahoo, Ramesh C.; Singh, Anand B.			Kidney Bean: A Major Sensitizer among Legumes in Asthma and Rhinitis Patients from India	PLOS ONE			English	Article							FOOD ALLERGY; PREVALENCE; CHILDREN; PROTEINS; UTILITY; POLLEN; PEANUT; EGG	Background: The prevalence of IgE mediated food allergies has increased over the last two decades. Food allergy has been reported to be fatal in highly sensitive individuals. Legumes are important food allergens but their prevalence may vary among different populations. The present study identifies sensitization to common legumes among Indian population, characterizes allergens of kidney bean and establishes its cross reactivity with other legumes. Methodology: Patients (n = 355) with history of legume allergy were skin prick tested (SPT) with 10 legumes. Specific IgE (sIgE) and total IgE were estimated in sera by enzyme-linked immunosorbent assay. Characterization of kidney bean allergens and their cross reactivity was investigated by immunobiochemical methods. Identification of major allergens of kidney bean was carried out by mass spectrometry. Principal Findings: Kidney bean exhibited sensitization in 78 (22.0%) patients followed by chickpea 65 (18.0%) and peanut 53 (15%). SPT positive patients depicted significantly elevated sIgE levels against different legumes (r = 0.85, p<0.0001). Sera from 30 kidney bean sensitive individuals exhibited basophil histamine release (16-54%) which significantly correlated with their SPT (r = 0.83, p<0.0001) and sIgE (r = 0.99, p<0.0001). Kidney bean showed eight major allergens of 58, 50, 45, 42, 40, 37, 34 and 18 kDa on immunoblot and required 67.3 +/- 2.51 ng of homologous protein for 50% IgE inhibition. Inhibition assays revealed extensive cross reactivity among kidney bean, peanut, black gram and pigeon pea. nLC-MS/MS analysis identified four allergens of kidney bean showing significant matches with known proteins namely lectin (phytohemagglutinin), phaseolin, alpha-amylase inhibitor precursor and group 3 late embryogenesis abundant protein. Conclusion/Significance: Among legumes, kidney bean followed by chick pea and peanut are the major allergic triggers in asthma and rhinitis patients in India. Kidney bean showed eight major allergens and cross reacted with other legumes. A combination of SPT, sIgE and histamine release assay is helpful in allergy diagnosis.	[Kasera, Ramkrashan; Singh, Bhanu Pratap; Singh, Anand B.] Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India; [Lavasa, Sakuntala] USLavasa Med & Res Ctr, Chandigarh, India; [Prasad, Komerla N.] Bangalore Allergy Ctr, Bangalore, Karnataka, India; [Kasera, Ramkrashan; Singh, Bhanu Pratap] Univ Pune, Pune, Maharashtra, India; [Sahoo, Ramesh C.] Manipal Med Coll, Mangalore, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University; Manipal Academy of Higher Education (MAHE)	Kasera, R (corresponding author), Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India.	singha49@hotmail.com	Kasera, Ramkrashan/D-3727-2012		Indian Council of Medical Research, Delhi, India	Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR))	The study is funded by Indian Council of Medical Research, Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Asero R, 2009, CURR OPIN ALLERGY CL, V9, P379, DOI 10.1097/ACI.0b013e32832d9049; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Budde IK, 2001, INT ARCH ALLERGY IMM, V126, P277, DOI 10.1159/000049524; Crespo JF, 2003, ALLERGY, V58, P98, DOI 10.1034/j.1398-9995.2003.02170.x; Eggesbo M, 2001, ALLERGY, V56, P403, DOI 10.1034/j.1398-9995.2001.056005403.x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Gupta SK, 1996, LUNG INDIA, V14, P60; Ibanez M D, 2003, Allergol Immunopathol (Madr), V31, P151; Kluh I, 2005, PHYTOCHEMISTRY, V66, P31, DOI 10.1016/j.phytochem.2004.11.001; Kukreja N, 2009, FEMS IMMUNOL MED MIC, V56, P32, DOI 10.1111/j.1574-695X.2009.00542.x; Kumar R, 2007, IMMUNOBIOLOGY, V212, P141, DOI 10.1016/j.imbio.2006.11.006; Kumari D, 2006, ALLERGY, V61, P104, DOI 10.1111/j.1398-9995.2006.00990.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mari A, 2003, CLIN EXP ALLERGY, V33, P1429, DOI 10.1046/j.1365-2222.2003.01783.x; Misra A, 2008, IMMUNOPHARM IMMUNOT, V30, P529, DOI 10.1080/08923970802135294; Nowak-Wegrzyn A, 2006, MED CLIN N AM, V90, P97, DOI 10.1016/j.mcna.2005.08.012; O'Cualain RDM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-286; ORANJE AP, 1992, ACTA DERM-VENEREOL, P41; Osterballe M, 2009, PEDIAT ALLERG IMM-UK, V20, P686, DOI 10.1111/j.1399-3038.2008.00842.x; Pascual CY, 1999, J ALLERGY CLIN IMMUN, V103, P154, DOI 10.1016/S0091-6749(99)70539-7; Patil SP, 2001, ANN ALLERG ASTHMA IM, V87, P140, DOI 10.1016/S1081-1206(10)62209-0; Penard-Morand C, 2005, ALLERGY, V60, P1165, DOI 10.1111/j.1398-9995.2005.00860.x; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Rouge P, 2011, ALLERGY, V66, P301, DOI 10.1111/j.1398-9995.2010.02466.x; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sanchez-Monge R, 2000, J ALLERGY CLIN IMMUN, V106, P955, DOI 10.1067/mai.2000.109912; Sandin DI, 1999, ALLERGY, V54, P1209, DOI 10.1034/j.1398-9995.1999.00299.x; Sato S, 2011, INT ARCH ALLERGY IMM, V155, P96, DOI 10.1159/000327490; Shaikh WA, 1990, BOMBAY HOSP J, V32, P31; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Sharma S, 2006, CLIN EXP ALLERGY, V36, P1019, DOI 10.1111/j.1365-2222.2006.02525.x; Sharman Jyotsna, 2000, Indian Journal of Pediatrics, V67, P713, DOI 10.1007/BF02723925; Sicherer SH, 2009, ANNU REV MED, V60, P261, DOI 10.1146/annurev.med.60.042407.205711; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; SINGH AB, 1992, ASIAN PAC J ALLERGY, V10, P103; Singh AK, 2006, ALLERGY, V61, P491, DOI 10.1111/j.1398-9995.2006.01049.x; SINGH BP, 1992, BIOCHEM INT, V27, P477; Spiewak R, 2000, ANN AGR ENV MED, V7, P55; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang JL, 2005, J ALLERGY CLIN IMMUN, V115, P1076, DOI 10.1016/j.jaci.2005.02.014	43	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27193	10.1371/journal.pone.0027193	http://dx.doi.org/10.1371/journal.pone.0027193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096535	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800035
J	Wang, SS; Lu, YN; Rothman, N; Abdou, AM; Cerhan, JR; De Roos, A; Davis, S; Severson, RK; Cozen, W; Chanock, SJ; Bernstein, L; Morton, LM; Hartge, P				Wang, Sophia S.; Lu, Yani; Rothman, Nathaniel; Abdou, Amr M.; Cerhan, James R.; De Roos, Anneclaire; Davis, Scott; Severson, Richard K.; Cozen, Wendy; Chanock, Stephen J.; Bernstein, Leslie; Morton, Lindsay M.; Hartge, Patricia			Variation in Effects of Non-Hodgkin Lymphoma Risk Factors According to the Human Leukocyte Antigen (HLA)-DRB1*01:01 Allele and Ancestral Haplotype 8.1	PLOS ONE			English	Article							NECROSIS-FACTOR TNF; POOLED ANALYSIS; SUN EXPOSURE; POLYMORPHISMS; IL10	Genetic variations in human leukocyte antigens (HLA) are critical in host responses to infections, transplantation, and immunological diseases. We previously identified associations with non-Hodgkin lymphoma (NHL) and the HLA-DRB1*01:01 allele and extended ancestral haplotype (AH) 8.1 (HLA-A*01-B*08-DR*03-TNF-308A). To illuminate how HLA alleles and haplotypes may influence NHL etiology, we examined potential interactions between HLA-DRB1*01:01 and AH 8.1, and a wide range of NHL risk factors among 685 NHL cases and 646 controls from a United States population-based case-control study. We calculated odds ratios and 95% confidence intervals by HLA allele or haplotype status, adjusted for sex, age, race and study center for NHL and two major subtypes using polychotomous unconditional logistic regression models. The previously reported elevation in NHL risk associated with exposures to termite treatment and polychlorinated biphenyls were restricted to individuals who did not possess HLA-DRB1*01:01. Previous associations for NHL and DLBCL with decreased sun exposure, higher BMI, and autoimmune conditions were statistically significant only among those with AH 8.1, and null among those without AH 8.1. Our results suggest that NHL risk factors vary in their association based on HLA-DRB1*01:01 and AH 8.1 status. Our results further suggest that certain NHL risk factors may act through a common mechanism to alter NHL risk. Finally, control participants with either HLA-DRB1*01:01 or AH 8.1 reported having a family history of NHL twice as likely as those who did not have either allele or haplotype, providing the first empirical evidence that HLA associations may explain some of the well-established relationship between family history and NHL risk.	[Wang, Sophia S.; Lu, Yani; Bernstein, Leslie] Beckman Res Inst & City Hope, Div Canc Etiol, Dept Populat Sci, Duarte, CA USA; [Rothman, Nathaniel; Chanock, Stephen J.; Morton, Lindsay M.; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA; [Abdou, Amr M.] Natl Res Ctr, Dept Microbiol & Immunol, Cairo, Egypt; [Cerhan, James R.] Mayo Clin, Div Epidemiol, Coll Med, Rochester, MN USA; [De Roos, Anneclaire; Davis, Scott] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Severson, Richard K.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Karmanos Canc Inst, Detroit, MI USA; [Cozen, Wendy] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA	City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Mayo Clinic; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Southern California	Wang, SS (corresponding author), Beckman Res Inst & City Hope, Div Canc Etiol, Dept Populat Sci, Duarte, CA USA.	sowang@coh.org	Morton, Lindsay M/B-5234-2015; Morton, Lindsay/AAE-7495-2022	Morton, Lindsay M/0000-0001-9767-2310; Morton, Lindsay/0000-0001-9767-2310; Abdou, Amr/0000-0002-3373-2406; WANG, SOPHIA/0000-0003-2597-9393; Cerhan, James/0000-0002-7482-178X	National Institutes of Health (NHI) National Cancer Institute (NCI) [HHSN261200800001E]; Public Health Service (PHS) [N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, N02-PC-71105]; NIH, National Cancer Institute, Center for Cancer Research; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010, N01PC065064, N01PC067009, N01PC067008] Funding Source: NIH RePORTER	National Institutes of Health (NHI) National Cancer Institute (NCI); Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences)	The NCI-SEER study was supported by the Intramural Research Program of the National Institutes of Health (NHI) National Cancer Institute (NCI), and by Public Health Service (PHS) contracts N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, and N02-PC-71105. HLA typing for the study was funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E and in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AM, 2010, LEUKEMIA, V24, P1055, DOI 10.1038/leu.2010.17; Anderson LA, 2009, INT J CANCER, V125, P398, DOI 10.1002/ijc.24287; Candore Giuseppina, 2002, Autoimmunity Reviews, V1, P29, DOI 10.1016/S1568-9972(01)00004-0; Colt JS, 2009, BLOOD, V113, P1899, DOI 10.1182/blood-2008-04-153858; Colt JS, 2005, EPIDEMIOLOGY, V16, P516, DOI 10.1097/01.ede.0000164811.25760.f1; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; De Roos AJ, 2005, CANCER RES, V65, P11214, DOI 10.1158/0008-5472.CAN-05-1755; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; Devlin JF, 2003, GROUND WATER, V41, P316, DOI 10.1111/j.1745-6584.2003.tb02600.x; Gathany AH, 2009, CANCER CAUSE CONTROL, V20, P1291, DOI 10.1007/s10552-009-9348-5; Hurley MTJHC, 2002, IHWG TECHNICAL MANUA; Kricker A, 2008, INT J CANCER, V122, P144, DOI 10.1002/ijc.23003; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Morton LM, 2005, CANCER EPIDEM BIOMAR, V14, P925, DOI 10.1158/1055-9965.EPI-04-0693; Morton LM, 2005, LANCET ONCOL, V6, P469, DOI 10.1016/S1470-2045(05)70214-X; Percy C., INT CLASSIFICATION D; Purdue MP, 2007, CANCER CAUSE CONTROL, V18, P989, DOI 10.1007/s10552-007-9039-z; Purdue MP, 2010, AM J EPIDEMIOL, V172, P58, DOI 10.1093/aje/kwq117; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Wang SS, 2007, CANCER RES, V67, P5042, DOI 10.1158/0008-5472.CAN-06-4752; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Willett EV, 2008, INT J CANCER, V122, P2062, DOI 10.1002/ijc.23344	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26949	10.1371/journal.pone.0026949	http://dx.doi.org/10.1371/journal.pone.0026949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096508	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800017
J	Floden, AM; Watt, JA; Brissette, CA				Floden, Angela M.; Watt, John A.; Brissette, Catherine A.			Borrelia burgdorferi Enolase Is a Surface-Exposed Plasminogen Binding Protein	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ALPHA-ENOLASE; STREPTOCOCCUS-PNEUMONIAE; IDENTIFICATION; EXPRESSION; FIBRONECTIN; RECEPTOR; ISOLATE; AUTOANTIBODIES; PENETRATION	Borrelia burgdorferi is the causative agent of Lyme disease, the most commonly reported arthropod-borne disease in the United States. B. burgdorferi is a highly invasive bacterium, yet lacks extracellular protease activity. In order to aid in its dissemination, B. burgdorferi binds plasminogen, a component of the hosts' fibrinolytic system. Plasminogen bound to the surface of B. burgdorferi can then be activated to the protease plasmin, facilitating the bacterium's penetration of endothelial cell layers and degradation of extracellular matrix components. Enolases are highly conserved proteins with no sorting sequences or lipoprotein anchor sites, yet many bacteria have enolases bound to their outer surfaces. B. burgdorferi enolase is both a cytoplasmic and membrane associated protein. Enolases from other pathogenic bacteria are known to bind plasminogen. We confirmed the surface localization of B. burgdorferi enolase by in situ protease degradation assay and immunoelectron microscopy. We then demonstrated that B. burgdorferi enolase binds plasminogen in a dose-dependent manner. Lysine residues were critical for binding of plasminogen to enolase, as the lysine analog eaminocaproic acid significantly inhibited binding. Ionic interactions did not play a significant role in plasminogen binding by enolase, as excess NaCl had no effects on the interaction. Plasminogen bound to recombinant enolase could be converted to active plasmin. We conclude that B. burgdorferi enolase is a moonlighting cytoplasmic protein which also associates with the bacterial outer surface and facilitates binding to host plasminogen.	[Floden, Angela M.; Brissette, Catherine A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Microbiol, Grand Forks, ND 58201 USA; [Floden, Angela M.; Brissette, Catherine A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Immunol, Grand Forks, ND 58201 USA; [Watt, John A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Anat, Grand Forks, ND 58201 USA; [Watt, John A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Cell Biol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks	Floden, AM (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Microbiol, Grand Forks, ND 58201 USA.	catherine.brissette@med.und.edu		Brissette, Catherine/0000-0003-0792-1403	ND EPSCoR [UND0014095]	ND EPSCoR	ND EPSCoR (UND0014095; www.ndepscor.nodak.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1998, J AUTOIMMUN, V11, P671, DOI 10.1006/jaut.1998.0239; Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Castellino FJ, 1997, CIBA F SYMP, V212, P46; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; El-Hage N, 2001, MICROBIOL-SGM, V147, P821, DOI 10.1099/00221287-147-4-821; Eroles P, 1997, MICROBIOL-SGM, V143, P313, DOI 10.1099/00221287-143-2-313; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; Gebbia JA, 2001, INFECT IMMUN, V69, P456, DOI 10.1128/IAI.69.1.456-462.2001; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Haile WB, 2006, CELL MICROBIOL, V8, P1349, DOI 10.1111/j.1462-5822.2006.00717.x; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hara H, 2000, MICROBIOL IMMUNOL, V44, P349, DOI 10.1111/j.1348-0421.2000.tb02505.x; HOLT SC, 1978, MICROBIOL REV, V42, P114, DOI 10.1128/MMBR.42.1.114-160.1978; Hu LT, 1997, INFECT IMMUN, V65, P4989, DOI 10.1128/IAI.65.12.4989-4995.1997; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LOTTENBERG R, 1987, INFECT IMMUN, V55, P1914, DOI 10.1128/IAI.55.8.1914-1918.1987; Mbow ML, 2002, HYBRIDOMA HYBRIDOM, V21, P179, DOI 10.1089/153685902760173890; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Smith DR, 2010, MBIO, V1, DOI 10.1128/mBio.00131-10; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; ULLBERG M, 1990, INFECT IMMUN, V58, P21, DOI 10.1128/IAI.58.1.21-25.1990; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Zuckert WR, 2007, CURRENT PROTOCOLS MI, p12C1111	63	77	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27502	10.1371/journal.pone.0027502	http://dx.doi.org/10.1371/journal.pone.0027502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087329	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700053
J	Fuji, N; Suzuki, A; Lupisan, S; Sombrero, L; Galang, H; Kamigaki, T; Tamaki, R; Saito, M; Aniceto, R; Olveda, R; Oshitani, H				Fuji, Naoko; Suzuki, Akira; Lupisan, Socorro; Sombrero, Lydia; Galang, Hazel; Kamigaki, Taro; Tamaki, Raita; Saito, Mariko; Aniceto, Rapunzel; Olveda, Remigio; Oshitani, Hitoshi			Detection of Human Rhinovirus C Viral Genome in Blood among Children with Severe Respiratory Infections in the Philippines	PLOS ONE			English	Article							IDENTIFIED HUMAN RHINOVIRUS; TISSUE TROPISM; HRV-C; CLINICAL-FEATURES; GENETIC DIVERSITY; PROTOTYPE STRAINS; SPECIES C; RECOMBINATION; DETERMINANTS; ILLNESS	Human rhinovirus (HRV) C was recently identified as the third species of HRV using a molecular technique. Infections caused by previously identified HRVs (A and B) are thought to be limited to the respiratory tract; however, pathogenesis of HRVC is still largely unknown. A total of 816 nasopharyngeal swabs from hospitalized children with severe respiratory infections in the Philippines (May 2008-May 2009) were tested for HRV by reverse transcription polymerase chain reaction (RT-PCR), and 243 samples (29.8%) were positive for HRV. Among these patients, serum samples were also tested to determine whether specific HRV species were associated with viremia. Only 30 serum samples (12.3%) were positive for HRV. However, the HRV positive rates were different among HRV species, 3% (4/135) for HRVA, 0% (0/25) for HRVB, and 31% (26/83) for HRVC, and were the highest on 2 days after the onset of symptoms. These results suggest that HRVC may have a different pathogenicity and can more commonly cause viremia than HRVA and HRVB. Serum positive rates for HRV are affected by age, i.e., higher positive rates for those aged 1 year or more. HRVC that were detected from serum exhibited the same level of sequence diversity as those positive only for nasopharyngeal samples in phylogenetic analysis. However, all HRVA which were detected from serum were clustered in a monophyletic clade based on their 5' non-coding region (NCR) sequences, which is closely related with a certain HRVC genotype (A2) in 5'-NCR. This finding suggests that the 5'NCR region may be associated with viremia.	[Fuji, Naoko; Suzuki, Akira; Kamigaki, Taro; Tamaki, Raita; Saito, Mariko; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Suzuki, Akira; Kamigaki, Taro; Tamaki, Raita; Saito, Mariko; Aniceto, Rapunzel; Oshitani, Hitoshi] Tohoku RITM Collaborating Res Ctr Emerging & Reem, Muntinlupa, Metro Manila, Philippines; [Lupisan, Socorro; Sombrero, Lydia; Olveda, Remigio] Res Inst Trop Med, Muntinlupa, Metro Manila, Philippines; [Aniceto, Rapunzel] Eastern Visayas Reg Med Ctr, Leyte, Tacloban, Philippines	Tohoku University; Research Institute for Tropical Medicine - Philippines	Fuji, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019	Suzuki, Akira/0000-0002-8223-0314	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology, Japan	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by a grant-in-aid for The Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Calvo C, 2010, PEDIATR INFECT DIS J, V29, P717, DOI 10.1097/INF.0b013e3181d7a708; Cheung PKM, 2005, J MED VIROL, V77, P414, DOI 10.1002/jmv.20470; CHO CT, 1982, INFECT IMMUN, V37, P720, DOI 10.1128/IAI.37.2.720-727.1982; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; GREGG I, 1972, BRIT MED J, V3, P824, DOI 10.1136/bmj.3.5830.824-c; Han TH, 2009, ARCH VIROL, V154, P987, DOI 10.1007/s00705-009-0383-z; Harvala H, 2005, J GEN VIROL, V86, P1897, DOI 10.1099/vir.0.80603-0; Harvala H, 2002, J GEN VIROL, V83, P1697, DOI 10.1099/0022-1317-83-7-1697; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MCKAY HW, 1963, AM J PUBLIC HEALTH N, V53, P274, DOI 10.2105/AJPH.53.2.274; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Miller EK, 2009, J CLIN VIROL, V46, P85, DOI 10.1016/j.jcv.2009.06.007; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Pallansch M. A., 2007, ENTEROVIRUSES POLIOV, P839; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Piralla A, 2009, J CLIN VIROL, V45, P311, DOI 10.1016/j.jcv.2009.04.016; RONALD B, 2007, RHINOVIRUSES, P895; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Sandager MM, 2008, VIROLOGY, V372, P35, DOI 10.1016/j.virol.2007.10.020; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; URQUHART GE, 1970, BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5726.28; URQUHART GE, 1972, J CLIN PATHOL, V25, P443, DOI 10.1136/jcp.25.5.443; *WHO, 1990, MAN YOUNG CHILDR AC; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC	37	46	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27247	10.1371/journal.pone.0027247	http://dx.doi.org/10.1371/journal.pone.0027247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087272	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700022
J	Chauvigne, F; Plummer, S; Lesne, L; Cravedi, JP; Dejucq-Rainsford, N; Fostier, A; Jegou, B				Chauvigne, Francois; Plummer, Simon; Lesne, Laurianne; Cravedi, Jean-Pierre; Dejucq-Rainsford, Nathalie; Fostier, Alexis; Jegou, Bernard			Mono-(2-ethylhexyl) Phthalate Directly Alters the Expression of Leydig Cell Genes and CYP17 Lyase Activity in Cultured Rat Fetal Testis	PLOS ONE			English	Article							IN-UTERO EXPOSURE; REPRODUCTIVE-TRACT; DIETHYLHEXYL PHTHALATE; SEXUAL-DIFFERENTIATION; TESTOSTERONE SYNTHESIS; DI(N-BUTYL) PHTHALATE; POSTNATAL-DEVELOPMENT; PROGRAMMING WINDOW; DIBUTYL PHTHALATE; STEROIDOGENESIS	Exposure to phthalates in utero alters fetal rat testis gene expression and testosterone production, but much remains to be done to understand the mechanisms underlying the direct action of phthalate within the fetal testis. We aimed to investigate the direct mechanisms of action of mono-(2-ethylhexyl) phthalate (MEHP) on the rat fetal testis, focusing on Leydig cell steroidogenesis in particular. We used an in vitro system based on the culture for three days, with or without MEHP, of rat fetal testes obtained at 14.5 days post-coitum. Exposure to MEHP led to a dose-dependent decrease in testosterone production. Moreover, the production of 5 alpha-dihydrotestosterone (5 alpha-DHT) (-68%) and androstenedione (-54%) was also inhibited by 10 mu M MEHP, whereas 17 alpha-hydroxyprogesterone (17 alpha-OHP) production was found to increase (+41%). Testosterone synthesis was rescued by the addition of androstenedione but not by any of the other precursors used. Thus, the hormone data suggested that steroidogenesis was blocked at the level of the 17,20 lyase activity of the P450c17 enzyme (CYP17), converting 17 alpha-OHP to androstenedione. The subsequent gene expression and protein levels supported this hypothesis. In addition to Cyp17a1, microarray analysis showed that several other genes important for testes development were affected by MEHP. These genes included those encoding insulin-like factor 3 (INSL3), which is involved in controlling testicular descent, and Inha, which encodes the alpha subunit of inhibin B. These findings indicate that under in vitro conditions known to support normal differentiation of the fetal rat testis, the exposure to MEHP directly inhibits several important Leydig cell factors involved in testis function and that the Cyp17a1 gene is a specific target to MEHP explaining the MEHP-induced suppression of steroidogenesis observed.	[Chauvigne, Francois; Lesne, Laurianne; Dejucq-Rainsford, Nathalie; Jegou, Bernard] IRSET, INSERM, U625, Rennes, France; [Plummer, Simon] CXR Biosci Ltd, Dundee, Scotland; [Fostier, Alexis] SCRIBE, INRA, UR1037, Rennes, France; [Cravedi, Jean-Pierre] INRA Toxalim, UMR 1331, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chauvigne, F (corresponding author), IRSET, INSERM, U625, Rennes, France.	bernard.jegou@inserm.fr	Chauvigne, Francois/D-6854-2017; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Jégou, Bernard/I-4742-2015; Lesne, Laurianne/AAD-6180-2019	Chauvigne, Francois/0000-0001-5571-7517; Lesne, Laurianne/0000-0003-3165-9986; JEGOU, Bernard/0000-0003-0623-3609; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690	INSERM (Institut National de la Sante et de la Recherche Medicale); Ministere de l'Enseignement Superieur et de la Recherche; European Union [212844]; European Council;  [ANR-06PNRA-008-05];  [ANR-07 SEST 019]	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); European Union(European Commission); European Council; ; 	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale), Ministere de l'Enseignement Superieur et de la Recherche, and grants from the European Union (DEER for Developmental Effects of Environment on Reproductive Health, grant number [212844]), the European Council for Plasticizers and Intermediates, and by ANR-06PNRA-008-05 (PLAST-IMPACT), ANR-07 SEST 019 (PHTALATESTIS) and Centre Regional d'Innovation et de Transfert de Technologies Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ATSDR, 2002, TOX PROF DIETH PHTHA; Bae SH, 2001, BIOCHEM J, V353, P689, DOI 10.1042/0264-6021:3530689; Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Chen J, 2009, TALANTA, V80, P826, DOI 10.1016/j.talanta.2009.07.066; Clewell RA, 2010, TOXICOL IN VITRO, V24, P327, DOI 10.1016/j.tiv.2009.08.003; Fan JJ, 2010, ENDOCRINOLOGY, V151, P3348, DOI 10.1210/en.2010-0010; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; FOSTIER A, 1986, FISH PHYSIOL BIOCHEM, V2, P87, DOI 10.1007/BF02264076; Friry-Santini C, 2007, TOXICOL SCI, V97, P81, DOI 10.1093/toxsci/kfm022; Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; HABERT R, 1991, MOL CELL ENDOCRINOL, V82, P199, DOI 10.1016/0303-7207(91)90032-N; Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Janulis L, 2000, PROSTATE, V43, P195, DOI 10.1002/(SICI)1097-0045(20000515)43:3<195::AID-PROS5>3.0.CO;2-#; Jegou B, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P445; Johnson KJ, 2007, BIOL REPROD, V77, P978, DOI 10.1095/biolreprod.107.062950; Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Lague E, 2008, ENDOCRINOLOGY, V149, P4688, DOI 10.1210/en.2008-0310; Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049; Lassurguere J, 2003, TOXICOL SCI, V73, P160, DOI 10.1093/toxsci/kfg065; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Majdic G, 1997, ENDOCRINOLOGY, V138, P2136, DOI 10.1210/en.138.5.2136; McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676; Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403; Miller WL, 1997, STEROIDS, V62, P133, DOI 10.1016/S0039-128X(96)00172-9; Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Plummer S, 2007, TOXICOL SCI, V97, P520, DOI 10.1093/toxsci/kfm062; ROYO T, 1993, J LIPID RES, V34, P867; Schiffler B, 2001, J BIOL CHEM, V276, P36225, DOI 10.1074/jbc.M102320200; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233; Suna S, 2007, TOXICOL LETT, V173, P107, DOI 10.1016/j.toxlet.2007.06.015; Svechnikov K, 2008, REPROD TOXICOL, V25, P485, DOI 10.1016/j.reprotox.2008.05.057; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Travert C, 2000, MOL CELL BIOCHEM, V213, P51, DOI 10.1023/A:1007178532236; Vinggaard AM, 2002, TOXICOL SCI, V69, P344, DOI 10.1093/toxsci/69.2.344; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Wilson JD, 2001, REPROD FERT DEVELOP, V13, P673, DOI 10.1071/RD01074; Zhang GQ, 1998, J LIPID RES, V39, P2406; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	53	44	49	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27172	10.1371/journal.pone.0027172	http://dx.doi.org/10.1371/journal.pone.0027172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087261	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700025
J	Cocklin, R; Goebl, M				Cocklin, Ross; Goebl, Mark			Nutrient Sensing Kinases PKA and Sch9 Phosphorylate the Catalytic Domain of the Ubiquitin-Conjugating Enzyme Cdc34	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; REGULATORY SUBUNIT; LIFE-SPAN; BUDDING YEAST; INHIBITOR SIC1; LIGASE COMPLEX; IN-VITRO; ACTIVATION	Cell division is controlled in part by the timely activation of the CDK, Cdc28, through its association with G1 and G2 cyclins. Cdc28 complexes are regulated in turn by the ubiquitin conjugating enzyme Cdc34 and SCF ubiquitin ligase complexes of the ubiquitin-proteasome system (UPS) to control the initiation of DNA replication. Here we demonstrate that the nutrient sensing kinases PKA and Sch9 phosphorylate S97 of Cdc34. S97 is conserved across species and restricted to the catalytic domain of Cdc34/Ubc7-like E2s. Cdc34-S97 phosphorylation is cell cycle regulated, elevated during active cell growth and division and decreased during cell cycle arrest. Cell growth and cell division are orchestrated to maintain cell size homeostasis over a wide range of nutrient conditions. Cells monitor changes in their environment through nutrient sensing protein kinases. Thus Cdc34 phosphorylation by PKA and Sch9 provides a direct tether between G1 cell division events and cell growth.	[Cocklin, Ross; Goebl, Mark] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Cocklin, R (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA.	mgoebl@iupui.edu			National Science Foundation [MCB-0091317]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB-0091317 to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Cocklin R, 2011, GENETICS, V187, P701, DOI 10.1534/genetics.110.125302; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOEBL MG, 1994, MOL CELL BIOL, V14, P3022, DOI 10.1128/MCB.14.5.3022; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; Harlow E., 1999, USING ANTIBODIES LAB; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; HIXSON CS, 1980, J BIOL CHEM, V255, P2137; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Hsieh CC, 2002, MECH AGEING DEV, V123, P1229, DOI 10.1016/S0047-6374(02)00036-2; Irniger S, 2000, GENETICS, V154, P1509; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lass A, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-7; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schweltzer K, 2005, YEAST, V22, P553, DOI 10.1002/yea.1234; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tripodi F, 2007, BIOCHEM BIOPH RES CO, V359, P921, DOI 10.1016/j.bbrc.2007.05.195; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zaremberg V, 1996, EUR J BIOCHEM, V237, P136, DOI 10.1111/j.1432-1033.1996.0136n.x; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x	69	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27099	10.1371/journal.pone.0027099	http://dx.doi.org/10.1371/journal.pone.0027099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087249	Green Submitted, gold, Green Published			2022-12-27	WOS:000297347700017
J	Luo, PH; Lin, ML; Li, L; Yang, B; He, QJ				Luo, Peihua; Lin, Meili; Li, Lin; Yang, Bo; He, Qiaojun			The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article							ACID RECEPTOR-ALPHA; TRANS-RETINOIC ACID; GROWTH-FACTOR; APOPTOSIS; CANCER; ONCOLOGY; ANGIOGENESIS; DEGRADATION; EXPRESSION; LEUKEMIA	Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. Differentiated human NBs are associated with better outcome and lower stage; induction of differentiation is considered to be therapeutically advantageous. All-trans retinoic acid (ATRA) has been shown to induce the differentiation of neuroblastoma (NB) cell lines. The proteasome inhibitor bortezomib inhibits cell growth and angiogenesis in NBs. Here, we investigated the synergistic effect between bortezomib and ATRA in inducing NB cell differentiation in different NB cell lines. Bortezomib combined with ATRA had a significantly enhanced antiproliferative effect. This inhibition was characterized by a synergistic increase in neuronal differentiation. At the same time, the combination therapy showed little neuronal toxicity which was assessed in primary cultures of rat cerebellar granule cells by the MTT assay, PI staining. The combination of bortezomib and ATRA triggered increased differentiation through the activation of proteins, including RAR alpha, RAR beta, RAR gamma, p-JNK and p21, compared with ATRA treatment alone. Using JNK inhibitor SP600125 to block JNK-dependent activity, the combination therapy-induced neuronal differentiation was partially attenuated. In addition, p21 shRNA had no effect on the combination therapy-induced neuronal differentiation. The in vivo antitumor activities were examined in human NB cell xenografts and GFP-labeled human NB cell xenografts. Treatment of human NB cell CHP126-bearing nude mice with ATRA plus bortezomib resulted in more significant tumor growth inhibition than mice treated with either drug alone. These findings provide the rationale for the development of a new therapeutic strategy for NB based on the pharmacological combination of ATRA and bortezomib.	[Luo, Peihua; Lin, Meili; Li, Lin; Yang, Bo; He, Qiaojun] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Peoples R China	Zhejiang University	Luo, PH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Peoples R China.	qiaojunhe@zju.edu.cn			National Natural Science Foundation of China [30572211, 307725911]; National Post-doctor Foundation of China [20090460104]; Zhejiang Provincial Foundation of National Science [Y2100618]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Post-doctor Foundation of China(China Postdoctoral Science Foundation); Zhejiang Provincial Foundation of National Science; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30572211 and 307725911), the National Post-doctor Foundation of China (No. 20090460104), the Zhejiang Provincial Foundation of National Science (Y2100618) and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson PC, 2007, PEDIATR BLOOD CANCER, V49, P661, DOI 10.1002/pbc.21011; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Garattini E, 2007, CURR PHARM DESIGN, V13, P1375, DOI 10.2174/138161207780618786; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Karlsson J, 2007, ONCOGENE, V26, P6150, DOI 10.1038/sj.onc.1210439; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu Y, 2008, J NEUROCHEM, V106, P1104, DOI 10.1111/j.1471-4159.2008.05445.x; Luo PH, 2006, MOL CANCER THER, V5, P1; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marimpietri D, 2007, CLIN CANCER RES, V13, P3977, DOI 10.1158/1078-0432.CCR-06-2757; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; MARSHALL GM, 1995, ONCOGENE, V11, P485; Murakami M, 2010, J NEUROCHEM, V112, P511, DOI 10.1111/j.1471-4159.2009.06486.x; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Nagai J, 2004, CANCER RES, V64, P7910, DOI 10.1158/0008-5472.CAN-04-1178; Nordstrom EK, 2005, J NEUROSCI, V25, P8451, DOI 10.1523/JNEUROSCI.2349-05.2005; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Perez-Juste G, 1999, ONCOGENE, V18, P5393, DOI 10.1038/sj.onc.1202906; Redova M, 2010, INT J MOL MED, V25, P271, DOI 10.3892/ijmm_00000341; Rocchi P, 2005, ONCOL REP, V13, P1139; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Wang DD, 2009, CELL MOL NEUROBIOL, V29, P391, DOI 10.1007/s10571-008-9331-9; Washio A, 2009, EXP CELL RES, V315, P3036, DOI 10.1016/j.yexcr.2009.07.006; Yang B, 2005, CLIN CANCER RES, V11, P2774, DOI 10.1158/1078-0432.CCR-04-2382; Zhang C, 2008, EUR J PHARM SCI, V33, P415, DOI 10.1016/j.ejps.2008.01.012; Zhang JW, 2002, J NEUROCHEM, V81, P307, DOI 10.1046/j.1471-4159.2002.00824.x; Zhang LA, 2010, CLIN CANCER RES, V16, P4478, DOI 10.1158/1078-0432.CCR-10-0859; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	39	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27298	10.1371/journal.pone.0027298	http://dx.doi.org/10.1371/journal.pone.0027298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087283	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700036
J	Sun, L; Tan, LJ; Lei, SF; Chen, XD; Li, X; Pan, R; Yin, F; Liu, QW; Yan, XF; Papasian, CJ; Deng, HW				Sun, Lu; Tan, Li-Jun; Lei, Shu-Feng; Chen, Xiang-Ding; Li, Xi; Pan, Rong; Yin, Fang; Liu, Quan-Wei; Yan, Xiao-Feng; Papasian, Christopher J.; Deng, Hong-Wen			Bivariate Genome-Wide Association Analyses of Femoral Neck Bone Geometry and Appendicular Lean Mass	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; HEXOKINASE-II; MINERAL DISTRIBUTION; RISK-ASSESSMENT; HIP GEOMETRY; STRENGTH; MUSCLE; FRACTURE; PROTEIN; ENERGY	Objective: Femoral neck geometric parameters (FNGPs), such as periosteal diameter (W), cross-sectional area (CSA), cortical thickness (CT), buckling ratio (BR), and section modulus (Z), are highly genetically correlated with body lean mass. However, the specific SNPs/genes shared by these phenotypes are largely unknown. Methods: To identify the specific SNPs/genes shared between FNGPs and appendicular lean mass (ALM), we performed an initial bivariate genome-wide association study (GWAS) by scanning similar to 690,000 SNPs in 1,627 unrelated Han Chinese adults (802 males and 825 females) and a follow-up replicate study in 2,286 unrelated US Caucasians. Results: We identified 13 interesting SNPs that may be important for both FNGPs and ALM. Two SNPs, rs681900 located in the HK2 (hexokinase 2) gene and rs11859916 in the UMOD (uromodulin) gene, were bivariately associated with FNGPs and ALM (p = 7.58610(-6) for ALM-BR and p = 2.93610(-6) for ALM-W, respectively). The associations were then replicated in Caucasians, with corresponding p values of 0.024 for rs681900 and 0.047 for rs11859916. Meta-analyses yielded combined p values of 3.05610(-6) and 2.31610(-6) for rs681900 and rs11859916, respectively. Our findings are consistent with previous biological studies that implicated HK2 and UMOD in both FNGPs and ALM. Our study also identified a group of 11 contiguous SNPs, which spanned a region of similar to 130 kb, were bivariately associated with FNGPs and ALM, with p values ranging from 3.06610(-7) to 4.60610(-6) for ALM-BR. The region contained two neighboring miRNA coding genes, MIR873 (MicroRNA873) and MIR876 (MicroRNA876). Conclusion: Our study implicated HK2, UMOD, MIR873 and MIR876, as pleiotropic genes underlying variation of both FNGPs and ALM, thus suggesting their important functional roles in co-regulating both FNGPs and ALM.	[Sun, Lu; Tan, Li-Jun; Lei, Shu-Feng; Chen, Xiang-Ding; Li, Xi; Pan, Rong; Yin, Fang; Liu, Quan-Wei; Yan, Xiao-Feng; Deng, Hong-Wen] Hunan Normal Univ, Lab Mol & Stat Genet, Coll Life Sci, Changsha, Hunan, Peoples R China; [Tan, Li-Jun; Deng, Hong-Wen] Tulane Univ, Ctr Bioinformat & Genom, Dept Biostat, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Dept Orthoped Surg, Kansas City, MO 64108 USA; [Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Systemat Biomed Res, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Technol, Beijing, Peoples R China	Hunan Normal University; Tulane University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Shanghai for Science & Technology; Beijing Jiaotong University	Sun, L (corresponding author), Hunan Normal Univ, Lab Mol & Stat Genet, Coll Life Sci, Changsha, Hunan, Peoples R China.	hdeng2@tulane.edu	Tan, Li-Jun/AAO-1130-2020	Deng, Hong-Wen/0000-0002-0387-8818	Natural Science Foundation of China (NSFC) [30900810, 30771222, 31071097, 30600364]; NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative [30811120436]; NSFC/RGC [30731160618]; Shanghai Leading Academic Discipline Project [S30501]; Shanghai University of Science and Technology; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Franklin D. Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR057049, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR)); NSFC/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai University of Science and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the Natural Science Foundation of China (NSFC) (30900810, 30771222, 31071097, and 30600364), the NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal (30811120436), the NSFC/RGC Joint Research Scheme (30731160618), the Shanghai Leading Academic Discipline Project (S30501) and startup fund from Shanghai University of Science and Technology. HWD was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221) and the Franklin D. Dickson/Missouri Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9; Beck T, 2003, OSTEOPOROSIS INT, V14, pS81, DOI 10.1007/s00198-003-1478-0; Beck TJ, 2001, J BONE MINER RES, V16, P1108, DOI 10.1359/jbmr.2001.16.6.1108; Bethesda, 1995, J GERONTOL A-BIOL, V50, P1; BRAITHWAITE SS, 1995, DIABETES, V44, P43, DOI 10.2337/diabetes.44.1.43; Carvalho M, 2002, BRAZ J MED BIOL RES, V35, P1165, DOI 10.1590/S0100-879X2002001000009; Chang PY, 1996, J BIOL CHEM, V271, P14834, DOI 10.1074/jbc.271.25.14834; Chen Y, 2010, BONE, V46, P129, DOI 10.1016/j.bone.2009.09.025; Crabtree N, 2000, BONE, V27, P151, DOI 10.1016/S8756-3282(00)00300-8; Crabtree NJ, 2002, OSTEOPOROSIS INT, V13, P48, DOI 10.1007/s198-002-8337-y; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Deng FY, 2007, J BONE MINER RES, V22, P808, DOI 10.1359/JBMR.070303; Ferretti JL, 2003, MECH AGEING DEV, V124, P269, DOI 10.1016/S0047-6374(02)00194-X; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Handoll HHG, 2007, J R SOC PROMO HEALTH, V127, P168, DOI 10.1177/1466424007079491; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; Izumi K, 2010, AM J MED GENET A, V152A, P2115, DOI 10.1002/ajmg.a.33511; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kim HJ, 2010, J BONE MINER RES, V25, P1771, DOI 10.1002/jbmr.60; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Leidy HJ, 2007, OBESITY, V15, P421, DOI 10.1038/oby.2007.531; LIECHTY EA, 1991, PEDIATR RES, V30, P423, DOI 10.1203/00006450-199111000-00006; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Marcora S, 2006, RHEUMATOLOGY, V45, P1385, DOI 10.1093/rheumatology/kel127; Melton LJ, 2005, OSTEOPOROSIS INT, V16, P460, DOI 10.1007/s00198-004-1820-1; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Movcessian S G, 1972, Vopr Biokhim Mozga, V7, P11; Okamoto Y, 2006, NEUROGENETICS, V7, P175, DOI 10.1007/s10048-006-0046-0; Palmer Christina G S, 2008, J Genet Couns, V17, P129, DOI 10.1007/s10897-007-9134-z; PEACOCK M, 1995, OSTEOPOROSIS INT, V5, P167, DOI 10.1007/BF02106096; PENG Z, 1994, BONE, V15, P523, DOI 10.1016/8756-3282(94)90276-3; Pulkkinen P, 2004, OSTEOPOROSIS INT, V15, P274, DOI 10.1007/s00198-003-1556-3; Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; STREFFER C, 1994, ADV EXP MED BIOL, V345, P327; Sun X, 2006, CALCIFIED TISSUE INT, V79, P43, DOI 10.1007/s00223-006-0041-3; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vestergaard H, 1995, J CLIN INVEST, V96, P2639, DOI 10.1172/JCI118329; Wu S, 2007, ANN HUM BIOL, V34, P344, DOI 10.1080/03014460701275749; Zhao LJ, 2010, J BONE MINER RES, V25, P320, DOI 10.1359/jbmr.090726; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706	47	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27325	10.1371/journal.pone.0027325	http://dx.doi.org/10.1371/journal.pone.0027325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087292	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700041
J	Kida, Y; Xia, ZX; Zheng, SJ; Mordwinkin, NM; Louie, SG; Zheng, SG; Feng, M; Shi, HB; Duan, ZP; Han, YP				Kida, Yujiro; Xia, Zanxian; Zheng, Sujun; Mordwinkin, Nicholas M.; Louie, Stan G.; Zheng, Song Guo; Feng, Min; Shi, Hongbo; Duan, Zhongping; Han, Yuan-Ping			Interleukin-1 as an Injury Signal Mobilizes Retinyl Esters in Hepatic Stellate Cells through Down Regulation of Lecithin Retinol Acyltransferase	PLOS ONE			English	Article							RAT-LIVER; T-CELLS; ACID; ACTIVATION; EXPRESSION; FIBROSIS; MICE; OLIGONUCLEOTIDES; METABOLISM; LIPOCYTES	Retinoids are mostly stored as retinyl esters in hepatic stellate cells (HSCs) through esterification of retinol and fatty acid, catalyzed by lecithin-retinol acyltransferase (LRAT). This study is designated to address how retinyl esters are mobilized in liver injury for tissue repair and wound healing. Initially, we speculated that acute inflammatory cytokines may act as injury signal to mobilize retinyl esters by down-regulation of LRAT in HSCs. By examining a panel of cytokines we found interleukin-1 (IL-1) can potently down-regulate mRNA and protein levels of LRAT, resulting in mobilization of retinyl esters in primary rat HSCs. To simulate the microenvironment in the space of Disse, HSCs were embedded in three-dimensional extracellular matrix, by which HSCs retaine quiescent phenotypes, indicated by up-regulation of LRAT and accumulation of lipid droplets. Upon IL-1 stimulation, LRAT expression went down together with mobilization of lipid droplets. Secreted factors from Kupffer cells were able to suppress LRAT expression in HSCs, which was neutralized by IL-1 receptor antagonist. To explore the underlying mechanism we noted that the stability of LRAT protein is not significantly regulated by IL-1, indicating the regulation is likely at transcriptional level. Indeed, we found that IL-1 failed to down-regulate recombinant LRAT protein expressed in HSCs by adenovirus, while transcription of endogenous LRAT was promptly decreased. Following liver damage, IL-1 was promptly elevated in a close pace with down-regulation of LRAT transcription, implying their causative relationship. After administration of IL-1, retinyl ester levels in the liver, as measured by LC/MS/MS, decreased in association with down-regulation of LRAT. Likewise, IL-1 receptor knockout mice were protected from injury-induced down-regulation of LRAT. In summary, we identified IL-1 as an injury signal to mobilize retinyl ester in HSCs through down-regulation of LRAT, implying a mechanism governing transition from hepatic injury to wound healing.	[Kida, Yujiro; Xia, Zanxian; Feng, Min] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Zheng, Sujun; Shi, Hongbo; Duan, Zhongping; Han, Yuan-Ping] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China; [Mordwinkin, Nicholas M.; Louie, Stan G.] Univ So Calif, Sch Pharm, Los Angeles, CA USA; [Zheng, Song Guo] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Han, Yuan-Ping] Beijing Hepo Med Res Inst, Beijing, Peoples R China; [Han, Yuan-Ping] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; Capital Medical University; University of Southern California; University of Southern California; University of Southern California	Kida, Y (corresponding author), Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA.	duan2517@163.com.cn; yhan@surgery.usc.edu		Mordwinkin, Nicholas/0000-0002-3019-0170	National Institutes of Health [R01s, DK069418, AR051558, R01 AR059103]; Robert and May Wright Foundation; Chinese State Key Projects for Basic Research [2007CB512801]; American College of Rheumatology; Arthritis Foundation; National Natural Science Foundation of China [30728007]; Non-Parenchymal Liver Cell Core [R24AA12885]; USC Research Center for Alcoholic Liver and Pancreatic Diseases [P50AA11999]; Analytical-Metabolic-Instrumental Core of the Research Center for Liver Diseases [P30 DK048522]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051558, R01AR059103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069418, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and May Wright Foundation; Chinese State Key Projects for Basic Research; American College of Rheumatology(General Electric); Arthritis Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Non-Parenchymal Liver Cell Core; USC Research Center for Alcoholic Liver and Pancreatic Diseases; Analytical-Metabolic-Instrumental Core of the Research Center for Liver Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is supported in part by National Institutes of Health Grants R01s, DK069418 and AR051558, as well as the Robert and May Wright Foundation to Y-PH. The study is also supported in part by the Chinese State Key Projects for Basic Research, No. 2007CB512801 to ZD. This work was partially supported by grants from the National Institutes of Health (R01 AR059103), the American College of Rheumatology (Within Our Reach), the Arthritis Foundation, and by an Outstanding Youth Scientist Investigator Award from the National Natural Science Foundation of China, 30728007, to SGZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Dr. Hidekazu Tsukamoto for his advice and tissue share, Jiaohong Wang for isolation of liver cells, and Hongyun She for control adenovirus, which have been supported in part by Non-Parenchymal Liver Cell Core (R24AA12885) and USC Research Center for Alcoholic Liver and Pancreatic Diseases (P50AA11999). We also thank Drs. Akiko Maeda and Krzysztof Palczewski for providing anti-LRAT antibody. The qRT-PCR and LC/MS/MS analyses were performed at the Analytical-Metabolic-Instrumental Core of the Research Center for Liver Diseases (P30 DK048522).	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Han YP, 2004, J BIOL CHEM, V279, P4820, DOI 10.1074/jbc.M310999200; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Hautekeete ML, 1998, ALCOHOL CLIN EXP RES, V22, P494, DOI 10.1111/j.1530-0277.1998.tb03678.x; Hellemans K, 2003, J LIPID RES, V44, P280, DOI 10.1194/jlr.M200376-JLR200; HENDRIKS HFJ, 1988, HEPATOLOGY, V8, P276, DOI 10.1002/hep.1840080215; Ho LJ, 2005, BIOCHEM PHARMACOL, V70, P200, DOI 10.1016/j.bcp.2005.04.039; Ichikawa S, 2011, J IMMUNOL, V186, P5549, DOI 10.4049/jimmunol.1003917; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; JONES AL, 1984, J LIPID RES, V25, P1151; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Motomura K, 1997, J GASTROEN HEPATOL, V12, P887, DOI 10.1111/j.1440-1746.1997.tb00388.x; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; TIEGS G, J AUTOIMMUN, V34, P1; Wake K, 1980, Int Rev Cytol, V66, P303; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yamaguchi K, 2008, HEPATOLOGY, V47, P625, DOI 10.1002/hep.21988; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	34	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26644	10.1371/journal.pone.0026644	http://dx.doi.org/10.1371/journal.pone.0026644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073179	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200015
J	Lee, GA; Crawford, GW; Liu, L; Sasaki, Y; Chen, XX				Lee, Gyoung-Ah; Crawford, Gary W.; Liu, Li; Sasaki, Yuka; Chen, Xuexiang			Archaeological Soybean (Glycine max) in East Asia: Does Size Matter?	PLOS ONE			English	Article							GENETIC DIVERSITY; DOMESTICATION; CHINA; WILD; PATTERNS; ORIGINS; SOJA; AGRICULTURE; CALIBRATION; SEQUENCE	The recently acquired archaeological record for soybean from Japan, China and Korea is shedding light on the context in which this important economic plant became associated with people and was domesticated. This paper examines archaeological (charred) soybean seed size variation to determine what insight can be gained from a comprehensive comparison of 949 specimens from 22 sites. Seed length alone appears to represent seed size change through time, although the lengthxwidthxthickness product has the potential to provide better size change resolution. A widespread early association of small seeded soybean is as old as 9000-8600 cal BP in northern China and 7000 cal BP in Japan. Direct AMS radiocarbon dates on charred soybean seeds indicate selection resulted in large seed sizes in Japan by 5000 cal BP (Middle Jomon) and in Korea by 3000 cal BP (Early Mumun). Soybean seeds recovered in China from the Shang through Han periods are similar in length to the large Korean and Japanese specimens, but the overall size of the large Middle and Late Jomon, Early Mumun through Three Kingdom seeds is significantly larger than any of the Chinese specimens. The archaeological record appears to disconfirm the hypothesis of a single domestication of soybean and supports the view informed by recent phyologenetic research that soybean was domesticated in several locations in East Asia.	[Lee, Gyoung-Ah] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Crawford, Gary W.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Liu, Li] Stanford Univ, E Asian Languages & Cultures Stanford Archaeol Ct, Stanford, CA 94305 USA; [Sasaki, Yuka] Paleo Labo Co Ltd, Toda, Saitama, Japan; [Chen, Xuexiang] Shandong Univ, Dept Archaeol, Jinan 250100, Peoples R China	University of Oregon; University of Toronto; University Toronto Mississauga; Stanford University; Shandong University	Lee, GA (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	galee@uoregon.edu	Crawford, Gary W./A-4808-2008	Crawford, Gary W./0000-0002-3370-0527; Lee, Gyoung-Ah/0000-0001-7873-6841	Henry Luce/American Council of Learned Society Initiative on East and Southeast Asian Archaeology and Early History; La Trobe University; University of Oregon; Australian Research Council [DP0450025]; Social Sciences and Humanities Research Council of Canada [72022345]; Program of Introducing Talents of Discipline to Universities [111-2-09]; National Natural Science Foundation of China [40472087, 40772105]; National Science Foundation [BCS-99-11128]	Henry Luce/American Council of Learned Society Initiative on East and Southeast Asian Archaeology and Early History; La Trobe University; University of Oregon; Australian Research Council(Australian Research Council); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	GHL used the following funds for conducting sample collection and analysis listed in the paper: The Henry Luce/American Council of Learned Society Initiative on East and Southeast Asian Archaeology and Early History, La Trobe University Postdoctoral fellowship and the University of Oregon Junior Professor Development fund and Summer Research Award. The Australian Research Council (DP0450025) supported LL to conduct the Yiluo Archaeology Project. The Social Sciences and Humanities Research Council of Canada (grant 72022345) sponsored GWC to conduct the research at the Liangchenzhen and Shantaisi sites and the first phases of the archaeobotany research in the Yiluo valley, China. The Program of Introducing Talents of Discipline to Universities (111-2-09) supported XC and GWC to procure data from the Shang sites, China. The National Natural Science Foundation of China (grant 40472087, 40772105) supported JZ (University of Science and Technology of China) to conduct the excavation of the Jiahu site where the authors collected data. The National Science Foundation (award BCS-99-11128 to Anne Underhill, Yale University and Gary Feinman, Field Museum) sponsored GWC to collect data from Shandong, China. The University of Oregon Office of Research Grant helped DJK (University of Oregon) to establish the Archaeometry Facility, where some of the samples in this study were prepared for AMS dating. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Braadbaart F, 2004, VEG HIST ARCHAEOBOT, V14, P65; Braadbaart F, 2007, ECON BOT, V61, P137, DOI 10.1663/0013-0001(2007)61[137:CIMADO]2.0.CO;2; BROICH SL, 1981, EUPHYTICA, V30, P55, DOI 10.1007/BF00033659; Carlson JB, 2004, SOYBEANS IMPROVEMENT, P71; Carter T. E, 2004, SOYBEANS IMPROVEMENT, V3rd, DOI DOI 10.2134/AGRONMONOGR16.3ED.C8; Choi Duk-Hyang, 2004, NONGYE KAOGU, V3, p[225, 285]; Crawford G, 2005, CURR ANTHROPOL, V46, P309, DOI 10.1086/428788; Crawford G.W., 2006, E ASIA ARCHAEOLOGY, V3, P247; Crawford GW, 2008, WORLD ARCHAEOL, V40, P445, DOI 10.1080/00438240802451181; Crawford GW, 2003, ANTIQUITY, V77, P87, DOI 10.1017/S0003598X00061378; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; Crawford GW, 1983, PALEOETHNOBOTANY KAM; Dong YS, 2004, THEOR APPL GENET, V108, P931, DOI 10.1007/s00122-003-1503-x; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Gai J.Y., 2000, ACTA AGRONOMICA SINI, V26, P513, DOI DOI 10.3321/J.ISSN:0496-3490.2000.05.001; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Han Z, 1995, SHIJING YIZHU; Hancock J.F., 2004, PLANT EVOLUTION ORIG; Harlan JR, 1992, CROPS MAN; Ho P-T, 1975, CRADLE E INQUIRY IND; Hunan Institute of Archaeology, 2006, PENGT BASH; Hymowitz T., 2004, SOYBEANS IMPROVEMENT, P97; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kirkbride J.H, 2003, FRUITS SEEDS GENERA; Kong Z, 1999, KAOGU, V7, P59; Kudo Y., 2010, B NATL MUS JPN HIST, V158, P1; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee G-A, 2003, THESIS U TORONTO TOR; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Liu L, 2002, J FIELD ARCHAEOL, V29, P75, DOI 10.2307/3181486; Liu L, 1987, KAOGU, V4, P365; Liu L, 2012, KAOGU IN PRESS, V12; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Luoyang Relics Team, 2002, LUOYANG ZAOJ; Nakayama S, 2009, B YAMANASHI PREFECTU, V3, P1; Obata H., 2007, JPN J HIST BOT, V15, P97, DOI [10.34596/hisbot.15.2_97, DOI 10.34596/HISBOT.15.2_97]; Obata H, 2011, CURRENT RES NEOLITHI, P1; Obata H, 2011, JOMON AGR PALEOETHNO; Qutob D, 2008, BOTANY, V86, P219, DOI 10.1139/B08-002; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rosen AM, 2007, BULL INDO PAC PRE HI, V27, P39; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rovner I, 2007, ECON BOT, V61, P154, DOI 10.1663/0013-0001(2007)61[154:CMANMF]2.0.CO;2; Sakamoto S, 2006, J FOSSIL RES, V39, P1; Sasaki Y., 2007, JAPANESE J HIST BOT, V15, P35; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shelach G, 2000, J WORLD PREHIST, V14, P363, DOI 10.1023/A:1011124209079; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Stuiver M, CALIB 6 0; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; USDA ARS National Genetic Resources Program, 2011, TAX GLYC MAX L MERR; USDA ARS National Genetic Resources Program, 2011, TAX GLYC SOJ SIEB ZU; Vavilov NI, 2009, ORIGIN GEOGRAPHY CUL; Xu B, 1986, SOYBEAN SCI, V5, P123; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yang XY, 2005, J ARCHAEOL SCI, V32, P1045, DOI 10.1016/j.jas.2005.02.003; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zhang JZ, 1999, NATURE, V401, P366, DOI 10.1038/43865; Zhao T, 2004, SCI AGR SINICA, V37, P945; Zhao Z., 2004, DONGFANG KAOGU, V1, P210; Zhao Z, 2007, KEJI KAOGU, V2, P1; Zhao Z, 2010, PALAEOETHNOBOTANY TH, P90; Zhao Z, 2010, PALAEOETHNOBOTANY TH, P145; Zhao Z. J., 2005, ANTIQUITIES E ASIA A, P188; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887	69	114	124	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26720	10.1371/journal.pone.0026720	http://dx.doi.org/10.1371/journal.pone.0026720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073186	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200017
J	Mirkovic, B; Sosic, I; Gobec, S; Kos, J				Mirkovic, Bojana; Sosic, Izidor; Gobec, Stanislav; Kos, Janko			Redox-Based Inactivation of Cysteine Cathepsins by Compounds Containing the 4-Aminophenol Moiety	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; EXPRESSION; INHIBITORS; PHOSPHATASE; DISCOVERY; PROTEASES; ASSAY; MECHANISM; TOXICITY	Background: Redox cycling compounds have been reported to cause false positive inhibition of proteases in drug discovery studies. This kind of false positives can lead to unusually high hit rates in high-throughput screening campaigns and require further analysis to distinguish true from false positive hits. Such follow-up studies are both time and resource consuming. Methods and Findings: In this study we show that 5-aminoquinoline-8-ol is a time-dependent inactivator of cathepsin B with a k(inact)/K-I of 36.7 +/- 13.6 M(-1)s(-1) using enzyme kinetics. 5-Aminoquinoline-8-ol inhibited cathepsins H, L and B in the same concentration range, implying a non-specific mechanism of inhibition. Further analogues, 4-aminonaphthalene-1-ol and 4-aminophenol, also displayed time-dependent inhibition of cathepsin B with k(inact)/K-I values of 406.4 +/- 10.8 and 36.5 +/- 1.3 M(-1)s(-1). No inactivation occurred in the absence of either the amino or the hydroxyl group, suggesting that the 4-aminophenol moiety is a prerequisite for enzyme inactivation. Induction of redox oxygen species (ROS) by 4-aminophenols in various redox environments was determined by the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate. Addition of catalase to the assay buffer significantly abrogated the ROS signal, indicating that H2O2 is a component of the ROS induced by 4-aminophenols. Furthermore, using mass spectrometry, active site probe DCG-04 and isoelectric focusing we show that redox inactivation of cysteine cathepsins by 5-aminoquinoline-8-ol is active site directed and leads to the formation of sulfinic acid. Conclusions: In this study we report that compounds containing the 4-aminophenol moiety inactivate cysteine cathepsins through a redox-based mechanism and are thus likely to cause false positive hits in the screening assays for cysteine proteases.	[Mirkovic, Bojana; Kos, Janko] Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Ljubljana, Slovenia; [Sosic, Izidor; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Dept Med Chem, Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Mirkovic, B (corresponding author), Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Ljubljana, Slovenia.	bojana.mirkovic@ffa.uni-lj.si		Sosic, Izidor/0000-0002-3370-4587; Gobec, Stanislav/0000-0002-9678-3083	Slovenian Research Agency [J4-4123]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (grant number J4-4123 [to J.K.]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann E, 2004, J MED CHEM, V47, P5833, DOI 10.1021/jm0493111; [Anonymous], EXPASY PROT SERV PRO; [Anonymous], UNIPROT UNIPROTKB; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bauer CG, 1996, ANAL CHEM, V68, P2453, DOI 10.1021/ac960218x; Beers C, 2005, J IMMUNOL, V174, P1205, DOI 10.4049/jimmunol.174.3.1205; Bova MP, 2004, ARCH BIOCHEM BIOPHYS, V429, P30, DOI 10.1016/j.abb.2004.05.010; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Copeland R. A., 2005, EVALUATION ENZYME IN; Das J, 2007, ANAL CHEM, V79, P2790, DOI 10.1021/ac062291l; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DOLINAR M, 1995, BIOL CHEM H-S, V376, P385; Du JQ, 2008, J BIOL CHEM, V283, P30205, DOI 10.1074/jbc.M803347200; Foreman BD, 2008, TOXICOL APPL PHARM, V230, P144, DOI 10.1016/j.taap.2008.02.014; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hallman MA, 2000, TOXICOLOGY, V156, P37, DOI 10.1016/S0300-483X(00)00326-7; Hamer I, 2009, BIOL CELL, V101, P31, DOI 10.1042/BC20080043; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; IWAHASHI H, 1988, BIOCHEM J, V251, P893, DOI 10.1042/bj2510893; Johnston PA, 2010, CURR OPIN CHEM BIOL, V15, P1; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; JOSEPHY PD, 1983, MOL PHARMACOL, V23, P461; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; LIN WS, 1975, CAN J BIOCHEM CELL B, V53, P298, DOI 10.1139/o75-042; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Markt P, 2008, J CHEM INF MODEL, V48, P1693, DOI 10.1021/ci800101j; Mirkovic B, 2011, CHEMMEDCHEM, V6, P1351, DOI 10.1002/cmdc.201100098; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pinitglang S, 1997, BIOCHEMISTRY-US, V36, P9968, DOI 10.1021/bi9705974; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ren WP, 1996, BIOCHEM J, V319, P793, DOI 10.1042/bj3190793; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Schweiger A, 1997, J IMMUNOL METHODS, V201, P165, DOI 10.1016/S0022-1759(96)00218-9; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Stirnimann G, 2010, SWISS MED WKLY, V140, P18, DOI 10.4414/smw.2010.13080; Tardito S, 2007, J MED CHEM, V50, P1916, DOI 10.1021/jm061174f; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; Zager V, 2010, RADIOL ONCOL, V44, P42, DOI 10.2478/v10019-010-0010-3	47	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27197	10.1371/journal.pone.0027197	http://dx.doi.org/10.1371/journal.pone.0027197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073285	Green Submitted, gold, Green Published			2022-12-27	WOS:000297198200049
J	Lavilla-Alonso, S; Abo-Ramadan, U; Halavaara, J; Escutenaire, S; Tatlisumak, T; Saksela, K; Kanerva, A; Hemminki, A; Pesonen, S				Lavilla-Alonso, Sergio; Abo-Ramadan, Usama; Halavaara, Juha; Escutenaire, Sophie; Tatlisumak, Turgut; Saksela, Kalle; Kanerva, Anna; Hemminki, Akseli; Pesonen, Sari			Optimized Mouse Model for the Imaging of Tumor Metastasis upon Experimental Therapy	PLOS ONE			English	Article							COLON-CANCER CELLS; IN-VIVO; LIVER; DISSEMINATION; EXPRESSION; MICE	Development of new cancer treatments focuses increasingly on the relation of cancer tissue with its microenvironment. A major obstacle for the development of new anti-cancer therapies has been the lack of relevant animal models that would reproduce all the events involved in disease progression from the early-stage primary tumor until the development of mature metastatic tissue. To this end, we have developed a readily imageable mouse model of colorectal cancer featuring highly reproducible formation of spontaneous liver metastases derived from intrasplenic primary tumors. We optimized several experimental variables, and found that the correct choice of cell line and the genetic background, as well as the age of the recipient mice, were critical for establishing a useful model system. Among a panel of colorectal cancer cell lines tested, the epithelial carcinoma HT29 line was found to be the most suitable in terms of producing homogeneous tumor growth and metastases. In our hands, SCID mice at the age of 125 days or older were the most suitable in supporting consistent HT29 tumor growth after splenic implantation followed by reproducible metastasis to the liver. A magnetic resonance imaging (MRI) protocol was optimized for use with this mouse model, and demonstrated to be a powerful method for analyzing the antitumor effects of an experimental therapy. Specifically, we used this system to with success to verify by MRI monitoring the efficacy of an intrasplenically administered oncolytic adenovirus therapy in reducing visceral tumor load and development of liver metastases. In summary, we have developed a highly optimized mouse model for liver metastasis of colorectal cancer, which allows detection of the tumor load at the whole body level and enables an accurate timing of therapeutic interventions to target different stages of cancer progression and metastatic development.	[Lavilla-Alonso, Sergio; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli; Pesonen, Sari] Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp,Mol Canc Biol Program, Helsinki, Finland; [Lavilla-Alonso, Sergio; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli; Pesonen, Sari] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Lavilla-Alonso, Sergio; Escutenaire, Sophie; Hemminki, Akseli; Pesonen, Sari] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Abo-Ramadan, Usama; Tatlisumak, Turgut] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Halavaara, Juha] Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki, Finland; [Halavaara, Juha] Jorvi Hosp, Dept Radiol, SF-02740 Espoo, Finland; [Lavilla-Alonso, Sergio; Saksela, Kalle] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Lavilla-Alonso, S (corresponding author), Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp,Mol Canc Biol Program, Helsinki, Finland.	akseli.hemminki@helsinki.fi; sari.pesonen@helsinki.fi		Saksela, Kalle/0000-0003-0827-122X; Tatlisumak, Turgut/0000-0002-2430-8988	European Research Council; European Union [THERADPOX, APOTHERAPY]; Helsinki University Central Hospital; Sigrid Juselius Foundation; Academy of Finland; Emil Aaltonen Foundation; Finnish Cancer Society; Biocentrum Helsinki; University of Helsinki; Helsinki Biomedical Graduate School	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Helsinki University Central Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Cancer Society; Biocentrum Helsinki; University of Helsinki; Helsinki Biomedical Graduate School	Funding was provided by European Research Council, European Union grants THERADPOX and APOTHERAPY, Helsinki University Central Hospital, Sigrid Juselius Foundation, Academy of Finland, Emil Aaltonen Foundation, Finnish Cancer Society, Biocentrum Helsinki, Research Funds of the University of Helsinki, and Helsinki Biomedical Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Chiappa A, 2009, CRIT REV ONCOL HEMAT, V72, P65, DOI 10.1016/j.critrevonc.2008.11.003; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Ito K, 2010, CANCER J, V16, P103, DOI 10.1097/PPO.0b013e3181d7e8e5; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koike N, 2009, WORLD J GASTROENTERO, V15, P5805, DOI 10.3748/wjg.15.5805; Liu XY, 2006, CELL RES, V16, P740, DOI 10.1038/sj.cr.7310088; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Peeters CFJM, 2008, ANN SURG ONCOL, V15, P3308, DOI 10.1245/s10434-008-0029-5; Satoh Yuji, 2002, J Exp Ther Oncol, V2, P337, DOI 10.1046/j.1359-4117.2002.01050.x; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Thalheimer A, 2009, EUR SURG RES, V42, P195, DOI 10.1159/000205825; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Yamamoto N, 2003, CANCER RES, V63, P7785; Yu HK, 2004, CANCER RES, V64, P7092, DOI 10.1158/0008-5472.CAN-04-0364; Zechmann CM, 2007, NEOPLASIA, V9, P57, DOI 10.1593/neo.06688	23	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26810	10.1371/journal.pone.0026810	http://dx.doi.org/10.1371/journal.pone.0026810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073198	gold, Green Submitted, Green Published			2022-12-27	WOS:000297197000001
J	Keijzer, C; Slutter, B; van der Zee, R; Jiskoot, W; van Eden, W; Broere, F				Keijzer, Chantal; Slutter, Bram; van der Zee, Ruurd; Jiskoot, Wim; van Eden, Willem; Broere, Femke			PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity	PLOS ONE			English	Article							REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; N-TRIMETHYL CHITOSAN; SHOCK-PROTEIN HSP; DENDRITIC CELLS; INTRANASAL VACCINATION; MICROSPHERES PROLONGS; CHRONIC INFLAMMATION; ADJUVANT ARTHRITIS; MUCOSAL IMMUNITY	Development of vaccines in autoimmune diseases has received wide attention over the last decade. However, many vaccines showed limited clinical efficacy. To enhance vaccine efficacy in infectious diseases, biocompatible and biodegradable polymeric nanoparticles have gained interest as antigen delivery systems. We investigated in mice whether antigen-encapsulated PLGA (poly-lactic-co-glycolic acid), PLGA-TMC (N-trimethyl chitosan) or TMC-TPP (tri-polyphosphate) nanoparticles can also be used to modulate the immunological outcome after nasal vaccination. These three nanoparticles enhanced the antigen presentation by dendritic cells, as shown by increased in vitro and in vivo CD4(+) T-cell proliferation. However, only nasal PLGA nanoparticles were found to induce an immunoregulatory response as shown by enhanced Foxp3 expression in the nasopharynx associated lymphoid tissue and cervical lymph nodes. Nasal administration of OVA-containing PLGA particle resulted in functional suppression of an OVA-specific Th-1 mediated delayed-type hypersensitivity reaction, while TMC-TPP nanoparticles induced humoral immunity, which coincided with the enhanced generation of OVA-specific B-cells in the cervical lymph nodes. Intranasal treatment with Hsp70-mB29a peptide-loaded PLGA nanoparticles suppressed proteoglycan-induced arthritis, leading to a significant reduction of disease. We have uncovered a role for PLGA nanoparticles to enhance CD4(+) T-cell mediated immunomodulation after nasal application. The exploitation of this differential regulation of nanoparticles to modulate nasal immune responses can lead to innovative vaccine development for prophylactic or therapeutic vaccination in infectious or autoimmune diseases.	[Keijzer, Chantal; van der Zee, Ruurd; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Slutter, Bram; Jiskoot, Wim] LACDR, Div Drug Delivery Technol, Leiden, Netherlands	Utrecht University	Keijzer, C (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	Broere, femke/C-2675-2012; van der Zee, Ruurd/O-5256-2015	van der Zee, Ruurd/0000-0002-4331-2755; Broere, Femke/0000-0001-9343-0111; van Eden, Willem/0000-0003-1272-704X	European Union [TOLERAGE: HEALTH-F4-2008-202156]; TI Pharma Project [D5-106]; BSIK VIRGO consortium [03012]; Dutch Arthritis Association	European Union(European Commission); TI Pharma Project; BSIK VIRGO consortium(Ministry of Economic Affairs, Netherlands); Dutch Arthritis Association	This work was supported by grants from the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156, TI Pharma Project D5-106, BSIK VIRGO consortium grant no. 03012, and the Dutch Arthritis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT REV IMMUNOL, V2, P629, DOI 10.1038/nm745; Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; Audran R, 2003, VACCINE, V21, P1250, DOI 10.1016/S0264-410X(02)00521-2; Broere F, 2009, MUCOSAL IMMUNOL, V2, P254, DOI 10.1038/mi.2009.2; Brownlie RJ, 2006, ARTHRITIS RHEUM-US, V54, P854, DOI 10.1002/art.21654; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Finnegan A, 1999, J IMMUNOL, V163, P5383; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; Hagenaars N, 2009, PHARM RES-DORDR, V26, P1353, DOI 10.1007/s11095-009-9845-y; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Hauet-Broere F, 2006, ANN RHEUM DIS, V65, P65, DOI 10.1136/ard.2006.058495; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jaganathan KS, 2006, VACCINE, V24, P4201, DOI 10.1016/j.vaccine.2006.01.011; Jin L, 2010, VACCINE, V28, P3312, DOI 10.1016/j.vaccine.2010.02.100; Kim WU, 2002, ARTHRITIS RHEUM-US, V46, P1109, DOI 10.1002/art.10198; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Liu ZG, 2009, INT ARCH ALLERGY IMM, V150, P221, DOI 10.1159/000222674; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; Marazuela EG, 2008, CLIN EXP ALLERGY, V38, P520, DOI 10.1111/j.1365-2222.2007.02922.x; Mestecky J, 2005, VACCINE, V23, P1800, DOI 10.1016/j.vaccine.2004.11.009; Metzler B, 1999, IMMUNOLOGY, V97, P257; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Rodriguez-Monroy MA, 2007, SCAND J IMMUNOL, V65, P276, DOI 10.1111/j.1365-3083.2006.01898.x; Shi FD, 1998, J NEUROL SCI, V155, P1, DOI 10.1016/S0022-510X(97)00232-3; Slutter B, 2010, VACCINE, V28, P6282, DOI 10.1016/j.vaccine.2010.06.121; Slutter B, 2009, J CONTROL RELEASE, V138, P113, DOI 10.1016/j.jconrel.2009.05.011; Tanaka S, 1999, J IMMUNOL, V163, P5560; Tarkowski A, 1999, ARTHRITIS RHEUM, V42, P1628, DOI 10.1002/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T; Unger WWJ, 2003, J IMMUNOL, V171, P4592, DOI 10.4049/jimmunol.171.9.4592; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Waeckerle-Men Y, 2006, VACCINE, V24, P1847, DOI 10.1016/j.vaccine.2005.10.032; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711; Wieten L, 2009, THESIS ENSCHEDE; Wieten L, 2007, FEBS LETT, V581, P3716, DOI 10.1016/j.febslet.2007.04.082; Wu HY, 1996, IMMUNOLOGY, V88, P493, DOI 10.1046/j.1365-2567.1996.d01-690.x	44	61	65	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26684	10.1371/journal.pone.0026684	http://dx.doi.org/10.1371/journal.pone.0026684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073184	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900032
J	Han, HM; Liu, QJ; He, W; Ong, K; Liu, XL; Gao, B				Han, Huamin; Liu, Qingjun; He, Wen; Ong, Kristy; Liu, Xiaoli; Gao, Bin			An Efficient Vector System to Modify Cells Genetically	PLOS ONE			English	Article							RETROVIRALLY TRANSDUCED CELLS; FLUORESCENCE-BASED SELECTION; EMBRYONIC STEM-CELLS; METABOLIC BIOTINYLATION; IN-VIVO; DENDRITIC CELLS; SURFACE PROTEINS; MAMMALIAN-CELLS; FLOW-CYTOMETRY; GENE-TRANSFER	The transfer of foreign genes into mammalian cells has been essential for understanding the functions of genes and mechanisms of genetic diseases, for the production of coding proteins and for gene therapy applications. Currently, the identification and selection of cells that have received transferred genetic material can be accomplished by methods, including drug selection, reporter enzyme detection and GFP imaging. These methods may confer antibiotic resistance, or be disruptive, or require special equipment. In this study, we labeled genetically modified cells with a cell surface biotinylation tag by co-transfecting cells with BirA, a biotin ligase. The modified cells can be quickly isolated for downstream applications using a simple streptavidin bead method. This system can also be used to screen cells expressing two sets of genes from separate vectors.	[Han, Huamin; Liu, Qingjun; He, Wen; Gao, Bin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China; [Han, Huamin; He, Wen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ong, Kristy] UCL Inst Child Hlth, London, England; [Liu, Xiaoli] Epigen Biotec Ltd, Beijing, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of London; University College London; Chinese Academy of Sciences; Institute of Microbiology, CAS	Han, HM (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China.	bgao2004@gmail.com	Liu, Xiaoli/HGE-7614-2022		Ministry of Health [2008ZX10003-012, 2009ZX10004-305]; Innovative Research Group of the National Natural Science Foundation of China (NSFC) [81021003]	Ministry of Health; Innovative Research Group of the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Project of "Eleventh Five-year Plan" of Ministry of Health (grants 2008ZX10003-012, 2009ZX10004-305). BG is a principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (NSFC, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGNIS C, 1995, LEUKEMIA, V9, pS61; Barat B, 2007, BIOMOL ENG, V24, P283, DOI 10.1016/j.bioeng.2007.02.003; Beausejour CM, 2001, CANCER GENE THER, V8, P669, DOI 10.1038/sj.cgt.7700358; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Byun HM, 2005, BIOCHEM BIOPH RES CO, V332, P518, DOI 10.1016/j.bbrc.2005.04.155; Chang Lung-Ji, 2002, Methods Mol Med, V69, P303; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; CHUNG HM, 2007, STEM CELLS DEV, V16, P537; David R, 2005, STEM CELLS, V23, P477, DOI 10.1634/stemcells.2004-0177; Fehse B, 1997, HUM GENE THER, V8, P1815, DOI 10.1089/hum.1997.8.15-1815; FISHER PB, 1999, NUCLEIC ACIDS RES, V27, P4775; Fontanellas A, 1999, J GENE MED, V1, P322; Giaretta I, 2000, HAEMATOLOGICA, V85, P680; Gotoh H, 2007, GENE, V389, P146, DOI 10.1016/j.gene.2006.10.019; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Kawahara M, 2004, BIOCHEM BIOPH RES CO, V315, P132, DOI 10.1016/j.bbrc.2004.01.030; Kawahara M, 2004, J IMMUNOL METHODS, V284, P187, DOI 10.1016/j.jim.2003.10.007; Kawahara M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng032; Kawahara M, 2002, J BIOSCI BIOENG, V93, P399, DOI 10.1263/jbb.93.399; Kawahara M, 2007, BBA-GEN SUBJECTS, V1770, P206, DOI 10.1016/j.bbagen.2006.10.014; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; Liu Qingjun, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1888; Locke P, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt63; LU YA, 2011, J NEUROINFLAMMATION, V8; Lundqvist A, 2002, MED ONCOL, V19, P197, DOI 10.1385/MO:19:4:197; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Millington M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006461; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Nakamura M, 2005, ONCOLOGY-BASEL, V68, P163, DOI 10.1159/000086770; Nesbeth D, 2006, MOL THER, V13, P814, DOI 10.1016/j.ymthe.2005.09.016; Parrott MB, 2000, MOL THER, V1, P96, DOI 10.1006/mthe.1999.0011; Parrott MB, 2001, BIOCHEM BIOPH RES CO, V281, P993, DOI 10.1006/bbrc.2001.4437; PODDA S, 1992, P NATL ACAD SCI USA, V89, P9676, DOI 10.1073/pnas.89.20.9676; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SORRENTINO BP, 1992, SCIENCE, V257, P99, DOI 10.1126/science.1352414; Tirat A, 2006, INT J BIOL MACROMOL, V39, P66, DOI 10.1016/j.ijbiomac.2006.01.012; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; Wang B, 2006, VACCINE, V24, P3477, DOI 10.1016/j.vaccine.2006.02.025; Ward M, 1996, CLIN CANCER RES, V2, P873; Wei K, 1996, J BIOL CHEM, V271, P3812, DOI 10.1074/jbc.271.7.3812; Wu Y, 2010, INT J CANCER, V126, P2373, DOI 10.1002/ijc.24932; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yang JB, 2004, HUM IMMUNOL, V65, P692, DOI 10.1016/j.humimm.2004.04.001; YEYATI PL, 1995, HUM GENE THER, V6, P975, DOI 10.1089/hum.1995.6.8-975; Yoshikawa T, 2001, BIOTECHNOL BIOENG, V74, P435, DOI 10.1002/bit.1134	47	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26380	10.1371/journal.pone.0026380	http://dx.doi.org/10.1371/journal.pone.0026380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096482	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900003
J	Lawhon, SD; Khare, S; Rossetti, CA; Everts, RE; Galindo, CL; Luciano, SA; Figueiredo, JF; Nunes, JES; Gull, T; Davidson, GS; Drake, KL; Garner, HR; Lewin, HA; Baumler, AJ; Adams, LG				Lawhon, Sara D.; Khare, Sangeeta; Rossetti, Carlos A.; Everts, Robin E.; Galindo, Cristi L.; Luciano, Sarah A.; Figueiredo, Josely F.; Nunes, Jairo E. S.; Gull, Tamara; Davidson, George S.; Drake, Kenneth L.; Garner, Harold R.; Lewin, Harris A.; Baeumler, Andreas J.; Adams, Leslie Garry			Role of SPI-1 Secreted Effectors in Acute Bovine Response to Salmonella enterica Serovar Typhimurium: A Systems Biology Analysis Approach	PLOS ONE			English	Article							EPITHELIAL-CELLS; MOLECULAR CHARACTERIZATION; BAYESIAN FRAMEWORK; EXPRESSION DATA; RHO GTPASES; WILD-TYPE; INFECTION; INVASION; INTERFERON; SOPB	Salmonella enterica Serovar Typhimurium (S. Typhimurium) causes enterocolitis with diarrhea and polymorphonuclear cell (PMN) influx into the intestinal mucosa in humans and calves. The Salmonella Type III Secretion System (T3SS) encoded at Pathogenicity Island I translocates Salmonella effector proteins SipA, SopA, SopB, SopD, and SopE2 into epithelial cells and is required for induction of diarrhea. These effector proteins act together to induce intestinal fluid secretion and transcription of C-X-C chemokines, recruiting PMNs to the infection site. While individual molecular interactions of the effectors with cultured host cells have been characterized, their combined role in intestinal fluid secretion and inflammation is less understood. We hypothesized that comparison of the bovine intestinal mucosal response to wild type Salmonella and a SipA, SopABDE2 effector mutant relative to uninfected bovine ileum would reveal heretofore unidentified diarrhea-associated host cellular pathways. To determine the coordinated effects of these virulence factors, a bovine ligated ileal loop model was used to measure responses to wild type S. Typhimurium (WT) and a Delta sipA, sopABDE2 mutant (MUT) across 12 hours of infection using a bovine microarray. Data were analyzed using standard microarray analysis and a dynamic Bayesian network modeling approach (DBN). Both analytical methods confirmed increased expression of immune response genes to Salmonella infection and novel gene expression. Gene expression changes mapped to 219 molecular interaction pathways and 1620 gene ontology groups. Bayesian network modeling identified effects of infection on several interrelated signaling pathways including MAPK, Phosphatidylinositol, mTOR, Calcium, Toll-like Receptor, CCR3, Wnt, TGF-beta, and Regulation of Actin Cytoskeleton and Apoptosis that were used to model of host-pathogen interactions. Comparison of WT and MUT demonstrated significantly different patterns of host response at early time points of infection (15 minutes, 30 minutes and one hour) within phosphatidylinositol, CCR3, Wnt, and TGF-b signaling pathways and the regulation of actin cytoskeleton pathway.	[Lawhon, Sara D.; Khare, Sangeeta; Rossetti, Carlos A.; Luciano, Sarah A.; Figueiredo, Josely F.; Nunes, Jairo E. S.; Gull, Tamara; Adams, Leslie Garry] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Everts, Robin E.; Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Sch, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Davidson, George S.] Sandia Natl Labs, Computat Comp & Math Ctr, Albuquerque, NM 87185 USA; [Drake, Kenneth L.] Serologix LLC, Austin, TX USA; [Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Davis	Lawhon, SD (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	gadams@cvm.tamu.edu	LEWIN, HARRIS/HGC-6543-2022; Khare, SangeetA/Q-5470-2019; Lawhon, Sara D./G-5147-2011; Baumler, Andreas J/H-2301-2011	LEWIN, HARRIS/0000-0002-1043-7287; Khare, SangeetA/0000-0002-9496-6636; Lawhon, Sara D./0000-0001-9154-8909; Baumler, Andreas J/0000-0001-9152-7809	National Institute of Allergy and Infectious Disease [1 R01 A144170-01-A1, 1 R01 AI076246 01-A2]; USDA [2002-35204-12247]; Public Health Service [AI060933]; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076246, K08AI060933] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA(United States Department of Agriculture (USDA)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants to AJB and LGA from the National Institute of Allergy and Infectious Disease (1 R01 A144170-01-A1, 1 R01 AI076246 01-A2 and USDA 2002-35204-12247). Additionally, SDL received support from the Public Health Service Grant (AI060933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: KD is employed by Seralogix, LLC where his primary role is Chief Technology Officer. Seralogix is a bioinformatics research and services company commercializing computational systems biology software tools that are being sponsored by the National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute. KD participated in conducting certain genomic data processing involving pathway analyses and modeling that helped to provide a more system level perspective of host immune response to the Texas A&M University researchers. Data were processed by KD, utilizing Seralogix's proprietary computational pipeline for biological systems analysis. The relation between Seralogix and Texas A&M University, College of Veterinary Medicine is strictly on a collaborative (mutually beneficial) research basis with no financial arrangements, commitments or interests. KD's motivation is to see his computational tools produce results that contribute to the improved understanding of host response to pathogen invasions (an objective of his National Health Institute research grants). KD contributed to the interpretation of the analysis results provided to the Texas A&M University researchers. Seralogix has no ownership of the data, nor results produced by their tools. RE is currently employed by Sequenom Inc. SK is currently employed by the United States Food and Drug Administration. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Bakowski MA, 2007, CELL MICROBIOL, V9, P2839, DOI 10.1111/j.1462-5822.2007.01000.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cronin Maureen, 2004, Clin Chem, V50, P1464, DOI 10.1373/clinchem.2004.035675; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Everts RE, 2005, VET IMMUNOL IMMUNOP, V105, P235, DOI 10.1016/j.vetimm.2005.02.003; FRANCIS CL, 1992, MOL MICROBIOL, V6, P3077, DOI 10.1111/j.1365-2958.1992.tb01765.x; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; GALAN JE, 1992, J BACTERIOL, V174, P4338; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gerold G, 2007, SEMIN IMMUNOL, V19, P41, DOI 10.1016/j.smim.2006.12.003; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2008, J INFECT DEV COUNTR, V2, P438, DOI 10.3855/jidc.158; Guiney DG, 2005, CURR TOP MICROBIOL, V289, P131; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; JONES BD, 1994, INFECT IMMUN, V62, P3745, DOI 10.1128/IAI.62.9.3745-3752.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; Kim H, 2002, BIOTECHNIQUES, V33, P924, DOI 10.2144/02334mt06; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; LIPINSKI M, 1980, EUR J IMMUNOL, V10, P246, DOI 10.1002/eji.1830100405; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Murphy KP, 1999, MODELING GENE EXPRES; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2007, INFECT IMMUN, V75, P4342, DOI 10.1128/IAI.01571-06; Reis BP, 2003, VET MICROBIOL, V97, P269, DOI 10.1016/j.vetmic.2003.09.019; Rossetti CA, 2011, RES VET SCI, V91, P40, DOI 10.1016/j.rvsc.2010.09.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Santos RL, 2003, BRAZ J MED BIOL RES, V36, P3, DOI 10.1590/S0100-879X2003000100002; Santos RL, 2002, AM J VET RES, V63, P1145, DOI 10.2460/ajvr.2002.63.1145; Santos RL, 2002, J INFECT DIS, V186, P372, DOI 10.1086/341509; Santos RL, 2002, VET PATHOL, V39, P200, DOI 10.1354/vp.39-2-200; Santos RL, 2001, INFECT IMMUN, V69, P4610, DOI 10.1128/IAI.69.7.4610-4617.2001; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Schlumberger MC, 2003, J BIOL CHEM, V278, P27149, DOI 10.1074/jbc.M302475200; Simon R, 2007, J INTERF CYTOK RES, V27, P317, DOI 10.1089/jir.2006.0141; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Takeuchi A, 1972, Nihon Ishikai Zasshi, V67, P725; Tam MA, 2008, CELL MICROBIOL, V10, P1517, DOI 10.1111/j.1462-5822.2008.01144.x; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; VIRELIZIER JL, 1978, J IMMUNOL, V120, P1616; VIRELIZIER JL, 1981, ARCH FR PEDIATR, V38, P77; Weil MR, 2002, BIOTECHNIQUES, V32, P1310, DOI 10.2144/02326mt01; WINTER SE, 2009, INFECT IMMUN; Zhang SP, 2003, INFECT IMMUN, V71, P4795, DOI 10.1128/IAI.71.8.4795-4803.2003; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176; 2010, CTR DIS CONTROL PREV, V59, P418; 2008, CTR DIS CONTROL PREV, V57, P366	77	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26869	10.1371/journal.pone.0026869	http://dx.doi.org/10.1371/journal.pone.0026869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096503	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900013
J	Carraro, L; Castelli, L; Macchiella, C				Carraro, Luciana; Castelli, Luigi; Macchiella, Claudia			The Automatic Conservative: Ideology-Based Attentional Asymmetries in the Processing of Valenced Information	PLOS ONE			English	Article							POLITICAL CONSERVATISM; THREAT; LIBERALISM; VARY; NEED	Research has widely explored the differences between conservatives and liberals, and it has been also recently demonstrated that conservatives display different reactions toward valenced stimuli. However, previous studies have not yet fully illuminated the cognitive underpinnings of these differences. In the current work, we argued that political ideology is related to selective attention processes, so that negative stimuli are more likely to automatically grab the attention of conservatives as compared to liberals. In Experiment 1, we demonstrated that negative ( vs. positive) information impaired the performance of conservatives, more than liberals, in an Emotional Stroop Task. This finding was confirmed in Experiment 2 and in Experiment 3 employing a Dot-Probe Task, demonstrating that threatening stimuli were more likely to attract the attention of conservatives. Overall, results support the conclusion that people embracing conservative views of the world display an automatic selective attention for negative stimuli.	[Carraro, Luciana; Castelli, Luigi; Macchiella, Claudia] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy	University of Padua	Carraro, L (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.	luciana.carraro@unipd.it		Carraro, Luciana/0000-0001-8100-4609; Castelli, Luigi/0000-0002-1472-4507	Italian Ministry for Education, University and Research (MIUR) [2008H2JPTN]	Italian Ministry for Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The project was partially supported by a research grant from the Italian Ministry for Education, University and Research (MIUR) to the second author (2008H2JPTN). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Altemeyer B, 1998, ADV EXP SOC PSYCHOL, V30, P47, DOI 10.1016/S0065-2601(08)60382-2; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Caprara GV, 2004, AM PSYCHOL, V59, P581, DOI 10.1037/0003-066X.59.7.581; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; Castelli L, 2011, J EXP SOC PSYCHOL, V47, P1013, DOI 10.1016/j.jesp.2011.03.016; Crowson HM, 2009, J PSYCHOL, V143, P449, DOI 10.3200/JRL.143.5.449-463; Duckitt J, 2003, POLIT PSYCHOL, V24, P199, DOI 10.1111/0162-895X.00322; Duckitt J, 2001, ADV EXP SOC PSYCHOL, V33, P41, DOI 10.1016/S0065-2601(01)80004-6; Janoff-Bulman R, 2008, J EXP SOC PSYCHOL, V44, P1091, DOI 10.1016/j.jesp.2007.11.003; Janoff-Bulman R, 2009, PSYCHOL INQ, V20, P120, DOI 10.1080/10478400903028581; Johnson SD, 2001, J SOC PSYCHOL, V141, P233, DOI 10.1080/00224540109600549; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; KRUGLANSKI AW, 1993, J PERS SOC PSYCHOL, V65, P861, DOI 10.1037/0022-3514.65.5.861; Lang P.J., 2008, A8 U FLOR; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Matthews M, 2009, POLIT PSYCHOL, V30, P921, DOI 10.1111/j.1467-9221.2009.00733.x; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Roets A, 2011, PERS INDIV DIFFER, V50, P90, DOI 10.1016/j.paid.2010.09.004; Rule NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008733; Shook NJ, 2009, J EXP SOC PSYCHOL, V45, P995, DOI 10.1016/j.jesp.2009.04.003; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; Vigil JM, 2010, GROUP PROCESS INTERG, V13, P547, DOI 10.1177/1368430209356930; WILSON GD, 1973, J PERS SOC PSYCHOL, V25, P286, DOI 10.1037/h0033972	34	74	74	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26456	10.1371/journal.pone.0026456	http://dx.doi.org/10.1371/journal.pone.0026456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852II	22096486	gold, Green Submitted, Green Published			2022-12-27	WOS:000297350800007
J	Lan, WX; Wang, ZH; Yang, ZZ; Zhu, J; Ying, TL; Jiang, XW; Zhang, XM; Wu, HM; Liu, ML; Tan, XS; Cao, CY; Huang, ZX				Lan, Wenxian; Wang, Zhonghua; Yang, Zhongzheng; Zhu, Jing; Ying, Tianlei; Jiang, Xianwang; Zhang, Xu; Wu, Houming; Liu, Maili; Tan, Xiangshi; Cao, Chunyang; Huang, Zhong-Xian			Conformational Toggling of Yeast Iso-1-Cytochrome c in the Oxidized and Reduced States	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR COOA; MITOCHONDRIAL CYTOCHROME-C; GATED ELECTRON-TRANSFER; CIRCULAR-DICHROISM; FERRICYTOCHROME-C; LIGAND-EXCHANGE; MET80X MUTANTS; ALKALINE FORM; AXIAL LIGAND; HEME	To convert cyt c into a peroxidase-like metalloenzyme, the P71H mutant was designed to introduce a distal histidine. Unexpectedly, its peroxidase activity was found even lower than that of the native, and that the axial ligation of heme iron was changed to His71/His18 in the oxidized state, while to Met80/His18 in the reduced state, characterized by UV-visible, circular dichroism, and resonance Raman spectroscopy. To further probe the functional importance of Pro71 in oxidation state dependent conformational changes occurred in cyt c, the solution structures of P71H mutant in both oxidation states were determined. The structures indicate that the half molecule of cyt c (aa 50-102) presents a kind of "zigzag riveting ruler" structure, residues at certain positions of this region such as Pro71, Lys73 can move a big distance by altering the tertiary structure while maintaining the secondary structures. This finding provides a molecular insight into conformational toggling in different oxidation states of cyt c that is principle significance to its biological functions in electron transfer and apoptosis. Structural analysis also reveals that Pro71 functions as a key hydrophobic patch in the folding of the polypeptide of the region (aa 50-102), to prevent heme pocket from the solvent.	[Lan, Wenxian; Yang, Zhongzheng; Zhu, Jing; Wu, Houming; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Wang, Zhonghua; Ying, Tianlei; Tan, Xiangshi; Huang, Zhong-Xian] Fudan Univ, Dept Chem, Biol Chem Lab, Shanghai 200433, Peoples R China; [Jiang, Xianwang; Zhang, Xu; Liu, Maili] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Fudan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Lan, WX (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn; zxhuang@fudan.edu.cn	Zhang, Xu/B-4753-2015; 应, 天雷/P-5396-2019; Liu, Maili/A-8543-2011	应, 天雷/0000-0002-9597-2843; Liu, Maili/0000-0002-9359-915X	National Basic Research Program of China [2009CB918600, 2011CB966300]; National Science Foundation of China [20921091, 30430180]; Science and Technology Commission of Shanghai Municipality, China [08PJ1411700]; State Key laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, CAS [T152902]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); State Key laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, CAS(Chinese Academy of Sciences)	This work was supported partially by the National Basic Research Program of China under No. 2009CB918600 and 2011CB966300, by the National Science Foundation of China under No. 20921091 and No. 30430180, by Pujiang talents awards from Science and Technology Commission of Shanghai Municipality, China under No. 08PJ1411700 and by the funding from State Key laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, CAS, under No. T152902. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; AYERS PW, 2006, J CHEM PHYS, V124; Baddam S, 2006, INORG CHEM, V45, P6338, DOI 10.1021/ic0603712; Baistrocchi P, 1996, BIOCHEMISTRY-US, V35, P13788, DOI 10.1021/bi961110e; BANCI L, 1989, INORG CHEM, V28, P4650, DOI 10.1021/ic00325a023; Banci L, 1997, BIOCHEMISTRY-US, V36, P8992, DOI 10.1021/bi963025c; Bandi S, 2008, J AM CHEM SOC, V130, P7540, DOI 10.1021/ja801941r; Bandi S, 2007, BIOCHEMISTRY-US, V46, P10643, DOI 10.1021/bi700992y; BARKER PD, 1992, J AM CHEM SOC, V114, P3619, DOI 10.1021/ja00036a006; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BERGHUIS AM, 1992, J MOL BIOL, V223, P959, DOI 10.1016/0022-2836(92)90255-I; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; CUTLER RL, 1987, PROTEIN ENG, V1, P95, DOI 10.1093/protein/1.2.95; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; Feinberg BA, 1998, BIOCHEMISTRY-US, V37, P13091, DOI 10.1021/bi981037n; FERRER JC, 1993, J AM CHEM SOC, V115, P7505; GAO Y, 1990, BIOCHEMISTRY-US, V29, P6994, DOI 10.1021/bi00482a007; HAWKINS BK, 1994, J AM CHEM SOC, V116, P3111, DOI 10.1021/ja00086a046; Hay S, 2005, BIOCHEMISTRY-US, V44, P431, DOI 10.1021/bi0492298; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KAMINSKY LS, 1973, BIOCHEMISTRY-US, V12, P2215, DOI 10.1021/bi00736a006; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LOOZE Y, 1978, INT J PEPT PROT RES, V12, P233; LOUIE GV, 1988, J MOL BIOL, V199, P295, DOI 10.1016/0022-2836(88)90315-4; MACURA S, 1982, J MAGN RESON, V47, P351, DOI 10.1016/0022-2364(82)90128-7; Mines GA, 1996, CHEM BIOL, V3, P491, DOI 10.1016/S1074-5521(96)90097-6; Moore G. R., 1990, CYTOCHROMES C EVOLUT, P1; MURPHY ME, THESIS U BRIT COLUMB, P96; Nakajima H, 2001, J BIOL CHEM, V276, P37895; Nakajima H, 2001, J BIOL CHEM, V276, P7055, DOI 10.1074/jbc.M003972200; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; PIELAK GJ, 1988, EUR J BIOCHEM, V177, P167, DOI 10.1111/j.1432-1033.1988.tb14359.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; RAPHAEL AL, 1989, PROTEINS, V6, P338, DOI 10.1002/prot.340060316; Reynolds MF, 1998, J AM CHEM SOC, V120, P9080, DOI 10.1021/ja981146p; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; Santucci R, 1997, J INORG BIOCHEM, V68, P211, DOI 10.1016/S0162-0134(97)00100-1; Schejter A, 1996, J AM CHEM SOC, V118, P477, DOI 10.1021/ja9529448; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone GG, 2005, J AM CHEM SOC, V127, P92, DOI 10.1021/ja045719b; STELLWAGEN E, 1974, BIOCHEM BIOPH RES CO, V60, P371, DOI 10.1016/0006-291X(74)90214-9; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; Vogel KM, 1999, BIOCHEMISTRY-US, V38, P2679, DOI 10.1021/bi982375r; Wallace CJA, 1997, BIOCHEMISTRY-US, V36, P14733, DOI 10.1021/bi971595m; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130; WUTTKE DS, 1993, PROTEIN ENG, V3, P555; Yeh SR, 1997, NAT STRUCT BIOL, V4, P51, DOI 10.1038/nsb0197-51; Ying TL, 2010, CHEM COMMUN, V46, P3541, DOI 10.1039/b926261j; Ying TL, 2009, CHEM COMMUN, P4512, DOI 10.1039/b904347k; Zheng JW, 2000, BIOPOLYMERS, V57, P77, DOI 10.1002/(SICI)1097-0282(2000)57:2<77::AID-BIP4>3.0.CO;2-Y	61	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27219	10.1371/journal.pone.0027219	http://dx.doi.org/10.1371/journal.pone.0027219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087268	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700020
J	Liu, XP; Liu, JH				Liu, Xi-Peng; Liu, Jian-Hua			Characterization of Family IV UDG from Aeropyrum pernix and Its Application in Hot-Start PCR by Family B DNA Polymerase	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; URACIL RECOGNITION; GLYCOSYLASE; ENDONUCLEASE; PROCESSIVITY; SPECIFICITY; EXPRESSION; HYPOXANTHINE; DEAMINATION	Recombinant uracil-DNA glycosylase (UDG) from Aeropyrum pernix (A. pernix) was expressed in E. coli. The biochemical characteristics of A. pernix UDG (ApeUDG) were studied using oligonucleotides carrying a deoxyuracil (dU) base. The optimal temperature range and pH value for dU removal by ApeUDG were 55-65 degrees C and pH 9.0, respectively. The removal of dU was inhibited by the divalent ions of Zn, Cu, Co, Ni, and Mn, as well as a high concentration of NaCl. The opposite base in the complementary strand affected the dU removal by ApeUDG as follows: U/C approximate to U/G>U/T approximate to U/AP approximate to U/->U/U approximate to U/I>U/A. The phosphorothioate around dU strongly inhibited dU removal by ApeUDG. Based on the above biochemical characteristics and the conservation of amino acid residues, ApeUDG was determined to belong to the IV UDG family. ApeUDG increased the yield of PCR by Pfu DNA polymerase via the removal of dU in amplified DNA. Using the dU-carrying oligonucleotide as an inhibitor and ApeUDG as an activator of Pfu DNA polymerase, the yield of undesired DNA fragments, such as primer-dimer, was significantly decreased, and the yield of the PCR target fragment was increased. This strategy, which aims to amplify the target gene with high specificity and yield, can be applied to all family B DNA polymerases.	[Liu, Xi-Peng; Liu, Jian-Hua] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, XP (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	jianhualiudl@sjtu.edu.cn			National High Technology Research and Development Program of China [2006AA02Z108]; National Basic Research Program of China [2005CB724301, 2007CB914504, 2009CB118906]; National Science Foundation of China [30700131, 30870512]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National High Technology Research and Development Program of China (Grant No. 2006AA02Z108), the National Basic Research Program of China (Grant Nos. 2005CB724301, 2007CB914504, and 2009CB118906), and the National Science Foundation of China (Grant Nos. 30700131 and 30870512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes WM, 2002, MOL CELL PROBE, V16, P167, DOI 10.1006/mcpr.2002.0407; Bjornberg O, 2003, J BIOL CHEM, V278, P20667, DOI 10.1074/jbc.M213010200; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Dang C, 1996, J MOL BIOL, V264, P268, DOI 10.1006/jmbi.1996.0640; Davidson JF, 2003, NUCLEIC ACIDS RES, V31, P4702, DOI 10.1093/nar/gkg667; Emptage K, 2008, J MOL BIOL, V383, P762, DOI 10.1016/j.jmb.2008.08.018; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Gill S, 2007, J MOL BIOL, V372, P855, DOI 10.1016/j.jmb.2007.07.015; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Hitchcock TM, 2004, NUCLEIC ACIDS RES, V32, P4071, DOI 10.1093/nar/gkh747; Hogrefe HH, 2002, P NATL ACAD SCI USA, V99, P596, DOI 10.1073/pnas.012372799; Huang JM, 2001, BIOCHEMISTRY-US, V40, P8738, DOI 10.1021/bi010183h; Kaboev OK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e94; KAIJALAINEN S, 1993, NUCLEIC ACIDS RES, V21, P2959, DOI 10.1093/nar/21.12.2959; Kainz P, 2000, BIOTECHNIQUES, V28, P278, DOI 10.2144/00282st04; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kermekchiev MB, 2003, NUCLEIC ACIDS RES, V31, P6139, DOI 10.1093/nar/gkg813; Kiyonari S, 2008, J BIOL CHEM, V283, P24185, DOI 10.1074/jbc.M802837200; Kiyonari S, 2009, NUCLEIC ACIDS RES, V37, P6439, DOI 10.1093/nar/gkp720; Lee HW, 2011, J BIOL CHEM, V286, P31282, DOI 10.1074/jbc.M111.249524; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu XP, 2010, PROTEIN EXPRES PURIF, V70, P1, DOI 10.1016/j.pep.2009.10.006; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mansfield C, 2003, FEBS LETT, V540, P171, DOI 10.1016/S0014-5793(03)00257-6; Moretti T, 1998, BIOTECHNIQUES, V25, P716; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; Nilsson J, 1997, BIOTECHNIQUES, V22, P744, DOI 10.2144/97224rr04; Parker JB, 2008, BIOCHEMISTRY-US, V47, P8614, DOI 10.1021/bi800854g; Pavlov AR, 2002, P NATL ACAD SCI USA, V99, P13510, DOI 10.1073/pnas.202127199; Sakai T, 2008, DNA REPAIR, V7, P663, DOI 10.1016/j.dnarep.2008.01.006; Sartori AA, 2002, EMBO J, V21, P3182, DOI 10.1093/emboj/cdf309; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; SHARKEY DJ, 1994, BIO-TECHNOL, V12, P506, DOI 10.1038/nbt0594-506; Shuttleworth G, 2004, J MOL BIOL, V337, P621, DOI 10.1016/j.jmb.2004.01.021; VARSHNEY U, 1988, J BIOL CHEM, V263, P7776; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Yang HJ, 2000, J BACTERIOL, V182, P1272, DOI 10.1128/JB.182.5.1272-1279.2000	39	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27248	10.1371/journal.pone.0027248	http://dx.doi.org/10.1371/journal.pone.0027248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087273	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700023
J	Seronello, S; Montanez, J; Presleigh, K; Barlow, M; Park, SB; Choi, J				Seronello, Scott; Montanez, Jessica; Presleigh, Kristen; Barlow, Miriam; Park, Seung Bum; Choi, Jinah			Ethanol and Reactive Species Increase Basal Sequence Heterogeneity of Hepatitis C Virus and Produce Variants with Reduced Susceptibility to Antivirals	PLOS ONE			English	Article							INTERFERON-ALPHA; RNA REPLICATION; OXIDATIVE STRESS; DNA-DAMAGE; NONSTRUCTURAL PROTEIN; HEPATOMA-CELLS; IRON DEPLETION; CYCLOSPORINE-A; ALCOHOL; RESISTANCE	Hepatitis C virus (HCV) exhibits a high level of genetic variability, and variants with reduced susceptibility to antivirals can occur even before treatment begins. In addition, alcohol decreases efficacy of antiviral therapy and increases sequence heterogeneity of HCV RNA but how ethanol affects HCV sequence is unknown. Ethanol metabolism and HCV infection increase the level of reactive species that can alter cell metabolism, modify signaling, and potentially act as mutagen to the viral RNA. Therefore, we investigated whether ethanol and reactive species affected the basal sequence variability of HCV RNA in hepatocytes. Human hepatoma cells supporting a continuous replication of genotype 1b HCV RNA (Con1, AJ242652) were exposed to ethanol, acetaldehyde, hydrogen peroxide, or L-buthionine-S,R-sulfoximine (BSO) that decreases intracellular glutathione as seen in patients. Then, NS5A region was sequenced and compared with genotype 1b HCV sequences in the database. Ethanol and BSO elevated nucleotide and amino acid substitution rates of HCV RNA by 4-18 folds within 48 hrs which were accompanied by oxidative RNA damage. Iron chelator and glutathione ester decreased both RNA damage and mutation rates. Furthermore, infectious HCV and HCV core gene were sufficient to induce oxidative RNA damage even in the absence of ethanol or BSO. Interestingly, the dn/ds ratio and percentage of sites undergoing positive selection increased with ethanol and BSO, resulting in an increased detection of NS5A variants with reduced susceptibility to interferon alpha, cyclosporine, and ribavirin and others implicated in immune tolerance and modulation of viral replication. Therefore, alcohol is likely to synergize with virus-induced oxidative/nitrosative stress to modulate the basal mutation rate of HCV. Positive selection induced by alcohol and reactive species may contribute to antiviral resistance.	[Seronello, Scott; Montanez, Jessica; Presleigh, Kristen; Barlow, Miriam; Park, Seung Bum; Choi, Jinah] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced	Seronello, S (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	jchoi@ucmerced.edu	Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433; Park, Seung Bum/0000-0003-2834-9071	UC-Merced; NIH [1R56AI083353-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083353] Funding Source: NIH RePORTER	UC-Merced; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by start up funds and faculty research grants to J.C. from UC-Merced and an NIH grant #1R56AI083353-01A1 (http://projectreporter.nih.gov/project_info_details.cfm?aid = 8130414&icde = 10161487). Partial sequencing was donated by Eddy Rubin, director of the DOE Joint Genome Institute, through the sequencing quota allocated to the UC Merced Genome Biology course (BIS 142) in Spring 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2001, REV MED VIROL, V11, P87, DOI 10.1002/rmv.303; Barbaro G, 1999, J HEPATOL, V30, P774, DOI 10.1016/S0168-8278(99)80128-7; Bebenek K, 1999, MUTAT RES-FUND MOL M, V429, P149, DOI 10.1016/S0027-5107(99)00119-0; BELOQUI O, 1993, J INTERFERON RES, V13, P279, DOI 10.1089/jir.1993.13.279; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Burlando B, 2003, CELL PHYSIOL BIOCHEM, V13, P147, DOI 10.1159/000071865; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Carriere M, 2006, J VIRAL HEPATITIS, V13, P633, DOI 10.1111/j.1365-2893.2006.00737.x; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Choi J, 2006, FREE RADICAL BIO MED, V41, P1488, DOI 10.1016/j.freeradbiomed.2006.08.008; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Cromie SL, 1996, J HEPATOL, V25, P821, DOI 10.1016/S0168-8278(96)80284-4; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Doreswamy K, 2004, J ANDROL, V25, P996; Duan H, 2010, VACCINE, V28, P4138, DOI 10.1016/j.vaccine.2010.04.024; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Eysseric H, 1997, ALCOHOL, V14, P111, DOI 10.1016/S0741-8329(96)00112-7; Fargion S, 1997, EUR J GASTROEN HEPAT, V9, P497, DOI 10.1097/00042737-199705000-00016; Feld JJ, 2011, GASTROENTEROLOGY, V140, P830, DOI 10.1053/j.gastro.2010.09.010; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Filipowicz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015492; Fong TL, 1998, J HEPATOL, V28, P369, DOI 10.1016/S0168-8278(98)80308-5; Fontana RJ, 2000, HEPATOLOGY, V31, P730, DOI 10.1002/hep.510310325; Forman HJ, 1997, OXIDATIVE STRESS SIG; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; Gentile I, 2009, J CLIN APHERESIS, V24, P190, DOI 10.1002/jca.20210; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Haviryaji KSG, 1997, NEUROCHEM RES, V22, P699, DOI 10.1023/A:1027302126493; Hofmann WP, 2005, J CLIN VIROL, V32, P86, DOI 10.1016/j.jcv.2004.08.004; Huang H, 2007, P NATL ACAD SCI USA, V104, P18666, DOI 10.1073/pnas.0708423104; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Hwang DR, 2005, J VIROL METHODS, V129, P170, DOI 10.1016/j.jviromet.2005.05.026; Kamiya H, 2009, FREE RADICAL BIO MED, V46, P1703, DOI 10.1016/j.freeradbiomed.2009.04.005; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kohashi T, 2006, J VIRAL HEPATITIS, V13, P582, DOI 10.1111/j.1365-2893.2006.00739.x; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Kuroki M, 2009, J VIROL, V83, P2338, DOI 10.1128/JVI.01840-08; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Look MP, 1999, ANTIVIR RES, V43, P113, DOI 10.1016/S0166-3542(99)00041-8; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Noguchi T, 2008, VIROLOGY, V375, P424, DOI 10.1016/j.virol.2008.02.009; Osada S, 2006, J GASTROEN HEPATOL, V21, P988, DOI 10.1111/j.1440-1746.2006.04223.x; OSHITA M, 1994, HEPATOLOGY, V20, P1115; Pawlotsky JM, 2003, CURR OPIN INFECT DIS, V16, P587, DOI 10.1097/00001432-200312000-00012; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; Rispeter K, 2000, VIRUS GENES, V21, P179, DOI 10.1023/A:1008135413215; Romero-Gomez M, 2001, DIGEST LIVER DIS, V33, P698, DOI 10.1016/S1590-8658(01)80048-7; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sata M, 1996, J VIRAL HEPATITIS, V3, P143, DOI 10.1111/j.1365-2893.1996.tb00005.x; SAWADA M, 1993, ALCOHOL ALCOHOLISM, V28, P85, DOI 10.1093/alcalc/28.Supplement_1B.85; Seronello S, 2007, FREE RADICAL BIO MED, V43, P869, DOI 10.1016/j.freeradbiomed.2007.05.036; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; Sherman KE, 1999, HEPATOLOGY, V30, P265, DOI 10.1002/hep.510300131; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Takahashi K, 2001, J GASTROEN HEPATOL, V16, P416, DOI 10.1046/j.1440-1746.2001.02462.x; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Thomson M, 2001, GASTROENTEROLOGY, V121, P1226, DOI 10.1053/gast.2001.28669; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; TSUKAMOTO S, 1989, ALCOHOL ALCOHOLISM, V24, P101, DOI 10.1093/oxfordjournals.alcalc.a044872; Tsutsumi T, 2003, HEPATOLOGY, V38, P820, DOI 10.1053/jhep.2003.50399; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06; Yano M, 2009, HEPATOLOGY, V50, P678, DOI 10.1002/hep.23026; Zhang T, 2003, HEPATOLOGY, V38, P57, DOI 10.1053/jhep.2003.50295; Zubkova I, 2009, VACCINE, V27, P2594, DOI 10.1016/j.vaccine.2009.02.045	75	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27436	10.1371/journal.pone.0027436	http://dx.doi.org/10.1371/journal.pone.0027436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087316	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700045
J	Lou, HY; Li, SL; Yang, YJ; Kang, LL; Zhang, X; Jin, WF; Wu, BL; Jin, L; Xu, SH				Lou, Haiyi; Li, Shilin; Yang, Yajun; Kang, Longli; Zhang, Xin; Jin, Wenfei; Wu, Bailin; Jin, Li; Xu, Shuhua			A Map of Copy Number Variations in Chinese Populations	PLOS ONE			English	Article							STRUCTURAL VARIATION; GENETIC-MARKERS; ARRAY CGH; VARIANTS; GENOME; HAPLOTYPE; SCALE; NUCLEOTIDE; INFERENCE; ADMIXTURE	It has been shown that the human genome contains extensive copy number variations (CNVs). Investigating the medical and evolutionary impacts of CNVs requires the knowledge of locations, sizes and frequency distribution of them within and between populations. However, CNV study of Chinese minorities, which harbor the majority of genetic diversity of Chinese populations, has been underrepresented considering the same efforts in other populations. Here we constructed, to our knowledge, a first CNV map in seven Chinese populations representing the major linguistic groups in China with 1,440 CNV regions identified using Affymetrix SNP 6.0 Array. Considerable differences in distributions of CNV regions between populations and substantial population structures were observed. We showed that similar to 35% of CNV regions identified in minority ethnic groups are not shared by Han Chinese population, indicating that the contribution of the minorities to genetic architecture of Chinese population could not be ignored. We further identified highly differentiated CNV regions between populations. For example, a common deletion in Dong and Zhuang (44.4% and 50%), which overlaps two keratin-associated protein genes contributing to the structure of hair fibers, was not observed in Han Chinese. Interestingly, the most differentiated CNV deletion between HapMap CEU and YRI containing CCL3L1 gene reported in previous studies was also the highest differentiated regions between Tibetan and other populations. Besides, by jointly analyzing CNVs and SNPs, we found a CNV region containing gene CTDSPL were in almost perfect linkage disequilibrium between flanking SNPs in Tibetan while not in other populations except HapMap CHD. Furthermore, we found the SNP taggability of CNVs in Chinese populations was much lower than that in European populations. Our results suggest the necessity of a full characterization of CNVs in Chinese populations, and the CNV map we constructed serves as a useful resource in further evolutionary and medical studies.	[Lou, Haiyi; Jin, Wenfei; Jin, Li; Xu, Shuhua] Chinese Acad Sci, Key Lab Computat Biol, Shanghai, Peoples R China; [Li, Shilin; Yang, Yajun; Kang, Longli; Zhang, Xin; Wu, Bailin; Jin, Li] Fudan Univ, Minist Educ MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Shilin; Yang, Yajun; Kang, Longli; Zhang, Xin; Wu, Bailin; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wu, Bailin] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA USA; [Lou, Haiyi; Jin, Wenfei; Jin, Li; Xu, Shuhua] Chinese Acad Sci, Max Planck Soc CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Fudan University; Fudan University; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Lou, HY (corresponding author), Chinese Acad Sci, Key Lab Computat Biol, Shanghai, Peoples R China.	ljin007@gmail.com; xushua@picb.ac.cn	Jin, Wenfei/V-9944-2019; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Jin, Wenfei/H-5330-2011; XU, SHUHUA/D-5345-2009; Xu, Shuhua/AAH-7620-2020	Jin, Wenfei/0000-0002-0028-3739; Jin, Li/0000-0002-4546-2415; Jin, Wenfei/0000-0002-0028-3739; XU, SHUHUA/0000-0002-1975-1002; Xu, Shuhua/0000-0002-1975-1002	National Science Foundation of China [30971577, 31171218, 30890034]; Shanghai Rising-Star Program [11QA1407600]; Science Foundation of the Chinese Academy of Sciences [KSCX2-EW-Q-1-11, KSCX2-EW-R-01-05, KSCX2-EW-J-15-05]; Science and Technology Commission of Shanghai Municipality [09540704300]; Ministry of Science and Technology (MoST) International Cooperation Base of China; K.C. Wong Education Foundation, Hong Kong	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Science Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology (MoST) International Cooperation Base of China; K.C. Wong Education Foundation, Hong Kong	Shuhua Xu was supported by the National Science Foundation of China (30971577, 31171218), Shanghai Rising-Star Program (11QA1407600), and Science Foundation of the Chinese Academy of Sciences (KSCX2-EW-Q-1-11; KSCX2-EW-R-01-05; KSCX2-EW-J-15-05). Li Jin was supported by the National Science Foundation of China (30890034) and the Science and Technology Commission of Shanghai Municipality (09540704300). This research was supported in part by the Ministry of Science and Technology (MoST) International Cooperation Base of China. Shuhua Xu is a Max-Planck Independent Junior Research Group Leader and a member of CAS Youth Innovation Promotion Association. Shuhua Xu also gratefully acknowledges the support of K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Armengol L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007230; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kang TW, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-492, 10.1186/1471-2164-9-92]; Kato M, 2009, HUM MOL GENET, V18, P3579; Kato M, 2008, AM J HUM GENET, V83, P157, DOI 10.1016/j.ajhg.2008.06.021; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Ku CS, 2010, HUM MUTAT, V31, P851, DOI 10.1002/humu.21287; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Ruault M, 2003, GENOMICS, V81, P391, DOI 10.1016/S0888-7543(03)00025-9; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teo SM, 2011, J HUM GENET, V56, P524, DOI 10.1038/jhg.2011.52; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Xu SH, 2009, MOL BIOL EVOL, V26, P2197, DOI 10.1093/molbev/msp130; Xue FH, 2008, EUR J HUM GENET, V16, P705, DOI 10.1038/sj.ejhg.5201998; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	58	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27341	10.1371/journal.pone.0027341	http://dx.doi.org/10.1371/journal.pone.0027341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087296	gold, Green Submitted, Green Published			2022-12-27	WOS:000297347700043
J	Schueler, C; Becker, HM; McKenna, R; Deitmer, JW				Schueler, Christina; Becker, Holger M.; McKenna, Robert; Deitmer, Joachim W.			Transport Activity of the Sodium Bicarbonate Cotransporter NBCe1 Is Enhanced by Different Isoforms of Carbonic Anhydrase	PLOS ONE			English	Article							PROTON-TRANSFER; CATALYTIC-PROPERTIES; HYDROPHOBIC POCKET; LACTATE TRANSPORT; KINETIC-ANALYSIS; XENOPUS OOCYTES; CHEMICAL RESCUE; O-18 EXCHANGE; BINDING-SITE; II BINDS	Transport metabolons have been discussed between carbonic anhydrase II (CAII) and several membrane transporters. We have now studied different CA isoforms, expressed in Xenopus oocytes alone and together with the electrogenic sodium bicarbonate cotransporter 1 (NBCe1), to determine their catalytic activity and their ability to enhance NBCe1 transport activity. pH measurements in intact oocytes indicated similar activity of CAI, CAII and CAIII, while in vitro CAIII had no measurable activity and CAI only 30% of the activity of CAII. All three CA isoforms increased transport activity of NBCe1, as measured by the transport current and the rate of intracellular sodium rise in oocytes. Two CAII mutants, altered in their intramolecular proton pathway, CAII-H64A and CAII-Y7F, showed significant catalytic activity and also enhanced NBCe1 transport activity. The effect of CAI, CAII, and CAII mutants on NBCe1 activity could be reversed by blocking CA activity with ethoxyzolamide (EZA, 10 mu M), while the effect of the less EZA-sensitive CAIII was not reversed. Our results indicate that different CA isoforms and mutants, even if they show little enzymatic activity in vitro, may display significant catalytic activity in intact cells, and that the ability of CA to enhance NBCe1 transport appears to depend primarily on its catalytic activity.	[Schueler, Christina; Deitmer, Joachim W.] TU Kaiserslautern, FB Biol, Abt Allgemeine Zool, Kaiserslautern, Germany; [Becker, Holger M.] TU Kaiserslautern, FB Biol, AG Zool Membrantransport, Kaiserslautern, Germany; [McKenna, Robert] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Kaiserslautern; University of Kaiserslautern; State University System of Florida; University of Florida	Schueler, C (corresponding author), TU Kaiserslautern, FB Biol, Abt Allgemeine Zool, Kaiserslautern, Germany.	christina.schueler@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020		Deutsche Forschungsgemeinschaft [DE 231/24-1]; Graduate School GRK 845; Landesschwerpunkt Membrantransport (RIMP)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School GRK 845; Landesschwerpunkt Membrantransport (RIMP)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DE 231/24-1), by the Graduate School GRK 845 and by the Landesschwerpunkt Membrantransport (RIMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; An HQ, 2002, BIOCHEMISTRY-US, V41, P3235, DOI 10.1021/bi0120695; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; BEHRAVAN G, 1991, EUR J BIOCHEM, V198, P589, DOI 10.1111/j.1432-1033.1991.tb16054.x; BEHRAVAN G, 1990, EUR J BIOCHEM, V190, P351, DOI 10.1111/j.1432-1033.1990.tb15582.x; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Briganti F, 1997, BIOCHEMISTRY-US, V36, P10384, DOI 10.1021/bi970760v; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Budayova-Spano M, 2006, ACTA CRYSTALLOGR F, V62, P6, DOI 10.1107/S1744309105038248; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Duda D, 2001, BIOCHEMISTRY-US, V40, P1741, DOI 10.1021/bi002295z; Elder I, 2007, PROTEINS, V68, P337, DOI 10.1002/prot.21403; ENGBERG P, 1985, ARCH BIOCHEM BIOPHYS, V241, P628, DOI 10.1016/0003-9861(85)90589-2; ERIKSSON AE, 1993, PROTEINS, V16, P29, DOI 10.1002/prot.340160104; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P3803, DOI 10.1021/bi602620k; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; GRAMLICH TL, 1990, ARCH PATHOL LAB MED, V114, P415; Gross E, 2002, J PHYSIOL-LONDON, V544, P679, DOI 10.1113/jphysiol.2002.029777; JEFFERY S, 1980, BIOCHEM GENET, V18, P843, DOI 10.1007/BF00500117; JEWELL DA, 1991, BIOCHEMISTRY-US, V30, P1484, DOI 10.1021/bi00220a006; JONSSON BH, 1976, FEBS LETT, V64, P310, DOI 10.1016/0014-5793(76)80317-1; KARARLI T, 1985, J BIOL CHEM, V260, P3484; Kristensen JM, 2004, ACTA PHYSIOL SCAND, V182, P69, DOI 10.1111/j.1365-201X.2004.01297.x; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; LOGRASSO PV, 1991, BIOCHEMISTRY-US, V30, P8463, DOI 10.1021/bi00098a025; Loiselle FB, 2004, AM J PHYSIOL-CELL PH, V286, pC1423, DOI 10.1152/ajpcell.00382.2003; LONNERHOLM G, 1985, GASTROENTEROLOGY, V88, P1151; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; Luo J, 2007, CURR NEUROVASC RES, V4, P205; Maupin CM, 2008, J AM CHEM SOC, V130, P11399, DOI 10.1021/ja802264j; ODOWD JJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P241, DOI 10.1016/0304-4165(88)90015-3; Piermarini PM, 2007, J BIOL CHEM, V282, P1409, DOI 10.1074/jbc.M608261200; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Scozzafava A, 2002, J MED CHEM, V45, P284, DOI 10.1021/jm010958k; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Sterling D, 2001, JOP, V2, P165; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran CT, 2004, CRC ENZYM INHIB SER, P67; Swietach P, 2010, CARDIOVASC RES, V85, P729, DOI 10.1093/cvr/cvp343; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; TU CK, 1990, BIOCHEMISTRY-US, V29, P6400, DOI 10.1021/bi00479a009; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Weise A, 2007, J GEN PHYSIOL, V130, P203, DOI 10.1085/jgp.200709809; Weise A, 2011, CELL PHYSIOL BIOCHEM, V27, P79, DOI 10.1159/000325208; Wendel C, 2008, PFLUG ARCH EUR J PHY, V455, P885, DOI 10.1007/s00424-007-0351-y; Yamada H, 2011, CHANNELS, V5, P106, DOI 10.4161/chan.5.2.14341; Yu H, 2009, AM J PHYSIOL-GASTR L, V297, P1223	60	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27167	10.1371/journal.pone.0027167	http://dx.doi.org/10.1371/journal.pone.0027167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076132	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200044
J	Sunkara, LT; Achanta, M; Schreiber, NB; Bommineni, YR; Dai, G; Jiang, WY; Lamont, S; Lillehoj, HS; Beker, A; Teeter, RG; Zhang, GL				Sunkara, Lakshmi T.; Achanta, Mallika; Schreiber, Nicole B.; Bommineni, Yugendar R.; Dai, Gan; Jiang, Weiyu; Lamont, Susan; Lillehoj, Hyun S.; Beker, Ali; Teeter, Robert G.; Zhang, Guolong			Butyrate Enhances Disease Resistance of Chickens by Inducing Antimicrobial Host Defense Peptide Gene Expression	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SALMONELLA-ENTERITIDIS; CATHELICIDIN LL-37; MULTIPLE ROLES; IN-VITRO; CELLS; IDENTIFICATION; ANTIBACTERIAL; INHIBITORS	Host defense peptides (HDPs) constitute a large group of natural broad-spectrum antimicrobials and an important first line of immunity in virtually all forms of life. Specific augmentation of synthesis of endogenous HDPs may represent a promising antibiotic-alternative approach to disease control. In this study, we tested the hypothesis that exogenous administration of butyrate, a major type of short-chain fatty acids derived from bacterial fermentation of undigested dietary fiber, is capable of inducing HDPs and enhancing disease resistance in chickens. We have found that butyrate is a potent inducer of several, but not all, chicken HDPs in HD11 macrophages as well as in primary monocytes, bone marrow cells, and jejuna and cecal explants. In addition, butyrate treatment enhanced the antibacterial activity of chicken monocytes against Salmonella enteritidis, with a minimum impact on inflammatory cytokine production, phagocytosis, and oxidative burst capacities of the cells. Furthermore, feed supplementation with 0.1% butyrate led to a significant increase in HDP gene expression in the intestinal tract of chickens. More importantly, such a feeding strategy resulted in a nearly 10-fold reduction in the bacterial titer in the cecum following experimental infections with S. enteritidis. Collectively, the results indicated that butyrate-induced synthesis of endogenous HDPs is a phylogenetically conserved mechanism of innate host defense shared by mammals and aves, and that dietary supplementation of butyrate has potential for further development as a convenient antibiotic-alternative strategy to enhance host innate immunity and disease resistance.	[Sunkara, Lakshmi T.; Achanta, Mallika; Schreiber, Nicole B.; Bommineni, Yugendar R.; Dai, Gan; Jiang, Weiyu; Beker, Ali; Teeter, Robert G.; Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA; [Lamont, Susan] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Lillehoj, Hyun S.] ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, USDA, Beltsville, MD USA	Oklahoma State University System; Oklahoma State University - Stillwater; Iowa State University; United States Department of Agriculture (USDA)	Sunkara, LT (corresponding author), Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA.	zguolon@okstate.edu	Zhang, Guolong/AAU-8197-2020; Sunkara, Lakshmi/B-8108-2014; Zhang, Guolong/HCI-5587-2022	Zhang, Guolong/0000-0003-4781-5816; Sunkara, Lakshmi/0000-0003-2023-5010; jiang, weiyu/0000-0001-6199-4289	US Department of Agriculture NIFA [2008-35204-04544]; Oklahoma Center for the Advancement of Science and Technology [HR07-113, AR07.2-087]; Oklahoma Agricultural Experiment Station [H-2811]	US Department of Agriculture NIFA; Oklahoma Center for the Advancement of Science and Technology; Oklahoma Agricultural Experiment Station	This work was supported by a US Department of Agriculture NIFA grant (2008-35204-04544), Oklahoma Center for the Advancement of Science and Technology grants HR07-113 and AR07.2-087, and Oklahoma Agricultural Experiment Station project H-2811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Evans EW, 1995, VET MICROBIOL, V47, P295, DOI 10.1016/0378-1135(95)00126-3; Fernandez-Rubio C, 2009, POULTRY SCI, V88, P943, DOI 10.3382/ps.2008-00484; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Higgs R, 2005, IMMUNOGENETICS, V57, P90, DOI 10.1007/s00251-005-0777-3; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kaiser MG, 2002, POULTRY SCI, V81, P657, DOI 10.1093/ps/81.5.657; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEVISON ME, 1973, INFECT IMMUN, V8, P30, DOI 10.1128/IAI.8.1.30-35.1973; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Milona P, 2007, BIOCHEM BIOPH RES CO, V356, P169, DOI 10.1016/j.bbrc.2007.02.098; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Strominger JL, 2009, J IMMUNOL, V182, P6633, DOI 10.4049/jimmunol.0990038; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; van Dijk A, 2005, VET IMMUNOL IMMUNOP, V106, P321, DOI 10.1016/j.vetimm.2005.03.003; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Van Immerseel F, 2005, POULTRY SCI, V84, P1851, DOI 10.1093/ps/84.12.1851; Van Immerseel F, 2004, AVIAN DIS, V48, P384, DOI 10.1637/7094; Van Immerseel F, 2003, INT J FOOD MICROBIOL, V85, P237, DOI 10.1016/S0168-1605(02)00542-1; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Xie H, 2001, VET IMMUNOL IMMUNOP, V80, P225, DOI 10.1016/S0165-2427(01)00260-4; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	48	172	183	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27225	10.1371/journal.pone.0027225	http://dx.doi.org/10.1371/journal.pone.0027225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073293	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200052
J	Szczepankowska, AK; Prestel, E; Mariadassou, M; Bardowski, JK; Bidnenko, E				Szczepankowska, Agnieszka K.; Prestel, Eric; Mariadassou, Mahendra; Bardowski, Jacek K.; Bidnenko, Elena			Phylogenetic and Complementation Analysis of a Single-Stranded DNA Binding Protein Family from Lactococcal Phages Indicates a Non-Bacterial Origin	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; OB-FOLD; REPLICATION FORK; SSB; GENE; IDENTIFICATION; EVOLUTION; DOMAIN; RECOMBINATION; MIRABILIS	Background: The single-stranded-nucleic acid binding (SSB) protein superfamily includes proteins encoded by different organisms from Bacteria and their phages to Eukaryotes. SSB proteins share common structural characteristics and have been suggested to descend from an ancestor polypeptide. However, as other proteins involved in DNA replication, bacterial SSB proteins are clearly different from those found in Archaea and Eukaryotes. It was proposed that the corresponding genes in the phage genomes were transferred from the bacterial hosts. Recently new SSB proteins encoded by the virulent lactococcal bacteriophages (Orf14(bIL67)-like proteins) have been identified and characterized structurally and biochemically. Methodology/Principal Findings: This study focused on the determination of phylogenetic relationships between Orf14(bIL67)-like proteins and other SSBs. We have performed a large scale phylogenetic analysis and pairwise sequence comparisons of SSB proteins from different phyla. The results show that, in remarkable contrast to other phage SSBs, the Orf14(bIL67)-like proteins form a distinct, self-contained and well supported phylogenetic group connected to the archaeal SSBs. Functional studies demonstrated that, despite the structural and amino acid sequence differences from bacterial SSBs, Orf14(bIL67) protein complements the conditional lethal ssb-1 mutation of Escherichia coli. Conclusions/Significance: Here we identified for the first time a group of phages encoded SSBs which are clearly distinct from their bacterial counterparts. All methods supported the recognition of these phage proteins as a new family within the SSB superfamily. Our findings suggest that unlike other phages, the virulent lactococcal phages carry ssb genes that were not acquired from their hosts, but transferred from an archaeal genome. This represents a unique example of a horizontal gene transfer between Archaea and bacterial phages.	[Szczepankowska, Agnieszka K.; Prestel, Eric; Bidnenko, Elena] INRA, Inst Micalis, UMR1319, Jouy En Josas, France; [Szczepankowska, Agnieszka K.; Bardowski, Jacek K.] Inst Biochem & Biophys PAS, Dept Microbial Biochem, Warsaw, Poland; [Mariadassou, Mahendra] INRA, UR1077, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Szczepankowska, AK (corresponding author), INRA, Inst Micalis, UMR1319, Jouy En Josas, France.	elena.bidnenko@jouy.inra.fr	Szczepankowska, Agnieszka K/AAN-7311-2021; Szczepankowska, Agnieszka K/H-2488-2017	Szczepankowska, Agnieszka K/0000-0002-8733-3283; Szczepankowska, Agnieszka K/0000-0002-8733-3283	Institut National de la Recherche Agronomique (INRA), France; Ministry of Science and Higher Education (MSHE), Poland [INRA/26/2008]	Institut National de la Recherche Agronomique (INRA), France; Ministry of Science and Higher Education (MSHE), Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the joint research project between Institut National de la Recherche Agronomique (INRA), France, and the Ministry of Science and Higher Education (MSHE), Poland [number INRA/26/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abriouel H, 2011, INT J FOOD MICROBIOL, V144, P487, DOI 10.1016/j.ijfoodmicro.2010.11.006; ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bendtsen JD, 2002, J VIROL, V76, P9695, DOI 10.1128/JVI.76.19.9695-9701.2002; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BIDNENKO E, 1995, J BACTERIOL, V177, P3824, DOI 10.1128/jb.177.13.3824-3829.1995; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Chang HW, 2008, INT J FOOD MICROBIOL, V126, P159, DOI 10.1016/j.ijfoodmicro.2008.05.013; CHASE JW, 1983, J MOL BIOL, V164, P193, DOI 10.1016/0022-2836(83)90075-X; Chedin F, 1998, TRENDS BIOCHEM SCI, V23, P273, DOI 10.1016/S0968-0004(98)01243-2; Chilukuri LN, 1997, MICROBIOL-SGM, V143, P1163, DOI 10.1099/00221287-143-4-1163; CHOI MY, 1995, J BIOL CHEM, V270, P22541, DOI 10.1074/jbc.270.38.22541; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; DEVRIES J, 1994, MICROBIOL-SGM, V140, P889, DOI 10.1099/00221287-140-4-889; DEVRIES J, 1994, EUR J BIOCHEM, V224, P613; Durmaz E, 2000, APPL ENVIRON MICROB, V66, P895, DOI 10.1128/AEM.66.3.895-903.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gascon I, 2000, J MOL BIOL, V296, P989, DOI 10.1006/jmbi.2000.3521; Gill EE, 2011, BIOESSAYS, V33, P248, DOI 10.1002/bies.201000091; Giraldo R, 2003, FEMS MICROBIOL REV, V26, P533, DOI 10.1111/j.1574-6976.2003.tb00629.x; Gray MW, 2001, GENOME BIOL, V2; Guardino KM, 2009, INT J MOL SCI, V10, P2412, DOI 10.3390/ijms10052412; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haseltine CA, 2002, MOL MICROBIOL, V43, P1505, DOI 10.1046/j.1365-2958.2002.02807.x; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Kelly TJ, 1998, P NATL ACAD SCI USA, V95, P14634, DOI 10.1073/pnas.95.25.14634; Kerr ID, 2003, EMBO J, V22, P2561, DOI 10.1093/emboj/cdg272; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Labrie SJ, 2007, J BACTERIOL, V189, P1482, DOI 10.1128/JB.01111-06; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Lehnherr H, 1999, J BACTERIOL, V181, P6463, DOI 10.1128/JB.181.20.6463-6468.1999; Leipe DD, 1997, NUCLEIC ACIDS RES, V27, P3389; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; Moreira D, 2000, MOL MICROBIOL, V35, P1, DOI 10.1046/j.1365-2958.2000.01692.x; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Robbins JB, 2005, J BIOL CHEM, V280, P15325, DOI 10.1074/jbc.M412870200; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Scaltriti E, 2009, MOL MICROBIOL, V73, P1156, DOI 10.1111/j.1365-2958.2009.06844.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Szczepanska AK, 2007, VIROLOGY, V363, P104, DOI 10.1016/j.virol.2007.01.023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theobald DL, 2005, J MOL BIOL, V354, P722, DOI 10.1016/j.jmb.2005.08.071; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tye BK, 2000, P NATL ACAD SCI USA, V97, P2399, DOI 10.1073/pnas.97.6.2399; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Xu H, 2010, NUCLEIC ACIDS RES, V38, P4821, DOI 10.1093/nar/gkq219	62	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26942	10.1371/journal.pone.0026942	http://dx.doi.org/10.1371/journal.pone.0026942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073223	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200024
J	London, CA; Bear, MD; McCleese, J; Foley, KP; Paalangara, R; Inoue, T; Ying, WW; Barsoum, J				London, Cheryl A.; Bear, Misty D.; McCleese, Jennifer; Foley, Kevin P.; Paalangara, Reji; Inoue, Takayo; Ying, Weiwen; Barsoum, James			Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer	PLOS ONE			English	Article							MULTIPLE SIGNALING PATHWAYS; SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; CANINE OSTEOSARCOMA; TUMOR-GROWTH; HEAT-SHOCK-PROTEIN-90; CELLS; EXPRESSION; MACHINERY; APOPTOSIS	Background: The novel water soluble compound STA-1474 is metabolized to ganetespib (formerly STA-9090), a potent HSP90 inhibitor previously shown to kill canine tumor cell lines in vitro and inhibit tumor growth in the setting of murine xenografts. The purpose of the following study was to extend these observations and investigate the safety and efficacy of STA-1474 in dogs with spontaneous tumors. Methods and Findings: This was a Phase 1 trial in which dogs with spontaneous tumors received STA-1474 under one of three different dosing schemes. Pharmacokinetics, toxicities, biomarker changes, and tumor responses were assessed. Twenty-five dogs with a variety of cancers were enrolled. Toxicities were primarily gastrointestinal in nature consisting of diarrhea, vomiting, inappetence and lethargy. Upregulation of HSP70 protein expression was noted in both tumor specimens and PBMCs within 7 hours following drug administration. Measurable objective responses were observed in dogs with malignant mast cell disease (n = 3), osteosarcoma (n = 1), melanoma (n = 1) and thyroid carcinoma (n = 1), for a response rate of 24% (6/25). Stable disease (>10 weeks) was seen in 3 dogs, for a resultant overall biological activity of 36% (9/25). Conclusions: This study provides evidence that STA-1474 exhibits biologic activity in a relevant large animal model of cancer. Given the similarities of canine and human cancers with respect to tumor biology and HSP90 activation, it is likely that STA-1474 and ganetespib will demonstrate comparable anti-cancer activity in human patients.	[London, Cheryl A.; Bear, Misty D.; McCleese, Jennifer] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Foley, Kevin P.] GlaxoSmithKline, Translat Biol, Collegeville, PA USA; [Paalangara, Reji] Intervet Schering Plough Anim Hlth, Summit, NJ USA; [Inoue, Takayo] Synta Pharmaceut Corp, Drug Metab & Pharmacokinet, Lexington, MA USA; [Ying, Weiwen] Synta Pharmaceut Corp, Discovery Chem, Lexington, MA USA; [Barsoum, James] Theracrine Inc, Cambridge, MA USA	University System of Ohio; Ohio State University; Merck & Company	London, CA (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	london.20@osu.edu	London, Cheryl/E-6561-2012; Foley, Kevin/ABC-1041-2020	Foley, Kevin/0000-0001-5148-7689	Synta Pharmaceuticals Corp.; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	Synta Pharmaceuticals Corp.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This clinical trial was supported by funding from Synta Pharmaceuticals Corp. The funders contributed to the study design, pharmacokinetic analysis and preparation of manuscript, but had no role in the treatment and evaluation of dogs in this study.	Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Bansal H, 2010, BLOOD; Beere H M, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.93.re1; Beloueche-Babari M, 2010, ONCOTARGET, V1, P185; Chun R, 2003, VET CLIN N AM-SMALL, V33, P491, DOI 10.1016/S0195-5616(03)00021-4; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Dakappagari N, 2010, BIOMARKERS, V15, P31, DOI 10.3109/13547500903261347; Erlichman C, 2009, EXPERT OPIN INV DRUG, V18, P861, DOI 10.1517/13543780902953699; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Leav I, 2010, AM J PATHOL, V176, P393, DOI 10.2353/ajpath.2010.090521; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; London CA, 2003, CLIN CANCER RES, V9, P2755; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; McDowell CL, 2009, INT J BIOL MACROMOL, V45, P310, DOI 10.1016/j.ijbiomac.2009.06.012; Mueller F, 2007, ANTICANCER RES, V27, P155; Neckers Len, 2005, Expert Opin Emerg Drugs, V10, P137, DOI 10.1517/14728214.10.1.137; Neznanov N, 2011, ONCOTARGET, V2, P209, DOI 10.18632/oncotarget.246; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsuchida Y, 2001, MED PEDIATR ONCOL, V37, P1, DOI 10.1002/mpo.1154; Vastag B, 2006, NAT BIOTECHNOL, V24, P1307, DOI 10.1038/nbt1106-1307; Veterinary Co-operative Oncology Group, VET COMP ONCOL, V2, P195; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams CR, 2007, J UROLOGY, V178, P1528, DOI 10.1016/j.juro.2007.05.120; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yano M, 1996, JPN J CANCER RES, V87, P908, DOI 10.1111/j.1349-7006.1996.tb02119.x; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	38	37	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27018	10.1371/journal.pone.0027018	http://dx.doi.org/10.1371/journal.pone.0027018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073242	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000021
J	Ye, SQ; Fowler, TW; Pavlos, NJ; Ng, PY; Liang, K; Feng, YF; Zheng, MH; Kurten, R; Manolagas, SC; Zhao, HB				Ye, Shiqiao; Fowler, Tristan W.; Pavlos, Nathan J.; Ng, Pei Ying; Liang, Kai; Feng, Yunfeng; Zheng, Minghao; Kurten, Richard; Manolagas, Stavros C.; Zhao, Haibo			LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; M-CSF; NEURONAL MIGRATION; CLEAR ZONE; ORGANIZATION; PROTEIN; DIFFERENTIATION; PATHWAY; ACETYLHYDROLASE	Microtubule organization and lysosomal secretion are both critical for the activation and function of osteoclasts, highly specialized polykaryons that are responsible for bone resorption and skeletal homeostasis. Here, we have identified a novel interaction between microtubule regulator LIS1 and Plekhm1, a lysosome-associated protein implicated in osteoclast secretion. Decreasing LIS1 expression by shRNA dramatically attenuated osteoclast formation and function, as shown by a decreased number of mature osteoclasts differentiated from bone marrow macrophages, diminished resorption pits formation, and reduced level of CTx-I, a bone resorption marker. The ablated osteoclast formation in LIS1-depleted macrophages was associated with a significant decrease in macrophage proliferation, osteoclast survival and differentiation, which were caused by reduced activation of ERK and AKT by M-CSF, prolonged RANKL-induced JNK activation and declined expression of NFAT-c1, a master transcription factor of osteoclast differentiation. Consistent with its critical role in microtubule organization and dynein function in other cell types, we found that LIS1 binds to and colocalizes with dynein in osteoclasts. Loss of LIS1 led to disorganized microtubules and aberrant dynein function. More importantly, the depletion of LIS1 in osteoclasts inhibited the secretion of Cathepsin K, a crucial lysosomal hydrolase for bone degradation, and reduced the motility of osteoclast precursors. These results indicate that LIS1 is a previously unrecognized regulator of osteoclast formation, microtubule organization, and lysosomal secretion by virtue of its ability to modulate dynein function and Plekhm1.	[Ye, Shiqiao; Manolagas, Stavros C.; Zhao, Haibo] Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Ye, Shiqiao; Manolagas, Stavros C.; Zhao, Haibo] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Fowler, Tristan W.; Kurten, Richard] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Pavlos, Nathan J.; Ng, Pei Ying; Zheng, Minghao] Univ Western Australia, Sch Surg, Ctr Orthoped Res, Perth, WA 6009, Australia; [Liang, Kai] Univ Arkansas Med Sci, Dept Dermatol, Little Rock, AR 72205 USA; [Feng, Yunfeng] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Western Australia; University of Arkansas System; University of Arkansas Medical Sciences; Washington University (WUSTL)	Ye, SQ (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA.	hzhao@uams.edu	Zhao, Haibo/ABG-9729-2021; Ye, Shiqiao/N-2873-2015	Ye, Shiqiao/0000-0003-1529-7102; ZHAO, HAIBO/0000-0003-0836-7555; Zheng, Minghao/0000-0003-1185-4768; Pavlos, Nathan/0000-0001-7003-188X; Feng, Yunfeng/0000-0001-9150-7795	National Institutes of Health [AR055694, P01 AG13918]; UAMS; Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS; Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant AR055694, P01 AG13918 and UAMS Tobacco Settlement Funds provided by Arkansas Biosciences Institute to H Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechler ME, 2010, J CELL BIOL, V190, P45, DOI 10.1083/jcb.200908105; BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P287, DOI 10.1007/BF02554876; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunati AM, 1996, EUR J BIOCHEM, V240, P400, DOI 10.1111/j.1432-1033.1996.0400h.x; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Del Fattore A, 2008, J BONE MINER RES, V23, P380, DOI 10.1359/JBMR.071107; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hikiji H, 2004, J CLIN INVEST, V114, P85, DOI 10.1172/JC1200420504; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Linder S, 2000, J CELL SCI, V113, P4165; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mulari MTK, 2003, EXP CELL RES, V285, P221, DOI 10.1016/S0014-4827(03)00033-8; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reinholt FP, 1999, EXP CELL RES, V251, P477, DOI 10.1006/excr.1999.4585; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Tabata K, 2010, MOL BIOL CELL, V21, P4162, DOI 10.1091/mbc.E10-06-0495; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; van Wesenbeeck L, 2004, J BONE MINER RES, V19, P183, DOI 10.1359/jbmr.2004.19.2.183; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161; Zhao HB, 2002, BIOCHEM BIOPH RES CO, V293, P1060, DOI 10.1016/S0006-291X(02)00326-1; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	57	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27285	10.1371/journal.pone.0027285	http://dx.doi.org/10.1371/journal.pone.0027285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073305	Green Submitted, Green Published, gold			2022-12-27	WOS:000297197000041
J	Aplin, KP; Suzuki, H; Chinen, AA; Chesser, RT; ten Have, J; Donnellan, SC; Austin, J; Frost, A; Gonzalez, JP; Herbreteau, V; Catzeflis, F; Soubrier, J; Fang, YP; Robins, J; Matisoo-Smith, E; Bastos, ADS; Maryanto, I; Sinaga, MH; Denys, C; Van den Bussche, RA; Conroy, C; Rowe, K; Cooper, A				Aplin, Ken P.; Suzuki, Hitoshi; Chinen, Alejandro A.; Chesser, R. Terry; ten Have, Jose; Donnellan, Stephen C.; Austin, Jeremy; Frost, Angela; Gonzalez, Jean Paul; Herbreteau, Vincent; Catzeflis, Francois; Soubrier, Julien; Fang, Yin-Ping; Robins, Judith; Matisoo-Smith, Elizabeth; Bastos, Amanda D. S.; Maryanto, Ibnu; Sinaga, Martua H.; Denys, Christiane; Van den Bussche, Ronald A.; Conroy, Chris; Rowe, Kevin; Cooper, Alan			Multiple Geographic Origins of Commensalism and Complex Dispersal History of Black Rats	PLOS ONE			English	Article							RATTUS SENSU-LATO; STATISTICAL TESTS; POPULATION-GROWTH; LATE PLEISTOCENE; TIME DEPENDENCY; MITOCHONDRIAL; GENE; NEUTRALITY; PHYLOGENY; RODENTS	The Black Rat (Rattus rattus) spread out of Asia to become one of the world's worst agricultural and urban pests, and a reservoir or vector of numerous zoonotic diseases, including the devastating plague. Despite the global scale and inestimable cost of their impacts on both human livelihoods and natural ecosystems, little is known of the global genetic diversity of Black Rats, the timing and directions of their historical dispersals, and the risks associated with contemporary movements. We surveyed mitochondrial DNA of Black Rats collected across their global range as a first step towards obtaining an historical genetic perspective on this socioeconomically important group of rodents. We found a strong phylogeographic pattern with well-differentiated lineages of Black Rats native to South Asia, the Himalayan region, southern Indochina, and northern Indochina to East Asia, and a diversification that probably commenced in the early Middle Pleistocene. We also identified two other currently recognised species of Rattus as potential derivatives of a paraphyletic R. rattus. Three of the four phylogenetic lineage units within R. rattus show clear genetic signatures of major population expansion in prehistoric times, and the distribution of particular haplogroups mirrors archaeologically and historically documented patterns of human dispersal and trade. Commensalism clearly arose multiple times in R. rattus and in widely separated geographic regions, and this may account for apparent regionalism in their associated pathogens. Our findings represent an important step towards deeper understanding the complex and influential relationship that has developed between Black Rats and humans, and invite a thorough re-examination of host-pathogen associations among Black Rats.	[Aplin, Ken P.; Frost, Angela] CSIRO Ecosystem Sci, Australian Natl Wildlife Collect, Canberra, ACT, Australia; [Suzuki, Hitoshi; Chinen, Alejandro A.] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Chesser, R. Terry] Smithsonian Inst, Div Birds, Washington, DC 20560 USA; [ten Have, Jose] Off Gene Technol Regulator, Canberra, ACT, Australia; [Donnellan, Stephen C.] Univ Adelaide, S Australian Museum, Adelaide, SA, Australia; [Donnellan, Stephen C.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Austin, Jeremy; Soubrier, Julien; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Gonzalez, Jean Paul; Herbreteau, Vincent] Mahidol Univ, Inst Rech Dev, Res Unit 178, Ctr Vectors & Vector Dis,Fac Sci, Nakhon Pathom, Thailand; [Catzeflis, Francois] Univ Montpellier 2, Inst Sci Evolut, Lab Paleontol Phylogenie & Paleobiol, Montpellier, France; [Fang, Yin-Ping] Natl Chiayi Univ, Dept Biol Resources, Chiayi, Taiwan; [Robins, Judith] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand; [Bastos, Amanda D. S.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Maryanto, Ibnu; Sinaga, Martua H.] Indonesian Inst Sci LIPI, Cibinong, West Java, Indonesia; [Denys, Christiane] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Van den Bussche, Ronald A.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Conroy, Chris; Rowe, Kevin] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Maryanto, Ibnu; Sinaga, Martua H.] Museum Bogoriense, Cibinong, West Java, Indonesia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Hokkaido University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Adelaide; University of Adelaide; University of Adelaide; Institut de Recherche pour le Developpement (IRD); Mahidol University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Chiayi University; University of Auckland; University of Otago; University of Pretoria; Indonesian Institute of Sciences; Museum National d'Histoire Naturelle (MNHN); Oklahoma State University System; Oklahoma State University - Stillwater; University of California System; University of California Berkeley	Aplin, KP (corresponding author), CSIRO Ecosystem Sci, Australian Natl Wildlife Collect, Canberra, ACT, Australia.	aplin.ken@gmail.com	Denys, Christiane/K-8144-2019; Austin, Jeremy J/F-8729-2010; Soubrier, Julien/B-9951-2014; Cooper, Alan/E-8171-2012; Donnellan, Stephen C/F-2442-2013; Herbreteau, Vincent/L-4411-2013; Soubrier, Julien/AAX-9560-2021; Bastos, Armanda/B-6357-2009; Suzuki, Hitoshi/F-8539-2012; Gonzalez, J-P/C-3077-2013	Denys, Christiane/0000-0002-1519-1546; Austin, Jeremy J/0000-0003-4244-2942; Soubrier, Julien/0000-0001-9350-7369; Cooper, Alan/0000-0002-7738-7851; Donnellan, Stephen C/0000-0002-5448-3226; Herbreteau, Vincent/0000-0003-1762-6336; Soubrier, Julien/0000-0001-9350-7369; Bastos, Armanda/0000-0002-9223-4204; Suzuki, Hitoshi/0000-0003-4426-385X; Gonzalez, J-P/0000-0003-3063-1770; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Van Den Bussche, Ronald/0000-0002-6481-3209; Rowe, Kevin Christopher/0000-0002-1215-9153	Australian Centre for International Agricultural Research (ACIAR); Australian Government; Department for International Development(DfID) [R8190]; National Science Council; Council of Agriculture, Republic of China; European Commission's INCO-DEV [(ICA4-CT2002-10056]	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Australian Government(Australian GovernmentCGIAR); Department for International Development(DfID); National Science Council(Ministry of Science and Technology, Taiwan); Council of Agriculture, Republic of China; European Commission's INCO-DEV	Funding support that allowed KA and AF to collect samples in Myanmar, Vietnam, Laos and Cambodia was provided by Australian Centre for International Agricultural Research (ACIAR - (http://aciar.gov.au/) and AusAID (http://www.ausaid.gov.au/), funding agencies of the Australian Government. Collecting by KA in Bangladesh was supported by Department for International Development(DfID) grants through the Poverty Elimination through Rice Research Assistance and Crop Protection Programme programmes. Y-PF was supported by grants from the National Science Council (http://web1.nsc.gov.tw/) and the Council of Agriculture (http://eng.coa.gov.tw/), Republic of China. AB was supported by DFID (project number R8190) and the European Commission's INCO-DEV programme (ICA4-CT2002-10056: Ratzooman - http://www.nri.org/ratzooman). CD's collecting in Guinea was supported by the European Commission's INCO-DEV programme (project 'TREATCONTROL'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Aplin K., 2006, RICE LAOS, P291; Aplin KP, 2003, FIELD METHODS RODENT; ARMITAGE PL, 1994, ANTIQUITY, V68, P231, DOI 10.1017/S0003598X00046548; ATKINSON IAE, 1985, CONSERVATION ISLAND, P35; Audoin-Rouzeau Frederique, 1994, Revue de Paleobiologie, V13, P125; Avise John C., 1994, pi; Badenhorst D, 2009, J ZOOL, V279, P44, DOI 10.1111/j.1469-7998.2009.00588.x; Barnett S.A., 2001, STORY RATS THEIR IMP; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; BAVERSTOCK PR, 1983, GENETICS, V105, P969; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; BLENCH R, 2007, NEW PALAEOZOOGEOGRAP, V42, P69; Blench R. M., 2007, AZANIA, V42, P69, DOI 10.1080/00672700709480451; BROWN GG, 1981, GENETICS, V97, P125; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Chinen AA, 2005, GENES GENET SYST, V80, P367, DOI 10.1266/ggs.80.367; CHINEN AA, 2006, THESIS HOKKAIDO U; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conroy Chris J., 1999, Journal of Mammalian Evolution, V6, P221, DOI 10.1023/A:1020561623890; Corbet GB, 1992, MAMMALS INDO MALAYAN; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duplantier JM, 2003, BIOL J LINN SOC, V78, P335, DOI 10.1046/j.1095-8312.2003.00142.x; *E TIM, KPA WELL DAT A UNPUB; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Ervynck A, 2002, BONES MAN STUDIES HO, P95; Flannery TF, 1995, MAMMALS S W PACIFIC; Flannery TF, 1995, MAMMALS NEW GUINEA; FROST A, 2009, THESIS U QUEENSLAND; Frynta D, 2005, AGGRESSIVE BEHAV, V31, P283, DOI 10.1002/ab.15555; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GLOVER T, 1986, DEP PREHISTORY RES S; GOODMAN SM, 1995, CONSERV BIOL, V9, P450, DOI 10.1046/j.1523-1739.1995.9020450.x; GYLDENSTOLPE N, 1917, SDAFG, V57, P1; Henttonen H, 2008, ANN NY ACAD SCI, V1149, P84, DOI 10.1196/annals.1428.064; HIRATA DN, 1974, J MAMMAL, V55, P472, DOI 10.2307/1379024; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Kambe Y, 2011, ZOOL SCI, V28, P560, DOI 10.2108/zsj.28.560; Kawamura Y., 1989, Memoirs of the Faculty of Science Kyoto University Series of Geology and Mineralogy, V54, P1; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KUMAR S, 2001, MEGA MOL EVOLUTIONAR; Lansing JS, 2004, ANTIQUITY, V78, P287, DOI 10.1017/S0003598X00112955; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Marshall Jr J.T., 1977, MAMMALS THAILAND, P396; MARTIN JHD, 1971, THESIS U QUEENSLAND; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; Mayr E, 1970, POPULATIONS SPECIES; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Meerburg BG, 2009, PEST MANAG SCI, V65, P351, DOI 10.1002/ps.1718; Musser G.G., 1986, American Museum Novitates, P1; Musser G.G., 1985, American Museum Novitates, P1; MUSSER G G, 1981, Bulletin of the American Museum of Natural History, V169, P67; Musser G.G., 1984, Modern Quaternary Research in Southeast Asia, V8, P61; Musser G.G., 1986, AM MUS NOVIT, V2850, P1; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nemirov Kirill, 2004, Recent Research Developments in Virology, V6, P201; NIETHAMMER J, 1975, Zoologischer Anzeiger, V194, P405; Pages M, 2011, J MAMMAL, V92, P659, DOI 10.1644/10-MAMM-A-033.1; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Peterson GI, 2009, MOL BIOL EVOL, V26, P2595, DOI 10.1093/molbev/msp175; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Robins JH, 2008, MOL PHYLOGENET EVOL, V49, P460, DOI 10.1016/j.ympev.2008.08.001; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santel W, 1998, EISZEITALTER GEGENWA, V48, P162; SCHWARZ E, 1934, P ZOOL SOC LOND, V104, P723; SHENG CF, 1995, FLORA TAIWAN, V1, P3; SUN XJ, 1986, J BIOGEOGR, V13, P441; SUZUKI S, 2001, MED ENTOMOL ZOOL, V52, P1; TAJIMA F, 1983, GENETICS, V105, P437; Tchernov Eitan, 1996, Acta Zoologica Cracoviensia, V39, P513; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Tollenaere C, 2010, J BIOGEOGR, V37, P398, DOI 10.1111/j.1365-2699.2009.02228.x; Underhill AP, 1997, J WORLD PREHIST, V11, P103, DOI 10.1007/BF02221203; Verneau O, 1997, J MOL EVOL, V45, P424, DOI 10.1007/PL00006247; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; Watts C. H. S., 1981, RODENTS AUSTR, P321; White J. Peter, 2000, Pacific Science, V54, P105; White JC, 2004, QUATERN INT, V113, P111, DOI 10.1016/j.quaint.2003.09.001; Yalden D.W., 2003, British Wildlife, V14, P243; Yosida T. H., 1980, CYTOGENETICS BLACK R; Yu HT, 1996, ZOOL STUD, V35, P195	100	194	211	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26357	10.1371/journal.pone.0026357	http://dx.doi.org/10.1371/journal.pone.0026357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073158	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900019
J	Gonzalez, JM; Dong, Z; Romero, R; Girardi, G				Gonzalez, Juan M.; Dong, Zhong; Romero, Roberto; Girardi, Guillermina			Cervical Remodeling/Ripening at Term and Preterm Delivery: The Same Mechanism Initiated by Different Mediators and Different Effector Cells	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; EXPRESSION; MATRIX-METALLOPROTEINASE-9; METALLOPROTEINASES; LEUKOCYTES; PREGNANCY; BIRTH; WOMEN; LABOR	Background: Premature cervical remodeling/ripening is believed to contribute to preterm delivery (PTD), the leading cause of perinatal morbidity and mortality. Despite considerable research, the causes of term and PTD remain unclear, and there is no effective treatment for PTD. We previously demonstrated that complement activation plays a causative role in cervical remodeling that leads to PTD in mice. Methodology/Principal Findings: Here we found that complement activation is not required for the physiological process that leads to term delivery in mice. Neither increased C3 cervical deposition nor increased C3a and C5a serum levels were observed at term. In addition, macrophages infiltration was found in PTD in contrast to term delivery were no leukocytes were found. Despite the different role of complement and different cellular effector cells, PTD and term delivery share a common dowsntream pathway characterized by increased metalloproteinases (MMPs) release and increased collagen degradation. However, different sources of MMPs were identified. Macrophages are the source of MMPs in PTD while cervical fibroblasts and columnar epithelial cells synthesize MMPs at term delivery. A dramatic diminution in serum progesterone levels precedes parturition at term but not in PTD, suggesting that progesterone withdrawal initiates cervical remodeling at term. On the other hand, MMPs release in PTD is triggered by C5a. Conclusion and Significance: In conclusion, preterm and term cervical remodeling occur through the same mechanism but they are initiated by different mediators and effector cells. That complement activation is required for PTD but not for the physiological process that leads to term delivery, suggests that complement is a potential specific biomarker and selective target to prevent PTD and thus avert neonatal mortality and morbidity.	[Gonzalez, Juan M.; Dong, Zhong; Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Bethesda, MD 20892 USA; [Girardi, Guillermina] CUNY, York Coll, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); City University of New York (CUNY) System	Gonzalez, JM (corresponding author), NICHHD, Perinatol Res Branch, NIH, Bethesda, MD 20892 USA.	Guillermina.Girardi@ed.ac.uk	; Romero, Roberto/A-5268-2019	Girardi, Guillermina/0000-0002-5797-7731; Romero, Roberto/0000-0002-4448-5121	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS; Medical Research Council [G1002033] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; MRC [G1002033] Funding Source: UKRI	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	These studies were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher N, 2009, ACTA OBSTET GYN SCAN, V88, P502, DOI 10.1080/00016340902852898; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Choi SJ, 2009, EUR J OBSTET GYN R B, V142, P43, DOI 10.1016/j.ejogrb.2008.08.009; Dubicke A, 2008, MOL HUM REPROD, V14, P641, DOI 10.1093/molehr/gan060; Elimian A, 1998, OBSTET GYNECOL, V92, P72, DOI 10.1016/S0029-7844(98)00123-9; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; Holt R, 2011, ENDOCRINOLOGY, V152, P1036, DOI 10.1210/en.2010-1105; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Imada K, 1997, BIOL REPROD, V56, P575, DOI 10.1095/biolreprod56.3.575; Kelly RW, 2002, J REPROD IMMUNOL, V57, P217, DOI 10.1016/S0165-0378(02)00007-4; LIGGINS GC, 1978, SEMIN PERINATOL, V2, P261; Ludmir J, 2000, CLIN OBSTET GYNECOL, V43, P433, DOI 10.1097/00003081-200009000-00003; Lynch AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.044; Malmstrom E, 2007, MOL HUM REPROD, V13, P333, DOI 10.1093/molehr/gal117; Rodriguez HA, 2003, MOL HUM REPROD, V9, P807, DOI 10.1093/molehr/gag099; Russell WMS., 1959, MED J AUSTRALIA; Stygar D, 2002, BIOL REPROD, V67, P889, DOI 10.1095/biolreprod.102.005116; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Timmons BC, 2006, BIOL REPROD, V74, P236, DOI 10.1095/biolreprod.105.044891; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Tveita AA, 2008, KIDNEY INT, V74, P1150, DOI 10.1038/ki.2008.308; Vaisbuch E, 2009, J MATERN-FETAL NEO M, V22, P905, DOI 10.1080/14767050902994663; Word RA, 2007, CERVICAL FUNCTION PR, P19	29	68	70	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26877	10.1371/journal.pone.0026877	http://dx.doi.org/10.1371/journal.pone.0026877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073213	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900050
J	Hawthorne, DJ; Dively, GP				Hawthorne, David J.; Dively, Galen P.			Killing Them with Kindness? In-Hive Medications May Inhibit Xenobiotic Efflux Transporters and Endanger Honey Bees	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; TRANSEPITHELIAL TRANSPORT; MALPIGHIAN TUBULES; INSECTICIDES; PESTICIDES; TOXICITY; VINBLASTINE; MECHANISMS	Background: Honey bees (Apis mellifera) have recently experienced higher than normal overwintering colony losses. Many factors have been evoked to explain the losses, among which are the presence of residues of pesticides and veterinary products in hives. Multiple residues are present at the same time, though most often in low concentrations so that no single product has yet been associated with losses. Involvement of a combination of residues to losses may however not be excluded. To understand the impact of an exposure to combined residues on honey bees, we propose a mechanism-based strategy, focusing here on Multi-Drug Resistance (MDR) transporters as mediators of those interactions. Methodology/Principal Findings: Using whole-animal bioassays, we demonstrate through inhibition by verapamil that the widely used organophosphate and pyrethroid acaricides coumaphos and tau-fluvalinate, and three neonicotinoid insecticides: imidacloprid, acetamiprid and thiacloprid are substrates of one or more MDR transporters. Among the candidate inhibitors of honey bee MDR transporters is the in-hive antibiotic oxytetracycline. Bees prefed oxytetracycline were significantly sensitized to the acaricides coumaphos and tau-fluvalinate, suggesting that the antibiotic may interfere with the normal excretion or metabolism of these pesticides. Conclusions/Significance: Many bee hives receive regular treatments of oxytetracycline and acaricides for prevention and treatment of disease and parasites. Our results suggest that seasonal co-application of these medicines to bee hives could increase the adverse effects of these and perhaps other pesticides. Our results also demonstrate the utility of a mechanism-based strategy. By identifying pesticides and apicultural medicines that are substrates and inhibitors of xenobiotic transporters we prioritize the testing of those chemical combinations most likely to result in adverse interactions.	[Hawthorne, David J.; Dively, Galen P.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Hawthorne, DJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	djh@umd.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain LJ, 1997, ENVIRON HEALTH PERSP, V105, P812, DOI 10.1289/ehp.97105812; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Callaghan A, 2002, ECOTOX ENVIRON SAFE, V52, P211, DOI 10.1006/eesa.2002.2186; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DELAPLANE KS, 1994, AM BEE J, V134, P259; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Frazier M, 2008, AM BEE J, V148, P521; Gaertner LS, 1998, J EXP BIOL, V201, P2637; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Lanning CL, 1996, TOXICOL LETT, V85, P127, DOI 10.1016/0378-4274(96)03654-5; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Leader JP, 2005, J EXP BIOL, V208, P4363, DOI 10.1242/jeb.01911; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Maus Christian, 2003, Bulletin of Insectology, V56, P51; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sammataro D, 1998, BEEKEEPERS HDB, P190; Sanford MT, 2010, STOREYS GUIDE KEEPIN; Schrickx J, 2007, J VET PHARMACOL THER, V30, P25, DOI 10.1111/j.1365-2885.2007.00808.x; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; TSURUO T, 1981, CANCER RES, V41, P1967; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Winston M.L., 1991, BIOL HONEY BEE	39	63	65	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26796	10.1371/journal.pone.0026796	http://dx.doi.org/10.1371/journal.pone.0026796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073195	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900037
J	Lavandero, B; Figueroa, CC; Franck, P; Mendez, A				Lavandero, Blas; Figueroa, Christian C.; Franck, Pierre; Mendez, Angela			Estimating Gene Flow between Refuges and Crops: A Case Study of the Biological Control of Eriosoma lanigerum by Aphelinus mali in Apple Orchards	PLOS ONE			English	Article							LANDSCAPE COMPOSITION; POPULATION-GENETICS; MICROSATELLITE LOCI; HEMIPTERA APHIDIDAE; COMPUTER-PROGRAM; SPECIATION; DIVERSITY; HOMOPTERA; INVASION; INSECTS	Parasitoid disturbance populations in agroecosystems can be maintained through the provision of habitat refuges with host resources. However, specialized herbivores that feed on different host plants have been shown to form host-specialized races. Parasitoids may subsequently specialize on these herbivore host races and therefore prefer parasitizing insects from the refuge, avoiding foraging on the crop. Evidence is therefore required that parasitoids are able to move between the refuge and the crop and that the refuge is a source of parasitoids, without being an important source of herbivore pests. A North-South transect trough the Chilean Central Valley was sampled, including apple orchards and surrounding Pyracantha coccinea (M. Roem) (Rosales: Rosacea) hedges that were host of Eriosoma lanigerum (Hemiptera: Aphididae), a globally important aphid pest of cultivated apples. At each orchard, aphid colonies were collected and taken back to the laboratory to sample the emerging hymenopteran parasitoid Aphelinus mali (Hymenoptera: Aphelinidae). Aphid and parasitoid individuals were genotyped using species-specific microsatellite loci and genetic variability was assessed. By studying genetic variation, natural geographic barriers of the aphid pest became evident and some evidence for incipient host-plant specialization was found. However, this had no effect on the population-genetic features of its most important parasitoid. In conclusion, the lack of genetic differentiation among the parasitoids suggests the existence of a single large and panmictic population, which could parasite aphids on apple orchards and on P. coccinea hedges. The latter could thus comprise a suitable and putative refuge for parasitoids, which could be used to increase the effectiveness of biological control. Moreover, the strong geographical differentiation of the aphid suggests local reinfestations occur mainly from other apple orchards with only low reinfestation from P. cocinnea hedges. Finally, we propose that the putative refuge could act as a source of parasitoids without being a major source of aphids.	[Lavandero, Blas; Mendez, Angela] Univ Talca, Lab Interacciones Insecto Planta, Talca, Chile; [Franck, Pierre] INRA, Plantes Syst Culture Hort, Avignon, France; [Figueroa, Christian C.] Univ Austral Chile, Fac Ciencias, Inst Ecol & Evoluc, Valdivia, Chile	Universidad de Talca; INRAE; Universidad Austral de Chile	Lavandero, B (corresponding author), Univ Talca, Lab Interacciones Insecto Planta, Talca, Chile.	blavandero@utalca.cl	lavandero, blas/A-1340-2012; Méndez, Ángela/GRY-7666-2022; Figueroa, Christian C./A-1170-2008	Figueroa, Christian C./0000-0001-9218-5564; lavandero, blas/0000-0002-2423-7016; Franck, Pierre/0000-0002-1904-8325	International Foundation for Science [C/4023-2]; FONDECYT [11080013]	International Foundation for Science(International Foundation for Science); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by the International Foundation for Science Grant No C/4023-2 and FONDECYT (Project Number 11080013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P1471; Asante S. K., 1997, Plant Protection Quarterly, V12, P166; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Castaneda LE, 2010, BIOL J LINN SOC, V100, P237, DOI 10.1111/j.1095-8312.2010.01416.x; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Cohen H, 1996, ENTOMOPHAGA, V41, P225, DOI 10.1007/BF02764248; Dobson AJ, 2002, INTRO GEN LINEAR MOL; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; Forbes AA, 2009, SCIENCE, V323, P776, DOI 10.1126/science.1166981; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frantz AC, 2006, MOL ECOL, V15, P3191, DOI 10.1111/j.1365-294X.2006.03022.x; Fuentes-Contreras E, 2008, POPULATION, V101, P190; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hufbauer RA, 2004, MOL ECOL, V13, P337, DOI 10.1046/j.1365-294X.2003.02084.x; JAMES BD, 1982, ECOL ENTOMOL, V7, P277, DOI 10.1111/j.1365-2311.1982.tb00667.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lavandero B, 2009, B ENTOMOL RES, V99, P97, DOI 10.1017/S0007485308006196; Lavandero B, 2009, MOL ECOL RESOUR, V9, P302, DOI 10.1111/j.1755-0998.2008.02398.x; Lavandero B, 2010, INSECT SCI, V17, P549, DOI 10.1111/j.1744-7917.2010.01345.x; Marko V, 2008, J APPL ENTOMOL, V132, P26, DOI 10.1111/j.1439-0418.2007.01233.x; Moreno V, 2003, DINAMICA POBLACIONAL; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PENMAN DR, 1980, J ECON ENTOMOL, V73, P49, DOI 10.1093/jee/73.1.49; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandanayaka WRM, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.27; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WEBER DC, 1988, J ECON ENTOMOL, V81, P1170, DOI 10.1093/jee/81.4.1170; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x	40	25	28	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26694	10.1371/journal.pone.0026694	http://dx.doi.org/10.1371/journal.pone.0026694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073185	Green Published, gold			2022-12-27	WOS:000297154900033
J	Sahana, G; Mailund, T; Lund, MS; Guldbrandtsen, B				Sahana, Goutam; Mailund, Thomas; Lund, Mogens Sando; Guldbrandtsen, Bernt			Local Genealogies in a Linear Mixed Model for Genome-Wide Association Mapping in Complex Pedigreed Populations	PLOS ONE			English	Article								Introduction: The state-of-the-art for dealing with multiple levels of relationship among the samples in genome-wide association studies (GWAS) is unified mixed model analysis (MMA). This approach is very flexible, can be applied to both family-based and population-based samples, and can be extended to incorporate other effects in a straightforward and rigorous fashion. Here, we present a complementary approach, called 'GENMIX (genealogy based mixed model)' which combines advantages from two powerful GWAS methods: genealogy-based haplotype grouping and MMA. Subjects and Methods: We validated GENMIX using genotyping data of Danish Jersey cattle and simulated phenotype and compared to the MMA. We simulated scenarios for three levels of heritability (0.21, 0.34, and 0.64), seven levels of MAF (0.05, 0.10, 0.15, 0.20, 0.25, 0.35, and 0.45) and five levels of QTL effect (0.1, 0.2, 0.5, 0.7 and 1.0 in phenotypic standard deviation unit). Each of these 105 possible combinations (3 h 2 x 7 MAF x 5 effects) of scenarios was replicated 25 times. Results: GENMIX provides a better ranking of markers close to the causative locus' location. GENMIX outperformed MMA when the QTL effect was small and the MAF at the QTL was low. In scenarios where MAF was high or the QTL affecting the trait had a large effect both GENMIX and MMA performed similarly. Conclusion: In discovery studies, where high-ranking markers are identified and later examined in validation studies, we therefore expect GENMIX to enrich candidates brought to follow-up studies with true positives over false positives more than the MMA would.	[Sahana, Goutam; Lund, Mogens Sando; Guldbrandtsen, Bernt] Aarhus Univ, Dept Mol Biol & Genet, Fac Sci & Technol, Tjele, Denmark; [Mailund, Thomas] Aarhus Univ, Bioinformat Res Ctr BiRC, Aarhus C, Denmark	Aarhus University; Aarhus University	Sahana, G (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Fac Sci & Technol, Tjele, Denmark.	Goutam.Sahana@agrsci.dk	Sahana, Goutam/K-7613-2014; Lund, Mogens S/I-4321-2016; Sahana, Goutam/AAI-7579-2021	Sahana, Goutam/0000-0001-7608-7577; Sahana, Goutam/0000-0001-7608-7577; Mailund, Thomas/0000-0001-6206-9239	Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark [09-065751]; Danish Directorate for Food, Fisheries and Agri Business [3412-08-02253]; VikingGenetics; Nordic Genetic Evaluation; Aarhus University	Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark; Danish Directorate for Food, Fisheries and Agri Business; VikingGenetics; Nordic Genetic Evaluation; Aarhus University	The work was funded by the Danish Agency for Science, Technology and Innovation, Copenhagen, Denmark, FTP grant no. 09-065751. The genotypes and pedigree information on Danish Jersey population were from the project "Genomic Selection-From Function to Efficient Utilization in Cattle Breeding" (grant no. 3412-08-02253), funded by the Danish Directorate for Food, Fisheries and Agri Business, VikingGenetics, Nordic Genetic Evaluation, and Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Besenbacher S, 2009, GENETICS, V181, P747, DOI 10.1534/genetics.108.092643; CROOKS L, 2009, BMC P S1, V3; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ding ZH, 2008, BIOINFORMATICS, V24, P2215, DOI 10.1093/bioinformatics/btn406; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Mailund T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-454; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	10	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27061	10.1371/journal.pone.0027061	http://dx.doi.org/10.1371/journal.pone.0027061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073255	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900069
J	Wang, KY; Guo, YM; Wang, F; Wang, ZR				Wang, Kaiyu; Guo, Yanmeng; Wang, Fei; Wang, Zuoren			Drosophila TRPA Channel Painless Inhibits Male-Male Courtship Behavior through Modulating Olfactory Sensation	PLOS ONE			English	Article							SEXUAL RECEPTIVITY; SOCIAL EXPERIENCE; MELANOGASTER; PHEROMONE; GENE; NOCICEPTION; AVOIDANCE; TASTE; FLY	The Drosophila melanogaster TRPA family member painless, expressed in a subset of multidendritic neurons embeding in the larval epidermis, is necessary for larval nociception of noxious heat or mechanical stimuli. However, the function of painless in adult flies remains largely unknown. Here we report that mutation of painless leads to a defect in male-male courtship behavior and alteration in olfaction sensitivity in adult flies. Specific downregulation of the expression of the Painless protein in the olfactory projection neurons (PNs) of the antennal lobes (ALs) resulted in a phenotype resembling that found in painless mutant flies, whereas overexpression of Painless in PNs of painless mutant males suppressed male-male courtship behavior. The downregulation of Painless exclusively during adulthood also resulted in male-male courtship behavior. In addition, mutation of the painless gene in flies caused changes in olfaction, suggesting a role for this gene in olfactory processing. These results indicate that functions of painless in the adult central nervous system of Drosophila include modulation of olfactory processing and inhibition of male-male courtship behavior.	[Wang, Kaiyu; Guo, Yanmeng; Wang, Fei; Wang, Zuoren] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Wang, Kaiyu; Guo, Yanmeng; Wang, Fei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, KY (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China.	ZuorenWang@ion.ac.cn		Wang, Fei/0000-0002-8646-2411	China 973 project [2011CBA00404]	China 973 project(National Basic Research Program of China)	This work was supported by the China 973 project (2011CBA00404) awarded to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; FERVEUR JF, 2007, COMPLEX CHEM MESSAGE, P397; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Inoshita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019770; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lacaille F, 2009, BEHAV GENET, V39, P554, DOI 10.1007/s10519-009-9286-8; Lin MQ, 1996, P NATL ACAD SCI USA, V93, P10446, DOI 10.1073/pnas.93.19.10446; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Villella A, 1997, GENETICS, V147, P1107; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Zhou XJ, 2005, J BIOL RHYTHM, V20, P237, DOI 10.1177/0748730405274451	38	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25890	10.1371/journal.pone.0025890	http://dx.doi.org/10.1371/journal.pone.0025890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073144	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900003
J	Gotte, DR; Benestad, SL; Laude, H; Zurbriggen, A; Oevermann, A; Seuberlich, T				Goette, Dorothea R.; Benestad, Sylvie L.; Laude, Hubert; Zurbriggen, Andreas; Oevermann, Anna; Seuberlich, Torsten			Atypical Scrapie Isolates Involve a Uniform Prion Species with a Complex Molecular Signature	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SHEEP SCRAPIE; NORMAL BRAIN; PROTEIN; PRP; DISEASE; STRAINS; TRANSMISSION; AGENT; GENOTYPE	The pathobiology of atypical scrapie, a prion disease affecting sheep and goats, is still poorly understood. In a previous study, we demonstrated that atypical scrapie affecting small ruminants in Switzerland differs in the neuroanatomical distribution of the pathological prion protein (PrPd). To investigate whether these differences depend on host-related vs. pathogen-related factors, we transmitted atypical scrapie to transgenic mice over-expressing the ovine prion protein (tg338). The clinical, neuropathological, and molecular phenotype of tg338 mice is similar between mice carrying the Swiss atypical scrapie isolates and the Nor98, an atypical scrapie isolate from Norway. Together with published data, our results suggest that atypical scrapie is caused by a uniform type of prion, and that the observed phenotypic differences in small ruminants are likely host-dependant. Strikingly, by using a refined SDS-PAGE technique, we established that the prominent proteinase K-resistant prion protein fragment in atypical scrapie consists of two separate, unglycosylated peptides with molecular masses of roughly 5 and 8 kDa. These findings show similarities to those for other prion diseases in animals and humans, and lay the groundwork for future comparative research.	[Goette, Dorothea R.; Zurbriggen, Andreas; Oevermann, Anna; Seuberlich, Torsten] Univ Bern, NeuroCtr, Natl & OIE Reference Labs BSE & Scrapie, Div Expt Clin Res,Vetsuisse Fac, Bern, Switzerland; [Benestad, Sylvie L.] Norwegian Vet Inst, Dept Pathol, Oslo, Norway; [Laude, Hubert] INRA, Virol Immunol Mol 3U892, Jouy En Josas, France	University of Bern; Norwegian Veterinary Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gotte, DR (corresponding author), Univ Bern, NeuroCtr, Natl & OIE Reference Labs BSE & Scrapie, Div Expt Clin Res,Vetsuisse Fac, Bern, Switzerland.	torsten.seuberlich@vetsuisse.unibe.ch		Oevermann, Anna/0000-0002-3569-8547	Swiss Federal Veterinary Office [1.08.13]	Swiss Federal Veterinary Office	This study was funded by the Swiss Federal Veterinary Office (grant #1.08.13.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arsac JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007300; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bouzalas IG, 2011, J CLIN MICROBIOL, V49, P2109, DOI 10.1128/JCM.02033-10; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Bruce Moira E., 1996, P223; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; DICKINSON AG, 1977, SLOW VIRUS INFECTION, P3; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Everest SJ, 2006, J GEN VIROL, V87, P471, DOI 10.1099/vir.0.81539-0; Fediaevsky A, 2010, VET J, V185, P338, DOI 10.1016/j.tvjl.2009.06.019; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gonzalez L, 2010, J GEN VIROL, V91, P2630, DOI 10.1099/vir.0.022574-0; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Griffiths PC, 2010, J GEN VIROL, V91, P2132, DOI 10.1099/vir.0.018986-0; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Krebs B, 2007, ACTA NEUROPATHOL, V114, P195, DOI 10.1007/s00401-007-0242-5; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Langeveld JPM, 2011, J CLIN MICROBIOL, V49, P3026, DOI 10.1128/JCM.01102-11; Laude H, 2002, CR BIOL, V325, P49, DOI 10.1016/S1631-0691(02)01393-8; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Nentwig A, 2007, PLOS PATHOG, V3, P743, DOI 10.1371/journal.ppat.0030082; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rodriguez-Martinez AB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-17; Schneider K, 2008, BRAIN RES BULL, V77, P343, DOI 10.1016/j.brainresbull.2008.09.012; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; Simmons MM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-14; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Wemheuer WM, 2009, VET REC, V164, P677, DOI 10.1136/vr.164.22.677; Wemheuer WM, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-32; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	42	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27510	10.1371/journal.pone.0027510	http://dx.doi.org/10.1371/journal.pone.0027510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096587	Green Published, gold			2022-12-27	WOS:000297553900055
J	Wang, Y; Nie, M; Li, W; Ping, F; Hu, YY; Ma, LK; Gao, JS; Liu, JT				Wang, Ying; Nie, Min; Li, Wei; Ping, Fan; Hu, Yingying; Ma, Liangkun; Gao, Jinsong; Liu, Juntao			Association of Six Single Nucleotide Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; INSULIN-SECRETION; GENETIC-VARIANTS; TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2; COMMON VARIANTS; INCREASED RISK; TYPE-2; WOMEN; IGF2BP2	Background: To investigate whether the candidate genes that confer susceptibility to type 2 diabetes mellitus are also correlated with gestational diabetes mellitus (GDM) in pregnant Chinese women. Methodology/Principal Findings: In this study, 1764 unrelated pregnant women were recruited, of which 725 women had GDM and 1039 served as controls. Six single nucleotide polymorphisms (rs7754840 in CDKAL1, rs391300 in SRR, rs2383208 in CDKN2A/2B, rs4402960 in IGF2BP2, rs10830963 in MTNR1B, rs4607517 in GCK) were genotyped using TaqMan allelic discrimination assays. The genotype and allele distributions of each SNP between the GDM cases and controls and the combined effects of alleles for the risk of developing GDM were analyzed. We found that the rs4402960, rs2383208 and rs391300 were statistically associated with GDM (OR = 1.207, 95% CI = 1.029-1.417, p = 0.021; OR = 1.242, 95% CI = 1.077-1.432, p = 0.003; OR = 1.202, 95% CI = 1.020-1.416, P = 0.028, respectively). In addition, the effect was greater under a recessive model in rs391300 (OR = 1.820, 95% CI = 1.226-2.701, p = 0.003). Meanwhile, the joint effect of these three loci indicated an additive effect of multiple alleles on the risk of developing GDM with an OR of 1.196 per allele (p = 1.08 x 10(-4)). We also found that the risk alleles of rs2383208 (b = -0.085, p = 0.003), rs4402960 (b = -0.057, p = 0.046) and rs10830963 (b = -0.096, p = 0.001) were associated with HOMA-B, while rs7754840 was associated with decrease in insulin AUC during a 100 g OGTT given at the time of GDM diagnosis (b = -0.080, p = 0.007). Conclusions/Significance: Several risk alleles of type 2 diabetes were associated with GDM in pregnant Chinese women. The effects of these SNPs on GDM might be through the impairment of beta cell function and these risk loci contributed additively to the disease.	[Wang, Ying; Nie, Min; Li, Wei; Ping, Fan; Hu, Yingying] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrine,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China; [Wang, Ying] ShanXi Med Coll, Affiliated Hosp 2, Dept Endocrinol, Taiyuan, Shan Xi, Peoples R China; [Ma, Liangkun; Gao, Jinsong; Liu, Juntao] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wang, Y (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrine,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China.	nm_pumch@yahoo.com.cn			National Natural Science Foundation of China [81070630, 30672210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Project of National Natural Science Foundation of China (no. 81070630 and no. 30672210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2004, DIABETES CARE S1, V27, P380, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Chen Z, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-35; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fernandez-Mejia C, 2001, ENDOCRINOLOGY, V142, P1448, DOI 10.1210/en.142.4.1448; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; JASON YK, 2011, BMC MED GEN IN PRESS, V12, P82; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Linne Y, 2002, BJOG-INT J OBSTET GY, V109, P1227; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Pascoe L, 2008, DIABETOLOGIA, V51, P1989, DOI 10.1007/s00125-008-1124-7; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; RYAN EA, 1995, DIABETES, V44, P506, DOI 10.2337/diabetes.44.5.506; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaat N, 2007, DIABETOLOGIA, V50, P972, DOI 10.1007/s00125-007-0623-2; Shaat N, 2006, DIABETOLOGIA, V49, P1545, DOI 10.1007/s00125-006-0258-8; Shaat N, 2005, DIABETOLOGIA, V48, P2544, DOI 10.1007/s00125-005-0035-0; Shaat N, 2007, CURR MED CHEM, V14, P569, DOI 10.2174/092986707780059643; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; TSAI FJ, 2010, PLOS ONE, V19, P6; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Watanabe RM, 2007, DIABETES, V56, P1481, DOI 10.2337/db06-1682; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Williams MA, 2003, J REPROD MED, V48, P955; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xiang AH, 1999, DIABETES, V48, P848, DOI 10.2337/diabetes.48.4.848; XU M, 2010, PLOS ONE, V17, P5; Yang XL, 2002, DIABETES CARE, V25, P847, DOI 10.2337/diacare.25.5.847; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou Q, 2009, DIABETOLOGIA, V52, P2466, DOI 10.1007/s00125-009-1500-y	50	73	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26953	10.1371/journal.pone.0026953	http://dx.doi.org/10.1371/journal.pone.0026953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096510	Green Submitted, gold, Green Published			2022-12-27	WOS:000297553900016
J	Kibler, KV; Gomez, CE; Perdiguero, B; Wong, SM; Huynh, T; Holechek, S; Arndt, W; Jimenez, V; Gonzalez-Sanz, R; Denzler, K; Haddad, EK; Wagner, R; Sekaly, RP; Tartaglia, J; Pantaleo, G; Jacobs, BL; Esteban, M				Kibler, Karen V.; Gomez, Carmen E.; Perdiguero, Beatriz; Wong, Shukmei; Trung Huynh; Holechek, Susan; Arndt, William; Jimenez, Victoria; Gonzalez-Sanz, Ruben; Denzler, Karen; Haddad, Elias K.; Wagner, Ralf; Sekaly, Rafick P.; Tartaglia, James; Pantaleo, Giuseppe; Jacobs, Bertram L.; Esteban, Mariano			Improved NYVAC-Based Vaccine Vectors	PLOS ONE			English	Article							T-CELL RESPONSES; CLADE-C; GENE-EXPRESSION; VIRUS; MVA; IMMUNOGENICITY; ALVAC; DNA	While as yet there is no vaccine against HIV/AIDS, the results of the phase III Thai trial (RV144) have been encouraging and suggest that further improvements of the prime/boost vaccine combination of a poxvirus and protein are needed. With this aim, in this investigation we have generated derivatives of the candidate vaccinia virus vaccine vector NYVAC with potentially improved functions. This has been achieved by the re-incorporation into the virus genome of two host range genes, K1L and C7L, in conjunction with the removal of the immunomodulatory viral molecule B19, an antagonist of type I interferon action. These novel virus vectors, referred to as NYVAC-C-KC and NYVAC-C-KC-DB19R, have acquired relevant biological characteristics, giving higher levels of antigen expression in infected cells, replication-competency in human keratinocytes and dermal fibroblasts, activation of selective host cell signal transduction pathways, and limited virus spread in tissues. Importantly, these replication-competent viruses have been demonstrated to maintain a highly attenuated phenotype.	[Kibler, Karen V.; Wong, Shukmei; Trung Huynh; Holechek, Susan; Arndt, William; Denzler, Karen; Jacobs, Bertram L.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Gomez, Carmen E.; Perdiguero, Beatriz; Jimenez, Victoria; Gonzalez-Sanz, Ruben; Esteban, Mariano] Consejo Super Invest Cient, Ctr Nacl Biotecnol, Madrid, Spain; [Haddad, Elias K.; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Sekaly, Rafick P.] Univ Montreal, Montreal, PQ, Canada; [Wagner, Ralf] Univ Regensburg, Regensburg, Germany; [Tartaglia, James] Sanofi Pasteur, Swiftwater, PA USA; [Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	Arizona State University; Arizona State University-Tempe; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vaccine & Gene Therapy Institute of Florida; Universite de Montreal; University of Regensburg; Sanofi-Aventis; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kibler, KV (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	bjacobs@asu.edu; mesteban@cnb.csic.es	Esteban, Mariano/ABG-5375-2020; gonzalez, ruben/O-5088-2014; González, Rubén/N-7936-2019; Pantaleo, Giuseppe/K-6163-2016; Perdiguero, Beatriz/K-6587-2017; Gomez, Carmen Elena/K-1940-2014	Esteban, Mariano/0000-0003-0846-2827; Perdiguero, Beatriz/0000-0001-6276-7766; Gomez, Carmen Elena/0000-0002-5414-7935	Bill and Melinda Gates Foundation; Spanish grant [SAF2008-02036]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Spanish grant(Spanish Government)	This study was conducted as part of the Poxvirus T cell Vaccine Discovery Consortium (PTVDC) as part of the Collaboration for AIDS Vaccine Discovery (CAVD) with support from the Bill and Melinda Gates Foundation. Mariano Esteban was supported in part by a Spanish grant (SAF2008-02036). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JT is an employee of Sanofi Pasteur and as such, Sanofi Pasteur is considered by PLoS ONE to have contributed funding to this research.	ALCAMI A, 1995, J VIROL, V69, P4633; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Franchini Genoveffa, 2004, Expert Rev Vaccines, V3, pS75, DOI 10.1586/14760584.3.4.S75; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Li ZQ, 2004, VACCINE, V22, P1486, DOI 10.1016/j.vaccine.2003.10.022; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; PAOLETTI E, 1994, DEV BIOL STAND, V82, P65; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RODRIGUEZ JF, 1988, P NATL ACAD SCI USA, V85, P1667, DOI 10.1073/pnas.85.5.1667; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Willis KL, 2009, VIROLOGY, V394, P73, DOI 10.1016/j.virol.2009.08.020	30	48	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e25674	10.1371/journal.pone.0025674	http://dx.doi.org/10.1371/journal.pone.0025674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096477	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800002
J	D'Osualdo, A; Weichenberger, CX; Wagner, RN; Godzik, A; Wooley, J; Reed, JC				D'Osualdo, Andrea; Weichenberger, Christian X.; Wagner, Roland N.; Godzik, Adam; Wooley, John; Reed, John C.			CARD8 and NLRP1 Undergo Autoproteolytic Processing through a ZU5-Like Domain	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; HOMOLOGY DETECTION; ACTIVATION; PREDICTION; INFLAMMASOME; CASPASE-2; SERVER; FORMS	The "Function to Find Domain" (FIIND)-containing proteins CARD8 (Cardinal; Tucan) and NLRP1 (NALP1; NAC) are well known components of inflammasomes, multiprotein complexes responsible for activation of caspase-1, a regulator of inflammation and innate immunity. Although identified many years ago, the role of the FIIND is unknown. Here, we report that CARD8 and NLRP1 undergo autoproteolytic cleavage at a conserved SF/S motif within the FIIND. Using bioinformatics and computational modeling approaches, we detected striking structural similarity between the FIIND and the ZU5-UPA domain present in the autoproteolytic protein PIDD. This allowed us to generate a three-dimensional model and to gain insights in the molecular mechanism of the cleavage. Site-directed mutagenesis experiments revealed that the second serine of the SF/S motif is required for CARD8 and NLRP1 autoproteolysis. Furthermore, we discovered an important function for conserved glutamic acid and histidine residues, located in proximity of the cleavage site in regulating the autoprocessing efficiency. Altogether, these results identify a function for the FIIND and show that CARD8 and NLRP1 are ZU5-UPA domain-containing autoproteolytic proteins, thus suggesting a novel mechanism for regulating innate immune responses.	[D'Osualdo, Andrea; Weichenberger, Christian X.; Wagner, Roland N.; Godzik, Adam; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Weichenberger, Christian X.; Wooley, John] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Weichenberger, Christian X.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; European Academy of Bozen-Bolzano	D'Osualdo, A (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	reedoffice@sanfordburnham.org	Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Weichenberger, Christian X./0000-0002-2176-0274	National Institutes of Health (NIH) [AI-56324]; American-Italian Cancer Foundation; Austrian Science Fund (FWF) [J 3154] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056324] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Italian Cancer Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to the National Institutes of Health (NIH) for generous support (AI-56324). Andrea D'Osualdo was supported by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bagnall RD, 2008, EUR J HUM GENET, V16, P619, DOI 10.1038/sj.ejhg.5201996; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1998, NAT STRUCT BIOL, V5, P249, DOI 10.1038/nsb0498-249; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Sun Y, 2008, PROTEIN SCI, V17, P494, DOI 10.1110/ps.073311808; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	34	107	110	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27396	10.1371/journal.pone.0027396	http://dx.doi.org/10.1371/journal.pone.0027396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087307	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700040
J	Peng, XC; Gong, FM; Zhao, YW; Zhou, LX; Xie, YW; Liao, HL; Lin, HJ; Li, ZY; Tang, MH; Tong, AP				Peng, Xing-chen; Gong, Feng-ming; Zhao, Yu-wei; Zhou, Liang-xue; Xie, Ying-wei; Liao, Hong-li; Lin, Hong-jun; Li, Zhi-yong; Tang, Ming-hai; Tong, Ai-ping			Comparative Proteomic Approach Identifies Pkm2 and Cofilin-1 as Potential Diagnostic, Prognostic and Therapeutic Targets for Pulmonary Adenocarcinoma	PLOS ONE			English	Article							RENAL-CELL CANCER; K-RAS ONCOGENE; LUNG-CANCER; PYRUVATE-KINASE; CLINICAL PROTEOMICS; PANCREATIC-CANCER; SUPPRESSOR GENES; METASTASIS; EXPRESSION; CARCINOMA	Lung cancer is the leading cause of cancer-related death in the world. Non-small cell lung carcinomas (Non-SCLC) account for almost 80% of lung cancers, of which 40% were adenocarcinomas. For a better understanding of the molecular mechanisms behind the development and progression of lung cancer, particularly lung adenocarcinoma, we have used proteomics technology to search for candidate prognostic and therapeutic targets in pulmonary adenocarcinoma. The protein profile changes between human pulmonary adenocarcinoma tissue and paired surrounding normal tissue were analyzed using two-dimensional polyacrylamide gel electrophoresis (2-DE) based approach. Differentially expressed protein-spots were identified with ESI-Q-TOF MS/MS instruments. As a result, thirty two differentially expressed proteins (over 2-fold, p<0.05) were identified in pulmonary adenocarcinoma compared to normal tissues. Among them, two proteins (PKM2 and cofilin-1), significantly up-regulated in adenocarcinoma, were selected for detailed analysis. Immunohistochemical examination indicated that enhanced expression of PKM2 and cofilin-1 were correlated with the severity of epithelial dysplasia, as well as a relatively poor prognosis. Knockdown of PKM2 expression by RNA interference led to a significant suppression of cell growth and induction of apoptosis in pulmonary adenocarcinoma SPC-A1 cells in vitro, and tumor growth inhibition in vivo xenograft model (P<0.05). In addition, the shRNA expressing plasmid targeting cofilin-1 significantly inhibited tumor metastases and prolonged survival in LL/2 metastatic model. While additional works are needed to elucidate the biological significance and molecular mechanisms of these altered proteins identified in this study, PKM2 and cofilin-1 may serve as potential diagnostic and prognostic biomarkers, as well as therapeutic targets for pulmonary adenocarcinoma.	[Peng, Xing-chen; Gong, Feng-ming; Zhao, Yu-wei; Lin, Hong-jun; Li, Zhi-yong; Tang, Ming-hai; Tong, Ai-ping] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Peng, Xing-chen; Gong, Feng-ming; Zhao, Yu-wei; Lin, Hong-jun; Li, Zhi-yong; Tang, Ming-hai; Tong, Ai-ping] Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Zhou, Liang-xue] Sichuan Univ, Dept Neurosurg, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Xie, Ying-wei] Peoples Hosp Daxian Conuty, Dept Oncol, Dazhou, Sichuan, Peoples R China; [Liao, Hong-li] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Wenzhou Medical University	Peng, XC (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	aipingtong@gmail.com	Lin, Hongjun/G-8462-2011; Lin, Hongjun/R-7047-2019	Lin, Hongjun/0000-0003-1125-0681; Lin, Hongjun/0000-0002-0877-8189; Peng, Xingchen/0000-0001-7042-718X	National Natural Sciences Foundation of China [30900768]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Funding is gratefully acknowledged from the National Natural Sciences Foundation of China (30900768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bloomston M, 2006, CANCER RES, V66, P2592, DOI 10.1158/0008-5472.CAN-05-3659; Bonanno L, 2010, ANTICANCER RES, V30, P5121; Castro M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-86; Chen G, 1999, P NATL ACAD SCI USA, V96, P13537; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Eigenbrodt E, 1998, ANTICANCER RES, V18, P3267; Grills C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014635; Grubb RL, 2007, J UROLOGY, V177, P2074, DOI 10.1016/j.juro.2007.01.155; Guo WH, 2011, J CANCER RES CLIN, V137, P65, DOI 10.1007/s00432-010-0860-5; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; HORIO Y, 1993, CANCER RES, V53, P1; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kaura B, 2004, J OBSTET GYNAECOL RE, V30, P193, DOI 10.1111/j.1447-0756.2004.00187.x; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Lee EJ, 2006, EXP MOL MED, V38, P203, DOI 10.1038/emm.2006.25; LEONE A, 1993, ONCOGENE, V8, P2325; Lo WY, 2007, J PROTEOME RES, V6, P2143, DOI 10.1021/pr060551+; Maciel CM, 2005, J EXP THER ONCOL, V5, P31; Ogata Y, 2006, J PROTEOME RES, V5, P3318, DOI 10.1021/pr060344+; Ouatas T, 2003, J BIOENERG BIOMEMBR, V35, P73, DOI 10.1023/A:1023497924277; Palmieri D, 2006, J BIOENERG BIOMEMBR, V38, P151, DOI 10.1007/s10863-006-9039-9; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Peng XC, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-46; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Qu SM, 2008, CLIN CANCER RES, V14, P4787, DOI 10.1158/1078-0432.CCR-08-0083; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Schneider J, 2002, ANTICANCER RES, V22, P311; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; TANAKA T, 1967, J BIOCHEM-TOKYO, V62, P71, DOI 10.1093/oxfordjournals.jbchem.a128639; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Vimalachandran D, 2004, EXPERT REV PROTEOMIC, V1, P493, DOI 10.1586/14789450.1.4.493; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Xu YL, 2010, HUM REPROD, V25, P2480, DOI 10.1093/humrep/deq197; Yao HX, 2009, LUNG CANCER, V65, P41, DOI 10.1016/j.lungcan.2008.10.024; Yap CT, 2005, CELL MOTIL CYTOSKEL, V60, P153, DOI 10.1002/cm.20053; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zhang B, 2004, WORLD J GASTROENTERO, V10, P1643, DOI 10.3748/wjg.v10.i11.1643; Zochbauer-Muller S, 2002, ONCOLOGIST, V7, P451, DOI 10.1634/theoncologist.7-5-451	47	58	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27309	10.1371/journal.pone.0027309	http://dx.doi.org/10.1371/journal.pone.0027309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087286	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700029
J	Maarouf, CL; Daugs, ID; Kokjohn, TA; Walker, DG; Hunter, JM; Kruchowsky, JC; Woltjer, R; Kaye, J; Castano, EM; Sabbagh, MN; Beach, TG; Roher, AE				Maarouf, Chera L.; Daugs, Ian D.; Kokjohn, Tyler A.; Walker, Douglas G.; Hunter, Jesse M.; Kruchowsky, Jane C.; Woltjer, Randy; Kaye, Jeffrey; Castano, Eduardo M.; Sabbagh, Marwan N.; Beach, Thomas G.; Roher, Alex E.			Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; ENDOTHELIAL GROWTH-FACTOR; INSULIN-DEGRADING ENZYME; AMYLOID PRECURSOR PROTEIN; CEREBRAL-BLOOD-FLOW; CEREBROSPINAL-FLUID S100B; FIBRILLARY ACIDIC PROTEIN; PAIRED HELICAL FILAMENTS; PIGMENT-EPITHELIUM; APOLIPOPROTEIN-E	The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is the prime instigator of neurotoxicity and dementia, specific protective mechanisms must enable these HPC to evade cognitive decline. We evaluated the neuropathological and biochemical differences existing between non-demented (ND)-HPC and an agematched cohort with AD dementia. The ND-HPC selected for our study were clinically assessed as ND and possessed high amyloid plaque burdens. ELISA and Western blot analyses were used to quantify a group of proteins related to APP/A beta/tau metabolism and other neurotrophic and inflammation-related molecules that have been found to be altered in neurodegenerative disorders and are pivotal to brain homeostasis and mental health. The molecules assumed to be critical in AD dementia, such as soluble or insoluble A beta 40, A beta 42 and tau were quantified by ELISA. Interestingly, only A beta 42 demonstrated a significant increase in ND-HPC when compared to the AD group. The vascular amyloid load which was not used in the selection of cases, was on the average almost 2-fold greater in AD than the ND-HPC, suggesting that a higher degree of microvascular dysfunction and perfusion compromise was present in the demented cohort. Neurofibrillary tangles were less frequent in the frontal cortices of ND-HPC. Biochemical findings included elevated vascular endothelial growth factor, apolipoprotein E and the neuroprotective factor S100B in ND-HPC, while anti-angiogenic pigment epithelium derived factor levels were lower. The lack of clear A beta-related pathological/biochemical demarcation between AD and ND-HPC suggests that in addition to amyloid plaques other factors, such as neurofibrillary tangle density and vascular integrity, must play important roles in cognitive failure.	[Maarouf, Chera L.; Daugs, Ian D.; Kokjohn, Tyler A.; Hunter, Jesse M.; Roher, Alex E.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA; [Kokjohn, Tyler A.] Midwestern Univ, Dept Microbiol, Glendale, AZ USA; [Walker, Douglas G.; Kruchowsky, Jane C.] Banner Sun Hlth Res Inst, Lab Neuroinflammat, Sun City, AZ USA; [Woltjer, Randy] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Kaye, Jeffrey] Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA; [Castano, Eduardo M.] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Sabbagh, Marwan N.] Banner Sun Hlth Res Inst, Cleo Roberts Ctr Clin Res, Sun City, AZ USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Midwestern University; Banner Research; Banner Health; Banner Sun Health Research Institute; Oregon Health & Science University; Oregon Health & Science University; Leloir Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute	Maarouf, CL (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA.	alex.roher@bannerhealth.com		Kaye, Jeffrey/0000-0002-9971-3478	National Institute on Aging [R01 AG019795, R21 AG035078, R21 AG034409]; National Institute on Aging (Arizona Alzheimer's Disease Core Center) [P30 AG19610]; Arizona Department of Health Services (Arizona Alzheimer's Research Center) [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING [R01AG019795, R21AG034409, R21AG035078, U19AG010483, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging (Arizona Alzheimer's Disease Core Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services (Arizona Alzheimer's Research Center); Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants R01 AG019795, R21 AG035078 (to AER) and R21 AG034409 (to DGW). The Brain Donation Program at Banner Sun Health Research Institute is supported by the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Abramson LP, 2003, J PEDIATR SURG, V38, P336, DOI 10.1053/jpsu.2003.50104; Akkawia NM, 2003, DEMENT GERIATR COGN, V16, P163, DOI 10.1159/000071005; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Belohlavek M, 2009, J ULTRAS MED, V28, P1493, DOI 10.7863/jum.2009.28.11.1493; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Caccamo A, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-51; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chader GJ, 2001, P NATL ACAD SCI USA, V98, P2122, DOI 10.1073/pnas.061024098; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Corrada MM, 2010, ANN NEUROL, V67, P114, DOI 10.1002/ana.21915; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-1151OC; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Duh EJ, 2004, AM J OPHTHALMOL, V137, P668, DOI 10.1016/j.ajo.2003.11.015; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Goux WJ, 1996, J NEUROCHEM, V67, P723; GOUX WJ, 1995, FEBS LETT, V366, P81, DOI 10.1016/0014-5793(95)00486-S; Grammas P, 2002, J ALZHEIMERS DIS, V4, P217, DOI 10.3233/JAD-2002-4311; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Hai J, 2003, NEUROSURGERY, V53, P963, DOI 10.1227/01.NEU.0000083594.10117.7A; Hampel H, 2010, EXP NEUROL, V223, P334, DOI 10.1016/j.expneurol.2009.09.024; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; HIXSON JE, 1990, J LIPID RES, V31, P545; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jefferson AL, 2007, J AM GERIATR SOC, V55, P1044, DOI 10.1111/j.1532-5415.2007.01226.x; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; JELLINGER KA, 1995, ACTA NEUROPATHOL, V89, P112, DOI 10.1007/BF00294269; Jin J, 2003, CORNEA, V22, P473, DOI 10.1097/00003226-200307000-00015; Josephs KA, 2008, ANN NEUROL, V63, P204, DOI 10.1002/ana.21223; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; Kalaria RN, 2002, CEREBROVASC DIS, V13, P48, DOI 10.1159/000049150; Kalback W, 2004, NEUROL RES, V26, P525, DOI 10.1179/016164104225017668; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kawas Claudia H., 2006, Current Alzheimer Research, V3, P411, DOI 10.2174/156720506779025233; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kinsella K., 2009, AGING WORLD 2008 INT; Kobayashi Mie, 2009, Brain and Nerve (Tokyo), V61, P972; Kobayashi S, 2008, J NEUROL SCI, V264, P27, DOI 10.1016/j.jns.2007.07.015; Korczyn AD, 2008, ALZHEIMERS DEMENT, V4, P176, DOI 10.1016/j.jalz.2007.11.008; Korolainen MA, 2005, NEUROBIOL DIS, V20, P858, DOI 10.1016/j.nbd.2005.05.021; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Llovera RE, 2008, J BIOL CHEM, V283, P17039, DOI 10.1074/jbc.M706316200; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Maarouf CL, 2009, CURR ALZHEIMER RES, V6, P399, DOI 10.2174/156720509788929318; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MASLIAH E, 1991, AM J PATHOL, V138, P235; Matsuda H, 2002, EUR J NUCL MED MOL I, V29, P1502, DOI 10.1007/s00259-002-0930-2; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morelli L, 2004, J BIOL CHEM, V279, P56004, DOI 10.1074/jbc.M407283200; Mori T., 2010, CARDIOVASC PSYCHIAT; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Mulugeta E, 2008, DEMENT GERIATR COGN, V25, P278, DOI 10.1159/000118633; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nishimura T, 2007, ANN NUCL MED, V21, P15, DOI 10.1007/BF03033995; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Petzold A, 2003, NEUROSCI LETT, V336, P167, DOI 10.1016/S0304-3940(02)01257-0; Pinto S, 2011, HUM MUTAT, V32, pE1948, DOI 10.1002/humu.21393; Plassman Brenda L, 2006, Alzheimers Dement, V2, P2, DOI 10.1016/j.jalz.2005.11.001; POSTIGLIONE A, 1993, AGING-CLIN EXP RES, V5, P19, DOI 10.1007/BF03324122; Quigley H, 2011, INT J GERIATR PSYCH, V26, P991, DOI 10.1002/gps.2640; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P436, DOI 10.1016/j.jalz.2010.08.228; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rychli K, 2009, EXPERT OPIN THER TAR, V13, P1295, DOI 10.1517/14728220903241641; Sawant S, 2004, BIOCHEM BIOPH RES CO, V325, P408, DOI 10.1016/j.bbrc.2004.10.041; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Serbinek D, 2010, CARDIOVASC PSYCHIAT; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Silbert LC, 2003, NEUROLOGY, V61, P487, DOI 10.1212/01.WNL.0000079053.77227.14; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Spilt A, 2005, RADIOLOGY, V236, P990, DOI 10.1148/radiol.2363041454; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Streitparth F, 2008, RADIOLOGE, V48, P175, DOI 10.1007/s00117-006-1443-y; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Tanskanen M, 2005, NEUROPATH APPL NEURO, V31, P589, DOI 10.1111/j.1365-2990.2005.00652.x; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Gunten A, 2010, CURR GERONTOL GERIAT; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; Yamagishi S, 2004, MED HYPOTHESES, V63, P115, DOI 10.1016/j.mehy.2004.02.022; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54; [No title captured]	123	48	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27291	10.1371/journal.pone.0027291	http://dx.doi.org/10.1371/journal.pone.0027291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087282	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700035
J	Meissner, M; Herrema, H; van Dijk, TH; Gerding, A; Havinga, R; Boer, T; Muller, M; Reijngoud, DJ; Groen, AK; Kuipers, F				Meissner, Maxi; Herrema, Hilde; van Dijk, Theo H.; Gerding, Albert; Havinga, Rick; Boer, Theo; Mueller, Michael; Reijngoud, Dirk-Jan; Groen, Albert K.; Kuipers, Folkert			Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; TYPE-2 DIABETES-MELLITUS; PERIPHERAL INSULIN SENSITIVITY; COLESEVELAM HYDROCHLORIDE; NUCLEAR RECEPTOR; GLYCEMIC CONTROL; CARBOHYDRATE-METABOLISM; DOUBLE-BLIND; FATTY-ACIDS; OB/OB MICE	Aims/Hypothesis: Bile acid sequestrants (BAS) reduce plasma glucose levels in type II diabetics and in murine models of diabetes but the mechanism herein is unknown. We hypothesized that sequestrant-induced changes in hepatic glucose metabolism would underlie reduced plasma glucose levels. Therefore, in vivo glucose metabolism was assessed in db/db mice on and off BAS using tracer methodology. Methods: Lean and diabetic db/db mice were treated with 2% (wt/wt in diet) Colesevelam HCl (BAS) for 2 weeks. Parameters of in vivo glucose metabolism were assessed by infusing [U-C-13]- glucose, [2-C-13]- glycerol, [1-H-2]- galactose and paracetamol for 6 hours, followed by mass isotopologue distribution analysis, and related to metabolic parameters as well as gene expression patterns. Results: Compared to lean mice, db/db mice displayed an almost 3-fold lower metabolic clearance rate of glucose (p = 0.0001), a similar to 300% increased glucokinase flux (p = 0.001) and a similar to 200% increased total hepatic glucose production rate (p = 0.0002). BAS treatment increased glucose metabolic clearance rate by similar to 37% but had no effects on glucokinase flux nor total hepatic or endogenous glucose production. Strikingly, BAS-treated db/db mice displayed reduced long-chain acylcarnitine content in skeletal muscle (p = 0.0317) but not in liver (p = 0.189). Unexpectedly, BAS treatment increased hepatic FGF21 mRNA expression 2-fold in lean mice (p = 0.030) and 3-fold in db/db mice (p = 0.002). Conclusions/Interpretation: BAS induced plasma glucose lowering in db/db mice by increasing metabolic clearance rate of glucose in peripheral tissues, which coincided with decreased skeletal muscle long-chain acylcarnitine content.	[Meissner, Maxi; Herrema, Hilde; Havinga, Rick; Groen, Albert K.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [van Dijk, Theo H.; Gerding, Albert; Boer, Theo; Reijngoud, Dirk-Jan; Groen, Albert K.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [Herrema, Hilde; Mueller, Michael] Nutrigen Consortium TI Food & Nutr, Wageningen, Netherlands; [Herrema, Hilde; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands	University of Groningen; University of Groningen; Top Institute Food & Nutrition; Wageningen University & Research	Meissner, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.	meissner.maxi@gmail.com	Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Kuipers, Folkert/0000-0003-2518-737X; Meissner, Maxi/0000-0001-9422-4141; Herrema, Hilde/0000-0002-0112-6348; Reijngoud, Dirk-Jan/0000-0003-1157-4491	Groningen Expert Center for Kids with Obesity (GECKO); DaiichiSankyo (Pirsipanny, NJ)	Groningen Expert Center for Kids with Obesity (GECKO); DaiichiSankyo (Pirsipanny, NJ)	This study was funded by an unrestricted research grant of the Groningen Expert Center for Kids with Obesity (GECKO) and DaiichiSankyo (Pirsipanny, NJ). Neither GECKO nor DaiichiSankyo took part in the data collection nor the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Bays HE, 2008, ARCH INTERN MED, V168, P1975, DOI 10.1001/archinte.168.18.1975; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; Cariou B, 2005, ENDOCRINOLOGY, V146, P981, DOI 10.1210/en.2004-1595; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chace DH, 2001, CLIN CHEM, V47, P1166; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Claudel T, 2002, J CLIN INVEST, V109, P961; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Davidson MH, 2007, EXPERT OPIN PHARMACO, V8, P2569, DOI 10.1517/14656566.8.15.2569; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Donovan JM, 2005, DIGEST DIS SCI, V50, P1232, DOI 10.1007/s10620-005-2765-8; Duran-Sandoval D, 2005, BIOCHIMIE, V87, P93, DOI 10.1016/j.biochi.2004.11.018; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Fonseca VA, 2008, DIABETES CARE, V31, P1479, DOI 10.2337/dc08-0283; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Freeman Jeffrey S, 2009, Cleve Clin J Med, V76 Suppl 5, pS12, DOI 10.3949/ccjm.76.s5.03; GARG A, 1994, ANN INTERN MED, V121, P416, DOI 10.7326/0003-4819-121-6-199409150-00004; GATES SC, 1978, CLIN CHEM, V24, P1663; Goldberg RB, 2008, ARCH INTERN MED, V168, P1531, DOI 10.1001/archinte.168.14.1531; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; Herrema H, 2009, HEPATOLOGY; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lefebvre P., 2009, PHYSIOL REV, P147; Matsuzaki Y, 2002, J GASTROEN HEPATOL, V17, P1133, DOI 10.1046/j.1440-1746.2002.02860.x; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Onishi T, 2002, J GASTROEN HEPATOL, V17, P697, DOI 10.1046/j.1440-1746.2002.02765.x; Phielix E, 2008, PHYSIOL BEHAV, V94, P252, DOI 10.1016/j.physbeh.2008.01.020; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; SHAFRIR E, 1992, DIABETES METAB REV, V8, P179, DOI 10.1002/dmr.5610080302; Shang Q, 2010, AM J PHYSIOL-GASTR L, V298, pG419, DOI 10.1152/ajpgi.00362.2009; Stayrook KR, 2005, ENDOCRINOLOGY, V146, P984, DOI 10.1210/en.2004-0965; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zieve FJ, 2007, CLIN THER, V29, P74, DOI 10.1016/j.clinthera.2007.01.003	52	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e24564	10.1371/journal.pone.0024564	http://dx.doi.org/10.1371/journal.pone.0024564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087215	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700001
J	Yokoyama, T; Tam, J; Kuroda, S; Scott, AW; Aaron, J; Larson, T; Shanker, M; Correa, AM; Kondo, S; Roth, JA; Sokolov, K; Ramesh, R				Yokoyama, Tomohisa; Tam, Justina; Kuroda, Shinji; Scott, Ailing W.; Aaron, Jesse; Larson, Tim; Shanker, Manish; Correa, Arlene M.; Kondo, Seiji; Roth, Jack A.; Sokolov, Konstantin; Ramesh, Rajagopal			EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONITORING AUTOPHAGY; QUANTUM DOTS; THERAPY; ANTIBODIES; LC3; MUTATIONS; CETUXIMAB; DELIVERY; LIGAND	Background: The epidermal growth factor receptor (EGFR) is overexpressed in 80% of non-small cell lung cancer (NSCLC) and is associated with poor survival. In recent years, EGFR-targeted inhibitors have been tested in the clinic for NSCLC. Despite the emergence of novel therapeutics and their application in cancer therapy, the overall survival rate of lung cancer patients remains 15%. To develop more effective therapies for lung cancer we have combined the anti-EGFR antibody (Clone 225) as a molecular therapeutic with hybrid plasmonic magnetic nanoparticles (NP) and tested on non-small cell lung cancer (NSCLC) cells. Methodology/Principal Findings: Cell viability was determined by trypan-blue assay. Cellular protein expression was determined by Western blotting. C225-NPs were detected by electron microscopy and confocal microscopy, and EGFR expression using immunocytochemistry. C225-NP exhibited a strong and selective antitumor effect on EGFR-expressing NSCLC cells by inhibiting EGFR-mediated signal transduction and induced autophagy and apoptosis in tumor cells. Optical images showed specificity of interactions between C225-NP and EGFR-expressing NSCLC cells. No binding of C225-NP was observed for EGFR-null NSCLC cells. C225-NP exhibited higher efficiency in induction of cell killing in comparison with the same amount of free C225 antibody in tumor cells with different levels of EGFR expression. Furthermore, in contrast to C225-NP, free C225 antibody did not induce autophagy in cells. However, the therapeutic efficacy of C225-NP gradually approached the level of free antibodies as the amount of C225 antibody conjugated per nanoparticle was decreased. Finally, attaching C225 to NP was important for producing the enhanced tumor cell killing as addition of mixture of free C225 and NP did not demonstrate the same degree of cell killing activity. Conclusions/Significance: We demonstrated for the first time the molecular mechanism of C225-NP induced cytotoxic effects in lung cancer cells that are not characteristic for free molecular therapeutics thus increasing efficacy of therapy against NSCLC.	[Yokoyama, Tomohisa; Kuroda, Shinji; Scott, Ailing W.; Shanker, Manish; Correa, Arlene M.; Roth, Jack A.; Ramesh, Rajagopal] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Tam, Justina; Aaron, Jesse; Larson, Tim; Sokolov, Konstantin] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Kondo, Seiji] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Sokolov, Konstantin] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Grad Program Biomed Sci, Oklahoma City, OK USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Yokoyama, T (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	kostia@mail.utexas.edu; rajagopal-ramesh@ouhsc.edu		Sokolov, Konstantin/0000-0002-0198-2005	National Cancer Institute [R01CA103830, RO3EB009182, P50CA070907, CA16672]; Joans Legacy: United against Lung Cancer; NATIONAL CANCER INSTITUTE [R01CA103830, P50CA070907, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB009182] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joans Legacy: United against Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by the National Cancer Institute grants R01CA103830, RO3EB009182, P50CA070907 (SPORE in Lung Cancer), CA16672, and The Joans Legacy: United against Lung Cancer. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaron J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2737351; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Baker CH, 2002, AM J PATHOL, V161, P929, DOI 10.1016/S0002-9440(10)64253-8; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DeGrendele Heather, 2003, Clin Lung Cancer, V5, P83; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; GOOI HC, 1985, BIOSCIENCE REP, V5, P83; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Jablonski AE, 2010, J PHYS CHEM LETT, V1, P1312, DOI 10.1021/jz100248c; Ji XJ, 2007, J PHYS CHEM C, V111, P6245, DOI 10.1021/jp0702245; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kumar S, 2008, NAT PROTOC, V3, P314, DOI 10.1038/nprot.2008.1; Larabell CA, 2010, CURR OPIN STRUC BIOL, V20, P623, DOI 10.1016/j.sbi.2010.08.008; Larson TA, 2007, NANOTECHNOLOGY, V18, P325; Lyon JL, 2004, NANO LETT, V4, P719, DOI 10.1021/nl035253f; Ma LL, 2011, LANGMUIR, V27, P7681, DOI 10.1021/la200659z; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Milas L, 2004, INT J RADIAT ONCOL, V58, P966, DOI 10.1016/j.ijrobp.2003.08.035; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Poon Z, 2010, ANGEW CHEM INT EDIT, V49, P7266, DOI 10.1002/anie.201003445; Ramesh R, 2003, CANCER RES, V63, P5105; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Sokolov K, 2003, CANCER RES, V63, P1999; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; VEALE D, 1989, CANCER RES, V49, P1313; Wang AZ, 2008, CHEMMEDCHEM, V3, P1311, DOI 10.1002/cmdc.200800091; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941	39	79	81	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e25507	10.1371/journal.pone.0025507	http://dx.doi.org/10.1371/journal.pone.0025507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087216	Green Submitted, gold, Green Published			2022-12-27	WOS:000297347700002
J	Dalton, T; Dowd, SE; Wolcott, RD; Sun, Y; Watters, C; Griswold, JA; Rumbaugh, KP				Dalton, Trevor; Dowd, Scot E.; Wolcott, Randall D.; Sun, Yan; Watters, Chase; Griswold, John A.; Rumbaugh, Kendra P.			An In Vivo Polymicrobial Biofilm Wound Infection Model to Study Interspecies Interactions	PLOS ONE			English	Article							AERUGINOSA SWARMING MOTILITY; DIABETIC FOOT ULCER; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-MUTANS; MULTISPECIES BIOFILMS; TWITCHING MOTILITY; MOUSE MODEL; VIRULENCE; CELL; FLAGELLA	Chronic wound infections are typically polymicrobial; however, most in vivo studies have focused on monospecies infections. This project was designed to develop an in vivo, polymicrobial, biofilm-related, infected wound model in order to study multispecies biofilm dynamics and in relation to wound chronicity. Multispecies biofilms consisting of both Gram negative and Gram positive strains, as well as aerobes and anaerobes, were grown in vitro and then transplanted onto the wounds of mice. These in vitro-to-in vivo multi-species biofilm transplants generated polymicrobial wound infections, which remained heterogeneous with four bacterial species throughout the experiment. We observed that wounded mice given multispecies biofilm infections displayed a wound healing impairment over mice infected with a single-species of bacteria. In addition, the bacteria in the polymicrobial wound infections displayed increased antimicrobial tolerance in comparison to those in single species infections. These data suggest that synergistic interactions between different bacterial species in wounds may contribute to healing delays and/or antibiotic tolerance.	[Dalton, Trevor; Watters, Chase; Griswold, John A.; Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Dalton, Trevor; Watters, Chase; Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Lubbock, TX 79430 USA; [Dowd, Scot E.; Wolcott, Randall D.; Sun, Yan] Res & Testing Lab, Lubbock, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Dalton, T (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA.	kendra.rumbaugh@ttuhsc.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Griswold, John/0000-0002-0578-0646	American Diabetes Association [1-08-RA-165]	American Diabetes Association(American Diabetes Association)	This study was supported by American Diabetes Association research grant #1-08-RA-165 to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Burn Association, BURN INC TREATM US 2; American Diabetes Association, DAT 2011 NAT DIAB FA; BJORNSON HS, 1982, SURGERY, V92, P720; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; BROOK I, 1985, INFECT IMMUN, V50, P929, DOI 10.1128/IAI.50.3.929-931.1985; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; [Center for Disease Control Center U.S. Department of Health and Human Services Centers for Disease Control and Prevention], 2002, NAT EST GEN INF DIAB; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Cunningham AB, 2006, BIOFILMS HYPERTEXTBO; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gurjala AN, 2010, ADV WOUND CARE-SER, V1, P305, DOI 10.1089/awc.2009.0094; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hendricks KJ, 2001, J BONE JOINT SURG AM, V83A, P855, DOI 10.2106/00004623-200106000-00006; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Huelves L, 2007, MICROB PATHOGENESIS, V43, P114, DOI 10.1016/j.micpath.2007.05.005; INGHAM HR, 1977, LANCET, V2, P1252; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Mastropaolo MD, 2005, INFECT IMMUN, V73, P6055, DOI 10.1128/IAI.73.9.6055-6063.2005; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MERGENHAGEN SE, 1958, J INFECT DIS, V103, P33, DOI 10.1093/infdis/103.1.33; Nakagami G, 2008, WOUND REPAIR REGEN, V16, P30, DOI 10.1111/j.1524-475X.2007.00329.x; National Institute of General Medical Sciences, 2007, FACT SHEET TRAUM SHO; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Peyyala R, 2011, APPL ENVIRON MICROB, V77, P3413, DOI 10.1128/AEM.00039-11; Potokar TS, 2008, BURNS, V34, P3, DOI 10.1016/j.burns.2007.09.004; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8; Rickard AH, 2010, J APPL MICROBIOL, V108, P1509, DOI 10.1111/j.1365-2672.2009.04554.x; Rumbaugh K.P., 2010, BIOFILM INFECT; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Schaber JA, 2007, INFECT IMMUN, V75, P3715, DOI 10.1128/IAI.00586-07; Shinzato T, 1995, CLIN INFECT DIS, V21, pS238, DOI 10.1093/clind/21.Supplement_3.S238; Sun Y, 2009, J Wound Care, V18, P426; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Sun Y, 2010, INVEST OPHTH VIS SCI, V51, P1511, DOI 10.1167/iovs.09-4237; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Watters C, 2010, PSEUDOMONAS AERUGINO; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Wolcott RD, 2010, J WOUND CARE, V19, P320, DOI 10.12968/jowc.2010.19.8.77709; Xie Q, 2008, ORAL MICROBIOL IMMUN, V23, P459, DOI 10.1111/j.1399-302X.2008.00450.x; Zolfaghar I, 2003, INFECT IMMUN, V71, P5389, DOI 10.1128/IAI.71.9.5389-5393.2003	56	218	223	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27317	10.1371/journal.pone.0027317	http://dx.doi.org/10.1371/journal.pone.0027317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076151	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200065
J	Kirkby, JA; Blythe, HI; Drieghe, D; Liversedge, SP				Kirkby, Julie A.; Blythe, Hazel I.; Drieghe, Denis; Liversedge, Simon P.			Reading Text Increases Binocular Disparity in Dyslexic Children	PLOS ONE			English	Article							VERGENCE EYE-MOVEMENTS; MONOCULAR OCCLUSION; COORDINATION; PERCEPTION	Children with developmental dyslexia show reading impairment compared to their peers, despite being matched on IQ, socio-economic background, and educational opportunities. The neurological and cognitive basis of dyslexia remains a highly debated topic. Proponents of the magnocellular theory, which postulates abnormalities in the M-stream of the visual pathway cause developmental dyslexia, claim that children with dyslexia have deficient binocular coordination, and this is the underlying cause of developmental dyslexia. We measured binocular coordination during reading and a non-linguistic scanning task in three participant groups: adults, typically developing children, and children with dyslexia. A significant increase in fixation disparity was observed for dyslexic children solely when reading. Our study casts serious doubts on the claims of the magnocellular theory. The exclusivity of increased fixation disparity in dyslexics during reading might be a result of the allocation of inadequate attentional and/or cognitive resources to the reading process, or suboptimal linguistic processing per se.	[Kirkby, Julie A.] Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England; [Blythe, Hazel I.; Drieghe, Denis; Liversedge, Simon P.] Univ Southampton, Sch Psychol, Southampton, Hants, England	Bournemouth University; University of Southampton	Kirkby, JA (corresponding author), Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England.	jkirkby@bournemouth.ac.uk		Drieghe, Denis/0000-0001-9630-8410; Kirkby, Julie/0000-0001-6502-0676	Leverhulme Trust [F/00 180/W]; Economic and Social Research Council; Biotechnology and Biological Sciences Research Council [519168]; Economic and Social Research Council [RES-000-22-3398]	Leverhulme Trust(Leverhulme Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	J.A.K. was supported by the Leverhulme Trust. H.I.B. was supported by an Economic and Social Research Council Postdoctoral Fellowship. S.P.L. was supported by Biotechnology and Biological Sciences Research Council grant (519168), Economic and Social Research Council grant (RES-000-22-3398) and Leverhulme Trust grant (F/00 180/W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Boden C, 2007, PSYCHOL BULL, V133, P346, DOI 10.1037/0033-2909.133.2.346; BURT P, 1980, SCIENCE, V208, P615, DOI 10.1126/science.7367885; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; CORNELISSEN P, 1992, DEV MED CHILD NEUROL, V34, P296; Erkelens CJ, 2001, VISION RES, V41, P3497, DOI 10.1016/S0042-6989(01)00004-9; FENDER D, 1967, J OPT SOC AM, V57, P819, DOI 10.1364/JOSA.57.000819; GALABURDA AM, 1993, CURR OPIN NEUROBIOL, V3, P237, DOI 10.1016/0959-4388(93)90216-L; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; GALABURDA AM, 1993, NEUROL CLIN, V11, P161, DOI 10.1016/S0733-8619(18)30175-0; Heller D, 1999, CURRENT OCULOMOTOR RESEARCH, P341; Hendriks AW, 1996, ACTA PSYCHOL, V92, P131, DOI 10.1016/0001-6918(95)00011-9; Jainta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018694; Jaschinski W, 2004, KLIN MONATSBL AUGENH, V221, P854, DOI 10.1055/s-2004-813712; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; Ramus F, 2001, Dyslexia, V7, P197, DOI 10.1002/dys.205; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Rayner K, 2009, PERCEPTION, V38, P895, DOI 10.1068/ldmk-ray; Sheliga BM, 2006, VISION RES, V46, P3723, DOI 10.1016/j.visres.2006.04.020; Snowling M., 2000, DYSLEXIA; Snowling M.J., 1995, J RES READ, V18, P132, DOI DOI 10.1111/J.1467-9817.1995.TB00079.X; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; STEIN J, 1985, LANCET, V2, P69; Stein JF, 2000, BRAIN, V123, P164, DOI 10.1093/brain/123.1.164; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; Wechsler D., 2009, WECHSLER INDIVIDUAL, V3rd; Wechsler D., 2011, WASI 2 WECHSLER ABBR	34	39	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27105	10.1371/journal.pone.0027105	http://dx.doi.org/10.1371/journal.pone.0027105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073266	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200034
J	Sborgi, L; Verma, A; Munoz, V; de Alba, E				Sborgi, Lorenzo; Verma, Abhinav; Munoz, Victor; de Alba, Eva			Revisiting the NMR Structure of the Ultrafast Downhill Folding Protein gpW from Bacteriophage lambda	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SIMULATIONS; FIELD	GpW is a 68-residue protein from bacteriophage lambda that participates in virus head morphogenesis. Previous NMR studies revealed a novel alpha+beta fold for this protein. Recent experiments have shown that gpW folds in microseconds by crossing a marginal free energy barrier (i.e., downhill folding). These features make gpW a highly desirable target for further experimental and computational folding studies. As a step in that direction, we have re-determined the high-resolution structure of gpW by multidimensional NMR on a construct that eliminates the purification tags and unstructured C-terminal tail present in the prior study. In contrast to the previous work, we have obtained a full manual assignment and calculated the structure using only unambiguous distance restraints. This new structure confirms the alpha+beta topology, but reveals important differences in tertiary packing. Namely, the two alpha-helices are rotated along their main axis to form a leucine zipper. The beta-hairpin is orthogonal to the helical interface rather than parallel, displaying most tertiary contacts through strand 1. There also are differences in secondary structure: longer and less curved helices and a hairpin that now shows the typical right-hand twist. Molecular dynamics simulations starting from both gpW structures, and calculations with CS-Rosetta, all converge to our gpW structure. This confirms that the original structure has strange tertiary packing and strained secondary structure. A comparison of NMR datasets suggests that the problems were mainly caused by incomplete chemical shift assignments, mistakes in NOE assignment and the inclusion of ambiguous distance restraints during the automated procedure used in the original study. The new gpW corrects these problems, providing the appropriate structural reference for future work. Furthermore, our results are a cautionary tale against the inclusion of ambiguous experimental information in the determination of protein structures.	[Sborgi, Lorenzo; Verma, Abhinav; Munoz, Victor; de Alba, Eva] Consejo Super Invest Cient, Ctr Invest Biol, Madrid, Spain; [Munoz, Victor] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University System of Maryland; University of Maryland College Park	Sborgi, L (corresponding author), Consejo Super Invest Cient, Ctr Invest Biol, Madrid, Spain.	vmunoz@cib.csic.es; dealbae@cib.csic.es			Spanish Ministry of Science and Innovation [BFU2008-03278, BFU2008-03237, CSD2009-00088]; Marie Curie Excellence Award [MEXT-CT-2006-04233]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie Excellence Award(European Commission)	This work was supported by the grants BFU2008-03278 (to E.d.A.), BFU2008-03237 (to V.M.) and Consolider-Ingenio 2010 program grant CSD2009-00088 (to V.M. and E.d.A.) from the Spanish Ministry of Science and Innovation, and from Marie Curie Excellence Award MEXT-CT-2006-04233 (to V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bruscolini P, 2011, J AM CHEM SOC, V133, P5372, DOI 10.1021/ja110884m; Cavanagh J., PROTEIN NMR SPECTROS; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Sancho D, 2008, J COMPUT CHEM, V29, P1684, DOI 10.1002/jcc.20924; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; *DELANO SCI LLC, 2004, PYMOL MOL GRAPH SYST; Fung A, 2008, J AM CHEM SOC, V130, P7489, DOI 10.1021/ja801401a; GARRETT DS, 1991, J MAGN RESON, V95, P216; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maxwell KL, 2001, J MOL BIOL, V308, P9, DOI 10.1006/jmbi.2001.4582; Maxwell KL, 2000, J BIOL CHEM, V275, P18879, DOI 10.1074/jbc.M001178200; Moseley HNB, 1999, CURR OPIN STRUC BIOL, V9, P635, DOI 10.1016/S0959-440X(99)00019-6; Munoz V, 2008, HFSP J, V2, P342, DOI 10.2976/1.2988030; Murialdo H, 2003, BIOCHEM CELL BIOL, V81, P307, DOI 10.1139/O03-059; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273	25	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26409	10.1371/journal.pone.0026409	http://dx.doi.org/10.1371/journal.pone.0026409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22087227	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200010
J	Subiaul, F; Vonk, J; Rutherford, MD				Subiaul, Francys; Vonk, Jennifer; Rutherford, M. D.			The Ghosts in the Computer: The Role of Agency and Animacy Attributions in "Ghost Controls"	PLOS ONE			English	Article							GOAL-DIRECTED ACTIONS; COGNITIVE IMITATION; INFANTS PERCEPTION; CHILDREN; EMULATION; OTHERS; REENACTMENT; CHIMPANZEES; MECHANISMS; JUDGMENTS	Three studies evaluated the role of 4-year-old children's agency- and animacy-attributions when learning from a computerized ghost control (GC). In GCs, participants observe events occurring without an apparent agent, as if executed by a "ghost" or unobserved causal forces. Using a touch-screen, children in Experiment 1 responded to three pictures in a specific order under three learning conditions: (i) trial-and-error (Baseline), (ii) imitation and (iii) Ghost Control. Before testing in the GC, children were read one of three scripts that determined agency attributions. Post-test assessments confirmed that all children attributed agency to the computer and learned in all GCs. In Experiment 2, children were not trained on the computer prior to testing, and no scripts were used. Three different GCs, varying in number of agency cues, were used. Children failed to learn in these GCs, yet attributed agency and animacy to the computer. Experiment 3 evaluated whether children could learn from a human model in the absence of training under conditions where the information presented by the model and the computer was either consistent or inconsistent. Children evidenced learning in both of these conditions. Overall, learning in social conditions (Exp. 3) was significantly better than learning in GCs (Exp. 2). These results, together with other published research, suggest that children privilege social over non-social sources of information and are generally more adept at learning novel tasks from a human than from a computer or GC.	[Subiaul, Francys] George Washington Univ, Dept Speech & Hearing Sci, Washington, DC 20052 USA; [Vonk, Jennifer] Oakland Univ, Dept Psychol, Rochester, MI 48063 USA; [Rutherford, M. D.] McMaster Univ, Hamilton, ON, Canada	George Washington University; Oakland University; McMaster University	Subiaul, F (corresponding author), George Washington Univ, Dept Speech & Hearing Sci, Washington, DC 20052 USA.	Subiaul@gwu.edu	Vonk, Jennifer/ABB-5385-2021; Vonk, Jennifer/AAB-7316-2020	Vonk, Jennifer/0000-0002-4362-5989; SUBIAUL, FRANCYS/0000-0002-5873-9524	J. S. McDonnell Foundation; Centennial Fellowship; NSF [BCS-0748717, BCS-0946376]	J. S. McDonnell Foundation; Centennial Fellowship; NSF(National Science Foundation (NSF))	This research was supported in part by a J. S. McDonnell Foundation Research Award to H. Terrace, J. Metcalfe and F. Subiaul, and a Centennial Fellowship to Daniel J. Povinelli as well as an NSF CAREER (BCS-0748717) and EAGER (BCS-0946376) award to F. Subiaul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilock SL, 2007, PSYCHOL SCI, V18, P51, DOI 10.1111/j.1467-9280.2007.01848.x; Biro S, 2007, PROG BRAIN RES, V164, P303, DOI 10.1016/S0079-6123(07)64017-5; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Call J, 2002, FROM ANIM ANIMAT, P211; Carey S., 1985, CONCEPTUAL CHANGE CH; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Carpenter M, 2002, DEVELOPMENTAL SCI, V5, P22, DOI 10.1111/1467-7687.00199; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Heyes C, 2003, PSYCHOL REV, V110, P713, DOI 10.1037/0033-295X.110.4.713; Hopper LM, 2010, BIOL REV CAMB PHILOS; Hopper LM, 2010, J EXPT CHILD PSYCHOL; Hopper LM, 2008, P ROY SOC B-BIOL SCI, V275, P835, DOI 10.1098/rspb.2007.1542; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Huang CT, 2005, J EXP CHILD PSYCHOL, V92, P276, DOI 10.1016/j.jecp.2005.06.003; Huang CT, 2002, DEV PSYCHOL, V38, P840, DOI 10.1037//0012-1649.38.5.840; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Kushnir T, 2005, PSYCHOL SCI, V16, P678, DOI 10.1111/j.1467-9280.2005.01595.x; Laland KN, 2004, LEARN BEHAV, V32, P4; Lyons Derek E., 2009, P77, DOI 10.1007/978-1-59745-479-7_4; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Piaget Jean, 1929, CHILDS CONCEPTION WO; PREMACK D, 1990, COGNITION, V36, P1, DOI 10.1016/0010-0277(90)90051-K; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schulz LE, 2007, DEVELOPMENTAL SCI, V10, P322, DOI 10.1111/j.1467-7687.2007.00587.x; Schulz LE, 2004, DEV PSYCHOL, V40, P162, DOI 10.1037/0012-1649.40.2.162; Sobel DM, 2009, DEV PSYCHOL, V45, P511, DOI 10.1037/a0014944; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; Sommerville JA, 2005, COGNITION, V95, P1, DOI 10.1016/j.cognition.2003.12.004; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Subiaul F, 2006, PLOS ONE; Subiaul F, 2007, ANIM COGN, V10, P369, DOI 10.1007/s10071-006-0070-3; Subiaul F, 2007, COGNITIVE DEV, V22, P230, DOI 10.1016/j.cogdev.2006.10.003; Subiaul F, 2010, BEHAV PROCESS, V83, P222, DOI 10.1016/j.beproc.2009.12.002; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Tennie C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010544; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Thompson DE, 2004, DEV PSYCHOL, V40, P882, DOI 10.1037/0012-1649.40.5.882; Tomasello M, 1997, PRIMATE COGNITION, pix; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Vonk J, 2009, ANIM COGN, V12, P267, DOI 10.1007/s10071-008-0189-5; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Williamson RA, 2008, DEV PSYCHOL, V44, P275, DOI 10.1037/0012-1649.44.1.275; Williamson RA, 2006, DEV PSYCHOL, V42, P723, DOI 10.1037/0012-1649.42.4.723; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Yang SJ, 2009, J EXP PSYCHOL LEARN, V35, P1359, DOI 10.1037/a0016547; Zentall TR, 2006, ANIM COGN, V9, P335, DOI 10.1007/s10071-006-0039-2	56	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26429	10.1371/journal.pone.0026429	http://dx.doi.org/10.1371/journal.pone.0026429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073165	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200012
J	Eiserhardt, WL; Bjorholm, S; Svenning, JC; Rangel, TF; Balslev, H				Eiserhardt, Wolf L.; Bjorholm, Stine; Svenning, Jens-Christian; Rangel, Thiago F.; Balslev, Henrik			Testing the Water-Energy Theory on American Palms (Arecaceae) Using Geographically Weighted Regression	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; LATITUDINAL GRADIENT; DIVERSITY PATTERNS; GLOBAL PATTERNS; SCALE VARIATION; CLIMATE; DETERMINANTS; PTERIDOPHYTE; EXPLANATION; ECOLOGY	Water and energy have emerged as the best contemporary environmental correlates of broad-scale species richness patterns. A corollary hypothesis of water-energy dynamics theory is that the influence of water decreases and the influence of energy increases with absolute latitude. We report the first use of geographically weighted regression for testing this hypothesis on a continuous species richness gradient that is entirely located within the tropics and subtropics. The dataset was divided into northern and southern hemispheric portions to test whether predictor shifts are more pronounced in the less oceanic northern hemisphere. American palms (Arecaceae, n = 547 spp.), whose species richness and distributions are known to respond strongly to water and energy, were used as a model group. The ability of water and energy to explain palm species richness was quantified locally at different spatial scales and regressed on latitude. Clear latitudinal trends in agreement with water-energy dynamics theory were found, but the results did not differ qualitatively between hemispheres. Strong inherent spatial autocorrelation in local modeling results and collinearity of water and energy variables were identified as important methodological challenges. We overcame these problems by using simultaneous autoregressive models and variation partitioning. Our results show that the ability of water and energy to explain species richness changes not only across large climatic gradients spanning tropical to temperate or arctic zones but also within megathermal climates, at least for strictly tropical taxa such as palms. This finding suggests that the predictor shifts are related to gradual latitudinal changes in ambient energy (related to solar flux input) rather than to abrupt transitions at specific latitudes, such as the occurrence of frost.	[Eiserhardt, Wolf L.; Bjorholm, Stine; Svenning, Jens-Christian; Balslev, Henrik] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, Aarhus, Denmark; [Rangel, Thiago F.] Univ Fed Goias, ICB, Dept Ecol, Goiania, Go, Brazil	Aarhus University; Universidade Federal de Goias	Eiserhardt, WL (corresponding author), Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, Aarhus, Denmark.	henrik.balslev@biology.au.dk	Balslev, Henrik/J-9191-2013; Rangel, Thiago F/H-8708-2012; Svenning, Jens-Christian/C-8977-2012; Balslev, Hendrik/AAE-4071-2020; Eiserhardt, Wolf L./D-7677-2011	Balslev, Henrik/0000-0002-7101-7120; Rangel, Thiago F/0000-0002-2001-7382; Svenning, Jens-Christian/0000-0002-3415-0862; Eiserhardt, Wolf L./0000-0002-8136-5233	Danish Council for Independent Research - Natural Sciences [272-07-0242, 10-083348]; European Community [212631]; faculty of Natural Sciences at the University of Aarhus	Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); European Community(European Commission); faculty of Natural Sciences at the University of Aarhus	This work was supported by the Danish Council for Independent Research - Natural Sciences (grant# 272-07-0242 to JCS, #10-083348 to HB) and the European Community (FP7 grant #212631 to HB). The faculty of Natural Sciences at the University of Aarhus supported SB's PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; [Anonymous], 2010, R LANG ENV STAT COMP; Balslev H, 2011, BOT REV IN PRESS, DOI [10.1007/s12229-12011-19084-x, DOI 10.1007/S12229-12011-19084-X]; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Bickford SA, 2006, GLOBAL ECOL BIOGEOGR, V15, P588, DOI 10.1111/j.1466-8238.2006.00250.x; Bjorholm S, 2006, BOT J LINN SOC, V151, P113, DOI 10.1111/j.1095-8339.2006.00527.x; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brunsdon C, 2001, INT J CLIMATOL, V21, P455, DOI 10.1002/joc.614; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dransfield J., 2008, GENERA PALMARUM; Eiserhardt WL, 2011, ANN BOT IN PRESS; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Foody GM, 2005, GLOBAL ECOL BIOGEOGR, V14, P99, DOI 10.1111/j.1466-822X.2005.00142.x; Foody GM, 2004, GLOBAL ECOL BIOGEOGR, V13, P315, DOI 10.1111/j.1466-822X.2004.00097.x; Foody GM, 2003, REMOTE SENS ENVIRON, V88, P283, DOI 10.1016/j.rse.2003.08.004; Fotheringham A. S., 2002, GEOGRAPHICALLY WEIGH; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; HENDERSON A, 1995, FIELD GUIDE PALMS AM; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Jetz W, 2005, GLOBAL ECOL BIOGEOGR, V14, P97, DOI 10.1111/j.1466-822X.2004.00129.x; Keil P, 2008, INSECT CONSERV DIVER, V1, P142, DOI 10.1111/j.1752-4598.2008.00019.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2006, ECOGRAPHY, V29, P21, DOI 10.1111/j.2005.0906-7590.04203.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kreft H, 2010, ECOGRAPHY, V33, P408, DOI 10.1111/j.1600-0587.2010.06434.x; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lyons SK, 2002, ECOLOGY, V83, P47; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Salm Rodolfo, 2007, Acta Amaz., V37, P17, DOI 10.1590/S0044-59672007000100002; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Svenning JC, 2008, J BIOGEOGR, V35, P394, DOI 10.1111/j.1365-2699.2007.01841.x; Svenning JC, 2009, ECOGRAPHY, V32, P13, DOI 10.1111/j.1600-0587.2008.05732.x; Terribile LC, 2009, ACTA OECOL, V35, P163, DOI 10.1016/j.actao.2008.09.006; Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; [No title captured]; [No title captured]	56	27	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27027	10.1371/journal.pone.0027027	http://dx.doi.org/10.1371/journal.pone.0027027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073244	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000023
J	Fottrell, E; Kahn, K; Tollman, S; Byass, P				Fottrell, Edward; Kahn, Kathleen; Tollman, Stephen; Byass, Peter			Probabilistic Methods for Verbal Autopsy Interpretation: InterVA Robustness in Relation to Variations in A Priori Probabilities	PLOS ONE			English	Article							SOUTH-AFRICA; DEATH; TRANSITION; MORTALITY; MODEL	Background: InterVA is a probabilistic method for interpreting verbal autopsy (VA) data. It uses a priori approximations of probabilities relating to diseases and symptoms to calculate the probability of specific causes of death given reported symptoms recorded in a VA interview. The extent to which InterVA's ability to characterise a population's mortality composition might be sensitive to variations in these a priori probabilities was investigated. Methods: A priori InterVA probabilities were changed by 1, 2 or 3 steps on the logarithmic scale on which the original probabilities were based. These changes were made to a random selection of 25% and 50% of the original probabilities, giving six model variants. A random sample of 1,000 VAs from South Africa, were used as a basis for experimentation and were processed using the original InterVA model and 20 random instances of each of the six InterVA model variants. Rank order of cause of death and cause-specific mortality fractions (CSMFs) from the original InterVA model and the mean, maximum and minimum results from the 20 randomly modified InterVA models for each of the six variants were compared. Results: CSMFs were functionally similar between the original InterVA model and the models with modified a priori probabilities such that even the CSMFs based on the InterVA model with the greatest degree of variation in the a priori probabilities would not lead to substantially different public health conclusions. The rank order of causes were also similar between all versions of InterVA. Conclusion: InterVA is a robust model for interpreting VA data and even relatively large variations in a priori probabilities do not affect InterVA-derived results to a great degree. The original physician-derived a priori probabilities are likely to be sufficient for the global application of InterVA in settings without routine death certification.	[Fottrell, Edward; Kahn, Kathleen; Tollman, Stephen; Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, Umea, Sweden; [Fottrell, Edward] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London, England; [Kahn, Kathleen; Tollman, Stephen; Byass, Peter] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa	Umea University; University of London; University College London; University of Witwatersrand	Fottrell, E (corresponding author), Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, Umea, Sweden.	Edward.Fottrell@epiph.umu.se		Tollman, Stephen/0000-0003-0744-7588; Byass, Peter/0000-0001-5474-4361; Kahn, Kathleen/0000-0003-3339-3931; Fottrell, Edward/0000-0003-0518-7161	FAS; Swedish Council for Working Life and Social Research [2006-1512]; Wellcome Trust, UK; University of the Witwatersrand and Medical Research Council, South Africa;  [058893/Z/99/A];  [069683/Z/02/Z];  [085477/Z/08/Z]	FAS; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Wellcome Trust, UK(Wellcome Trust); University of the Witwatersrand and Medical Research Council, South Africa; ; ; 	This work was undertaken with support from FAS, the Swedish Council for Working Life and Social Research (grant 2006-1512) (www.fas.se). The Agincourt health and socio-demographic surveillance system, including conduct of verbal autopsies, is funded by The Wellcome Trust, UK (www.wellcome.ac.uk) (grant numbers 058893/Z/99/A, 069683/Z/02/Z and 085477/Z/08/Z) and the University of the Witwatersrand and Medical Research Council, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Byass P, 2003, SCAND J PUBLIC HEALT, V31, P32, DOI 10.1080/14034950310015086; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000325; Byass P, 2007, PLOS MED, V4, P1715, DOI 10.1371/journal.pmed.0040333; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1; Fottrell E, 2010, TROP MED INT HEALTH, V15, P1256, DOI 10.1111/j.1365-3156.2010.02601.x; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; King G, 2008, STAT SCI, V23, P78, DOI 10.1214/07-STS247; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327	15	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27200	10.1371/journal.pone.0027200	http://dx.doi.org/10.1371/journal.pone.0027200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073287	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000031
J	Biswas, S; Nyman, JS; Alvarez, J; Chakrabarti, A; Ayres, A; Sterling, J; Edwards, J; Rana, T; Johnson, R; Perrien, DS; Lonning, S; Shyr, Y; Matrisian, LM; Mundy, GR				Biswas, Swati; Nyman, Jeffry S.; Alvarez, JoAnn; Chakrabarti, Anwesa; Ayres, Austin; Sterling, Julie; Edwards, James; Rana, Tapasi; Johnson, Rachelle; Perrien, Daniel S.; Lonning, Scott; Shyr, Yu; Matrisian, Lynn M.; Mundy, Gregory R.			Anti-Transforming Growth Factor beta Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone	PLOS ONE			English	Article							I RECEPTOR KINASE; TGF-BETA; OSTEOCLAST DIFFERENTIATION; SKELETAL COMPLICATIONS; DOUBLE-BLIND; EXPRESSION; PAMIDRONATE; INHIBITION; CELLS; PTHRP	Breast cancer often metastasizes to bone causing osteolytic bone resorption which releases active TGF beta. Because TGF beta favors progression of breast cancer metastasis to bone, we hypothesized that treatment using anti-TGF beta antibody may reduce tumor burden and rescue tumor-associated bone loss in metastatic breast cancer. In this study we have tested the efficacy of an anti-TGF beta antibody 1D11 preventing breast cancer bone metastasis. We have used two preclinical breast cancer bone metastasis models, in which either human breast cancer cells or murine mammary tumor cells were injected in host mice via left cardiac ventricle. Using several in vivo, in vitro and ex vivo assays, we have demonstrated that anti-TGF beta antibody treatment have significantly reduced tumor burden in the bone along with a statistically significant threefold reduction in osteolytic lesion number and tenfold reduction in osteolytic lesion area. A decrease in osteoclast numbers (p = 0.027) in vivo and osteoclastogenesis ex vivo were also observed. Most importantly, in tumor-bearing mice, anti-TGF beta treatment resulted in a twofold increase in bone volume (p<0.01). In addition, treatment with anti-TGF beta antibody increased the mineral-to-collagen ratio in vivo, a reflection of improved tissue level properties. Moreover, anti-TGF beta antibody directly increased mineralized matrix formation in calverial osteoblast (p = 0.005), suggesting a direct beneficial role of anti-TGF beta antibody treatment on osteoblasts. Data presented here demonstrate that anti-TGF beta treatment may offer a novel therapeutic option for tumor-induced bone disease and has the dual potential for simultaneously decreasing tumor burden and rescue bone loss in breast cancer to bone metastases. This approach of intervention has the potential to reduce skeletal related events (SREs) in breast cancer survivors.	[Biswas, Swati; Rana, Tapasi] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Chakrabarti, Anwesa; Ayres, Austin; Sterling, Julie; Edwards, James; Johnson, Rachelle; Perrien, Daniel S.; Mundy, Gregory R.] Vanderbilt Univ, Sch Med, Ctr Bone Biol, Nashville, TN 37212 USA; [Nyman, Jeffry S.; Perrien, Daniel S.] Vanderbilt Univ, Sch Med, Dept Orthoped, Nashville, TN 37212 USA; [Perrien, Daniel S.] Vanderbilt Univ, Sch Med, Inst Imaging Sci, Nashville, TN 37212 USA; [Biswas, Swati; Matrisian, Lynn M.; Mundy, Gregory R.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Alvarez, JoAnn; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Lonning, Scott] Genzyme Corp, Framingham, MA 01701 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Sanofi-Aventis; Genzyme Corporation	Biswas, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA.	swati.biswas@vanderbilt.edu	Nyman, Jeffry/L-5736-2013; Perrien, Daniel S/AAH-3889-2020	Perrien, Daniel/0000-0002-5488-3932; Nyman, Jeffry/0000-0001-7403-7605	NIH [PO1 CA040035, U54 CA126505]; NCI; NATIONAL CANCER INSTITUTE [T32CA009592, P01CA040035, U54CA126505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work presented here has been funded by the PO1 CA040035 (NIH) grants awarded to the late Dr. Gregory R. Mundy (current PIs Matrisian and Elefteriou), U54 CA126505 (NIH) awarded to Dr. Lynn Matrisian (Dr. Mundy, project leader), and the Vanderbilt Breast Spore Program (NCI) awarded to Dr. Carlos Arteaga. Dr. Biswas was a BIRCWH fellow (2007-2010) whose work was supported by the Building Interdisciplinary Research Careers in Women's Health (BIRCWH) career development award (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genzyme has provided us with the anti-TGF beta antibody and was involved in study design as a follow up of their preliminary finding with this antibody. They have not taken part in acquiring or analyzing the data presented here.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Baselga J, 2008, BIOMARKERS, V13, P217, DOI [10.1080/13547500701676019, 10.1080/13547500701676019 ]; Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0; Berenson JR, 1998, ONCOLOGY-NY, V12, P1573; BERENSON JR, 1998, ONCOLOGY WILLISTON P, V12, P1579; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; COLEMAN RE, CANC TREAT REV, V36, P615; DASCH JR, 1989, J IMMUNOL, V142, P1536; DJULBEGOVIC B, 2002, COCHRANE DB SYST REV; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Gallwitz WE, 2002, J CLIN INVEST, V110, P1559, DOI 10.1172/JCI200211936; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Hortobagyi GN, 1996, SEMIN ONCOL, V23, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JEMAL A, CANC EPIDEMIOL BIOMA, V19, P1893; Kanis John A., 2000, Cancer, V88, P3022, DOI 10.1002/1097-0142(20000615)88:12+<3022::AID-CNCR19>3.0.CO;2-R; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Khanna AK, 2004, CIRCULATION, V110, P3822, DOI 10.1161/01.CIR.0000150400.15354.7D; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; Michigami T, 2002, BREAST CANCER RES TR, V75, P249, DOI 10.1023/A:1019905111666; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Mundy GR, 1997, AM J MED, V103, P134, DOI 10.1016/S0002-9343(97)80047-2; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; MUNDY GR, 1978, NATURE, V275, P132, DOI 10.1038/275132a0; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Mundy GR, 2008, J AM SOC NEPHROL, V19, P672, DOI 10.1681/ASN.2007090981; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; PFEILSCHIFTER J, 1990, ENDOCRINOLOGY, V127, P69, DOI 10.1210/endo-127-1-69; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; STEWART AF, 1982, J CLIN ENDOCR METAB, V55, P219, DOI 10.1210/jcem-55-2-219; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Theriault RL, 1999, J CLIN ONCOL, V17, P846, DOI 10.1200/JCO.1999.17.3.846; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	53	64	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27090	10.1371/journal.pone.0027090	http://dx.doi.org/10.1371/journal.pone.0027090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096521	gold, Green Submitted, Green Published			2022-12-27	WOS:000297553900020
J	Cheng, M; Chan, SYW; Zhao, Q; Chan, EYM; Au, SWN; Lee, SST; Cheung, WT				Cheng, Man; Chan, Shirley Y. W.; Zhao, Qi; Chan, Elaine Y. M.; Au, Shannon W. N.; Lee, Susanna S. T.; Cheung, Wing-Tai			Construction and Characterization of Single-Chain Variable Fragment Antibody Library Derived from Germline Rearranged Immunoglobulin Variable Genes	PLOS ONE			English	Article							PHAGE DISPLAY LIBRARY; SARS-CORONAVIRUS; IMMUNE-RESPONSE; HYPERVARIABLE REGIONS; SOMATIC HYPERMUTATION; CROSS-REACTIVITY; PEPTIDE LIBRARY; CDR3 REGION; PROTEIN; MATURATION	Antibody repertoires for library construction are conventionally harvested from mRNAs of immune cells. To examine whether germline rearranged immunoglobulin (Ig) variable region genes could be used as source of antibody repertoire, an immunized phage-displayed scFv library was prepared using splenocytic genomic DNA as template. In addition, a novel frame-shifting PCR (fsPCR) step was introduced to rescue stop codon and to enhance diversity of the complementarity-determining region 3 (CDR3). The germline scFv library was initially characterized against the hapten antigen phenyloxazolone (phOx). Sequence analysis of the phOx-selective scFvs indicated that the CDRs consisted of novel as well as conserved motifs. In order to illustrate that the diversity of CDR3 was increased by the fsPCR step, a second scFv library was constructed using a single scFv clone L3G7C as a template. Despite showing similar binding characteristics towards phOx, the scFv clones that were obtained from the L3G7C-derived antibody library gave a lower non-specific binding than that of the parental L3G7C clone. To determine whether germline library represented the endogenous immune status, specific scFv clones for nucleocapsid (N) protein of SARS-associated coronavirus (SCoV) were obtained both from naive and immunized germline scFv libraries. Both libraries yielded specific anti-N scFvs that exhibited similar binding characteristics towards recombinant N protein, except the immunized library gave a larger number of specific anti-N scFv, and clones with identical nucleotide sequences were found. In conclusion, highly diversified antibody library can be efficiently constructed using germline rearranged immunoglobulin variable genes as source of antibody repertoires and fsPCR to diversify the CDR3.	[Cheng, Man; Chan, Shirley Y. W.; Zhao, Qi; Chan, Elaine Y. M.; Cheung, Wing-Tai] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Au, Shannon W. N.; Lee, Susanna S. T.] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Cheng, M (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	wtcheung@cuhk.edu.hk	Chan, Elaine/GRR-5490-2022; Cheung, Wing-Tai/AAE-2658-2020	Cheung, Wing-Tai/0000-0001-6358-7855; Zhao, Qi/0000-0002-5969-6407	CUHK [44M4028]; Research Grants Council of Hong Kong Special Administrative Region (HKSAR) [CUHK4536/03M]; HKSAR Innovation and Technology Commission [GHP/030/06];  [US7241598 B2]	CUHK(Chinese University of Hong Kong); Research Grants Council of Hong Kong Special Administrative Region (HKSAR)(Hong Kong Research Grants Council); HKSAR Innovation and Technology Commission; 	This work was partly supported by a CUHK Strategic Research Program Grant (44M4028), an Earmarked research grant (CUHK4536/03M) from Research Grants Council of Hong Kong Special Administrative Region (HKSAR) and a research grant from HKSAR Innovation and Technology Commission (GHP/030/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: A United States patent (US7241598 B2) on frame-shifting PCR had been granted in 2007, which is indicated in the manuscript (Materials and Methods) and the patent is listed in the References (Ref. 32). The authors declare that at the present moment, no product is in development. Neither direct or indirect interests exist, nor funding, consultancy, nor employment provided by companies for commercial-related purposes and activities. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; BARBAS CF, 2001, PHADE DISPLAY LAB MA, P9; Barrios Y, 2004, J MOL RECOGNIT, V17, P332, DOI 10.1002/jmr.679; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Bikkavilli RK, 2006, BIOCHEM PHARMACOL, V71, P319, DOI 10.1016/j.bcp.2005.10.050; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Carcamo J, 1998, P NATL ACAD SCI USA, V95, P11146, DOI 10.1073/pnas.95.19.11146; Cheng M, 2005, BIOCHEM BIOPH RES CO, V338, P1654, DOI 10.1016/j.bbrc.2005.10.088; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; FROYEN G, 1995, MOL IMMUNOL, V32, P515, DOI 10.1016/0161-5890(95)00010-C; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Goldman E, 2000, FASEB J, V14, P603, DOI 10.1096/fasebj.14.3.603; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; Johnson G, 1998, INT IMMUNOL, V10, P1801, DOI 10.1093/intimm/10.12.1801; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Koh WWL, 2010, J BIOL CHEM, V285, P19116, DOI 10.1074/jbc.M110.116699; Krichevsky A, 2003, VIROLOGY, V305, P77, DOI 10.1006/viro.2002.1765; Kuan CT, 2000, INT J CANCER, V88, P962, DOI 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U; Kupsch JM, 1999, CLIN CANCER RES, V5, P925; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; Lim TS, 2010, NEW BIOTECHNOL, V27, P108, DOI 10.1016/j.nbt.2010.01.001; MAKELA O, 1978, J EXP MED, V148, P1644, DOI 10.1084/jem.148.6.1644; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Ramsland PA, 2001, EXP CLIN IMMUNOGENET, V18, P176, DOI 10.1159/000049197; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wen YJ, 1998, BRIT J HAEMATOL, V100, P464, DOI 10.1046/j.1365-2141.1998.00592.x; White H, 2000, J EXP MED, V191, P2209, DOI 10.1084/jem.191.12.2209; Wilson DR, 1998, CAN J MICROBIOL, V44, P313, DOI 10.1139/cjm-44-4-313; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011; ZAGHOUANI H, 1993, SCIENCE, V259, P224, DOI 10.1126/science.7678469; Zhao Q, 2009, PROTEIN EXPRES PURIF, V68, P190, DOI 10.1016/j.pep.2009.08.004	54	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27406	10.1371/journal.pone.0027406	http://dx.doi.org/10.1371/journal.pone.0027406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096568	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900041
J	Koutsopoulos, OS; Koch, C; Tosch, V; Bohm, J; North, KN; Laporte, J				Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; North, Kathryn N.; Laporte, Jocelyn			Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; MAMMALIAN-CELLS; NEONATAL ONSET; SH3 DOMAIN; MICROTUBULES; BINDING; TUBULIN; GTPASE; FAMILY; DIFFERENTIATION	The large GTPase dynamin 2 is a key player in membrane and cytoskeletal dynamics mutated in centronuclear myopathy (CNM) and Charcot-Marie Tooth (CMT) neuropathy, two discrete dominant neuromuscular disorders affecting skeletal muscle and peripheral nerves respectively. The molecular basis for the tissue-specific phenotypes observed and the physiopathological mechanisms linked to dynamin 2 mutations are not well established. In this study, we have analyzed the impact of CNM and CMT implicated dynamin 2 mutants using ectopic expression of four CNM and two CMT mutations, and patient fibroblasts harboring two dynamin 2 CNM mutations in established cellular processes of dynamin 2 action. Wild type and CMT mutants were seen in association with microtubules whereas CNM mutants lacked microtubules association and did not disrupt interphase microtubules dynamics. Most dynamin 2 mutants partially decreased clathrin-mediated endocytosis when ectopically expressed in cultured cells; however, experiments in patient fibroblasts suggested that endocytosis is overall not defective. Furthermore, CNM mutants were seen in association with enlarged clathrin stained structures whereas the CMT mutant constructs were associated with clathrin structures that appeared clustered, similar to the structures observed in Dnm1 and Dnm2 double knock-out cells. Other roles of dynamin 2 including its interaction with BIN1 (amphiphysin 2), and its function in Golgi maintenance and centrosome cohesion were not significantly altered. Taken together, these mild functional defects are suggestive of differences between CMT and CNM disease-causing dynamin 2 mutants and suggest that a slight impairment in clathrin-mediated pathways may accumulate over time to foster the respective human diseases.	[Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] IGBMC, Dept Translat Med, Illkirch Graffenstaden, France; [Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] CNRS, UMR7104, Illkirch Graffenstaden, France; [Koutsopoulos, Olga S.; Koch, Catherine; Tosch, Valerie; Boehm, Johann; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [North, Kathryn N.] Univ Sydney, Discipline Paediat & Child Hlth, Fac Med, Sydney, NSW 2006, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Sydney; University of Sydney	Koutsopoulos, OS (corresponding author), IGBMC, Dept Translat Med, Illkirch Graffenstaden, France.	Jocelyn@igbmc.fr	Laporte, Jocelyn/H-6801-2016; Böhm, Johann/O-1652-2016; North, Kathryn N/K-6476-2012; laporte, jocelyn/O-4888-2019; laporte, jocelyn/J-7008-2012	Böhm, Johann/0000-0001-8019-9504; North, Kathryn N/0000-0003-0841-8009; Koch, Catherine/0000-0003-0790-1429; Bohm, Johann/0000-0001-7370-3469	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg (UdS); College de France; Association Francaise contre les Myopathies (AFM); Fondation Recherche Medicale [DEQ20071210538]; E-rare program; Agence Nationale de la Recherche [ANR-07-BLAN-0065-01, ANR-08-GENOPAT-005]; Deutsche Forschungsgemeinschaft (DFG)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (UdS)(European Commission); College de France; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Recherche Medicale; E-rare program; Agence Nationale de la Recherche(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), University of Strasbourg (UdS), College de France, Association Francaise contre les Myopathies (AFM), Fondation Recherche Medicale (DEQ20071210538), E-rare program, and Agence Nationale de la Recherche (ANR-07-BLAN-0065-01 and ANR-08-GENOPAT-005). Johann Bohm was supported by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chang W, 2002, J BIOL CHEM, V277, P30690, DOI 10.1074/jbc.M204930200; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Claeys KG, 2009, BRAIN, V132, P1741, DOI 10.1093/brain/awp115; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; DIATLOFFZITO C, 1995, GENE, V163, P301, DOI 10.1016/0378-1119(95)00275-B; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P955, DOI 10.1016/j.nmd.2007.06.467; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gonzalez-Bellido PT, 2009, J NEUROSCI, V29, P14199, DOI 10.1523/JNEUROSCI.2873-09.2009; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Hamao K, 2009, EXP CELL RES, V315, P1336, DOI 10.1016/j.yexcr.2009.01.025; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maier O, 1996, BIOCHEM BIOPH RES CO, V223, P229, DOI 10.1006/bbrc.1996.0876; Melberg A, 2010, NEUROMUSCULAR DISORD, V20, P53, DOI 10.1016/j.nmd.2009.10.006; NAKATA T, 1993, J CELL SCI, V105, P1; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Susman RD, 2010, NEUROMUSCULAR DISORD, V20, P229, DOI 10.1016/j.nmd.2010.02.016; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	43	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27498	10.1371/journal.pone.0027498	http://dx.doi.org/10.1371/journal.pone.0027498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096584	Green Published, gold			2022-12-27	WOS:000297553900053
J	Shah, M; Kariuki, S; Eng, JV; Blackstock, AJ; Garner, K; Gatei, W; Gimnig, JE; Lindblade, K; Terlouw, D; ter Kuile, F; Hawley, WA; Phillips-Howard, P; Nahlen, B; Walker, E; Hamel, MJ; Slutsker, L; Shi, YP				Shah, Monica; Kariuki, Simon; Eng, Jodi Vanden; Blackstock, Anna J.; Garner, Kimberly; Gatei, Wangeci; Gimnig, John E.; Lindblade, Kim; Terlouw, Dianne; ter Kuile, Feiko; Hawley, William A.; Phillips-Howard, Penelope; Nahlen, Bernard; Walker, Edward; Hamel, Mary J.; Slutsker, Laurence; Shi, Ya Ping			Effect of Transmission Reduction by Insecticide-Treated Bednets (ITNs) on Antimalarial Drug Resistance in Western Kenya	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; PLASMODIUM-FALCIPARUM MALARIA; REAL-TIME PCR; BED NETS; MUTATIONS; CHLOROQUINE; PREVALENCE; INTENSITY; SPREAD; AREA	Despite the clear public health benefit of insecticide-treated bednets (ITNs), the impact of malaria transmission-reduction by vector control on the spread of drug resistance is not well understood. In the present study, the effect of sustained transmission reduction by ITNs on the prevalence of Plasmodium falciparum gene mutations associated with resistance to the antimalarial drugs sulfadoxine-pyrimethamine (SP) and chloroquine (CQ) in children under the age of five years was investigated during an ITN trial in Asembo area, western Kenya. During the ITN trial, the national first line antimalarial treatment changed from CQ to SP. Smear-positive samples collected from cross sectional surveys prior to ITN introduction (baseline, n = 250) and five years post-ITN intervention (year 5 survey, n = 242) were genotyped for single nucleotide polymorphisms (SNPs) at dhfr-51, 59, 108, 164 and dhps-437, 540 (SP resistance), and pfcrt-76 and pfmdr1-86 (CQ resistance). The association between the drug resistance mutations and epidemiological variables was evaluated. There were significant increases in the prevalence of SP dhps mutations and the dhfr/dhps quintuple mutant, and a significant reduction in the proportion of mixed infections detected at dhfr-51, 59 and dhps-437, 540 SNPs from baseline to the year 5 survey. There was no change in the high prevalence of pfcrt-76 and pfmdr1-86 mutations. Multivariable regression analysis further showed that current antifolate use and year of survey were significantly associated with more SP drug resistance mutations. These results suggest that increased antifolate drug use due to drug policy change likely led to the high prevalence of SP mutations 5 years post-ITN intervention and reduced transmission had no apparent effect on the existing high prevalence of CQ mutations. There is no evidence from the current study that sustained transmission reduction by ITNs reduces the prevalence of genes associated with malaria drug resistance.	[Shah, Monica; Eng, Jodi Vanden; Blackstock, Anna J.; Gatei, Wangeci; Gimnig, John E.; Lindblade, Kim; Hawley, William A.; Hamel, Mary J.; Slutsker, Laurence; Shi, Ya Ping] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Shah, Monica; Blackstock, Anna J.; Garner, Kimberly] Atlanta Res & Educ Fdn, Atlanta, GA USA; [Kariuki, Simon; Phillips-Howard, Penelope; Hamel, Mary J.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Terlouw, Dianne; ter Kuile, Feiko] Univ Liverpool, Liverpool Sch Trop Med, Malaria Epidemiol Unit, Liverpool L3 5QA, Merseyside, England; [Hawley, William A.] UNICEF, Jakarta, Indonesia; [Phillips-Howard, Penelope] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Nahlen, Bernard] Presidents Malaria Initiat, Washington, DC USA; [Walker, Edward] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool John Moores University; Michigan State University	Shah, M (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	yps0@cdc.gov	Nahlen, Bernard/AAH-2051-2021; Kuile, Feiko ter/ABD-6681-2020; Kariuki, Simon/AFT-6596-2022	Kuile, Feiko ter/0000-0003-3663-5617; Phillips-Howard, Penelope A/0000-0003-1018-116X; gatei, wangeci/0000-0002-3644-5445; Lindblade, Kim/0000-0002-5593-0470	Multilateral Initiative on Malaria through the WHO [A40046]; U.S. National Science Foundation [EF-0723770]; Emerging Infectious Diseases Fellowship	Multilateral Initiative on Malaria through the WHO; U.S. National Science Foundation(National Science Foundation (NSF)); Emerging Infectious Diseases Fellowship	The study was supported by the Multilateral Initiative on Malaria grant # A40046 through the WHO Special Program for Research and Training in Tropical Diseases and was partially supported by U.S. National Science Foundation, Ecology of Infectious Diseases grant # EF-0723770. Monica Shah was partially supported by the Emerging Infectious Diseases Fellowship administered by the Association of Public Health Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifrangis M, 2003, AM J TROP MED HYG, V69, P238, DOI 10.4269/ajtmh.2003.69.238; Alker AP, 2004, ANTIMICROB AGENTS CH, V48, P2924, DOI 10.1128/AAC.48.8.2924-2929.2004; [Anonymous], 2009, WORLD MAL REP 2009; Diallo DA, 2007, AM J TROP MED HYG, V76, P237, DOI 10.4269/ajtmh.2007.76.237; Figueiredo P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-236; Gamble C, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003755.PUB2; Gatei W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-353; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Hastings IM, 2010, AM J TROP MED HYG, V83, P489, DOI 10.4269/ajtmh.2010.10-0072; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; Hill J, 2006, ADV PARASIT, V61, P77, DOI 10.1016/S0065-308X(05)61003-2; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Lengeler C, 2004, B WORLD HEALTH ORGAN, V82, P84; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Malisa AL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-190; Menegon M, 2010, AM J TROP MED HYG, V83, P250, DOI 10.4269/ajtmh.2010.09-0514; Mharakurwa S, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-35; Osman ME, 2007, INFECT GENET EVOL, V7, P52, DOI 10.1016/j.meegid.2006.03.008; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.10; Phillps-Howard PA, 2003, AM J TROP MED HYG, V68, P44, DOI 10.4269/ajtmh.2003.68.44; Purfield A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-9; Singer LM, 2003, J INFECT DIS, V187, P1756, DOI 10.1086/375241; Spalding MD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-338; Talisuna AO, 2007, AM J TROP MED HYG, V77, P170; Talisuna AO, 2006, INFECT GENET EVOL, V6, P241, DOI 10.1016/j.meegid.2005.06.003; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P68, DOI 10.4269/ajtmh.2003.68.68; Terlouw DJ, 2003, ANTIMICROB AGENTS CH, V47, P2929, DOI 10.1128/AAC.47.9.2929-2932.2003; Wilson PE, 2005, ACTA TROP, V93, P97, DOI 10.1016/j.actatropica.2004.09.010; Wiseman V, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.161; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Zimmerman PA, 2003, AM J TROP MED HYG, V69, P236, DOI 10.4269/ajtmh.2003.69.236	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26746	10.1371/journal.pone.0026746	http://dx.doi.org/10.1371/journal.pone.0026746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096496	Green Published, gold, Green Accepted			2022-12-27	WOS:000297553900008
J	Apaldetti, C; Martinez, RN; Alcober, OA; Pol, D				Apaldetti, Cecilia; Martinez, Ricardo N.; Alcober, Oscar A.; Pol, Diego			A New Basal Sauropodomorph (Dinosauria: Saurischia) from Quebrada del Barro Formation (Marayes-El Carrizal Basin), Northwestern Argentina	PLOS ONE			English	Article							UPPER ELLIOT FORMATION; ISCHIGUALASTO FORMATION; EVOLUTION; PROSAUROPODA; YUNNAN; YOUNG; SKULL	Background: Argentinean basal sauropodomorphs are known by several specimens from different basins; Ischigualasto, El Tranquilo, and Mogna. The Argentinean record is diverse and includes some of the most primitive known sauropodomorphs such as Panphagia and Chromogisaurus, as well as more derived forms, including several massospondylids. Until now, the Massospondylidae were the group of basal sauropodomorphs most widely spread around Pangea with a record in almost all continents, mostly from the southern hemisphere, including the only record from Antarctica. Methodology/Principal Finding: We describe here a new basal sauropodomorph, Leyesaurus marayensis gen. et sp. nov., from the Quebrada del Barro Formation, an Upper Triassic-Lower Jurassic unit that crops out in northwestern Argentina. The new taxon is represented by a partial articulated skeleton that includes the skull, vertebral column, scapular and pelvic girdles, and hindlimb. Leyesaurus is diagnosed by a set of unique features, such as a sharply acute angle (50 degrees) formed by the ascending process of the maxilla and the alveolar margin, a straight ascending process of the maxilla with a longitudinal ridge on its lateral surface, noticeably bulging labial side of the maxillary teeth, greatly elongated cervical vertebrae, and proximal articular surface of metatarsal III that is shelf-like and medially deflected. Phylogenetic analysis recovers Leyesaurus as a basal sauropodomorph, sister taxon of Adeopapposaurus within the Massospondylidae. Moreover, the results suggest that massospondylids achieved a higher diversity than previously thought. Conclusions/Significance: Our phylogenetic results differ with respect to previous analyses by rejecting the massospondylid affinities of some taxa from the northern hemisphere (e. g., Seitaad, Sarahsaurus). As a result, the new taxon Leyesaurus, coupled with other recent discoveries, suggests that the diversity of massospondylids in the southern hemisphere was higher than in other regions of Pangea. Finally, the close affinities of Leyesaurus with the Lower Jurassic Massospondylus suggest a younger age for the Quebrada del Barro Formation than previously postulated.	[Apaldetti, Cecilia; Martinez, Ricardo N.; Alcober, Oscar A.] Univ Nacl San Juan, Museo Ciencias Nat, San Juan, Argentina; [Apaldetti, Cecilia; Pol, Diego] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Pol, Diego] Museo Paleontol Egidio Feruglio, Trelew, Argentina	Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Apaldetti, C (corresponding author), Univ Nacl San Juan, Museo Ciencias Nat, San Juan, Argentina.	capaldetti@unsj.edu.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; Consejo de Investigaciones de Ciencia TecnologA-a y Arte (CICITCA); Jurassic Foundation	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; Consejo de Investigaciones de Ciencia TecnologA-a y Arte (CICITCA); Jurassic Foundation	This work was supported by Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; Consejo de Investigaciones de Ciencia TecnologA-a y Arte (CICITCA), and the Jurassic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Attridge J., 1985, Journal of Vertebrate Paleontology, V5, P128; Attridge J., 1963, South African Journal of Science, V59, P242; Bai Z.-Q., 1990, YUXIWENBO, V1, P14; Barrett PM, 2007, ZOOL J LINN SOC-LOND, V150, P319, DOI 10.1111/j.1096-3642.2007.00290.x; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Barrett PM, 2004, S AFR J SCI, V100, P501; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bergmann F. A. J., 1948, REV MINERA GEOLOGIA, V19, P3; Bodenbender G, 1912, AN MIN AGR SECC GEOL, V8, P9; BONAPARTE J F, 1979, Ameghiniana, V16, P173; BONAPARTE J F, 1978, Ameghiniana, V15, P327; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Bonaparte Jose F., 1995, Ameghiniana, V32, P341; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Borrello A.V., 1946, REV SOC GEOL ARGENT, V1, P167; Bossi GE, 1978, ACTA GEOL LILLOANA 1, V1, P41; Bossi GE, 1975, 4 C GEOL ARG, V1; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Fedak TJ, 2007, SPEC PAP PALAEONTOL, P245; Flores M., 1969, 4 JORN GEOL ARG ACT, P311; Galton P.M., 1990, P320; GALTON P M, 1973, Palaeontologische Zeitschrift, V47, P229; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2001, Revue de Paleobiologie, V20, P435; Galton PM, 2000, NEUES JAHRB GEOL P-A, V216, P233; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Kellner AWA, 2000, AN ACAD BRAS CIENC, V72, P509, DOI 10.1590/S0001-37652000000400005; Knoll F, 2010, GEOL MAG, V147, P814, DOI 10.1017/S001675681000018X; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; Leal LA, 2004, ZOOTAXA, P1; Lu Junchang, 2007, Memoir of the Fukui Prefectural Dinosaur Museum, V6, P1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Martin R. A., 1999, Journal of Vertebrate Paleontology, V19, p61A; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; OLSEN PE, 1987, SCIENCE, V237, P1025, DOI 10.1126/science.3616622; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Pol Diego, 2007, Historical Biology, V19, P125, DOI 10.1080/08912960601140085; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Rassmuss J, 1922, GEOLOGIA HIDROLOGI B, V32, P7; Rowe TB, 2011, P ROY SOC B-BIOL SCI, V278, P1044, DOI 10.1098/rspb.2010.1867; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sertich JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009789; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2004, Postilla, V230, P1; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x; YOUNG C. C., 1947, PALEONTOL SINICA NEW SER, V12, P1; Young C. C., 1942, Bulletin of the Geological Society of China, V22, P63; Young C. C., 1941, Palaeontologia Sinica N S C, V7, P1; Yrigoyen M, 1970, ACT 4 JORN GEOL ARG, P2; Yrigoyen M, 1974, 1 C ARG PAL BIOESTR; ZHANG Y, 1994, COMPLETE OSTEOLOGY P	71	60	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26964	10.1371/journal.pone.0026964	http://dx.doi.org/10.1371/journal.pone.0026964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096511	gold, Green Published			2022-12-27	WOS:000297350800019
J	Gu, GY; Hu, JH; Cevallos-Cevallos, JM; Richardson, SM; Bartz, JA; van Bruggen, AHC				Gu, Ganyu; Hu, Jiahuai; Cevallos-Cevallos, Juan M.; Richardson, Susanna M.; Bartz, Jerry A.; van Bruggen, Ariena H. C.			Internal Colonization of Salmonella enterica Serovar Typhimurium in Tomato Plants	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; O-ANTIGEN CAPSULE; MULTISTATE OUTBREAK; AGGREGATIVE FIMBRIAE; IRRIGATION WATER; GENETIC-ANALYSIS; ALFALFA SPROUTS; UNITED-STATES; CELLULOSE; SURVIVAL	Several Salmonella enterica outbreaks have been traced back to contaminated tomatoes. In this study, the internalization of S. enterica Typhimurium via tomato leaves was investigated as affected by surfactants and bacterial rdar morphotype, which was reported to be important for the environmental persistence and attachment of Salmonella to plants. Surfactants, especially Silwet L-77, promoted ingress and survival of S. enterica Typhimurium in tomato leaves. In each of two experiments, 84 tomato plants were inoculated two to four times before fruiting with GFP-labeled S. enterica Typhimurium strain MAE110 (with rdar morphotype) or MAE119 (without rdar). For each inoculation, single leaflets were dipped in 10(9) CFU/ml Salmonella suspension with Silwet L-77. Inoculated and adjacent leaflets were tested for Salmonella survival for 3 weeks after each inoculation. The surface and pulp of ripe fruits produced on these plants were also examined for Salmonella. Populations of both Salmonella strains in inoculated leaflets decreased during 2 weeks after inoculation but remained unchanged (at about 10(4) CFU/g) in week 3. Populations of MAE110 were significantly higher (P<0.05) than those of MAE119 from day 3 after inoculation. In the first year, nine fruits collected from one of the 42 MAE119 inoculated plants were positive for S. enterica Typhimurium. In the second year, Salmonella was detected in adjacent non-inoculated leaves of eight tomato plants (five inoculated with strain MAE110). The pulp of 12 fruits from two plants inoculated with MAE110 was Salmonella positive (about 10(6) CFU/g). Internalization was confirmed by fluorescence and confocal laser microscopy. For the first time, convincing evidence is presented that S. enterica can move inside tomato plants grown in natural field soil and colonize fruits at high levels without inducing any symptoms, except for a slight reduction in plant growth.	[Gu, Ganyu; Hu, Jiahuai; Cevallos-Cevallos, Juan M.; Richardson, Susanna M.; van Bruggen, Ariena H. C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Gu, Ganyu; Hu, Jiahuai; Cevallos-Cevallos, Juan M.; Richardson, Susanna M.; Bartz, Jerry A.; van Bruggen, Ariena H. C.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gu, GY (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	ggu@ufl.edu; ahcvanbruggen@ufl.edu		Cevallos-Cevallos, Juan/0000-0003-4609-7998; Ravel, Jacques/0000-0002-0851-2233	Institute of Food and Agricultural Sciences, University of Florida	Institute of Food and Agricultural Sciences, University of Florida(University of Florida)	This work was supported by Institute of Food and Agricultural Sciences, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P325; Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Bedunah D. J., 1995, WILDLAND PLANTS PHYS; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Calvin L., 2005, Amber Waves, V3, P20; Campbell JV, 2001, J INFECT DIS, V183, P984, DOI 10.1086/319254; Cating RA, 2010, FLA ENTOMOL, V93, P100, DOI 10.1653/024.093.0113; Chen YL, 2006, FOREST ECOL MANAG, V222, P439, DOI 10.1016/j.foreco.2005.10.050; CHUNG KC, 1970, J FOOD SCI, V35, P326, DOI 10.1111/j.1365-2621.1970.tb12176.x; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; Food and Drug Administration (FDA), 2010, FDA TREND AN REP OCC; Franz E, 2008, J APPL MICROBIOL, V105, P1569, DOI 10.1111/j.1365-2672.2008.03915.x; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gong ChunMing, 2005, Japanese Journal of Soil Science and Plant Nutrition, V76, P865; Gottwald TR, 1997, PLANT DIS, V81, P1305, DOI 10.1094/PDIS.1997.81.11.1305; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Guo X, 2002, J FOOD PROTECT, V65, P274, DOI 10.4315/0362-028X-65.2.274; Guo X, 2001, APPL ENVIRON MICROB, V67, P4760, DOI 10.1128/AEM.67.10.4760-4764.2001; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; HO LC, 1987, PLANT CELL ENVIRON, V10, P157, DOI 10.1111/j.1365-3040.1987.tb02092.x; HOLLOWAY PJ, 1992, PESTIC SCI, V34, P109, DOI 10.1002/ps.2780340204; Horby PW, 2003, EPIDEMIOL INFECT, V130, P169, DOI 10.1017/S0950268802008063; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Jablasone J, 2004, J SCI FOOD AGR, V84, P287, DOI 10.1002/jsfa.1646; Jafari R. A., 2006, International Journal of Poultry Science, V5, P491; Kirk J, 2002, PREV VET MED, V54, P169, DOI 10.1016/S0167-5877(02)00025-9; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Liang ZB, 2011, SOIL BIOL BIOCHEM, V43, P1591, DOI 10.1016/j.soilbio.2011.04.010; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Mohle-Boetani JC, 1999, J INFECT DIS, V180, P1361, DOI 10.1086/314995; Noel JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012406; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P229, DOI 10.1017/S0950268800059392; OYARZABAL OA, 1995, POULTRY SCI, V74, P1418, DOI 10.3382/ps.0741418; PLATZ S, 1980, ZBL BAKT MIK HYG B, V171, P256; Robinson R. A., 1968, ELECTROLYTE SOLUTION; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005; Semenov AV, 2007, FEMS MICROBIOL ECOL, V60, P419, DOI 10.1111/j.1574-6941.2007.00306.x; Sieverding E, 2006, J PLANT DIS PROTECT, P1005; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Suarez A, 1997, GENE, V196, P69, DOI 10.1016/S0378-1119(97)00197-2; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; VANBRUGGEN AHC, 1987, PHYTOPATHOLOGY, V77, P401, DOI 10.1094/Phyto-77-401; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winthrop KL, 2003, J FOOD PROTECT, V66, P13, DOI 10.4315/0362-028X-66.1.13; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	66	113	116	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27340	10.1371/journal.pone.0027340	http://dx.doi.org/10.1371/journal.pone.0027340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096553	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800045
J	Knapp, CW; McCluskey, SM; Singh, BK; Campbell, CD; Hudson, G; Graham, DW				Knapp, Charles W.; McCluskey, Seanin M.; Singh, Brajesh K.; Campbell, Colin D.; Hudson, Gordon; Graham, David W.			Antibiotic Resistance Gene Abundances Correlate with Metal and Geochemical Conditions in Archived Scottish Soils	PLOS ONE			English	Article							COPPER AMENDMENT; BACTERIAL; LAGOONS; WASTE	The vast majority of antibiotic resistant genes (ARG) acquired by human pathogens have originated from the natural environment. Therefore, understanding factors that influence intrinsic levels of ARG in the environment could be epidemiologically significant. The selection for metal resistance often promotes AR in exposed organisms; however, the relationship between metal levels in nature and the intrinsic presence of ARG has not been fully assessed. Here, we quantified, using qPCR, the abundance of eleven ARG and compared their levels with geochemical conditions in randomly selected soils from a Scottish archive. Many ARG positively correlated with soil copper levels, with approximately half being highly significant (p<0.05); whereas chromium, nickel, lead, and iron also significantly correlated with specific ARG. Results show that geochemical metal conditions innately influence the potential for AR in soil. We suggest soil geochemical data might be used to estimate baseline gene presence on local, regional and global scales within epidemiological risk studies related to AR transmission from the environment.	[Knapp, Charles W.; McCluskey, Seanin M.] Univ Strathclyde, David Livingstone Ctr Sustainabil, Dept Civil Engn, Glasgow, Lanark, Scotland; [Singh, Brajesh K.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Campbell, Colin D.; Hudson, Gordon] James Hutton Inst, Aberdeen, Scotland; [Campbell, Colin D.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Graham, David W.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Strathclyde; Western Sydney University; James Hutton Institute; Swedish University of Agricultural Sciences; Newcastle University - UK	Knapp, CW (corresponding author), Univ Strathclyde, David Livingstone Ctr Sustainabil, Dept Civil Engn, Glasgow, Lanark, Scotland.	charles.knapp@strath.ac.uk	Knapp, Charles W/D-3373-2009; Singh, Brajesh/R-6321-2019; Campbell, Colin D/B-3944-2010	Knapp, Charles W/0000-0001-7997-8543; Singh, Brajesh/0000-0003-4413-4185; Campbell, Colin D/0000-0002-5163-7656; Mccluskey, Seanin/0000-0002-5200-4076; Graham, David W/0000-0002-9753-496X	ECOSERV; EU [MEXT-CT-2006-023469]; University of Strathclyde [2009-1551]	ECOSERV; EU(European Commission); University of Strathclyde	Funding for the project was provided by ECOSERV, an EU Marie Curie Excellence Programme (#MEXT-CT-2006-023469), and University of Strathclyde Research Development Fund (#2009-1551). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CA, 2007, CHEMOSPHERE, V69, P1428, DOI 10.1016/j.chemosphere.2007.04.068; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Berg J, 2005, LETT APPL MICROBIOL, V40, P146, DOI 10.1111/j.1472-765X.2004.01650.x; Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r; Berger Antony R., 2003, P5; BROWN NL, 1991, J CELL BIOCHEM, V46, P106; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Knapp CW, 2008, ENVIRON SCI TECHNOL, V42, P5348, DOI 10.1021/es703199g; Knapp CW, 2010, ENVIRON POLLUT, V158, P1506, DOI 10.1016/j.envpol.2009.12.020; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Macdonald CA, 2008, FEMS MICROBIOL ECOL, V65, P555, DOI 10.1111/j.1574-6941.2008.00538.x; MAFF Ministry of Agriculture Fisheries Food, 1986, AN AGR MAT MAFF REF; Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x; Rosen BP, 1996, J BIOL INORG CHEM, V1, P273, DOI 10.1007/s007750050053; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Stepanauskas R, 2005, ENVIRON SCI TECHNOL, V39, P3671, DOI 10.1021/es048468f; Stepanauskas R, 2006, ENVIRON MICROBIOL, V8, P1510, DOI 10.1111/j.1462-2920.2006.01091.x; Tom-Petersen A, 2003, FEMS MICROBIOL ECOL, V46, P53, DOI 10.1016/S0168-6496(03)00192-2; Tzeneva VA, 2009, RES MICROBIOL, V160, P89, DOI 10.1016/j.resmic.2008.12.001; Ugur A, 2003, ARCH MED RES, V34, P130, DOI 10.1016/S0188-4409(03)00006-7; Wright MS, 2006, FEMS MICROBIOL ECOL, V58, P293, DOI 10.1111/j.1574-6941.2006.00154.x	24	224	250	6	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27300	10.1371/journal.pone.0027300	http://dx.doi.org/10.1371/journal.pone.0027300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096547	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000297350800042
J	Han, L; Ma, QY; Li, JH; Liu, H; Li, W; Ma, GD; Xu, QH; Zhou, S; Wu, EX				Han, Liang; Ma, Qingyong; Li, Junhui; Liu, Han; Li, Wei; Ma, Guodong; Xu, Qinhong; Zhou, Shuang; Wu, Erxi			High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; KINASE; ACTIVATION; PROTEIN	Multiple lines of evidence suggest that a large portion of pancreatic cancer patients suffer from either hyperglycemia or diabetes, both of which are characterized by high blood glucose level. However, the underlying biological mechanism of this phenomenon is largely unknown. In the present study, we demonstrated that the proliferative ability of two human pancreatic cancer cell lines, BxPC-3 and Panc-1, was upregulated by high glucose in a concentration-dependent manner. Furthermore, the promoting effect of high glucose levels on EGF transcription and secretion but not its receptors in these PC cell lines was detected by using an EGF-neutralizing antibody and RT-PCR. In addition, the EGFR transactivation is induced by high glucose levels in concentration- and time-dependent manners in PC cells in the presence of the EGF-neutralizing antibody. These results suggest that high glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. Our findings may provide new insight on the links between high glucose level and PC in terms of the molecular mechanism and reveal a novel therapeutic strategy for PC patients who simultaneously suffer from either diabetes or hyperglycemia.	[Han, Liang; Ma, Qingyong; Li, Junhui; Liu, Han; Li, Wei; Ma, Guodong; Xu, Qinhong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China; [Zhou, Shuang; Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	Xi'an Jiaotong University; North Dakota State University Fargo	Han, L (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China.	qyma56@mail.xjtu.edu.cn		Wu, Erxi/0000-0002-1680-3639; Zhou, Shuang/0000-0002-2403-7161	National Natural Scientific Foundation of China [81172360, 30900705]; 13115 major project of Shaanxi province [2010ZDKG-49]; ND EPSCoR; Centers of Biomedical Research Excellence (COBRE); NIH from the National Center for Research Resources (NCRR) [P20 RR020151]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); 13115 major project of Shaanxi province; ND EPSCoR; Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Natural Scientific Foundation of China (No. 81172360 (to QM), No. 30900705 (to JL)), a 13115 major project of Shaanxi province 2010ZDKG-49 (to QM), ND EPSCoR (to EW), and Pilot Project Grant (to EW) from the Centers of Biomedical Research Excellence (COBRE) grant NIH P20 RR020151 from the National Center for Research Resources (NCRR). NCRR is a component of the National Institutes of Health (NIH). The contents of this report are solely the responsibility of the authors and do not necessarily reflect the official views of the NIH or NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2003, HYPERTENSION, V41, P781, DOI 10.1161/01.HYP.0000049426.61176.DF; Carpenter G, 2000, SCI STKE, V2000, pE1; Cartwright Thomas, 2008, Cancer Control, V15, P308; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Gekle M, 2002, AM J PHYSIOL-RENAL, V282, pF669, DOI 10.1152/ajprenal.00159.2001; Georgopoulos NT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013621; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Greco S, 2003, J CELL PHYSIOL, V196, P370, DOI 10.1002/jcp.10313; Gschwind A, 2002, CANCER RES, V62, P6329; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Lee E, 2010, CANCER LETT, V290, P43, DOI 10.1016/j.canlet.2009.08.022; Li JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017385; Liu H, 2011, MOL CELL BIOCHEM, V347, P95, DOI 10.1007/s11010-010-0617-0; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10; Najafov A, 2010, P NATL ACAD SCI USA, V107, P19135, DOI 10.1073/pnas.1014047107; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Saad S, 2005, KIDNEY INT, V68, P985, DOI 10.1111/j.1523-1755.2005.00492.x; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Suzuki K, 2007, PROSTATE CANCER P D, V10, P384, DOI 10.1038/sj.pcan.4500976; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; WAHL MI, 1987, CLIN PHYSIOL BIOCH, V5, P130; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Yamamoto M, 1999, INT J CANCER, V83, P98, DOI 10.1002/(SICI)1097-0215(19990924)83:1<98::AID-IJC18>3.0.CO;2-V; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565	33	88	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27074	10.1371/journal.pone.0027074	http://dx.doi.org/10.1371/journal.pone.0027074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087246	Green Submitted, gold, Green Published			2022-12-27	WOS:000297349700015
J	Dean, AJ; Bellgrove, MA; Hall, T; Wei, MJP; Eyles, DW; Kvaskoff, D; McGrath, JJ				Dean, Angela J.; Bellgrove, Mark A.; Hall, Teresa; Wei Ming Jonathan Phan; Eyles, Darryl W.; Kvaskoff, David; McGrath, John J.			Effects of Vitamin D Supplementation on Cognitive and Emotional Functioning in Young Adults - A Randomised Controlled Trial	PLOS ONE			English	Article							D DEFICIENCY; PERFORMANCE; SYMPTOMS; MOOD; SCHIZOPHRENIA; ASSOCIATION; DEPRESSION; INVENTORY; RISK; D-3	Background: Epidemiological research links vitamin D status to various brain-related outcomes. However, few trials examine whether supplementation can improve such outcomes and none have examined effects on cognition. This study examined whether Vitamin D supplementation led to improvements in diverse measures of cognitive and emotional functioning, and hypothesised that supplementation would lead to improvements in these outcomes compared to placebo. Methods/Principal Findings: Healthy young adults were recruited to a parallel-arm, double-blind trial conducted at The University of Queensland. Participants were randomly allocated to receive Vitamin D (one capsule daily, containing 5000 IU cholecalciferol) or identical placebo capsule for six weeks. All participants and outcome assessors were blinded to group assignment. Primary outcome measures assessed at baseline and 6 weeks were working memory, response inhibition and cognitive flexibility. Secondary outcomes were: hallucination-proneness, psychotic-like experiences, and ratings of depression, anxiety and anger. 128 participants were recruited, randomised and included in primary analyses (vitamin D n = 63; placebo n = 65). Despite significant increases in vitamin D status in the active group, no significant changes were observed in working memory (F = 1.09; p = 0.30), response inhibition (F = 0.82; p = 0.37), cognitive flexibility (F = 1.37; p = 0.24) or secondary outcomes. No serious adverse effects were reported. Conclusions: Our findings indicate that vitamin D supplementation does not influence cognitive or emotional functioning in healthy young adults. Future controlled trials in targeted populations of interest are required to determine whether supplementation can improve functioning in these domains. Australian and New Zealand Clinical Trials Registry; ACTRN12610000318088.	[Dean, Angela J.; Bellgrove, Mark A.; Hall, Teresa; Wei Ming Jonathan Phan; Eyles, Darryl W.; Kvaskoff, David; McGrath, John J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Eyles, Darryl W.; McGrath, John J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [McGrath, John J.] Univ Queensland, Dept Psychiat, Sch Med, St Lucia, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Dean, AJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	a.dean@uq.edu.au	Eyles, Darryl W/X-3386-2018; McGrath, John Joseph/G-5493-2010; Kvaskoff, David/F-1010-2017; Bellgrove, Mark/AAB-3114-2019; Dean, Angela/D-5618-2011	Eyles, Darryl W/0000-0002-5023-7095; McGrath, John Joseph/0000-0002-4792-6068; Kvaskoff, David/0000-0002-5569-7226; Dean, Angela/0000-0003-4017-4809; Bellgrove, Mark/0000-0003-0186-8349	Queensland Health	Queensland Health	Funding was provided by Queensland Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Buell JS, 2009, J GERONTOL A-BIOL, V64, P888, DOI 10.1093/gerona/glp032; Dumville JC, 2006, J NUTR HEALTH AGING, V10, P151; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Galdos M, 2010, SCHIZOPHR B IN PRESS; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HARRIS S, 1993, PSYCHIAT RES, V49, P77, DOI 10.1016/0165-1781(93)90031-B; Heaney RP, 2003, AM J CLIN NUTR, V78, P912, DOI 10.1093/ajcn/78.5.912; Hedelin M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-38; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; IOM, 2011, DIET REF INT CALC VI; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Lanham-New S A, 2011, Br J Nutr, V105, P144, DOI 10.1017/S0007114510002576; Lansdowne ATG, 1998, PSYCHOPHARMACOLOGY, V135, P319, DOI 10.1007/s002130050517; Lee DM, 2009, J NEUROL NEUROSUR PS, V80, P722, DOI 10.1136/jnnp.2008.165720; Llewellyn DJ, 2009, J GERIATR PSYCH NEUR, V22, P188, DOI 10.1177/0891988708327888; Logan Gordon D., 1994, P189; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath J, 2001, TRENDS NEUROSCI, V24, P570, DOI 10.1016/S0166-2236(00)01949-4; McGrath J, 2007, NEUROEPIDEMIOLOGY, V29, P49, DOI 10.1159/000108918; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Milaneschi Y., 2010, J CLIN ENDOCR METAB; Miyake A, 2004, ACTA PSYCHOL, V115, P123, DOI 10.1016/j.actpsy.2003.12.004; NEVEU I, 1994, J NEUROSCI RES, V38, P214, DOI 10.1002/jnr.490380212; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Przybelski RJ, 2007, ARCH BIOCH BIOPHYS; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger CD, 1999, STAXI 2 STATE TRAIT; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c	36	108	112	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e25966	10.1371/journal.pone.0025966	http://dx.doi.org/10.1371/journal.pone.0025966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073146	Green Published, gold			2022-12-27	WOS:000297198200004
J	Eller-Vainicher, C; Chiodini, I; Santi, I; Massarotti, M; Pietrogrande, L; Cairoli, E; Beck-Peccoz, P; Longhi, M; Galmarini, V; Gandolini, G; Bevilacqua, M; Grossi, E				Eller-Vainicher, Cristina; Chiodini, Iacopo; Santi, Ivana; Massarotti, Marco; Pietrogrande, Luca; Cairoli, Elisa; Beck-Peccoz, Paolo; Longhi, Matteo; Galmarini, Valter; Gandolini, Giorgio; Bevilacqua, Maurizio; Grossi, Enzo			Recognition of Morphometric Vertebral Fractures by Artificial Neural Networks: Analysis from GISMO Lombardia Database	PLOS ONE			English	Article							BONE-MINERAL DENSITY; DEFORMITY INDEX SDI; OSTEOPOROTIC FRACTURE; POSTMENOPAUSAL WOMEN; RISK-FACTOR; CLASSIFICATION; METAANALYSIS; PREDICTION; REGRESSION; WELL	Background: It is known that bone mineral density (BMD) predicts the fracture's risk only partially and the severity and number of vertebral fractures are predictive of subsequent osteoporotic fractures (OF). Spinal deformity index (SDI) integrates the severity and number of morphometric vertebral fractures. Nowadays, there is interest in developing algorithms that use traditional statistics for predicting OF. Some studies suggest their poor sensitivity. Artificial Neural Networks (ANNs) could represent an alternative. So far, no study investigated ANNs ability in predicting OF and SDI. The aim of the present study is to compare ANNs and Logistic Regression (LR) in recognising, on the basis of osteoporotic risk-factors and other clinical information, patients with SDI >= 1 and SDI >= 5 from those with SDI = 0. Methodology: We compared ANNs prognostic performance with that of LR in identifying SDI >= 1/SDI >= 5 in 372 women with postmenopausal-osteoporosis (SDI >= 1, n = 176; SDI = 0, n = 196; SDI >= 5, n = 51), using 45 variables (44 clinical parameters plus BMD). ANNs were allowed to choose relevant input data automatically (TWIST-system-Semeion). Among 45 variables, 17 and 25 were selected by TWIST-system-Semeion, in SDI >= 1 vs SDI = 0 (first) and SDI >= 5 vs SDI = 0 (second) analysis. In the first analysis sensitivity of LR and ANNs was 35.8% and 72.5%, specificity 76.5% and 78.5% and accuracy 56.2% and 75.5%, respectively. In the second analysis, sensitivity of LR and ANNs was 37.3% and 74.8%, specificity 90.3% and 87.8%, and accuracy 63.8% and 81.3%, respectively. Conclusions: ANNs showed a better performance in identifying both SDI >= 1 and SDI >= 5, with a higher sensitivity, suggesting its promising role in the development of algorithm for predicting OF.	[Eller-Vainicher, Cristina; Chiodini, Iacopo; Cairoli, Elisa; Beck-Peccoz, Paolo] Ca Granda Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci, Endocrinol & Diabetol Unit, Dept Med Sci, Milan, Italy; [Santi, Ivana] Ist Geriatr Azienda Serv Persona Ist Milanesi Mar, Milan, Italy; [Massarotti, Marco] Ist Ricovero & Cura Carattere Sci Humanitas, Milan, Italy; [Pietrogrande, Luca] Univ Milan, Orthoped Clin, Dipartimento Med Chirurg & Odontoiatria San Paolo, Milan, Italy; [Longhi, Matteo] Ist Ricovero & Cura Carattere Sci Ist Ortoped Gal, Unit Reumathol, Milan, Italy; [Galmarini, Valter] Azienda Osped Fatebenefratelli & Oftalm, Milan, Italy; [Gandolini, Giorgio] Ist Ricovero & Cura Carattere Sci Don Gnocchi, Milan, Italy; [Bevilacqua, Maurizio] Univ Milan, Endocrinol & Diabet Unit, Luigi Sacco Hosp Vialba, Milan, Italy; [Grossi, Enzo] San Donato Milanese, Bracco Med Dept, Milan, Italy; [Grossi, Enzo] Semeion Res Ctr, Rome, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Luigi Sacco Hospital; Bracco	Eller-Vainicher, C (corresponding author), Ca Granda Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci, Endocrinol & Diabetol Unit, Dept Med Sci, Milan, Italy.	eller.vainicher@gmail.com	Iacopo, Chiodini/W-9911-2019; Grossi, Enzo/AAF-7765-2020; Cairoli, Elisa/AAB-7010-2019	Iacopo, Chiodini/0000-0001-7594-3300; Cairoli, Elisa/0000-0001-8767-6385; Massarotti, Marco/0000-0001-9603-2098				Agenzia Italiana per il Farmaco, 79 AIFA; Andriulli A, 2003, DIGEST LIVER DIS, V35, P222, DOI 10.1016/S1590-8658(03)00057-4; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; Buscema M, 2005, ARTIF INTELL MED, V34, P279, DOI 10.1016/j.artmed.2004.12.001; Buscema M, 2004, EXPERT SYST, V21, P63, DOI 10.1111/j.1468-0394.2004.00264.x; Buscema M, 2007, COMPUT INTEL NEUROSC, V35021, P1; Caocci G, 2010, EXP HEMATOL, V38, P426, DOI 10.1016/j.exphem.2010.02.012; Crans GG, 2005, BONE, V37, P175, DOI 10.1016/j.bone.2005.04.003; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Laet C, 2005, OSTEOPOROSIS INT, V16, P313, DOI 10.1007/s00198-004-1689-z; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Di Monaco M, 2011, AM J PHYS MED REHAB, V90, P1, DOI 10.1097/PHM.0b013e31820174e8; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Garrett IR, 1999, J BONE MINER RES, V14, pS180; Gehlbach SH, 2000, OSTEOPOROSIS INT, V11, P577, DOI 10.1007/s001980070078; Genant HK, 2007, OSTEOPOROSIS INT, V18, P69, DOI 10.1007/s00198-006-0199-6; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Guglielmi G, 2009, EUR J RADIOL, V69, P173, DOI 10.1016/j.ejrad.2007.09.040; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2002, BONE, V30, P251, DOI 10.1016/S8756-3282(01)00653-6; Kerkeni S, 2009, OSTEOPOROSIS INT, V20, P1547, DOI 10.1007/s00198-008-0832-7; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lim LS, 2009, J AM GERIATR SOC, V57, P855, DOI 10.1111/j.1532-5415.2009.02195.x; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Melton LJ, 2006, OSTEOPOROSIS INT, V17, P978, DOI 10.1007/s00198-006-0106-1; MINNE HW, 1988, BONE MINER, V3, P335; Morelli V, 2010, EUR J CLIN INVEST, V40, P803, DOI 10.1111/j.1365-2362.2010.02330.x; Mussolino ME, 2006, ANN EPIDEMIOL, V16, P395, DOI 10.1016/j.annepidem.2005.06.051; National Institute on Alcohol Abuse and Alcoholism U.S. Dept of Health and Human Services, 2005, DESCR STAND DRINKS C; Nilsson J, 2006, J THORAC CARDIOV SUR, V132, P12, DOI 10.1016/j.jtcvs.2005.12.055; Ottenbacher KJ, 2004, ANN EPIDEMIOL, V14, P551, DOI 10.1016/j.annepidem.2003.10.005; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; Rejnmark L, 2006, J BONE MINER RES, V21, P163, DOI 10.1359/JBMR.051003; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Rumelhart D.E., 1988, PARALLEL DISTRIBUTED, V1, DOI [10.1016/B978-1-4832-1446-7.50010-8, DOI 10.1016/B978-1-4832-1446-7.50010-8]; Snow PB, 2001, CANCER, V91, P1673, DOI 10.1002/1097-0142(20010415)91:8+<1673::AID-CNCR1182>3.0.CO;2-T; Sornay-Rendu E, 2010, J BONE MINER RES, V25, P2101, DOI 10.1002/jbmr.106; TREMOLLIERES FA, 2010, SCIENCE, V25, P1002; Varenna M, 2001, OSTEOPOROSIS INT, V12, P296, DOI 10.1007/s001980170119; WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Levels, 2004, ASSESSMENT OSTEOPORO; Zadeh LA, 1997, FUZZY SET SYST, V90, P111, DOI 10.1016/S0165-0114(97)00077-8	49	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27277	10.1371/journal.pone.0027277	http://dx.doi.org/10.1371/journal.pone.0027277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076144	Green Published, gold			2022-12-27	WOS:000297198200058
J	Li, ZW; Potts-Kant, EN; Garantziotis, S; Foster, WM; Hollingsworth, JW				Li, Zhuowei; Potts-Kant, Erin N.; Garantziotis, Stavros; Foster, W. Michael; Hollingsworth, John W.			Hyaluronan Signaling during Ozone-Induced Lung Injury Requires TLR4, MyD88, and TIRAP	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; AIRWAY HYPERRESPONSIVENESS; CUTTING EDGE; MOUSE LUNG; MICE; INFLAMMATION; MORTALITY; SUSCEPTIBILITY; EXPOSURE; ASTHMA	Ozone exposure is associated with exacerbation of reactive airways disease. We have previously reported that the damage-associated molecular pattern, hyaluronan, is required for the complete biological response to ambient ozone and that hyaluronan fragments signal through toll-like receptor 4 (TLR4). In this study, we further investigated the role of TLR4 adaptors in ozone-induced airway hyperresponsiveness (AHR) and the direct response to hyaluronan fragments (HA). Using a murine model of AHR, C57BL/6J, TLR4(-/-), MyD88(-/-), and TIRAP(-/-) mice were characterized for AHR after exposure to either ozone (1 ppmx3 h) or HA fragments. Animals were characterized for AHR with methacholine challenge, cellular inflammation, lung injury, and production of pro-inflammatory cytokines. Ozone-exposed C57BL/6J mice developed cellular inflammation, lung injury, pro-inflammatory cytokines, and AHR, while mice deficient in TLR4, MyD88 or TIRAP demonstrated both reduced AHR and reduced levels of pro-inflammatory cytokines including TNF alpha, IL-1 beta, MCP-1, IL-6 and KC. The level of hyaluronan was increased after inhalation of ozone in each strain of mice. Direct challenge of mice to hyaluronan resulted in AHR in C57BL/6J mice, but not in TLR4(-/-), MyD88(-/-), or TIRAP(-/-) mice. HA-induced cytokine production in wild-type mice was significantly reduced in TLR4(-/-), MyD88(-/-), or TIRAP(-/-) mice. In conclusion, our findings support that ozone-induced airway hyperresponsiveness is dependent on the HA-TLR4-MyD88-TIRAP signaling pathway.	[Li, Zhuowei; Potts-Kant, Erin N.; Foster, W. Michael; Hollingsworth, John W.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Hollingsworth, John W.] Duke Univ, Dept Immunol, Durham, NC USA; [Garantziotis, Stavros] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Li, ZW (corresponding author), Duke Univ, Dept Med, Durham, NC 27710 USA.	john.hollingsworth@duke.edu	Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X	National Institute of Environmental Health Sciences [ES016126, ES020426]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, ZIAES102605, R21ES020426] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (ES016126, ES020426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Auten RL, 2009, AM J RESP CRIT CARE, V180, P1218, DOI 10.1164/rccm.200901-0116OC; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bauer AK, 2011, ENVIRON HEALTH PERSP, V119, P1091, DOI 10.1289/ehp.1003326; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Chang HH, 2010, INT J ENV RES PUB HE, V7, P2866, DOI 10.3390/ijerph7072866; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; DeLorme MP, 2002, J TOXICOL ENV HEAL A, V65, P1453, DOI 10.1080/00984100290071432; Foster WM, 2010, AM J PHYSIOL-LUNG C, V299, pL345, DOI 10.1152/ajplung.00067.2010; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; GRYPARIS A, 2004, AM J RESP CRIT CARE, V28, P28; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620, DOI 10.1165/ajrcmb.22.5.3912; Kleeberger SR, 2001, AM J PHYSIOL-LUNG C, V280, pL326, DOI 10.1152/ajplung.2001.280.2.L326; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Leu SW, 2011, J IMMUNOL, V186, P556, DOI 10.4049/jimmunol.1001630; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Li ZW, 2010, J IMMUNOL, V185, P6891, DOI 10.4049/jimmunol.1000283; Lukacs Nicholas W., 2007, V14, P68, DOI 10.1159/000107055; Matsumoto K, 1999, EUR RESPIR J, V14, P1088, DOI 10.1183/09031936.99.14510889; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Park JW, 2004, AM J RESP CELL MOL, V30, P830, DOI 10.1165/rcmb.2003-0373OC; Que LG, 2011, J APPL PHYSL; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Schroder NWJ, 2007, ALLERGY, V62, P579, DOI 10.1111/j.1398-9995.2007.01386.x; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; WIESTER MJ, 1988, TOXICOL APPL PHARM, V96, P140, DOI 10.1016/0041-008X(88)90256-6; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Williams MA, 2007, BIOMARK INSIGHTS, V2, P226; Wood LG, 2011, CLIN EXP ALLERGY, V41, P640, DOI 10.1111/j.1365-2222.2010.03669.x; Wu ZX, 2008, RESP PHYSIOL NEUROBI, V164, P300, DOI 10.1016/j.resp.2008.07.019; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	50	52	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27137	10.1371/journal.pone.0027137	http://dx.doi.org/10.1371/journal.pone.0027137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073274	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200038
J	Xu, N; Kwon, S; Abbott, DH; Geller, DH; Dumesic, DA; Azziz, R; Guo, XQ; Goodarzi, MO				Xu, Ning; Kwon, Soonil; Abbott, David H.; Geller, David H.; Dumesic, Daniel A.; Azziz, Ricardo; Guo, Xiuqing; Goodarzi, Mark O.			Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys	PLOS ONE			English	Article							CAG REPEAT POLYMORPHISM; DNA METHYLATION; PROSTATE CARCINOGENESIS; GENETIC ASSOCIATION; FEMALE REPRODUCTION; EXCESS; WOMEN; FETAL; FOLLISTATIN; SUSCEPTIBILITY	The pathogenesis of polycystic ovary syndrome (PCOS) is poorly understood. PCOS-like phenotypes are produced by prenatal androgenization (PA) of female rhesus monkeys. We hypothesize that perturbation of the epigenome, through altered DNA methylation, is one of the mechanisms whereby PA reprograms monkeys to develop PCOS. Infant and adult visceral adipose tissues (VAT) harvested from 15 PA and 10 control monkeys were studied. Bisulfite treated samples were subjected to genome-wide CpG methylation analysis, designed to simultaneously measure methylation levels at 27,578 CpG sites. Analysis was carried out using Bayesian Classification with Singular Value Decomposition (BCSVD), testing all probes simultaneously in a single test. Stringent criteria were then applied to filter out invalid probes due to sequence dissimilarities between human probes and monkey DNA, and then mapped to the rhesus genome. This yielded differentially methylated loci between PA and control monkeys, 163 in infant VAT, and 325 in adult VAT (BCSVD P<0.05). Among these two sets of genes, we identified several significant pathways, including the antiproliferative role of TOB in T cell signaling and transforming growth factor-beta (TGF-beta) signaling. Our results suggest PA may modify DNA methylation patterns in both infant and adult VAT. This pilot study suggests that excess fetal androgen exposure in female nonhuman primates may predispose to PCOS via alteration of the epigenome, providing a novel avenue to understand PCOS in humans.	[Xu, Ning; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Kwon, Soonil; Guo, Xiuqing; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Geller, David H.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Azziz, Ricardo; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Abbott, David H.; Dumesic, Daniel A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Goodarzi, Mark O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Dumesic, Daniel A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Xu, N (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Azziz, Ricardo/N-7229-2014; Goodarzi, Mark/AAH-7106-2021	Azziz, Ricardo/0000-0002-3917-0483; Goodarzi, Mark/0000-0001-6364-5103; Dumesic, Daniel/0000-0003-0387-1277	National Institutes of Health [R01-HD029364, K24-HD001346, R01-DK079888, R01-RR013635, P50-HD044405, U01-HD044650]; National Center for Research Resources [P51-RR00167, P51-RR000169, M01-RR000425]; Research Facilities Improvement Program [RR-015459-01, RR-020141-01]; Winnick Clinical Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD044405] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001346, R01HD029364, U01HD044650] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, P51RR000167, C06RR015459, R01RR013635, M01RR000425, P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Winnick Clinical Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [R01-HD029364, K24-HD001346 to R. A., R01-DK079888 to M.O.G., R01-RR013635 to D. H. A., P50-HD044405 to Andrea Dunaif, U01-HD044650 to D. A. D.]; National Center for Research Resources [P51-RR00167 to the Wisconsin National Primate Research Center (WNPRC), P51-RR000169 to the California National Primate Research Center (CNPRC), M01-RR000425 to the Cedars-Sinai General Clinical Research Center]; Research Facilities Improvement Program Grants RR-015459-01 and RR-020141-01 to the WNPRC; and the Winnick Clinical Scholars Award [to M.O.G.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2008, BIOL REPROD, V79, P154, DOI 10.1095/biolreprod.108.067702; Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Abbott DH, 2002, POLYCYSTIC OVARY SYNDROME, P119; Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Anderson H, 2010, J CLIN ENDOCR METAB, V95, P2180, DOI 10.1210/jc.2009-2651; Arifin E, 2008, VET PATHOL, V45, P512, DOI 10.1354/vp.45-4-512; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; BECKPECCOZ P, 1991, J CLIN ENDOCR METAB, V73, P525, DOI 10.1210/jcem-73-3-525; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Bennett KL, 2009, CANCER RES, V69, P9301, DOI 10.1158/0008-5472.CAN-09-3073; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bruns CM, 2007, INT J OBESITY, V31, P1579, DOI 10.1038/sj.ijo.0803638; Calvo RM, 2000, J CLIN ENDOCR METAB, V85, P1735, DOI 10.1210/jc.85.4.1735; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Eisner JR, 2003, OBES RES, V11, P279, DOI 10.1038/oby.2003.42; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Eldar-Geva T, 2001, HUM REPROD, V16, P2552, DOI 10.1093/humrep/16.12.2552; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Fernandez-Morera JL, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/605163; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frontelo P, 2004, ONCOGENE, V23, P5242, DOI 10.1038/sj.onc.1207660; Goodarzi MO, 2008, SEMIN REPROD MED, V26, P5, DOI 10.1055/s-2007-992919; Goodarzi MO, 2008, DIABETES CARE, V31, P2284, DOI 10.2337/dc08-0532; GOY RW, 1982, BANBURY REPORT, V11, P355; Hanson MA, 2008, BASIC CLIN PHARMACOL, V102, P90, DOI 10.1111/j.1742-7843.2007.00186.x; Hickey M, 2009, J CLIN ENDOCR METAB, V94, P3714, DOI 10.1210/jc.2009-0544; Hickey TE, 2006, J CLIN ENDOCR METAB, V91, P2789, DOI 10.1210/jc.2006-0069; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Jones MR, 2007, MOL HUM REPROD, V13, P237, DOI 10.1093/molehr/gal120; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Kuijper EAM, 2009, J CLIN ENDOCR METAB, V94, P1987, DOI 10.1210/jc.2009-0191; Kwon Soonil, 2009, BMC Proc, V3 Suppl 7, pS9; La Marca A, 2006, CLIN ENDOCRINOL, V64, P603, DOI 10.1111/j.1365-2265.2006.02533.x; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Moran LJ, 2008, MUTAT RES-FUND MOL M, V639, P55, DOI 10.1016/j.mrfmmm.2007.11.007; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prodoehl MJ, 2009, MOL CELL ENDOCRINOL, V307, P133, DOI 10.1016/j.mce.2009.03.002; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Raja-Khan N, 2010, FERTIL STERIL, V94, P2916, DOI 10.1016/j.fertnstert.2010.05.047; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Shah R, 2006, HUM GENET, V120, P461, DOI 10.1007/s00439-006-0194-1; Song F, 2009, GENOMICS, V93, P130, DOI 10.1016/j.ygeno.2008.09.003; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; Yesilada E, 2006, EUR J ENDOCRINOL, V154, P563, DOI 10.1530/eje.1.02117; Zhu JQ, 2010, MOL HUM REPROD, V16, P260, DOI 10.1093/molehr/gap089	64	103	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27286	10.1371/journal.pone.0027286	http://dx.doi.org/10.1371/journal.pone.0027286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076147	Green Submitted, gold, Green Published			2022-12-27	WOS:000297198200061
J	Lisso, J; Schroder, F; Fisahn, J; Mussig, C				Lisso, Janina; Schroeder, Florian; Fisahn, Joachim; Muessig, Carsten			NFX1-LIKE2 (NFXL2) Suppresses Abscisic Acid Accumulation and Stomatal Closure in Arabidopsis thaliana	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; DROUGHT STRESS TOLERANCE; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; HYDROGEN-PEROXIDE; GENE-EXPRESSION; WATER-STRESS; ABA; INTERACTS; UBIQUITIN	The NFX1-LIKE1 (NFXL1) and NFXL2 genes were identified as regulators of salt stress responses. The NFXL1 protein is a nuclear factor that positively affects adaptation to salt stress. The nfxl1-1 loss-of-function mutant displayed reduced survival rates under salt and high light stress. In contrast, the nfxl2-1 mutant, defective in the NFXL2 gene, and NFXL2-antisense plants exhibited enhanced survival under these conditions. We show here that the loss of NFXL2 function results in abscisic acid (ABA) overaccumulation, reduced stomatal conductance, and enhanced survival under drought stress. The nfxl2-1 mutant displayed reduced stomatal aperture under all conditions tested. Fusicoccin treatment, exposition to increasing light intensities, and supply of decreasing CO2 concentrations demonstrated full opening capacity of nfxl2-1 stomata. Reduced stomatal opening presumably is a consequence of elevated ABA levels. Furthermore, seedling growth, root growth, and stomatal closure were hypersensitive to exogenous ABA. The enhanced ABA responses may contribute to the improved drought stress resistance of the mutant. Three NFXL2 splice variants were cloned and named NFXL2-78, NFXL2-97, and NFXL2-100 according to the molecular weight of the putative proteins. Translational fusions to the green fluorescent protein suggest nuclear localisation of the NFXL2 proteins. Stable expression of the NFXL2-78 splice variant in nfxl2-1 plants largely complemented the mutant phenotype. Our data show that NFXL2 controls ABA levels and suppresses ABA responses. NFXL2 may prevent unnecessary and costly stress adaptation under favourable conditions.	[Lisso, Janina; Schroeder, Florian; Fisahn, Joachim; Muessig, Carsten] Univ Potsdam, Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society; University of Potsdam	Lisso, J (corresponding author), Univ Potsdam, Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	muessig@uni-potsdam.de			Deutsche Forschungsgemeinschaft [MU 1738/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (MU 1738/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Berger D, 2000, GENE DEV, V14, P1119; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Johansson M, 2011, PLANT PHYSIOL, V155, P2108, DOI 10.1104/pp.110.167155; Jubany-Mari T, 2010, PLANT PHYSIOL BIOCH, V48, P351, DOI 10.1016/j.plaphy.2010.01.021; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katzenellenbogen RA, 2009, J VIROL, V83, P6446, DOI 10.1128/JVI.02556-08; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Lisso J, 2006, FEBS LETT, V580, P4851, DOI 10.1016/j.febslet.2006.07.079; Liu HX, 2011, PLANT SIGNAL BEHAV, V6, P344, DOI 10.4161/psb.6.3.13914; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luna CM, 2005, J EXP BOT, V56, P417, DOI 10.1093/jxb/eri039; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mussig C, 2010, PLANT BIOLOGY, V12, P381, DOI 10.1111/j.1438-8677.2009.00303.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muschak M, 1999, PLANTA, V209, P104, DOI 10.1007/s004250050611; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Pandey S, 2007, FEBS LETT, V581, P2325, DOI 10.1016/j.febslet.2007.04.008; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; SONG ZM, 1994, J EXP MED, V180, P1763, DOI 10.1084/jem.180.5.1763; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07; Xu M, 2010, J VIROL, V84, P11461, DOI 10.1128/JVI.00538-10; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	77	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26982	10.1371/journal.pone.0026982	http://dx.doi.org/10.1371/journal.pone.0026982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073231	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000018
J	Liu, JX; Qin, W; Nan, JF; Li, J; Yuan, K; Zhao, L; Zeng, F; Sun, JB; Yu, DH; Dong, MH; Liu, P; von Deneen, KM; Gong, QY; Liang, FR; Tian, J				Liu, Jixin; Qin, Wei; Nan, Jiaofen; Li, Jing; Yuan, Kai; Zhao, Ling; Zeng, Fang; Sun, Jinbo; Yu, Dahua; Dong, Minghao; Liu, Peng; von Deneen, Karen M.; Gong, Qiyong; Liang, Fanrong; Tian, Jie			Gender-Related Differences in the Dysfunctional Resting Networks of Migraine Suffers	PLOS ONE			English	Article							STRUCTURAL CORTICAL NETWORKS; GRAPH-THEORETICAL ANALYSIS; GREY-MATTER CHANGES; QUALITY-OF-LIFE; SEX-DIFFERENCES; CONNECTIVITY PATTERNS; ANATOMICAL NETWORKS; BRAIN NETWORKS; YOUNG-ADULTS; HEADACHE	Background: Migraine shows gender-specific incidence and has a higher prevalence in females. However, little is known about gender-related differences in dysfunctional brain organization, which may account for gender-specific vulnerability and characteristics of migraine. In this study, we considered gender-related differences in the topological property of resting functional networks. Methodology/Principal Findings: Data was obtained from 38 migraine patients (18 males and 20 females) and 38 healthy subjects (18 males and 20 females). We used the graph theory analysis, which becomes a powerful tool in investigating complex brain networks on a whole brain scale and could describe functional interactions between brain regions. Using this approach, we compared the brain functional networks between these two groups, and several network properties were investigated, such as small-worldness, network resilience, nodal centrality, and interregional connections. In our findings, these network characters were all disrupted in patients suffering from chronic migraine. More importantly, these functional damages in the migraine-affected brain had a skewed balance between males and females. In female patients, brain functional networks showed worse resilience, more regions exhibited decreased nodal centrality, and more functional connections revealed abnormalities than in male patients. Conclusions: These results indicated that migraine may have an additional influence on females and lead to more dysfunctional organization in their resting functional networks.	[Liu, Jixin; Qin, Wei; Nan, Jiaofen; Li, Jing; Yuan, Kai; Sun, Jinbo; Yu, Dahua; Dong, Minghao; Liu, Peng; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling; Zeng, Fang; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Peoples R China; [Gong, Qiyong] Sichuan Univ, HMRRC, Dept Radiol, Ctr Med Imaging,W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Sichuan University; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, JX (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	chinwei@mail.xidian.edu.cn; lfr@cdutcm.edu.cn; tian@ieee.org	秦, 伟/J-9770-2016; Tian, Jie/H-1190-2011; tian, jie/M-6336-2013; JinBo, Sun/GLT-2082-2022; Dong, Minghao/A-6425-2014; Yuan, Kai/I-4150-2016; Gong, Qiyong/W-3052-2019; Yuan, Kai/M-9403-2013; Life, PAM/M-9552-2013; Yu, Dahua/N-7242-2013	秦, 伟/0000-0003-4583-0406; Tian, Jie/0000-0003-0498-0432; Dong, Minghao/0000-0002-0190-6985; Yuan, Kai/0000-0002-3098-1124; Gong, Qiyong/0000-0002-5912-4871; Yu, Dahua/0000-0001-7850-7512; Liang, Fanrong/0000-0003-2210-2027	National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 30901900, 81001504, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171]; Fundamental Research Funds for the Central Universities; Chinese Academy of Sciences [KGCX2-YW-129]; Inner Mongolia University of Science and Technology [2010NC030, 2010NC037]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Academy of Sciences(Chinese Academy of Sciences); Inner Mongolia University of Science and Technology	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702 and 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 30901900, 81001504, 81000640, 81000641, 81071217, 81101036, 81101108 and 31150110171, the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129, and the Innovation Fund Project of Inner Mongolia University of Science and Technology Nos. 2010NC030 and 2010NC037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bernhardt BC, 2011, CEREB CORTE IN PRESS; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao Y, 2002, NEUROLOGY, V59, P72, DOI 10.1212/WNL.59.1.72; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; Detsky ME, 2006, JAMA-J AM MED ASSOC, V296, P1274, DOI 10.1001/jama.296.10.1274; Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081; Filippi M, 2008, NEUROL SCI, V29, pS336, DOI 10.1007/s10072-008-1011-5; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gong G, 2011, NEUROSCIENT IN PRESS; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gur RC, 1999, J NEUROSCI, V19, P4065; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton C, 2009, COGNITION SEX DIFFER, V51, P965; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Kang DH, 2010, KOREAN J PAIN, V23, P159, DOI 10.3344/kjp.2010.23.3.159; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Salat DH, 2002, CEREB CORTEX, V12, P494, DOI 10.1093/cercor/12.5.494; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmidt-Wilcke T, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2007.01428.x; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sporns Olaf, 2001, Complexity, V7, P28, DOI 10.1002/cplx.10015; Stewart WF, 2008, CEPHALALGIA, V28, P1170, DOI 10.1111/j.1468-2982.2008.01666.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Terwindt GM, 2000, NEUROLOGY, V55, P624, DOI 10.1212/WNL.55.5.624; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Welch KMA, 1998, NEUROLOGY, V51, P1465, DOI 10.1212/WNL.51.5.1465; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	73	46	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27049	10.1371/journal.pone.0027049	http://dx.doi.org/10.1371/journal.pone.0027049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073251	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900010
J	Ouvrier, A; Alves, G; Damon-Soubeyrand, C; Marceau, G; Cadet, R; Janny, L; Brugnon, F; Kocer, A; Pommier, A; Lobaccaro, JMA; Drevet, JR; Saez, F				Ouvrier, Aurelia; Alves, Georges; Damon-Soubeyrand, Christelle; Marceau, Geoffroy; Cadet, Remi; Janny, Laurent; Brugnon, Florence; Kocer, Ayhan; Pommier, Aurelien; Lobaccaro, Jean-Marc A.; Drevet, Joel R.; Saez, Fabrice			Dietary Cholesterol-Induced Post-Testicular Infertility	PLOS ONE			English	Article							LIVER-X-RECEPTORS; HOMEOSTASIS; LXR; EXPRESSION; CAVEOLAE; OBESITY; LIPIDS; BETA; MICE	This work shows that an overload of dietary cholesterol causes complete infertility in dyslipidemic male mice (the Liver X Receptor-deficient mouse model). Infertility resulted from post-testicular defects affecting the fertilizing potential of spermatozoa. Spermatozoa of cholesterol-fed lxr-/- animals were found to be dramatically less viable and motile, and highly susceptible to undergo a premature acrosome reaction. We also provide evidence, that this lipid-induced infertility is associated with the accelerated appearance of a highly regionalized epididymal phenotype in segments 1 and 2 of the caput epididymidis that was otherwise only observed in aged LXR-deficient males. The epididymal epithelial phenotype is characterized by peritubular accumulation of cholesteryl ester lipid droplets in smooth muscle cells lining the epididymal duct, leading to their transdifferentiation into foam cells that eventually migrate through the duct wall, a situation that resembles the inflammatory atherosclerotic process. These findings establish the high level of susceptibility of epididymal sperm maturation to dietary cholesterol overload and could partly explain reproductive failures encountered by young dyslipidemic men as well as ageing males wishing to reproduce.	[Ouvrier, Aurelia; Damon-Soubeyrand, Christelle; Cadet, Remi; Kocer, Ayhan; Drevet, Joel R.; Saez, Fabrice] Univ Blaise Pascal, Equipe Epididyme & Maturat Gametes, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Alves, Georges; Damon-Soubeyrand, Christelle; Pommier, Aurelien; Lobaccaro, Jean-Marc A.] Univ Blaise Pascal, Equipe LXR Oxysterols & Tissus Steroidogenes, UnivUMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Alves, Georges; Damon-Soubeyrand, Christelle; Pommier, Aurelien; Lobaccaro, Jean-Marc A.] Univ Blaise Pascal, Ctr Rech Nutr Humaine Auvergne CRNH, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Marceau, Geoffroy] Univ Blaise Pascal, Equipe Implicat & Metab & Mol Retinoides Dev Huma, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Janny, Laurent; Brugnon, Florence] Univ Clermont 1, EA 975, Clermont Ferrand, France; [Janny, Laurent; Brugnon, Florence] CECOS, CHU Estaing, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Ouvrier, A (corresponding author), Univ Blaise Pascal, Equipe Epididyme & Maturat Gametes, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France.	joel.drevet@univ-bpclermont.fr	Kocer, Ayhan/N-7927-2014; Drevet, Joël/W-2692-2019; LOBACCARO, Jean-Marc/L-6151-2015; Lobaccaro, Jean-Marc/Q-3926-2019; Brugnon, Florence/X-9423-2019	Drevet, Joël/0000-0003-3077-6558; Lobaccaro, Jean-Marc/0000-0001-9890-2392; Brugnon, Florence/0000-0002-8402-8734; MARCEAU, GEOFFROY/0000-0003-4713-7162				ABE K, 1983, ARCH HISTOL JAPON, V46, P51, DOI 10.1679/aohc.46.51; Bakos HW, 2010, INT J ANDROL, P1; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Dondorp W, 2010, HUM REPROD, V25, P578, DOI 10.1093/humrep/dep458; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; El-Hajjaji FZ, 2011, BBA-MOL BASIS DIS, V1812, P974, DOI 10.1016/j.bbadis.2011.02.004; Fielding CJ, 2001, ADV DRUG DELIVER REV, V49, P251, DOI 10.1016/S0169-409X(01)00140-5; Frenoux JM, 2004, J MOL ENDOCRINOL, V33, P361, DOI 10.1677/jme.1.01515; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hassan HH, 2006, CAN J CARDIOL, V22, p35B, DOI 10.1016/S0828-282X(06)70985-0; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; KRUTSKIKH A, ENDOCRINOLOGY, V152, P689, DOI DOI 10.1210/EN.2007-1805; Ledger WL, 2009, REPROD BIOMED ONLINE, V18, pS11, DOI 10.1016/S1472-6483(10)60442-7; Mouzat K, 2007, J BIOL CHEM, V282, P4693, DOI 10.1074/jbc.M606718200; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Ohtsuka M, 2006, J ATHEROSCLER THROMB, V13, P256, DOI 10.5551/jat.13.256; Ouvrier A, 2009, J LIPID RES, V50, P1766, DOI 10.1194/jlr.M800657-JLR200; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Reyland ME, 2000, J BIOL CHEM, V275, P36637, DOI 10.1074/jbc.M006456200; Robertson KM, 2005, ENDOCRINOLOGY, V146, P2519, DOI 10.1210/en.2004-1413; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Saez F, 2007, ASIAN J ANDROL, V9, P574, DOI 10.1111/j.1745-7262.2007.00301.x; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; SSS, SSSSS; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Vukovic Irena, 2006, Exp Clin Cardiol, V11, P123; Zappalla FR, 2009, ENDOCRIN METAB CLIN, V38, P171, DOI 10.1016/j.ecl.2008.11.006	34	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26966	10.1371/journal.pone.0026966	http://dx.doi.org/10.1371/journal.pone.0026966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073227	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900055
J	Brehm, C; Huenecke, S; Quaiser, A; Esser, R; Bremm, M; Kloess, S; Soerensen, J; Kreyenberg, H; Seidl, C; Becker, PSA; Muhl, H; Klingebiel, T; Bader, P; Passweg, JR; Schwabe, D; Koehl, U				Brehm, Claudia; Huenecke, Sabine; Quaiser, Andrea; Esser, Ruth; Bremm, Melanie; Kloess, Stephan; Soerensen, Jan; Kreyenberg, Hermann; Seidl, Christian; Becker, Petra S. A.; Muehl, Heiko; Klingebiel, Thomas; Bader, Peter; Passweg, Jakob R.; Schwabe, Dirk; Koehl, Ulrike			IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study	PLOS ONE			English	Article							NATURAL-KILLER-CELL; IN-VIVO; TRANSPLANTATION; IMMUNOTHERAPY; EXPANSION; CYTOTOXICITY; RECEPTORS; SUBPOPULATIONS; INTERLEUKIN-2; TRAFFICKING	In an ongoing clinical phase I/II study, 16 pediatric patients suffering from high risk leukemia/tumors received highly purified donor natural killer (NK) cell immunotherapy (NK-DLI) at day (+3) +40 and +100 post haploidentical stem cell transplantation. However, literature about the influence of NK-DLI on recipient's immune system is scarce. Here we present concomitant results of a noninvasive in vivo monitoring approach of recipient's peripheral blood (PB) cells after transfer of either unstimulated (NK-DLI((unstim))) or IL-2 (1000 U/ml, 9-14 days) activated NK cells (NK-DLI((IL-2 stim))) along with their ex vivo secreted cytokine/chemokines. We performed phenotypical and functional characterizations of the NK-DLIs, detailed flow cytometric analyses of various PB cells and comprehensive cytokine/chemokine arrays before and after NK-DLI. Patients of both groups were comparable with regard to remission status, immune reconstitution, donor chimerism, KIR mismatching, stem cell and NK-DLI dose. Only after NK-DLI((IL-2 stim)) was a rapid, almost complete loss of CD56((bright))CD16((dim/-)) immune regulatory and CD56((dim))CD16((+)) cytotoxic NK cells, monocytes, dendritic cells and eosinophils from PB circulation seen 10 min after infusion, while neutrophils significantly increased. The reduction of NK cells was due to both, a decrease in patients' own CD69((-)) NCR((low))CD62L((+)) NK cells as well as to a diminishing of the transferred cells from the NK-DLI((IL-2 stim)) with the CD56((bright))CD16((+/-))CD69((+))NCR((high))CD62L((-)) phenotype. All cell counts recovered within the next 24 h. Transfer of NK-DLI((IL-2 stim)) translated into significantly increased levels of various cytokines/chemokines (i.e. IFN-gamma, IL-6, MIP-1 beta) in patients' PB. Those remained stable for at least 1 h, presumably leading to endothelial activation, leukocyte adhesion and/or extravasation. In contrast, NK-DLI((unstim)) did not cause any of the observed effects. In conclusion, we assume that the adoptive transfer of NK-DLI((IL-2 stim)) under the influence of ex vivo and in vivo secreted cytokines/chemokines may promote NK cell trafficking and therefore might enhance efficacy of immunotherapy.	[Brehm, Claudia; Huenecke, Sabine; Quaiser, Andrea; Esser, Ruth; Bremm, Melanie; Kloess, Stephan; Soerensen, Jan; Kreyenberg, Hermann; Klingebiel, Thomas; Bader, Peter; Schwabe, Dirk; Koehl, Ulrike] Johann Wolfgang Goethe Univ Hosp, Lab Stem Cell Transplantat & Immunotherapy, Frankfurt, Germany; [Seidl, Christian; Becker, Petra S. A.] Inst Transfus Med & Immunohematol, Red Cross Blood Donor Serv, Frankfurt, Germany; [Muehl, Heiko] Johann Wolfgang Goethe Univ Hosp, Pharmazentrum Frankfurt, Frankfurt, Germany; [Passweg, Jakob R.] Univ Basel Hosp, Div Hematol, CH-4031 Basel, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Basel	Brehm, C (corresponding author), Johann Wolfgang Goethe Univ Hosp, Lab Stem Cell Transplantat & Immunotherapy, Frankfurt, Germany.	Claudia.Brehm@kgu.de	passweg, jakob/AAG-3911-2020	Passweg, Jakob R/0000-0001-7092-3351; Koehl, Ulrike/0000-0002-8159-9160	Deutsche Forschungsgemeinschaft (DFG) [GRK 1172]; Frankfurter Stiftung fur krebskranke Kinder; Hilfe fur krebskranke Kinder Frankfurt e.V.; A. Gutermuth Stiftung; LOEWE Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst (HMWK) [III L 4-518/17.004]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Frankfurter Stiftung fur krebskranke Kinder; Hilfe fur krebskranke Kinder Frankfurt e.V.; A. Gutermuth Stiftung; LOEWE Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst (HMWK)	This project was supported by the "Deutsche Forschungsgemeinschaft (DFG)" (GRK 1172), "Frankfurter Stiftung fur krebskranke Kinder" and "Hilfe fur krebskranke Kinder Frankfurt e.V.", the "A. Gutermuth Stiftung", as well as the "LOEWE Center for Cell and Gene Therapy Frankfurt" funded by: Hessisches Ministerium fur Wissenschaft und Kunst (HMWK); funding reference number: III L 4-518/17.004 (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON FR, 1988, J IMMUNOL, V141, P158; Becker S, 2003, HUM IMMUNOL, V64, P183, DOI 10.1016/S0198-8859(02)00802-9; Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Farag SS, 2002, BLOOD, V100, P1935, DOI 10.1182/blood-2002-02-0350; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Huenecke S, 2008, EUR J HAEMATOL, V80, P532, DOI 10.1111/j.1600-0609.2008.01052.x; Huenecke S, 2010, J IMMUNOTHER, V33, P200, DOI 10.1097/CJI.0b013e3181bb46f7; Kloess S, 2010, EUR J IMMUNOL, V40, P3255, DOI 10.1002/eji.201040568; Koehl U, 2008, INT J HEMATOL, V87, P98, DOI 10.1007/s12185-007-0018-7; Koehl U, 2005, KLIN PADIATR, V217, P345, DOI 10.1055/s-2005-872520; Koehl U, 2004, BLOOD CELL MOL DIS, V33, P261, DOI 10.1016/j.bcmd.2004.08.013; Kreyenberg H, 2003, LEUKEMIA, V17, P237, DOI 10.1038/sj.leu.2402761; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; LOTZE MT, 1985, J IMMUNOL, V135, P2865; Meller B, 2004, EUR J NUCL MED MOL I, V31, P403, DOI 10.1007/s00259-003-1398-4; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nguyen S, 2005, BLOOD, V105, P4135, DOI 10.1182/blood-2004-10-4113; Nishimura R, 2008, BLOOD, V112, P2563, DOI 10.1182/blood-2007-06-092817; Nowak B, 2007, EUR J NUCL MED MOL I, V34, P715, DOI 10.1007/s00259-006-0275-3; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Passweg JR, 2006, BEST PRACT RES CL HA, V19, P811, DOI 10.1016/j.beha.2006.06.004; Passweg JR, 2005, BONE MARROW TRANSPL, V35, P637, DOI 10.1038/sj.bmt.1704810; Passweg JR, 2004, LEUKEMIA, V18, P1835, DOI 10.1038/sj.leu.2403524; Pegram HJ, 2010, CANCER IMMUNOL IMMUN, V59, P1235, DOI 10.1007/s00262-010-0848-7; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; Rizzieri DA, 2010, BIOL BLOOD MARROW TR, V16, P1107, DOI 10.1016/j.bbmt.2010.02.018; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; SALVO G, 1992, EUR J CANCER, V28A, P818, DOI 10.1016/0959-8049(92)90122-I; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Siebert JC, 2010, IMMUNOTHERAPY-UK, V2, P799, DOI [10.2217/imt.10.76, 10.2217/IMT.10.76]; Zimmermann SY, 2005, J IMMUNOL METHODS, V296, P63, DOI 10.1016/j.jim.2004.10.014	40	68	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27351	10.1371/journal.pone.0027351	http://dx.doi.org/10.1371/journal.pone.0027351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096557	Green Published, gold			2022-12-27	WOS:000297350800047
J	Gartner, FR; Nieuwenhuijsen, K; van Dijk, FJH; Sluiter, JK				Gartner, Fania R.; Nieuwenhuijsen, Karen; van Dijk, Frank J. H.; Sluiter, Judith K.			Psychometric Properties of the Nurses Work Functioning Questionnaire (NWFQ)	PLOS ONE			English	Article							SF-36 HEALTH SURVEY; PSYCHOLOGICAL DISTRESS; CLINICAL MEASUREMENT; JOB-PERFORMANCE; RISK-FACTORS; PRODUCTIVITY; PRESENTEEISM; DEPRESSION; POPULATION; ANXIETY	Objectives: The Nurses Work Functioning Questionnaire (NWFQ) is a 50-item self-report questionnaire specifically developed for nurses and allied health professionals. Its seven subscales measure impairments in the work functioning due to common mental disorders. Aim of this study is to evaluate the psychometric properties of the NWFQ, by assessing reproducibility and construct validity. Methods: The questionnaire was administered to 314 nurses and allied health professionals with a re-test in 112 subjects. Reproducibility was assessed by the intraclass correlations coefficients (ICC) and the standard error of measurement (SEM). For construct validity, correlations were calculated with a general work functioning scale, the Endicott Work Productivity Scale (EWPS) (convergent validity) and with a physical functioning scale (divergent validity). For discriminative validity, a Mann Whitney U test was performed testing for significant differences between subjects with mental health complaints and without. Results: All subscales showed good reliability (ICC: 0.72-0.86), except for one (ICC = 0.16). Convergent validity was good in six subscales, correlations ranged from 0.38-0.62. However, in one subscale the correlation with the EWPS was too low (0.22). Divergent validity was good in all subscales based on correlations ranged from (-0.06)-(-0.23). Discriminative validity was good in all subscales, based on significant differences between subjects with and without mental health complaints (p<0.001-p=0.003). Conclusion: The NWFQ demonstrates good psychometric properties, for six of the seven subscales. Subscale "impaired decision making" needs improvement before further use.	[Gartner, Fania R.; Nieuwenhuijsen, Karen; van Dijk, Frank J. H.; Sluiter, Judith K.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Gartner, FR (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	F.R.Gartner@amc.uva.nl			Dutch Foundation Institute Gak	Dutch Foundation Institute Gak	This study was supported by a grant from the Dutch Foundation Institute Gak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DA, 2006, AM J PSYCHIAT, V163, P1569, DOI 10.1176/appi.ajp.163.9.1569; Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Bultmann U, 2002, J OCCUP ENVIRON MED, V44, P116; Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8; Burton WN, 1999, J OCCUP ENVIRON MED, V41, P863, DOI 10.1097/00043764-199910000-00007; Burton WN, 2004, J OCCUP ENVIRON MED, V46, pS38, DOI 10.1097/01.jom.0000126687.49652.44; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Endicott J, 1997, PSYCHOPHARMACOL BULL, V33, P13; Gartner FR, 2010, INT J NURS STUD, V47, P1047, DOI 10.1016/j.ijnurstu.2010.03.013; GARTNER FR, IMPAIRED WORK FUNCTI; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Haslam C, 2005, OCCUP ENVIRON MED, V62, P538, DOI 10.1136/oem.2004.016196; Hilton MF, 2008, J OCCUP ENVIRON MED, V50, P1228, DOI 10.1097/JOM.0b013e31818c30a8; Hultman Barbro, 2006, Work, V26, P47; Innes Ev, 1999, Work, V13, P125; Jenkinson C, 1996, J EPIDEMIOL COMMUN H, V50, P377, DOI 10.1136/jech.50.3.377; Koopman C, 2002, J OCCUP ENVIRON MED, V44, P14, DOI 10.1097/00043764-200201000-00004; Lerner D, 2004, J OCCUP ENVIRON MED, V46, pS46, DOI 10.1097/01.jom.0000126684.82825.0a; Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P401, DOI 10.1097/JOM.0b013e31816bae50; Mantha S, 2000, ANESTH ANALG, V90, P593, DOI 10.1097/00000539-200003000-00018; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McKnight PE, 2009, CLIN PSYCHOL REV, V29, P243, DOI 10.1016/j.cpr.2009.01.005; Nieuwenhuijsen K, 2010, J OCCUP ENVIRON MED, V52, P778, DOI 10.1097/JOM.0b013e3181ec7cd3; Pilette PC, 2005, J NURS ADMIN, V35, P300; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Schultz AB, 2007, J OCCUP REHABIL, V17, P547, DOI 10.1007/s10926-007-9096-x; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Suzuki K, 2004, J OCCUP HEALTH, V46, P448, DOI 10.1539/joh.46.448; Terluin B, 2004, WORK STRESS, V18, P187, DOI 10.1080/0267837042000297535; Terluin B, 1998, PSYCHOLOOG, V33, P18; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van Rhenen W, 2008, J OCCUP MED TOXICOL, V3, P3, DOI DOI 10.1186/1745-6673-3-3; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wieclaw J, 2006, OCCUP ENVIRON MED, V63, P314, DOI 10.1136/oem.2004.019398	40	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26565	10.1371/journal.pone.0026565	http://dx.doi.org/10.1371/journal.pone.0026565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HZ	22087231	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700008
J	Moyes, DL; Murciano, C; Runglall, M; Islam, A; Thavaraj, S; Naglik, JR				Moyes, David L.; Murciano, Celia; Runglall, Manohursingh; Islam, Ayesha; Thavaraj, Selvam; Naglik, Julian R.			Candida albicans Yeast and Hyphae are Discriminated by MAPK Signaling in Vaginal Epithelial Cells	PLOS ONE			English	Article							GROWTH-INHIBITION; HOST-DEFENSE; EXPRESSION; GENE; INFECTION; RESPONSES; VIRULENCE; IMMUNITY; HISTORY; FAMILY	We previously reported that a bi-phasic innate immune MAPK response, constituting activation of the mitogen-activated protein kinase (MAPK) phosphatase MKP1 and c-Fos transcription factor, discriminates between the yeast and hyphal forms of Candida albicans in oral epithelial cells (ECs). Since the vast majority of mucosal Candida infections are vaginal, we sought to determine whether a similar bi-phasic MAPK-based immune response was activated by C. albicans in vaginal ECs. Here, we demonstrate that vaginal ECs orchestrate an innate response to C. albicans via NF-kappa B and MAPK signaling pathways. However, unlike in oral ECs, the first MAPK response, defined by c-Jun transcription factor activation, is delayed until 2 h in vaginal ECs but is still independent of hypha formation. The 'second' or 'late' MAPK response, constituting MKP1 and c-Fos transcription factor activation, is identical to oral ECs and is dependent upon both hypha formation and fungal burdens. NF-kappa B activation is immediate but independent of morphology. Furthermore, the proinflammatory response in vaginal ECs is different to oral ECs, with an absence of G-CSF and CCL20 and low level IL-6 production. Therefore, differences exist in how C. albicans activates signaling mechanisms in oral and vaginal ECs; however, the activation of MAPK-based pathways that discriminate between yeast and hyphal forms is retained between these mucosal sites. We conclude that this MAPK-based signaling pathway is a common mechanism enabling different human epithelial tissues to orchestrate innate immune responses specifically against C. albicans hyphae.	[Moyes, David L.; Murciano, Celia; Runglall, Manohursingh; Islam, Ayesha; Thavaraj, Selvam; Naglik, Julian R.] Kings Coll London, Kings Coll London Dent Inst, Dept Oral Med Pathol & Immunol, London WC2R 2LS, England	University of London; King's College London	Moyes, DL (corresponding author), Kings Coll London, Kings Coll London Dent Inst, Dept Oral Med Pathol & Immunol, London WC2R 2LS, England.	julian.naglik@kcl.ac.uk	Thavaraj, Selvam/AAO-9113-2020; Murciano, Celia/K-8816-2014	Thavaraj, Selvam/0000-0001-5720-7422; Murciano, Celia/0000-0003-0035-5306; Moyes, David/0000-0002-1657-918X; Naglik, Julian/0000-0002-8072-7917; /0000-0002-3948-9697; Runglall, Manohursingh/0000-0002-0549-9029	National Institutes of Dental and Craniofacial Research [DE017514]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Wellcome Trust; Federation of European Microbiological Societies; King's College London; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017514] Funding Source: NIH RePORTER	National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Federation of European Microbiological Societies(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King's College London; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Dental and Craniofacial Research (DE017514). The authors also acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust in partnership with King's College London. DM is supported by a Wellcome Trust Value In People award, CM by a Federation of European Microbiological Societies Advanced Fellowship and AI by a King's College London Overseas Research Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barousse MM, 2001, J INFECT DIS, V184, P1489, DOI 10.1086/324532; Black CA, 1998, INFECT IMMUN, V66, P1273, DOI 10.1128/IAI.66.3.1273-1275.1998; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Dongari-Bagtzoglou A, 2004, MED MYCOL, V42, P531, DOI 10.1080/1369378042000193194; Dongari-Bagtzoglou A, 2003, ORAL MICROBIOL IMMUN, V18, P165, DOI 10.1034/j.1399-302X.2003.00061.x; Eversole LR, 1997, ORAL SURG ORAL MED O, V84, P372, DOI 10.1016/S1079-2104(97)90035-4; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; Fidel PL, 2004, TRENDS MICROBIOL, V12, P220, DOI 10.1016/j.tim.2004.03.006; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 1999, INFECT IMMUN, V67, P3135, DOI 10.1128/IAI.67.6.3135-3140.1999; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Korting HC, 2003, J MED MICROBIOL, V52, P623, DOI 10.1099/jmm.0.05125-0; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; LeBlanc DM, 2006, INFECT IMMUN, V74, P3213, DOI 10.1128/IAI.01824-05; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Murciano C, 2007, EUR CYTOKINE NETW, V18, P38; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Nomanbhoy F, 2002, INFECT IMMUN, V70, P7081, DOI 10.1128/IAI.70.12.7081-7088.2002; Odds F. C., 1988, CANDIDA CANDIDOSIS, P468; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Schaller M, 2002, J INVEST DERMATOL, V118, P652, DOI 10.1046/j.1523-1747.2002.01699.x; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sobel J D, 1988, Ann N Y Acad Sci, V544, P547, DOI 10.1111/j.1749-6632.1988.tb40450.x; Steele C, 1999, MED MYCOL, V37, P251, DOI 10.1046/j.1365-280X.1999.00228.x; Steele C, 1999, J INFECT DIS, V180, P802, DOI 10.1086/314964; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x	41	76	79	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26580	10.1371/journal.pone.0026580	http://dx.doi.org/10.1371/journal.pone.0026580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087232	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700009
J	Wang, L; Lin, JP; Zhou, Z; Huo, RF; Shen, BH; Sun, Y; Li, NL				Wang, Li; Lin, Jinpiao; Zhou, Zhou; Huo, Rongfen; Shen, Baihua; Sun, Yue; Li, Ningli			Up-Regulation of Th17 Cells May Underlie Inhibition of Treg Development Caused by Immunization with Activated Syngeneic T Cells	PLOS ONE			English	Article							IN-VIVO; DENDRITIC CELLS; MEDIATED SUPPRESSION; IMMUNE-RESPONSES; TUMOR-IMMUNITY; CANCER; GROWTH; DIFFERENTIATION; LINEAGE; T(H)17	Background: Our previous work showed that mice immunized with attenuated activated syngeneic T cells (aTCV) led to damping Treg function which resulted in enhancing anti-tumor immunity. It is well known that DC plays a very important role in controlling Th cell differentiation; whether DC involves Treg attenuation in immunized mice remained unknown. In this study, we provided evidence that increased mature DC (mDC) after immunization with aTCV skewed Th17 differentiation, which resulted in inhibition of Treg differentiation through IL-6 signaling pathway. Principal Findings: In the present study, we found that the frequency of mDCs increased dramatically in the immunized mice accompanied by lower Treg cells compared to the controls. Moreover, both DCs and serum derived from the immunized mice suppressed Treg differentiation in vitro, respectively. mDCs generated from bone marrow precursor cells in vitro strongly inhibited Treg development and simultaneously drove Th17 differentiation with elevated IL-6 production. However, PD-L1, a potent Treg inducer did not show effect on Treg down-regulation. Assay with transwell systems showed that cell-cell contact was necessary for IL-6 production to a threshold to activate Th17 transcriptional factor ROR gamma t and to inhibit Treg counterpart Foxp3. Conclusions: Our results implicate up-regulated Th17 development might be one of mechanisms of enhancing anti-tumor immunity induced by immunization with aTCV, which provide a novel insight in numerous mechanisms responsible for antitumor immunity.	[Wang, Li; Lin, Jinpiao; Zhou, Zhou; Huo, Rongfen; Shen, Baihua; Sun, Yue; Li, Ningli] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Wang, Li] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	ninglixiaoxue57@yahoo.com.cn			National Natural Science Foundation of China [30872990 1/4 CE11072468]; National Basic Research Program of China [2010CB529103]; Science and Technology Commission of Shanghai Municipality [10JC1408300]; Shanghai Municipal Education [J50207]; Shanghai Health Bureau [2010036]; Shanghai Jiao Tong University School of Medicine [YBPY2009009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education(Shanghai Municipal Education Commission (SHMEC)); Shanghai Health Bureau; Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (Grant No. 30872990 1/4 CE11072468), National Basic Research Program of China (Grant No. 2010CB529103), Science and Technology Commission of Shanghai Municipality (10JC1408300), Shanghai Municipal Education J50207 and Shanghai Health Bureau (2010036), Shanghai Jiao Tong University School of Medicine (YBPY2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Canderan G, 2010, IMMUNOTHERAPY-UK, V2, P21, DOI [10.2217/imt.09.83, 10.2217/IMT.09.83]; Cao Q, 2007, CELL RES, V17, P627, DOI 10.1038/cr.2007.46; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Langroudi L, 2010, INT IMMUNOPHARMACOL, V10, P1055, DOI 10.1016/j.intimp.2010.06.005; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Litzinger MT, 2007, BLOOD, V110, P3192, DOI 10.1182/blood-2007-06-094615; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Onizuka S, 1999, CANCER RES, V59, P3128; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, J IMMUNOL, V176, P6202, DOI 10.4049/jimmunol.176.10.6202; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vissers JLM, 2001, J LEUKOCYTE BIOL, V69, P785; Wang L, 2006, CELL RES, V16, P702, DOI 10.1038/sj.cr.7310083; Yamamoto M, 2009, ONCOL REP, V22, P337, DOI 10.3892/or_00000442; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2009, INT IMMUNOPHARMACOL, V9, P593, DOI 10.1016/j.intimp.2009.01.026; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	40	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27289	10.1371/journal.pone.0027289	http://dx.doi.org/10.1371/journal.pone.0027289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087281	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700027
J	Fang, F; Hoglund, CO; Arck, P; Lundholm, C; Langstrom, N; Lichtenstein, P; Lekander, M; Almqvist, C				Fang, Fang; Hoglund, Caroline Olgart; Arck, Petra; Lundholm, Cecilia; Langstrom, Niklas; Lichtenstein, Paul; Lekander, Mats; Almqvist, Catarina			Maternal Bereavement and Childhood Asthma-Analyses in Two Large Samples of Swedish Children	PLOS ONE			English	Article							REGULATORY T-CELLS; PRENATAL STRESS; GENDER-DIFFERENCES; NATIONWIDE; RISK; EXPRESSION; PREGNANCY; COHORT; ATOPY; LIFE	Background: Prenatal factors such as prenatal psychological stress might influence the development of childhood asthma. Methodology and Principal Findings: We assessed the association between maternal bereavement shortly before and during pregnancy, as a proxy for prenatal stress, and the risk of childhood asthma in the offspring, based on two samples of children 1-4 (n = 426 334) and 7-12 (n = 493 813) years assembled from the Swedish Medical Birth Register. Exposure was maternal bereavement of a close relative from one year before pregnancy to child birth. Asthma event was defined by a hospital contact for asthma or at least two dispenses of inhaled corticosteroids or montelukast. In the younger sample we calculated hazards ratios (HRs) of a first-ever asthma event using Cox models and in the older sample odds ratio (ORs) of an asthma attack during 12 months using logistic regression. Compared to unexposed boys, exposed boys seemed to have a weakly higher risk of first-ever asthma event at 1-4 years (HR: 1.09; 95% confidence interval [CI]: 0.98, 1.22) as well as an asthma attack during 12 months at 7-12 years (OR: 1.10; 95% CI: 0.96, 1.24). No association was suggested for girls. Boys exposed during the second trimester had a significantly higher risk of asthma event at 1-4 years (HR: 1.55; 95% CI: 1.19, 2.02) and asthma attack at 7-12 years if the bereavement was an older child (OR: 1.58; 95% CI: 1.11, 2.25). The associations tended to be stronger if the bereavement was due to a traumatic death compared to natural death, but the difference was not statistically significant. Conclusions/Significance: Our results showed some evidence for a positive association between prenatal stress and childhood asthma among boys but not girls.	[Fang, Fang; Lundholm, Cecilia; Langstrom, Niklas; Lichtenstein, Paul; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Resp Med Unit, Dept Med Solna, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hoglund, Caroline Olgart; Lekander, Mats] Karolinska Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Arck, Petra] Univ Hosp Hamburg Eppendorf, Lab Expt Fetomaternal Med, Dept Obstet & Fetal Med, Hamburg, Germany; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Almqvist, Catarina] Astrid Lindgren Childrens Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stockholm University; Karolinska Institutet; Karolinska University Hospital	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	catarina.almqvist@ki.se	Arck, Petra C/D-7094-2013; Langstrom, Niklas/C-5615-2009	Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287; Fang, Fang/0000-0002-3310-6456; Arck, Petra/0000-0002-2932-926X; Lundholm, Cecilia/0000-0002-6546-3650	Stockholm County Council; Karolinska Institutet; Swedish Research Council (SIMSAM) [80748301]; Centre for Allergy Research; Hjarnfonden; Swedish Heart Lung Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061817] Funding Source: NIH RePORTER	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council (SIMSAM)(Swedish Research Council); Centre for Allergy Research; Hjarnfonden; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, grants from the Swedish Research Council (SIMSAM grant number 80748301), Centre for Allergy Research and the Strategic Research Program in Epidemiology at Karolinska Institutet. Fang Fang was partially supported by a postdoctoral fellowship from Hjarnfonden. Caroline Olgart Hoglund was supported by the Karolinska Institutet and the Swedish Heart Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Burlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Dolznig H, 2004, METH MOLEC MED, V105, P323; Hoglund CO, 2006, CLIN EXP ALLERGY, V36, P982, DOI 10.1111/j.1365-2222.2006.02529.x; Holt PG, 2009, J EXP MED, V206, P2861, DOI 10.1084/jem.20092469; Joachim RA, 2008, AM J PATHOL, V173, P1379, DOI 10.2353/ajpath.2008.080105; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2008, EPILEPSY RES, V81, P52, DOI 10.1016/j.eplepsyres.2008.04.014; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Li J, 2009, J AUTISM DEV DISORD, V39, P1047, DOI 10.1007/s10803-009-0717-4; Li J, 2009, PEDIATRICS, V123, P1102, DOI 10.1542/peds.2008-1734; Loisel DA, 2011, J ALLERGY CLIN IMMUN, V128, P524, DOI 10.1016/j.jaci.2011.06.016; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Ortqvist AK, 2009, PEDIATRICS, V124, pE737, DOI 10.1542/peds.2009-0305; Pincus-Knackstedt MK, 2006, J IMMUNOL, V177, P8484, DOI 10.4049/jimmunol.177.12.8484; Rieger M, 2004, ANN NY ACAD SCI, V1032, P228, DOI 10.1196/annals.1314.026; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sausenthaler S, 2009, J INVEST ALLERG CLIN, V19, P481; Solano ME, J REPROD IM IN PRESS; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Uekert SJ, 2006, J ALLERGY CLIN IMMUN, V118, P1375, DOI 10.1016/j.jaci.2006.09.008; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Virk J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011523; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; vonMutius E, 1996, THORAX, V51, pS3, DOI 10.1136/thx.51.Suppl_1.S3; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright RJ, 2007, PAEDIATR PERINAT EP, V21, P8, DOI 10.1111/j.1365-3016.2007.00879.x; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC	35	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27202	10.1371/journal.pone.0027202	http://dx.doi.org/10.1371/journal.pone.0027202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087265	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700029
J	Yang, DC; Tsai, CC; Liao, YF; Fu, HC; Tsay, HJ; Huang, TF; Chen, YH; Hung, SC				Yang, Der-Chih; Tsai, Chih-Chien; Liao, Yun-Feng; Fu, Hui-Chuan; Tsay, Huey-Jen; Huang, Tung-Fu; Chen, Yau-Hung; Hung, Shih-Chieh			Twist Controls Skeletal Development and Dorsoventral Patterning by Regulating Runx2 in Zebrafish	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTORS; OSTEOBLAST DIFFERENTIATION; BONE-DEVELOPMENT; GENE-EXPRESSION; EMBRYO; ISOFORM; MODELS; MOUSE; ONSET	Background: Twist1a and twist1b are the principal components of twists that negatively regulate a number of cellular signaling events. Expression of runx2 and downstream targets is essential for skeletal development and ventral organizer formation and specification in early vertebrate embryos, but what controls ventral activity of maternal runx2 and how twists function in zebrafish embryogenesis still remain unclear. Methodology/Principal Findings: By studying the loss of twist induced by injection of morpholino-oligonucleotide in zebrafish, we found that twist1a and twist1b, but not twist2 or twist3, were required for proper skeletal development and dorsoventral patterning in early embryos. Overexpression of twist1a or twist1b following mRNA injection resulted in deteriorated skeletal development and formation of typical dorsalized embryos, whereas knockdown of twist1a and twist1b led to the formation of abnormal embryos with enhanced skeletal formation and typical ventralized patterning. Overexpression of twist1a or twist1b decreased the expression of runx2b, whereas twist1a and twist1b knockdown increased runx2b expression. We have further demonstrated that phenotypes induced by twist1a and twist1b knockdown were rescued by runx2b knockdown. Conclusions/Significance: Together, these results suggest that twist1a and twist1b control skeletal development and dorsoventral patterning by regulating runx2b in zebrafish and provide potential targets for the treatment of diseases or syndromes associated with decreased skeletal development.	[Yang, Der-Chih; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tsai, Chih-Chien; Tsay, Huey-Jen; Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Pharmaol, Taipei 112, Taiwan; Natl Yang Ming Univ, Dept Neurosci, Taipei 112, Taiwan; [Huang, Tung-Fu] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Liao, Yun-Feng; Fu, Hui-Chuan; Chen, Yau-Hung] Tamkang Univ, Dept Chem, Taipei, Taiwan; [Yang, Der-Chih; Tsai, Chih-Chien; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Tung-Fu; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tamkang University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	yauhung@mail.tku.edu.tw; hungsc@vghtpe.gov.tw			National Science Council [100-2313-B-032-001]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from the National Science Council (100-2313-B-032-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen YH, 2009, BONE, V44, P777, DOI 10.1016/j.bone.2009.01.374; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MVC, 2008, NAT CELL BIOL, V10, P346, DOI 10.1038/ncb1697; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Frajese G V, 2005, J Endocrinol Invest, V28, P3; Germanguz I, 2007, DEV DYNAM, V236, P2615, DOI 10.1002/dvdy.21267; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Kelly C, 2000, DEVELOPMENT, V127, P3899; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2004, DEV CELL, V6, P317, DOI 10.1016/S1534-5807(04)00069-3; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Miraoui H, 2010, J CELL BIOCHEM, V110, P1147, DOI 10.1002/jcb.22628; Mullins MC, 1996, DEVELOPMENT, V123, P81; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schilling TF, 1997, DEVELOPMENT, V124, P2945; SIMPSON P, 1983, GENETICS, V105, P615; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	35	20	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27324	10.1371/journal.pone.0027324	http://dx.doi.org/10.1371/journal.pone.0027324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087291	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700040
J	Bellanger, C; Dubanet, L; Lise, MC; Fauchais, AL; Bordessoule, D; Jauberteau, MO; Troutaud, D				Bellanger, Cynthia; Dubanet, Lydie; Lise, Marie-Claude; Fauchais, Anne-Laure; Bordessoule, Dominique; Jauberteau, Marie-Odile; Troutaud, Danielle			Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SURVIVAL; LYMPHOCYTES; SORTILIN; PATHWAY; EPRATUZUMAB; ACTIVATION; P75(NTR); ANTIBODY; RECEPTOR	Background: Diffuse large B-cell lymphoma (DLBCL) is a common and often fatal malignancy. Immunochemotherapy, a combination of rituximab to standard chemotherapy, has resulted in improved survival. However a substantial proportion of patients still fail to reach sustained remission. We have previously demonstrated that autocrine brain-derived neurotrophic factor (BDNF) production plays a function in human B cell survival, at least partly via sortilin expression. As neurotrophin receptor (Trks) signaling involved activation of survival pathways that are inhibited by rituximab, we speculated that neurotrophins may provide additional support for tumour cell survival and therapeutic resistance in DLBCL. Methodology/Principal Findings: In the present study, we used two DLBCL cell lines, SUDHL4 and SUDHL6, known to be respectively less and more sensitive to rituximab. We found by RT-PCR, western blotting, cytometry and confocal microscopy that both cell lines expressed, in normal culture conditions, BDNF and to a lesser extent NGF, as well as truncated TrkB and p75(NTR)/sortilin death neurotrophin receptors. Furthermore, BDNF secretion was detected in cell supernatants. NGF and BDNF production and Trk receptor expression, including TrkA, are regulated by apoptotic conditions (serum deprivation or rituximab exposure). Indeed, we show for the first time that rituximab exposure of DLBCL cell lines induces NGF secretion and that differences in rituximab sensitivity are associated with differential expression patterns of neurotrophins and their receptors (TrkA). Finally, these cells are sensitive to the Trk-inhibitor, K252a, as shown by the induction of apoptosis. Furthermore, K252a exhibits additive cytotoxic effects with rituximab. Conclusions/Significance: Collectively, these data strongly suggest that a neurotrophin axis, such NGF/TrkA pathway, may contribute to malignant cell survival and rituximab resistance in DLBCL.	[Bellanger, Cynthia; Dubanet, Lydie; Lise, Marie-Claude; Fauchais, Anne-Laure; Jauberteau, Marie-Odile; Troutaud, Danielle] Univ Limoges, EA3842, Limoges, France; [Bordessoule, Dominique] Univ Limoges, CNRS, UMR 6101, Limoges, France; [Bordessoule, Dominique] CHU Limoges, Serv Hematol Clin, Limoges, France	Universite de Limoges; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges; CHU Limoges	Bellanger, C (corresponding author), Univ Limoges, EA3842, Limoges, France.	danielle.troutaud@unilim.fr		Troutaud, Danielle/0000-0002-2619-5059; Fauchais, Anne Laure/0000-0002-0489-8570; Jauberteau, Marie-Odile/0000-0002-8811-8948	Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne); CORC (Comite d'Orientation Recherche Cancer en Limousin)	Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne); CORC (Comite d'Orientation Recherche Cancer en Limousin)	This work and C.B. were supported by Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne) and CORC (Comite d'Orientation Recherche Cancer en Limousin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram M, 2009, J IMMUNOL, V182, P4705, DOI 10.4049/jimmunol.0802814; Akil H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025097; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Carnahan J, 2007, MOL IMMUNOL, V44, P1331, DOI 10.1016/j.molimm.2006.05.007; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Coiffier B, 2002, ANTI-CANCER DRUG, V13, pS43, DOI 10.1097/00001813-200211002-00007; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; De Paepe P, 2007, LEUKEMIA, V21, P37, DOI 10.1038/sj.leu.2404449; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; Fauchais AL, 2008, J IMMUNOL, V181, P3027, DOI 10.4049/jimmunol.181.5.3027; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; Lyu MA, 2010, NEOPLASIA, V12, P366, DOI 10.1593/neo.91960; Melamed I, 1996, EUR J IMMUNOL, V26, P1985, DOI 10.1002/eji.1830260903; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Rezvani AR, 2011, BEST PRACT RES CL HA, V24, P203, DOI 10.1016/j.beha.2011.02.009; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sniderhan LF, 2009, EXP HEMATOL, V37, P1295, DOI 10.1016/j.exphem.2009.08.005; Stein R, 2004, CLIN CANCER RES, V10, P2868, DOI 10.1158/1078-0432.CCR-03-0493; Suzuki E, 2007, ONCOGENE, V26, P6184, DOI 10.1038/sj.onc.1210448; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tervonen TA, 2006, EUR J NEUROSCI, V24, P1277, DOI 10.1111/j.1460-9568.2006.05010.x; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Verdier M, 2006, CYTOM PART A, V69A, P999, DOI 10.1002/cyto.a.20310; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27213	10.1371/journal.pone.0027213	http://dx.doi.org/10.1371/journal.pone.0027213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076137	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200050
J	Benitez, BA; Alvarado, D; Cai, YF; Mayo, K; Chakraverty, S; Norton, J; Morris, JC; Sands, MS; Goate, A; Cruchaga, C				Benitez, Bruno A.; Alvarado, David; Cai, Yefei; Mayo, Kevin; Chakraverty, Sumitra; Norton, Joanne; Morris, John C.; Sands, Mark S.; Goate, Alison; Cruchaga, Carlos			Exome-Sequencing Confirms DNAJC5 Mutations as Cause of Adult Neuronal Ceroid-Lipofuscinosis	PLOS ONE			English	Article							CYSTEINE-STRING PROTEIN; KUFS-DISEASE; CSP-ALPHA; AUTOSOMAL-DOMINANT; SYNAPTIC VESICLES; ONSET; PALMITOYLATION; DEFICIENCY; PREDICTION; CHAPERONE	We performed whole-exome sequencing in two autopsy-confirmed cases and an elderly unaffected control from a multigenerational family with autosomal dominant neuronal ceroid lipofuscinosis (ANCL). A novel single-nucleotide variation (c.344T>G) in the DNAJC5 gene was identified. Mutational screening in an independent family with autosomal dominant ANCL found an in-frame single codon deletion (c.346_348 delCTC) resulting in a deletion of p.Leu116del. These variants fulfill all genetic criteria for disease-causing mutations: they are found in unrelated families with the same disease, exhibit complete segregation between the mutation and the disease, and are absent in healthy controls. In addition, the associated amino acid substitutions are located in evolutionarily highly conserved residues and are predicted to functionally affect the encoded protein (CSP alpha). The mutations are located in a cysteine-string domain, which is required for membrane targeting/binding, palmitoylation, and oligomerization of CSP alpha. We performed a comprehensive in silico analysis of the functional and structural impact of both mutations on CSP alpha. We found that these mutations dramatically decrease the affinity of CSP alpha for the membrane. We did not identify any significant effect on palmitoylation status of CSP alpha. However, a reduction of CSP alpha membrane affinity may change its palmitoylation and affect proper intracellular sorting. We confirm that CSP alpha has a strong intrinsic aggregation propensity; however, it is not modified by the mutations. A complementary disease-network analysis suggests a potential interaction with other NCLs genes/pathways. This is the first replication study of the identification of DNAJC5 as the disease-causing gene for autosomal dominant ANCL. The identification of the novel gene in ANCL will allow us to gain a better understanding of the pathological mechanism of ANCLs and constitutes a great advance toward the development of new molecular diagnostic tests and may lead to the development of potential therapies.	[Benitez, Bruno A.; Cai, Yefei; Mayo, Kevin; Chakraverty, Sumitra; Norton, Joanne; Goate, Alison; Cruchaga, Carlos] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Alvarado, David; Sands, Mark S.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Morris, John C.; Goate, Alison] Washington Univ, Dept Neurol, St Louis, MO USA; [Sands, Mark S.; Goate, Alison; Cruchaga, Carlos] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Goate, Alison] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Benitez, BA (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	cruchagac@psychiatry.wustl.edu	Benitez, Bruno A./E-7116-2014; Cruchaga, Carlos/ABF-4065-2020	Benitez, Bruno A./0000-0002-2699-3878; Cruchaga, Carlos/0000-0002-0276-2899; Goate, Alison/0000-0002-0576-2472	NIH [1P30NS069329-01, P50AG005681]; Barnes-Jewish Hospital Foundation; Hope Center for Neurological Disorders; Danforth Foundation Challenge at Washington University; NCI Cancer Center [P30 CA91842]; ICTS/CTSA [UL1RR024992]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Hope Center for Neurological Disorders; Danforth Foundation Challenge at Washington University; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants: NIH (1P30NS069329-01, P50AG005681), the Barnes-Jewish Hospital Foundation. This work was also supported by pilot funding from the Hope Center for Neurological Disorders and the Danforth Foundation Challenge at Washington University. We thank the Genome Technology Access Center in the Department of Genetics for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1RR024992 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Alvarado DM, 2011, J BONE JOINT SURG AM, V93A, P1045, DOI 10.2106/JBJS.J.02004; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; BERKOVIC SF, 1988, BRAIN, V111, P27, DOI 10.1093/brain/111.1.27; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Hawkins-Salsbury JA, 2011, HUM MOL GENET, V20, pR54, DOI 10.1093/hmg/ddr112; Heinonen O, 2000, MOL GENET METAB, V69, P123, DOI 10.1006/mgme.2000.2961; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Josephson SA, 2001, J NEUROL SCI, V188, P51, DOI 10.1016/S0022-510X(01)00546-9; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Mastrogiacomo A, 1998, FEBS LETT, V436, P85, DOI 10.1016/S0014-5793(98)01092-8; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ramadan H, 2007, NEUROLOGY, V68, P387, DOI 10.1212/01.wnl.0000252825.85947.2f; Ranjan R, 1998, J NEUROSCI, V18, P956; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Sadzot B, 2000, J NEUROL, V247, P447, DOI 10.1007/s004150070174; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schuierer S, 2010, BIOINFORMATICS, V26, P1922, DOI 10.1093/bioinformatics/btq307; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Sims KB, 2011, NEW ENGL J MED, V364, P1062, DOI 10.1056/NEJMcpc1013927; Sleat DE, 2009, MOL CELL PROTEOMICS, V8, P1708, DOI 10.1074/mcp.M900122-MCP200; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2007, STRUCTURE, V15, P139, DOI 10.1016/j.str.2006.12.007; Tartaglia GG, 2010, J MOL BIOL, V402, P919, DOI 10.1016/j.jmb.2010.08.013; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; van Diggelen OP, 2001, ANN NEUROL, V50, P269, DOI 10.1002/ana.1103; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Virmani T, 2005, NEUROBIOL DIS, V20, P314, DOI 10.1016/j.nbd.2005.03.012; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	65	82	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26741	10.1371/journal.pone.0026741	http://dx.doi.org/10.1371/journal.pone.0026741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073189	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200019
J	Miyazaki, M; Schroder, E; Edelmann, SE; Hughes, ME; Kornacker, K; Balke, CW; Esser, KA				Miyazaki, Mitsunori; Schroder, Elizabeth; Edelmann, Stephanie E.; Hughes, Michael E.; Kornacker, Karl; Balke, C. William; Esser, Karyn A.			Age-Associated Disruption of Molecular Clock Expression in Skeletal Muscle of the Spontaneously Hypertensive Rat	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; INSULIN-RESISTANCE; CIRCADIAN CLOCK; SOLEUS MUSCLES; GENE-EXPRESSION; IN-VIVO; DISEASE; CELLS; MOUSE; TRANSCRIPTION	It is well known that spontaneously hypertensive rats (SHR) develop muscle pathologies with hypertension and heart failure, though the mechanism remains poorly understood. Woon et al. (2007) linked the circadian clock gene Bmal1 to hypertension and metabolic dysfunction in the SHR. Building on these findings, we compared the expression pattern of several core-clock genes in the gastrocnemius muscle of aged SHR (80 weeks; overt heart failure) compared to aged-matched control WKY strain. Heart failure was associated with marked effects on the expression of Bmal1, Clock and Rora in addition to several non-circadian genes important in regulating skeletal muscle phenotype including Mck, Ttn and Mef2c. We next performed circadian time-course collections at a young age (8 weeks; pre-hypertensive) and adult age (22 weeks; hypertensive) to determine if clock gene expression was disrupted in gastrocnemius, heart and liver tissues prior to or after the rats became hypertensive. We found that hypertensive/hypertrophic SHR showed a dampening of peak Bmal1 and Reverb expression in the liver, and the clock-controlled gene Pgc1 alpha in the gastrocnemius. In addition, the core-clock gene Clock and the muscle-specific, clock-controlled gene Myod1, no longer maintained a circadian pattern of expression in gastrocnemius from the hypertensive SHR. These findings provide a framework to suggest a mechanism whereby chronic heart failure leads to skeletal muscle pathologies; prolonged dysregulation of the molecular clock in skeletal muscle results in altered Clock, Pgc1 alpha and Myod1 expression which in turn leads to the mis-regulation of target genes important for mechanical and metabolic function of skeletal muscle.	[Miyazaki, Mitsunori; Schroder, Elizabeth; Edelmann, Stephanie E.; Esser, Karyn A.] Univ Kentucky, Ctr Muscle Biol, Dept Physiol, Lexington, KY 40536 USA; [Hughes, Michael E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Kornacker, Karl] Ohio State Univ, Div Sensory Biophys, Columbus, OH 43210 USA; [Balke, C. William] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94143 USA; [Balke, C. William] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Kentucky; Yale University; University System of Ohio; Ohio State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miyazaki, M (corresponding author), Univ Kentucky, Ctr Muscle Biol, Dept Physiol, Lexington, KY 40536 USA.	eschr0@uky.edu	Miyazaki, Mitsunori/AAM-8598-2021	Miyazaki, Mitsunori/0000-0001-7824-2091	NIAMS [R01AR055246]; NIEHS [RC1ES018636]; American Heart Association [0825668D]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018636] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01AR055246 from NIAMS, RC1ES018636 from NIEHS, and a postdoctoral fellowship provided by the American Heart Association to Mitsunori Miyazaki (0825668D), http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; AMEEN M, 1991, ANN NY ACAD SCI, V639, P550, DOI 10.1111/j.1749-6632.1991.tb17348.x; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; ANDREWS JL, P NATL ACAD SCI US, V107, P19090; ATRAKCHI A, 1994, AM J PHYSIOL, V267, pC827, DOI 10.1152/ajpcell.1994.267.3.C827; Bortolotto SK, 1999, AM J PHYSIOL-CELL PH, V276, pC628, DOI 10.1152/ajpcell.1999.276.3.C628; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Cabassi A, 2001, HYPERTENSION, V37, P698, DOI 10.1161/01.HYP.37.2.698; CAPALDO B, 1991, METABOLISM, V40, P1320, DOI 10.1016/0026-0495(91)90036-V; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Geyer C., 2003, STAT 5102 NOTES NONP; GRAY SD, 1994, AM J PHYSIOL, V267, pR735, DOI 10.1152/ajpregu.1994.267.3.R735; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6; Harridge SDR, 1996, EUR HEART J, V17, P896; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; HULMAN S, 1993, METABOLISM, V42, P14, DOI 10.1016/0026-0495(93)90165-K; Kobayashi N, 2005, ARTERIOSCL THROM VAS, V25, P2114, DOI 10.1161/01.ATV.0000178993.13222.f2; Lampert E, 1996, J AM COLL CARDIOL, V28, P980, DOI 10.1016/S0735-1097(96)00272-0; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; LIPKIN DP, 1988, INT J CARDIOL, V20, P161; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lunde PK, 2001, ACTA PHYSIOL SCAND, V171, P277, DOI 10.1046/j.1365-201x.2001.00830.x; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; Maywood ES, 2006, PROG BRAIN RES, V153, P253, DOI 10.1016/S0079-6123(06)53015-8; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; PICKAR JG, 1994, AM J PHYSIOL, V267, pC836, DOI 10.1152/ajpcell.1994.267.3.C836; Pogue-Geile KL, 2006, CANCER LETT, V243, P55, DOI 10.1016/j.canlet.2005.11.049; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; RUDIC RD, 2005, PERIPHERAL CLOCKS RE, P524; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sullivan MJ, 1997, MED SCI SPORT EXER, V29, P860, DOI 10.1097/00005768-199707000-00004; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vissing K, 2005, J APPL PHYSIOL, V99, P164, DOI 10.1152/japplphysiol.01172.2004; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	54	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27168	10.1371/journal.pone.0027168	http://dx.doi.org/10.1371/journal.pone.0027168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076133	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200045
J	Tsuei, DJ; Lee, PH; Peng, HY; Lu, SL; Su, DS; Jeng, YM; Hsu, HC; Hsu, SH; Wu, JF; Ni, YH; Chang, MH				Tsuei, Daw-Jen; Lee, Po-Huang; Peng, Hsiao-Yu; Lu, Shau-Lin; Su, De-Shiuan; Jeng, Yung-Ming; Hsu, Hey-Chi; Hsu, Shu-Hao; Wu, Jia-Feng; Ni, Yen-Hsuan; Chang, Mei-Hwei			Male Germ Cell-Specific RNA Binding Protein RBMY: A New Oncogene Explaining Male Predominance in Liver Cancer	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ANDROGEN-RECEPTOR; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL ACTIVITY; GENDER DISPARITY; EXPRESSION; SAM68; TESTOSTERONE; VACCINATION; REPEATS	Male gender is a risk factor for the development of hepatocellular carcinoma (HCC) but the mechanisms are not fully understood. The RNA binding motif gene on the Y chromosome (RBMY), encoding a male germ cell-specific RNA splicing regulator during spermatogenesis, is aberrantly activated in human male liver cancers. This study investigated the in vitro oncogenic effect and the possible mechanism of RBMY in human hepatoma cell line HepG2 and its in vivo effect with regards to the livers of human and transgenic mice. RBMY expression in HepG2 cells was knocked down by RNA interference and the cancer cell phenotype was characterized by soft-agar colony formation and sensitivity to hydrogenperoxide-induced apoptosis. The results revealed that RBMY knockdown reduced the transformation and anti-apoptotic efficiency of HepG2 cells. The expression of RBMY, androgen receptor (AR) and its inhibitory variant AR45, AR-targeted genes insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) was analyzed by quantitative RT-PCR. Up-regulation of AR45 variant and reduction of IGF-1 and IGFBP-3 expression was only detected in RBMY knockdown cells. Moreover, RBMY positive human male HCC expressed lower level of AR45 as compared to RBMY negative HCC tissues. The oncogenic properties of RBMY were further assessed in a transgenic mouse model. Liver-specific RBMY transgenic mice developed hepatic pre-cancerous lesions, adenoma, and HCC. RBMY also accelerated chemical carcinogen-induced hepatocarcinogenesis in transgenic mice. Collectively, these findings suggest that Y chromosome-specific RBMY is likely involved in the regulation of androgen receptor activity and contributes to male predominance of HCC.	[Tsuei, Daw-Jen; Peng, Hsiao-Yu; Lu, Shau-Lin; Su, De-Shiuan; Hsu, Shu-Hao; Wu, Jia-Feng; Ni, Yen-Hsuan; Chang, Mei-Hwei] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Lee, Po-Huang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei, Taiwan; [Jeng, Yung-Ming; Hsu, Hey-Chi] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pathol, Taipei, Taiwan; [Chang, Mei-Hwei] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsuei, DJ (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan.	changmh@ntu.edu.tw	Wu, Jia-Feng/H-8125-2019	Wu, Jia-Feng/0000-0001-6343-1658; JENG, YUNG-MING/0000-0002-3878-4491; HSU, SHU-HAO/0000-0002-9444-4192; LEE, PO-HUANG/0000-0001-5831-035X; Chang, Mei Hwei/0000-0002-3648-9261; Ni, Yen-Hsuan/0000-0002-1158-5249	National Health Research Institute of Taiwan [NHRI-EX93-117BN, NHRI-EX95 (96, 97, 98)-9418BI]	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants NHRI-EX93-117BN, NHRI-EX95 (96, 97, 98)-9418BI from the National Health Research Institute of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens-Fath I, 2005, FEBS J, V272, P74, DOI 10.1111/j.1432-1033.2004.04395.x; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chang MH, 2000, JAMA-J AM MED ASSOC, V284, P3040, DOI 10.1001/jama.284.23.3040; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Dreumont N, 2010, J CELL SCI, V123, P40, DOI 10.1242/jcs.055889; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Kanda T, 2008, J VIROL, V82, P11066, DOI 10.1128/JVI.01300-08; KEMP CJ, 1989, P NATL ACAD SCI USA, V86, P7505, DOI 10.1073/pnas.86.19.7505; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Peng LH, 2006, ENDOCRINOLOGY, V147, P4599, DOI 10.1210/en.2006-0560; Prieto Jesus, 2008, J Hepatol, V48, P380, DOI 10.1016/j.jhep.2007.11.007; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Ruggieri A, 2010, INT J CANCER, V127, P499, DOI 10.1002/ijc.25298; Tsuei DJ, 2004, ONCOGENE, V23, P5815, DOI 10.1038/sj.onc.1207773; Tsuei DJ, 2002, J MED VIROL, V68, P513, DOI 10.1002/jmv.10240; Venables JP, 1999, HUM MOL GENET, V8, P959, DOI 10.1093/hmg/8.6.959; Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Yu MW, 2000, J NATL CANCER I, V92, P2023, DOI 10.1093/jnci/92.24.2023	33	25	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26948	10.1371/journal.pone.0026948	http://dx.doi.org/10.1371/journal.pone.0026948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073224	Green Submitted, gold, Green Published			2022-12-27	WOS:000297198200025
J	Yu, CF; Li, Y; Holmes, A; Szafranski, K; Faulkes, CG; Coen, CW; Buffenstein, R; Platzer, M; de Magalhaes, JP; Church, GM				Yu, Chuanfei; Li, Yang; Holmes, Andrew; Szafranski, Karol; Faulkes, Chris G.; Coen, Clive W.; Buffenstein, Rochelle; Platzer, Matthias; de Magalhaes, Joao Pedro; Church, George M.			RNA Sequencing Reveals Differential Expression of Mitochondrial and Oxidation Reduction Genes in the Long-Lived Naked Mole-Rat When Compared to Mice	PLOS ONE			English	Article							LIVING RODENT; LONGEVITY; ALPHA-2-MACROGLOBULIN; FIBROBLASTS; DIVERGENCE; RESISTANT; PATTERNS; EXPLAIN; STRESS; MODEL	The naked mole-rat (Heterocephalus glaber) is a long-lived, cancer resistant rodent and there is a great interest in identifying the adaptations responsible for these and other of its unique traits. We employed RNA sequencing to compare liver gene expression profiles between naked mole-rats and wild-derived mice. Our results indicate that genes associated with oxidoreduction and mitochondria were expressed at higher relative levels in naked mole-rats. The largest effect is nearly 300-fold higher expression of epithelial cell adhesion molecule (Epcam), a tumour-associated protein. Also of interest are the protease inhibitor, alpha2-macroglobulin (A2m), and the mitochondrial complex II subunit Sdhc, both ageing-related genes found strongly over-expressed in the naked mole-rat. These results hint at possible candidates for specifying species differences in ageing and cancer, and in particular suggest complex alterations in mitochondrial and oxidation reduction pathways in the naked mole-rat. Our differential gene expression analysis obviated the need for a reference naked mole-rat genome by employing a combination of Illumina/Solexa and 454 platforms for transcriptome sequencing and assembling transcriptome contigs of the non-sequenced species. Overall, our work provides new research foci and methods for studying the naked mole-rat's fascinating characteristics.	[Yu, Chuanfei; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Li, Yang; Holmes, Andrew; de Magalhaes, Joao Pedro] Univ Liverpool, Inst Integrat Biol, Integrat Genom Ageing Grp, Liverpool L69 3BX, Merseyside, England; [Holmes, Andrew; Platzer, Matthias] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Faulkes, Chris G.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Coen, Clive W.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Aging & Longev Studies, San Antonio, TX 78229 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	Harvard University; Harvard Medical School; University of Liverpool; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of London; Queen Mary University London; University of London; King's College London; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Yu, CF (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	jp@senescence.info	de Magalhaes, Joao Pedro/B-4741-2010; Faulkes, Chris/O-8101-2019	de Magalhaes, Joao Pedro/0000-0002-6363-2465; Li, Yang/0000-0002-0736-251X; church, george/0000-0001-6232-9969; Coen, Clive/0000-0003-1303-216X	Ellison Medical Foundation; EC; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council (BBSRC) [BBD5265291, BBD5231861]; National Institutes of Health/National Institute on Aging [AG-022891]; Biotechnology and Biological Sciences Research Council [BB/D523186/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG022891] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); EC(European CommissionEuropean Commission Joint Research Centre); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a grant from the Ellison Medical Foundation to GMC and a Marie Curie International Reintegration Grant within EC-FP7 to JPdM. YL was supported by a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. AH thanks support from a Biotechnology and Biological Sciences Research Council (BBSRC) studentship (BBD5265291). CWC and CGF were supported by the BBSRC (BBD5231861). Naked mole-rats used in this study were from the colony of RB housed at City College of New York and their care was supported by funding from National Institutes of Health/National Institute on Aging (AG-022891) to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Austad SN, 2009, J GERONTOL A-BIOL, V64, P199, DOI 10.1093/gerona/gln060; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Csiszar A, 2007, AM J PHYSIOL-HEART C, V293, pH919, DOI 10.1152/ajpheart.01287.2006; CUTLER RG, 1979, MECH AGEING DEV, V9, P337, DOI 10.1016/0047-6374(79)90110-6; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; de Magalhaes JP, 2010, AGEING RES REV, V9, P315, DOI 10.1016/j.arr.2009.10.006; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Hulbert AJ, 2008, AGE, V30, P89, DOI 10.1007/s11357-008-9055-2; Hulbert AJ, 2006, J GERONTOL A-BIOL, V61, P1009, DOI 10.1093/gerona/61.10.1009; Kasaikina MV, 2011, J BIOL CHEM, V286, P17005, DOI 10.1074/jbc.M110.216267; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Ma H, 2004, EXP GERONTOL, V39, P415, DOI 10.1016/j.exger.2003.11.012; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Neira-Oviedo M, 2011, INSECT MOL BIOL, V20, P141, DOI 10.1111/j.1365-2583.2010.01053.x; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rozen S, 2000, Methods Mol Biol, V132, P365; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Van Daele PAAG, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P357	39	67	69	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26729	10.1371/journal.pone.0026729	http://dx.doi.org/10.1371/journal.pone.0026729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073188	Green Published, gold			2022-12-27	WOS:000297197000011
J	Dass, SAH; Vasudevan, A; Dutta, D; Soh, LJT; Sapolsky, RM; Vyas, A				Dass, Shantala Arundathi Hari; Vasudevan, Anand; Dutta, Deborah; Soh, Linda Jing Ting; Sapolsky, Robert Morris; Vyas, Ajai			Protozoan Parasite Toxoplasma gondii Manipulates Mate Choice in Rats by Enhancing Attractiveness of Males	PLOS ONE			English	Article							NORWAY RATS; FEMALE MICE; BEHAVIOR; INFECTION; COLORATION; EVOLUTION; PATTERN; FITNESS; SEX	Females in various species typically avoid males infected with parasites, while parasite-free males advertise their status through conspicuous phenotypic traits. This process selects for heritable resistance and reduces direct exposure of the female to parasites. Coevolving parasites are likely to attempt to circumvent this obstacle. In this paper, we demonstrate a case of parasitic manipulation of host mate choice. We report that Toxoplasma gondii, a sexually transmitted infection of brown rats, enhances sexual attractiveness of infected males. Thus under some evolutionary niches, parasites can indeed manipulate host sexual signaling to their own advantage.	[Dass, Shantala Arundathi Hari; Vasudevan, Anand; Dutta, Deborah; Soh, Linda Jing Ting; Vyas, Ajai] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sapolsky, Robert Morris] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University	Dass, SAH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	avyas@ntu.edu.sg	Vyas, Ajai/A-2223-2011; Vasudevan, Anand/J-8983-2019	Vyas, Ajai/0000-0002-2592-6796; Vasudevan, Anand/0000-0002-7890-3782; dutta, deborah/0000-0003-2445-7139; Hari Dass, Shantala/0000-0002-1852-4641	Nanyang Technological University, Singapore; Stanley Medical Research Institute; National Institute of Health, USA [AI41014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041014] Funding Source: NIH RePORTER	Nanyang Technological University, Singapore(Nanyang Technological University); Stanley Medical Research Institute; National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by Nanyang Technological University, Singapore, through its Nanyang Assistant Professorship program; Stanley Medical Research Institute and National Institute of Health, USA (grant AI41014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able DJ, 1996, P NATL ACAD SCI USA, V93, P2229, DOI 10.1073/pnas.93.5.2229; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Arantes TP, 2009, EXP PARASITOL, V123, P190, DOI 10.1016/j.exppara.2009.07.003; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BERDOY M, 1995, PARASITOLOGY, V111, P403, DOI 10.1017/S0031182000065902; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Dawkins R., 1982, pi; Dawson RD, 2006, NATURWISSENSCHAFTEN, V93, P597, DOI 10.1007/s00114-006-0146-6; Deaton R, 2009, BEHAV PROCESS, V80, P1, DOI 10.1016/j.beproc.2008.07.010; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Ehman KD, 2002, PARASITOLOGY, V125, P461, DOI 10.1017/S003118200200224X; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; Fisher RA, 1915, EUGEN REV, V7, P184; Gutierrez J, 2010, VET PARASITOL, V172, P8, DOI 10.1016/j.vetpar.2010.04.035; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; KAVALIERS M, 1995, P ROY SOC B-BIOL SCI, V261, P31, DOI 10.1098/rspb.1995.0113; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P398, DOI 10.1016/S0003-3472(82)80051-1; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P410, DOI 10.1016/S0003-3472(82)80052-3; McLachlan A, 1999, ANIM BEHAV, V57, P1199, DOI 10.1006/anbe.1999.1087; Merila J, 1999, ECOSCIENCE, V6, P12, DOI 10.1080/11956860.1999.11952203; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; MOLLER AP, 1990, EVOLUTION, V44, P771, DOI 10.1111/j.1558-5646.1990.tb03804.x; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; MOLLER AP, 1991, ANIM BEHAV, V41, P723, DOI 10.1016/S0003-3472(05)80909-1; Moore J., 2002, PARASITES BEHAV ANIM; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Poulin R, 1998, PARASITOLOGY, V116, pS3, DOI 10.1017/S0031182000084894; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	44	60	62	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27229	10.1371/journal.pone.0027229	http://dx.doi.org/10.1371/journal.pone.0027229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073295	Green Published, gold			2022-12-27	WOS:000297154900092
J	Steinbach, K; McDonald, CL; Reindl, M; Schweigreiter, R; Bandtlow, C; Martin, R				Steinbach, Karin; McDonald, Claire L.; Reindl, Markus; Schweigreiter, Ruediger; Bandtlow, Christine; Martin, Roland			Nogo-Receptors NgR1 and NgR2 Do Not Mediate Regulation of CD4 T Helper Responses and CNS Repair in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; B-LYMPHOCYTE STIMULATOR; MULTIPLE-SCLEROSIS; AXONAL REGENERATION; NEURITE OUTGROWTH; FUNCTIONAL LIGAND; CELL-ADHESION; IDENTIFICATION; INFLAMMATION; DISEASE	Myelin-associated inhibition of axonal regrowth after injury is considered one important factor that contributes to regeneration failure in the adult central nervous system (CNS). Blocking strategies targeting this pathway have been successfully applied in several nerve injury models, including experimental autoimmune encephalomyelitis (EAE), suggesting myelin-associated inhibitors (MAIs) and functionally related molecules as targets to enhance regeneration in multiple sclerosis. NgR1 and NgR2 were identified as interaction partners for the myelin proteins Nogo-A, MAG and OMgp and are probably mediating their growth-inhibitory effects on axons, although the in vivo relevance of this pathway is currently under debate. Recently, alternative functions of MAIs and NgRs in the regulation of immune cell migration and T cell differentiation have been described. Whether and to what extent NgR1 and NgR2 are contributing to Nogo and MAG-related inhibition of neuroregeneration or immunomodulation during EAE is currently unknown. Here we show that genetic deletion of both receptors does not promote functional recovery during EAE and that NgR1 and NgR2-mediated signals play a minor role in the development of CNS inflammation. Induction of EAE in Ngr1/2-double mutant mice resulted in indifferent disease course and tissue damage when compared to WT controls. Further, the development of encephalitogenic CD4(+) Th1 and Th17 responses was unchanged. However, we observed a slightly increased leukocyte infiltration into the CNS in the absence of NgR1 and NgR2, indicating that NgRs might be involved in the regulation of immune cell migration in the CNS. Our study demonstrates the urgent need for a more detailed knowledge on the multifunctional roles of ligands and receptors involved in CNS regeneration failure.	[Steinbach, Karin; Martin, Roland] Inst Neuroimmunol & Clin MS Res, Hamburg, Germany; [McDonald, Claire L.; Reindl, Markus] Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria; [Schweigreiter, Ruediger; Bandtlow, Christine] Innsbruck Med Univ, Dept Neurobiochem, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Steinbach, K (corresponding author), Inst Neuroimmunol & Clin MS Res, Hamburg, Germany.	roland.martin@usz.ch	Reindl, Markus/ABE-5880-2020	McDonald, Claire/0000-0002-0583-742X; Reindl, Markus/0000-0003-2817-1402; Martin, Roland/0000-0002-0982-1329	Gemeinnuetzige Hertie-Stiftung; Austrian Research Foundation (FWF) [W1206]; Novartis	Gemeinnuetzige Hertie-Stiftung; Austrian Research Foundation (FWF)(Austrian Science Fund (FWF)); Novartis(Novartis)	This work was supported by a research grant of the Gemeinnuetzige Hertie-Stiftung (Grant No. 1.01.1/ 08/ 001); the Gemeinnuetzige Hertie-Stiftung supports the The Institute for Neuroimmunology and Clinical Multiple Sclerosis (MS) Research as well. Claire McDonald is enrolled in the graduate program SPIN that is supported by the Austrian Research Foundation (FWF W1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author has read the journal's policy and may have a conflict of interest related to the work reported in the submitted manuscript.; It may be seen as a conflict that the corresponding author has previously received remuneration for consulting or advisory function to companies developing or marketing treatments for MS (Biogen, Merck Serono, Teva, Sanofi-Aventis); however, none of these were directly related to the work reported here. The corresponding author (in his prior function as director of the Institute for Neuroimmunology and Clinical MS Research) has received unrestricted grant support by Novartis, which is developing an anti-Nogo antibody for the treatment of spinal cord injury, but, due to largely negative results, the data - although not directly addressing this issue - are negative if anything for the efforts of Novartis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Fontoura P, 2004, J IMMUNOL, V173, P6981, DOI 10.4049/jimmunol.173.11.6981; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; MCDONALD CL, J NEUROINFLAMMATION, V8, P113; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schanda Kathrin, 2011, BMC Res Notes, V4, P6, DOI 10.1186/1756-0500-4-6; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; TALLANTYRE EC, MULT SCLER, V16, P406; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wang H, 2008, NEUROLOGY, V71, P1142, DOI 10.1212/01.wnl.0000316195.52001.e1; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Worter V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005218; Wright PL, 2010, J EXP MED, V207, P2595, DOI 10.1084/jem.20100786; YANG Y, ANN NEUROL, V67, P498; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Zhang L, 2009, J NEUROSCI, V29, P6348, DOI 10.1523/JNEUROSCI.5040-08.2009; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26341	10.1371/journal.pone.0026341	http://dx.doi.org/10.1371/journal.pone.0026341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096481	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000297553900002
J	Morandi, A; Barbetti, V; Riverso, M; Dello Sbarba, P; Rovida, E				Morandi, Andrea; Barbetti, Valentina; Riverso, Maria; Dello Sbarba, Persio; Rovida, Elisabetta			The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines	PLOS ONE			English	Article							C-FMS PROTOONCOGENE; GENE-EXPRESSION; GROWTH-FACTOR; CONSTITUTIVE PRODUCTION; SIGNAL-TRANSDUCTION; MICROARRAY ANALYSIS; SUPPRESSES GROWTH; TUMOR XENOGRAFTS; MAMMARY-TUMORS; COPY NUMBER	Breast cancer is the second leading cause of cancer-related deaths in western countries. Colony-Stimulating Factor-1 (CSF-1) and its receptor (CSF-1R) regulate macrophage and osteoclast production, trophoblast implantation and mammary gland development. The expression of CSF-1R and/or CSF-1 strongly correlates with poor prognosis in several human epithelial tumors, including breast carcinomas. We demonstrate that CSF-1 and CSF-1R are expressed, although at different levels, in 16/17 breast cancer cell lines tested with no differences among molecular subtypes. The role of CSF-1/CSF-1R in the proliferation of breast cancer cells was then studied in MDAMB468 and SKBR3 cells belonging to different subtypes. CSF-1 administration induced ERK1/2 phosphorylation and enhanced cell proliferation in both cell lines. Furthermore, the inhibition of CSF-1/CSF-1R signaling, by CSF-1R siRNA or imatinib treatment, impaired CSF-1 induced ERK1/2 activation and cell proliferation. We also demonstrate that c-Jun, cyclin D1 and c-Myc, known for their involvement in cell proliferation, are downstream CSF-1R in breast cancer cells. The presence of a proliferative CSF-1/CSF-1R autocrine loop involving ERK1/2 was also found. The wide expression of the CSF-1/CSF-1R pair across breast cancer cell subtypes supports CSF-1/CSF-1R targeting in breast cancer therapy.	Univ Florence, Dipartimento Patol & Oncol Sperimentali, Florence, Italy; Ist Toscano Tumori, Florence, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Morandi, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	persio@unifi.it; erovida@unifi.it	Rovida, Elisabetta/F-3565-2015; Morandi, Andrea/AAC-1901-2022; Dello Sbarba, Persio/AAX-9887-2020	Rovida, Elisabetta/0000-0002-5949-3239; Morandi, Andrea/0000-0002-9222-5332; 	Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG5220]; Ministero della Salute (Ricerca Finalizzata); Regione Toscana (Programma per la Ricerca in Materia di Salute); Associazione Italiana per la lotta contro le Leucemie e i Linfomi; sezione di Prato; Fondazione Cassa di Risparmio di Volterra; Federazione Italiana per la Ricerca sul Cancro (FIRC/AIRC)	Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Regione Toscana (Programma per la Ricerca in Materia di Salute)(Regione Toscana); Associazione Italiana per la lotta contro le Leucemie e i Linfomi(Fondazione AIRC per la ricerca sul cancro); sezione di Prato; Fondazione Cassa di Risparmio di Volterra; Federazione Italiana per la Ricerca sul Cancro (FIRC/AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Istituto Toscano Tumori (PDS), Associazione Italiana per la Ricerca sul Cancro (AIRC, contr.n. IG5220; PDS), Ministero della Salute (Ricerca Finalizzata; PDS), Regione Toscana (Programma per la Ricerca in Materia di Salute; PDS), Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL) sezione di Prato (PDS), Fondazione Cassa di Risparmio di Volterra (PDS). VB was recipient of a fellowship from Federazione Italiana per la Ricerca sul Cancro (FIRC/AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Aharinejad S, 2002, CANCER RES, V62, P5317; ASHMUN RA, 1989, BLOOD, V73, P827; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brownlow N, 2008, LEUKEMIA, V22, P649, DOI 10.1038/sj.leu.2404944; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Espinosa I, 2009, AM J PATHOL, V174, P2347, DOI 10.2353/ajpath.2009.081037; FILDERMAN AE, 1992, CANCER RES, V52, P3661; FlidelRimon O, 1997, J PEDIATR-US, V131, P748, DOI 10.1016/S0022-3476(97)70105-7; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gallet M, 2006, APOPTOSIS, V11, P1909, DOI 10.1007/s10495-006-9507-z; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; HORIGUCHI J, 1988, BIOCHEM BIOPH RES CO, V157, P395, DOI 10.1016/S0006-291X(88)80060-3; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; KACINSKI BM, 1991, ONCOGENE, V6, P941; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kirma N, 2004, CANCER RES, V64, P4162, DOI 10.1158/0008-5472.CAN-03-2971; Kirma N, 2007, CANCER RES, V67, P1918, DOI 10.1158/0008-5472.CAN-06-1991; Kluger HM, 2004, LAB INVEST, V84, P320, DOI 10.1038/labinvest.3700044; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AWM, 1999, ONCOGENE, V18, P7477, DOI 10.1038/sj.onc.1203123; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher MG, 1998, CLIN CANCER RES, V4, P1851; Mashkani B, 2010, BIOORGAN MED CHEM, V18, P1789, DOI 10.1016/j.bmc.2010.01.056; Meegalla SK, 2008, BIOORG MED CHEM LETT, V18, P3632, DOI 10.1016/j.bmcl.2008.04.059; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; RAMAKRISHNAN S, 1989, J CLIN INVEST, V83, P921, DOI 10.1172/JCI113977; ROHRSCHNEIDER LR, 1989, ONCOGENE, V4, P1015; Roussel MF, 1997, MOL REPROD DEV, V46, P11, DOI 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U; ROUSSEL MF, 1989, P NATL ACAD SCI USA, V86, P7924, DOI 10.1073/pnas.86.20.7924; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sapi E, 2004, EXP BIOL MED, V229, P1; Sapi E, 1996, CANCER RES, V56, P5704; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; SHERR CJ, 1990, BLOOD, V75, P1; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Tamimi RM, 2008, CANCER RES, V68, P18, DOI 10.1158/0008-5472.CAN-07-3234; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yee LD, 2000, ANTICANCER RES, V20, P4379	62	35	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27450	10.1371/journal.pone.0027450	http://dx.doi.org/10.1371/journal.pone.0027450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096574	Green Submitted, gold, Green Published			2022-12-27	WOS:000297350800053
J	Abdou, M; Peng, C; Huang, JH; Zyaan, O; Wang, S; Li, S; Wang, J				Abdou, Mohamed; Peng, Cheng; Huang, Jianhua; Zyaan, Ola; Wang, Sheng; Li, Sheng; Wang, Jian			Wnt Signaling Cross-Talks with JH Signaling by Suppressing Met and gce Expression	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; BEETLE TRIBOLIUM-CASTANEUM; STATUS-QUO ACTION; DROSOPHILA-MELANOGASTER; BROAD-COMPLEX; METHOPRENE-TOLERANT; TRANSCRIPTION FACTORS; NEGATIVE REGULATION; MUTANT DROSOPHILA; WNT/BETA-CATENIN	Juvenile hormone (JH) plays key roles in controlling insect growth and metamorphosis. However, relatively little is known about the JH signaling pathways. Until recent years, increasing evidence has suggested that JH modulates the action of 20-hydroxyecdysone (20E) by regulating expression of broad (br), a 20E early response gene, through Met/Gce and Kr-h1. To identify other genes involved in JH signaling, we designed a novel Drosophila genetic screen to isolate mutations that derepress JH-mediated br suppression at early larval stages. We found that mutations in three Wnt signaling negative regulators in Drosophila, Axin (Axn), supernumerary limbs (slmb), and naked cuticle (nkd), caused precocious br expression, which could not be blocked by exogenous JHA. A similar phenotype was observed when armadillo (arm), the mediator of Wnt signaling, was overexpressed. qRT-PCR revealed that Met, gce and Kr-h1expression was suppressed in the Axn, slmb and nkd mutants as well as in arm gain-of-function larvae. Furthermore, ectopic expression of gce restored Kr-h1 expression but not Met expression in the arm gain-of-function larvae. Taken together, we conclude that Wnt signaling cross-talks with JH signaling by suppressing transcription of Met and gce, genes that encode for putative JH receptors. The reduced JH activity further induces down-regulation of Kr-h1expression and eventually derepresses br expression in the Drosophila early larval stages.	[Abdou, Mohamed; Peng, Cheng; Huang, Jianhua; Zyaan, Ola; Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Wang, Sheng; Li, Sheng] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Abdou, M (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jianwang@umd.edu	Wang, Sheng/Q-3708-2016; Zyaan, Ola/D-5964-2017; Abdou, Mohamed A/D-6024-2017; Zyaan, Ola/F-6939-2018	Wang, Sheng/0000-0002-5625-403X; Zyaan, Ola/0000-0001-8200-3261; Abdou, Mohamed A/0000-0002-2285-7246; Zyaan, Ola/0000-0001-8200-3261	National Science Foundation [IOS1021767]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (IOS1021767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; ALTARATZ M, 1991, MOL CELL ENDOCRINOL, V81, P205, DOI 10.1016/0303-7207(91)90219-I; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Crossgrove K, 1996, DEV BIOL, V180, P745, DOI 10.1006/dbio.1996.0343; DIBELLO PR, 1991, GENETICS, V129, P385; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Pai LM, 1997, DEVELOPMENT, V124, P2255; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; POSTLETHWAIT JH, 1974, BIOL BULL-US, V147, P119, DOI 10.2307/1540573; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; RIDDIFORD LM, 1991, GEN COMP ENDOCR, V82, P172, DOI 10.1016/0016-6480(91)90181-5; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Sen SE, 2007, INSECT BIOCHEM MOLEC, V37, P1198, DOI 10.1016/j.ibmb.2007.07.011; SHEMSHEDINI L, 1990, P NATL ACAD SCI USA, V87, P2072, DOI 10.1073/pnas.87.6.2072; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Wang L, 2007, J BONE MINER RES, V22, P1988, DOI 10.1359/JBMR.070806; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou XF, 2002, DEVELOPMENT, V129, P2259	50	18	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26772	10.1371/journal.pone.0026772	http://dx.doi.org/10.1371/journal.pone.0026772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087234	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700010
J	Aparicio, F; Aparicio-Sanchis, R; Gadea, J; Sanchez-Navarro, JA; Pallas, V; Murguia, JR				Aparicio, Frederic; Aparicio-Sanchis, Rafael; Gadea, Jose; Angel Sanchez-Navarro, Jesus; Pallas, Vicente; Ramon Murguia, Jose			A Plant Virus Movement Protein Regulates the Gcn2p Kinase in Budding Yeast	PLOS ONE			English	Article							CELL-TO-CELL; NECROTIC-RINGSPOT-VIRUS; MESSENGER-RNA TRANSLATION; MOSAIC-VIRUS; BINDING DOMAIN; COAT PROTEIN; MODEL HOST; EXPRESSION; PHOSPHORYLATION; EIF2-ALPHA	Virus life cycle heavily depends on their ability to command the host machinery in order to translate their genomes. Animal viruses have been shown to interfere with host translation machinery by expressing viral proteins that either maintain or inhibit eIF2 alpha function by phosphorylation. However, this interference mechanism has not been described for any plant virus yet. Prunnus necrotic ringspot virus (PNRSV) is a serious pathogen of cultivated stone fruit trees. The movement protein (MP) of PNRSV is necessary for the cell-to-cell movement of the virus. By using a yeast-based approach we have found that overexpression of the PNRSV MP caused a severe growth defect in yeast cells. cDNA microarrays analysis carried out to characterise at the molecular level the growth interference phenotype reported the induction of genes related to amino acid deprivation suggesting that expression of MP activates the GCN pathway in yeast cells. Accordingly, PNRSV MP triggered activation of the Gcn2p kinase, as judged by increased eIF2 alpha phosphorylation. Activation of Gcn2p by MP expression required a functional Tor1p kinase, since rapamycin treatment alleviated the yeast cell growth defect and blocked eIF2 alpha phosphorylation triggered by MP expression. Overall, these findings uncover a previously uncharacterised function for PNRSV MP viral protein, and point out at Tor1p and Gcn2p kinases as candidate susceptibility factors for plant viral infections.	[Aparicio, Frederic; Aparicio-Sanchis, Rafael; Gadea, Jose; Angel Sanchez-Navarro, Jesus; Pallas, Vicente; Ramon Murguia, Jose] Inst Biol Mol & Celular Plantas UPV CSIC, Dept Stress Biol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Aparicio, F (corresponding author), Inst Biol Mol & Celular Plantas UPV CSIC, Dept Stress Biol, Valencia, Spain.	muribajo@ibmcp.upv.es	APARICIO, FREDERIC/R-2008-2018; Vacas, José Gadea/S-2446-2019; Sánchez-Navarro, Jesus Angel/K-8787-2014; Murguia, Jose R./H-4419-2015; Pallas, Vicente/N-1317-2014	APARICIO, FREDERIC/0000-0002-1586-9978; Vacas, José Gadea/0000-0002-3612-7914; Sánchez-Navarro, Jesus Angel/0000-0002-3320-2827; Murguia, Jose R./0000-0001-9364-4603; Pallas, Vicente/0000-0003-4954-989X; Aparicio-Sanchis, Rafael/0000-0001-9993-7722	Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana) [GV/2007/064, GV/2011/003]	Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants GV/2007/064 (Proyecto para grupos de investigacion emergentes) and (GV/2011/003) (Prometeo Project) from Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Rodrigues I, 2006, VIRUS RES, V120, P49, DOI 10.1016/j.virusres.2005.11.018; Aparicio F, 2003, VIROLOGY, V313, P213, DOI 10.1016/S0042-6822(03)00284-8; Aparicio F, 2002, VIRUS GENES, V25, P75, DOI 10.1023/A:1020126309692; Bilgin DD, 2003, DEV CELL, V4, P651, DOI 10.1016/S1534-5807(03)00125-4; Boevink P, 2005, PLANT PHYSIOL, V138, P1815, DOI 10.1104/pp.105.066761; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Curin M, 2007, PLANT PHYSIOL, V143, P801, DOI 10.1104/pp.106.091488; Di Terlizzi B, 2001, ARCH VIROL, V146, P825, DOI 10.1007/s007050170151; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fernandez-Calvino L, 2011, RECENT ADV PLANT VIR, P470; Fiore N, 2008, ARCH VIROL, V153, P909, DOI 10.1007/s00705-008-0066-1; Halford NG, 2006, ADV BOT RES, V43, P93, DOI 10.1016/S0065-2296(05)43002-5; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Herranz MC, 2005, VIROLOGY, V339, P31, DOI 10.1016/j.virol.2005.05.020; Herranz MC, 2004, J GEN VIROL, V85, P761, DOI 10.1099/vir.0.19534-0; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kaido M, 2007, MOL PLANT MICROBE IN, V20, P671, DOI 10.1094/MPMI-20-6-0671; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lageix S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-134; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Martinez-Gil L, 2009, J VIROL, V83, P5535, DOI 10.1128/JVI.00393-09; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Menacho-Marquez M, 2007, CELL CYCLE, V6, P2302, DOI 10.4161/cc.6.18.4668; Mink G.I., 1992, Advances in Disease Vector Research, V9, P261; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Pallas V, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P75; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Qian WJ, 1996, J BIOL CHEM, V271, P13202, DOI 10.1074/jbc.271.22.13202; Reiter AK, 2004, INT J BIOCHEM CELL B, V36, P2169, DOI 10.1016/j.biocel.2004.04.004; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; SanchezNavarro JA, 1997, ARCH VIROL, V142, P749, DOI 10.1007/s007050050116; Sasaki N, 2009, MOL PLANT PATHOL, V10, P161, DOI 10.1111/j.1364-3703.2008.00517.x; Schepetilnikov M, 2011, EMBO J, V30, P1343, DOI 10.1038/emboj.2011.39; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Steffensen L, 2006, EUKARYOT CELL, V5, P248, DOI 10.1128/EC.5.2.248-261.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Waigmann E, 2004, CRIT REV PLANT SCI, V23, P195, DOI 10.1080/07352680490452807; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Zhang YH, 2003, PLANTA, V217, P668, DOI 10.1007/s00425-003-1025-4; Zhang YH, 2008, J EXP BOT, V59, P3131, DOI 10.1093/jxb/ern169	47	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27409	10.1371/journal.pone.0027409	http://dx.doi.org/10.1371/journal.pone.0027409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087310	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700042
J	Jiang, H; Lu, Y; Yuan, L; Liu, JH				Jiang, Hui; Lu, Yi; Yuan, Liang; Liu, Jianghuai			Regulation of Interleukin-10 Receptor Ubiquitination and Stability by Beta-TrCP-Containing Ubiquitin E3 Ligase	PLOS ONE			English	Article							INTERFERON-ALPHA RECEPTOR; T-CELLS; DOWN-REGULATION; I INTERFERON; IL-10; DEGRADATION; PHOSPHORYLATION; EXPRESSION; PATHWAY; GROWTH	Interleukin-10 (IL-10) initiates potent anti-inflammatory effects via activating its cell surface receptor, composed of IL-10R1 and IL-10R2 subunits. The level of IL-10R1 is a major determinant of the cells' responsiveness to IL-10. Here, via a series of biochemical analyses using 293T cells reconstituted with IL-10R1, we identify the latter as a novel substrate of beta TrCP-containing ubiquitin E3 ligase. Within the intracellular tail of IL-10R1, a canonical ((318)DpSGFGpS) and a slightly deviated ((369)DpSGICLQEP) beta TrCP recognition motif can additively recruit beta TrCP in a phosphorylation-dependent manner. beta TrCP recruitment leads to ubiquitination, endocytosis and degradation of IL-10R1, subsequently reducing the cellular responsiveness to IL-10. Our study uncovers a novel negative regulatory mechanism that may potentially affect IL-10 function in target cells under physiological or pathological conditions.	[Jiang, Hui; Lu, Yi; Yuan, Liang; Liu, Jianghuai] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Animals Dis Study, Nanjing 210008, Peoples R China; [Jiang, Hui; Lu, Yi; Yuan, Liang; Liu, Jianghuai] Natl Resource Ctr Mutant Mice, Nanjing, Peoples R China; [Liu, Jianghuai] Wenzhou Med Coll, Sch Life Sci, Zhejiang Key Lab Technol & Applicat Model Organis, Wenzhou, Peoples R China	Nanjing University; Wenzhou Medical University	Jiang, H (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Animals Dis Study, Nanjing 210008, Peoples R China.	liujianghuai@nju.edu.cn		Liu, Jianghuai/0000-0002-2382-9140; Jiang, Hui/0000-0003-1170-0224	National Natural Science Foundation of China [30971512, 31071231]; Chinese Ministry of Science and Technology [2010CB945100, 2011CB944104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China grants (www.nsfc.gov.cn) #30971512 and #31071231 to JL; and Chinese Ministry of Science and Technology 973 grants (www.most.gov.cn) #2010CB945100 and #2011CB944104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ST, 2000, J IMMUNOL, V165, P5227, DOI 10.4049/jimmunol.165.9.5227; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Belouzard S, 2006, EMBO J, V25, P932, DOI 10.1038/sj.emboj.7600989; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DELPRETE G, 1993, J IMMUNOL, V150, P353; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Fernandez S, 2004, J IMMUNOL, V172, P2613, DOI 10.4049/jimmunol.172.4.2613; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Groux H, 1998, J IMMUNOL, V160, P3188; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Gruber SG, 2008, EUR J IMMUNOL, V38, P3365, DOI 10.1002/eji.200837718; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HO ASY, 1995, MOL CELL BIOL, V15, P5043; HuangFu WC, 2008, FEBS LETT, V582, P3206, DOI 10.1016/j.febslet.2008.08.013; HuangFu WC, 2010, PIGM CELL MELANOMA R, V23, P838, DOI 10.1111/j.1755-148X.2010.00770.x; Ji JD, 2003, J EXP MED, V197, P1573, DOI 10.1084/jem.20021820; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Joss A, 2000, EUR J IMMUNOL, V30, P1683, DOI 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qian J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002065; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Santin AD, 2000, J VIROL, V74, P4729, DOI 10.1128/JVI.74.10.4729-4737.2000; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shanahan F, 2000, SCIENCE, V289, P1311, DOI 10.1126/science.289.5483.1311; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Wei SHY, 2006, J INTERF CYTOK RES, V26, P281, DOI 10.1089/jir.2006.26.281; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	71	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27464	10.1371/journal.pone.0027464	http://dx.doi.org/10.1371/journal.pone.0027464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087322	Green Published, gold, Green Submitted			2022-12-27	WOS:000297349700049
J	Shu, XS; Geng, H; Li, LL; Ying, JM; Ma, CH; Wang, YJ; Poon, FF; Wang, X; Ying, Y; Yeo, W; Srivastava, G; Tsao, SW; Yu, J; Sung, JJY; Huang, S; Chan, ATC; Tao, Q				Shu, Xing-sheng; Geng, Hua; Li, Lili; Ying, Jianming; Ma, Chunhong; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Srivastava, Gopesh; Tsao, Sai Wah; Yu, Jun; Sung, Joseph J. Y.; Huang, Shi; Chan, Anthony T. C.; Tao, Qian			The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/beta-Catenin Signaling and Is Frequently Silenced in Multiple Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC-CANCER; CYCLIN D1; GENE; INACTIVATION; METHYLATION; CARCINOMA; NASOPHARYNGEAL; PATHWAY; TARGET	Background: PRDM (PRDI-BF1 and RIZ domain containing) proteins are zinc finger proteins involved in multiple cellular regulations by acting as epigenetic modifiers. We studied a recently identified PRDM member PRDM5 for its epigenetic abnormality and tumor suppressive functions in multiple tumorigeneses. Methodology/Principal Findings: Semi-quantitative RT-PCR showed that PRDM5 was broadly expressed in human normal tissues, but frequently silenced or downregulated in multiple carcinoma cell lines due to promoter CpG methylation, including 80% (4/5) nasopharyngeal, 44% (8/18) esophageal, 76% (13/17) gastric, 50% (2/4) cervical, and 25% (3/12) hepatocellular carcinoma cell lines, but not in any immortalized normal epithelial cell lines. PRDM5 expression could be restored by 5-aza-2'-deoxycytidine demethylation treatment in silenced cell lines. PRDM5 methylation was frequently detected by methylation-specific PCR (MSP) in multiple primary tumors, including 93% (43/46) nasopharyngeal, 58% (25/43) esophageal, 88% (37/42) gastric and 63% (29/46) hepatocellular tumors. PRDM5 was further found a stress-responsive gene, but its response was impaired when the promoter was methylated. Ectopic PRDM5 expression significantly inhibited tumor cell clonogenicity, accompanied by the inhibition of TCF/beta-catenin-dependent transcription and downregulation of CDK4, TWIST1 and MDM2 oncogenes, while knocking down of PRDM5 expression lead to increased cell proliferation. ChIP assay showed that PRDM5 bound to its target gene promoters and suppressed their transcription. An inverse correlation between the expression of PRDM5 and activated beta-catenin was also observed in cell lines. Conclusions/Significance: PRDM5 functions as a tumor suppressor at least partially through antagonizing aberrant WNT/beta-catenin signaling and oncogene expression. Frequent epigenetic silencing of PRDM5 is involved in multiple tumorigeneses, which could serve as a tumor biomarker.	[Shu, Xing-sheng; Geng, Hua; Li, Lili; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Chan, Anthony T. C.; Tao, Qian] Chinese Univ Hong Kong, Dept Clin Oncol, Canc Epigenet Lab, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Shu, Xing-sheng; Geng, Hua; Li, Lili; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Chan, Anthony T. C.; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Shu, Xing-sheng; Geng, Hua; Li, Lili; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Chan, Anthony T. C.; Tao, Qian] CUHK Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Ying, Jianming] Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China; [Ying, Jianming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Ma, Chunhong] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China; [Srivastava, Gopesh] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai Wah] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Shi] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Shandong University; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Central South University	Shu, XS (corresponding author), Chinese Univ Hong Kong, Dept Clin Oncol, Canc Epigenet Lab, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China.	qtao@clo.cuhk.edu.hk	Tao, Qian/T-4743-2018; Yeo, Winnie/R-4792-2018; Yu, Jun/D-8569-2015; Li, Lili/Q-5750-2018; Sung, Joseph J. Y./R-3203-2018; Chan, Anthony Tak Cheung/R-3940-2018	Tao, Qian/0000-0001-5383-4808; Yeo, Winnie/0000-0002-0863-8469; Yu, Jun/0000-0001-5008-2153; Li, Lili/0000-0002-0292-5889; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Anthony Tak Cheung/0000-0002-6912-8091; Wang, Xian/0000-0003-0041-7589	Research Grants Council of Hong Kong (GRF) [473908]; National Natural Science Foundation of China (NSFC) [30928012]	Research Grants Council of Hong Kong (GRF)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Research Grants Council of Hong Kong (GRF #473908) (http://www.ugc.edu.hk/eng/rgc/index.htm) and the National Natural Science Foundation of China (NSFC #30928012) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Du Y, 2001, CANCER RES, V61, P8094; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; Esteller M, 2000, CANCER RES, V60, P4366; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kim KC, 2003, CANCER BIOL THER, V2, P491, DOI 10.4161/cbt.2.5.629; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Meani N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004273; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Sato N, 2003, CANCER RES, V63, P3735; Senyuk V, 2005, CANCER RES, V65, P7603, DOI 10.1158/0008-5472.CAN-05-0412; Shivapurkar N, 2001, HUM PATHOL, V32, P169, DOI 10.1053/hupa.2001.21560; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Yang XH, 1999, GENOMICS, V61, P319, DOI 10.1006/geno.1999.5967; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Yu J, 2009, CANCER-AM CANCER SOC, V115, P49, DOI 10.1002/cncr.23989; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	35	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27346	10.1371/journal.pone.0027346	http://dx.doi.org/10.1371/journal.pone.0027346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087297	Green Published, gold			2022-12-27	WOS:000297349700034
J	Torres, R; Drummond, H; Velando, A				Torres, Roxana; Drummond, Hugh; Velando, Alberto			Parental Age and Lifespan Influence Offspring Recruitment: A Long-Term Study in a Seabird	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BREEDING EXPERIENCE; LIVED BIRD; SENESCENCE; PERFORMANCE; EVOLUTION; DECLINE; HISTORY; QUALITY; SPERM	Recent studies of wild populations provide compelling evidence that survival and reproduction decrease with age because of senescence, a decline in functional capacities at old ages. However, in the wild, little is known about effects of parental senescence on offspring quality. We used data from a 21-year study to examine the role of parental age on offspring probability of recruitment in a long-lived bird, the blue-footed booby (Sula nebouxii). Offspring probability of recruiting into the breeding population varied over the life of parents and effects age were similar in mothers and fathers. Offspring recruitment was high when parents were roughly 6-12 years old and low before and after then. Effects of parental age on offspring recruitment varied with lifespan (parental age at last reproduction) and previous breeding experience. Offspring recruitment from young and old parents with long reproductive lifespans was greater than that of offspring from parents with short lifespans at young and old ages. For parents with little previous breeding experience recruitment of offspring decreased with their hatch date, but experienced parents were no similarly affected. We found evidence of terminal effects on offspring recruitment in young parents but not in older parents, suggesting that senescence is more likely a gradual process of deterioration than a process of terminal illness. Failure to recruit probably reflects mortality during the first years after independence but also during the fledgling transition to full independence. Our results show effects of parental age and quality on offspring viability in a long-lived wild vertebrate and support the idea that wild populations are composed of individuals of different quality, and that this individual heterogeneity can influence the dynamics of age-structured populations.	[Torres, Roxana; Drummond, Hugh] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico; [Velando, Alberto] Univ Vigo, Dept Ecoloxia & Biol Anim, Vigo 36310, Spain	Universidad Nacional Autonoma de Mexico; Universidade de Vigo	Torres, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico.	avelando@uvigo.es	Velando, Alberto/B-1701-2009	Velando, Alberto/0000-0001-8909-0724	Universidad Nacional Autonoma de Mexico [IN228309]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [4722-N9407, D112-903581, PCCNCNA-031528, 34500-V, CO1-47599, 81823]; Spanish Ministerio de Ciencia y Tecnologia [CGL2009-10883-C02-01]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study was supported by the Universidad Nacional Autonoma de Mexico (IN228309), the Consejo Nacional de Ciencia y Tecnologia (CONACYT 4722-N9407, D112-903581, PCCNCNA-031528, 34500-V, CO1-47599, 81823), and the Spanish Ministerio de Ciencia y Tecnologia (CGL2009-10883-C02-01). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2007, EVOL ECOL RES, V9, P355; Angelier F, 2007, BEHAV ECOL SOCIOBIOL, V61, P611, DOI 10.1007/s00265-006-0290-1; [Anonymous], 2006, SAS MIXED MODELS; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Baudisch A, 2005, P NATL ACAD SCI USA, V102, P8263, DOI 10.1073/pnas.0502155102; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Bennett P. M., 2002, OX ECOL EV; Bouwhuis S, 2010, J EVOLUTION BIOL, V23, P636, DOI 10.1111/j.1420-9101.2009.01929.x; Bouwhuis S, 2009, P ROY SOC B-BIOL SCI, V276, P2769, DOI 10.1098/rspb.2009.0457; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coulson JC, 2001, J AVIAN BIOL, V32, P146, DOI 10.1034/j.1600-048X.2001.320207.x; Crespin L, 2006, J ANIM ECOL, V75, P228, DOI 10.1111/j.1365-2656.2006.01035.x; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; DAAN S, 1990, BEHAVIOUR, V114, P83, DOI 10.1163/156853990X00068; Daunt F, 1999, P ROY SOC B-BIOL SCI, V266, P1489, DOI 10.1098/rspb.1999.0805; Descamps S, 2008, OIKOS, V117, P1406, DOI 10.1111/j.0030-1299.2008.16545.x; Drummond H, 2003, AM NAT, V161, P794, DOI 10.1086/375170; Fitzgerald C, 1998, YALE J BIOL MED, V71, P367; GUERRA M, 1995, BEHAVIOUR, V132, P479, DOI 10.1163/156853995X00162; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kern S, 2001, EVOLUTION, V55, P1822, DOI 10.1111/j.0014-3820.2001.tb00831.x; Kim SY, 2011, J EVOLUTION BIOL, V24, P295, DOI 10.1111/j.1420-9101.2010.02165.x; Kim SY, 2007, BEHAV ECOL, V18, P1132, DOI 10.1093/beheco/arm091; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Lynch M., 1998, GENETICS ANAL QUANTI; McCleery RH, 2008, P R SOC B, V275, P963, DOI 10.1098/rspb.2007.1418; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Moore PJ, 2003, P ROY SOC B-BIOL SCI, V270, pS192, DOI 10.1098/rsbl.2003.0051; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Nelson B., 1978, SULIDAE GANNETS BOOB; Nikola T, 2004, EVOL ECOL, V18, P187, DOI 10.1023/B:EVEC.0000021090.51851.bd; Nilsson J-A, 1999, P 22 INT ORN C DURB, P234; NOL E, 1987, J ANIM ECOL, V56, P301, DOI 10.2307/4816; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; OSORIOBERISTAIN M, 1993, AUK, V110, P234; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; Rattiste K, 2004, P ROY SOC B-BIOL SCI, V271, P2059, DOI 10.1098/rspb.2004.2832; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reid JM, 2010, J ANIM ECOL, V79, P851, DOI 10.1111/j.1365-2656.2010.01669.x; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Sanz-Aguilar A, 2008, ECOLOGY, V89, P3195, DOI 10.1890/08-0431.1; SAS Institute, 1999, SAS ONL DOC VERS 8; Sharp SP, 2010, J ANIM ECOL, V79, P176, DOI 10.1111/j.1365-2656.2009.01616.x; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Torres R, 1999, J ANIM ECOL, V68, P1133, DOI 10.1046/j.1365-2656.1999.00357.x; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Velando A, 2000, ANIM BEHAV, V60, P181, DOI 10.1006/anbe.2000.1445; Velando A, 2011, J EVOLUTION BIOL, V24, P693, DOI 10.1111/j.1420-9101.2010.02201.x; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; Waskar M, 2005, AGE, V27, P201, DOI 10.1007/s11357-005-2914-1; West-Eberhard Mary Jane, 2003, pi; White J, 2008, P NATL ACAD SCI USA, V105, P13947, DOI 10.1073/pnas.0803067105; Williams G. C., 1966, P307; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; Yilmaz M, 2008, BIOGERONTOLOGY, V9, P163, DOI 10.1007/s10522-008-9125-y	77	38	38	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27245	10.1371/journal.pone.0027245	http://dx.doi.org/10.1371/journal.pone.0027245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087271	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700021
J	Dong, CH; Della-Morte, D; Wang, LY; Cabral, D; Beecham, A; McClendon, MS; Luca, CC; Blanton, SH; Sacco, RL; Rundek, T				Dong, Chuanhui; Della-Morte, David; Wang, Liyong; Cabral, Digna; Beecham, Ashley; McClendon, Mark S.; Luca, Corneliu C.; Blanton, Susan H.; Sacco, Ralph L.; Rundek, Tatjana			Association of the Sirtuin and Mitochondrial Uncoupling Protein Genes with Carotid Plaque	PLOS ONE			English	Article							NORTHERN MANHATTAN; BLOOD-PRESSURE; PRINCIPAL-COMPONENTS; CARIBBEAN HISPANICS; ANGIOTENSIN-II; METABOLISM; MECHANISMS; OBESITY; MICE; POLYMORPHISMS	Objective: Sirtuins (SIRTs) and mitochondrial uncoupling proteins (UCPs) have been implicated in cardiovascular diseases through the control of reactive oxygen species production. This study sought to investigate the association between genetic variants in the SIRT and UCP genes and carotid plaque. Methods: In a group of 1018 stroke-free subjects from the Northern Manhattan Study with high-definition carotid ultrasonography and genotyping, we investigated the associations of 85 single nucleotide polymorphisms (SNPs) in the 11 SIRT and UCP genes with the presence and number of carotid plaques, and evaluated interactions of SNPs with sex, smoking, diabetes and hypertension as well as interactions between SNPs significantly associated with carotid plaque. Results: Overall, 60% of subjects had carotid plaques. After adjustment for demographic and vascular risk factors, T-carriers of the SIRT6 SNP rs107251 had an increased risk for carotid plaque (odds ratio, OR = 1.71, 95% CI = 1.23-2.37, Bonferroni-corrected p = 0.03) and for a number of plaques (rate ratio, RR = 1.31, 1.18-1.45, Bonferroni-corrected p = 1.4x10(-5)), whereas T-carriers of the UCP5 SNP rs5977238 had an decreased risk for carotid plaque (OR = 0.49, 95% CI = 0.32-0.74, Bonferroni-corrected p = 0.02) and plaque number (RR = 0.64, 95% CI = 0.52-0.78, Bonferroni-corrected p = 4.9x10(-4)). Some interactions with a nominal p <= 0.01 were found between sex and SNPs in the UCP1 and UCP3 gene; between smoking, diabetes, hypertension and SNPs in UCP5 and SIRT5; and between SNPs in the UCP5 gene and the UCP1, SIRT1, SIRT3, SIRT5, and SIRT6 genes in association with plaque phenotypes. Conclusion: We observed significant associations between genetic variants in the SIRT6 and UCP5 genes and atherosclerotic plaque. We also found potential effect modifications by sex, smoking and vascular risk factors of the SIRT/UCP genes in the associations with atherosclerotic plaque. Further studies are needed to validate our observations.	[Dong, Chuanhui; Della-Morte, David; Cabral, Digna; McClendon, Mark S.; Luca, Corneliu C.; Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Wang, Liyong; Beecham, Ashley; Blanton, Susan H.; Sacco, Ralph L.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, John T McDonald Dept Human Genet, Miami, FL 33136 USA; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Della-Morte, David] IRCCS San Raffaele Pisana, Dept Lab Med & Adv Biotechnol, Rome, Italy	University of Miami; University of Miami; University of Miami; IRCCS San Raffaele Pisana	Dong, CH (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	TRundek@med.miami.edu	Sacco, Ralph/Y-9278-2019; Della-Morte, David/K-1011-2018; Blanton, Susan Halloran/ABF-1323-2021	DELLA MORTE, DAVID/0000-0002-4054-5318; Luca, Corneliu/0000-0001-8435-222X	National Institute of Neurologic Disorders and Stroke (NINDS) [R01 NS NS40807, R01 NS047655, K24 NS062737]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065114, R01NS047655, R01NS040807, K24NS062737] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants R01 NS NS40807 (Dr. Sacco), R01 NS047655 (Dr. Rundek); and K24 NS062737 (Dr. Rundek) from the National Institute of Neurologic Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAUR J, 2010, SIRTUINS OXIDATIV PA, P2; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Camins A, 2010, BBA-GENE REGUL MECH, V1799, P740, DOI 10.1016/j.bbagrm.2010.06.005; Cha MH, 2008, J KOREAN MED SCI, V23, P776, DOI 10.3346/jkms.2008.23.5.776; Cha MH, 2007, METABOLISM, V56, P806, DOI 10.1016/j.metabol.2007.01.023; Chen H, 2008, BRAIN RES, V1228, P81, DOI 10.1016/j.brainres.2008.06.067; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; de Parre TJLV, 2008, CARDIOVASC RES, V77, P425, DOI 10.1093/cvr/cvm003; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Dong CH, 2010, STROKE, V41, P2750, DOI 10.1161/STROKEAHA.110.596981; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Guo P, 2006, J HYPERTENS, V24, P1097, DOI 10.1097/01.hjh.0000226200.73065.5d; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Hunt KJ, 2002, STROKE, V33, P2775, DOI 10.1161/01.STR.0000043827.03966.EF; JIA JJ, 2009, MOL BIOL REP; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; Kwok KHH, 2010, FREE RADICAL BIO MED, V49, P1023, DOI 10.1016/j.freeradbiomed.2010.06.017; Labayen I, 2009, PEDIATR RES, V66, P350, DOI 10.1203/PDR.0b013e3181b1bd35; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Potente M, 2010, CIRC RES, V106, P1316, DOI 10.1161/CIRCRESAHA.110.219352; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos KS, 2007, MUTAT RES-FUND MOL M, V621, P18, DOI 10.1016/j.mrfmmm.2006.12.009; Rodriguez AM, 2004, INT J OBESITY, V28, P500, DOI 10.1038/sj.ijo.0802588; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sacco RL, 2007, ETHNIC DIS, V17, P351; Sacco RL, 2009, J AM COLL CARDIOL, V54, P2303, DOI 10.1016/j.jacc.2009.07.047; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Ungvari Z, 2008, FRONT BIOSCI-LANDMRK, V13, P5056, DOI 10.2741/3064; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Ungvari Z, 2010, J MOL MED, V88, P1021, DOI 10.1007/s00109-010-0667-5; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143; Zillikens MC, 2009, FREE RADICAL BIO MED, V46, P836, DOI 10.1016/j.freeradbiomed.2008.12.022	56	51	54	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27157	10.1371/journal.pone.0027157	http://dx.doi.org/10.1371/journal.pone.0027157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087257	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700022
J	Ligthart, ST; Coumans, FAW; Attard, G; Cassidy, AM; de Bono, JS; Terstappen, LWMM				Ligthart, Sjoerd T.; Coumans, Frank A. W.; Attard, Gerhardt; Cassidy, Amy Mulick; de Bono, Johann S.; Terstappen, Leon W. M. M.			Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; METASTATIC BREAST-CANCER; ABIRATERONE ACETATE; PROGRESSION-FREE; PREDICT; CYP17; INHIBITOR; TRIAL; BLOOD	Circulating tumour cells (CTC) in patients with metastatic carcinomas are associated with poor survival and can be used to guide therapy. Classification of CTC however remains subjective, as they are morphologically heterogeneous. We acquired digital images, using the CellSearch (TM) system, from blood of 185 castration resistant prostate cancer (CRPC) patients and 68 healthy subjects to define CTC by computer algorithms. Patient survival data was used as the training parameter for the computer to define CTC. The computer-generated CTC definition was validated on a separate CRPC dataset comprising 100 patients. The optimal definition of the computer defined CTC (aCTC) was stricter as compared to the manual CellSearch CTC (mCTC) definition and as a consequence aCTC were less frequent. The computer-generated CTC definition resulted in hazard ratios (HRs) of 2.8 for baseline and 3.9 for follow-up samples, which is comparable to the mCTC definition (baseline HR 2.9, follow-up HR 4.5). Validation resulted in HRs at baseline/follow-up of 3.9/5.4 for computer and 4.8/5.8 for manual definitions. In conclusion, we have defined and validated CTC by clinical outcome using a perfectly reproducing automated algorithm.	[Ligthart, Sjoerd T.; Coumans, Frank A. W.; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, Med Cell BioPhys Grp, NL-7500 AE Enschede, Netherlands; [Attard, Gerhardt; Cassidy, Amy Mulick; de Bono, Johann S.] Royal Marsden Natl Hlth Serv Fdn Trust, Sutton, Surrey, England	University of Twente; Royal Marsden NHS Foundation Trust	Ligthart, ST (corresponding author), Univ Twente, MIRA Inst, Med Cell BioPhys Grp, POB 217, NL-7500 AE Enschede, Netherlands.	l.w.m.m.terstappen@utwente.nl	terstappen, leon/O-4923-2018	terstappen, leon/0000-0001-5944-3787; Mulick, Amy/0000-0002-4009-2080; Coumans, Frank/0000-0001-6282-6009; Attard, Gerhardt/0000-0002-4811-7983; de Bono, Johann S/0000-0002-2034-595X	Veridex LLC; Cancer Research United Kingdom; Experimental Cancer Medical Centre; Department of Health [C51/A7401]; National Health Service; National Institute for Health Research [CL-2008-22-001] Funding Source: researchfish	Veridex LLC; Cancer Research United Kingdom(Cancer Research UK); Experimental Cancer Medical Centre; Department of Health; National Health Service; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Veridex LLC. (http://www.veridex.com/). GA, AMC and JdB are supported by a Cancer Research United Kingdom program grant and an Experimental Cancer Medical Centre grant from Cancer Research United Kingdom and the Department of Health (Ref: C51/A7401). GA and JdB acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2011, CURR OPIN GENET DEV, V21, P50, DOI 10.1016/j.gde.2010.10.010; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Kagan M, 2002, J CLIN LIGAND ASSAY, V25, P104; Kraan J, 2010, CYTOM PART B-CLIN CY, V80B, P112; Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454	21	34	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27419	10.1371/journal.pone.0027419	http://dx.doi.org/10.1371/journal.pone.0027419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087312	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000297347700051
J	Tamura, T; Sone, M; Iwatsubo, T; Tagawa, K; Wanker, EE; Okazawa, H				Tamura, Takuya; Sone, Masaki; Iwatsubo, Takeshi; Tagawa, Kazuhiko; Wanker, Erich E.; Okazawa, Hitoshi			Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; SPINOCEREBELLAR ATAXIA; CELL-DEATH; PROTEINS; TRANSCRIPTION; TOXICITY; MICE; GENE	DNA damage accumulates in genome DNA during the long life of neurons, thus DNA damage repair is indispensable to keep normal functions of neurons. We previously reported that Ku70, a critical molecule for DNA double strand break (DSB) repair, is involved in the pathology of Huntington's disease (HD). Mutant huntingtin (Htt) impaired Ku70 function via direct interaction, and Ku70 supplementation recovered phenotypes of a mouse HD model. In this study, we generate multiple Drosophila HD models that express mutant huntingtin (Htt) in eye or motor neuron by different drivers and show various phenotypes. In such fly models, Ku70 co-expression recovers lifespan, locomotive activity and eye degeneration. In contrast, Ku70 reduction by heterozygous null mutation or siRNA-mediated knock down accelerates lifespan shortening and locomotion disability. These results collectively support that Ku70 is a critical mediator of the HD pathology and a candidate therapeutic target in HD.	[Tamura, Takuya; Sone, Masaki; Tagawa, Kazuhiko; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Tokyo, Japan; [Sone, Masaki] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo, Japan; [Wanker, Erich E.] Max Delbruck Ctr Mol Med, Dept Neurogenet, Berlin, Germany; [Okazawa, Hitoshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Toho University; University of Tokyo; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Japan Science & Technology Agency (JST)	Tamura, T (corresponding author), Tokyo Med & Dent Univ, Dept Neuropathol, Med Res Inst, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Sone, Masaki/Q-9058-2019	Wanker, Erich/0000-0001-8072-1630	Japan Science Technology Agency (CREST, JST, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan [16390249, 16650076, 18390254, 18650097, 17025017, 18023014, 20023011]; Foundation of Synapse and Neurocircuit Pathology; National Genome Research Network (NGFN); DFG Collaborative Research Centre [SFB577, SFB740, SFB618]	Japan Science Technology Agency (CREST, JST, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Synapse and Neurocircuit Pathology; National Genome Research Network (NGFN); DFG Collaborative Research Centre(German Research Foundation (DFG))	This work was supported by grants to H.O. from Japan Science Technology Agency (CREST, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011) and Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology). Financial support to E. E. W. was provided by National Genome Research Network (NGFN) grants and DFG Collaborative Research Centre grants (SFB577, SFB740, SFB618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Johnson-Schlitz DM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030050; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Sekelsky JJ, 1998, GENETICS, V148, P1587; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Sone M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004466; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052	42	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27408	10.1371/journal.pone.0027408	http://dx.doi.org/10.1371/journal.pone.0027408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22096569	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700049
J	Vivet-Boudou, V; Isel, C; Sleiman, M; Smyth, R; Ben Gaied, N; Barhoum, P; Laumond, G; Bec, G; Gotte, M; Mak, J; Aubertin, AM; Burger, A; Marquet, R				Vivet-Boudou, Valerie; Isel, Catherine; Sleiman, Marwan; Smyth, Redmond; Ben Gaied, Nouha; Barhoum, Patrick; Laumond, Geraldine; Bec, Guillaume; Goette, Matthias; Mak, Johnson; Aubertin, Anne-Marie; Burger, Alain; Marquet, Roland			8-Modified-2 '-Deoxyadenosine Analogues Induce Delayed Polymerization Arrest during HIV-1 Reverse Transcription	PLOS ONE			English	Article							NUCLEOSIDE ANALOGS; NONNUCLEOSIDE INHIBITORS; ANTIRETROVIRAL THERAPY; PURINE NUCLEOSIDES; DRUG-RESISTANCE; EXCISION; TYPE-1; POTENT; REPLICATION; ENTECAVIR	The occurrence of resistant viruses to any of the anti-HIV-1 compounds used in the current therapies against AIDS underlies the urge for the development of new drug targets and/or new drugs acting through novel mechanisms. While all anti-HIV-1 nucleoside analogues in clinical use and in clinical trials rely on ribose modifications for activity, we designed nucleosides with a natural deoxyribose moiety and modifications of position 8 of the adenine base. Such modifications might induce a steric clash with helix alpha H in the thumb domain of the p66 subunit of HIV-1 RT at a distance from the catalytic site, causing delayed chain termination. Eleven new 2'-deoxyadenosine analogues modified on position 8 of the purine base were synthesized and tested in vitro and in cell-based assays. In this paper we demonstrate for the first time that chemical modifications on position 8 of 2'-deoxyadenosine induce delayed chain termination in vitro, and also inhibit DNA synthesis when incorporated in a DNA template strand. Furthermore, one of them had moderate anti-HIV-1 activity in cell-culture. Our results constitute a proof of concept indicating that modification on the base moiety of nucleosides can induce delayed polymerization arrest and inhibit HIV-1 replication.	[Vivet-Boudou, Valerie; Isel, Catherine; Sleiman, Marwan; Barhoum, Patrick; Bec, Guillaume; Marquet, Roland] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France; [Smyth, Redmond; Mak, Johnson] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Ben Gaied, Nouha; Burger, Alain] Univ Nice Sophia Antipolis, CNRS, Inst Chim Nice, Lab Chim Mol Bioact & Aromes, Nice, France; [Laumond, Geraldine; Aubertin, Anne-Marie] Univ Strasbourg, INSERM, Fac Med, Virol Lab, Strasbourg, France; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Burnet Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; McGill University	Vivet-Boudou, V (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France.	v.vivet@ibmc-cnrs.unistra.fr; c.isel@ibmc-cnrs.unistra.fr	Isel, Catherine/AAH-2174-2020; mak, johnson/S-2457-2019; Isel, Catherine/B-9406-2015; mak, johnson/H-4605-2014; Burger, Alain F/B-9586-2009; Smyth, Redmond/AAP-1637-2020	Isel, Catherine/0000-0002-8014-7525; mak, johnson/0000-0002-5229-5707; Isel, Catherine/0000-0001-7258-869X; mak, johnson/0000-0002-5229-5707; LAUMOND, Geraldine/0000-0003-1867-0734; Smyth, Redmond/0000-0002-1580-0671; Sleiman, Marwan/0000-0003-4457-8069; Marquet, Roland/0000-0002-4209-3976	Agence Nationale de Recherche sur le Sida, SIDACTION; University of Strasbourg	Agence Nationale de Recherche sur le Sida, SIDACTION(ANRS); University of Strasbourg	The work was supported by the Agence Nationale de Recherche sur le Sida, SIDACTION and the University of Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Hoyos AJ, 2010, VIRUSES-BASEL, V2, P372, DOI 10.3390/v2020372; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Boyer PL, 2007, J MOL BIOL, V371, P873, DOI 10.1016/j.jmb.2007.05.043; Boyer PL, 2009, J MED CHEM, V52, P5356, DOI 10.1021/jm801176e; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; Capek P, 2006, ORG BIOMOL CHEM, V4, P2278, DOI 10.1039/b604010a; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; El Safadi Y, 2010, J MED CHEM, V53, P1534, DOI 10.1021/jm901758f; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Fukushima K, 2008, HEPATOL RES, V38, P842, DOI 10.1111/j.1872-034X.2008.00332.x; Gaied NB, 2005, NUCLEIC ACIDS RES, V33, P1031, DOI 10.1093/nar/gki253; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Greenberg M, 2004, REV MED VIROL, V14, P321, DOI 10.1002/rmv.440; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Lindberg J, 2002, EUR J BIOCHEM, V269, P1670, DOI 10.1046/j.1432-1327.2002.02811.x; LONG RA, 1967, J ORG CHEM, V32, P2751, DOI 10.1021/jo01284a024; MARQUET R, 1994, NUCLEIC ACIDS RES, V22, P145, DOI 10.1093/nar/22.2.145; Marquez VE, 2006, ANTIVIR RES, V71, P268, DOI 10.1016/j.antiviral.2006.04.012; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Menendez-Arias L, 2008, VIRUS RES, V134, P1, DOI 10.1016/j.virusres.2008.01.009; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; MIZRAHI V, 1994, J BIOL CHEM, V269, P19245; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Ohrui H, 2006, CHEM REC, V6, P133, DOI 10.1002/tcr.20078; Ohrui Hiroshi, 2001, Current Drug Targets - Infectious Disorders, V1, P1, DOI 10.2174/1568005013343218; Pomerantz RJ, 2003, NAT MED, V9, P867, DOI 10.1038/nm0703-867; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAGI G, 1994, J MED CHEM, V37, P1307, DOI 10.1021/jm00035a010; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Skalka AM, 1993, COLD SPRING HARBOR M, V23, P492; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; VANAERSCHOT AA, 1993, J MED CHEM, V36, P2938, DOI 10.1021/jm00072a013; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; Vu BC, 2011, ANTIMICROB AGENTS CH, V55, P2379, DOI 10.1128/AAC.01290-10	41	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27456	10.1371/journal.pone.0027456	http://dx.doi.org/10.1371/journal.pone.0027456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087320	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700055
J	Gu, BA; Kale, SD; Wang, QH; Wang, DH; Pan, QN; Cao, H; Meng, YL; Kang, ZS; Tyler, BM; Shan, WX				Gu, Biao; Kale, Shiv D.; Wang, Qinhu; Wang, Dinghe; Pan, Qiaona; Cao, Hua; Meng, Yuling; Kang, Zhensheng; Tyler, Brett M.; Shan, Weixing			Rust Secreted Protein Ps87 Is Conserved in Diverse Fungal Pathogens and Contains a RXLR-like Motif Sufficient for Translocation into Plant Cells	PLOS ONE			English	Article							EFFECTOR PROTEINS; FLAX RUST; AVIRULENCE PROTEINS; DISEASE RESISTANCE; OOMYCETE; BACTERIAL; GENOMICS; DELIVERY; SEQUENCE; GENES	Background: Effector proteins of biotrophic plant pathogenic fungi and oomycetes are delivered into host cells and play important roles in both disease development and disease resistance response. How obligate fungal pathogen effectors enter host cells is poorly understood. The Ps87 gene of Puccinia striiformis encodes a protein that is conserved in diverse fungal pathogens. Ps87 homologs from a clade containing rust fungi are predicted to be secreted. The aim of this study is to test whether Ps87 may act as an effector during Puccinia striiformis infection. Methodology/Principal Findings: Yeast signal sequence trap assay showed that the rust protein Ps87 could be secreted from yeast cells, but a homolog from Magnaporthe oryzae that was not predicted to be secreted, could not. Cell re-entry and protein uptake assays showed that a region of Ps87 containing a conserved RXLR-like motif [K/R]RLTG was confirmed to be capable of delivering oomycete effector Avr1b into soybean leaf cells and carrying GFP into soybean root cells. Mutations in the Ps87 motif (KRLTG) abolished the protein translocation ability. Conclusions/Significance: The results suggest that Ps87 and its secreted homologs could utilize similar protein translocation machinery as those of oomycete and other fungal pathogens. Ps87 did not show direct suppression activity on plant defense responses. These results suggest Ps87 may represent an "emerging effector" that has recently acquired the ability to enter plant cells but has not yet acquired the ability to alter host physiology.	[Gu, Biao; Wang, Dinghe; Meng, Yuling; Kang, Zhensheng; Shan, Weixing] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Kale, Shiv D.; Tyler, Brett M.] Viginia Bioinformat Inst, Blacksburg, VA USA; [Wang, Qinhu; Pan, Qiaona; Cao, Hua] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Gu, Biao; Wang, Qinhu; Wang, Dinghe; Pan, Qiaona; Cao, Hua; Meng, Yuling; Kang, Zhensheng; Shan, Weixing] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Shan, WX (corresponding author), NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	btyler@vbi.vt.edu; wxshan@nwsuaf.edu.cn	Wang, Qinhu/AAD-4793-2021; Zhao, jing/B-7349-2008; Gu, Biao/AAT-8220-2021; Pan, Qiaona/AAI-4570-2021; Wang, Qinhu/I-6274-2012	Wang, Qinhu/0000-0003-1251-073X; Wang, Qinhu/0000-0003-1251-073X; Shan, Weixing/0000-0001-7286-4041; Kang, Zhensheng/0000-0001-5575-0122	China Agriculture Research System [CARS-10]; National Natural Science Foundation of China [30971881]; Ministry of Education of China [B07049]; National Research Initiative of the USDA National Institute of Food and Agriculture [2007-35319-18100]; Virginia Bioinformatics Institute (BMT); U.S. National Science Foundation	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Research Initiative of the USDA National Institute of Food and Agriculture; Virginia Bioinformatics Institute (BMT); U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by China Agriculture Research System (grant number #CARS-10), National Natural Science Foundation of China (grant number #30971881) and the 111 Project from Ministry of Education of China (grant number #B07049) (WS), and in part by the National Research Initiative of the USDA National Institute of Food and Agriculture, grant number #2007-35319-18100 (BMT), and funds from the Virginia Bioinformatics Institute (BMT). SDK was supported in part by a U.S. National Science Foundation predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Gan PHP, 2010, PLANT SIGNAL BEHAV, V5, P1272, DOI 10.4161/psb.5.10.13013; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2002, CAN J PLANT PATHOL, V24, P6, DOI 10.1080/07060660109506963; Kamoun S, 1998, PHYTOPATHOLOGY, V88, P1315, DOI 10.1094/PHYTO.1998.88.12.1315; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S3; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang Y, 2011, MOL PLANT PATHOL, V12, P187, DOI 10.1111/j.1364-3703.2010.00659.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Zhang YH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203	37	57	65	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27217	10.1371/journal.pone.0027217	http://dx.doi.org/10.1371/journal.pone.0027217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076138	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200051
J	Costa, NR; Paulo, P; Caffrey, T; Hollingsworth, MA; Santos-Silva, F				Costa, Natalia R.; Paulo, Paula; Caffrey, Thomas; Hollingsworth, Michael A.; Santos-Silva, Filipe			Impact of MUC1 Mucin Downregulation in the Phenotypic Characteristics of MKN45 Gastric Carcinoma Cell Line	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; MULTIPLE-MYELOMA CELLS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; BETA-CATENIN; RNA INTERFERENCE; CIRCULATING GALECTIN-3; TUMOR PROGRESSION; EPITHELIAL MUCIN; EPISIALIN MUC1	Background: Gastric carcinoma is the second leading cause of cancer-associated death worldwide. The high mortality associated with this disease is in part due to limited knowledge about gastric carcinogenesis and a lack of available therapeutic and prevention strategies. MUC1 is a high molecular weight transmembrane mucin protein expressed at the apical surface of most glandular epithelial cells and a major component of the mucus layer above gastric mucosa. Overexpression of MUC1 is found in approximately 95% of human adenocarcinomas, where it is associated with oncogenic activity. The role of MUC1 in gastric cancer progression remains to be clarified. Methodology: We downregulated MUC1 expression in a gastric carcinoma cell line by RNA interference and studied the effects on cellular proliferation (MTT assay), apoptosis (TUNEL assay), migration (migration assay), invasion (invasion assay) and aggregation (aggregation assay). Global gene expression was evaluated by microarray analysis to identify alterations that are regulated by MUC1 expression. In vivo assays were also performed in mice, in order to study the tumorigenicity of cells with and without MUC1 downregulation in MKN45 gastric carcinoma cell line. Results: Downregulation of MUC1 expression increased proliferation and apoptosis as compared to controls, whereas cell-cell aggregation was decreased. No significant differences were found in terms of migration and invasion between the downregulated clones and the controls. Expression of TCN1, KLK6, ADAM29, LGAL4, TSPAN8 and SHPS-1 was found to be significantly different between MUC1 downregulated clones and the control cells. In vivo assays have shown that mice injected with MUC1 downregulated cells develop smaller tumours when compared to mice injected with the control cells. Conclusions: These results indicate that MUC1 downregulation alters the phenotype and tumorigenicity of MKN45 gastric carcinoma cells and also the expression of several molecules that can be involved in tumorigenic events. Therefore, MUC1 should be further studied to better clarify its potential as a novel therapeutic target for gastric cancer.	[Costa, Natalia R.; Paulo, Paula; Santos-Silva, Filipe] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Caffrey, Thomas; Hollingsworth, Michael A.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Santos-Silva, Filipe] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; University of Nebraska System; University of Nebraska Medical Center; Universidade do Porto	Costa, NR (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	fsilva@ipatimup.pt	Santos-Silva, Filipe/J-4535-2013; Paulo, Paula/F-1441-2016	Santos-Silva, Filipe/0000-0001-7143-1025; Paulo, Paula/0000-0001-8387-2127; Costa, Natalia Rios/0000-0002-1858-2438; Costa, Maria/0000-0001-5798-6470; Caffrey, Thomas/0000-0001-6707-8468	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [POCTI/SAU-IMI/56895/2004, PTDC/SAU-OBD/65616/2006, SFRH/BD/21693/2005, SFRH/BD/36961/2007]; Fundacao Luso-Americana (FLAD)	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundacao Luso-Americana (FLAD)	This work was supported by grants from the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, Projects POCTI/SAU-IMI/56895/2004 and PTDC/SAU-OBD/65616/2006 and fellowships SFRH/BD/21693/2005 and SFRH/BD/36961/2007 and Fundacao Luso-Americana (FLAD). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Benjamin JBE, 2010, CLIN CHIM ACTA, V411, P2067, DOI 10.1016/j.cca.2010.09.003; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Chaturvedi R, 2005, INT J ONCOL, V26, P1169; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guang W, 2009, INT J BIOCHEM CELL B, V41, P1354, DOI 10.1016/j.biocel.2008.12.004; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Hattrup CL, 2008, BREAST CANCER-BASIC, V1, P57; Hayashi T, 2001, DIGESTION, V63, P87, DOI 10.1159/000051917; Henkhaus RS, 2008, BIOL CHEM, V389, P757, DOI 10.1515/BC.2008.087; Heuze-Vourc'h N, 2009, J CELL MOL MED, V13, P4014, DOI 10.1111/j.1582-4934.2009.00763.x; Huang Lei, 2010, Genes Cancer, V1, P239; Inagaki Y, 2011, ANTICANCER RES, V31, P535; Kawano T, 2008, INT J ONCOL, V33, P153; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KLINGE CM, 2011, MOL CANC THER; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Li Q, 2004, BIOCHEM BIOPH RES CO, V315, P471, DOI 10.1016/j.bbrc.2004.01.075; Li XJ, 2005, CANCER BIOL THER, V4, P968, DOI 10.4161/cbt.4.9.1913; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Lillehoj EP, 2007, BBA-MOL CELL RES, V1773, P1028, DOI 10.1016/j.bbamcr.2007.04.009; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nath D, 1999, IMMUNOLOGY, V98, P213; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Rahn JJ, 2005, CLIN EXP METASTAS, V22, P475, DOI 10.1007/s10585-005-3098-x; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Regimbald LH, 1996, CANCER RES, V56, P4244; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; SATELLI A, 2010, INT J CANC; Satelli A, 2011, INT J CANCER, V129, P799, DOI 10.1002/ijc.25750; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Xu Y, 2009, BIOLOGICALS, V37, P18, DOI 10.1016/j.biologicals.2008.08.002; Ye Q, 2011, LAB INVEST, V91, P778, DOI 10.1038/labinvest.2011.12; Yonezawa S, 1997, PATHOL INT, V47, P813, DOI 10.1111/j.1440-1827.1997.tb03713.x; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Yuan Z, 2007, BIOCHEM BIOPH RES CO, V362, P740, DOI 10.1016/j.bbrc.2007.08.074; Yuan ZL, 2009, J SURG RES, V157, pE39, DOI 10.1016/j.jss.2008.09.005; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	62	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26970	10.1371/journal.pone.0026970	http://dx.doi.org/10.1371/journal.pone.0026970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073229	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900056
J	Lowe, PK; Bruno, JF; Selig, ER; Spencer, M				Lowe, Phillip K.; Bruno, John F.; Selig, Elizabeth R.; Spencer, Matthew			Empirical Models of Transitions between Coral Reef States: Effects of Region, Protection, and Environmental Change	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHASE-SHIFTS; CLIMATE-CHANGE; MARINE; COMMUNITIES; MANAGEMENT; PATTERNS; FUTURE; CONSERVATION; SENSITIVITY	There has been substantial recent change in coral reef communities. To date, most analyses have focussed on static patterns or changes in single variables such as coral cover. However, little is known about how community-level changes occur at large spatial scales. Here, we develop Markov models of annual changes in coral and macroalgal cover in the Caribbean and Great Barrier Reef (GBR) regions. We analyzed reef surveys from the Caribbean and GBR (1996-2006). We defined a set of reef states distinguished by coral and macroalgal cover, and obtained Bayesian estimates of the annual probabilities of transitions between these states. The Caribbean and GBR had different transition probabilities, and therefore different rates of change in reef condition. This could be due to differences in species composition, management or the nature and extent of disturbances between these regions. We then estimated equilibrium probability distributions for reef states, and coral and macroalgal cover under constant environmental conditions. In both regions, the current distributions are close to equilibrium. In the Caribbean, coral cover is much lower and macroalgal cover is higher at equilibrium than in the GBR. We found no evidence for differences in transition probabilities between the first and second halves of our survey period, or between Caribbean reefs inside and outside marine protected areas. However, our power to detect such differences may have been low. We also examined the effects of altering transition probabilities on the community state equilibrium, along a continuum from unfavourable (e.g., increased sea surface temperature) to favourable (e.g., improved management) conditions. Both regions showed similar qualitative responses, but different patterns of uncertainty. In the Caribbean, uncertainty was greatest about effects of favourable changes, while in the GBR, we are most uncertain about effects of unfavourable changes. Our approach could be extended to provide risk analysis for management decisions.	[Lowe, Phillip K.; Spencer, Matthew] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Selig, Elizabeth R.] Conservat Int, Sci & Knowledge Div, Arlington, VA USA	University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill; Conservation International	Lowe, PK (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	m.spencer@liverpool.ac.uk						Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ANDERSON TW, 1957, ANN MATH STAT, V28, P89, DOI 10.1214/aoms/1177707039; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2011, REEFS RISK REVISITED; Carr MH, 2003, ECOL APPL, V13, pS90; Caswell, 2000, MATRIX POPULATION MO; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Freckleton RP, AM NATURALI IN PRESS; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garthwaite P., 2002, STAT INFERENCE; Gelman A., 2004, BAYESIAN DATA ANAL; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Graham NAJ, 2011, CORAL REEFS IN PRESS; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P435, DOI 10.1098/rspb.2002.2230; Hill MF, 2004, AM NAT, V164, pE46, DOI 10.1086/422340; Himes AH, 2007, OCEAN COAST MANAGE, V50, P329, DOI 10.1016/j.ocecoaman.2006.09.005; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huntington BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012327; Jackson JBC, 2010, PHILOS T R SOC B, V365, P3765, DOI 10.1098/rstb.2010.0278; KNOWLTON N, 1992, AM ZOOL, V32, P674; Logofet DO, 2000, ECOL MODEL, V126, P285, DOI 10.1016/S0304-3800(00)00269-6; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; MCCLANAHAN TR, 1995, ECOL MODEL, V80, P1, DOI 10.1016/0304-3800(94)00042-G; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Melbourne-Thomas J, ENV MODELLI IN PRESS; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Queenborough SA, METHODS ECO IN PRESS; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rogers CS, 2006, MAR ECOL PROG SER, V306, P103, DOI 10.3354/meps306103; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Solow AR, 2006, J APPL ECOL, V43, P185, DOI 10.1111/j.1365-2664.2005.01127.x; Steneck RS, 1988, P 6 INT COR REEF S T; Tanner JE, 2009, ECOLOGY, V90, P506, DOI 10.1890/08-0399.1; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Tanner JE, 1996, ECOLOGY, V77, P108, DOI 10.2307/2265660; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Taylor CM, 2004, ECOLOGY, V85, P3254, DOI 10.1890/03-0640; USHER MB, 1979, J ANIM ECOL, V48, P413, DOI 10.2307/4170; *WDPA CONS, 2005, WORLD DAT PROT AR 20; West, 1970, STUDIES VEGETATIONAL, P117; Wilkinson Clive, 2000, P21; Wing SR, 2001, CORAL REEFS, V20, P1; Wolanski E, 2005, ESTUAR COAST SHELF S, V64, P504, DOI 10.1016/j.ecss.2005.03.017; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	74	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26339	10.1371/journal.pone.0026339	http://dx.doi.org/10.1371/journal.pone.0026339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073157	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900018
J	Shimo, K; Ueno, T; Younger, J; Nishihara, M; Inoue, S; Ikemoto, T; Taniguchi, S; Ushida, T				Shimo, Kazuhiro; Ueno, Takefumi; Younger, Jarred; Nishihara, Makoto; Inoue, Shinsuke; Ikemoto, Tatsunori; Taniguchi, Shinichirou; Ushida, Takahiro			Visualization of Painful Experiences Believed to Trigger the Activation of Affective and Emotional Brain Regions in Subjects with Low Back Pain	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; POSITRON-EMISSION-TOMOGRAPHY; SINGLE-TRIAL FMRI; HUMAN PULVINAR; CORTICAL REPRESENTATION; CATASTROPHIC THINKING; SOMATOSENSORY CORTEX; NEURAL RESPONSES; FUNCTIONAL MRI; MUSCLE PAIN	In the management of clinical low back pain (LBP), actual damage to lower back areas such as muscles, intervertebral discs etc. are normally targeted for therapy. However, LBP may involve not only sensory pain, but also underlying affective pain which may also play an important role overall in painful events. Therefore we hypothesized that visualization of a painful event may trigger painful memories, thus provoking the affective dimension of pain. The present study investigated neural correlates of affect processing in subjects with LBP (n = 11) and subjects without LBP (n = 11) through the use of virtual LBP stimuli. Whole brain functional magnetic resonance imaging (MRI) was performed for all subjects while they were shown a picture of a man carrying luggage in a half-crouching position. All subjects with LBP reported experiencing discomfort and 7 LBP subjects reported experiencing pain. In contrast to subjects without LBP, subjects with LBP displayed activation of the cortical area related to pain and emotions: the insula, supplementary motor area, premotor area, thalamus, pulvinar, posterior cingulate cortex, hippocampus, fusiform, gyrus, and cerebellum. These results suggest that the virtual LBP stimuli caused memory retrieval of unpleasant experiences and therefore may be associated with prolonged chronic LBP conditions.	[Shimo, Kazuhiro; Nishihara, Makoto; Inoue, Shinsuke; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Aichi, Japan; [Ueno, Takefumi] Kyushu Univ, Dept Neuropsychiat, Fukuoka 812, Japan; [Younger, Jarred] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA; [Ikemoto, Tatsunori] NPO Pain Med Res Informat Ctr, Kochi, Japan; [Taniguchi, Shinichirou; Ushida, Takahiro] Kochi Med Sch, Dept Orthopaed Surg, Kochi, Japan	Aichi Medical University; Kyushu University; Stanford University; Kochi University	Shimo, K (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Aichi, Japan.	ushidat-koc@umin.ac.jp	Ikemoto, Tatsunori/E-3839-2018	Ikemoto, Tatsunori/0000-0002-4521-7639	Ministry of Health, Labour, and Welfare	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Cotton PL, 2007, J NEUROPHYSIOL, V98, P1600, DOI 10.1152/jn.00419.2007; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Fischer J, 2009, HUM BRAIN MAPP, V30, P101, DOI 10.1002/hbm.20485; Freund W, 2010, CLIN J PAIN, V26, P339, DOI 10.1097/AJP.0b013e3181cb4055; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Henderson LA, 2007, PAIN, V128, P20, DOI 10.1016/j.pain.2006.08.013; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hsieh JC, 1996, PAIN, V64, P303, DOI 10.1016/0304-3959(95)00129-8; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kobayashi Yoshitaka, 2009, Spine (Phila Pa 1976), V34, P2431, DOI 10.1097/BRS.0b013e3181b1fb76; Korotkov A, 2002, NEUROSCI LETT, V335, P119, DOI 10.1016/S0304-3940(02)01181-3; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Mantani T, 2005, BIOL PSYCHIAT, V57, P982, DOI 10.1016/j.biopsych.2005.01.047; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Peyron R, 2007, NEUROPHYSIOL CLIN, V37, P249, DOI 10.1016/j.neucli.2007.07.002; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Qiu YH, 2006, CEREB CORTEX, V16, P1289, DOI 10.1093/cercor/bhj071; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Ruehle BS, 2006, J NEUROSCI, V26, P5492, DOI 10.1523/JNEUROSCI.2059-05.2006; Sander K, 2007, HUM BRAIN MAPP, V28, P1007, DOI 10.1002/hbm.20333; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Smith AT, 2009, J NEUROPHYSIOL, V101, P917, DOI 10.1152/jn.90963.2008; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 2005, PAIN, V113, P310, DOI 10.1016/j.pain.2004.11.003; Sullivan MJL, 2001, PAIN, V91, P147, DOI 10.1016/S0304-3959(00)00430-9; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Talairach J., 1988, COPLANAR STEREOTAXIC; Ushicla T, 2008, NEUROSCI LETT, V439, P7, DOI 10.1016/j.neulet.2008.04.085; Ushida T, 2005, BRAIN TOPOGR, V18, P27, DOI 10.1007/s10548-005-7898-8; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	56	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26681	10.1371/journal.pone.0026681	http://dx.doi.org/10.1371/journal.pone.0026681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073183	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900031
J	Geurts, N; Martens, E; Verhenne, S; Lays, N; Thijs, G; Magez, S; Cauwe, B; Li, S; Heremans, H; Opdenakker, G; Van den Steen, PE				Geurts, Nathalie; Martens, Erik; Verhenne, Sebastien; Lays, Natacha; Thijs, Greet; Magez, Stefan; Cauwe, Benedicte; Li, Sandra; Heremans, Hubertine; Opdenakker, Ghislain; Van den Steen, Philippe E.			Insufficiently Defined Genetic Background Confounds Phenotypes in Transgenic Studies As Exemplified by Malaria Infection in Tlr9 Knockout Mice	PLOS ONE			English	Article							ACTIVATES DENDRITIC CELLS; MURINE CEREBRAL MALARIA; TOLL-LIKE RECEPTORS; PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSES; B-CELLS; C57BL/6 MICE; MOUSE; SUSCEPTIBILITY; RESISTANCE	The use of genetically modified mice, i.e. transgenic as well as gene knockout (KO) and knock-in mice, has become an established tool to study gene function in many animal models for human diseases. However, a gene functions in a particular genomic context. This implies the importance of a well-defined homogenous genetic background for the analysis and interpretation of phenotypes associated with genetic mutations. By studying a Plasmodium chabaudi chabaudi AS (PcAS) malaria infection in mice bearing a TLR9 null mutation, we found an increased susceptibility to infection, i.e. higher parasitemia levels and increased mortality. However, this was not triggered by the deficient TLR9 gene itself. Instead, this disease phenotype was dependent on the heterogeneous genetic background of the mice, which appeared insufficiently defined as determined by single nucleotide polymorphism (SNP) analysis. Hence, it is of critical importance to study gene KO phenotypes on a homogenous genetic background identical to that of their wild type (WT) control counterparts. In particular, to avoid problems related to an insufficiently defined genetic background, we advocate that for each study involving genetically modified mice, at least a detailed description of the origin and genetic background of both the WT control and the altered strain of mice is essential.	[Geurts, Nathalie; Martens, Erik; Verhenne, Sebastien; Lays, Natacha; Thijs, Greet; Cauwe, Benedicte; Li, Sandra; Heremans, Hubertine; Opdenakker, Ghislain; Van den Steen, Philippe E.] Univ Louvain, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium; [Magez, Stefan] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium	KU Leuven; Vrije Universiteit Brussel	Geurts, N (corresponding author), Univ Louvain, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium.	Philippe.VandenSteen@rega.kuleuven.be	Opdenakker, Ghislain/Q-3130-2017; Martens, Erik/F-9214-2015; Van den Steen, Philippe E/K-5132-2012; Opdenakker, Ghislain/V-8562-2019; Cauwe, Bénédicte/B-9959-2012; Magez, Stefan/D-9497-2014; Magez, Stefan/AAC-5682-2021	Opdenakker, Ghislain/0000-0003-1714-2294; Martens, Erik/0000-0002-7947-6567; Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968	Fund for Scientific Research-Flanders (FWO-Vlaanderen); 'Geconcerteerde OnderzoeksActies' (GOA); Research Fund of the University of Leuven [CREA 09/023]	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); 'Geconcerteerde OnderzoeksActies' (GOA); Research Fund of the University of Leuven	This study was supported by The Fund for Scientific Research-Flanders (FWO-Vlaanderen), the 'Geconcerteerde OnderzoeksActies' (GOA 2007-2011) and a CREA-grant (CREA 09/023) from the Research Fund of the University of Leuven. NG is a research assistant of the FWO-Vlaanderen and PVDS is a Research Professor of the Research Fund of the University of Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanmori BD, 1996, PARASITE IMMUNOL, V18, P193, DOI 10.1046/j.1365-3024.1996.d01-80.x; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Basu M, 2010, INFECT GENET EVOL, V10, P686, DOI 10.1016/j.meegid.2010.03.008; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; *CLEA JAP, 2011, JAP MOUS RAT STRAIN; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Coban Cevayir, 2010, Allergology International, V59, P115, DOI 10.2332/allergolint.10-RAI-0194; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2002, GENES IMMUN, V3, P177, DOI 10.1038/sj.gene.6363841; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Franklin BS, 2011, P NATL ACAD SCI USA, V108, P3689, DOI 10.1073/pnas.1015406108; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gowda DC, 2007, TRENDS PARASITOL, V23, P596, DOI 10.1016/j.pt.2007.09.003; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Griffith JW, 2007, J INFECT DIS, V196, P1553, DOI 10.1086/522865; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hernandez-Valladares M, 2004, IMMUNOGENETICS, V56, P115, DOI 10.1007/s00251-004-0667-0; Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; *JACKS LAB, 2007, BREED STRAT MAINT CO; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Jepson A, 1997, BRIT MED J, V315, P96, DOI 10.1136/bmj.315.7100.96; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Kordes M, 2011, INFECT IMMUN, V79, P3633, DOI 10.1128/IAI.05459-11; Kwiatkowski D, 2000, CURR OPIN GENET DEV, V10, P320, DOI 10.1016/S0959-437X(00)00087-3; Langhorne J, 2002, CHEM IMMUNOL, V80, P204; Lepenies B, 2008, MED MICROBIOL IMMUN, V197, P39, DOI 10.1007/s00430-007-0057-y; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Lyke KE, 2011, TISSUE ANTIGENS, V77, P562, DOI 10.1111/j.1399-0039.2011.01661.x; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Mota MM, 1998, INFECT IMMUN, V66, P4080; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Sanford LP, 2000, METH MOL B, V158, P217; Sanni LA, 2004, INFECT IMMUN, V72, P3054, DOI 10.1128/IAI.72.5.3054-3058.2004; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Stevens JC, 2007, TRENDS MOL MED, V13, P512, DOI 10.1016/j.molmed.2007.10.001; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Taft RA, 2006, TRENDS GENET, V22, P649, DOI 10.1016/j.tig.2006.09.010; Taylor-Robinson AW, 2010, EXP PARASITOL, V126, P406, DOI 10.1016/j.exppara.2010.01.028; TAYLORROBINSON AW, 1994, INFECT IMMUN, V62, P2490, DOI 10.1128/IAI.62.6.2490-2498.1994; Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; WUNDERLICH F, 1991, PARASITE IMMUNOL, V13, P357, DOI 10.1111/j.1365-3024.1991.tb00289.x; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94	80	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27131	10.1371/journal.pone.0027131	http://dx.doi.org/10.1371/journal.pone.0027131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096530	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900024
J	Kiedrowski, MR; Kavanaugh, JS; Malone, CL; Mootz, JM; Voyich, JM; Smeltzer, MS; Bayles, KW; Horswill, AR				Kiedrowski, Megan R.; Kavanaugh, Jeffrey S.; Malone, Cheryl L.; Mootz, Joe M.; Voyich, Jovanka M.; Smeltzer, Mark S.; Bayles, Kenneth W.; Horswill, Alexander R.			Nuclease Modulates Biofilm Formation in Community-Associated Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							GENE REGULATOR AGR; EXTRACELLULAR DNA; BACTERIAL-CONTAMINATION; COMPUTER KEYBOARDS; HEMATOGENOUS OSTEOMYELITIS; PLASMA-PROTEINS; SARA MUTANTS; IN-VITRO; VIRULENCE; RELEASE	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging contributor to biofilm-related infections. We recently reported that strains lacking sigma factor B (sigB) in the USA300 lineage of CA-MRSA are unable to develop a biofilm. Interestingly, when spent media from a USA300 sigB mutant was incubated with other S. aureus strains, biofilm formation was inhibited. Following fractionation and mass spectrometry analysis, the major anti-biofilm factor identified in the spent media was secreted thermonuclease (Nuc). Considering reports that extracellular DNA (eDNA) is an important component of the biofilm matrix, we investigated the regulation and role of Nuc in USA300. The expression of the nuc gene was increased in a sigB mutant, repressed by glucose supplementation, and was unaffected by the agr quorum-sensing system. A FRET assay for Nuc activity was developed and confirmed the regulatory results. A USA300 nuc mutant was constructed and displayed an enhanced biofilm-forming capacity, and the nuc mutant also accumulated more high molecular weight eDNA than the WT and regulatory mutant strains. Inactivation of nuc in the USA300 sigB mutant background partially repaired the sigB biofilm-negative phenotype, suggesting that nuc expression contributes to the inability of the mutant to form biofilm. To test the generality of the nuc mutant biofilm phenotypes, the mutation was introduced into other S. aureus genetic backgrounds and similar increases in biofilm formation were observed. Finally, using multiple S. aureus strains and regulatory mutants, an inverse correlation between Nuc activity and biofilm formation was demonstrated. Altogether, our findings confirm the important role for eDNA in the S. aureus biofilm matrix and indicates Nuc is a regulator of biofilm formation.	[Kiedrowski, Megan R.; Kavanaugh, Jeffrey S.; Malone, Cheryl L.; Mootz, Joe M.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Voyich, Jovanka M.] Montana State Univ, Dept Vet Microbiol, Bozeman, MT 59717 USA; [Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Bayles, Kenneth W.] Univ Nebraska, Nebraska Med Ctr, Dept Pathol, Omaha, NE 68182 USA	University of Iowa; Montana State University System; Montana State University Bozeman; University of Arkansas System; University of Arkansas Medical Sciences; University of Nebraska System; University of Nebraska Medical Center	Kiedrowski, MR (corresponding author), Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu	; Smeltzer, Mark/M-2009-2018	Kiedrowski, Megan/0000-0003-4610-182X; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Diseases [AI083211, AI074087]; National Institute of Health-National Center for Research Resources [P20RR020185]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211, R13AI074087, R01AI090046] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to MSS from the National Institute of Allergy and Infectious Diseases (AI083211, ARH, KWB and AI074087) and JMV was supported by the National Institute of Health-National Center for Research Resources grant (P20RR020185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anderson G, 2009, AM J INFECT CONTROL, V37, P507, DOI 10.1016/j.ajic.2008.10.032; Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; ARNONE A, 1971, J BIOL CHEM, V246, P2302; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Baranovskii AG, 2004, BIOCHEMISTRY-MOSCOW+, V69, P587, DOI 10.1023/B:BIRY.0000033731.50496.01; Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Beer D, 2006, PEDIATR INFECT DIS J, V25, P1074, DOI 10.1097/01.inf.0000242649.27400.94; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Brady RRW, 2007, ANN ROY COLL SURG, V89, P656, DOI 10.1308/003588407X209347; Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat James E., 2007, V391, P127; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Cuatrecasas P, 1968, Brookhaven Symp Biol, V21, P172; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS A, 1977, J BIOL CHEM, V252, P6544; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; DEWEZ B, 1993, EUR J CLIN CHEM CLIN, V31, P793; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DYKE KGH, 1966, LANCET, V1, P835; Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; FUCHS S, 1967, J BIOL CHEM, V242, P4768; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; GOODMAN SD, 2011, MUCOSAL IMMUNOLOGY; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Haque NZ, 2007, INT J ANTIMICROB AG, V30, P72, DOI 10.1016/j.ijantimicag.2007.02.007; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; HEINS JN, 1967, J BIOL CHEM, V242, P1016; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; KLEVENS RM, 2007, United States Jama, V298, P1763; Kourbatova EV, 2005, AM J INFECT CONTROL, V33, P385, DOI 10.1016/j.ajic.2005.06.006; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagae-Wiens PRS, 2007, J CLIN MICROBIOL, V45, P3478, DOI 10.1128/JCM.01477-07; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; LEE SP, 1994, ANAL BIOCHEM, V220, P377, DOI 10.1006/abio.1994.1353; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Motta RHL, 2007, INFECT CONT HOSP EP, V28, P185, DOI 10.1086/510867; NADANO D, 1993, CLIN CHEM, V39, P448; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schultz M, 2003, INFECT CONT HOSP EP, V24, P302, DOI 10.1086/502200; Seybold U, 2007, INFECTION, V35, P190, DOI 10.1007/s15010-007-6058-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMELTZER MS, 1993, INFECT IMMUN, V61, P919, DOI 10.1128/IAI.61.3.919-925.1993; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; TANIUCHI H, 1966, J BIOL CHEM, V241, P4366; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; VAUDAUX PE, 1995, INFECT IMMUN, V63, P585, DOI 10.1128/IAI.63.2.585-590.1995; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Williams Christa, 2009, Clin Lab Sci, V22, P34	89	169	176	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26714	10.1371/journal.pone.0026714	http://dx.doi.org/10.1371/journal.pone.0026714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096493	gold, Green Submitted, Green Published			2022-12-27	WOS:000297553900007
J	van der Meer, V; van den Hout, WB; Bakker, MJ; Rabe, KF; Sterk, PJ; Assendelft, WJJ; Kievit, J; Sont, JK				van der Meer, Victor; van den Hout, Wilbert B.; Bakker, Moira J.; Rabe, Klaus F.; Sterk, Peter J.; Assendelft, Willem J. J.; Kievit, Job; Sont, Jacob K.		SMASHING Self-Management Asthma	Cost-Effectiveness of Internet-Based Self-Management Compared with Usual Care in Asthma	PLOS ONE			English	Article							ECONOMIC-EVALUATION; DECISION-MAKING; LONG-TERM; EDUCATION; INSTRUMENTS; OUTCOMES; UTILITY	Background: Effectiveness of Internet-based self-management in patients with asthma has been shown, but its cost-effectiveness is unknown. We conducted a cost-effectiveness analysis of Internet-based asthma self-management compared with usual care. Methodology and Principal Findings: Cost-effectiveness analysis alongside a randomized controlled trial, with 12 months follow-up. Patients were aged 18 to 50 year and had physician diagnosed asthma. The Internet-based self-management program involved weekly on-line monitoring of asthma control with self-treatment advice, remote Web communications, and Internet-based information. We determined quality adjusted life years (QALYs) as measured by the EuroQol-5D and costs for health care use and absenteeism. We performed a detailed cost price analysis for the primary intervention. QALYs did not statistically significantly differ between the Internet group and usual care: difference 0.024 (95% CI, -0.016 to 0.065). Costs of the Internet-based intervention were $254 (95% CI, $243 to $265) during the period of 1 year. From a societal perspective, the cost difference was $641 (95% CI, $21957 to $3240). From a health care perspective, the cost difference was $37 (95% CI, $2874 to $950). At a willingness-to-pay of $50000 per QALY, the probability that Internet-based self-management was cost-effective compared to usual care was 62% and 82% from a societal and health care perspective, respectively. Conclusions: Internet-based self-management of asthma can be as effective as current asthma care and costs are similar.	[van der Meer, Victor; van den Hout, Wilbert B.; Bakker, Moira J.; Kievit, Job; Sont, Jacob K.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [van der Meer, Victor; Assendelft, Willem J. J.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Rabe, Klaus F.; Sont, Jacob K.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Sterk, Peter J.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	van der Meer, V (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands.	v.van_der_meer@lumc.nl	Sterk, P.J./AAK-8175-2020; Sont, Jacob K/J-8071-2015; Assendelft, W.J.J./H-8008-2014; Rabe, Klaus F./AAW-6296-2021; assendelft, willem/AAW-1854-2021; Toussaint, Pieter/O-9523-2016	Sont, Jacob K/0000-0002-5840-0651; Assendelft, W.J.J./0000-0002-2966-3778; Rabe, Klaus F./0000-0002-7020-1401; assendelft, willem/0000-0002-2966-3778; Toussaint, Pieter/0000-0001-7340-7213; van den Hout, Wilbert B./0000-0002-6425-0135	governmental Netherlands Organization for Health Research and Development [945-04-061, 920-03-354]; Netherlands Asthma Foundation [3.4.03.45]	governmental Netherlands Organization for Health Research and Development; Netherlands Asthma Foundation	This study was supported by grants from the governmental Netherlands Organization for Health Research and Development (www.zonmw.nl grantnrs 945-04-061 and 920-03-354) and Netherlands Asthma Foundation (www.astmafonds.nl grantnr 3.4.03.45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray GA, 1999, DIABETES CARE, V22, P623; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Chan DS, 2007, PEDIATRICS, V119, P569, DOI 10.1542/peds.2006-1884; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Cowie RL, 1997, CHEST, V112, P1534, DOI 10.1378/chest.112.6.1534; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; *DUTCH HLTH INS EX, 2007, PHARM COMP; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Gallefoss F, 2001, EUR RESPIR J, V17, P206, DOI 10.1183/09031936.01.17202060; Ghosh CS, 1998, SOC SCI MED, V46, P1087, DOI 10.1016/S0277-9536(97)10047-8; GIBSON PG, 2003, COCHRANE LIB; Jan RL, 2007, TELEMED J E-HEALTH, V13, P257, DOI 10.1089/tmj.2006.0053; Jones A, 2000, BMJ-BRIT MED J, V321, P1507, DOI 10.1136/bmj.321.7275.1507; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Kauppinen R, 2001, RESP MED, V95, P56, DOI 10.1053/rmed.2000.0971; Lahdensuo A, 1998, BRIT MED J, V316, P1138, DOI 10.1136/bmj.316.7138.1138; Lamberts H., 1987, ICPC INT CLASSIFICAT; McTaggart-Cowan HM, 2008, QUAL LIFE RES, V17, P453, DOI 10.1007/s11136-008-9309-6; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; *OECD, 2008, PURCH POW PAR PPPS O; OOSTENBRINK JB, 2004, MANUAL COST ANAL MET; Rasmussen LM, 2005, J ALLERGY CLIN IMMUN, V115, P1137, DOI 10.1016/j.jaci.2005.03.030; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Rubin DB, 2004, MULTIPLE IMPUTATION; RUTTENVANMOLKEN MPMH, 1995, EUR RESPIR J, V8, P888; Schermer TR, 2002, AM J RESP CRIT CARE, V166, P1062, DOI 10.1164/rccm.2105116; Statistic Netherlands, 2008, CONS PRIC IND; Stiggelbout AM, 1996, INT J TECHNOL ASSESS, V12, P291, DOI 10.1017/S0266462300009648; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Szende A, 2004, PHARMACOECONOMICS, V22, P537; Taylor DR, 2008, EUR RESPIR J, V32, P545, DOI 10.1183/09031936.00155307; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Meer V, 2009, ANN INTERN MED, V151, P110, DOI 10.7326/0003-4819-151-2-200907210-00008; Willems DCM, 2006, INT J TECHNOL ASSESS, V22, P436, DOI 10.1017/S026646230605135X; Willems Danielle C M, 2007, Cost Eff Resour Alloc, V5, P10; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	37	31	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27108	10.1371/journal.pone.0027108	http://dx.doi.org/10.1371/journal.pone.0027108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HG	22096523	Green Published, gold			2022-12-27	WOS:000297553900021
J	Economopoulos, V; Noad, JC; Krishnamoorthy, S; Rutt, BK; Foster, PJ				Economopoulos, Vasiliki; Noad, Jennifer C.; Krishnamoorthy, Shruti; Rutt, Brian K.; Foster, Paula J.			Comparing the MRI Appearance of the Lymph Nodes and Spleen in Wild-Type and Immuno-Deficient Mouse Strains	PLOS ONE			English	Article							BREAST-CANCER; MICE; NUDE; METASTASIS; ENGRAFTMENT; GROWTH; MODELS; CELLS	The goal of this study was to investigate the normal MRI appearance of lymphoid organs in immuno-competent and immuno-deficient mice commonly used in research. Four mice from each of four different mouse strains (nude, NOG, C57BL/6, CB-17 SCID (SCID)) were imaged weekly for one month. Images were acquired with a 3D balanced steady state free precession (bSSFP) sequence. The volume of the lymph nodes and spleens were measured from MR images. In images of nude and SCID mice, lymph nodes sometimes contained a hyperintense region visible on MRI images. Volumes of the nodes were highly variable in nude mice. Nodes in SCID mice were smaller than in nude or C57Bl/6 mice (p<0.0001). Lymph node volumes changed slightly over time in all strains. The spleens of C57Bl/6 and nude mice were similar in size and appearance. Spleens of SCID and NOG mice were significantly smaller (p<0.0001) and abnormal in appearance. The MRI appearance of the normal lymph nodes and spleen varies considerably in the various mouse strains examined in this study. This is important to recognize in order to avoid the misinterpretation of MRI findings as abnormal when these strains are used in MRI imaging studies.	[Economopoulos, Vasiliki; Noad, Jennifer C.; Krishnamoorthy, Shruti; Foster, Paula J.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Economopoulos, Vasiliki; Noad, Jennifer C.; Krishnamoorthy, Shruti; Foster, Paula J.] Univ Western Ontario, Imaging Res Grp, Robarts Res Inst, London, ON, Canada; [Rutt, Brian K.] Stanford Univ, Dept Radiol, Richard M Lucas Ctr Imaging, Stanford, CA 94305 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Stanford University	Foster, PJ (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	pfoster@imaging.robarts.ca	Foster, Paula/M-2201-2013	Foster, Paula/0000-0002-4868-3395; Economopoulos, Vasiliki/0000-0001-7187-7254	Canadian Cancer Society Research Institute [19397]; Canadian Breast Cancer Foundation - Ontario Region; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR062068] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation - Ontario Region; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this study was provided by the Canadian Cancer Society Research Institute (Grant # 19397). VE is supported by a fellowship from the Canadian Breast Cancer Foundation - Ontario Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2006, CONTRAST MEDIA MOL I, V1, P230, DOI 10.1002/cmmi.116; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BRUNNER N, 1993, BREAST CANCER RES TR, V24, P257, DOI 10.1007/BF01833265; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Clarke R, 1996, BREAST CANCER RES TR, V39, P69, DOI 10.1007/BF01806079; Croy BA, 2001, COMPARATIVE MED, V51, P300; Dadiani M, 2006, CANCER RES, V66, P8037, DOI 10.1158/0008-5472.CAN-06-0728; Dewan MZ, 2005, BIOMED PHARMACOTHER, V59, pS375, DOI 10.1016/S0753-3322(05)80082-4; GE W, 1991, CHINESE J CANCER RES, V3, P6; GREINER DL, 1995, AM J PATHOL, V146, P888; Hudson WA, 1998, LEUKEMIA, V12, P2029, DOI 10.1038/sj.leu.2401236; HUTTER R V P, 1984, P175; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Matsui J, 2008, CLIN CANCER RES, V14, P5459, DOI 10.1158/1078-0432.CCR-07-5270; MIKHAILOV AD, 1995, B EXP BIOL MED+, V119, P201, DOI 10.1007/BF02445879; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; PRICE JE, 1990, CANCER RES, V50, P717; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SAINTEMARIE G, 1983, LAB INVEST, V49, P420; SCHULER W, 1989, CURR TOP MICROBIOL, V152, P55; SHULTZ LD, 1995, J IMMUNOL, V154, P180; TAGHIAN A, 1993, CANCER RES, V53, P5012; Troiani T, 2008, CRIT REV ONCOL HEMAT, V65, P200, DOI 10.1016/j.critrevonc.2007.10.003; XIE X, 1992, CLIN EXP METASTAS, V10, P201, DOI 10.1007/BF00132752	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27508	10.1371/journal.pone.0027508	http://dx.doi.org/10.1371/journal.pone.0027508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096586	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800056
J	Rheindt, FE; Szekely, T; Edwards, SV; Lee, PLM; Burke, T; Kennerley, PR; Bakewell, DN; Alrashidi, M; Kosztolanyi, A; Weston, MA; Liu, WT; Lei, WP; Shigeta, Y; Javed, S; Zefania, S; Kupper, C				Rheindt, Frank E.; Szekely, Tamas; Edwards, Scott V.; Lee, Patricia L. M.; Burke, Terry; Kennerley, Peter R.; Bakewell, David N.; Alrashidi, Monif; Kosztolanyi, Andras; Weston, Michael A.; Liu, Wei-Ting; Lei, Wei-Pan; Shigeta, Yoshimitsu; Javed, Salim; Zefania, Sama; Kuepper, Clemens			Conflict between Genetic and Phenotypic Differentiation: The Evolutionary History of a 'Lost and Rediscovered' Shorebird	PLOS ONE			English	Article							CONSERVED MICROSATELLITE MARKERS; CHARADRIUS-ALEXANDRINUS; POPULATION-STRUCTURE; LINKED LOCI; INFERENCE; PHYLOGENY; KENTISH; AMPLIFICATION; DIVERGENCE; MORPHOLOGY	Understanding and resolving conflicts between phenotypic and genetic differentiation is central to evolutionary research. While phenotypically monomorphic species may exhibit deep genetic divergences, some morphologically distinct taxa lack notable genetic differentiation. Here we conduct a molecular investigation of an enigmatic shorebird with a convoluted taxonomic history, the White-faced Plover (Charadrius alexandrinus dealbatus), widely regarded as a subspecies of the Kentish Plover (C. alexandrinus). Described as distinct in 1863, its name was consistently misapplied in subsequent decades until taxonomic clarification ensued in 2008. Using a recently proposed test of species delimitation, we reconfirm the phenotypic distinctness of dealbatus. We then compare three mitochondrial and seven nuclear DNA markers among 278 samples of dealbatus and alexandrinus from across their breeding range and four other closely related plovers. We fail to find any population genetic differentiation between dealbatus and alexandrinus, whereas the other species are deeply diverged at the study loci. Kentish Plovers join a small but growing list of species for which low levels of genetic differentiation are accompanied by the presence of strong phenotypic divergence, suggesting that diagnostic phenotypic characters may be encoded by few genes that are difficult to detect. Alternatively, gene expression differences may be crucial in producing different phenotypes whereas neutral differentiation may be lagging behind.	[Rheindt, Frank E.; Edwards, Scott V.; Alrashidi, Monif; Kuepper, Clemens] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rheindt, Frank E.; Edwards, Scott V.; Alrashidi, Monif; Kuepper, Clemens] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Lee, Patricia L. M.] Swansea Univ, Dept Biosci, Inst Environm Sustainabil, Swansea, W Glam, Wales; [Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Bakewell, David N.] Whimbrel Cottage, Eye, Suffolk, England; [Alrashidi, Monif] Univ Hail, Dept Biol, Coll Sci, Hail, Saudi Arabia; [Kosztolanyi, Andras] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Weston, Michael A.] Deakin Univ, Sch Life & Environm Sci, Fac Sci & Technol, Burwood, Vic, Australia; [Liu, Wei-Ting] Tunghai Univ, Taiwan Wader Study Grp, Dept Environm Sci, Taichung 40704, Taiwan; [Lei, Wei-Pan] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Shigeta, Yoshimitsu] Yamashina Inst Ornithol, Bird Migrat Res Ctr, Div Avian Conservat, Abiko, Chiba, Japan; [Javed, Salim] Environm Agcy, Biodivers Management Sect, Abu Dhabi, U Arab Emirates; [Zefania, Sama] Univ Antananarivo, Dept Anim Biol, Antananarivo, Madagascar	Harvard University; Harvard University; University of Bath; Swansea University; University of Sheffield; University Ha'il; Eotvos Lorand University; Deakin University; Tunghai University; Beijing Normal University; University Antananarivo	Rheindt, FE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	frankrheindt@yahoo.com.au	Kosztolanyi, Andras/B-8008-2016; Szekely, Tamas/I-7089-2016; Lee, Patricia/N-4157-2013; GenePool, The/D-8812-2012; Burke, Terry/B-3196-2011; Küpper, Clemens/D-8116-2011; Javed, Salim/AAV-7507-2020; Rheindt, Frank/D-7826-2014; Edwards, Scott V./D-9071-2018	Kosztolanyi, Andras/0000-0002-9109-5871; Szekely, Tamas/0000-0003-2093-0056; Lee, Patricia/0000-0002-8489-9206; Burke, Terry/0000-0003-3848-1244; Küpper, Clemens/0000-0002-1507-8033; Rheindt, Frank/0000-0001-8946-7085; Edwards, Scott V./0000-0003-2535-6217; Lei, Weipan/0000-0001-7616-7200	National Geographic Society [8403-08]; Natural Environmental Research Council [MGF184]; German Academic Exchange Service (DAAD); Hungarian Scientific Research Fund (OTKA) [K81953]; National Natural Science Foundation of China-Guangdong [U0833005]; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010001, NBAF010003] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NBAF010001] Funding Source: researchfish	National Geographic Society(National Geographic Society); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Natural Science Foundation of China-Guangdong(National Natural Science Foundation of China (NSFC)National Natural Science Foundation of Guangdong Province); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for fieldwork was provided by the National Geographic Society (8403-08). Genetic analyses were funded by the Natural Environmental Research Council (MGF184). FER and CK were supported by postdoctoral fellowships of German Academic Exchange Service (DAAD). AK was supported by the Hungarian Scientific Research Fund (OTKA, K81953 to Adam Miklosi). LW was supported by the National Natural Science Foundation of China-Guangdong Joint Fund (Grant No. U0833005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alstrom P, 2008, MOL PHYLOGENET EVOL, V47, P960, DOI 10.1016/j.ympev.2007.12.007; Avise John C., 1994, pi; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; Brooks TM, 2010, NATURE, V467, P540, DOI 10.1038/467540a; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Darwin C, 1859, ORIGIN SPECIES MEANS; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk WC, 2007, CONSERV GENET, V8, P1287, DOI 10.1007/s10592-006-9278-7; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Grant P. R., 2008, WHY SPECIES MULTIPLY; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Hartert E, 1915, IBIS, V57, P526, DOI [10.1111/j.1474-919X.1915.tb08204.x, DOI 10.1111/J.1474-919X.1915.TB08204.X]; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kennerley PR, 2008, FORKTAIL, P63; Kupper C, 2010, MOL ECOL, V19, P5172, DOI 10.1111/j.1365-294X.2010.04867.x; Kupper C, 2009, AUK, V126, P839, DOI 10.1525/auk.2009.08174; Kupper C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-502; Kupper C, 2007, MOL ECOL NOTES, V7, P35, DOI 10.1111/j.1471-8286.2006.01517.x; Lee PLM, 2008, MOL ECOL RESOUR, V8, P551, DOI 10.1111/j.1471-8286.2007.02042.x; Magallon S., 2009, TIMETREE LIFE, P133; Mayr G, 2011, ZOOL J LINN SOC-LOND, V161, P916, DOI 10.1111/j.1096-3642.2010.00654.x; Olsson U, 2005, MOL PHYLOGENET EVOL, V36, P261, DOI 10.1016/j.ympev.2005.01.012; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Piersma T., 1996, HDB BIRDS WORLD, P384; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRIMMER CR, 1995, MOL ECOL, V4, P493, DOI 10.1111/j.1365-294X.1995.tb00243.x; Pritchard JK, 2000, GENETICS, V155, P945; Rheindt FE, 2008, MOL PHYLOGENET EVOL, V48, P150, DOI 10.1016/j.ympev.2008.04.016; Rheindt FE, 2009, ZOOL SCR, V38, P143, DOI 10.1111/j.1463-6409.2008.00369.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Saitoh T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-35; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swinhoe R, 1863, P ZOOL SOC LOND, V1863, P259; Swinhoe R, 1870, P ZOOL SOC LOND, V1870, P136; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szekely T, 2006, BIOSCIENCE, V56, P801, DOI 10.1641/0006-3568(2006)56[801:SCEABS]2.0.CO;2; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Uy JAC, 2009, AM NAT, V174, P244, DOI 10.1086/600084; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang ZS, 2003, EVOLUTION, V57, P2852; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	55	40	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26995	10.1371/journal.pone.0026995	http://dx.doi.org/10.1371/journal.pone.0026995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096515	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000297350800022
J	Blom, EJ; Ridder, ANJA; Lulko, AT; Roerdink, JBTM; Kuipers, OP				Blom, Evert-Jan; Ridder, Anja N. J. A.; Lulko, Andrzej T.; Roerdink, Jos B. T. M.; Kuipers, Oscar P.			Time-Resolved Transcriptomics and Bioinformatic Analyses Reveal Intrinsic Stress Responses during Batch Culture of Bacillus subtilis	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEOME; CANNIBALISM; STARVATION; RESISTANCE; SEQUENCE; GENOME; DEATH; TOOL; IDENTIFICATION	We have determined the time-resolved transcriptome of the model gram-positive organism B. subtilis during growth in a batch fermentor on rich medium. DNA microarrays were used to monitor gene transcription using 10-minute intervals at 40 consecutive time points. From the growth curve and analysis of all gene expression levels, we identified 4 distinct growth phases and one clear transition point: a lag phase, an exponential growth phase, the transition point and the very clearly separated early and late stationary growth phases. The gene expression profiles suggest the occurrence of stress responses at specific times although no external stresses were applied. The first one is a small induction of the SigB regulon that occurs at the transition point. Remarkably, a very strong response is observed for the SigW regulon, which is highly upregulated at the onset of the late stationary phase. Bioinformatic analyses that were performed on our data set suggest several novel putative motifs for regulator binding. In addition, the expression profiles of several genes appeared to correlate with the oxygen concentration. This data set of the expression profiles of all B. subtilis genes during the entire growth curve on rich medium constitutes a rich repository that can be further mined by the scientific community.	[Blom, Evert-Jan; Ridder, Anja N. J. A.; Lulko, Andrzej T.; Kuipers, Oscar P.] Univ Groningen, Dept Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Roerdink, Jos B. T. M.] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	University of Groningen; University of Groningen	Blom, EJ (corresponding author), Keygene NV, Wageningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Roerdink, Jos B.T.M/B-3631-2008	Kuipers, Oscar/0000-0001-5596-7735; 	Netherlands Organisation for Scientific Research; NWO-BMI [050.50.206]; Center IOP Genomics; NWO Molecule to Cell	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO-BMI(Netherlands Organization for Scientific Research (NWO)); Center IOP Genomics; NWO Molecule to Cell	This study was supported by a grant from The Netherlands Organisation for Scientific Research and industrial partners in the NWO-BMI project number 050.50.206 on Computational Genomics of Prokaryotes. In addition, this study was supported by the Center IOP Genomics and NWO Molecule to Cell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2006, J BACTERIOL, V188, P5299, DOI 10.1128/JB.00084-06; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banse AV, 2008, P NATL ACAD SCI USA, V105, P15547, DOI 10.1073/pnas.0805203105; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Becher D, 2011, PROTEOMICS, V11, P2971, DOI 10.1002/pmic.201100090; Beier L, 2002, J BACTERIOL, V184, P3232, DOI 10.1128/JB.184.12.3232-3241.2002; Bernhardt J, 2003, GENOME RES, V13, P224, DOI 10.1101/gr.905003; Blom EJ, 2007, BIOINFORMATICS, V23, P1161, DOI 10.1093/bioinformatics/btl658; Blom EJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-535; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Butcher BG, 2006, MOL MICROBIOL, V60, P765, DOI 10.1111/j.1365-2958.2006.05131.x; Chandramohan L, 2009, J BACTERIOL, V191, P4103, DOI 10.1128/JB.00314-09; Chumsakul O, 2011, NUCLEIC ACIDS RES, V39, P414, DOI 10.1093/nar/gkq780; Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Gaballa A, 2003, MICROBIOL-SGM, V149, P3413, DOI 10.1099/mic.0.26225-0; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rudrappa T, 2007, PLANTA, V226, P283, DOI 10.1007/s00425-007-0480-8; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Wolff S, 2007, J CHROMATOGR B, V849, P129, DOI 10.1016/j.jchromb.2006.09.029; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; Yu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020092	42	30	31	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27160	10.1371/journal.pone.0027160	http://dx.doi.org/10.1371/journal.pone.0027160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087258	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700017
J	Clavijo, G; Doremus, T; Ravallec, M; Mannucci, MA; Jouan, V; Volkoff, AN; Darboux, I				Clavijo, Gabriel; Doremus, Tristan; Ravallec, Marc; Mannucci, Marie-Anne; Jouan, Veronique; Volkoff, Anne-Nathalie; Darboux, Isabelle			Multigenic Families in Ichnovirus: A Tissue and Host Specificity Study through Expression Analysis of Vankyrins from Hyposoter didymator Ichnovirus	PLOS ONE			English	Article							CAMPOLETIS-SONORENSIS ICHNOVIRUS; POLYDNAVIRUS INDUCES APOPTOSIS; GENE FAMILY; IN-VITRO; SPODOPTERA-FRUGIPERDA; IMMUNE-RESPONSE; CELLS; SEQUENCE; GENOME; VIRUS	The viral ankyrin (vankyrin) gene family is represented in all polydnavirus (PDVs) genomes and encodes proteins homologous to I-kappaBs, inhibitors of NF-kappaB transcription factors. The structural similarities led to the hypothesis that vankyrins mimic eukaryotic factors to subvert important physiological pathways in the infected host. Here, we identified nine vankyrin genes in the genome of the Hyposoter didymator Ichnovirus (HdIV). Time-course gene expression experiments indicate that all members are expressed throughout parasitism of Spodoptera frugiperda, as assessed using RNA extracted from whole larvae. To study tissue and/or species specificity transcriptions, the expression of HdIV vankyrin genes were compared between HdIV-injected larvae of S. frugiperda and S. littoralis. The transcriptional profiles were similar in the two species, including the largely predominant expression of Hd27-vank1 in all tissues examined. However, in various insect cell lines, the expression patterns of HdIV vankyrins differed according to species. No clear relationship between vankyrin expression patterns and abundance of vankyrin-bearing genomic segments were found in the lepidopteran cell lines. Moreover, in these cells, the amount of vankyrin-bearing genomic segments differed substantially between cytosol and nuclei of infected cells, implying the existence of an unexpected step regulating the copy number of HdIV segments in cell nuclei. Our in vitro results reveal a host-specific transcriptional profile of vankyrins that may be related to the success of parasitism in different hosts. In Spodoptera hosts, the predominant expression of Hd27-vank1 suggests that this protein might have pleiotropic functions during parasitism of these insect species.	[Clavijo, Gabriel; Doremus, Tristan; Ravallec, Marc; Mannucci, Marie-Anne; Jouan, Veronique; Volkoff, Anne-Nathalie; Darboux, Isabelle] INRA, UMR Divers Genomes & Interact Microorganismes Ins, F-34060 Montpellier, France; [Clavijo, Gabriel; Doremus, Tristan; Ravallec, Marc; Mannucci, Marie-Anne; Jouan, Veronique; Volkoff, Anne-Nathalie; Darboux, Isabelle] Univ Montpellier 2, UMR Divers Genomes & Interact Microorganismes Ins, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier	Clavijo, G (corresponding author), INRA, UMR Divers Genomes & Interact Microorganismes Ins, F-34060 Montpellier, France.	darboux@supagro.inra.fr		Darboux, Isabelle/0000-0003-4990-8856; Volkoff, Anne-Nathalie/0000-0002-7211-1370	French Agency for National Research [ANR-09-BLAN-0243-02]; French National Institute for Agricultural Research (INRA); University of Montpellier	French Agency for National Research; French National Institute for Agricultural Research (INRA); University of Montpellier	This study was supported by the French Agency for National Research (grant number ANR-09-BLAN-0243-02) and G. Clavijo's post-doctoral position was supported by grants from the French National Institute for Agricultural Research (INRA) and University of Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT U, 1994, J GEN VIROL, V75, P3353, DOI 10.1099/0022-1317-75-12-3353; Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beliveau C, 2003, J INSECT PHYSIOL, V49, P501, DOI 10.1016/S0022-1910(03)00055-6; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; COHEN S, BIOCH BIOPHYS ACTA; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Falabella P, 2007, J GEN VIROL, V88, P92, DOI 10.1099/vir.0.82306-0; Friedman R, 2006, INFECT GENET EVOL, V6, P315, DOI 10.1016/j.meegid.2005.10.001; Galibert L, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-48; GOODWIN RH, 1978, IN VITRO CELL DEV B, V14, P485; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; KRELL PJ, 1982, J VIROL, V43, P859, DOI 10.1128/JVI.43.3.859-870.1982; Kroemer JA, 2005, J VIROL, V79, P7617, DOI 10.1128/JVI.79.12.7617-7628.2005; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Kroemer JA, 2006, J VIROL, V80, P12219, DOI 10.1128/JVI.01187-06; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; PROVOST B, 2011, INSECT BIOCH MOL BIO; Rasoolizadeh A, 2009, J GEN VIROL, V90, P1505, DOI 10.1099/vir.0.008664-0; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; STOLTZ DB, 1988, J GEN VIROL, V69, P903, DOI 10.1099/0022-1317-69-4-903; STOLTZ DB, 1979, CAN J MICROBIOL, V25, P207, DOI 10.1139/m79-032; Stoltz D, 2007, J GEN VIROL, V88, P2977, DOI 10.1099/vir.0.83118-0; STRAND MR, 1995, J GEN VIROL, V76, P283, DOI 10.1099/0022-1317-76-2-283; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; SUMMERS MD, 1995, P NATL ACAD SCI USA, V92, P29, DOI 10.1073/pnas.92.1.29; Tanaka K, 2007, VIROLOGY, V363, P26, DOI 10.1016/j.virol.2006.11.034; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Volkoff AN, 1999, VIROLOGY, V263, P349, DOI 10.1006/viro.1999.9929; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Zhang GM, 2004, J BIOL CHEM, V279, P41580, DOI 10.1074/jbc.M406865200	38	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27522	10.1371/journal.pone.0027522	http://dx.doi.org/10.1371/journal.pone.0027522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087334	Green Published, gold			2022-12-27	WOS:000297349700056
J	Yamanaka, A; Mulyatno, KC; Susilowati, H; Hendrianto, E; Ginting, AP; Sary, DD; Rantam, FA; Soegijanto, S; Konishi, E				Yamanaka, Atsushi; Mulyatno, Kris C.; Susilowati, Helen; Hendrianto, Eryk; Ginting, Amor P.; Sary, Dian D.; Rantam, Fedik A.; Soegijanto, Soegeng; Konishi, Eiji			Displacement of the Predominant Dengue Virus from Type 2 to Type 1 with a Subsequent Genotype Shift from IV to I in Surabaya, Indonesia 2008-2010	PLOS ONE			English	Article							SEROTYPE-SPECIFIC DIFFERENCES; GUANGDONG PROVINCE; MOLECULAR CHARACTERIZATION; HEMORRHAGIC-FEVER; EASTER-ISLAND; EVOLUTION; EPIDEMIC; OUTBREAK; THAILAND; BANGKOK	Indonesia has annually experienced approximately 100,000 reported cases of dengue fever (DF) and dengue hemorrhagic fever (DHF) in recent years. However, epidemiological surveys of dengue viruses (DENVs) have been limited in this country. In Surabaya, the second largest city, a single report indicated that dengue virus type 2 (DENV2) was the predominant circulating virus in 2003-2005. We conducted three surveys in Surabaya during: (i) April 2007, (ii) June 2008 to April 2009, and (iii) September 2009 to December 2010. A total of 231 isolates were obtained from dengue patients and examined by PCR typing. We found that the predominant DENV shifted from type 2 to type 1 between October and November 2008. Another survey using wild-caught mosquitoes in April 2009 confirmed that dengue type 1 virus (DENV1) was the predominant type in Surabaya. Phylogenetic analyses of the nucleotide sequences of the complete envelope gene of DENV1 indicated that all 22 selected isolates in the second survey belonged to genotype IV and all 17 selected isolates in the third survey belonged to genotype I, indicating a genotype shift between April and September 2009. Furthermore, in December 2010, isolates were grouped into a new clade of DENV1 genotype I, suggesting clade shift between September and December 2010. According to statistics reported by the Surabaya Health Office, the proportion of DHF cases among the total number of dengue cases increased about three times after the type shift in 2008. In addition, the subsequent genotype shift in 2009 was associated with the increased number of total dengue cases. This indicates the need for continuous surveillance of circulating viruses to predict the risk of DHF and DF.	[Yamanaka, Atsushi; Mulyatno, Kris C.; Susilowati, Helen; Hendrianto, Eryk; Ginting, Amor P.; Sary, Dian D.; Rantam, Fedik A.; Soegijanto, Soegeng] Airlangga Univ, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Inst Trop Dis, Surabaya, Indonesia; [Yamanaka, Atsushi; Konishi, Eiji] Kobe Univ, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan; [Konishi, Eiji] Kobe Univ, Dept Int Hlth, Grad Sch Hlth, Kobe, Hyogo 657, Japan; [Konishi, Eiji] Mahidol Univ, BIKEN Endowed Dept Dengue Vaccine Dev, Fac Trop Med, Bangkok, Thailand	Airlangga University; Kobe University; Kobe University; Mahidol University	Yamanaka, A (corresponding author), Airlangga Univ, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Inst Trop Dis, Surabaya, Indonesia.	paradios99@yahoo.co.jp	Abdul Rantam, Fedik/GSO-2120-2022; Mulyatno, Kris Cahyo/GSE-4955-2022; Hendrianto, Eryk/H-7407-2015	Abdul Rantam, Fedik/0000-0001-8182-1465; Mulyatno, Kris Cahyo/0000-0001-8926-3031; Soegijanto, Soegeng/0000-0002-9470-8223; Yamanaka, Atsushi/0000-0002-2757-2792; Hendrianto, Eryk/0000-0001-9723-8098; SUSILOWATI, HELEN/0000-0002-3358-5231	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan	This work was supported in part by a grant-in-aid through the Program of Founding Research Centers for Emerging and Re-emerging Infectious Diseases, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The "BIKEN Endowed Department of Dengue Vaccine Development" was endowed from The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan to Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.	Aryati, 2006, THESIS AIRLANGGA U S; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; Corwin AL, 2001, T ROY SOC TROP MED H, V95, P257, DOI 10.1016/S0035-9203(01)90229-9; Dash P. K., 2010, EPIDEMIOL INFECT, V30, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunham EJ, 2007, J MOL EVOL, V64, P656, DOI 10.1007/s00239-006-0278-5; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Guzman MG, 2000, LANCET, V355, P1902, DOI 10.1016/S0140-6736(00)02303-5; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HOTTA S, 1970, Kobe Journal of Medical Sciences, V16, P235; Ito M, 2007, J TRAVEL MED, V14, P233, DOI 10.1111/j.1708-8305.2007.00130.x; Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Nukui Y, 2006, EMERG INFECT DIS, V12, P343, DOI 10.3201/eid1202.050733; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Perret C, 2003, EMERG INFECT DIS, V9, P1465, DOI 10.3201/eid0911.020788; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Setiati T. E., 2006, Dengue Bulletin, V30, P1; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Sittisombut N, 1997, AM J TROP MED HYG, V57, P100, DOI 10.4269/ajtmh.1997.57.100; SUMARMO, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P269; Susilowati A, 1999, DENGUE B, V23; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; van Peenen P F, 1978, Southeast Asian J Trop Med Public Health, V9, P25; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; Zhang FuChun, 2007, Dengue Bulletin, V31, P10; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617	47	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27322	10.1371/journal.pone.0027322	http://dx.doi.org/10.1371/journal.pone.0027322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087290	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700039
J	Bakhtiarizadeh, MR; Ebrahimi, M; Ebrahimie, E				Bakhtiarizadeh, Mohammad Reza; Ebrahimi, Mansour; Ebrahimie, Esmaeil			Discovery of EST-SSRs in Lung Cancer: Tagged ESTs with SSRs Lead to Differential Amino Acid and Protein Expression Patterns in Cancerous Tissues	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; GENOME-WIDE ANALYSIS; MICROSATELLITE INSTABILITY; ENZYME THERMOSTABILITY; LINKAGE ANALYSIS; TANDEM REPEATS; MARKERS; FEATURES; FREQUENCY; ABUNDANCE	Tandem repeats are found in both coding and non-coding sequences of higher organisms. These sequences can be used in cancer genetics and diagnosis to unravel the genetic basis of tumor formation and progression. In this study, a possible relationship between SSR distributions and lung cancer was studied by comparative analysis of EST-SSRs in normal and lung cancerous tissues. While the EST-SSR distribution was similar between tumorous tissues, this distribution was different between normal and tumorous tissues. Trinucleotides tandem repeats were highly different; the number of trinucleotides in ESTs of lung cancer was 3 times higher than normal tissue. Significant negative correlation between normal and cancerous tissue showed that cancerous tissue generates different types of trinucleotides. GGC and CGC were the more frequent expressed trinucleotides in cancerous tissue, but these SSRs were not expressed in normal tissue. Similar to the EST level, the expression pattern of EST-SSRs-derived amino acids was significantly different between normal and cancerous tissues. Arg, Pro, Ser, Gly, and Lys were the most abundant amino acids in cancerous tissues, and Leu, Cys, Phe, and His were significantly more abundant in normal tissues than in cancerous tissues. Next, the putative functions of triplet SSR-containing genes were analyzed. In cancerous tissue, EST-SSRs produce different types of proteins. Chromodomain helicase DNA binding proteins were one of the major protein products of EST-SSRs in the cancerous library, while these proteins were not produced from EST-SSRs in normal tissue. For the first time, the findings of this study confirmed that EST-SSRs in normal lung tissues are different than in unhealthy tissues, and tagged ESTs with SSRs cause remarkable differences in amino acid and protein expression patterns in cancerous tissue. We suggest that EST-SSRs and EST-SSRs differentially expressed in cancerous tissue may be suitable candidate markers for lung cancer diagnosis and prediction.	[Bakhtiarizadeh, Mohammad Reza] Univ Tehran, Dept Anim Sci, Karaj, Iran; [Ebrahimi, Mansour] Univ Qom, Dept Biol, Qom, Iran; [Ebrahimi, Mansour] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Tehran; University of Adelaide	Bakhtiarizadeh, MR (corresponding author), Univ Tehran, Dept Anim Sci, Karaj, Iran.	esmaeil.ebrahimie@adelaide.edu.au	ebrahimi, mansour/D-9950-2011; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567	Shiraz University; Esmaeil Ebrahimie and Bioinformatics Research Group of Qom University	Shiraz University; Esmaeil Ebrahimie and Bioinformatics Research Group of Qom University	This study has been supported by Shiraz University grant of Esmaeil Ebrahimie and Bioinformatics Research Group of Qom University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alvarez A, 2007, CURR OPIN UROL, V17, P341, DOI 10.1097/MOU.0b013e3282c8c72b; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Brandstrom M, 2008, GENOME RES, V18, P881, DOI 10.1101/gr.075242.107; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Demokan Semra, 2002, Pathology and Oncology Research, V8, P138; Deng Shun-sheng, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P468; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Edwards SF, 2009, MOL CARCINOGEN, V48, P336, DOI 10.1002/mc.20534; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grossman J, 2008, J ADDICT NURS, V19, P1, DOI 10.1080/10884600801896918; Haddad LA, 1998, GENE, V223, P369, DOI 10.1016/S0378-1119(98)00242-X; Janatova M, 2004, Prague Med Rep, V105, P111; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Madsen BE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-410; Miao XX, 2008, GENET RES, V90, P151, DOI 10.1017/S0016672308009221; Miller LD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1662; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Ndifon W, 2006, B MATH BIOL, V68, P1747, DOI 10.1007/s11538-005-9029-9; Nelson PS, 1998, GENOMICS, V47, P12, DOI 10.1006/geno.1997.5035; Nomura M, 2007, PLOS MED, V4, P715, DOI 10.1371/journal.pmed.0040125; Oda S, 2005, SURG TODAY, V35, P1005, DOI 10.1007/s00595-005-3125-1; Oda S, 2005, NUCLEIC ACIDS RES, V33, P1628, DOI 10.1093/nar/gki303; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Riar DS, 2011, J HERED, V102, P17, DOI 10.1093/jhered/esq103; Rich SS, 2008, J CARDIOVASC TRANSL, V1, P21, DOI 10.1007/s12265-007-9003-z; Schiemann U, 2004, DIGESTION, V69, P166, DOI 10.1159/000078223; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Slate J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-52; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Tahrokh E, 2011, GENES GENOM, V33, P565, DOI 10.1007/s13258-011-0057-6; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tinelli A, 2010, MINI-REV MED CHEM, V10, P1356, DOI 10.2174/138955710793564098; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Venkatesan RN, 2006, DNA REPAIR, V5, P294, DOI 10.1016/j.dnarep.2005.10.012; Vergara D, 2010, CURR CANCER DRUG TAR, V10, P107, DOI 10.2174/156800910790980269; Villalta I, 2005, THEOR APPL GENET, V110, P881, DOI 10.1007/s00122-004-1906-3; Vivekanandan P, 2008, EXPERT REV PROTEOMIC, V5, P45, DOI 10.1586/14789450.5.1.45; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Wen Mingfu, 2010, BMC Res Notes, V3, P42, DOI 10.1186/1756-0500-3-42; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262	55	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27118	10.1371/journal.pone.0027118	http://dx.doi.org/10.1371/journal.pone.0027118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073269	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200035
J	Shmelkov, E; Nadas, A; Swetnam, J; Zolla-Pazner, S; Cardozo, T				Shmelkov, Evgeny; Nadas, Arthur; Swetnam, James; Zolla-Pazner, Susan; Cardozo, Timothy			Indirect Detection of an Epitope-Specific Response to HIV-1 gp120 Immunization in Human Subjects	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; HUMAN MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY; GENETIC SUBTYPES; TRIAL; THAILAND; INFECTION; NEUTRALIZATION; DOMAIN	A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a result of vaccination of human subjects with the surface envelope glycoprotein (gp120) of HIV-1 has not previously been documented. Here, we used computational analysis to assess the epitope-specific responses of human subjects, which were immunized with recombinant gp120 immunogens in the VAX003 and VAX004 clinical trials. Our computational methodology-a variation of sieve analysis-compares the occurrence of specific nAb targeted conformational 3D epitopes on viruses from infected individuals who received vaccination to the occurrence of matched epitopes in the viruses infecting placebo subjects. We specifically studied seven crystallographically defined nAb targeted conformational epitopes in the V3 loop, an immunogenic region of gp120. Of the six epitopes present in the immunogens and targeted by known monoclonal neutralizing antibodies, only the one targeted by the anti-V3 nAb 2219 exhibited a significant reduction in occurrence in vaccinated subjects compared to the placebo group. This difference occurred only in the VAX003 Thailand cohort. No difference was seen between vaccinated and placebo groups for the occurrence of an epitope that was not present in the immunogen. Thus, it can be theorized that a specific 2219-like human neutralizing antibody immune response to AIDSVAX immunization occurred in the VAX003 cohort, and that this response protected subjects from a narrow subset of HIV-1 viruses circulating in Thailand in the 1990s and bearing the conformational epitope targeted by the neutralizing antibody 2219.	[Shmelkov, Evgeny; Swetnam, James; Cardozo, Timothy] NYUSoM, Dept Pharmacol, New York, NY USA; [Nadas, Arthur] NYUSoM, Dept Environm Med, New York, NY USA; [Zolla-Pazner, Susan] NYUSoM, Dept Pathol, New York, NY USA; [Zolla-Pazner, Susan] Vet Affairs Med Ctr, New York, NY USA	New York University; New York University; New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Shmelkov, E (corresponding author), NYUSoM, Dept Pharmacol, New York, NY USA.	cardot01@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	Bill and Melinda Gates Foundation [38631]; NIH [DP2 OD004631, R01 AI084119, AI36085, HL59725, AI27742]; NSF [0333389]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036085, P30AI027742, R01AI084119] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from the Bill and Melinda Gates Foundation (#38631; http://www.gatesfoundation.org/Pages/home.aspx); the NIH (http://www.nih.gov/), including DP2 OD004631(TC), R01 AI084119 (TC), AI36085 (SZP), HL59725 (SZP), and AI27742 (NYU Center for AIDS Research); the NSF (http://www.nsf.gov/), including #0333389 training support for ES; and research funds from the Department of Veterans Affairs (http://www.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL A, 2011, VACCINE; Albrecht H, 2003, AIDS Clin Care, V15, P42; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4; GILBERT P, 2011, SIEVE ANAL HIV SEQUE, P5; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; OU CY, 1992, AIDS RES HUM RETROV, V8, P1471, DOI 10.1089/aid.1992.8.1471; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Swetnam J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015994; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27279	10.1371/journal.pone.0027279	http://dx.doi.org/10.1371/journal.pone.0027279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076145	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200059
J	Fu, XM; Wang, P; Zhu, BT				Fu, Xin-Miao; Wang, Pan; Zhu, Bao Ting			Characterization of the Estradiol-Binding Site Structure of Human Protein Disulfide Isomerase (PDI)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TARGET-CELLS; ESTROGEN-RECEPTOR; HORMONE-BINDING; HIV-1 ENTRY; INHIBITORS; GLYCOPROTEIN-120; CHAPERONE; DOMAIN; BONDS	Background: Earlier studies showed that 17 beta-estradiol (E-2), an endogenous female sex hormone, can bind to human protein disulfide isomerase (PDI), a protein folding catalyst for disulfide bond formation and rearrangement. This binding interaction can modulate the intracellular levels of E-2 and its biological actions. However, the structure of PDI's E-2-binding site is still unclear at present, which is the focus of this study. Methodology/Principal Findings: The E-2-binding site structure of human PDI was studied by using various biochemical approaches coupled with radiometric receptor-binding assays, site-directed mutagenesis, and molecular computational modeling. Analysis of various PDI protein fragments showed that the [H-3]E-2-binding activity is not associated with the single b or b' domain but is associated with the b-b' domain combination. Computational docking analyses predicted that the E-2-binding site is located in a hydrophobic pocket composed mainly of the b' domain and partially of the b domain. A hydrogen bond, formed between the 3-hydroxyl group of E-2 and His256 of PDI is critical for the binding interaction. This binding model was jointly confirmed by a series of detailed experiments, including site-directed mutagenesis of the His256 residue coupled with selective modifications of the ligand structures to alter the binding interaction. Conclusions/Significance: The results of this study elucidated the structural basis for the PDI-E-2 binding interaction and the reservoir role of PDI in modulating the intracellular E-2 levels. The identified PDI E-2-binding site is quite different from its known peptide binding sites. Given that PDI is a potential therapeutic target for cancer chemotherapy and HIV prevention and that E-2 can inhibit PDI activity in vitro, the E-2-binding site structure of human PDI determined here offers structural insights which may aid in the rational design of novel PDI inhibitors.	[Fu, Xin-Miao; Wang, Pan; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Fu, Xin-Miao] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing 100871, Peoples R China; [Fu, Xin-Miao] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China	University of Kansas; University of Kansas Medical Center; Peking University; Peking University	Fu, XM (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904	National Institutes of Health [CA97109]; KU Endowment; NATIONAL CANCER INSTITUTE [R01CA097109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in part, by a grant from the National Institutes of Health (CA97109). The other part is from KU Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Fu XM, 2010, BIOCHEM J, V429, P157, DOI 10.1042/BJ20091954; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Fu XM, 2009, J STEROID BIOCHEM, V115, P20, DOI 10.1016/j.jsbmb.2009.02.008; Fu XM, 2008, J STEROID BIOCHEM, V112, P127, DOI 10.1016/j.jsbmb.2008.09.005; Fu XM, 2010, BIOCHEMISTRY; GABBARD RB, 1983, STEROIDS, V41, P791, DOI 10.1016/0039-128X(83)90054-5; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x; Khan MM SS, 2010, ACS CHEM BIOL; KITAGAWA S, 1987, J BIOL CHEM, V262, P3903; Klett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009507; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; SITIA R, 2004, SCI STKE, pPE27; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yoshiro M, 1997, J FERMENT BIOENG, V84, P588; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	40	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27185	10.1371/journal.pone.0027185	http://dx.doi.org/10.1371/journal.pone.0027185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073283	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000030
J	Hammerschlag-Peyer, CM; Yeager, LA; Araujo, MS; Layman, CA				Hammerschlag-Peyer, Caroline M.; Yeager, Lauren A.; Araujo, Marcio S.; Layman, Craig A.			A Hypothesis-Testing Framework for Studies Investigating Ontogenetic Niche Shifts Using Stable Isotope Ratios	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; TROPHIC POSITION; SIZE; DIET; DELTA-C-13; PREDATION; ECOLOGY; MODELS; VARIABILITY; DELTA-N-15	Ontogenetic niche shifts occur across diverse taxonomic groups, and can have critical implications for population dynamics, community structure, and ecosystem function. In this study, we provide a hypothesis-testing framework combining univariate and multivariate analyses to examine ontogenetic niche shifts using stable isotope ratios. This framework is based on three distinct ontogenetic niche shift scenarios, i.e., (1) no niche shift, (2) niche expansion/reduction, and (3) discrete niche shift between size classes. We developed criteria for identifying each scenario, as based on three important resource use characteristics, i.e., niche width, niche position, and niche overlap. We provide an empirical example for each ontogenetic niche shift scenario, illustrating differences in resource use characteristics among different organisms. The present framework provides a foundation for future studies on ontogenetic niche shifts, and also can be applied to examine resource variability among other population sub-groupings (e.g., by sex or phenotype).	[Hammerschlag-Peyer, Caroline M.; Yeager, Lauren A.; Araujo, Marcio S.; Layman, Craig A.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, N Miami, FL USA	State University System of Florida; Florida International University	Hammerschlag-Peyer, CM (corresponding author), Florida Int Univ, Marine Sci Program, Dept Biol Sci, N Miami, FL USA.	cpeye001@fiu.edu	Yeager, Lauren/F-8237-2011; Araujo, Marcio Silva/G-9485-2011	Yeager, Lauren/0000-0002-6623-0752; Araujo, Marcio Silva/0000-0003-3533-744X	National Science Foundation [0746164, 0842196]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Florida International University	National Science Foundation(National Science Foundation (NSF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Florida International University	The authors would like to thank their funding agencies, National Science Foundation (OCE #0746164, DEB #0842196; www.nsf.gov/) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br/), and Florida International University Dissertation Year Fellowship (gradschool.fiu.edu/Fellowships.html) for their financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boveri MB, 2002, VERHANDLUNGEN INT VE, V28, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Claessen D, 2002, ECOLOGY, V83, P1660, DOI 10.2307/3071986; Cotter PA, 2006, COMP BIOCHEM PHYS A, V145, P158, DOI 10.1016/j.cbpa.2006.06.001; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Faunce CH, 2007, B MAR SCI, V80, P473; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; GROSSMAN GD, 1980, OECOLOGIA, V47, P233, DOI 10.1007/BF00346826; Hammerschlag N, 2009, MARINE ECOLOGY EVOLU, V31, P364; Hammerschlag-Peyer CM, B MARINE SC IN PRESS; Hentschel BT, 1998, ECOLOGY, V79, P1357, DOI 10.1890/0012-9658(1998)079[1357:IVICIO]2.0.CO;2; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JONES D, 1986, J ECON ENTOMOL, V79, P1156, DOI 10.1093/jee/79.5.1156; Keast A., 1977, Evolutionary Biol, V10, P333; Kieckbusch DK, 2004, B MAR SCI, V74, P271; KIRKPATRICK M, 1984, ECOLOGY, V65, P1874, DOI 10.2307/1937785; LANDMAN NH, 1983, PALEOBIOLOGY, V9, P269, DOI 10.1017/S0094837300007685; Layman CA, BIOL REV CA IN PRESS; Layman CA, 2008, ECOLOGY, V89, P2358, DOI 10.1890/08-0167.1; Layman CA, 2007, B MAR SCI, V80, P513; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MINNS CK, 1995, CAN J FISH AQUAT SCI, V52, P1499, DOI 10.1139/f95-144; Mueller-Lupp T, 2003, BOREAS, V32, P292, DOI 10.1080/03009480310001984; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; OLSON MH, 1995, ECOLOGY, V76, P1758, DOI 10.2307/1940708; Olson MH, 1996, ECOLOGY, V77, P179, DOI 10.2307/2265667; Persson L., 1988, P203; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Quevedo M, 2006, J FISH BIOL, V69, P141, DOI 10.1111/j.1095-8649.2006.01072.x; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; ROUNICK JS, 1986, BIOSCIENCE, V36, P171, DOI 10.2307/1310304; Royall R., 1997, STAT EVIDENCE LIKELI; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; STEIN R A, 1988, P161; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Taylor MD, 2010, MAR FRESHWATER RES, V61, P302, DOI 10.1071/MF09014; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner EE, 1979, PREDATOR PREY SYSTEM, P311; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Yeager LA, 2011, AQUAT ECOL, V45, P267, DOI 10.1007/s10452-011-9352-1; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060	66	71	74	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27104	10.1371/journal.pone.0027104	http://dx.doi.org/10.1371/journal.pone.0027104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073265	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000027
J	Alkan, Y; Biswal, BB; Alvarez, TL				Alkan, Yelda; Biswal, Bharat B.; Alvarez, Tara L.			Differentiation between Vergence and Saccadic Functional Activity within the Human Frontal Eye Fields and Midbrain Revealed through fMRI	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; PREFRONTAL CORTEX; ANTERIOR CINGULATE; NEURAL CONTROL; CEREBELLAR CONTRIBUTIONS; VOLITIONAL SACCADES; RETINAL DISPARITY; OCULOMOTOR VERMIS; ADAPTIVE-CONTROL; GAZE-SHIFTS	Purpose: Eye movement research has traditionally studied solely saccade and/or vergence eye movements by isolating these systems within a laboratory setting. While the neural correlates of saccadic eye movements are established, few studies have quantified the functional activity of vergence eye movements using fMRI. This study mapped the neural substrates of vergence eye movements and compared them to saccades to elucidate the spatial commonality and differentiation between these systems. Methodology: The stimulus was presented in a block design where the 'off' stimulus was a sustained fixation and the 'on' stimulus was random vergence or saccadic eye movements. Data were collected with a 3T scanner. A general linear model (GLM) was used in conjunction with cluster size to determine significantly active regions. A paired t-test of the GLM beta weight coefficients was computed between the saccade and vergence functional activities to test the hypothesis that vergence and saccadic stimulation would have spatial differentiation in addition to shared neural substrates. Results: Segregated functional activation was observed within the frontal eye fields where a portion of the functional activity from the vergence task was located anterior to the saccadic functional activity (z > 2.3; p < 0.03). An area within the midbrain was significantly correlated with the experimental design for the vergence but not the saccade data set. Similar functional activation was observed within the following regions of interest: the supplementary eye field, dorsolateral prefrontal cortex, ventral lateral prefrontal cortex, lateral intraparietal area, cuneus, precuneus, anterior and posterior cingulates, and cerebellar vermis. The functional activity from these regions was not different between the vergence and saccade data sets assessed by analyzing the beta weights of the paired t-test (p > 0.2). Conclusion: Functional MRI can elucidate the differences between the vergence and saccade neural substrates within the frontal eye fields and midbrain.	[Alkan, Yelda; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Biswal, Bharat B.] Univ Med & Dent New Jersey, Dept Radiol, Newark, NJ 07103 USA	New Jersey Institute of Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center	Alkan, Y (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	bbiswal@gmail.com; tara.l.alvarez@njit.edu		Lauwereyns, Jan/0000-0003-0551-2550; Alvarez, Tara/0000-0002-8797-1613	NSF [BES-044713]; NIH [5R01NS049176, 5R01AG032088-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by NSF CAREER BES-044713 to TLA, NIH 5R01NS049176 and NIH 5R01AG032088-02 to BBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2005, EXP BRAIN RES, V164, P92, DOI 10.1007/s00221-004-2213-6; Alkan Y, 2011, VISUAL NEUROSCIENCE, V28; Alvarez TL, 2010, VISION RES, V50, P2163, DOI 10.1016/j.visres.2010.08.018; Alvarez TL, 2010, VISION RES; Alvarez TL, 2010, OPTOM VIS SCI; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bababekova Y, 2011, OPTOMETRY VISION SCI, V88, P795, DOI 10.1097/OPX.0b013e3182198792; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Berns G S, 1999, J Neurosci, V19, pRC17; Bhattacharyya R, 2009, J NEUROPHYSIOL, V102, P805, DOI 10.1152/jn.90359.2008; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Biswal B, 2011, J NEUROL SCI, V301, P9, DOI 10.1016/j.jns.2010.11.018; Busettini C, 2005, J NEUROPHYSIOL, V94, P2312, DOI 10.1152/jn.01337.2004; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Ciuffreda KJ, EYE MOVEMENT BASICS, P36; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; Coubard OA, 2008, GRAEF ARCH CLIN EXP, V246, P521, DOI 10.1007/s00417-007-0714-2; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dean HL, 2006, J NEUROSCI, V26, P1117, DOI 10.1523/JNEUROSCI.2497-05.2006; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; ENRIGHT JT, 1984, J PHYSIOL-LONDON, V350, P9, DOI 10.1113/jphysiol.1984.sp015186; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P441, DOI 10.1098/rspb.1989.0031; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Ferraina S, 2009, J NEUROSCI, V29, P11461, DOI 10.1523/JNEUROSCI.1305-09.2009; Fukushima K, 2002, NATURE, V419, P157, DOI 10.1038/nature00953; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gavrilescu M, 2008, HUM BRAIN MAPP, V29, P1040, DOI 10.1002/hbm.20446; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hasebe H, 1999, NEUROIMAGE, V10, P200, DOI 10.1006/nimg.1999.0453; Herrington TM, 2010, J NEUROSCI, V30, P3287, DOI 10.1523/JNEUROSCI.6025-09.2010; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Howarth PA, 2011, OPHTHAL PHYSL OPT, V31, P111, DOI 10.1111/j.1475-1313.2011.00822.x; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kannurpatti SS, 2011, HUM BRAIN MAPP, V32, P1125, DOI 10.1002/hbm.21097; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Kojima Y, 2010, J NEUROSCI, V30, P3715, DOI 10.1523/JNEUROSCI.4953-09.2010; Kumar AN, 2005, J NEUROPHYSIOL, V93, P2797, DOI 10.1152/jn.00858.2004; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Liu YQ, 2010, NAT NEUROSCI, V13, P495, DOI 10.1038/nn.2496; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; Matsuda T, 2004, PSYCHIAT RES-NEUROIM, V131, P147, DOI 10.1016/j.pscychresns.2003.12.007; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; MAYS LE, 1984, J NEUROPHYSIOL, V52, P743, DOI 10.1152/jn.1984.52.4.743; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Missimer JH, 2010, J MAGN RESON IMAGING, V31, P821, DOI 10.1002/jmri.22122; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Nybakken GE, 2002, NEURORADIOLOGY, V44, P403, DOI 10.1007/s00234-001-0722-6; Oakes TR, 2005, NEUROIMAGE, V28, P529, DOI 10.1016/j.neuroimage.2005.05.058; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Quigley MA, 2002, AM J NEURORADIOL, V23, P49; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Richter HO, 2004, EUR J NEUROSCI, V20, P2722, DOI 10.1111/j.1460-9568.2004.03743.x; Rosano C, 2002, CEREB CORTEX, V12, P107, DOI 10.1093/cercor/12.2.107; Rosenthal CR, 2008, PROG BRAIN RES, V171, P419, DOI 10.1016/S0079-6123(08)00661-4; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; Schall JD, 2007, COGN AFFECT BEHAV NE, V7, P396, DOI 10.3758/CABN.7.4.396; Schendan HE, 2008, CEREB CORTEX, V18, P1695, DOI 10.1093/cercor/bhm197; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; Schmid A, 2001, NEUROREPORT, V12, P1409, DOI 10.1097/00001756-200105250-00023; Semmlow JL, 2002, CAH PSYCHOL COGN, V21, P343; Semmlow JL, 2007, J EYE MOVEMENT RES, V1; Semmlow JL, 2009, J EYE MOVEMENT RES, V2; Serra A, 2011, CURR OPIN NEUROL, V24, P32, DOI 10.1097/WCO.0b013e328341eebd; Takagi M, 2003, PROG BRAIN RES, V142, P19; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; van Broekhoven PCA, 2009, CEREBELLUM, V8, P403, DOI 10.1007/s12311-009-0116-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; van Leeuwen AF, 1998, VISION RES, V38, P3943, DOI 10.1016/S0042-6989(98)00092-3; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Vernet M, 2009, J VISION, V9, DOI 10.1167/9.7.2; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Zee D S, 1992, Baillieres Clin Neurol, V1, P455; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624; ZHANG Y, 1992, J NEUROPHYSIOL, V67, P944, DOI 10.1152/jn.1992.67.4.944; ZHANG Y, 1991, EXP BRAIN RES, V84, P525	103	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25866	10.1371/journal.pone.0025866	http://dx.doi.org/10.1371/journal.pone.0025866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073141	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900001
J	Gowrishankar, G; Zitzmann-Kolbe, S; Junutula, A; Reeves, R; Levi, J; Srinivasan, A; Bruus-Jensen, K; Cyr, J; Dinkelborg, L; Gambhir, SS				Gowrishankar, Gayatri; Zitzmann-Kolbe, Sabine; Junutula, Anitha; Reeves, Robert; Levi, Jelena; Srinivasan, Ananth; Bruus-Jensen, Kjerstin; Cyr, John; Dinkelborg, Ludger; Gambhir, Sanjiv S.			GLUT 5 Is Not Over-Expressed in Breast Cancer Cells and Patient Breast Cancer Tissues	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; FRUCTOSE TRANSPORTER; PET; PROLIFERATION; F-18-FDG; FAMILY; TUMORS; LUNG	F18 2-Fluoro 2-deoxyglucose (FDG) has been the gold standard in positron emission tomography (PET) oncologic imaging since its introduction into the clinics several years ago. Seeking to complement FDG in the diagnosis of breast cancer using radio labeled fructose based analogs, we investigated the expression of the chief fructose transporter-GLUT 5 in breast cancer cells and human tissues. Our results indicate that GLUT 5 is not over-expressed in breast cancer tissues as assessed by an extensive immunohistochemistry study. RT-PCR studies showed that the GLUT 5 mRNA was present at minimal amounts in breast cancer cell lines. Further knocking down the expression of GLUT 5 in breast cancer cells using RNA interference did not affect the fructose uptake in these cell lines. Taken together these results are consistent with GLUT 5 not being essential for fructose uptake in breast cancer cells and tissues.	[Gowrishankar, Gayatri; Junutula, Anitha; Reeves, Robert; Levi, Jelena; Gambhir, Sanjiv S.] Dept Radiol, Mol Imaging Program, Div Nucl Med, Stanford, CA USA; [Zitzmann-Kolbe, Sabine; Srinivasan, Ananth; Bruus-Jensen, Kjerstin; Cyr, John; Dinkelborg, Ludger] Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany; [Gambhir, Sanjiv S.] Dept Bioengn & Mat Sci & Engn, Stanford, CA USA	Bayer AG; Bayer Healthcare Pharmaceuticals	Gowrishankar, G (corresponding author), Dept Radiol, Mol Imaging Program, Div Nucl Med, Stanford, CA USA.	sgambhir@stanford.edu			Bayer Schering Pharma AG; Bayer Schering Pharma	Bayer Schering Pharma AG(Bayer AG); Bayer Schering Pharma(Bayer AG)	This study was funded by the authors' collaborators at Bayer Schering Pharma AG. These collaborators also participated in the study design and in the scientific discussions during the course of the study.; The study was funded by Bayer Schering Pharma. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alavi A, 2004, SEMIN NUCL MED, V34, P56, DOI 10.1053/j.semnuclmed.2003.09.007; Avril N, 2000, J CLIN ONCOL, V18, P3495, DOI 10.1200/JCO.2000.18.20.3495; BROWN RS, 1993, CANCER, V72, P2979, DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X; Buck AK, 2003, J NUCL MED, V44, P1426; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Chan KK, 2004, J CELL BIOCHEM, V93, P1134, DOI 10.1002/jcb.20270; Concha II, 1997, BLOOD, V89, P4190, DOI 10.1182/blood.V89.11.4190; Godoy A, 2006, J CELL PHYSIOL, V207, P614, DOI 10.1002/jcp.20606; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Grover-McKay M, 1998, Pathol Oncol Res, V4, P115; JAMES DE, 1994, J CELL BIOL, V126, P1123, DOI 10.1083/jcb.126.5.1123; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Jung CY, 1998, EXP PHYSIOL, V83, P267, DOI 10.1113/expphysiol.1998.sp004112; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Keshari KR, 2009, J AM CHEM SOC, V131, P17591, DOI 10.1021/ja9049355; Kostakoglu L, 2003, J NUCL MED, V44, P224; Lazar V, 1999, J CLIN ENDOCR METAB, V84, P3228, DOI 10.1210/jc.84.9.3228; Levi J, 2007, BIOCONJUGATE CHEM, V18, P628, DOI 10.1021/bc060184s; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Trayner BJ, 2009, BIOORGAN MED CHEM, V17, P5488, DOI 10.1016/j.bmc.2009.06.034; ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847; Zeng H, 1996, BIOPHYS J, V70, P14, DOI 10.1016/S0006-3495(96)79560-7; 1996, P NATL ACAD SCI US, V93, P15522	25	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26902	10.1371/journal.pone.0026902	http://dx.doi.org/10.1371/journal.pone.0026902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073218	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900052
J	Leite, TKM; Fonseca, RMC; de Franca, NM; Parra, EJ; Pereira, RW				Leite, Tailce K. M.; Fonseca, Romulo M. C.; de Franca, Nanci M.; Parra, Esteban J.; Pereira, Rinaldo W.			Genomic Ancestry, Self-Reported "Color'' and Quantitative Measures of Skin Pigmentation in Brazilian Admixed Siblings	PLOS ONE			English	Article							GENETIC ANCESTRY; ASSOCIATION; SLC24A5; AGREEMENT; ADMIXTURE; INFERENCE; RISK	A current concern in genetic epidemiology studies in admixed populations is that population stratification can lead to spurious results. The Brazilian census classifies individuals according to self-reported "color'', but several studies have demonstrated that stratifying according to "color'' is not a useful strategy to control for population structure, due to the dissociation between self-reported "color'' and genomic ancestry. We report the results of a study in a group of Brazilian siblings in which we measured skin pigmentation using a reflectometer, and estimated genomic ancestry using 21 Ancestry Informative Markers (AIMs). Self-reported "color'', according to the Brazilian census, was also available for each participant. This made it possible to evaluate the relationship between self-reported "color'' and skin pigmentation, self-reported "color'' and genomic ancestry, and skin pigmentation and genomic ancestry. We observed that, although there were significant differences between the three "color'' groups in genomic ancestry and skin pigmentation, there was considerable dispersion within each group and substantial overlap between groups. We also saw that there was no good agreement between the "color'' categories reported by each member of the sibling pair: 30 out of 86 sibling pairs reported different "color'', and in some cases, the sibling reporting the darker "color'' category had lighter skin pigmentation. Socioeconomic status was significantly associated with self-reported "color'' and genomic ancestry in this sample. This and other studies show that subjective classifications based on self-reported "color'', such as the one that is used in the Brazilian census, are inadequate to describe the population structure present in recently admixed populations. Finally, we observed that one of the AIMs included in the panel (rs1426654), which is located in the known pigmentation gene SLC24A5, was strongly associated with skin pigmentation in this sample.	[Leite, Tailce K. M.; Fonseca, Romulo M. C.; de Franca, Nanci M.; Pereira, Rinaldo W.] Univ Catolica Brasilia, Programa Pos Grad Educ Fis, Brasilia, DF, Brazil; [Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Pereira, Rinaldo W.] Univ Catolica Brasilia, Programa Pos Grad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; University of Toronto; University Toronto Mississauga; Universidade Catolica de Brasilia	Leite, TKM (corresponding author), Univ Catolica Brasilia, Programa Pos Grad Educ Fis, Brasilia, DF, Brazil.	rinaldo.pereira@catolica.edu.br	Leite, Tailce/AAI-2666-2021; Fonseca, Romulo MC/G-3206-2012; genomicas, ciencias/D-9871-2013; Pereira, Rinaldo W/B-9255-2011	Fonseca, Romulo MC/0000-0002-2097-7498; Pereira, Rinaldo W/0000-0003-3704-2848; Leite, Tailce/0000-0002-4251-729X; parra, esteban J/0000-0002-2057-8577	National Counsel of Technological and Scientific Development - CNPq - Brazil [MCT/CNPq-02/2006-Universal- 475438/2006-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pro-Reitoria de Pos-graduacao e Pesquisa - Universidade Catolica de Brasilia (PRPGP - UCB)	National Counsel of Technological and Scientific Development - CNPq - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pos-graduacao e Pesquisa - Universidade Catolica de Brasilia (PRPGP - UCB)	This study was supported by grants from the following Brazilian agencies: National Counsel of Technological and Scientific Development - CNPq - Brazil (process id: MCT/CNPq-02/2006-Universal- 475438/2006-0), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Pro-Reitoria de Pos-graduacao e Pesquisa - Universidade Catolica de Brasilia (PRPGP - UCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Associacao Brasileira das Empresas de Pesquisa (ABEP), 2003, CRIT CLASS EC BRAS; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dimisianos G, 2009, EXP DERMATOL, V18, P175, DOI 10.1111/j.1600-0625.2008.00758.x; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Fonseca RMC, 2011, JOINT BONE IN PRESS, DOI 101016/jjbspin201105007; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gravlee CC, 2005, AM J PUBLIC HEALTH, V95, P2191, DOI 10.2105/AJPH.2005.065615; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; IBGE-Instituto Brasileiro de Geografia e Estatisticas, 2000, CENS DEM 2000 CAR GE; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Klimentidis YC, 2009, AM J PHYS ANTHROPOL, V138, P375, DOI 10.1002/ajpa.20945; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lins TC, 2011, J EPIDEMIOL, DOI 102188/jeaJE20100164; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Parra EJ, 2007, CLIN GENET, V71, P359, DOI 10.1111/j.1399-0004.2007.00780.x; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Ruiz-Narvaez EA, 2010, BREAST CANCER RES TR, V123, P525, DOI 10.1007/s10549-010-0775-5; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Valenzuela RK, 2010, J FORENSIC SCI, V55, P315, DOI 10.1111/j.1556-4029.2009.01317.x; Viera AJ, 2005, FAM MED, V37, P360	41	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27162	10.1371/journal.pone.0027162	http://dx.doi.org/10.1371/journal.pone.0027162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073278	gold, Green Published			2022-12-27	WOS:000297154900082
J	Lippert, S; Callaham, ML; Lo, B				Lippert, Suzanne; Callaham, Michael L.; Lo, Bernard			Perceptions of Conflict of Interest Disclosures among Peer Reviewers	PLOS ONE			English	Article							QUALITY; MANUSCRIPTS; PERFORMANCE; TRIAL; INSTRUMENT; EDITORS	Background: Disclosure of financial conflicts of interest (COI) is intended to help reviewers assess the impact of potential bias on the validity of research results; however, there have been no empiric assessments of how reviewers understand and use disclosures in article evaluation. We investigate reviewers' perceptions of potential bias introduced by particular author disclosures, and whether reviewer characteristics are associated with a greater likelihood of perceiving bias. Methodology/Principal Findings: Of the 911 active reviewers from the Annals of Emergency Medicine, 410 were randomly selected and invited to complete our web-based, 3-part survey. We completed descriptive analysis of all survey responses and compared those responses across reviewer characteristics using 262 analyses and the Fisher exact test. We had a response rate of 54%. The majority of reviewers surveyed reported a high level of skepticism regarding financial relationships between authors and industry without a clear or consistent translation of that skepticism into the self-reported actions that characterize manuscript assessment. Only 13% of respondents believed physician consultants authoring articles based on company data are likely to have unlimited data access. 54% believed that bias most likely exists with any honorarium, regardless of monetary amount. Between 46% and 64%, depending on the type of financial relationship disclosed, reported that their recommendation for publication remains unchanged. Respondents reporting personal financial ties to industry were less likely to perceive bias in industry relationships and less likely to believe that bias exists with any monetary amount of honoraria. Conclusions: We recommend that the monetary amount of all financial relationships be reported with manuscript submissions, lead authors certify that they have unrestricted access to data, and reviewers disclose any financial ties to industry whether or not they are related to the manuscript under review. Further research is required to better understand reviewers' perceptions of financial relationships between authors and industry in order to develop clear and consistent guidelines for incorporating the perception of potential bias into manuscript assessments.	[Lippert, Suzanne] Alameda Cty Med Ctr, Dept Emergency Med, Oakland, CA USA; [Callaham, Michael L.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Callaham, Michael L.] Amer Coll Emergency Phys, Irving, TX USA; [Lo, Bernard] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lippert, S (corresponding author), Stanford Hosp & Clin, Div Emergency Med, Stanford, CA USA.	slippert@stanford.edu		Callaham, Michael/0000-0003-2284-256X	University California San Francisco (UCSF), Department of Emergency Medicine; National Center for Research Resources (NCRR), National Institutes of Health (NIH) [1 UL1 RR024131-01]; National Institutes of Health (NIH) [MH062246]; Greenwall Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	University California San Francisco (UCSF), Department of Emergency Medicine; National Center for Research Resources (NCRR), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	University California San Francisco (UCSF), Department of Emergency Medicine provided funding to cover costs of surveymonkey fees and PLoS fees. BL was supported by the National Institutes of Health (NIH) (1 UL1 RR024131-01) from the National Center for Research Resources (NCRR), by National Institutes of Health (MH062246) and by NIH Roadmap for Medical Research and by the Greenwall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxt WG, 1998, ANN EMERG MED, V32, P310, DOI 10.1016/S0196-0644(98)70006-X; CALLAHAM M, 2003, PEER REV HLTH SCI, P164; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229; Callaham ML, 2002, ANN EMERG MED, V40, P323, DOI 10.1067/mem.2002.127121; Callaham ML, 1998, ANN EMERG MED, V32, P318, DOI 10.1016/S0196-0644(98)70007-1; Callahan ML, 2002, JAMA-J AM MED ASSOC, V287, P2781, DOI 10.1001/jama.287.21.2781; DeAngelis CD, 2010, JAMA-J AM MED ASSOC, V303, P1196, DOI 10.1001/jama.2010.337; Fontanarosa PB, 2010, JAMA-J AM MED ASSOC, V304, P1496, DOI 10.1001/jama.2010.1429; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; *ICMJE, 2011, BIOMEDICAL J UNPUB; Landkroon AR, 2006, OBSTET GYNECOL, V108, P979, DOI 10.1097/01.AOG.0000231675.74957.48; Lo B., 2009, CONFLICT INTEREST ME; Lo B, 2009, CONFLICT INTEREST ME; NYLENNA M, 1994, JAMA-J AM MED ASSOC, V272, P149, DOI 10.1001/jama.272.2.149; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Schroter S, 2004, BRIT MED J, V328, P673, DOI 10.1136/bmj.38023.700775.AE; Schroter S, 2008, J ROY SOC MED, V101, P507, DOI 10.1258/jrsm.2008.080062; *THOM REUT, 2008, J CITATION REPORTS I; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1	20	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26900	10.1371/journal.pone.0026900	http://dx.doi.org/10.1371/journal.pone.0026900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073216	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900051
J	Perveen, R; Funk, K; Thuma, J; Ridge, SW; Cao, YY; Akkerman, JWN; Chen, XZ; Akbar, H				Perveen, Rehana; Funk, Kevin; Thuma, Jean; Ridge, Shelli Wulf; Cao, Yanyan; Akkerman, Jan Willem N.; Chen, Xiaozhuo; Akbar, Huzoor			A Novel Small Molecule 1,2,3,4,6-penta-O-galloyl-alpha-D-glucopyranose Mimics the Antiplatelet Actions of Insulin	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PLATELET ACTIVATION; SIGNALING PATHWAYS; P2Y(12) RECEPTOR; IN-VIVO; INHIBITION; AGGREGATION; HYPERACTIVITY; INFLAMMATION; RESISTANCE	Background: We have shown that 1,2,3,4,6-penta-O-galloyl-alpha-D-glucopyranose (alpha-PGG), an orally effective hypoglycemic small molecule, binds to insulin receptors and activates insulin-mediated glucose transport. Insulin has been shown to bind to its receptors on platelets and inhibit platelet activation. In this study we tested our hypothesis that if insulin possesses anti-platelet properties then insulin mimetic small molecules should mimic antiplatelet actions of insulin. Principal Findings: Incubation of human platelets with insulin or alpha-PGG induced phosphorylation of insulin receptors and IRS-1 and blocked ADP or collagen induced aggregation. Pre-treatment of platelets with alpha-PGG inhibited thrombin-induced release of P-selectin, secretion of ATP and aggregation. Addition of ADP or thrombin to platelets significantly decreased the basal cyclic AMP levels. Pre-incubation of platelets with alpha-PGG blocked ADP or thrombin induced decrease in platelet cyclic AMP levels but did not alter the basal or PGE(1) induced increase in cAMP levels. Addition of alpha-PGG to platelets blocked agonist induced rise in platelet cytosolic calcium and phosphorylation of Akt. Administration of alpha-PGG (20 mg kg(-1)) to wild type mice blocked ex vivo platelet aggregation induced by ADP or collagen. Conclusions: These data suggest that alpha-PGG inhibits platelet activation, at least in part, by inducing phosphorylation of insulin receptors leading to inhibition of agonist induced: (a) decrease in cyclic AMP; (b) rise in cytosolic calcium; and (c) phosphorylation of Akt. These findings taken together with our earlier reports that alpha-PGG mimics insulin signaling suggest that inhibition of platelet activation by alpha-PGG mimics antiplatelet actions of insulin.	[Perveen, Rehana; Funk, Kevin; Thuma, Jean; Ridge, Shelli Wulf; Chen, Xiaozhuo; Akbar, Huzoor] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Cao, Yanyan; Chen, Xiaozhuo; Akbar, Huzoor] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Akkerman, Jan Willem N.] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands	University System of Ohio; Ohio University; University System of Ohio; Ohio University; Utrecht University; Utrecht University Medical Center	Perveen, R (corresponding author), Baqai Med Univ, Karachi, Pakistan.	akbar@ohio.edu			Ohio University College of Osteopathic Medicine (OUCOM) The Research & Scholarly Affairs Committee; Higher Education Commission of Pakistan; OUCOM	Ohio University College of Osteopathic Medicine (OUCOM) The Research & Scholarly Affairs Committee; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); OUCOM	This research was supported in part by the Ohio University College of Osteopathic Medicine (OUCOM) The Research & Scholarly Affairs Committee. RP was a post-doctoral trainee funded by the Higher Education Commission of Pakistan. SWR, a 2nd year medical student was a recipient of an OUCOM summer research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL KC, 1994, BIOCHEM PHARMACOL, V48, P1909, DOI 10.1016/0006-2952(94)90589-4; Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; AKBAR H, 1993, AM J HYPERTENS, V6, P857; Akbar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022117; Angiolillo DJ, 2006, J THROMB HAEMOST, V4, P2563, DOI 10.1111/j.1538-7836.2006.02209.x; Angiolillo DJ, 2006, J AM COLL CARDIOL, V48, P298, DOI 10.1016/j.jacc.2006.03.038; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Biondi-Zoccai GGL, 2003, J AM COLL CARDIOL, V41, P1071, DOI 10.1016/S0735-1097(03)00088-3; Cao YY, 2011, APOPTOSIS, V16, P902, DOI 10.1007/s10495-011-0614-0; Cattaneo M, 2007, J THROMB HAEMOST, V5, P577, DOI 10.1111/j.1538-7836.2007.02356.x; Colwell JA, 2003, DIABETES CARE, V26, P2181, DOI 10.2337/diacare.26.7.2181; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; FALCON C, 1988, BIOCHEM BIOPH RES CO, V157, P1190, DOI 10.1016/S0006-291X(88)81000-3; Ferreira IA, 2006, ARTERIOSCL THROM VAS, V26, P417, DOI 10.1161/01.ATV.0000199519.37089.a0; Ferreira IA, 2005, J BIOL CHEM, V280, P32625, DOI 10.1074/jbc.M507221200; Ferreira IA, 2004, J BIOL CHEM, V279, P3254, DOI 10.1074/jbc.M305474200; Ferroni P, 2004, J THROMB HAEMOST, V2, P1282, DOI 10.1111/j.1538-7836.2004.00836.x; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; HAJEK AS, 1979, J CLIN INVEST, V63, P1060, DOI 10.1172/JCI109375; HARTMANN K, 1989, J RECEPTOR RES, V9, P181, DOI 10.3109/10799898909066053; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; HUZOOR A, 1993, P NATL ACAD SCI USA, V90, P868; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Li Y, 2001, AM J PHYSIOL-HEART C, V280, pH1480, DOI 10.1152/ajpheart.2001.280.4.H1480; Li YS, 2005, BIOCHEM BIOPH RES CO, V336, P430, DOI 10.1016/j.bbrc.2005.08.103; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; LOPEZAPARICIO P, 1992, BIOCHEM BIOPH RES CO, V186, P517, DOI 10.1016/S0006-291X(05)80838-1; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Orchard TJ, 1998, INT J EPIDEMIOL, V27, P976, DOI 10.1093/ije/27.6.976; Quinton TM, 2004, J THROMB HAEMOST, V2, P978, DOI 10.1111/j.1538-7836.2004.00741.x; Ren YL, 2006, J MED CHEM, V49, P2829, DOI 10.1021/jm060087k; Schlein M, 2001, BIOCHEMISTRY-US, V40, P13520, DOI 10.1021/bi015672w; TROVATI M, 1994, DIABETES, V43, P1015, DOI 10.2337/diabetes.43.8.1015; TROVATI M, 1988, DIABETES, V37, P780, DOI 10.2337/diabetes.37.6.780; Trovati M, 1998, DIABETOLOGIA, V41, P609, DOI 10.1007/s001250050958; Turk Z, 1996, HORM METAB RES, V28, P95, DOI 10.1055/s-2007-979136; Vericel E, 2004, DIABETES, V53, P1046, DOI 10.2337/diabetes.53.4.1046; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Westerbacka J, 2002, ARTERIOSCL THROM VAS, V22, P167, DOI 10.1161/hq0102.101546; WINOCOUR PD, 1992, DIABETES, V41, P26, DOI 10.2337/diab.41.2.S26; WINOCOUR PD, 1992, EUR J CLIN INVEST, V22, P19, DOI 10.1111/j.1365-2362.1992.tb01930.x; Yngen M, 2004, DIABETOLOGIA, V47, P537, DOI 10.1007/s00125-004-1352-4; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	46	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26238	10.1371/journal.pone.0026238	http://dx.doi.org/10.1371/journal.pone.0026238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073153	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900016
J	Beggs, KT; Tyndall, JDA; Mercer, AR				Beggs, Kyle T.; Tyndall, Joel D. A.; Mercer, Alison R.			Honey Bee Dopamine and Octopamine Receptors Linked to Intracellular Calcium Signaling Have a Close Phylogenetic and Pharmacological Relationship	PLOS ONE			English	Article							DROSOPHILA MUSHROOM BODIES; MESSENGER-RNA LOCALIZATION; PROTEIN COUPLED RECEPTORS; APIS-MELLIFERA BRAIN; FUNCTIONAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; NEUROHORMONE GPCRS; TYRAMINE RECEPTOR; MELANOGASTER	Background: Three dopamine receptor genes have been identified that are highly conserved among arthropod species. One of these genes, referred to in honey bees as Amdop2, shows a close phylogenetic relationship to the a-adrenergic-like octopamine receptor family. In this study we examined in parallel the functional and pharmacological properties of AmDOP2 and the honey bee octopamine receptor, AmOA1. For comparison, pharmacological properties of the honey bee dopamine receptors AmDOP1 and AmDOP3, and the tyramine receptor AmTYR1, were also examined. Methodology/Principal Findings: Using HEK293 cells heterologously expressing honey bee biogenic amine receptors, we found that activation of AmDOP2 receptors, like AmOA1 receptors, initiates a rapid increase in intracellular calcium levels. We found no evidence of calcium signaling via AmDOP1, AmDOP3 or AmTYR1 receptors. AmDOP2- and AmOA1-mediated increases in intracellular calcium were inhibited by 10 mu M edelfosine indicating a requirement for phospholipase C-beta activity in this signaling pathway. Edelfosine treatment had no effect on AmDOP2-or AmOA1-mediated increases in intracellular cAMP. The synthetic compounds mianserin and epinastine, like cis-(Z)-flupentixol and spiperone, were found to have significant antagonist activity on AmDOP2 receptors. All 4 compounds were effective antagonists also on AmOA1 receptors. Analysis of putative ligand binding sites offers a possible explanation for why epinastine acts as an antagonist at AmDOP2 receptors, but fails to block responses mediated via AmDOP1. Conclusions/Significance: Our results indicate that AmDOP2, like AmOA1, is coupled not only to cAMP, but also to calcium-signalling and moreover, that the two signalling pathways are independent upstream of phospholipase C-beta activity. The striking similarity between the pharmacological properties of these 2 receptors suggests an underlying conservation of structural properties related to receptor function. Taken together, these results strongly support phylogenetic analyses indicating that the AmDOP2 and AmOA1 receptor genes are immediate paralogs.	[Beggs, Kyle T.; Mercer, Alison R.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Tyndall, Joel D. A.] Univ Otago, Sch Pharm, Dunedin, New Zealand	University of Otago; University of Otago	Beggs, KT (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	alison.mercer@stonebow.otago.ac.nz	tyndall, joel/C-2803-2008	tyndall, joel/0000-0003-0783-1635; Mercer, Alison/0000-0001-8110-4247	Royal Society of New Zealand [UOO0615]	Royal Society of New Zealand(Royal Society of New Zealand)	This research was supported by a grant from the Royal Society of New Zealand Marsden Fund (UOO0615, http://marsden.rsnz.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldauf SL, 2003, TRENDS GENET, V19, P345, DOI 10.1016/S0168-9525(03)00112-4; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Barbas D, 2006, J NEUROCHEM, V96, P414, DOI 10.1111/j.1471-4159.2005.03561.x; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Clark MC, 2006, COMP BIOCHEM PHYS B, V143, P294, DOI 10.1016/j.cbpb.2005.11.017; Clark MC, 2007, COMP BIOCHEM PHYS B, V146, P9, DOI 10.1016/j.cbpb.2006.08.018; Degen J, 2000, BRIT J PHARMACOL, V130, P587, DOI 10.1038/sj.bjp.0703338; Enan EE, 2005, INSECT BIOCHEM MOLEC, V35, P309, DOI 10.1016/j.ibmb.2004.12.007; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Feng GP, 1996, J NEUROSCI, V16, P3925; FISER A, METHODS ENZYMOLOGY D, V374; GANTZ I, 1992, J BIOL CHEM, V267, P20840; Gerber S, 2006, INSECT BIOCHEM MOLEC, V36, P749, DOI 10.1016/j.ibmb.2006.07.003; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293, DOI 10.1124/mol.51.2.293; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mustard JA, 2005, ARCH INSECT BIOCHEM, V59, P103, DOI 10.1002/arch.20065; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; Ohta H, 2009, INSECT BIOCHEM MOLEC, V39, P342, DOI 10.1016/j.ibmb.2009.01.011; Ohtani A, 2006, INSECT MOL BIOL, V15, P763, DOI 10.1111/j.1365-2583.2006.00676.x; Ono H, 2004, INSECT BIOCHEM MOLEC, V34, P1247, DOI 10.1016/j.ibmb.2004.08.009; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; POWIS G, 1992, CANCER RES, V52, P2835; Reale V, 1997, J NEUROSCI, V17, P6545; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; VERNIER P, 1995, TRENDS PHARMACOL SCI, V16, P375, DOI 10.1016/S0165-6147(00)89078-1	44	66	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26809	10.1371/journal.pone.0026809	http://dx.doi.org/10.1371/journal.pone.0026809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096499	gold, Green Submitted, Green Published			2022-12-27	WOS:000297553900009
J	Leung, JWC; Wong, WT; Koon, HW; Mo, FM; Tam, S; Huang, Y; Vanhoutte, PM; Chung, SSM; Chung, SK				Leung, Justin Wai-Chung; Wong, Wing Tak; Koon, Hon Wai; Mo, Fong Ming; Tam, Sidney; Huang, Yu; Vanhoutte, Paul M.; Chung, Stephen Sum Man; Chung, Sookja Kim			Transgenic Mice Over-Expressing ET-1 in the Endothelial Cells Develop Systemic Hypertension with Altered Vascular Reactivity	PLOS ONE			English	Article							SMALL ARTERY STRUCTURE; BLOOD-PRESSURE; NITRIC-OXIDE; OVEREXPRESSING ENDOTHELIN-1; POTENTIAL ROLE; KNOCKOUT MICE; RATS; RECEPTOR; ANTAGONIST; GENE	Endothelin-1 (ET-1) is a potent vasoconstrictor involved in the regulation of vascular tone and implicated in hypertension. However, the role of small blood vessels endothelial ET-1 in hypertension remains unclear. The present study investigated the effect of chronic over-expression of endothelial ET-1 on arterial blood pressure and vascular reactivity using transgenic mice approach. Transgenic mice (TET-1) with endothelial ET-1 over-expression showed increased in ET-1 level in the endothelial cells of small pulmonary blood vessels. Although TET-1 mice appeared normal, they developed mild hypertension which was normalized by the ETA receptor (BQ123) but not by ETB receptor (BQ788) antagonist. Tail-cuff measurements showed a significant elevation of systolic and mean blood pressure in conscious TET-1 mice. The mice also exhibited left ventricular hypertrophy and left axis deviation in electrocardiogram, suggesting an increased peripheral resistance. The ionic concentrations in the urine and serum were normal in 8-week old TET-1 mice, indicating that the systemic hypertension was independent of renal function, although, higher serum urea levels suggested the occurrence of kidney dysfunction. The vascular reactivity of the aorta and the mesenteric artery was altered in the TET-1 mice indicating that chronic endothelial ET-1 up-regulation leads to vascular tone imbalance in both conduit and resistance arteries. These findings provide evidence for the role of spatial expression of ET-1 in the endothelium contributing to mild hypertension was mediated by ETA receptors. The results also suggest that chronic endothelial ET-1 over-expression affects both cardiac and vascular functions, which, at least in part, causes blood pressure elevation.	[Leung, Justin Wai-Chung; Koon, Hon Wai; Mo, Fong Ming; Chung, Sookja Kim] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wong, Wing Tak; Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Wong, Wing Tak; Huang, Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Tam, Sidney] Univ Hong Kong, Dept Clin Biochem, Hong Kong, Hong Kong, Peoples R China; [Vanhoutte, Paul M.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Chung, Stephen Sum Man] United Int Coll, Div Sci & Technol, Zhuhai, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; Beijing Normal University - Hong Kong Baptist University United International College; University of Hong Kong	Leung, JWC (corresponding author), Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	skchung@hkucc.hku.hk	Wong, Wing Tak Jack/Q-4512-2018; Huang, Yu/K-2866-2017	Wong, Wing Tak Jack/0000-0002-4514-3780; Huang, Yu/0000-0002-1277-6784; Leung, Justin Wai Chung/0000-0003-4601-390X	Hong Kong Research Grant Council [HKU 7220/02M]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084256] Funding Source: NIH RePORTER	Hong Kong Research Grant Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present work was supported by a research grant from the Hong Kong Research Grant Council (HKU 7220/02M) to SKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Amiri F, 2008, J HYPERTENS, V26, P1102, DOI 10.1097/HJH.0b013e3282fc2184; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Chan TSK, 1995, EUR J BIOCHEM, V234, P819, DOI 10.1111/j.1432-1033.1995.819_a.x; DAY R, 1995, AM J HYPERTENS, V8, P294, DOI 10.1016/0895-7061(95)96213-4; dUscio LV, 1997, HYPERTENSION, V30, P905, DOI 10.1161/01.HYP.30.4.905; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Gustafsson E, 2001, J CELL SCI, V114, P671; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Ho MCY, 2001, FASEB J, V15, P618, DOI 10.1096/fj.99-1022com; Hocher B, 2000, AM J RESP CELL MOL, V23, P19, DOI 10.1165/ajrcmb.23.1.4030; Hocher B, 1997, J CLIN INVEST, V99, P1380, DOI 10.1172/JCI119297; Iglarz M, 1998, EUR J PHARMACOL, V359, P69, DOI 10.1016/S0014-2999(98)00616-5; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LARIVIERE R, 1993, HYPERTENSION, V21, P916, DOI 10.1161/01.HYP.21.6.916; Leung JWC, 2004, J CARDIOVASC PHARM, V44, pS293, DOI 10.1097/01.fjc.0000166277.70538.b0; Li JS, 1998, AM J HYPERTENS, V11, P554, DOI 10.1016/S0895-7061(97)00405-6; LIU JJ, 1994, CLIN EXP PHARMACOL P, V21, P49, DOI 10.1111/j.1440-1681.1994.tb02435.x; LUSCHER TF, 1993, HYPERTENSION, V21, P752, DOI 10.1161/01.HYP.21.6.752; MANSOOR AM, 1995, BIOCHEM BIOPH RES CO, V215, P981, DOI 10.1006/bbrc.1995.2560; MCMAHON EG, 1991, J CARDIOVASC PHARM, V17, pS29, DOI 10.1097/00005344-199100177-00009; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; SCHIFFRIN EL, 1995, BRIT J PHARMACOL, V115, P1377, DOI 10.1111/j.1476-5381.1995.tb16626.x; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P769, DOI 10.1161/01.HYP.25.4.769; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P1135, DOI 10.1161/01.HYP.25.6.1135; Schmetterer L, 1998, BRIT J PHARMACOL, V124, P930, DOI 10.1038/sj.bjp.0701923; Sharifi AM, 1998, J CARDIOVASC PHARM, V31, pS309, DOI 10.1097/00005344-199800001-00086; Shindo T, 2002, J MOL MED, V80, P105, DOI 10.1007/s00109-001-0284-4; Tharaux PL, 1999, CIRCULATION, V99, P2185, DOI 10.1161/01.CIR.99.16.2185; Verdecchia P, 1999, CIRCULATION, V100, P1802, DOI 10.1161/01.CIR.100.17.1802; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; ZACHARIAH PK, 1988, J CLIN PHARMACOL, V28, P843, DOI 10.1002/j.1552-4604.1988.tb03226.x	37	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26994	10.1371/journal.pone.0026994	http://dx.doi.org/10.1371/journal.pone.0026994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096514	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900017
J	Milkereit, R; Rotin, D				Milkereit, Ruth; Rotin, Daniela			A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins	PLOS ONE			English	Article							AMINO-ACID PERMEASE; HEPATOCELLULAR-CARCINOMA; MULTIDRUG-RESISTANCE; TETRATRANSMEMBRANE PROTEIN; INTRACELLULAR TRAFFICKING; SACCHAROMYCES-CEREVISIAE; LYSOSOMES; EXPRESSION; GENE; CANCER	Background: The Lysosome associated protein transmembrane (LAPTM) family is comprised of three members: LAPTM5, LAPTM4a and LAPTM4b, with the latter previously shown to be overexpressed in numerous cancers. While we had demonstrated earlier the requirement of the E3 ubiquitin ligase Nedd4 for LAPTM5 sorting to lysosomes, the regulation of sorting of LAPTM4 proteins is less clear. Methodology/Principal Findings: Here we show that LAPTM4a and LAPTM4b are localized to the lysosome, but unique to LAPTM4b, a fraction of it is present at the plasma membrane and its overexpression induces the formation of actin-based membrane protrusions. We demonstrate that LAPTM4s, like LAPTM5, are able to co-immunoprecipitate with the E3 ubiquitin ligase Nedd4, an interaction that is dependent on LAPTM4 PY motifs and plays a role in membrane sorting. Accordingly, in Nedd4 knockout mouse embryonic fibroblasts (MEFs), LAPTM4a and LAPTM4b show reduced lysosomal localization. Moreover, lack of PY motifs leads to enhanced missorting of LAPTM4b to the plasma membrane instead of the lysosome. Conclusions/Significance: These results suggest that while some requisites of LAPTM5 lysosomal sorting are conserved among LAPTM4 proteins, LAPTM4a and LAPTM4b have also developed distinct sorting requirements.	[Milkereit, Ruth; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Cell Biol Program, Dept Biochem, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Milkereit, R (corresponding author), Univ Toronto, Hosp Sick Children, Cell Biol Program, Dept Biochem, Toronto, ON M5G 1X8, Canada.	drotin@sickkids.ca			Canadian Institute of Health Research (CIHR) [MOP-13494]; Ontario Graduate Scholarship	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the Canadian Institute of Health Research (CIHR, MOP-13494, http://www.cihr-irsc.gc.ca/e/193.html, to DR). RM is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship and Ontario Graduate Scholarship. DR holds a Canada Research Chair (Tier I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Boman AL, 2001, J CELL SCI, V114, P3413; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cabrita MA, 1999, CANCER RES, V59, P4890; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Hayami Y, 2003, LEUKEMIA, V17, P1650, DOI 10.1038/sj.leu.2403026; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hogue DL, 1996, J BIOL CHEM, V271, P9801, DOI 10.1074/jbc.271.16.9801; Hogue DL, 2002, BIOCHEM J, V365, P721, DOI 10.1042/BJ20020205; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu JJ, 2000, CHINESE MED J-PEKING, V113, P881; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Meng FL, 2010, INT J GYNECOL PATHOL, V29, P587, DOI 10.1097/PGP.0b013e3181e0898e; Morris DG, 2005, EUR J ENDOCRINOL, V153, P143, DOI 10.1530/eje.1.01937; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Passey S, 2004, BIOCHEM SOC T, V32, P1115, DOI 10.1042/BST0321115; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Porcelli L, 2009, CURR TOP MED CHEM, V9, P197, DOI 10.2174/156802609787521562; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Steenhuis P, 2010, TRAFFIC, V11, P987, DOI 10.1111/j.1600-0854.2010.01073.x; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; YANG H, 2010, CANC LETT; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; YIN M, 2010, INT J CANC; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	50	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27478	10.1371/journal.pone.0027478	http://dx.doi.org/10.1371/journal.pone.0027478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096579	gold, Green Published, Green Submitted			2022-12-27	WOS:000297553900049
J	Wunderli, W; Meerbach, A; Guengoer, T; Berger, C; Greiner, O; Caduff, R; Trkola, A; Bossart, W; Gerlach, D; Schibler, M; Cordey, S; Mckee, TA; Van Belle, S; Kaiser, L; Tapparel, C				Wunderli, Werner; Meerbach, Astrid; Guengoer, Tayfun; Berger, Christoph; Greiner, Oliver; Caduff, Rosmarie; Trkola, Alexandra; Bossart, Walter; Gerlach, Daniel; Schibler, Manuel; Cordey, Samuel; McKee, Thomas Alexander; Van Belle, Sandra; Kaiser, Laurent; Tapparel, Caroline			Astrovirus Infection in Hospitalized Infants with Severe Combined Immunodeficiency after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; RT-PCR; RECIPIENTS; NOROVIRUS; DNA; GASTROENTERITIS; RHINOVIRUSES; SEQUENCE; DIARRHEA; DISEASE	Infants with severe primary combined immunodeficiency (SCID) and children post-allogeneic hematopoietic stem cell transplantation (HSCT) are extremely susceptible to unusual infections. The lack of generic tools to detect disease-causing viruses among more than 200 potential human viral pathogens represents a major challenge to clinicians and virologists. We investigated retrospectively the causes of a fatal disseminated viral infection with meningoencephalitis in an infant with gamma C-SCID and of chronic gastroenteritis in 2 other infants admitted for HSCT during the same time period. Analysis was undertaken by combining cell culture, electron microscopy and sequence-independent single primer amplification (SISPA) techniques. Caco-2 cells inoculated with fecal samples developed a cytopathic effect and non-enveloped viral particles in infected cells were detected by electron microscopy. SISPA led to the identification of astrovirus as the pathogen. Both sequencing of the capsid gene and the pattern of infection suggested nosocomial transmission from a chronically excreting index case to 2 other patients leading to fatal infection in 1 and to transient disease in the others. Virus-specific, real-time reverse transcription polymerase chain reaction was then performed on different stored samples to assess the extent of infection. Infection was associated with viremia in 2 cases and contributed to death in 1. At autopsy, viral RNA was detected in the brain and different other organs, while immunochemistry confirmed infection of gastrointestinal tissues. This report illustrates the usefulness of the combined use of classical virology procedures and modern molecular tools for the diagnosis of unexpected infections. It illustrates that astrovirus has the potential to cause severe disseminated lethal infection in highly immunocompromised pediatric patients.	[Wunderli, Werner; Meerbach, Astrid; Trkola, Alexandra; Bossart, Walter] Univ Zurich, Div Clin Virol, Zurich, Switzerland; [Wunderli, Werner; Schibler, Manuel; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent; Tapparel, Caroline] Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Wunderli, Werner; Schibler, Manuel; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent; Tapparel, Caroline] Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Guengoer, Tayfun; Berger, Christoph; Greiner, Oliver] Univ Childrens Hosp, Div Immunol & Bone Marrow Transplantat, Zurich, Switzerland; [Caduff, Rosmarie] Univ Zurich Hosp, Div Pathol, CH-8091 Zurich, Switzerland; [Gerlach, Daniel] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Gerlach, Daniel] Univ Geneva, Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Cordey, Samuel] Univ Hosp Geneva, Swiss Natl Reference Ctr Emerging Viruses CRIVE, Geneva, Switzerland; [McKee, Thomas Alexander] Univ Hosp Geneva, Div Pathol, Geneva, Switzerland	University of Zurich; University of Geneva; University of Geneva; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Geneva	Wunderli, W (corresponding author), Univ Zurich, Div Clin Virol, Zurich, Switzerland.	wunderli.werner@virology.uzh.ch; caroline.tapparel@hcuge.ch	Cordey, Samuel/C-9240-2018; Trkola, Alexandra/K-2115-2012; Güngör, Tayfun/ABF-4256-2020	Cordey, Samuel/0000-0002-2684-5680; Trkola, Alexandra/0000-0003-1013-876X; Güngör, Tayfun/0000-0002-3261-1186; McKee, Thomas/0000-0002-2147-3136; Tapparel Vu, Caroline/0000-0002-0411-6567; Gerlach, Daniel/0000-0001-9338-3765; Kaiser, Laurent/0000-0002-0857-2252	SNF [FNS 310030-127159]; Laurent Kaiser [32003B_127160]	SNF; Laurent Kaiser	The study was supported by SNF funding awarded to Caroline Tapparel (FNS 310030-127159) and Laurent Kaiser (32003B_127160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Bagci S, 2008, PEDIATR INFECT DIS J, V27, P347, DOI 10.1097/INF.0b013e318162a17a; Berger C, 2001, J MED VIROL, V64, P505, DOI 10.1002/jmv.1078; Cubitt WD, 1999, J MED VIROL, V57, P313, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;313::AID-JMV16&gt;3.0.CO;2-A; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; de Mezerville MH, 2006, PEDIATR INFECT DIS J, V25, P815, DOI 10.1097/01.inf.0000233542.48267.fd; de Vries M, 2008, J CLIN MICROBIOL, V46, P759, DOI 10.1128/JCM.02009-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Glass RI, 1996, ARCH VIROL, P287; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Hohne M, 2004, J MED VIROL, V72, P312, DOI 10.1002/jmv.10573; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; Kronenberg A, 2002, CLIN INFECT DIS, V35, P330, DOI 10.1086/341492; Liakopoulou E, 2005, BONE MARROW TRANSPL, V36, P691, DOI 10.1038/sj.bmt.1705127; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; Pevenstein SR, 1999, J VIROL, V73, P10514, DOI 10.1128/JVI.73.12.10514-10518.1999; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Schorn R, 2010, CLIN INFECT DIS, V51, P307, DOI 10.1086/653939; Sebire NJ, 2004, J CLIN PATHOL, V57, P1001, DOI 10.1136/jcp.2004.017178; Soccal PM, 2010, CLIN INFECT DIS, V51, P163, DOI 10.1086/653529; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Walter JE, 2003, CURR OPIN INFECT DIS, V16, P247, DOI 10.1097/00001432-200306000-00011; Yun ZB, 2000, TRANSPLANTATION, V69, P1733	31	81	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27483	10.1371/journal.pone.0027483	http://dx.doi.org/10.1371/journal.pone.0027483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096580	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000297553900050
J	Hogel, H; Rantanen, K; Jokilehto, T; Grenman, R; Jaakkola, PM				Hogel, Heidi; Rantanen, Krista; Jokilehto, Terhi; Grenman, Reidar; Jaakkola, Panu M.			Prolyl Hydroxylase PHD3 Enhances the Hypoxic Survival and G1 to S Transition of Carcinoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR; CYCLE PROGRESSION; TUMOR-GROWTH; HIF-ALPHA; RETINOBLASTOMA PROTEIN; NEURONAL APOPTOSIS; EXPRESSION; CANCER; OXYGEN; ARREST	Hypoxia restricts cell proliferation and cell cycle progression at the G1/S interface but at least a subpopulation of carcinoma cells can escape the restriction. In carcinoma hypoxia may in fact select for cells with enhanced hypoxic survival and increased aggressiveness. The cellular oxygen sensors HIF proline hydroxylases (PHDs) adapt the cellular functions to lowered environmental oxygen tension. PHD3 isoform has shown the strongest hypoxic upregulation among the family members. We detected a strong PHD3 mRNA expression in tumors of head and neck squamous cell carcinoma (HNSCC). The PHD3 expression associated with expression of hypoxic marker gene. Using siRNA in cell lines derived from HNSCC we show that specific inhibition of PHD3 expression in carcinoma cells caused reduced cell survival in hypoxia. The loss of PHD3, but not that of PHD2, led to marked cell number reduction. Although caspase-3 was activated at early hypoxia no induction of apoptosis was detected. However, hypoxic PHD3 inhibition caused a block in cell cycle progression. Cell population in G1 phase was increased and the population in S phase reduced demonstrating a block in G1 to S transition under PHD3 inhibition. In line with this, the level of hyperphosphorylated retinoblastoma protein Rb was reduced by PHD3 knock-down in hypoxia. PHD3 loss led to increase in cyclin-dependent kinase inhibitor p27 expression but not that of p21 or p16. The data demonstrated that increased PHD3 expression under hypoxia enhances cell cycle progression and survival of carcinoma cells.	[Hogel, Heidi; Rantanen, Krista; Jokilehto, Terhi; Jaakkola, Panu M.] Turku Univ, Turku Ctr Biotechnol, Turku, Finland; [Hogel, Heidi; Rantanen, Krista; Jokilehto, Terhi; Jaakkola, Panu M.] Abo Akad Univ, Turku, Finland; [Grenman, Reidar] Turku Univ, Dept Med Biochem, Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Jaakkola, Panu M.] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Hogel, H (corresponding author), Turku Univ, Turku Ctr Biotechnol, Turku, Finland.	panjaa@utu.fi	Högel, Heidi/A-1814-2019; Jaakkola, Panu M/B-4355-2012	Högel, Heidi/0000-0001-6592-5723; Jaakkola, Panu/0000-0002-2365-4985	Academy of Finland [200462]; Emil Aaltonen Foundation; Turku University Hospital [EVO13031]; Turku University Foundation	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Turku University Hospital; Turku University Foundation	This study was supported by The Academy of Finland (grant 200462), Emil Aaltonen Foundation, Turku University Hospital (EVO13031) and The Turku University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMELLEM O, 1991, CELL PROLIFERAT, V24, P127, DOI 10.1111/j.1365-2184.1991.tb01144.x; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Baba M, 2003, ONCOGENE, V22, P2728, DOI 10.1038/sj.onc.1206373; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; GRENMAN R, 1992, ARCH OTOLARYNGOL, V118, P542; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heikkinen PT, 2010, CANCER RES, V70, P5984, DOI 10.1158/0008-5472.CAN-09-3777; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Jokilehto T, 2010, EXP CELL RES, V316, P1169, DOI 10.1016/j.yexcr.2010.02.012; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; LUDLOW JW, 1993, ONCOGENE, V8, P331; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Oncomine, ONC; PETTERSEN EO, 1983, BRIT J CANCER, V48, P809, DOI 10.1038/bjc.1983.271; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rantanen K, 2008, MOL BIOL CELL, V19, P2231, DOI 10.1091/mbc.E07-11-1124; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Schlisio S, 2009, J CELL MOL MED, V13, P4104, DOI 10.1111/j.1582-4934.2009.00881.x; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SPIRO IJ, 1984, INT J RADIAT ONCOL, V10, P1275, DOI 10.1016/0360-3016(84)90332-8; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029; Zygmunt A, 2002, EXP CELL RES, V278, P53, DOI 10.1006/excr.2002.5564	53	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27112	10.1371/journal.pone.0027112	http://dx.doi.org/10.1371/journal.pone.0027112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087251	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700016
J	Liao, LM; Brennan, P; van Bemmel, DM; Zaridze, D; Matveev, V; Janout, V; Kollarova, H; Bencko, V; Navratilova, M; Szeszenia-Dabrowska, N; Mates, D; Rothman, N; Boffetta, P; Chow, WH; Moore, LE				Liao, Linda M.; Brennan, Paul; van Bemmel, Dana M.; Zaridze, David; Matveev, Vsevolod; Janout, Vladimir; Kollarova, Hellena; Bencko, Vladimir; Navratilova, Marie; Szeszenia-Dabrowska, Neonila; Mates, Dana; Rothman, Nathaniel; Boffetta, Paolo; Chow, Wong-Ho; Moore, Lee E.			LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer	PLOS ONE			English	Article							KIDNEY CANCER; COLORECTAL ADENOMA; VEGETABLE INTAKE; BLADDER-CANCER; CENTRAL-EUROPE; LIFE-STYLE; SERUM DNA; HYPOMETHYLATION; GENES; HYPERMETHYLATION	Purpose: Leukocyte global DNA methylation levels are currently being considered as biomarkers of cancer susceptibility and have been associated with risk of several cancers. In this study, we aimed to examine the association between long interspersed nuclear elements (LINE-1) methylation levels, as a biomarker of global DNA methylation in blood cell DNA, and renal cell cancer risk. Experimental Design: LINE-1 methylation of bisulfite-converted genomic DNA isolated from leukocytes was quantified by pyrosequencing measured in triplicate, and averaged across 4 CpG sites. A total of 328 RCC cases and 654 controls frequency-matched(2:1) on age(+/- 5years), sex and study center, from a large case-control study conducted in Central and Eastern Europe were evaluated. Results: LINE-1 methylation levels were significantly higher in RCC cases with a median of 81.97% (interquartile range[IQR]: 80.84-83.47) compared to 81.67% (IQR: 80.35-83.03) among controls (p = 0.003, Wilcoxon). Compared to the lowest LINE-1 methylation quartile(Q1), the adjusted ORs for increasing methylation quartiles were as follows: OR(Q2) = 1.84(1.20-2.81), OR(Q3) = 1.72(1.11-2.65) and OR(Q4) = 2.06(1.34-3.17), with a p-trend = 0.004. The association was stronger among current smokers (p-trend<0.001) than former or never smokers (p-interaction = 0.03). To eliminate the possibility of selection bias among controls, the relationship between LINE-1 methylation and smoking was evaluated and confirmed in a case-only analysis, as well. Conclusions: Higher levels of LINE-1 methylation appear to be positively associated with RCC risk, particularly among current smokers. Further investigations using both post-and pre-diagnostic genomic DNA is warranted to confirm findings and will be necessary to determine whether the observed differences occur prior to, or as a result of carcinogenesis.	[Liao, Linda M.; van Bemmel, Dana M.; Rothman, Nathaniel; Chow, Wong-Ho; Moore, Lee E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Zaridze, David; Matveev, Vsevolod] Inst Carcinogenesis, Moscow, Russia; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Janout, Vladimir; Kollarova, Hellena] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Bencko, Vladimir] Charles Univ Prague, Prague, Czech Republic; [Navratilova, Marie] Masaryk Mem Canc Inst, Brno, Czech Republic; [Szeszenia-Dabrowska, Neonila] Inst Occupat Med, Lodz, Poland; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); Palacky University Olomouc; Charles University Prague; Masaryk Memorial Cancer Institute; Nofer Institute of Occupational Medicine; Icahn School of Medicine at Mount Sinai	Liao, LM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	liaolm@mail.nih.gov	Szeszenia-Dabrowska, Neonila/F-7190-2010; Zaridze, David/K-5605-2013; Janout, Vladimir/M-5133-2014; Liao, Linda M/B-3960-2011; Bencko, Vladimir/H-8598-2017; Boffetta, Paolo/AAI-7767-2021; Matveev, Vsevolod B/O-7476-2017	Liao, Linda M/0000-0002-1923-5294; Bencko, Vladimir/0000-0003-1935-2228; Boffetta, Paolo/0000-0002-3811-2791; Matveev, Vsevolod B/0000-0001-7748-9527; Kollarova, Helena/0000-0001-6951-6716; mates, dana/0000-0002-6219-9807	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (Bethesda, MD, USA); NATIONAL CANCER INSTITUTE [ZIACP010120] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (Bethesda, MD, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2009, CARCINOGENESIS, V30, P214, DOI 10.1093/carcin/bgn268; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Brennan P, 2008, BRIT J CANCER, V99, P1912, DOI 10.1038/sj.bjc.6604761; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; ENGLAND R, 2005, NATURE METHODS, V2, P1; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Hoque MO, 2004, CANCER RES, V64, P5511, DOI 10.1158/0008-5472.CAN-04-0799; Hou L., 2010, INT J CANC; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Liu H, 2007, ONCOGENE, V26, P5900, DOI 10.1038/sj.onc.1210400; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Mathew A, 2002, EUR J CANCER PREV, V11, P171, DOI 10.1097/00008469-200204000-00010; Minardi D, 2009, J CELL MOL MED, V13, P2115, DOI 10.1111/j.1582-4934.2008.00482.x; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Moore LE, 2007, CARCINOGENESIS, V28, P1960, DOI 10.1093/carcin/bgm151; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Moore LE, 2008, INT J CANCER, V122, P1710, DOI 10.1002/ijc.23318; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; POAGE GM, 2011, CLIN CANC RES; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	47	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27361	10.1371/journal.pone.0027361	http://dx.doi.org/10.1371/journal.pone.0027361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076155	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200069
J	Hanf, M; Van-Melle, A; Fraisse, F; Roger, A; Carme, B; Nacher, M				Hanf, Matthieu; Van-Melle, Astrid; Fraisse, Florence; Roger, Amaury; Carme, Bernard; Nacher, Mathieu			Corruption Kills: Estimating the Global Impact of Corruption on Children Deaths	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; MORTALITY; DIARRHEA; UNDERNUTRITION	Background: Information on the global risk factors of children mortality is crucial to guide global efforts to improve survival. Corruption has been previously shown to significantly impact on child mortality. However no recent quantification of its current impact is available. Methods: The impact of corruption was assessed through crude Pearson's correlation, univariate and multivariate linear models coupling national under-five mortality rates in 2008 to the national "perceived level of corruption" (CPI) and a large set of adjustment variables measured during the same period. Findings: The final multivariable model (adjusted R-2 = 0.89) included the following significant variables: percentage of people with improved sanitation (p.value<0.001), logarithm of total health expenditure (p.value = 0.006), Corruption Perception Index (p.value<0.001), presence of an arid climate on the national territory (p = 0.006), and the dependency ratio (p.value<0.001). A decrease in CPI of one point (i.e. a more important perceived corruption) was associated with an increase in the log of national under-five mortality rate of 0.0644. According to this result, it could be roughly hypothesized that more than 140000 annual children deaths could be indirectly attributed to corruption. Interpretations: Global response to children mortality must involve a necessary increase in funds available to develop water and sanitation access and purchase new methods for prevention, management, and treatment of major diseases drawing the global pattern of children deaths. However without paying regard to the anti-corruption mechanisms needed to ensure their proper use, it will also provide further opportunity for corruption. Policies and interventions supported by governments and donors must integrate initiatives that recognise how they are inter-related.	[Hanf, Matthieu; Van-Melle, Astrid; Fraisse, Florence; Roger, Amaury; Carme, Bernard; Nacher, Mathieu] Cayenne Gen Hosp, Ctr Invest Clin Epidemiol Clin Antilles Guyane CI, Cayenne, French Guiana; [Hanf, Matthieu; Van-Melle, Astrid; Carme, Bernard; Nacher, Mathieu] Univ Antilles Guyane, Dept Parasitol & Mycol, Team EA 3593, Cayenne, French Guiana		Hanf, M (corresponding author), Cayenne Gen Hosp, Ctr Invest Clin Epidemiol Clin Antilles Guyane CI, Cayenne, French Guiana.	matthieu@hanf.fr	nacher, mathieu/AAH-4796-2021	nacher, mathieu/0000-0001-9397-3204; Hanf, Matthieu/0000-0001-7133-1323	Cayenne General Hospital (French Guiana); INSERM (Institut National de la Sante et de la Recherche Medicale)	Cayenne General Hospital (French Guiana); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Cayenne General Hospital (French Guiana) and INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABED, 2002, GOVERNANCE CORRUPTIO; Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; Anbarci N, 2007, ACTION CORRUPTION AC; [Anonymous], 2010, R LANG ENV STAT COMP; Azfar O, 2008, DOES CORRUPTION AFFE; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Calder PC, 2000, NUTR RES REV, V13, P3, DOI 10.1079/095442200108728981; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Cazelles B, 2006, PLOS MED, V3, P1212, DOI 10.1371/journal.pmed.0030328; Centre for Research on the Epidemiology of Disasters (CRED), 2011, EM EV DAT EM DAT; Falissard B, 1996, J CLASSIF, V13, P267, DOI 10.1007/BF01246102; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Food and Agricultural Organisation, 2011, FAO STAT DAT FAOSTAT; Freedom House, 2011, FREED WORLD 2008 SUR; Gapminder, 2011, GAPM DAT; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lloyd SJ, 2007, CLIM RES, V34, P119, DOI 10.3354/cr034119; Maestad O, 2011, HEALTH POLICY, V99, P107, DOI 10.1016/j.healthpol.2010.07.011; Mauro P, 1998, J PUBLIC ECON, V69, P263, DOI 10.1016/S0047-2727(98)00025-5; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; Transparency International, 2006, GLOB CORR REP 2006 C; TRANSPARENCY INTERNATIONAL, 2008, GLOB CORR REP 2008 C; United Nations, 2000, MILL DEV GOALS REP 2; United Nations Statistics Division, 2011, UN STAT DAT; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; World Bank, 2011, TAL TRANSM PROJ; World Bank, 2000, HELP COUNTR COMB COR; World Health Organization, 2009, STAT WORLDS VACC IMM	35	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26990	10.1371/journal.pone.0026990	http://dx.doi.org/10.1371/journal.pone.0026990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073233	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900058
J	Hummelen, R; Macklaim, JM; Bisanz, JE; Hammond, JA; McMillan, A; Vongsa, R; Koenig, D; Gloor, GB; Reid, G				Hummelen, Ruben; Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Vongsa, Rebecca; Koenig, David; Gloor, Gregory B.; Reid, Gregor			Vaginal Microbiome and Epithelial Gene Array in Post-Menopausal Women with Moderate to Severe Dryness	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION; BACTERIAL VAGINOSIS; EXPRESSION; DIVERSITY; DATABASE; IMPACT; FLORA	After menopause, many women experience vaginal dryness and atrophy of tissue, often attributed to the loss of estrogen. An understudied aspect of vaginal health in women who experience dryness due to atrophy is the role of the resident microbes. It is known that the microbiota has an important role in healthy vaginal homeostasis, including maintaining the pH balance and excluding pathogens. The objectives of this study were twofold: first to identify the microbiome of postmenopausal women with and without vaginal dryness and symptoms of atrophy; and secondly to examine any differences in epithelial gene expression associated with atrophy. The vaginal microbiome of 32 post-menopausal women was profiled using Illumina sequencing of the V6 region of the 16S rRNA gene. Sixteen subjects were selected for follow-up sampling every two weeks for 10 weeks. In addition, 10 epithelial RNA samples (6 healthy and 4 experiencing vaginal dryness) were acquired for gene expression analysis by Affymetrix Human Gene array. The microbiota abundance profiles were relatively stable over 10 weeks compared to previously published data on premenopausal women. There was an inverse correlation between Lactobacillus ratio and dryness and an increased bacterial diversity in women experiencing moderate to severe vaginal dryness. In healthy participants, Lactobacillus iners and L. crispatus were generally the most abundant, countering the long-held view that lactobacilli are absent or depleted in menopause. Vaginal dryness and atrophy were associated with down-regulation of human genes involved in maintenance of epithelial structure and barrier function, while those associated with inflammation were up-regulated consistent with the adverse clinical presentation.	[Hummelen, Ruben; Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Gloor, Gregory B.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Hummelen, Ruben] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Gloor, Gregory B.; Reid, Gregor] Univ Western Ontario, London, ON, Canada; [Vongsa, Rebecca; Koenig, David] Kimberly Clark Inc, Corp Res & Engn Microbial Control, Neenah, WI USA	Western University (University of Western Ontario); Erasmus University Rotterdam; Erasmus MC; Western University (University of Western Ontario); Kimberly-Clark	Hummelen, R (corresponding author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.	gregor@uwo.ca	Hummelen, Ruben/ABG-5746-2021; Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020	Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380; Bisanz, Jordan/0000-0002-8649-1706	Kimberly Clark Corporation, USA	Kimberly Clark Corporation, USA	The study was funded by a grant-in-aid from Kimberly Clark Corporation, USA. Two Kimberly Clark scientists (BV, DK) provided input into the study design with GR, but had no role in data collection or decision to publish. They provided at the other authors' request some statistical analysis and input into the manuscript, but no content or data was altered as a result of their corporate positions. Rather, they were true scientific collaborators.	Agresti L, 2002, CATEGORICAL DATA ANA, P600; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Burton JP, 2002, J INFECT DIS, V186, P1770, DOI 10.1086/345761; Cheng XL, 2009, J BIOL CHEM, V284, P30897, DOI 10.1074/jbc.M109.011213; Cotreau MM, 2007, MATURITAS, V58, P366, DOI 10.1016/j.maturitas.2007.09.009; Lara LAD, 2009, J SEX MED, V6, P3097, DOI 10.1111/j.1743-6109.2009.01407.x; Dahn A, 2008, MICROBES INFECT, V10, P620, DOI 10.1016/j.micinf.2008.02.007; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Heinemann C, 2005, CAN J MICROBIOL, V51, P777, DOI [10.1139/w05-070, 10.1139/W05-070]; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Ibe C, 2010, J SEX MED, V7, P1042, DOI 10.1111/j.1743-6109.2009.01692.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Kim S, 2009, EXP DERMATOL, V18, P1016, DOI 10.1111/j.1600-0625.2009.00894.x; Kirjavainen P.K., 2008, INT J PROBIOTICS, V3, P99; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Mac Bride MB, 2010, MAYO CLIN PROC, V85, P87, DOI 10.4065/mcp.2009.0413; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; Puthenedam M, 2011, INFLAMM BOWEL DIS, V17, P260, DOI 10.1002/ibd.21443; R Core Team, 2021, R LANGUAGE ENV STAT; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102; Santoro N, 2009, J SEX MED, V6, P2133, DOI 10.1111/j.1743-6109.2009.01335.x; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Simon JA, 2009, MENOPAUSE, V16, P73, DOI 10.1097/gme.0b013e31817b614a; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Sturdee DW, 2010, CLIMACTERIC, V13, P509, DOI 10.3109/13697137.2010.522875; Ting AY, 2004, BIOL REPROD, V71, P1397, DOI 10.1095/biolreprod.104.030023; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411	39	114	125	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26602	10.1371/journal.pone.0026602	http://dx.doi.org/10.1371/journal.pone.0026602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073175	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900007
J	Jia, CY; Li, HH; Zhu, XC; Dong, YW; Fu, D; Zhao, QL; Wu, W; Wu, XZ				Jia, Cheng You; Li, Hui Hui; Zhu, Xu Chao; Dong, Yi Wei; Fu, Da; Zhao, Qian Lei; Wu, Wei; Wu, Xing Zhong			MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; PROTEIN-KINASE-C; MICRORNA-223; EXPRESSION; DIFFERENTIATION; METASTASIS; BIOGENESIS; MECHANISM; PATHWAY; CANCER	To study the roles of microRNA-223 (miR-223) in regulation of cell growth, we established a miR-223 over-expression model in HeLa cells infected with miR-223 by Lentivirus pLL3.7 system. We observed in this model that miR-223 significantly suppressed the proliferation, growth rate, colony formation of HeLa cells in vitro, and in vivo tumorigenicity or tumor formation in nude mice. To investigate the mechanisms involved, we scanned and examined the potential and putative target molecules of miR-223 by informatics, quantitative PCR and Western blot, and found that insulin-like growth factor-1 receptor (IGF-1R) was the functional target of miR-223 inhibition of cell proliferation. Targeting IGF-1R by miR-223 was not only seen in HeLa cells, but also in leukemia and hepatoma cells. The downstream pathway, Akt/mTOR/p70S6K, to which the signal was mediated by IGF-1R, was inhibited as well. The relative luciferase activity of the reporter containing wild-type 3'UTR(3'untranslated region) of IGF-1R was significantly suppressed, but the mutant not. Silence of IGF-1R expression by vector-based short hairpin RNA resulted in the similar inhibition with miR-223. Contrarily, rescued IGF-1R expression in the cells that over-expressed miR-223, reversed the inhibition caused by miR-223 via introducing IGF-1R cDNA that didn't contain the 39UTR. Meanwhile, we also noted that miR-223 targeted Rasa1, but the downstream molecules mediated by Rasa1 was neither targeted nor regulated. Therefore we believed that IGF-1R was the functional target for miR-223 suppression of cell proliferation and its downstream PI3K/Akt/mTOR/p70S6K pathway suppressed by miR-223 was by targeting IGF-1R.	[Jia, Cheng You; Li, Hui Hui; Zhu, Xu Chao; Dong, Yi Wei; Fu, Da; Zhao, Qian Lei; Wu, Wei; Wu, Xing Zhong] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200433, Peoples R China	Fudan University	Jia, CY (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200433, Peoples R China.	xz_wu@shmu.edu.cn	Jia, Chengyou/AAV-1153-2021; ravegnini, gloria/K-1330-2016; Fu, Da/F-1763-2013	ravegnini, gloria/0000-0002-7774-402X; Wu, Xing Zhong/0000-0003-3506-5544	National Natural Science Foundation of China [30570414, 30970641, 31170767]; State Key Laboratory of Medical Neurobiology; Fudan University; National Key Basic Research Program of China [2012CB822104]; Shanghai Leading Academic Discipline [B110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Medical Neurobiology; Fudan University; National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	This work was supported by grants from The National Natural Science Foundation of China (30570414, 30970641, 31170767), the Opening Project of State Key Laboratory of Medical Neurobiology, Fudan University, National Key Basic Research Program of China (2012CB822104), and the Shanghai Leading Academic Discipline Project (B110). The funders had no role in the study design, data analysis, collection and decision to publish.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; PARK S, HAEMATOLOGICA, V95, P819; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SCHERR M, METHODS MOL BIOL, V614, P175; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wu LH, 2010, BRAIN PATHOL, V20, P1042, DOI 10.1111/j.1750-3639.2010.00410.x; Wu XZ, 2006, CELL BIOL INT, V30, P672, DOI 10.1016/j.cellbi.2006.04.009; WU XZ, 1991, CHINESE MED J-PEKING, V104, P32; Wu XZ, 2004, INT J CANCER, V110, P504, DOI 10.1002/ijc.20127; WU XZ, 1989, LEUKEMIA RES, V13, P869, DOI 10.1016/0145-2126(89)90039-8; Wu XZ, 1996, CHINESE MED J-PEKING, V109, P295; XU Y, J BIOL CHEM, V285, P34439; Zheng J, 2009, CLIN CHIM ACTA, V405, P119, DOI 10.1016/j.cca.2009.04.017	30	117	124	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27008	10.1371/journal.pone.0027008	http://dx.doi.org/10.1371/journal.pone.0027008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073238	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900063
J	Riyahi, TY; Frese, F; Steinert, M; Omosigho, NN; Glockner, G; Eichinger, L; Orabi, B; Williams, RSB; Noegel, AA				Riyahi, Tanja Y.; Frese, Frederike; Steinert, Michael; Omosigho, Napoleon N.; Gloeckner, Gernot; Eichinger, Ludwig; Orabi, Benoit; Williams, Robin S. B.; Noegel, Angelika A.			RpkA, a Highly Conserved GPCR with a Lipid Kinase Domain, Has a Role in Phagocytosis and Anti-Bacterial Defense	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; PHOSPHOINOSITIDE METABOLISM; INTRACELLULAR GROWTH; PHAGOSOME MATURATION; LEGIONNAIRES-DISEASE; DRINKING-WATER; SOCIAL AMEBAS; VALPROIC ACID; HELA-CELLS	RpkA (Receptor phosphatidylinositol kinase A) is an unusual seven-helix transmembrane protein of Dictyostelium discoideum with a G protein coupled receptor (GPCR) signature and a C-terminal lipid kinase domain (GPCR-PIPK) predicted as a phosphatidylinositol-4-phosphate 5-kinase. RpkA-homologs are present in all so far sequenced Dictyostelidae as well as in several other lower eukaryotes like the oomycete Phytophthora, and in the Legionella host Acanthamoeba castellani. Here we show by immunofluorescence that RpkA localizes to endosomal membranes and is specifically recruited to phagosomes. RpkA interacts with the phagosomal protein complex V-ATPase as proteins of this complex co-precipitate with RpkA-GFP as well as with the GST-tagged PIPK domain of RpkA. Loss of RpkA leads to a defect in phagocytosis as measured by yeast particle uptake. The uptake of the pathogenic bacterium Legionella pneumophila was however unaltered whereas its intracellular replication was significantly enhanced in rpkA(-). The difference between wild type and rpkA(-) was even more prominent when L. hackeliae was used. When we investigated the reason for the enhanced susceptibility for L. pneumophila of rpkA(-) we could not detect a difference in endosomal pH but rpkA(-) showed depletion of phosphoinositides (PIP and PIP2) when we compared metabolically labeled phosphoinositides from wild type and rpkA(-). Furthermore rpkA(-) exhibited reduced nitrogen starvation tolerance, an indicator for a reduced autophagy rate. Our results indicate that RpkA is a component of the defense system of D. discoideum as well as other lower eukaryotes.	[Riyahi, Tanja Y.; Omosigho, Napoleon N.; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Inst Biochem 1, Fac Med, CMMC,Cologne Excellence Cluster Cellular Stress R, Cologne, Germany; [Frese, Frederike; Steinert, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany; [Gloeckner, Gernot] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Orabi, Benoit; Williams, Robin S. B.] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, Egham, Surrey, England	University of Cologne; Braunschweig University of Technology; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of London; Royal Holloway University London	Riyahi, TY (corresponding author), Univ Cologne, Inst Biochem 1, Fac Med, CMMC,Cologne Excellence Cluster Cellular Stress R, Cologne, Germany.	noegel@uni-koeln.de	Glöckner, Gernot/A-7800-2010; Eichinger, Ludwig/AAJ-8895-2021; Williams, Robin/G-6807-2011	Glöckner, Gernot/0000-0002-9061-1061; Eichinger, Ludwig/0000-0003-1594-6117; 	Deutsche Forschungsgemeinschaft (DFG) [SFB 670]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG), in particular SFB 670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bakthavatsalam D, 2007, CURR BIOL, V17, P892, DOI 10.1016/j.cub.2007.04.029; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Boulais J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.80; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Burden LM, 1999, BIOCHEMISTRY-US, V38, P15141, DOI 10.1021/bi991571a; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Clarke M, 2002, J CELL SCI, V115, P2893; Clarke M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-154; CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DREYFUS LA, 1987, MICROB PATHOGENESIS, V3, P45, DOI 10.1016/0882-4010(87)90036-2; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fischer M, 2006, FEBS LETT, V580, P2495, DOI 10.1016/j.febslet.2006.03.082; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Heidel A, 2011, GENOME RES; Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; Kular G, 1997, BIOCHEM J, V325, P299, DOI 10.1042/bj3250299; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lu H, 2005, CELL MICROBIOL, V7, P995, DOI 10.1111/j.1462-5822.2005.00528.x; Marciano-Cabral F, 2010, J WATER HEALTH, V8, P71, DOI 10.2166/wh.2009.129; Marston Barbara J., 1997, Archives of Internal Medicine, V157, P1709, DOI 10.1001/archinte.157.15.1709; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Pawolleck N, 2009, METHODS MOL BIOL, V571, P283, DOI 10.1007/978-1-60761-198-1_19; Peracino B, 2010, J CELL SCI, V123, P4039, DOI 10.1242/jcs.072124; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Ruiz-Trillo I, 2004, CURR BIOL, V14, pR946, DOI 10.1016/j.cub.2004.10.037; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; SCHOPOHL D, 1992, J BIOL CHEM, V267, P2400; Schreiner T, 2002, EUKARYOT CELL, V1, P906, DOI 10.1128/EC.1.6.906-914.2002; Shevchuk O, 2009, INT J MED MICROBIOL, V299, P489, DOI 10.1016/j.ijmm.2009.03.006; Shina MC, 2010, J BIOL CHEM, V285, P9249, DOI 10.1074/jbc.M109.083725; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003; Swanson MS, 2002, TRAFFIC, V3, P170, DOI 10.1034/j.1600-0854.2002.030302.x; Temesvari LA, 1996, J CELL SCI, V109, P1479; Thomas JM, 2011, ENVIRON SCI TECHNOL, V45, P860, DOI 10.1021/es102876y; Tung SM, 2010, CELL MICROBIOL, V12, P765, DOI 10.1111/j.1462-5822.2010.01432.x; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Valster RM, 2010, APPL ENVIRON MICROB, V76, P7144, DOI 10.1128/AEM.00926-10; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Wienke D, 2006, EUR J CELL BIOL, V85, P991, DOI 10.1016/j.ejcb.2006.04.010; WILKINSON HW, 1985, J CLIN MICROBIOL, V22, P488, DOI 10.1128/JCM.22.4.488-489.1985; Xu XH, 2007, EUKARYOT CELL, V6, P899, DOI 10.1128/EC.00104-06; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	73	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27311	10.1371/journal.pone.0027311	http://dx.doi.org/10.1371/journal.pone.0027311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073313	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900098
J	Tondo, ML; Musumeci, MA; Delprato, ML; Ceccarelli, EA; Orellano, EG				Laura Tondo, Maria; Musumeci, Matias A.; Laura Delprato, Maria; Ceccarelli, Eduardo A.; Orellano, Elena G.			Structural-Functional Characterization and Physiological Significance of Ferredoxin-NADP(+) Reductase from Xanthomonas axonopodis pv. citri	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATALYTIC EFFICIENCY; RHODOBACTER-CAPSULATUS; SUPEROXIDE STRESS; NADP+ REDUCTASE; SOXRS RESPONSE; BINDING-SITE; PLANT; GENE; OXIDOREDUCTASE	Xanthomonas axonopodis pv. citri is a phytopathogen bacterium that causes severe citrus canker disease. Similar to other phytopathogens, after infection by this bacterium, plants trigger a defense mechanism that produces reactive oxygen species. Ferredoxin-NADP(+) reductases (FNRs) are redox flavoenzymes that participate in several metabolic functions, including the response to reactive oxygen species. Xanthomonas axonopodis pv. citri has a gene (fpr) that encodes for a FNR (Xac-FNR) that belongs to the subclass I bacterial FNRs. The aim of this work was to search for the physiological role of this enzyme and to characterize its structural and functional properties. The functionality of Xac-FNR was tested by cross-complementation of a FNR knockout Escherichia coli strain, which exhibit high susceptibility to agents that produce an abnormal accumulation of O-center dot(2)-. Xac-FNR was able to substitute for the FNR in E. coli in its antioxidant role. The expression of fpr in X. axonopodis pv. citri was assessed using semiquantitative RT-PCR and Western blot analysis. A 2.2-fold induction was observed in the presence of the superoxide-generating agents methyl viologen and 2,3-dimethoxy-1,4-naphthoquinone. Structural and functional studies showed that Xac-FNR displayed different functional features from other subclass I bacterial FNRs. Our analyses suggest that these differences may be due to the unusual carboxy-terminal region. We propose a further classification of subclass I bacterial FNRs, which is useful to determine the nature of their ferredoxin redox partners. Using sequence analysis, we identified a ferredoxin (XAC1762) as a potential substrate of Xac-FNR. The purified ferredoxin protein displayed the typical broad UV-visible spectrum of [4Fe-4S] clusters and was able to function as substrate of Xac-FNR in the cytochrome c reductase activity. Our results suggest that Xac-FNR is involved in the oxidative stress response of Xanthomonas axonopodis pv. citri and performs its biological function most likely through the interaction with ferredoxin XAC1762.	[Laura Tondo, Maria; Musumeci, Matias A.; Laura Delprato, Maria; Ceccarelli, Eduardo A.; Orellano, Elena G.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Tondo, ML (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina.	ceccarelli@ibr.gov.ar; orellano@ibr.gov.ar	Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306; Tondo, Maria Laura/0000-0002-0160-1882; Musumeci, Matias/0000-0003-2358-1365	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2007 01-00645]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 252, 112-2009-01-00873]; University of Rosario, Argentina [BIO187, BIO162]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Rosario, Argentina	This work was supported by grants PICT-2007 01-00645, Agencia Nacional de Promocion Cientifica y Tecnologica to EAC, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina (www.agencia.mincyt.gov.ar); PIP 252 to EAC and 112-2009-01-00873 to EGO from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (www.conicet.gov.ar); BIO187 to EAC and BIO162 to EGO from the University of Rosario, Argentina (www.unr.edu.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY MA, 1956, ARCH BIOCHEM BIOPHYS, V65, P475, DOI 10.1016/0003-9861(56)90207-7; ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; BASTIAENS PIH, 1992, BIOCHEMISTRY-US, V31, P7061, DOI 10.1021/bi00146a006; BIANCHI V, 1995, J BACTERIOL, V177, P4528, DOI 10.1128/jb.177.15.4528-4531.1995; BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; Bittel C, 2003, FEBS LETT, V553, P408, DOI 10.1016/S0014-5793(03)01075-5; Bortolotti A, 2009, BBA-PROTEINS PROTEOM, V1794, P199, DOI 10.1016/j.bbapap.2008.09.013; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Carrillo N, 1987, TOPICS PHOTOSYNTHESI, V8, P527; Catalano-Dupuy DL, 2006, BIOCHEMISTRY-US, V45, P13899, DOI 10.1021/bi061152v; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; CENTENO F, 1992, BIOCHEMISTRY-US, V31, P8473, DOI 10.1021/bi00151a013; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; EDMONDSO.DE, 1971, BIOCHEMISTRY-US, V10, P113; Fukuyama K, 2006, HDB METALLOPROTEINS, P543; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; ISAS JM, 1994, J BIOL CHEM, V269, P19404; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Jung YS, 1999, J BIOL CHEM, V274, P2978, DOI 10.1074/jbc.274.5.2978; Khan KK, 1997, EUR J BIOCHEM, V244, P361, DOI 10.1111/j.1432-1033.1997.00361.x; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Manchado M, 2000, J BACTERIOL, V182, P6842, DOI 10.1128/JB.182.23.6842-6844.2000; Medina M, 2004, PHOTOSYNTH RES, V79, P113, DOI 10.1023/B:PRES.0000015386.67746.2c; Milani M, 2007, J MOL BIOL, V367, P501, DOI 10.1016/j.jmb.2007.01.005; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Musumeci MA, 2011, BIOCHEMISTRY-US, V50, P2111, DOI 10.1021/bi101772a; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nascimento AS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-69; Nogues I, 2005, BIOCHEMISTRY-US, V44, P11730, DOI 10.1021/bi0508183; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; ORELLANO EG, 1993, J BIOL CHEM, V268, P19267; Paladini DH, 2009, BIOCHEMISTRY-US, V48, P5760, DOI 10.1021/bi9004232; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Piubelli L, 2000, J BIOL CHEM, V275, P10472, DOI 10.1074/jbc.275.14.10472; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; RITCHIE SW, 1994, PLANT MOL BIOL, V26, P679, DOI 10.1007/BF00013753; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHIN M, 1965, J BIOL CHEM, V240, P1405; Tondo M.L., 2008, FLAVINS FLAVOPROTEIN, P255; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Wang A, 2007, BIOCHEMISTRY-US, V46, P12198, DOI 10.1021/bi7013135; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	56	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27124	10.1371/journal.pone.0027124	http://dx.doi.org/10.1371/journal.pone.0027124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096528	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800029
J	Leek, JT; Taub, MA; Pineda, FJ				Leek, Jeffrey T.; Taub, Margaret A.; Pineda, Fernando J.			Cooperation between Referees and Authors Increases Peer Review Accuracy	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY; TRANSPARENCY	Peer review is fundamentally a cooperative process between scientists in a community who agree to review each other's work in an unbiased fashion. Peer review is the foundation for decisions concerning publication in journals, awarding of grants, and academic promotion. Here we perform a laboratory study of open and closed peer review based on an online game. We show that when reviewer behavior was made public under open review, reviewers were rewarded for refereeing and formed significantly more cooperative interactions (13% increase in cooperation, P = 0.018). We also show that referees and authors who participated in cooperative interactions had an 11% higher reviewing accuracy rate (P = 0.016). Our results suggest that increasing cooperation in the peer review process can lead to a decreased risk of reviewing errors.	[Leek, Jeffrey T.; Taub, Margaret A.; Pineda, Fernando J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Pineda, Fernando J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Leek, JT (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	jleek@jhsph.edu		Leek, Jeffrey/0000-0002-2873-2671				Callaham M, 2011, ANN EMERG MED, V57, P141, DOI 10.1016/j.annemergmed.2010.07.027; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; FABIATO A, 1994, CARDIOVASC RES, V28, P1134, DOI 10.1093/cvr/28.8.1134; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2784, DOI 10.1001/jama.287.21.2784; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; KNOLL E, 1990, JAMA-J AM MED ASSOC, V263, P1330, DOI 10.1001/jama.263.10.1330; Linkov F, 2006, J ROY SOC MED, V99, P596, DOI 10.1258/jrsm.99.12.596; Mietchen D, 2011, NATURE, V473, P452, DOI 10.1038/473452b; Myerson R., 1997, GAME THEORY ANAL CON; Ploegh H, 2011, NATURE, V472, P391, DOI 10.1038/472391a; Pulverer B, 2011, NATURE, V474, P285, DOI 10.1038/474285c; Pulverer B, 2010, NATURE, V468, P29, DOI 10.1038/468029a; Smith R, 1999, BRIT MED J, V318, P4; Tite L, 2006, BRIT MED J, V333, P366, DOI 10.1136/bmj.333.7564.366; van Rooyen S, 1999, J GEN INTERN MED, V14, P622, DOI 10.1046/j.1525-1497.1999.09058.x; van Rooyen S, 1999, BRIT MED J, V318, P23; van Rooyen S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5729; Walsh E, 2000, BRIT J PSYCHIAT, V176, P47, DOI 10.1192/bjp.176.1.47; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0	20	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26895	10.1371/journal.pone.0026895	http://dx.doi.org/10.1371/journal.pone.0026895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096506	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800016
J	Singh, T; Sharma, SD; Katiyar, SK				Singh, Tripti; Sharma, Som D.; Katiyar, Santosh K.			Grape Proanthocyanidins Induce Apoptosis by Loss of Mitochondrial Membrane Potential of Human Non-Small Cell Lung Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							DEPENDENT KINASES; CYCLE CONTROL; BCL-2 FAMILY; INHIBIT; GROWTH; PROTEIN; DEATH; ACTIVATION; BERBERINE; THERAPY	Lung cancer remains the leading cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) represents approximately 80% of total lung cancer cases. The use of non-toxic dietary phytochemicals can be considered as a chemotherapeutic strategy for the management of the NSCLC. Here, we report that grape seed proanthocyanidins (GSPs) induce apoptosis of NSCLC cells, A549 and H1299, in vitro which is mediated through increased expression of pro-apoptotic protein Bax, decreased expression of anti-apoptotic proteins Bcl2 and Bcl-xl, disruption of mitochondrial membrane potential, and activation of caspases 9, 3 and poly (ADP-ribose) polymerase (PARP). Pre-treatment of A549 and H1299 cells with the caspase-3 inhibitor (z-DEVD-fmk) significantly blocked the GSPs-induced apoptosis of these cells confirmed that GSPs-induced apoptosis is mediated through activation of caspases-3. Treatments of A549 and H1299 cells with GSPs resulted in an increase in G1 arrest. G0/G1 phase of the cell cycle is known to be controlled by cyclin dependent kinases (Cdk), cyclin-dependent kinase inhibitors (Cdki) and cyclins. Our western blot analyses showed that GSPs-induced G1 cell cycle arrest was mediated through the increased expression of Cdki proteins (Cip1/p21 and Kip1/p27), and a simultaneous decrease in the levels of Cdk2, Cdk4, Cdk6 and cyclins. Further, administration of 50, 100 or 200 mg GSPs/kg body weight of mice by oral gavage (5 d/week) markedly inhibited the growth of s.c. A549 and H1299 lung tumor xenografts in athymic nude mice, which was associated with the induction of apoptotic cell death, increased expression of Bax, reduced expression of anti-apoptotic proteins and activation of caspase-3 in tumor xenograft cells. Based on the data obtained in animal study, human equivalent dose of GSPs was calculated, which seems affordable and attainable. Together, these results suggest that GSPs may represent a potential therapeutic agent for the non-small cell lung cancer.	[Singh, Tripti; Sharma, Som D.; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Singh, T (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu			Veterans Administration Merit Review Award	Veterans Administration Merit Review Award(US Department of Veterans Affairs)	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, CLIN CANCER RES, V15, P821, DOI 10.1158/1078-0432.CCR-08-1901; America Cancer Society, 2011, CANC FACTS FIG; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Facino RM, 1996, PLANTA MED, V62, P495, DOI 10.1055/s-2006-957956; Ferrigno D, 2000, LUNG CANCER-J IASLC, V29, P91, DOI 10.1016/S0169-5002(00)00112-4; Fischer P M, 2001, Curr Opin Drug Discov Devel, V4, P623; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; GRANA X, 1995, ONCOGENE, V11, P211; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Maziak DE, 2004, ANN THORAC SURG, V77, P1484, DOI 10.1016/j.athoracsur.2003.07.017; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; WRIGHT SC, 1994, FASEB J, V8, P654, DOI 10.1096/fasebj.8.9.8005393; Ye X, 1999, MOL CELL BIOCHEM, V196, P99, DOI 10.1023/A:1006926414683; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0	41	70	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27444	10.1371/journal.pone.0027444	http://dx.doi.org/10.1371/journal.pone.0027444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087318	Green Published, gold, Green Submitted			2022-12-27	WOS:000297349700046
J	Yang, DR; Liu, NAL; Zuo, CH; Lei, SH; Wu, XJ; Zhou, F; Liu, C; Zhu, HZ				Yang, Darong; Liu, Nianli; Zuo, Chaohui; Lei, Shoahua; Wu, Xinjiao; Zhou, Fei; Liu, Chen; Zhu, Haizhen			Innate Host Response in Primary Human Hepatocytes with Hepatitis C Virus Infection	PLOS ONE			English	Article							INDUCED APOPTOSIS; IMMUNE-RESPONSES; ADAPTER PROTEIN; RIG-I; REPLICATION; DISRUPTION; CULTURE; TRAIL	Background and Aim: The interaction between hepatitis C virus (HCV) and innate antiviral defense systems in primary human hepatocytes is not well understood. The objective of this study is to examine how primary human hepatocytes response to HCV infection. Methods: An infectious HCV isolate JFH1 was used to infect isolated primary human hepatocytes. HCV RNA or NS5A protein in the cells was detected by real-time PCR or immunofluorescence staining respectively. Apoptosis was examined with flow cytometry. Mechanisms of HCV-induced IFN-beta expression and apoptosis were determined. Results: Primary human hepatocytes were susceptible to JFH1 virus and released infectious virus. IFN-alpha inhibited viral RNA replication in the cells. IFN-b and interferon-stimulated genes were induced in the cells during acute infection. HCV infection induced apoptosis of primary human hepatocytes through the TRAIL-mediated pathway. Silencing RIG-I expression in primary human hepatocytes inhibited IFN-beta and TRAIL expression and blocked apoptosis of the cells, which facilitated viral RNA replication in the cells. Moreover, HCV NS34A protein inhibited viral induced IFN-beta expression in primary human hepatocytes. Conclusion: Innate host response is intact in HCV-infected primary human hepatocytes. RIG-I plays a key role in the induction of IFN and TRAIL by viruses and apoptosis of primary human hepatocytes via activation of the TRAIL-mediated pathway. HCV NS34A protein appears to be capable of disrupting the innate antiviral host responses in primary human hepatocytes. Our study provides a novel mechanism by which primary human hepatocytes respond to natural HCV infection.	[Yang, Darong; Liu, Nianli; Lei, Shoahua; Wu, Xinjiao; Zhou, Fei; Zhu, Haizhen] Hunan Univ, Dept Mol Med, Coll Biol, Changsha 410082, Hunan, Peoples R China; [Yang, Darong; Liu, Nianli; Lei, Shoahua; Wu, Xinjiao; Zhou, Fei; Zhu, Haizhen] Hunan Univ, State Key Lab Chem Biosensesing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Zuo, Chaohui; Zhu, Haizhen] Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Zuo, Chaohui; Zhu, Haizhen] Hunan Univ, Res Ctr Canc Prevent & Treatment, Changsha 410082, Hunan, Peoples R China; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Hunan University; Hunan University; Hunan University; State University System of Florida; University of Florida	Yang, DR (corresponding author), Hunan Univ, Dept Mol Med, Coll Biol, Changsha 410082, Hunan, Peoples R China.	zhuhaizhen69@yahoo.com	Lei, Shaohua/GPS-5028-2022; Yang, Darong/HHZ-5465-2022	Yang, Darong/0000-0002-5343-9047	National Grand Program on Key Infectious Disease [2009ZX10004-312]; Program for New Century Excellent Talents in University [NCET-09-0339]; Key Scientific and Technical Innovation Program of Hunan [2010TD2012];  [NIH-DK002958]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002958] Funding Source: NIH RePORTER	National Grand Program on Key Infectious Disease; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Scientific and Technical Innovation Program of Hunan; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Grand Program on Key Infectious Disease (2009ZX10004-312), Program for New Century Excellent Talents in University (NCET-09-0339), Key Scientific and Technical Innovation Program of Hunan (2010TD2012) to HZ and grant NIH-DK002958 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HH, 2009, HEPATOLOGY, V50, P689, DOI 10.1002/hep.23034; Balfe Peter, 2009, J Hepatol, V51, P609, DOI 10.1016/j.jhep.2009.06.014; Banaudha K, 2010, HEPATOLOGY, V51, P1922, DOI 10.1002/hep.23616; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Berg CP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-213; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Clarke P, 2003, APOPTOSIS, V8, P141, DOI 10.1023/A:1022966508671; Eksioglu EA, 2011, PLOS ONE, pe21186; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Jouan L, 2010, J HEPATOL, V52, P167, DOI 10.1016/j.jhep.2009.11.011; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; McHutchison JG, 2004, AM J MANAG CARE, V10, pS21; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Stiffler JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006661; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017; Zhu Haizhen, 2009, V510, P373, DOI 10.1007/978-1-59745-394-3_28; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	37	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27552	10.1371/journal.pone.0027552	http://dx.doi.org/10.1371/journal.pone.0027552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087337	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700059
J	Yen, P; Finley, SD; Engel-Stefanini, MO; Popel, AS				Yen, Phillip; Finley, Stacey D.; Engel-Stefanini, Marianne O.; Popel, Aleksander S.			A Two-Compartment Model of VEGF Distribution in the Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CAPILLARY BASEMENT-MEMBRANE; SKELETAL-MUSCLE; ISOFORM EXPRESSION; COMPARTMENT MODEL; BLOOD-VOLUME; PLASMA VEGF; ANGIOGENESIS; RECEPTOR-1; BIOLOGY	Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis - the growth of new microvessels from existing microvasculature. Angiogenesis is a complex process involving numerous molecular species, and to better understand it, a systems biology approach is necessary. In vivo preclinical experiments in the area of angiogenesis are typically performed in mouse models; this includes drug development targeting VEGF. Thus, to quantitatively interpret such experimental results, a computational model of VEGF distribution in the mouse can be beneficial. In this paper, we present an in silico model of VEGF distribution in mice, determine model parameters from existing experimental data, conduct sensitivity analysis, and test the validity of the model. The multiscale model is comprised of two compartments: blood and tissue. The model accounts for interactions between two major VEGF isoforms (VEGF(120) and VEGF(164)) and their endothelial cell receptors VEGFR-1, VEGFR-2, and co-receptor neuropilin-1. Neuropilin-1 is also expressed on the surface of parenchymal cells. The model includes transcapillary macromolecular permeability, lymphatic transport, and macromolecular plasma clearance. Simulations predict that the concentration of unbound VEGF in the tissue is approximately 50-fold greater than in the blood. These concentrations are highly dependent on the VEGF secretion rate. Parameter estimation was performed to fit the simulation results to available experimental data, and permitted the estimation of VEGF secretion rate in healthy tissue, which is difficult to measure experimentally. The model can provide quantitative interpretation of preclinical animal data and may be used in conjunction with experimental studies in the development of pro- and anti-angiogenic agents. The model approximates the normal tissue as skeletal muscle and includes endothelial cells to represent the vasculature. As the VEGF system becomes better characterized in other tissues and cell types, the model can be expanded to include additional compartments and vascular elements.	[Yen, Phillip; Finley, Stacey D.; Engel-Stefanini, Marianne O.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Yen, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	sdfinley@jhu.edu	Popel, Aleksander S/A-6724-2009	Popel, Aleksander/0000-0002-6706-9235; Yen, Phillip/0000-0002-0234-7791; Finley, Stacey/0000-0001-6901-3692	National Institutes of Health (NIH) [R01 HL101200, R01 CA138264]; NATIONAL CANCER INSTITUTE [R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 HL101200 and R01 CA138264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; CUTHBERTSON RA, 1986, INVEST OPHTH VIS SCI, V27, P1653; Daly T, 2009, VEGF BINDING FUSION; Ee LC, 2000, AM J PHYSIOL-GASTR L, V279, pG325, DOI 10.1152/ajpgi.2000.279.2.G325; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Filion RJ, 2004, ANN BIOMED ENG, V32, P645, DOI 10.1023/B:ABME.0000030231.88326.78; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; GARLICK DG, 1970, AM J PHYSIOL, V219, P1595, DOI 10.1152/ajplegacy.1970.219.6.1595; Gibson JG, 1937, J CLIN INVEST, V16, P317, DOI 10.1172/JCI100860; Haas TL, 1997, MICROVASC RES, V53, P113, DOI 10.1006/mvre.1996.1999; Hagstrom L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/137817; Hernandez N, 1999, ANAT REC, V256, P425; HICKS P, 1983, NEUROBIOL AGING, V4, P69, DOI 10.1016/0197-4580(83)90057-X; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Hoff J, 2000, LAB ANIMAL, V29, P47; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; Kleinheinz J, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-17; Leighl NB, 2010, J THORAC ONCOL, V5, P1054, DOI 10.1097/JTO.0b013e3181e2f7fb; LEUENBERGER PM, 1970, DOC OPHTHALMOL, V28, P191, DOI 10.1007/BF00153877; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; MAN M, 1975, BIOCHEM BIOPH RES CO, V66, P9, DOI 10.1016/S0006-291X(75)80287-7; MATHIEUCOSTELLO O, 1989, RESP PHYSIOL, V76, P289, DOI 10.1016/0034-5687(89)90070-4; MAYROVITZ HN, 1992, MICROVASC RES, V43, P46, DOI 10.1016/0026-2862(92)90005-A; Medeiros A, 2008, BRAZ J MED BIOL RES, V41, P812, DOI 10.1590/S0100-879X2008000900012; MENDEZ J, 1977, J APPL PHYSIOL, V42, P731, DOI 10.1152/jappl.1977.42.5.731; Nakamura M, 2002, PATHOL INT, V52, P331, DOI 10.1046/j.1440-1827.2002.01367.x; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; North Central Cancer Treatment Group, 2007, PHAS 2 TRIAL VEGF TR; Olewniczak Slawomir, 2003, Polish Journal of Pathology, V54, P53; Olewniczak Slawomir, 2002, Polish Journal of Pathology, V53, P183; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; PODRAZKY V, 1966, EXPERIENTIA, V22, P792, DOI 10.1007/BF01897416; Qutub AA, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P316; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; SASSEN A, 1968, EXPERIENTIA, V24, P1203, DOI 10.1007/BF02146620; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; SHEFF MF, 1982, J PHYSIOL-LONDON, V328, P507, DOI 10.1113/jphysiol.1982.sp014280; SHER J, 1976, ACTA NEUROL SCAND, V54, P45, DOI 10.1111/j.1600-0404.1976.tb07619.x; Soukup T, 2002, ACTA HISTOCHEM, V104, P399, DOI 10.1078/0065-1281-00660; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Stefanini MO, 2011, MATH MED BIOL; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Testa U, 2008, J CARDIOVASC MED, V9, P1190, DOI 10.2459/JCM.0b013e3283117d37; THOMAS FC, 1994, MATH PROGRAM, V67, P189; Tokunaga T, 1998, ONCOL REP, V5, P1115; Truskey G. A., 2004, TRANSPORT PHENOMENA; van der Meer SFT, 2011, ANN ANAT, V193, P56, DOI 10.1016/j.aanat.2010.08.004; van Patot MCT, 2005, J APPL PHYSIOL, V98, P1626, DOI 10.1152/japplphysiol.00589.2004; Vempati P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-59; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Wachsberger PR, 2007, INT J RADIAT ONCOL, V67, P1526, DOI 10.1016/j.ijrobp.2006.11.011; Wagatsuma A, 2005, EXP PHYSIOL, V90, P403, DOI 10.1113/expphysiol.2004.029769; WASSMER B, 1988, COMP BIOCHEM PHYS B, V91, P179, DOI 10.1016/0305-0491(88)90132-0; Wong LE, 2009, J APPL PHYSIOL, V106, P1660, DOI 10.1152/japplphysiol.91233.2008; Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Wu FTH, 2009, METHOD ENZYMOL, V467, P461, DOI 10.1016/S0076-6879(09)67018-X; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097	78	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27514	10.1371/journal.pone.0027514	http://dx.doi.org/10.1371/journal.pone.0027514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087332	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700055
J	Araujo-Palomares, CL; Richthammer, C; Seiler, S; Castro-Longoria, E				Araujo-Palomares, Cynthia L.; Richthammer, Corinna; Seiler, Stephan; Castro-Longoria, Ernestina			Functional Characterization and Cellular Dynamics of the CDC-42-RAC - CDC-24 Module in Neurospora crassa	PLOS ONE			English	Article							FUNGUS USTILAGO-MAYDIS; INVASIVE FILAMENTOUS GROWTH; RHO-TYPE GTPASE; CANDIDA-ALBICANS; ASPERGILLUS-NIDULANS; GENOME SEQUENCE; EXCHANGE FACTOR; HYPHAL GROWTH; PENICILLIUM-MARNEFFEI; SEPTUM FORMATION	Rho-type GTPases are key regulators that control eukaryotic cell polarity, but their role in fungal morphogenesis is only beginning to emerge. In this study, we investigate the role of the CDC-42 - RAC - CDC-24 module in Neurospora crassa. rac and cdc-42 deletion mutants are viable, but generate highly compact colonies with severe morphological defects. Double mutants carrying conditional and loss of function alleles of rac and cdc-42 are lethal, indicating that both GTPases share at least one common essential function. The defects of the GTPase mutants are phenocopied by deletion and conditional alleles of the guanine exchange factor (GEF) cdc-24, and in vitro GDP-GTP exchange assays identify CDC-24 as specific GEF for both CDC-42 and RAC. In vivo confocal microscopy shows that this module is organized as membrane-associated cap that covers the hyphal apex. However, the specific localization patterns of the three proteins are distinct, indicating different functions of RAC and CDC-42 within the hyphal tip. CDC-42 localized as confined apical membrane-associated crescent, while RAC labeled a membrane-associated ring excluding the region labeled by CDC42. The GEF CDC-24 occupied a strategic position, localizing as broad apical membrane-associated crescent and in the apical cytosol excluding the Spitzenkorper. RAC and CDC-42 also display distinct localization patterns during branch initiation and germ tube formation, with CDC-42 accumulating at the plasma membrane before RAC. Together with the distinct cellular defects of rac and cdc-42 mutants, these localizations suggest that CDC-42 is more important for polarity establishment, while the primary function of RAC may be maintaining polarity. In summary, this study identifies CDC-24 as essential regulator for RAC and CDC-42 that have common and distinct functions during polarity establishment and maintenance of cell polarity in N. crassa.	[Araujo-Palomares, Cynthia L.; Castro-Longoria, Ernestina] Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Richthammer, Corinna; Seiler, Stephan] Univ Gottingen, Inst Mikrobiol & Genet, Gottingen, Germany	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Gottingen	Araujo-Palomares, CL (corresponding author), Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	sseiler@gwdg.de; ecastro@cicese.mx	Castro-Longoria, Ernestina/GYV-4776-2022	Araujo Palomares, Cynthia Lizzeth/0000-0002-5007-8426	SEP-CONACyT [CB-2006-1-61524]; Deutsche Forschungsgesellschaft [SE1054/3-2, SE1054/4-1]; CONACyT	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a SEP-CONACyT grant (CB-2006-1-61524) to Dr. Castro-Longoria and the grants SE1054/3-2 and SE1054/4-1 from the Deutsche Forschungsgesellschaft to Dr. Seiler. We also thank CONACyT for a grant to Dr. Araujo-Palomares. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Banuett F, 2008, FUNGAL GENET BIOL, V45, pS3, DOI 10.1016/j.fgb.2008.05.012; Bardiya N, 2008, GENETICS, V178, P593, DOI 10.1534/genetics.107.079384; Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bohmer C, 2008, J CELL SCI, V121, P143, DOI 10.1242/jcs.014449; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Boyce KJ, 2005, MOL MICROBIOL, V55, P1487, DOI 10.1111/j.1365-2958.2005.04485.x; Boyce KJ, 2003, J CELL SCI, V116, P1249, DOI 10.1242/jcs.00319; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Dunkler A, 2007, EUKARYOT CELL, V6, P844, DOI 10.1128/EC.00201-06; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Frieser SH, 2011, MOL BIOL CELL, V22, P3253, DOI 10.1091/mbc.E11-04-0314; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2011, MOL MICROBIOL, V79, P1123, DOI 10.1111/j.1365-2958.2010.07525.x; Harris SD, 2009, FUNGAL GENET BIOL, V46, pS82, DOI 10.1016/j.fgb.2008.07.023; Hazan I, 2002, EUKARYOT CELL, V1, P856, DOI 10.1128/EC.1.6.856-864.2002; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hlubek A, 2008, MOL MICROBIOL, V68, P615, DOI 10.1111/j.1365-2958.2008.06177.x; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Hope H, 2010, MOL MICROBIOL, V76, P1572, DOI 10.1111/j.1365-2958.2010.07186.x; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Kwon MJ, 2011, MOL MICROBIOL, V79, P1151, DOI 10.1111/j.1365-2958.2010.07524.x; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; Ridley AJ, 2001, J CELL SCI, V114, P2713; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Rolke Y, 2008, MOL MICROBIOL, V68, P405, DOI 10.1111/j.1365-2958.2008.06159.x; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; Vogel H.J., 1956, MICROB GENET B, V13, P42; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Wendland J, 2001, GENETICS, V157, P601; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339	55	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27148	10.1371/journal.pone.0027148	http://dx.doi.org/10.1371/journal.pone.0027148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087253	Green Submitted, gold, Green Published			2022-12-27	WOS:000297347700019
J	Zuo, LJ; Zhang, CK; Wang, F; Li, CSR; Zhao, HY; Lu, LG; Zhang, XY; Lu, L; Zhang, HP; Zhang, FY; Krystal, JH; Luo, XG				Zuo, Lingjun; Zhang, Clarence K.; Wang, Fei; Li, Chiang-Shan R.; Zhao, Hongyu; Lu, Lingeng; Zhang, Xiang-Yang; Lu, Lin; Zhang, Heping; Zhang, Fengyu; Krystal, John H.; Luo, Xingguang			A Novel, Functional and Replicable Risk Gene Region for Alcohol Dependence Identified by Genome-Wide Association Study	PLOS ONE			English	Article							POLYMORPHISMS; EXPRESSION; FINGER	Several genome-wide association studies (GWASs) reported tens of risk genes for alcohol dependence, but most of them have not been replicated or confirmed by functional studies. The present study used a GWAS to search for novel, functional and replicable risk gene regions for alcohol dependence. Associations of all top-ranked SNPs identified in a discovery sample of 681 African-American (AA) cases with alcohol dependence and 508 AA controls were retested in a primary replication sample of 1,409 European-American (EA) cases and 1,518 EA controls. The replicable associations were then subjected to secondary replication in a sample of 6,438 Australian family subjects. A functional expression quantitative trait locus (eQTL) analysis of these replicable risk SNPs was followed-up in order to explore their cis-acting regulatory effects on gene expression. We found that within a 90 Mb region around PHF3-PTP4A1 locus in AAs, a linkage disequilibrium (LD) block in PHF3-PTP4A1 formed the only peak associated with alcohol dependence at p<10(-4). Within this block, 30 SNPs associated with alcohol dependence in AAs (1.6x10(-5) <= p <= 0.050) were replicated in EAs (1.3x10(-3)<= p <= 0.038), and 18 of them were also replicated in Australians (1.8x10(-3)<= p <= 0.048). Most of these risk SNPs had strong cis-acting regulatory effects on PHF3-PTP4A1 mRNA expression across three HapMap samples. The distributions of -log(p) values for association and functional signals throughout this LD block were highly consistent across AAs, EAs, Australians and three HapMap samples. We conclude that the PHF3-PTP4A1 region appears to harbor a causal locus for alcohol dependence, and proteins encoded by PHF3 and/or PTP4A1 might play a functional role in the disorder.	[Zuo, Lingjun; Wang, Fei; Li, Chiang-Shan R.; Krystal, John H.; Luo, Xingguang] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Zuo, Lingjun; Krystal, John H.; Luo, Xingguang] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Zhang, Clarence K.; Zhao, Hongyu; Lu, Lingeng; Zhang, Heping] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Peoples R China; [Zhang, Xiang-Yang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Zhang, Fengyu] NIMH, Gene Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; China Medical University; Baylor College of Medicine; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zuo, LJ (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Lingjun.Zuo@yale.edu; Xingguang.Luo@yale.edu	Zhang, He/GXN-0028-2022; Zhang, Fengyu/M-1396-2019; Li, Chiang-Shan Ray/J-2813-2016	Zhang, Fengyu/0000-0001-8504-0770; Li, Chiang-Shan Ray/0000-0002-9393-1212	National Institute on Drug Abuse (NIDA) [K01 DA029643, K24 DA017899, R01 DA016750, K02 DA026990, R01 DA013423]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA016015, R21 AA020319, R21 AA018004, K24 AA013736, R01 AA11330, R01 AA017535, P50 AA012870, U10 AA008401]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Award [17616]; Department of Veterans Affairs through VA Alcohol Research Center; VA National Center for PTSD; Depression REAP; National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) [U01 HG004422, U01HG004438]; GENEVA Coordinating Center [U01 HG004446]; National Cancer Institute [P01 CA089392]; NIH [HHSN268200782096C]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004422, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA012870, R21AA018004, R01AA011330, R01AA016015, R01AA017535, K24AA013736, U10AA008401, R21AA020319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017899, K01DA029643, R01DA013423, K02DA026990, R01DA016750] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Alliance for Research on Schizophrenia and Depression (NARSAD) Award; Department of Veterans Affairs through VA Alcohol Research Center(US Department of Veterans Affairs); VA National Center for PTSD; Depression REAP; National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GENEVA Coordinating Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institute on Drug Abuse (NIDA) grants K01 DA029643, K24 DA017899, R01 DA016750 and K02 DA026990, National Institute on Alcohol Abuse and Alcoholism (NIAAA) grants R01 AA016015, R21 AA020319, R21 AA018004, K24 AA013736, R01 AA11330, R01 AA017535, and P50 AA012870 and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Award 17616 (L.Z.). This work also received support from the Department of Veterans Affairs through its support of the VA Alcohol Research Center, the VA National Center for PTSD, and the Depression REAP. The authors thank National Institutes of Health GWAS Data Repository, the Contributing Investigator(s) (Drs. Bierut and Edenberg) who contributed the phenotype and genotype data (SAGE and COGA) from his/her original study, and the primary funding organization that supported the contributing study. Funding support for SAGE and COGA was provided through the National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) Grant U01 HG004422 and U01HG004438; the GENEVA Coordinating Center (U01 HG004446); the National Institute on Alcohol Abuse and Alcoholism (U10 AA008401); the National Institute on Drug Abuse (R01 DA013423); the National Cancer Institute (P01 CA089392); and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research or at deCODE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Chang YT, 2002, MOL PSYCHIATR, V7, P828, DOI 10.1038/sj.mp.4001110; Chen XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016002; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019210; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Li TK, 2007, ADDICTION, V102, P1522, DOI 10.1111/j.1360-0443.2007.01911.x; Lind PA, 2009, PSYCHIAT GENET, V19, P117, DOI 10.1097/YPG.0b013e32832a4f7b; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; McHugh RK, 2010, DRUG ALCOHOL DEPEN, V108, P1, DOI 10.1016/j.drugalcdep.2009.11.017; Mosing MA, 2010, TWIN RES HUM GENET, V13, P398, DOI 10.1375/twin.13.4.398; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oroszi G, 2005, ALCOHOL CLIN EXP RES, V29, P303, DOI 10.1097/01.ALC.0000156128.28257.2E; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuo L, 2011, NEUROPSYCHOPHARMACOL, DOI [10.1038/npp.2011.1229, DOI 10.1038/NPP.2011.1229]; Zuo LJ, 2007, BIOL PSYCHIAT, V62, P616, DOI 10.1016/j.biopsych.2006.12.004	28	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26726	10.1371/journal.pone.0026726	http://dx.doi.org/10.1371/journal.pone.0026726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22096494	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700009
J	Ratelade, J; Bennett, JL; Verkman, AS				Ratelade, Julien; Bennett, Jeffrey L.; Verkman, A. S.			Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema	PLOS ONE			English	Article							INSENSITIVE WATER CHANNEL; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; ANTIBODY; SPECTRUM; IMMUNOGLOBULIN; CONSEQUENCES; LOCALIZATION; PERMEABILITY; DISTINCTION	The pathogenesis of neuromyelitis optica (NMO) involves binding of IgG autoantibodies (NMO-IgG) to aquaporin-4 (AQP4) on astrocytes in the central nervous system (CNS). We studied the in vivo processing in mice of a recombinant monoclonal human NMO-IgG that binds strongly to mouse AQP4. Following intravenous administration, serum [NMO-IgG] decreased with t(1/2) similar to 18 hours in wildtype mice and similar to 41 hours in AQP4 knockout mice. NMO-IgG was localized to AQP4-expressing cell membranes in kidney (collecting duct), skeletal muscle, trachea (epithelial cells) and stomach (parietal cells). NMO-IgG was seen on astrocytes in the area postrema in brain, but not elsewhere in brain, spinal cord, optic nerve or retina. Intravenously administered NMO-IgG was also seen in brain following mechanical disruption of the blood-brain barrier. Selective cellular localization was not found for control (non-NMO) IgG, or for NMO-IgG in AQP4 knockout mice. NMO-IgG injected directly into brain parenchyma diffused over an area of similar to 5 mm(2) over 24 hours and targeted astrocyte foot-processes. Our data establish NMO-IgG pharmacokinetics and tissue distribution in mice. The rapid access of serum NMO-IgG to AQP4 in peripheral organs but not the CNS indicates that restricted antibody access cannot account for the absence of NMO pathology in peripheral organs.	[Ratelade, Julien; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ratelade, Julien; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ratelade, J (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu		Ratelade, Julien/0000-0001-7968-5409	Guthy-Jackson Charitable Foundation; National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; National Multiple Sclerosis Society [RG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, RC1DK086125, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	Guthy-Jackson Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Guthy-Jackson Charitable Foundation (ASV, JLB), grants EY13574, EB00415, DK35124, HL73856, DK86125 and DK72517 from the National Institutes of Health (ASV) and grant RG4320 from the National Multiple Sclerosis Society (JLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bonnan M, 2009, MULT SCLER J, V15, P487, DOI 10.1177/1352458508100837; Brabb T, 1997, J IMMUNOL, V159, P497; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Burgoon MP, 1999, J NEUROIMMUNOL, V94, P204, DOI 10.1016/S0165-5728(98)00243-4; Chan KH, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-50; Crane JM, 2010, NEUROSCIENCE, V168, P892, DOI 10.1016/j.neuroscience.2009.08.034; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; FRIGERI A, 1995, J CELL SCI, V108, P2993; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nielsen S, 1997, J NEUROSCI, V17, P171; Popescu BFG, 2011, NEUROLOGY, V76, P1229, DOI 10.1212/WNL.0b013e318214332c; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Schoderboeck L, 2009, NEUROBIOL DIS, V35, P368, DOI 10.1016/j.nbd.2009.05.026; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; VERKMAN AS, 2011, ACTA PHARM SIN; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG448, DOI 10.1152/ajpgi.2000.279.2.G448; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yang BX, 2000, AM J PHYSIOL-CELL PH, V278, pC1108, DOI 10.1152/ajpcell.2000.278.6.C1108; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com	41	66	72	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27412	10.1371/journal.pone.0027412	http://dx.doi.org/10.1371/journal.pone.0027412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076159	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200073
J	Zanin, M; Del Pozo, F; Boccaletti, S				Zanin, Massimiliano; Del Pozo, Francisco; Boccaletti, Stefano			Computation Emerges from Adaptive Synchronization of Networking Neurons	PLOS ONE			English	Article								The activity of networking neurons is largely characterized by the alternation of synchronous and asynchronous spiking sequences. One of the most relevant challenges that scientists are facing today is, then, relating that evidence with the fundamental mechanisms through which the brain computes and processes information, as well as with the arousal (or progress) of a number of neurological illnesses. In other words, the problem is how to associate an organized dynamics of interacting neural assemblies to a computational task. Here we show that computation can be seen as a feature emerging from the collective dynamics of an ensemble of networking neurons, which interact by means of adaptive dynamical connections. Namely, by associating logical states to synchronous neuron's dynamics, we show how the usual Boolean logics can be fully recovered, and a universal Turing machine can be constructed. Furthermore, we show that, besides the static binary gates, a wider class of logical operations can be efficiently constructed as the fundamental computational elements interact within an adaptive network, each operation being represented by a specific motif. Our approach qualitatively differs from the past attempts to encode information and compute with complex systems, where computation was instead the consequence of the application of control loops enforcing a desired state into the specific system's dynamics. Being the result of an emergent process, the computation mechanism here described is not limited to a binary Boolean logic, but it can involve a much larger number of states. As such, our results can enlighten new concepts for the understanding of the real computing processes taking place in the brain.	[Zanin, Massimiliano; Del Pozo, Francisco; Boccaletti, Stefano] Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain; [Zanin, Massimiliano] Innaxis Fdn & Res Inst, Madrid, Spain	Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Zanin, M (corresponding author), Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain.	massimiliano.zanin@ctb.upm.es	Boccaletti, Stefano/U-7603-2019; POZO GUERRERO, FRANCISCO DEL/H-6668-2015	Boccaletti, Stefano/0000-0002-5758-7012; POZO GUERRERO, FRANCISCO DEL/0000-0001-9919-9125; Zanin, Massimiliano/0000-0002-5839-0393				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartee, 1991, COMPUTER ARCHITECTUR; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Breakspear M, 2004, J COMPUT NEUROSCI, V16, P49, DOI 10.1023/B:JCNS.0000004841.66897.7d; Ditto WL, 2010, CHAOS, V20; Fries P, 2002, J NEUROSCI, V22, P3739; HAYES S, 1993, PHYS REV LETT, V70, P3031, DOI 10.1103/PhysRevLett.70.3031; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Murali K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.025201; Pikovsky AS, 1984, RADIOPHYS QUANTUM EL, V27; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sinha S, 1998, PHYS REV LETT, V81, P2156, DOI 10.1103/PhysRevLett.81.2156; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wernick W, 1942, T AM MATH SOC, V51, P117, DOI 10.2307/1989982	22	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26467	10.1371/journal.pone.0026467	http://dx.doi.org/10.1371/journal.pone.0026467			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073167	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200014
J	Elschot, M; Nijsen, JFW; Dam, AJ; de Jong, HWAM				Elschot, Mattijs; Nijsen, Johannes Franciscus Wilhelmus; Dam, Alida Johanna; de Jong, Hugo Wilhelmus Antonius Maria			Quantitative Evaluation of Scintillation Camera Imaging Characteristics of Isotopes Used in Liver Radioembolization	PLOS ONE			English	Article							HOLMIUM-LOADED MICROSPHERES; Y-90 MICROSPHERES; SCATTER CORRECTION; HO-166; THERAPY; SPECT; MALIGNANCIES; BIODISTRIBUTION; QUANTIFICATION; RADIOTHERAPY	Background: Scintillation camera imaging is used for treatment planning and post-treatment dosimetry in liver radioembolization (RE). In yttrium-90 (90Y) RE, scintigraphic images of technetium-99m (99mTc) are used for treatment planning, while 90Y Bremsstrahlung images are used for post-treatment dosimetry. In holmium-166 (166Ho) RE, scintigraphic images of 166Ho can be used for both treatment planning and post-treatment dosimetry. The aim of this study is to quantitatively evaluate and compare the imaging characteristics of these three isotopes, in order that imaging protocols can be optimized and RE studies with varying isotopes can be compared. Methodology/Principal Findings: Phantom experiments were performed in line with NEMA guidelines to assess the spatial resolution, sensitivity, count rate linearity, and contrast recovery of 99mTc, 90Y and 166Ho. In addition, Monte Carlo simulations were performed to obtain detailed information about the history of detected photons. The results showed that the use of a broad energy window and the high-energy collimator gave optimal combination of sensitivity, spatial resolution, and primary photon fraction for 90Y Bremsstrahlung imaging, although differences with the medium-energy collimator were small. For 166Ho, the high-energy collimator also slightly outperformed the medium-energy collimator. In comparison with 99mTc, the image quality of both 90Y and 166Ho is degraded by a lower spatial resolution, a lower sensitivity, and larger scatter and collimator penetration fractions. Conclusions/Significance: The quantitative evaluation of the scintillation camera characteristics presented in this study helps to optimize acquisition parameters and supports future analysis of clinical comparisons between RE studies.	[Elschot, Mattijs; Nijsen, Johannes Franciscus Wilhelmus; Dam, Alida Johanna; de Jong, Hugo Wilhelmus Antonius Maria] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands; [Dam, Alida Johanna] Gelre Hosp, Dept Med Technol, Gelderland, Netherlands	Utrecht University; Utrecht University Medical Center; Gelre Hospitals	Elschot, M (corresponding author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands.	m.elschot@umcutrecht.nl	Nijsen, Frank/C-2839-2018; Elschot, Mattijs/AAD-4362-2021	Nijsen, Frank/0000-0001-7625-2253; Elschot, Mattijs/0000-0002-8056-9103	University Medical Center Utrecht	University Medical Center Utrecht	This work received funding from the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYOUTH JE, 1994, PHYS MED BIOL, V39, P265, DOI 10.1088/0031-9155/39/2/004; Bult W, 2009, Q J NUCL MED MOL IM, V53, P325; CLARKE LP, 1992, J NUCL MED, V33, P161; Da Silva AJ, 2001, J NUCL MED, V42, P772; de Wit TC, 2006, PHYS MED BIOL, V51, P4773, DOI 10.1088/0031-9155/51/19/004; Fabbri C, 2009, CANCER BIOTHER RADIO, V24, P145, DOI 10.1089/cbr.2008.0543; Flamen P, 2008, PHYS MED BIOL, V53, P6591, DOI 10.1088/0031-9155/53/22/019; Gates VL, 2011, J NUCL MED, V52, P72, DOI 10.2967/jnumed.110.080986; Gulec SA, 2007, ARCH SURG-CHICAGO, V142, P675, DOI 10.1001/archsurg.142.7.675; Hendricks JS, 2005, LAUR052675 LOS AL NA; Ho S, 1997, BRIT J RADIOL, V70, P823, DOI 10.1259/bjr.70.836.9486047; Ho S, 1997, EUR J NUCL MED, V24, P293, DOI 10.1007/BF01728766; Ito S, 2009, ANN NUCL MED, V23, P257, DOI 10.1007/s12149-009-0233-9; Kennedy AS, 2010, CANCER J, V16, P163, DOI 10.1097/PPO.0b013e3181d7e8cf; Knesaurek K, 2010, TECHNOL CANCER RES T, V9, P253, DOI 10.1177/153303461000900304; Koch W, 2008, MED RADIOL DIAGN IMA, P75, DOI 10.1007/978-3-540-35423-9_8; Lhommel R, 2010, EUR J NUCL MED MOL I, V37, P1654, DOI 10.1007/s00259-010-1470-9; Lhommel R, 2009, EUR J NUCL MED MOL I, V36, P1696, DOI 10.1007/s00259-009-1210-1; Mansberg R, 2007, EUR J NUCL MED MOL I, V34, P1887, DOI 10.1007/s00259-007-0536-9; Minarik D, 2008, PHYS MED BIOL, V53, P5689, DOI 10.1088/0031-9155/53/20/008; Minarik D, 2009, PHYS MED BIOL, V54, P5873, DOI 10.1088/0031-9155/54/19/014; National Electrical Manufacturers Association, 2007, NEMA STAND PUBL NU 1; Nijsen JFW, 2004, RADIOLOGY, V231, P491, DOI 10.1148/radiol.2312030594; Nijsen JFW, 1999, EUR J NUCL MED, V26, P699, DOI 10.1007/s002590050440; Rault E, 2010, MED PHYS, V37, P2943, DOI 10.1118/1.3431998; Sabet A, 2011, J NUCL MED, V52, P1063, DOI 10.2967/jnumed.110.083626; Salem R, 2008, AM J CLIN ONCOL-CANC, V31, P431, DOI 10.1097/COC.0b013e318168ef65; Seevinck PR, 2008, MAGN RESON MED, V60, P1466, DOI 10.1002/mrm.21785; Seppenwoolde JH, 2005, MAGN RESON MED, V53, P76, DOI 10.1002/mrm.20320; Shcherbinin S, 2008, PHYS MED BIOL, V53, P4595, DOI 10.1088/0031-9155/53/17/009; SHEN S, 1994, J NUCL MED, V35, P1381; Smits MLJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-70; SORENSON JA, 1975, J NUCL MED, V16, P284; Vandervoort E, 2007, PHYS MED BIOL, V52, P1527, DOI 10.1088/0031-9155/52/5/020; Vente MAD, 2008, EUR J NUCL MED MOL I, V35, P1259, DOI 10.1007/s00259-008-0747-8; Vente MAD, 2010, EUR RADIOL, V20, P862, DOI 10.1007/s00330-009-1613-1; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Walrand S, 2010, J NUCL MED, V51, P1969, DOI 10.2967/jnumed.110.080093; Zeintl J, 2010, J NUCL MED, V51, P921, DOI 10.2967/jnumed.109.071571	39	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26174	10.1371/journal.pone.0026174	http://dx.doi.org/10.1371/journal.pone.0026174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073149	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000007
J	Gole, L; Riviere, C; Hayakawa, Y; Rieu, JP				Gole, Laurent; Riviere, Charlotte; Hayakawa, Yoshinori; Rieu, Jean-Paul			A Quorum-Sensing Factor in Vegetative Dictyostelium Discoideum Cells Revealed by Quantitative Migration Analysis	PLOS ONE			English	Article							PERSISTENT RANDOM MOTION; EUKARYOTIC CELLS; AMEBOID CELLS; MOTILITY; CHEMOTAXIS; DYNAMICS; EXTENSION; MOVEMENT; STRATEGY; ADHESION	Background: Many cells communicate through the production of diffusible signaling molecules that accumulate and once a critical concentration has been reached, can activate or repress a number of target genes in a process termed quorum sensing (QS). In the social amoeba Dictyostelium discoideum, QS plays an important role during development. However little is known about its effect on cell migration especially in the growth phase. Methods and Findings: To investigate the role of cell density on cell migration in the growth phase, we use multisite timelapse microscopy and automated cell tracking. This analysis reveals a high heterogeneity within a given cell population, and the necessity to use large data sets to draw reliable conclusions on cell motion. In average, motion is persistent for short periods of time (t <= 5min), but normal diffusive behavior is recovered over longer time periods. The persistence times are positively correlated with the migrated distances. Interestingly, the migrated distance decreases as well with cell density. The adaptation of cell migration to cell density highlights the role of a secreted quorum sensing factor (QSF) on cell migration. Using a simple model describing the balance between the rate of QSF generation and the rate of QSF dilution, we were able to gather all experimental results into a single master curve, showing a sharp cell transition between high and low motile behaviors with increasing QSF. Conclusion: This study unambiguously demonstrates the central role played by QSF on amoeboid motion in the growth phase.	[Gole, Laurent; Riviere, Charlotte; Rieu, Jean-Paul] Univ Lyon 1, CNRS, Lab Phys Matiere Condense & Nanostruct, UMR 5586, F-69622 Villeurbanne, France; [Hayakawa, Yoshinori] Tohoku Univ, Ctr Informat Technol Educ, Sendai, Miyagi 980, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Tohoku University	Gole, L (corresponding author), Univ Lyon 1, CNRS, Lab Phys Matiere Condense & Nanostruct, UMR 5586, F-69622 Villeurbanne, France.	jean-paul.rieu@univ-lyon1.fr		Riviere, Charlotte/0000-0002-5048-5662	French Ministere de l'Enseignement Superieur et de la Recherche	French Ministere de l'Enseignement Superieur et de la Recherche	This work was supported financially by the French Ministere de l'Enseignement Superieur et de la Recherche (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Bodeker HU, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/28005; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Campos D, 2010, J THEOR BIOL, V267, P526, DOI 10.1016/j.jtbi.2010.09.022; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Delanoe-Ayari H, 2008, CELL MOTIL CYTOSKEL, V65, P314, DOI 10.1002/cm.20262; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Gomer RH, 2011, DEV GROWTH DIFFER, V53, P482, DOI 10.1111/j.1440-169X.2010.01248.x; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Gruver JS, 2010, BIOPHYS J, V99, P367, DOI 10.1016/j.bpj.2010.03.073; Hickson J, 2009, CLIN EXP METASTAS, V26, P67, DOI 10.1007/s10585-008-9177-z; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Kolbinger A, 2005, EUKARYOT CELL, V4, P991, DOI 10.1128/EC.4.6.991-998.2005; Kruppa M, 2009, MYCOSES, V52, P1, DOI 10.1111/j.1439-0507.2008.01626.x; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Maeda Y, 2005, INT REV CYTOL, V244, P287, DOI 10.1016/S0074-7696(05)44007-3; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; Potdar AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009636; POTEL MJ, 1979, J CELL SCI, V36, P281; Rappel WJ, 2002, BIOPHYS J, V83, P1361, DOI 10.1016/S0006-3495(02)73906-4; Ray S, 2011, CELL SIGNAL, V23, P335, DOI 10.1016/j.cellsig.2010.09.017; Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Soll DR, 2002, J MUSCLE RES CELL M, V23, P659, DOI 10.1023/A:1024459124427; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Tang L, 2002, P NATL ACAD SCI USA, V99, P1371, DOI 10.1073/pnas.022516099; Tang L, 2001, J BIOL CHEM, V276, P27663, DOI 10.1074/jbc.M102205200; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Van Haastert PJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006814; VanHaastert PJM, 1996, J CELL BIOL, V134, P1543, DOI 10.1083/jcb.134.6.1543; Viswanathan GM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011111; Whitney TJ, 2010, GENET MOL RES, V9, P394, DOI 10.4238/vol9-1gmr752	42	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26901	10.1371/journal.pone.0026901	http://dx.doi.org/10.1371/journal.pone.0026901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073217	Green Submitted, Green Published, gold			2022-12-27	WOS:000297197000015
J	Chuck, CP; Chow, HF; Wan, DCC; Wong, KB				Chuck, Chi-Pang; Chow, Hak-Fun; Wan, David Chi-Cheong; Wong, Kam-Bo			Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; IDENTIFICATION; VIRUSES; PROTEINASE; INHIBITOR; GENOME; RATES; HKU1	Background: Coronaviruses (CoVs) can be classified into alphacoronavirus (group 1), betacoronavirus (group 2), and gammacoronavirus (group 3) based on diversity of the protein sequences. Their 3C-like protease (3CL(pro)), which catalyzes the proteolytic processing of the polyproteins for viral replication, is a potential target for anti-coronaviral infection. Methodology/Principal Findings: Here, we profiled the substrate specificities of 3CL(pro) from human CoV NL63 (group 1), human CoV OC43 (group 2a), severe acute respiratory syndrome coronavirus (SARS-CoV) (group 2b) and infectious bronchitis virus (IBV) (group 3), by measuring their activity against a substrate library of 1968 of variants with single substitutions at P5 to P3' positions. The results were correlated with structural properties like side chain volume, hydrophobicity, and secondary structure propensities of substituting residues. All 3CL(pro) prefer Gln at P1 position, Leu at P2 position, basic residues at P3 position, small hydrophobic residues at P4 position, and small residues at P1' and P2' positions. Despite 3CL(pro) from different groups of CoVs share many similarities in substrate specificities, differences in substrate specificities were observed at P4 positions, with IBV 3CL(pro) prefers P4-Pro and SARS-CoV 3CL(pro) prefers P4-Val. By combining the most favorable residues at P3 to P5 positions, we identified super-active substrate sequences 'VARLQ down arrow SGF' that can be cleaved efficiently by all 3CL(pro) with relative activity of 1.7 to 3.2, and 'VPRLQ down arrow SGF' that can be cleaved specifically by IBV 3CL(pro) with relative activity of 4.3. Conclusions/Significance: The comprehensive substrate specificities of 3CL(pro) from each of the group 1, 2a, 2b, and 3 CoVs have been profiled in this study, which may provide insights into a rational design of broad-spectrum peptidomimetic inhibitors targeting the proteases.	[Chuck, Chi-Pang; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chow, Hak-Fun] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Wan, David Chi-Cheong] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chuck, CP (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021; Chow, Hak-Fun/A-9925-2008; Wan, David C/H-3335-2014	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Chow, Hak-Fun/0000-0002-7621-0851; 	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government [09080282]	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government	This work was supported by the Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government (project number: 09080282) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; BEAUDETTE F. R., 1937, Journal of the American Veterinary Medical Association, V90, P51; Binn L N, 1974, Proc Annu Meet U S Anim Health Assoc, P359; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; CHEEVER FS, 1949, J EXP MED, V90, P181, DOI 10.1084/jem.90.3.181; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Chuck CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013197; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Goetz DH, 2007, BIOCHEMISTRY-US, V46, P8744, DOI 10.1021/bi0621415; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Ignjatovic J, 2000, REV SCI TECH OIE, V19, P493, DOI 10.20506/rst.19.2.1228; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lee S, 2008, BIOPHYS CHEM, V134, P185, DOI 10.1016/j.bpc.2008.02.009; Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007; Lin CW, 2004, FEBS LETT, V574, P131, DOI 10.1016/j.febslet.2004.08.017; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; TYRRELL DA, 1966, LANCET, V1, P76; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang HT, 2005, PLOS BIOL, V3, P1742, DOI 10.1371/journal.pbio.0030324; Zhao Q, 2008, J VIROL, V82, P8647, DOI 10.1128/JVI.00298-08; Zhu LL, 2011, ANTIVIR RES, V92, P204, DOI 10.1016/j.antiviral.2011.08.001	38	44	45	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27228	10.1371/journal.pone.0027228	http://dx.doi.org/10.1371/journal.pone.0027228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073294	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900012
J	Qi, F; Wang, C; Liu, YL; Kaleem, I; Li, Q; Li, C				Qi, Feng; Wang, Chao; Liu, Yanli; Kaleem, Imdad; Li, Qian; Li, Chun			Transcriptional Profiling of Protein Expression Related Genes of Pichia pastoris under Simulated Microgravity	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; BIOSYNTHESIS; GLYCYRRHIZIN; DISPLAY; REVEALS; GROWTH; PCR	The physiological responses and transcription profiling of Pichia pastoris GS115 to simulated microgravity (SMG) were substantially changed compared with normal gravity (NG) control. We previously reported that the recombinant P. pastoris grew faster under SMG than NG during methanol induction phase and the efficiencies of recombinant enzyme production and secretion were enhanced under SMG, which was considered as the consequence of changed transcriptional levels of some key genes. In this work, transcriptiome profiling of P. pastoris cultured under SMG and NG conditions at exponential and stationary phases were determined using next-generation sequencing (NGS) technologies. Four categories of 141 genes function as methanol utilization, protein chaperone, RNA polymerase and protein transportation or secretion classified according to Gene Ontology (GO) were chosen to be analyzed on the basis of NGS results. And 80 significantly changed genes were weighted and estimated by Cluster 3.0. It was found that most genes of methanol metabolism (85% of 20 genes) and protein transportation or secretion (82.2% of 45 genes) were significantly up-regulated under SMG. Furthermore the quantity and fold change of up-regulated genes in exponential phase of each category were higher than those of stationary phase. The results indicate that the up-regulated genes of methanol metabolism and protein transportation or secretion mainly contribute to enhanced production and secretion of the recombinant protein under SMG.	[Qi, Feng; Wang, Chao; Liu, Yanli; Kaleem, Imdad; Li, Qian; Li, Chun] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Li, Chun] Shihezi Univ, Sch Chem & Chem Engn, Shihezi, Peoples R China; [Qi, Feng] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China	Beijing Institute of Technology; Shihezi University; Tianjin University Science & Technology	Qi, F (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	lichun@bit.edu.cn	Li, Chun/B-3292-2013	Qi, Feng/0000-0001-6349-179X	Natural Science Foundation of China [20976014]; Natural Science Foundation of Beijing [2112035]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work is supported by Natural Science Foundation of China (20976014) and Natural Science Foundation of Beijing (2112035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PW, 2004, MICROGRAVITY SCI TEC, V15, P39, DOI 10.1007/BF02870967; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Demain AL, 2001, CHEM REC, V1, P333, DOI 10.1002/tcr.1018; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang A, 2000, LETT APPL MICROBIOL, V31, P39; Feng SJ, 2006, J MOL CATAL B-ENZYM, V43, P63, DOI 10.1016/j.molcatb.2006.06.016; Gill RT, 1999, APPL ENVIRON MICROB, V65, P5386; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Johanson K, 2006, BIOTECHNOL BIOENG, V93, P1050, DOI 10.1002/bit.20810; Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4; Lee EJ, 2006, ANAL BIOCHEM, V357, P299, DOI 10.1016/j.ab.2006.06.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; Purevdorj-Gage B, 2006, APPL ENVIRON MICROB, V72, P4569, DOI 10.1128/AEM.03050-05; Qi F, 2011, J CHEM TECHNOL BIOT, V86, P505, DOI 10.1002/jctb.2541; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Sambrook J., 2001, MOL CLONING LAB MANU; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Sreekrishna K, 1997, GENE, V190, P55, DOI 10.1016/S0378-1119(96)00672-5; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104	24	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26613	10.1371/journal.pone.0026613	http://dx.doi.org/10.1371/journal.pone.0026613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073176	gold, Green Submitted, Green Published			2022-12-27	WOS:000297154900027
J	Liu, XL; Song, YX; Lu, HJ; Tang, B; Piao, XY; Hou, N; Peng, S; Jiang, N; Yin, JG; Liu, MY; Chen, QJ				Liu, Xiaolei; Song, Yanxia; Lu, Huijun; Tang, Bin; Piao, Xianyu; Hou, Nan; Peng, Shuai; Jiang, Ning; Yin, Jigang; Liu, Mingyuan; Chen, Qijun			Transcriptome of Small Regulatory RNAs in the Development of the Zoonotic Parasite Trichinella spiralis	PLOS ONE			English	Article							ENDOGENOUS SIRNAS; GENE-EXPRESSION; MICRORNAS; IDENTIFICATION; DROSOPHILA; 21U-RNAS; PATHWAY; PLANT; PIWI; BIOGENESIS	Background: Trichinella spiralis is a parasite with unique features. It is a multicellular organism but with an intracellular parasitization and development stage. T. spiralis is the helminthic pathogen that causes zoonotic trichinellosis and afflicts more than 10 million people worldwide, whereas the parasite's biology, especially the developmental regulation is largely unknown. In other organisms, small non-coding RNAs, such as microRNAs (miRNA) and small interfering RNAs (siRNA) execute post-transcriptional regulation by translational repression or mRNA degradation, and a large number of miRNAs have been identified in diverse species. In T. spiralis, the profile of small non-coding RNAs and their function remains poorly understood. Methodology and Principal Findings: Here, the transcriptional profiles of miRNA and siRNA in three developmental stages of T. spiralis in the rat host were investigated, and compared by high-throughput cDNA sequencing technique ("RNA-seq"). 5,443,641 unique sequence tags were obtained. Of these, 21 represented conserved miRNAs related to 13 previously identified metazoan miRNA families and 213 were novel miRNAs so far unique to T. spiralis. Some of these miRNAs exhibited stage-specific expression. Expression of miRNAs was confirmed in three stages of the life cycle by qRT-PCR and northern blot analysis. In addition, endogenous siRNAs (endo-siRNAs) were found mainly derived from natural antisense transcripts (NAT) and transposable elements (TE) in the parasite. Conclusions and Significance: We provide evidence for the presence of miRNAs and endo-siRNAs in T. spiralis. The miRNAs accounted for the major proportion of the small regulatory RNA population of T. spiralis, while fewer endogenous siRNAs were found. The finding of stage-specific expression patterns of the miRNAs in different developmental stages of T. spiralis suggests that miRNAs may play important roles in parasite development. Our data provide a basis for further understanding of the molecular regulation and functional evolution of miRNAs in parasitic nematodes.	[Liu, Xiaolei; Song, Yanxia; Lu, Huijun; Tang, Bin; Peng, Shuai; Jiang, Ning; Yin, Jigang; Liu, Mingyuan; Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Piao, Xianyu; Hou, Nan; Chen, Qijun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Pathogen Biol, Parasitol Lab, Beijing 100730, Peoples R China; [Song, Yanxia] Jilin Univ, Affiliated Hosp 1, Biol Therapy Ctr, Changchun 130023, Peoples R China	Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College; Jilin University	Liu, XL (corresponding author), Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China.	liumy@jlu.edu.cn; cqj@jlu.edu.cn	yin, jigang/GWV-1397-2022		National Natural Science Foundation of China (NSFC) [30625029, 30825033, 31030064, 30950110328, 81070311]; Institute of Pathogen Biology, CAMS [2008IPB204]; national science and technology specific projects [2008ZX-10004-011, 2008ZX10401]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology, CAMS; national science and technology specific projects	This study was supported by the National Natural Science Foundation of China (NSFC 30625029, 30825033, 31030064, 30950110328, 81070311), the intramural grant from Institute of Pathogen Biology, CAMS (2008IPB204), and the national science and technology specific projects (2008ZX-10004-011, 2008ZX10401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen MX, 2011, EXP PARASITOL, V128, P116, DOI 10.1016/j.exppara.2011.02.019; Chen MX, 2011, PARASITOL RES; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cucher M, 2011, INT J PARASITOL, V41, P439, DOI 10.1016/j.ijpara.2010.11.010; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; DESPOMMIER DD, 1977, PARASITOLOGY, V74, P109, DOI 10.1017/S0031182000047570; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Friedlander MR, 2009, P NATL ACAD SCI USA, V106, P11546, DOI 10.1073/pnas.0905222106; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu MY, 2001, PARASITE, V8, pS34, DOI 10.1051/parasite/200108s2034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998c; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Simoes MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-47; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wakelin D, 1996, INT J PARASITOL, V26, P471, DOI 10.1016/0020-7519(96)89377-5; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Zarlenga DS, 2006, P NATL ACAD SCI USA, V103, P7354, DOI 10.1073/pnas.0602466103; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	63	14	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26448	10.1371/journal.pone.0026448	http://dx.doi.org/10.1371/journal.pone.0026448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22096484	Green Submitted, Green Published, gold			2022-12-27	WOS:000297150900012
J	Abbasi, K; DuBois, KN; Dacks, JB; Field, MC				Abbasi, Kanwal; DuBois, Kelly N.; Dacks, Joel B.; Field, Mark C.			A Novel Rho-Like Protein TbRHP Is Involved in Spindle Formation and Mitosis in Trypanosomes	PLOS ONE			English	Article							AFRICAN TRYPANOSOME; GTPASE FAMILY; LOWE SYNDROME; LIFE-CYCLE; CELL-CYCLE; BRUCEI; CYTOKINESIS; GENOME; HOMOLOG; CRUZI	Background: In animals and fungi Rho subfamily small GTPases are involved in signal transduction, cytoskeletal function and cellular proliferation. These organisms typically possess multiple Rho paralogues and numerous downstream effectors, consistent with the highly complex contributions of Rho proteins to cellular physiology. By contrast, trypanosomatids have a much simpler Rho-signaling system, and the Trypanosoma brucei genome contains only a single divergent Rho-related gene, TbRHP (Tb927.10.6240). Further, only a single RhoGAP-like protein (Tb09.160.4180) is annotated, contrasting with the >70 Rho GAP proteins from Homo sapiens. We wished to establish the function(s) of TbRHP and if Tb09.160.4180 is a potential GAP for this protein. Methods/Findings: TbRHP represents an evolutionarily restricted member of the Rho GTPase clade and is likely trypanosomatid restricted. TbRHP is expressed in both mammalian and insect dwelling stages of T. brucei and presents with a diffuse cytoplasmic location and is excluded from the nucleus. RNAi ablation of TbRHP results in major cell cycle defects and accumulation of multi-nucleated cells, coinciding with a loss of detectable mitotic spindles. Using yeast two hybrid analysis we find that TbRHP interacts with both Tb11.01.3180 (TbRACK), a homolog of Rho-kinase, and the sole trypanosome RhoGAP protein Tb09.160.4180, which is related to human OCRL. Conclusions: Despite minimization of the Rho pathway, TbRHP retains an important role in spindle formation, and hence mitosis, in trypanosomes. TbRHP is a partner for TbRACK and an OCRL-related trypanosome Rho-GAP.	[Abbasi, Kanwal; DuBois, Kelly N.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Cambridge; University of Alberta	Abbasi, K (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mcf34@cam.ac.uk	Dacks, Joel/AAE-3308-2021; Field, Mark/AAD-6455-2021	Dacks, Joel/0000-0003-4520-5694; Field, Mark/0000-0002-4866-2885	Wellcome Trust; Commonwealth Scholarships scheme	Wellcome Trust(Wellcome TrustEuropean Commission); Commonwealth Scholarships scheme	Funding for this work was from the Wellcome Trust and the Commonwealth Scholarships scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Allen CL, 2007, MOL BIOCHEM PARASIT, V156, P175, DOI 10.1016/j.molbiopara.2007.07.020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Castagnetti S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000512; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; de Melo LDB, 2004, BIOCHEM BIOPH RES CO, V323, P1009, DOI 10.1016/j.bbrc.2004.08.197; De Melo LDB, 2006, BIOCHEM BIOPH RES CO, V345, P617, DOI 10.1016/j.bbrc.2006.04.075; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGSTLER M, 2007, TRYPANOSOMES GENOME; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Field MC, 2008, TRENDS PARASITOL, V24, P253, DOI 10.1016/j.pt.2008.03.005; Field MC, 2005, TRENDS PARASITOL, V21, P447, DOI 10.1016/j.pt.2005.08.008; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Loovers HM, 2007, TRAFFIC, V8, P618, DOI 10.1111/j.1600-0854.2007.00546.x; Loovers HM, 2003, J BIOL CHEM, V278, P5652, DOI 10.1074/jbc.M208396200; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Nepomuceno-Silva JL, 2004, GENE, V327, P221, DOI 10.1016/j.gene.2003.11.010; Nepomuceno-Silva JL, 2001, J BIOL CHEM, V276, P29711, DOI 10.1074/jbc.M102920200; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Ploubidou A, 1999, J CELL SCI, V112, P4641; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Swan LE, 2010, P NATL ACAD SCI USA, V107, P3511, DOI 10.1073/pnas.0914658107; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Vlahou G, 2006, EUR J CELL BIOL, V85, P947, DOI 10.1016/j.ejcb.2006.04.011; Wherlock M, 2002, J CELL SCI, V115, P239; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26890	10.1371/journal.pone.0026890	http://dx.doi.org/10.1371/journal.pone.0026890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096505	gold, Green Published, Green Submitted			2022-12-27	WOS:000297553900014
J	Jedlicka, JA; Greenberg, R; Letourneau, DK				Jedlicka, Julie A.; Greenberg, Russell; Letourneau, Deborah K.			Avian Conservation Practices Strengthen Ecosystem Services in California Vineyards	PLOS ONE			English	Article							REDUCE CATERPILLAR DAMAGE; APPLE ORCHARDS; COFFEE FARMS; GREAT TITS; SUN COFFEE; PREDATORS; BIRDS; PEST; BIODIVERSITY; SHADE	Insectivorous Western Bluebirds (Sialia mexicana) occupy vineyard nest boxes established by California winegrape growers who want to encourage avian conservation. Experimentally, the provision of available nest sites serves as an alternative to exclosure methods for isolating the potential ecosystem services provided by foraging birds. We compared the abundance and species richness of avian foragers and removal rates of sentinel prey in treatments with songbird nest boxes and controls without nest boxes. The average species richness of avian insectivores increased by over 50 percent compared to controls. Insectivorous bird density nearly quadrupled, primarily due to a tenfold increase in Western Bluebird abundance. In contrast, there was no significant difference in the abundance of omnivorous or granivorous bird species some of which opportunistically forage on grapes. In a sentinel prey experiment, 2.4 times more live beet armyworms (Spodoptera exigua) were removed in the nest box treatment than in the control. As an estimate of the maximum foraging services provided by insectivorous birds, we found that larval removal rates measured immediately below occupied boxes averaged 3.5 times greater than in the control. Consequently the presence of Western Bluebirds in vineyard nest boxes strengthened ecosystem services to winegrape growers, illustrating a benefit of agroecological conservation practices. Predator addition and sentinel prey experiments lack some disadvantages of predator exclusion experiments and were robust methodologies for detecting ecosystem services.	[Jedlicka, Julie A.; Letourneau, Deborah K.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Greenberg, Russell] Smithsonian Conservat Biol Inst, Migratory Bird Ctr, Washington, DC USA	University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Jedlicka, JA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	julie.jedlicka@gmail.com		Jedlicka, Julie/0000-0003-4691-445X	The Organic Farming Research Foundation; Animal Behavior Society; Wilson Ornithological Society; Smithsonian Migratory Bird Center; Annie's Sustainable Agriculture Graduate Scholarship; Environmental Studies Department at University of California Santa Cruz	The Organic Farming Research Foundation; Animal Behavior Society; Wilson Ornithological Society; Smithsonian Migratory Bird Center(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Annie's Sustainable Agriculture Graduate Scholarship; Environmental Studies Department at University of California Santa Cruz	Funding for this research was provided by: The Organic Farming Research Foundation (http://ofrf.org); Animal Behavior Society (http://animalbehaviorsociety.org); Wilson Ornithological Society (http://www.wilsonsociety.org); Smithsonian Migratory Bird Center (http://nationalzoo.si.edu/scbi/migratorybirds/default.cfm); Annie's Sustainable Agriculture Graduate Scholarship (http://www.annies.com/sustainable_agriculture_scholarship); and the Environmental Studies Department at University of California Santa Cruz (http://envs.ucsc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Bird Conservancy, 2007, TOP 20 MOST THREAT B; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Borkhataria RR, 2006, ECOL APPL, V16, P696, DOI 10.1890/1051-0761(2006)016[0696:AEOVPO]2.0.CO;2; Brown CR, 1992, VIOLET GREEN SWALLOW; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; California Department of Food and Agriculture, 2011, CAL AGR RES DIR 2010; California Department of Food and Agriculture, 2010, CAL AGR PROD STAT 20; California Partners in Flight, 2002, VERS 2 0 OAK WOODL B; Chang GC, 2004, BIOL CONTROL, V31, P453, DOI 10.1016/j.biocontrol.2004.07.009; Cornell Lab of Ornithology, 2008, NESTWATCH; Cossentine JE, 2008, EUR J ENTOMOL, V105, P241, DOI 10.14411/eje.2008.034; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Danne A, 2010, ENVIRON ENTOMOL, V39, P970, DOI 10.1603/EN09144; Dickinson JL, 1996, ANIM BEHAV, V52, P981, DOI 10.1006/anbe.1996.0246; Ehler LE, 2007, BIOCONTROL, V52, P323, DOI 10.1007/s10526-006-9023-7; Englund G, 1997, ECOLOGY, V78, P2316; Evenden M.D., 1995, FOR CONSERV HIST, V39, P172, DOI DOI 10.2307/3983958; Fiehler CM, 2006, WILSON J ORNITHOL, V118, P552, DOI 10.1676/05-066.1; GRADWOHL J, 1982, ECOLOGY, V63, P581, DOI 10.2307/1938974; Greenberg R, 1997, CONSERV BIOL, V11, P448, DOI 10.1046/j.1523-1739.1997.95464.x; Guinan J. A., 2008, W BLUEBIRD SIALIA ME; Hagler JR, 2006, ANN APPL BIOL, V149, P153, DOI 10.1111/j.1744-7348.2006.00076.x; Heaton E., 2000, California Agriculture, V54, P12, DOI 10.3733/ca.v054n03p12; Heaton E., 2008, U CALIFORNIA AGR NAT; Holmes R.T, 1990, STUD AVIAN BIOL, V13, P6; Jacobson SK, 2003, CONSERV BIOL, V17, P595, DOI 10.1046/j.1523-1739.2003.01472.x; Johnson MD, 2010, ANIM CONSERV, V13, P140, DOI 10.1111/j.1469-1795.2009.00310.x; Kellermann JL, 2008, CONSERV BIOL, V22, P1177, DOI 10.1111/j.1523-1739.2008.00968.x; Kirk David A., 1996, Current Ornithology, V13, P175; Koball D, 2010, COMMUNICATION   0120; KOPTUR S, 1984, ECOLOGY, V65, P1787, DOI 10.2307/1937775; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; LETOURNEAU DK, 1983, OECOLOGIA, V60, P122, DOI 10.1007/BF00379331; Martin AC., 1951, AM WILDLIFE PLANTS G; Merenlender A. M., 1998, U CALIFORNIA DIVISIO, V21577; Middleton AL, 1998, CHIPPING SPARROW SPI; MOCK PJ, 1991, CONDOR, V93, P598, DOI 10.2307/1368192; MOCK PJ, 1991, AUK, V108, P34; Mols CMM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000202; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; North American Bluebird Society, 2008, E W BLUEB NESTB; Pearce S, 2006, J APPL ECOL, V43, P128, DOI 10.1111/j.1365-2664.2005.01118.x; Perfecto I, 2004, ECOLOGY, V85, P2677, DOI 10.1890/03-3145; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Prasifka JR, 2006, ENVIRON ENTOMOL, V35, P1423, DOI 10.1603/0046-225X(2006)35[1423:EOLMOP]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ralph CJ, 1993, HDB FIELD METHODS MO; Raynolds LT, 2004, WORLD DEV, V32, P725, DOI 10.1016/j.worlddev.2003.11.008; Stange Christian, 2003, Vogelwelt, V124, P25; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Toops C, 1994, BLUEBIRDS FOREVER; University of California Agriculture and Natural Resources, 1992, U CAL AGR NAT RES PU, V3343; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Walker KR, 2004, ENVIRON ENTOMOL, V33, P1327, DOI 10.1603/0046-225X-33.5.1327; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Winkler D. W., 2011, TREE SWALLOW TACHYCI	58	79	81	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27347	10.1371/journal.pone.0027347	http://dx.doi.org/10.1371/journal.pone.0027347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096555	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800046
J	Ohmi, K; Zhao, HZ; Neufeld, EF				Ohmi, Kazuhiro; Zhao, Hui-Zhi; Neufeld, Elizabeth F.			Defects in the Medial Entorhinal Cortex and Dentate Gyrus in the Mouse Model of Sanfilippo Syndrome Type B	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS IIIB MICE; ALPHA-N-ACETYLGLUCOSAMINIDASE; HEPARAN-SULFATE PROTEOGLYCANS; MITOCHONDRIAL ATP SYNTHASE; LYSOSOMAL STORAGE DISEASE; GENE DELIVERY; MPS IIIB; NEUROLOGICAL DISEASE; ALZHEIMERS-DISEASE; MURINE MODEL	Sanfilippo syndrome type B (MPS IIIB) is characterized by profound mental retardation in childhood, dementia and death in late adolescence; it is caused by deficiency of alpha-N-acetylglucosaminidase and resulting lysosomal storage of heparan sulfate. A mouse model, generated by homologous recombination of the Naglu gene, was used to study pathological changes in the brain. We found earlier that neurons in the medial entorhinal cortex (MEC) and the dentate gyrus showed a number of secondary defects, including the presence of hyperphosphorylated tau (Ptau) detected with antibodies raised against Ptau in Alzheimer disease brain. By further use of immunohistochemistry, we now show staining in neurons of the same area for beta amyloid, extending the resemblance to Alzheimer disease. Ptau inclusions in the dentate gyrus of MPS IIIB mice were reduced in number when the mice were administered LiCl, a specific inhibitor of Gsk3 beta. Additional proteins found elevated in MEC include proteins involved in autophagy and the heparan sulfate proteoglycans, glypicans 1 and 5, the latter closely related to the primary defect. The level of secondary accumulations was associated with elevation of glypican, as seen by comparing brains of mice at different ages or with different mucopolysaccharide storage diseases. The MEC of an MPS IIIA mouse had the same intense immunostaining for glypican 1 and other markers as MPS IIIB, while MEC of MPS I and MPS II mice had weak staining, and MEC of an MPS VI mouse had no staining at all for the same proteins. A considerable amount of glypican was found in MEC of MPS IIIB mice outside of lysosomes. We propose that it is the extralysosomal glypican that would be harmful to neurons, because its heparan sulfate branches could potentiate the formation of Ptau and beta amyloid aggregates, which would be toxic as well as difficult to degrade.	[Ohmi, Kazuhiro; Zhao, Hui-Zhi; Neufeld, Elizabeth F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ohmi, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	eneufeld@mednet.ucla.edu			National Institutes of Health [NS022376]; Children's Medical Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Research Foundation	The work was funded by a grant from the National Institutes of Health (NS022376) and a grant from the Children's Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; [Anonymous], 2006, ALL MOUS BRAIN ATL; Arrasate M, 1997, AM J PATHOL, V151, P1115; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Di Domenico C, 2009, AM J MED GENET A, V149A, P1209, DOI 10.1002/ajmg.a.32861; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Fu H, 2007, GENE THER, V14, P1065, DOI 10.1038/sj.gt.3302961; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Fu HY, 2010, J GENE MED, V12, P624, DOI 10.1002/jgm.1480; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Killedar S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-39; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Li XH, 2005, J NEUROCHEM, V92, P701, DOI 10.1111/j.1471-4159.2004.02898.x; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; McCarty DM, 2009, GENE THER, V16, P1340, DOI 10.1038/gt.2009.85; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Vitry S, 2010, AM J PATHOL, V177, P2984, DOI 10.2353/ajpath.2010.100447; WANG QM, 1994, J BIOL CHEM, V269, P14566; Yu WH, 2000, MOL GENET METAB, V71, P573, DOI 10.1006/mgme.2000.3095; Zheng Y, 2004, MOL GENET METAB, V82, P286, DOI 10.1016/j.ymgme.2004.06.004	43	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27461	10.1371/journal.pone.0027461	http://dx.doi.org/10.1371/journal.pone.0027461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096577	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800054
J	Steirer, LM; Moe, GR				Steirer, Lindsay M.; Moe, Gregory R.			An Antibody to De-N-Acetyl Sialic Acid Containing-Polysialic Acid Identifies an Intracellular Antigen and Induces Apoptosis in Human Cancer Cell Lines	PLOS ONE			English	Article							GROUP-B POLYSACCHARIDE; GROWTH-FACTOR RECEPTOR; MENINGITIDIS GROUP-B; HUMAN-MELANOMA CELLS; ADHESION MOLECULE; MONOCLONAL-ANTIBODIES; GD3 GANGLIOSIDE; LUNG-CANCER; EXPRESSION; NEUROBLASTOMA	Polysialic acid (PSA), an alpha 2,8-linked homopolymer of N-acetylneuraminic acid (Neu5Ac), is developmentally regulated and its expression is thought to be restricted to a few tissues in adults. Recently, we showed that two human pathogens expressed a derivative of PSA containing de-N-acetyl sialic acid residues (NeuPSA). Here we show that an epitope identified by the anti-NeuPSA monoclonal antibody, SEAM 3 (SEAM 3-reactive antigen or S3RA), is expressed in human melanomas, and also intracellularly in a human melanoma cell line (SK-MEL-28), a human T cell leukemia cell line (Jurkat), and two neuroblastoma cell lines (CHP-134 and SH-SY5Y). SEAM 3 binding induced apoptosis in the four cell lines tested. The unusual intracellular distribution of S3RA was similar to that described for the PSA polysialyltransferases, STX and PST, which are also expressed in the four cell lines used here. Interestingly, suppression of PST mRNA expression by transfection of SK-MEL-28 cells with PST-specific short interfering RNA (siRNA) resulted in decreased SEAM 3 binding. The results suggest further studies of the utility of antibodies such as SEAM 3 as therapeutic agents for certain malignancies.	[Steirer, Lindsay M.; Moe, Gregory R.] CHORI, Ctr Canc, Oakland, CA USA; [Moe, Gregory R.] CHORI, Immunobiol & Vaccine Dev, Oakland, CA USA	Children's Hospital Oakland Research Institute; Children's Hospital Oakland Research Institute	Steirer, LM (corresponding author), CHORI, Ctr Canc, Oakland, CA USA.	gmoe@chori.org			NIH NIAID [AI064314]; NIH NCRR [CO6 RR-16226, S10RR025472]; Children's Hospital Branches, Inc.; NIH NHLBI [T-32 5T32DK078514-09]; Swim Across America San Francisco Bay Area; Jennifer Leigh Wells Family; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064314, R56AI064314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK078514] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital Branches, Inc.; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swim Across America San Francisco Bay Area; Jennifer Leigh Wells Family; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by NIH NIAID grant number AI064314 (www.niaid.nih.gov/Pages/default.aspx), NIH NCRR grant numbers CO6 RR-16226 and S10RR025472 (www.ncrr.nih.gov), Children's Hospital Branches, Inc. (www.childrenshospitalbranches.org), NIH NHLBI T-32 5T32DK078514-09 (grants.nih.gov/training/nrsa.htm), Swim Across America San Francisco Bay Area (www.swimacrossamerica.org), and the Jennifer Leigh Wells Family (www.moonlight4meningitis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2002, IEEE T MED IMAGING, V21, P296, DOI 10.1109/TMI.2002.1000254; Amoureux MC, BMC CANC, V10, P91; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRODIN T, 1985, BIOCHIM BIOPHYS ACTA, V837, P349, DOI 10.1016/0005-2760(85)90059-1; Chammas R, 1999, CANCER RES, V59, P1337; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Debarbieux S, 2009, ACTA DERMATOVENER CR, V17, P209; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Flitter BA, 2010, VACCINE, V28, P5967, DOI 10.1016/j.vaccine.2010.06.119; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gluer S, 1998, PEDIATR RES, V43, P145, DOI 10.1203/00006450-199801000-00022; Granoff DM, 1998, J IMMUNOL, V160, P5028; HANAI N, 1987, BIOCHEM BIOPH RES CO, V147, P127, DOI 10.1016/S0006-291X(87)80096-7; HANAI N, 1988, J BIOL CHEM, V263, P6296; Iovannisci DM, 2010, J EUKARYOT MICROBIOL, V57, P405, DOI 10.1111/j.1550-7408.2010.00496.x; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kang Y, 2006, GLYCOBIOLOGY, V16, P375, DOI 10.1093/glycob/cwj087; Korja M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-57; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; MANDRELL RE, 1982, J IMMUNOL, V129, P2172; MANZI AE, 1990, J BIOL CHEM, V265, P13091; Moe GR, 2006, MOL IMMUNOL, V43, P1424, DOI 10.1016/j.molimm.2005.07.033; Moe GR, 2005, INFECT IMMUN, V73, P2123, DOI 10.1128/IAI.73.4.2123-2128.2005; Moe GR, 2009, J IMMUNOL, V182, P6610, DOI 10.4049/jimmunol.0803677; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Petridis AK, 2009, ACTA NEUROCHIR, V151, P601, DOI 10.1007/s00701-009-0324-3; Popa I, 2007, GLYCOBIOLOGY, V17, P367, DOI 10.1093/glycob/cwm006; ROTH J, 1988, AM J PATHOL, V133, P227; Ruan ST, 1999, J NEUROCHEM, V72, P514, DOI 10.1046/j.1471-4159.1999.0720514.x; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Seidenfaden R, 2001, J NEUROBIOL, V46, P11, DOI 10.1002/1097-4695(200101)46:1<11::AID-NEU2>3.0.CO;2-#; SJOBERG ER, 1995, J BIOL CHEM, V270, P2921, DOI 10.1074/jbc.270.7.2921; Sonnenburg JL, 2002, J BIOL CHEM, V277, P17502, DOI 10.1074/jbc.M110867200; Tanaka F, 2000, CANCER RES, V60, P3072; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZHOU QG, 1994, J BIOL CHEM, V269, P1959; ZUBER C, 1992, J BIOL CHEM, V267, P9965	44	4	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27249	10.1371/journal.pone.0027249	http://dx.doi.org/10.1371/journal.pone.0027249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096542	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800039
J	Wantia, N; Rodriguez, N; Cirl, C; Ertl, T; Durr, S; Layland, LE; Wagner, H; Miethke, T				Wantia, Nina; Rodriguez, Nuria; Cirl, Christine; Ertl, Tanja; Duerr, Susanne; Layland, Laura E.; Wagner, Hermann; Miethke, Thomas			Toll-Like Receptors 2 and 4 Regulate the Frequency of IFN gamma-Producing CD4(+) T-Cells during Pulmonary Infection with Chlamydia pneumoniae	PLOS ONE			English	Article							MYD88-DEFICIENT DENDRITIC CELLS; IN-VIVO; ACTIVATION; TLR2; MACROPHAGES; ENDOTOXIN; INNATE; ALPHA	TLR2 and TLR4 are crucial for recognition of Chlamydia pneumoniae in vivo, since infected TLR2/4 double-deficient mice are unable to control the infection as evidenced by severe loss of body weight and progressive lethal pneumonia. Unexpectedly, these mice display higher pulmonary levels of the protective cytokine IFN gamma than wild type mice. We show here, that antigen-specific CD4(+) T-cells are responsible for the observed IFN gamma-secretion in vivo and their frequency is higher in TLR2/4 double-deficient than in wild type mice. The capacity of TLR2/4 double-deficient dendritic cells to re-stimulate CD4(+) T-cells did not differ from wild type dendritic cells. However, the frequency of CD4(+)CD25(+)Foxp3(+) T-cells was considerably higher in wild type compared to TLR2/4 double-deficient mice and was inversely related to the number of IFN gamma-secreting CD4(+) effector T-cells. Despite increased IFN gamma-levels, at least one IFN gamma-mediated response, protective NO-secretion, could not be induced in the absence of TLR2 and 4. In summary, CD4(+)CD25(+)Foxp3(+) regulatory T-cells fail to expand in the absence of TLR2 and TLR4 during pulmonary infection with C. pneumoniae, which in turn enhances the frequency of CD4(+)IFN gamma(+) effector T-cells. Failure of IFN gamma to induce NO in TLR2/4 double-deficient cells represents one possible mechanism why TLR2/4 double-deficient mice are unable to control pneumonia caused by C. pneumoniae and succumb to the infection.	[Wantia, Nina; Rodriguez, Nuria; Cirl, Christine; Ertl, Tanja; Duerr, Susanne; Layland, Laura E.; Wagner, Hermann; Miethke, Thomas] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Munich, Germany	Technical University of Munich	Wantia, N (corresponding author), Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Munich, Germany.	Thomas.Miethke@mikrobio.med.tum.de			Bayerische Forschungsstiftung, FORINGEN [VA5]	Bayerische Forschungsstiftung, FORINGEN	The work was supported by the Bayerische Forschungsstiftung, FORINGEN, Project VA5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; da Costa CUP, 2004, EUR J IMMUNOL, V34, P2874, DOI 10.1002/eji.200425101; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Rodriguez N, 2005, J IMMUNOL, V174, P4836, DOI 10.4049/jimmunol.174.8.4836; Rodriguez N, 2008, J LEUKOCYTE BIOL, V84, P1585, DOI 10.1189/jlb.0508304; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rothfuchs AG, 2004, J IMMUNOL, V172, P2407, DOI 10.4049/jimmunol.172.4.2407; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SUMMERSGILL JT, 1995, INFECT IMMUN, V63, P2801, DOI 10.1128/IAI.63.7.2801-2803.1995; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200	23	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26101	10.1371/journal.pone.0026101	http://dx.doi.org/10.1371/journal.pone.0026101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096480	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800004
J	Rostami, E; Krueger, F; Zoubak, S; Dal Monte, O; Raymont, V; Pardini, M; Hodgkinson, CA; Goldman, D; Risling, M; Grafman, J				Rostami, Elham; Krueger, Frank; Zoubak, Serguei; Dal Monte, Olga; Raymont, Vanessa; Pardini, Matteo; Hodgkinson, Colin A.; Goldman, David; Risling, Marten; Grafman, Jordan			BDNF Polymorphism Predicts General Intelligence after Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GENE; FACTOR VAL66MET POLYMORPHISM; TRKB MESSENGER-RNA; BIPOLAR DISORDER; CONFERS SUSCEPTIBILITY; MOLECULAR-CLONING; APOLIPOPROTEIN-E; CANDIDATE GENES; HUMAN-MEMORY; ASSOCIATION	Neuronal plasticity is a fundamental factor in cognitive outcome following traumatic brain injury. Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, plays an important role in this process. While there are many ways to measure cognitive outcome, general cognitive intelligence is a strong predictor of everyday decision-making, occupational attainment, social mobility and job performance. Thus it is an excellent measure of cognitive outcome following traumatic brain injury (TBI). Although the importance of the single-nucleotide polymorphisms polymorphism on cognitive function has been previously addressed, its role in recovery of general intelligence following TBI is unknown. We genotyped male Caucasian Vietnam combat veterans with focal penetrating TBI (pTBI) (n = 109) and non-head injured controls (n = 38) for 7 BDNF single-nucleotide polymorphisms. Subjects were administrated the Armed Forces Qualification Test (AFQT) at three different time periods: pre-injury on induction into the military, Phase II (10-15 years post-injury, and Phase III (30-35 years post-injury). Two single-nucleotide polymorphisms, rs7124442 and rs1519480, were significantly associated with post-injury recovery of general cognitive intelligence with the most pronounced effect at the Phase II time point, indicating lesion-induced plasticity. The genotypes accounted for 5% of the variance of the AFQT scores, independently of other significant predictors such as pre-injury intelligence and percentage of brain volume loss. These data indicate that genetic variations in BDNF play a significant role in lesion-induced recovery following pTBI. Identifying the underlying mechanism of this brain-derived neurotrophic factor effect could provide insight into an important aspect of post-traumatic cognitive recovery.	[Rostami, Elham; Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Dal Monte, Olga] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, NIH, Bethesda, MD USA; [Zoubak, Serguei; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Zoubak, Serguei] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Pardini, Matteo] Univ Genoa, Dept Neurosci Ophtalmol & Genet, Genoa, Italy; [Pardini, Matteo] Univ Genoa, Magnet Resonance Res Ctr Nervous Syst Dis, Genoa, Italy; [Zoubak, Serguei] Henry Jackson Fdn Adv Mil Med, Rockville, MD USA; [Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ USA; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Karolinska Institutet; George Mason University; George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Uniformed Services University of the Health Sciences - USA; University of Genoa; University of Genoa; Kessler Institute for Rehabilitation; Johns Hopkins University; Imperial College London	Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	jgrafman@kesslerfoundation.org	Goldman, David/F-9772-2010; Pardini, Matteo/F-8414-2010; Majid, Salma/AAT-2616-2020; Dal Monte, Olga/P-3759-2018	Goldman, David/0000-0002-1724-5405; Pardini, Matteo/0000-0002-4740-1982; Majid, Salma/0000-0002-1724-5405; Dal Monte, Olga/0000-0002-7823-4769; Hodgkinson, Colin/0000-0002-5365-8119; Grafman, Jordan H./0000-0001-8645-4457	U.S. National Institute of Neurological Disorders and Stroke; U.S. Army Medical Research and Material Command; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the U.S. National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the U.S. Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study). No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Conner JM, 1997, J NEUROSCI, V17, P2295; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Domschke K, 2010, INT J NEUROPSYCHOPH, V13, P93, DOI 10.1017/S1461145709000030; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Faul MXL, 2010, TRAUMATIC BRAIN INJU, P1; FLOOD DG, 1988, NEUROBIOL AGING, V9, P453, DOI 10.1016/S0197-4580(88)80098-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao BL, 2000, J NEUROPSYCH CLIN N, V12, P385, DOI 10.1176/appi.neuropsych.12.3.385; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hayashi M, 2001, BRAIN RES, V918, P191, DOI 10.1016/S0006-8993(01)03002-5; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kadish I, 2009, J ALZHEIMERS DIS, V18, P429, DOI 10.3233/JAD-2009-1157; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kaufman A.S., 2006, ASSESSING ADOLESCENT, V3rd; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kolb B, 1995, BRAIN PLASTICITY BEH; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lemos C, 2010, CEPHALALGIA, V30, P1375, DOI 10.1177/0333102410368443; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu LX, 2008, PSYCHIAT GENET, V18, P267, DOI 10.1097/YPG.0b013e3283060f59; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; Luikart BW, 2006, PROG BRAIN RES, V157, P15, DOI 10.1016/S0079-6123(06)57002-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nishimura K, 2007, BIOCHEM BIOPH RES CO, V356, P200, DOI 10.1016/j.bbrc.2007.02.135; Okada T, 2006, MOL PSYCHIATR, V11, P695, DOI 10.1038/sj.mp.4001822; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Resnick SM, 2003, J NEUROSCI, V23, P3295; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ronnlund M, 2006, INTELLIGENCE, V34, P63, DOI 10.1016/j.intell.2005.06.004; Ryan JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P311, DOI 10.1016/S0887-6177(99)00019-0; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Seitz RJ, 2005, ACT NEUR S, V93, P65; Shimada A, 1999, NEUROBIOL AGING, V20, P125, DOI 10.1016/S0197-4580(99)00044-5; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Szczepankiewicz A, 2009, INT ARCH ALLERGY IMM, V149, P343, DOI 10.1159/000205580; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Toulopoulou T, 2004, BIOL PSYCHIAT, V56, P447, DOI 10.1016/j.biopsych.2004.06.026; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P13, DOI 10.1159/000075333; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volkow ND, 1998, ANN NEUROL, V44, P143, DOI 10.1002/ana.410440125; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D, 1958, MEASUREMENT APPRAISA; Wechsler D., 1939, MEASUREMENT ADULT IN; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Xiromerisiou G, 2007, NEUROSCI LETT, V415, P59, DOI 10.1016/j.neulet.2006.12.038	97	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27389	10.1371/journal.pone.0027389	http://dx.doi.org/10.1371/journal.pone.0027389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087305	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700038
J	Marban, C; Su, T; Ferrari, R; Li, B; Vatakis, D; Pellegrini, M; Zack, JA; Rohr, O; Kurdistani, SK				Marban, Celine; Su, Trent; Ferrari, Roberto; Li, Bing; Vatakis, Dimitrios; Pellegrini, Matteo; Zack, Jerome A.; Rohr, Olivier; Kurdistani, Siavash K.			Genome-Wide Binding Map of the HIV-1 Tat Protein to the Human Genome	PLOS ONE			English	Article							REPRESSES TRANSCRIPTION; EXPRESSION; GENE; INCREASES; SEQUENCES; KINASE; ETS-1	The HIV-1 Trans-Activator of Transcription (Tat) protein binds to multiple host cellular factors and greatly enhances the level of transcription of the HIV genome. While Tat's control of viral transcription is well-studied, much less is known about the interaction of Tat with the human genome. Here, we report the genome-wide binding map of Tat to the human genome in Jurkat T cells using chromatin immunoprecipitation combined with next-generation sequencing. Surprisingly, we found that similar to 53% of the Tat target regions are within DNA repeat elements, greater than half of which are Alu sequences. The remaining target regions are located in introns and distal intergenic regions; only similar to 7% of Tat-bound regions are near transcription start sites (TSS) at gene promoters. Interestingly, Tat binds to promoters of genes that, in Jurkat cells, are bound by the ETS1 transcription factor, the CBP histone acetyltransferase and/or are enriched for histone H3 lysine 4 tri-methylation (H3K4me3) and H3K27me3. Tat binding is associated with genes enriched with functions in T cell biology and immune response. Our data reveal that Tat's interaction with the host genome is more extensive than previously thought, with potentially important implications for the viral life cycle.	[Marban, Celine; Rohr, Olivier] Univ Strasbourg, Inst Virol, Strasbourg, France; [Marban, Celine; Su, Trent; Ferrari, Roberto; Li, Bing; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Su, Trent] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Vatakis, Dimitrios; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA USA; [Pellegrini, Matteo; Zack, Jerome A.; Kurdistani, Siavash K.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Rohr, Olivier] Inst Univ France IUF, Paris, France; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Institut Universitaire de France; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Marban, C (corresponding author), Univ Strasbourg, Inst Virol, Strasbourg, France.	olivier.rohr@unistra.fr; skurdistani@mednet.ucla.edu	Ferrari, Roberto/O-8143-2015; Vatakis, Dimitrios/AAD-1257-2020; Li, Bing/B-7056-2013	Ferrari, Roberto/0000-0002-0453-0899; Vatakis, Dimitrios/0000-0002-7255-0226; Pellegrini, Matteo/0000-0001-9355-9564; Kurdistani, Siavash/0000-0003-3295-3511; ROHR, Olivier/0000-0001-8992-2025	Agence Nationale de Recherche sur le Sida; Howard Hughes Medical Institute; National Institutes of Health (NIH); California Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Marban was supported in part by a fellowship from the Agence Nationale de Recherche sur le Sida. This work was also supported by a Howard Hughes Medical Institute award, and a National Institutes of Health (NIH) Innovator award as well as a California Institute for Regenerative Medicine grant to Dr. Kurdistani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Caldwell RL, 2000, J IMMUNOL, V165, P7035, DOI 10.4049/jimmunol.165.12.7035; CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372; Carroll IR, 1998, MOL IMMUNOL, V35, P1171, DOI 10.1016/S0161-5890(98)00107-2; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JANG KL, 1992, J ACQ IMMUN DEF SYND, V5, P1142; Jeang K T, 1991, AIDS, V5 Suppl 2, pS3, DOI 10.1097/00002030-199101001-00002; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601	25	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26894	10.1371/journal.pone.0026894	http://dx.doi.org/10.1371/journal.pone.0026894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073215	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200022
J	Ruby, MA; Nomura, DK; Hudak, CSS; Barber, A; Casida, JE; Krauss, RM				Ruby, Maxwell A.; Nomura, Daniel K.; Hudak, Carolyn S. S.; Barber, Anne; Casida, John E.; Krauss, Ronald M.			Acute Overactive Endocannabinoid Signaling Induces Glucose Intolerance, Hepatic Steatosis, and Novel Cannabinoid Receptor 1 Responsive Genes	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; CB1 RECEPTOR; INSULIN-RESISTANCE; OVERWEIGHT PATIENTS; METABOLIC SYNDROME; RIMONABANT; ACTIVATION; SYSTEM; ANTAGONIST; BLOCKADE	Endocannabinoids regulate energy balance and lipid metabolism by stimulating the cannabinoid receptor type 1 (CB1). Genetic deletion and pharmacological antagonism have shown that CB1 signaling is necessary for the development of obesity and related metabolic disturbances. However, the sufficiency of endogenously produced endocannabinoids to cause hepatic lipid accumulation and insulin resistance, independent of food intake, has not been demonstrated. Here, we show that a single administration of isopropyl dodecylfluorophosphonate (IDFP), perhaps the most potent pharmacological inhibitor of endocannabinoid degradation, increases hepatic triglycerides (TG) and induces insulin resistance in mice. These effects involve increased CB1 signaling, as they are mitigated by pre-administration of a CB1 antagonist (AM251) and in CB1 knockout mice. Despite the strong physiological effects of CB1 on hepatic lipid and glucose metabolism, little is known about the downstream targets responsible for these effects. To elucidate transcriptional targets of CB1 signaling, we performed microarrays on hepatic RNA isolated from DMSO (control), IDFP and AM251/IDFP-treated mice. The gene for the secreted glycoprotein lipocalin 2 (lcn2), which has been implicated in obesity and insulin resistance, was among those most responsive to alterations in CB1 signaling. The expression pattern of IDFP mice segregated from DMSO mice in hierarchal cluster analysis and AM251 pre-administration reduced (>50%) the majority (303 of 533) of the IDFP induced alterations. Pathway analysis revealed that IDFP altered expression of genes involved in lipid, fatty acid and steroid metabolism, the acute phase response, and amino acid metabolism in a CB1-dependent manner. PCR confirmed array results of key target genes in multiple independent experiments. Overall, we show that acute IDFP treatment induces hepatic TG accumulation and insulin resistance, at least in part through the CB1 receptor, and identify novel cannabinoid responsive genes.	[Ruby, Maxwell A.; Barber, Anne; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA; [Nomura, Daniel K.; Hudak, Carolyn S. S.; Casida, John E.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Ruby, MA (corresponding author), Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, 747 52nd St, Oakland, CA 94609 USA.	rkrauss@chori.org		Ruby, Maxwell/0000-0003-4790-590X	Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute; Sanofi-Aventis	Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute; Sanofi-Aventis(Sanofi-Aventis)	This work was supported by the Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute (R.M.K.). J.E.C. acknowledges the University of California Berkeley William Muriece Hoskins Chair in Chemical and Molecular Entomology. The microarrays were funded by Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Caraceni P, 2009, GUT, V58, P1135, DOI 10.1136/gut.2007.147652; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Croci T, 2003, BRIT J PHARMACOL, V140, P115, DOI 10.1038/sj.bjp.0705412; De Gottardi A, 2010, LIVER INT, V30, P1482, DOI 10.1111/j.1478-3231.2010.02298.x; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; HOLLISTER LE, 1974, CLIN PHARMACOL THER, V16, P297; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; MELLER D, 1981, CAN MED ASSOC J, V124, P745; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Segall Y, 2003, TOXICOL SCI, V76, P131, DOI 10.1093/toxsci/kfg216; Seifert J, 2001, B ENVIRON CONTAM TOX, V67, P463, DOI 10.1007/s001280146; Shobha T R, 2000, J Assoc Physicians India, V48, P1197; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Taschler U, 2011, J BIOL CHEM; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Ueyama J, 2008, TOXICOL LETT, V182, P42, DOI 10.1016/j.toxlet.2008.08.004; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Van Gaal LF, 2008, EUR HEART J, V29, P1761, DOI 10.1093/eurheartj/ehn076; ZADIK Z, 1983, J TOXICOL-CLIN TOXIC, V20, P381, DOI 10.3109/15563658308990606; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	62	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26415	10.1371/journal.pone.0026415	http://dx.doi.org/10.1371/journal.pone.0026415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073164	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000297198200011
J	Yount, NY; Cohen, SE; Kupferwasser, D; Waring, AJ; Ruchala, P; Sharma, S; Wasserman, K; Jung, CL; Yeaman, MR				Yount, Nannette Y.; Cohen, Samuel E.; Kupferwasser, Deborah; Waring, Alan J.; Ruchala, Piotr; Sharma, Shantanu; Wasserman, Karlman; Jung, Chun-Ling; Yeaman, Michael R.			Context Mediates Antimicrobial Efficacy of Kinocidin Congener Peptide RP-1	PLOS ONE			English	Article							PLATELET MICROBICIDAL PROTEIN-1; MOLECULAR-DYNAMICS SIMULATIONS; SOLID-STATE NMR; STAPHYLOCOCCUS-AUREUS; CANDIDA-ALBICANS; LIPID-BILAYERS; MEMBRANE; MECHANISMS; SUSCEPTIBILITY; CONFORMATION	Structure-mechanism relationships are key determinants of host defense peptide efficacy. These relationships are influenced by anatomic, physiologic and microbiologic contexts. Structure-mechanism correlates were assessed for the synthetic peptide RP-1, modeled on microbicidal domains of platelet kinocidins. Antimicrobial efficacies and mechanisms of action against susceptible ((S)) or resistant ((R)) Salmonella typhimurium (ST), Staphylococcus aureus (SA), and Candida albicans (CA) strain pairs were studied at pH 7.5 and 5.5. Although RP-1 was active against all study organisms, it exhibited greater efficacy against bacteria at pH 7.5, but greater efficacy against CA at pH 5.5. RP-1 de-energized SA and CA, but caused hyperpolarization of ST in both pH conditions. However, RP-1 permeabilized ST(S) and CA strains at both pH, whereas permeabilization was modest for ST(R) or SA strain at either pH. Biochemical analysis, molecular modeling, and FTIR spectroscopy data revealed that RP-1 has indistinguishable net charge and backbone trajectories at pH 5.5 and 7.5. Yet, concordant with organism-specific efficacy, surface plasmon resonance, and FTIR, molecular dynamics revealed modest helical order increases but greater RP-1 avidity and penetration of bacterial than eukaryotic lipid systems, particularly at pH 7.5. The present findings suggest that pH- and target-cell lipid contexts influence selective antimicrobial efficacy and mechanisms of RP-1 action. These findings offer new insights into selective antimicrobial efficacy and context-specificity of antimicrobial peptides in host defense, and support design strategies for potent anti-infective peptides with minimal concomitant cytotoxicity.	[Yount, Nannette Y.; Cohen, Samuel E.; Kupferwasser, Deborah; Yeaman, Michael R.] Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Infect Dis, Torrance, CA USA; [Yount, Nannette Y.; Cohen, Samuel E.; Kupferwasser, Deborah; Waring, Alan J.; Wasserman, Karlman; Yeaman, Michael R.] Univ Calif Los Angeles Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst Harbor, Torrance, CA USA; [Cohen, Samuel E.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Wasserman, Karlman] Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Pulm Crit Care Med, Torrance, CA USA; [Waring, Alan J.; Ruchala, Piotr; Jung, Chun-Ling; Yeaman, Michael R.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Waring, Alan J.] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Irvine, CA 92717 USA; [Sharma, Shantanu] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Waring, Alan J.; Yeaman, Michael R.] Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Mol Med, Torrance, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Yount, NY (corresponding author), Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Infect Dis, Torrance, CA USA.	MRYeaman@ucla.edu		Yount, Nannette/0000-0002-7079-5211; RUCHALA, PIOTR/0000-0002-5574-2779	National Institute of Health [AI-39001, AI-48031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048031, R29AI039001, R01AI039001] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in-part by National Institute of Health grants AI-39001 and AI-48031 (MY). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Bayer AS, 2006, J BACTERIOL, V188, P211, DOI 10.1128/JB.188.1.211-222.2006; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Dorn A, 2005, J BIOMOL SCREEN, V10, P339, DOI 10.1177/1087057104272045; Elmore DE, 2010, BIOCHEM MOL BIOL EDU, V38, P216, DOI 10.1002/bmb.20396; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; FU Y, 2005, SSD1 IS INTEGRAL ANT; Gautier R, 2004, NUCLEIC ACIDS RES, V32, pW508, DOI 10.1093/nar/gkh388; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Guyton A., 2005, TXB MED PHYSL, P1104; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Harrick N.J., 1967, INTERNAL REFLECTION; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; HESS M, 2008, J CHEM THEORY COMPUT, V4; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Katzif S, 2003, INFECT IMMUN, V71, P4304, DOI 10.1128/IAI.71.8.4304-4312.2003; Kauppine J, 1981, APPL SPECTROSC, V35, P272; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Lipp MM, 1996, SCIENCE, V273, P1196, DOI 10.1126/science.273.5279.1196; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Marx F, 2008, CELL MOL LIFE SCI, V65, P445, DOI 10.1007/s00018-007-7364-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Shai Y, 2001, PEPTIDES, V22, P1629, DOI 10.1016/S0196-9781(01)00498-3; Slack M, 2006, J BIOMOL SCREEN, V11, P57, DOI 10.1177/1087057105282712; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; WAUGH A, 2007, NATOMY PHYSL HLTH IL; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Xiong YQ, 2006, ANTIMICROB AGENTS CH, V50, P3786, DOI 10.1128/AAC.00038-06; Yamaguchi S, 2002, BIOCHEMISTRY-US, V41, P9852, DOI 10.1021/bi0257991; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeaman MR, 2005, ASM NEWS, V71, P21; Yeaman MR, 2004, ANTIMICROB AGENTS CH, V48, P3051, DOI 10.1128/AAC.48.8.3051-3056.2004; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883, DOI 10.1128/AAC.46.12.3883-3891.2002; YEAMAN MR, 2009, EFFICACY INTRAVENOUS; Yount NY, 2007, BBA-BIOMEMBRANES, V1768, P598, DOI 10.1016/j.bbamem.2006.11.011; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Yount NY, 2004, ANTIMICROB AGENTS CH, V48, P4395, DOI 10.1128/AAC.48.11.4395-4404.2004; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zidovetzki R, 2003, BIOPHYS CHEM, V100, P555, DOI 10.1016/S0301-4622(02)00306-X; Zurgil N, 2000, BIOCHEM BIOPH RES CO, V268, P155, DOI 10.1006/bbrc.1999.1934	52	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26727	10.1371/journal.pone.0026727	http://dx.doi.org/10.1371/journal.pone.0026727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073187	gold, Green Published, Green Accepted			2022-12-27	WOS:000297198200018
J	Carvalho, RN; Bopp, SK; Lettieri, T				Carvalho, Raquel N.; Bopp, Stephanie K.; Lettieri, Teresa			Transcriptomics Responses in Marine Diatom Thalassiosira pseudonana Exposed to the Polycyclic Aromatic Hydrocarbon Benzo[a]pyrene	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; CELL-DEATH; DIHYDRODIOL DEHYDROGENASE; PROTEOMIC ANALYSIS; DNA; PROTEIN; GENOME; STRESS; BENZO<A>PYRENE; ECOTOXICOLOGY	Diatoms are unicellular, photosynthetic, eukaryotic algae with a ubiquitous distribution in water environments and they play an important role in the carbon cycle. Molecular or morphological changes in these species under ecological stress conditions are expected to serve as early indicators of toxicity and can point to a global impact on the entire ecosystem. Thalassiosira pseudonana, a marine diatom and the first with a fully sequenced genome has been selected as an aquatic model organism for ecotoxicological studies using molecular tools. A customized DNA microarray containing probes for the available gene sequences has been developed and tested to analyze the effects of a common pollutant, benzo(a)pyrene (BaP), at a sub-lethal concentration. This approach in diatoms has helped to elucidate pathway/metabolic processes involved in the mode of action of this pollutant, including lipid metabolism, silicon metabolism and stress response. A dose-response of BaP on diatoms has been made and the effect of this compound on the expression of selected genes was assessed by quantitative real time-PCR. Up-regulation of the long-chain acyl-CoA synthetase and the anti-apoptotic transmembrane Bax inhibitor, as well as down-regulation of silicon transporter 1 and a heat shock factor was confirmed at lower concentrations of BaP, but not the heat-shock protein 20. The study has allowed the identification of molecular biomarkers to BaP to be later on integrated into environmental monitoring for water quality assessment.	[Carvalho, Raquel N.; Bopp, Stephanie K.; Lettieri, Teresa] European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Rural Water & Ecosyst Resources Unit, Ispra, Varese, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Carvalho, RN (corresponding author), European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Rural Water & Ecosyst Resources Unit, Ispra, Varese, Italy.	Teresa.Lettieri@jrc.ec.europa.eu		Lettieri, Teresa/0000-0002-3363-9666; Bopp, Stephanie/0000-0003-1082-8007	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Commission. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barhoumi R, 2000, TOXICOL SCI, V53, P264, DOI 10.1093/toxsci/53.2.264; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bopp SK, 2007, GENE, V396, P293, DOI 10.1016/j.gene.2007.03.013; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Burczynski ME, 1999, CANCER RES, V59, P607; Carvalho RN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-159; Carvalho RN, 2011, AQUAT TOXICOL, V101, P244, DOI 10.1016/j.aquatox.2010.10.004; Davis AK, 2006, EUKARYOT CELL, V5, P1157, DOI 10.1128/EC.00042-06; De Stefano L, 2008, ACTA BIOMATER, V4, P126, DOI 10.1016/j.actbio.2007.09.003; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401; Garcia-Reyero N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-308; GLATT HR, 1979, NATURE, V277, P319, DOI 10.1038/277319a0; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; HESSE S, 1982, CARCINOGENESIS, V3, P757, DOI 10.1093/carcin/3.7.757; Hooven LA, 2008, TOXICOLOGY, V249, P1, DOI 10.1016/j.tox.2008.03.019; JERNSTROM B, 1994, BIOPHYS CHEM, V49, P185, DOI 10.1016/0301-4622(93)E0087-L; Jimenez M, 2002, ENVIRON TOXICOL CHEM, V21, P787, DOI 10.1897/1551-5028(2002)021<0787:TCTBAP>2.0.CO;2; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Lorrain S, 2004, PLANT CELL, V16, P2217, DOI 10.1105/tpc.104.022038; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neff JM, 2005, INTEGR ENVIRON ASSES, V1, P22, DOI 10.1897/IEAM_2004a-016.1; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3; Shaw JR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-477; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Tekpli X, 2010, TOXICOL APPL PHARM, V243, P68, DOI 10.1016/j.taap.2009.11.014; Thamatrakoln K, 2007, EUKARYOT CELL, V6, P271, DOI 10.1128/EC.00235-06; Thamatrakoln K, 2012, ENVIRON MICROBIOL, V14, P67, DOI 10.1111/j.1462-2920.2011.02468.x; Tonon T, 2005, PLANT PHYSIOL, V138, P402, DOI 10.1104/pp.104.054528; Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1; Watanabe N, 2009, INT J MOL SCI, V10, P3149, DOI 10.3390/ijms10073149; Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126	40	43	43	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26985	10.1371/journal.pone.0026985	http://dx.doi.org/10.1371/journal.pone.0026985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073232	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000019
J	O'Brien, HE; Gong, YC; Fung, P; Wang, PW; Guttman, DS				O'Brien, Heath E.; Gong, Yunchen; Fung, Pauline; Wang, Pauline W.; Guttman, David S.			Use of Low-Coverage, Large-Insert, Short-Read Data for Rapid and Accurate Generation of Enhanced-Quality Draft Pseudomonas Genome Sequences	PLOS ONE			English	Article							SYRINGAE; REVEALS; ANNOTATIONS; REPERTOIRE; VIRULENCE; PATHOGEN	Next-generation genomic technology has both greatly accelerated the pace of genome research as well as increased our reliance on draft genome sequences. While groups such as the Genomics Standards Consortium have made strong efforts to promote genome standards there is a still a general lack of uniformity among published draft genomes, leading to challenges for downstream comparative analyses. This lack of uniformity is a particular problem when using standard draft genomes that frequently have large numbers of low-quality sequencing tracts. Here we present a proposal for an "enhanced-quality draft'' genome that identifies at least 95% of the coding sequences, thereby effectively providing a full accounting of the genic component of the genome. Enhanced-quality draft genomes are easily attainable through a combination of small-and large-insert next-generation, paired-end sequencing. We illustrate the generation of an enhanced-quality draft genome by re-sequencing the plant pathogenic bacterium Pseudomonas syringae pv. phaseolicola 1448A ( Pph 1448A), which has a published, closed genome sequence of 5.93 Mbp. We use a combination of Illumina paired-end and mate-pair sequencing, and surprisingly find that de novo assemblies with 100x paired-end coverage and mate-pair sequencing with as low as low as 2-5x coverage are substantially better than assemblies based on higher coverage. The rapid and low-cost generation of large numbers of enhanced-quality draft genome sequences will be of particular value for microbial diagnostics and biosecurity, which rely on precise discrimination of potentially dangerous clones from closely related benign strains.	[O'Brien, Heath E.; Wang, Pauline W.; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Gong, Yunchen; Fung, Pauline; Wang, Pauline W.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	O'Brien, HE (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	heath.obrien@utoronto.ca	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869	Natural Sciences & Engineering Research Council (NSERC) of Canada; Canada Research Chairs Program	Natural Sciences & Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by grants from the Natural Sciences & Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp) and the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) to DSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dondoshansky I., 2000, BLASTCLUST BLAST SCO; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; O'Brien HE, 2011, ANNU REV PHYTOPATHOL, V49, P269, DOI 10.1146/annurev-phyto-072910-095242; Qi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016451; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Yahara T, 2010, CURR OPIN ENV SUST, V2, P43, DOI 10.1016/j.cosust.2010.03.008	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27199	10.1371/journal.pone.0027199	http://dx.doi.org/10.1371/journal.pone.0027199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073286	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900088
J	Wheaton, BJ; Callaway, JK; Ek, CJ; Dziegielewska, KM; Saunders, NR				Wheaton, Benjamin J.; Callaway, Jennifer K.; Ek, C. Joakim; Dziegielewska, Katarzyna M.; Saunders, Norman R.			Spontaneous Development of Full Weight-Supported Stepping after Complete Spinal Cord Transection in the Neonatal Opossum, Monodelphis domestica	PLOS ONE			English	Article							SHORT-TAILED OPOSSUM; SUPRASPINAL AXONS; LOCOMOTOR FUNCTION; GAIT ANALYSIS; CONNECTIONS; RECOVERY; GROWTH; INJURY; LESION; GRAY	Spinal cord trauma in the adult nervous system usually results in permanent loss of function below the injury level. The immature spinal cord has greater capacity for repair and can develop considerable functionality by adulthood. This study used the marsupial laboratory opossum Monodelphis domestica, which is born at a very early stage of neural development. Complete spinal cord transection was made in the lower-thoracic region of pups at postnatal-day 7 (P7) or P28, and the animals grew to adulthood. Injury at P7 resulted in a dense neuronal tissue bridge that connected the two ends of the cord; retrograde neuronal labelling indicated that supraspinal and propriospinal innervation spanned the injury site. This repair was associated with pronounced behavioural recovery, coordinated gait and an ability to use hindlimbs when swimming. Injury at P28 resulted in a cyst-like cavity encased in scar tissue forming at the injury site. Using retrograde labelling, no labelled brainstem or propriospinal neurons were found above the lesion, indicating that detectable neuronal connectivity had not spanned the injury site. However, these animals could use their hindlimbs to take weight-supporting steps but could not use their hindlimbs when swimming. White matter, demonstrated by Luxol Fast Blue staining, was present in the injury site of P7- but not P28-injured animals. Overall, these studies demonstrated that provided spinal injury occurs early in development, regrowth of supraspinal innervation is possible. This repair appears to lead to improved functional outcomes. At older ages, even without detectable axonal growth spanning the injury site, substantial development of locomotion was still possible. This outcome is discussed in conjunction with preliminary findings of differences in the local propriospinal circuits following spinal cord injury (demonstrated with fluororuby labelling), which may underlie the weight bearing locomotion observed in the apparent absence of axons bridging the lesion site in P28-injured Monodelphis.	[Wheaton, Benjamin J.; Callaway, Jennifer K.; Ek, C. Joakim; Dziegielewska, Katarzyna M.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	University of Melbourne	Wheaton, BJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Wheaton, Benjamin/0000-0003-0619-4777; Saunders, Norman/0000-0001-6660-7639	Victorian Neurotrauma Initiative Grant Body [DP049]	Victorian Neurotrauma Initiative Grant Body	This work was supported by the Victorian Neurotrauma Initiative Grant Body (Grant 11 #DP049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; FADEM BH, 1982, LAB ANIM SCI, V32, P405; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; HOWLAND DR, 1995, EXP NEUROL, V135, P108, DOI 10.1006/exnr.1995.1071; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lane MA, 2007, EUR J NEUROSCI, V25, P1725, DOI 10.1111/j.1460-9568.2007.05439.x; Lane MA, 2004, RESPONSE DEV NERVOUS; Migliavacca A, 1930, ARCH ITAL BIOL, V83, P109; NICHOLLS JG, 1994, PROG BRAIN RES, V103, P263; Oswald-Cruz E, 1968, BRAIN OPOSSUM DIDELP; QIN YQ, 1993, DEV BRAIN RES, V75, P75, DOI 10.1016/0165-3806(93)90067-K; ROBINSON GA, 1986, EXP BRAIN RES, V62, P373, DOI 10.1007/BF00238857; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1995, CLIN EXP PHARMACOL P, V22, P518, DOI 10.1111/j.1440-1681.1995.tb02060.x; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; STELZNER DJ, 1975, EXP NEUROL, V46, P156, DOI 10.1016/0014-4886(75)90039-4; STELZNER DJ, 1979, BRAIN RES, V172, P407, DOI 10.1016/0006-8993(79)90575-4; Stolp HB, 2009, NEUROSCI LETT, V451, P232, DOI 10.1016/j.neulet.2009.01.021; TREHERNE JM, 1992, P NATL ACAD SCI USA, V89, P431, DOI 10.1073/pnas.89.1.431; VANDEBERG JL, 1999, UFAW HDB CARE MANAGE, P193; Wang XM, 1998, J COMP NEUROL, V398, P83; Wang XM, 1998, EXP NEUROL, V151, P50, DOI 10.1006/exnr.1998.6795; Wang XM, 1996, J COMP NEUROL, V371, P104; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7; WOODWARD SKA, 1993, J EXP BIOL, V176, P77	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26826	10.1371/journal.pone.0026826	http://dx.doi.org/10.1371/journal.pone.0026826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073202	Green Published, gold			2022-12-27	WOS:000297154900009
J	Cassera, MB; Hazleton, KZ; Merino, EF; Obaldia, N; Ho, MC; Murkin, AS; DePinto, R; Gutierrez, JA; Almo, SC; Evans, GB; Babu, YS; Schramm, VL				Cassera, Maria B.; Hazleton, Keith Z.; Merino, Emilio F.; Obaldia, Nicanor, III; Ho, Meng-Chiao; Murkin, Andrew S.; DePinto, Richard; Gutierrez, Jemy A.; Almo, Steven C.; Evans, Gary B.; Babu, Yarlagadda S.; Schramm, Vern L.			Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model	PLOS ONE			English	Article							MALARIA PARASITES; PLASMA-MEMBRANE; IN-VITRO; METABOLISM; INHIBITORS; ENZYME; SUSCEPTIBILITY; HYPOXANTHINE; ARTEMISININ; COMBINATION	Plasmodium falciparum causes most of the one million annual deaths from malaria. Drug resistance is widespread and novel agents against new targets are needed to support combination-therapy approaches promoted by the World Health Organization. Plasmodium species are purine auxotrophs. Blocking purine nucleoside phosphorylase (PNP) kills cultured parasites by purine starvation. DADMe-Immucillin-G (BCX4945) is a transition state analogue of human and Plasmodium PNPs, binding with picomolar affinity. Here, we test BCX4945 in Aotus primates, an animal model for Plasmodium falciparum infections. Oral administration of BCX4945 for seven days results in parasite clearance and recrudescence in otherwise lethal infections of P. falciparum in Aotus monkeys. The molecular action of BCX4945 is demonstrated in crystal structures of human and P. falciparum PNPs. Metabolite analysis demonstrates that PNP blockade inhibits purine salvage and polyamine synthesis in the parasites. The efficacy, oral availability, chemical stability, unique mechanism of action and low toxicity of BCX4945 demonstrate potential for combination therapies with this novel antimalarial agent.	[Cassera, Maria B.; Hazleton, Keith Z.; Merino, Emilio F.; Ho, Meng-Chiao; Murkin, Andrew S.; Gutierrez, Jemy A.; Almo, Steven C.; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA; [Obaldia, Nicanor, III] Gorgas Mem Inst Hlth Studies, Malaria Drug & Vaccine Evaluat Ctr, Panama City, Panama; [DePinto, Richard] Waters Corp, Parsippany, NJ USA; [Evans, Gary B.] Ind Res Ltd, Carbohydrate Chem Grp, Lower Hutt, New Zealand; [Babu, Yarlagadda S.] BioCryst Pharmaceut Inc, Dept Biol Sci, Birmingham, AL USA; [Murkin, Andrew S.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	Yeshiva University; Albert Einstein College of Medicine; Instituto Conmemorativo Gorgas de Estudios de la Salud; Waters Corporation; Callaghan Innovation; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Cassera, MB (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	vern.schramm@einstein.yu.edu	Cassera, Maria/L-1572-2013; Ho, Meng-Chiao/H-2448-2015; Evans, Gary/B-8343-2011; Obaldia, Nicanor/K-4042-2019; Evans, Gary/I-4123-2019; Hazleton, Keith Z./AAD-3979-2019; Obaldia, Nicanor/AAV-1084-2021; Obaldia, Nicanor T/O-8460-2015; Murkin, Andrew/K-3146-2012	Ho, Meng-Chiao/0000-0002-5424-4524; Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002; Hazleton, Keith Z./0000-0003-4098-3411; Obaldia, Nicanor/0000-0002-3711-9449; Murkin, Andrew/0000-0002-2559-4605	NIH [AI049512, GM41916]; Albert Einstein College of Medicine; Medicines for Malaria; New Zealand Foundation for Research, Science Technology [BCX4945, C08X0209]; BioCryst Pharmaceuticals, Inc. [BCX4945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041916, T32GM007288, R01GM041916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Medicines for Malaria; New Zealand Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology); BioCryst Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided primarily by NIH grant AI049512 (V. L. S.) and by the Albert Einstein College of Medicine. Early portions of the Aotus study were supported by Medicines for Malaria. The original synthesis of DADMe-Immucillin-G (BCX4945) by G. B. E. was supported by research contract C08X0209 from the New Zealand Foundation for Research, Science & Technology and NIH grant GM41916 (V. L. S.). BioCryst Pharmaceuticals, Inc., provided BCX4945 used for the Aotus study. Waters Corporation provided gratis access to a UPLC-ms instrument and technical help from R. D. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2010, BLOOD, V116, P886, DOI 10.1182/blood-2010-02-272039; Bantia S, 2010, INT IMMUNOPHARMACOL, V10, P784, DOI 10.1016/j.intimp.2010.04.009; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; BITONTI AJ, 1989, P NATL ACAD SCI USA, V86, P651, DOI 10.1073/pnas.86.2.651; BUNGENER W, 1968, Z TROPENMED PARASIT, V19, P185; Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; Clark K, 2010, AMINO ACIDS, V38, P633, DOI 10.1007/s00726-009-0424-7; *CLINICALTRIAL, 2010, NCT00985127 CLINICAL; Collaborative-Computational-ProjectG, 1994, ACTA CRYSTALLOGRAP D, V50, P760; Deng H, 2004, J AM CHEM SOC, V126, P9516, DOI 10.1021/ja049296p; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; EARLE WC, 1932, J LAB CLIN MED, V17, P1124; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Edwards AA, 2009, BIOCHEMISTRY-US, V48, P5226, DOI 10.1021/bi9005896; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Evans GB, 2003, ORG LETT, V5, P3639, DOI 10.1021/ol035293q; Farthing D, 2007, J CHROMATOGR B, V854, P158, DOI 10.1016/j.jchromb.2007.04.013; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Haider N, 2005, MOL BIOCHEM PARASIT, V142, P224, DOI 10.1016/j.molbiopara.2005.04.004; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; Huser H, 1970, ATLAS COMP PRIMATE H; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; LAMBERT JDH, 1991, REGUL TOXICOL PHARM, V14, P189, DOI 10.1016/0273-2300(91)90006-H; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Madrid DC, 2008, J BIOL CHEM, V283, P35899, DOI 10.1074/jbc.M807218200; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; OBALDIA N, 1991, LAB ANIM, V25, P133, DOI 10.1258/002367791781082603; Pascale RM, 2002, ALCOHOL, V27, P193, DOI 10.1016/S0741-8329(02)00227-6; PEGG AE, 1988, CANCER RES, V48, P759; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pukrittayakamee S, 1997, EUR J CLIN PHARMACOL, V52, P487, DOI 10.1007/s002280050323; Quashie NB, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-95; Ringia EAT, 2005, CURR TOP MED CHEM, V5, P1237, DOI 10.2174/156802605774463088; Sajiki H, 2005, SYNLETT, P1385, DOI 10.1055/s-2005-868489; SCHREIBER G, 1986, INT J PRIMATOL, V7, P521, DOI 10.1007/BF02736659; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; TAYLOR DW, 1979, J PARASITOL, V65, P267, DOI 10.2307/3280160; TENG R, 2008, NMR BIOMED, V22, P292; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; TITULAER HAC, 1991, INT J PHARMACEUT, V69, P83, DOI 10.1016/0378-5173(91)90213-8; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	49	52	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26916	10.1371/journal.pone.0026916	http://dx.doi.org/10.1371/journal.pone.0026916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096507	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900015
J	Costion, C; Ford, A; Cross, H; Crayn, D; Harrington, M; Lowe, A				Costion, Craig; Ford, Andrew; Cross, Hugh; Crayn, Darren; Harrington, Mark; Lowe, Andrew			Plant DNA Barcodes Can Accurately Estimate Species Richness in Poorly Known Floras	PLOS ONE			English	Article							CONSERVATION; DIVERSITY; GENUS; IDENTIFICATION; TREES	Background: Widespread uptake of DNA barcoding technology for vascular plants has been slow due to the relatively poor resolution of species discrimination (similar to 70%) and low sequencing and amplification success of one of the two official barcoding loci, matK. Studies to date have mostly focused on finding a solution to these intrinsic limitations of the markers, rather than posing questions that can maximize the utility of DNA barcodes for plants with the current technology. Methodology/Principal Findings: Here we test the ability of plant DNA barcodes using the two official barcoding loci, rbcLa and matK, plus an alternative barcoding locus, trnH-psbA, to estimate the species diversity of trees in a tropical rainforest plot. Species discrimination accuracy was similar to findings from previous studies but species richness estimation accuracy proved higher, up to 89%. All combinations which included the trnH-psbA locus performed better at both species discrimination and richness estimation than matK, which showed little enhanced species discriminatory power when concatenated with rbcLa. The utility of the trnH-psbA locus is limited however, by the occurrence of intraspecific variation observed in some angiosperm families to occur as an inversion that obscures the monophyly of species. Conclusions/Significance: We demonstrate for the first time, using a case study, the potential of plant DNA barcodes for the rapid estimation of species richness in taxonomically poorly known areas or cryptic populations revealing a powerful new tool for rapid biodiversity assessment. The combination of the rbcLa and trnH-psbA loci performed better for this purpose than any two-locus combination that included matK. We show that although DNA barcodes fail to discriminate all species of plants, new perspectives and methods on biodiversity value and quantification may overshadow some of these shortcomings by applying barcode data in new ways.	[Costion, Craig; Cross, Hugh; Lowe, Andrew] Univ Adelaide, Australian Ctr Ecol & Evolutionary Biol, Adelaide, SA, Australia; [Costion, Craig; Crayn, Darren; Harrington, Mark] James Cook Univ, Australian Trop Herbarium, Cairns, Qld, Australia; [Ford, Andrew] Trop Forest Res Ctr, CSIRO Ecosyst Sci, Atherton, Qld, Australia; [Cross, Hugh; Lowe, Andrew] State Herbarium S Australia, Dept Environm & Nat Resources, Adelaide, SA, Australia	University of Adelaide; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Costion, C (corresponding author), Univ Adelaide, Australian Ctr Ecol & Evolutionary Biol, Adelaide, SA, Australia.	ccostion@googlemail.com; andrew.lowe@adelaide.edu.au	Ford, Andrew J/D-3761-2011; Crayn, Darren M/A-7386-2011	Crayn, Darren M/0000-0001-6614-4216; Lowe, Andrew/0000-0003-1139-2516	University of Adelaide	University of Adelaide	This study was supported by an Australian Postgraduate Fees Waiver Scholarship under the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonants P., 2010, Bulletin OEPP, V40, P30, DOI 10.1111/j.1365-2338.2009.02350.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Cross H.B., 2010, 50 YEARS INVASION EC; DU ZY, 2011, J SYST EVOL IN PRESS; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jackson RB, 1999, P NATL ACAD SCI USA, V96, P11387, DOI 10.1073/pnas.96.20.11387; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2008, BIOTROPICA, V40, P405, DOI 10.1111/j.1744-7429.2008.00426.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lowe AJ, 2011, IAWA J, V32, P251, DOI 10.1163/22941932-90000055; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533	36	70	77	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26841	10.1371/journal.pone.0026841	http://dx.doi.org/10.1371/journal.pone.0026841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096501	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000297553900011
J	Konar, A; Shah, N; Singh, R; Saxena, N; Kaul, SC; Wadhwa, R; Thakur, MK				Konar, Arpita; Shah, Navjot; Singh, Rumani; Saxena, Nishant; Kaul, Sunil C.; Wadhwa, Renu; Thakur, Mahendra K.			Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; INDUCED AMNESIA; BACOPA-MONNIERA; GENE-EXPRESSION; BDNF GENE; MEMORY; RECEPTORS; GROWTH; INVOLVEMENT; PROMOTERS	Background: Scopolamine is a well-known cholinergic antagonist that causes amnesia in human and animal models. Scopolamine-induced amnesia in rodent models has been widely used to understand the molecular, biochemical, behavioral changes, and to delineate therapeutic targets of memory impairment. Although this has been linked to the decrease in central cholinergic neuronal activity following the blockade of muscarinic receptors, the underlying molecular and cellular mechanism(s) particularly the effect on neuroplasticity remains elusive. In the present study, we have investigated (i) the effects of scopolamine on the molecules involved in neuronal and glial plasticity both in vivo and in vitro and (ii) their recovery by alcoholic extract of Ashwagandha leaves (i-Extract). Methodology/Principal Findings: As a drug model, scopolamine hydrobromide was administered intraperitoneally to mice and its effect on the brain function was determined by molecular analyses. The results showed that the scopolamine caused downregulation of the expression of BDNF and GFAP in dose and time dependent manner, and these effects were markedly attenuated in response to i-Extract treatment. Similar to our observations in animal model system, we found that the scopolamine induced cytotoxicity in IMR32 neuronal and C6 glioma cells. It was associated with downregulation of neuronal cell markers NF-H, MAP2, PSD-95, GAP-43 and glial cell marker GFAP and with upregulation of DNA damage- gamma H2AX and oxidative stress-ROS markers. Furthermore, these molecules showed recovery when cells were treated with i-Extract or its purified component, withanone. Conclusion: Our study suggested that besides cholinergic blockade, scopolamine-induced memory loss may be associated with oxidative stress and Ashwagandha i-Extract, and withanone may serve as potential preventive and therapeutic agents for neurodegenerative disorders and hence warrant further molecular analyses.	[Konar, Arpita; Thakur, Mahendra K.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India; [Shah, Navjot; Singh, Rumani; Saxena, Nishant; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Banaras Hindu University (BHU); National Institute of Advanced Industrial Science & Technology (AIST)	Konar, A (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	renu-wadhwa@aist.go.jp; mkt_bhu@yahoo.com	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Konar, Arpita/0000-0002-1761-1065	Council of Scientific and Industrial Research (CSIR), India; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Honjo International Scholarship Foundation, Japan; Department of Science and Technology [SR/SO/HS-54/2008]; Indian Council of Medical Research, Government of India [3/6/2004-BMS]; AIST (Japan)	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Honjo International Scholarship Foundation, Japan; Department of Science and Technology(Department of Science & Technology (India)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); AIST (Japan)	A. Konar is a recipient of Junior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), India. N. Shah and R. Singh are supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) scholarships, Japan. N. Saxena is supported by Honjo International Scholarship Foundation, Japan. The work was supported by grants from the Department of Science and Technology (SR/SO/HS-54/2008) and Indian Council of Medical Research (3/6/2004-BMS), Government of India to M. K. Thakur, and from AIST (Japan) to S.C. Kaul and R. Wadhwa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinav Kanwal, 2010, Pharmacology and Pharmacy, V1, P1, DOI 10.4103/0976-500X.64527; Acosta JI, 2009, HORM BEHAV, V55, P454, DOI 10.1016/j.yhbeh.2008.11.008; Agrawal R, 2009, INDIAN J PHARMACOL, V41, P192, DOI 10.4103/0253-7613.56072; Ahmed T, 2009, PHARMACOL BIOCHEM BE, V91, P554, DOI 10.1016/j.pbb.2008.09.010; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Albrecht C, 2000, J BIOL CHEM, V275, P28929, DOI 10.1074/jbc.M003053200; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; BERZAGHI MD, 1993, J NEUROSCI, V13, P3818; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; BLOKLAND A, 2005, SCOPOLAMINE REV, V1; Brouillette J, 2007, J NEUROCHEM, V102, P1978, DOI 10.1111/j.1471-4159.2007.04666.x; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Cho WS, 2010, HUM MOL GENET, V19, P3169, DOI 10.1093/hmg/ddq227; Choudhary MI, 2004, CHEM PHARM BULL, V52, P1358, DOI 10.1248/cpb.52.1358; Das A, 2002, PHARMACOL BIOCHEM BE, V73, P893, DOI 10.1016/S0091-3057(02)00940-1; Drozdov OL, 2003, NEUROPHYSIOLOGY+, V35, P98, DOI 10.1023/A:1026060607740; French SJ, 1999, MOL BRAIN RES, V67, P124, DOI 10.1016/S0169-328X(99)00048-0; Garzon D, 2002, J NEUROCHEM, V82, P1058, DOI 10.1046/j.1471-4159.2002.01030.x; GILBEA FJ, 2010, HIPPOCAMPUS; Guizzetti M, 2003, NEUROSCIENCE, V120, P941, DOI 10.1016/S0306-4522(03)00401-9; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Hung CH, 2004, NEUROSCI LETT, V364, P63, DOI 10.1016/j.neulet.2004.02.074; KOKAIA Z, 1994, EUR J NEUROSCI, V6, P587, DOI 10.1111/j.1460-9568.1994.tb00303.x; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kurosinski P, 2002, ARCH NEUROL-CHICAGO, V59, P1524, DOI 10.1001/archneur.59.10.1524; Lee B, 2010, J PHARM PHARMACOL, V62, P263, DOI 10.1211/jpp.62.02.0015; Lee JH, 2010, J PHARM PHARMACOL, V62, P1, DOI [10.1211/jpp.62.01.0001, 10.1211/jpp/62.01.0001]; Lee YB, 2004, J NUTR, V134, P1827, DOI 10.1093/jn/134.7.1827; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Nathanson NM, 2000, P NATL ACAD SCI USA, V97, P6245, DOI 10.1073/pnas.97.12.6245; Power JM, 2002, J NEUROSCI, V22, P3454; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Saraf MK, 2008, NEUROSCIENCE, V155, P476, DOI 10.1016/j.neuroscience.2008.05.043; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; SILVA AL, 2009, PSYCHOPHARMACOLOGY, V202, P165; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tohda C, 2009, BRIT J PHARMACOL, V157, P1427, DOI 10.1111/j.1476-5381.2009.00313.x; VanDeMark KL, 2009, ALCOHOL CLIN EXP RES, V33, P1945, DOI 10.1111/j.1530-0277.2009.01032.x; VANDERWOLF CH, 1991, BEHAV BRAIN RES, V44, P217, DOI 10.1016/S0166-4328(05)80027-0; Wakabayashi T, 1999, BIOTECHNIQUES, V26, P302, DOI 10.2144/99262st04; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Yamada K, 2003, J PHARMACOL SCI, V91, P267	50	111	111	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27265	10.1371/journal.pone.0027265	http://dx.doi.org/10.1371/journal.pone.0027265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096544	Green Submitted, gold, Green Published			2022-12-27	WOS:000297553900028
J	Shu, XH; Li, H; Sun, XX; Wang, Q; Sun, Z; Wu, ML; Chen, XY; Li, C; Kong, QY; Liu, J				Shu, Xiao-Hong; Li, Hong; Sun, Xiao-Xin; Wang, Qian; Sun, Zheng; Wu, Mo-Li; Chen, Xiao-Yan; Li, Chong; Kong, Qing-You; Liu, Jia			Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies	PLOS ONE			English	Article							STAT3; EXPRESSION; APOPTOSIS; GROWTH; SULFOTRANSFERASE; BIOAVAILABILITY; LOCALIZATION; BRAIN; 1A1	Background: Trans-resveratrol rather than its biotransformed monosulfate metabolite exerts anti-medulloblastoma effects by suppressing STAT3 activation. Nevertheless, its effects on human glioblastoma cells are variable due to certain unknown reason(s). Methodology/Principal Findings: Citing resveratrol-sensitive UW228-3 medulloblastoma cell line and primarily cultured rat brain cells/PBCs as controls, the effect of resveratrol on LN-18 human glioblastoma cells and its relevance with metabolic pattern(s), brain-associated sulfotransferase/SULT expression and the statuses of STAT3 signaling and protein inhibitor of activated STAT3 (PIAS3) were elucidated by multiple experimental approaches. Meanwhile, the expression patterns of three SULTs (SULT1A1, 1C2 and 4A1) in human glioblastoma tumors were profiled immunohistochemically. The results revealed that 100 mu M resveratrol-treated LN-18 generated the same metabolites as UW228-3 cells, while additional metabolite in molecular weight of 403.0992 in negative ion mode was found in PBCs. Neither growth arrest nor apoptosis was found in resveratrol-treated LN-18 and PBC cells. Upon resveratrol treatment, the levels of SULT1A1, 1C2 and 4A1 expression in LN-18 cells were more up-regulated than that expressed in UW228-3 cells and close to the levels in PBCs. Immunohistochemical staining showed that 42.0%, 27.1% and 19.6% of 149 glioblastoma cases produced similar SULT1A1, 1C2 and 4A1 levels as that of tumor-surrounding tissues. Unlike the situation in UW228-3 cells, STAT3 signaling remained activated and its protein inhibitor PIAS3 was restricted in the cytosol of resveratrol-treated LN-18 cells. No nuclear translocation of STAT3 and PIAS3 was observed in resveratrol-treated PBCs. Treatment with STAT3 chemical inhibitor, AG490, committed majority of LN-18 and UW228-3 cells but not PBCs to apoptosis within 48 hours. Conclusions/Significance: LN-18 glioblastoma cells are insensitive to resveratrol due to the more inducible brain-associated SULT expression, insufficiency of resveratrol to suppress activated STAT3 signaling and the lack of PIAS3 nuclear translocation. The findings from PBCs suggest that an effective anticancer dose of resveratrol exerts little side effect on normal brain cells.	[Shu, Xiao-Hong; Li, Hong; Sun, Xiao-Xin; Wang, Qian; Sun, Zheng; Wu, Mo-Li; Chen, Xiao-Yan; Li, Chong; Kong, Qing-You; Liu, Jia] Dalian Med Univ, Liaoning Lab Canc Genet & Epigenet, Dept Cell Biol, Dalian, Peoples R China; [Shu, Xiao-Hong] Dalian Med Univ, Dept Med Chem, Coll Pharm, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Shu, XH (corresponding author), Dalian Med Univ, Liaoning Lab Canc Genet & Epigenet, Dept Cell Biol, Dalian, Peoples R China.	jialiudl@yahoo.com.cn	Shu, Xiaohong/J-1920-2019	Shu, Xiaohong/0000-0003-0299-1963	National Natural Science Foundation of China [30670946, 30971038, 81072063]; China Postdoctoral Science Foundation [20100481217]; Liaoning Department of Education [20060193, 2007-7-26, 2008T028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Liaoning Department of Education	This work was supported by the grants from National Natural Science Foundation of China (No. 30670946, 30971038 and 81072063), China Postdoctoral Science Foundation (No. 20100481217) and Liaoning Department of Education for key laboratory (20060193) and for the creative research team (2007-7-26 and 2008T028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bastianetto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012935; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Birner P, 2010, J NEURO-ONCOL, V100, P339, DOI 10.1007/s11060-010-0195-8; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Gagliano N, 2010, ANTI-CANCER DRUG, V21, P140, DOI 10.1097/CAD.0b013e32833498f1; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Keles GE, 1995, ONCOL RES, V7, P493; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; LI H, 1993, CANCER RES, V53, P5345; Liyou NE, 2003, J HISTOCHEM CYTOCHEM, V51, P1655, DOI 10.1177/002215540305101209; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Murias M, 2008, CANCER LETT, V261, P172, DOI 10.1016/j.canlet.2007.11.008; Ogata Y, 2006, NEOPLASIA, V8, P817, DOI 10.1593/neo.06409; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Urpi-Sarda M, 2007, CLIN CHEM, V53, P292, DOI 10.1373/clinchem.2006.071936; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang DG, 2005, J CHROMATOGR B, V829, P97, DOI 10.1016/j.jchromb.2005.09.040; Wang QA, 2003, NEUROSCI LETT, V351, P83, DOI 10.1016/j.neulet.2003.07.002; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Yang F, 2008, MOL CANCER THER, V7, P3519, DOI 10.1158/1535-7163.MCT-08-0138; Yang YP, 2012, J CELL PHYSIOL, V227, P976, DOI 10.1002/jcp.22806; Yu LJ, 2008, NEOPLASIA, V10, P736, DOI 10.1593/neo.08304	35	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27484	10.1371/journal.pone.0027484	http://dx.doi.org/10.1371/journal.pone.0027484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096581	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900051
J	Tharad, M; Samuchiwal, SK; Bhalla, K; Ghosh, A; Kumar, K; Kumar, S; Ranganathan, A				Tharad, Megha; Samuchiwal, Sachin Kumar; Bhalla, Kuhulika; Ghosh, Anamika; Kumar, Krishan; Kumar, Sushil; Ranganathan, Anand			A Three-Hybrid System to Probe In Vivo Protein-Protein Interactions: Application to the Essential Proteins of the RD1 Complex of M. tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTIONAL ACTIVATOR; PATHOGENIC MYCOBACTERIA; VIRULENCE DETERMINANT; ESAT-6-CFP-10 COMPLEX; INFECTION; GRANULOMA; 2-HYBRID; ESAT-6; SECRETION	Background: Protein-protein interactions play a crucial role in enabling a pathogen to survive within a host. In many cases the interactions involve a complex of proteins rather than just two given proteins. This is especially true for pathogens like M. tuberculosis that are able to successfully survive the inhospitable environment of the macrophage. Studying such interactions in detail may help in developing small molecules that either disrupt or augment the interactions. Here, we describe the development of an E. coli based bacterial three-hybrid system that can be used effectively to study ternary protein complexes. Methodology/Principal Findings: The protein-protein interactions involved in M. tuberculosis pathogenesis have been used as a model for the validation of the three-hybrid system. Using the M. tuberculosis RD1 encoded proteins CFP10, ESAT6 and Rv3871 for our proof-of-concept studies, we show that the interaction between the proteins CFP10 and Rv3871 is strengthened and stabilized in the presence of ESAT6, the known heterodimeric partner of CFP10. Isolating peptide candidates that can disrupt crucial protein-protein interactions is another application that the system offers. We demonstrate this by using CFP10 protein as a disruptor of a previously established interaction between ESAT6 and a small peptide HCL1; at the same time we also show that CFP10 is not able to disrupt the strong interaction between ESAT6 and another peptide SL3. Conclusions/Significance: The validation of the three-hybrid system paves the way for finding new peptides that are stronger binders of ESAT6 compared even to its natural partner CFP10. Additionally, we believe that the system offers an opportunity to study tri-protein complexes and also perform a screening of protein/peptide binders to known interacting proteins so as to elucidate novel tri-protein complexes.	[Tharad, Megha; Samuchiwal, Sachin Kumar; Bhalla, Kuhulika; Ghosh, Anamika; Kumar, Krishan; Kumar, Sushil; Ranganathan, Anand] Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Tharad, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, Aruna Asaf Ali Marg, New Delhi, India.	anand@icgeb.res.in	Samuchiwal, Sachin/AAL-2904-2021; Bhalla, Kuhulika/P-3280-2019; KUMAR, SUSHIL/T-8493-2017	Bhalla, Kuhulika/0000-0002-6608-2120; KUMAR, SUSHIL/0000-0001-8481-9221; SAMUCHIWAL, SACHIN/0000-0001-6232-5650; KUMAR, KRISHAN/0000-0003-3957-2084	Council for Scientific and Industrial Research (CSIR), India; International Centre for Genetic Engineering and Biotechnology (ICGEB); Department of Biotechnology (DBT), Government of India [BT/PR7760/Med/14/1104/2006]	Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); International Centre for Genetic Engineering and Biotechnology (ICGEB); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	MT was funded by a fellowship from the Council for Scientific and Industrial Research (CSIR), India. The work was funded by internal grants of the International Centre for Genetic Engineering and Biotechnology (ICGEB) and a grant provided by the Department of Biotechnology (DBT), Government of India, Grant no. BT/PR7760/Med/14/1104/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff EA, 2002, ANGEW CHEM INT EDIT, V41, P2327, DOI 10.1002/1521-3773(20020703)41:13<2327::AID-ANIE2327>3.0.CO;2-U; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Callahan B, 2010, J BACTERIOL, V192, P326, DOI 10.1128/JB.01032-09; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Chang Y, 2009, PROTEIN SCI, V18, P2316, DOI 10.1002/pro.242; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chopra S, 2003, CHEM BIOL, V10, P917, DOI 10.1016/j.chembiol.2003.09.007; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; DOVE SL, 1997, LETT NAT, V386, P627; Firestine SM, 2000, NAT BIOTECHNOL, V18, P544, DOI 10.1038/75414; Fletcher S, 2007, CURR TOP MED CHEM, V7, P922, DOI 10.2174/156802607780906735; Garg S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-1; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kumar K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007615; Licitra JE, 1996, P NATL ACAD SCI USA, V93, P12817; Loregian A, 2005, J CELL PHYSIOL, V204, P750, DOI 10.1002/jcp.20356; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Miller J.H., 1972, EXPT MOL GENETICS; O'Hare H, 2008, J MICROBIOL METH, V73, P79, DOI 10.1016/j.mimet.2008.02.008; Parida BK, 2005, TUBERCULOSIS, V85, P347, DOI 10.1016/j.tube.2005.08.001; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rao A, 2005, J BIOL CHEM, V280, P23605, DOI 10.1074/jbc.M503056200; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sperandio Olivier, 2008, Open Biochem J, V2, P29, DOI 10.2174/1874091X00802010029; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Tirode F, 1997, J BIOL CHEM, V272, P22995, DOI 10.1074/jbc.272.37.22995; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO Media centre, 2010, TUB; Zhang J, 1996, ANAL BIOCHEM, V242, P68, DOI 10.1006/abio.1996.0429	46	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27503	10.1371/journal.pone.0027503	http://dx.doi.org/10.1371/journal.pone.0027503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087330	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700054
J	Kallio, H; Tolvanen, M; Janis, J; Pan, PW; Laurila, E; Kallioniemi, A; Kilpinen, S; Tuominen, VJ; Isola, J; Valjakka, J; Pastorekova, S; Pastorek, J; Parkkila, S				Kallio, Heini; Tolvanen, Martti; Janis, Janne; Pan, Pei-wen; Laurila, Eeva; Kallioniemi, Anne; Kilpinen, Sami; Tuominen, Vilppu J.; Isola, Jorma; Valjakka, Jarkko; Pastorekova, Silvia; Pastorek, Jaromir; Parkkila, Seppo			Characterization of Non-Specific Cytotoxic Cell Receptor Protein 1: A New Member of the Lectin-Type Subfamily of F-Box Proteins	PLOS ONE			English	Article							NCCRP-1; GENE; EXPRESSION; (NCCRP)-1; BINDING; CLONING; FAMILY; IX	Our previous microarray study showed that the non-specific cytotoxic cell receptor protein 1 (Nccrp1) transcript is significantly upregulated in the gastric mucosa of carbonic anhydrase IX (CA IX)-deficient (Car9(-/-)) mice. In this paper, we aimed to characterize human NCCRP1 and to elucidate its relationship to CA IX. Recombinant NCCRP1 protein was expressed in Escherichia coli, and a novel polyclonal antiserum was raised against the purified full-length protein. Immunocytochemistry showed that NCCRP1 is expressed intracellularly, even though it has previously been described as a transmembrane protein. Using bioinformatic analyses, we identified orthologs of NCCRP1 in 35 vertebrate genomes, and up to five paralogs per genome. These paralogs are FBXO genes whose protein products are components of the E3 ubiquitin ligase complexes. NCCRP1 proteins have no signal peptides or transmembrane domains. NCCRP1 has mainly been studied in fish and was thought to be responsible for the cytolytic function of nonspecific cytotoxic cells (NCCs). Our analyses showed that in humans, NCCRP1 mRNA is expressed in tissues containing squamous epithelium, whereas it shows a more ubiquitous tissue expression pattern in mice. Neither human nor mouse NCCRP1 expression is specific to immune tissues. Silencing CA9 using siRNAs did not affect NCCRP1 levels, indicating that its expression is not directly regulated by CA9. Interestingly, silencing NCCRP1 caused a statistically significant decrease in the growth of HeLa cells. These studies provide ample evidence that the current name, "non-specific cytotoxic cell receptor protein 1," is not appropriate. We therefore propose that the gene name be changed to FBXO50.	[Kallio, Heini; Tolvanen, Martti; Pan, Pei-wen; Laurila, Eeva; Kallioniemi, Anne; Tuominen, Vilppu J.; Isola, Jorma; Valjakka, Jarkko; Parkkila, Seppo] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Parkkila, Seppo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kallio, Heini; Pan, Pei-wen; Kallioniemi, Anne; Parkkila, Seppo] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Kilpinen, Sami] MediSapiens Ltd, Helsinki, Finland; [Pastorek, Jaromir; Parkkila, Seppo] Slovak Acad Sci, Inst Virol, Ctr Mol Med, Bratislava, Slovakia	Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland; Slovak Academy of Sciences	Kallio, H (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	heini.kallio@uta.fi	Pastorek, Jaromir/AAR-2647-2020; Pastorekova, Silvia/C-6685-2018; Jänis, Janne/B-7326-2014	Kilpinen, Sami/0000-0003-3444-2539; Kallioniemi, Anne/0000-0003-3552-8158; Tolvanen, Martti/0000-0003-3434-7646; Laurila, Eeva/0000-0003-0090-4547; Kallio, Heini M.L./0000-0003-4345-1787; Parkkila, Seppo/0000-0001-7323-8536	Tampere University Hospital; Sigrid Juselius Foundation; Academy of Finland	Tampere University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by the Competitive Research Funding of the Tampere University Hospital and by grants from the Sigrid Juselius Foundation and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bootorabi Fatemeh, 2008, BMC Biochemistry, V9, P32, DOI 10.1186/1471-2091-9-32; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cuesta A, 2005, DEV COMP IMMUNOL, V29, P637, DOI 10.1016/j.dci.2004.11.003; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Evans DL, 1998, CELL IMMUNOL, V187, P19, DOI 10.1006/cimm.1998.1310; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Gut MO, 2002, GASTROENTEROLOGY, V123, P1889, DOI 10.1053/gast.2002.37052; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ishimoto Y, 2004, FISH SHELLFISH IMMUN, V16, P163, DOI 10.1016/S1050-4648(03)00059-7; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jaso-Friedmann L, 2002, J MOL EVOL, V54, P386, DOI 10.1007/s00239-001-0027-8; Jaso-Friedmann L, 1997, MOL IMMUNOL, V34, P955, DOI 10.1016/S0161-5890(97)00086-2; Jaso-Friedmann L, 2001, DEV COMP IMMUNOL, V25, P701, DOI 10.1016/S0145-305X(01)00031-3; Kallio H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-397; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 2004, CANC THER, V2, P245; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reimers K, 2006, J COMP PHYSIOL B, V176, P599, DOI 10.1007/s00360-006-0083-x; Sakata H, 2005, COMP BIOCHEM PHYS C, V140, P287, DOI 10.1016/j.cca.2005.02.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yoshida Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2623, DOI 10.1271/bbb.70074; Zhang L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-78	34	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27152	10.1371/journal.pone.0027152	http://dx.doi.org/10.1371/journal.pone.0027152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087255	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700021
J	Wei, QZ; Condie, BG				Wei, Qiaozhi; Condie, Brian G.			A Focused In Situ Hybridization Screen Identifies Candidate Transcriptional Regulators of Thymic Epithelial Cell Development and Function	PLOS ONE			English	Article							3RD PHARYNGEAL POUCH; HOMEOBOX GENE; MOUSE EMBRYO; EXPRESSION; MICE; DIFFERENTIATION; ENDODERM; MORPHOGENESIS; ABNORMALITIES; NKX2.6	Background: Thymic epithelial cells (TECs) are necessary for normal T cell development. Currently, one transcription factor, Foxn1 is known to be necessary for the progression of fetal TEC differentiation. However, some aspects of fetal TEC differentiation occur in Foxn1 mutants, suggesting the existence of additional transcriptional regulators of TEC differentiation. The goal of this study was to identify some of the additional candidate transcription factors that may be involved in the specification and/or differentiation of TECs during fetal development. Methodology/Principal Findings: We identified candidate fetal TEC transcriptional regulators via data and text mining. From our data mining we selected the transcription factors Foxg1, Isl1, Gata3, Nkx2-5, Nkx2- 6 and Sox2 for further studies. Whole mount in situ hybridizations confirmed the expression of these transcription factors within subdomains of the third pharyngeal pouch from E9.5-E10.5. By E11.5 days Foxg1 and Isl1 transcripts were the only mRNAs from this group of genes detected exclusively within the thymus domain of the third pouch. Based on this initial in situ hybridization analysis, we focused on defining the expression of Foxg1 and Isl1 during multiple stages of thymus development and TEC differentiation. We found that Foxg1 and Isl1 are specifically expressed in differentiating TECs during fetal and postnatal stages of thymus development. In addition, we found differential expression of Islet1 and Foxn1 within the fetal and postnatal TEC population. Conclusions/Significance: Our studies have identified two developmental transcription factors that are excellent candidate regulators of thymic epithelial cell specification and differentiation during fetal development. Our results suggest that Foxg1 and Isl1 may play a role in the regulation of TEC differentiation during fetal and postnatal stages. Our results also demonstrate heterogeneity of TECs marked by the differential expression of transcription factors, potentially providing new insights into the regulation of TEC differentiation.	[Wei, Qiaozhi; Condie, Brian G.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Wei, QZ (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	bcondie@uga.edu			University of Georgia; NICHD	University of Georgia; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The 39.4D5 anti-ISL1 monoclonal antibody developed by Dr. Thomas Jessell was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Baird AM, 2000, J IMMUNOL, V165, P3680, DOI 10.4049/jimmunol.165.7.3680; Biben C, 1998, MECH DEVELOP, V73, P125, DOI 10.1016/S0925-4773(98)00037-9; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Chung YC, 2011, GENE EXPR PATTERNS, V11, P84, DOI 10.1016/j.gep.2010.09.007; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dupe V, 1999, DEVELOPMENT, V126, P5051; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Fotaki V, 2011, J COMP NEUROL, V519, P1640, DOI 10.1002/cne.22592; Friedrichs M, 2008, DEV BIOL, V318, P203, DOI 10.1016/j.ydbio.2008.03.032; Garces A, 2000, J NEUROSCI, V20, P4992; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2010, DEV BIOL, V339, P141, DOI 10.1016/j.ydbio.2009.12.026; Grevellec A, 2010, SEMIN CELL DEV BIOL, V21, P325, DOI 10.1016/j.semcdb.2010.01.022; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Grigorieva IV, 2010, J CLIN INVEST, V120, P2144, DOI 10.1172/JCI42021; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hidaka K, 2010, STEM CELLS DEV, V19, P1735, DOI 10.1089/scd.2009.0466; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Kist R, 2007, GENESIS, V45, P460, DOI 10.1002/dvg.20295; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Manaia A, 2000, DEVELOPMENT, V127, P643; Manley NR, 2004, DEV BIOL, V276, P301, DOI 10.1016/j.ydbio.2004.08.030; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nikolova M, 1997, MECH DEVELOP, V69, P215, DOI 10.1016/S0925-4773(97)00174-3; Ohnemus S, 2002, MECH DEVELOP, V119, P127, DOI 10.1016/S0925-4773(02)00345-3; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Parmar H, 2001, GENESIS, V31, P57, DOI 10.1002/gene.10005; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Rizzoti K, 2007, DEVELOPMENT, V134, P3437, DOI 10.1242/dev.007906; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Sultana DA, 2009, BLOOD, V113, P2976, DOI 10.1182/blood-2008-06-164921; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanaka M, 2000, MOL CELL BIOL, V20, P2874, DOI 10.1128/MCB.20.8.2874-2879.2000; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Urbanski WM, 2009, GENESIS, V47, P842, DOI 10.1002/dvg.20575; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei Q, 2011, J VIS EXP, V10, pe2797; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xu PX, 2002, DEVELOPMENT, V129, P3033; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yu T, 2009, J COMP NEUROL, V512, P613, DOI 10.1002/cne.21918; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229; Zou D, 2006, DEV BIOL, V293, P499, DOI 10.1016/j.ydbio.2005.12.015	59	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26795	10.1371/journal.pone.0026795	http://dx.doi.org/10.1371/journal.pone.0026795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087235	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700010
J	Hou, M; Liu, YH; Zhu, LJ; Sun, B; Guo, M; Buren, J; Li, XN				Hou, Miao; Liu, Yanhua; Zhu, Lijun; Sun, Bin; Guo, Mei; Buren, Jonas; Li, Xiaonan			Neonatal Overfeeding Induced by Small Litter Rearing Causes Altered Glucocorticoid Metabolism in Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; OBESE ZUCKER RATS; ADIPOSE-TISSUE; CORTISOL METABOLISM; EXPRESSION; CHILDREN; LEPTIN; LIVER; MODEL; MICE	Elevated glucocorticoid (GC) activity may be involved in the development of the metabolic syndrome. Tissue GC exposure is determined by the tissue-specific GC-activating enzyme 11 beta-hydroxysteriod dehydrogenase type 1 (11 beta-HSD1) and the GC-inactivating enzyme 5 alpha-reductase type 1 (5 alpha R1), as well as 5 beta-reductase (5 beta R). Our aim was to study the effects of neonatal overfeeding induced by small litter rearing on the expression of GC-regulating enzymes in adipose tissue and/or liver and on obesity-related metabolic disturbances during development. Male Sprague-Dawley rat pup litters were adjusted to litter sizes of three (small litters, SL) or ten (normal litters, NL) on postnatal day 3 and then given standard chow from postnatal week 3 onward (W3). Small litter rearing induced obesity, hyperinsulinemia, and higher circulating corticosterone in adults. 11 beta-HSD1 expression and enzyme activity in retroperitoneal, but not in epididymal, adipose tissue increased with postnatal time and peaked at W5/W6 in both groups before declining. From W8, 11 beta-HSD1 expression and enzyme activity levels in retroperitoneal fat persisted at significantly higher levels in SL compared to NL rats. Hepatic 11 beta-HSD1 enzyme activity in SL rats was elevated from W3 to W16 compared to NL rats. Hepatic 5 alpha R1 and 5 beta R expression was higher in SL compared to NL rats after weaning until W6, whereupon expression decreased in the SL rats and remained similar to that in NL rats. In conclusion, small litter rearing in rats induced peripheral tissue-specific alterations in 11 beta-HSD1 expression and activity and 5 alpha R1 and 5 beta R expression during puberty, which could contribute to elevated tissue-specific GC exposure and aggravate the development of metabolic dysregulation in adults.	[Hou, Miao; Liu, Yanhua; Zhu, Lijun; Li, Xiaonan] Nanjing Med Univ, Dept Children Hlth Care, Nanjing Childrens Hosp, Nanjing, Peoples R China; [Sun, Bin] Nanjing Med Univ, Dept Gen Surg, Nanjing Childrens Hosp, Nanjing, Peoples R China; [Guo, Mei; Li, Xiaonan] Nanjing Med Univ, Pediat Res Inst, Nanjing, Peoples R China; [Buren, Jonas] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Umea University	Hou, M (corresponding author), Nanjing Med Univ, Dept Children Hlth Care, Nanjing Childrens Hosp, Nanjing, Peoples R China.	xnli@njmu.edu.cn	liu, yan/HCI-5542-2022	Buren, Jonas/0000-0001-5846-9002	Natural Science Foundation of the Jiangsu Health Department of China; Scientific Research Foundation for Returned Overseas Scholars of the Ministry of Education of China	Natural Science Foundation of the Jiangsu Health Department of China; Scientific Research Foundation for Returned Overseas Scholars of the Ministry of Education of China	This work was supported by the Natural Science Foundation of the Jiangsu Health Department of China (2009) and the Scientific Research Foundation for Returned Overseas Scholars of the Ministry of Education of China (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2007, CLIN ENDOCRINOL, V66, P459, DOI 10.1111/j.1365-2265.2007.02763.x; Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Barat P, 2007, ENDOCRINOLOGY, V148, P4836, DOI 10.1210/en.2007-0597; Baudrand R, 2010, OBES SURG, V20, P77, DOI 10.1007/s11695-009-9937-0; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Buren J, 2007, ENDOCRINOLOGY, V148, P2716, DOI 10.1210/en.2006-0897; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, pS31, DOI 10.1210/jc.2008-1363; Campino C, 2010, ENDOCRINE, V37, P106, DOI 10.1007/s12020-009-9269-9; Chen HC, 2002, J LIPID RES, V43, P986; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Dieudonne MN, 2006, J STEROID BIOCHEM, V99, P189, DOI 10.1016/j.jsbmb.2006.01.007; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Dunger DB, 2007, P NUTR SOC, V66, P451, DOI 10.1017/S0029665107005721; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; GUSTAFSSON JA, 1974, J BIOL CHEM, V249, P711; Ishii-Yonemoto T, 2010, AM J PHYSIOL-ENDOC M, V298, pE930, DOI 10.1152/ajpendo.00320.2009; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; LAKSHMI V, 1988, ENDOCRINOLOGY, V123, P2390, DOI 10.1210/endo-123-5-2390; Li X, 2007, INT J OBESITY, V31, P820, DOI 10.1038/sj.ijo.0803470; Liu YJ, 2003, DIABETES, V52, P1409, DOI 10.2337/diabetes.52.6.1409; LIVINGSTONE D, 2009, J ENDOCRINOL; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Metges CC, 2009, ADV EXP MED BIOL, V646, P105, DOI 10.1007/978-1-4020-9173-5_11; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Nyirenda MJ, 2009, DIABETES, V58, P2873, DOI 10.2337/db09-0873; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rodrigues AL, 2009, J PHYSIOL-LONDON, V587, P2647, DOI 10.1113/jphysiol.2009.169045; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; Stimson R H, 2007, Minerva Endocrinol, V32, P141; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tirelli E, 2003, NEUROSCI BIOBEHAV R, V27, P163, DOI 10.1016/S0149-7634(03)00018-6; Tomlinson JW, 2008, DIABETES, V57, P2652, DOI 10.2337/db08-0495; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Westerbacka J, 2003, J CLIN ENDOCR METAB, V88, P4924, DOI 10.1210/jc.2003-030596; Wiegand S, 2007, EUR J ENDOCRINOL, V157, P319, DOI 10.1530/EJE-07-0193; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Zhu LJ, 2010, J CLIN ENDOCR METAB, V95, P3300, DOI 10.1210/jc.2009-2708	49	36	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e25726	10.1371/journal.pone.0025726	http://dx.doi.org/10.1371/journal.pone.0025726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073140	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200002
J	Liu, YT; Gibson, J; Wheeler, J; Kwee, LC; Santiago-Turla, CM; Akafo, SK; Lichter, PR; Gaasterland, DE; Moroi, SE; Challa, P; Herndon, LW; Girkin, CA; Budenz, DL; Richards, JE; Allingham, RR; Hauser, MA				Liu, Yutao; Gibson, Jason; Wheeler, Joshua; Kwee, Lydia Coulter; Santiago-Turla, Cecile M.; Akafo, Stephen K.; Lichter, Paul R.; Gaasterland, Douglas E.; Moroi, Sayoko E.; Challa, Pratap; Herndon, Leon W.; Girkin, Christopher A.; Budenz, Donald L.; Richards, Julia E.; Allingham, R. Rand; Hauser, Michael A.			GALC Deletions Increase the Risk of Primary Open-Angle Glaucoma: The Role of Mendelian Variants in Complex Disease	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENOME-WIDE ASSOCIATION; NORMAL-TENSION GLAUCOMA; KRABBE-DISEASE; COMMON VARIANTS; GENE; SUSCEPTIBILITY; IDENTIFICATION; LEUKODYSTROPHY; MUTATIONS	DNA copy number variants (CNVs) have been reported in many human diseases including autism and schizophrenia. Primary Open Angle Glaucoma (POAG) is a complex adult-onset disorder characterized by progressive optic neuropathy and vision loss. Previous studies have identified rare CNVs in POAG; however, their low frequencies prevented formal association testing. We present here the association between POAG risk and a heterozygous deletion in the galactosylceramidase gene (GALC). This CNV was initially identified in a dataset containing 71 Caucasian POAG cases and 478 ethnically matched controls obtained from dbGAP (study accession phs000126.v1.p1.) (p = 0.017, fisher's exact test). It was validated with array comparative genomic hybridization (arrayCGH) and realtime PCR, and replicated in an independent POAG dataset containing 959 cases and 1852 controls (p = 0.021, OR (odds ratio) = 3.5, 95% CI 21.1-12.0). Evidence for association was strengthened when the discovery and replication datasets were combined (p = 0.002; OR = 5.0, 95% CI 1.6-16.4). Several deletions with different endpoints were identified by array CGH of POAG patients. Homozygous deletions that eliminate GALC enzymatic activity cause Krabbe disease, a recessive Mendelian disorder of childhood displaying bilateral optic neuropathy and vision loss. Our findings suggest that heterozygous deletions that reduce GALC activity are a novel mechanism increasing risk of POAG. This is the first report of a statistically-significant association of a CNV with POAG risk, contributing to a growing body of evidence that CNVs play an important role in complex, inherited disorders. Our findings suggest an attractive biomarker and potential therapeutic target for patients with this form of POAG.	[Liu, Yutao; Gibson, Jason; Wheeler, Joshua; Kwee, Lydia Coulter; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Liu, Yutao; Gibson, Jason; Wheeler, Joshua; Kwee, Lydia Coulter; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Santiago-Turla, Cecile M.; Challa, Pratap; Herndon, Leon W.; Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Eye, Durham, NC 27710 USA; [Akafo, Stephen K.] Univ Ghana, Sch Med, Dept Surg, Unit Ophthalmol, Korle Bu, Ghana; [Lichter, Paul R.; Moroi, Sayoko E.; Richards, Julia E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Richards, Julia E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Gaasterland, Douglas E.] Eye Doctors Washington, Chevy Chase, MD USA; [Girkin, Christopher A.] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA; [Budenz, Donald L.] Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA	Duke University; Duke University; Duke University; University of Ghana; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; Bascom Palmer Eye Institute	Liu, YT (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	yutao.liu@duke.edu		Girkin, Chris/0000-0002-9676-4499; Lichter, Paul/0000-0001-8394-4813; Girkin, Christopher/0000-0002-5781-7682; Moroi, Sayoko E/0000-0002-0418-0657	National Institutes of Health (NIH) [R01EY013315, R01EY019126, R03EY014939, R01EY015543, R01EY011671, R01EY09580]; Glaucoma Research Foundation; National Glaucoma Research of American Health Assistance Foundation; Research to Prevent Blindness; Glaucoma Foundation; Duke University NCRR/NIH [1 UL1 RR024128-01]; Duke Center for Human Genetics; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009580, R03EY014939, R01EY019126, P30EY005722, R01EY015543, R01EY011671, R01EY013315] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Research Foundation; National Glaucoma Research of American Health Assistance Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Glaucoma Foundation; Duke University NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Duke Center for Human Genetics; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by National Institutes of Health (NIH) grants R01EY013315 (MAH), R01EY019126 (MAH), R03EY014939 (RRA), R01EY015543 (RRA), R01EY011671 (JER), R01EY09580 (JER), the Glaucoma Research Foundation (YL), National Glaucoma Research of American Health Assistance Foundation (YL), Research to Prevent Blindness (JER) and The Glaucoma Foundation (YL). This study was also supported in part by Duke University's CTSA grant 1 UL1 RR024128-01 from NCRR/NIH, as well as the research infrastructure of the Duke Center for Human Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2009, MOL VIS, V15, P1594; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; BROWNSTEIN S, 1978, ARCH OPHTHALMOL-CHIC, V96, P864, DOI 10.1001/archopht.1978.03910050466015; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; Davis L, 2011, INVEST OPHTHALMOL VI; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Fraser CR, 2009, AM J CLIN PATHOL, V132, P928, DOI 10.1309/AJCPWQ0I0DGXBMHO; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Libby RT, 2005, ANNU REV GENOM HUM G, V6, P15, DOI 10.1146/annurev.genom.6.080604.162209; LIU Y, 2011, EXP EYE RES; Liu YT, 2008, INVEST OPHTH VIS SCI, V49, P3465, DOI 10.1167/iovs.08-1850; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; LUZI P, 1995, GENOMICS, V26, P407, DOI 10.1016/0888-7543(95)80230-J; LUZI P, 1995, HUM MOL GENET, V4, P2335, DOI 10.1093/hmg/4.12.2335; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Manni G, 2008, PROG BRAIN RES, V173, P25, DOI 10.1016/S0079-6123(08)01103-5; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RAFI MA, 1995, HUM MOL GENET, V4, P1285, DOI 10.1093/hmg/4.8.1285; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wenger DA, 1997, HUM MUTAT, V10, P268, DOI 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D; Wenger DA, 2000, MOL GENET METAB, V70, P1, DOI 10.1006/mgme.2000.2990; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	39	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27134	10.1371/journal.pone.0027134	http://dx.doi.org/10.1371/journal.pone.0027134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073273	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200037
J	Murdoch, BM; Murdoch, GK; Settles, M; McKay, S; Williams, JL; Moore, SS				Murdoch, Brenda M.; Murdoch, Gordon K.; Settles, Matthew; McKay, Stephanie; Williams, John L.; Moore, Stephen S.			Genome-Wide Scan Identifies Loci Associated with Classical BSE Occurrence	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PRION PROTEIN; INCUBATION PERIOD; CATTLE; GENE; MICE; CJD	Classical bovine spongiform encephalopathy (BSE) is an acquired prion disease that is invariably fatal in cattle and has been implicated as a significant human health risk. Sequence variations in the coding region of the prion gene (PRNP) have been associated with acquired transmissible spongiform encephalopathy (TSE) susceptibility in mammals; however, this is not the case in cattle. It has been hypothesized that genes, in addition to the prion gene, contribute to genetic susceptibility of acquired TSEs. Accordingly, genetic studies of classical BSE in cattle identified loci other than PRNP that are associated with disease incidence. The objective of this study was to utilize a genome-wide association study to test for genetic loci associated with classical BSE. The samples include 143 BSE affected (case) and 173 unaffected half sib (control) animals collected in the mid 1990s in Southern England. The data analysis identifies loci on two different chromosomes associated with BSE disease occurrence. Most notable is a single nucleotide polymorphism on chromosome 1 at 29.15 Mb that is associated with BSE disease (p = 3.09E-05). Additionally, a locus on chromosome 14, within a cluster of SNPs showed a trend toward significance (p = 5.24E-05). It is worth noting that in a human vCJD study markers on human chromosome 8, a region with shared synteny to the region identified on cattle chromosome 14, were associated with disease. Further, our candidate genes appear to have plausible biological relevance with the known etiology of TSE disease. One of the candidate genes is hypothetical gene LOC521010, similar to FK506 binding protein 2 located on chromosome 1 at 29.32 Mb. This gene encodes a protein that is a member of the immunophilin protein family and is involved in basic cellular processes including protein folding. The chromosomal regions identified in this study and candidate genes within these regions merit further investigation.	[Murdoch, Brenda M.; Moore, Stephen S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Murdoch, Brenda M.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Settles, Matthew] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [McKay, Stephanie] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Williams, John L.] Polo Univ, Lodi, Italy	University of Alberta; Washington State University; Idaho; University of Idaho; University of Missouri System; University of Missouri Columbia	Murdoch, BM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	brenda_murdoch@wsu.edu	Settles, Matthew L/F-2031-2011; Moore, Stephen S/F-5285-2013	Settles, Matthew L/0000-0002-3424-1086; Moore, Stephen/0000-0002-9758-166X; McKay, Stephanie/0000-0003-1434-3111; Williams, John/0000-0001-5188-7957; Murdoch, Brenda M/0000-0001-8675-3473	PrioNet Canada; Alberta Prion Research Institute [200500696]	PrioNet Canada; Alberta Prion Research Institute	The authors would like to thank the PrioNet Canada and Alberta Prion Research Institute (200500696) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2006, J ANIM SCI, V84, P259, DOI 10.2527/2006.842259x; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Hernandez-Sanchez J, 2002, MAMM GENOME, V13, P164, DOI 10.1007/BF02684022; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moreno CR, 2008, GENETICS, V179, P723, DOI 10.1534/genetics.108.088146; Moreno CR, 2003, GENETICS, V165, P2085; Murdoch BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012786; Murdoch BM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-20; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zhang C, 2004, GENETICS, V167, P1863, DOI 10.1534/genetics.104.026401	31	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26819	10.1371/journal.pone.0026819	http://dx.doi.org/10.1371/journal.pone.0026819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073200	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200020
J	Qin, A; Cheng, TS; Lin, Z; Pavlos, NJ; Jiang, Q; Xu, JK; Dai, KR; Zheng, MH				Qin, An; Cheng, Tak S.; Lin, Zhen; Pavlos, Nathan J.; Jiang, Qing; Xu, Jiake; Dai, Ke R.; Zheng, Ming H.			Versatile Roles of V-ATPases Accessory Subunit Ac45 in Osteoclast Formation and Function	PLOS ONE			English	Article							VACUOLAR PROTON PUMP; AUTOSOMAL RECESSIVE OSTEOPETROSIS; RESORPTION IN-VITRO; BONE-RESORPTION; H+-ATPASE; EXTRACELLULAR ACIDIFICATION; GRANULAR ACIDIFICATION; ESSENTIAL COMPONENT; GENE-EXPRESSION; MEMBRANE-FUSION	Vacuolar-type H+-ATPases (V-ATPases) are macromolecular proton pumps that acidify intracellular cargos and deliver protons across the plasma membrane of a variety of specialized cells, including bone-resorbing osteoclasts. Extracellular acidification is crucial for osteoclastic bone resorption, a process that initiates the dissolution of mineralized bone matrix. While the importance of V-ATPases in osteoclastic resorptive function is well-defined, whether V-ATPases facilitate additional aspects of osteoclast function and/or formation remains largely obscure. Here we report that the V-ATPase accessory subunit Ac45 participates in both osteoclast formation and function. Using a siRNA-based approach, we show that targeted suppression of Ac45 impairs intracellular acidification and endocytosis, both are prerequisite for osteoclastic bone resorptive function in vitro. Interestingly, we find that knockdown of Ac45 also attenuates osteoclastogenesis owing to a reduced fusion capacity of osteoclastic precursor cells. Finally, in an effort to gain more detailed insights into the functional role of Ac45 in osteoclasts, we attempted to generate osteoclast-specific Ac45 conditional knockout mice using a Cathepsin K-Cre-LoxP system. Surprisingly, however, insertion of the neomycin cassette in the Ac45-Flox(Neo) mice resulted in marked disturbances in CNS development and ensuing embryonic lethality thus precluding functional assessment of Ac45 in osteoclasts and peripheral bone tissues. Based on these unexpected findings we propose that, in addition to its canonical function in V-ATPase-mediated acidification, Ac45 plays versatile roles during osteoclast formation and function.	[Qin, An; Dai, Ke R.] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200030, Peoples R China; [Qin, An; Cheng, Tak S.; Lin, Zhen; Pavlos, Nathan J.; Zheng, Ming H.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Perth, WA 6009, Australia; [Lin, Zhen] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Surg, Div Orthopaed, Guangzhou, Guangdong, Peoples R China; [Jiang, Qing; Zheng, Ming H.] Nanjing Univ, Model Anim Res Ctr, Australian China Joint Ctr Bone & Joint Res, Nanjing 210008, Peoples R China; [Jiang, Qing] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Peoples R China; [Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Dai, Ke R.] Shanghai Jiao Tong Univ, Chinese Acad Sci, Inst Hlth Sci, Orthopaed Cellular & Mol Biol Lab,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of Western Australia; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Nanjing University; Nanjing University; University of Western Australia; Chinese Academy of Sciences; Shanghai Jiao Tong University	Qin, A (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200030, Peoples R China.	krdai@163.com; minghao.zheng@uwa.edu.au		/0000-0002-2151-3433; Pavlos, Nathan/0000-0001-7003-188X; Xu, Jiake/0000-0003-2021-8309; Zheng, Minghao/0000-0003-1185-4768	National Health and Medical Research Council of Australia (NHMRC) [APP572670]; Key Disciplines of Shanghai Municipal Education Commission of China [J50206]; Guangdong Natural Science Foundation [9451008004002071]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Key Disciplines of Shanghai Municipal Education Commission of China; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by grants awarded by the National Health and Medical Research Council of Australia (NHMRC) to Dr. Zheng and Dr. Xu (APP572670), grants awarded by the Key Disciplines of Shanghai Municipal Education Commission of China to Dr. Dai (J50206), and grants awarded by Guangdong Natural Science Foundation to Dr. Lin (9451008004002071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Crawford LW, 2010, TOXICOL PATHOL, V38, P872, DOI 10.1177/0192623310374329; Drose S, 1997, J EXP BIOL, V200, P1; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Forgac M, 2000, J EXP BIOL, V203, P71; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Getlawi F, 1996, NEUROSCI LETT, V219, P13, DOI 10.1016/S0304-3940(96)13151-7; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Holthuis JCM, 1999, EUR J BIOCHEM, V262, P484, DOI 10.1046/j.1432-1327.1999.00396.x; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Ishizuka H, 2011, J BONE MINER RES, V26, P169, DOI 10.1002/jbmr.199; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2010, MOL BIOL CELL, V21, P3330, DOI 10.1091/mbc.E10-04-0274; Jansen EJR, 2008, BBA-MOL CELL RES, V1783, P2301, DOI 10.1016/j.bbamcr.2008.06.020; LAITALA T, 1994, J CLIN INVEST, V93, P2311, DOI 10.1172/JCI117235; Laitala-Leinonen T, 1999, J CELL SCI, V112, P3657; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Ochotny N, 2011, J BONE MINER RES, V26, P1484, DOI 10.1002/jbmr.355; PALMGREN MG, 1991, ANAL BIOCHEM, V192, P316, DOI 10.1016/0003-2697(91)90542-2; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Ramirez MI, 2002, J HISTOCHEM CYTOCHEM, V50, P33, DOI 10.1177/002215540205000104; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Schoonderwoert VTG, 2002, MOL MEMBR BIOL, V19, P67, DOI 10.1080/09687680110112910; Scimeca JC, 2003, HUM MUTAT, V21, P151, DOI 10.1002/humu.10165; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUNDQUIST K, 1990, BIOCHEM BIOPH RES CO, V168, P309, DOI 10.1016/0006-291X(90)91709-2; SUNDQUIST KT, 1994, J BONE MINER RES, V9, P1575; SUPEK F, 1994, J BIOL CHEM, V269, P24102; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Vaananen HK, 2000, J CELL SCI, V113, P377; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xu J, 2003, J CELL BIOCHEM, V88, P1256, DOI 10.1002/jcb.10477; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	59	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27155	10.1371/journal.pone.0027155	http://dx.doi.org/10.1371/journal.pone.0027155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22087256	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200040
J	Chadha, SS; Bn, S; Reddy, K; Jaju, J; Ph, V; Rao, S; Parmar, M; Satyanarayana, S; Sachdeva, KS; Wilson, N; Harries, AD				Chadha, Sarabjit S.; Bn, Sharath; Reddy, Kishore; Jaju, Jyothi; Ph, Vishnu; Rao, Sreenivas; Parmar, Malik; Satyanarayana, Srinath; Sachdeva, Kuldeep Singh; Wilson, Nevin; Harries, Anthony D.			Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, India	PLOS ONE			English	Article							TUBERCULOSIS	Background: Revised National TB Control Programme (RNTCP), Andhra Pradesh, India. There is limited information on whether MDR-TB suspects are identified, undergo diagnostic assessment and are initiated on treatment according to the programme guidelines. Objectives: To assess i) using the programme definition, the number and proportion of MDR-TB suspects in a large cohort of TB patients on first-line treatment under RNTCP ii) the proportion of these MDR-TB suspects who underwent diagnosis for MDR-TB and iii) the number and proportion of those diagnosed as MDR-TB who were successfully initiated on treatment. Methods: A retrospective cohort analysis, by reviewing RNTCP records and reports, was conducted in four districts of Andhra Pradesh, India, among patients registered for first line treatment during October 2008 to December 2009. Results: Among 23,999 TB patients registered for treatment there were 559 (2%) MDR-TB suspects (according to programme definition) of which 307 (55%) underwent diagnosis and amongst these 169 (55%) were found to be MDR-TB. Of the MDR-TB patients, 112 (66%) were successfully initiated on treatment. Amongst those eligible for MDR-TB services, significant proportions are lost during the diagnostic and treatment initiation pathway due to a variety of operational challenges. The programme needs to urgently address these challenges for effective delivery and utilisation of the MDR-TB services.	[Chadha, Sarabjit S.; Satyanarayana, Srinath; Wilson, Nevin] Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India; [Bn, Sharath; Jaju, Jyothi; Parmar, Malik] World Hlth Org, Off WHO Representat India, New Delhi, India; [Reddy, Kishore; Ph, Vishnu] State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India; [Rao, Sreenivas] Govt Andhra Pradesh, State TB Off, Directorate Hlth, Hyderabad, Andhra Pradesh, India; [Harries, Anthony D.] Int Union TB & Lung Dis Union, Paris, France; [Sachdeva, Kuldeep Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India	World Health Organization	Chadha, SS (corresponding author), Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India.	schadha@theunion.org	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Wilson, Nevin/0000-0002-0191-8855	Centre for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France; Operational Research Unit, Medecins sans Frontieres, Brussels	Centre for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France; Operational Research Unit, Medecins sans Frontieres, Brussels	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France and the Operational Research Unit, Medecins sans Frontieres, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CENTR TUB DIV, 2010, DOTS PLUS GUID DIR G; Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; CHAN M, 2009, MDR TB OVERCOMING RE; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; *STOP T PARTN WHO, 2006, GLOB PLAN STOP TB 20; *WHO GEN, 2010, WHOHTMTB201003; *WHO GEN, 2008, WHOHTMTB2008402; *WHO GEN, 2003, TREATM TUB GUID NAT	11	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26659	10.1371/journal.pone.0026659	http://dx.doi.org/10.1371/journal.pone.0026659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073182	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900008
J	Denkel, LA; Horst, SA; Rouf, SF; Kitowski, V; Bohm, OM; Rhen, M; Jager, T; Bange, FC				Denkel, Luisa A.; Horst, Sarah A.; Rouf, Syed Fazle; Kitowski, Vera; Bohm, Oliver M.; Rhen, Mikael; Jager, Timo; Bange, Franz-Christoph			Methionine Sulfoxide Reductases Are Essential for Virulence of Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; STAPHYLOCOCCUS-AUREUS; R-SULFOXIDE; MYCOBACTERIUM-SMEGMATIS; EXPRESSION; DAMAGE; GENES; MSRA; MACROPHAGES	Production of reactive oxygen species represents a fundamental innate defense against microbes in a diversity of host organisms. Oxidative stress, amongst others, converts peptidyl and free methionine to a mixture of methionine-S-(Met-S-SO) and methionine-R-sulfoxides (Met-R-SO). To cope with such oxidative damage, methionine sulfoxide reductases MsrA and MsrB are known to reduce MetSOs, the former being specific for the S-form and the latter being specific for the R-form. However, at present the role of methionine sulfoxide reductases in the pathogenesis of intracellular bacterial pathogens has not been fully detailed. Here we show that deletion of msrA in the facultative intracellular pathogen Salmonella ( S.) enterica serovar Typhimurium increased susceptibility to exogenous H(2)O(2), and reduced bacterial replication inside activated macrophages, and in mice. In contrast, a Delta msrB mutant showed the wild type phenotype. Recombinant MsrA was active against free and peptidyl Met-S-SO, whereas recombinant MsrB was only weakly active and specific for peptidyl Met-R-SO. This raised the question of whether an additional Met-R-SO reductase could play a role in the oxidative stress response of S. Typhimurium. MsrC is a methionine sulfoxide reductase previously shown to be specific for free Met-R-SO in Escherichia (E.) coli. We tested a Delta msrC single mutant and a Delta msrB Delta msrC double mutant under various stress conditions, and found that MsrC is essential for survival of S. Typhimurium following exposure to H(2)O(2), as well as for growth in macrophages, and in mice. Hence, this study demonstrates that all three methionine sulfoxide reductases, MsrA, MsrB and MsrC, facilitate growth of a canonical intracellular pathogen during infection. Interestingly MsrC is specific for the repair of free methionine sulfoxide, pointing to an important role of this pathway in the oxidative stress response of Salmonella Typhimurium.	[Denkel, Luisa A.; Horst, Sarah A.; Rouf, Syed Fazle; Kitowski, Vera; Bange, Franz-Christoph] Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany; [Bohm, Oliver M.; Jager, Timo] Mol Links Sachsen Anhalt Gesell Beschrankter Haft, Magdeburg, Germany; [Rouf, Syed Fazle; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Hannover Medical School; Karolinska Institutet	Denkel, LA (corresponding author), Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany.	bange.franz@mh-hannover.de	Denkel, Luisa/AIC-3404-2022	Rouf, Syed Fazle/0000-0003-3776-5018; Denkel, Luisa/0000-0003-4005-1315	International Research Training Group [1273]; German Research Foundation; Swedish Medical Research Council; German Research Foundation (Deutsche Forschungsgemeinschaft)	International Research Training Group; German Research Foundation(German Research Foundation (DFG)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the International Research Training Group 1273 funded by the German Research Foundation to SAH, LAD, and SFR. MR was supported by the Swedish Medical Research Council. Publication fee for this study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bong SM, 2010, J BIOL CHEM, V285, P25044, DOI 10.1074/jbc.M110.103119; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; EJIRI SI, 1979, J BACTERIOL, V139, P161, DOI 10.1128/JB.139.1.161-164.1979; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Gruez A, 2010, J BIOL CHEM, V285, P25033, DOI 10.1074/jbc.M110.134528; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mintz KP, 2002, MICROBIOL-SGM, V148, P3695, DOI 10.1099/00221287-148-11-3695; Moskovitz J, 2002, BIOCHEM BIOPH RES CO, V290, P62, DOI 10.1006/bbrc.2001.6171; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Singh VK, 2001, MICROBIOL-SGM, V147, P3037, DOI 10.1099/00221287-147-11-3037; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	39	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26974	10.1371/journal.pone.0026974	http://dx.doi.org/10.1371/journal.pone.0026974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073230	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900057
J	Mothe, AJ; Zahir, T; Santaguida, C; Cook, D; Tator, CH				Mothe, Andrea J.; Zahir, Tasneem; Santaguida, Carlo; Cook, Douglas; Tator, Charles H.			Neural Stem/Progenitor Cells from the Adult Human Spinal Cord Are Multipotent and Self-Renewing and Differentiate after Transplantation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM-CULTURE; PROGENITOR CELLS; IN-VITRO; GROWTH-FACTOR; HUMAN BRAIN; HUMAN NEUROSPHERES; PRECURSOR CELLS; RADIAL GLIA	Neural stem/progenitor cell (NSPC) transplantation is a promising therapy for spinal cord injury (SCI). However, little is known about NSPC from the adult human spinal cord as a donor source. We demonstrate for the first time that multipotent and self-renewing NSPC can be cultured, passaged and transplanted from the adult human spinal cord of organ transplant donors. Adult human spinal cord NSPC require an adherent substrate for selection and expansion in EGF (epidermal growth factor) and FGF2 (fibroblast growth factor) enriched medium. NSPC as an adherent monolayer can be passaged for at least 9 months and form neurospheres when plated in suspension culture. In EGF/FGF2 culture, NSPC proliferate and primarily express nestin and Sox2, and low levels of markers for differentiating cells. Leukemia inhibitory factor (LIF) promotes NSPC proliferation and significantly enhances GFAP expression in hypoxia. In differentiating conditions in the presence of serum, these NSPC show multipotentiality, expressing markers of neurons, astrocytes, and oligodendrocytes. Dibutyryl cyclic AMP (dbcAMP) significantly enhances neuronal differentiation. We transplanted the multipotent NSPC into SCI rats and show that the xenografts survive, are post-mitotic, and retain the capacity to differentiate into neurons and glia. Together, these findings reveal that multipotent self-renewing NSPC cultured and passaged from adult human spinal cords of organ transplant donors, respond to exogenous factors that promote selective differentiation, and survive and differentiate after transplantation into the injured spinal cord.	[Mothe, Andrea J.] Univ Toronto, Toronto Western Hosp, Div Genet & Dev, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mothe, AJ (corresponding author), Univ Toronto, Toronto Western Hosp, Div Genet & Dev, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada.	amothe@uhnres.utoronto.ca		Mothe, Andrea/0000-0002-1062-1025	AOSpine North America; Physicians' Services Inc. Foundation [09-34]; Canadian Paraplegic Association (ON branch); Christopher and Dana Reeve Foundation [TA1-0402-2]	AOSpine North America; Physicians' Services Inc. Foundation; Canadian Paraplegic Association (ON branch); Christopher and Dana Reeve Foundation	This work was supported by AOSpine North America Young Investigator Research Grant (no grant#), Physicians' Services Inc. Foundation (grant# 09-34), the Canadian Paraplegic Association (ON branch)(no grant#), and the Christopher and Dana Reeve Foundation (grant# TA1-0402-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson E, 2007, PHYSIOL BEHAV, V92, P60, DOI 10.1016/j.physbeh.2007.05.056; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barami K, 2001, NEUROL RES, V23, P260, DOI 10.1179/016164101101198406; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dervan AG, 2003, J COMP NEUROL, V458, P293, DOI 10.1002/cne.10594; Dromard C, 2008, J NEUROSCI RES, V86, P1916, DOI 10.1002/jnr.21646; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guo XF, 2010, J TISSUE ENG REGEN M, V4, P181, DOI 10.1002/term.223; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Klassen H, 2004, J NEUROSCI RES, V77, P334, DOI 10.1002/jnr.20183; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Lopez-Toledano MA, 2004, J HISTOCHEM CYTOCHEM, V52, P1177, DOI 10.1369/jhc.3A6244.2004; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Piao JH, 2006, J NEUROSCI RES, V84, P471, DOI 10.1002/jnr.20955; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Quinn SM, 1999, J NEUROSCI RES, V57, P590, DOI 10.1002/(SICI)1097-4547(19990901)57:5<590::AID-JNR2>3.0.CO;2-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rao Mahendra S., 2009, V549, P3, DOI 10.1007/978-1-60327-931-4_1; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rivlin A S, 1978, Surg Neurol, V10, P38; Roy NS, 2004, NAT BIOTECHNOL, V22, P297, DOI 10.1038/nbt944; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Studer L, 2000, J NEUROSCI, V20, P7377; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; Weiss S, 1996, J NEUROSCI, V16, P7599; WOLSWIJK G, 1991, GLIA, V4, P495, DOI 10.1002/glia.440040509; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	70	64	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27079	10.1371/journal.pone.0027079	http://dx.doi.org/10.1371/journal.pone.0027079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073257	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900071
J	Niu, S; Shingle, DL; Garbarino-Pico, E; Kojima, S; Gilbert, M; Green, CB				Niu, Shuang; Shingle, Danielle L.; Garbarino-Pico, Eduardo; Kojima, Shihoko; Gilbert, Misty; Green, Carla B.			The Circadian Deadenylase Nocturnin Is Necessary for Stabilization of the iNOS mRNA in Mice	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; POSTTRANSCRIPTIONAL REGULATION; COMPLEX; IDENTIFICATION; LIPOPOLYSACCHARIDE; TRANSLATION; INVOLVEMENT; EXPRESSION; MECHANISM; ENDOTOXIN	Nocturnin is a member of the CCR4 deadenylase family, and its expression is under circadian control with peak levels at night. Because it can remove poly(A) tails from mRNAs, it is presumed to play a role in post-transcriptional control of circadian gene expression, but its target mRNAs are not known. Here we demonstrate that Nocturnin expression is acutely induced by the endotoxin lipopolysaccharide (LPS). Mouse embryo fibroblasts (MEFs) lacking Nocturnin exhibit normal patterns of acute induction of TNF alpha and iNOS mRNAs during the first three hours following LPS treatment, but by 24 hours, while TNFa mRNA levels are indistinguishable from WT cells, iNOS message is significantly reduced 20-fold. Accordingly, analysis of the stability of the mRNAs showed that loss of Nocturnin causes a significant decrease in the half-life of the iNOS mRNA (t(1/2) = 3.3 hours in Nocturnin knockout MEFs vs. 12.4 hours in wild type MEFs), while having no effect on the TNFa message. Furthermore, mice lacking Nocturnin lose the normal nighttime peak of hepatic iNOS mRNA, and have improved survival following LPS injection. These data suggest that Nocturnin has a novel stabilizing activity that plays an important role in the circadian response to inflammatory signals.	[Niu, Shuang; Shingle, Danielle L.; Garbarino-Pico, Eduardo; Kojima, Shihoko; Gilbert, Misty; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Shingle, Danielle L.; Kojima, Shihoko; Green, Carla B.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Niu, S (corresponding author), Stanford Med Sch, Dept Pediat, Palo Alto, CA USA.	Carla.Green@UTSouthwestern.edu		Kojima (xiao dao zhi bao zi), Shihoko/0000-0001-9579-7830; Garbarino Pico, Eduardo/0000-0002-2931-2038	National Institutes of Health [R01 GM076626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM076626 (to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Baggs Julie E, 2006, Methods Mol Biol, V317, P243; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Cao D, 2001, RNA, V7, P1192, DOI 10.1017/S1355838201010330; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Franco-Molina MA, 2004, INT IMMUNOPHARMACOL, V4, P1577, DOI 10.1016/j.intimp.2004.06.014; Garbarino-Pico E, 2007, COLD SPRING HARB SYM, V72, P145, DOI 10.1101/sqb.2007.72.022; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GELLER DA, 1995, J IMMUNOL, V155, P4890; Gilbert MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017051; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Green CB, 1996, MOL BRAIN RES, V37, P157, DOI 10.1016/0169-328X(95)00307-E; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; HRUSHESKY WJM, 1994, J EXP MED, V180, P1059, DOI 10.1084/jem.180.3.1059; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Keene JD, 2007, COLD SPRING HARB SYM, V72, P157, DOI 10.1101/sqb.2007.72.013; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kitade H, 1996, HEPATOLOGY, V23, P797, DOI 10.1002/hep.510230421; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kuo SM, 2005, J NUTR, V135, P2411, DOI 10.1093/jn/135.10.2411; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Netea MG, 2001, EUR J IMMUNOL, V31, P2529, DOI 10.1002/1521-4141(200109)31:9<2529::AID-IMMU2529>3.0.CO;2-B; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Soderberg M, 2002, MOL PHARMACOL, V62, P423, DOI 10.1124/mol.62.2.423; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tracz MJ, 2007, AM J PATHOL, V170, P1820, DOI 10.2353/ajpath.2007.061093; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Xu J., 2005, CURR PROT MOL BIOL, V28, P28; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	48	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26954	10.1371/journal.pone.0026954	http://dx.doi.org/10.1371/journal.pone.0026954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073225	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900054
J	Rands, SA; Evans, MR; Johnstone, RA				Rands, Sean A.; Evans, Matthew R.; Johnstone, Rufus A.			The Dynamics of Honesty: Modelling the Growth of Costly, Sexually-Selected Ornaments	PLOS ONE			English	Article							FAT RESERVES; HORN GROWTH; ANTLER; ALLOMETRY; EVOLUTION; PATTERNS	The handicap principle suggests that individuals of superior quality can more easily bear the cost of developing extravagant ornaments. Consequently, ornament size should provide reliable information about quality or condition. Previous models have largely ignored the process of ornament growth, focusing only on final ornament size. We model ornament growth schedules for individuals of different qualities, where higher quality individuals experience lower costs of carrying energy reserves of a given size, but where all individuals pay a net cost of carrying ornaments of a given size. If the costs of ornament production ensure that final ornament size reliably signals quality, the information conveyed by the signal can change dramatically during growth. Higher quality individuals should delay growth until closer to breeding. Taking a snapshot of partially developed ornaments prior to breeding would show them to be larger in poorer quality individuals. The claim that costly ornaments honestly signal quality thus needs to be understood in a dynamic context, and may only hold during some phases of growth.	[Rands, Sean A.; Evans, Matthew R.] Univ Exeter Cornwall, Ctr Ecol & Conservat, Penryn, England; [Rands, Sean A.; Johnstone, Rufus A.] Univ Cambridge, Dept Zool, Cambridge, England; [Rands, Sean A.] Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England; [Evans, Matthew R.] Univ London, Sch Biol & Chem Sci, London, England	University of Exeter; University of Cambridge; University of Bristol; University of London	Rands, SA (corresponding author), Univ Exeter Cornwall, Ctr Ecol & Conservat, Penryn, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X; Evans, Matthew/0000-0002-5630-7621	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	This work was funded by a Leverhulme Trust research grant to MRE and RAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Aparicio JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P273, DOI 10.1007/s002650000302; Badyaev AV, 2004, EVOL ECOL RES, V6, P975; BARNARD P, 1995, BIOL J LINN SOC, V55, P129, DOI 10.1111/j.1095-8312.1995.tb01055.x; Bartos L, 2009, BONE, V44, P691, DOI 10.1016/j.bone.2008.12.004; Bender LC, 2003, AM MIDL NAT, V150, P169, DOI 10.1674/0003-0031(2003)150[0169:BMAADP]2.0.CO;2; Bergeron P, 2008, OIKOS, V117, P77, DOI 10.1111/j.2007.0030-1299.16158.x; Bonduriansky R, 2005, EVOLUTION, V59, P138, DOI 10.1111/j.0014-3820.2005.tb00901.x; Bonenfant C, 2009, J ANIM ECOL, V78, P161, DOI 10.1111/j.1365-2656.2008.01477.x; Clark CW, 2000, OX ECOL EV; Crigel MH, 2001, ANN MED VET, V145, P25; Curio E, 2004, J ORNITHOL, V145, P227, DOI 10.1007/s10336-004-0033-x; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P753, DOI 10.1007/s10344-008-0185-8; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P1, DOI 10.1007/s10344-007-0096-0; Grose J, 2011, BIOL PHILOS, V26, P677, DOI 10.1007/s10539-011-9275-1; HOUSTON A, 1988, NATURE, V332, P29, DOI 10.1038/332029a0; Houston AI, 1997, OIKOS, V78, P331, DOI 10.2307/3546301; HOUSTON AI, 1993, ORNIS SCAND, V24, P205, DOI 10.2307/3676736; HOUSTON AI, 1988, BEHAV BRAIN SCI, V11, P117, DOI 10.1017/S0140525X00053061; Houston AI, 1999, MODELS ADAPTIVE BEHA; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Johnstone RA, 2009, J EVOLUTION BIOL, V22, P2387, DOI 10.1111/j.1420-9101.2009.01822.x; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kozlowski J, 1997, AM NAT, V149, P352; Lindstrom J, 2009, AM NAT, V174, P515, DOI 10.1086/606008; Lindstrom J, 2005, FUNCT ECOL, V19, P421, DOI 10.1111/j.1365-2435.2005.00974.x; Mangel M., 1988, DYNAMIC MODELING BEH; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; R Development Core Team, 2005, R LANG ENV STAT COMP; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002252; Rands SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022104; Rands SA, 2010, BEHAV PROCESS, V84, P668, DOI 10.1016/j.beproc.2010.03.001; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Spinage CA., 1986, NATURAL HIST ANTELOP; Tomkins JL, 2005, AM NAT, V165, P389, DOI 10.1086/427732; Vanpe C, 2007, AM NAT, V169, P481, DOI 10.1086/512046; Veit AC, 2004, IBIS, V146, P355, DOI 10.1111/j.1474-919X.2004.00265.x; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	44	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27174	10.1371/journal.pone.0027174	http://dx.doi.org/10.1371/journal.pone.0027174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073280	gold, Green Published			2022-12-27	WOS:000297154900084
J	Utani, K; Okamoto, A; Shimizu, N				Utani, Koh-ichi; Okamoto, Atsushi; Shimizu, Noriaki			Generation of Micronuclei during Interphase by Coupling between Cytoplasmic Membrane Blebbing and Nuclear Budding	PLOS ONE			English	Article							EXTRACHROMOSOMALLY AMPLIFIED DNA; GENE AMPLIFICATION; DOUBLE MINUTES; CANCER-CELLS; HL-60 CELLS; MOLECULAR-MECHANISMS; MYC GENES; S PHASE; C-MYC; CHROMATIN	Micronucleation, mediated by interphase nuclear budding, has been repeatedly suggested, but the process is still enigmatic. In the present study, we confirmed the previous observation that there are lamin B1-negative micronuclei in addition to the positive ones. A large cytoplasmic bleb was found to frequently entrap lamin B1-negative micronuclei, which were connected to the nucleus by a thin chromatin stalk. At the bottom of the stalk, the nuclear lamin B1 structure appeared broken. Chromatin extrusion through lamina breaks has been referred to as herniation or a blister of the nucleus, and has been observed after the expression of viral proteins. A cell line in which extrachromosomal double minutes and lamin B1 protein were simultaneously visualized in different colors in live cells was established. By using these cells, time-lapse microscopy revealed that cytoplasmic membrane blebbing occurred simultaneously with the extrusion of nuclear content, which generated lamin B1-negative micronuclei during interphase. Furthermore, activation of cytoplasmic membrane blebbing by the addition of fresh serum or camptothecin induced nuclear budding within 1 to 10 minutes, which suggested that blebbing might be the cause of the budding. After the induction of blebbing, the frequency of lamin-negative micronuclei increased. The budding was most frequent during S phase and more efficiently entrapped small extrachromosomal chromatin than the large chromosome arm. Based on these results, we suggest a novel mechanism in which cytoplasmic membrane dynamics pulls the chromatin out of the nucleus through the lamina break. Evidence for such a mechanism was obtained in certain cancer cell lines including human COLO 320 and HeLa. The mechanism could significantly perturb the genome and influence cancer cell phenotypes.	[Utani, Koh-ichi; Okamoto, Atsushi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan	Hiroshima University	Utani, K (corresponding author), NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA.	shimizu@hiroshima-u.ac.jp		Utani, Koichi/0000-0002-8065-3161	Japan Society for the Promotion of Science [17370002, 21657051]; Ministry of Education, Science, Sports and Culture of Japan [19038016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) [grant number 17370002] and a Grant-in-Aid for Challenging Exploratory Research [grant number 21657051] both from the Japan Society for the Promotion of Science to NS and a Grant-in-Aid for Scientific Research on Priority Areas - Nuclear dynamics [grant number 19038016] from the Ministry of Education, Science, Sports and Culture of Japan to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cimini D, 2002, J CELL SCI, V115, P507; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; DIXON SJ, 1987, J CELL PHYSIOL, V132, P215, DOI 10.1002/jcp.1041320205; DIXON SJ, 1987, J CELL PHYSIOL, V132, P473, DOI 10.1002/jcp.1041320309; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2009, MUTAT RES-REV MUTAT, V681, P111, DOI 10.1016/j.mrrev.2008.11.003; FOISY S, 1988, BIOCHEM BIOPH RES CO, V156, P205, DOI 10.1016/S0006-291X(88)80825-8; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Hagmann J, 1999, J CELL BIOCHEM, V73, P488, DOI 10.1002/(SICI)1097-4644(19990615)73:4<488::AID-JCB7>3.0.CO;2-P; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Hoyt CC, 2004, J VIROL, V78, P6360, DOI 10.1128/JVI.78.12.6360-6369.2004; Itoh N, 1998, J CELL SCI, V111, P3275; Kanda T, 2000, J CELL BIOCHEM, P107; LEVAN A, 1978, HEREDITAS, V88, P81; Lindberg HK, 2007, MUTAT RES-FUND MOL M, V617, P33, DOI 10.1016/j.mrfmmm.2006.12.002; Machesky LM, 2009, CANCER CELL, V16, P5, DOI 10.1016/j.ccr.2009.06.009; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Paulin LM, 1996, CHROMOSOMA, V104, P367; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; SHIMIZU N, 1991, J BIOL CHEM, V266, P12157; Shimizu N, 2005, NUCLEIC ACIDS RES, V33, P6296, DOI 10.1093/nar/gki946; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; SHIMIZU N, 1994, CANCER RES, V54, P3561; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Shimizu N, 2011, MUTAGENESIS, V26, P119, DOI 10.1093/mutage/geq053; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tanaka T, 2000, J CELL SCI, V113, P697; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651	47	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27233	10.1371/journal.pone.0027233	http://dx.doi.org/10.1371/journal.pone.0027233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073297	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900093
J	Wang, CK; Simon, A; Jessen, CM; Oliveira, CLP; Mack, L; Braunewell, KH; Ames, JB; Pedersen, JS; Hofmann, A				Wang, Conan K.; Simon, Anne; Jessen, Christian M.; Oliveira, Cristiano L. P.; Mack, Lynsey; Braunewell, Karl-Heinz; Ames, James B.; Pedersen, Jan Skov; Hofmann, Andreas			Divalent Cations and Redox Conditions Regulate the Molecular Structure and Function of Visinin-Like Protein-1	PLOS ONE			English	Article							NEURONAL CALCIUM SENSOR-1; GUANYLYL CYCLASE; DNA-BINDING; IN-VITRO; VILIP-1; SCATTERING; IDENTIFICATION; LOCALIZATION; DIMERIZATION; EXPRESSION	The NCS protein Visinin-like Protein 1 (VILIP-1) transduces calcium signals in the brain and serves as an effector of the non-retinal receptor guanylyl cyclases (GCs) GC-A and GC-B, and nicotinic acetyl choline receptors (nAchR). Analysis of the quaternary structure of VILIP-1 in solution reveals the existence of monomeric and dimeric species, the relative contents of which are affected but not exclusively regulated by divalent metal ions and Redox conditions. Using small-angle X-ray scattering, we have investigated the low resolution structure of the calcium-bound VILIP-1 dimer under reducing conditions. Scattering profiles for samples with high monomeric and dimeric contents have been obtained. The dimerization interface involves residues from EF-hand regions EF3 and EF4. Using monolayer adsorption experiments, we show that myristoylated and unmyristoylated VILIP-1 can bind lipid membranes. The presence of calcium only marginally improves binding of the protein to the monolayer, suggesting that charged residues at the protein surface may play a role in the binding process. In the presence of calcium, VILIP-1 undergoes a conformational re-arrangement, exposing previously hidden surfaces for interaction with protein partners. We hypothesise a working model where dimeric VILIP-1 interacts with the membrane where it binds membrane-bound receptors in a calcium-dependent manner.	[Wang, Conan K.; Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Struct Chem Program, Brisbane, Qld 4111, Australia; [Simon, Anne] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France; [Jessen, Christian M.] Univ Sao Paulo, Dept Expt Phys, Complex Fluids Grp, Sao Paulo, Brazil; [Oliveira, Cristiano L. P.; Pedersen, Jan Skov] Univ Aarhus, Dept Chem, Aarhus, Denmark; [Oliveira, Cristiano L. P.; Pedersen, Jan Skov] Univ Aarhus, iNANO Interdisciplinary Nanosci Ctr, Aarhus, Denmark; [Mack, Lynsey; Hofmann, Andreas] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Braunewell, Karl-Heinz] So Res Inst, Dept Biochem & Mol Biol, Mol & Cellular Neurosci Lab, Birmingham, AL 35255 USA; [Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Griffith University; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidade de Sao Paulo; Aarhus University; Aarhus University; University of Edinburgh; University of California System; University of California Davis	Wang, CK (corresponding author), Griffith Univ, Eskitis Inst Cell & Mol Therapies, Struct Chem Program, Brisbane, Qld 4111, Australia.	conan.wang@griffith.edu.au	Hofmann, Andreas/M-9870-2019; Complexos, INCT Fluidos/H-9172-2013; Pedersen, Jan Skov/A-8346-2008; SIMON, Anne/D-6046-2011; Jessen, Christian/B-5238-2012; Hofmann, Andreas/B-9515-2008; Wang, Conan K/D-1481-2010; Oliveira, Cristiano L P/B-4403-2008	Hofmann, Andreas/0000-0003-4408-5467; Pedersen, Jan Skov/0000-0002-7768-0206; Hofmann, Andreas/0000-0003-4408-5467; Wang, Conan K/0000-0002-7973-7632; Oliveira, Cristiano L P/0000-0002-3426-6507	Fundacao Bial; Rebecca Cooper Foundation; National Institutes of Health [EY012347]; National Health and Medical Research Council [37677]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER	Fundacao Bial(Bial Foundation); Rebecca Cooper Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in parts by Fundacao Bial, the Rebecca Cooper Foundation (AH), and National Institutes of Health (grant EY012347, J.B.A.). C. W. is supported by an National Health and Medical Research Council postdoctoral training fellowship (37677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Brackmann M, 2005, J CELL SCI, V118, P2495, DOI 10.1242/jcs.02376; Brackmann M, 2006, NEURONAL CALCIUM SEN, P115; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Braunewell KH, 2006, CALCIUM BINDING PROT, V1, P12; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; COX JA, 1994, J BIOL CHEM, V269, P32807; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Hofmann A, 2002, BIOINFORMATICS, V18, P209, DOI 10.1093/bioinformatics/18.1.209; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabbani N, 2002, J NEUROSCI, V22, P8476; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li CM, 2011, J BIOL CHEM, V286, P6354, DOI 10.1074/jbc.M110.173724; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Mahloogi H, 2003, CANCER RES, V63, P4997; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; Meyer T, 1999, NAT CELL BIOL, V1, pE93, DOI 10.1038/12090; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Permyakov SE, 2007, J PROTEOME RES, V6, P1855, DOI 10.1021/pr070015x; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Spilker C, 1997, NEUROSCI LETT, V225, P126, DOI 10.1016/S0304-3940(97)00201-2; Spilker C, 2002, J NEUROSCI, V22, P7331; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Vogel A, 2007, BBA-BIOMEMBRANES, V1768, P3171, DOI 10.1016/j.bbamem.2007.08.024; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001	43	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26793	10.1371/journal.pone.0026793	http://dx.doi.org/10.1371/journal.pone.0026793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073194	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900036
J	Lindstedt, F; Johansson, B; Martinsen, S; Kosek, E; Fransson, P; Ingvar, M				Lindstedt, Fredrik; Johansson, Bo; Martinsen, Sofia; Kosek, Eva; Fransson, Peter; Ingvar, Martin			Evidence for Thalamic Involvement in the Thermal Grill Illusion: An fMRI Study	PLOS ONE			English	Article							CENTRAL NEUROPATHIC PAIN; MEDIAL PREFRONTAL CORTEX; INSULAR CORTEX; LATERAL INHIBITION; PARADOXICAL HEAT; C-FIBERS; STIMULATION; MECHANISMS; BRAIN; UNPLEASANTNESS	Background: Perceptual illusions play an important role in untangling neural mechanisms underlying conscious phenomena. The thermal grill illusion (TGI) has been suggested as a promising model for exploring percepts involved in neuropathic pain, such as cold-allodynia (pain arising from contact with innocuous cold). The TGI is an unpleasant/painful sensation from touching juxtapositioned bars of cold and warm innocuous temperatures. Aim: To develop an MRI-compatible TGI-unit and explore the supraspinal correlates of the illusion, using fMRI, in a group of healthy volunteers. Methods: We constructed a TGI-thermode allowing the rapid presentation of warm(41 degrees C), cold(18 degrees C) and interleaved( 41 degrees C+ 18 degrees C = TGI) temperatures in an fMRI-environment. Twenty volunteers were tested. The affective-motivational ("unpleasantness") and sensory-disciminatory ("pain-intensity") dimensions of each respective stimulus were rated. Functional images were analyzed at a corrected alpha-level <0.05. Results: The TGI was rated as significantly more unpleasant and painful than stimulation with each of its constituent temperatures. Also, the TGI was rated as significantly more unpleasant than painful. Thermal stimulation versus neutral baseline revealed bilateral activations of the anterior insulae and fronto-parietal regions. Unlike its constituent temperatures the TGI displayed a strong activation of the right (contralateral) thalamus. Exploratory contrasts at a slightly more liberal threshold-level also revealed a TGI-activation of the right mid/anterior insula, correlating with ratings of unpleasantness(rho = 0.31). Conclusion/Significance: To the best of our knowledge, this is the first fMRI-study of the TGI. The activation of the anterior insula is consistent with this region's putative role in processing of homeostatically relevant feeling-states. Our results constitute the first neurophysiologic evidence of thalamic involvement in the TGI. Similar thalamic activity has previously been observed during evoked cold-allodynia in patients with central neuropathic pain. Our results further the understanding of the supraspinal correlates of the TGI-phenomenon and pave the way for future inquiries into if and how it may relate to neuropathic pain.	[Lindstedt, Fredrik; Martinsen, Sofia; Kosek, Eva; Fransson, Peter; Ingvar, Martin] Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Johansson, Bo] Somed AB, Horby, Sweden	Karolinska Institutet	Lindstedt, F (corresponding author), Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden.	fredrik.lindstedt@ki.se	Fransson, Peter/M-5679-2014	Fransson, Peter/0000-0002-1305-9875; Kosek, Eva/0000-0003-0488-8177; Ingvar, Martin/0000-0002-9041-5714	Osher foundation; Swedish Research Council [2009-2322]	Osher foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Osher foundation (www.osherfoundation.org) and the Swedish Research Council (www.vr.se), grant nr 2009-2322 (MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2000, J NEUROPHYSIOL, V84, P484, DOI 10.1152/jn.2000.84.1.484; BEKESY GV, 1962, J APPL PHYSIOL, V17, P1003, DOI 10.1152/jappl.1962.17.6.1003; BERIC A, 1988, PAIN, V34, P109, DOI 10.1016/0304-3959(88)90155-8; Boettger MK, 2011, PAIN, V152, P123, DOI 10.1016/j.pain.2010.10.003; Bouhassira D, 2005, PAIN, V114, P160, DOI 10.1016/j.pain.2004.12.014; Campero M, 2009, J PHYSIOL-LONDON, V587, P5633, DOI 10.1113/jphysiol.2009.176040; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; CESARO P, 1991, PAIN, V47, P329, DOI 10.1016/0304-3959(91)90224-L; Craig AD, 2008, PAIN, V135, P215, DOI 10.1016/j.pain.2008.01.022; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Craig ADB, 1998, PAIN FORUM, V7, P1; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Davis KD, 2004, J NEUROPHYSIOL, V92, P1248, DOI 10.1152/jn.00084.2004; Defrin R, 2008, PAIN, V138, P577, DOI 10.1016/j.pain.2008.02.012; Dimitrova A, 2003, J NEUROPHYSIOL, V90, P1877, DOI 10.1152/jn.00053.2003; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Ducreux D, 2006, BRAIN, V129, P963, DOI 10.1093/brain/awl016; Dunckley P, 2005, NEUROSCIENCE, V133, P533, DOI 10.1016/j.neuroscience.2005.02.041; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Finnerup NB, 2008, CURR OPIN ANESTHESIO, V21, P586, DOI 10.1097/ACO.0b013e32830a4c11; Fruhstorfer H, 2003, EUR J PAIN, V7, P63, DOI 10.1016/S1090-3801(02)00056-3; Graziano A, 2004, J NEUROSCI, V24, P248, DOI 10.1523/JNEUROSCI.4122-03.2004; GREENSPAN JD, 1993, SOMATOSENS MOT RES, V10, P467, DOI 10.3109/08990229309028851; Griffiths D, 2007, NEUROUROL URODYNAM, V26, P899, DOI 10.1002/nau.20488; HAMALAINEN H, 1982, BRAIN RES, V251, P77, DOI 10.1016/0006-8993(82)91275-6; Hatem SM, 2010, BRAIN, V133, P3409, DOI 10.1093/brain/awq244; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Kammers MPM, 2010, CURR BIOL, V20, P1819, DOI 10.1016/j.cub.2010.08.038; Kern D, 2008, PAIN, V139, P653, DOI 10.1016/j.pain.2008.07.001; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Kim JH, 2007, J NEUROSCI, V27, P4995, DOI 10.1523/JNEUROSCI.0716-07.2007; Lavallee P, 2004, J NEUROSCI, V24, P6098, DOI 10.1523/JNEUROSCI.0973-04.2004; Lee JI, 2005, J NEUROPHYSIOL, V94, P1676, DOI 10.1152/jn.00343.2005; Leung AY, 2005, PAIN, V116, P26, DOI 10.1016/j.pain.2005.03.026; Li X, 2009, NEUROPHYSIOL CLIN, V39, P275, DOI 10.1016/j.neucli.2009.06.006; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; MAUGUIERE F, 1988, ARCH NEUROL-CHICAGO, V45, P1312, DOI 10.1001/archneur.1988.00520360030007; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Nasreddine ZS, 1997, NEUROLOGY, V48, P1196, DOI 10.1212/WNL.48.5.1196; Oshiro Y, 2009, J NEUROSCI, V29, P14924, DOI 10.1523/JNEUROSCI.5538-08.2009; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2000, PAIN, V84, P77, DOI 10.1016/S0304-3959(99)00190-6; Peyron R, 1998, BRAIN, V121, P345, DOI 10.1093/brain/121.2.345; Pinault D, 1998, EUR J NEUROSCI, V10, P3462, DOI 10.1046/j.1460-9568.1998.00362.x; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Ralston HJ, 2003, J COMP NEUROL, V459, P329, DOI 10.1002/cne.10614; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 2007, NEURON, V55, P339, DOI 10.1016/j.neuron.2007.07.019; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Thunberg T., 1896, UPPSALA L AKFOREN FO, V2, P489; Ushida T, 2005, BRAIN TOPOGR, V18, P27, DOI 10.1007/s10548-005-7898-8; Ushida Takahiro, 2010, Open Neuroimag J, V4, P182, DOI 10.2174/1874440001004010182; Veldhuijzen Dieuwke S, 2007, Curr Pain Headache Rep, V11, P183, DOI 10.1007/s11916-007-0189-1; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; VONBEKESY G, 1967, J GEN PHYSIOL, V50, P519, DOI 10.1085/jgp.50.3.519; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; Weaver KE, 2009, J NEUROSCI, V29, P11424, DOI 10.1523/JNEUROSCI.3263-09.2009; Willis WD, 2002, J PAIN, V3, P79, DOI 10.1054/jpai.2002.122949	78	39	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27075	10.1371/journal.pone.0027075	http://dx.doi.org/10.1371/journal.pone.0027075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096519	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900019
J	Zeng, JY; Xiang, N; Jiang, L; Jones, G; Zheng, YM; Liu, BW; Zhang, SY				Zeng, Jinyao; Xiang, Ning; Jiang, Lei; Jones, Gareth; Zheng, Yongmei; Liu, Bingwan; Zhang, Shuyi			Moth Wing Scales Slightly Increase the Absorbance of Bat Echolocation Calls	PLOS ONE			English	Article							BUTTERFLIES; COLORS; INFORMATION; PREY	Coevolutionary arms races between predators and prey can lead to a diverse range of foraging and defense strategies, such as countermeasures between nocturnal insects and echolocating bats. Here, we show how the fine structure of wing scales may help moths by slightly increasing sound absorbance at frequencies typically used in bat echolocation. Using four widespread species of moths and butterflies, we found that moth scales are composed of honeycomb-like hollows similar to sound-absorbing material, but these were absent from butterfly scales. Micro-reverberation chamber experiments revealed that moth wings were more absorbent at the frequencies emitted by many echolocating bats (40-60 kHz) than butterfly wings. Furthermore, moth wings lost absorbance at these frequencies when scales were removed, which suggests that some moths have evolved stealth tactics to reduce their conspicuousness to echolocating bats. Although the benefits to moths are relatively small in terms of reducing their target strengths, scales may nonetheless confer survival advantages by reducing the detection distances of moths by bats by 5-6%.	[Zeng, Jinyao; Zhang, Shuyi] E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Jiang, Lei; Zheng, Yongmei] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Xiang, Ning] Rensselaer Polytech Inst, Sch Architecture, Troy, NY USA; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Liu, Bingwan] NE Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China	East China Normal University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Rensselaer Polytechnic Institute; University of Bristol; Northeast Forestry University - China	Zeng, JY (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn		Jones, Gareth/0000-0002-1904-3735	CAS; National "985" Project; BBSRC; BBSRC [BB/G530392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish	CAS(Chinese Academy of Sciences); National "985" Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a CAS grant and the National "985" Project awarded to Shuyi Zhang, and a China Partnering award from the BBSRC to Gareth Jones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauert J., 2008, ACOUSTICS ENG TROY L; Brakefield PM, 2000, P ROY SOC B-BIOL SCI, V267, P1953, DOI 10.1098/rspb.2000.1235; BRUNTON CFA, 1995, P ROY SOC B-BIOL SCI, V260, P199, DOI 10.1098/rspb.1995.0080; Burghardt F, 2000, NATURWISSENSCHAFTEN, V87, P304, DOI 10.1007/s001140050726; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Culver S. J., 2000, BIOTIC RESPONSE GLOB; D'antonio P., 2009, ACOUSTIC ABSORBERS D; Denny M., 2007, BLIP PING BUZZ MAKIN; EISNER T, 1964, SCIENCE, V146, P1058, DOI 10.1126/science.146.3647.1058; FULLARD JH, 1982, CAN J ZOOL, V60, P2572, DOI 10.1139/z82-330; Fullard JH, 1998, SPR HDB AUD, V10, P279; GHIRADELLA H, 1991, APPL OPTICS, V30, P3492, DOI 10.1364/AO.30.003492; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Gopfert MC, 2002, P ROY SOC B-BIOL SCI, V269, P89, DOI 10.1098/rspb.2001.1646; Jones G, 2003, BAT ECOLOGY, P301; KINGSOLVER JG, 1983, AM NAT, V121, P32, DOI 10.1086/284038; Luo F, 2007, ZOOL STUD, V46, P622; MAA DY, 1975, SCI SINICA, V18, P55; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; ROEDER KD, 1963, BIOL BULL, V124, P200, DOI 10.2307/1539496; Sabine, 1922, COLLECTED PAPERS ACO; SCHROEDE.MR, 1965, J ACOUST SOC AM, V37, P409, DOI 10.1121/1.1909343; SIMMONS JA, 1989, J ACOUST SOC AM, V86, P1333, DOI 10.1121/1.398694; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; Surlykke A, 1999, NATURWISSENSCHAFTEN, V86, P238, DOI 10.1007/s001140050607; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Vane-Wright D, 2004, NATURE, V428, P477, DOI 10.1038/428477a; Veselka N, 2010, NATURE, V463, P939, DOI 10.1038/nature08737; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wang P, 1981, ICONOCRAPHIA HETEROC; Waters DA, 2003, PHYSIOL ENTOMOL, V28, P237, DOI 10.1111/j.1365-3032.2003.00355.x; Xiang N, 2003, J ACOUST SOC AM, V113, P2754, DOI 10.1121/1.1561498; Xiang N, 2001, J ACOUST SOC AM, V110, P1415, DOI 10.1121/1.1390334; XIANG N, 1993, APPL ACOUST, V38, P267, DOI 10.1016/0003-682X(93)90056-C; Yoshioka S, 2006, P ROY SOC B-BIOL SCI, V273, P129, DOI 10.1098/rspb.2005.3314	39	18	18	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27190	10.1371/journal.pone.0027190	http://dx.doi.org/10.1371/journal.pone.0027190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096534	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800034
J	Jacob, RE; Lamm, WJ				Jacob, Richard E.; Lamm, Wayne J.			Stable Small Animal Ventilation for Dynamic Lung Imaging to Support Computational Fluid Dynamics Models	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RESOLUTION; SIMULATIONS; MECHANICS; INJURY; CT	Pulmonary computational fluid dynamics models require that three-dimensional images be acquired over multiple points in the dynamic breathing cycle without breath holds or changes in ventilatory mechanics. With small animals, these requirements can result in long imaging times (similar to 90 minutes), over which lung mechanics, such as compliance, may gradually change if not carefully monitored and controlled. These changes, caused by derecruitment of parenchymal tissue, are manifested as an upward drift in peak inspiratory pressure (PIP) or by changes in the pressure waveform and/or lung volume over the course of the experiment. We demonstrate highly repeatable mechanical ventilation in anesthetized rats over a long duration for dynamic lung x-ray computed tomography (CT) imaging. We describe significant updates to a basic commercial ventilator that was acquired for these experiments. Key to achieving consistent results was the implementation of periodic deep breaths, or sighs, of extended duration to maintain lung recruitment. In addition, continuous monitoring of breath-to-breath pressure and volume waveforms and long-term trends in PIP and flow provide diagnostics of changes in breathing mechanics.	[Jacob, Richard E.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Lamm, Wayne J.] Univ Washington, Sch Med, Seattle, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle	Jacob, RE (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	Richard.jacob@pnnl.gov			PNNL through internal Laboratory Directed Research and Development (LDRD); National Heart, Lung, and Blood Institute [R01HL073598]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073598] Funding Source: NIH RePORTER	PNNL through internal Laboratory Directed Research and Development (LDRD); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by PNNL through internal Laboratory Directed Research and Development (LDRD) funding, and by Award Number R01HL073598 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bate JHT, 2008, RESP PHYSIOL NEUROBI, V163, P54, DOI 10.1016/j.resp.2008.03.012; Carson JP, 2010, COMPUT MED IMAG GRAP, V34, P572, DOI 10.1016/j.compmedimag.2010.03.001; Carson JP, 2010, BIOMECH MODEL MECHAN, V9, P187, DOI 10.1007/s10237-009-0170-5; CILLEY RE, 1993, J PEDIATR SURG, V28, P488, DOI 10.1016/0022-3468(93)90253-H; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Einstein DR, 2008, ANAT REC, V291, P1628, DOI 10.1002/ar.20771; Ford NL, 2007, J APPL PHYSIOL, V102, P2046, DOI 10.1152/japplphysiol.00629.2006; GOTTLIEB SF, 1962, J APPL PHYSIOL, V17, P576; Hedlund Laurence W, 2002, ILAR J, V43, P159; Hedlund LW, 2000, MAGN RESON IMAGING, V18, P753, DOI 10.1016/S0730-725X(00)00154-5; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Hu JC, 2004, ACAD RADIOL, V11, P961, DOI 10.1016/j.acra.2004.05.019; Kuprat AP, 2009, J COMPUT PHYS, V228, P619, DOI 10.1016/j.jcp.2008.09.030; Kyriazis A, 2010, IEEE T BIO-MED ENG, V57, P1745, DOI 10.1109/TBME.2010.2042596; Mai W, 2005, MAGN RESON MED, V53, P858, DOI 10.1002/mrm.20400; MEAD J, 1959, J APPL PHYSIOL, V14, P669, DOI 10.1152/jappl.1959.14.5.669; NICHOLAS TE, 1982, RESP PHYSIOL, V49, P315, DOI 10.1016/0034-5687(82)90119-0; Sera T, 2008, PHYS MED BIOL, V53, P4285, DOI 10.1088/0031-9155/53/16/005; Thiesse J, 2010, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; Walker MG, 2011, RESPIRATION, V81, P333, DOI 10.1159/000323609	20	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27577	10.1371/journal.pone.0027577	http://dx.doi.org/10.1371/journal.pone.0027577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087338	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700060
J	Xie, FL; Sun, GL; Stiller, JW; Zhang, BH				Xie, Fuliang; Sun, Guiling; Stiller, John W.; Zhang, Baohong			Genome-Wide Functional Analysis of the Cotton Transcriptome by Creating an Integrated EST Database	PLOS ONE			English	Article							GENETIC DIVERSITY; FLOWERING TIME; PLANT; IDENTIFICATION; MICRORNAS; DNA; ARABIDOPSIS; MAP; BIOGENESIS; SELECTION	A total of 28,432 unique contigs (25,371 in consensus contigs and 3,061 as singletons) were assembled from all 268,786 cotton ESTs currently available. Several in silico approaches [comparative genomics, Blast, Gene Ontology (GO) analysis, and pathway enrichment by Kyoto Encyclopedia of Genes and Genomes (KEGG)] were employed to investigate global functions of the cotton transcriptome. Cotton EST contigs were clustered into 5,461 groups with a maximum cluster size of 196 members. A total of 27,956 indel mutants and 149,616 single nucleotide polymorphisms (SNPs) were identified from consensus contigs. Interestingly, many contigs with significantly high frequencies of indels or SNPs encode transcription factors and protein kinases. In a comparison with six model plant species, cotton ESTs show the highest overall similarity to grape. A total of 87 cotton miRNAs were identified; 59 of these have not been reported previously from experimental or bioinformatics investigations. We also predicted 3,260 genes as miRNAs targets, which are associated with multiple biological functions, including stress response, metabolism, hormone signal transduction and fiber development. We identified 151 and 4,214 EST-simple sequence repeats (SSRs) from contigs and raw ESTs respectively. To make these data widely available, and to facilitate access to EST-related genetic information, we integrated our results into a comprehensive, fully downloadable web-based cotton EST database (www.leonxie.com).	[Xie, Fuliang; Sun, Guiling; Stiller, John W.; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Xie, FL (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Zhang, Baohong/O-4948-2016	Stiller, John/0000-0002-0668-8243	USDA; Cotton Incorporated	USDA(United States Department of Agriculture (USDA)); Cotton Incorporated(Cotton R&D Corp)	This work was supported partially by the USDA and the Cotton Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An C, 2008, THEOR APPL GENET, V116, P1015, DOI 10.1007/s00122-008-0732-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; delaHoz MPS, 1996, GENOME, V39, P112, DOI 10.1139/g96-015; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hattori J, 2005, GENOME, V48, P197, DOI [10.1139/g04-106, 10.1139/G04-106]; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; IAC, 1996, COTT REV WORLD SIT; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kantartzi SK, 2009, GENETICA, V136, P141, DOI 10.1007/s10709-008-9327-x; Krawczak M, 1999, ELECTROPHORESIS, V20, P1676, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1676::AID-ELPS1676>3.3.CO;2-4; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; RYCHLIK W, 1995, MOL BIOTECHNOL, V3, P129, DOI 10.1007/BF02789108; Schneider K, 2007, THEOR APPL GENET, V115, P601, DOI 10.1007/s00122-007-0591-4; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Seki M, 1997, PLANT J, V12, P481, DOI 10.1046/j.1365-313X.1997.12020481.x; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Venne LS, 2008, B ENVIRON CONTAM TOX, V80, P497, DOI 10.1007/s00128-008-9457-y; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y	45	83	111	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26980	10.1371/journal.pone.0026980	http://dx.doi.org/10.1371/journal.pone.0026980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087239	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700011
J	Izzo, V; Pinelli, M; Tinto, N; Esposito, MV; Cola, A; Sperandeo, MP; Tucci, F; Cocozza, S; Greco, L; Sacchetti, L				Izzo, Valentina; Pinelli, Michele; Tinto, Nadia; Esposito, Maria Valeria; Cola, Arturo; Sperandeo, Maria Pia; Tucci, Francesca; Cocozza, Sergio; Greco, Luigi; Sacchetti, Lucia			Improving the Estimation of Celiac Disease Sibling Risk by Non-HLA Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; MARKERS	Celiac Disease (CD) is a polygenic trait, and HLA genes explain less than half of the genetic variation. Through large GWAs more than 40 associated non-HLA genes were identified, but they give a small contribution to the heritability of the disease. The aim of this study is to improve the estimate of the CD risk in siblings, by adding to HLA a small set of non-HLA genes. One-hundred fifty-seven Italian families with a confirmed CD case and at least one other sib and both parents were recruited. Among 249 sibs, 29 developed CD in a 6 year follow-up period. All individuals were typed for HLA and 10 SNPs in non-HLA genes: CCR1/CCR3 (rs6441961), IL12A/SCHIP1 and IL12A (rs17810546 and rs9811792), TAGAP (rs1738074), RGS1 (rs2816316), LPP (rs1464510), OLIG3 (rs2327832), REL (rs842647), IL2/IL21 (rs6822844), SH2B3 (rs3184504). Three associated SNPs (in LPP, REL, and RGS1 genes) were identified through the Transmission Disequilibrium Test and a Bayesian approach was used to assign a score (BS) to each detected HLA+SNPs genotype combination. We then classified CD sibs as at low or at high risk if their BS was respectively < or >= median BS value within each HLA risk group. A larger number (72%) of CD sibs showed a BS >= the median value and had a more than two fold higher OR than CD sibs with a BS value < the median (O. R = 2.53, p = 0.047). Our HLA+SNPs genotype classification, showed both a higher predictive negative value (95% vs 91%) and diagnostic sensitivity (79% vs 45%) than the HLA only. In conclusion, the estimate of the CD risk by HLA+SNPs approach, even if not applicable to prevention, could be a precious tool to improve the prediction of the disease in a cohort of first degree relatives, particularly in the low HLA risk groups.	[Izzo, Valentina; Sperandeo, Maria Pia; Tucci, Francesca; Greco, Luigi] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Izzo, Valentina; Sperandeo, Maria Pia; Tucci, Francesca; Greco, Luigi] Univ Naples Federico II, European Lab Food Induced Dis, Naples, Italy; [Pinelli, Michele; Cocozza, Sergio] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol L Califano, Naples, Italy; [Tinto, Nadia; Esposito, Maria Valeria; Cola, Arturo; Sacchetti, Lucia] Scarl, CEINGE Adv Biotechnol, Naples, Italy; [Tinto, Nadia; Esposito, Maria Valeria; Cola, Arturo; Sacchetti, Lucia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Izzo, V (corresponding author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	ydongre@unina.it	Cocozza, Sergio/F-6488-2010; Tucci, Francesca/AAB-2184-2022; Pinelli, Michele/A-1584-2010	Tucci, Francesca/0000-0001-8798-8987; Pinelli, Michele/0000-0002-5927-1185	PREVENT-CD [EU-FP6-2005-FOOD4B, 036383]; CEINGE Regione Campania (DGRC), Italy [1901/2009]; Associazione Italiana Celiachia (AIC)	PREVENT-CD; CEINGE Regione Campania (DGRC), Italy; Associazione Italiana Celiachia (AIC)	This work was funded by the PREVENT-CD project: EU-FP6-2005-FOOD4B-contract no. 036383 and by CEINGE Regione Campania (DGRC 1901/2009) Italy. The authors thank Associazione Italiana Celiachia (AIC) for a supporting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Amundsen SS, 2010, GENES IMMUN, V11, P79, DOI 10.1038/gene.2009.67; Bonamico M, 2006, J PEDIATR GASTR NUTR, V42, P150, DOI 10.1097/01.mpg.0000189337.08139.83; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Dema B, 2009, J MED GENET, V46, P617, DOI 10.1136/jmg.2009.067041; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Liou HC, 2011, IMMUNOL CELL BIOL, V89, P27, DOI 10.1038/icb.2010.120; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Romanos J, 2009, J MED GENET, V46, P60, DOI 10.1136/jmg.2008.061457; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Son JS, 2011, BIOCHEM BIOPH RES CO, V407, P141, DOI 10.1016/j.bbrc.2011.02.126; THOMSON G, 1995, AM J HUM GENET, V57, P487; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	22	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26920	10.1371/journal.pone.0026920	http://dx.doi.org/10.1371/journal.pone.0026920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087237	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700012
J	Ouandaogo, ZG; Haouzi, D; Assou, S; Dechaud, H; Kadoch, IJ; De Vos, J; Hamamah, S				Ouandaogo, Zamalou Gisele; Haouzi, Delphine; Assou, Said; Dechaud, Herve; Kadoch, Issac Jacques; De Vos, John; Hamamah, Samir			Human Cumulus Cells Molecular Signature in Relation to Oocyte Nuclear Maturity Stage	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; GENE-EXPRESSION; GRANULOSA-CELLS; GROWTH-FACTOR; IN-VITRO; EMBRYO; TRANSCRIPTOME; MATURATION; PROFILES; RECEPTOR	The bi-directional communication between the oocyte and the surrounding cumulus cells (CCs) is crucial for the acquisition of oocyte competence. We investigated the transcriptomic profile of human CCs isolated from mature and immature oocytes under stimulated cycle. We used human Genome U133 Plus 2.0 microarrays to perform an extensive analysis of the genes expressed in human CCs obtained from patients undergoing intra-cytoplasmic sperm injection. CC samples were isolated from oocyte at germinal vesicle, stage metaphase I and stage metaphase II. For microarray analysis, we used eight chips for each CC category. Significance analysis of microarray multiclass was used to analyze the microarray data. Validation was performed by RT-qPCR using an independent cohort of CC samples. We identified differentially over-expressed genes between the three CC categories. This study revealed a specific signature of gene expression in CCs issued from MII oocyte compared with germinal vesicle and metaphase I. The CC gene expression profile, which is specific of MII mature oocyte, can be useful as predictors of oocyte quality.	[Ouandaogo, Zamalou Gisele; Haouzi, Delphine; Assou, Said; Dechaud, Herve; De Vos, John; Hamamah, Samir] Hop St Eloi, CHU Montpellier, Inst Res Biotherapy, INSERM U1040, Montpellier, France; [Ouandaogo, Zamalou Gisele; Assou, Said; Dechaud, Herve; De Vos, John; Hamamah, Samir] Univ Montpellier 1, UFR Med, Montpellier, France; [Dechaud, Herve; Hamamah, Samir] Hop Arnaud de Villeneuve, ART PGD Dept, CHU Montpellier, Montpellier, France; [Kadoch, Issac Jacques] Univ Montreal, Dept Obstet & Gynecol, Hop St Luc, CHUM, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montreal	Ouandaogo, ZG (corresponding author), Hop St Eloi, CHU Montpellier, Inst Res Biotherapy, INSERM U1040, Montpellier, France.	s-hamamah@chu-montpellier.fr	DE VOS, John/A-5703-2010	DE VOS, John/0000-0003-1880-4130; assou, said/0000-0001-6448-7995	Ferring company; Schering-Plough Pharmaceutical company; Vitrolife company; Ferring; Schering-Plough Pharmaceutical; Vitrolife; University Hospital of Montpellier	Ferring company(Ferring Pharmaceuticals); Schering-Plough Pharmaceutical company; Vitrolife company; Ferring(Ferring Pharmaceuticals); Schering-Plough Pharmaceutical; Vitrolife; University Hospital of Montpellier	This work was supported by Ferring, Schering-Plough Pharmaceutical and Vitrolife companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was funded by Ferring, Schering-Plough Pharmaceutical and Vitrolife. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We thank the University Hospital of Montpellier for its support and the ART/PGD teams for providing the samples.	Adriaenssens T, 2010, HUM REPROD, V25, P1259, DOI 10.1093/humrep/deq049; Adriaenssens T, 2011, J ASSIST REPROD GEN, V28, P31, DOI 10.1007/s10815-010-9481-9; Adriaenssens T, 2009, BIOL REPROD, V80, P1015, DOI 10.1095/biolreprod.107.067462; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103; Duffy DM, 2005, HUM REPROD, V20, P1485, DOI 10.1093/humrep/deh784; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feuerstein P, 2007, HUM REPROD, V22, P3069, DOI 10.1093/humrep/dem336; Goud PT, 1998, HUM REPROD, V13, P1638, DOI 10.1093/humrep/13.6.1638; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Haouzi D, 2011, HUM REPROD, V26, P1440, DOI 10.1093/humrep/der075; Haouzi D, 2009, HUM REPROD, V24, P2868, DOI 10.1093/humrep/dep263; Higuchi T, 1999, MOL HUM REPROD, V5, P920, DOI 10.1093/molehr/5.10.920; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Hogg K, 2010, ENDOCRINOLOGY, V151, P1247, DOI 10.1210/en.2009-0914; Johnson AL, 2008, ENDOCRINOLOGY, V149, P3187, DOI 10.1210/en.2007-1659; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Koks S, 2010, MOL HUM REPROD, V16, P229, DOI 10.1093/molehr/gap103; Markosyan N, 2006, BIOL REPROD, V75, P868, DOI 10.1095/biolreprod.106.053769; Marteil G, 2009, REPROD BIOL, V9, P203, DOI 10.1016/S1642-431X(12)60027-8; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; McRae RS, 2005, ENDOCRINOLOGY, V146, P309, DOI 10.1210/en.2004-0999; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Segi E, 2003, BIOL REPROD, V68, P804, DOI 10.1095/biolreprod.102.003590; Tamba S, 2010, BIOCHIMIE, V92, P665, DOI 10.1016/j.biochi.2010.04.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Verbraak EJC, 2011, THERIOGENOLOGY, V75, P362, DOI 10.1016/j.theriogenology.2010.09.008; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	32	56	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27179	10.1371/journal.pone.0027179	http://dx.doi.org/10.1371/journal.pone.0027179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087263	Green Submitted, gold, Green Published			2022-12-27	WOS:000297347700027
J	Schuetz, A; Haule, A; Reither, K; Ngwenyama, N; Rachow, A; Meyerhans, A; Maboko, L; Koup, RA; Hoelscher, M; Geldmacher, C				Schuetz, Alexandra; Haule, Antelmo; Reither, Klaus; Ngwenyama, Njabulo; Rachow, Andrea; Meyerhans, Andreas; Maboko, Leonard; Koup, Richard A.; Hoelscher, Michael; Geldmacher, Christof			Monitoring CD27 Expression to Evaluate Mycobacterium Tuberculosis Activity in HIV-1 Infected Individuals In Vivo	PLOS ONE			English	Article							T-CELLS; PULMONARY TUBERCULOSIS; INFECTION; HIV; PREVALENCE; RESPONSES; GAMMA; CD4	The level of bacterial activity is only poorly defined during asymptomatic Mycobacterium tuberculosis (MTB) infection. The objective was to study the capacity of a new biomarker, the expression of the T cell maturation marker CD27 on MTB-specific CD4 T cells, to identify active tuberculosis (TB) disease in subjects from a MTB and HIV endemic region. The frequency and CD27 expression of circulating MTB-specific CD4 T cells was determined in 96 study participants after stimulation with purified protein derivative (PPD) using intracellular cytokine staining for IFNgamma (IFN gamma). Subjects were then stratified by their TB and HIV status. Within PPD responders, a CD27(-) phenotype was associated with active TB in HIV- (p = 0.0003) and HIV+ (p = 0.057) subjects, respectively. In addition, loss of CD27 expression preceded development of active TB in one HIV seroconverter. Interestingly, in contrast to HIV- subjects, MTB-specific CD4 T cell populations from HIV+ TB-asymptomatic subjects were often dominated by CD27(-) cells. These data indicate that down-regulation of CD27 on MTB-specific CD4 T cell could be used as a biomarker of active TB, potentially preceding clinical TB disease. Furthermore, these data are consistent with the hypothesis that late, chronic HIV infection is frequently associated with increased mycobacterial activity in vivo. The analysis of T cell maturation and activation markers might thus be a useful tool to monitor TB disease progression.	[Schuetz, Alexandra; Haule, Antelmo; Reither, Klaus; Rachow, Andrea; Maboko, Leonard] Referral Hosp, NIMR Mbeya Med Res Programme, Mbeya, Tanzania; [Reither, Klaus; Rachow, Andrea; Hoelscher, Michael; Geldmacher, Christof] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Ngwenyama, Njabulo; Koup, Richard A.; Geldmacher, Christof] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Meyerhans, Andreas] Univ Saarland, Inst Infect Med, Inst Virol, D-6650 Homburg, Germany	University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Saarland University	Schuetz, A (corresponding author), USAMC AFRIMS, Henry M Jackson Fdn Adv Mil Med, Walter Reed Program, Dept Retrovirol, Bangkok, Thailand.	alexandra.schuetz@afrims.org	Hoelscher, Michael/D-3436-2012; Meyerhans, Andreas/S-2559-2019; Meyerhans, Andreas/D-3382-2014	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317; Reither, Klaus/0000-0001-6195-8237	European Commission [ERBICA4-CT-2002-10035, SANTE/2004/078-545/130]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was supported by grants from the European Commission (DG XII, INCO-DC, ERBICA4-CT-2002-10035 and DG X, EuropeAID SANTE/2004/078-545/130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; GRAHAM NMH, 1992, JAMA-J AM MED ASSOC, V267, P369, DOI 10.1001/jama.267.3.369; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sester M, 2000, AIDS, V14, P2653, DOI 10.1097/00002030-200012010-00004; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735	16	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27284	10.1371/journal.pone.0027284	http://dx.doi.org/10.1371/journal.pone.0027284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087280	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700034
J	Yamaguchi, I; Ogawa, Y; Jimbo, Y; Nakao, H; Kotani, K				Yamaguchi, Ikuhiro; Ogawa, Yutaro; Jimbo, Yasuhiko; Nakao, Hiroya; Kotani, Kiyoshi			Reduction Theories Elucidate the Origins of Complex Biological Rhythms Generated by Interacting Delay-Induced Oscillations	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; EPILEPTIC SEIZURES; NEURONAL NETWORKS; CIRCADIAN-RHYTHM; MODEL; BIFURCATION; MULTISTABILITY; STIMULATION; STABILITY; RESPONSES	Time delay is known to induce sustained oscillations in many biological systems such as electroencephalogram (EEG) activities and gene regulations. Furthermore, interactions among delay-induced oscillations can generate complex collective rhythms, which play important functional roles. However, due to their intrinsic infinite dimensionality, theoretical analysis of interacting delay-induced oscillations has been limited. Here, we show that the two primary methods for finite-dimensional limit cycles, namely, the center manifold reduction in the vicinity of the Hopf bifurcation and the phase reduction for weak interactions, can successfully be applied to interacting infinite-dimensional delay-induced oscillations. We systematically derive the complex Ginzburg-Landau equation and the phase equation without delay for general interaction networks. Based on the reduced low-dimensional equations, we demonstrate that diffusive (linearly attractive) coupling between a pair of delay-induced oscillations can exhibit nontrivial amplitude death and multimodal phase locking. Our analysis provides unique insights into experimentally observed EEG activities such as sudden transitions among different phase-locked states and occurrence of epileptic seizures.	[Yamaguchi, Ikuhiro; Ogawa, Yutaro; Jimbo, Yasuhiko; Kotani, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan; [Nakao, Hiroya] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 152, Japan; [Nakao, Hiroya] JST, CREST, Kyoto, Japan	University of Tokyo; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Yamaguchi, I (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan.	kotani@k.u-tokyo.ac.jp	Nakao, Hiroya/B-9264-2015; Nakao, Hiroya/K-2771-2019	Nakao, Hiroya/0000-0003-3394-0392; Nakao, Hiroya/0000-0003-3394-0392; Yamaguchi, Ikuhiro/0000-0003-2875-6494	 [23240065];  [22684020];  [23680024]	; ; 	This study was supported in part by Grants-in-Aid for Scientific Research (23240065 to YJ, 22684020 to HN, and 23680024 to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON DG, 1990, PHYSICA D, V41, P403, DOI 10.1016/0167-2789(90)90007-C; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Campbell SA, 2006, PHYSICA D, V214, P101, DOI 10.1016/j.physd.2005.12.008; Campbell SA, 2005, NONLINEARITY, V18, P2827, DOI 10.1088/0951-7715/18/6/022; Censi F, 2000, MED BIOL ENG COMPUT, V38, P416, DOI 10.1007/BF02345011; Ermentrout B, 2009, SIAM J APPL DYN SYST, V8, P253, DOI 10.1137/080724010; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Forger DB, 2004, J THEOR BIOL, V230, P533, DOI 10.1016/j.jtbi.2004.04.041; Freeman WJ, 2003, CHAOS, V13, P1067, DOI 10.1063/1.1596553; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Golomb D, 1999, P NATL ACAD SCI USA, V96, P13480, DOI 10.1073/pnas.96.23.13480; Guckenheimer J, 2013, APPL MATH SCI, V42; Hale J.K, 2013, INTRO FUNCTIONAL DIF, V99; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ito J, 2005, BIOL CYBERN, V92, P54, DOI 10.1007/s00422-004-0533-z; Izhikevich EM, 1998, PHYS REV E, V58, P905, DOI 10.1103/PhysRevE.58.905; Kim JW, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031907; Kim JW, 2009, J THEOR BIOL, V257, P527, DOI 10.1016/j.jtbi.2008.12.009; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kotani K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041904; Lema MA, 2000, J THEOR BIOL, V204, P565, DOI 10.1006/jtbi.2000.2038; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Loddenkemper T, 2001, J CLIN NEUROPHYSIOL, V18, P514, DOI 10.1097/00004691-200111000-00002; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Nakao H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036214; Ncube I, 2002, FIELDS I COMMUNICATI, V36, P179; PETROV V, 1992, J CHEM PHYS, V97, P6191, DOI 10.1063/1.463727; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Sano S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016207; Scheper TO, 1999, J NEUROSCI, V19, P40, DOI 10.1523/JNEUROSCI.19-01-00040.1999; Seidel H, 1998, PHYSICA D, V115, P145, DOI 10.1016/S0167-2789(97)00229-7; Shayer LP, 2000, SIAM J APPL MATH, V61, P673, DOI 10.1137/S0036139998344015; Sriram K, 2004, J THEOR BIOL, V231, P23, DOI 10.1016/j.jtbi.2004.04.006; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stone E, 2004, J NONLINEAR SCI, V14, P27, DOI 10.1007/s00332-003-0553-1; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; WISCHERT W, 1994, PHYS REV E, V49, P203, DOI 10.1103/PhysRevE.49.203; YAMAGUCHI Y, 1984, PHYSICA D, V11, P212, DOI 10.1016/0167-2789(84)90444-5; Yoshino K, 2002, BIOL CYBERN, V86, P483, DOI 10.1007/s00422-002-0314-5; Zucconi M, 2005, NEUROL SCI, V26, pS199, DOI 10.1007/s10072-005-0487-5	55	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26497	10.1371/journal.pone.0026497	http://dx.doi.org/10.1371/journal.pone.0026497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087228	Green Submitted, gold, Green Published			2022-12-27	WOS:000297347700006
J	Gonzalez, G; DaFonseca, S; Errazuriz, E; Coric, P; Souquet, F; Turcaud, S; Boulanger, P; Bouaziz, S; Hong, SS				Gonzalez, Gaelle; DaFonseca, Sandrina; Errazuriz, Elisabeth; Coric, Pascale; Souquet, Florence; Turcaud, Serge; Boulanger, Pierre; Bouaziz, Serge; Hong, Saw See			Characterization of a Novel Type of HIV-1 Particle Assembly Inhibitor Using a Quantitative Luciferase-Vpr Packaging-Based Assay	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BACULOVIRUS-INFECTED CELLS; BETULINIC ACID-DERIVATIVES; ALPHA-HELICAL STRUCTURE; GAG PRECURSOR; IN-VITRO; ADENOVIRUS DODECAHEDRON; VIRION INCORPORATION; FUSION PROTEINS; REGULATORY PROTEIN	The HIV-1 auxiliary protein Vpr and Vpr-fusion proteins can be copackaged with Gag precursor (Pr55Gag) into virions or membrane-enveloped virus-like particles (VLP). Taking advantage of this property, we developed a simple and sensitive method to evaluate potential inhibitors of HIV-1 assembly in a living cell system. Two proteins were coexpressed in recombinant baculovirus-infected Sf9 cells, Pr55Gag, which formed the VLP backbone, and luciferase fused to the N-terminus of Vpr (LucVpr). VLP-encapsidated LucVpr retained the enzymatic activity of free luciferase. The levels of luciferase activity present in the pelletable fraction recovered from the culture medium correlated with the amounts of extracellular VLP released by Sf9 cells assayed by conventional immunological methods. Our luciferase-based assay was then applied to the characterization of betulinic acid (BA) derivatives that differed from the leader compound PA-457 (or DSB) by their substituant on carbon-28. The beta-alanine-conjugated and lysine-conjugated DSB could not be evaluated for their antiviral potentials due to their high cytotoxicity, whereas two other compounds with a lesser cytotoxicity, glycine-conjugated and epsilon-NH-Boc-lysine-conjugated DSB, exerted a dose-dependent negative effect on VLP assembly and budding. A fifth compound with a low cytotoxicity, EP-39 (ethylene diamine-conjugated DSB), showed a novel type of antiviral effect. EP-39 provoked an aberrant assembly of VLP, resulting in nonenveloped, morula-like particles of 100-nm in diameter. Each morula was composed of nanoparticle subunits of 20-nm in diameter, which possibly mimicked transient intermediates of the HIV-1 Gag assembly process. Chemical cross-linking in situ suggested that EP-39 favored the formation or/and persistence of Pr55Gag trimers over other oligomeric species. EP-39 showed a novel type of negative effect on HIV-1 assembly, targeting the Pr55Gag oligomerisation. The biological effect of EP-39 underlined the critical role of the nature of the side chain at position 28 of BA derivatives in their anti-HIV-1 activity.	[Gonzalez, Gaelle; Errazuriz, Elisabeth] Univ Lyon 1, Fac Med, Ctr Commun Imagerie Laennec, F-69365 Lyon, France; [Gonzalez, Gaelle; DaFonseca, Sandrina; Boulanger, Pierre; Hong, Saw See] INRA, UMR 754, Lyon, France; [Coric, Pascale; Bouaziz, Serge] Univ Paris 05, UFR Sci Pharmaceut & Biol, CNRS, Lab Cristallog & RMN Biol,UMR 8015, Paris, France; [Souquet, Florence; Turcaud, Serge] Univ Paris 05, UFR Sci Pharmaceut & Biol, CNRS, Lab Synth & Struct Mol Interet Pharmacol,UMR 8638, Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Gonzalez, G (corresponding author), Univ Lyon 1, Fac Med, Ctr Commun Imagerie Laennec, F-69365 Lyon, France.	serge.bouaziz@parisdescartes.fr; sawsee.hong@univ-lyon1.fr	Boulanger, Pierre/AFV-2750-2022; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Hong, Saw See/M-9818-2017	Bouaziz, Serge/0000-0001-7792-8307; Hong, Saw See/0000-0001-8871-0901; CORIC, Pascale/0000-0001-8484-1381	French AIDS foundation (SIDACTION) [A/19-3-01541]; Agence Nationale de Recherche sur le SIDA (ANRS) [DendrAde]; French Foundation for Cystic Fibrosis	French AIDS foundation (SIDACTION); Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); French Foundation for Cystic Fibrosis	This work has been supported by the French AIDS foundation (SIDACTION-contract A/19-3-01541) and the Agence Nationale de Recherche sur le SIDA (ANRS, Grant DendrAde 2007-2008). SDF was the recipient of an ANRS fellowship, and GG was the recipient of a fellowship from the French Foundation for Cystic Fibrosis (Vaincre la Mucoviscidose). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Adamson CS, 2006, J VIROL, V80, P10957, DOI 10.1128/JVI.01369-06; Adamson CS, 2010, ANTIVIR RES, V85, P119, DOI 10.1016/j.antiviral.2009.09.009; Adamson CS, 2009, J VIROL, V83, P4884, DOI 10.1128/JVI.02659-08; Adamson CS, 2004, REV MED VIROL, V14, P107, DOI 10.1002/rmv.418; Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Aiken C, 2005, TRENDS MOL MED, V11, P31, DOI 10.1016/j.molmed.2004.11.001; Alfadhli A, 2005, J VIROL, V79, P14498, DOI 10.1128/JVI.79.23.14498-14506.2005; Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; CARRIERE C, 1995, J VIROL, V69, P2366; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHAZAL N, 1994, J VIROL, V68, P111, DOI 10.1128/JVI.68.1.111-122.1994; CHAZAL N, 1995, J VIROL, V69, P365, DOI 10.1128/JVI.69.1.365-375.1995; Cimarelli A, 2002, CELL MOL LIFE SCI, V59, P1166, DOI 10.1007/s00018-002-8495-6; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; DaFonseca S, 2007, ANTIVIR THER, V12, P1185; DaFonseca S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-162; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Dorr CR, 2011, BIOORG MED CHEM LETT, V21, P542, DOI 10.1016/j.bmcl.2010.10.078; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2008, VIROLOGY, V371, P155, DOI 10.1016/j.virol.2007.09.026; Fritz JV, 2010, J VIROL, V84, P1585, DOI 10.1128/JVI.01691-09; Gay B, 1998, VIROLOGY, V247, P160, DOI 10.1006/viro.1998.9237; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; Hong SS, 1997, EMBO J, V16, P2294, DOI 10.1093/emboj/16.9.2294; Huvent I, 1998, J GEN VIROL, V79, P1069, DOI 10.1099/0022-1317-79-5-1069; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; Jenkins Y, 2001, J VIROL, V75, P10537, DOI 10.1128/JVI.75.21.10537-10542.2001; Jeong HJ, 1999, BIOORG MED CHEM LETT, V9, P1201, DOI 10.1016/S0960-894X(99)00165-1; Kanamoto T, 2001, ANTIMICROB AGENTS CH, V45, P1225, DOI 10.1128/AAC.45.4.1225-1230.2001; Kashiwada Y, 1996, J MED CHEM, V39, P1016, DOI 10.1021/jm950922q; Keller PW, 2011, J VIROL, V85, P1420, DOI 10.1128/JVI.01926-10; KLIKOVA M, 1995, J VIROL, V69, P1093, DOI 10.1128/JVI.69.2.1093-1098.1995; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; Kobinger GP, 1998, J VIROL, V72, P5441, DOI 10.1128/JVI.72.7.5441-5448.1998; Labrosse B, 1997, J VIROL, V71, P8230, DOI 10.1128/JVI.71.11.8230-8236.1997; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; LAVALLEE C, 1994, J VIROL, V68, P1926; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Li F, 2006, VIROLOGY, V356, P217, DOI 10.1016/j.virol.2006.07.023; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; LU YL, 1995, J VIROL, V69, P6873, DOI 10.1128/JVI.69.11.6873-6879.1995; MAHALINGAM S, 1995, P NATL ACAD SCI USA, V92, P3794, DOI 10.1073/pnas.92.9.3794; MAYAUX JF, 1994, P NATL ACAD SCI USA, V91, P3564, DOI 10.1073/pnas.91.9.3564; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller B, 2000, J VIROL, V74, P9727, DOI 10.1128/JVI.74.20.9727-9731.2000; Muriaux D, 2004, CURR PHARM DESIGN, V10, P3725, DOI 10.2174/1381612043382701; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Perrin-Tricaud C, 1999, VIROLOGY, V255, P20, DOI 10.1006/viro.1998.9573; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; ROYER M, 1992, J VIROL, V66, P3230, DOI 10.1128/JVI.66.5.3230-3235.1992; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; Royer M, 1997, J GEN VIROL, V78, P131, DOI 10.1099/0022-1317-78-1-131; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; Sakuragi S, 2006, MICROBES INFECT, V8, P1875, DOI 10.1016/j.micinf.2006.02.027; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Shvadchak V, 2009, BIOCHIMIE, V91, P916, DOI 10.1016/j.biochi.2009.04.014; Singh SP, 2000, J VIROL, V74, P10650, DOI 10.1128/JVI.74.22.10650-10657.2000; Soler F, 1996, J MED CHEM, V39, P1069, DOI 10.1021/jm950669u; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Tan M, 2011, J VIROL, V85, P753, DOI 10.1128/JVI.01835-10; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; TURCAUD S, 2011, J MED CHEM UNPUB; Votteler J, 2007, J VIROL, V81, P9572, DOI 10.1128/JVI.02803-06; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; WANG CT, 1994, VIROLOGY, V200, P524, DOI 10.1006/viro.1994.1215; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Yao Xiao-Jian, 2004, Retrovirology, V1, P21, DOI 10.1186/1742-4690-1-21; Yao XJ, 1999, GENE THER, V6, P1590, DOI 10.1038/sj.gt.3300988; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Yuan XO, 2004, VIROLOGY, V324, P525, DOI 10.1016/j.virol.2004.04.009; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004; Zhou Jing, 2004, Retrovirology, V1, P15, DOI 10.1186/1742-4690-1-15; ZHOU X, 1994, J VIROL, V68, P2556	88	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27234	10.1371/journal.pone.0027234	http://dx.doi.org/10.1371/journal.pone.0027234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073298	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000297197000035
J	Shiramizo, SCPL; Marra, AR; Durao, MS; Paes, AT; Edmond, MB; dos Santos, OFP				Pereira Lima Shiramizo, Sandra Christina; Marra, Alexandre R.; Durao, Marcelino S.; Paes, Angela T.; Edmond, Michael B.; Pavao dos Santos, Oscar Fernando			Decreasing Mortality in Severe Sepsis and Septic Shock Patients by Implementing a Sepsis Bundle in a Hospital Setting	PLOS ONE			English	Article							GOAL-DIRECTED THERAPY; SURVIVING SEPSIS; CAMPAIGN GUIDELINES; MANAGEMENT; CARE; MULTICENTER; PROGRAM	Background: The Surviving Sepsis Campaign (SSC) guidelines for the management of severe sepsis (SS) and septic shock (SSh) have been recommended to reduce morbidity and mortality. Materials and Methods: A quasi-experimental study was conducted in a medical-surgical ICU. Multiple interventions to optimize SS and SSh shock patients' clinical outcomes were performed by applying sepsis bundles (6- and 24-hour) in May 2006. We compared bundle compliance and patient outcomes before (July 2005-April 2006) and after (May 2006-December 2009) implementation of the interventions. Results: A total of 564 SS and SSh patients were identified. Prior to the intervention, compliance with the 6 hour-sepsis resuscitation bundle was only 6%. After the intervention, compliance was as follows: 8.2% from May to December 2006, 9.3% in 2007, 21.1% in 2008 and 13.7% in 2009. For the 24 hour-management bundle, baseline compliance was 15.0%. After the intervention, compliance was 15.1% from May to December 2006, 21.4% in 2007, 27.8% in 2008 and 44.4% in 2009. The in-hospital mortality was 54.0% from July 2005 to April 2006, 41.1% from May to December 2006, 39.3% in 2007, 41.4% in 2008 and 16.2% in 2009. Conclusion: These results suggest reducing SS and SSh patient mortality is a complex process that involves multiple performance measures and interventions.	[Pereira Lima Shiramizo, Sandra Christina; Marra, Alexandre R.; Durao, Marcelino S.; Pavao dos Santos, Oscar Fernando] Hosp Israelita Albert Einstein, Crit Care Unit, Sao Paulo, Brazil; [Paes, Angela T.] IIEP, Dept Stat, Sao Paulo, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Dept Internal Med, Sch Med, Richmond, VA USA	Hospital Israelita Albert Einstein; Virginia Commonwealth University	Shiramizo, SCPL (corresponding author), Hosp Israelita Albert Einstein, Crit Care Unit, Sao Paulo, Brazil.	alexmarra@einstein.br	Paes, Angela T/B-7110-2014; Santos, Oscar Fernando Pavão dos/B-8761-2017; Shiramizo, Sandra/O-3359-2017	Santos, Oscar Fernando Pavão dos/0000-0002-8731-1201; Shiramizo, Sandra/0000-0002-8735-4930; Paes, Angela/0000-0002-7405-3442; Edmond, Michael/0000-0002-4144-8974				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; De Miguel-Yanes JM, 2009, AM J EMERG MED, V27, P668, DOI 10.1016/j.ajem.2008.05.010; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Durao MS, 2010, ANAESTH INTENS CARE, V38, P467, DOI 10.1177/0310057X1003800309; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Marra AR, 2010, AM J INFECT CONTROL, V38, P434, DOI 10.1016/j.ajic.2009.11.012; Marra AR, 2009, AM J INFECT CONTROL, V37, P619, DOI 10.1016/j.ajic.2009.03.009; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x	22	52	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26790	10.1371/journal.pone.0026790	http://dx.doi.org/10.1371/journal.pone.0026790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073193	Green Submitted, Green Published, gold			2022-12-27	WOS:000297197000013
J	Carnero-Pardo, C; Espejo-Martinez, B; Lopez-Alcalde, S; Espinosa-Garcia, M; Saez-Zea, C; Hernandez-Torres, E; Navarro-Espigares, JL; Vilchez-Carrillo, R				Carnero-Pardo, Cristobal; Espejo-Martinez, Beatriz; Lopez-Alcalde, Samuel; Espinosa-Garcia, Maria; Saez-Zea, Carmen; Hernandez-Torres, Elisa; Luis Navarro-Espigares, Jose; Vilchez-Carrillo, Rosa			Diagnostic Accuracy, Effectiveness and Cost for Cognitive Impairment and Dementia Screening of Three Short Cognitive Tests Applicable to Illiterates	PLOS ONE			English	Article							MINI-MENTAL-STATE; CLINICAL-DIAGNOSIS; ALZHEIMERS-DISEASE; QUESTIONNAIRE; VALIDATION; BATTERY; TOOL	Background: Illiteracy, a universal problem, limits the utilization of the most widely used short cognitive tests. Our objective was to assess and compare the effectiveness and cost for cognitive impairment (CI) and dementia (DEM) screening of three short cognitive tests applicable to illiterates. Methods: Phase III diagnostic test evaluation study was performed during one year in four Primary Care centers, prospectively including individuals with suspicion of CI or DEM. All underwent the Eurotest, Memory Alteration Test (M@T), and Phototest, applied in a balanced manner. Clinical, functional, and cognitive studies were independently performed in a blinded fashion in a Cognitive Behavioral Neurology Unit, and the gold standard diagnosis was established by consensus of expert neurologists on the basis of these results. Effectiveness of tests was assessed as the proportion of correct diagnoses (diagnostic accuracy [DA]) and the kappa index of concordance (k) with respect to gold standard diagnoses. Costs were based on public prices at the time and hospital accounts. Results: The study included 139 individuals: 47 with DEM, 36 with CI, and 56 without CI. No significant differences in effectiveness were found among the tests. For DEM screening: Eurotest (k = 0.71 [0.59-0.83], DA = 0.87 [0.80-0.92]), M@T (k = 0.72 [0.60-0.84], DA = 0.87 [0.80-0.92]), Phototest (k = 0.70 [0.57-0.82], DA = 0.86 [0.79-0.91]). For CI screening: Eurotest (k = 0.67 [0.55-0.79]; DA = 0.83 [0.76-0.89]), M@T (k = 0.52 [0.37-0.67]; DA = 0.80 [0.72-0.86]), Phototest (k = 0.59 [0.46-0.72]; DA = 0.79 [0.71-0.86]). There were no differences in the cost of DEM screening, but the cost of CI screening was significantly higher with M@T (330.7 +/- 177.1(sic), mean +/- sd) than with Eurotest (294.1 +/- 195.0(sic)) or Phototest (296.0 +/- 196.5(sic)). Application time was shorter with Phototest (2.8 +/- 0.8 min) than with Eurotest (7.1 +/- 1.8 min) or M@T (6.8 +/- 2.2 min). Conclusions: Eurotest, M@T, and Phototest are equally effective. Eurotest and Phototest are both less expensive options but Phototest is the most efficient, requiring the shortest application time.	[Carnero-Pardo, Cristobal; Lopez-Alcalde, Samuel; Espinosa-Garcia, Maria; Saez-Zea, Carmen; Vilchez-Carrillo, Rosa] Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain; [Carnero-Pardo, Cristobal; Espinosa-Garcia, Maria] FIDYAN Neuroctr, Granada, Spain; [Espejo-Martinez, Beatriz] Complejo Hosp La Mancha Ctr, Serv Neurol, Alcazar De San Juan, Spain; [Saez-Zea, Carmen] Univ Jaen, Dept Psicol, Jaen, Spain; [Hernandez-Torres, Elisa; Luis Navarro-Espigares, Jose] Hosp Univ Virgen Nieves, Subdirecc Control Gest, Granada, Spain	Hospital Universitario Virgen de las Nieves; Universidad de Jaen; Hospital Universitario Virgen de las Nieves	Carnero-Pardo, C (corresponding author), Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain.	ccarnero@neurocenter.es	Carnero-Pardo, Cristóbal/I-6777-2018; García, María Espinosa/AAS-2903-2020; Navarro Espigares, Jose Luis/L-7643-2014	Carnero-Pardo, Cristóbal/0000-0003-3415-6727; Navarro Espigares, Jose Luis/0000-0003-3509-7810; Saez Zea, Carmen/0000-0003-3719-4948; HERNANDEZ-TORRES, ELISA/0000-0002-7266-7408	Carlos III National Health Research Institute [PI06/90034]	Carlos III National Health Research Institute	Funding was provided by the Carlos III National Health Research Institute (grant PI06/90034). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Boada M, 2002, NEUROLOGIA, V17, P317; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Carnero-Pardo C, 2007, NEUROLOGIA, V22, P860; Carnero-Pardo C, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-15; Carnero-Pardo C, 2004, REV NEUROLOGIA, V39, P801, DOI 10.33588/rn.3909.2004095; Carnero-Pardo C, 2011, NEUROLOGIA, V26, P20, DOI 10.1016/j.nrl.2010.09.021; Carnero-Pardo C, 2004, REV NEUROLOGIA, V38, P201, DOI 10.33588/rn.3803.2003489; Carnero-Pardo C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-92; CARNEROPARDO C, 2011, NEUROLOGIA; CARNEROPARDO C, 2009, ALZH REAL INVEST DEM, V42, P14; CARNEROPARDO C, 2005, THESIS U GRANADA GRA; *CONS EC INN CIENC, 2001, CENS POBL; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; *EPT MON REP TEAM, 2010, REP 2010 REACH MARG; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gold MR, 1996, COST EFFECTIVENESS H; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Iturra-Mena Ann Mary, 2007, Rev. chil. neuro-psiquiatr., V45, P296; Kutner M., 2007, 2007480 NCES; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; MAHONEY F I, 1965, Md State Med J, V14, P61; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Prince M, 2000, INT J GERIATR PSYCH, V15, P14, DOI 10.1002/(SICI)1099-1166(200001)15:1<14::AID-GPS70>3.0.CO;2-8; Prince M, 2011, INT J GERIATR PSYCH, V26, P899, DOI 10.1002/gps.2622; Rami L, 2007, INT J GERIATR PSYCH, V22, P294, DOI 10.1002/gps.1672; Rami L, 2010, ARCH GERONTOL GERIAT, V50, P171, DOI 10.1016/j.archger.2009.03.005; Ridha B., 2010, PRACT NEUROL, V5, P298, DOI [10.1111/j.1474-7766.2005.00333.x, DOI 10.1111/J.1474-7766.2005.00333.X]; Robles A, 2002, NEUROLOGIA, V17, P17; Rosselli D, 2000, REV NEUROLOGIA, V30, P428, DOI 10.33588/rn.3005.99125; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Saez-Zea C, 2008, NEUROLOGIA, V23, P356; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Storey JE, 2004, INT PSYCHOGERIATR, V16, P13, DOI 10.1017/S1041610204000043; *US FDA, 2003, STAT GUID REP RES ST; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	53	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27069	10.1371/journal.pone.0027069	http://dx.doi.org/10.1371/journal.pone.0027069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073256	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900070
J	Cousins, MM; Laeyendecker, O; Beauchamp, G; Brookmeyer, R; Towler, WI; Hudelson, SE; Khaki, L; Koblin, B; Chesney, M; Moore, RD; Kelen, GD; Coates, T; Celum, C; Buchbinder, SP; Seage, GR; Quinn, TC; Donnell, D; Eshleman, SH				Cousins, Matthew M.; Laeyendecker, Oliver; Beauchamp, Geetha; Brookmeyer, Ronald; Towler, William I.; Hudelson, Sarah E.; Khaki, Leila; Koblin, Beryl; Chesney, Margaret; Moore, Richard D.; Kelen, Gabor D.; Coates, Thomas; Celum, Connie; Buchbinder, Susan P.; Seage, George R., III; Quinn, Thomas C.; Donnell, Deborah; Eshleman, Susan H.			Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; GENETIC DIVERSITY; PROGRESSION; EVOLUTION; IDENTIFICATION; SEROCONVERSION; POLYMORPHISM; CHALLENGES; PLASMA; DONORS	Background: Cross-sectional assessment of HIV incidence relies on laboratory methods to discriminate between recent and non-recent HIV infection. Because HIV diversifies over time in infected individuals, HIV diversity may serve as a biomarker for assessing HIV incidence. We used a high resolution melting (HRM) diversity assay to compare HIV diversity in adults with different stages of HIV infection. This assay provides a single numeric HRM score that reflects the level of genetic diversity of HIV in a sample from an infected individual. Methods: HIV diversity was measured in 203 adults: 20 with acute HIV infection (RNA positive, antibody negative), 116 with recent HIV infection (tested a median of 189 days after a previous negative HIV test, range 14-540 days), and 67 with non-recent HIV infection (HIV infected >2 years). HRM scores were generated for two regions in gag, one region in pol, and three regions in env. Results: Median HRM scores were higher in non-recent infection than in recent infection for all six regions tested. In multivariate models, higher HRM scores in three of the six regions were independently associated with non-recent HIV infection. Conclusions: The HRM diversity assay provides a simple, scalable method for measuring HIV diversity. HRM scores, which reflect the genetic diversity in a viral population, may be useful biomarkers for evaluation of HIV incidence, particularly if multiple regions of the HIV genome are examined.	[Cousins, Matthew M.; Towler, William I.; Hudelson, Sarah E.; Khaki, Leila; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Laeyendecker, Oliver; Moore, Richard D.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA; [Beauchamp, Geetha; Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Brookmeyer, Ronald] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; [Koblin, Beryl] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Chesney, Margaret; Buchbinder, Susan P.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21205 USA; [Coates, Thomas] Univ Calif Los Angeles, Program Global Hlth, Los Angeles, CA USA; [Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; New York Blood Center; University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; San Francisco Department of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Cousins, MM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009	Cousins, Matthew/0000-0003-0067-9087; Laeyendecker, Oliver/0000-0002-6429-4760; Kelen, Gabor/0000-0002-3236-8286; Beauchamp, Geetha/0000-0001-6721-3930; Donnell, Deborah/0000-0002-0587-7480	HIV Network for Prevention Trials (HIVNET); U.S. National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Dept. of Health and Human Services (DHHS) [NO1-AI35176, N01-AI35173, N01-AI45200, U01-AI046745, U01-AI068613, UM1-AI068613]; National Institute on Drug Abuse (NIDA) [R01-DA011602]; National Institute of Mental Health; Office of AIDS Research of the NIH; National Institute of Alcohol Abuse and Alcoholism [R01-AA016893]; Emergency Medicine Foundation (Center of Excellence); NIAID [R01-AI095068]; Division of Intramural Research, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045200, UM1AI068613, ZIAAI000361, U01AI046745, R01AI095068, U01AI068613, N01AI035173, N01AI035176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602] Funding Source: NIH RePORTER	HIV Network for Prevention Trials (HIVNET); U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Health and Human Services (DHHS); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research of the NIH; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Emergency Medicine Foundation (Center of Excellence); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: (1) the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), the National Institutes of Health (NIH), and Dept. of Health and Human Services (DHHS) (NO1-AI35176; N01-AI35173; N01-AI45200; U01-AI046745), (2) the HIV Prevention Trials Network (HPTN) sponsored by the NIAID, the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health, and the Office of AIDS Research of the NIH and DHHS (U01-AI068613 and UM1-AI068613) (3) NIDA (R01-DA011602), (4) the National Institute of Alcohol Abuse and Alcoholism (R01-AA016893), (5) the Emergency Medicine Foundation (Center of Excellence grant), (6) NIAID (R01-AI095068), and (7) the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badreddine S, 2007, AIDS RES HUM RETROV, V23, P667, DOI 10.1089/aid.2007.0185; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Delwart EL, 1997, J VIROL, V71, P7498, DOI 10.1128/JVI.71.10.7498-7508.1997; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dorn J, 2000, J CLIN MICROBIOL, V38, P773, DOI 10.1128/JCM.38.2.773-780.2000; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frahm Nicole, 2007, Curr Infect Dis Rep, V9, P161, DOI 10.1007/s11908-007-0012-5; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Kuiken C, 2010, HIV SEQUENCE COMPEND; LAEYENDECKER O, 2010, 17 C RETR OPP INF SA; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu SY, 2008, ARCH VIROL, V153, P1233, DOI 10.1007/s00705-008-0107-9; Long EM, 2000, NAT MED, V6, P71; Machado DM, 2002, AIDS, V16, P113, DOI 10.1097/00002030-200201040-00014; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Murphy G, 2008, EURO SURVEILL, V13; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Richman Douglas D, 2004, Trans Am Clin Climatol Assoc, V115, P289; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Swanson P, 2003, AIDS RES HUM RETROV, V19, P625, DOI 10.1089/088922203322231003; Tebit DM, 2007, AIDS REV, V9, P75; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; Vrancken B, 2010, AIDS REV, V12, P89; Wilson E, 2011, 18 C RETR OPP INF BO	39	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27211	10.1371/journal.pone.0027211	http://dx.doi.org/10.1371/journal.pone.0027211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073290	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900090
J	Duchene, S; Archer, FI; Vilstrup, J; Caballero, S; Morin, PA				Duchene, Sebastian; Archer, Frederick I.; Vilstrup, Julia; Caballero, Susana; Morin, Phillip A.			Mitogenome Phylogenetics: The Impact of Using Single Regions and Partitioning Schemes on Topology, Substitution Rate and Divergence Time Estimation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; KILLER WHALE; GENE TREES; SPECIES TREES; MULTILOCUS PHYLOGENY; ORCINUS-ORCA; POPULATION; RESOLUTION; EVOLUTION; GENOME	The availability of mitochondrial genome sequences is growing as a result of recent technological advances in molecular biology. In phylogenetic analyses, the complete mitogenome is increasingly becoming the marker of choice, usually providing better phylogenetic resolution and precision relative to traditional markers such as cytochrome b (CYTB) and the control region (CR). In some cases, the differences in phylogenetic estimates between mitogenomic and single-gene markers have yielded incongruent conclusions. By comparing phylogenetic estimates made from different genes, we identified the most informative mitochondrial regions and evaluated the minimum amount of data necessary to reproduce the same results as the mitogenome. We compared results among individual genes and the mitogenome for recently published complete mitogenome datasets of selected delphinids (Delphinidae) and killer whales (genus Orcinus). Using Bayesian phylogenetic methods, we investigated differences in estimation of topologies, divergence dates, and clock-like behavior among genes for both datasets. Although the most informative regions were not the same for each taxonomic group (COX1, CYTB, ND3 and ATP6 for Orcinus, and ND1, COX1 and ND4 for Delphinidae), in both cases they were equivalent to less than a quarter of the complete mitogenome. This suggests that gene information content can vary among groups, but can be adequately represented by a portion of the complete sequence. Although our results indicate that complete mitogenomes provide the highest phylogenetic resolution and most precise date estimates, a minimum amount of data can be selected using our approach when the complete sequence is unavailable. Studies based on single genes can benefit from the addition of a few more mitochondrial markers, producing topologies and date estimates similar to those obtained using the entire mitogenome.	[Duchene, Sebastian; Caballero, Susana] Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Bogota, Colombia; [Archer, Frederick I.; Morin, Phillip A.] Natl Ocean & Atmospher Adm, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Vilstrup, Julia] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark	Universidad de los Andes (Colombia); National Oceanic Atmospheric Admin (NOAA) - USA; University of Copenhagen	Duchene, S (corresponding author), Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Bogota, Colombia.	phillip.morin@noaa.gov	Morin, Phillip A/E-9515-2010; Vilstrup Mouatt, Julia T./N-4553-2017; Duchene, Sebastian/E-3527-2012	Vilstrup Mouatt, Julia T./0000-0001-6534-8452; Morin, Phillip/0000-0002-3279-1519; Duchene, Sebastian/0000-0002-2863-0907	Universidad de los Andes	Universidad de los Andes	Funding provided by Proyecto semilla Grant from Universidad de los Andes (www.uniandes.edu.co). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo C, 2010, BOOT BOOTSTRAP R S P, P2; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2008, BAYESIAN EVOLUTIONAR; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2010, MITOCHONDR DNA, V21, P138, DOI 10.3109/19401736.2010.494727; Ho SYW, 2010, SITESAMPLER V1 1; Ho SYW, 2005, MOL BIOL EVOL, V27, P7; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; Innan H, 2002, MOL BIOL EVOL, V19, P1122, DOI 10.1093/oxfordjournals.molbev.a004170; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Kass RE, 1995, J AM STAT ASSOC, V90, P13; Knaus Brian J., 2011, BMC Ecology, V11, P10, DOI 10.1186/1472-6785-11-10; Lartillot N, 2008, PHILOS T R SOC LON B, V363, P9; LeDuc RG, 2008, BIOL LETT, V4, P3; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; McGowen MR, 2011, MOL PHYLOGENET EVOL, V60, P345, DOI 10.1016/j.ympev.2011.05.003; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parsons KM, 2009, ANIM BEHAV, V77, P963, DOI 10.1016/j.anbehav.2009.01.018; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Pilot M, 2010, J EVOLUTION BIOL, V23, P20, DOI 10.1111/j.1420-9101.2009.01887.x; Pitman RL, 2007, J MAMMAL, V88, P43, DOI 10.1644/06-MAMM-A-118R1.1; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Posada D, 2008, MOL BIOL EVOL, V25, P3; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Rand DM, 2001, ANNU REV ECOL SYST, V32, P33; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Sanders KL, 2007, BIOLOGY LETT, V3, P275, DOI 10.1098/rsbl.2007.0063; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Slatkin M, 2006, GENETICS, V172, P1979, DOI 10.1534/genetics.105.049593; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Venables WN., 2002, MODERN APPL STAT S, V4; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Viricel A, 2012, MAR MAMMAL SCI, V28, P37, DOI 10.1111/j.1748-7692.2010.00460.x; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	73	93	97	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27138	10.1371/journal.pone.0027138	http://dx.doi.org/10.1371/journal.pone.0027138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073275	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900011
J	Engelson, EJ; Buckner, FS; Van Voorhis, WC				Engelson, Erin J.; Buckner, Frederick S.; Van Voorhis, Wesley C.			An Essential Farnesylated Kinesin in Trypanosoma brucei	PLOS ONE			English	Article							FARNESYLTRANSFERASE INHIBITORS; EXPRESSION; ALIGNMENT; SYSTEM; POTENT	Kinesins are a family of motor proteins conserved throughout eukaryotes. In our present study we characterize a novel kinesin, Kinesin(CaaX), orthologs of which are only found in the kinetoplastids and not other eukaryotes. Kinesin(CaaX) has the CVIM amino acids at the C-terminus, and CVIM was previously shown to be an ideal signal for protein farnesylation in T. brucei. In this study we show Kinesin(CaaX) is farnesylated using radiolabeling studies and that farnesylation is dependent on the CVIM motif. Using RNA interference, we show Kinesin(CaaX) is essential for T. brucei proliferation. Additionally RNAi Kinesin(CaaX) depleted T. brucei are 4 fold more sensitive to the protein farneysltransferase (PFT) inhibitor LN-59, suggesting that Kinesin(CaaX) is a target of PFT inhibitors' action to block proliferation of T. brucei. Using tetracycline-induced exogenous tagged Kinesin(CaaX) and Kinesin(CVIMdeletion) (non-farnesylated Kinesin) expression lines in T. brucei, we demonstrate Kinesin(CaaX) is farnesylated in T. brucei cells and this farnesylation has functional effects. In cells expressing a CaaX-deleted version of Kinesin, the localization is more diffuse which suggests correct localization depends on farnesylation. Through our investigation of cell cycle, nucleus and kinetoplast quantitation and immunofluorescence assays an important role is suggested for Kinesin(CaaX) in the separation of nuclei and kinetoplasts during and after they have been replicated. Taken together, our work suggests Kinesin(CaaX) is a target of PFT inhibition of T. brucei cell proliferation and Kinesin(CaaX) functions through both the motor and farnesyl groups.	[Engelson, Erin J.; Buckner, Frederick S.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Engelson, Erin J.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Van Voorhis, Wesley C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Van Voorhis, Wesley C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Engelson, EJ (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	wesley@uw.edu	Buckner, Frederick/AAF-3938-2020	Buckner, Frederick/0000-0001-7796-6477	Molecular and Cellular Biology Program; University of Washington [R01CA52874, 1R01AI089441, 1R01AI080625]; NATIONAL CANCER INSTITUTE [R01CA052874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080625, R01AI089441] Funding Source: NIH RePORTER	Molecular and Cellular Biology Program; University of Washington(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of funding include the Molecular and Cellular Biology Program and the Royalty Research Fund at the University of Washington, R01CA52874, 1R01AI089441 and 1R01AI080625. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, HUM AFR TRYP NUMB NE; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Ayong L, 2011, MOL BIOCHEM PARASIT, V175, P162, DOI 10.1016/j.molbiopara.2010.11.007; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Buckner Frederick S, 2005, Curr Opin Investig Drugs, V6, P791; Buckner FS, 2000, J BIOL CHEM, V275, P21870, DOI 10.1074/jbc.M000975200; Buckner FS, 2002, BIOCHEM J, V367, P809, DOI 10.1042/BJ20020277; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Conner RJ, 1992, PROGRAMME CONTROL AF; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Fletcher S, 2008, J MED CHEM, V51, P5176, DOI 10.1021/jm800113p; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Kull FJ, 2002, J CELL SCI, V115, P15; Lawrence CJ, 2002, J MOL EVOL, V54, P42, DOI 10.1007/s00239-001-0016-y; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Matovu E, 2001, MICROBES INFECT, V3, P763, DOI 10.1016/S1286-4579(01)01432-0; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Nallan L, 2005, J MED CHEM, V48, P3704, DOI 10.1021/jm0491039; Nepomuceno-Silva JL, 2001, J BIOL CHEM, V276, P29711, DOI 10.1074/jbc.M102920200; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Ojo KK, 2008, ANTIMICROB AGENTS CH, V52, P3710, DOI 10.1128/AAC.00364-08; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2010, PLOS, V11; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wood KW, 2008, CLIN CANCER RES, V14, P7588, DOI 10.1158/1078-0432.CCR-07-4443; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; World Health Organization, 2010, WHO AFR TRYP SLEEP S; Yokoyama K, 1997, MOL BIOCHEM PARASIT, V87, P61, DOI 10.1016/S0166-6851(97)00043-1; Yokoyama K, 1998, J BIOL CHEM, V273, P26497, DOI 10.1074/jbc.273.41.26497; Yokoyama K, 1998, MOL BIOCHEM PARASIT, V94, P87, DOI 10.1016/S0166-6851(98)00053-X; Yokoyama K, 2008, MOL BIOCHEM PARASIT, V157, P32, DOI 10.1016/j.molbiopara.2007.09.006	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26508	10.1371/journal.pone.0026508	http://dx.doi.org/10.1371/journal.pone.0026508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073170	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900023
J	Erwin, PM; Olson, JB; Thacker, RW				Erwin, Patrick M.; Olson, Julie B.; Thacker, Robert W.			Phylogenetic Diversity, Host-Specificity and Community Profiling of Sponge-Associated Bacteria in the Northern Gulf of Mexico	PLOS ONE			English	Article							RESTRICTION-FRAGMENT-LENGTH; IN-SITU HYBRIDIZATION; CYANOBACTERIUM OSCILLATORIA-SPONGELIAE; BARRIER-REEF SPONGE; MARINE SPONGES; MICROBIAL COMMUNITY; VERTICAL TRANSMISSION; CARIBBEAN SPONGE; POLYMORPHISM ANALYSIS; NITROGEN-FIXATION	Background: Marine sponges can associate with abundant and diverse consortia of microbial symbionts. However, associated bacteria remain unexamined for the majority of host sponges and few studies use phylogenetic metrics to quantify symbiont community diversity. DNA fingerprinting techniques, such as terminal restriction fragment length polymorphisms (T-RFLP), might provide rapid profiling of these communities, but have not been explicitly compared to traditional methods. Methodology/Principal Findings: We investigated the bacterial communities associated with the marine sponges Hymeniacidon heliophila and Haliclona tubifera, a sympatric tunicate, Didemnum sp., and ambient seawater from the northern Gulf of Mexico by combining replicated clone libraries with T-RFLP analyses of 16S rRNA gene sequences. Clone libraries revealed that bacterial communities associated with the two sponges exhibited lower species richness and lower species diversity than seawater and tunicate assemblages, with differences in species composition among all four source groups. T-RFLP profiles clustered microbial communities by source; individual T-RFs were matched to the majority (80.6%) of clone library sequences, indicating that T-RFLP analysis can be used to rapidly profile these communities. Phylogenetic metrics of community diversity indicated that the two sponge-associated bacterial communities include dominant and host-specific bacterial lineages that are distinct from bacteria recovered from seawater, tunicates, and unrelated sponge hosts. In addition, a large proportion of the symbionts associated with H. heliophila were shared with distant, conspecific host populations in the southwestern Atlantic (Brazil). Conclusions/Significance: The low diversity and species-specific nature of bacterial communities associated with H. heliophila and H. tubifera represent a distinctly different pattern from other, reportedly universal, sponge-associated bacterial communities. Our replicated sampling strategy, which included samples that reflect the ambient environment, allowed us to differentiate resident symbionts from potentially transient or prey bacteria. Pairing replicated clone library construction with rapid community profiling via T-RFLP analyses will greatly facilitate future studies of sponge-microbe symbioses.	[Erwin, Patrick M.; Thacker, Robert W.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Olson, Julie B.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Tuscaloosa	Erwin, PM (corresponding author), CSIC, Ctr Adv Studies Blanes, Blanes, Girona, Spain.	thacker@uab.edu	Erwin, Patrick/E-9926-2016	Erwin, Patrick/0000-0001-9276-0020	Mississippi-Alabama Sea Grant Consortium; National Institute for Undersea Science and Technology; National Science Foundation [0209329, 0853089]; National Institutes of Health Centers for AIDS Research [P30 AI27767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	Mississippi-Alabama Sea Grant Consortium; National Institute for Undersea Science and Technology; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Centers for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by grants from the Mississippi-Alabama Sea Grant Consortium (www.masgc.org) awarded to PME and the National Institute for Undersea Science and Technology (www.niust.org) awarded to RT. This material is based upon work supported by the National Science Foundation (www.nsf.gov) under Grant No. 0209329 awarded to RT and Grant No. 0853089 award to PME. This work has been facilitated by the infrastructure and resources provided by the National Institutes of Health Centers for AIDS Research Core Grant P30 AI27767 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson SA, 2010, FEMS MICROBIOL ECOL, V72, P328, DOI 10.1111/j.1574-6941.2010.00869.x; [Anonymous], IEEE T PATTERN ANAL; ARILLO A, 1993, MAR BIOL, V117, P159, DOI 10.1007/BF00346438; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Burja AM, 2001, HYDROBIOLOGIA, V461, P41, DOI 10.1023/A:1012713130404; CHESHIRE AC, 1991, MAR BIOL, V109, P13, DOI 10.1007/BF01320226; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Colwell RK, 2013, ESTIMATES STAT ESTIM; COX GC, 1985, MAR BIOL, V89, P149, DOI 10.1007/BF00392886; Diaz Maria Cristina, 1993, Scientia Marina, V57, P283; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Dobretsov S, 2005, MAR ECOL PROG SER, V297, P119, DOI 10.3354/meps297119; Dorigo U, 2005, WATER RES, V39, P2207, DOI 10.1016/j.watres.2005.04.007; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flatt P, 2005, MAR BIOL, V147, P761, DOI 10.1007/s00227-005-1614-9; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Friedrich AB, 1999, MAR BIOL, V134, P461, DOI 10.1007/s002270050562; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Henrikson AA, 1995, J EXP MAR BIOL ECOL, V194, P157, DOI 10.1016/0022-0981(95)00088-7; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2006, MAR BIOTECHNOL, V8, P373, DOI 10.1007/s10126-006-5152-3; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Hooper J. N. A., 2002, SYSTEMA PORIFERA GUI, V1-2; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Ihara K, 1997, INT J SYST BACTERIOL, V47, P73, DOI 10.1099/00207713-47-1-73; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Lee EY, 2003, BIOMOL ENG, V20, P299, DOI 10.1016/S1389-0344(03)00034-0; Lee OO, 2006, MICROB ECOL, V52, P693, DOI 10.1007/s00248-006-9077-1; Lee OO, 2009, APPL ENVIRON MICROB, V75, P6147, DOI 10.1128/AEM.00023-09; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Lee OO, 2010, INT SOC MICROB ECOL, P1; Lemoine N, 2007, SERIE LIVROS MUSEU N, P239; Li ZY, 2007, WORLD J MICROB BIOT, V23, P1265, DOI 10.1007/s11274-007-9359-x; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; LITTLE FRANK J., 1963, TULANE STUD ZOOL, V11, P31; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Luter HM, 2010, APPL ENVIRON MICROB, V76, P5736, DOI 10.1128/AEM.00653-10; Lysek N, 2003, Z NATURFORSCH C, V58, P568; Manz W, 2000, J MICROBIOL METH, V40, P125, DOI 10.1016/S0167-7012(99)00103-7; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martinez-Garcia M, 2008, ENVIRON MICROBIOL, V10, P2991, DOI 10.1111/j.1462-2920.2008.01761.x; Martinez-Garcia M, 2007, ENVIRON MICROBIOL, V9, P521, DOI 10.1111/j.1462-2920.2006.01170.x; Martinez-Garcia M, 2007, MAR DRUGS, V5, P52, DOI 10.3390/md503052; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Moss C, 2003, MAR BIOL, V143, P99, DOI 10.1007/s00227-003-1060-5; Munchhoff J, 2007, ENVIRON MICROBIOL, V9, P890, DOI 10.1111/j.1462-2920.2006.01209.x; Olson JB, 2005, AQUAT MICROB ECOL, V39, P47, DOI 10.3354/ame039047; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; Rutzler Klaus, 2009, P285; SANTAVY DL, 1990, MAR ECOL PROG SER, V67, P73, DOI 10.3354/meps067073; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Sipkema D, 2010, MAR BIOL, V157, P627, DOI 10.1007/s00227-009-1347-2; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Steindler L, 2002, SYMBIOSIS, V33, P263; Tait E, 2007, J EXP MAR BIOL ECOL, V342, P138, DOI 10.1016/j.jembe.2006.10.024; Taylor MW, 2007, ISME J, V1, P187, DOI 10.1038/ismej.2007.32; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, ENVIRON MICROBIOL, V3, P19, DOI 10.1046/j.1462-2920.2001.00155.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Webster NS, 2008, ISME J, P1; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1978, MAR BIOL, V49, P169, DOI 10.1007/BF00387116; WILKINSON CR, 1981, MICROBIAL ECOL, V7, P13, DOI 10.1007/BF02010474; WILKINSON CR, 1987, SCIENCE, V236, P1654, DOI 10.1126/science.236.4809.1654; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Zhang R, 2008, FEMS MICROBIOL ECOL, V65, P169, DOI 10.1111/j.1574-6941.2008.00493.x	104	59	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26806	10.1371/journal.pone.0026806	http://dx.doi.org/10.1371/journal.pone.0026806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073197	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900039
J	Kariya, Y; Gu, JG				Kariya, Yoshinobu; Gu, Jianguo			N-Glycosylation of beta 4 Integrin Controls the Adhesion and Motility of Keratinocytes	PLOS ONE			English	Article							I-LIKE DOMAIN; ALPHA-6-BETA-4 INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; LIPID RAFTS; BIOLOGICAL FUNCTION; CARCINOMA INVASION; BISECTING GLCNAC; CELL-ADHESION; LAMININ-332; EXPRESSION	alpha 6 beta 4 integrin is an essential component of hemidesmosomes and modulates cell migration in wound healing and cancer invasion. To elucidate the role of N-glycosylation on beta 4 integrin, we investigated keratinocyte adhesion and migration through the re-expression of wild-type or N-glycosylation-defective beta 4 integrin (Delta N beta 4) in beta 4 integrin null keratinocytes. N-glycosylation of beta 4 integrin was not essential for the heterodimer formation of beta 4 integrin with alpha 6 integrin and its expression on a cell surface, but N-glycosylation was required for integrin-mediated cell adhesion and migration. Concomitantly with the reduction of beta 4 integrin in the membrane microdomain, the intracellular signals of Akt and ERK activation were decreased in cells expressing DN beta 4 integrin. Forced cross-linking of beta 4 integrin rescued the decreased ERK activation in Delta N beta 4 integrin-expressing cells to a similar extent in wild-type beta 4 integrin-expressing cells. Surprisingly, compared with cells expressing wild-type beta 4 integrin, an alternation in N-glycan structures expressed on epidermal growth factor receptor (EGFR), and the induction of a stronger association between EGFR and beta 4 integrin were observed in Delta N beta 4 integrin-expressing cells. These results clearly demonstrated that N-glycosylation on beta 4 integrin plays an essential role in keratinocyte cellular function by allowing the appropriate complex formation on cell surfaces.	[Kariya, Yoshinobu; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Kariya, Yoshinobu] Fukushima Med Univ Sch Med, Dept Biochem, Fukushima, Japan	Tohoku Medical & Pharmaceutical University; Fukushima Medical University	Kariya, Y (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan.	kariya@fmu.ac.jp; jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020		Japan Society for the Promotion of Science [21370059, 23651196]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Fukushima Medical University; Uehara Memorial Foundation of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukushima Medical University; Uehara Memorial Foundation of Japan(Uehara Memorial Foundation)	This work was partially supported by a Grant-in-Aid for Scientific Research No. 21370059 (JG) and for Challenging Exploratory Research No. 23651196 (JG) from the Japan Society for the Promotion of Science, and by the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Fukushima Medical University Research Project from Fukushima Medical University and the Uehara Memorial Foundation of Japan (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2009, MINI-REV MED CHEM, V9, P1284, DOI 10.2174/138955709789878114; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kariya Y, 2008, J BIOL CHEM, V283, P33036, DOI 10.1074/jbc.M804526200; Kim HI, 2008, CANCER PREV RES, V1, P385, DOI 10.1158/1940-6207.CAPR-08-0087; Ko MS, 2010, DERMATOL CLIN, V28, P1, DOI 10.1016/j.det.2009.10.001; Leitinger B, 2002, J CELL SCI, V115, P963; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Niessen CM, 1996, J CELL SCI, V109, P1695; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Soung YH, 2011, MOL CANCER THER, V10, P883, DOI 10.1158/1535-7163.MCT-10-1053; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	35	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27084	10.1371/journal.pone.0027084	http://dx.doi.org/10.1371/journal.pone.0027084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073258	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900072
J	Moftah, M; Aziz, SHA; Elramah, S; Favereaux, A				Moftah, Marie; Aziz, Sayeda H. Abdel; Elramah, Sara; Favereaux, Alexandre			Classification of Sharks in the Egyptian Mediterranean Waters Using Morphological and DNA Barcoding Approaches	PLOS ONE			English	Article							SQUALUS-ACANTHIAS; SPINY DOGFISH; IDENTIFICATION; NUCLEOTIDE; AMINO; PHYLOGENY; SPARIDAE; ATLANTIC; NUCLEAR; REGION	The identification of species constitutes the first basic step in phylogenetic studies, biodiversity monitoring and conservation. DNA barcoding, i.e. the sequencing of a short standardized region of DNA, has been proposed as a new tool for animal species identification. The present study provides an update on the composition of shark in the Egyptian Mediterranean waters off Alexandria, since the latest study to date was performed 30 years ago, DNA barcoding was used in addition to classical taxonomical methodologies. Thus, 51 specimen were DNA barcoded for a 667 bp region of the mitochondrial COI gene. Although DNA barcoding aims at developing species identification systems, some phylogenetic signals were apparent in the data. In the neighbor-joining tree, 8 major clusters were apparent, each of them containing individuals belonging to the same species, and most with 100% bootstrap value. This study is the first to our knowledge to use DNA barcoding of the mitochondrial COI gene in order to confirm the presence of species Squalus acanthias, Oxynotus centrina, Squatina squatina, Scyliorhinus canicula, Scyliorhinus stellaris, Mustelus mustelus, Mustelus punctulatus and Carcharhinus altimus in the Egyptian Mediterranean waters. Finally, our study is the starting point of a new barcoding database concerning shark composition in the Egyptian Mediterranean waters (Barcoding of Egyptian Mediterranean Sharks [BEMS], http://www.boldsystems.org/views/projectlist.php?&#Barcoding%20Fish%20%28FishBOL%29).	[Moftah, Marie] Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt; [Aziz, Sayeda H. Abdel; Elramah, Sara] Univ Alexandria, Fac Sci, Dept Oceanog, Alexandria, Egypt; [Elramah, Sara; Favereaux, Alexandre] Univ Bordeaux, IINS, UMR 5297, F-33000 Bordeaux, France; [Elramah, Sara; Favereaux, Alexandre] CNRS, IINS, UMR 5297, F-33000 Bordeaux, France	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Moftah, M (corresponding author), Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt.	alexandre.favereaux@u-bordeaux2.fr	Favereaux, Alexandre/C-9744-2016	Moftah, Marie/0000-0001-5179-9615; FAVEREAUX, Alexandre/0000-0003-0881-9224	Agence Universitaire de la Francophonie	Agence Universitaire de la Francophonie	SER received a travel funding by Agence Universitaire de la Francophonie to perform sequencing analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco M, 2008, J AGR FOOD CHEM, V56, P9868, DOI 10.1021/jf8015128; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; Craig MT, 2001, MOL PHYLOGENET EVOL, V19, P121, DOI 10.1006/mpev.2000.0913; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heist EJ, 1999, FISH B-NOAA, V97, P53; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hong J, 1996, J MOL EVOL, V43, P602, DOI 10.1007/BF02202108; Hosny CF, 1981, THESIS; Iglesias SP, 2005, MOL PHYLOGENET EVOL, V34, P569, DOI 10.1016/j.ympev.2004.10.022; Kabasakal Hakan, 2009, Pan-American Journal of Aquatic Sciences, V4, P609; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAVERY S, 1992, AUST J MAR FRESH RES, V43, P97; Martin Andrew P., 1993, NOAA Technical Report NMFS, V115, P53; Mazhar FM, 1974, B I OCEAN FISH ARE, V4; Nei M, 1998, P NATL ACAD SCI USA, V95, P12390, DOI 10.1073/pnas.95.21.12390; Renon P, 2001, ELECTROPHORESIS, V22, P1534, DOI 10.1002/1522-2683(200105)22:8&lt;1534::AID-ELPS1534&gt;3.0.CO;2-D; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salaneck E, 2003, MOL BIOL EVOL, V20, P1271, DOI 10.1093/molbev/msg133; Stelbrink B, 2010, MOL PHYLOGENET EVOL, V54, P395, DOI 10.1016/j.ympev.2009.07.029; Stock DW, 1995, MOL MAR BIOL BIOTECH, V4, P284; Strauss R.E., 1990, P109; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	33	21	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27001	10.1371/journal.pone.0027001	http://dx.doi.org/10.1371/journal.pone.0027001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22087242	gold, Green Submitted, Green Published			2022-12-27	WOS:000297154900060
J	Pires, MM; Prado, PI; Guimaraes, PR				Pires, Mathias M.; Prado, Paulo I.; Guimaraes, Paulo R., Jr.			Do Food Web Models Reproduce the Structure of Mutualistic Networks?	PLOS ONE			English	Article							BODY-SIZE; NESTEDNESS; PATTERNS; ARCHITECTURE; MODULARITY; RULES	Background: Simple models inspired by processes shaping consumer-resource interactions have helped to establish the primary processes underlying the organization of food webs, networks of trophic interactions among species. Because other ecological interactions such as mutualisms between plants and their pollinators and seed dispersers are inherently based in consumer-resource relationships we hypothesize that processes shaping food webs should organize mutualistic relationships as well. Methodology/Principal Findings: We used a likelihood-based model selection approach to compare the performance of food web models and that of a model designed for mutualisms, in reproducing the structure of networks depicting mutualistic relationships. Our results show that these food web models are able to reproduce the structure of most of the mutualistic networks and even the simplest among the food web models, the cascade model, often reproduce overall structural properties of real mutualistic networks. Conclusions/Significance: Based on our results we hypothesize that processes leading to feeding hierarchy, which is a characteristic shared by all food web models, might be a fundamental aspect in the assembly of mutualisms. These findings suggest that similar underlying ecological processes might be important in organizing different types of interactions.	[Pires, Mathias M.] Univ Sao Paulo, Inst Biociencias, Programa Pos Grad Ecol, Sao Paulo, Brazil; [Prado, Paulo I.; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pires, MM (corresponding author), Univ Sao Paulo, Inst Biociencias, Programa Pos Grad Ecol, Sao Paulo, Brazil.	prguima@usp.br	Prado, Paulo Inácio/AAN-6512-2021; Guimarães-Junior, Paulo R/M-1298-2016; Guimaraes, Paulo R./E-1915-2016; Pires, Mathias/I-4489-2012; Guimaraes, Paulo/B-1099-2008; Prado, Paulo I/G-3353-2012	Prado, Paulo Inácio/0000-0002-7174-5005; Guimaraes, Paulo R./0000-0001-9161-8305; Pires, Mathias/0000-0003-2500-4748; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/54567-6, 2009/054422-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; url:www.fapesp.org) grants 2009/54567-6 to MMP and 2009/054422-8 to PRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell C, 2011, P NATL ACAD SCI USA, V108, P197, DOI 10.1073/pnas.1008204108; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Chamberlain SA, 2009, FUNCT ECOL, V23, P196, DOI 10.1111/j.1365-2435.2008.01472.x; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2006, SFI S SCI C, P27; Dunne JA, 2009, PHILOS T R SOC B, V364, P1711, DOI 10.1098/rstb.2008.0219; Dupont YL, 2011, OIKOS, V120, P170, DOI 10.1111/j.1600-0706.2010.18699.x; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hartig F., 2011, ECOL LETT IN PRESS; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; Idro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014001; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Montoya JM, 2003, ECOL LETT, V6, P587, DOI 10.1046/j.1461-0248.2003.00469.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; Royall R., 1997, STAT EVIDENCE LIKELI; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Takemoto K, 2010, J THEOR BIOL, V264, P782, DOI 10.1016/j.jtbi.2010.03.029; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J. N., 2005, INTERSPEC INTERACT; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zook AE, 2011, J THEOR BIOL, V271, P106, DOI 10.1016/j.jtbi.2010.11.045	52	22	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27280	10.1371/journal.pone.0027280	http://dx.doi.org/10.1371/journal.pone.0027280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073303	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900096
J	Vazquez, A; Markert, EK; Oltvai, ZN				Vazquez, Alexei; Markert, Elke K.; Oltvai, Zoltan N.			Serine Biosynthesis with One Carbon Catabolism and the Glycine Cleavage System Represents a Novel Pathway for ATP Generation	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; CELL-PROLIFERATION; PYRUVATE-KINASE; SKELETAL-MUSCLE; GENOME-SCALE; CANCER-CELLS; TUMOR-CELLS; METABOLISM; LACTATE; PERFORMANCE	Previous experimental evidence indicates that some cancer cells have an alternative glycolysis pathway with net zero ATP production, implying that upregulation of glycolysis in these cells may not be related to the generation of ATP. Here we use a genome-scale model of human cell metabolism to investigate the potential metabolic alterations in cells using net zero ATP glycolysis. We uncover a novel pathway for ATP generation that involves reactions from serine biosynthesis, one-carbon metabolism and the glycine cleavage system, and show that the pathway is transcriptionally upregulated in an inducible murine model of Myc-driven liver tumorigenesis. This pathway has a predicted two-fold higher flux rate in cells using net zero ATP glycolysis than those using standard glycolysis and generates twice as much ATP with significantly lower rate of lactate - but higher rate of alanine secretion. Thus, in cells using the standard - or the net zero ATP glycolysis pathways a significant portion of the glycolysis flux is always associated with ATP generation, and the ratio between the flux rates of the two pathways determines the rate of ATP generation and lactate and alanine secretion during glycolysis.	[Vazquez, Alexei] Canc Inst New Jersey, Dept Radiat Oncol, Div Bioinformat & Surveillance, New Brunswick, NJ USA; [Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Markert, Elke K.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Oltvai, Zoltan N.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Institute for Advanced Study - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vazquez, A (corresponding author), Canc Inst New Jersey, Dept Radiat Oncol, Div Bioinformat & Surveillance, New Brunswick, NJ USA.	vazqueal@umdnj.edu			Robert Wood Johnson (RWJ) Foundation; National Institutes of Health (NIH) [NIAID U01 AI070499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070499] Funding Source: NIH RePORTER	Robert Wood Johnson (RWJ) Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AV was sponsored by the Robert Wood Johnson (RWJ) Foundation. This work has been supported in part by National Institutes of Health (NIH) grant NIAID U01 AI070499 to ZNO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other external funding sources for this study.	Alberts B, 2008, MOL BIOL CELL; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BISMUT H, 1995, BIOCHEM J, V308, P761, DOI 10.1042/bj3080761; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; CURTHOYS NP, 1972, J BIOL CHEM, V247, P1965; EICHLER HG, 1981, BIOSCIENCE REP, V1, P101, DOI 10.1007/BF01117006; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; FRAME KK, 1990, BIOTECHNOL BIOENG, V36, P191, DOI 10.1002/bit.260360211; GLAS U, 1966, J CELL BIOL, V29, P507, DOI 10.1083/jcb.29.3.507; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hou XY, 2002, CLIN PHYSIOL FUNCT I, V22, P226, DOI 10.1046/j.1475-097X.2002.00423.x; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; KIT S, 1955, CANCER RES, V15, P715; LEE B, 1983, P NATL ACAD SCI USA, V80, P622, DOI 10.1073/pnas.80.2.622; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mo ML, 2007, MOL BIOSYST, V3, P598, DOI 10.1039/b705597h; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; MUNYON WH, 1959, EXP CELL RES, V17, P490, DOI 10.1016/0014-4827(59)90069-2; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trabold O, 2003, WOUND REPAIR REGEN, V11, P504, DOI 10.1046/j.1524-475X.2003.11621.x; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019538; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; VOET D, 2006, FUNDAMENTALS BIOCH L; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; WILLIAMS R, 1993, J INVEST DERMATOL, V100, P834, DOI 10.1111/1523-1747.ep12476744; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	52	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25881	10.1371/journal.pone.0025881	http://dx.doi.org/10.1371/journal.pone.0025881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073143	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000297154900002
J	Walla, P; Brenner, G; Koller, M				Walla, Peter; Brenner, Gerhard; Koller, Monika			Objective Measures of Emotion Related to Brand Attitude: A New Way to Quantify Emotion-Related Aspects Relevant to Marketing	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; STARTLE REFLEX; BRAIN POTENTIALS; COGNITION; MODULATION; ADVERTISEMENT; RESPONSES; BEHAVIOR; HUMANS; CORTEX	With this study we wanted to test the hypothesis that individual like and dislike as occurring in relation to brand attitude can be objectively assessed. First, individuals rated common brands with respect to subjective preference. Then, they volunteered in an experiment during which their most liked and disliked brand names were visually presented while three different objective measures were taken. Participant's eye blinks as responses to acoustic startle probes were registered with electromyography (EMG) (i) and their skin conductance (ii) and their heart rate (iii) were recorded. We found significantly reduced eye blink amplitudes related to liked brand names compared to disliked brand names. This finding suggests that visual perception of liked brand names elicits higher degrees of pleasantness, more positive emotion and approach-oriented motivation than visual perception of disliked brand names. Also, skin conductance and heart rate were both reduced in case of liked versus disliked brand names. We conclude that all our physiological measures highlight emotion-related differences depending on the like and dislike toward individual brands. We suggest that objective measures should be used more frequently to quantify emotion-related aspects of brand attitude. In particular, there might be potential interest to introduce startle reflex modulation to measure emotion-related impact during product development, product design and various further fields relevant to marketing. Our findings are discussed in relation to the idea that self reported measures are most often cognitively polluted.	[Walla, Peter] Univ Newcastle, Fac Sci & Informat Technol, Sch Psychol, Newcastle, NSW 2300, Australia; [Walla, Peter] Univ Vienna, Fac Psychol, Biol Psychol Unit, Vienna, Austria; [Brenner, Gerhard; Koller, Monika] Vienna Univ Econ & Business, Inst Mkt Management, Vienna, Austria; [Walla, Peter] Neuroconsult eU, Vienna, Austria	University of Newcastle; University of Vienna; Vienna University of Economics & Business	Walla, P (corresponding author), Univ Newcastle, Fac Sci & Informat Technol, Sch Psychol, Newcastle, NSW 2300, Australia.	peter.walla@newcastle.edu.au	Walla, Peter/G-8167-2013	Walla, Peter/0000-0002-0207-7699	Bank Austria	Bank Austria	This study was financially supported (money to pay subjects for participation) by the Bank Austria through Wolfgang Ruediger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2010, BIOL PSYCHOL, V83, P37, DOI 10.1016/j.biopsycho.2009.10.001; BATRA R, 1986, J CONSUM RES, V13, P234, DOI 10.1086/209063; Batra R., 1990, MARKET LETT, V2, P159, DOI DOI 10.1007/BF00436035; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; Bradley MM, 1999, INT AFFECTIVE DIGITI; Chaudhuri A, 2001, J MARKETING, V65, P81, DOI 10.1509/jmkg.65.2.81.18255; Critchley HD, 2000, J NEUROSCI, V20, P3033; Dunning JP, 2010, PSYCHOPHYSIOLOGY, V47, P874, DOI 10.1111/j.1469-8986.2010.01007.x; Duregger C, 2007, J NEURAL TRANSM, V114, P359, DOI 10.1007/s00702-006-0568-5; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Friedkin NE, 2010, SOC PSYCHOL QUART, V73, P196, DOI 10.1177/0190272510369661; Geiser M, 2011, APPL SCI-BASEL, V1, P1, DOI 10.3390/app1010001; Gibson B, 2008, J CONSUM RES, V35, P178, DOI 10.1086/527341; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; GRESHAM LG, 1985, J ADVERTISING, V14, P10, DOI 10.1080/00913367.1985.10672924; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Himmelfarb S, 1993, PSYCHOL ATTITUDES; Lang P.J., 2008, A8 U FLOR; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lanzenberger R, 2005, CLIN NEUROL NEUROSUR, V107, P147, DOI 10.1016/j.clineuro.2004.06.006; Lastovicka JL, 1981, J ECON PSYCHOL, V2, P57; Lemon KN, 2001, MARK MANAG, V10, P20; Low G.S., 2000, J PROD BRAND MANAG, V9, P350, DOI DOI 10.1108/10610420010356966; Mackay T, 2009, INT J ADVERT, V28, P423, DOI 10.2501/S0265048709200680; MITCHELL AA, 1981, J MARKETING RES, V18, P318, DOI 10.2307/3150973; MITCHELL AA, 1986, J CONSUM RES, V13, P12, DOI 10.1086/209044; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Puregger E, 2003, NEUROIMAGE, V20, P2235, DOI 10.1016/j.neuroimage.2003.08.015; Reimann M, 2010, J ECON PSYCHOL, V31, P767, DOI 10.1016/j.joep.2010.03.002; Rugg MD, 1998, EXP BRAIN RES, V123, P18, DOI 10.1007/s002210050540; Schaefer M, 2006, NEUROIMAGE, V31, P861, DOI 10.1016/j.neuroimage.2005.12.047; Schipke J. D., 1999, J CLIN BASIC CARDIOL, V2, P92, DOI DOI 10.1161/01.CIR.93.5.1043; Sweldens S, 2010, J CONSUM RES, V37, P473, DOI 10.1086/653656; Thompson CJ, 2006, J MARKETING, V70, P50, DOI 10.1509/jmkg.2006.70.1.50; Till B. D., 2010, BRAND MANAGEMENT, V17, P413; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; VRANA SR, 1990, J ABNORM PSYCHOL, V99, P189, DOI 10.1037/0021-843X.99.2.189; Walla P, 2003, NEUROIMAGE, V18, P104, DOI 10.1006/nimg.2002.1324; Walla P, 1999, NEUROSCI LETT, V269, P129, DOI 10.1016/S0304-3940(99)00430-9; Walla P, 2010, SENSORS-BASEL, V10, P8185, DOI 10.3390/s100908185; Walla P, 2010, J PSYCHOPHYSIOL, V24, P25, DOI 10.1027/0269-8803/a000003	46	54	57	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26782	10.1371/journal.pone.0026782	http://dx.doi.org/10.1371/journal.pone.0026782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073192	gold, Green Accepted, Green Published			2022-12-27	WOS:000297154900035
J	Heins, RA; Choi, JH; Sohka, T; Ostermeier, M				Heins, Richard A.; Choi, Jay H.; Sohka, Takayuki; Ostermeier, Marc			In Vitro Recombination of Non-Homologous Genes Can Result in Gene Fusions that Confer a Switching Phenotype to Cells	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; BETA-LACTAMASE; STABILITY; FLUORESCENCE; CREATION; SERINE; VIVO	Regulation of protein activity is central to the complexity of life. The ability to regulate protein activity through exogenously added molecules has biotechnological/biomedical applications and offers tools for basic science. Such regulation can be achieved by establishing a means to modulate the specific activity of the protein (i.e. allostery). An alternative strategy for intracellular regulation of protein activity is to control the amount of protein through effects on its production, accumulation, and degradation. We have previously demonstrated that the non-homologous recombination of the genes encoding maltose binding protein (MBP) and TEM1 beta-lactamase (BLA) can result in fusion proteins in which beta-lactamase enzyme activity is allosterically regulated by maltose. Here, through use of a two-tiered genetic selection scheme, we demonstrate that such recombination can result in genes that confer maltose-dependent resistance to beta-lactam even though they do not encode allosteric enzymes. These 'phenotypic switch' genes encode fusion proteins whose accumulation is a result of a specific interaction with maltose. Phenotypic switches represent an important class of proteins for basic science and biotechnological applications in vivo.	[Heins, Richard A.; Choi, Jay H.; Sohka, Takayuki; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University	Heins, RA (corresponding author), Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; Defense Threat Reduction Agency [HDTRA1-09-1-0016]; Asahi Kasei Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Asahi Kasei Corporation(Asahi Kasei Corporation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medicine at the National Institutes of Health [R01 GM066972]; the Defense Threat Reduction Agency [HDTRA1-09-1-0016]; and a gift from Asahi Kasei Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by a gift from Asahi Kasei Corporation. There are currently pending patents, but no other products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	BETTON JM, 1994, EMBO J, V13, P1226, DOI 10.1002/j.1460-2075.1994.tb06372.x; Coombs GS, 1998, J BIOL CHEM, V273, P4323, DOI 10.1074/jbc.273.8.4323; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Goldsmith M, 2007, PROTEIN ENG DES SEL, V20, P315, DOI 10.1093/protein/gzm026; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guntas G, 2004, CHEM BIOL, V11, P1483, DOI 10.1016/j.chembiol.2004.08.020; Guntas G, 2004, J MOL BIOL, V336, P263, DOI 10.1016/j.jmb.2003.12.016; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; MARTINEAU P, 1990, J MOL BIOL, V214, P337, DOI 10.1016/0022-2836(90)90165-I; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Ostermeier M, 2009, CURR OPIN STRUC BIOL, V19, P442, DOI 10.1016/j.sbi.2009.04.007; Pace C N, 1986, Methods Enzymol, V131, P266; RAIBAUD O, 1980, J BACTERIOL, V143, P761, DOI 10.1128/JB.143.2.761-771.1980; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Rosgen J, 2005, BIOPHYS J, V89, P2988, DOI [10.1529/biophysj.105.067330, 10.1529/biophsyj.105.067330]; SIGAL IS, 1984, J BIOL CHEM, V259, P5327; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; VANHOVE M, 1995, BIOCHEM J, V308, P859, DOI 10.1042/bj3080859; Wright CM, 2011, P NATL ACAD SCI USA, V108, P16206, DOI 10.1073/pnas.1102803108	22	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27302	10.1371/journal.pone.0027302	http://dx.doi.org/10.1371/journal.pone.0027302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096548	gold, Green Published, Green Submitted			2022-12-27	WOS:000297553900030
J	Tu, E; Ang, DKY; Hogan, TV; Read, S; Chia, CPZ; Gleeson, PA; van Driel, IR				Tu, Eric; Ang, Desmond K. Y.; Hogan, Thea V.; Read, Simon; Chia, Cheryl P. Z.; Gleeson, Paul A.; van Driel, Ian R.			A Convenient Model of Severe, High Incidence Autoimmune Gastritis Caused by Polyclonal Effector T Cells and without Perturbation of Regulatory T Cells	PLOS ONE			English	Article							ORGAN-SPECIFIC AUTOIMMUNITY; H,K-ATPASE ALPHA-SUBUNIT; ATPASE BETA-SUBUNIT; TCR TRANSGENIC MICE; H+,K+-ADENOSINE TRIPHOSPHATASE; PERNICIOUS-ANEMIA; NEONATAL THYMECTOMY; PARIETAL-CELLS; SELF-TOLERANCE; H+/K+-ATPASE	Autoimmune gastritis results from the breakdown of T cell tolerance to the gastric H(+)/K(+) ATPase. The gastric H(+)/K(+) ATPase is responsible for the acidification of gastric juice and consists of an alpha subunit (H/K alpha) and a beta subunit (H/K beta). Here we show that CD4(+) T cells from H/K alpha-deficient mice (H/K alpha(-/-)) are highly pathogenic and autoimmune gastritis can be induced in sublethally irradiated wildtype mice by adoptive transfer of unfractionated CD4(+) T cells from H/K alpha(-/-) mice. All recipient mice consistently developed the most severe form of autoimmune gastritis 8 weeks after the transfer, featuring hypertrophy of the gastric mucosa, complete depletion of the parietal and zymogenic cells, and presence of autoantibodies to H(+)/K(+) ATPase in the serum. Furthermore, we demonstrated that the disease significantly affected stomach weight and stomach pH of recipient mice. Depletion of parietal cells in this disease model required the presence of both H/K alpha and H/K beta since transfer of H/K alpha(-/-) CD4(+) T cells did not result in depletion of parietal cells in H/K alpha(-/-) or H/K beta(-/-) recipient mice. The consistency of disease severity, the use of polyclonal T cells and a specific T cell response to the gastric autoantigen make this an ideal disease model for the study of many aspects of organ-specific autoimmunity including prevention and treatment of the disease.	[Tu, Eric; Ang, Desmond K. Y.; Hogan, Thea V.; Read, Simon; Chia, Cheryl P. Z.; Gleeson, Paul A.; van Driel, Ian R.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	University of Melbourne	Tu, E (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	ivd@unimelb.edu.au		van Driel, Ian/0000-0001-5371-120X; Gleeson, Paul/0000-0002-5336-6503; Hogan, Thea/0000-0002-3140-0192	National Health and Medical Research Council of Australia; University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	This work was supported by research grants from the National Health and Medical Research Council of Australia and the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderuccio F, 1997, AUTOIMMUNITY, V25, P167, DOI 10.3109/08916939709008023; Alderuccio F, 2000, INT IMMUNOL, V12, P343, DOI 10.1093/intimm/12.3.343; ALDERUCCIO F, 1993, J EXP MED, V178, P419, DOI 10.1084/jem.178.2.419; Allen S, 2005, J IMMUNOL, V175, P5759, DOI 10.4049/jimmunol.175.9.5759; Amedei A, 2003, J EXP MED, V198, P1147, DOI 10.1084/jem.20030530; Ang DKY, 2007, INT IMMUNOL, V19, P1135, DOI 10.1093/intimm/dxm087; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BARRETT SP, 1995, EUR J IMMUNOL, V25, P2686, DOI 10.1002/eji.1830250943; BARRETT SP, 1995, EUR J IMMUNOL, V25, P238, DOI 10.1002/eji.1830250139; Beggah AT, 1999, J BIOL CHEM, V274, P8217, DOI 10.1074/jbc.274.12.8217; Bergman MP, 2003, EUR J IMMUNOL, V33, P539, DOI 10.1002/immu.200310030; CALLAGHAN JM, 1993, AUTOIMMUNITY, V16, P289, DOI 10.3109/08916939309014648; Candon S, 2004, J IMMUNOL, V172, P2917, DOI 10.4049/jimmunol.172.5.2917; Carmel R, 1996, ARCH INTERN MED, V156, P1097, DOI 10.1001/archinte.156.10.1097; D'Elios MM, 2001, GASTROENTEROLOGY, V120, P377, DOI 10.1053/gast.2001.21187; De Silva HD, 1999, IMMUNOLOGY, V96, P145; De Silva HD, 1998, IMMUNOLOGY, V93, P405; JONES CM, 1991, GASTROENTEROLOGY, V101, P287, DOI 10.1016/0016-5085(91)90002-3; Judd LM, 1999, AM J PHYSIOL-GASTR L, V277, pG209, DOI 10.1152/ajpgi.1999.277.1.G209; KARLSSON FA, 1988, J CLIN INVEST, V81, P475, DOI 10.1172/JCI113344; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Laurie KL, 2002, J IMMUNOL, V169, P2361, DOI 10.4049/jimmunol.169.5.2361; Martinelli TM, 1996, GASTROENTEROLOGY, V110, P1791, DOI 10.1053/gast.1996.v110.pm8964405; McHugh RS, 2001, EUR J IMMUNOL, V31, P2094, DOI 10.1002/1521-4141(200107)31:7<2094::AID-IMMU2094>3.0.CO;2-S; Monteiro JP, 2008, J IMMUNOL, V181, P5895, DOI 10.4049/jimmunol.181.9.5895; Read S, 2007, GASTROENTEROLOGY, V133, P547, DOI 10.1053/j.gastro.2007.05.050; SAKAGUCHI S, 1994, J IMMUNOL, V152, P1471; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scarff KJ, 1997, IMMUNOLOGY, V92, P91, DOI 10.1046/j.1365-2567.1997.00302.x; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Silveira PA, 1999, J IMMUNOL, V162, P5106; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; SuriPayer E, 1996, J IMMUNOL, V157, P1799; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Zwar TA, 2006, J IMMUNOL, V176, P1609, DOI 10.4049/jimmunol.176.3.1609	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27153	10.1371/journal.pone.0027153	http://dx.doi.org/10.1371/journal.pone.0027153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096532	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800032
J	Fried, PJ; Elkin-Frankston, S; Rushmore, RJ; Hilgetag, CC; Valero-Cabre, A				Fried, Peter J.; Elkin-Frankston, Seth; Rushmore, Richard Jarrett; Hilgetag, Claus C.; Valero-Cabre, Antoni			Characterization of Visual Percepts Evoked by Noninvasive Stimulation of the Human Posterior Parietal Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CONCURRENT TMS-FMRI; CORTICAL EXCITABILITY; PHOSPHENE THRESHOLDS; SPATIAL ATTENTION; INTRAPARIETAL SULCUS; EXTRASTRIATE CORTEX; SUPERIOR COLLICULUS; LOW-FREQUENCY; MOTOR CORTEX	Phosphenes are commonly evoked by transcranial magnetic stimulation (TMS) to study the functional organization, connectivity, and excitability of the human visual brain. For years, phosphenes have been documented only from stimulating early visual areas (V1-V3) and a handful of specialized visual regions (V4, V5/MT+) in occipital cortex. Recently, phosphenes were reported after applying TMS to a region of posterior parietal cortex involved in the top-down modulation of visuo-spatial processing. In the present study, we systematically characterized parietal phosphenes to determine if they are generated directly by local mechanisms or emerge through indirect activation of other visual areas. Using technology developed in-house to record the subjective features of phosphenes, we found no systematic differences in the size, shape, location, or frame-of-reference of parietal phosphenes when compared to their occipital counterparts. In a second experiment, discrete deactivation by 1 Hz repetitive TMS yielded a double dissociation: phosphene thresholds increased at the deactivated site without producing a corresponding change at the non-deactivated location. Overall, the commonalities of parietal and occipital phosphenes, and our ability to independently modulate their excitability thresholds, lead us to conclude that they share a common neural basis that is separate from either of the stimulated regions.	[Fried, Peter J.; Elkin-Frankston, Seth; Rushmore, Richard Jarrett; Valero-Cabre, Antoni] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Hilgetag, Claus C.] Univ Med Ctr Hamburg Eppendorf, Dept Computat Neurosci, Hamburg, Germany; [Valero-Cabre, Antoni] Univ Paris 06, Inst Cerveau & Moelle, Paris, France	Boston University; University of Hamburg; University Medical Center Hamburg-Eppendorf; UDICE-French Research Universities; Sorbonne Universite	Fried, PJ (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	rushmore@bu.edu; avalerocabre@gmail.com	Hilgetag, Claus C/L-7282-2013; Hilgetag, Claus C/AAH-1760-2020	Hilgetag, Claus C/0000-0003-2129-8910; Hilgetag, Claus C/0000-0003-2129-8910; Valero-Cabre, Antoni/0000-0002-5033-2279	Boston University, via the National Institutes of Health [MH020064-09]; Department of Anatomy and Neurobiology at Boston University School of Medicine; Spivak Foundation; National Institutes of Health [NSS062317]; FP6; ANR; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020064] Funding Source: NIH RePORTER	Boston University, via the National Institutes of Health; Department of Anatomy and Neurobiology at Boston University School of Medicine; Spivak Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP6(European Commission); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The contributions of PJF and SEF were funded through the Graduate Program in Neuroscience at Boston University, via the National Institutes of Health (MH020064-09) and the Department of Anatomy and Neurobiology at Boston University School of Medicine. The work of RJR and AVC was supported by the Spivak Foundation, the National Institutes of Health (NSS062317), and FP6& ANR project eraNET-NEURON BEYONDVIS (AV-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra J, 1998, ANN NEUROL, V44, P209, DOI 10.1002/ana.410440211; Antal A, 2006, CEPHALALGIA, V26, P865, DOI 10.1111/j.1468-2982.2006.01132.x; Aurora SK, 1998, NEUROLOGY, V50, P1111, DOI 10.1212/WNL.50.4.1111; BARKER AT, 1985, LANCET, V1, P1106; Bestmann S, 2007, CURR BIOL, V17, P134, DOI 10.1016/j.cub.2006.11.063; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Boulay C, 2005, EXP BRAIN RES, V167, P297, DOI 10.1007/s00221-005-0103-1; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Brighina F, 2002, EXP BRAIN RES, V145, P177, DOI 10.1007/s00221-002-1096-7; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2005, NEUROPSYCHOLOGIA, V43, P2041, DOI 10.1016/j.neuropsychologia.2005.03.020; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Elkin-Frankston S, 2011, J NEUROSCI METHODS; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Fierro B, 2003, NEUROLOGY, V61, P1446, DOI 10.1212/01.WNL.0000094823.74175.92; Fumal A, 2003, EXP BRAIN RES, V150, P332, DOI 10.1007/s00221-003-1423-7; Gerwig M, 2003, J NEUROL SCI, V215, P75, DOI 10.1016/S0022-510X(03)00228-4; Gothe J, 2002, BRAIN, V125, P479, DOI 10.1093/brain/awf045; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; HARTING JK, 1992, J COMP NEUROL, V324, P379, DOI 10.1002/cne.903240308; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 1999, NEUROPSYCHOLOGIA, V37, P191; Kammer T, 2005, EXP BRAIN RES, V160, P129, DOI 10.1007/s00221-004-1992-0; Khedr EM, 2006, NEUROPHYSIOL CLIN, V36, P13, DOI 10.1016/j.neucli.2006.01.007; KIM D, 2007, NEUROL ASIA, V12, P84; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Mahaney KB, 2008, NEUROSURGERY, V63, P195, DOI 10.1227/01.NEU.0000313121.58694.4A; MARG E, 1991, OPTOMETRY VISION SCI, V68, P427, DOI 10.1097/00006324-199106000-00004; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; Marzi CA, 2009, EXP BRAIN RES, V192, P431, DOI 10.1007/s00221-008-1496-4; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Mullette-Gillman OA, 2008, CEREB CORTEX; Orban GA, 2006, NEUROPSYCHOLOGIA, V44, P2647, DOI 10.1016/j.neuropsychologia.2005.11.001; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Pascual-Leone A., 2002, HDB TRANSCRANIAL MAG; Pertzov Y, 2011, J NEUROSCI, V31, P1059, DOI 10.1523/JNEUROSCI.3721-10.2011; Pitskel NB, 2007, NEUROREPORT, V18, P1703, DOI 10.1097/WNR.0b013e3282f0d2c1; Rossi S, 2009, CLIN NEUROPHYSIOL; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Ruff CC, 2009, J COGNITIVE NEUROSCI, V21, P1146, DOI 10.1162/jocn.2009.21097; SANDERS MD, 1974, LANCET, V1, P707; Silvanto J, 2005, NAT NEUROSCI, V8, P143, DOI 10.1038/nn1379; Silvanto J, 2007, NEUROPSYCHOLOGIA, V45, P3346, DOI 10.1016/j.neuropsychologia.2007.06.008; Silvanto J, 2007, EUR J NEUROSCI, V25, P1874, DOI 10.1111/j.1460-9568.2007.05440.x; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Silvanto J, 2010, NEUROIMAGE, V50, P1683, DOI 10.1016/j.neuroimage.2010.01.021; Silvanto J, 2009, CEREB CORTEX, V19, P327, DOI 10.1093/cercor/bhn091; Stewart L, 1999, EEG CL N SU, P334; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Taylor PCJ, 2010, HUM BRAIN MAPP; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Vallar G, 1999, EXP BRAIN RES, V124, P281, DOI 10.1007/s002210050624; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X	75	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27204	10.1371/journal.pone.0027204	http://dx.doi.org/10.1371/journal.pone.0027204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087266	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700018
J	Wang, RZ; Huang, WW; Chen, L; Ma, LN; Guo, CY; Liu, XQ				Wang, Renzhong; Huang, Wenwen; Chen, Liang; Ma, Linna; Guo, Chengyuan; Liu, Xiaoqiang			Anatomical and Physiological Plasticity in Leymus chinensis (Poaceae) along Large-Scale Longitudinal Gradient in Northeast China	PLOS ONE			English	Article							TRANSECT NECT; LEAF MORPHOLOGY; PROLINE ACCUMULATION; WATER-STRESS; DROUGHT; RESPONSES; CLIMATE; GROWTH; PLANTS; VARIABILITY	Background: Although it has been widely accepted that global changes will pose the most important constrains to plant survival and distribution, our knowledge of the adaptive mechanism for plant with large-scale environmental changes (e.g. drought and high temperature) remains limited. Methodology/Principal findings: An experiment was conducted to examine anatomical and physiological plasticity in Leymus chinensis along a large-scale geographical gradient from 115 degrees to 124 degrees E in northeast China. Ten sites selected for plant sampling at the gradient have approximately theoretical radiation, but differ in precipitation and elevation. The significantly increasing in leaf thickness, leaf mass per area, vessel and vascular diameters, and decreasing in stoma density and stoma index exhibited more obvious xerophil-liked traits for the species from the moist meadow grassland sites in contrast to that from the dry steppe and desert sites. Significant increase in proline and soluble sugar accumulation, K(+)/Na(+) for the species with the increasing of stresses along the gradient showed that osmotic adjustment was enhanced. Conclusion/Significance: Obvious xerophytic anatomical traits and stronger osmotic adjustment in stress conditions suggested that the plants have much more anatomical and physiological flexibilities than those in non-stress habitats along the large-scale gradient.	[Wang, Renzhong; Huang, Wenwen; Chen, Liang; Ma, Linna; Guo, Chengyuan; Liu, Xiaoqiang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Chen, Liang] Hubei Normal Univ, Coll Life Sci, Huangshi, Hubei, Peoples R China; [Liu, Xiaoqiang] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Hubei Normal University; Indiana University System; Indiana University-Purdue University Indianapolis	Wang, RZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	wangrz@ibcas.ac.cn	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022		National Scientific Foundation of China [31170304, 30970306, 31070228]; Chinese Academy of Sciences [KSCX2-EW-J-1]; State Key Laboratory of Vegetation and Environmental Change, Institute of Botany (VEWALAN)	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Vegetation and Environmental Change, Institute of Botany (VEWALAN)	This work was supported by the National Scientific Foundation of China (31170304, 30970306, 31070228) and in part by Key Project of the Chinese Academy of Sciences (KSCX2-EW-J-1) and State Key Laboratory of Vegetation and Environmental Change, Institute of Botany (VEWALAN - project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu RC, 2001, PLANT BREEDING, V120, P233, DOI 10.1046/j.1439-0523.2001.00578.x; Bandurska H, 2000, ACTA PHYSIOL PLANT, V22, P409, DOI 10.1007/s11738-000-0081-7; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; CALKIN HW, 1986, J EXP BOT, V37, P1054, DOI 10.1093/jxb/37.7.1054; CastroDiez P, 1997, TREES-STRUCT FUNCT, V11, P127, DOI 10.1007/s004680050068; Cellier F, 2000, J EXP BOT, V51, P299, DOI 10.1093/jexbot/51.343.299; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen L, 2009, AGR ECOSYST ENVIRON, V134, P46, DOI 10.1016/j.agee.2009.05.015; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; EBELL LF, 1965, PHYTOCHEMISTRY, V21, P227; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P301, DOI 10.1111/j.1365-3040.1992.tb00977.x; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Gullo MA, 1995, PLANT CELL ENVIRON, V18, P661; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Jackson RB, 2000, TRENDS PLANT SCI, V5, P482, DOI 10.1016/S1360-1385(00)01766-0; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; LI J.D., 1978, J NE NORMAL U, V1, P145; LU JM, 1994, J NORTHEST NORMAL U, V21, P79; Maroco JP, 2000, J ARID ENVIRON, V45, P119, DOI 10.1006/jare.2000.0638; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; Paakkonen E, 1998, PLANT CELL ENVIRON, V21, P671, DOI 10.1046/j.1365-3040.1998.00303.x; Pena-Rojas K, 2005, FUNCT PLANT BIOL, V32, P117, DOI 10.1071/FP04137; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; SARADHI PP, 1995, BIOCHEM BIOPH RES CO, V209, P1, DOI 10.1006/bbrc.1995.1461; Siso S, 2001, TREES-STRUCT FUNCT, V15, P341, DOI 10.1007/s004680100110; Sobrado MA, 2007, NEW PHYTOL, V173, P584, DOI 10.1111/j.1469-8137.2006.01927.x; Villalba R, 1998, ECOLOGY, V79, P2624, DOI 10.1890/0012-9658(1998)079[2624:IOLSCV]2.0.CO;2; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; Wang RZ, 2004, DIVERS DISTRIB, V10, P65, DOI 10.1111/j.1472-4642.2004.00056.x; Wang RZ, 2003, J ARID ENVIRON, V54, P653, DOI 10.1006/jare.2002.1087; Wang RZ, 2003, GLOBAL ECOL BIOGEOGR, V12, P249, DOI 10.1046/j.1466-822X.2003.00027.x; Zhang Xin-Shi, 1997, Acta Botanica Sinica, V39, P785	35	32	42	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26209	10.1371/journal.pone.0026209	http://dx.doi.org/10.1371/journal.pone.0026209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087223	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700005
J	Lamb, TM; Goldsmith, CS; Bennett, L; Finch, KE; Bell-Pedersen, D				Lamb, Teresa M.; Goldsmith, Charles S.; Bennett, Lindsay; Finch, Katelyn E.; Bell-Pedersen, Deborah			Direct Transcriptional Control of a p38 MAPK Pathway by the Circadian Clock in Neurospora crassa	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OSMOTIC-STRESS; SACCHAROMYCES-CEREVISIAE; FUNGICIDE RESISTANCE; PHOTIC REGULATION; PHENYLPYRROLE FUNGICIDES; GLYCEROL ACCUMULATION; MOLECULAR-MECHANISM; TEMPORAL REGULATION; GENE-EXPRESSION	MAPK signal transduction pathways are important regulators of stress responses, cellular growth, and differentiation. In Neurospora, the circadian clock controls rhythms in phosphorylation of the p38-like MAPK (OS-2); however, the mechanism for this regulation is not known. We show that the WCC, a transcription factor and clock component, binds to the os-4 MAPKKK promoter in response to light and rhythmically in constant darkness, peaking in the subjective morning. Deletion of the WCC binding sites in the os-4 promoter disrupts both os-4 mRNA and OS-2 phosphorylation rhythms. The clock also indirectly regulates rhythmic expression of the histidyl-phosphotransferase gene, hpt-1, which peaks in the evening. Anti-phase expression of positive (OS-4) and negative (HPT-1) MAPK pathway regulators likely coordinate to enhance rhythmic MAPK activation to prepare cells to respond to osmotic stress during the day in the natural environment. Consistent with this idea, we show that wild type cells have a clock-dependent morning kinetic advantage in glycerol accumulation after salt stress as compared to evening treatment. Thus, circadian transcriptional control of MAPK pathway components leads to striking time-of-day-specific effects on the signaling status and physiological response of the pathway.	[Lamb, Teresa M.; Goldsmith, Charles S.; Bennett, Lindsay; Finch, Katelyn E.; Bell-Pedersen, Deborah] Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, Program Biol Filamentous Fungi,Interdisciplinary, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Lamb, TM (corresponding author), Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, Program Biol Filamentous Fungi,Interdisciplinary, College Stn, TX 77843 USA.	dpedersen@bio.tamu.edu	Bell-Pedersen, Deborah/H-8012-2016	Bell-Pedersen, Deborah/0000-0002-1639-8215	National Institute of Health [GM58529, NS39546]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health grants GM58529 and NS39546 to Dr. Bell-Pedersen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 1997, FEBS LETT, V403, P173, DOI 10.1016/S0014-5793(97)00048-3; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Banno S, 2007, CURR GENET, V51, P197, DOI 10.1007/s00294-006-0116-8; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Coogan AN, 2003, J NEUROSCI, V23, P3085; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Paula RM, 2008, CELL CYCLE, V7, P2630, DOI 10.4161/cc.7.17.6516; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunlap J., 2004, CHRONOBIOLOGY; Dunlap JC, 2007, COLD SPRING HARB SYM, V72, P57, DOI 10.1101/sqb.2007.72.072; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fujimura M, 2000, J PESTIC SCI, V25, P31; Fujimura M, 2003, BIOSCI BIOTECH BIOCH, V67, P186, DOI 10.1271/bbb.67.186; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gery S, 2007, COLD SPRING HARB SYM, V72, P459, DOI 10.1101/sqb.2007.72.004; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hasegawa M, 2004, J BIOL CHEM, V279, P22738, DOI 10.1074/jbc.M401389200; Hayashi Y, 2003, J BIOL CHEM, V278, P25166, DOI 10.1074/jbc.M212726200; Hayashi Y, 2001, FEBS LETT, V491, P71, DOI 10.1016/S0014-5793(01)02153-6; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Irmler S, 2006, PESTIC BIOCHEM PHYS, V84, P25, DOI 10.1016/j.pestbp.2005.05.001; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Korotayev K, 2008, CELL SIGNAL, V20, P1221, DOI 10.1016/j.cellsig.2008.02.012; Kozma-Bognar L, 2008, CHEMBIOCHEM, V9, P2565, DOI 10.1002/cbic.200800385; Krantz M, 2006, CURR GENET, V49, P137, DOI 10.1007/s00294-005-0038-x; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Loros JJ, 2007, COLD SPRING HARB SYM, V72, P201, DOI 10.1101/sqb.2007.72.067; Loros JJ, 1998, CURR OPIN MICROBIOL, V1, P698, DOI 10.1016/S1369-5274(98)80118-5; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; Nakaya M, 2003, BIOCHEM BIOPH RES CO, V305, P494, DOI 10.1016/S0006-291X(03)00791-5; Noguchi R, 2007, FUNGAL GENET BIOL, V44, P208, DOI 10.1016/j.fgb.2006.08.003; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Panda S, 2003, NOVART FDN SYMP, V253, P102; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Pillonel C, 1997, PESTIC SCI, V49, P229, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;229::AID-PS525&gt;3.0.CO;2-T; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Ripperger JA, 2000, GENE DEV, V14, P679; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P2856, DOI 10.1271/bbb.70410; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	73	30	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27149	10.1371/journal.pone.0027149	http://dx.doi.org/10.1371/journal.pone.0027149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087254	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700020
J	Kizil, C; Brand, M				Kizil, Caghan; Brand, Michael			Cerebroventricular Microinjection (CVMI) into Adult Zebrafish Brain Is an Efficient Misexpression Method for Forebrain Ventricular Cells	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; GENE-EXPRESSION; IN-VIVO; TRANSGENIC ZEBRAFISH; FIN REGENERATION; CAUDAL FIN; STEM-CELLS; NEUROGENESIS; PROLIFERATION; MORPHOLINOS	The teleost fish Danio rerio (zebrafish) has a remarkable ability to generate newborn neurons in its brain at adult stages of its lifespan-a process called adult neurogenesis. This ability relies on proliferating ventricular progenitors and is in striking contrast to mammalian brains that have rather restricted capacity for adult neurogenesis. Therefore, investigating the zebrafish brain can help not only to elucidate the molecular mechanisms of widespread adult neurogenesis in a vertebrate species, but also to design therapies in humans with what we learn from this teleost. Yet, understanding the cellular behavior and molecular programs underlying different biological processes in the adult zebrafish brain requires techniques that allow manipulation of gene function. As a complementary method to the currently used misexpression techniques in zebrafish, such as transgenic approaches or electroporation-based delivery of DNA, we devised a cerebroventricular microinjection (CVMI)-assisted knockdown protocol that relies on vivo morpholino oligonucleotides, which do not require electroporation for cellular uptake. This rapid method allows uniform and efficient knockdown of genes in the ventricular cells of the zebrafish brain, which contain the neurogenic progenitors. We also provide data on the use of CVMI for growth factor administration to the brain - in our case FGF8, which modulates the proliferation rate of the ventricular cells. In this paper, we describe the CVMI method and discuss its potential uses in zebrafish.	[Kizil, Caghan] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Dresden, Germany; Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany	German Research Foundation (DFG); Technische Universitat Dresden; Technische Universitat Dresden	Kizil, C (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010; Kizil, Caghan/AFG-2073-2022; Kizil, Caghan/J-6923-2015	Brand, Michael/0000-0001-5711-6512; Kizil, Caghan/0000-0002-8164-9762; Kizil, Caghan/0000-0002-8164-9762	Deutsche Forschungsgemeinschaft [SFB-655]; European Union (ZF Health); Technical University of Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health)(European Commission); Technical University of Dresden	This work is supported by Deutsche Forschungsgemeinschaft SFB-655 (http://www.sfb655.de/START-EN/sonderforschungsbereich-655?set_language=en), The European Union (ZF Health) (http://zf-health.org), and Technical University of Dresden (www.tu-dresden.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Brand Michael, 2002, P7; Burket CT, 2008, TRANSGENIC RES, V17, P265, DOI 10.1007/s11248-007-9152-5; Carl M, 2002, DEVELOPMENT, V129, P4057; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chapouton P, 2010, METHOD CELL BIOL, V100, P73, DOI 10.1016/B978-0-12-384892-5.00004-9; Corey DR, 2001, GENOME BIOL, V2; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Golberg A, 2010, TECHNOL CANCER RES T, V9, P423, DOI 10.1177/153303461000900412; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Hardy S, 2010, BIOL CELL, V102, P561, DOI 10.1042/BC20100038; Haugland R.P., 2002, HDB FLUORESCENT PROB; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2009, DEV BIOL, V325, P329, DOI 10.1016/j.ydbio.2008.09.032; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Li YF, 2008, BIOCONJUGATE CHEM, V19, P1464, DOI 10.1021/bc8001437; Mimoto MS, 2011, METHODS MOL BIOL, V770, P55, DOI 10.1007/978-1-61779-210-6_3; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moulton JD, 2009, MOLECULES, V14, P1304, DOI 10.3390/molecules14031304; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; PAN YA, 2011, CSH PROTOCOLS; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Xiao DY, 2011, CELL BIOL INT, V35, P99, DOI 10.1042/CBI20100464; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	45	45	46	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27395	10.1371/journal.pone.0027395	http://dx.doi.org/10.1371/journal.pone.0027395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076157	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200071
J	Sanchez-Ruiz, Y; Valitutti, S; Dupre, L				Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic			Stepwise Maturation of Lytic Granules during Differentiation and Activation of Human CD8(+) T Lymphocytes	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SECRETORY LYSOSOMES; PROTEIN; PERFORIN; CYTOTOXICITY; PURIFICATION; STIMULATION; BIOGENESIS; EXOCYTOSIS; ORGANELLES	During differentiation, cytotoxic T lymphocytes (CTL) acquire their killing potential through the biogenesis and maturation of lytic granules that are secreted upon target cell recognition. How lytic granule load in lytic molecules evolves during CTL differentiation and which subsets of lytic granules are secreted following activation remains to be investigated. We set up a flow cytometry approach to analyze single lytic granules isolated from primary human CTL according to their size and molecular content. During CTL in vitro differentiation, a relatively homogeneous population of lytic granules appeared through the progressive loading of Granzyme B, Perforin and Granzyme A within LAMP1(+) lysosomes. PMA/ionomycin-induced lytic granule exocytosis was preceded by a rapid association of the docking molecule Rab27a to approximately half of the lytic granules. Activated CTL were found to limit exocytosis by sparing lytic granules including some associated to Rab27a. Our study provides a quantification of key steps of lytic granule biogenesis and highlights the potential of flow cytometry to study organelle composition and dynamics.	[Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic] CNRS, U5282, Toulouse, France; [Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sanchez-Ruiz, Y (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	loic.dupre@inserm.fr	dupre, loic/L-8174-2014; Valitutti, Salvatore/M-2999-2014	dupre, loic/0000-0002-7278-6503; Valitutti, Salvatore/0000-0002-6432-4421	European Community [MEXT-CT-2005-025032]; "Ligue Contre le Cancer'' foundation; Comite regional Midi-Pyrenees	European Community(European Commission); "Ligue Contre le Cancer'' foundation; Comite regional Midi-Pyrenees	This work received financial support from the European Community (Marie Curie Excellence grant, contract MEXT-CT-2005-025032 to LD) and from the "Ligue Contre le Cancer'' foundation (grant from the "Comite regional Midi-Pyrenees'' to LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1990, J IMMUNOL, V144, P574; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; CHATTOPADHYAY P, 2008, J LEUKOCYTE BIOL; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; Liu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012870; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MILLARD PJ, 1984, J IMMUNOL, V132, P3197; OLSEN I, 1990, EUR J IMMUNOL, V20, P2161, DOI 10.1002/eji.1830201003; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PODACK ER, 1984, J EXP MED, V160, P695, DOI 10.1084/jem.160.3.695; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; WOLF ME, 1989, J NEUROSCI, V9, P106; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27057	10.1371/journal.pone.0027057	http://dx.doi.org/10.1371/journal.pone.0027057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073254	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200032
J	Buzzi, LI; Simonetta, SH; Parodi, AJ; Castro, OA				Buzzi, Lucila I.; Simonetta, Sergio H.; Parodi, Armando J.; Castro, Olga A.			The Two Caenorhabditis elegans UDP-Glucose: Glycoprotein Glucosyltransferase Homologues Have Distinct Biological Functions	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA; CALRETICULIN; EXPRESSION; ENZYME; PURIFICATION; HOMOGENEITY; VIABILITY	The UDP-Glc: glycoprotein glucosyltransferase (UGGT) is the sensor of glycoprotein conformations in the glycoprotein folding quality control as it exclusively glucosylates glycoproteins not displaying their native conformations. Monoglucosylated glycoproteins thus formed may interact with the lectin-chaperones calnexin (CNX) and calreticulin (CRT). This interaction prevents premature exit of folding intermediates to the Golgi and enhances folding efficiency. Bioinformatic analysis showed that in C. elegans there are two open reading frames (F48E3.3 and F26H9.8 to be referred as uggt-1 and uggt-2, respectively) coding for UGGT homologues. Expression of both genes in Schizosaccharomyces pombe mutants devoid of UGGT activity showed that uggt-1 codes for an active UGGT protein (CeUGGT-1). On the other hand, uggt-2 coded for a protein (CeUGGT-2) apparently not displaying a canonical UGGT activity. This protein was essential for viability, although cnx/crt null worms were viable. We constructed transgenic worms carrying the uggt-1 promoter linked to the green fluorescent protein (GFP) coding sequence and found that CeUGGT-1 is expressed in cells of the nervous system. uggt-1 is upregulated under ER stress through the ire-1 arm of the unfolded protein response (UPR). Real-time PCR analysis showed that both uggt-1 and uggt-2 genes are expressed during the entire C. elegans life cycle. RNAi-mediated depletion of CeUGGT-1 but not of CeUGGT-2 resulted in a reduced lifespan and that of CeUGGT-1 and CeUGGT-2 in a developmental delay. We found that both CeUGGT1 and CeUGGT2 play a protective role under ER stress conditions, since 10 mu g/ml tunicamycin arrested development at the L2/L3 stage of both uggt-1(RNAi) and uggt-2(RNAi) but not of control worms. Furthermore, we found that the role of CeUGGT-2 but not CeUGGT-1 is significant in relieving low ER stress levels in the absence of the ire-1 unfolding protein response signaling pathway. Our results indicate that both C. elegans UGGT homologues have distinct biological functions.	[Buzzi, Lucila I.; Parodi, Armando J.; Castro, Olga A.] Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina; [Simonetta, Sergio H.] Fdn Inst Leloir, Lab Genet & Mol Physiol, Buenos Aires, DF, Argentina; [Parodi, Armando J.; Castro, Olga A.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Castro, Olga A.] Univ Buenos Aires, Sch Sci, Buenos Aires, DF, Argentina	Leloir Institute; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Buzzi, LI (corresponding author), Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina.	ocastro@leloir.org.ar			National Institutes of Health [GM-44500];  [PICT 2008-700];  [PIP 20080100567]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	Grants: PICT 2008-700 www.agencia.gov.ar and PIP 20080100567 www.conicet.gov.ar (both to Olga Castro). Howard Hughes Medical Institute, and National Institutes of Health grant GM-44500 to Armando Parodi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; Arnold SM, 2003, J BIOL CHEM, V278, P43320, DOI 10.1074/jbc.M305800200; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Conte L, 2003, MOL BIOL CELL, V14, P3529, DOI 10.1091/mbc.E03-04-0228; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Guerin M, 2003, J BIOL CHEM, V278, P20540, DOI 10.1074/jbc.M300891200; Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200; Lee D, 2007, J MOL BIOL, V372, P331, DOI 10.1016/j.jmb.2007.06.071; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Mello C, 1995, METHOD CELL BIOL, V48, P451; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Samuelson AV, 2007, COLD SPRING HARB SYM, V72, P489, DOI 10.1101/sqb.2007.72.068; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Walker GA, 2003, FASEB J, V17, P1960, DOI 10.1096/fj.03-0164fje; WRIGHT A, 1965, BIOCHIM BIOPHYS ACTA, V104, P594, DOI 10.1016/0304-4165(65)90366-1; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122	34	20	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27025	10.1371/journal.pone.0027025	http://dx.doi.org/10.1371/journal.pone.0027025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073243	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900065
J	Hellman, M; Tossavainen, H; Rappu, P; Heino, J; Permi, P				Hellman, Maarit; Tossavainen, Helena; Rappu, Pekka; Heino, Jyrki; Permi, Perttu			Characterization of Intrinsically Disordered Prostate Associated Gene (PAGE5) at Single Residue Resolution by NMR Spectroscopy	PLOS ONE			English	Article							T-CELL RESPONSES; BACKBONE ASSIGNMENT; DNA-BINDING; WEB SERVER; PROTEINS; SEQUENCE; MELANOMA; N-15; PREDICTION; TESTIS	Background: The Cancer-Testis antigens (CTA) are proteins expressed in human germ line and certain cancer cells. CTAs form a large gene family, representing 10% of X-chromosomal genes. They have high potential for cancer-specific immunotherapy. However, their biological functions are currently unknown. Prostate associated genes (PAGE) are characterized as CTAs. PAGE5 is one of six proteins belonging to this protein family, also called CT16. Methodology/Principal findings: In this study we show, using bioinformatics, chromatographic and solution state NMR spectroscopic methods, that PAGE5 is an intrinsically disordered protein (IDP). Conclusion/Significance: The study stands out as the first time structural characterization of the PAGE family protein and introduces how solution state NMR spectroscopy can be effectively utilized for identification of molecular recognition regions (MoRF) in IDPs, known often as transiently populated secondary structures.	[Hellman, Maarit; Tossavainen, Helena; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland; [Rappu, Pekka; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Helsinki; University of Turku	Hellman, M (corresponding author), Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland.	Perttu.Permi@helsinki.fi		Rappu, Pekka/0000-0002-5068-2842	Academy of Finland [122170, 133144, 127168]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland grants 122170 and 133144 to PP and 127168 to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Atkinson RA, 1999, J BIOMOL NMR, V13, P83, DOI 10.1023/A:1008323420405; Brichard VG, 2007, VACCINE, V25, pB61, DOI 10.1016/j.vaccine.2007.06.038; Brinkmann U, 1998, P NATL ACAD SCI USA, V95, P10757, DOI 10.1073/pnas.95.18.10757; Chen ME, 1998, J BIOL CHEM, V273, P17618, DOI 10.1074/jbc.273.28.17618; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Goddard T.D., 2002, SPARKY 3; GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mantylahti S, 2011, J BIOMOL NMR, V49, P99, DOI 10.1007/s10858-011-9470-z; Mantylahti S, 2010, J BIOMOL NMR, V47, P171, DOI 10.1007/s10858-010-9421-0; Mantylahti S, 2009, J BIOMOL NMR, V45, P301, DOI 10.1007/s10858-009-9373-4; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Puttonen E, 2006, MAGN RESON CHEM, V44, P168; Rappu P, 2011, INT J CANCER, V128, P2382, DOI 10.1002/ijc.25571; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Slingluff CL, 2007, CLIN CANCER RES, V13, P6386, DOI 10.1158/1078-0432.CCR-07-0486; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tossavainen H, 2004, J MAGN RESON, V170, P244, DOI 10.1016/j.jmr.2004.06.018; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vansteenkiste JF, 2008, P AM SOC CLIN ON S15, V26, P7501; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wirmer J, 2002, J BIOMOL NMR, V23, P47, DOI 10.1023/A:1015384805098; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zbilut JP, 2004, J PROTEOME RES, V3, P1243, DOI 10.1021/pr049883+; Zendman AJW, 2002, INT J CANCER, V99, P361, DOI 10.1002/ijc.10371; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	52	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26633	10.1371/journal.pone.0026633	http://dx.doi.org/10.1371/journal.pone.0026633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073178	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900029
J	Xiao, JH; Jia, JG; Murphy, RW; Huang, DW				Xiao, Jin-Hua; Jia, Jing-Guo; Murphy, Robert W.; Huang, Da-Wei			Rapid Evolution of the Mitochondrial Genome in Chalcidoid Wasps (Hymenoptera: Chalcidoidea) Driven by Parasitic Lifestyles	PLOS ONE			English	Article							TRANSFER-RNA GENES; MOLECULAR EVOLUTION; REARRANGEMENTS; SEQUENCE; FIG; DNA; PHYLOGENY; PROGRAM; INSECTA; DIPTERA	Among the Chalcidoids, hymenopteran parasitic wasps that have diversified lifestyles, a partial mitochondrial genome has been reported only from Nasonia. This genome had many unusual features, especially a dramatic reorganization and a high rate of evolution. Comparisons based on more mitochondrial genomic data from the same superfamily were required to reveal weather these unusual features are peculiar to Nasonia or not. In the present study, we sequenced the nearly complete mitochondrial genomes from the species Philotrypesis. pilosa and Philotrypesis sp., both of which were associated with Ficus hispida. The acquired data included all of the protein-coding genes, rRNAs, and most of the tRNAs, and in P. pilosa the control region. High levels of nucleotide divergence separated the two species. A comparison of all available hymenopteran mitochondrial genomes (including a submitted partial genome from Ceratosolen solmsi) revealed that the Chalcidoids had dramatic mitochondrial gene rearrangments, involved not only the tRNAs, but also several protein-coding genes. The AT-rich control region was translocated and inverted in Philotrypesis. The mitochondrial genomes also exhibited rapid rates of evolution involving elevated nonsynonymous mutations.	[Xiao, Jin-Hua; Jia, Jing-Guo; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Jia, Jing-Guo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Huang, Da-Wei] Hebei Univ, Coll Life Sci, Baoding, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hebei University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum	Xiao, JH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw619@gmail.com		Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [31090253, 30900137]; Chinese Academy of Sciences [KSCX2-EW-Z-2, KSCX2-YW-Z-0908]; Ministry of Science and Technology of the Republic of China [2006FY110500]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Sciences and Engineering Research Council [A3148]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); National Science Fund for Fostering Talents in Basic Research; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by National Natural Science Foundation of China (NSFC grant no. 31090253, 30900137), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2, KSCX2-YW-Z-0908), by Program of Ministry of Science and Technology of the Republic of China (2006FY110500), by National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy, NSFC-J0930004), and by a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences. Manuscript preparation was supported by a Visiting Professorship for Senior International Scientists from the Chinese Academy of Sciences and by the National Sciences and Engineering Research Council (Discovery Grant A3148) to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; CROZIER RH, 1993, GENETICS, V133, P97; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jiang ZF, 2006, J EVOLUTION BIOL, V19, P1157, DOI 10.1111/j.1420-9101.2006.01087.x; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Xu W, 2006, J MOL EVOL, V63, P375, DOI 10.1007/s00239-005-0246-5; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	30	41	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26645	10.1371/journal.pone.0026645	http://dx.doi.org/10.1371/journal.pone.0026645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073180	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900030
J	Ahmad, S; Nichols, DP; Strand, M; Rancourt, RC; Randell, SH; White, CW; Ahmad, A				Ahmad, Shama; Nichols, David P.; Strand, Matthew; Rancourt, Raymond C.; Randell, Scott H.; White, Carl W.; Ahmad, Aftab			SERCA2 Regulates Non-CF and CF Airway Epithelial Cell Response to Ozone	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; INTRACELLULAR CALCIUM; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; RETICULUM CA2+; KAPPA-B; ACTIVATION; EXPRESSION; INFECTION	Calcium mobilization can regulate a wide range of essential functions of respiratory epithelium, including ion transport, ciliary beat frequency, and secretion of mucus, all of which are modified in cystic fibrosis (CF). SERCA2, an important controller of calcium signaling, is deficient in CF epithelium. We conducted this study to determine whether SERCA2 deficiency can modulate airway epithelial responses to environmental oxidants such as ozone. This could contribute to the pathogenesis of pulmonary exacerbations, which are important and frequent clinical events in CF. To address this, we used air-liquid interface (ALI) cultures of non-CF and CF cell lines, as well as differentiated cultures of cells derived from non-CF and CF patients. We found that ozone exposure caused enhanced membrane damage, mitochondrial dysfunction and apoptotic cell death in CF airway epithelial cell lines relative to non-CF. Ozone exposure caused increased proinflammatory cytokine production in CF airway epithelial cell lines. Elevated proinflammatory cytokine production also was observed in shRNA-mediated SERCA2 knockdown cells. Overexpression of SERCA2 reversed ozone-induced proinflammatory cytokine production. Ozone-induced proinflammatory cytokine production was NF-kappa B-dependent. In a stable NF-kappa B reporter cell line, SERCA2 inhibition and knockdown both upregulated cytomix-induced NF-kappa B activity, indicating importance of SERCA2 in modulating NF-kappa B activity. In this system, increased NF-kappa B activity was also accompanied by increased IL-8 production. Ozone also induced NF-kappa B activity and IL-8 release, an effect that was greater in SERCA2-silenced NF-kappa B-reporter cells. SERCA2 overexpression reversed cytomix-induced increased IL-8 release and total nuclear p65 in CFTR-deficient (16HBE-AS) cells. These studies suggest that SERCA2 is an important regulator of the proinflammatory response of airway epithelial cells and could be a potential therapeutic target.	[Ahmad, Shama; Nichols, David P.; Rancourt, Raymond C.; White, Carl W.; Ahmad, Aftab] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Strand, Matthew] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Randell, Scott H.] Univ N Carolina, Dept Med, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA	National Jewish Health; National Jewish Health; University of North Carolina; University of North Carolina Chapel Hill	Ahmad, S (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO USA.	ahmads@njhealth.org	ahmad, shama/GNH-1803-2022; Strand, Matt/AAU-3762-2021; Ahmad, Aftab/ABC-2734-2020	ahmad, shama/0000-0003-1049-5054; Strand, Matt/0000-0002-9083-5989; Ahmad, Aftab/0000-0003-0686-0987; Nichols, David/0000-0001-8611-7960	National Institute of Environmental Health Sciences (NIEHS), NIH [R01-ES014448]; Max and Yetta Karasik Family Foundation [R01-HL080322]; CF Foundation [RDP CORE C: R026-R02]; National Center for Research Resources (NCRR) [K12 KL2RR025779]; American Heart Association [0830418N]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025779] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014448] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Max and Yetta Karasik Family Foundation; CF Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01-ES014448 from the National Institute of Environmental Health Sciences (NIEHS), NIH, and by the Max and Yetta Karasik Family Foundation (CWW), R01-HL080322 and CF Foundation Resources Development Program Grant RDP CORE C: R026-R02 (SR). SA is supported by K12 KL2RR025779 from the National Center for Research Resources (NCRR). AA is supported by the Scientist Development Grant award (0830418N) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2006, FREE RADICAL BIO MED, V40, P1108, DOI 10.1016/j.freeradbiomed.2005.10.045; Ahmad S, 2005, FREE RADICAL BIO MED, V39, P213, DOI 10.1016/j.freeradbiomed.2005.03.009; Ahmad S, 2004, J BIOL CHEM, V279, P16317, DOI 10.1074/jbc.M313890200; Ahmad S, 2001, AM J PHYSIOL-LUNG C, V280, pL779, DOI 10.1152/ajplung.2001.280.4.L779; Ahmad S, 2009, AM J RESP CRIT CARE, V179, P816, DOI 10.1164/rccm.200807-1104OC; Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Bosson J, 2003, CLIN EXP ALLERGY, V33, P777, DOI 10.1046/j.1365-2222.2003.01662.x; Cebo C, 2001, J BIOL CHEM, V276, P5685, DOI 10.1074/jbc.M008662200; Cho HY, 2000, AM J RESP CRIT CARE, V162, P629, DOI 10.1164/ajrccm.162.2.9811078; Ciarlet M, 2001, J VIROL, V75, P11834, DOI 10.1128/JVI.75.23.11834-11850.2001; Damera G, 2009, AM J PHYSIOL-LUNG C, V296, pL674, DOI 10.1152/ajplung.90585.2008; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gilliland FD, 2009, PEDIATRICS, V123, pS168, DOI 10.1542/peds.2008-2233G; Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC; HARKEMA JR, 1993, AM J PATHOL, V143, P857; HARKEMA JR, 1993, TOXICOL LETT, V68, P251, DOI 10.1016/0378-4274(93)90136-L; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Larsen ST, 2010, J TOXICOL ENV HEAL A, V73, P738, DOI 10.1080/15287391003614034; Lattanzio FA, 2005, CARDIOVASC TOXICOL, V5, P377, DOI 10.1385/CT:5:4:377; LIN H, 1989, AM J RESP CELL MOL, V1, P41, DOI 10.1165/ajrcmb/1.1.41; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; Meehan S, 1997, AM J PHYSIOL-CELL PH, V273, pC2030, DOI 10.1152/ajpcell.1997.273.6.C2030; Nichols DP, 2009, AM J PHYSIOL-LUNG C, V297, pL828, DOI 10.1152/ajplung.00171.2009; Oslund KL, 2008, AM J RESP CELL MOL, V39, P279, DOI 10.1165/rcmb.2008-0009OC; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Qu F, 2009, CHEM-BIOL INTERACT, V179, P219, DOI 10.1016/j.cbi.2008.10.059; Rabinovitch N, 2006, AM J RESP CRIT CARE, V173, P1098, DOI 10.1164/rccm.200509-1393OC; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Reid DW, 2007, RESPIROLOGY, V12, P63, DOI 10.1111/j.1440-1843.2006.00962.x; Ribeiro Carla Maria Pedrosa, 2006, Drugs R D, V7, P17, DOI 10.2165/00126839-200607010-00002; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Rusznak C, 1996, EUR RESPIR J, V9, P2298, DOI 10.1183/09031936.96.09112298; Sathishkumar K, 2009, FREE RADICAL BIO MED, V47, P548, DOI 10.1016/j.freeradbiomed.2009.05.020; Spannhake EW, 2002, ENVIRON HEALTH PERSP, V110, P665, DOI 10.1289/ehp.02110665; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Thompson DC, 1998, AM J PHYSIOL-LUNG C, V274, pL922, DOI 10.1152/ajplung.1998.274.6.L922; Uhlson C, 2002, CHEM RES TOXICOL, V15, P896, DOI 10.1021/tx010183i; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Wagner JG, 2003, TOXICOL SCI, V74, P437, DOI 10.1093/toxsci/kfg120; Warburg O, 1942, BIOCHEM Z, V310, P384; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005	53	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27451	10.1371/journal.pone.0027451	http://dx.doi.org/10.1371/journal.pone.0027451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096575	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900046
J	Blas, MM; Alva, IE; Cabello, R; Carcamo, C; Kurth, AE				Blas, Magaly M.; Alva, Isaac E.; Cabello, Robinson; Carcamo, Cesar; Kurth, Ann E.			Risk Behaviors and Reasons for not Getting Tested for HIV among Men Who Have Sex with Men: An Online Survey in Peru	PLOS ONE			English	Article							INTERNET USE; ASSOCIATION	Background: Men who have sex with men (MSM) account for the greatest burden of the HIV epidemic in Peru. Given that MSM are frequent users of the Internet, understanding the risk behaviors and the reasons for not getting tested among MSM who surf the Internet may improve the tailoring of future online behavioral interventions. Methods: From October 2007 to April 2008, we conducted an online survey among users of seven Peruvian gay websites. Results: We received 1,481 surveys, 1,301 of which were included in the analysis. The median age of the participants was 22.5 years (range 12 - 71), 67% were homosexual, and the remainder was bisexual. Of survey respondents, 49.4% had never been tested for HIV and only 11.3% were contacted in-person during the last year by peer health educators from the Peruvian Ministry of Health and NGOs. Additionally, 50.8% had unprotected anal or vaginal sex at last intercourse, and a significant percentage reported a condom broken (22.1%), slipped (16.4%) or sexual intercourse initiated without wearing a condom (39.1%). The most common reasons for not getting tested for HIV among high-risk MSM were "I fear the consequences of a positive test result" (n = 55, 34.4%), and "I don't know where I can get tested" (n = 50, 31.3%). Conclusions: A small percentage of Peruvian MSM who answered our online survey, were reached by traditional peer-based education programs. Given that among high-risk MSM, fear of a positive test result and lack of awareness of places where to get tested are the most important reasons for not taking an HIV test, Internet interventions aimed at motivating HIV testing should work to reduce fear of testing and increase awareness of places that offer free HIV testing services to MSM.	[Blas, Magaly M.; Alva, Isaac E.; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol HIV & STD Unit, Lima, Peru; [Kurth, Ann E.] Univ Washington, Sch Nursing, Dept Global Hlth, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol HIV & STD Unit, Lima, Peru.	magalyblas@gmail.com	Oliveira, Claudia DL/G-8618-2011; Kurth, Ann E/A-1615-2013		University of Washington; Fogarty International Center/National Institutes of Health (FIC/NIH) [5D43TW007551]; QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH [D43TW008438-0109]; FIC/NIH [R01TW008398]; FOGARTY INTERNATIONAL CENTER [D43TW008438, D43TW007551, R01TW008398] Funding Source: NIH RePORTER	University of Washington(University of Washington); Fogarty International Center/National Institutes of Health (FIC/NIH); QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH; FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by The University of Washington AMAUTA Global Informatics Research and Training Program, a Fogarty International Center/National Institutes of Health (FIC/NIH) funded grant (5D43TW007551); QUIPU: The Andean Global Health Informatics Research and Training Center, a FIC/NIH funded grant (D43TW008438-0109); and, by a grant from the FIC/NIH (R01TW008398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EP FACT SHEET HIV AI; Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Curioso WH, 2007, PLOS MED, V4, P248, DOI [10.1371/journal.pmed.0040011, 10.1371/jourmal.pmed.0040011]; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Green EC, 2006, J HEALTH COMMUN, V11, P245, DOI 10.1080/10810730600613807; Kalichman SC, 2002, AIDS EDUC PREV, V14, P51, DOI 10.1521/aeap.14.1.51.24335; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Mikolajczak J, 2006, AIDS BEHAV, V10, P431, DOI 10.1007/s10461-006-9068-8; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Peruvian Ministry of Health, 2006, AN SIT EP VIH SIDA P; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Slavin S, 2007, AIDS CARE, V19, P130, DOI 10.1080/09540120600866473; UNAIDS, 2007, UNAIDS POL BRIEF HIV; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Zhang D, 2007, SEX TRANSM INFECT, V83, P571, DOI 10.1136/sti.2007.026138	17	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27334	10.1371/journal.pone.0027334	http://dx.doi.org/10.1371/journal.pone.0027334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852II	22096551	gold, Green Submitted, Green Published			2022-12-27	WOS:000297350800043
J	Houck, SA; Landsbury, A; Clark, JI; Quinlan, RA				Houck, Scott A.; Landsbury, Andrew; Clark, John I.; Quinlan, Roy A.			Multiple Sites in alpha B-Crystallin Modulate Its Interactions with Desmin Filaments Assembled In Vitro	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; AGGREGATE FORMATION; A-CRYSTALLIN; DOMAIN; MYOPATHY; MUTATION; SEQUENCES; INSIGHTS; CELLS	The beta 3- and beta 8-strands and C-terminal residues 155-165 of alpha B-crystallin were identified by pin arrays as interaction sites for various client proteins including the intermediate filament protein desmin. Here we present data using 5 well-characterised alpha B-crystallin protein constructs with substituted beta 3- and beta 8-strands and with the C-terminal residues 155-165 deleted to demonstrate the importance of these sequences to the interaction of alpha B-crystallin with desmin filaments. We used electron microscopy of negatively stained samples to visualize increased interactions followed by sedimentation assays to quantify our observations. A low-speed sedimentation assay measured the ability of alpha B-crystallin to prevent the self-association of desmin filaments. A high-speed sedimentation assay measured alpha B-crystallin cosedimentation with desmin filaments. Swapping the beta 8-strand of alpha B-crystallin or deleting residues 155-165 increased the cosedimentation of alpha B-crystallin with desmin filaments, but this coincided with increased filament-filament interactions. In contrast, substitution of the beta 3-strand with the equivalent alpha A-crystallin sequences improved the ability of alpha B-crystallin to prevent desmin filament-filament interactions with no significant change in its cosedimentation properties. These data suggest that all three sequences (beta 3-strand, beta 8-strand and C-terminal residues 155-165) contribute to the interaction of alpha B-crystallin with desmin filaments. The data also suggest that the cosedimentation of alpha B-crystallin with desmin filaments does not necessarily correlate with preventing desmin filament-filament interactions. This important observation is relevant not only to the formation of the protein aggregates that contain both desmin and alpha B-crystallin and typify desmin related myopathies, but also to the interaction of alpha B-crystallin with other filamentous protein polymers.	[Houck, Scott A.; Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Landsbury, Andrew; Quinlan, Roy A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Quinlan, Roy A.] Univ Durham, Biophys Sci Inst, Durham, England	University of Washington; University of Washington Seattle; Durham University; University of Washington; University of Washington Seattle; Durham University	Houck, SA (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	clarkji@u.washington.edu; r.a.quinlan@dur.ac.uk	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123	National Eye Institute [EY04542]; BBSRC [BB/E527898]; Leverhulme Trust [RF0546]; NATIONAL EYE INSTITUTE [R01EY004542, P30EY001730] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grant EY04542 from the National Eye Institute (http://www.nei.nih.gov/), BBSRC (BB/E527898 http://www.bbsrc.ac.uk/) and Leverhulme Trust (RF0546: http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2007, INT J BIOCH CELL BIO; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Ghosh JG, 2008, INT J BIOCHEM CELL B, V40, P954, DOI 10.1016/j.biocel.2007.10.035; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P9878, DOI 10.1021/bi060970k; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hayes VH, 2008, J BIOL CHEM, V283, P10500, DOI 10.1074/jbc.M706453200; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Koyama Y, 1999, AM J PATHOL, V154, P1563, DOI 10.1016/S0002-9440(10)65409-0; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Latham JC, 2009, ANAL CHEM, V81, P1865, DOI 10.1021/ac802327h; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Perng MD, 1999, J CELL SCI, V112, P2099; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Quinlan R, 1999, NAT MED, V5, P25, DOI 10.1038/4704; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Sokal R.R., 2012, BIOMETRY; Sreelakshmi Y, 2001, J PROTEIN CHEM, V20, P123, DOI 10.1023/A:1011077307262; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e25859	10.1371/journal.pone.0025859	http://dx.doi.org/10.1371/journal.pone.0025859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096479	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000297350800003
J	Krauss, J; Farzaneh-Far, R; Puterman, E; Na, B; Lin, J; Epel, E; Blackburn, E; Whooley, MA				Krauss, Jeffrey; Farzaneh-Far, Ramin; Puterman, Eli; Na, Beeya; Lin, Jue; Epel, Elissa; Blackburn, Elizabeth; Whooley, Mary A.			Physical Fitness and Telomere Length in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study	PLOS ONE			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; ARTERY-DISEASE; REPLICATIVE SENESCENCE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; QUANTITATIVE PCR; DNA-DAMAGE; EXERCISE	Background: Short telomere length (TL) is an independent predictor of mortality in patients with coronary heart disease (CHD). However, the relationship between physical fitness and TL has not been explored in these patients. Methods: In a cross sectional study of 944 outpatients with stable CHD, we performed exercise treadmill testing, assessed self-reported physical activity, and measured leukocyte TL using a quantitative PCR assay. We used generalized linear models to calculate mean TL (T/S ratio), and logistic regression models to compare the proportion of patients with short TL (defined as the lowest quartile), among participants with low, medium and high physical fitness, based on metabolic equivalent tasks achieved (METs). Results: 229 participants had low physical fitness (<5 METS), 334 had moderate physical fitness (5-7 METS), and 381 had high physical fitness (>7 METS). Mean +/- T/S ratio ranged from 0.86=0.21 (5349 +/- 3781 base pairs) in those with low physical fitness to 0.95 +/- 0.23 (5566 +/- 3829 base pairs) in those with high physical fitness (p<001). This association remained strong after adjustment for numerous patient characteristics, including measures of cardiac disease severity and physical inactivity (p = 0.005). Compared with participants with high physical fitness, those with low physical fitness had 2-fold greater odds of having TL in the lowest quartile (OR 2.39, 95% CI 1.60-3.55; p<.001). This association was similar after multivariable adjustment (OR 1.94, 95%CI, 1.18-3.20; p = 0.009). Self-reported physical inactivity was associated with shorter TL in unadjusted analyses, but not after multivariable adjustment. Conclusions: We found that worse objectively-assessed physical fitness is associated with shorter leukocyte telomere length in patients with CHD. The clinical implications of this association deserve further study.	[Krauss, Jeffrey] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Farzaneh-Far, Ramin] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Puterman, Eli; Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Na, Beeya; Whooley, Mary A.] Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; [Lin, Jue; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krauss, J (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	Mary.Whooley@ucsf.edu	Puterman, Eli/AAA-5237-2022	Puterman, Eli/0000-0002-5898-2348; Krauss, Jeffrey/0000-0001-6794-3052	American Federation for Aging Research; Department of Veterans Affairs; National Heart, Lung and Blood Institute; Robert Wood Johnson Foundation; Ischemia Research and Education Foundation	American Federation for Aging Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation	Jeffrey Krauss was funded by a Medical Student in Aging Research grant from the American Federation for Aging Research. The Heart and Soul Study was funded by the Department of Veterans Affairs, the National Heart, Lung and Blood Institute, the Robert Wood Johnson Foundation, the American Federation for Aging Research, and the Ischemia Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atturu G, 2010, EUR J VASC ENDOVASC; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Diaz VA, 2010, AM J CARDIOL, V106, P659, DOI 10.1016/j.amjcard.2010.04.018; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Lin J, 2009, HDB NEUROSCIENCE BEH, P1280; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa; Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V348, P669, DOI 10.1016/j.bbrc.2006.07.103; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Radak Z, 2005, BIOGERONTOLOGY, V6, P71, DOI 10.1007/s10522-004-7386-7; Rennie KL, 1998, PUBLIC HEALTH NUTR, V1, P265, DOI 10.1079/PHN19980043; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Shin YA, 2008, MECH AGEING DEV, V129, P254, DOI 10.1016/j.mad.2008.01.001; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Woo J, 2008, ARCH INTERN MED, V168, P2163, DOI 10.1001/archinte.168.19.2163; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004	55	49	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26983	10.1371/journal.pone.0026983	http://dx.doi.org/10.1371/journal.pone.0026983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096513	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800021
J	Nagao, T; Oshikawa, G; Wu, N; Kurosu, T; Miura, O				Nagao, Toshikage; Oshikawa, Gaku; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu			DNA Damage Stress and Inhibition of Jak2-V617F Cause Its Degradation and Synergistically Induce Apoptosis through Activation of GSK3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ERYTHROPOIETIN RECEPTOR; JAK2 V617F; KINASE; PHOSPHORYLATION; PATHWAY; CELLS; CBL; CASPASE-2; NEOPLASMS	The cytoplasmic tyrosine kinase Jak2 plays a crucial role in cytokine receptor signaling in hematopoietic cells. The activated Jak2-V617F mutant is present in most cases of BCR/ABL-negative myeloproliferative neoplasms and constitutively activates downstream signals from homodimeric cytokine receptors, such as the erythropoietin receptor (EpoR). Here we examine the effects of DNA damage stress on Jak2 or Jak2-V617F and on induction of apoptosis in hematopoietic cells. Etoposide or doxorubicin dose-dependently decreased the expression level of Jak2 in UT7 or 32D cells expressing EpoR in the absence of Epo and that of exogenously expressed Jak2-V617F in UT7 cells when cotreated with the Jak2 inhibitor JakI-1 or AG490. Studies with pharmacological inhibitors and genetic manipulations further showed that downregulation of the PI3K/Akt pathway leading to the activation of GSK3 beta may be involved in downregulation of Jak2 or Jak2-V617F as well as in synergistic induction of Bax activation and apoptosis. The downregulation of Jak2 was inhibited by the proteasome inhibitor MG132 or by expression of both of loss-of-function mutants of c-Cbl and Cbl-b, E3 ubiquitin ligases which facilitated ubiquitination of Jak2-V617F when co-expressed in 293T cells. The pan-caspase inhibitor Boc-d-fmk also inhibited the Jak2 downregulation as well as appearance of a 100-kDa fragment that contained the N-terminal portion of Jak2 in response to DNA damage. Together, these data suggest that DNA damage stress with simultaneous inhibition of the kinase activity causes degradation of Jak2 or Jak2-V617F by caspase cleavage and proteasomal degradation through GSK3b activation, which is closely involved in synergistic induction of apoptosis in hematopoietic cells.	[Nagao, Toshikage; Oshikawa, Gaku; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Nagao, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591194, 22591030]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 21591194 and 22591030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chen CL, 2006, MOL PHARMACOL, V70, P510, DOI 10.1124/mol.106.024059; Chin H, 1998, BLOOD, V91, P3734; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Haan S, 2009, ONCOGENE, V28, P3069, DOI 10.1038/onc.2009.155; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jin ZH, 2005, ONCOGENE, V24, P1973, DOI 10.1038/sj.onc.1208408; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; KOMATSU N, 1991, CANCER RES, V51, P341; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Kurosu T, 2007, ONCOGENE, V26, P2975, DOI 10.1038/sj.onc.1210117; Kurosu T, 2010, APOPTOSIS, V15, P608, DOI 10.1007/s10495-010-0457-0; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Makin G, 2003, TRENDS MOL MED, V9, P251, DOI 10.1016/S1471-4914(03)00084-4; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Oshikawa G, 2011, J BIOL CHEM, V286, P30263, DOI 10.1074/jbc.M111.232348; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Verstovsek S, 2008, CLIN CANCER RES, V14, P788, DOI 10.1158/1078-0432.CCR-07-0524; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P1581, DOI 10.1016/S0960-894X(03)00135-5; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yun SI, 2009, APOPTOSIS, V14, P771, DOI 10.1007/s10495-009-0348-4	42	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27397	10.1371/journal.pone.0027397	http://dx.doi.org/10.1371/journal.pone.0027397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087308	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700041
J	Kim, HH; van den Heuvel, APJ; Schmidt, JW; Ross, SR				Kim, Hyoung H.; van den Heuvel, A. Pieter J.; Schmidt, John W.; Ross, Susan R.			Novel Common Integration Sites Targeted by Mouse Mammary Tumor Virus Insertion in Mammary Tumors Have Oncogenic Activity	PLOS ONE			English	Article							EPITHELIAL-CELLS; TCF7L2 VARIANT; MMTV; TUMORIGENESIS; RECEPTOR; GENES; IDENTIFICATION; PROLIFERATION; MORPHOGENESIS; TRANSCRIPTION	Non-acute transforming retroviruses like mouse mammary tumor virus (MMTV) cause cancer, at least in part, through integration near cellular genes involved in growth control, thereby de-regulating their expression. It is well-established that MMTV commonly integrates near and activates expression of members of the Wnt and Fgf pathways in mammary tumors. However, there are a significant number of tumors for which the proviral integration sites have not been identified. Here, we used high through-put screening to identify common integration sites (CISs) in MMTV-induced tumors from C3H/HeN and BALB/c mice. As expected, members of both the Wnt and Fgf families were identified in this screen. In addition, a number of novel CISs were found, including Tcf7l2, Antxr1/Tem8, and Arhgap18. We show here that expression of these three putative oncogenes in normal murine mammary gland cells altered their growth kinetics and caused their morphological transformation when grown in three dimensional cultures. Additionally, expression of Tcf7l2 and Antxr1/Tem8 sensitized cells to exogenous WNT ligand. As Tcf7l2, Antxr1/Tem8, and Arhgap18 have been associated with human breast and other cancers, these data demonstrate that MMTV-induced insertional mutation remains an important means for identifying genes involved in breast cancer.	[Kim, Hyoung H.; van den Heuvel, A. Pieter J.; Schmidt, John W.; Ross, Susan R.] Univ Penn, Dept Microbiol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Kim, HH (corresponding author), Univ Penn, Dept Microbiol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.	rosss@mail.med.upenn.edu	Schmidt, John/H-5937-2019; van den Heuvel, Antonius PJ/J-8145-2012	Schmidt, John/0000-0003-0494-2436; Ross, Susan R/0000-0002-3094-3769	Public Health Services (PHS) [R01 CA114273, T32 AI7324]; NATIONAL CANCER INSTITUTE [R01CA114273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324] Funding Source: NIH RePORTER	Public Health Services (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Public Health Services (PHS) grant R01 CA114273 to SR. JS was supported by PHS Training Grant T32 AI7324 to the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Buggiano V, 2002, BREAST CANCER RES TR, V75, P191, DOI 10.1023/A:1019932516887; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P269, DOI 10.1007/s10911-008-9094-4; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Gattelli A, 2006, J VIROL, V80, P11409, DOI 10.1128/JVI.00234-06; Goode EL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-312; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katz E, 2005, J EXP MED, V201, P431, DOI 10.1084/jem.20041471; Maeda M, 2011, MOL BIOL CELL; MERLO GR, 1994, ONCOGENE, V9, P443; Merlo GR, 1996, EUR J CELL BIOL, V70, P97; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Naidu R, 2011, MED ONCOL; Nusse R, 1997, CELL, V89, P321, DOI 10.1016/S0092-8674(00)80210-X; Robertson ES, 2011, CANC ASS VI IN PRESS; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; St Croix B, 2000, SCIENCE, V289, P1197; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Tsedensodnom O, 2011, EXP CELL RES, V317, P920, DOI 10.1016/j.yexcr.2011.01.015; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Verma K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022334; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	42	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27425	10.1371/journal.pone.0027425	http://dx.doi.org/10.1371/journal.pone.0027425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087314	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700053
J	Allendorph, GP; Read, JD; Kawakami, Y; Kelber, JA; Isaacs, MJ; Choe, S				Allendorph, George P.; Read, Jessica D.; Kawakami, Yasuhiko; Kelber, Jonathan A.; Isaacs, Michael J.; Choe, Senyon			Designer TGF beta Superfamily Ligands with Diversified Functionality	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACTIVIN-A; BINDING-SPECIFICITY; CRYSTAL-STRUCTURE; GROWTH-FACTORS; RECEPTORS; DIFFERENTIATION; COMPLEX; PURIFICATION; KINASE	Transforming Growth Factor - beta (TGF beta) superfamily ligands, including Activins, Growth and Differentiation Factors (GDFs), and Bone Morphogenetic Proteins (BMPs), are excellent targets for protein-based therapeutics because of their pervasiveness in numerous developmental and cellular processes. We developed a strategy termed RASCH (Random Assembly of Segmental Chimera and Heteromer), to engineer chemically-refoldable TGF beta superfamily ligands with unique signaling properties. One of these engineered ligands, AB208, created from Activin-beta A and BMP-2 sequences, exhibits the refolding characteristics of BMP-2 while possessing Activin-like signaling attributes. Further, we find several additional ligands, AB204, AB211, and AB215, which initiate the intracellular Smad1-mediated signaling pathways more strongly than BMP-2 but show no sensitivity to the natural BMP antagonist Noggin unlike natural BMP-2. In another design, incorporation of a short N-terminal segment from BMP-2 was sufficient to enable chemical refolding of BMP-9, without which was never produced nor refolded. Our studies show that the RASCH strategy enables us to expand the functional repertoire of TGF beta superfamily ligands through development of novel chimeric TGF beta ligands with diverse biological and clinical values.	[Allendorph, George P.; Isaacs, Michael J.; Choe, Senyon] Gachon Univ Med & Sci, Joint Ctr Biosci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Allendorph, George P.; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Read, Jessica D.; Kelber, Jonathan A.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	Gachon University; Salk Institute; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Allendorph, GP (corresponding author), Gachon Univ Med & Sci, Joint Ctr Biosci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	choe@salk.edu		Kelber, Jonathan/0000-0002-4606-1445; Kawakami, Yasuhiko/0000-0002-0043-9705	United States of America Defense Advanced Research Projects Agency; California Institute for Regenerative Medicine; IFEZ; WCU, Korea	United States of America Defense Advanced Research Projects Agency; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); IFEZ; WCU, Korea	This work was supported by grants from the United States of America Defense Advanced Research Projects Agency (to SC), California Institute for Regenerative Medicine (to SC), IFEZ and WCU, Korea (to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Blunk T, 2003, GROWTH FACTORS, V21, P71, DOI 10.1080/0897719031000148822; Bradley L, 2008, CELL MOL LIFE SCI, V65, P2119, DOI 10.1007/s00018-008-8077-3; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Cui YZ, 2001, GENE DEV, V15, P2797; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; DERYNCK R, 2008, COLD SPRING HARBOR M, V50, P1114; Ejima D, 2006, PROTEIN EXPRES PURIF, V47, P45, DOI 10.1016/j.pep.2005.08.013; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; ISRAEL DI, 1996, GROWTH FACTORS, V13, P10; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kweon DH, 2004, BIOTECHNOL PROGR, V20, P277, DOI 10.1021/bp0341895; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Long SN, 2006, PROTEIN EXPRES PURIF, V46, P374, DOI 10.1016/j.pep.2005.09.025; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Mellor SL, 2000, J CLIN ENDOCR METAB, V85, P4851, DOI 10.1210/jc.85.12.4851; Miyazono K, 2000, J CELL SCI, V113, P1101; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Pangas SA, 2002, J ENDOCRINOL, V172, P199, DOI 10.1677/joe.0.1720199; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SONG K, 2010, J BIOL CHEM; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	53	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26402	10.1371/journal.pone.0026402	http://dx.doi.org/10.1371/journal.pone.0026402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073163	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200009
J	Ambruosi, B; Uranio, MF; Sardanelli, AM; Pocar, P; Martino, NA; Paternoster, MS; Amati, F; Dell'Aquila, ME				Ambruosi, Barbara; Uranio, Manuel Filioli; Sardanelli, Anna Maria; Pocar, Paola; Martino, Nicola Antonio; Paternoster, Maria Stefania; Amati, Francesca; Dell'Aquila, Maria Elena			In Vitro Acute Exposure to DEHP Affects Oocyte Meiotic Maturation, Energy and Oxidative Stress Parameters in a Large Animal Model	PLOS ONE			English	Article							NONESTERIFIED-FATTY-ACIDS; BOVINE GRANULOSA-CELLS; MONO-(2-ETHYLHEXYL) PHTHALATE; DEVELOPMENTAL COMPETENCE; DI(2-ETHYLHEXYL) PHTHALATE; MITOCHONDRIAL DISTRIBUTION; CHROMATIN CONFIGURATION; SUPEROXIDE-DISMUTASE; EMBRYO DEVELOPMENT; PORCINE OOCYTES	Phthalates are ubiquitous environmental contaminants because of their use in plastics and other common consumer products. Di-(2-ethylhexyl) phthalate (DEHP) is the most abundant phthalate and it impairs fertility by acting as an endocrine disruptor. The aim of the present study was to analyze the effects of in vitro acute exposure to DEHP on oocyte maturation, energy and oxidative status in the horse, a large animal model. Cumulus cell (CC) apoptosis and oxidative status were also investigated. Cumulus-oocyte complexes from the ovaries of slaughtered mares were cultured in vitro in presence of 0.12, 12 and 1200 mu M DEHP. After in vitro maturation (IVM), CCs were removed and evaluated for apoptosis (cytological assessment and TUNEL) and intracellular reactive oxygen species (ROS) levels. Oocytes were evaluated for nuclear chromatin configuration. Matured (Metaphase II stage; MII) oocytes were further evaluated for cytoplasmic energy and oxidative parameters. DEHP significantly inhibited oocyte maturation when added at low doses (0.12 mu M; P<0.05). This effect was related to increased CC apoptosis (P<0.001) and reduced ROS levels (P<0.0001). At higher doses (12 and 1200 mu M), DEHP induced apoptosis (P<0.0001) and ROS increase (P<0.0001) in CCs without affecting oocyte maturation. In DEHP-exposed MII oocytes, mitochondrial distribution patterns, apparent energy status (MitoTracker fluorescence intensity), intracellular ROS localization and levels, mt/ROS colocalization and total SOD activity did not vary, whereas increased ATP content (P<0.05), possibly of glycolytic origin, was found. Co-treatment with N-Acetyl-Cysteine reversed apoptosis and efficiently scavenged excessive ROS in DEHP-treated CCs without enhancing oocyte maturation. In conclusion, acute in vitro exposure to DEHP inhibits equine oocyte maturation without altering ooplasmic energy and oxidative stress parameters in matured oocytes which retain the potential to be fertilized and develop into embryos even though further studies are necessary to confirm this possibility.	[Ambruosi, Barbara; Uranio, Manuel Filioli; Martino, Nicola Antonio; Dell'Aquila, Maria Elena] Univ Bari Aldo Moro, Dept Anim Prod, Bari, Italy; [Sardanelli, Anna Maria; Paternoster, Maria Stefania; Amati, Francesca] Univ Bari Aldo Moro, Dept Med Biochem Biol & Phys, Bari, Italy; [Pocar, Paola] Univ Milan, Dipartimento Patol Anim Igiene & Sanit Pubbl Vet, Milan, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Milan	Ambruosi, B (corresponding author), Univ Bari Aldo Moro, Dept Anim Prod, Bari, Italy.	m.filioliuranio@gmail.com	Sardanelli, Anna Maria/AAD-4745-2021; Martino, Nicola/AAP-9891-2020; POCAR, PAOLA/K-7293-2017; Martino, Nicola Antonio/N-4096-2014	Sardanelli, Anna Maria/0000-0002-8535-7601; POCAR, PAOLA/0000-0002-1362-001X; Martino, Nicola Antonio/0000-0001-6853-2757; Dell'Aquila, Maria Elena/0000-0003-3629-7005	University of Bari "Aldo Moro" - Italy [2007S75KSE_003]	University of Bari "Aldo Moro" - Italy	This work was supported by Progetto COFIN PRIN 2007 (2007S75KSE_003 Contributo d'Ateneo) University of Bari "Aldo Moro" - Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Ambruosi B, 2009, THERIOGENOLOGY, V71, P1093, DOI 10.1016/j.theriogenology.2008.12.002; Anas MKI, 2003, REPROD TOXICOL, V17, P305, DOI 10.1016/S0890-6238(03)00014-5; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Bonilla E, 2010, REPROD TOXICOL, V30, P387, DOI 10.1016/j.reprotox.2010.04.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; Carnevale EM, 2008, THERIOGENOLOGY, V69, P23, DOI 10.1016/j.theriogenology.2007.09.011; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Dalman A, 2008, BIOFACTORS, V33, P149, DOI 10.1002/biof.5520330207; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; Dell'Aquila ME, 2008, MOL REPROD DEV, V75, P1229, DOI 10.1002/mrd.20869; Dell'Aquila Maria Elena, 2004, Reprod Biol Endocrinol, V2, P44, DOI 10.1186/1477-7827-2-44; Dell'Aquila ME, 2003, BIOL REPROD, V68, P2065, DOI 10.1095/biolreprod.102.009852; EIMANI H, 2005, YAKHTEH, V7, P56; European Food Safety Authority (EFSA), 2005, STAT SCI PAN FOOD AD; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Goudet G, 1997, BIOL REPROD, V57, P232, DOI 10.1095/biolreprod57.2.232; Goudet G, 1999, BIOL REPROD, V60, P1120, DOI 10.1095/biolreprod60.5.1120; Guixue Z, 2001, THERIOGENOLOGY, V55, P1733, DOI 10.1016/S0093-691X(01)00516-7; HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9; Hinrichs K, 2005, BIOL REPROD, V72, P1142, DOI 10.1095/biolreprod.104.036012; Hinrichs K, 2000, BIOL REPROD, V62, P1402, DOI 10.1095/biolreprod62.5.1402; Jorritsma R, 2004, ANIM REPROD SCI, V81, P225, DOI 10.1016/j.anireprosci.2003.10.005; KANDA T, 1990, BIOCHEM BIOPH RES CO, V168, P1053, DOI 10.1016/0006-291X(90)91136-G; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Komar CM, 2001, ENDOCRINOLOGY, V142, P4831, DOI 10.1210/en.142.11.4831; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9; Manojkumar V, 1998, VOX SANG, V75, P139, DOI 10.1159/000030975; Martinelli MI, 2006, HUM EXP TOXICOL, V25, P531, DOI 10.1191/0960327106het651oa; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mlynarcikova A, 2009, TOXICOL IN VITRO, V23, P371, DOI 10.1016/j.tiv.2008.12.017; Modina S, 2001, MARC MALPIG SYMP SER, V8, P241; *NAT TOX PROGR, 2006, NTP CERHR MON POT HU, P76; OEHHA, 2001, NO SIGN RISK LEV NSR; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Raval J, 2006, FREE RADICAL BIO MED, V41, P1645, DOI 10.1016/j.freeradbiomed.2006.07.023; Reinsberg J, 2009, TOXICOL APPL PHARM, V239, P116, DOI 10.1016/j.taap.2009.05.022; Rogalska A, 2011, TOXICOL IN VITRO, V25, P1712, DOI 10.1016/j.tiv.2011.08.009; Santhosh A, 1998, INDIAN J MED RES, V108, P17; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; TAKAGI A, 1990, JPN J CANCER RES, V81, P213, DOI 10.1111/j.1349-7006.1990.tb02551.x; Torner H, 2004, THERIOGENOLOGY, V61, P1675, DOI 10.1016/j.theriogenology.2003.09.013; TREINEN KA, 1990, TOXICOL APPL PHARM, V106, P334, DOI 10.1016/0041-008X(90)90252-P; Ukeda H, 1999, BIOSCI BIOTECH BIOCH, V63, P485, DOI 10.1271/bbb.63.485; Valentini L, 2010, ANIM REPROD SCI, V117, P166, DOI 10.1016/j.anireprosci.2009.03.008; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Wakefield SL, 2008, AM J PHYSIOL-ENDOC M, V294, pE425, DOI 10.1152/ajpendo.00409.2007; Whitaker BD, 2010, REPROD DOMEST ANIM, V45, P755, DOI 10.1111/j.1439-0531.2009.01344.x; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yang MY, 2000, BIOL REPROD, V62, P1209, DOI 10.1095/biolreprod62.5.1209; Zhang WY, 2011, TOXICOL IN VITRO, V25, P979, DOI 10.1016/j.tiv.2011.03.009; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	65	76	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27452	10.1371/journal.pone.0027452	http://dx.doi.org/10.1371/journal.pone.0027452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076161	gold, Green Submitted, Green Published			2022-12-27	WOS:000297198200075
J	Aucher, W; Davison, S; Fouet, A				Aucher, Willy; Davison, Sophie; Fouet, Agnes			Characterization of the Sortase Repertoire in Bacillus anthracis	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CELL-WALL ENVELOPE; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; SORTING MOTIF; PEPTIDOGLYCAN; SEQUENCE; PLASMID; SRTA; CAPSULE	LPXTG proteins, present in most if not all Gram-positive bacteria, are known to be anchored by sortases to the bacterial peptidoglycan. More than one sortase gene is often encoded in a bacterial species, and each sortase is supposed to specifically anchor given LPXTG proteins, depending of the sequence of the C-terminal cell wall sorting signal (cwss), bearing an LPXTG motif or another recognition sequence. B. anthracis possesses three sortase genes. B. anthracis sortase deleted mutant strains are not affected in their virulence. To determine the sortase repertoires, we developed a genetic screen using the property of the gamma phage to lyse bacteria only when its receptor, GamR, an LPXTG protein, is exposed at the surface. We identified 10 proteins that contain a cell wall sorting signal and are covalently anchored to the peptidoglycan. Some chimeric proteins yielded phage lysis in all sortase mutant strains, suggesting that cwss proteins remained surface accessible in absence of their anchoring sortase, probably as a consequence of membrane localization of yet uncleaved precursor proteins. For definite assignment of the sortase repertoires, we consequently relied on a complementary test, using a biochemical approach, namely immunoblot experiments. The sortase anchoring nine of these proteins has thus been determined. The absence of virulence defect of the sortase mutants could be a consequence of the membrane localization of the cwss proteins.	[Aucher, Willy; Davison, Sophie; Fouet, Agnes] Inst Pasteur, Unite Toxines, Dept Microbiol, Paris, France; [Aucher, Willy; Davison, Sophie; Fouet, Agnes] Inst Pasteur, Unite Pathogenie Bacterienne, Dept Microbiol, Paris, France; [Aucher, Willy] Inst Pasteur, Unite Genet Mol, CNRS, URA 2172, Paris, France; [Fouet, Agnes] INSERM, Inst Cochin, Team FRM Barriers & Pathogens, U1016, Paris, France; [Fouet, Agnes] CNRS, UMR 8104, Paris, France; [Fouet, Agnes] Univ Paris 05, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Aucher, W (corresponding author), Inst Pasteur, Unite Genet Mol, CNRS, URA 2172, Paris, France.	agnes.fouet@inserm.fr		Fouet, Agnes/0000-0001-7715-9157	Direction Generale a l'Armement; Agence Nationale de la Recherche [ANR-09-MIEN-010-02]	Direction Generale a l'Armement; Agence Nationale de la Recherche(French National Research Agency (ANR))	S. Davison was funded by the Direction Generale a l'Armement. This work was supported in part by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) through the project ANR-09-MIEN-010-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Davison S, 2005, J BACTERIOL, V187, P6742, DOI 10.1128/JB.187.19.6742-6749.2005; DAVISON S, 2007, CARACTERISATION PROT; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Egan SA, 2010, J PROTEOME RES, V9, P1088, DOI 10.1021/pr901025w; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HONSA ES, 2011, BIOMETALS; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Lee SG, 2006, J BACTERIOL, V188, P389, DOI 10.1128/JB.188.2.389-398.2006; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; Maniatis T., 1982, MOL CLONING LAB MANU; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; RISTROPH JD, 1983, INFECT IMMUN, V39, P483, DOI 10.1128/IAI.39.1.483-486.1983; Sambrook J., 2002, MOL CLONING LAB MANU; Sirard JC, 2000, INT J MED MICROBIOL, V290, P313; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; TRIEUCUOT P, 1987, FEMS MICROBIOL LETT, V48, P289, DOI 10.1111/j.1574-6968.1987.tb02558.x; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Zink SD, 2005, INFECT IMMUN, V73, P5222, DOI 10.1128/IAI.73.8.5222-5228.2005	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27411	10.1371/journal.pone.0027411	http://dx.doi.org/10.1371/journal.pone.0027411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076158	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200072
J	Girmatsion, Z; Biliczki, P; Takac, I; Schwerthelm, C; Hohnloser, SH; Ehrlich, JR				Girmatsion, Zenawit; Biliczki, Peter; Takac, Ina; Schwerthelm, Christin; Hohnloser, Stefan H.; Ehrlich, Joachim R.			N-Terminal Arginines Modulate Plasma-Membrane Localization of Kv7.1/KCNE1 Channel Complexes	PLOS ONE			English	Article							LONG QT SYNDROME; DELAYED RECTIFIER CURRENT; KCNQ1 POTASSIUM CHANNEL; I-KS; ATRIAL-FIBRILLATION; MINK; KVLQT1; PROTEINS; KCNE1; TRAFFICKING	Background and Objective: The slow delayed rectifier current (I(Ks)) is important for cardiac action potential termination. The underlying channel is composed of Kv7.1 alpha-subunits and KCNE1 beta-subunits. While most evidence suggests a role of KCNE1 transmembrane domain and C-terminus for the interaction, the N-terminal KCNE1 polymorphism 38G is associated with reduced I(Ks) and atrial fibrillation (a human arrhythmia). Structure-function relationship of the KCNE1 N-terminus for I(Ks) modulation is poorly understood and was subject of this study. Methods: We studied N-terminal KCNE1 constructs disrupting structurally important positively charged amino-acids (arginines) at positions 32, 33, 36 as well as KCNE1 constructs that modify position 38 including an N-terminal truncation mutation. Experimental procedures included molecular cloning, patch-clamp recording, protein biochemistry, real-time-PCR and confocal microscopy. Results: All KCNE1 constructs physically interacted with Kv7.1. I(Ks) resulting from co-expression of Kv7.1 with non-atrial fibrillation '38S' was greater than with any other construct. Ionic currents resulting from co-transfection of a KCNE1 mutant with arginine substitutions ('38G-3xA') were comparable to currents evoked from cells transfected with an N-terminally truncated KCNE1-construct ('Delta 1-38'). Western-blots from plasma-membrane preparations and confocal images consistently showed a greater amount of Kv7.1 protein at the plasma-membrane in cells co-transfected with the non-atrial fibrillation KCNE1-38S than with any other construct. Conclusions: The results of our study indicate that N-terminal arginines in positions 32, 33, 36 of KCNE1 are important for reconstitution of I(Ks). Furthermore, our results hint towards a role of these N-terminal amino-acids in membrane representation of the delayed rectifier channel complex.	[Girmatsion, Zenawit; Biliczki, Peter; Schwerthelm, Christin; Hohnloser, Stefan H.; Ehrlich, Joachim R.] Goethe Univ Frankfurt, Sect Electrophysiol, Div Cardiol, Frankfurt, Germany; [Takac, Ina] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Girmatsion, Z (corresponding author), Goethe Univ Frankfurt, Sect Electrophysiol, Div Cardiol, Frankfurt, Germany.	j.ehrlich@em.uni-frankfurt.de			Adolf-Messer Stiftung	Adolf-Messer Stiftung	Author Ehrlich received financial support from the Adolf-Messer Stiftung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Ehrlich JR, 2005, CARDIOVASC RES, V67, P520, DOI 10.1016/j.cardiores.2005.03.007; GALLUSSER A, 1990, EMBO J, V9, P2723, DOI 10.1002/j.1460-2075.1990.tb07459.x; Husser D, 2009, CIRC-ARRHYTHMIA ELEC, V2, P24, DOI 10.1161/CIRCEP.108.799098; Jaskolski F, 2005, J BIOL CHEM, V280, P22968, DOI 10.1074/jbc.M413166200; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; Kurokawa J, 2001, J MOL CELL CARDIOL, V33, P873, DOI 10.1006/jmcc.2001.1377; Lai LP, 2002, AM HEART J, V144, P485, DOI 10.1067/mhj.2002.123573; Liu AP, 2005, ARCH BIOCHEM BIOPHYS, V443, P101, DOI 10.1016/j.abb.2005.09.007; Lundby A, 2010, HEART RHYTHM, V7, P708, DOI 10.1016/j.hrthm.2009.12.017; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Peroz D, 2009, J BIOL CHEM, V284, P5250, DOI 10.1074/jbc.M806459200; Romey G, 1997, J BIOL CHEM, V272, P16713, DOI 10.1074/jbc.272.27.16713; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Stryer L, 2002, BIOCHEMISTRY; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26967	10.1371/journal.pone.0026967	http://dx.doi.org/10.1371/journal.pone.0026967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073228	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200027
J	Lobanov, MY; Galzitskaya, OV				Lobanov, Michail Yu.; Galzitskaya, Oxana V.			Disordered Patterns in Clustered Protein Data Bank and in Eukaryotic and Bacterial Proteomes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; WEB SERVER; PREDICTION; REGIONS; REPEATS; SEARCH; TANDEM; ORDER	We have constructed the clustered Protein Data Bank and obtained clusters of chains of different identity inside each cluster, http://bioinfo.protres.ru/st_pdb/. We have compiled the largest database of disordered patterns (141) from the clustered PDB where identity between chains inside of a cluster is larger or equal to 75% (version of 28 June 2010) by using simple rules of selection. The results of these analyses would help to further our understanding of the physicochemical and structural determinants of intrinsically disordered regions that serve as molecular recognition elements. We have analyzed the occurrence of the selected patterns in 97 eukaryotic and in 26 bacterial proteomes. The disordered patterns appear more often in eukaryotic than in bacterial proteomes. The matrix of correlation coefficients between numbers of proteins where a disordered pattern from the library of 141 disordered patterns appears at least once in 9 kingdoms of eukaryota and 5 phyla of bacteria have been calculated. As a rule, the correlation coefficients are higher inside of the considered kingdom than between them. The patterns with the frequent occurrence in proteomes have low complexity (PPPPP, GGGGG, EEEED, HHHH, KKKKK, SSTSS, QQQQQP), and the type of patterns vary across different proteomes, http://bioinfo.protres.ru/fp/search_new_pattern.html.	[Lobanov, Michail Yu.; Galzitskaya, Oxana V.] Russian Acad Sci, Inst Prot Res, Grp Bioinformat, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences	Lobanov, MY (corresponding author), Russian Acad Sci, Inst Prot Res, Grp Bioinformat, Pushchino 142292, Moscow Region, Russia.	ogalzit@vega.protres.ru	GALZITSKAYA, OXANA V/L-2664-2015		Russian Foundation for Basic Research [11-04-00763]; Russian Academy of Sciences [01200959110]; Federal Agency for Science and Innovations [02.740.11.0295, 16.512.11.2204]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI))	The work was supported by the Russian Foundation for Basic Research (grant No 11-04-00763), Russian Academy of Sciences (programs "Molecular and Cell Biology'' (01200959110) and "Fundamental Sciences to Medicine''), as well as a grant from the Federal Agency for Science and Innovations (#02.740.11.0295) and a grant from the Federal Agency for Science and Innovations (No16.512.11.2204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bogatyreva Natalya S., 2006, Journal of Bioinformatics and Computational Biology, V4, P597, DOI 10.1142/S0219720006002016; Bordelon T, 2004, J BIOL CHEM, V279, P43085, DOI 10.1074/jbc.M406139200; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P681, DOI 10.1142/S021972000800362X; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hecker J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S9; Hemmer B, 2000, INT IMMUNOL, V12, P375, DOI 10.1093/intimm/12.3.375; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Lobanov MY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P192, DOI 10.1134/S0006297910020094; Lobanov MY, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035004; Lobanov MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000958; Lobanov MY, 2010, NUCLEIC ACIDS RES, V38, pD283, DOI 10.1093/nar/gkp963; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nikiforovich GV, 2002, P NATL ACAD SCI USA, V99, P10388, DOI 10.1073/pnas.162362199; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Rajasekaran S, 2011, PROTEINS, V79, P153, DOI 10.1002/prot.22868; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zbilut JP, 2006, FEBS LETT, V580, P4861, DOI 10.1016/j.febslet.2006.07.076	42	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27142	10.1371/journal.pone.0027142	http://dx.doi.org/10.1371/journal.pone.0027142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073276	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200039
J	Oduro, AR; Bojang, KA; Conway, DJ; Corrah, T; Greenwood, BM; Schellenberg, D				Oduro, Abraham R.; Bojang, Kalifa A.; Conway, David J.; Corrah, Tumani; Greenwood, Brian M.; Schellenberg, David			Health Centre Surveys as a Potential Tool for Monitoring Malaria Epidemiology by Area and over Time	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; FACILITY-BASED DATA; TREATED BED NETS; WEST-AFRICA; TARGETED CHEMOPROPHYLAXIS; CASE DEFINITIONS; RURAL AREA; GAMBIA; TRANSMISSION; CHILDREN	Background: Presently, many malaria control programmes use health facility data to evaluate the impact of their interventions. Facility-based malaria data, although useful, have problems with completeness, validity and representativeness and reliance on routinely collected health facility data might undermine demonstration of the magnitude of the impact of the recent scaleups of malaria interventions. To determine whether carefully conducted health centre surveys can be reliable means of monitoring area specific malaria epidemiology, we have compared malaria specific indices obtained from surveys in health centres with indices obtained from cross-sectional surveys conducted in their catchment communities. Methods: A series of age stratified, seasonal, cross-sectional surveys were conducted during the peak malaria transmission season in 2008 and during the following dry season in 2009 in six ecologically diverse areas in The Gambia. Participants were patients who attended the health centres plus a representative sample from the catchment villages of these health facilities. Parasitaemia, anaemia, attributable proportion of fever and anti-MSP1-(19) antibody seroprevalence were compared in the health facility attendees and community participants. Results: A total of 16,230 subjects completed the study; approximately half participated in the health centre surveys and half in the wet season surveys. Data from both the health centre and community surveys showed that malaria endemicity in The Gambia is now low, heterogeneous and seasonal. In the wet season, parasitaemia, seroprevalence and fever prevalence were higher in subjects seen in the health centres than in the community surveys. Age patterns of parasitaemia, attributable proportions of fever and seroprevalence rates were similar in subjects who participated in the community and health centre surveys. Conclusion: Health centre surveys have potential as a surveillance tool for evaluating area specific malaria control activities and for monitoring changes in local malaria epidemiology over time.	[Oduro, Abraham R.; Bojang, Kalifa A.; Conway, David J.; Corrah, Tumani] MRC Labs, Banjul, Gambia; [Oduro, Abraham R.; Conway, David J.; Greenwood, Brian M.; Schellenberg, David] London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Oduro, AR (corresponding author), MRC Labs, Banjul, Gambia.	aroduro@yahoo.com		Schellenberg, David/0000-0001-8222-0186; Bojang, Kalifa/0000-0001-7506-0938; Conway, David/0000-0002-8711-3037; ODURO, ABRAHAM/0000-0002-4191-7419	Medical Research Council (UK); MRC [MC_U190092707, MC_UP_A900_1118] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1118, MC_U190092707] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was sponsored by a Medical Research Council (UK) PhD studentship and supported by core funding to the Malaria Programme at the Medical Research Council Laboratories in The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Central Intelligence Agency, 2010, WORLD FACTB; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Gambia Bureau of Statistics (GBOS), 2003, GAMB BUR STAT GBOS C; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; GREENWOOD BM, 1987, ANN TROP MED PARASIT, V81, P345, DOI 10.1080/00034983.1987.11812130; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P19, DOI 10.1016/0035-9203(93)90171-L; MCGREGOR IA, 1952, T ROY SOC TROP MED H, V46, P403, DOI 10.1016/0035-9203(52)90058-8; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; Omosun YO, 2005, ACTA TROP, V95, P233, DOI 10.1016/j.actatropica.2005.06.019; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; Roll Back Malaria MEASURE Evaluation World Health Organization UNICEF, 2006, GUID COR POP COV IND; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Skarbinski J, 2008, TROP MED INT HEALTH, V13, P396, DOI 10.1111/j.1365-3156.2008.02014.x; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Thomson M, 1996, SOC SCI MED, V43, P101, DOI 10.1016/0277-9536(95)00346-0; UNICEF, 2010, MULT IND CLUST SURV; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd	27	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26305	10.1371/journal.pone.0026305	http://dx.doi.org/10.1371/journal.pone.0026305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073155	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000297198200007
J	Lopez-Rios, L; Novoa, FJ; Chirino, R; Varillas, F; Boronat-Cortes, M; Wagner, AM				Lopez-Rios, Laura; Novoa, Francisco J.; Chirino, Ricardo; Varillas, Francisco; Boronat-Cortes, Mauro; Waegner, Ana M.			Interaction between Cholesteryl Ester Transfer Protein and Hepatic Lipase Encoding Genes and the Risk of Type 2 Diabetes: Results from the Telde Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; IMPAIRED GLUCOSE-TOLERANCE; PLASMA-LIPID LEVELS; CETP GENE; PROMOTER POLYMORPHISM; TRIGLYCERIDE LIPASE; INSULIN-RESISTANCE; HEART-DISEASE; FATTY-ACIDS; ASSOCIATION	Background and Aim: Diabetic dyslipidaemia is common in type 2 diabetes (T2D) and insulin resistance and often precedes the onset of T2D. The Taq1B polymorphism in CETP (B1 and B2 alleles) (rs708272) and the G-250A polymorphism in LIPC (rs2070895) are associated with changes in enzyme activity and lipid concentrations. Our aim was to assess the effects of both polymorphisms on the risk of T2D. Methods and Results: In a case-control study from the population-based Telde cohort, both polymorphisms were analysed by PCR-based methods. Subjects were classified, according to an oral glucose tolerance test, into diabetic (N = 115) and pre-diabetic (N = 116); 226 subjects with normal glucose tolerance, matched for age and gender, were included as controls. Chi-square (comparison between groups) and logistic regression (identification of independent effects) were used for analysis. The B1B1 Taq1B CETP genotype frequency increased with worsening glucose metabolism (42.5%, 46.1% and 54.3% in control, IGR and diabetic group; p = 0.042). This polymorphism was independently associated with an increased risk of diabetes (OR: 1.828; IC 95%: 1.12-2.99; p = 0.016), even after adjusting by confounding variables, whereas the LIPC polymorphism was not. Regarding the interaction between both polymorphisms, in the B1B1 genotype carriers, the absence of the minor (A) allele of the LIPC polymorphism increased the risk of having diabetes. Conclusion: The presence of the B1B1 Taq1B CETP genotype contributes to the presence of diabetes, independently of age, sex, BMI and waist. However, among carriers of B1B1, the presence of GG genotype of the -250 LIPC polymorphism increases this risk further.	[Lopez-Rios, Laura; Novoa, Francisco J.; Boronat-Cortes, Mauro; Waegner, Ana M.] Complejo Hosp Univ Insular Maternoinfantil Gran C, Serv Endocrinol, Las Palmas Gran Canaria, Spain; [Lopez-Rios, Laura; Novoa, Francisco J.; Boronat-Cortes, Mauro; Waegner, Ana M.] Univ Las Palmas Gran Canaria, Dept Ciencias Med & Quirurg, Las Palmas Gran Canaria, Spain; [Chirino, Ricardo] Univ Las Palmas Gran Canaria, Dept Bioquim Biol Mol Fisiol Genet & Inmunol, Las Palmas Gran Canaria, Spain; [Varillas, Francisco] Hosp Gen Fuerteventura, Fuerteventura, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Lopez-Rios, L (corresponding author), Complejo Hosp Univ Insular Maternoinfantil Gran C, Serv Endocrinol, Las Palmas Gran Canaria, Spain.	awagner@dcmq.ulpgc.es	Boronat, Mauro/I-2851-2017; Wägner, Ana M/AAS-9601-2021; Chirino, Ricardo/ABB-1873-2021	Boronat, Mauro/0000-0001-8535-8543; Wägner, Ana M/0000-0002-7663-9308; Chirino, Ricardo/0000-0002-5681-8931	Fundacion Canaria de Investigacion y Salud (FUNCIS, Spain); ULPGC; Ministerio de Ciencia e Innovacion [PI08/1113, PI10/2310]; European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk)	Fundacion Canaria de Investigacion y Salud (FUNCIS, Spain); ULPGC; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk)(Novo NordiskJuvenile Diabetes Research Foundation)	This work has been supported in part by grants from Fundacion Canaria de Investigacion y Salud (FUNCIS, Spain; ref: Canarias Bioregion). LLR is being supported by a post-doctoral fellowship from ULPGC. FJN and AMW receive funding from Ministerio de Ciencia e Innovacion (PI08/1113 and PI10/2310) and the European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk Programme 2008). No additional external funding was provided for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; BLADES B, 1993, ARTERIOSCLER THROMB, V13, P1227, DOI 10.1161/01.ATV.13.8.1227; Boekholdt SM, 2004, CURR OPIN LIPIDOL, V15, P393, DOI 10.1097/01.mol.0000137226.54278.60; Boronat M, 2006, DIABETIC MED, V23, P148, DOI 10.1111/j.1464-5491.2005.01739.x; Carr MC, 1999, ARTERIOSCL THROM VAS, V19, P2701, DOI 10.1161/01.ATV.19.11.2701; Corella D, 2000, ATHEROSCLEROSIS, V152, P367, DOI 10.1016/S0021-9150(99)00477-3; Deeb SS, 2000, J LIPID RES, V41, P155; DESPRES JP, 1989, ARTERIOSCLEROSIS, V9, P485, DOI 10.1161/01.ATV.9.4.485; DULLAART RPF, 1994, EUR J CLIN INVEST, V24, P188, DOI 10.1111/j.1365-2362.1994.tb00987.x; Grarup N, 2008, J CLIN ENDOCR METAB, V93, P2294, DOI 10.1210/jc.2007-2815; Gudnason V, 1999, EUR J CLIN INVEST, V29, P116, DOI 10.1046/j.1365-2362.1999.00412.x; IKEWAKI K, 1993, J CLIN INVEST, V92, P1650, DOI 10.1172/JCI116750; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Isaacs A, 2007, J CLIN ENDOCR METAB, V92, P2680, DOI 10.1210/jc.2007-0269; Jackson KG, 2000, AM J CLIN NUTR, V71, P13; KONDO I, 1989, CLIN GENET, V35, P49; LAGROST L, 1993, ARTERIOSCLER THROMB, V13, P815, DOI 10.1161/01.ATV.13.6.815; Lambert G, 1999, J LIPID RES, V40, P1294; Lindi V, 2008, NUTR METAB CARDIOVAS, V18, P88, DOI 10.1016/j.numecd.2006.09.008; Lopez-Rios L, 2009, NUTR METABO IN PRESS; Morton RE, 1999, CURR OPIN LIPIDOL, V10, P321, DOI 10.1097/00041433-199908000-00006; Noone E, 2000, BRIT J NUTR, V84, P203; Novoa FJ, 2005, DIABETES CARE, V28, P2388, DOI 10.2337/diacare.28.10.2388; Sandhofer A, 2008, OBESITY, V16, P919, DOI 10.1038/oby.2007.130; Smaoui M, 2006, NUTR METAB CARDIOVAS, V16, P44, DOI 10.1016/j.numecd.2005.05.011; Soyal SM, 2011, ATHEROSCLEROSIS, V216, P374, DOI 10.1016/j.atherosclerosis.2011.01.052; Tahvanainen E, 1998, J CLIN INVEST, V101, P956, DOI 10.1172/JCI1144; Thuren T, 2000, CURR OPIN LIPIDOL, V11, P277, DOI 10.1097/00041433-200006000-00008; Todorova B, 2004, J CLIN ENDOCR METAB, V89, P2019, DOI 10.1210/jc.2003-031325; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wu JH, 2001, ATHEROSCLEROSIS, V159, P451, DOI 10.1016/S0021-9150(01)00524-X; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zacharova J, 2005, J INTERN MED, V257, P185, DOI 10.1111/j.1365-2796.2004.01435.x; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zambon A, 1998, ARTERIOSCL THROM VAS, V18, P1723, DOI 10.1161/01.ATV.18.11.1723	35	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27208	10.1371/journal.pone.0027208	http://dx.doi.org/10.1371/journal.pone.0027208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073289	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000032
J	Nielsen, GK; Dagnaes-Hansen, F; Holm, IE; Meaney, S; Symula, D; Andersen, NT; Heegaard, CW				Nielsen, Gitte Krogh; Dagnaes-Hansen, Frederik; Holm, Ida Elisabeth; Meaney, Steve; Symula, Derek; Andersen, Niels Trolle; Heegaard, Christian Wurtz			Protein Replacement Therapy Partially Corrects the Cholesterol-Storage Phenotype in a Mouse Model of Niemann-Pick Type C2 Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RECEPTOR-MEDIATED TRANSPORT; LYSOSOMAL-ENZYME; EVERY ORGAN; NPC2; LIVER; MICE; DEFICIENT; MIGLUSTAT; GENE	Niemann-Pick type C2 (NPC2) disease is a fatal autosomal recessive neurovisceral degenerative disorder characterized by late endosomal-lysosomal sequestration of low-density lipoprotein derived cholesterol. The breach in intracellular cholesterol homeostasis is caused by deficiency of functional NPC2, a soluble sterol binding protein targeted to the lysosomes by binding the mannose-6-phosphate receptor. As currently there is no effective treatment for the disorder, we have investigated the efficacy of NPC2 replacement therapy in a murine gene-trap model of NPC2-disease generated on the 129P2/OlaHsd genetic background. NPC2 was purified from bovine milk and its functional competence assured in NPC2-deficient fibroblasts using the specific cholesterol fluorescent probe filipin. For evaluation of phenotype correction in vivo, three-week-old NPC2(-/-) mice received two weekly intravenous injections of 5 mg/kg NPC2 until trial termination 66 days later. Whereas the saline treated NPC2(-/-) mice exhibited massive visceral cholesterol storage as compared to their wild-type littermates, administration of NPC2 caused a marked reduction in cholesterol build up. The histological findings, indicating an amelioration of the disease pathology in liver, spleen, and lungs, corroborated the biochemical results. Little or no difference in the overall cholesterol levels was observed in the kidneys, blood, cerebral cortex and hippocampus when comparing NPC2(-/-) and wild type mice. However, cerebellum cholesterol was increased about two fold in NPC2(-/-) mice compared with wild-type littermates. Weight gain performance was slightly improved as a result of the NPC2 treatment but significant motor coordination deficits were still observed. Accordingly, ultrastructural cerebellar abnormalities were detected in both saline treated and NPC2 treated NPC2(-/-) animals 87 days post partum. Our data indicate that protein replacement may be a beneficial therapeutic approach in the treatment of the visceral manifestations in NPC2 disease and further suggest that neurodegeneration is not secondary to visceral dysfunction.	[Nielsen, Gitte Krogh; Heegaard, Christian Wurtz] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Holm, Ida Elisabeth] Aarhus Univ, Expt Neuropathol Lab, Dept Pathol, Randers Hosp, Aarhus, Denmark; [Holm, Ida Elisabeth] Aarhus Univ, Inst Clin, Aarhus, Denmark; [Meaney, Steve] Dublin Inst Technol, Sch Biol Sci, Dublin, Ireland; [Symula, Derek] Wadsworth Ctr, Albany, NY USA; [Andersen, Niels Trolle] Aarhus Univ, Dept Biostat, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Technological University Dublin; Wadsworth Center; Aarhus University	Nielsen, GK (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.	gkn@mb.au.dk; cwh@mb.au.dk	Heegaard, Christian W/A-4814-2019; Meaney, Steve/X-9289-2019	Wurtz Heegaard, Christian/0000-0002-7989-2624; Meaney, Steve/0000-0002-7789-516X; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Lundbeck Foundation [R7A682B187]; Danish Agency for Science Technology and Innovation [2101-07-0094]; Milk Protein Research Consortium; Lundbeck Foundation [R7-2006-682] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Agency for Science Technology and Innovation; Milk Protein Research Consortium; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation (grant No. R7A682B187), the Danish Agency for Science Technology and Innovation (grant No. 2101-07-0094), and the Milk Protein Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Bjurulf B, 2008, MED SCI MONITOR, V14, pCS71; Bonney DK, 2010, J INHERIT METAB DIS; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Csepeggi C, 2011, J BIOL CHEM, V286, P2078, DOI 10.1074/jbc.M110.135897; Csepeggi C, 2010, J BIOL CHEM, V285, P30347, DOI 10.1074/jbc.M110.135939; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Elstein D, 2004, J INHERIT METAB DIS, V27, P757, DOI 10.1023/B:BOLI.0000045756.54006.17; Fecarotta S, 2011, AM J MED GENET A; FINK JK, 1989, NEUROLOGY, V39, P1040, DOI 10.1212/WNL.39.8.1040; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; Griese M, 2010, CLIN GENET, V77, P119, DOI 10.1111/j.1399-0004.2009.01325.x; Heo K, 2006, STEM CELLS, V24, P1549, DOI 10.1634/stemcells.2005-0458; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Larsen LB, 1997, EUR J BIOCHEM, V243, P437, DOI 10.1111/j.1432-1033.1997.0437a.x; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Lim-Melia ER, 2009, PEDIATR ANN, V38, P448, DOI 10.3928/00904481-20090723-09; Lindemann R, 2007, PEDIATR CRIT CARE ME, V8, P486, DOI 10.1097/01.PCC.0000282757.25347.6C; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lonser RR, 2005, ANN NEUROL, V57, P542, DOI 10.1002/ana.20444; MOOS T, 1993, NEUROPATH APPL NEURO, V19, P120, DOI 10.1111/j.1365-2990.1993.tb00416.x; Morisot C, 2005, ARCH PEDIATRIE, V12, P434, DOI 10.1016/j.arcped.2005.01.015; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2010, J CHILD NEUROL, V25, P300, DOI 10.1177/0883073809344222; Peake KB, 2010, FEBS LETT, V584, P2731, DOI 10.1016/j.febslet.2010.04.047; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; STEWART PA, 1987, DEV BRAIN RES, V32, P271, DOI 10.1016/0165-3806(87)90107-6; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Sugawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015777; Turner CT, 1999, MOL GENET METAB, V67, P194, DOI 10.1006/mgme.1999.2859; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Verot L, 2007, CLIN GENET, V71, P320, DOI 10.1111/j.1399-0004.2007.00782.x; Vite C, 2011, MOL GENET METAB, V102, pS44, DOI 10.1016/j.ymgme.2010.11.148; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yamanashi Y, 2011, GASTROENTEROLOGY, V140, P1664, DOI 10.1053/j.gastro.2011.01.050; Zervas M, 2001, J NEUROPATH EXP NEUR, V60, P49, DOI 10.1093/jnen/60.1.49; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	60	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27287	10.1371/journal.pone.0027287	http://dx.doi.org/10.1371/journal.pone.0027287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073306	gold, Green Published			2022-12-27	WOS:000297197000042
J	Ferrier, A; Charron, A; Sadozai, Y; Switaj, L; Szutenbach, A; Smith, PA				Ferrier, Andrew; Charron, Alexandra; Sadozai, Yama; Switaj, Lynn; Szutenbach, Anneliese; Smith, Pliny A.			Multiple Phenotypes Resulting from a Mutagenesis Screen for Pharynx Muscle Mutations in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; CELLULAR INTERACTIONS; GENE ENCODES; PROTEIN; ORGANOGENESIS; PHA-4/FOXA; WORMBASE; RESOURCE; HOMOLOG	We describe a novel screen to isolate pharyngeal cell morphology mutants in Caenorhabditis elegans using myo-2::GFP to rapidly identify abnormally shaped pharynxes in EMS (Ethyl Methanesulfonate) mutagenized worms. We observed over 83 C. elegans lines with distinctive pharyngeal phenotypes in worms surviving to the L1 larval stage, with phenotypes ranging from short pharynx, unattached pharynx, missing cells, asymmetric morphology, and non-adherent pharynx cells. Thirteen of these mutations have been chromosomally mapped using Single Nucleotide Polymorphisms (SNPs) and deficiency strain complementation. Our studies have focused on genetically mapping and functionally testing two phenotypes, the short pharynx and the loss of muscle cohesion phenotypes. We have also identified new alleles of sma-1, and our screen suggests many genes directing pharynx assembly and structure may be either pharynx specific or less critical in other tissues.	[Ferrier, Andrew; Charron, Alexandra; Sadozai, Yama; Switaj, Lynn; Szutenbach, Anneliese; Smith, Pliny A.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA		Ferrier, A (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	smith@lakeforest.edu			Lake Forest College; NIH National Center for Research Resources (NCRR)	Lake Forest College; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by Lake Forest College. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Ashleigh Porter, Elizabeth Pahamov, Carlos Becerra, Ejaz Ali, Ariel Nguyen, Victoria Egedus, former and current members of the Smith lab for their contributions to this research. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We acknowledge Dustin Updike for his insightful recommendations for using the PD4792 worm strain.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; AVERY L, 1993, GENETICS, V133, P897; BRENNER S, 1974, GENETICS, V77, P71; Broitman-Maduro G, 2006, DEVELOPMENT, V133, P3097, DOI 10.1242/dev.02475; Chanal P, 1997, GENETICS, V146, P207; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Christensen S, 1996, DEVELOPMENT, V122, P1373; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; DELONG L, 1993, GENETICS, V133, P875; ELLIS RE, 1991, GENETICS, V129, P79; Epstein HF, 1995, CAENORHABDITIS ELEGA, pxxi659; FERGUSON EL, 1985, GENETICS, V110, P17; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GREENWALD IS, 1980, GENETICS, V96, P147; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Jafari G, 2010, GENETICS, V186, P969, DOI 10.1534/genetics.110.120519; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kao G, 2006, DEV BIOL, V290, P211, DOI 10.1016/j.ydbio.2005.11.026; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; MANGO SE, 1994, DEVELOPMENT, V120, P3019; McKeown C, 1998, DEVELOPMENT, V125, P2087; McMahon L, 2001, J CELL SCI, V114, P2265; Morck C, 2004, DEV BIOL, V272, P403, DOI 10.1016/j.ydbio.2004.05.011; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Portereiko MF, 2004, CURR BIOL, V14, P932, DOI 10.1016/j.cub.2004.05.052; Praitis V, 2001, GENETICS, V157, P1217; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; PRUSS RM, 1981, CELL, V27, P419, DOI 10.1016/0092-8674(81)90383-4; Roy Chowdhuri S, 2006, DEV BIOL; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Smith PA, 2007, DEV BIOL, V302, P25, DOI 10.1016/j.ydbio.2006.08.023; Stewart HI, 1998, MOL GEN GENET, V260, P280, DOI 10.1007/PL00013816; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Takeda K, 2008, GENES CELLS, V13, P653, DOI 10.1111/j.1365-2443.2008.01195.x; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161	49	6	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26594	10.1371/journal.pone.0026594	http://dx.doi.org/10.1371/journal.pone.0026594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073173	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900025
J	Guo, F; Carter, DE; Mukhopadhyay, A; Leask, A				Guo, Fen; Carter, David E.; Mukhopadhyay, Anuradha; Leask, Andrew			Gingival Fibroblasts Display Reduced Adhesion and Spreading on Extracellular Matrix: A Possible Basis for Scarless Tissue Repair?	PLOS ONE			English	Article							TGF-BETA; MYOFIBROBLAST; CCN2; DIFFERENTIATION; FIBRONECTIN; CONTRACTION; EXPRESSION; FIBROSIS; DISEASE; KINASE	Unlike skin, oral gingiva do not scar in response to injury. The basis of this difference is likely to be revealed by comparing the responses of dermal and gingival fibroblasts to fibrogenic stimuli. Previously, we showed that, compared to dermal fibroblasts, gingival fibroblasts are less responsive to the potent pro-fibrotic cytokine TGF beta, due to a reduced production of endothelin-1 (ET-1). In this report, we show that, compared to dermal fibroblasts, human gingival fibroblasts show reduced expression of pro-adhesive mRNAs and proteins including integrins alpha 2 and alpha 4 and focal adhesion kinase (FAK). Consistent with these observations, gingival fibroblasts are less able to adhere to and spread on both fibronectin and type I collagen. Moreover, the enhanced production of ET-1 mRNA and protein in dermal fibroblasts is reduced by the FAK/src inhibitor PP2. Given our previous observations suggesting that fibrotic fibroblasts display elevated adhesive properties, our data suggest that scarring potential may be based, at least in part, on differences in adhesive properties among fibroblasts resident in connective tissue. Controlling adhesive properties may be of benefit in controlling scarring in response to tissue injury.	[Guo, Fen; Mukhopadhyay, Anuradha; Leask, Andrew] Univ Western Ontario, Dept Dent, London, ON, Canada; [Carter, David E.] Robarts Res Inst, London, ON, Canada; [Leask, Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Guo, F (corresponding author), Univ Western Ontario, Dept Dent, London, ON, Canada.	andrew.leask@schulich.uwo.ca	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020		Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institute of Health Research funded this paper. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham David J, 2007, Curr Rheumatol Rep, V9, P136, DOI 10.1007/s11926-007-0008-z; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P125, DOI 10.1007/s12079-011-0122-6; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Matsui S, 2011, J CLIN BIOCHEM NUTR, V48, P209, DOI 10.3164/jcbn.10-85; San Miguel SM, 2011, ARCH ORAL BIOL, V56, P812, DOI 10.1016/j.archoralbio.2011.01.001; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schor S L, 1996, Oral Dis, V2, P155; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29	26	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27097	10.1371/journal.pone.0027097	http://dx.doi.org/10.1371/journal.pone.0027097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073262	gold, Green Submitted, Green Published			2022-12-27	WOS:000297154900075
J	Singh, P; Yadav, GP; Gupta, S; Tripathi, AK; Ramachandran, R; Tripathi, RK				Singh, Pankaj; Yadav, Gaya Prasad; Gupta, Sudeepti; Tripathi, Anil Kumar; Ramachandran, Ravishankar; Tripathi, Raj Kamal			A Novel Dimer-Tetramer Transition Captured by the Crystal Structure of the HIV-1 Nef	PLOS ONE			English	Article							QUATERNARY STRUCTURE; PROTEIN; DOMAIN; SEQUENCES; COMPLEX; CELLS; CORE; GENE	HIV-1 Nef modulates disease progression through interactions with over 30 host proteins. Individual chains fold into membrane-interacting N-terminal and C-terminal core (Nef(core)) domains respectively. Nef exists as small oligomers near membranes and associates into higher oligomers such as tetramers or hexadecamers in the cytoplasm. Earlier structures of the Nef(core) in apo and complexed forms with the Fyn-kinase SH3 domain revealed dimeric association details and the role of the conserved PXXP recognition motif (residues 72-78) of Nef in SH3-domain interactions. The crystal structure of the tetrameric Nef reported here corresponds to the elusive cytoplasmic stage. Comparative analyses show that subunits of Nef(core) dimers (open conformation) swing out with a relative displacement of similar to 22 angstrom and rotation of similar to 174 degrees to form the 'closed' tetrameric structure. The changes to the association are around Asp125, a conserved residue important for viral replication and the important XR motif (residues 107-108). The tetramer associates through C4 symmetry instead of the 222 symmetry expected when two dimers associate together. This novel dimer-tetramer transition agrees with earlier solution studies including small angle X-ray scattering, analytical ultracentrifugation, dynamic laser light scattering and our glutaraldehyde cross-linking experiments. Comparisons with the Nef(core)-Fyn-SH3 domain complexes reveal that the PXXP motif that interacts with the SH3-domain in the dimeric form is sterically occluded in the tetramer. However the 151-180 loop that is distal to the PXXP motif and contains several protein interaction motifs remains accessible. The results suggest how changes to the oligomeric state of Nef can help it distinguish between protein partners.	[Singh, Pankaj; Gupta, Sudeepti; Tripathi, Raj Kamal] CSIR, Cent Drug Res Inst, Div Toxicol, Lucknow, Uttar Pradesh, India; [Yadav, Gaya Prasad; Ramachandran, Ravishankar] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India; [Tripathi, Anil Kumar] Chatrapati Shahuji Maharaj Med Univ, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Singh, P (corresponding author), CSIR, Cent Drug Res Inst, Div Toxicol, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, India.	r_ravishankar@cdri.res.in; rk_tripathi@cdri.res.in	yadav, gaya/AAA-3576-2021; Yadav, Gaya P/F-3720-2019	Yadav, Gaya P/0000-0002-4514-4679; Ramachandran, Ravishankar/0000-0002-0723-9861; Tripathi, Anil/0000-0001-9139-8701	Council of Scientific and Industrial Research (CSIR), India [MLP007, NWP034]; CSIR; Indian Council for Medical Research	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by grants MLP007 and NWP034 from the Council of Scientific and Industrial Research (CSIR), India. GY, SG and PS acknowledge fellowships from CSIR and Indian Council for Medical Research respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arold S, 2000, PROTEIN SCI, V9, P1137, DOI 10.1110/ps.9.6.1137; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; Carl S, 2000, J INFECT DIS, V181, P132, DOI 10.1086/315187; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; CORNISHBOWDEN AJ, 1971, J BIOL CHEM, V246, P3092; Dennis CA, 2005, PROTEINS, V60, P658, DOI 10.1002/prot.20544; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; FREUND J, 1994, EUR J BIOCHEM, V221, P811, DOI 10.1111/j.1432-1033.1994.tb18795.x; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Hoffmann S, 2007, BIOL CHEM, V388, P181, DOI 10.1515/BC.2007.020; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim WM, 2010, ACTA CRYSTALLOGR D, V66, P163, DOI 10.1107/S090744490904880X; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Klotz IM, 1975, PROTEINS, V1, P293; Kwak YT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-77; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Leslie AGW, 1992, NEWS LETT PROTEIN CR, V26; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; Piguet V, STRUCTURE FUNCTION A, P448; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Roussel A, 1990, ACTA CRYSTALLOGR A, V46, pC66; Schorr J, 1996, J VIROL, V70, P9051, DOI 10.1128/JVI.70.12.9051-9054.1996; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3	37	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26629	10.1371/journal.pone.0026629	http://dx.doi.org/10.1371/journal.pone.0026629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073177	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900028
J	Va, P; Yang, WS; Nechuta, S; Chow, WH; Cai, H; Yang, G; Gao, S; Gao, YT; Zheng, W; Shu, XO; Xiang, YB				Va, Puthiery; Yang, Wan-Shui; Nechuta, Sarah; Chow, Wong-Ho; Cai, Hui; Yang, Gong; Gao, Shan; Gao, Yu-Tang; Zheng, Wei; Shu, Xiao-Ou; Xiang, Yong-Bing			Marital Status and Mortality among Middle Age and Elderly Men and Women in Urban Shanghai	PLOS ONE			English	Article							GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; HEART-DISEASE; HEALTH; ASSOCIATION; MARRIAGE; PATTERNS; SUPPORT; DIETARY; REPRODUCIBILITY	Background: Previous studies have suggested that marital status is associated with mortality, but few studies have been conducted in China where increasing aging population and divorce rates may have major impact on health and total mortality. Methods: We examined the association of marital status with mortality using data from the Shanghai Women's Health Study (1996-2009) and Shanghai Men's Health Study (2002-2009), two population-based cohort studies of 74,942 women aged 40-70 years and 61,500 men aged 40-74 years at the study enrollment. Deaths were identified by biennial home visits and record linkage with the vital statistics registry. Marital status was categorized as married, never married, divorced, widowed, and all unmarried categories combined. Cox regression models were used to derive hazard ratios (HR) and 95% confidence interval (CI). Results: Unmarried and widowed women had an increased all-cause HR = 1.11, 95% CI: 1.03, 1.21 and HR = 1.10, 95% CI: 1.02, 1.20 respectively) and cancer (HR = 1.17, 95% CI: 1.04, 1.32 and HR = 1.18, 95% CI: 1.04, 1.34 respectively) mortality. Never married women had excess all-cause mortality (HR = 1.46, 95% CI: 1.03, 2.09). Divorce was associated with elevated cardiovascular disease (CVD) mortality in women (HR = 1.47, 95% CI: 1.01, 2.13) and elevated all-cause mortality (HR = 2.45, 95% CI: 1.55, 3.86) in men. Amongst men, not being married was associated with excess all-cause (HR = 1.45, 95% CI: 1.12, 1.88) and CVD (HR = 1.65, 95% CI: 1.07, 2.54) mortality. Conclusions: Marriage is associated with decreased all cause mortality and CVD mortality, in particular, among both Chinese men and women.	[Va, Puthiery] Univ New England, Coll Osteopath Med, Biddeford, ME USA; [Yang, Wan-Shui; Gao, Shan; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogene & Related Genes,Sch Med, Shanghai 200030, Peoples R China; [Yang, Wan-Shui; Gao, Shan; Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Renji Hosp, Dept Epidemiol, Shanghai Canc Inst,Sch Med, Shanghai 200030, Peoples R China; [Nechuta, Sarah; Cai, Hui; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Chow, Wong-Ho] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA	University of New England - Maine; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Va, P (corresponding author), Univ New England, Coll Osteopath Med, Biddeford, ME USA.	ybxiang@shsci.org	gao, yi/HCI-8298-2022; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022; Nechuta, Sarah/AAG-4025-2020; Yang, Wanshui/S-9322-2019; Zheng, Wei/O-3351-2013; Gao, Y./GWZ-3665-2022; Swaibu, Ramadhani A/H-3164-2011	Nechuta, Sarah/0000-0003-2773-6678; Yang, Wanshui/0000-0002-7365-2689; Zheng, Wei/0000-0003-1226-070X; 	US National Institutes of Health [R37 CA070867, R01 CA82729, R01 HL095931]; funds of state key project specialized for infectious diseases of China [2008ZX10002-015]; Fogarty International Clinical Research Scholars; Vanderbilt Institute for Global Health; Fogarty International Center, NIH [R24TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA070867, R01CA082729, U54CA163069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095931] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); funds of state key project specialized for infectious diseases of China; Fogarty International Clinical Research Scholars; Vanderbilt Institute for Global Health; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the US National Institutes of Health (R37 CA070867, R01 CA82729, and R01 HL095931) and the funds of state key project specialized for infectious diseases of China (No. 2008ZX10002-015). Puthiery Va is supported by the Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health, funded by the Fogarty International Center, NIH, through an R24 Training Grant (Grant number: R24TW007988). The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bozkurt Biykem, 2010, Methodist Debakey Cardiovasc J, V6, P21; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Cheung YB, 2000, INT J EPIDEMIOL, V29, P93, DOI 10.1093/ije/29.1.93; Cornman JC, 2003, J AGING HEALTH, V15, P616, DOI 10.1177/0898264303256215; Coulter SA, 2011, TEX HEART I J, V38, P137; Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80; Dupre ME, 2009, AM J EPIDEMIOL, V170, P546, DOI 10.1093/aje/kwp194; ELDER GH, 1976, J FAM HIST, V1, P34, DOI 10.1177/036319907600100104; ENGEL JW, 1984, INT J FAM THER, V6, P192, DOI 10.1007/BF00926931; Forthofer MS, 1996, J HEALTH SOC BEHAV, V37, P121, DOI 10.2307/2137268; Gao YT, 2000, INT J CANCER, V87, P295, DOI 10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7; GOLDMAN N, 1993, DEMOGRAPHY, V30, P189, DOI 10.2307/2061837; Grundy EMD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-554; Guralnik JM, 2009, AGING CLIN EXP RES, V21, P174; Hamer M, 2008, PHYSIOL BEHAV, V94, P536, DOI 10.1016/j.physbeh.2008.03.010; Ikeda A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-73; Jin L, 2009, DEMOGRAPHY, V46, P605, DOI 10.1353/dem.0.0066; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Joung IMA, 1998, SOC SCI MED, V46, P425, DOI 10.1016/S0277-9536(97)00186-X; Kerr-Correa F, 2007, J AFFECT DISORDERS, V102, P265, DOI 10.1016/j.jad.2006.09.031; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; Kouvonen A, 2010, EUR J CLIN NUTR, V64, P16; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Malyutina S, 2004, ANN EPIDEMIOL, V14, P244, DOI 10.1016/S1047-2797(03)00133-9; Malyutina S, 2004, ALCOHOL ALCOHOLISM, V39, P64, DOI 10.1093/alcalc/agh022; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Matthews CE, 2003, AM J EPIDEMIOL, V158, P1114, DOI 10.1093/aje/kwg255; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Miller D, 2005, J NUTR EDUC BEHAV, V37, P226, DOI 10.1016/S1499-4046(06)60276-5; Ministry Chinese Civil Affair, 2009, CIV AFF DEV STAT REP, P2; Molloy GJ, 2009, SOC SCI MED, V69, P223, DOI 10.1016/j.socscimed.2009.05.010; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; Nilsson PM, 2005, SCAND J PUBLIC HEALT, V33, P412, DOI 10.1080/14034940510005905; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Pimentel EF, 2000, J MARRIAGE FAM, V62, P32, DOI 10.1111/j.1741-3737.2000.00032.x; Poston DL, 2000, J FAM ISSUES, V21, P714, DOI 10.1177/019251300021006003; Prescott CA, 2001, J STUD ALCOHOL, V62, P589, DOI 10.15288/jsa.2001.62.589; Prigerson HG, 1999, MED CARE, V37, P858, DOI 10.1097/00005650-199909000-00003; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sbarra DA, 2009, PSYCHOSOM MED, V71, P828, DOI 10.1097/PSY.0b013e3181b4c4f2; Scafato E, 2008, SOC SCI MED, V67, P1456, DOI 10.1016/j.socscimed.2008.06.026; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; SHYE D, 1995, SOC SCI MED, V41, P935, DOI 10.1016/0277-9536(94)00404-H; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Turner-Cobb JM, 2000, PSYCHOSOM MED, V62, P337, DOI 10.1097/00006842-200005000-00007; Tzotzas T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-732; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Wachterman MW, 2006, J PALLIAT MED, V9, P343, DOI 10.1089/jpm.2006.9.343; Waldron I, 1997, SOC SCI MED, V45, P1387, DOI 10.1016/S0277-9536(97)00065-8; Wang, 2003, ANN ECON FINANC, V4, P343; Whisman MA, 2010, J FAM PSYCHOL, V24, P367, DOI 10.1037/a0019547; WYKE S, 1992, SOC SCI MED, V34, P523, DOI 10.1016/0277-9536(92)90208-8; Yi SW, 2009, J ALTERN COMPLEM MED, V15, P921, DOI 10.1089/acm.2008.0296; Zeng Y., 2003, DEMOGR RES, V8, P215, DOI [10.4054/DemRes.2003.8.7, DOI 10.4054/DEMRES.2003.8.7]; Zeng Y, 2000, DEMOGRAPHIC RES; Zeng Y., 2002, DEMOGR RES, V7, P407, DOI [10.4054/DemRes.2002.7.11, DOI 10.4054/DemRes.2002.7.11]; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	64	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26600	10.1371/journal.pone.0026600	http://dx.doi.org/10.1371/journal.pone.0026600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073174	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900026
J	Xu, JL; Cao, SX; Wang, L; Xu, R; Chen, G; Xu, Q				Xu, Jianliang; Cao, Shaoxian; Wang, Lu; Xu, Rui; Chen, Gong; Xu, Qiang			VEGF Promotes the Transcription of the Human PRL-3 Gene in HUVEC through Transcription Factor MEF2C	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TYROSINE-PHOSPHATASE; COLORECTAL-CANCER; METASTASIS; EXPRESSION; GROWTH; DIFFERENTIATION; SUPPRESSES; CARCINOMA; MIGRATION	Phosphatase of regenerating liver 3 (PRL-3) is known to be overexpressed in many tumors, and its transcript level is high in the vasculature and endothelial cells of malignant tumor tissue. However, the mechanism(s) underlying its enhanced expression and its function in endothelial cells remain unknown. Here, we report that vascular endothelial growth factor (VEGF) can induce PRL-3 transcription in human umbilical vein endothelial cells (HUVEC). An analysis of its 5'UTR revealed that PRL-3 transcription is initiated from two distinct sites, which results in the formation of the two transcripts, PRL-3-iso1 and PRL-3-iso2, but only the latter is up-regulated in HUVEC by VEGF. The PRL-3-iso2 promoter region includes two functional MEF2 (myocyte enhancer factor2) binding sites. The over-expression of the constitutively active form of MEF2C promotes the abundance of the PRL-3-iso2 transcript in a number of human cell lines. The siRNA-induced knockdown of MEF2C abolished the stimulative effect of VEGF on PRL-3 transcript in HUVEC, indicating that the VEGF-induced promotion of PRL-3 expression requires the presence of MEF2C. Finally, blocking PRL-3 activity or expression suppresses tube formation by HUVEC. We suggest that PRL-3 functions downstream of the VEGF/MEF2C pathway in endothelial cells and may play an important role in tumor angiogenesis.	[Xu, Jianliang; Cao, Shaoxian; Wang, Lu; Xu, Rui; Chen, Gong; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China	Nanjing University	Xu, JL (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	molpharm@163.com	Xu, Jianliang/AGG-2739-2022	Xu, Jianliang/0000-0003-4154-4322	National Science and Technology Major Project of China [2009ZX09303-001, 2009ZX09102-129]; Science Fund for Creative Research Groups [30821006]; Natural Science Foundation of Jiangsu Province [BK2008022]	National Science and Technology Major Project of China; Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was in part supported by National Science and Technology Major Project of China (No. 2009ZX09303-001 and 2009ZX09102-129), Science Fund for Creative Research Groups (No. 30821006) and Natural Science Foundation of Jiangsu Province (BK2008022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Ambler CA, 2003, DEV BIOL, V257, P205, DOI 10.1016/S0012-1606(03)00042-3; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Choi MS, 2011, BIOCHEM BIOPH RES CO, V406, P305, DOI 10.1016/j.bbrc.2011.02.037; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kong L, 2007, NEUROPATHOLOGY, V27, P516, DOI 10.1111/j.1440-1789.2007.00818.x; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu YQ, 2008, ARCH PATHOL LAB MED, V132, P1307, DOI 10.1043/1543-2165(2008)132[1307:EOPORL]2.0.CO;2; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Sager JA, 2004, CANCER BIOL THER, V3, P952, DOI 10.4161/cbt.3.10.1115; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291	41	18	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27165	10.1371/journal.pone.0027165	http://dx.doi.org/10.1371/journal.pone.0027165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073279	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900083
J	Bensmihen, S; de Billy, F; Gough, C				Bensmihen, Sandra; de Billy, Francoise; Gough, Clare			Contribution of NFP LysM Domains to the Recognition of Nod Factors during the Medicago truncatula/Sinorhizobium meliloti Symbiosis	PLOS ONE			English	Article							RECEPTOR-LIKE KINASES; RHIZOBIUM-MELILOTI; ARABIDOPSIS-THALIANA; TRUNCATULA CONTROLS; NODULATION FACTORS; FACTOR PERCEPTION; HOST-SPECIFICITY; GENE; BINDING; PROTEIN	The root nodule nitrogen fixing symbiosis between legume plants and soil bacteria called rhizobia is of great agronomical and ecological interest since it provides the plant with fixed atmospheric nitrogen. The establishment of this symbiosis is mediated by the recognition by the host plant of lipo-chitooligosaccharides called Nod Factors (NFs), produced by the rhizobia. This recognition is highly specific, as precise NF structures are required depending on the host plant. Here, we study the importance of different LysM domains of a LysM-Receptor Like Kinase (LysM-RLK) from Medicago truncatula called Nod factor perception (NFP) in the recognition of different substitutions of NFs produced by its symbiont Sinorhizobium meliloti. These substitutions are a sulphate group at the reducing end, which is essential for host specificity, and a specific acyl chain at the non-reducing end, that is critical for the infection process. The NFP extracellular domain (ECD) contains 3 LysM domains that are predicted to bind NFs. By swapping the whole ECD or individual LysM domains of NFP for those of its orthologous gene from pea, SYM10 (a legume plant that interacts with another strain of rhizobium producing NFs with different substitutions), we showed that NFP is not directly responsible for specific recognition of the sulphate substitution of S. meliloti NFs, but probably interacts with the acyl substitution. Moreover, we have demonstrated the importance of the NFP LysM2 domain for rhizobial infection and we have pinpointed the importance of a single leucine residue of LysM2 in that step of the symbiosis. Together, our data put into new perspective the recognition of NFs in the different steps of symbiosis in M. truncatula, emphasising the probable existence of a missing component for early NF recognition and reinforcing the important role of NFP for NF recognition during rhizobial infection.	[Bensmihen, Sandra; de Billy, Francoise; Gough, Clare] INRA, LIPM, F-31326 Castanet Tolosan, France; [Bensmihen, Sandra; de Billy, Francoise; Gough, Clare] CNRS, LIPM, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bensmihen, S (corresponding author), INRA, LIPM, F-31326 Castanet Tolosan, France.	sandra.bensmihen@toulouse.inra.fr		bensmihen, sandra/0000-0003-1351-7220	French Agence Nationale de la Recherche [ANR-05-BLAN-0243-01]; European Community through a Marie Curie Research Training Network [MRTN-CT-2006-035546]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community through a Marie Curie Research Training Network	This work was funded by the French Agence Nationale de la Recherche (contract ANR-05-BLAN-0243-01 "NodBindsLysM") and by the European Community's Sixth Framework Programme through a Marie Curie Research Training Network (contract MRTN-CT-2006-035546 "NODPERCEPTION"). This work is part of the "Laboratoire d'Excellence (LABEX) entitled TULIP (ANR -10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bek AS, 2010, MOL PLANT MICROBE IN, V23, P58, DOI 10.1094/MPMI-23-1-0058; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Catoira R, 2001, DEVELOPMENT, V128, P1507; Charron D, 2004, PLANT PHYSIOL, V136, P3582, DOI 10.1104/pp.104.051110; Cronk Q, 2006, CURR OPIN PLANT BIOL, V9, P99, DOI 10.1016/j.pbi.2006.01.011; Cullimore J, 2003, SCIENCE, V302, P575, DOI 10.1126/science.1091269; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; DEBELLE F, 1988, J BACTERIOL, V170, P5718, DOI 10.1128/jb.170.12.5718-5727.1988; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; FAUCHER C, 1988, J BACTERIOL, V170, P5489, DOI 10.1128/jb.170.12.5489-5499.1988; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Oldroyd GED, 2001, PLANT J, V28, P191, DOI 10.1046/j.1365-313X.2001.01149.x; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; STAEHELIN C, 1994, PLANT J, V5, P319, DOI 10.1111/j.1365-313X.1994.00319.x; Wais RJ, 2002, PLANT PHYSIOL, V129, P211, DOI 10.1104/pp.010690; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097	43	46	50	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26114	10.1371/journal.pone.0026114	http://dx.doi.org/10.1371/journal.pone.0026114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087221	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700003
J	Rasmussen, AR; Murphy, JC; Ompi, M; Gibbons, JW; Uetz, P				Rasmussen, Arne Redsted; Murphy, John C.; Ompi, Medy; Gibbons, J. Whitfield; Uetz, Peter			Marine Reptiles	PLOS ONE			English	Review							BYCATCH REDUCTION DEVICES; PRAWN TRAWL BYCATCH; SEA-SNAKES; MOLECULAR PHYLOGENY; REPRODUCTIVE-BIOLOGY; CROCODYLUS-POROSUS; RELATIVE ABUNDANCE; SALT-GLANDS; BY-CATCH; SERPENTES		[Rasmussen, Arne Redsted] Royal Danish Acad Fine Arts, Sch Conservat, Copenhagen, Denmark; [Murphy, John C.] Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA; [Ompi, Medy] Sam Ratulangi Univ, Fac Fisheries & Marine Sci, Marine Biol Lab, Manado, N Sulawesi, Indonesia; [Gibbons, J. Whitfield] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Field Museum of Natural History (Chicago); Universitas Sam Ratulangi; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; Virginia Commonwealth University	Rasmussen, AR (corresponding author), Royal Danish Acad Fine Arts, Sch Conservat, Copenhagen, Denmark.	peter@uetz.us	Uetz, Peter/A-7119-2012; Ompi, Medy/AAB-9625-2021	Uetz, Peter/0000-0001-6194-4927; Ompi, Medy/0000-0002-1229-9682; Rasmussen, Arne Redsted/0000-0001-5454-4423	U.S. Department of Energy [DE-FC09-07SR22506]; European Union	U.S. Department of Energy(United States Department of Energy (DOE)); European Union(European Commission)	Support for manuscript preparation was provided by the U.S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation and Savannah River Ecology Laboratory (JWG). PU acknowledges support by the European Union for the Reptile Database under the Catalogue of Life (4D4Life) e-Infrastructure projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AC, 1986, GUIDE PHILIPPINE FLO, V10, P1; Alfaro ME, 2004, J BIOGEOGR, V31, P1277, DOI 10.1111/j.1365-2699.2004.01114.x; ANDERSON PAUL K., 1961, AMER MIDLAND NAT, V66, P235, DOI 10.2307/2422879; Bacolod P.T., 1990, Philippine Scientist, V27, P61; Barbieri F., 2006, ATLAS ITALIAN AMPHIB, V1, P362; Bergman AM, 1943, COPEIA, V1943, P156; Branch B, 1998, FIELD GUIDE SNAKES O, P399; Brewer D, 1998, FISH RES, V36, P195, DOI 10.1016/S0165-7836(98)00096-4; Brewer D, 2006, FISH RES, V81, P176, DOI 10.1016/j.fishres.2006.07.009; Brischoux F, 2010, AUSTR ECOLOGY; Bussarawit S., 1989, Natural History Bulletin of the Siam Society, V37, P209; Castoe TA, 2007, ZOOL J LINN SOC-LOND, V151, P809, DOI 10.1111/j.1096-3642.2007.00350.x; COGGER H, 1987, J HERPETOL, V21, P255, DOI 10.2307/1563967; Cogger H.G., 1975, BIOL SEA SNAKES, P59; Cogger HG, 2006, REC AUST MUS, V58, P245, DOI 10.3853/j.0067-1975.58.2006.1452; Cramp RL, 2010, J EXP BIOL, V213, P1301, DOI 10.1242/jeb.039305; David P., 1999, DUMERILIA, V3, P3; DUNSON WA, 1982, COPEIA, P374, DOI 10.2307/1444618; DUNSON WA, 1969, AM J PHYSIOL, V216, P995, DOI 10.1152/ajplegacy.1969.216.4.995; Fry G. C., 2001, Pacific Conservation Biology, V7, P55; Golay P., 1993, ENDOGLYPHS OTHER MAJ; GORMAN GC, 1981, J HERPETOL, V15, P335, DOI 10.2307/1563438; Greer A.E., 1997, BIOL EVOLUTION AUSTR; Guinea Michael L., 2005, Beagle, P199; Guinea Michael L., 1994, P212; Hansknecht KA, 2010, J COMP PSYCHOL, V124, P159, DOI 10.1037/a0019143; Heales DS, 2008, FISH RES, V89, P76, DOI 10.1016/j.fishres.2007.09.002; Heatwole H, 2005, HERPETOL MONOGR, V19, P1, DOI 10.1655/0733-1347(2005)019[0001:GVISKO]2.0.CO;2; Heatwole H, 1997, WILDLIFE SOC B, V25, P766; Heatwole H, 1994, FAMILY HYDROPHIIDAE, P1; Heatwole H, 1999, SEA SNAKES, V148, P112; HIGGINS PJ, 1978, BIOSCIENCE, V28, P512, DOI 10.2307/1307298; Ineich I, 2007, MAR BIOL, V151, P793, DOI 10.1007/s00227-006-0527-6; Ineich Ivan, 1996, Herpetological Review, V27, P154; Karns DR, 2002, RAFFLES B ZOOL, V50, P487; Karthikeyan R, 2008, APPL HERPETOL, V5, P75, DOI 10.1163/157075408783489220; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Keogh JS, 1998, BIOL J LINN SOC, V63, P177, DOI 10.1006/bijl.1997.0178; KHARIN V E, 1989, Vestnik Zoologii, P29; Kharin V.E., 2004, RUSSIAN J MARINE BIO, V30, P196; Kharin V.E., 2005, IZV TINRO, V140, P71; Kharin V.E., 2004, RUSSIAN J MARINE BIO, V30, P387; KHARIN VE, 1984, ZOOL ZH, V63, P1535; Kharin Vladimir E., 2009, Russian Journal of Herpetology, V16, P183; Kharin Vladimir E., 2006, Russian Journal of Herpetology, V13, P227; KIRSCHNER LB, 1980, AM J PHYSIOL, V238, pR219, DOI 10.1152/ajpregu.1980.238.3.R219; LEMEN CA, 1981, J ANIM ECOL, V50, P89, DOI 10.2307/4033; Liner E.A., 1994, HERPETOLOGICAL CIRCU, V23, P1; Lobo AS, 2007, RESONANCE, V12, P60, DOI 10.1007/s12045-007-0051-0; Lohmann KJ, 2007, CURR BIOL, V17, pR102, DOI 10.1016/j.cub.2007.01.023; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Lucker H, 2002, ELAPHE, V10, P49; Luiselli L, 2002, AFR J ECOL, V40, P220, DOI 10.1046/j.1365-2028.2002.00358.x; Luiselli L, 2005, CONTRIB ZOOL, V74, P41, DOI 10.1163/18759866-0740102003; Lukoschek V, 2006, BIOL J LINN SOC, V89, P523, DOI 10.1111/j.1095-8312.2006.00691.x; Mao SH, 1980, NATL SCI COUNCIL SPE, V4, P1; Martin S, 2008, HYDROBIOLOGIA, V595, P587, DOI 10.1007/s10750-007-9030-4; Masunaga G, 2003, HERPETOL J, V13, P113; MAZZOTTI FJ, 1984, COMP BIOCHEM PHYS A, V79, P641, DOI 10.1016/0300-9629(84)90462-6; McCarthy C.J., 1986, Bulletin of the British Museum (Natural History) Zoology, V50, P127; McCord WP, 2003, CHELONIAN ILLUSTRATI, P34; McCosker J., 1975, BIOL SEA SNAKES, V75, P217; McDowell S.B., 1972, Transactions Zool Soc London, V32, P189; MCDOWELL SB, 1967, J ZOOL, V151, P497; MCDOWELL SB, 1970, J ZOOL, V161, P145; Meganathan PR, 2010, MOL PHYLOGENET EVOL, V57, P393, DOI 10.1016/j.ympev.2010.06.011; Minton S.A., 1975, BIOL SEA SNAKES, P21; Montague J.J., 1983, Herpetological Review, V14, P36; Murphy J. C., 2007, HOMALOPSID SNAKES EV; Naro-Maciel E, 2008, MOL PHYLOGENET EVOL, V49, P659, DOI 10.1016/j.ympev.2008.08.004; Neill WT, 1957, B MAR SCI GULF CARIB, V8, P1; Nguyen V. S., 2009, HERPETOFAUNA VIETNAM; Povel D, 1997, NETH J ZOOL, V47, P443; Punay EY, 1975, BIOL SEA SNAKES, P417; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rasmussen A.R, 2000, LIVING MARINE RESOUR, V6, P3987; Rasmussen A.R., 1989, AMPHIBIA-REPTILIA, V10, P397, DOI DOI 10.1163/156853889X00043; RASMUSSEN AR, 1994, ZOOL J LINN SOC-LOND, V111, P161, DOI 10.1111/j.1096-3642.1994.tb01481.x; RASMUSSEN AR, 1992, HERPETOLOGICA, V48, P85; Rasmussen AR, 2001, HERPETOLOGICA, V57, P23; Rasmussen AR, ZOOTAXA IN PRESS; Rasmussen Arne Redsted, 2002, Steenstrupia, V27, P47; Rasmussen Arne Redsted, 2000, Hamadryad, V25, P91; Rasmussen Arne Redsted, 2007, Hamadryad, V31, P288; Rasmussen Arne Redsted, 1996, Symposia of the Zoological Society of London, V70, P15; Rasmussen Arne Redsted, 1993, Bulletin of the British Museum (Natural History) Zoology, V59, P97; Rassmann K, 1997, J ZOOL, V242, P729, DOI 10.1111/j.1469-7998.1997.tb05822.x; Reid HA, 1975, BIOL SEA SNAKES, P417; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2010, J EVOLUTION BIOL, V23, P2685, DOI 10.1111/j.1420-9101.2010.02131.x; Scanlon JD, 2004, ZOOL SCR, V33, P335, DOI 10.1111/j.0300-3256.2004.00151.x; SCHLEICH H. H., 1996, AMPHIBIANS REPTILES; Seminoff JA, 2011, IUCN RED LIST CHELON; Shine R, 2003, P ROY SOC B-BIOL SCI, V270, P995, DOI 10.1098/rspb.2002.2307; SHINE R, 1986, COPEIA, P424, DOI 10.2307/1445000; SLOWINSKI JB, 1989, COPEIA, P783, DOI 10.2307/1445518; Smith M. A., 1943; Smith M. A., 1935, Dana Reports, VNo. 8, P1; Smith M. A., 1926, MONOGRAPH SEA SNAKES; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Switak KH, 1996, REPTILES, V4, P12; TAPLIN LE, 1981, SCIENCE, V212, P1045, DOI 10.1126/science.212.4498.1045; TAPLIN LE, 1988, COMP BIOCHEM PHYS A, V89, P443, DOI 10.1016/0300-9629(88)91054-7; Taylor E. H., 1963, Copeia, V1963, P429, DOI 10.2307/1441364; Tonks ML, 2008, FISH RES, V89, P276, DOI 10.1016/j.fishres.2007.09.007; Toriba M., 1994, P206; TU MC, 1990, J HERPETOL, V24, P119, DOI 10.2307/1564218; Uetz P., REPTILE DATABASE; Vidal NRJ, 2009, TIMETREE LIFE CHRONO; Vincent SE, 2005, ANIM BEHAV, V70, P715, DOI 10.1016/j.anbehav.2005.01.002; Volsoe H, 1939, DANISH SCI INVESTIGA, V1, P9; Voris H., 1972, J MAR BIOL ASSOC IND, V14, P429; VORIS H K, 1977, Fieldiana Zoology, V70, P79; Voris HK, 2002, J NAT HIST, V36, P1621, DOI 10.1080/00222930110062642; VORIS HK, 1983, AM ZOOL, V23, P411; VORIS HK, 1979, COPEIA, P307; Ward TM, 1996, MAR FRESHWATER RES, V47, P631, DOI 10.1071/MF9960631; Ward TM, 2000, MAR FRESHWATER RES, V51, P155, DOI 10.1071/MF98134; Ward TM, 2001, MAR FRESHWATER RES, V52, P193, DOI 10.1071/MF00025; Warrell David A., 1994, P1; WASSENBERG TJ, 1994, AUST J MAR FRESH RES, V45, P429, DOI 10.1071/MF9940429; Wassenberg TJ, 2001, BIOL CONSERV, V100, P271, DOI 10.1016/S0006-3207(01)00031-3; Wells RW, 2007, AUSTR BIODIVERSITY R, V8, P1325; Werneburg I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-82; Zug GR, 2001, HERPETOLOGY	127	89	93	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27373	10.1371/journal.pone.0027373	http://dx.doi.org/10.1371/journal.pone.0027373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087300	Green Submitted, gold, Green Published			2022-12-27	WOS:000297349700035
J	Pieper, R; Zhang, QS; Clark, DJ; Huang, ST; Suh, MJ; Braisted, JC; Payne, SH; Fleischmann, RD; Peterson, SN; Tzipori, S				Pieper, Rembert; Zhang, Quanshun; Clark, David J.; Huang, Shih-Ting; Suh, Moo-Jin; Braisted, John C.; Payne, Samuel H.; Fleischmann, Robert D.; Peterson, Scott N.; Tzipori, Saul			Characterizing the Escherichia coli O157:H7 Proteome Including Protein Associations with Higher Order Assemblies	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; EXTRACELLULAR PROTEINS; STATISTICAL-MODEL; ABSOLUTE PROTEIN; MASS; IDENTIFICATION; O157-H7; EXPRESSION; MEMBRANE; SEQUENCE	Background: The recent outbreak of severe infections with Shiga toxin (Stx) producing Escherichia coli (STEC) serotype O104:H4 highlights the need to understand horizontal gene transfer among E. coli strains, identify novel virulence factors and elucidate their pathogenesis. Quantitative shotgun proteomics can contribute to such objectives, allowing insights into the part of the genome translated into proteins and the connectivity of biochemical pathways and higher order assemblies of proteins at the subcellular level. Methodology/Principal Findings: We examined protein profiles in cell lysate fractions of STEC strain 86-24 (serotype O157:H7), following growth in cell culture or bacterial isolation from intestines of infected piglets, in the context of functionally and structurally characterized biochemical pathways of E. coli. Protein solubilization in the presence of Triton X-100, EDTA and high salt was followed by size exclusion chromatography into the approximate M-r ranges greater than 280 kDa, 280-80 kDa and 80-10 kDa. Peptide mixtures resulting from these and the insoluble fraction were analyzed by quantitative 2D-LC-nESI-MS/MS. Of the 2521 proteins identified at a 1% false discovery rate, representing 47% of all predicted E. coli O157:H7 gene products, the majority of integral membrane proteins were enriched in the high Mr fraction. Hundreds of proteins were enriched in a Mr range higher than that predicted for a monomer supporting their participation in protein complexes. The insoluble STEC fraction revealed enrichment of aggregation-prone proteins, including many that are part of large structure/function entities such as the ribosome, cytoskeleton and O-antigen biosynthesis cluster. Significance: Nearly all E. coli O157:H7 proteins encoded by prophage regions were expressed at low abundance levels or not detected. Comparative quantitative analyses of proteins from distinct cell lysate fractions allowed us to associate uncharacterized proteins with membrane attachment, potential participation in stable protein complexes, and susceptibility to aggregation as part of larger structural assemblies.	[Pieper, Rembert; Clark, David J.; Huang, Shih-Ting; Suh, Moo-Jin; Braisted, John C.; Payne, Samuel H.; Fleischmann, Robert D.; Peterson, Scott N.] J Craig Venter Inst, Rockville, MD USA; [Zhang, Quanshun; Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Div Infect Dis, North Grafton, MA USA	J. Craig Venter Institute; Tufts University	Pieper, R (corresponding author), J Craig Venter Inst, Rockville, MD USA.	rpieper@jcvi.org	Suh, Moo-Jin/A-5436-2010; Payne, Samuel/AAC-6388-2021	Suh, Moo-Jin/0000-0003-0003-393X; Payne, Samuel/0000-0002-8351-1994; Clark, David/0000-0003-0527-8469	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [N01-AI-30050, N01-AI15447]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funder was the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The funder was involved in the selection process of this White Paper research project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At Tufts University, the work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) under contract number N01-AI-30050. At the J Craig Venter Institute, the work was funded by the NIAID, NIH, under contract number N01-AI15447. The funders had no role in study design, data collection and analysis or preparation of the manuscript. Because the work was funded via two NIH contracts, the funder reserved the right to approve submission of the manuscript for publication, but the research teams made the decision to publish.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ARAKAWA T, 2001, CURR PROTOC PROTEIN, pCH20; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Asakura H, 2007, MICROBIOL IMMUNOL, V51, P875, DOI 10.1111/j.1348-0421.2007.tb03969.x; Bernsel A, 2009, TRENDS MICROBIOL, V17, P444, DOI 10.1016/j.tim.2009.07.005; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; COLE ST, 1988, J BACTERIOL, V170, P2448, DOI 10.1128/jb.170.6.2448-2456.1988; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Cornick NA, 2000, J INFECT DIS, V181, P242, DOI 10.1086/315172; Denamur E, 2011, CLIN MICROBIOL INFEC, V17, P1124, DOI 10.1111/j.1469-0691.2011.03620.x; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hyde R, 2011, LANCET, V377, P1991, DOI 10.1016/S0140-6736(11)60847-7; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Kaberdin VR, 2009, RNA BIOL, V6, P402, DOI 10.4161/rna.6.4.9320; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kuntumalla S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-147; Kuntumalla S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-22; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lee JH, 2011, CURR MICROBIOL, V62, P1321, DOI 10.1007/s00284-010-9862-4; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Link AJ, 2002, TRENDS BIOTECHNOL, V20, pS8, DOI 10.1016/S1471-1931(02)00202-1; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PAGE WJ, 1988, J GEN MICROBIOL, V134, P2925; Pan JY, 2010, J PROTEOME RES, V9, P3730, DOI 10.1021/pr100301f; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; PICKERING LK, 1994, PEDIATR INFECT DIS J, V13, P459, DOI 10.1097/00006454-199406000-00001; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Pieper R, 2009, PROTEOMICS, V9, P5029, DOI 10.1002/pmic.200900196; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rudnick PA, 2010, MOL CELL PROTEOMICS, V9, P225, DOI 10.1074/mcp.M900223-MCP200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P545, DOI 10.1128/JB.108.1.545-552.1971; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P553, DOI 10.1128/JB.108.1.553-563.1971; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Swanson SK, 2005, DRUG DISCOV TODAY, V10, P719, DOI 10.1016/S1359-6446(05)03450-1; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; VOEGELE RT, 1993, J BACTERIOL, V175, P1087, DOI 10.1128/JB.175.4.1087-1094.1993; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Whittam, 2006, ECMLST MULTILOCUS SE; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Xiong XL, 1996, J BACTERIOL, V178, P1213, DOI 10.1128/jb.178.4.1213-1215.1996; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zhang J, 2007, PROTEOMICS, V7, P500, DOI 10.1002/pmic.200500880; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	83	14	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26554	10.1371/journal.pone.0026554	http://dx.doi.org/10.1371/journal.pone.0026554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087229	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700007
J	Armand, AS; Laziz, I; Djeghloul, D; Lecolle, S; Bertrand, AT; Biondi, O; De Windt, LJ; Chanoine, C				Armand, Anne-Sophie; Laziz, Iman; Djeghloul, Dounia; Lecolle, Sylvie; Bertrand, Anne T.; Biondi, Olivier; De Windt, Leon J.; Chanoine, Christophe			Apoptosis-Inducing Factor Regulates Skeletal Muscle Progenitor Cell Number and Muscle Phenotype	PLOS ONE			English	Article							GLUTAMATE CYSTEINE LIGASE; OXIDATIVE STRESS; SATELLITE CELLS; STEM-CELLS; FIBER-TYPE; MYONUCLEAR NUMBER; IN-VIVO; ATROPHY; REGENERATION; MOUSE	Apoptosis Inducing Factor (AIF) is a highly conserved, ubiquitous flavoprotein localized in the mitochondrial intermembrane space. In vivo, AIF provides protection against neuronal and cardiomyocyte apoptosis induced by oxidative stress. Conversely in vitro, AIF has been demonstrated to have a pro-apoptotic role upon induction of the mitochondrial death pathway, once AIF translocates to the nucleus where it facilitates chromatin condensation and large scale DNA fragmentation. Given that the aif hypomorphic harlequin (Hq) mutant mouse model displays severe sarcopenia, we examined skeletal muscle from the aif hypomorphic mice in more detail. Adult AIF-deficient skeletal myofibers display oxidative stress and a severe form of atrophy, associated with a loss of myonuclei and a fast to slow fiber type switch, both in "slow" muscles such as soleus, as well as in "fast" muscles such as extensor digitorum longus, most likely resulting from an increase of MEF2 activity. This fiber type switch was conserved in regenerated soleus and EDL muscles of Hq mice subjected to cardiotoxin injection. In addition, muscle regeneration in soleus and EDL muscles of Hq mice was severely delayed. Freshly cultured myofibers, soleus and EDL muscle sections from Hq mice displayed a decreased satellite cell pool, which could be rescued by pretreating aif hypomorphic mice with the manganese-salen free radical scavenger EUK-8. Satellite cell activation seems to be abnormally long in Hq primary culture compared to controls. However, AIF deficiency did not affect myoblast cell proliferation and differentiation. Thus, AIF protects skeletal muscles against oxidative stress-induced damage probably by protecting satellite cells against oxidative stress and maintaining skeletal muscle stem cell number and activation.	[Armand, Anne-Sophie; Laziz, Iman; Djeghloul, Dounia; Lecolle, Sylvie; Biondi, Olivier; Chanoine, Christophe] Univ Paris 05, Ctr Etude Sensori Motricite, Ctr Univ St Peres, UMR CNRS 8194, Paris, France; [Bertrand, Anne T.] Royal Netherlands Acad Sci, Hubrecht Inst, Utrecht, Netherlands; [Bertrand, Anne T.] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [De Windt, Leon J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands	UDICE-French Research Universities; Universite Paris Cite; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University	Armand, AS (corresponding author), Univ Paris 05, Ctr Etude Sensori Motricite, Ctr Univ St Peres, UMR CNRS 8194, Paris, France.	christophe.chanoine@parisdescartes.fr	Bertrand, Anne/AAR-6751-2020; de Windt, Leon/AAO-6395-2020	de Windt, Leon/0000-0002-7793-2856; Bertrand, Anne/0000-0001-7153-848X; Armand, Anne-Sophie/0000-0002-0291-6421; chanoine, christophe/0000-0001-8155-2357	Fondation Bettencourt Schueller; Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Association Francaise contre les Myopathies; Netherlands Organization for Health Research and Development [912-04-054, 912-04-017, 917-863-72]; Netherlands Heart Foundation [NHS2007B167]; European Union [LSHM-CT-005-018833/EUGeneHeart]; Fondation Leducq Transatlantic Network of Excellence	Fondation Bettencourt Schueller; Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); European Union(European Commission); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation)	ATB was supported by a young investigator's award of the Fondation Bettencourt Schueller. OB held a doctoral fellowship from the Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT). This work was supported by grants from the Association Francaise contre les Myopathies. This work was also supported by grants 912-04-054, 912-04-017 and a VIDI award 917-863-72 from The Netherlands Organization for Health Research and Development; grant NHS2007B167 from The Netherlands Heart Foundation; the European Union Contract No. LSHM-CT-005-018833/EUGeneHeart; and the Fondation Leducq Transatlantic Network of Excellence (to LJDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Armand AS, 2004, EXP CELL RES, V297, P27, DOI 10.1016/j.yexcr.2004.02.021; BALABAN RS, 2005, MITOCHONDRIA, V120, P483; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dupont-Versteegden EE, 1999, AM J PHYSIOL-CELL PH, V277, pC589, DOI 10.1152/ajpcell.1999.277.3.C589; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Gundersen K, 2008, J PHYSIOL-LONDON, V586, P2675, DOI 10.1113/jphysiol.2008.154369; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Ishimura R, 2008, J NEUROSCI, V28, P4938, DOI 10.1523/JNEUROSCI.0229-08.2008; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Krzywanski DM, 2004, ARCH BIOCHEM BIOPHYS, V423, P116, DOI 10.1016/j.abb.2003.11.004; Launay T, 2001, J HISTOCHEM CYTOCHEM, V49, P887, DOI 10.1177/002215540104900709; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Perier C, 2010, ANN NEUROL, V68, P184, DOI 10.1002/ana.22034; PETERSON CA, 1995, J GERONTOL A-BIOL, V50, P142; Reimann J, 2004, CELL TISSUE RES, V315, P233, DOI 10.1007/s00441-003-0833-y; Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wang LC, 2001, J ANAT, V199, P631, DOI 10.1046/j.1469-7580.2001.19960631.x; Wigmore PM, 2002, INT REV CYTOL, V216, P175; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	61	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27283	10.1371/journal.pone.0027283	http://dx.doi.org/10.1371/journal.pone.0027283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076146	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200060
J	Strom, TS; Anur, P; Prislovsky, A				Strom, Ted S.; Anur, Praveen; Prislovsky, Amanda			A Numerical Analysis Model for Interpretation of Flow Cytometric Studies of Ex Vivo Phagocytosis	PLOS ONE			English	Article							MEDIATED PHAGOCYTOSIS; PLATELET	The study of ex vivo phagocytosis via flow cytometry requires that one distinguish experimentally between uptake and adsorption of fluorescently labeled targets by phagocytes. Removal of the latter quantity from the analysis is the most common means of analyzing such data. Because the probability of phagocytosis is a function of the probability of adsorption, and because partially quenched fluorescence after uptake often overlaps with that of negative controls, this approach is suboptimal at best. Here, we describe a numerical analysis model which overcomes these limitations. We posit that the random adsorption of targets to macrophages, and subsequent phagocytosis, is a function of three parameters: the ratio of targets to macrophages (m), the mean fluorescence intensity imparted to the phagocyte by the internalized target (alpha), and the probability of phagocytosis per adsorbed target (p). The potential values of these parameters define a parameter space and their values at any point in parameter space can be used to predict the fraction of adsorption(+) and [adsorption(-), phagocytosis(+)] cells that might be observed experimentally. By systematically evaluating the points in parameter space for the latter two values and comparing them to experimental data, the model arrives at sets of parameter values that optimally predict such data. Using activated THP-1 cells as macrophages and platelets as targets, we validate the model by demonstrating that it can distinguish between the effects of experimental changes in m, alpha, and p. Finally, we use the model to demonstrate that platelets from a congenitally thrombocytopenic WAS patient show an increased probability of ex vivo phagocytosis. This finding correlates with other evidence that rapid in vivo platelet consumption contributes significantly to the thrombocytopenia of WAS. Our numerical analysis method represents a useful and innovative approach to multivariate analysis.	[Strom, Ted S.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Strom, Ted S.; Prislovsky, Amanda] Memphis Vet Adm Med Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Anur, Praveen] Oregon Hlth & Sci Univ, Portland, OR USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Oregon Health & Science University	Strom, TS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.	tstrom@uthsc.edu			National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [1R21AI079757]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079757] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) award 1R21AI079757 (TS, PI) and by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam R, 2007, TRANSFUSION, V47, P2161, DOI 10.1111/j.1537-2995.2007.01441.x; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Dewey RA, 2006, EXP HEMATOL, V34, P1162, DOI 10.1016/j.exphem.2006.04.021; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Marathe BM, 2009, EXP HEMATOL, V37, P1353, DOI 10.1016/j.exphem.2009.08.007; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Prislovsky A, 2008, EXP HEMATOL, V36, pe915; Prislovsky A, 2008, EXP HEMATOL, V36, P906; Wiener E, 2003, EUR J HAEMATOL, V70, P67, DOI 10.1034/j.1600-0609.2003.00025.x; Zimring JC, 2005, BLOOD, V106, P1105, DOI 10.1182/blood-2005-03-1040	11	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26657	10.1371/journal.pone.0026657	http://dx.doi.org/10.1371/journal.pone.0026657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073181	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200016
J	Camorlinga-Ponce, M; Perez-Perez, G; Gonzalez-Valencia, G; Mendoza, I; Penaloza-Espinosa, R; Ramos, I; Kersulyte, D; Reyes-Leon, A; Romo, C; Granados, J; Munoz, L; Berg, DE; Torres, J				Camorlinga-Ponce, Margarita; Perez-Perez, Guillermo; Gonzalez-Valencia, Gerardo; Mendoza, Irma; Penaloza-Espinosa, Rosenda; Ramos, Irma; Kersulyte, Dangeruta; Reyes-Leon, Adriana; Romo, Carolina; Granados, Julio; Munoz, Leopoldo; Berg, Douglas E.; Torres, Javier			Helicobacter pylori Genotyping from American Indigenous Groups Shows Novel Amerindian vacA and cagA Alleles and Asian, African and European Admixture	PLOS ONE			English	Article							Y-CHROMOSOME POLYMORPHISMS; MITOCHONDRIAL-DNA; NATIVE-AMERICAN; NORTH-AMERICA; POPULATIONS; STRAINS; MEXICO; DIVERSITY; MTDNA; ASSOCIATION	It is valuable to extend genotyping studies of Helicobacter pylori to strains from indigenous communities across the world to better define adaption, evolution, and associated diseases. We aimed to genetically characterize both human individuals and their infecting H. pylori from indigenous communities of Mexico, and to compare them with those from other human groups. We studied individuals from three indigenous groups, Tarahumaras from the North, Huichols from the West and Nahuas from the center of Mexico. Volunteers were sampled at their community site, DNA was isolated from white blood cells and mtDNA, Y-chromosome, and STR alleles were studied. H. pylori was cultured from gastric juice, and DNA extracted for genotyping of virulence and housekeeping genes. We found Amerindian mtDNA haplogroups (A, B, C, and D), Y-chromosome DYS19T, and Amerindian STRs alleles frequent in the three groups, confirming Amerindian ancestry in these Mexican groups. Concerning H. pylori cagA phylogenetic analyses, although most isolates were of the Western type, a new Amerindian cluster neither Western nor Asian, was formed by some indigenous Mexican, Colombian, Peruvian and Venezuelan isolates. Similarly, vacA phylogenetic analyses showed the existence of a novel Amerindian type in isolates from Alaska, Mexico and Colombia. With hspA strains from Mexico and other American groups clustered within the three major groups, Asian, African or European. Genotyping of housekeeping genes confirmed that Mexican strains formed a novel Asian-related Amerindian group together with strains from remote Amazon Aborigines. This study shows that Mexican indigenous people with Amerindian markers are colonized with H. pylori showing admixture of Asian, European and African strains in genes known to interact with the gastric mucosa. We present evidence of novel Amerindian cagA and vacA alleles in indigenous groups of North and South America.	[Camorlinga-Ponce, Margarita; Gonzalez-Valencia, Gerardo; Mendoza, Irma; Ramos, Irma; Munoz, Leopoldo; Torres, Javier] Inst Mexicano Seguro Social, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Perez-Perez, Guillermo] NYU, Sch Med, New York, NY USA; [Penaloza-Espinosa, Rosenda] Inst Mexicano Seguro Social, Unidad Invest Genet Humana, Mexico City, DF, Mexico; [Kersulyte, Dangeruta; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Reyes-Leon, Adriana; Romo, Carolina] Inst Nacl Pediat, Mexico City, DF, Mexico; [Granados, Julio] Inst Nacl Nutr & Ciencias Med, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; New York University; Instituto Mexicano del Seguro Social; Washington University (WUSTL); Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Camorlinga-Ponce, M (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	jtorresl57@yahoo.com.mx	Perez, Guillermo Perez/AAJ-3761-2020	Perez Perez, Guillermo/0000-0002-0131-5798	CONACYT, Mexico; NYU Center for the Study of Asian American Health; National Institutes of Health Research Center of Excellence [P60 MD000538-05]; Fudacion IMSS, Mexico; US National Institutes of Health [R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078237, R21AI088337] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD000538] Funding Source: NIH RePORTER	CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NYU Center for the Study of Asian American Health; National Institutes of Health Research Center of Excellence; Fudacion IMSS, Mexico; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by CONACYT, Mexico, and by the NYU Center for the Study of Asian American Health, a National Institutes of Health Research Center of Excellence (P60 MD000538-05). JT was a recipient of a exclusivity scholarship from Fudacion IMSS, Mexico. DB received support from the US National Institutes of Health (grants R21 AI078237 and R21 AI088337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Azuma T, 2004, ALIMENT PHARM THER, V20, P7, DOI 10.1111/j.1365-2036.2004.01980.x; Barrot C, 2005, INT J LEGAL MED, V119, P111, DOI 10.1007/s00414-004-0488-6; Bonilla C, 2005, AM J PHYS ANTHROPOL, V128, P861, DOI 10.1002/ajpa.20227; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Gonzalez-Valencia G, 2000, J INFECT DIS, V182, P1450, DOI 10.1086/315864; Guardado-Estrada M, 2009, J HUM GENET, V54, P695, DOI 10.1038/jhg.2009.98; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lisker R, 1996, HUM BIOL, V68, P395; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Mazieres S, 2008, ANN HUM GENET, V72, P145, DOI 10.1111/j.1469-1809.2007.00392.x; McNulty SL, 2004, J CLIN MICROBIOL, V42, P5658, DOI 10.1128/JCM.42.12.5658-5663.2004; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Penaloza-Espinosa RI, 2007, HUM BIOL, V79, P313, DOI 10.1353/hub.2007.0042; Rangel-Villalobos H, 2008, AM J PHYS ANTHROPOL, V135, P448, DOI 10.1002/ajpa.20765; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; Reyes-Leon A, 2007, INFECT IMMUN, V75, P3445, DOI 10.1128/IAI.01951-06; Romo-Gonzalez C, 2009, INFECT IMMUN, V77, P2201, DOI 10.1128/IAI.01284-08; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Sanchez-Boiso A, 2011, RIC IN PRESS; Schauer K, 2010, J BACTERIOL, V192, P1231, DOI 10.1128/JB.01216-09; Spohn G, 2002, J BACTERIOL, V184, P2925, DOI 10.1128/JB.184.11.2925-2930.2002; Suzuki M, 2011, J BIOL CHEM, DOI 101074/jbc.M111.263715; Torres J, 2001, J CLIN MICROBIOL, V39, P1650, DOI 10.1128/JCM.39.4.1650-1651.2001; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; WALLACE DC, 1992, HUM BIOL, V64, P403; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	38	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27212	10.1371/journal.pone.0027212	http://dx.doi.org/10.1371/journal.pone.0027212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073291	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000033
J	Fuster-Matanzo, A; Llorens-Martin, M; de Barreda, EG; Avila, J; Hernandez, F				Fuster-Matanzo, Almudena; Llorens-Martin, Maria; Gomez de Barreda, Elena; Avila, Jesus; Hernandez, Felix			Different Susceptibility to Neurodegeneration of Dorsal and Ventral Hippocampal Dentate Gyrus: A Study with Transgenic Mice Overexpressing GSK3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; TAU-PROTEIN; GSK-3-BETA; PHOSPHORYLATION; INHIBITORS; NEURONS; LITHIUM; HYPERPHOSPHORYLATION; 3-BETA	Dorsal hippocampal regions are involved in memory and learning processes, while ventral areas are related to emotional and anxiety processes. Hippocampal dependent memory and behaviour alterations do not always come out in neurodegenerative diseases at the same time. In this study we have tested the hypothesis that dorsal and ventral dentate gyrus (DG) regions respond in a different manner to increased glycogen synthase kinase-3 beta (GSK3 beta) levels in GSK3 beta transgenic mice, a genetic model of neurodegeneration. Reactive astrocytosis indicate tissue stress in dorsal DG, while ventral area does not show that marker. These changes occurred with a significant reduction of total cell number and with a significantly higher level of cell death in dorsal area than in ventral one as measured by fractin-positive cells. Biochemistry analysis showed higher levels of phosphorylated GSK3 beta in those residues that inactivate the enzyme in hippocampal ventral areas compared with dorsal area suggesting that the observed susceptibility is in part due to different GSK3 regulation. Previous studies carried out with this animal model had demonstrated impairment in Morris Water Maze and Object recognition tests point out to dorsal hippocampal atrophy. Here, we show that two tests used to evaluate emotional status, the light-dark box and the novelty suppressed feeding test, suggest that GSK3 beta mice do not show any anxiety-related disorder. Thus, our results demonstrate that in vivo overexpression of GSK3 beta results in dorsal but not ventral hippocampal DG neurodegeneration and suggest that both areas do not behave in a similar manner in neurodegenerative processes.	[Fuster-Matanzo, Almudena; Llorens-Martin, Maria; Gomez de Barreda, Elena; Avila, Jesus; Hernandez, Felix] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Avila, Jesus; Hernandez, Felix] Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Fuster-Matanzo, A (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	fhernandez@cbm.uam.es	Avila, Jesus/I-2610-2015; Hernandez, Felix/L-2114-2015; Llorens-Martin, Maria/R-4613-2017	Avila, Jesus/0000-0002-6288-0571; Hernandez, Felix/0000-0001-8753-8249; Llorens-Martin, Maria/0000-0001-9129-5198	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT) [SAF2010-15525, SAF 2006-02424]; Comunidad de Madrid (NEURODEGMODELS-CM) [SAL/0202/2006]; Fundacion Centro de Investigaciones de Enfermedades Neurologicas (Fundacion CIEN) [PI 008-09]; Centro de Investigacion Biomedica en Red on Neurodegeneration (CIBER); Fundacion Botin; Fundacion Ramon Areces	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad de Madrid (NEURODEGMODELS-CM)(Comunidad de Madrid); Fundacion Centro de Investigaciones de Enfermedades Neurologicas (Fundacion CIEN); Centro de Investigacion Biomedica en Red on Neurodegeneration (CIBER); Fundacion Botin; Fundacion Ramon Areces	This work was supported by grants from the Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT; SAF2010-15525, SAF 2006-02424), the Comunidad de Madrid (NEURODEGMODELS-CM, SAL/0202/2006), Fundacion Centro de Investigaciones de Enfermedades Neurologicas (Fundacion CIEN, PI 008-09), the Centro de Investigacion Biomedica en Red on Neurodegeneration (CIBER) and by institutional grants from Fundacion Botin and Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Engel T, 2006, J NEUROCHEM, V99, P1445, DOI 10.1111/j.1471-4159.2006.04139.x; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hetman M, 2000, J NEUROSCI, V20, P2567; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2002, EUR NEUROPSYCHOPHARM, V12, P13, DOI 10.1016/S0924-977X(01)00131-6; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Ohm TG, 2007, PROG BRAIN RES, V163, P723, DOI 10.1016/S0079-6123(07)63039-8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Paxinos G., 2001, MOUSE BRAIN; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pruessner JC, 2001, J NEUROSCI, V21, P194, DOI 10.1523/JNEUROSCI.21-01-00194.2001; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	34	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27262	10.1371/journal.pone.0027262	http://dx.doi.org/10.1371/journal.pone.0027262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073301	Green Published, gold			2022-12-27	WOS:000297197000038
J	Goatley, CHR; Bellwood, DR				Goatley, Christopher H. R.; Bellwood, David R.			The Roles of Dimensionality, Canopies and Complexity in Ecosystem Monitoring	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; HABITAT COMPLEXITY; BENTHIC COMPOSITION; CARBONATE BUDGETS; HIGH DIVERSITY; CLIMATE-CHANGE; PHASE-SHIFTS; DISTURBANCE; ALGAE	Canopies are common among autotrophs, increasing their access to light and thereby increasing competitive abilities. If viewed from above canopies may conceal objects beneath them creating a 'canopy effect'. Due to complexities in collecting 3-dimensional data, most ecosystem monitoring programmes reduce dimensionality when sampling, resorting to planar views. The resultant 'canopy effects' may bias data interpretation, particularly following disturbances. Canopy effects are especially relevant on coral reefs where coral cover is often used to evaluate and communicate ecosystem health. We show that canopies hide benthic components including massive corals and algal turfs, and as planar views are almost ubiquitously used to monitor disturbances, the loss of vulnerable canopy-forming corals may bias findings by presenting pre-existing benthic components as an altered system. Our reliance on planar views in monitoring ecosystems, especially coral cover on reefs, needs to be reassessed if we are to better understand the ecological consequences of ever more frequent disturbances.	[Goatley, Christopher H. R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Goatley, CHR (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	christopher.goatley@jcu.edu.au	Goatley, Christopher/C-1492-2016	Goatley, Christopher/0000-0002-2930-5591	Lizard Island Reef Research Foundation; Australian Museum; Australian Research Council	Lizard Island Reef Research Foundation; Australian Museum; Australian Research Council(Australian Research Council)	This work was funded by the Lizard Island Reef Research Foundation and the Australian Museum through a Lizard Island Doctoral Fellowship (C.H.R.G.) and the Australian Research Council (D.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, MAR ECOL PROG SER, V165, P271, DOI 10.3354/meps165271; [Anonymous], AUSTR I MAR SCI REEF; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Booth DT, 2008, ENVIRON MANAGE, V42, P1091, DOI 10.1007/s00267-008-9110-x; Braun C, 2009, P 11 CORAL REEF S, V18, P865; Brooker RM, 2010, J FISH BIOL, V76, P2578, DOI 10.1111/j.1095-8649.2010.02644.x; Bythell JC, 2001, CORAL REEFS, V20, P193; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; CARPENTER RC, 1993, LIMNOL OCEANOGR, V38, P687, DOI 10.4319/lo.1993.38.3.0687; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Depczynski M, 2003, MAR ECOL PROG SER, V256, P183, DOI 10.3354/meps256183; Diaz MC, 2001, B MAR SCI, V69, P535; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G., 2007, CLIMATE CHANGE GREAT, P153; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Done T.J., 1982, Proceedings of the International Coral Reef Symposium, P315; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Fox HE, 2003, MAR POLLUT BULL, V46, P1024, DOI 10.1016/S0025-326X(03)00246-7; GEHLBACH F R, 1975, Biological Conservation, V8, P79, DOI 10.1016/0006-3207(75)90033-6; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Harding DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023471; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; KOHN AJ, 1976, OECOLOGIA, V25, P199, DOI 10.1007/BF00345098; Korpela I, 2004, SILVA FENN, P1; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Madin JS, 2008, BIOL LETTERS, V4, P490, DOI 10.1098/rsbl.2008.0249; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Mallela J, 2007, CORAL REEFS, V26, P129, DOI 10.1007/s00338-006-0169-7; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; MCINTYRE GA, 1953, J ECOL, V41, P319, DOI 10.2307/2257044; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; OCONNOR NA, 1991, OECOLOGIA, V85, P504, DOI 10.1007/BF00323762; ONEILL RV, 1991, LANDSCAPE ECOL, V5, P137, DOI 10.1007/BF00158061; Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; Perry CT, 2006, PALAEOGEOGR PALAEOCL, V242, P1, DOI 10.1016/j.palaeo.2006.05.006; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Pratchett MS, 2010, CORAL REEFS, V29, P717, DOI 10.1007/s00338-010-0602-9; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; SAVINO JF, 1989, ANIM BEHAV, V37, P311, DOI 10.1016/0003-3472(89)90120-6; SCHMID WD, 1965, ECOLOGY, V46, P816, DOI 10.2307/1934014; Seefeldt SS, 2006, ENVIRON MANAGE, V37, P703, DOI 10.1007/s00267-005-0016-6; Shuman CS, 2003, RESTOR ECOL, V11, P325, DOI 10.1046/j.1526-100X.2003.00182.x; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Vroom Peter S., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/164127; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279	82	72	72	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27307	10.1371/journal.pone.0027307	http://dx.doi.org/10.1371/journal.pone.0027307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073311	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000297197000046
J	Luo, RT; Piovoso, MJ; Martinez-Picado, J; Zurakowski, R				Luo, Rutao; Piovoso, Michael J.; Martinez-Picado, Javier; Zurakowski, Ryan			Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRUCTURED TREATMENT INTERRUPTION; ACTIVE ANTIRETROVIRAL THERAPY; SOCIETY-USA PANEL; CD8(+) T-CELLS; INFECTED PATIENTS; DRUG-RESISTANCE; RANDOMIZED-TRIAL; TYPE-1; BENEFIT	The development of resistant strains of HIV is the most significant barrier to effective long-term treatment of HIV infection. The most common causes of resistance development are patient noncompliance and pre-existence of resistant strains. In this paper, methods of antiviral regimen switching are developed that minimize the risk of pre-existing resistant virus emerging during therapy switches necessitated by virological failure. Two distinct cases are considered; a single previous virological failure and multiple virological failures. These methods use optimal control approaches on experimentally verified mathematical models of HIV strain competition and statistical models of resistance risk. It is shown that, theoretically, order-of-magnitude reduction in risk can be achieved, and multiple previous virological failures enable greater success of these methods in reducing the risk of subsequent treatment failures.	[Luo, Rutao; Zurakowski, Ryan] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Piovoso, Michael J.] Penn State Univ Great Valley, Dept Elect Engn, Malvern, PA USA; [Martinez-Picado, Javier] IrsiCaixa, Inst Recerca SIDA, Badalona, Spain; [Martinez-Picado, Javier] ICREA, Barcelona, Spain; [Zurakowski, Ryan] Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Luo, RT (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	ryanz@udel.edu	Martinez-Picado, Javier/G-5507-2012	Martinez-Picado, Javier/0000-0002-4916-2129; Zurakowski, Ryan/0000-0003-3726-3114	National Institute Of Allergy And Infectious Diseases [R21AI078842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078842] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	The project described was supported by Award Number R21AI078842 from the National Institute Of Allergy And Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy And Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Benson CA, 2006, J INFECT DIS, V194, P1309, DOI 10.1086/508289; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; Bonjoch A, 2008, HIV CLIN TRIALS, V9, P387, DOI 10.1310/hct0906-387; CARDOZO EF, 2011, P IEEE ENG MED BIOL, P116; Colgrove R, 1999, ANTIVIR RES, V41, P45, DOI 10.1016/S0166-3542(98)00062-X; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; Ghosn J, 2005, AIDS, V19, P1643, DOI 10.1097/01.aids.0000181322.17679.b2; Gray CM, 2000, AIDS RES HUM RETROV, V16, P1357, DOI 10.1089/08892220050140900; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang YX, 2006, BIOMETRICS, V62, P413, DOI 10.1111/j.1541-0420.2005.00447.x; Katlama C, 2004, AIDS, V18, P217, DOI 10.1097/00002030-200401230-00011; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Luo R, 2008, P AMER CONTR CONF, P2112, DOI 10.1109/ACC.2008.4586804; Luo R, 2010, P AMER CONTR CONF, P5155; Luo RT, 2011, J PROCESS CONTR, V21, P367, DOI 10.1016/j.jprocont.2010.11.010; Luo RT, 2009, P AMER CONTR CONF, P2295, DOI 10.1109/ACC.2009.5160358; Mansky LM, 1996, AIDS RES HUM RETROV, V12, P307, DOI 10.1089/aid.1996.12.307; Martinez-Picado J, 2003, ANN INTERN MED, V139, P81, DOI 10.7326/0003-4819-139-2-200307150-00007; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Rosero-Garcia EE, 2010, P AMER CONTR CONF, P460; Ruiz L, 2001, AIDS, V15, pF19, DOI 10.1097/00002030-200106150-00001; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Wodarz D, 2001, J THEOR BIOL, V213, P447, DOI 10.1006/jtbi.2001.2426; Wong JK, 1997, J VIROL, V71, P2059, DOI 10.1128/JVI.71.3.2059-2071.1997; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996; ZURAKOWSKI R, 2007, P 46 IEEE C DEC CONT, P5174; Zurakowski R, 2011, P AMER CONTR CONF, P5418; Zurakowski R, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-40	39	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27047	10.1371/journal.pone.0027047	http://dx.doi.org/10.1371/journal.pone.0027047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073250	gold, Green Submitted, Green Published			2022-12-27	WOS:000297197000025
J	Ahmad, E; Rabbani, G; Zaidi, N; Singh, S; Rehan, M; Khan, MM; Rahman, SK; Quadri, Z; Shadab, M; Ashraf, MT; Subbarao, N; Bhat, R; Khan, RH				Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Singh, Saurabh; Rehan, Mohd; Khan, Mohd Moin; Rahman, Shah Kamranur; Quadri, Zainuddin; Shadab, Mohd.; Ashraf, Mohd Tashfeen; Subbarao, Naidu; Bhat, Rajiv; Khan, Rizwan Hasan			Stereo-Selectivity of Human Serum Albumin to Enantiomeric and Isoelectronic Pollutants Dissected by Spectroscopy, Calorimetry and Bioinformatics	PLOS ONE			English	Article							ARTIFICIAL PROTEIN; CRYSTAL-STRUCTURE; BINDING SITE; FLUORESCENCE; THERMODYNAMICS; SPECIFICITY	1-naphthol (1N), 2-naphthol (2N) and 8-quinolinol (8H) are general water pollutants. 1N and 2N are the configurational enantiomers and 8H is isoelectronic to 1N and 2N. These pollutants when ingested are transported in the blood by proteins like human serum albumin (HSA). Binding of these pollutants to HSA has been explored to elucidate the specific selectivity of molecular recognition by this multiligand binding protein. The association constants (K-b) of these pollutants to HSA were moderate (10(4)-10(5) M-1). The proximity of the ligands to HSA is also revealed by their average binding distance, r, which is estimated to be in the range of 4.39-5.37 nm. The binding free energy (Delta G) in each case remains effectively the same for each site because of enthalpy-entropy compensation (EEC). The difference observed between Delta C-p(exp) and Delta C-p(calc) are suggested to be caused by binding-induced flexibility changes in the HSA. Efforts are also made to elaborate the differences observed in binding isotherms obtained through multiple approaches of calorimetry, spectroscopy and bioinformatics. We suggest that difference in dissociation constants of pollutants by calorimetry, spectroscopic and computational approaches could correspond to occurrence of different set of populations of pollutants having different molecular characteristics in ground state and excited state. Furthermore, our observation of enhanced binding of pollutants (2N and 8H) in the presence of hemin signifies that ligands like hemin may enhance the storage period of these pollutants in blood that may even facilitate the ill effects of these pollutants.	[Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Khan, Mohd Moin; Rahman, Shah Kamranur; Quadri, Zainuddin; Shadab, Mohd.; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Singh, Saurabh; Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Rehan, Mohd; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Ashraf, Mohd Tashfeen] Gautam Buddha Univ, Sch Biotechnol, Greater Noida, India	Aligarh Muslim University; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Gautam Buddha University	Ahmad, E (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Ahmad, Ejaz/L-1506-2013; Khan, Mohd Moin/GYQ-7170-2022; Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022; Subbarao, Prof Naidu/AAZ-1832-2020; Rehan, Mohd/H-9835-2012; Quadri, Zainuddin/GYD-5172-2022; Khan, Rizwan Hasan/F-8276-2014	Ahmad, Ejaz/0000-0002-5713-6713; Rabbani, Gulam/0000-0002-5293-8231; Subbarao, Prof Naidu/0000-0002-1720-2165; Quadri, Zainuddin/0000-0002-4068-6153; Khan, Rizwan Hasan/0000-0002-9965-8982; Shadab, Mohammad/0000-0003-4148-0365; Zaidi, Dr Nida/0000-0003-2579-2190; Rahman, Shah Kamranur/0000-0002-8835-7092; Rehan, Mohd/0000-0003-4898-6043; Mohd., Tashfeen Ashraf/0000-0003-1580-0003	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to E. Ahmad in the form of a Senior Research Fellowship was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PA, 1980, BIOCHEM J, V191, P95, DOI 10.1042/bj1910095; Alkilany AM, 2008, LANGMUIR, V24, P10235, DOI 10.1021/la8018343; Bevington PR, DATA REDUCTION ERROR; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; Bjelic S, 2008, J MOL RECOGNIT, V21, P289, DOI 10.1002/jmr.909; Brodersen R, 1982, BILIRUBIN, V1; CROSS AJ, 1986, BIOPHYS J, V50, P507, DOI 10.1016/S0006-3495(86)83488-9; Cyril L, BIOCH HDB; DeLano W.L., PYMOL MOL GRAPHICS S; Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303; DONOVAN JW, 1969, J BIOL CHEM, V244, P1961; DROGE JHM, 1985, BIOCHEM PHARMACOL, V34, P3299, DOI 10.1016/0006-2952(85)90349-1; Feng XZ, 1998, TALANTA, V47, P1223, DOI 10.1016/S0039-9140(98)00198-2; Fitzgerald MM, 1996, NAT STRUCT BIOL, V3, P626, DOI 10.1038/nsb0796-626; Flora K, 1998, BIOPHYS J, V75, P1084, DOI 10.1016/S0006-3495(98)77598-8; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gomez MA, 2003, EXCITED STATE PROPER; Hu YJ, 2005, J MOL STRUCT, V750, P174, DOI 10.1016/j.molstruc.2005.04.032; Hubbard SJ, NACCESS COMPUTER PRO; Il'ichev YV, 2002, J PHYS CHEM B, V106, P452, DOI 10.1021/jp012314u; Jelen F, 2009, J STRUCT BIOL, V165, P10, DOI 10.1016/j.jsb.2008.09.007; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; KRAGHHANSEN U, 1991, BIOCHEM J, V273, P641, DOI 10.1042/bj2730641; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Lakowicz J. R., PRINCIPLES FLUORESCE; Meeker JD, 2006, EPIDEMIOLOGY, V17, P61, DOI 10.1097/01.ede.0000190602.14691.70; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Musah RA, 2002, J MOL BIOL, V315, P845, DOI 10.1006/jmbi.2001.5287; Otosu T, 2010, J BIOCHEM, V147, P191, DOI 10.1093/jb/mvp175; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINKERTON TC, 1990, ANAL CHEM, V62, P2114, DOI 10.1021/ac00218a013; Privalov PL, 1987, METHOD ENZYMOL, V131, P4; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sahoo BK, 2008, BIOPHYS CHEM, V132, P81, DOI 10.1016/j.bpc.2007.10.007; Sharma R, 2008, J CHEM THERMODYN, V40, P1141, DOI 10.1016/j.jct.2008.02.009; Singh SK, 2006, J PHYS CHEM B, V110, P9728, DOI 10.1021/jp0608426; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Yeung BKS, 1997, CHEM BIOL, V4, P215, DOI 10.1016/S1074-5521(97)90291-X	49	120	120	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26186	10.1371/journal.pone.0026186	http://dx.doi.org/10.1371/journal.pone.0026186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073150	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900014
J	Fisher, R; Knowlton, N; Brainard, RE; Caley, MJ				Fisher, Rebecca; Knowlton, Nancy; Brainard, Russell E.; Caley, M. Julian			Differences among Major Taxa in the Extent of Ecological Knowledge across Four Major Ecosystems	PLOS ONE			English	Article							BIODIVERSITY; RESILIENCE; DIVERSITY; ASSEMBLAGES; RICHNESS; SYSTEMS; FUTURE; PLUS; FISH	Existing knowledge shapes our understanding of ecosystems and is critical for ecosystem-based management of the world's natural resources. Typically this knowledge is biased among taxa, with some taxa far better studied than others, but the extent of this bias is poorly known. In conjunction with the publically available World Registry of Marine Species database (WoRMS) and one of the world's premier electronic scientific literature databases (Web of Science (R)), a text mining approach is used to examine the distribution of existing ecological knowledge among taxa in coral reef, mangrove, seagrass and kelp bed ecosystems. We found that for each of these ecosystems, most research has been limited to a few groups of organisms. While this bias clearly reflects the perceived importance of some taxa as commercially or ecologically valuable, the relative lack of research of other taxonomic groups highlights the problem that some key taxa and associated ecosystem processes they affect may be poorly understood or completely ignored. The approach outlined here could be applied to any type of ecosystem for analyzing previous research effort and identifying knowledge gaps in order to improve ecosystem-based conservation and management.	[Fisher, Rebecca] Australian Inst Marine Sci, UWA Oceans Inst, Crawley, WA, Australia; [Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Brainard, Russell E.] Natl Marine Fisheries Serv, Coral Reef Ecosyst Div, Pacific Isl Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Honolulu, HI USA; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego; Scripps Institution of Oceanography; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Australian Institute of Marine Science	Fisher, R (corresponding author), Australian Inst Marine Sci, UWA Oceans Inst, Crawley, WA, Australia.	r.fisher@aims.gov.au	Fisher, Rebecca/C-5459-2011; Caley, Julian/A-4042-2008	Fisher, Rebecca/0000-0001-5148-6731; Caley, Julian/0000-0001-5739-749X	BHP Billiton through CReefs Australia	BHP Billiton through CReefs Australia	This work was funded by BHP Billiton through CReefs Australia, a partnership between BHP Billiton, the Great Barrier Reef Foundation, the Census of Marine Life and the Australian Institute of Marine Science (AIMS). CReefs Australia is a node of the Census of Coral Reef Ecosystems (CReefs), a project of the Census of Marine Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Anderson MJ, 2005, J EXP MAR BIOL ECOL, V320, P35, DOI 10.1016/j.jembe.2004.12.023; Barnes RD, 1982, INVERTEBRATE ZOOLOGY, P104; Beger M, 2007, CONSERV BIOL, V21, P1584, DOI 10.1111/j.1523-1739.2007.00795.x; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BOUCHET P, 2006, EXPLORATION MARINE B, P32; Bowen W, 1997, MAR ECOL PROG SER, V158, P74; Boxshall G., 2010, HARPACTICOIDA; Burgess SC, 2010, GLOBAL ECOL BIOGEOGR, V19, P363, DOI 10.1111/j.1466-8238.2009.00516.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Fisher R, 2010, CONSERVATION LETT; GARFIELD E, 1990, CURR CONTENTS, V1, P3; GARFIELD E, 1990, CURR CONTENTS, V33, P5; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harborne AR, 2006, ADV MARINE BIOL; HECK KL, 1995, J EXP MAR BIOL ECOL, V189, P205, DOI 10.1016/0022-0981(95)00012-G; HECK KL, 1977, J BIOGEOGR, V4, P135, DOI 10.2307/3038158; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Kuiter RH, 2006, WORLD ATLAS MARINE F; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PEARSON DL, 1994, PHILOS T ROY SOC B, V345, P75, DOI 10.1098/rstb.1994.0088; Pinheiro J, 2001, MIXED EFFECTS MODELS; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; R Core Team, 2020, R LANG ENV STAT COMP; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Zuur Alain F., 2009, P1	48	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26556	10.1371/journal.pone.0026556	http://dx.doi.org/10.1371/journal.pone.0026556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073172	Green Published, gold			2022-12-27	WOS:000297154900024
J	Stockl, AL; Petie, R; Nilsson, DE				Stockl, Anna Lisa; Petie, Ronald; Nilsson, Dan-Eric			Setting the Pace: New Insights into Central Pattern Generator Interactions in Box Jellyfish Swimming	PLOS ONE			English	Article							TRIPEDALIA-CYSTOPHORA; NERVOUS-SYSTEM; MEDUSAE; PACEMAKERS; RHOPALIA; CNIDARIA; CUBOZOA; MUSCLES; NEURONS; NERVES	Central Pattern Generators (CPGs) produce rhythmic behaviour across all animal phyla. Cnidarians, which have a radially symmetric nervous system and pacemaker centres in multiples of four, provide an interesting comparison to bilaterian animals for studying the coordination between CPGs. The box jellyfish Tripedalia cystophora is remarkable among cnidarians due to its most elaborate visual system. Together with their ability to actively swim and steer, they use their visual system for multiple types of behaviour. The four swim CPGs are directly regulated by visual input. In this study, we addressed the question of how the four pacemaker centres of this radial symmetric cnidarian interact. We based our investigation on high speed camera observations of the timing of swim pulses of tethered animals (Tripedalia cystophora) with one or four rhopalia, under different simple light regimes. Additionally, we developed a numerical model of pacemaker interactions based on the inter pulse interval distribution of animals with one rhopalium. We showed that the model with fully resetting coupling and hyperpolarization of the pacemaker potential below baseline fitted the experimental data best. Moreover, the model of four swim pacemakers alone underscored the proportion of long inter pulse intervals (IPIs) considerably. Both in terms of the long IPIs as well as the overall swim pulse distribution, the simulation of two CPGs provided a better fit than that of four. We therefore suggest additional sources of pacemaker control than just visual input. We provide guidelines for future research on the physiological linkage of the cubozoan CPGs and show the insight from bilaterian CPG research, which show that pacemakers have to be studied in their bodily and nervous environment to capture all their functional features, are also manifest in cnidarians.	[Stockl, Anna Lisa; Petie, Ronald; Nilsson, Dan-Eric] Lund Univ, Dept Biol, Vis Grp, Lund, Sweden	Lund University	Stockl, AL (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	stoeckl@bio.lmu.de		Stockl, Anna/0000-0002-0833-9995; Petie, Ronald/0000-0002-4092-4756	Swedish Research Council [G21-2010-3503]; Elite Network of Bavaria	Swedish Research Council(Swedish Research CouncilEuropean Commission); Elite Network of Bavaria	The study was funded by the Swedish Research Council (grant to D.-E. Nilsson, grant no. G21-2010-3503) and supported by the Elite Network of Bavaria (travel grant to Anna Stockl, no grant-no exists). http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. https://www.elitenetzwerk.bayern.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DEMONT ME, 1988, J EXP BIOL, V134, P333; Garm A, 2008, J COMP PHYSIOL A, V194, P641, DOI 10.1007/s00359-008-0336-0; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2007, CELL TISSUE RES, V329, P147, DOI 10.1007/s00441-007-0393-7; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; GLADFELTER WG, 1973, HELGOLAND WISS MEER, V25, P228, DOI 10.1007/BF01611199; Grimmelikhuijzen C.J.P., 1995, Experientia Supplementum (Basel), V72, P7; HORRIDGE GA, 1955, J EXP BIOL, V32, P642; HORRIDGE GA, 1959, J EXP BIOL, V36, P72; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; LASKA G, 1984, ZOOMORPHOLOGY, V104, P163, DOI 10.1007/BF00312135; Laska G, 1982, ZOOL JB ANAT, V108, P17; LERNER J, 1971, J EXP BIOL, V55, P177; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MURRAY MJ, 1977, J COMP PHYSIOL, V117, P63, DOI 10.1007/BF00605524; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Parkefelt L, 2005, J COMP NEUROL, V492, P251, DOI 10.1002/cne.20658; Parkefelt L, 2009, J COMP NEUROL, V516, P157, DOI 10.1002/cne.22072; PASSANO LM, 1965, AM ZOOL, V5, P465; Petie R, 2011, J EXP BIOL IN PRESS, V214; Prinz AA, 2006, CURR OPIN NEUROBIOL, V16, P615, DOI 10.1016/j.conb.2006.10.001; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Romanes G J, 1876, J Anat Physiol, V10, P707; ROMANES GJ, 1877, PHILOS T ROY SOC LON, V167, P659; SATTERLIE RA, 1979, J COMP PHYSIOL, V133, P357, DOI 10.1007/BF00661138; SATTERLIE RA, 1979, NATURE, V281, P141, DOI 10.1038/281141a0; Satterlie RA, 2001, J EXP BIOL, V204, P1413; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Shorten M, 2005, J ZOOL, V267, P371, DOI 10.1017/S0952836905007600; Spencer AN, 1995, AM ZOOL, V35, P520; Yatsu N., 1917, J COLL SCI IMP U TOK, V11, P1	36	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27201	10.1371/journal.pone.0027201	http://dx.doi.org/10.1371/journal.pone.0027201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073288	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900089
J	Biggs, PJ; Fearnhead, P; Hotter, G; Mohan, V; Collins-Emerson, J; Kwan, E; Besser, TE; Cookson, A; Carter, PE; French, NP				Biggs, Patrick J.; Fearnhead, Paul; Hotter, Grant; Mohan, Vathsala; Collins-Emerson, Julie; Kwan, Errol; Besser, Thomas E.; Cookson, Adrian; Carter, Philip E.; French, Nigel P.			Whole-Genome Comparison of Two Campylobacter jejuni Isolates of the Same Sequence Type Reveals Multiple Loci of Different Ancestral Lineage	PLOS ONE			English	Article							MICROBIAL GENE IDENTIFICATION; RECOMBINATION; POLYMORPHISM; ANNOTATION; DIVERGENCE; ALIGNMENT; ORTHOMCL; ARTEMIS; CLONES; DNA	Campylobacter jejuni ST-474 is the most important human enteric pathogen in New Zealand, and yet this genotype is rarely found elsewhere in the world. Insight into the evolution of this organism was gained by a whole genome comparison of two ST-474, flaA SVR-14 isolates and other available C. jejuni isolates and genomes. The two isolates were collected from different sources, human (H22082) and retail poultry (P110b), at the same time and from the same geographical location. Solexa sequencing of each isolate resulted in similar to 1.659 Mb (H22082) and similar to 1.656 Mb (P110b) of assembled sequences within 28 (H22082) and 29 (P110b) contigs. We analysed 1502 genes for which we had sequences within both ST-474 isolates and within at least one of 11 C. jejuni reference genomes. Although 94.5% of genes were identical between the two ST-474 isolates, we identified 83 genes that differed by at least one nucleotide, including 55 genes with non-synonymous substitutions. These covered 101 kb and contained 672 point differences. We inferred that 22 (3.3%) of these differences were due to mutation and 650 (96.7%) were imported via recombination. Our analysis estimated 38 recombinant breakpoints within these 83 genes, which correspond to recombination events affecting at least 19 loci regions and gives a tract length estimate of similar to 2 kb. This includes a similar to 12 kb region displaying non-homologous recombination in one of the ST-474 genomes, with the insertion of two genes, including ykgC, a putative oxidoreductase, and a conserved hypothetical protein of unknown function. Furthermore, our analysis indicates that the source of this recombined DNA is more likely to have come from C. jejuni strains that are more closely related to ST-474. This suggests that the rates of recombination and mutation are similar in order of magnitude, but that recombination has been much more important for generating divergence between the two ST-474 isolates.	[Biggs, Patrick J.; Mohan, Vathsala; Collins-Emerson, Julie; Kwan, Errol; French, Nigel P.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Fearnhead, Paul] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Hotter, Grant] AgResearch, Hopkirk Res Inst, Anim Hlth Sect, Palmerston North, New Zealand; [Besser, Thomas E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Cookson, Adrian] AgResearch Ltd, Rumen Microbiol Anim Nutr & Hlth Capabil Grp, Palmerston North, New Zealand; [Carter, Philip E.] Inst Environm Sci & Res Ltd, Wellington, New Zealand	Massey University; Lancaster University; AgResearch - New Zealand; Washington State University; AgResearch - New Zealand; Institute of Environmental Science & Research (ESR) - New Zealand	Biggs, PJ (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	p.biggs@massey.ac.nz	Cookson, Adrian/R-6617-2019; Fearnhead, Paul/A-1653-2008; Fearnhead, Paul/A-5938-2015; Hotter, Georgina/R-1156-2018; Mohan, Vathsala/R-5017-2016; French, Nigel/F-5725-2011; Biggs, Patrick Jon/H-3355-2014	Fearnhead, Paul/0000-0002-9386-2341; Fearnhead, Paul/0000-0002-9386-2341; Mohan, Vathsala/0000-0003-4486-9368; French, Nigel/0000-0002-6334-0657; Biggs, Patrick Jon/0000-0002-0285-4101	Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North [RM12767]; Royal Society of New Zealand [MAU0802]	Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North; Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by the Building Research Capability in Strategically Relevant Areas (BRCSRA) fund, Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North (RM12767) and The Royal Society of New Zealand Marsden Fund (MAU0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson J, 2012, ZOONOSES PUBLIC HLTH, V59, P52, DOI 10.1111/j.1863-2378.2011.01418.x; Baker MG, 2007, EPIDEMIOL INFECT, V135, P163, DOI 10.1017/S0950268806006583; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2008, EMERG INFECT DIS, V14, P1620, DOI 10.3201/eid1410.071109; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; DONNELLY P, 2010, LONDON MATH SOC LECT, V378; Falush D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000627; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; Fearnhead P, 2002, J ROY STAT SOC B, V64, P657, DOI 10.1111/1467-9868.00355; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; GUERRY P, 1990, J BACTERIOL, V172, P1853, DOI 10.1128/jb.172.4.1853-1860.1990; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li N, 2003, GENETICS, V165, P2213; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muellner P, 2011, PREV VET MED, V102, P242, DOI 10.1016/j.prevetmed.2011.07.011; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rozen Y, 2001, MICROB ECOL, V42, P635, DOI 10.1007/s00248-001-1012-x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18; SEARS A, 2011, NZ EMERGING INFECT D, V17, P1007; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; Sheppard SK, 2011, MICROBIOL-SGM, V157, P1066, DOI 10.1099/mic.0.045153-0; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	63	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27121	10.1371/journal.pone.0027121	http://dx.doi.org/10.1371/journal.pone.0027121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096527	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000297553900023
J	Olsson, MG; Allhorn, M; Larsson, J; Cederlund, M; Lundqvist, K; Schmidtchen, A; Sorensen, OE; Morgelin, M; Akerstrom, B				Olsson, Magnus G.; Allhorn, Maria; Larsson, Jorgen; Cederlund, Martin; Lundqvist, Katarina; Schmidtchen, Artur; Sorensen, Ole E.; Morgelin, Matthias; Akerstrom, Bo			Up-Regulation of A1M/alpha(1)-Microglobulin in Skin by Heme and Reactive Oxygen Species Gives Protection from Oxidative Damage	PLOS ONE			English	Article							MONOCLONAL ANTI-ALPHA-1-MICROGLOBULIN ANTIBODIES; LIPOCALIN ALPHA(1)-MICROGLOBULIN; STRESS; ALPHA-1-MICROGLOBULIN; HEMOGLOBIN; ANTIOXIDANTS; PURIFICATION; MECHANISMS; REDUCTION; COMPLEXES	During bleeding the skin is subjected to oxidative insults from free heme and radicals, generated from extracellular hemoglobin. The lipocalin alpha(1)-microglobulin (A1M) was recently shown to have reductase properties, reducing heme-proteins and other substrates, and to scavenge heme and radicals. We investigated the expression and localization of A1M in skin and the possible role of A1M in the protection of skin tissue from damage induced by heme and reactive oxygen species. Skin explants, keratinocyte cultures and purified collagen I were exposed to heme, reactive oxygen species, and/or A1M and investigated by biochemical methods and electron microscopy. The results demonstrate that A1M is localized ubiquitously in the dermal and epidermal layers, and that the A1M-gene is expressed in keratinocytes and up-regulated after exposure to heme and reactive oxygen species. A1M inhibited the heme-and reactive oxygen species-induced ultrastructural damage, up-regulation of antioxidation and cell cycle regulatory genes, and protein carbonyl formation in skin and keratinocytes. Finally, A1M bound to purified collagen I (K-d = 0.96 x 10(-6) M) and could inhibit and repair the destruction of collagen fibrils by heme and reactive oxygen species. The results suggest that A1M may have a physiological role in protection of skin cells and matrix against oxidative damage following bleeding.	[Olsson, Magnus G.; Allhorn, Maria; Larsson, Jorgen; Cederlund, Martin; Sorensen, Ole E.; Morgelin, Matthias; Akerstrom, Bo] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden; [Lundqvist, Katarina; Schmidtchen, Artur] Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, Lund, Sweden	Lund University; Lund University	Olsson, MG (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden.	magnus_g.olsson@med.lu.se	Schmidtchen, Artur/F-9507-2015; Gram, Magnus/AAM-4825-2021	Gram, Magnus/0000-0002-5880-2925	Swedish Research Council [7144, 7480]; government funds for clinical research (ALF); Royal Physiographic Society in Lund; Foundations of Greta and Johan Kock and Alfred Osterlund; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Blood and Defence Network; Lund University; Magnus Bergvalls foundation; Swedish Society for Medical Research; Preelumina AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); government funds for clinical research (ALF); Royal Physiographic Society in Lund; Foundations of Greta and Johan Kock and Alfred Osterlund; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Blood and Defence Network; Lund University; Magnus Bergvalls foundation; Swedish Society for Medical Research; Preelumina AB(HOGANAS ABStatisticon AB)	This work was funded by grants from the Swedish Research Council (7144 and 7480), government funds for clinical research (ALF) to Lund University and Lund University Hospital, the Royal Physiographic Society in Lund, the Foundations of Greta and Johan Kock and Alfred Osterlund, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Blood and Defence Network, Lund University, Magnus Bergvalls foundation, the Swedish Society for Medical Research and Preelumina AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1990, TRENDS BIOCHEM SCI, V15, P240, DOI 10.1016/0968-0004(90)90037-C; AKERSTROM B, 1985, EUR J BIOCHEM, V146, P353; Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Akerstrom Bo, 2006, P1; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; APPLEGATE LA, 1991, CANCER RES, V51, P974; BABIKERMOHAMED H, 1991, SCAND J IMMUNOL, V34, P655, DOI 10.1111/j.1365-3083.1991.tb01589.x; Berggard T, 1997, EUR J BIOCHEM, V245, P676, DOI 10.1111/j.1432-1033.1997.00676.x; BJORCK L, 1977, SCAND J IMMUNOL, V6, P1063; BOUIC P, 1985, BRIT J DERMATOL, V112, P35, DOI 10.1111/j.1365-2133.1985.tb02288.x; Bunn H., 1992, HEMOGLOBIN; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; DEMARS DD, 1989, CLIN CHEM, V35, P766; Faivre B, 1998, ARTIF CELL BLOOD SUB, V26, P17, DOI 10.3109/10731199809118943; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Konopacka M, 1998, MUTAT RES-GEN TOX EN, V417, P85, DOI 10.1016/S1383-5718(98)00095-3; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson J, 2004, ARCH BIOCHEM BIOPHYS, V432, P196, DOI 10.1016/j.abb.2004.09.021; Larsson J, 2001, J LAB CLIN MED, V137, P165, DOI 10.1067/mlc.2001.112957; Li YX, 2010, J AGR FOOD CHEM, V58, P578, DOI 10.1021/jf902811j; Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; NILSON B, 1987, J IMMUNOL METHODS, V99, P39, DOI 10.1016/0022-1759(87)90029-9; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Olsson MG, 2010, RADIAT RES, V174, P590, DOI 10.1667/RR2213.1; Orciani M, 2010, FREE RADICAL BIO MED, V49, P830, DOI 10.1016/j.freeradbiomed.2010.06.007; Packer L, 2002, SKIN PHARMACOL APPL, V15, P282, DOI 10.1159/000064531; PLESNER T, 1975, SCAND J CLIN LAB INV, V35, P729, DOI 10.3109/00365517509095804; Ray Gibanananda, 2002, Indian Journal of Experimental Biology, V40, P1213; ROTH J, 1986, J MICROSC-OXFORD, V143, P125, DOI 10.1111/j.1365-2818.1986.tb02771.x; Santin M, 1999, SCAND J IMMUNOL, V50, P289; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; TEJLER L, 1978, BIOCHIM BIOPHYS ACTA, V542, P506, DOI 10.1016/0304-4165(78)90380-X; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; Ushakova T, 1999, FREE RADICAL BIO MED, V26, P887, DOI 10.1016/S0891-5849(98)00281-0; VINCENT C, 1987, EUR J BIOCHEM, V165, P699, DOI 10.1111/j.1432-1033.1987.tb11497.x	42	48	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27505	10.1371/journal.pone.0027505	http://dx.doi.org/10.1371/journal.pone.0027505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096585	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900054
J	Platt, B; Drever, B; Koss, D; Stoppelkamp, S; Jyoti, A; Plano, A; Utan, A; Merrick, G; Ryan, D; Melis, V; Wan, H; Mingarelli, M; Porcu, E; Scrocchi, L; Welch, A; Riedel, G				Platt, Bettina; Drever, Benjamin; Koss, David; Stoppelkamp, Sandra; Jyoti, Amar; Plano, Andrea; Utan, Aneli; Merrick, Georgina; Ryan, Duncan; Melis, Valeria; Wan, Hong; Mingarelli, Marco; Porcu, Emanuele; Scrocchi, Louise; Welch, Andy; Riedel, Gernot			Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1	PLOS ONE			English	Article							AMYLOID-BETA OLIGOMERS; INTRACELLULAR A-BETA; TRANSGENIC MICE; ANIMAL-MODELS; DISEASE; MEMORY; DEFICITS; IMMUNIZATION; ACCUMULATION; HIPPOCAMPUS	Late-stage neuropathological hallmarks of Alzheimer's disease (AD) are beta-amyloid (beta A) and hyperphosphorylated tau peptides, aggregated into plaques and tangles, respectively. Corresponding phenotypes have been mimicked in existing transgenic mice, however, the translational value of aggressive over-expression has recently been questioned. As controlled gene expression may offer animal models with better predictive validity, we set out to design a transgenic mouse model that circumvents complications arising from pronuclear injection and massive over-expression, by targeted insertion of human mutated amyloid and tau transgenes, under the forebrain-and neurone-specific CaMKII alpha promoter, termed PLB1(Double). Crossing with an existing presenilin 1 line resulted in PLB1(Triple) mice. PLB1(Triple) mice presented with stable gene expression and age-related pathology of intra-neuronal amyloid and hyperphosphorylated tau in hippocampus and cortex from 6 months onwards. At this early stage, pre-clinical (18)FDG PET/CT imaging revealed cortical hypometabolism with increased metabolic activity in basal forebrain and ventral midbrain. Quantitative EEG analyses yielded heightened delta power during wakefulness and REM sleep, and time in wakefulness was already reliably enhanced at 6 months of age. These anomalies were paralleled by impairments in long-term and short-term hippocampal plasticity and preceded cognitive deficits in recognition memory, spatial learning, and sleep fragmentation all emerging at similar to 12 months. These data suggest that prodromal AD phenotypes can be successfully modelled in transgenic mice devoid of fibrillary plaque or tangle development. PLB1(Triple) mice progress from a mild (MCI-like) state to a more comprehensive AD-relevant phenotype, which are accessible using translational tools such as wireless EEG and microPET/CT.	[Platt, Bettina; Drever, Benjamin; Koss, David; Stoppelkamp, Sandra; Jyoti, Amar; Plano, Andrea; Utan, Aneli; Merrick, Georgina; Ryan, Duncan; Melis, Valeria; Mingarelli, Marco; Porcu, Emanuele; Welch, Andy; Riedel, Gernot] Univ Aberdeen, Coll Life Sci & Med, Sch Med Sci, Aberdeen, Scotland; [Wan, Hong] Pfizer BioTherapeut, Translat & Mol Med, Collegeville, PA USA; [Scrocchi, Louise] Amorfix Life Sci, Mississauga, ON, Canada	University of Aberdeen; Pfizer	Platt, B (corresponding author), Univ Aberdeen, Coll Life Sci & Med, Sch Med Sci, Aberdeen, Scotland.	b.platt@abdn.ac.uk		Koss, David/0000-0002-8034-9880; Platt, Bettina/0000-0002-7852-0749	KHIDI (Korea Health Industry Development Institute) [A040147]; TMRI (Translational Medicine Research Initiative) [NS_AU_098]	KHIDI (Korea Health Industry Development Institute); TMRI (Translational Medicine Research Initiative)	Part-funding from KHIDI (Korea Health Industry Development Institute; Project A040147) and TMRI (Translational Medicine Research Initiative, NS_AU_098) is acknowledged (to BP and GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bliwise Donald L, 2004, Clin Cornerstone, V6 Suppl 1A, pS16, DOI 10.1016/S1098-3597(04)90014-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brankack J, 2009, PROG NEURO-PSYCHOPH, V33, P806, DOI 10.1016/j.pnpbp.2009.03.027; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cvetkovic B, 2000, J BIOL CHEM, V275, P1073, DOI 10.1074/jbc.275.2.1073; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deiana S, 2009, PSYCHOPHARMACOLOGY, V202, P53, DOI 10.1007/s00213-008-1394-2; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Drever BD, 2007, J ALZHEIMERS DIS, V12, P319; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Echeverria V, 2004, J ALZHEIMERS DIS, V6, P209; Epis R, 2010, EUR J PHARMACOL, V626, P57, DOI 10.1016/j.ejphar.2009.10.020; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Hale G, 2005, BEHAV NEUROSCI, V119, P884, DOI 10.1037/0735-7044.119.4.884; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kessels RPC, 2010, AGING NEUROPSYCHOL C, V17, P556, DOI 10.1080/13825585.2010.481354; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; Kuntner C, 2009, MOL IMAGING BIOL, V11, P236, DOI 10.1007/s11307-009-0198-z; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; LUO F, 2010, NEUROBIOL A IN PRESS; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Micheau J, 2004, BEHAV NEUROSCI, V118, P1022, DOI 10.1037/0735-7044.118.5.1022; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicholson RM, 2010, BRAIN RES, V1347, P179, DOI 10.1016/j.brainres.2010.05.084; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Platt B, 2011, BEHAV BRAIN RES, V221, P499, DOI 10.1016/j.bbr.2011.01.017; Prichep LS, 2007, ANN NY ACAD SCI, V1097, P156, DOI 10.1196/annals.1379.008; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Riedel G, 2009, BEHAV BRAIN RES, V204, P217, DOI 10.1016/j.bbr.2009.06.012; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; STOPPELKAMP S, 2011, EXP NEUROL; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tampellini D, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00013; Tanghe A., 2010, INT J ALZHEIMERS DIS, V2010, DOI DOI 10.4061/2010/417314; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Vale C, 2010, CELL MOL NEUROBIOL, V30, P577, DOI 10.1007/s10571-009-9482-3; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Woodruff-Pak DS, 2008, J ALZHEIMERS DIS, V15, P507; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Zhang B, 2005, AM J PATHOL, V167, P1361, DOI 10.1016/S0002-9440(10)61223-0; 2010, ANN NEUROL, V68, pA9	64	87	89	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27068	10.1371/journal.pone.0027068	http://dx.doi.org/10.1371/journal.pone.0027068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096518	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900018
J	Shin, DM; Lee, CH; Morse, HC				Shin, Dong-Mi; Lee, Chang-Hoon; Morse, Herbert C., III			IRF8 Governs Expression of Genes Involved in Innate and Adaptive Immunity in Human and Mouse Germinal Center B Cells	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; INTERFERON REGULATORY FACTOR-8; LEUKEMIA-LIKE SYNDROME; TRANSCRIPTION FACTORS; DENDRITIC CELLS; IN-VIVO; TARGET GENES; FACTOR PU.1; ACTIVATION; FAMILY	IRF8 (Interferon Regulatory Factor 8) is a transcription factor expressed throughout B cell differentiation except for mature plasma cells. Previous studies showed it is part of the transcriptional network governing B cell specification and commitment in the bone marrow, regulates the distribution of mature B cells into the splenic follicular and marginal zone compartments, and is expressed at highest levels in germinal center (GC) B cells. Here, we investigated the transcriptional programs and signaling pathways affected by IRF8 in human and mouse GC B cells as defined by ChIP-chip analyses and transcriptional profiling. We show that IRF8 binds a large number of genes by targeting two distinct motifs, half of which are also targeted by PU.1. Over 70% of the binding sites localized to proximal and distal promoter regions with similar to 25% being intragenic. There was significant enrichment among targeted genes for those involved in innate and adaptive immunity with over 30% previously defined as interferon stimulated genes. We also showed that IRF8 target genes contributes to multiple aspects of the biology of mature B cells including critical components of the molecular crosstalk among GC B cells, T follicular helper cells, and follicular dendritic cells.	[Shin, Dong-Mi; Lee, Chang-Hoon; Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shin, DM (corresponding author), NIAID, Immunopathol Lab, NIH, Rockville, MD USA.	hmorse@niaid.nih.gov		Morse, Herbert/0000-0002-9331-3705	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001024, ZIAAI001057, ZIAAI000858] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeKoter RP, 2010, J IMMUNOL, V185, P7374, DOI 10.4049/jimmunol.1001413; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Hartley JW, 2000, LAB INVEST, V80, P159, DOI 10.1038/labinvest.3780020; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; MARECKI S, 2000, BIOCHEMISTRY-US, V33, P127; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Nelson N, 1996, J IMMUNOL, V156, P3711; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poovassery JS, 2009, J IMMUNOL, V183, P2974, DOI 10.4049/jimmunol.0900495; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sharf R, 1997, J BIOL CHEM, V272, P9785; Shin DM, 2008, CANCER RES, V68, P9202, DOI 10.1158/0008-5472.CAN-07-6555; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weigelt K, 2008, BIOTECHNIQUES, V45, P131, DOI 10.2144/000112819; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhou JX, 2009, J IMMUNOL, V183, P3188, DOI 10.4049/jimmunol.0803693	51	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27384	10.1371/journal.pone.0027384	http://dx.doi.org/10.1371/journal.pone.0027384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096565	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900039
J	Baron, D; Magot, A; Ramstein, G; Steenman, M; Fayet, G; Chevalier, C; Jourdon, P; Houlgatte, R; Savagner, F; Pereon, Y				Baron, Daniel; Magot, Armelle; Ramstein, Gerard; Steenman, Marja; Fayet, Guillemette; Chevalier, Catherine; Jourdon, Philippe; Houlgatte, Remi; Savagner, Frederique; Pereon, Yann			Immune Response and Mitochondrial Metabolism Are Commonly Deregulated in DMD and Aging Skeletal Muscle	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TRANSCRIPTIONAL LANDSCAPE; CALORIC RESTRICTION; OXIDATIVE DAMAGE; ATROPHY INVOLVE; RECEPTOR-ALPHA; RAINBOW-TROUT; MICROARRAY; AGE; DNA	Duchenne Muscular Dystrophy (DMD) is a complex process involving multiple pathways downstream of the primary genetic insult leading to fatal muscle degeneration. Aging muscle is a multifactorial neuromuscular process characterized by impaired muscle regeneration leading to progressive atrophy. We hypothesized that these chronic atrophying situations may share specific myogenic adaptative responses at transcriptional level according to tissue remodeling. Muscle biopsies from four young DMD and four AGED subjects were referred to a group of seven muscle biopsies from young subjects without any neuromuscular disorder and explored through a dedicated expression microarray. We identified 528 differentially expressed genes (out of 2,745 analyzed), of which 328 could be validated by an exhaustive meta-analysis of public microarray datasets referring to DMD and Aging in skeletal muscle. Among the 328 validated co-expressed genes, 50% had the same expression profile in both groups and corresponded to immune/fibrosis responses and mitochondrial metabolism. Generalizing these observed meta-signatures with large compendia of public datasets reinforced our results as they could be also identified in other pathological processes and in diverse physiological conditions. Focusing on the common gene signatures in these two atrophying conditions, we observed enrichment in motifs for candidate transcription factors that may coordinate either the immune/fibrosis responses (ETS1, IRF1, NF1) or the mitochondrial metabolism (ESRRA). Deregulation in their expression could be responsible, at least in part, for the same transcriptome changes initiating the chronic muscle atrophy. This study suggests that distinct pathophysiological processes may share common gene responses and pathways related to specific transcription factors.	[Baron, Daniel; Steenman, Marja; Chevalier, Catherine; Jourdon, Philippe; Houlgatte, Remi; Savagner, Frederique; Pereon, Yann] INSERM, UMR915, Nantes, France; [Baron, Daniel; Ramstein, Gerard; Steenman, Marja; Jourdon, Philippe; Houlgatte, Remi; Pereon, Yann] Univ Nantes, Nantes, France; [Baron, Daniel; Magot, Armelle; Steenman, Marja; Fayet, Guillemette; Chevalier, Catherine; Jourdon, Philippe; Houlgatte, Remi; Pereon, Yann] CHU Nantes, Inst Thorax, CIC, F-44035 Nantes 01, France; [Magot, Armelle; Fayet, Guillemette; Pereon, Yann] CHU Nantes, Lab Explorat Fonct, F-44035 Nantes 01, France; [Magot, Armelle; Fayet, Guillemette; Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires Rares Enfant, F-44035 Nantes 01, France; [Ramstein, Gerard] Ecole Polytech, Lab Informat Nantes Atlantique LINA, Nantes, France; [Savagner, Frederique] INSERM, UMR 694, Angers, France; [Savagner, Frederique] Univ Angers, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers	Baron, D (corresponding author), INSERM, UMR915, Nantes, France.	daniel.baron@inserm.fr	chevalier, catherine/L-4803-2015; Steenman, Marja/D-3618-2015; Steenman, Marja/S-8433-2019; Houlgatte, Remi/P-3020-2017	Steenman, Marja/0000-0003-4547-4448; Steenman, Marja/0000-0003-4547-4448; Ramstein, Gerard/0000-0003-0239-3330	"Institut National de la Sante et de la Recherche Medicale'' (INSERM); "Association Francaise contre les Myopathies'' (AFM)	"Institut National de la Sante et de la Recherche Medicale'' (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Association Francaise contre les Myopathies'' (AFM)(Association Francaise contre les Myopathies)	Funding were provided by the "Institut National de la Sante et de la Recherche Medicale'' (INSERM) and the "Association Francaise contre les Myopathies'' (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aure K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Baron D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-113; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Cossu G, 2000, J CLIN INVEST, V105, P1669, DOI 10.1172/JCI10376; Danko CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-31; Deschenes MR, 2011, CURR AGING SCI  0429; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Fierro AC, 2008, CURR GENOMICS, V9, P525, DOI 10.2174/138920208786847935; Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004; Flanigan KM, 1998, NEUROL CLIN, V16, P659, DOI 10.1016/S0733-8619(05)70087-6; French L, 2009, BIOINFORMATICS, V25, P1543, DOI 10.1093/bioinformatics/btp259; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; GUTMANN DH, 1995, DEV DYNAM, V202, P302, DOI 10.1002/aja.1002020309; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Jafari Peyman, 2006, BMC Med Inform Decis Mak, V6, P27, DOI 10.1186/1472-6947-6-27; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; Kossler N, 2011, HUM MOL GENET; Lamirault G, 2010, J CELL MOL MED, V14, P1443, DOI 10.1111/j.1582-4934.2009.00913.x; Le Meur N, 2004, NUCLEIC ACIDS RES, V32, P5349, DOI 10.1093/nar/gkh870; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lopez F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004001; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rhodes DR, 2002, CANCER RES, V62, P4427; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; Steenman M, 2005, EUR J HEART FAIL, V7, P157, DOI 10.1016/j.ejheart.2004.05.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trovo-Marqui AB, 2006, CLIN GENET, V70, P1, DOI 10.1111/j.1399-0004.2006.00639.x; TURNER PR, 1993, J MEMBRANE BIOL, V133, P243; Virtanen C, 2008, APPL PHYSIOL NUTR ME, V33, P124, DOI 10.1139/H07-150; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	66	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26952	10.1371/journal.pone.0026952	http://dx.doi.org/10.1371/journal.pone.0026952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096509	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800018
J	Besnard, V; Wert, SE; Ikegami, M; Xu, Y; Heffner, C; Murray, SA; Donahue, LR; Whitsett, JA				Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae; Whitsett, Jeffrey A.			Maternal Synchronization of Gestational Length and Lung Maturation	PLOS ONE			English	Article							SURFACTANT PROTEIN-C; GLUCOCORTICOID-RECEPTOR; TARGETED DISRUPTION; RESPIRATORY-FAILURE; LIQUID CLEARANCE; PRETERM BIRTH; NEWBORN MICE; C/EBP-ALPHA; SP-B; DIFFERENTIATION	Among all mammals, fetal growth and organ maturation must be precisely synchronized with gestational length to optimize survival at birth. Lack of pulmonary maturation is the major cause of infant mortality in preterm birth. Whether fetal or maternal genotypes influence the close relationship between the length of gestation and lung function at birth is unknown. Structural and biochemical indicators of pulmonary maturity were measured in two mouse strains whose gestational length differed by one day. Shorter gestation in C57BL/6J mice was associated with advanced morphological and biochemical pulmonary development and better perinatal survival when compared to A/J pups born prematurely. After ovarian transplantation, A/J pups were born early in C57BL/6J dams and survived after birth, consistent with maternal control gestational length. Expression of genes critical for perinatal lung function was assessed in A/J pups born after ovarian transfer. A subset of mRNAs important for perinatal respiratory adaptation was selectively induced in the A/J pups born after ovarian transfer. mRNAs precociously induced after ovarian transfer indicated an important role for the transcription factors C/EBP alpha and CREB in maternally induced lung maturation. We conclude that fetal lung maturation is determined by both fetal and maternal genotypes. Ovarian transfer experiments demonstrated that maternal genotype determines the timing of birth and can influence fetal lung growth and maturation to ensure perinatal survival.	[Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Whitsett, Jeffrey A.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Perinatal Inst, Cincinnati, OH USA; [Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Whitsett, Jeffrey A.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Sect Neonatol Perinatal & Pulm Biol, Cincinnati, OH USA; [Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Whitsett, Jeffrey A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Jackson Laboratory	Besnard, V (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Perinatal Inst, Cincinnati, OH USA.	jeff.whitsett@cchmc.org		, Yan/0000-0003-2025-027X; Besnard, Valerie/0000-0002-2614-629X; Heffner, Caleb/0000-0002-2631-6201	March of Dimes (MOD) [MOD154, 6-FY109-235]; National Institutes of Health [HL095469, HL090156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, R01HL090156] Funding Source: NIH RePORTER	March of Dimes (MOD)(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the March of Dimes (MOD) [to YX, JAW, MI], MOD154 [to LRD], 6-FY109-235 from MOD [to MI], National Institutes of Health HL095469 [to MI]; and the National Institutes of Health HL090156 [to JAW, YX, SEW]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Beck S, 2009, B WORLD HEALTH ORGAN, V88, P31; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bird AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017843; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Heleve O, 2009, NEONATOLOGY, V95, P347; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418; Nakatani T, 2004, J BIOL CHEM, V279, P16356, DOI 10.1074/jbc.M311740200; Oshika E, 1998, PEDIATR RES, V43, P305, DOI 10.1203/00006450-199803000-00001; Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641; Ramachandrappa A, 2009, PEDIATR CLIN N AM, V56, P565, DOI 10.1016/j.pcl.2009.03.009; Sztein J, 1998, BIOL REPROD, V58, P1071, DOI 10.1095/biolreprod58.4.1071; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Wert SE, 2008, NORMAL ABNORMAL STRU, P783; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26682	10.1371/journal.pone.0026682	http://dx.doi.org/10.1371/journal.pone.0026682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096492	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800011
J	Namba, T; Tanaka, KI; Hoshino, T; Azuma, A; Mizushima, T				Namba, Takushi; Tanaka, Ken-Ichiro; Hoshino, Tatsuya; Azuma, Arata; Mizushima, Tohru			Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis	PLOS ONE			English	Article							CELL LUNG-CANCER; INDUCED GASTRIC-LESIONS; HEAT-SHOCK FACTOR-1; GENETIC-EVIDENCE; PROTECTIVE ROLE; MUCOSAL CELLS; DISEASE; ZD1839; EGFR; INDOMETHACIN	Drug-induced interstitial lung disease (ILD), particularly pulmonary fibrosis, is of serious clinical concern. Gefitinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), is beneficial as a drug for treating non-small cell lung cancer; however, this drug induces ILD and the molecular mechanisms underpinning this condition remain unclear. We recently reported that expression of heat shock protein 70 (HSP70) protects against bleomycin-induced pulmonary fibrosis, an animal model of pulmonary fibrosis. In this study, we have examined the effects of drugs known to induce ILD clinically on the expression of HSP70 in cultured lung epithelial cells and have found that gefitinib has a suppressive effect. Results of a luciferase reporter assay, pulse-labelling analysis of protein and experiments using an inhibitor of translation or transcription suggest that gefitinib suppresses the expression of HSP70 at the level of translation. Furthermore, the results of experiments with siRNA for Dicer1, an enzyme responsible for synthesis of microRNA, and real-time RT-PCR analysis suggest that some microRNAs are involved in the gefitinib-induced translational inhibition of HSP70. Mutations in the EGFR affect the concentration of gefitinib required for suppressing the expression of HSP70. These results suggest that gefitinib suppresses the translation of HSP70 through an EGFR-and microRNA-mediated mechanism. In vivo, while oral administration of gefitinib suppressed the pulmonary expression of HSP70 and exacerbated bleomycin-induced pulmonary fibrosis in wild-type mice, these effects were not as distinct in transgenic mice expressing HSP70. Furthermore, oral co-administration of geranylgeranylacetone (GGA), an inducer of HSP70, suppressed gefitinib-induced exacerbation of bleomycin-induced pulmonary fibrosis. Taken together, these findings suggest that gefitinib-induced exacerbation of bleomycin-induced pulmonary fibrosis is mediated by suppression of pulmonary expression of HSP70 and that an inducer of HSP70 expression, such as GGA, may be therapeutically beneficial for the treatment of gefitinib-induced pulmonary fibrosis.	[Namba, Takushi; Tanaka, Ken-Ichiro; Hoshino, Tatsuya; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto, Japan; [Azuma, Arata] Nippon Med Sch, Dept Internal Med, Div Resp Infect & Oncol, Tokyo 113, Japan; [Mizushima, Tohru] Keio Univ, Fac Pharm, Dept Analyt Chem, Tokyo, Japan	Kumamoto University; Nippon Medical School; Keio University	Namba, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto, Japan.	mizu@gpo.kumamoto-u.ac.jp		Azuma, Arata/0000-0003-0506-9966; Tanaka, Ken-ichiro/0000-0003-1893-0751	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid of Scientific Research from the Ministry of Health, Labour, and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/), and Grants-in-Aid of the Japan Science and Technology Agency (http://www.jst.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Blackledge G, 2004, BRIT J CANCER, V90, P566, DOI 10.1038/sj.bjc.6601550; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camus P, 2004, RESPIRATION, V71, P301, DOI 10.1159/000079633; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Flieder DB, 2004, CLIN CHEST MED, V25, P37, DOI 10.1016/S0272-5231(03)00138-2; Fujibayashi Takayoshi, 2009, BMC Pulm Med, V9, P45, DOI 10.1186/1471-2466-9-45; Fumeaux T, 2001, INTENS CARE MED, V27, P1868, DOI 10.1007/s00134-001-1150-0; Gridelli C, 2007, ONCOLOGIST, V12, P840, DOI 10.1634/theoncologist.12-7-840; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kataoka K, 2006, RESP MED, V100, P698, DOI 10.1016/j.rmed.2005.07.015; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li J, 2006, JNCI-J NATL CANCER I, V98, P1714, DOI 10.1093/jnci/djj466; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Miyata H, 2006, INT J ONCOL, V28, P915; Moon DO, 2007, ACTA PHARMACOL SIN, V28, P1205, DOI 10.1111/j.1745-7254.2007.00615.x; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Namba T, 2010, CELL DEATH DIFFER, V17, P1882, DOI 10.1038/cdd.2010.64; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Ono M, 2004, MOL CANCER THER, V3, P465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Suzuki H, 2003, CANCER RES, V63, P5054; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tomisato W, 2000, DIGEST DIS SCI, V45, P1674, DOI 10.1023/A:1005597902470; Van Schaeybroeck S, 2006, MOL CANCER THER, V5, P1154, DOI 10.1158/1535-7163.MCT-05-0446; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007	51	33	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27296	10.1371/journal.pone.0027296	http://dx.doi.org/10.1371/journal.pone.0027296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096546	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800041
J	Valle, D; Clark, JS; Zhao, KG				Valle, Denis; Clark, James S.; Zhao, Kaiguang			Enhanced Understanding of Infectious Diseases by Fusing Multiple Datasets: A Case Study on Malaria in the Western Brazilian Amazon Region	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIAGNOSTIC-TESTS; GLOBAL DISTRIBUTION; HIGH PREVALENCE; DEFORESTATION; SPECIFICITY; SENSITIVITY; IMMUNITY; JOINT; STATE	Background: A common challenge to the study of several infectious diseases consists in combining limited cross-sectional survey data, collected with a more sensitive detection method, with a more extensive (but biased) syndromic sentinel surveillance data, collected with a less sensitive method. Our article describes a novel modeling framework that overcomes this challenge, resulting in enhanced understanding of malaria in the Western Brazilian Amazon. Methodology/Principal Findings: A cohort of 486 individuals was monitored using four cross-sectional surveys, where all participants were sampled regardless of symptoms (aggressive-active case detection), resulting in 1,383 microscopy and 1,400 polymerase chain reaction tests. Data on the same individuals were also obtained from the local surveillance facility (i.e., passive and active case detection), totaling 1,694 microscopy tests. Our model accommodates these multiple pathogen and case detection methods. This model is shown to outperform logistic regression in terms of interpretability of its parameters, ability to recover the true parameter values, and predictive performance. We reveal that the main infection determinant was the extent of forest, particularly during the rainy season and in close proximity to water bodies, and participation on forest activities. We find that time residing in Acrelandia (as a proxy for past malaria exposure) decreases infection risk but surprisingly increases the likelihood of reporting symptoms once infected, possibly because non-naive settlers are only susceptible to more virulent Plasmodium strains. We suggest that the search for asymptomatic carriers should focus on those at greater risk of being infected but lower risk of reporting symptoms once infected. Conclusions/Significance: The modeling framework presented here combines cross-sectional survey data and syndromic sentinel surveillance data to shed light on several aspects of malaria that are critical for public health policy. This framework can be adapted to enhance inference on infectious diseases whenever asymptomatic carriers are important and multiple datasets are available.	[Valle, Denis; Clark, James S.] Duke Univ, Univ Program Ecol, Durham, NC 27706 USA; [Clark, James S.; Zhao, Kaiguang] Duke Univ, Dept Biol, Durham, NC USA; [Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Valle, D (corresponding author), Duke Univ, Univ Program Ecol, Durham, NC 27706 USA.	drv4@duke.edu	Valle, Denis/B-7650-2012; Zhao, Kaiguang/D-1172-2010	Zhao, Kaiguang/0000-0001-5858-4967; Valle, Denis/0000-0002-9830-8876	Duke Global Health Initiative	Duke Global Health Initiative	Denis Valle was partly supported by a pilot project grant from the Duke Global Health Initiative. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; BARKER RH, 1994, EXP PARASITOL, V79, P41, DOI 10.1006/expr.1994.1057; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; Castro MC, 2001, MALARIA FOCI COLONIZ; Clark JS, 2009, BAYESIAN ANAL, V4, P337, DOI 10.1214/09-BA413; da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Ferreira MU, 2010, J INFECT DEV COUNTR, V4, P533, DOI 10.3855/jidc.760; *FUNASA, 2001, MAN TER MAL; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6; Hardnett FP, 2004, CLIN INFECT DIS, V38, pS121, DOI 10.1086/381602; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hedt BL, 2011, STAT MED, V30, P560, DOI 10.1002/sim.3920; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Katsuragawa TH, 2009, CAD SAUDE PUBLICA, V25, P1486, DOI 10.1590/S0102-311X2009000700006; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LASERSON KF, 1994, AM J TROP MED HYG, V50, P169, DOI 10.4269/ajtmh.1994.50.169; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Markus MB, 2011, PARASITOL RES, V108, P247, DOI 10.1007/s00436-010-2072-y; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; O'Meara WP, 2005, AM J TROP MED HYG, V73, P593, DOI 10.4269/ajtmh.2005.73.593; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Oliveira EC, 2011, MALARIA J, P10; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Olson SH, 2009, EMERG INFECT DIS, V15, P659, DOI 10.3201/eid1504.080822; Pruss-Ustun A., 2006, WORLD HEALTH; R Development Core Team, 2007, R LANG ENV STAT COMP; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Schwartz SL, 2010, STAT MED, V29, P1710, DOI 10.1002/sim.3900; Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002; Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021; Slasor P, 2003, STAT MED, V22, P2137, DOI 10.1002/sim.1439; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Su CL, 2004, STAT MED, V23, P2237, DOI 10.1002/sim.1809; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3	53	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27462	10.1371/journal.pone.0027462	http://dx.doi.org/10.1371/journal.pone.0027462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087321	Green Published, gold, Green Submitted			2022-12-27	WOS:000297349700048
J	Nguyen, NQN; Castermans, K; Berndt, S; Herkenne, S; Tabruyn, SP; Blacher, S; Lion, M; Noel, A; Martial, JA; Struman, I				Ngoc-Quynh-Nhu Nguyen; Castermans, Karolien; Berndt, Sarah; Herkenne, Stephanie; Tabruyn, Sebastien P.; Blacher, Silvia; Lion, Michelle; Noel, Agnes; Martial, Joseph A.; Struman, Ingrid			The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR-KAPPA-B; NONPRODUCTIVE ANGIOGENESIS; PERICYTE RECRUITMENT; UP-REGULATION; CELLS; ACTIVATION; EXPRESSION; THERAPY; CANCER	Background: Angiogenesis, the formation of new blood vessels from existing vasculature, plays an essential role in tumor growth, invasion, and metastasis. 16K hPRL, the antiangiogenic 16-kDa N-terminal fragment of human prolactin was shown to prevent tumor growth and metastasis by modifying tumor vessel morphology. Methodology/Principal Findings: Here we investigated the effect of 16K hPRL on tumor vessel maturation and on the related signaling pathways. We show that 16K hPRL treatment leads, in a murine B16-F10 tumor model, to a dysfunctional tumor vasculature with reduced pericyte coverage, and disruption of the PDGF-B/PDGFR-B, Ang/Tie2, and Delta/Notch pathways. In an aortic ring assay, 16K hPRL impairs endothelial cell and pericyte outgrowth from the vascular ring. In addition, 16K hPRL prevents pericyte migration to endothelial cells. This event was independent of a direct inhibitory effect of 16K hPRL on pericyte viability, proliferation, or migration. In endothelial cell-pericyte cocultures, we found 16K hPRL to disturb Notch signaling. Conclusions/Significance: Taken together, our data show that 16K hPRL impairs functional tumor neovascularization by inhibiting vessel maturation and for the first time that an endogenous antiangiogenic agent disturbs Notch signaling. These findings provide new insights into the mechanisms of 16K hPRL action and highlight its potential for use in anticancer therapy.	[Ngoc-Quynh-Nhu Nguyen; Castermans, Karolien; Herkenne, Stephanie; Tabruyn, Sebastien P.; Lion, Michelle; Martial, Joseph A.; Struman, Ingrid] Univ Liege, Unit Mol Biol & Genet Engn, GIGA Res, Liege, Belgium; [Berndt, Sarah; Blacher, Silvia; Noel, Agnes] Univ Liege, Lab Biol Tumor & Dev, GIGA Res, Liege, Belgium	University of Liege; University of Liege	Nguyen, NQN (corresponding author), Univ Liege, Unit Mol Biol & Genet Engn, GIGA Res, Liege, Belgium.	I.Struman@ulg.ac.be		Herkenne, stephanie/0000-0002-2106-9360; Noel, Agnes/0000-0002-7670-6179; struman, ingrid/0000-0003-2550-3707	Fonds National de la Recherche Scientifique [FP7-HEALTH-2007-A, 201279]; Belgian Science Policy (Brussels, Belgium); Service Public de Wallonie [616476]; Belgian Foundation against Cancer	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Service Public de Wallonie; Belgian Foundation against Cancer	This work was supported by the "Fonds National de la Recherche Scientifique", FP7-HEALTH-2007-A, proposal No. 201279 "MICROENVIMET", the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium) and the Neoangio program #616476 of the "Service Public de Wallonie", the Belgian Foundation against Cancer. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentzien F, 2001, CANCER RES, V61, P7356; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; CLAPP C, 1992, ENDOCRINOLOGY, V130, P1380, DOI 10.1210/en.130.3.1380; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Furuhashi M, 2004, CANCER RES, V64, P2725, DOI 10.1158/0008-5472.CAN-03-1489; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2010, J EXP MED, V207, P491, DOI 10.1084/jem.20091846; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kim J, 2003, CANCER RES, V63, P386; Kinet V, 2009, CANCER LETT, V284, P222, DOI 10.1016/j.canlet.2009.04.030; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Li JL, 2011, CANC RES; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Martini JF, 2000, MOL ENDOCRINOL, V14, P1536, DOI 10.1210/me.14.10.1536; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Nguyen NQN, 2007, MOL THER, V15, P2094, DOI 10.1038/sj.mt.6300294; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pan H, 2004, INVEST OPHTH VIS SCI, V45, P2413, DOI 10.1167/iovs.03-1001; Patel NS, 2006, CLIN CANCER RES, V12, P4836, DOI 10.1158/1078-0432.CCR-06-0285; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Real C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018323; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361; Sun JZ, 2004, CANCER RES, V64, P3586, DOI 10.1158/0008-5472.CAN-03-2673; Tabruyn SP, 2007, MOL ENDOCRINOL, V21, P1422, DOI 10.1210/me.2007-0021; Tabruyn SP, 2005, MOL ENDOCRINOL, V19, P1932, DOI 10.1210/me.2004-0515; Tabruyn SP, 2003, MOL ENDOCRINOL, V17, P1815, DOI 10.1210/me.2003-0132; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27318	10.1371/journal.pone.0027318	http://dx.doi.org/10.1371/journal.pone.0027318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087289	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700038
J	Riesch, R; Schlupp, I; Langerhans, RB; Plath, M				Riesch, Ruediger; Schlupp, Ingo; Langerhans, R. Brian; Plath, Martin			Shared and Unique Patterns of Embryo Development in Extremophile Poeciliids	PLOS ONE			English	Article							TOXIC HYDROGEN-SULFIDE; IMMIGRANTS MAINTAINS DIFFERENTIATION; DWELLING ATLANTIC MOLLIES; SEXUAL SELECTION; GENETIC DIFFERENTIATION; ECOLOGICAL SPECIATION; CAVEFISH ASTYANAX; MEXICAN CAVE; EVOLUTION; FISH	Background: Closely related lineages of livebearing fishes have independently adapted to two extreme environmental factors: toxic hydrogen sulphide (H2S) and perpetual darkness. Previous work has demonstrated in adult specimens that fish from these extreme habitats convergently evolved drastically increased head and offspring size, while cave fish are further characterized by reduced pigmentation and eye size. Here, we traced the development of these (and other) divergent traits in embryos of Poecilia mexicana from benign surface habitats ("surface mollies") and a sulphidic cave ("cave mollies"), as well as in embryos of the sister taxon, Poecilia sulphuraria from a sulphidic surface spring ("sulphur mollies"). We asked at which points during development changes in the timing of the involved processes (i.e., heterochrony) would be detectible. Methods and Results: Data were extracted from digital photographs taken of representative embryos for each stage of development and each type of molly. Embryo mass decreased in convergent fashion, but we found patterns of embryonic fat content and ovum/embryo diameter to be divergent among all three types of mollies. The intensity of yellow colouration of the yolk (a proxy for carotenoid content) was significantly lower in cave mollies throughout development. Moreover, while relative head size decreased through development in surface mollies, it increased in both types of extremophile mollies, and eye growth was arrested in mid-stage embryos of cave mollies but not in surface or sulphur mollies. Conclusion: Our results clearly demonstrate that even among sister taxa convergence in phenotypic traits is not always achieved by the same processes during embryo development. Furthermore, teleost development is crucially dependent on sufficient carotenoid stores in the yolk, and so we discuss how the apparent ability of cave mollies to overcome this carotenoid-dependency may represent another potential mechanism explaining the lack of gene flow between surface and cave mollies.	[Riesch, Ruediger; Langerhans, R. Brian] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Riesch, Ruediger; Langerhans, R. Brian] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Riesch, Ruediger; Schlupp, Ingo] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; [Plath, Martin] Goethe Univ Frankfurt, Dept Ecol & Evolut, Frankfurt, Germany	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Oklahoma System; University of Oklahoma - Norman; Goethe University Frankfurt	Riesch, R (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	rwriesch.evolutionarybiology@gmail.com	Riesch, Rüdiger/A-5787-2008; Schlupp, Ingo/C-3913-2012; Langerhans, R. Brian/ABE-6246-2021	Riesch, Rüdiger/0000-0002-6769-8808; Schlupp, Ingo/0000-0002-2460-5667; Riesch, Rudiger/0000-0002-0223-1254	National Science Foundation of the United States [NSF: DEB-0743406, DEB-0813783, DEB 0842364]; Deutsche Forschungsgemeinschaft [DFG: PL 470/3-1]	National Science Foundation of the United States(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the National Science Foundation of the United States (NSF: DEB-0743406, DEB-0813783, and DEB 0842364) and the Deutsche Forschungsgemeinschaft (DFG: PL 470/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez del Villar J., 1948, ANALES ESCUELA NACL, V5, P275; Anderson J., 1990, P21; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Beatty RA, 1941, J EXP BIOL, V18, P144; Berti R, 2001, CAN J ZOOL, V79, P1278, DOI 10.1139/cjz-79-7-1278; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; BURTON GW, 1989, J NUTR, V119, P109, DOI 10.1093/jn/119.1.109; CARTER G. S., 1931, JOUR LINN SOC LONDON ZOOL, V37, P327; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Coelho SG, 2006, PHOTOCHEM PHOTOBIOL, V82, P651, DOI 10.1562/2005-08-02-TSN-635; CRAIK JCA, 1985, AQUACULTURE, V47, P61, DOI 10.1016/0044-8486(85)90008-0; Culver DC, 1982, CAVE LIFE EVOLUTION; CZECZUGA B, 1970, Hydrobiologia, V36, P353, DOI 10.1007/BF00039794; DURAND JP, 1976, BIOL BULL, V151, P450, DOI 10.2307/1540499; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Feulner Philine G.D., 2009, Communicative & Integrative Biology, V2, P329; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; GORDON MALCOLM S., 1962, COPEIA, V2, P360; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; HAYNES JL, 1995, COPEIA, P147; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Hervant F, 1998, J CRUSTACEAN BIOL, V18, P717, DOI 10.2307/1549148; HEULETT ST, 1995, COPEIA, P97, DOI 10.2307/1446803; Hoffmann AA, 1997, EXTREME ENV CHANGE E; HUBBS C, 1957, J EXP ZOOL, V134, P33, DOI 10.1002/jez.1401340103; HUBBS CLARK, 1958, PHYSIOL ZOOL, V31, P280; JAPPINEN P, 1990, BRIT J IND MED, V47, P824; Jeffery WR, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P141, DOI 10.1201/EBK1578086702-c6; Jeffery WR, 2009, CURR TOP DEV BIOL, V86, P191, DOI 10.1016/S0070-2153(09)01008-4; Korner KE, 2006, J FISH BIOL, V69, P54, DOI 10.1111/j.1095-8649.2006.01056.x; Kolluru GR, 2006, BIOL J LINN SOC, V89, P301, DOI 10.1111/j.1095-8312.2006.00675.x; KRAMER DL, 1978, CAN J ZOOL, V56, P717, DOI 10.1139/z78-101; Kueppop Kathrin, 2005, P4; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lexer C, 2005, J EVOLUTION BIOL, V18, P893, DOI 10.1111/j.1420-9101.2005.00901.x; Li JC, 2006, RAFFLES B ZOOL, V54, P277; Malard F, 1999, FRESHWATER BIOL, V41, P1, DOI 10.1046/j.1365-2427.1999.00379.x; Marsh-Matthews E, 2011, P 3 INT S V IN PRESS; Marsh-Matthews Edie, 2011, P18; Martyn U, 2006, DEV DYNAM, V235, P617, DOI 10.1002/dvdy.20664; McCauley DW, 2004, EVOL DEV, V6, P209, DOI 10.1111/j.1525-142X.2004.04026.x; Miller R. R, 2005, FRESHWATER FISHES ME; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Morrongiello JR, 2010, J EVOLUTION BIOL, V23, P2718, DOI 10.1111/j.1420-9101.2010.02149.x; Niemiller ML, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P169, DOI 10.1201/EBK1578086702-c7; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Nyman T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-49; Ozgo M, 2008, EVOL ECOL RES, V10, P721; Parichy DM, 2001, BEYOND HETEROCHRONY, P229; Parzefali J, 1999, HDB REPTILIEN AMPHIB, V4, P57; Parzefall J, 2001, ENVIRON BIOL FISH, V62, P263, DOI 10.1023/A:1011899817764; Plath M, 2007, MOL ECOL, V16, P967, DOI 10.1111/j.1365-294X.2006.03212.x; Plath M, 2004, BEHAV ECOL SOCIOBIOL, V55, P596, DOI 10.1007/s00265-003-0750-9; Plath M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-256; Plath M, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P281; Plath M, 2010, NATURWISSENSCHAFTEN, V97, P769, DOI 10.1007/s00114-010-0691-x; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; REZNICK D, 1981, EVOLUTION, V35, P941, DOI [10.2307/2407865, 10.1111/j.1558-5646.1981.tb04960.x]; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Riesch R, 2011, J EVOLUTION BIOL, V24, P596, DOI 10.1111/j.1420-9101.2010.02194.x; Riesch R, 2011, BIOL LETT IN PRESS; Riesch R, 2011, ENV BIOL FI IN PRESS; Riesch R, 2010, EVOL ECOL, V24, P789, DOI 10.1007/s10682-009-9335-z; Riesch R, 2010, ECOLOGY, V91, P1494, DOI 10.1890/09-1008.1; Riesch R, 2010, NATURWISSENSCHAFTEN, V97, P133, DOI 10.1007/s00114-009-0613-y; Riesch R, 2009, ENVIRON BIOL FISH, V84, P89, DOI 10.1007/s10641-008-9392-0; Roach KA, 2011, ECOLOGY IN PRESS; Ruehl CB, 2011, BIOL J LINN SOC, V103, P147, DOI 10.1111/j.1095-8312.2011.01626.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCRIMSHAW NS, 1945, BIOL BULL, V88, P233, DOI 10.2307/1538312; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Smith KK, 2003, INT J DEV BIOL, V47, P613; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Tobler M, 2008, J FISH BIOL, V72, P523, DOI 10.1111/j.1095-8649.2007.01716.x; Tobler M, 2009, J EVOLUTION BIOL, V22, P2298, DOI 10.1111/j.1420-9101.2009.01844.x; Tobler M, 2008, BIOL J LINN SOC, V95, P517, DOI 10.1111/j.1095-8312.2008.01063.x; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler Michael, 2011, P120; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; Vershinin A, 1999, BIOFACTORS, V10, P99, DOI 10.1002/biof.5520100203; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; WILKENS H, 1988, EVOL BIOL, V23, P271; Wilkens H, 2003, BIOL J LINN SOC, V80, P545, DOI 10.1111/j.1095-8312.2003.00230.x; Wilkens H, 2001, ENVIRON BIOL FISH, V62, P251, DOI 10.1023/A:1011897805681; Wilkens Horst, 2005, P241; WINEMILLER KO, 1989, COPEIA, P382; WOLFE DA, 1964, SCIENCE, V144, P1467, DOI 10.1126/science.144.3625.1467; Wourms J.P., 1988, P1; Wray GA, 2002, BRAIN BEHAV EVOLUT, V59, P327, DOI 10.1159/000063566	101	28	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27377	10.1371/journal.pone.0027377	http://dx.doi.org/10.1371/journal.pone.0027377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087302	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700046
J	Stamm, JA; Belloli, EA; Zhang, YZ; Bon, J; Sciurba, FC; Gladwin, MT				Stamm, Jason A.; Belloli, Elizabeth A.; Zhang, Yingze; Bon, Jessica; Sciurba, Frank C.; Gladwin, Mark T.			Elevated N-Terminal Pro-Brain Natriuretic Peptide Is Associated with Mortality in Tobacco Smokers Independent of Airflow Obstruction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; PULMONARY-DISEASE; CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; BETA-BLOCKERS; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; FAILURE; RISK	Background: Tobacco use is associated with an increased prevalence of cardiovascular disease. N-terminal pro-brain natiuretic peptide (NT-proBNP), a widely available biomarker that is associated with cardiovascular outcomes in other conditions, has not been investigated as a predictor of mortality in tobacco smokers. We hypothesized that NT-proBNP would be an independent prognostic marker in a cohort of well-characterized tobacco smokers without known cardiovascular disease. Methods: Clinical data from 796 subjects enrolled in two prospective tobacco exposed cohorts was assessed to determine factors associated with elevated NT-proBNP and the relationship of these factors and NT-proBNP with mortality. Results: Subjects were followed for a median of 562 (IQR 252 - 826) days. Characteristics associated with a NT-proBNP above the median (>= 49 pg/mL) were increased age, female gender, and decreased body mass index. By time-to-event analysis, an NT-proBNP above the median (>= 49 pg/mL) was a significant predictor of mortality (log rank p = 0.02). By proportional hazard analysis controlling for age, gender, cohort, and severity of airflow obstruction, an elevated NT-proBNP level (>= 49 pg/mL) remained an independent predictor of mortality (HR = 2.19, 95% CI 1.07-4.46, p = 0.031). Conclusions: Elevated NT-proBNP is an independent predictor of mortality in tobacco smokers without known cardiovascular disease, conferring a 2.2 fold increased risk of death. Future studies should assess the ability of this biomarker to guide further diagnostic testing and to direct specific cardiovascular risk reduction inventions that may positively impact quality of life and survival.	[Stamm, Jason A.] Geisinger Med Ctr, Div Pulm & Crit Care Med, Danville, PA 17822 USA; [Belloli, Elizabeth A.] Univ Pittsburgh, Div Gen Internal Med, Med Ctr, Pittsburgh, PA USA; [Zhang, Yingze; Bon, Jessica; Sciurba, Frank C.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Med Ctr, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Med Ctr, Pittsburgh, PA USA	Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stamm, JA (corresponding author), Geisinger Med Ctr, Div Pulm & Crit Care Med, Danville, PA 17822 USA.	gladwinmt@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Bon, Jessica/AAK-6714-2021	sciurba, frank/0000-0001-7468-2225	National Institutes of Health through the University of Pittsburgh SCCOR in COPD [NHLBI 1P50 HL084948, P50-CA90440]; Roche Diagnostics (Manheim, Germany); NIH [R01HL098032, RO1HL096973, PO1HL103455]; Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania; NATIONAL CANCER INSTITUTE [P50CA090440] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948, R01HL096973, P01HL103455, R01HL098032] Funding Source: NIH RePORTER	National Institutes of Health through the University of Pittsburgh SCCOR in COPD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Roche Diagnostics (Manheim, Germany); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health through the University of Pittsburgh SCCOR in COPD [NHLBI 1P50 HL084948 and P50-CA90440] and through an investigator-initiated grant (Dr. Zhang) from Roche Diagnostics (Manheim, Germany). Dr. Gladwin receives research support from NIH grants R01HL098032, RO1HL096973, and PO1HL103455, the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen AK, 2006, AM J CARDIOL, V98, P525, DOI 10.1016/j.amjcard.2006.02.061; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Au DH, 2004, AM J MED, V117, P925, DOI 10.1016/j.amjmed.2004.07.043; BANG KM, 1993, CHEST, V103, P536, DOI 10.1378/chest.103.2.536; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; de Lemos JA, 2008, AM J CARDIOL, V101, p16A, DOI [10.1016/j.amjcard.2007.11.014, 10.1016/j.amjcard.2607.11.014]; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Dini FL, 2008, AM J CARDIOL, V102, P463, DOI 10.1016/j.amjcard.2008.03.083; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Galasko GIW, 2005, EUR HEART J, V26, P2269, DOI 10.1093/eurheartj/ehi410; Gerardi DA, 1996, EUR RESPIR J, V9, P431, DOI 10.1183/09031936.96.09030431; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; JAJICH CL, 1984, JAMA-J AM MED ASSOC, V252, P2831, DOI 10.1001/jama.252.20.2831; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Krauser DG, 2005, AM HEART J, V149, P744, DOI 10.1016/j.ahj.2004.07.010; Kruger S, 2002, J AM COLL CARDIOL, V40, P718, DOI 10.1016/S0735-1097(02)02032-6; Lorgis L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1605; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Otsuka T, 2010, AM J CARDIOL, V106, P1456, DOI 10.1016/j.amjcard.2010.06.075; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Rutten FH, 2007, EUR J HEART FAIL, V9, P651, DOI 10.1016/j.ejheart.2007.01.010; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Wu AHB, 2006, AM HEART J, V152, P828, DOI 10.1016/j.ahj.2006.08.021	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27416	10.1371/journal.pone.0027416	http://dx.doi.org/10.1371/journal.pone.0027416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087311	gold, Green Accepted, Green Published			2022-12-27	WOS:000297347700050
J	Harmidy, K; Tufenkji, N; Gruenheid, S				Harmidy, Kevin; Tufenkji, Nathalie; Gruenheid, Samantha			Perturbation of Host Cell Cytoskeleton by Cranberry Proanthocyanidins and Their Effect on Enteric Infections	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL ADHESION; SALMONELLA-TYPHIMURIUM; VACCINIUM-MACROCARPON; BIOFILM FORMATION; GROWTH; JUICE; PHYTOCHEMICALS; INHIBITION; EXPRESSION	Cranberry-derived compounds, including a fraction known as proanthocyanidins (PACs) exhibit anti-microbial, anti-infective, and anti-adhesive properties against a number of disease-causing organisms. In this study, the effect of cranberry proanthocyanidins (CPACs) on the infection of epithelial cells by two enteric bacterial pathogens, enteropathogenic Escherichia coli (EPEC) and Salmonella Typhimurium was investigated. Immunofluorescence data showed that actin pedestal formation, required for infection by enteropathogenic Escherichia coli (EPEC), was disrupted in the presence of CPACs. In addition, invasion of HeLa cells by Salmonella Typhimurium was significantly reduced, as verified by gentamicin protection assay and immunofluorescence. CPACs had no effect on bacterial growth, nor any detectable effect on the production of bacterial effector proteins of the type III secretion system. Furthermore, CPACs did not affect the viability of host cells. Interestingly, we found that CPACs had a potent and dose-dependent effect on the host cell cytoskeleton that was evident even in uninfected cells. CPACs inhibited the phagocytosis of inert particles by a macrophage cell line, providing further evidence that actin-mediated host cell functions are disrupted in the presence of cranberry CPACs. Thus, although CPAC treatment inhibited Salmonella invasion and EPEC pedestal formation, our results suggest that this is likely primarily because of the perturbation of the host cell cytoskeleton by CPACs rather than an effect on bacterial virulence itself. These findings have significant implications for the interpretation of experiments on the effects of CPACs on bacteria-host cell interactions.	[Harmidy, Kevin; Tufenkji, Nathalie] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada; [Harmidy, Kevin; Gruenheid, Samantha] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Harmidy, Kevin; Gruenheid, Samantha] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Harmidy, K (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.	nathalie.tufenkji@mcgill.ca; samantha.gruenheid@mcgill.ca		Gruenheid, Samantha/0000-0002-0908-6715	NSERC; CRC; Hydro-Quebec Scholars Program; McGill University; Wisconsin Cranberry Board; Cranberry Institute	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Hydro-Quebec Scholars Program; McGill University; Wisconsin Cranberry Board; Cranberry Institute	The authors acknowledge the financial support of NSERC, the CRC Program, the Hydro-Quebec Scholars Program, the EUL Fund at McGill University, the Wisconsin Cranberry Board and the Cranberry Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecher GR, 2004, PHARM BIOL, V42, P2, DOI 10.3109/13880200490893474; Burger O, 2002, CRIT REV FOOD SCI, V42, P279, DOI 10.1080/10408390209351916; Camesano TA, 2007, AGRO FOOD IND HI TEC, V18, P24; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; de la Iglesia R, 2010, BIOFACTORS, V36, P159, DOI 10.1002/biof.79; Eydelnant IA, 2008, LANGMUIR, V24, P10273, DOI 10.1021/la801525d; Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Guo ML, 2007, DALTON T, P4951, DOI 10.1039/b705136k; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P6852, DOI 10.1128/AEM.05561-11; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P1532, DOI 10.1128/AEM.02201-10; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Howell AB, 1998, NEW ENGL J MED, V339, P1408; Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022; Howell AB, 2002, JAMA-J AM MED ASSOC, V287, P3082, DOI 10.1001/jama.287.23.3082; Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Kresty LA, 2008, J AGR FOOD CHEM, V56, P676, DOI 10.1021/jf071997t; Labrecque J, 2006, J ANTIMICROB CHEMOTH, V58, P439, DOI 10.1093/jac/dkl220; Lacombe A, 2010, INT J FOOD MICROBIOL, V139, P102, DOI 10.1016/j.ijfoodmicro.2010.01.035; LEVINE MM, 1978, LANCET, V1, P1119; Lipson SM, 2011, FOOD ENVIRON VIROL, V3, P46, DOI 10.1007/s12560-011-9055-8; Liu M, 2009, J AGR FOOD CHEM, V57, P762, DOI 10.1021/jf802780k; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Matsushima M, 2008, J GASTROEN HEPATOL, V23, pS175, DOI 10.1111/j.1440-1746.2008.05409.x; Mayer R, 2008, J AGR FOOD CHEM, V56, P6959, DOI 10.1021/jf800832r; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mckay DL, 2007, NUTR REV, V65, P490, DOI 10.1301/nr.2007.nov.490-502; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Narayansingh R, 2009, J SCI FOOD AGR, V89, P542, DOI 10.1002/jsfa.3471; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neto CC, 2008, MOL NUTR FOOD RES, V52, pS18, DOI 10.1002/mnfr.200700433; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; Pappas E, 2009, CRIT REV FOOD SCI, V49, P741, DOI 10.1080/10408390802145377; Pinzon-Arango PA, 2009, J MED FOOD, V12, P259, DOI 10.1089/jmf.2008.0196; ROBSON HG, 1972, J INFECT DIS, V126, P378, DOI 10.1093/infdis/126.4.378; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Ruel G, 2007, MOL NUTR FOOD RES, V51, P692, DOI 10.1002/mnfr.200600286; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Souto FO, 2011, J NAT PROD, V74, P113, DOI 10.1021/np1003017; Su XW, 2010, FOOD MICROBIOL, V27, P985, DOI 10.1016/j.fm.2010.05.027; Suzuki T, 2011, J NUTR, V141, P87, DOI 10.3945/jn.110.125633; Tufenkji N, 2010, FOOD RES INT, V43, P922, DOI 10.1016/j.foodres.2009.10.022; Vikram A, 2010, J APPL MICROBIOL, V109, P515, DOI 10.1111/j.1365-2672.2010.04677.x; Vikram A, 2010, INT J FOOD MICROBIOL, V140, P109, DOI 10.1016/j.ijfoodmicro.2010.04.012; Wu VCH, 2008, LWT-FOOD SCI TECHNOL, V41, P1834, DOI 10.1016/j.lwt.2008.01.001; Zhang L, 2005, HELICOBACTER, V10, P139, DOI 10.1111/j.1523-5378.2005.00301.x	50	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27267	10.1371/journal.pone.0027267	http://dx.doi.org/10.1371/journal.pone.0027267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076143	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200057
J	Liskovykh, M; Chuykin, I; Ranjan, A; Safina, D; Popova, E; Tolkunova, E; Mosienko, V; Minina, JM; Zhdanova, NS; Mullins, JJ; Bader, M; Alenina, N; Tomilin, A				Liskovykh, Mikhail; Chuykin, Ilya; Ranjan, Ashish; Safina, Dina; Popova, Elena; Tolkunova, Elena; Mosienko, Valentina; Minina, Julia M.; Zhdanova, Natalia S.; Mullins, John J.; Bader, Michael; Alenina, Natalia; Tomilin, Alexey			Derivation, Characterization, and Stable Transfection of Induced Pluripotent Stem Cells from Fischer344 Rats	PLOS ONE			English	Article							GENE; GENERATION; MOUSE; EXPRESSION; MODELS; NANOG; LINES; TIME	The rat represents an important animal model that, in many respects, is superior to the mouse for dissecting behavioral, cardiovascular and other physiological pathologies relevant to humans. Derivation of induced pluripotent stem cells from rats (riPS) opens the opportunity for gene targeting in specific rat strains, as well as for the development of new protocols for the treatment of different degenerative diseases. Here, we report an improved lentivirus-based hit-and-run riPS derivation protocol that makes use of small inhibitors of MEK and GSK3. We demonstrate that the excision of proviruses does not affect either the karyotype or the differentiation ability of these cells. We show that the established riPS cells are readily amenable to genetic manipulations such as stable electroporation. Finally, we propose a genetic tool for an improvement of riPS cell quality in culture. These data may prompt iPS cell-based gene targeting in rat as well as the development of iPS cell-based therapies using disease models established in this species.	[Liskovykh, Mikhail; Safina, Dina; Tolkunova, Elena; Tomilin, Alexey] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Chuykin, Ilya; Ranjan, Ashish; Popova, Elena; Mosienko, Valentina; Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Berlin, Germany; [Minina, Julia M.; Zhdanova, Natalia S.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Mullins, John J.] Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Edinburgh	Liskovykh, M (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	alenina@mdc-berlin.de; antom@mail.cytspb.rssi.ru	Tomilin, Alexey N/C-3361-2014; Bader, Michael/K-2124-2013; Minina, Julia/AAZ-4280-2020; Mosienko, Valentina/AAN-5983-2020; Tomilin, Alexey/AAA-8774-2022; Tomilin, Alexey/AAK-3068-2021; Tolkunova, Elena/U-7174-2017	Tomilin, Alexey N/0000-0002-1137-7167; Minina, Julia/0000-0003-1504-9803; Tomilin, Alexey/0000-0002-1137-7167; Bader, Michael/0000-0003-4780-4164; Mosienko, Valentina/0000-0002-8562-532X; Tolkunova, Elena/0000-0003-1254-2619	Russian Foundation for Basic Research (Russia) - Helmholtz Society (Germany) [07-04-92281/HRJRG-024]; EURATRANS; European Union; Presidium of Russian Academy of Sciences; Russian Ministry of Education and Science [02.512.11.2253, 16.512.11.2085, 16.512.11.2242]; non-profit foundation Dynasty (Russia); DAAD [A0799669, A0890020]; BHF Centre of Research Excellence; Wellcome Trust	Russian Foundation for Basic Research (Russia) - Helmholtz Society (Germany)(Russian Foundation for Basic Research (RFBR)Helmholtz Association); EURATRANS; European Union(European Commission); Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); non-profit foundation Dynasty (Russia); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); BHF Centre of Research Excellence; Wellcome Trust(Wellcome Trust)	This work was supported by joint Russian Foundation for Basic Research (Russia) - Helmholtz Society (Germany) to NA and AT (07-04-92281/HRJRG-024), by the EURATRANS integrated project funded by the Seventh Framework Programme of the European Union, by the Presidium of Russian Academy of Sciences program "Molecular and Cellular Biology" to AT, by the state contracts between AT and the Russian Ministry of Education and Science (02.512.11.2253, 16.512.11.2085, and 16.512.11.2242), by a studentship from the non-profit foundation Dynasty (Russia) to ML, by DAAD studentship to VM (A0799669) and to IC (A0890020). The authors acknowledge support from the BHF Centre of Research Excellence, and JJM was the recipient of a Wellcome Trust Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bader M, 2010, METHODS MOL BIOL, V597, P403, DOI 10.1007/978-1-60327-389-3_27; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Chuykin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009794; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kotnik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005124; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Minina Iu M, 2010, Tsitologiia, V52, P420; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; O'Brien SJ, 2006, ATLAS MAMMALIAN CHRO, pxlii; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Popova E, 2005, METH MOLEC MED, V108, P33; Popova E, 2005, TRANSGENIC RES, V14, P729, DOI 10.1007/s11248-005-7218-9; Popova E, 2008, TRANSGENIC RES, V17, P955, DOI 10.1007/s11248-008-9189-0; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sugawara A, 2006, COMPARATIVE MED, V56, P31; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	40	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27345	10.1371/journal.pone.0027345	http://dx.doi.org/10.1371/journal.pone.0027345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076153	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000297198200067
J	Turnbull, ER; Kaunda, K; Harris, JB; Kapata, N; Muvwimi, MW; Kruuner, A; Henostroza, G; Reid, SE				Turnbull, Eleanor R.; Kaunda, Kaunda; Harris, Jennifer B.; Kapata, Nathan; Muvwimi, Mweemba W.; Kruuner, Annika; Henostroza, German; Reid, Stewart E.			An Evaluation of the Performance and Acceptability of Three LED Fluorescent Microscopes in Zambia: Lessons Learnt for Scale-Up	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; ZIEHL-NEELSEN; TUBERCULOSIS	The World Health Organization recommends the roll-out of light-emitting diode (LED) fluorescent microscopes (FM) as an alternative to light microscopes in resource-limited settings. We evaluated the acceptability and performance of three LED FMs after a short orientation among laboratory technicians from government health centers in Zambia. Sixteen technicians with varied light microscopy experience were oriented to FMs and divided into groups; each group read a different set of 40 slides on each LED FM (Primo Star iLED (TM), Lumin (TM), FluoLED (TM)) and on a reference mercury-vapor FM (Olympus BX41TF). Slide reading times were recorded. An experienced FM technician examined each slide on the Olympus BX41TF. Sensitivity and specificity compared to TB culture were calculated. Misclassification compared to the experienced technician and inter-rater reliability between trainees was assessed. Trainees rated microscopes on technical aspects. Primo Star iLED (TM), FluoLED (TM) and Olympus BX41TF had comparable sensitivities (67%, 65% and 65% respectively), with the Lumin (TM) significantly worse (56%; p<0.05). Specificity was low for trainees on all microscopes (75.9%) compared to the experienced technician on Olympus BX41TF (100%). Primo Star iLED (TM) had significantly less misclassification (21.1% p<0.05) than FluoLED (TM) (26.5%) and Lumin (TM) (26.8%) and significantly higher inter-rater reliability (0.611; p<0.05), compared to FluoLED (TM) (0.523) and Lumin (TM) (0.492). Slide reading times for LED FMs were slower than the reference, but not significantly different from each other. Primo Star iLED (TM) rated highest in acceptability measures, followed by FluoLED (TM) then Lumin (TM). Primo Star iLED (TM) was consistently better than FluoLED (TM) and Lumin (TM), and performed comparably to the Olympus BX41TF in all analyses, except reading times. The Lumin (TM) compared least favorably and was thought unacceptable for use. Specificity and inter-rater reliability were low for all microscopes suggesting that a brief orientation was insufficient in this setting. These results provide important data for resource-limited settings to consider as they scale-up LED FMs.	[Turnbull, Eleanor R.; Kaunda, Kaunda; Harris, Jennifer B.; Kruuner, Annika; Henostroza, German; Reid, Stewart E.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Turnbull, Eleanor R.; Harris, Jennifer B.; Kruuner, Annika; Henostroza, German; Reid, Stewart E.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Turnbull, Eleanor R.; Harris, Jennifer B.; Kruuner, Annika; Henostroza, German; Reid, Stewart E.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Kapata, Nathan] Zambian Minist Hlth, Natl TB Leprosy Program, Lusaka, Zambia; [Muvwimi, Mweemba W.] Zambian Minist Hlth, Natl TB Reference Lab, Chest Dis Lab, Lusaka, Zambia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Turnbull, ER (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	eleanor.turnbull@cidrz.org	Kapata, Nathan/AAW-2469-2020	Reid, Stewart/0000-0001-7779-4820; Kapata, Nathan/0000-0002-3877-8809	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [PS08-803 PS001421]; Tulane University [U62/CCU622410-04]	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Tulane University	This study was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) (Cooperative Agreement PS08-803 PS001421) and Tulane University (Cooperative Agreement Number U62/CCU622410-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2010, INT J TUBERC LUNG D, V14, P160; Albert H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015206; Ba F, 1999, INT J TUBERC LUNG D, V3, P1101; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017214; Carl Zeiss Microimaging GmbH, 2011, PRIM ILED; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Foundation for Innovative New Diagnostics, 2010, FIND PRIM ILED COUNT; Foundation for Innovative New Diagnostics, 2008, DEM PROJ ILED TRAIN; Government of the Republic of Zambia, 2011, MONTHLY          JAN; Government of the Republic of Zambia Ministry of Health, 2005, NAT HLTH STRAT PLAN; Hanscheid T, 2008, T ROY SOC TROP MED H, V102, P520, DOI 10.1016/j.trstmh.2008.02.020; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Hung NV, 2007, LANCET INFECT DIS, V7, P238; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]; Mizuno Kazue, 2009, Kekkaku, V84, P627; Mugusi F, 2006, INT J TUBERC LUNG D, V10, P663; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Prasanthi K, 2005, Indian J Med Microbiol, V23, P179; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Siddiqi S. H, 2006, MGIT PROCEDURE MANUA; TOMAN K, 2004, TOMANS TUBERCULOSIS, P31; Trusov A, 2009, INT J TUBERC LUNG D, V13, P836; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; World Health Organization, 2010, WHOHTMTB20107; World Health Organization, 2010, FLUOR LIGHT EM DIOD; World Health Organization, 2009, WHOHTMTB2009411; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27125	10.1371/journal.pone.0027125	http://dx.doi.org/10.1371/journal.pone.0027125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073271	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200036
J	Viviani, R; Messina, I; Walter, M				Viviani, Roberto; Messina, Irene; Walter, Martin			Resting State Functional Connectivity in Perfusion Imaging: Correlation Maps with BOLD Connectivity and Resting State Perfusion	PLOS ONE			English	Article							DEFAULT MODE NETWORK; CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; GLOBAL SIGNAL; FLUCTUATIONS; CORTEX; FMRI; ARCHITECTURE; SINGLE	Functional connectivity is a property of the resting state that may provide biomarkers of brain function and individual differences. Classically, connectivity is estimated as the temporal correlation of spontaneous fluctuations of BOLD signal. We investigated differences in connectivity estimated from the BOLD and CBF signal present in volumes acquired with arterial spin labeling technique in a large sample (N = 265) of healthy individuals. Positive connectivity was observable in both BOLD and CBF signal, and was present in the CBF signal also at frequencies lower than 0.009 Hz, here investigated for the first time. Negative connectivity was more variable. The validity of positive connectivity was confirmed by the existence of correlation across individuals in its intensity estimated from the BOLD and CBF signal. In contrast, there was little or no correlation across individuals between intensity of connectivity and mean perfusion levels, suggesting that these two biomarkers correspond to distinct sources of individual differences.	[Viviani, Roberto; Messina, Irene] Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany; [Messina, Irene] Univ Padua, Dept Appl Psychol, Padua, Italy; [Walter, Martin] Otto Von Guericke Univ, Dept Psychiat, Clin Affect Neuroimaging Lab, Magdeburg, Germany	Ulm University; University of Padua; Otto von Guericke University	Viviani, R (corresponding author), Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany.	roberto.viviani@uni-ulm.de	Viviani, Roberto/A-8787-2015	Walter, Martin/0000-0001-7857-4483; Viviani, Roberto/0000-0002-7517-6006				Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aguirre GK, 2005, INT REV NEUROBIOL, V66, P213, DOI 10.1016/S0074-7742(05)66007-2; Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Alsop DC, 1998, RADIOLOGY, V208, P410, DOI 10.1148/radiology.208.2.9680569; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Detre JA, 1992, MAGN RESON MED, V3, P454; Drevets Wayne C., 1995, P1153; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salvador R, 2010, HUM BRAIN MAPP, V31, P2003, DOI 10.1002/hbm.20993; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Viviani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-30; Viviani R, 2009, NEUROIMAGE, V46, P12, DOI 10.1016/j.neuroimage.2009.01.041; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	47	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27050	10.1371/journal.pone.0027050	http://dx.doi.org/10.1371/journal.pone.0027050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073252	Green Published, gold			2022-12-27	WOS:000297198200031
J	Yeo, HC; Beh, TT; Quek, JJL; Koh, G; Chan, KKK; Lee, DY				Yeo, Hock Chuan; Beh, Thian Thian; Quek, Jovina Jia Ling; Koh, Geoffrey; Chan, Ken Kwok Keung; Lee, Dong-Yup			Integrated Transcriptome and Binding Sites Analysis Implicates E2F in the Regulation of Self-Renewal in Human Pluripotent Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FAMILY-MEMBERS; BETA-CATENIN; GENE; TARGET; EXPRESSION; ACTIVATION; NETWORK; NANOG; CYCLE	Rapid cellular growth and multiplication, limited replicative senescence, calibrated sensitivity to apoptosis, and a capacity to differentiate into almost any cell type are major properties that underline the self-renewal capabilities of human pluripotent stem cells (hPSCs). We developed an integrated bioinformatics pipeline to understand the gene regulation and functions involved in maintaining such self-renewal properties of hPSCs compared to matched fibroblasts. An initial genome-wide screening of transcription factor activity using in silico binding-site and gene expression microarray data newly identified E2F as one of major candidate factors, revealing their significant regulation of the transcriptome. This is underscored by an elevated level of its transcription factor activity and expression in all tested pluripotent stem cell lines. Subsequent analysis of functional gene groups demonstrated the importance of the TFs to self-renewal in the pluripotency-coupled context; E2F directly targets the global signaling (e. g. self-renewal associated WNT and FGF pathways) and metabolic network (e. g. energy generation pathways, molecular transports and fatty acid metabolism) to promote its canonical functions that are driving the self-renewal of hPSCs. In addition, we proposed a core self-renewal module of regulatory interplay between E2F and, WNT and FGF pathways in these cells. Thus, we conclude that E2F plays a significant role in influencing the self-renewal capabilities of hPSCs.	[Yeo, Hock Chuan; Beh, Thian Thian; Koh, Geoffrey; Chan, Ken Kwok Keung; Lee, Dong-Yup] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Quek, Jovina Jia Ling; Lee, Dong-Yup] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Yeo, HC (corresponding author), ASTAR, Bioproc Technol Inst, Singapore, Singapore.	kenkkc@hku.hk; cheld@nus.edu.sg	Lee, Dong-Yup/D-6650-2011	Lee, Dong-Yup/0000-0003-0901-708X; Yeo, Hock Chuan/0000-0001-5176-8800	Agency for Science, Technology and Research (A*STAR); National University of Singapore [R-279-000-328-112]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	The financial support of the Agency for Science, Technology and Research (A*STAR) is gratefully acknowledged. This work was also supported by the Academic Research Fund (R-279-000-328-112) from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2003, CELL CYCLE, V2, P538, DOI 10.4161/cc.2.6.550; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chan KKK, 2008, STEM CELLS DEV, V17, P825, DOI 10.1089/scd.2008.0233; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; DeGregori J, 2006, CURR MOL MED, V6, P739; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Kanai M, 2009, GENE, V438, P49, DOI 10.1016/j.gene.2009.03.004; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luciakova K, 2000, BIOCHEM J, V351, P251, DOI 10.1042/0264-6021:3510251; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stewart R, 2006, EUR J CANCER, V42, P1257, DOI 10.1016/j.ejca.2006.01.033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tashiro E, 2003, ONCOGENE, V22, P5630, DOI 10.1038/sj.onc.1206636; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Winn J, 2011, GENETICS, V188, P897, DOI 10.1534/genetics.111.128421; Wu SM, 2010, STEM CELL RES, V4, P38, DOI 10.1016/j.scr.2009.09.002; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	57	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27231	10.1371/journal.pone.0027231	http://dx.doi.org/10.1371/journal.pone.0027231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076139	gold, Green Submitted, Green Published			2022-12-27	WOS:000297198200053
J	Loucoubar, C; Goncalves, B; Tall, A; Sokhna, C; Trape, JF; Sarr, FD; Faye, J; Badiane, A; Ly, AB; Diop, A; Bar-Hen, A; Bureau, JF; Sakuntabhai, A; Paul, R				Loucoubar, Cheikh; Goncalves, Bronner; Tall, Adama; Sokhna, Cheikh; Trape, Jean-Francois; Sarr, Fatoumata Diene; Faye, Joseph; Badiane, Abdoulaye; Ly, Alioune Badara; Diop, Aliou; Bar-Hen, Avner; Bureau, Jean-Francois; Sakuntabhai, Anavaj; Paul, Richard			Impact of Changing Drug Treatment and Malaria Endemicity on the Heritability of Malaria Phenotypes in a Longitudinal Family-Based Cohort Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD INFECTION LEVELS; PLASMODIUM-FALCIPARUM; MISSING HERITABILITY; RESISTANCE; POPULATION; SUSCEPTIBILITY; TRANSMISSION; PROTECTION; PARASITES	Despite considerable success of genome wide association (GWA) studies in identifying causal variants for many human diseases, their success in unraveling the genetic basis to complex diseases has been more mitigated. Pathogen population structure may impact upon the infectious phenotype, especially with the intense short-term selective pressure that drug treatment exerts on pathogens. Rigorous analysis that accounts for repeated measures and disentangles the influence of genetic and environmental factors must be performed. Attempts should be made to consider whether pathogen diversity will impact upon host genetic responses to infection. We analyzed the heritability of two Plasmodium falciparum phenotypes, the number of clinical malaria episodes (PFA) and the proportion of these episodes positive for gametocytes (Pfgam), in a family-based cohort followed for 19 years, during which time there were four successive drug treatment regimes, with documented appearance of drug resistance. Repeated measures and variance components analyses were performed with fixed environmental, additive genetic, intra-individual and maternal effects for each drug period. Whilst there was a significant additive genetic effect underlying PFA during the first drug period of study, this was lost in subsequent periods. There was no additive genetic effect for Pfgam. The intra-individual effect increased significantly in the chloroquine period. The loss of an additive genetic effect following novel drug treatment may result in significant loss of power to detect genes in a GWA study. Prior genetic analysis must be a pre-requisite for more detailed GWA studies. The temporal changes in the individual genetic and the intra-individual estimates are consistent with those expected if there were specific host-parasite interactions. The complex basis to the human response to malaria parasite infection likely includes dominance/epistatic genetic effects encompassed within the intra-individual variance component. Evaluating their role in influencing the outcome of infection through host genotype by parasite genotype interactions warrants research effort.	[Loucoubar, Cheikh; Goncalves, Bronner; Bureau, Jean-Francois; Sakuntabhai, Anavaj; Paul, Richard] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France; [Loucoubar, Cheikh; Bar-Hen, Avner] Univ Paris 05, Lab Math Appl Paris 5, UMR 8145, Paris, France; [Loucoubar, Cheikh; Tall, Adama; Sarr, Fatoumata Diene; Faye, Joseph; Badiane, Abdoulaye; Ly, Alioune Badara] Univ Cheikh Anta Diop, Inst Pasteur Dakar, Unite Epidemiol Malad Infect, ED SEV,UR 172, Dakar, Senegal; [Loucoubar, Cheikh; Bar-Hen, Avner] Ecole Hautes Etud Sante Publ, Rennes, France; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, Dakar, Senegal; [Diop, Aliou] Univ Gaston Berger, Lab Etud & Rech Stat & Dev, St Louis, Senegal; [Sakuntabhai, Anavaj] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Mahidol University	Loucoubar, C (corresponding author), Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France.	rpaul@pasteur.fr		Paul, Richard/0000-0002-0665-5089; Bureau, Jean-Francois/0000-0003-1945-1883; DIOP, Aliou/0000-0002-0808-5622	Ecole des Hautes Etudes en Sante Publique	Ecole des Hautes Etudes en Sante Publique	Doctoral finances for Cheikh Loucoubar awarded by the Ecole des Hautes Etudes en Sante Publique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ali E, 2006, T ROY SOC TROP MED H, V100, P176, DOI 10.1016/j.trstmh.2005.04.021; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Babiker HA, 1997, PARASITOL TODAY, V13, P262, DOI 10.1016/S0169-4758(97)01075-2; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Barnes KI, 2005, ACTA TROP, V94, P230, DOI 10.1016/j.actatropica.2005.04.014; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Davila S, 2009, GENOME MED, V1, DOI 10.1186/gm19; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; GRAVES PM, 1984, AM J TROP MED HYG, V33, P1045, DOI 10.4269/ajtmh.1984.33.1045; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; Lee SH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-22; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenzie FE, 2008, ADV PARASIT, V66, P1, DOI 10.1016/S0065-308X(08)00201-7; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; [National Human Genome Research Institute National Institutes of Health], 2011, CAT PUBL GEN WID ASS; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Ntoumi F, 2007, AM J TROP MED HYG, V77, P270, DOI 10.4269/ajtmh.2007.77.270; Paul REL, 2003, ECOL LETT, V6, P866, DOI 10.1046/j.1461-0248.2003.00509.x; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Rao DC, 2008, ADV GENET, V60, P3, DOI 10.1016/S0065-2660(07)00401-4; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; SAS, 2010, MIXED PROC SAS STAT; SAS, 2010, INBREED PROC SAS STA; SAS Institute Inc, 2010, GLIMMIX PROC SAS STA; Schneider P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-257; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26364	10.1371/journal.pone.0026364	http://dx.doi.org/10.1371/journal.pone.0026364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073159	gold, Green Published			2022-12-27	WOS:000297197000008
J	Nakano, A; Tsuji, D; Miki, H; Cui, Q; El Sayed, SM; Ikegame, A; Oda, A; Amou, H; Nakamura, S; Harada, T; Fujii, S; Kagawa, K; Takeuchi, K; Sakai, A; Ozaki, S; Okano, K; Nakamura, T; Itoh, K; Matsumoto, T; Abe, M				Nakano, Ayako; Tsuji, Daisuke; Miki, Hirokazu; Cui, Qu; El Sayed, Salah Mohamed; Ikegame, Akishige; Oda, Asuka; Amou, Hiroe; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Kagawa, Kumiko; Takeuchi, Kyoko; Sakai, Akira; Ozaki, Shuji; Okano, Kazuma; Nakamura, Takahiro; Itoh, Kohji; Matsumoto, Toshio; Abe, Masahiro			Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; SIDE POPULATION; GLUCOSE-METABOLISM; P-GLYCOPROTEIN; CANCER; PROTEIN; LINES	Cancer cells eventually acquire drug resistance largely via the aberrant expression of ATP-binding cassette (ABC) transporters, ATP-dependent efflux pumps. Because cancer cells produce ATP mostly through glycolysis, in the present study we explored the effects of inhibiting glycolysis on the ABC transporter function and drug sensitivity of malignant cells. Inhibition of glycolysis by 3-bromopyruvate (3BrPA) suppressed ATP production in malignant cells, and restored the retention of daunorubicin or mitoxantrone in ABC transporter-expressing, RPMI8226 (ABCG2), KG-1 (ABCB1) and HepG2 cells (ABCB1 and ABCG2). Interestingly, although side population (SP) cells isolated from RPMI8226 cells exhibited higher levels of glycolysis with an increased expression of genes involved in the glycolytic pathway, 3BrPA abolished Hoechst 33342 exclusion in SP cells. 3BrPA also disrupted clonogenic capacity in malignant cell lines including RPMI8226, KG-1, and HepG2. Furthermore, 3BrPA restored cytotoxic effects of daunorubicin and doxorubicin on KG-1 and RPMI8226 cells, and markedly suppressed subcutaneous tumor growth in combination with doxorubicin in RPMI8226-implanted mice. These results collectively suggest that the inhibition of glycolysis is able to overcome drug resistance in ABC transporter-expressing malignant cells through the inactivation of ABC transporters and impairment of SP cells with enhanced glycolysis as well as clonogenic cells.	[Nakano, Ayako; Miki, Hirokazu; Cui, Qu; Ikegame, Akishige; Oda, Asuka; Amou, Hiroe; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Kagawa, Kumiko; Matsumoto, Toshio; Abe, Masahiro] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Tsuji, Daisuke; Okano, Kazuma; Nakamura, Takahiro; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Med Biotechnol, Inst Med Res, Tokushima 770, Japan; [El Sayed, Salah Mohamed] Univ Tokushima, Grad Sch Med, Dept Pediat, Tokushima 770, Japan; [Takeuchi, Kyoko] Tokushima Univ Hosp, Div Transfus Med, Tokushima, Japan; [Sakai, Akira] Hiroshima Univ, Dept Hematol & Oncol, RIRBM, Hiroshima, Japan; [Ozaki, Shuji] Tokushima Prefectural Hosp, Div Internal Med, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Hiroshima University	Nakano, A (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan.	masabe@clin.med.tokushima-u.ac.jp	Tsuji, Daisuke/F-7085-2013	Tsuji, Daisuke/0000-0002-1528-7820	Ministry of Education, Culture, Science and Sports of Japan; National Cancer Center from the Ministry of Health, Labor and Welfare of Japan [21-8-5]	Ministry of Education, Culture, Science and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-aid for Scientific Research (A) to T. M., Grants-in-Aid for Scientific Research (C) to M. A. from the Ministry of Education, Culture, Science and Sports of Japan, and a National Cancer Center Research and Development Fund (21-8-5) to M. A. from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2000, CANCER RES, V60, P5761; Allen JD, 1999, CANCER RES, V59, P4237; Arai Fumio, 2008, STEMBOOK, DOI 10.3824/stembook.1.6.1; Asano J, 2011, LEUKEMIA, V25, P1182, DOI 10.1038/leu.2011.60; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Buda G, 2007, BRIT J HAEMATOL, V137, P454, DOI 10.1111/j.1365-2141.2007.06605.x; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hiasa M, 2009, BLOOD, V114, P4517, DOI 10.1182/blood-2009-04-215020; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hulleman E, 2009, BLOOD, V113, P2014, DOI 10.1182/blood-2008-05-157842; Kitazoe K, 2009, INT J HEMATOL, V89, P45, DOI 10.1007/s12185-008-0226-9; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Lin Q, 2008, GENE REGUL SYST BIO, V2, P43; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Minderman H, 2004, CLIN CANCER RES, V10, P1826, DOI 10.1158/1078-0432.CCR-0914-3; Modok S, 2006, CURR OPIN PHARMACOL, V6, P350, DOI 10.1016/j.coph.2006.01.009; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Turner JG, 2006, BLOOD, V108, P3881, DOI 10.1182/blood-2005-10-009084; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	35	76	81	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27222	10.1371/journal.pone.0027222	http://dx.doi.org/10.1371/journal.pone.0027222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073292	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900091
J	Tseng, KY; Caballero, A; Dec, A; Cass, DK; Simak, N; Sunu, E; Park, MJ; Blume, SR; Sammut, S; Park, DJ; West, AR				Tseng, Kuei Y.; Caballero, Adriana; Dec, Alexander; Cass, Daryn K.; Simak, Natalie; Sunu, Elizabeth; Park, Michael J.; Blume, Shannon R.; Sammut, Stephen; Park, Diana J.; West, Anthony R.			Inhibition of Striatal Soluble Guanylyl Cyclase-cGMP Signaling Reverses Basal Ganglia Dysfunction and Akinesia in Experimental Parkinsonism	PLOS ONE			English	Article							NITRIC OXIDE/CGMP PATHWAY; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC-TRANSMISSION; OSCILLATORY ACTIVITY; NEOSTRIATAL NEURONS; PROJECTION NEURONS; FORELIMB AKINESIA; ACTIVITY STATES; RAT-BRAIN	Objective: There is clearly a necessity to identify novel non-dopaminergic mechanisms as new therapeutic targets for Parkinson's disease (PD). Among these, the soluble guanylyl cyclase (sGC)-cGMP signaling cascade is emerging as a promising candidate for second messenger-based therapies for the amelioration of PD symptoms. In the present study, we examined the utility of the selective sGC inhibitor 1H-[1,2,4] oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ) for reversing basal ganglia dysfunction and akinesia in animal models of PD. Methods: The utility of the selective sGC inhibitor ODQ for reversing biochemical, electrophysiological, histochemical, and behavioral correlates of experimental PD was performed in 6-OHDA-lesioned rats and mice chronically treated with MPTP. Results: We found that one systemic administration of ODQ is sufficient to reverse the characteristic elevations in striatal cGMP levels, striatal output neuron activity, and metabolic activity in the subthalamic nucleus observed in 6-OHDA-lesioned rats. The latter outcome was reproduced after intrastriatal infusion of ODQ. Systemic administration of ODQ was also effective in improving deficits in forelimb akinesia induced by 6-OHDA and MPTP. Interpretation: Pharmacological inhibition of the sGC-cGMP signaling pathway is a promising non-dopaminergic treatment strategy for restoring basal ganglia dysfunction and attenuating motor symptoms associated with PD.	[Tseng, Kuei Y.; Caballero, Adriana; Cass, Daryn K.; Simak, Natalie; Blume, Shannon R.] Rosalind Franklin Univ, Dept Cellular & Mol Pharmacol, Chicago Med Sch, N Chicago, IL USA; [Dec, Alexander; Sunu, Elizabeth; Park, Michael J.; Sammut, Stephen; Park, Diana J.; West, Anthony R.] Rosalind Franklin Univ, Dept Neurosci, Chicago Med Sch, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Tseng, KY (corresponding author), Rosalind Franklin Univ, Dept Cellular & Mol Pharmacol, Chicago Med Sch, N Chicago, IL USA.	kuei-yuan.tseng@rosalindfranklin.edu; Anthony.West@rosalindfranklin.edu	Sammut, Stephen/AAE-9787-2021	Caballero, Adriana/0000-0001-7052-7594; Sammut, Stephen/0000-0003-1507-5235	Parkinson's Disease Foundation; United States Public Health grants [NS047452, NS047452-S1]; Rosalind Franklin University; PRI;  [DA004093]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004093, R37DA004093] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; United States Public Health grants; Rosalind Franklin University; PRI; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Parkinson's Disease Foundation and United States Public Health grants NS047452 and NS047452-S1 to ARW, and DA004093, Rosalind Franklin University start-up funds, and PRI innovation grant to KYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1990, EUR J PHARMACOL, V181, P17; ARIANO MA, 1983, NEUROSCIENCE, V10, P707, DOI 10.1016/0306-4522(83)90212-9; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Calabresi P, 1999, J NEUROSCI, V19, P2489; Chalimoniuk M, 2007, NEUROCHEM INT, V50, P821, DOI 10.1016/j.neuint.2007.02.002; Chalimoniuk M, 2004, BIOCHEM BIOPH RES CO, V324, P118, DOI 10.1016/j.bbrc.2004.09.028; Chepkova AN, 2009, PFLUG ARCH EUR J PHY, V459, P131, DOI 10.1007/s00424-009-0714-7; COLWELL CS, 1995, J NEUROSCI, V15, P1704, DOI 10.1523/JNEUROSCI.15-03-01704.1995; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Ding JD, 2004, J COMP NEUROL, V472, P437, DOI 10.1002/cne.20054; Doreulee N, 2003, BRAIN RES, V964, P159, DOI 10.1016/S0006-8993(02)04121-5; Galati S, 2008, SYNAPSE, V62, P409, DOI 10.1002/syn.20510; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Giorgi M, 2008, EUR J NEUROSCI, V28, P941, DOI 10.1111/j.1460-9568.2008.06387.x; Hirsch EC, 2000, TRENDS NEUROSCI, V23, pS78, DOI 10.1016/S1471-1931(00)00021-5; HOFMANN M, 1977, J NEUROCHEM, V29, P395; Jouvert P, 2004, J NEUROSCI, V24, P10716, DOI 10.1523/JNEUROSCI.1398-04.2004; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; ODonnell P, 1997, NEUROSCIENCE, V76, P1; OLSSON M, 1995, J NEUROSCI, V15, P3863; Ondracek JM, 2008, EUR J NEUROSCI, V27, P1739, DOI 10.1111/j.1460-9568.2008.06157.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Roedter A, 2001, J COMP NEUROL, V432, P217, DOI 10.1002/cne.1098; Sammut S, 2007, J NEUROCHEM, V103, P1145, DOI 10.1111/j.1471-4159.2007.04811.x; Sammut S, 2010, NEUROPHARMACOLOGY, V58, P624, DOI 10.1016/j.neuropharm.2009.11.011; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Stocchi F, 2008, MOVEMENT DISORD, V23, pS599, DOI 10.1002/mds.22052; Taqatqeh F, 2009, J NEUROSCI, V29, P9344, DOI 10.1523/JNEUROSCI.1902-09.2009; Threlfell S, 2009, J PHARMACOL EXP THER, V328, P785, DOI 10.1124/jpet.108.146332; Tseng KY, 2006, BIOL PSYCHIAT, V60, P585, DOI 10.1016/j.biopsych.2006.03.030; Tseng KY, 2005, EUR J NEUROSCI, V22, P2579, DOI 10.1111/j.1460-9568.2005.04456.x; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; TSOU K, 1993, P NATL ACAD SCI USA, V90, P3462, DOI 10.1073/pnas.90.8.3462; West AR, 2004, J NEUROSCI, V24, P1924, DOI 10.1523/JNEUROSCI.4470-03.2004; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; West AR, 2010, US HDB BASAL GANGLIA, P187; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	46	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27187	10.1371/journal.pone.0027187	http://dx.doi.org/10.1371/journal.pone.0027187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073284	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900087
J	Zhang, ZY; Teruya, K; Eto, H; Shirahata, S				Zhang, Zhongyuan; Teruya, Kiichiro; Eto, Hiroshi; Shirahata, Sanetaka			Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated Pathways	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; BREAST-CANCER CELLS; N-TERMINAL KINASE; DOWN-REGULATION; DEATH; ERK; ANTITUMOR; INVOLVEMENT; MODULATION; INHIBITION	Background: Fucoidan extract (FE), an enzymatically digested compound with a low molecular weight, is extracted from brown seaweed. As a natural compound with various actions, FE is attractive, especially in Asian countries, for improving the therapeutic efficacy and safety of cancer treatment. The present study was carried out to investigate the anti-tumor properties of FE in human carcinoma cells and further examine the underlying mechanisms of its activities. Methodology/Principal Finding: FE inhibits the growth of MCF-7, MDA-MB-231, HeLa, and HT1080 cells. FE-mediated apoptosis in MCF-7 cancer cells is accompanied by DNA fragmentation, nuclear condensation, and phosphatidylserine exposure. FE induces mitochondrial membrane permeabilization (MMP) through loss of mitochondrial membrane potential (Delta Psi m) and regulation of the expression of Bcl-2 family members. Release of apoptosis-inducing factor (AIF) and cytochrome c precedes MMP. AIF release causes DNA fragmentation, the final stage of apoptosis, via a caspase-independent mitochondrial pathway. Additionally, FE was found to induce phosphorylation of c-Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK) 1/2, and apoptosis was found to be attenuated by inhibition of JNK. Furthermore, FE-mediated apoptosis was found to involve the generation of reactive oxygen species (ROS), which are responsible for the decrease of Delta Psi m and phosphorylation of JNK, p38, and ERK1/2 kinases. Conclusions/Significance: These data suggest that FE activates a caspase-independent apoptotic pathway in MCF-7 cancer cells through activation of ROS-mediated MAP kinases and regulation of the Bcl-2 family protein-mediated mitochondrial pathway. They also provide evidence that FE deserves further investigation as a natural anticancer and cancer preventive agent.	[Zhang, Zhongyuan; Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan; [Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Eto, Hiroshi] Daiichi Sangyo Co Ltd, Osaka, Japan	Kyushu University; Kyushu University; Daiichi Sankyo Company Limited	Zhang, ZY (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan.	kteruya@grt.kyushu-u.ac.jp			Daiichi Sangyo Co., Ltd.	Daiichi Sangyo Co., Ltd.(Daiichi Sankyo Company Limited)	This work was supported by Daiichi Sangyo Co., Ltd. Hiroshi Eto is an employee of Daiichi Sangyo Co., Ltd. and contributed analysis tools to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Athukorala Y, 2009, J APPL PHYCOL, V21, P307, DOI 10.1007/s10811-008-9368-7; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; COOMBE DR, 1987, INT J CANCER, V39, P82, DOI 10.1002/ijc.2910390115; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Egawa-Takata T, 2010, CANCER SCI, V101, P2171, DOI 10.1111/j.1349-7006.2010.01670.x; Engles JM, 2006, J NUCL MED, V47, P603; Ham YM, 2003, J BIOL CHEM, V278, P50330, DOI 10.1074/jbc.M302997200; Haneji K, 2005, NUTR CANCER, V52, P189, DOI 10.1207/s15327914nc5202_9; Harmon AW, 2004, BREAST CANCER RES TR, V85, P103, DOI 10.1023/B:BREA.0000025397.56192.e2; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Hyun JH, 2009, BIOL PHARM BULL, V32, P1760, DOI 10.1248/bpb.32.1760; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jin JO, 2010, MOL CARCINOGEN, V49, P771, DOI 10.1002/mc.20654; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Maruyama H, 2006, PLANTA MED, V72, P1415, DOI 10.1055/s-2006-951703; Moley KH, 2000, APOPTOSIS, V5, P99, DOI 10.1023/A:1009697908332; Nagamine T, 2009, NUTR CANCER, V61, P340, DOI 10.1080/01635580802567133; Nishimoto SJ, 2004, J INT SOC LIFE INFO, V22, P497; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Parreno M, 2008, CANCER RES, V68, P6313, DOI 10.1158/0008-5472.CAN-08-1054; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Shrivastava A, 2006, J BIOL CHEM, V281, P19762, DOI 10.1074/jbc.M600746200; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Takada E, 2001, J IMMUNOL, V166, P1641, DOI 10.4049/jimmunol.166.3.1641; TAKADA M, 2007, 5 ANN M JAP SOC MED; Tokita Y, 2010, BIOSCI BIOTECH BIOCH, V74, P350, DOI 10.1271/bbb.90705; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015; Wang XD, 2001, GENE DEV, V15, P2922; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamasaki-Miyamoto Y, 2009, J AGR FOOD CHEM, V57, P8677, DOI 10.1021/jf9010406; Ye J, 2005, CYTOTECHNOLOGY, V47, P117, DOI 10.1007/s10616-005-3761-8	60	82	86	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27441	10.1371/journal.pone.0027441	http://dx.doi.org/10.1371/journal.pone.0027441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096572	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900044
J	Li, JF; Bush, J; Xiong, Y; Li, L; McCormack, M				Li, Jian-Feng; Bush, Jenifer; Xiong, Yan; Li, Lei; McCormack, Matthew			Large-Scale Protein-Protein Interaction Analysis in Arabidopsis Mesophyll Protoplasts by Split Firefly Luciferase Complementation	PLOS ONE			English	Article							AUXIN RESPONSE; REGULATED PROTEIN; CIRCADIAN CLOCK; GENE-EXPRESSION; AUX/IAA PROTEIN; BIOLUMINESCENCE; ASSAY; ARF; DNA; IDENTIFICATION	Protein-protein interactions (PPIs) constitute the regulatory network that coordinates diverse cellular functions. There are growing needs in plant research for creating protein interaction maps behind complex cellular processes and at a systems biology level. However, only a few approaches have been successfully used for large-scale surveys of PPIs in plants, each having advantages and disadvantages. Here we present split firefly luciferase complementation (SFLC) as a highly sensitive and noninvasive technique for in planta PPI investigation. In this assay, the separate halves of a firefly luciferase can come into close proximity and transiently restore its catalytic activity only when their fusion partners, namely the two proteins of interest, interact with each other. This assay was conferred with quantitativeness and high throughput potential when the Arabidopsis mesophyll protoplast system and a microplate luminometer were employed for protein expression and luciferase measurement, respectively. Using the SFLC assay, we could monitor the dynamics of rapamycin-induced and ascomycin-disrupted interaction between Arabidopsis FRB and human FKBP proteins in a near real-time manner. As a proof of concept for large-scale PPI survey, we further applied the SFLC assay to testing 132 binary PPIs among 8 auxin response factors (ARFs) and 12 Aux/IAA proteins from Arabidopsis. Our results demonstrated that the SFLC assay is ideal for in vivo quantitative PPI analysis in plant cells and is particularly powerful for large-scale binary PPI screens.	[Li, Jian-Feng; Xiong, Yan; Li, Lei; McCormack, Matthew] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Li, Jian-Feng; Bush, Jenifer; Xiong, Yan; Li, Lei; McCormack, Matthew] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Li, JF (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	jli@molbio.mgh.harvard.edu	Li, Lei/F-9826-2015		Massachusetts General Hospital; National Institutes of Health [GM070567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567] Funding Source: NIH RePORTER	Massachusetts General Hospital(General Electric); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Massachusetts General Hospital postdoctoral fellowship for medical discovery awarded to Dr. Li, and the National Institutes of Health grant GM070567 to Dr. Sheen (Massachusetts General Hospital, United States of America). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Boruc J, 2010, PLANT SIGNAL BEHAV, V5, P1276, DOI 10.4161/psb.5.10.13037; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Faraco M, 2011, PLANT PHYSIOL, V156, P474, DOI 10.1104/pp.111.173708; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fukaki H, 2005, PLANT J, V44, P382, DOI 10.1111/j.1365-313X.2005.02537.x; Gehl C, 2011, PLANT J, V67, P542, DOI 10.1111/j.1365-313X.2011.04607.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Kim JY, 2010, J BIOL CHEM, V285, P23307, DOI 10.1074/jbc.M110.105981; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Porter JR, 2008, J AM CHEM SOC, V130, P6488, DOI 10.1021/ja7114579; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Rose A, 2004, PLANT PHYSIOL, V134, P927, DOI 10.1104/pp.103.035626; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Weijers D, 2004, CURR OPIN PLANT BIOL, V7, P687, DOI 10.1016/j.pbi.2004.09.006; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YX, 2010, CURR GENOMICS, V11, P40, DOI 10.2174/138920210790218016	50	43	59	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27364	10.1371/journal.pone.0027364	http://dx.doi.org/10.1371/journal.pone.0027364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096563	gold, Green Published, Green Submitted			2022-12-27	WOS:000297350800050
J	Meng, H; Yuan, Y; Lee, VM				Meng, Hui; Yuan, Yuan; Lee, Vivian M.			Loss of Sphingosine Kinase 1/S1P Signaling Impairs Cell Growth and Survival of Neurons and Progenitor Cells in the Developing Sensory Ganglia	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; DORSAL-ROOT GANGLION; SPHINGOSINE 1-PHOSPHATE; IN-VIVO; LYSOPHOSPHOLIPID RECEPTORS; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; DEATH; EXPRESSION; DIFFERENTIATION	Background: Lysophospholipids such as lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are important signaling molecules that can regulate a wide range of cellular responses. We discovered that Sphingosine kinase 1 (Sphk1), a key enzyme that converts sphingosine to S1P, is expressed in neurons and progenitor cells in nascent trigeminal and dorsal root ganglia during mouse embryogenesis. Methods and Findings: Sphk1 null mouse embryos do not display overt deficits owing to compensation by Sphk2. Thus, we analyzed embryos that are deficient in both Sphk1 and Sphk2 (which essentially eliminates S1P function) in order to investigate the role(s) of Sphk1 during sensory ganglia formation. While animals lacking 1-3 alleles of Sphk1 and Sphk2 had no obvious phenotype, embryos without both genes displayed clear developmental defects. The complete absence of Sphk1 and Sphk2 resulted in trigeminal and dorsal root ganglia with fewer neurons and progenitor cells. The profound loss in cell number could be attributed to a decrease in cell proliferation as well as an increase in apoptosis. Furthermore, Sphk1/2 double mutants displayed an overall reduction in other sphingolipids as well as an imbalance of S1P/sphingosine and S1P/ceramide ratio, thereby favoring cell death and reducing cell growth. Conclusions: Together, these results provide strong in vivo evidence that sphingosine kinase/S1P signaling plays an important role in regulating early events during development of sensory ganglia.	[Meng, Hui; Lee, Vivian M.] Med Coll Wisconsin, Dept Pediat, Div Dev Biol, Milwaukee, WI 53226 USA; [Meng, Hui; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China	Medical College of Wisconsin; China Medical University	Meng, H (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Dev Biol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	leevivianm@gmail.com	Yuan, Yuan/GVS-5120-2022		March of Dimes Basil O'Connor	March of Dimes Basil O'Connor(March of Dimes)	This study was funded in part by a March of Dimes Basil O'Connor Starter Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agudo-Lopez A, 2010, NEUROSCI LETT, V470, P130, DOI 10.1016/j.neulet.2009.12.070; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Barrett GL, 2000, PROG NEUROBIOL, V61, P205, DOI 10.1016/S0301-0082(99)00056-8; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dobrowsky RT, 1998, ANN NY ACAD SCI, V845, P32, DOI 10.1111/j.1749-6632.1998.tb09660.x; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hapner SJ, 2006, DEV BIOL, V297, P182, DOI 10.1016/j.ydbio.2006.05.007; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Kanno T, 2010, NEUROSCIENCE, V171, P973, DOI 10.1016/j.neuroscience.2010.10.021; Le Douarin NM, 1999, NEURAL CREST, V2; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Meng H, 2009, DEV DYNAM, V238, P487, DOI 10.1002/dvdy.21852; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Ohuchi H, 2008, DEV DYNAM, V237, P3280, DOI 10.1002/dvdy.21736; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne NJ, 2009, ADV ENZYME REGUL, V49, P214, DOI 10.1016/j.advenzreg.2009.01.011; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Saba JD, 2004, J CELL BIOCHEM, V92, P967, DOI 10.1002/jcb.20128; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Wilkinson GA, 1996, J NEUROSCI, V16, P7661; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5	42	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27150	10.1371/journal.pone.0027150	http://dx.doi.org/10.1371/journal.pone.0027150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096531	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800031
J	Robson, LG; Di Foggia, V; Radunovic, A; Bird, K; Zhang, XY; Marino, S				Robson, Lesley G.; Di Foggia, Valentina; Radunovic, Aleksandar; Bird, Katy; Zhang, Xinyu; Marino, Silvia			Bmi1 Is Expressed in Postnatal Myogenic Satellite Cells, Controls Their Maintenance and Plays an Essential Role in Repeated Muscle Regeneration	PLOS ONE			English	Article							SELF-RENEWAL; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; PROLIFERATION; ORIGIN; MICE; SHOW; PROGENITORS; PROGRESSION; POPULATION	Satellite cells are the resident stem cell population of the adult mammalian skeletal muscle and they play a crucial role in its homeostasis and in its regenerative capacity after injury. We show here that the Polycomb group (PcG) gene Bmi1 is expressed in both the Pax7 positive (+)/Myf5 negative (-) stem cell population as well as the Pax7+/Myf5+ committed myogenic progenitor population. Depletion of Pax7+/Myf5- satellite cells with reciprocal increase in Pax7+/Myf5+ as well as MyoD positive (+) cells is seen in Bmi1-/- mice leading to reduced postnatal muscle fiber size and impaired regeneration upon injury. Bmi1-/- satellite cells have a reduced proliferative capacity and fail to re-enter the cell cycle when stimulated by high serum conditions in vitro, in keeping with a cell intrinsic defect. Thus, both the in vivo and in vitro results suggest that Bmi1 plays a crucial role in the maintenance of the stem cell pool in postnatal skeletal muscle and is essential for efficient muscle regeneration after injury especially after repeated muscle injury.	[Robson, Lesley G.; Di Foggia, Valentina; Bird, Katy; Zhang, Xinyu; Marino, Silvia] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Radunovic, Aleksandar] Barts & London NHS Trust, Neurosci Clin Acad Unit, London, England	University of London; Queen Mary University London; Barts Health NHS Trust	Robson, LG (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	s.marino@qmul.ac.uk	Radunovic, Aleksandar/D-2569-2012	Marino, Silvia/0000-0002-9612-2883	Medical Research Council UK; Muscular Dystrophy Campaign; MRC [G0802546] Funding Source: UKRI; Medical Research Council [G0802546] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the Medical Research Council UK and Muscular Dystrophy Campaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; ASP P, 2011, P NATL AC SCI US; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; BOLDRIN L, 2010, J HISTOCHEM CYTOCHEM; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cossu G, 2005, SEMIN CELL DEV BIOL, V16, P623, DOI 10.1016/j.semcdb.2005.07.003; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; GROUNDS MD, 1992, EXP CELL RES, V198, P357, DOI 10.1016/0014-4827(92)90391-K; Irintchev A, 1997, NEUROMUSCULAR DISORD, V7, P117, DOI 10.1016/S0960-8966(96)00422-1; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; MASSA R, 1994, ACTA NEUROPATHOL, V87, P377; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Menzel CL, 2011, J SURG RES, V166, pE149, DOI 10.1016/j.jss.2010.11.914; Nowak JA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-1; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pavlath GK, 2003, AM J PATHOL, V162, P1685, DOI 10.1016/S0002-9440(10)64303-9; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 1999, J CELL SCI, V112, P4627; Wilton SD, 1997, NEUROMUSCULAR DISORD, V7, P329, DOI 10.1016/S0960-8966(97)00058-8; Wilton SD, 1997, MUSCLE NERVE, V20, P728; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	47	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27116	10.1371/journal.pone.0027116	http://dx.doi.org/10.1371/journal.pone.0027116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096526	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800028
J	Cui, LB; Qi, YH; Li, HJ; Ge, YY; Zhao, KC; Qi, X; Guo, XL; Shi, ZY; Zhou, MH; Zhu, BL; Guo, Y; Li, J; Stratton, CW; Tang, YW; Wang, H				Cui, Lunbiao; Qi, Yuhua; Li, Haijing; Ge, Yiyue; Zhao, Kangchen; Qi, Xian; Guo, Xiling; Shi, Zhiyang; Zhou, Minghao; Zhu, Baoli; Guo, Yan; Li, Jun; Stratton, Charles W.; Tang, Yi-Wei; Wang, Hua			Serum MicroRNA Expression Profile Distinguishes Enterovirus 71 and Coxsackievirus 16 Infections in Patients with Hand-Foot-and-Mouth Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PLASMA; BIOMARKERS; IDENTIFICATION; DIAGNOSIS; CANCER	Altered circulating microRNA (miRNA) profiles have been noted in patients with microbial infections. We compared host serum miRNA levels in patients with hand-foot-and-mouth disease (HFMD) caused by enterovirus 71 (EV71) and coxsackievirus 16 (CVA16) as well as in other microbial infections and in healthy individuals. Among 664 different miRNAs analyzed using a miRNA array, 102 were up-regulated and 26 were down-regulated in sera of patients with enteroviral infections. Expression levels of ten candidate miRNAs were further evaluated by quantitative real-time PCR assays. A receiver operating characteristic (ROC) curve analysis revealed that six miRNAs (miR-148a, miR-143, miR-324-3p, miR-628-3p, miR-140-5p, and miR-362-3p) were able to discriminate patients with enterovirus infections from healthy controls with area under curve (AUC) values ranged from 0.828 to 0.934. The combined six miRNA using multiple logistic regression analysis provided not only a sensitivity of 97.1% and a specificity of 92.7% but also a unique profile that differentiated enterovirial infections from other microbial infections. Expression levels of five miRNAs (miR-148a, miR-143, miR-324-3p, miR-545, and miR-140-5p) were significantly increased in patients with CVA16 versus those with EV71 (p<0.05). Combination of miR-545, miR-324-3p, and miR-143 possessed a moderate ability to discrimination between CVA16 and EV71 with an AUC value of 0.761. These data indicate that sera from patients with different subtypes of enteroviral infection express unique miRNA profiles. Serum miRNA expression profiles may provide supplemental biomarkers for diagnosing and subtyping enteroviral HFMD infections.	[Cui, Lunbiao; Qi, Yuhua; Ge, Yiyue; Zhao, Kangchen; Qi, Xian; Guo, Xiling; Shi, Zhiyang; Zhou, Minghao; Zhu, Baoli; Wang, Hua] Jiangsu Prov Ctr Dis Prevent & Control, Inst Pathogen Microbiol, Nanjing, Peoples R China; [Cui, Lunbiao; Li, Haijing; Stratton, Charles W.; Tang, Yi-Wei] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Guo, Yan; Li, Jun] Nanjing Childrens Hosp, Nanjing, Peoples R China; [Stratton, Charles W.; Tang, Yi-Wei] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Cui, LB (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Inst Pathogen Microbiol, Nanjing, Peoples R China.	yiwei.tang@vanderbilt.edu; hua@jscdc.cn	ge, yiyue/AAW-9914-2021; cui, lunbiao/AAP-7931-2021; zhou, minghao/GZA-7244-2022		National Natural Science Foundation of China [30901285]; Important National Science and Technology Projects [2008ZX10004-002]; Natural Science Foundation of Jiangsu Province [BK2009434]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science and Technology Projects; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The study was supported by the National Natural Science Foundation of China (30901285, www.nsfc.gov.cn), Important National Science and Technology Specific Projects during the eleventh five-year plan period (2008ZX10004-002, www.most.gov.cn) and the Natural Science Foundation of Jiangsu Province (BK2009434, www.jstd.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIHRER V, 2011, AM J GASTROENTEROL; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cui LB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/425939; Deng XQ, 2003, J VIROL METHODS, V107, P141, DOI 10.1016/S0166-0934(02)00211-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Nuovo GJ, 2010, DIAGN MOL PATHOL, V19, P135, DOI 10.1097/PDM.0b013e3181c4daaa; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Reid G., 2010, CRIT REV ONCOL HEMAT, DOI 10,1016/j.critrevonc.,2010.11.004; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; [The Chinese Center for Disease Control and Prevention The Office of the World HealthOrganization in China], 2008, REP HAND FOOT MOUTH; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Xiao XL, 2009, ARCH VIROL, V154, P121, DOI 10.1007/s00705-008-0266-8; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	37	67	73	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27071	10.1371/journal.pone.0027071	http://dx.doi.org/10.1371/journal.pone.0027071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087245	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700014
J	Neiman, AB; Russell, DF; Rowe, MH				Neiman, Alexander B.; Russell, David F.; Rowe, Michael H.			Identifying Temporal Codes in Spontaneously Active Sensory Neurons	PLOS ONE			English	Article							SPIKE-TIMING PRECISION; INFORMATION-TRANSMISSION; DETECTION THRESHOLDS; STIMULI; SYSTEM; TRAINS; AFFERENTS; DYNAMICS; INTERNEURONS; VARIABILITY	The manner in which information is encoded in neural signals is a major issue in Neuroscience. A common distinction is between rate codes, where information in neural responses is encoded as the number of spikes within a specified time frame (encoding window), and temporal codes, where the position of spikes within the encoding window carries some or all of the information about the stimulus. One test for the existence of a temporal code in neural responses is to add artificial time jitter to each spike in the response, and then assess whether or not information in the response has been degraded. If so, temporal encoding might be inferred, on the assumption that the jitter is small enough to alter the position, but not the number, of spikes within the encoding window. Here, the effects of artificial jitter on various spike train and information metrics were derived analytically, and this theory was validated using data from afferent neurons of the turtle vestibular and paddlefish electrosensory systems, and from model neurons. We demonstrate that the jitter procedure will degrade information content even when coding is known to be entirely by rate. For this and additional reasons, we conclude that the jitter procedure by itself is not sufficient to establish the presence of a temporal code.	[Neiman, Alexander B.; Russell, David F.; Rowe, Michael H.] Ohio Univ, Neurosci Program, Athens, OH 45701 USA; [Neiman, Alexander B.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Russell, David F.; Rowe, Michael H.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Neiman, AB (corresponding author), Ohio Univ, Neurosci Program, Athens, OH 45701 USA.	rowe@ohio.edu	Neiman, Alexander B/G-2196-2010	Neiman, Alexander B/0000-0002-0906-9894	National Institutes of Health (NIH) [DC 04922, DC 05063]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004922, R01DC005063] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) DC 04922 and DC 05063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Aldworth ZN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002041; Aldworth ZN, 2005, J NEUROSCI, V25, P5323, DOI 10.1523/JNEUROSCI.0359-05.2005; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brichta AM, 2000, J NEUROPHYSIOL, V83, P1224, DOI 10.1152/jn.2000.83.3.1224; BRYANT HL, 1973, J NEUROPHYSIOL, V36, P205, DOI 10.1152/jn.1973.36.2.205; Butts DA, 2011, J NEUROSCI, V31, P11313, DOI 10.1523/JNEUROSCI.0434-11.2011; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Cox DR, 1966, STAT ANAL SERIES EVE; Dayan P, 2001, COMPUTATIONAL NEUROS; Engel TA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021919; Engelmann J, 2010, J NEUROPHYSIOL, V104, P1955, DOI 10.1152/jn.00503.2009; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Farkhooi F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021905; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; Gabbiani F, 1996, NETWORK-COMP NEURAL, V7, P61, DOI 10.1080/0954898X.1996.11978655; Goldberg J M, 1991, Curr Opin Neurobiol, V1, P229, DOI 10.1016/0959-4388(91)90083-J; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; Goldobin DS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.045201; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; HANGGI P, 1982, PHYS REP, V88, P207, DOI 10.1016/0370-1573(82)90045-X; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Koppl C, 1997, J NEUROSCI, V17, P3312; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marsalek PR, 1997, P NATL ACAD SCI USA, V94, P735, DOI 10.1073/pnas.94.2.735; Massot C, 2011, J NEUROPHYSIOL, V105, P1798, DOI 10.1152/jn.00910.2010; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Neiman AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061915; Neiman AB, 2004, J NEUROPHYSIOL, V92, P492, DOI 10.1152/jn.00742.2003; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Nguyen H, 2010, EUR PHYS J-SPEC TOP, V187, P179, DOI 10.1140/epjst/e2010-01282-3; Rathbun DL, 2010, J NEUROSCI, V30, P13558, DOI 10.1523/JNEUROSCI.0909-10.2010; Ratnam R, 2000, J NEUROSCI, V20, P6672, DOI 10.1523/JNEUROSCI.20-17-06672.2000; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F., 1997, SPIKES EXPLORING NEU; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; Rowe MH, 2011, BRAIN RES, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Schleimer JH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.248105; Strong S P, 1998, Pac Symp Biocomput, P621; Teramae J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.204103; Teramae JN, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.194102; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Tricas TC, 1998, J COMP PHYSIOL A, V182, P89; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Yoshimura K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.154101	56	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27380	10.1371/journal.pone.0027380	http://dx.doi.org/10.1371/journal.pone.0027380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087303	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700037
J	Pach, D; Brinkhaus, B; Roll, S; Wegscheider, K; Icke, K; Willich, SN; Witt, CM				Pach, Daniel; Brinkhaus, Benno; Roll, Stephanie; Wegscheider, Karl; Icke, Katja; Willich, Stefan N.; Witt, Claudia M.			Efficacy of Injections with Disci/Rhus Toxicodendron Compositum for Chronic Low Back Pain - A Randomized Placebo-Controlled Trial	PLOS ONE			English	Article							STERILE WATER; UNITED-STATES; MEDICINE USE; COMPLEMENTARY; ACUPUNCTURE; THERAPY; TRENDS	Background: The effectiveness of injection therapy for low-back pain is still debatable. We compared the efficacy of local injections of the homeopathic preparation Disci/Rhus toxicodendron compositum (verum) with placebo injections and with no treatment in patients with chronic low back pain. Methodology/Principal Findings: In a randomized controlled partly double blind multicenter trial patients with chronic low back pain from 9 German outpatient clinics were enrolled and randomly allocated in a 1: 1: 1 ratio to receive subcutaneous injections (verum or placebo) into painful sites on the lower back over 12 treatment sessions within eight weeks, or no treatment (rescue pain medication with paracetamol or NSAIDs). All trial personnel and participants were masked to treatment allocation. The primary outcome measure was the average pain intensity over the last seven days on a visual analogue scale (0-100 mm, 0 = no pain, 100 = worst imaginable pain) after eight weeks. Follow-up was 26 weeks. Primary analysis was by intention to treat. Between August 2007 and June 2008, 150 patients were randomly allocated to three groups (51 verum, 48 placebo and 51 no treatment). The mean baseline-adjusted low back pain intensity at week eight was: verum group 37.0 mm (97.5% CI 25.3;48.8), no treatment group 53.0 (41.8;64.2), and placebo group 41.8 (30.1;53.6). The verum was significantly superior to no treatment (P = 0.001), but not to placebo (P = 0.350). No significant side effects were reported. Conclusions/Significance: The homeopathic preparation was not superior to placebo. Compared to no treatment injections resulted in significant and clinical relevant chronic back pain relief.	[Pach, Daniel; Brinkhaus, Benno; Roll, Stephanie; Icke, Katja; Willich, Stefan N.; Witt, Claudia M.] Charite Univ Med Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University System of Maryland; University of Maryland Baltimore	Pach, D (corresponding author), Charite Univ Med Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	claudia.witt@charite.de	Brinkhaus, Benno/AAU-2428-2021; Witt, Claudia M./AAX-2370-2021	Brinkhaus, Benno/0000-0001-6290-744X; Witt, Claudia M./0000-0002-5440-7805; Pach, Daniel/0000-0002-2459-6596; Roll, Stephanie/0000-0003-1191-3289	WALA Heilmittel GmbH	WALA Heilmittel GmbH	The study was sponsored by WALA Heilmittel GmbH. The publication of this paper has no direct or indirect financial implications for the authors, their relatives, or their institution. The study was designed in collaboration with the funder. The funder had no role in data collection, data analysis, data interpretation, or writing of the report.	[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Chenot JF, 2007, Z ALLG MED, V83, P487; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Dillmann U, 1994, Schmerz, V8, P100, DOI 10.1007/BF02530415; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Eisenberg DM, 1999, VERBREITUNG ALTERNAT, P152; Ernst E, 2000, COMPLEMENT THER MED, V8, P32, DOI 10.1016/S0965-2299(00)90833-1; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Geissner E, 1995, Rehabilitation (Stuttg), V34, pXXXV; Geissner E, 1996, SCHMERZEMPFINDUNGSSK; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Hamre HJ, 2007, EUR J MED RES, V12, P302; Hamre HJ, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-57; Hartel U, 2004, Forsch Komplementarmed Klass Naturheilkd, V11, P327; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kohlmann T, 1996, Rehabilitation (Stuttg), V35, pI; Kushtagi P, 2009, ACTA OBSTET GYN SCAN, V88, P231, DOI 10.1080/00016340802635534; LEBARS D, 1979, PAIN, V6, P305, DOI 10.1016/0304-3959(79)90050-2; LeBars D, 1991, ACUPUNCT MED, V9, P47, DOI DOI 10.1136/AIM.9.2.47; Martensson L, 2008, AUST NZ J OBSTET GYN, V48, P369, DOI 10.1111/j.1479-828X.2008.00856.x; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Savigny P., 2009, LOND NATL COLLAB CEN; Speed C, 2004, BRIT MED J, V328, P1119, DOI 10.1136/bmj.328.7448.1119; Staal J Bart, 2008, Cochrane Database Syst Rev, pCD001824, DOI 10.1002/14651858.CD001824.pub3; Yelland MJ, 2004, SPINE, V29, P9, DOI 10.1097/01.BRS.0000105529.07222.5B	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26166	10.1371/journal.pone.0026166	http://dx.doi.org/10.1371/journal.pone.0026166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087222	Green Submitted, Green Published, gold			2022-12-27	WOS:000297349700004
J	Rapoport, DH; Becker, T; Mamlouk, AM; Schicktanz, S; Kruse, C				Rapoport, Daniel H.; Becker, Tim; Mamlouk, Amir Madany; Schicktanz, Simone; Kruse, Charli			A Novel Validation Algorithm Allows for Automated Cell Tracking and the Extraction of Biologically Meaningful Parameters	PLOS ONE			English	Article							LINEAGE CONSTRUCTION; REAL-TIME; IN-VITRO; SEGMENTATION; SYSTEM	Automated microscopy is currently the only method to non-invasively and label-free observe complex multi-cellular processes, such as cell migration, cell cycle, and cell differentiation. Extracting biological information from a time-series of micrographs requires each cell to be recognized and followed through sequential microscopic snapshots. Although recent attempts to automatize this process resulted in ever improving cell detection rates, manual identification of identical cells is still the most reliable technique. However, its tedious and subjective nature prevented tracking from becoming a standardized tool for the investigation of cell cultures. Here, we present a novel method to accomplish automated cell tracking with a reliability comparable to manual tracking. Previously, automated cell tracking could not rival the reliability of manual tracking because, in contrast to the human way of solving this task, none of the algorithms had an independent quality control mechanism; they missed validation. Thus, instead of trying to improve the cell detection or tracking rates, we proceeded from the idea to automatically inspect the tracking results and accept only those of high trustworthiness, while rejecting all other results. This validation algorithm works independently of the quality of cell detection and tracking through a systematic search for tracking errors. It is based only on very general assumptions about the spatiotemporal contiguity of cell paths. While traditional tracking often aims to yield genealogic information about single cells, the natural outcome of a validated cell tracking algorithm turns out to be a set of complete, but often unconnected cell paths, i.e. records of cells from mitosis to mitosis. This is a consequence of the fact that the validation algorithm takes complete paths as the unit of rejection/acceptance. The resulting set of complete paths can be used to automatically extract important biological parameters with high reliability and statistical significance. These include the distribution of life/cycle times and cell areas, as well as of the symmetry of cell divisions and motion analyses. The new algorithm thus allows for the quantification and parameterization of cell culture with unprecedented accuracy. To evaluate our validation algorithm, two large reference data sets were manually created. These data sets comprise more than 320,000 unstained adult pancreatic stem cells from rat, including 2592 mitotic events. The reference data sets specify every cell position and shape, and assign each cell to the correct branch of its genealogic tree. We provide these reference data sets for free use by others as a benchmark for the future improvement of automated tracking methods.	[Rapoport, Daniel H.; Becker, Tim; Schicktanz, Simone; Kruse, Charli] Fraunhofer Inst Marine Biotechnol, Lubeck, Germany; [Mamlouk, Amir Madany] Univ Lubeck, Inst Neuro & Bioinformat, Lubeck, Germany; [Becker, Tim; Mamlouk, Amir Madany] Univ Lubeck, Grad Sch Comp Med & Life Sci, Lubeck, Germany	Fraunhofer Gesellschaft; University of Lubeck; University of Lubeck	Rapoport, DH (corresponding author), Fraunhofer Inst Marine Biotechnol, Lubeck, Germany.	tim.becker@emb.fraunhofer.de	Becker, Tim/W-9985-2018	Becker, Tim/0000-0001-9615-0799	Graduate School for Computing in Medicine and Life Sciences; Germany's Excellence Initiative [DFG] [GSC 235/1]	Graduate School for Computing in Medicine and Life Sciences; Germany's Excellence Initiative [DFG](German Research Foundation (DFG))	TB was supported by the Graduate School for Computing in Medicine and Life Sciences funded by Germany's Excellence Initiative [DFG GSC 235/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Becker T, 2011, P WORKSH BILDV MED 2; Braun V, 2003, BIOINFORMATICS, V19, P851, DOI 10.1093/bioinformatics/btg087; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Debeir O, 2005, Eurocon 2005: The International Conference on Computer as a Tool, Vol 1 and 2 , Proceedings, P951; Degerman J, 2009, J MICROSC-OXFORD, V233, P178, DOI 10.1111/j.1365-2818.2008.03108.x; Degerman J, 2006, P INT WORKSH MICR IM; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Glauche I, 2009, CELL PROLIFERAT, V42, P248, DOI 10.1111/j.1365-2184.2009.00586.x; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gorjup E, 2009, EUR J CELL BIOL, V88, P409, DOI 10.1016/j.ejcb.2009.02.187; Hadjidemetriou S, 2008, P 3 INT WORKSH MICR; Hand AJ, 2009, J MICROSC-OXFORD, V234, P62, DOI 10.1111/j.1365-2818.2009.03144.x; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kirstein SL, 2006, ASSAY DRUG DEV TECHN, V4, P545, DOI 10.1089/adt.2006.4.545; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kruse C, 2006, ANN ANAT, V188, P503, DOI 10.1016/j.aanat.2006.07.012; Li K., 2007, P INT WORKSH MICR IM; Li K, 2006, P 2006 C COMP VIS PA, P65; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Mosig A, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-10; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Padfield D, 2008, I S BIOMED IMAGING, P376, DOI 10.1109/ISBI.2008.4541011; Pecreaux J, 2006, IEEE IMAGE PROC, P1949, DOI 10.1109/ICIP.2006.312796; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Ray N, 2002, P 5 IEEE SW S IM AN, P7; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roeder I, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/84656; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Shen HL, 2006, CHEMOMETR INTELL LAB, V82, P276, DOI 10.1016/j.chemolab.2005.07.007; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Yan K, 2009, VISAPP 2009: PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P281; Yang FX, 2005, LECT NOTES COMPUT SC, V3749, P302; Zhou XB, 2009, IEEE T INF TECHNOL B, V13, P152, DOI 10.1109/TITB.2008.2007098	39	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27315	10.1371/journal.pone.0027315	http://dx.doi.org/10.1371/journal.pone.0027315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087288	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700031
J	Benavides-Varela, S; Gomez, DM; Macagno, F; Bion, RAH; Peretz, I; Mehler, J				Benavides-Varela, Silvia; Gomez, David M.; Macagno, Francesco; Bion, Ricardo A. H.; Peretz, Isabelle; Mehler, Jacques			Memory in the Neonate Brain	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE DISCRIMINATION; AUDITORY-CORTEX; MUSIC; INTERFERENCE; RECOGNITION; ACQUISITION; NEWBORNS; SOUNDS	Background: The capacity to memorize speech sounds is crucial for language acquisition. Newborn human infants can discriminate phonetic contrasts and extract rhythm, prosodic information, and simple regularities from speech. Yet, there is scarce evidence that infants can recognize common words from the surrounding language before four months of age. Methodology/Principal Findings: We studied one hundred and twelve 1-5 day-old infants, using functional near-infrared spectroscopy (fNIRS). We found that newborns tested with a novel bisyllabic word show greater hemodynamic brain response than newborns tested with a familiar bisyllabic word. We showed that newborns recognize the familiar word after two minutes of silence or after hearing music, but not after hearing a different word. Conclusions/Significance: The data show that retroactive interference is an important cause of forgetting in the early stages of language acquisition. Moreover, because neonates forget words in the presence of some -but not all- sounds, the results indicate that the interference phenomenon that causes forgetting is selective.	[Benavides-Varela, Silvia; Gomez, David M.; Mehler, Jacques] Int Sch Adv Studies SISSA ISAS, Cognit Neurosci Sect, Trieste, Italy; [Gomez, David M.] Univ Chile, Ctr Adv Res Educ CIAE, Santiago, Chile; [Macagno, Francesco] Santa Maria della Misericordia Hosp, Dept Neonatal Pathol, Udine, Italy; [Bion, Ricardo A. H.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Peretz, Isabelle] Univ Montreal, BRAMS, Montreal, PQ, Canada	International School for Advanced Studies (SISSA); Universidad de Chile; Hospital Santa Maria della Misericordia; Stanford University; Universite de Montreal	Benavides-Varela, S (corresponding author), Int Sch Adv Studies SISSA ISAS, Cognit Neurosci Sect, Trieste, Italy.	benavide@sissa.it	Benavides-Varela, Silvia/ABG-7474-2020; Gómez, David M/C-3308-2011; Benavides-Varela, Silvia/K-5734-2016	Benavides-Varela, Silvia/0000-0003-4818-7372; Benavides-Varela, Silvia/0000-0003-4818-7372; Gomez, David Maximiliano/0000-0001-9509-6436	European Research Council under the European Union [269502]; Ministerio de Ciencia y TecnologUa (MICIT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICIT) of Costa Rica	European Research Council under the European Union(European Research Council (ERC)); Ministerio de Ciencia y TecnologUa (MICIT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICIT) of Costa Rica	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 269502 (PASCAL) to J.M.; and a grant from Ministerio de Ciencia y TecnologUa (MICIT) and Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICIT) of Costa Rica to S.B.V. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Benjamini Y, 2001, ANN STAT, V29, P1165; BERTONCINI J, 1989, BRAIN LANG, V37, P591, DOI 10.1016/0093-934X(89)90113-2; Bortfeld H, 2007, NEUROIMAGE, V34, P407, DOI 10.1016/j.neuroimage.2006.08.010; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; DeCasper AJ, 1986, INFANT BEHAV DEV, V17, P159; Dehaene-Lambertz G, 2010, BRAIN LANG, V114, P53, DOI 10.1016/j.bandl.2009.09.003; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Liberman AM, 1963, P S SPEECH COMM SE D, VD3, P2; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; MEHLER J, 1981, J VERB LEARN VERB BE, V20, P298, DOI 10.1016/S0022-5371(81)90450-3; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Nakano T, 2009, CEREB CORTEX, V19, P455, DOI 10.1093/cercor/bhn096; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Nespor M., 2008, PROSODIC PHONOLOGY; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Obrig Hellmuth, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00013; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Perani D, 2010, P NATL ACAD SCI USA, V107, P4758, DOI 10.1073/pnas.0909074107; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; QUERLEU D, 1988, EUR J OBSTET GYN R B, V28, P191, DOI 10.1016/0028-2243(88)90030-5; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Stevens KN, 2002, J ACOUST SOC AM, V111, P1872, DOI 10.1121/1.1458026; SWAIN IU, 1993, DEV PSYCHOL, V29, P312, DOI 10.1037/0012-1649.29.2.312; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Valiante AG, 2006, PEDIATRICS, V117, pE476, DOI 10.1542/peds.2004-2859; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; WERKER JF, 1983, CAN J PSYCHOL, V37, P278, DOI 10.1037/h0080725; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	38	31	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27497	10.1371/journal.pone.0027497	http://dx.doi.org/10.1371/journal.pone.0027497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HH	22087327	Green Published, gold			2022-12-27	WOS:000297347700059
J	Bordonaro, M; Tewari, S; Cicco, CE; Atamna, W; Lazarova, DL				Bordonaro, Michael; Tewari, Shruti; Cicco, Catherine E.; Atamna, Wafa; Lazarova, Darina L.			A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells	PLOS ONE			English	Article							ACID PHENETHYL ESTER; HISTONE-DEACETYLASE ACTIVITY; RECEPTOR TYROSINE KINASES; BETA-CATENIN; IN-VITRO; COMPENSATORY PROLIFERATION; COLORECTAL-CANCER; UP-REGULATION; FOLD-CHANGE; APOPTOSIS	Butyrate, a fermentation product of fiber in the colon, acts as a histone deacetylase inhibitor (HDACi) and induces apoptosis in colon cancer (CC) cells in vitro. We have reported that the apoptotic effects of butyrate are dependent upon the hyperactivation of the Wnt/beta-catenin pathway. However, prolonged exposure of CC cells to increasing concentrations of butyrate results in the acquisition of resistance to the Wnt/beta-catenin- and apoptosis-inducing effects of this agent, as well as cross-resistance to structurally different HDACis. Here we report that one mechanism whereby HDACi resistance arises is through the increase of beta-catenin-independent (noncanonical) Wnt signaling. Compared to HDACi-sensitive HCT-116 CC cells, HDACi-resistant HCT-R cells exhibit higher levels of AKT/PKB cell survival signaling, which is in part induced by WNT5A and its receptor ROR2. The induction of AKT signaling by HDACis is also detected in other CC cell lines, albeit to a lesser extent than in the drug-resistant HCT-R cells. The observations suggested that the apoptotic effect of butyrate and other HDACis in CC cells can be augmented by inhibitors of pAKT. In agreement with the hypothesis, the combination of MK2206, a pAKT inhibitor, and a HDACi (butyrate or LBH589) induced higher apoptosis in CC cells compared to each agent alone. The exposure to both agents also re-sensitized the HCT-R cells to apoptosis. Finally, the concept of simultaneously inducing canonical Wnt activity and suppressing AKT signaling was translated into a combination of diet-derived agents. Diet-derived pAKT inhibitors (caffeic acid phethyl ester, sulforaphane, dilallyl trisulfide) suppressed the butyrate-induced levels of pAKT, and increased the apoptotic effects of butyrate in both drug-sensitive and drug-resistant CC cells. Our findings can be translated into (a) CC therapy employing combinations of synthetic HDACis and inhibitors of pAKT, as well as (b) CC prevention based upon diets that result in sufficient amounts of butyrate and pAKT inhibitors.	[Bordonaro, Michael; Tewari, Shruti; Cicco, Catherine E.; Atamna, Wafa; Lazarova, Darina L.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Bordonaro, M (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	dlazarova@tcmedc.org			NIH/NCI [1R15CA152852-01]; Commonwealth Medical College (Scratnon, PA); AICR [09A002]; NIH/NCI-NIDDK [1R15CA149589-01]; NATIONAL CANCER INSTITUTE [R15CA152852, R15CA149589] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth Medical College (Scratnon, PA); AICR; NIH/NCI-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Darina Lazarova is supported by NIH/NCI grant #1R15CA152852-01 and institutional funds from The Commonwealth Medical College (Scratnon, PA). Michael Bordonaro is supported by AICR grant #09A002, NIH/NCI-NIDDK #1R15CA149589-01, and institutional funds from The Commonwealth Medical College (Scratnon, PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova MV, 2010, INT J BIOCHEM CELL B, V42, P1847, DOI 10.1016/j.biocel.2010.08.001; Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Barbier A, 2010, B CANCER, V97, pE9, DOI 10.1684/bdc.2010.1033; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; De Angelis Paula M, 2004, Mol Cancer, V3, P11, DOI 10.1186/1476-4598-3-11; Denlinger CE, 2005, J THORAC CARDIOV SUR, V130, P1422, DOI 10.1016/j.jtcvs.2005.06.051; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Feike AC, 2010, BIOCHEM BIOPH RES CO, V400, P500, DOI 10.1016/j.bbrc.2010.08.074; Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; He X, 2011, CANCER LETT, V301, P168, DOI 10.1016/j.canlet.2010.11.012; Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Izuishi K, 2000, CANCER RES, V60, P6201; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P159, DOI 10.1002/art.25017; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mahmoud NN, 2000, CARCINOGENESIS, V21, P921, DOI 10.1093/carcin/21.5.921; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyaki M, 1999, CANCER RES, V59, P4506; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; Sela U, 2008, NUTR CANCER, V60, P412, DOI 10.1080/01635580701733083; Shankar S, 2007, INT J ONCOL, V30, P905; Shen G, 2007, CANCER RES, V67, P9937, DOI 10.1158/0008-5472.CAN-07-1112; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; The Associations between Food Nutrition Physical Activitythe Risk of Colorectal Cancer, WCRF AICR SYST LIT R; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang LC, 2010, CLIN EXP IMMUNOL, V160, P223, DOI 10.1111/j.1365-2249.2009.04067.x; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Weyant MJ, 2000, CLIN CANCER RES, V6, P949; Xiao D, 2006, CARCINOGENESIS, V27, P533, DOI 10.1093/carcin/bgi228; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; ZHENG ZS, 1995, ONCOL RES, V7, P445	69	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27308	10.1371/journal.pone.0027308	http://dx.doi.org/10.1371/journal.pone.0027308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073312	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000047
J	Mou, XZ; Wan, SY; Li, YF; Zhang, SS; Sun, MJ; Liu, FL; Fu, HY; Zhang, X; Liu, HY; Cao, Q; Ke, YH; Xiang, C				Mou, Xiaozhou; Wan, Shuying; Li, Yifei; Zhang, Shanshan; Sun, Mingjiao; Liu, Fanglong; Fu, Huiying; Zhang, Xue; Liu, Haiying; Cao, Qian; Ke, Yuehai; Xiang, Charlie			Phenotypic Pattern-Based Assay for Dynamically Monitoring Host Cellular Responses to Salmonella Infections	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; SENSOR ARRAYS; MOUSE MODEL; LABEL-FREE; INVASION; SECRETION; APOPTOSIS; DEATH; IDENTIFICATION	The interaction between mammalian host cells and bacteria is a dynamic process, and the underlying pathologic mechanisms are poorly characterized. Limited information describing the host-bacterial interaction is based mainly on studies using label-based endpoint assays that detect changes in cell behavior at a given time point, yielding incomplete information. In this paper, a novel, label-free, real-time cell-detection system based on electronic impedance sensor technology was adapted to dynamically monitor the entire process of intestinal epithelial cells response to Salmonella infection. Changes in cell morphology and attachment were quantitatively and continuously recorded following infection. The resulting impedance-based time-dependent cell response profiles (TCRPs) were compared to standard assays and showed good correlation and sensitivity. Biochemical assays further suggested that TCRPs were correlated with cytoskeleton-associated morphological dynamics, which can be largely attenuated by inhibitions of actin and microtubule polymerization. Collectively, our data indicate that cell-electrode impedance measurements not only provide a novel, real-time, label-free method for investigating bacterial infection but also help advance our understanding of host responses in a more physiological and continuous manner that is beyond the scope of current endpoint assays.	[Mou, Xiaozhou; Li, Yifei; Liu, Fanglong; Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Wan, Shuying; Zhang, Shanshan; Sun, Mingjiao; Fu, Huiying; Zhang, Xue; Cao, Qian; Ke, Yuehai] Zhejiang Univ, Sch Med, Inst Mol Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Wan, Shuying; Zhang, Shanshan; Sun, Mingjiao; Fu, Huiying; Zhang, Xue; Cao, Qian; Ke, Yuehai] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Xiang, Charlie] Zhejiang California Int Nanosyst Inst ZCNI, Mol Diag Div, Hangzhou, Zhejiang, Peoples R China; [Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China; [Liu, Haiying] Peking Union Med Coll, Beijing 100021, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Mou, XZ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yke@zju.edu.cn; cxiang@zju.edu.cn	fu, huiying/GZG-2399-2022		National Basic Research Program of China (973 program) [2007CB513001]; China's National Science and Technology Major Project [2008ZX10002-009]; Zhejiang University; Zhejiang Provincial TCM Administration [N20090004]; National Natural Science Foundation of China [30900849]	National Basic Research Program of China (973 program)(National Basic Research Program of China); China's National Science and Technology Major Project; Zhejiang University; Zhejiang Provincial TCM Administration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (973 program) No. 2007CB513001, China's National Science and Technology Major Project No. 2008ZX10002-009 and a Qiu Shi Professorship from Zhejiang University to C.X., and partly supported by the key program of Zhejiang Provincial TCM Administration N20090004 and National Natural Science Foundation of China 30900849 to Y.H.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2004, J IMMUNOL METHODS, V292, P195, DOI 10.1016/j.jim.2004.06.022; Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Atienza JM, 2006, J BIOMOL SCREEN, V11, P634, DOI 10.1177/1087057106289334; Baldwin DN, 2003, GENOME BIOL, V4; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Chowers Y, 2000, J IMMUNOL, V165, P2955, DOI 10.4049/jimmunol.165.6.2955; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; FINLAY BB, 1991, J CELL SCI, V99, P283; FINLAY BB, 1988, J CELL BIOL, V107, P221, DOI 10.1083/jcb.107.1.221; Fu HY, 2011, ANAL CHEM, V83, P6518, DOI 10.1021/ac201670e; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; He XY, 2009, J MICROBIOL METH, V78, P97, DOI 10.1016/j.mimet.2009.04.007; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hobert ME, 2002, J BIOL CHEM, V277, P51025, DOI 10.1074/jbc.M210466200; Huang L, 2008, ANALYST, V133, P643, DOI 10.1039/b714384b; Ke N, 2010, ANAL CHEM, V82, P6495, DOI 10.1021/ac1007877; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kirstein SL, 2006, ASSAY DRUG DEV TECHN, V4, P545, DOI 10.1089/adt.2006.4.545; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Mastroeni P, 2004, MICROBES INFECT, V6, P398, DOI 10.1016/j.micinf.2003.12.009; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Sianina H, 2011, J MICROBIOL METH, V84, P101, DOI 10.1016/j.mimet.2010.11.004; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Steele-Mortimer Olivia, 2008, V431, P201; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005	46	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26544	10.1371/journal.pone.0026544	http://dx.doi.org/10.1371/journal.pone.0026544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073171	Green Submitted, Green Published, gold			2022-12-27	WOS:000297197000010
J	Suzuki, N; Furusawa, C; Kaneko, K				Suzuki, Narito; Furusawa, Chikara; Kaneko, Kunihiko			Oscillatory Protein Expression Dynamics Endows Stem Cells with Robust Differentiation Potential	PLOS ONE			English	Article							SELF-RENEWAL; GENE-EXPRESSION; NETWORK; PLURIPOTENCY; MOUSE; EMERGENCE; CIRCUITRY; NOISE; MODEL; FATE	The lack of understanding of stem cell differentiation and proliferation is a fundamental problem in developmental biology. Although gene regulatory networks (GRNs) for stem cell differentiation have been partially identified, the nature of differentiation dynamics and their regulation leading to robust development remain unclear. Herein, using a dynamical system modeling cell approach, we performed simulations of the developmental process using all possible GRNs with a few genes, and screened GRNs that could generate cell type diversity through cell-cell interactions. We found that model stem cells that both proliferated and differentiated always exhibited oscillatory expression dynamics, and the differentiation frequency of such stem cells was regulated, resulting in a robust number distribution. Moreover, we uncovered the common regulatory motifs for stem cell differentiation, in which a combination of regulatory motifs that generated oscillatory expression dynamics and stabilized distinct cellular states played an essential role. These findings may explain the recently observed heterogeneity and dynamic equilibrium in cellular states of stem cells, and can be used to predict regulatory networks responsible for differentiation in stem cell systems.	[Suzuki, Narito; Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Suzuki, Narito; Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Meguro Ku, Tokyo, Japan; [Furusawa, Chikara] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Lab Multiscale Biosyst Dynam, Suita, Osaka, Japan	University of Tokyo; University of Tokyo; Osaka University; RIKEN	Suzuki, N (corresponding author), Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	kaneko@complex.c.u-tokyo.ac.jp	Furusawa, Chikara/ABB-6516-2021; Furusawa, Chikara/N-6103-2015	Furusawa, Chikara/0000-0003-3554-4975; Furusawa, Chikara/0000-0003-3554-4975	people of Japan, via Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [21120004, 23650152]	people of Japan, via Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the people of Japan, via a Exploratory Research for Advanced Technology (ERATO) project from Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research (no. 21120004 and 23650152) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fujimori T, 2010, DEV GROWTH DIFFER, V52, P253, DOI 10.1111/j.1440-169X.2010.01172.x; Furusawa C, 1998, B MATH BIOL, V60, P659, DOI 10.1006/bulm.1997.0034; Furusawa C, 2001, J THEOR BIOL, V209, P395, DOI 10.1006/jtbi.2001.2264; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Goodwin B., 1963, TEMPORAL ORG CELLS; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirsch MW., 2003, DIFFERENTIAL EQUATIO, V2nd edn; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Huang S, 2007, PHYS REV LETT, V94; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kaneko K, 1997, B MATH BIOL, V59, P139, DOI 10.1016/S0092-8240(96)00044-4; KANEKO K, 1990, PHYSICA D, V41, P137, DOI 10.1016/0167-2789(90)90119-A; KANEKO K, 1994, PHYSICA D, V75, P89, DOI 10.1016/0167-2789(94)90277-1; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lander Arthur D., 2009, Journal of Biology (London), V8, P70, DOI 10.1186/jbiol177; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MIZUGUCHI T, 1995, PHYS REV LETT, V75, P966, DOI 10.1103/PhysRevLett.75.966; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Newman SA, 2009, J BIOSCIENCES, V34, P553, DOI 10.1007/s12038-009-0074-7; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Waddington C., 1957, STRATEGY GENES; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427	55	88	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27232	10.1371/journal.pone.0027232	http://dx.doi.org/10.1371/journal.pone.0027232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073296	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000034
J	Vallejo, S; Romacho, T; Angulo, J; Villalobos, LA; Cercas, E; Leivas, A; Bermejo, E; Carraro, R; Sanchez-Ferrer, CF; Peiro, C				Vallejo, Susana; Romacho, Tania; Angulo, Javier; Villalobos, Laura A.; Cercas, Elena; Leivas, Alejandra; Bermejo, Elena; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion			Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; OXIDATIVE STRESS; PLASMA VISFATIN; DIABETIC-RATS; DYSFUNCTION; EXPRESSION; CELLS; ATHEROSCLEROSIS; ASSOCIATION; NAMPT	Visfatin, also known as extracellular pre-B-cell colony-enhancing factor (PBEF) and nicotinamide phosphoribosyltransferase (Nampt), is an adipocytokine whose circulating levels are enhanced in metabolic disorders, such as type 2 diabetes mellitus and obesity. Circulating visfatin levels have been positively associated with vascular damage and endothelial dysfunction. Here, we investigated the ability of visfatin to directly impair vascular reactivity in mesenteric microvessels from both male Sprague-Dawley rats and patients undergoing non-urgent, non-septic abdominal surgery. The pre-incubation of rat microvessels with visfatin (50 and 100 ng/mL) did not modify the contractile response to noradrenaline (1 pmol/L to 30 mu mol/L), as determined using a small vessel myograph. However, visfatin (10 to 100 ng/mL) concentration-dependently impaired the relaxation to acetylcholine (ACh; 100 pmol/L to 3 mu mol/L), without interfering with the endothelium-independent relaxation to sodium nitroprusside (1 nmol/L to 3 mu mol/L). In both cultured human umbilical vein endothelial cells and rat microvascular preparations, visfatin (50 ng/mL) stimulated nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, as determined by lucigenin-derived chemiluminiscence. The relaxation to ACh impaired by visfatin was restored by the NADPH oxidase inhibitor apocynin (10 mu mol/L). Additionally, the Nampt inhibitor APO866 (10 mmol/L to 10 mu mol/L), but not an insulin receptor-blocking antibody, also prevented the stimulation of NADPH oxidase and the relaxation impairment elicited by visfatin. Accordingly, the product of Nampt activity nicotinamide mononucleotide (100 nmol/L to 1 mmol/L) stimulated endothelial NADPH oxidase activity and concentration-dependently impaired ACh-induced vasorelaxation. In human mesenteric microvessels pre-contracted with 35 mmol/L potassium chloride, the endothelium-dependent vasodilation to bradykinin (1 nmol/L to 3 mu mol/L) was equally impaired by visfatin and restored upon co-incubation with APO866. In conclusion, visfatin impairs endothelium-dependent relaxation through a mechanism involving NADPH oxidase stimulation and relying on Nampt enzymatic activity, and therefore arises as a potential new player in the development of endothelial dysfunction.	[Vallejo, Susana; Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Leivas, Alejandra; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Univ Autonoma Madrid, Dept Farmacol, Madrid, Spain; [Angulo, Javier] IRYCIS, Dept Histol, Madrid, Spain; [Bermejo, Elena] Hosp Princesa, Serv Cirugia Gen & Digest, Madrid, Spain; [Carraro, Raffaele] Hosp Princesa, Serv Endocrinol, Unidad Obesidad, Madrid, Spain; [Carraro, Raffaele] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Leivas, Alejandra; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Hosp Princesa, Inst Invest Sanitaria, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Hospital de La Princesa; Autonomous University of Madrid; Hospital de La Princesa	Vallejo, S (corresponding author), Univ Autonoma Madrid, Dept Farmacol, Madrid, Spain.	concha.peiro@uam.es	Romacho, Tania/B-2663-2016; Romacho, Tania/AAB-3306-2021; Peiro, Concepcion/B-9545-2017	Romacho, Tania/0000-0002-0962-7163; Romacho, Tania/0000-0002-0962-7163; Peiro, Concepcion/0000-0002-9690-7816; Leivas-Aldea, Alejandra/0000-0002-3950-9002; Carraro, Raffaele/0000-0002-5874-8076	Ministerio de Ciencia e Innovacion [SAF2008-01291, SAF2008-00942, SAF2011-28011, SAF2011-24648]; Instituto de Salud Carlos III (RETICEF) [RD06/0013, PI061779]; Ministerio de Educacion y Ciencia, Spain; CONACYT, Mexico	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (RETICEF)(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia, Spain(Spanish Government); CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-01291, SAF2008-00942, SAF2011-28011 and SAF2011-24648) and Instituto de Salud Carlos III (RETICEF RD06/0013, PI061779). T.R. and L.A.V. are the recipients of fellowships from Ministerio de Educacion y Ciencia, Spain, and CONACYT, Mexico, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Filippatos TD, 2007, J ENDOCRINOL INVEST, V30, P323, DOI 10.1007/BF03346300; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Kadoglou NPE, 2010, EXP CLIN ENDOCR DIAB, V118, P75, DOI 10.1055/s-0029-1237360; Kang YS, 2010, KIDNEY INT, V78, P170, DOI 10.1038/ki.2010.98; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Malam Z, 2011, J IMMUNOL, V186, P6474, DOI 10.4049/jimmunol.1003706; Malyszko J, 2009, TRANSPL P, V41, P150, DOI 10.1016/j.transproceed.2008.10.086; Malyszko J, 2010, NEPHROLOGY, V15, P190, DOI 10.1111/j.1440-1797.2009.01180.x; Mu JA, 2011, J NEPHROL, V24, P177, DOI 10.5301/JN.2010.3488; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rodriguez-Manas L, 2003, DIABETOLOGIA, V46, P556, DOI 10.1007/s00125-003-1056-1; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; TAYLOR R, 1987, BIOCHEM J, V242, P123, DOI 10.1042/bj2420123; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Yamawaki H, 2009, BIOCHEM BIOPH RES CO, V383, P503, DOI 10.1016/j.bbrc.2009.04.074; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727; Yilmaz MI, 2009, CLIN TRANSPLANT, V23, P241, DOI 10.1111/j.1399-0012.2008.00921.x	33	53	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27299	10.1371/journal.pone.0027299	http://dx.doi.org/10.1371/journal.pone.0027299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073309	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000044
J	Boonchawalit, S; Jullaksorn, D; Uttiyoung, J; Yowang, A; Krathong, N; Chautrakul, S; Yamashita, A; Ikuta, K; Roobsoong, A; Kanitvittaya, S; Sawanpanyalert, P; Kameoka, M				Boonchawalit, Samatchaya; Jullaksorn, Duangrat; Uttiyoung, Jiraporn; Yowang, Amara; Krathong, Nongkran; Chautrakul, Sununta; Yamashita, Akifumi; Ikuta, Kazuyoshi; Roobsoong, Amornsak; Kanitvittaya, Sangkom; Sawanpanyalert, Pathom; Kameoka, Masanori			Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE NEUTRALIZATION; POSITIVE SELECTION; HYPERMUTATION; GP120; DNA; RESISTANCE; POPULATION; INFECTION	Background: The envelope glycoproteins (Env), gp120 and gp41, are the most variable proteins of human immunodeficiency virus type 1 (HIV-1), and are the major targets of humoral immune responses against HIV-1. A circulating recombinant form of HIV-1, CRF01_AE, is prevalent throughout Southeast Asia; however, only limited information regarding the immunological characteristics of CRF01_AE Env is currently available. In this study, we attempted to examine the evolutionary pattern of CRF01_AE Env under the selection pressure of host immune responses. Methodology/Principal Findings: Peripheral blood samples were collected periodically over 3 years from 15 HIV-1-infected individuals residing in northern Thailand, and amplified env genes from the samples were subjected to computational analysis. The V5 region of gp120 showed highest variability in several samples over 3 years, whereas the V1/V2 and/or V4 regions of gp120 also showed high variability in many samples. In addition, the N-terminal part of the C3 region of gp120 showed highest amino acid diversity among the conserved regions of gp120. Chronological changes in the numbers of amino acid residues in gp120 variable regions and potential N-linked glycosylation (PNLG) sites are involved in increasing the variability of Env gp120. Furthermore, the C3 region contained several amino acid residues potentially under positive selection, and APOBEC3 family protein-mediated G to A mutations were frequently detected in such residues. Conclusions/Significance: Several factors, including amino acid substitutions particularly in gp120 C3 and V5 regions as well as changes in the number of PNLG sites and in the length of gp120 variable regions, were revealed to be involved in the molecular evolution of CRF01_AE Env. In addition, a similar tendency was observed between CRF01_AE and subtype C Env with regard to the amino acid variation of gp120 V3 and C3 regions. These results may provide important information for understanding the immunological characteristics of CRF01_AE Env.	[Boonchawalit, Samatchaya; Kameoka, Masanori] Thailand Japan Res Collaborat Ctr Emerging & Re E, Nonthaburi, Thailand; [Jullaksorn, Duangrat; Sawanpanyalert, Pathom] Minist Publ Hlth MOPH, Natl Inst Hlth, Dept Med Sci DMSc, Nonthaburi, Thailand; [Uttiyoung, Jiraporn; Yowang, Amara; Kanitvittaya, Sangkom] MOPH, DMSc, Reg Med Sci Ctr Chiangrai, Chiangrai, Thailand; [Krathong, Nongkran; Chautrakul, Sununta; Roobsoong, Amornsak] Mae Soay Hosp, Chiangrai, Thailand; [Yamashita, Akifumi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Ikuta, Kazuyoshi; Kameoka, Masanori] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Ministry of Public Health - Thailand; Tohoku University; Osaka University	Boonchawalit, S (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Re E, Nonthaburi, Thailand.	mkameoka@biken.osaka-u.ac.jp		Kameoka, Masanori/0000-0001-5525-9915	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan, and the research budget of the Department of Medical Sciences, Ministry of Public Health of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Arroyo MA, 2010, AIDS RES HUM RETROV, V26, P5, DOI 10.1089/aid.2009.0150; Bagnarelli P, 1999, J VIROL, V73, P3764, DOI 10.1128/JVI.73.5.3764-3777.1999; BALL JK, 1994, J GEN VIROL, V75, P867, DOI 10.1099/0022-1317-75-4-867; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Curran R, 2002, J MED VIROL, V67, P9, DOI 10.1002/jmv.2186; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Dieltjens T, 2009, AIDS RES HUM RETROV, V25, P1165, DOI 10.1089/aid.2008.0161; Frost SDW, 2001, VIROLOGY, V284, P250, DOI 10.1006/viro.2000.0887; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; GOUDSMIT J, 1988, AIDS, V2, P157; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Jullaksorn D, 2010, SE ASIAN J TROP MED, V41, P347; Karlsson AC, 1998, AIDS, V12, P839, DOI 10.1097/00002030-199808000-00005; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; LAMERS SL, 1993, J VIROL, V67, P3951, DOI 10.1128/JVI.67.7.3951-3960.1993; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mens H, 2007, AIDS RES HUM RETROV, V23, P107, DOI 10.1089/aid.2006.0089; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Utachee P, 2009, MICROBES INFECT, V11, P334, DOI 10.1016/j.micinf.2008.12.008; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	56	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27098	10.1371/journal.pone.0027098	http://dx.doi.org/10.1371/journal.pone.0027098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073263	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900076
J	He, NP; Han, XG; Yu, GR; Chen, QS				He, Nianpeng; Han, Xingguo; Yu, Guirui; Chen, Quansheng			Divergent Changes in Plant Community Composition under 3-Decade Grazing Exclusion in Continental Steppe	PLOS ONE			English	Article							LEYMUS-CHINENSIS GRASSLAND; TALLGRASS PRAIRIE; FIRE FREQUENCY; NITROGEN; LITTER; HETEROGENEITY; VARIABILITY; RESTORATION; STABILITY; ECOSYSTEM	An understanding of the factors controlling plant community composition will allow improved prediction of the responses of plant communities to natural and anthropogenic environmental change. Using monitoring data from 1980 to 2009, we quantified the changes in community composition in Leymus chinensis and Stipa grandis dominated grasslands in Inner Mongolia under long-term grazing-exclusion and free-grazing conditions, respectively. We demonstrated that the practice of long-term grazing exclusion has significant effects on the heterogeneity, the dominant species, and the community composition in the two grasslands. The community composition of L. chinensis and S. grandis grasslands exhibited directional changes with time under long-term grazing exclusion. Under free grazing, the L. chinensis community changed directionally with time, but the pattern of change was stochastic in the S. grandis community. We attributed the divergent responses to long-term grazing exclusion in the S. grandis and L. chinensis grasslands to litter accumulation and changes in the microenvironment after grazing exclusion, which collectively altered the growth and regeneration of the dominant species. The changes in the grazed grasslands were primarily determined by the selective feeding of sheep during long-term heavy grazing. Overall, the responses of the community composition of the Inner Mongolian grasslands to long-term grazing exclusion and heavy grazing were divergent, and depended primarily on the grassland type. Our findings provide new insights into the role of grazing in the maintenance of community structure and function and therefore have important implications for grassland management.	[He, Nianpeng; Yu, Guirui] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [He, Nianpeng; Han, Xingguo; Chen, Quansheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	He, NP (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	henp@igsnrr.ac.cn	Han, Xingguo/K-7552-2016; Chen, Quansheng/AGH-8083-2022; 于, 贵瑞/C-1768-2014	Han, Xingguo/0000-0002-1836-975X; Chen, Quansheng/0000-0003-2498-3278; 于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	State Key Basic Research Development Program in China [2010CB833500]; Natural Science Foundation in China [31070431, 40803024]	State Key Basic Research Development Program in China; Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the State Key Basic Research Development Program in China (No. 2010CB833500) and by Natural Science Foundation in China (No. 31070431 and 40803024). The authors also declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON F. W., 1965, ECOLOGY, V46, P714, DOI 10.2307/1935011; Baez S, 2006, ECOLOGY, V87, P2746, DOI 10.1890/0012-9658(2006)87[2746:BROPCS]2.0.CO;2; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bao YJ, 2001, GRASSLAND CHINA, V22, P17; Bao YJ, 2000, GRASSLAND CHINA, V21, P1; Baoyin T, 2009, RANGELAND ECOL MANAG, V62, P314, DOI 10.2111/08-161.1; Burns CE, 2009, BIODIVERS CONSERV, V18, P2327, DOI 10.1007/s10531-009-9590-x; CARSON WP, 1990, OECOLOGIA, V85, P8, DOI 10.1007/BF00317337; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Chen Z., 2000, TYPICAL STEPPE ECOSY; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; COLLINS SL, 1987, ECOLOGY, V68, P1243, DOI 10.2307/1939208; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; COLLINS SL, 1992, ECOLOGY, V73, P2001, DOI 10.2307/1941450; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hobbs RJ, 2007, ECOL MONOGR, V77, P545, DOI 10.1890/06-1530.1; Jiang S., 1988, RES GRASSLAND ECOSYS, V3, P1; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Li YH, 1994, GRASSLAND CHINA, V20, P11; Li YH, 2008, RESTOR ECOL, V16, P572, DOI 10.1111/j.1526-100X.2007.00332.x; Liu P, 2010, OECOLOGIA, V162, P771, DOI 10.1007/s00442-009-1506-7; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; Miller R.H., 1982, CHEM MICROBIOLOGICAL, V2nd, P1; Veen GF, 2008, OIKOS, V117, P859, DOI [10.1111/j.2008.0030-1299.16515.x, 10.1111/j.0030-1299.2008.16515.x]; Vermeire LT, 2008, AGR ECOSYST ENVIRON, V125, P111, DOI 10.1016/j.agee.2007.12.003; Wang SP, 2001, ACTA ECOLOGICA SINIC, V21, P264; Wang SP, 2001, ACTA ECOLOGICA SINIC, V20, P951; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Yang Hao, 2009, Chinese Journal of Plant Ecology, V33, P499, DOI 10.3773/j.issn.1005-264x.2009.03.009; Yang YF, 1998, ACTA ECOLOGICA SINIC, V28, P567	32	33	44	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26506	10.1371/journal.pone.0026506	http://dx.doi.org/10.1371/journal.pone.0026506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073169	gold, Green Published			2022-12-27	WOS:000297154900022
J	Pratama, G; Vaghjiani, V; Tee, JY; Liu, YH; Chan, J; Tan, C; Murthi, P; Gargett, C; Manuelpillai, U				Pratama, Gita; Vaghjiani, Vijesh; Tee, Jing Yang; Liu, Yu Han; Chan, James; Tan, Charmaine; Murthi, Padma; Gargett, Caroline; Manuelpillai, Ursula			Changes in Culture Expanded Human Amniotic Epithelial Cells: Implications for Potential Therapeutic Applications	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INDUCED EPITHELIOMESENCHYMAL TRANSITION; HUMAN FETAL MEMBRANES; IN-VITRO EXPANSION; STROMAL CELLS; ANIMAL SERUM; DIFFERENTIATION; TRANSPLANTATION; PROLIFERATION; REGENERATION	Human amniotic epithelial cells (hAEC) isolated from term placenta have stem cell-like properties, differentiate into tissue specific cells and reduce lung and liver inflammation and fibrosis following transplantation into disease models established in mice. These features together with their low immunogenicity and immunosuppressive properties make hAEC an attractive source of cells for potential therapeutic applications. However, generation of large cell numbers required for therapies through serial expansion in xenobiotic-free media may be a limiting factor. We investigated if hAEC could be expanded in xenobiotic-free media and if expansion altered their differentiation capacity, immunophenotype, immunosuppressive properties and production of immunomodulatory factors. Serial expansion in xenobiotic-free media was limited with cumulative cell numbers and population doubling times significantly lower than controls maintained in fetal calf serum. The epithelial morphology of primary hAEC changed into mesenchymal-stromal like cells by passage 4-5 (P4-P5) with down regulation of epithelial markers CK7, CD49f, EpCAM and E-cadherin and elevation of mesenchymal-stromal markers CD44, CD105, CD146 and vimentin. The P5 hAEC expanded in xenobiotic-free medium differentiated into osteocyte and alveolar epithelium-like cells, but not chondrocyte, hepatocyte, a-and b-pancreatic-like cells. Expression of HLA Class IA, Class II and co-stimulatory molecules CD80, CD86 and CD40 remained unaltered. The P5 hAEC suppressed mitogen stimulated T cell proliferation, but were less suppressive compared with primary hAEC at higher splenocyte ratios. Primary and P5 hAEC did not secrete the immunosuppressive factors IL-10 and HGF, whereas TGF-beta 1 and HLA-G were reduced and IL-6 elevated in P5 hAEC. These findings suggest that primary and expanded hAEC may be suitable for different cellular therapeutic applications.	[Pratama, Gita; Vaghjiani, Vijesh; Tee, Jing Yang; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Liu, Yu Han; Chan, James] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Tan, Charmaine; Gargett, Caroline] Monash Univ, Dept Obstet & Gynecol, Monash Inst Med Res, Clayton, Vic, Australia; [Tan, Charmaine; Gargett, Caroline] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Clayton, Vic, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Murthi, Padma] Royal Womens Hosp, Pregnancy Res Ctr, Dept Perinatal Med, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Monash University; University of Melbourne	Pratama, G (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia.	ursula.manuelpillai@monash.edu	Gargett, Caroline E/Q-7911-2019; Murthi, Padma/AAY-5395-2021; Gargett, Caroline Eve/I-4895-2019; Tee, Jing Yang/F-2821-2013; Pratama, Gita/AAX-8749-2021	Gargett, Caroline E/0000-0002-3590-2077; Tee, Jing Yang/0000-0003-1605-4938; Pratama, Gita/0000-0001-5626-1283; Vaghjiani, Vijesh/0000-0001-8004-3876	Australian National Health & Medical Research Council (NHMRC) [606473, 465121, 545992, 509140, 436634]; Australian Partnership Scholarship, AusAID; Victorian Government	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Partnership Scholarship, AusAID; Victorian Government	UM is funded by: the Australian National Health & Medical Research Council (NHMRC) project grant #606473; CG by NHMRC Career Development Award #465121 and project grant #545992; PM by NHMRC project grant #509140; JC by NHMRC program grant #436634. GP was supported by an Australian Partnership Scholarship, AusAID. Study was supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Banas RA, 2008, HUM IMMUNOL, V69, P321, DOI 10.1016/j.humimm.2008.04.007; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Chan J, 2008, AUTOIMMUNITY, V41, P405, DOI 10.1080/08916930802011258; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Kollar Katarina, 2009, Int J Cell Biol, V2009, P904682, DOI 10.1155/2009/904682; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pera MF, 2000, J CELL SCI, V113, P5; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804; Tamagawa T, 2009, HUM CELL, V22, P55, DOI 10.1111/j.1749-0774.2009.00069.x; Terada S, 2000, CELL TRANSPLANT, V9, P701, DOI 10.1177/096368970000900518; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; YEAGER AM, 1985, AM J MED GENET, V22, P347, DOI 10.1002/ajmg.1320220219; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	43	93	106	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26136	10.1371/journal.pone.0026136	http://dx.doi.org/10.1371/journal.pone.0026136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073147	Green Published, gold			2022-12-27	WOS:000297154900005
J	Trenado, HP; Orilio, AF; Marquez-Martin, B; Moriones, E; Navas-Castillo, J				Trenado, Helena P.; Orilio, Anelise F.; Marquez-Martin, Belen; Moriones, Enrique; Navas-Castillo, Jesus			Sweepoviruses Cause Disease in Sweet Potato and Related Ipomoea spp.: Fulfilling Koch's Postulates for a Divergent Group in the Genus Begomovirus	PLOS ONE			English	Article							LEAF-CURL-VIRUS; STREAK VIRUS; DNA; INFECTION; CLONES; REPLICATION; INOCULATION; PROTEIN; CLONING; COPIES	Sweet potato (Ipomoea batatas) and related Ipomoea species are frequently infected by monopartite begomoviruses (genus Begomovirus, family Geminiviridae), known as sweepoviruses. Unlike other geminiviruses, the genomes of sweepoviruses have been recalcitrant to rendering infectious clones to date. Thus, Koch's postulates have not been fullfilled for any of the viruses in this group. Three novel species of sweepoviruses have recently been described in Spain: Sweet potato leaf curl Lanzarote virus (SPLCLaV), Sweet potato leaf curl Spain virus (SPLCSV) and Sweet potato leaf curl Canary virus (SPLCCaV). Here we describe the generation of the first infectious clone of an isolate (ES:MAL:BG30:06) of SPLCLaV. The clone consisted of a complete tandem dimeric viral genome in a binary vector. Successful infection by agroinoculation of several species of Ipomoea (including sweet potato) and Nicotiana benthamiana was confirmed by PCR, dot blot and Southern blot hybridization. Symptoms observed in infected plants consisted of leaf curl, yellowing, growth reduction and vein yellowing. Two varieties of sweet potato, 'Beauregard' and 'Promesa', were infected by agroinoculation, and symptoms of leaf curl and interveinal loss of purple colouration were observed, respectively. The virus present in agroinfected plants was readily transmitted by the whitefly Bemisia tabaci to I. setosa plants. The progeny virus population present in agroinfected I. setosa and sweet potato plants was isolated and identity to the original isolate was confirmed by sequencing. Therefore, Koch's postulates were fulfilled for the first time for a sweepovirus.	[Trenado, Helena P.; Orilio, Anelise F.; Marquez-Martin, Belen; Moriones, Enrique; Navas-Castillo, Jesus] CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Trenado, HP (corresponding author), CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Malaga, Spain.	jnavas@eelm.csic.es	Navas-Castillo, Jesús/G-3894-2011; Orílio, Anelise/D-1235-2012; Navas-Castillo, Jesús/AAQ-2075-2021; MORIONES, ENRIQUE/Q-6090-2017	Navas-Castillo, Jesús/0000-0002-8616-6241; Navas-Castillo, Jesús/0000-0002-8616-6241; MORIONES, ENRIQUE/0000-0003-0295-7845	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain; Consejo Superior de Investigaciones Cientificas (CSIC), Spain [200440E119]	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas (CSIC), Spain	EM and JNC are members of the Research Group AGR-214, partially funded by Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain. HPT and AFO were funded by Consejo Superior de Investigaciones Cientificas (CSIC), Spain, through predoctoral fellowships (Proyecto Intramural Especial 200440E119 and JAE Program, respectively). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque LC, 2011, ARCH VIROL, V156, P1291, DOI 10.1007/s00705-011-1016-x; Banks G K, 1999, Plant Dis, V83, P486, DOI 10.1094/PDIS.1999.83.5.486B; BonillaRamirez GM, 1997, J GEN VIROL, V78, P947, DOI 10.1099/0022-1317-78-4-947; Briddon RW, 2006, PLANT PATHOL, V55, P286, DOI 10.1111/j.1365-3059.2005.01273.x; CHATANI M, 1991, J GEN VIROL, V72, P2325, DOI 10.1099/0022-1317-72-10-2325; CHUNG M-L, 1985, Plant Protection Bulletin (Taichung), V27, P333; Clark CA, 2006, PLANT DIS, V90, P83, DOI 10.1094/PD-90-0083; Cohen J, 1997, ANN APPL BIOL, V131, P273, DOI 10.1111/j.1744-7348.1997.tb05156.x; COHEN J, 1991, PLANT DIS, V75, P291, DOI 10.1094/PD-75-0291; Cuellar WJ, 2011, J GEN VIROL, V92, P1233, DOI 10.1099/vir.0.029975-0; DONSON J, 1988, VIROLOGY, V162, P248, DOI 10.1016/0042-6822(88)90416-3; ELMER JS, 1988, PLANT MOL BIOL, V10, P225, DOI 10.1007/BF00027399; Fauquet CM, 2003, ANN APPL BIOL, V142, P165, DOI 10.1111/j.1744-7348.2003.tb00241.x; Ferreira PDTDO, 2008, J VIROL METHODS, V147, P351, DOI 10.1016/j.jviromet.2007.10.001; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Fuentes S, 2003, PLANT DIS, V87, P9893; Gibson RW, 1997, ANN APPL BIOL, V130, P481, DOI 10.1111/j.1744-7348.1997.tb07676.x; Gibson RW, 2004, VIRUS RES, V100, P115, DOI 10.1016/j.virusres.2003.12.023; GRIMSLEY N, 1987, NATURE, V325, P177, DOI 10.1038/325177a0; HAYES RJ, 1988, J GEN VIROL, V69, P209, DOI 10.1099/0022-1317-69-1-209; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; Kwak Hae-ryun, 2006, The Plant Pathology Journal, V22, P239; Lapidot M, 2007, J VIROL METHODS, V144, P143, DOI 10.1016/j.jviromet.2007.04.011; LIANG Y G, 1990, Plant Protection Bulletin (Taichung), V32, P136; Ling KS, 2010, CROP PROT, V29, P757, DOI 10.1016/j.cropro.2010.02.017; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Lotrakul P, 1998, PLANT DIS, V82, P1253, DOI 10.1094/PDIS.1998.82.11.1253; Lotrakul P., 1999, MOL PLANT PATHOL; Lotrakul Pongtharin, 2003, Revista Mexicana de Fitopatologia, V21, P128; Lozano G, 2009, J GEN VIROL, V90, P2550, DOI 10.1099/vir.0.012542-0; Luan YS, 2006, PLANT DIS, V90, P1111, DOI 10.1094/PD-90-1111C; Luan YS, 2007, VIRUS GENES, V35, P379, DOI 10.1007/s11262-007-0084-1; Miano DW, 2006, PLANT DIS, V90, P832, DOI 10.1094/PD-90-0832B; Osaki T., 1991, Bulletin of the University of Osaka Prefecture Series B Agriculture and Biology, V43, P17; Paprotka T, 2010, VIRUS RES, V149, P224, DOI 10.1016/j.virusres.2010.02.003; Prasanth G, 2008, PLANT DIS, V92, P311, DOI 10.1094/PDIS-92-2-0311B; Simmons AM, 2009, CROP PROT, V28, P1007, DOI 10.1016/j.cropro.2009.06.011; STANLEY J, 1990, P NATL ACAD SCI USA, V87, P6291, DOI 10.1073/pnas.87.16.6291; STANLEY J, 1986, NUCLEIC ACIDS RES, V14, P5981, DOI 10.1093/nar/14.15.5981; STANLEY J, 2005, VIRUS TAXONOMY, P301; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; Unseld S, 2004, VIROLOGY, V318, P90, DOI 10.1016/j.virol.2003.09.003; Valverde RA, 2004, VIRUS RES, V100, P123, DOI 10.1016/j.virusres.2003.12.020; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Wasswa P, 2011, PLANT PATHOL, V60, P1030, DOI 10.1111/j.1365-3059.2011.02464.x; Wu CY, 2008, J VIROL METHODS, V147, P355, DOI 10.1016/j.jviromet.2007.10.002	46	16	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27329	10.1371/journal.pone.0027329	http://dx.doi.org/10.1371/journal.pone.0027329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073314	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900099
J	Kummer, S; Jeruschke, S; Wegerich, LV; Peters, A; Lehmann, P; Seibt, A; Mueller, F; Koleganova, N; Halbenz, E; Schmitt, CP; Bettendorf, M; Mayatepek, E; Gross-Weissmann, ML; Oh, J				Kummer, Sebastian; Jeruschke, Stefanie; Wegerich, Lara Vanessa; Peters, Andrea; Lehmann, Petra; Seibt, Annette; Mueller, Friederike; Koleganova, Nadezda; Halbenz, Elisabeth; Schmitt, Claus Peter; Bettendorf, Markus; Mayatepek, Ertan; Gross-Weissmann, Marie-Luise; Oh, Jun			Estrogen Receptor Alpha Expression in Podocytes Mediates Protection against Apoptosis In-Vitro and In-Vivo	PLOS ONE			English	Article							RENAL-DISEASE; NULL MICE; ER-ALPHA; GLOMERULOSCLEROSIS; PROGRESSION; RATS; GENDER; GROWTH; INJURY; BETA	Context/Objective: Epidemiological studies have demonstrated that women have a significantly better prognosis in chronic renal diseases compared to men. This suggests critical influences of gender hormones on glomerular structure and function. We examined potential direct protective effects of estradiol on podocytes. Methods: Expression of estrogen receptor alpha (ER alpha) was examined in podocytes in vitro and in vivo. Receptor localization was shown using Western blot of separated nuclear and cytoplasmatic protein fractions. Podocytes were treated with Puromycin aminonucleoside (PAN, apoptosis induction), estradiol, or both in combination. Apoptotic cells were detected with Hoechst nuclear staining and Annexin-FITC flow cytometry. To visualize mitochondrial membrane potential depolarization as an indicator for apoptosis, cells were stained with tetramethyl rhodamine methylester (TMRM). Estradiol-induced phosphorylation of ERK1/2 and p38 MAPK was examined by Western blot. Glomeruli of ER alpha knock-out mice and wild-type controls were analysed by histomorphometry and immunohistochemistry. Results: ER alpha was consistently expressed in human and murine podocytes. Estradiol stimulated ER alpha protein expression, reduced PAN-induced apoptosis in vitro by 26.5 +/- 24.6% or 56.6 +/- 5.9% (flow cytometry or Hoechst-staining, respectively; both p<0.05), and restored PAN-induced mitochondrial membrane potential depolarization. Estradiol enhanced ERK1/2 phosphorylation. In ER alpha knockout mice, podocyte number was reduced compared to controls (female/male: 80/86 vs. 132/135 podocytes per glomerulus, p<0.05). Podocyte volume was enhanced in ER alpha knockout mice (female/male: 429/371 mm(3) vs. 264/223 mm(3) in controls, p<0.05). Tgf beta 1 and collagen type IV expression were increased in knockout mice, indicating glomerular damage. Conclusions: Podocytes express ER alpha, whose activation leads to a significant protection against experimentally induced apoptosis. Possible underlying mechanisms include stabilization of mitochondrial membrane potential and activation of MAPK signalling. Characteristic morphological changes indicating glomerulopathy in ER alpha knock-out mice support the in vivo relevance of the ER alpha for podocyte viability and function. Thus, our findings provide a novel model for the protective influence of female gender on chronic glomerular diseases.	[Kummer, Sebastian; Jeruschke, Stefanie; Wegerich, Lara Vanessa; Peters, Andrea; Seibt, Annette; Mayatepek, Ertan; Oh, Jun] Univ Childrens Hosp Duesseldorf, Dept Gen Pediat & Neonatol, Dusseldorf, Germany; [Jeruschke, Stefanie] Univ Duisburg Essen, Essen, Germany; [Lehmann, Petra; Koleganova, Nadezda; Gross-Weissmann, Marie-Luise] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Bettendorf, Markus] Univ Childrens Hosp, Div Pediat Endocrinol & Diabetol, Heidelberg, Germany; [Schmitt, Claus Peter] Univ Childrens Hosp, Div Pediat Nephrol, Heidelberg, Germany; [Mueller, Friederike; Halbenz, Elisabeth; Oh, Jun] Univ Med Ctr, Dept Pediat Nephrol, Hamburg, Germany	University of Duisburg Essen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kummer, S (corresponding author), Univ Childrens Hosp Duesseldorf, Dept Gen Pediat & Neonatol, Dusseldorf, Germany.	Sebastian.Kummer@med.uni-duesseldorf.de	Gross, Wolfgang Ludwig WG/C-8733-2011; Oh, Jun/K-4039-2013		Peter-Stiftung fur die Nierenwissenschaft; Forschungskommission der Medizinischen Fakultat; Heinrich-Heine-University, Duesseldorf	Peter-Stiftung fur die Nierenwissenschaft; Forschungskommission der Medizinischen Fakultat; Heinrich-Heine-University, Duesseldorf	This work was supported by a grant from the "Peter-Stiftung fur die Nierenwissenschaft" (http://www.peter-stiftung.de) to S.K., and by a grant from the "Forschungskommission der Medizinischen Fakultat", Heinrich-Heine-University, Duesseldorf (http://medfak.uniklinikum-duessedorf.de/deutsch/MedizinischeFakultt/Dekanat/Kommissionen/Forschungskommission/page.html) to J.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2008, KIDNEY INT, V74, P370, DOI 10.1038/ki.2008.205; Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Amann K, 2001, KIDNEY INT, V60, P1309, DOI 10.1046/j.1523-1755.2001.00936.x; Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x; Aulmann S, 2006, J CLIN PATHOL, V59, P424, DOI 10.1136/jcp.2005.029264; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Boland R, 2008, STEROIDS, V73, P859, DOI 10.1016/j.steroids.2007.12.027; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Doublier S, 2011, KIDNEY INT, V79, P404, DOI 10.1038/ki.2010.398; Dupont S, 2000, DEVELOPMENT, V127, P4277; ELEMA JD, 1975, LAB INVEST, V33, P554; Elliot SJ, 2007, KIDNEY INT, V72, P464, DOI 10.1038/sj.ki.5002328; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; GILBOA N, 1987, LIFE SCI, V41, P1629, DOI 10.1016/0024-3205(87)90731-4; Gross ML, 2004, J AM SOC NEPHROL, V15, P348, DOI 10.1097/01.ASN.0000105993.63023.D8; Guo GJ, 2001, AM J PHYSIOL-RENAL, V280, pF777, DOI 10.1152/ajprenal.2001.280.5.F777; HAJDU A, 1971, EXPERIENTIA, V27, P956, DOI 10.1007/BF02135771; Inokuchi S, 1996, KIDNEY INT, V50, P1278, DOI 10.1038/ki.1996.439; IRZYNIEC T, 1992, AM J HYPERTENS, V5, P437, DOI 10.1093/ajh/5.7.437; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Koh PO, 2007, NEUROSCI LETT, V412, P68, DOI 10.1016/j.neulet.2006.10.060; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; KUMMER S, 2011, PEDIAT NEPHROLOGY; Lovegrove AS, 2004, AM J PHYSIOL-RENAL, V287, pF586, DOI 10.1152/ajprenal.00414.2003; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Meng XM, 2011, LIFE SCI, V88, P178, DOI 10.1016/j.lfs.2010.11.008; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Nielsen CB, 2004, VIRCHOWS ARCH, V444, P561, DOI 10.1007/s00428-004-1006-4; NITSCH W, 1955, Ther Ggw, V94, P364; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schopick EL, 2009, NEPHROL DIAL TRANSPL, V24, P3739, DOI 10.1093/ndt/gfp321; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Silbiger SR, 2003, ADV RENAL REPLACE TH, V10, P3, DOI 10.1053/jarr.2003.50001; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Sun JH, 2006, AM J PHYSIOL-RENAL, V290, pF319, DOI 10.1152/ajprenal.00271.2005; THOMAS D, 1995, J BIOL CHEM, V270, P28924, DOI 10.1074/jbc.270.48.28924; Tofovic SP, 2002, J AM SOC NEPHROL, V13, P2737, DOI 10.1097/01.ASN.0000031804.77546.F5; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang ZG, 2004, STEROIDS, V69, P523, DOI 10.1016/j.steroids.2004.05.012	49	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27457	10.1371/journal.pone.0027457	http://dx.doi.org/10.1371/journal.pone.0027457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096576	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900047
J	Meijaard, E; Buchori, D; Hadiprakarsa, Y; Utami-Atmoko, SS; Nurcahyo, A; Tjiu, A; Prasetyo, D; Nardiyono; Christie, L; Ancrenaz, M; Abadi, F; Antoni, ING; Armayadi, D; Dinato, A; Ella; Gumelar, P; Indrawan, TP; Kussaritano; Munajat, C; Priyono, CWP; Purwanto, Y; Puspitasari, D; Putra, MSW; Rahmat, A; Ramadani, H; Sammy, J; Siswanto, D; Syamsuri, M; Andayani, N; Wu, HH; Wells, JA; Mengersen, K				Meijaard, Erik; Buchori, Damayanti; Hadiprakarsa, Yokyok; Utami-Atmoko, Sri Suci; Nurcahyo, Anton; Tjiu, Albertus; Prasetyo, Didik; Nardiyono; Christie, Lenny; Ancrenaz, Marc; Abadi, Firman; Antoni, I. Nyoman Gede; Armayadi, Dedy; Dinato, Adi; Ella; Gumelar, Pajar; Indrawan, Tito P.; Kussaritano; Munajat, Cecep; Priyono, C. Wawan Puji; Purwanto, Yadi; Puspitasari, Dewi; Putra, M. Syukur Wahyu; Rahmat, Abdi; Ramadani, Harri; Sammy, Jim; Siswanto, Dedi; Syamsuri, Muhammad; Andayani, Noviar; Wu, Huanhuan; Wells, Jessie Anne; Mengersen, Kerrie			Quantifying Killing of Orangutans and Human-Orangutan Conflict in Kalimantan, Indonesia	PLOS ONE			English	Article							PONGO-ABELII; CONSERVATION; ATTITUDES; PRIMATES; SUMATRA	Human-orangutan conflict and hunting are thought to pose a serious threat to orangutan existence in Kalimantan, the Indonesian part of Borneo. No data existed prior to the present study to substantiate these threats. We investigated the rates, spatial distribution and causes of conflict and hunting through an interview-based survey in the orangutan's range in Kalimantan, Indonesia. Between April 2008 and September 2009, we interviewed 6983 respondents in 687 villages to obtain socio-economic information, assess knowledge of local wildlife in general and orangutan encounters specifically, and to query respondents about their knowledge on orangutan conflicts and killing, and relevant laws. This survey revealed estimated killing rates of between 750 and 1800 animals killed in the last year, and between 1950 and 3100 animals killed per year on average within the lifetime of the survey respondents. These killing rates are higher than previously thought and are high enough to pose a serious threat to the continued existence of orangutans in Kalimantan. Importantly, the study contributes to our understanding of the spatial variation in threats, and the underlying causes of those threats, which can be used to facilitate the development of targeted conservation management.	[Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik; Wells, Jessie Anne] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Buchori, Damayanti; Hadiprakarsa, Yokyok; Nardiyono] Nat Conservancy Indonesia Forest Program, Jakarta, Indonesia; [Buchori, Damayanti; Hadiprakarsa, Yokyok; Nardiyono] Nat Conservancy Indonesia Forest Program, Bogor, Indonesia; [Buchori, Damayanti] Inst Pertanian Bogor, Dept Plant Protect, Fac Agr, Bogor, Indonesia; [Hadiprakarsa, Yokyok; Utami-Atmoko, Sri Suci; Tjiu, Albertus; Prasetyo, Didik; Nardiyono; Christie, Lenny; Andayani, Noviar] Indonesian Assoc Primatologists PERHAPPI, Bogor, Indonesia; [Utami-Atmoko, Sri Suci] Univ Nas, Fac Biol, Jakarta, Indonesia; [Nurcahyo, Anton; Ella] Borneo Orangutan Survival Fdn, Orangutan Reintroduct Program Cent Kalimantan, Palangkaraya, Indonesia; [Tjiu, Albertus; Puspitasari, Dewi] World Wide Fund Nat Indonesia, Pontianak, Indonesia; [Ancrenaz, Marc] Kinabatangan Orang Utan Conservat Project, Sandakan, Sabah, Malaysia; [Abadi, Firman] Borneo Ecol & Biodivers Conservat Inst BEBSiC, Samarinda, Indonesia; [Antoni, I. Nyoman Gede] Friends Natl Pk Fdn FNFP, Kumai, Indonesia; [Armayadi, Dedy] People Resources & Conservat Fdn PRCF, Pontianak, Indonesia; [Dinato, Adi] SuaR Inst, Nanga Pinoh, Indonesia; [Gumelar, Pajar] BIOMA Fdn, Samarinda, Indonesia; [Indrawan, Tito P.] Gunung Palung Orangutan Conservat Program, Ketapang, Indonesia; [Kussaritano] Mitra Lingkungan Hidup KalTeng, Palangkaraya, Indonesia; [Munajat, Cecep] Orangutan Fdn Int, Pangkalanbun, Indonesia; [Priyono, C. Wawan Puji] Yayasan Dian Tama, Pontianak, Indonesia; [Purwanto, Yadi] Simpur Hutan, Pontianak, Indonesia; [Putra, M. Syukur Wahyu] Yayasan Titian, Pontianak, Indonesia; [Rahmat, Abdi] Yayasan Perhimpunan TeROPONG, Palangkaraya, Indonesia; [Ramadani, Harri] Sylva Indonesia PC UNTAN, Pontianak, Indonesia; [Sammy, Jim] Yayasan Riak Bumi, Pontianak, Indonesia; [Siswanto, Dedi] Yayasan Cakrawala Indonesia, Palangkaraya, Indonesia; [Syamsuri, Muhammad] Forum Komunikasi Kader Konservasi Indonesia FK3I, Pontianak, Indonesia; [Andayani, Noviar] Wildlife Conservat Soc, Bogor, Indonesia; [Wu, Huanhuan; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia	People & Nature Consulting International; University of Queensland; Australian National University; Bogor Agricultural University; Universitas Nasional Pionir Perubahan; Wildlife Conservation Society - Indonesia; Queensland University of Technology (QUT)	Meijaard, E (corresponding author), People & Nat Consulting Int, Jakarta, Indonesia.	emeijaard@gmail.com	Meijaard, Erik/A-2687-2016; Buchori, Damayanti/L-5878-2017; Mengersen, Kerrie/AHC-4096-2022; Wells, Jessie A/F-7318-2010	Meijaard, Erik/0000-0001-8685-3685; Buchori, Damayanti/0000-0002-2843-0737; Wells, Jessie A/0000-0002-3555-5108; Hadiprakarsa, Yokyok/0000-0001-5186-6742; Prasetyo, Didik/0000-0001-5486-2624; utami, sri/0000-0002-5138-242X; Mengersen, Kerrie/0000-0001-8625-9168; Andayani, Noviar/0000-0002-1888-193X	Adopt-an-Acre program; United States Agency for International Development (USAID); Directorate of Forest Protection and Nature Conservation of the Indonesian Ministry of Forestry	Adopt-an-Acre program; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Directorate of Forest Protection and Nature Conservation of the Indonesian Ministry of Forestry	The Adopt-an-Acre program and the United States Agency for International Development (USAID) provided funding and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Peter Kareiva and Robert Lalasz for their help in writing and structuring this manuscript, three anonymous reviewers for providing detailed and constructive input for improving our manuscript, the Directorate of Forest Protection and Nature Conservation of the Indonesian Ministry of Forestry for supporting our study, and the Association of Indonesian Primatologists (PERHAPPI) for coordinating the studies. We are most grateful to our many respondents for taking the time to discuss with us their views on conservation in Kalimantan.	Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Beaman J, 2005, J WILDLIFE MANAGE, V69, P967, DOI 10.2193/0022-541X(2005)069[0967:CPIHRO]2.0.CO;2; Calix M., 2018, EUROPEAN RED LIST SA; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020962; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Hartter J, 2011, J NAT CONSERV, V19, P79, DOI 10.1016/j.jnc.2010.06.005; Hockings K., 2009, BEST PRACTICE GUIDEL; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Husson Simon J., 2009, P77; Leadley P.W., 2010, CBD TECHNICAL SERIES, V50; Marshall Andrew J., 2009, P311; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; *MIN AGR REP IND, 2010, MAP DISTR OIL PALM P; *MIN FOR REP IND, 2010, MAP DISTR IUPHHK HA; NETER J, 1964, J AM STAT ASSOC, V59, P18, DOI 10.2307/2282857; Nijman V, 2010, INT J PEST MANAGE, V56, P153, DOI 10.1080/09670870903248850; NURCAHYO A, 2009, FOREST SC NEWS, V5, P8; Rijksen HD, 1999, OUR VANISHING RELATI; Singleton I., 2004, ORANGUTAN POPULATION; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; Wich SA, 2003, ORYX, V37, P49, DOI 10.1017/S0030605303000115; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X	30	90	92	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27491	10.1371/journal.pone.0027491	http://dx.doi.org/10.1371/journal.pone.0027491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096582	Green Published, gold			2022-12-27	WOS:000297553900052
J	Sun, L; Wang, CC				Sun, Lu; Wang, Ching C.			The Structural Basis of Localizing Polo-Like Kinase to the Flagellum Attachment Zone in Trypanosoma brucei	PLOS ONE			English	Article							BOX DOMAIN; CELL-DIVISION; SUBCELLULAR-LOCALIZATION; CYTOKINESIS; PLK1; BINDING; PHOSPHORYLATION; DUPLICATION; SEGREGATION; SUBSTRATE	The polo-like kinase in the deep branching eukaryote Trypanosoma brucei (TbPlk) has many unique features. Unlike all the other polo-like kinases known to associate with the nucleus and controlling both mitosis and cytokinesis, TbPlk localizes to the flagellum attachment zone (FAZ) and regulates only cytokinesis in T. brucei. TbPlk was, however, previously found capable of complementing all the multiple Plk (Cdc5) functions in Saccharomyces cerevisiae, indicating that it has acquired all the functions of Cdc5. In the present study, Cdc5 tagged with an enhanced yellow fluorescence protein (EYFP) localized exclusively in the FAZ of T. brucei, suggesting that the unusual localization and limited function of TbPlk are probably attributed to the particular environment in T. brucei cells. Structural basis for the FAZ localization of TbPlk was further investigated with TbPlk and TbPlk mutants tagged with EYFP and expressed in T. brucei. The results indicated that a kinase-inactive mutant N169A and a TbPlk mutant with the entire kinase domain (KD) deleted both localized to the FAZ. Substantial association with FAZ was also maintained when one of the two polo-boxes (PB1 or 2) or the linker region between them was deleted from TbPlk. But a deletion of both polo-boxes led to a complete exclusion of the protein from FAZ. All the deletion mutants retained the kinase activity, further indicating that the TbPlk kinase function does not play a role for FAZ localization. The two polo boxes in TbPlk are most likely instrumental in localizing the protein to FAZ through potential interactions with certain FAZ structural component(s). A putative cryptic bipartite nuclear targeting signal was identified in TbPlk, which was capable of directing TbPlk into the nucleus when either the kinase activity was lost or the PB1 was deleted from the protein.	[Sun, Lu; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sun, L (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			National Institutes of Health [AI21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 grants AI21786 to CCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Graham TM, 1998, GENE, V207, P71, DOI 10.1016/S0378-1119(97)00606-9; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Liao CZ, 2010, ACS MED CHEM LETT, V1, P110, DOI 10.1021/ml100020e; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma S, 2003, MOL CANCER RES, V1, P376; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Park CJ, 2008, EUKARYOT CELL, V7, P444, DOI 10.1128/EC.00283-07; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27303	10.1371/journal.pone.0027303	http://dx.doi.org/10.1371/journal.pone.0027303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096549	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900031
J	Miraglia, JL; Abdala, E; Hoff, PM; Luiz, AM; Oliveira, DS; Saad, CGS; Laurindo, IMM; Viso, ATR; Tayra, A; Pierrotti, LC; Azevedo, LS; Campos, LMA; Aikawa, NE; Timenetsky, MDST; Luna, E; Cardoso, MRA; Guedes, JD; Raw, I; Kalil, J; Precioso, AR				Miraglia, Joao L.; Abdala, Edson; Hoff, Paulo M.; Luiz, Andre M.; Oliveira, Danise S.; Saad, Carla G. S.; Laurindo, Ieda M. M.; Viso, Ana T. R.; Tayra, Angela; Pierrotti, Ligia C.; Azevedo, Luiz S.; Campos, Lucia Maria A.; Aikawa, Nadia E.; Timenetsky, Maria do Carmo S. T.; Luna, Expedito; Cardoso, Maria Regina A.; Guedes, Jose da S.; Raw, Isaias; Kalil, Jorge; Precioso, Alexander R.			Immunogenicity and Reactogenicity of 2009 Influenza A (H1N1) Inactivated Monovalent Non-Adjuvanted Vaccine in Elderly and Immunocompromised Patients	PLOS ONE			English	Article							RHEUMATIC-DISEASES; INFECTION; ARTHRITIS; CLASSIFICATION; CHILDREN	Background: Immunosuppressed individuals present serious morbidity and mortality from influenza, therefore it is important to understand the safety and immunogenicity of influenza vaccination among them. Methods: This multicenter cohort study evaluated the immunogenicity and reactogenicity of an inactivated, monovalent, non-adjuvanted pandemic (H1N1) 2009 vaccine among the elderly, HIV-infected, rheumatoid arthritis (RA), cancer, kidney transplant, and juvenile idiopathic arthritis (JIA) patients. Participants were included during routine clinical visits, and vaccinated according to conventional influenza vaccination schedules. Antibody response was measured by the hemagglutination-inhibition assay, before and 21 days after vaccination. Results: 319 patients with cancer, 260 with RA, 256 HIV-infected, 149 elderly individuals, 85 kidney transplant recipients, and 83 with JIA were included. The proportions of seroprotection, seroconversion, and the geometric mean titer ratios postvaccination were, respectively: 37.6%, 31.8%, and 3.2 among kidney transplant recipients, 61.5%, 53.1%, and 7.5 among RA patients, 63.1%, 55.7%, and 5.7 among the elderly, 59.0%, 54.7%, and 5.9 among HIV-infected patients, 52.4%, 49.2%, and 5.3 among cancer patients, 85.5%, 78.3%, and 16.5 among JIA patients. The vaccine was well tolerated, with no reported severe adverse events. Conclusions: The vaccine was safe among all groups, with an acceptable immunogenicity among the elderly and JIA patients, however new vaccination strategies should be explored to improve the immune response of immunocompromised adult patients.	[Miraglia, Joao L.; Guedes, Jose da S.; Raw, Isaias; Kalil, Jorge; Precioso, Alexander R.] Butantan Inst, Clin Trials Div, Sao Paulo, Brazil; [Abdala, Edson; Hoff, Paulo M.] Univ Sao Paulo, Fac Med, ICESP, Sao Paulo, Brazil; [Luiz, Andre M.; Oliveira, Danise S.] Univ Sao Paulo, Hosp Clin, CRIE, Sao Paulo, Brazil; [Saad, Carla G. S.; Laurindo, Ieda M. M.] Univ Sao Paulo, Fac Med, Div Rheumatol, Sao Paulo, Brazil; [Viso, Ana T. R.; Tayra, Angela] Ctr Referencia & Treinamento DST AIDS CRT DST AID, Sao Paulo, Brazil; [Pierrotti, Ligia C.; Azevedo, Luiz S.] Univ Sao Paulo, Fac Med, Renal Transplantat Unit, Sao Paulo, Brazil; [Campos, Lucia Maria A.; Aikawa, Nadia E.] Univ Sao Paulo, Pediat Rheumatol Unit, Childrens Inst, Hosp Clin,Fac Med, Sao Paulo, Brazil; [Timenetsky, Maria do Carmo S. T.] Adolfo Lutz Inst, Sao Paulo, Brazil; [Luna, Expedito] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil; [Cardoso, Maria Regina A.] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, Brazil; [Precioso, Alexander R.] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Pediat,Inst Crianco, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Miraglia, JL (corresponding author), Butantan Inst, Clin Trials Div, Sao Paulo, Brazil.	joaomiraglia@gmail.com	Pierrotti, Ligia/C-5804-2015; Aikawa, Nadia Emi/I-5962-2013; Saad, Carla/P-5230-2014; TIMENETSKY, MARIA/I-7593-2013; Azevedo, Luiz/M-4147-2014; KALIL, JORGE/C-8029-2012; Luna, Expedito J A/B-7948-2012; Pierrotti, Ligia Camera/U-9225-2017; Cardoso, Maria Regina A/J-7280-2012; Hoff, Paulo M. PH/M-7662-2017; Miraglia, Joao/H-5294-2013; Precioso, Alexander Roberto/A-9712-2013; Abdala, Edson/H-5165-2012	Aikawa, Nadia Emi/0000-0002-7585-4348; Saad, Carla/0000-0001-9720-0719; KALIL, JORGE/0000-0001-8415-4274; Luna, Expedito J A/0000-0002-1145-9672; Pierrotti, Ligia Camera/0000-0002-0216-3028; Hoff, Paulo M. PH/0000-0002-0065-2194; Precioso, Alexander Roberto/0000-0001-8657-9292; Abdala, Edson/0000-0003-0765-6654; Miraglia, Joao Luiz/0000-0002-4788-6254	Fundacao Butantan	Fundacao Butantan	Fundacao Butantan funded the study, and employed several of the authors. The funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P277; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; EMA, 1996, EUR MED AG PUBL; EMA, 2004, CPMPVEG471703 EMA EU; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kanakoudi-Tsakalidou F, 2001, CLIN EXP RHEUMATOL, V19, P589; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; MALLESON PN, 1993, J RHEUMATOL, V20, P1769; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MS, 2010, BAL PARC VAC GRIP A; MS/SVS/DVE/PNI, 2010, ESTR NAC VAC VIR INF; Ogimi C, 2011, PEDIATR INFECT DIS J, V30, P208, DOI 10.1097/INF.0b013e3181f7ce44; Petty RE, 2004, J RHEUMATOL, V31, P390; Plennevaux E, 2011, VACCINE, V29, P1569, DOI 10.1016/j.vaccine.2010.12.116; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Saad CGS, 2011, ANN RHEUM DIS, V70, P1068, DOI 10.1136/ard.2011.150250; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; The Institute of Clinical Research, 1996, INT C HARM TECHN REQ; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; U.S.F.D.A, 2007, GUID IND CLIN DAT NE; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; World Health Organization, 2009, GLOB AL RESP WHO REC; Yanagisawa N, 2011, VACCINE, V29, P5694, DOI 10.1016/j.vaccine.2011.06.003; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	35	31	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27214	10.1371/journal.pone.0027214	http://dx.doi.org/10.1371/journal.pone.0027214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087267	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700019
J	Singh, BN; Fu, JS; Srivastava, RK; Shankar, S				Singh, Brahma N.; Fu, Junsheng; Srivastava, Rakesh K.; Shankar, Sharmila			Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms	PLOS ONE			English	Article							GLI TRANSCRIPTION FACTORS; GENOMIC ANALYSES; SELF-RENEWAL; COLON-CANCER; PATHWAY; GROWTH; SURVIVAL; THERAPY; ACTIVATION; MEDULLOBLASTOMA	Background: Recent evidence from in vitro and in vivo studies has demonstrated that aberrant reactivation of the Sonic Hedgehog (SHH) signaling pathway regulates genes that promote cellular proliferation in various human cancer stem cells (CSCs). Therefore, the chemotherapeutic agents that inhibit activation of Gli transcription factors have emerged as promising novel therapeutic drugs for pancreatic cancer. GDC-0449 (Vismodegib), orally administrable molecule belonging to the 2-arylpyridine class, inhibits SHH signaling pathway by blocking the activities of Smoothened. The objectives of this study were to examine the molecular mechanisms by which GDC-0449 regulates human pancreatic CSC characteristics in vitro. Methodology/Principal Findings: GDC-0499 inhibited cell viability and induced apoptosis in three pancreatic cancer cell lines and pancreatic CSCs. This inhibitor also suppressed cell viability, Gli-DNA binding and transcriptional activities, and induced apoptosis through caspase-3 activation and PARP cleavage in pancreatic CSCs. GDC-0449-induced apoptosis in CSCs showed increased Fas expression and decreased expression of PDGFR alpha. Furthermore, Bcl-2 was down-regulated whereas TRAIL-R1/DR4 and TRAIL-R2/DR5 expression was increased following the treatment of CSCs with GDC-0449. Suppression of both Gli1 plus Gli2 by shRNA mimicked the changes in cell viability, spheroid formation, apoptosis and gene expression observed in GDC-0449-treated pancreatic CSCs. Thus, activated Gli genes repress DRs and Fas expressions, up-regulate the expressions of Bcl-2 and PDGFR alpha and facilitate cell survival. Conclusions/Significance: These data suggest that GDC-0499 can be used for the management of pancreatic cancer by targeting pancreatic CSCs.	[Singh, Brahma N.; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA; [Fu, Junsheng; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Singh, BN (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA.	sshankar@kumc.edu						Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Altaba ARI, 2004, CANCER LETT, V204, P145, DOI 10.1016/S0304-3835(03)00451-8; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Hidalgo M, 2009, NEW ENGL J MED, V361, P2094, DOI 10.1056/NEJMcibr0905857; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Hwang JH, 2009, CANCER LETT, V273, P266, DOI 10.1016/j.canlet.2008.08.028; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lee J, 2007, CHEMBIOCHEM, V8, P1916, DOI 10.1002/cbic.200700403; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Liu Hailan, 2011, Chin J Cancer, V30, P13; Mantamadiotis T, 2011, FRONT BIOSCI-LANDMRK, V16, P598, DOI 10.2741/3708; Marchese R, 2006, PANCREAS, V32, P171, DOI 10.1097/01.mpa.0000202938.63084.e3; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Tang SC, 2011, INT J CANC; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vogt A, 2004, J EXP MED, V199, P753, DOI 10.1084/jem.20031190; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Vorechovsky I, 1999, EUR J CANCER, V35, P711; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; WARSHAW AL, 1991, AM J SURG, V161, P26, DOI 10.1016/0002-9610(91)90356-I; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie JW, 2008, CURR ONCOL REP, V10, P107, DOI 10.1007/s11912-008-0018-7; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoshikawa N, 2009, J SURG RES, V153, P246, DOI 10.1016/j.jss.2008.04.021	50	146	155	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27306	10.1371/journal.pone.0027306	http://dx.doi.org/10.1371/journal.pone.0027306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087285	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700028
J	Strom, M; Mortensen, EL; Henriksen, TB; Olsen, SF				Strom, Marin; Mortensen, Erik L.; Henriksen, Tine B.; Olsen, Sjurdur F.			Fish Consumption Measured during Pregnancy and Risk of Cardiovascular Diseases Later in Life: An Observational Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; N-3 FATTY-ACIDS; ACUTE MYOCARDIAL-INFARCTION; DIETARY-INTAKE; MORTALITY; ALCOHOL; OMEGA-3-FATTY-ACIDS; STROKE; HEALTH; LIPIDS	Previous studies have indicated a protective effect of long chain n-3 PUFAs against cardiovascular disease; however, the overall evidence remains uncertain, and there is a general lack of knowledge in the field of cardiovascular epidemiology in women. Therefore, the objective of this study was to explore the association between fish intake and cardiovascular disease among 7429 women from a prospective pregnancy cohort in Aarhus, Denmark, who were followed for 12-17 years. Exposure information derived from a questionnaire sent to the women in gestation week 16, and daily fish consumption was quantified based on assumptions of standard portion sizes and food tables. Information on admissions to hospital was obtained from the Danish National Patient Registry and diagnoses of hypertensive, cerebrovascular and ischaemic heart disease were used to define the outcome: cardiovascular disease. During the follow-up period 263 events of cardiovascular disease were identified. Overall, there was no association between cardiovascular disease and fish intake, confidence intervals for effect estimates in the different fish intake groups were wide, overlapped and for all but one they encompassed unity. Restricting the analysis to women who had reported the same fish intake in a questionnaire in gestation week 30 did not alter these findings. In conclusion, our data from a prospective cohort of relatively young and initially healthy women from Aarhus linked with information from registries could not substantiate a protective effect of fish intake against cardiovascular disease.	[Strom, Marin; Olsen, Sjurdur F.] Statens Serum Inst, Dept Epidemiol Res, Maternal Nutr Grp, DK-2300 Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Inst Publ Hlth, Dept Environm Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Healthy Aging, Copenhagen, Denmark; [Henriksen, Tine B.] Aarhus Univ Hosp, Dept Paediat, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark	Statens Serum Institut; University of Copenhagen; University of Copenhagen; Aarhus University	Strom, M (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Maternal Nutr Grp, DK-2300 Copenhagen, Denmark.	mrm@ssi.dk		Strom, Marin/0000-0003-1926-6610; Olsen, Sjurdur/0000-0003-3017-7096; Mortensen, Erik Lykke/0000-0002-6985-451X	Faroese Research Council; Fisheries Research Fund of the Faroe Islands; Danish Council for Strategic Research [2101-07-0025]	Faroese Research Council; Fisheries Research Fund of the Faroe Islands; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Financial support for this study was obtained from the Faroese Research Council (http://www.gransking.fo/), the Fisheries Research Fund of the Faroe Islands (http://www.fvg.fo/), and the strategic network funded by the Danish Council for Strategic Research: "Global maternal and fetal care in prevention of adult non-comunicable disease (2101-07-0025)" (http://www.fi.dk/raad-og-udvalg/det-strategiske-forskningsraad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Andersen LT, 1996, SCAND J NUTR, V40, pS129; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; Bierregaard LJ, 2010, EUR HEART J, V31, P29, DOI 10.1093/eurheartj/ehp375; BURR ML, 1989, LANCET, V2, P757; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Cuco G, 2006, EUR J CLIN NUTR, V60, P364, DOI 10.1038/sj.ejcn.1602324; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958, DOI 10.1093/ajcn/28.9.958; European Society of Cardiology Press Office, 2009, NEED GEND SPEC RES H; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Hjerteforeningen and Statens Institut for Folkesundhed, 2004, 2004 HJERT; Hooper L, 2004, Cochrane Database Syst Rev, pCD003177; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Kesmodel U, 2002, ALCOHOL ALCOHOLISM, V37, P87, DOI 10.1093/alcalc/37.1.87; Kesmodel U, 2000, EPIDEMIOLOGY, V11, P512, DOI 10.1097/00001648-200009000-00005; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kromhout D, 1996, INT J EPIDEMIOL, V25, P753, DOI 10.1093/ije/25.4.753; Levnedsmiddelstyrelsen, 1996, LEVN; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Marckmann P, 1999, EUR J CLIN NUTR, V53, P585, DOI 10.1038/sj.ejcn.1600832; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Oken E, 2008, AM J CLIN NUTR, V88, P789, DOI 10.1093/ajcn/88.3.789; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Olsen SF, 2002, BMJ-BRIT MED J, V324, P447, DOI 10.1136/bmj.324.7335.447; Osler M, 2003, J CLIN EPIDEMIOL, V56, P274, DOI 10.1016/S0895-4356(02)00600-5; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; SHEKELLE RB, 1985, NEW ENGL J MED, V313, P820; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Vanden Heuvel John P, 2004, Curr Atheroscler Rep, V6, P432, DOI 10.1007/s11883-004-0083-9	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27330	10.1371/journal.pone.0027330	http://dx.doi.org/10.1371/journal.pone.0027330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087293	gold, Green Submitted, Green Published			2022-12-27	WOS:000297349700032
J	Zhou, D; Zhang, Y; Gong, W; Mohamed, SO; Ogbomo, H; Wang, XF; Liu, YB; Quan, ZW				Zhou, Di; Zhang, Yong; Gong, Wei; Mohamed, Sayid Omar; Ogbomo, Henry; Wang, Xuefeng; Liu, Yingbin; Quan, Zhiwei			Are Helicobacter Pylori and Other Helicobacter Species Infection Associated with Human Biliary Lithiasis? A Meta-Analysis	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; CHOLESTEROL GALLSTONE FORMATION; HUMAN LIVER SAMPLES; HUMAN BILE SAMPLES; GALLBLADDER TISSUE; GALL-BLADDER; DNA; DISEASES; IDENTIFICATION; CHOLECYSTITIS	Background: Since the isolation of Helicobacter species in biliary system, a hypothetical question was raised about the role of these agents in the development of cholelithiasis. This meta-analysis is to explore the association between the Helicobacter infection and biliary lithiasis. Methodology/Principal Findings: A systematic literature search was performed to identify all eligible articles. Meta-analysis which was carried out using odds ratio and random effect model, 95% confidence intervals for odds ratio was calculated. Quantitative assessment of heterogeneity was explored by chi-square test with significance set at P value 0.10 and was measured using I(2) statistic. Eighteen studies published between 1998 and 2011 were finally eligible for meta-analysis. H. Pylori, H. Bilis, H. Hepaticus, H. Pullorum and H. Ganmani were studied. With heterogeneity (I(2) = 69.5%, P<0.0001), significantly higher pooled infection rates of H. Pylori (OR: 2.59, 35.82% versus 26.75%, P = 0.01) and H. Hepaticus (OR: 3.13, 31.30% versus 12.12%, P = 0.02) were observed in lithiasis group. Higher prevalence of H. Pylori in cholelithiasis patients were reported by studies from East Asia, South Asia and South America. Evidences supporting the higher presence of H. Pylori in cholelithiasis patients could be found by PCR for detecting 16s rRNA in bile, 26kDa protein gene in biliary tissue and immunohistochemistry. Using multiple detection tests could increase the detection rate of H. Pylori. Conclusions/Significances: Our meta-analysis suggests a trend of higher presence of H. Pylori in cholelithiasis patients than control group and this trend was significant in the regions with higher prevalence of this agent. Evidences supporting the association between Helicobacter and cholelithiasis could be found by using different tests but the gold standard for the identification of these bacteria in biliary system has yet to be established. Considering obvious heterogeneity, a large multi-center study will facilitate us to further clarify the association between the Helicobacter infection and cholelithiasis.	[Zhou, Di; Zhang, Yong; Gong, Wei; Mohamed, Sayid Omar; Wang, Xuefeng; Liu, Yingbin; Quan, Zhiwei] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China; [Ogbomo, Henry] Univ Calgary, Fac Med, Dept Oncol, So Alberta Canc Res Inst, Calgary, AB, Canada; [Ogbomo, Henry] Univ Calgary, Fac Med, Dept Biochem, So Alberta Canc Res Inst, Calgary, AB, Canada; [Ogbomo, Henry] Univ Calgary, Fac Med, Dept Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada	Shanghai Jiao Tong University; University of Calgary; University of Calgary; University of Calgary	Zhou, D (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China.	laoniulyb@163.com; zhiweiquan@gmail.com	LIU, YING/GZL-7252-2022; Liu, Yingbin/AAI-1919-2020; Ahmed, Sayid omar/K-7053-2018	Liu, Yingbin/0000-0001-6110-0185; Ahmed, Sayid omar/0000-0002-3031-2764				Abayli B, 2005, J CLIN GASTROENTEROL, V39, P134; ARENA VC, 1983, COMPUT PROG BIOMED, V17, P65, DOI 10.1016/0010-468X(83)90026-0; ARNAOUT AH, 1990, J PATHOL, V160, P333, DOI 10.1002/path.1711600410; Bohr URM, 2007, CLIN MICROBIOL INFEC, V13, P525, DOI 10.1111/j.1469-0691.2007.01690.x; Boonyanugomol W, 2011, DIGEST DIS SCI, V56, P1682, DOI 10.1007/s10620-010-1512-y; Bostanoglu E, 2010, TURK J GASTROENTEROL, V21, P421, DOI 10.4318/tjg.2010.0130; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; BUCK JL, 1994, RADIOL CLIN N AM, V32, P1215; Bulajic M, 2002, CANCER-AM CANCER SOC, V95, P1946, DOI 10.1002/cncr.10893; Bulajic M, 2002, WORLD J GASTROENTERO, V8, P301; Casswall TH, 2010, SCAND J GASTROENTERO, V45, P160, DOI 10.3109/00365520903426915; Chen W, 2003, DIGEST LIVER DIS, V35, P237, DOI 10.1016/S1590-8658(03)00060-4; CLAYTON CL, 1992, J CLIN MICROBIOL, V30, P192, DOI 10.1128/JCM.30.1.192-200.1992; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Farshad S, 2004, EPIDEMIOL INFECT, V132, P1185, DOI 10.1017/S0950268804002985; Figura N, 1998, DIGEST DIS SCI, V43, P854, DOI 10.1023/A:1018838719590; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Garcia A, 2011, CANCER RES, V71, P2529, DOI 10.1158/0008-5472.CAN-10-1975; Griniatsos J, 2009, W INDIAN MED J, V58, P428; Hamada T, 2009, HELICOBACTER, V14, P545, DOI 10.1111/j.1523-5378.2009.00729.x; HAMMAR M, 1992, J CLIN MICROBIOL, V30, P54, DOI 10.1128/JCM.30.1.54-58.1992; HATTORI T, 1996, SCAND J GASTROENTE S, V214, P34; HO SA, 1991, J CLIN MICROBIOL, V29, P2543, DOI 10.1128/JCM.29.11.2543-2549.1991; Huang Y, 2004, J CLIN PATHOL, V57, P1273, DOI 10.1136/jcp.2004.018556; Jesnowski R, 2010, PANCREATOLOGY, V10, P462, DOI 10.1159/000264677; Kaakoush NO, 2010, HELICOBACTER, V15, P549, DOI 10.1111/j.1523-5378.2010.00792.x; Karagin PH, 2010, WORLD J GASTROENTERO, V16, P4817, DOI 10.3748/wjg.v16.i38.4817; Kobayashi T, 2005, DIGEST DIS SCI, V50, P862, DOI 10.1007/s10620-005-2654-1; LABIGNE A, 1991, J BACTERIOL, V173, P1920, DOI 10.1128/jb.173.6.1920-1931.1991; Lee JW, 2010, GUT LIVER, V4, P60, DOI 10.5009/gnl.2010.4.1.60; Leong RW, 2009, GASTROENTEROL CLIN N, V38, P363, DOI 10.1016/j.gtc.2009.03.010; LEONG RW, 2002, J GASTROENTROL HEP S, V16, pA35; LIN TT, 1995, DIGEST DIS SCI, V40, P2214, DOI 10.1007/BF02209009; Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Moher D, 2000, BRIT J SURG, V87, P1448, DOI 10.1046/j.1365-2168.2000.01610.x; Myung SJ, 2000, DIGEST DIS SCI, V45, P1405, DOI 10.1023/A:1005572507572; Nilsson HO, 2000, J CLIN MICROBIOL, V38, P1072, DOI 10.1128/JCM.38.3.1072-1076.2000; On SLW, 1996, CLIN MICROBIOL REV, V9, P405, DOI 10.1128/CMR.9.3.405; PANDEY, 2007, WORLD J SURG ONCOL, V5, P94; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Rudi J, 1999, GASTROENTEROLOGY, V116, P1016, DOI 10.1016/S0016-5085(99)70096-X; Shimoyama T, 2010, J GASTROEN HEPATOL, V25, pS86, DOI 10.1111/j.1440-1746.2010.06224.x; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Silva CP, 2003, J CLIN MICROBIOL, V41, P5615, DOI 10.1128/JCM.41.12.5615-5618.2003; Smith SI, 2004, WORLD J GASTROENTERO, V10, P1958; SWIDSINSKI A, 1995, GASTROENTEROLOGY, V108, P860, DOI 10.1016/0016-5085(95)90461-1; Tiwari SK, 2006, WORLD J GASTROENTERO, V12, P2181, DOI 10.3748/wjg.v12.i14.2181; Vorobjova T, 2006, DIGEST LIVER DIS, V38, P171, DOI 10.1016/j.dld.2005.12.008; Yakoob J, 2011, BRIT J BIOMED SCI, V68, P59, DOI 10.1080/09674845.2011.11730324; Yucebilgili K, 2009, J INFECT DEV COUNTR, V3, P856, DOI 10.3855/jidc.334	54	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27390	10.1371/journal.pone.0027390	http://dx.doi.org/10.1371/journal.pone.0027390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087306	Green Published, gold			2022-12-27	WOS:000297349700039
J	Huda, A; Tyagi, E; Marino-Ramirez, L; Bowen, NJ; Jjingo, D; Jordan, IK				Huda, Ahsan; Tyagi, Eishita; Marino-Ramirez, Leonardo; Bowen, Nathan J.; Jjingo, Daudi; Jordan, I. King			Prediction of Transposable Element Derived Enhancers Using Chromatin Modification Profiles	PLOS ONE			English	Article							UCSC GENOME BROWSER; GENE-EXPRESSION; HISTONE MODIFICATIONS; HYPERSENSITIVE SITES; CAP ANALYSIS; SELFISH DNA; STEM-CELLS; EVOLUTION; IDENTIFICATION; MOUSE	Experimentally characterized enhancer regions have previously been shown to display specific patterns of enrichment for several different histone modifications. We modelled these enhancer chromatin profiles in the human genome and used them to guide the search for novel enhancers derived from transposable element (TE) sequences. To do this, a computational approach was taken to analyze the genome-wide histone modification landscape characterized by the ENCODE project in two human hematopoietic cell types, GM12878 and K562. We predicted the locations of 2,107 and 1,448 TE-derived enhancers in the GM12878 and K562 cell lines respectively. A vast majority of these putative enhancers are unique to each cell line; only 3.5% of the TE-derived enhancers are shared between the two. We evaluated the functional effect of TE-derived enhancers by associating them with the cell-type specific expression of nearby genes, and found that the number of TE-derived enhancers is strongly positively correlated with the expression of nearby genes in each cell line. Furthermore, genes that are differentially expressed between the two cell lines also possess a divergent number of TE-derived enhancers in their vicinity. As such, genes that are up-regulated in the GM12878 cell line and down-regulated in K562 have significantly more TE-derived enhancers in their vicinity in the GM12878 cell line and vice versa. These data indicate that human TE-derived sequences are likely to be involved in regulating cell-type specific gene expression on a broad scale and suggest that the enhancer activity of TE-derived sequences is mediated by epigenetic regulatory mechanisms.	[Huda, Ahsan; Tyagi, Eishita; Bowen, Nathan J.; Jjingo, Daudi; Jordan, I. King] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Marino-Ramirez, Leonardo] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Marino-Ramirez, Leonardo; Jordan, I. King] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia; [Bowen, Nathan J.] Georgia Inst Technol, Ovarian Canc Inst, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University System of Georgia; Georgia Institute of Technology	Huda, A (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	king.jordan@biology.gatech.edu	Mariño-Ramírez, Leonardo/I-5759-2013; Mariño-Ramírez, Leonardo/N-5395-2019; Bowen, Nathan J./M-3202-2019	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Bowen, Nathan J./0000-0002-1609-6698	Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular Biology [BR-4839]; Georgia Institute of Technology; Integrated Cancer Research Center at the Georgia Institute of Technology; NIH, NLM, NCBI; Corporacion Colombiana de Investigacion Agropucuaria CORPOICA; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular Biology(Alfred P. Sloan Foundation); Georgia Institute of Technology; Integrated Cancer Research Center at the Georgia Institute of Technology; NIH, NLM, NCBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Corporacion Colombiana de Investigacion Agropucuaria CORPOICA; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	IKJ and AH were supported by an Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular Biology (BR-4839) (http://www.sloan.org/). Eishita Tyagi was supported by the Bioinformatics program at the Georgia Institute of Technology (http://www.bioinformatics.biology.gatech.edu/). NJB was supported by the Integrated Cancer Research Center at the Georgia Institute of Technology (http://ovariancancerinstitute.org/). This research was supported in part by the Intramural Research Program of the NIH, NLM, NCBI (http://www.ncbi.nlm.nih.gov/). LMR is supported by Corporacion Colombiana de Investigacion Agropucuaria CORPOICA (http://www.corpoica.org.co/SitioWeb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; HICKEY DA, 1982, GENETICS, V101, P519; Huda A, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-2; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2; Marino-Ramirez L, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-20; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MILLER CJ, 2007, DESCRIPTION EXONMAP; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Silva JC, 2003, GENET RES, V82, P1, DOI 10.1017/S0016672303006268; Smit AFA, GREEN P REPEATMASKER; Sokal R. R., 1981, BIOMETRY; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891	41	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27513	10.1371/journal.pone.0027513	http://dx.doi.org/10.1371/journal.pone.0027513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087331	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700061
J	Korn, MJ; Koppel, SJ; Cramer, KS				Korn, Matthew J.; Koppel, Scott J.; Cramer, Karina S.			Astrocyte-Secreted Factors Modulate a Gradient of Primary Dendritic Arbors in Nucleus Laminaris of the Avian Auditory Brainstem	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCES; AFFERENT INFLUENCES; POTASSIUM CHANNEL; GLUTAMATE RECEPTORS; N-MAGNOCELLULARIS; COCHLEAR NUCLEI; SUPERIOR OLIVE; SYNAPTIC INPUT; PURKINJE-CELLS; DELAY-LINES	Neurons in nucleus laminaris (NL) receive binaural, tonotopically matched input from nucleus magnocelluaris (NM) onto bitufted dendrites that display a gradient of dendritic arbor size. These features improve computation of interaural time differences, which are used to determine the locations of sound sources. The dendritic gradient emerges following a period of significant reorganization at embryonic day 15 (E15), which coincides with the emergence of astrocytes that express glial fibrillary acidic protein (GFAP) in the auditory brainstem. The major changes include a loss of total dendritic length, a systematic loss of primary dendrites along the tonotopic axis, and lengthening of primary dendrites on caudolateral NL neurons. Here we have tested whether astrocyte-derived molecules contribute to these changes in dendritic morphology. We used an organotypic brainstem slice preparation to perform repeated imaging of individual dye-filled NL neurons to determine the effects of astrocyte-conditioned medium (ACM) on dendritic morphology. We found that treatment with ACM induced a decrease in the number of primary dendrites in a tonotopically graded manner similar to that observed during normal development. Our data introduce a new interaction between astrocytes and neurons in the auditory brainstem and suggest that these astrocytes influence multiple aspects of auditory brainstem maturation.	[Korn, Matthew J.; Koppel, Scott J.; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Korn, MJ (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	cramerk@uci.edu		Koppel, Scott/0000-0001-9001-4454; Cramer, Karina/0000-0003-3793-4862	National Institutes of Health (NIH) [R01DC010796, P30DC008369]; National Science Foundation (NSF) [IOB-0642346]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010796, P30DC008369] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) R01DC010796, NIH P30DC008369, and National Science Foundation (NSF) IOB-0642346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KH, 2004, NEUROSCIENCE, V127, P137, DOI 10.1016/j.neuroscience.2004.04.032; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; BENES FM, 1977, BRAIN RES, V122, P1, DOI 10.1016/0006-8993(77)90658-8; Blondel O, 2000, J NEUROSCI, V20, P8012; BOORD RL, 1963, J COMP NEUROL, V120, P463, DOI 10.1002/cne.901200305; Buard I, 2010, GLIA, V58, P538, DOI 10.1002/glia.20943; Burette A, 1998, MICROSC RES TECHNIQ, V41, P224, DOI 10.1002/(SICI)1097-0029(19980501)41:3<224::AID-JEMT6>3.0.CO;2-T; CANADY KS, 1992, J NEUROSCI, V12, P1001; CARR CE, 1990, J NEUROSCI, V10, P3227; Carr CE, 1996, J COMP NEUROL, V373, P467, DOI 10.1002/(SICI)1096-9861(19960930)373:4<467::AID-CNE1>3.0.CO;2-#; Cheng SM, 2007, DEV NEUROBIOL, V67, P1957, DOI 10.1002/dneu.20541; Cochran SL, 1999, J COMP NEUROL, V413, P271, DOI 10.1002/(SICI)1096-9861(19991018)413:2<271::AID-CNE8>3.0.CO;2-L; Cramer KS, 2000, J COMP NEUROL, V426, P270; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; DEITCH JS, 1989, J COMP NEUROL, V281, P234, DOI 10.1002/cne.902810207; DEITCH JS, 1989, J COMP NEUROL, V281, P259, DOI 10.1002/cne.902810208; Diaz C, 2009, EUR J NEUROSCI, V29, P213, DOI 10.1111/j.1460-9568.2008.06578.x; Feng J, 2010, J NEUROSCI RES, V88, P86, DOI 10.1002/jnr.22179; Feng JJ, 2006, HEARING RES, V216, P116, DOI 10.1016/j.heares.2006.01.012; Friauf E, 1999, CELL TISSUE RES, V297, P187, DOI 10.1007/s004410051346; Gorlich A, 2010, NEUROSCIENCE, V168, P564, DOI 10.1016/j.neuroscience.2010.04.002; Hendricks SJ, 2006, J COMP NEUROL, V498, P433, DOI 10.1002/cne.21031; JACKSON H, 1982, J COMP NEUROL, V210, P80, DOI 10.1002/cne.902100109; JACKSON H, 1978, J COMP PHYSIOL PSYCH, V92, P682, DOI 10.1037/h0077496; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; JOSEPH AW, 1993, J NEUROPHYSIOL, V69, P1197, DOI 10.1152/jn.1993.69.4.1197; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Korn MJ, 2008, DEV NEUROBIOL, V68, P1093, DOI 10.1002/dneu.20645; KORN MJ, 2011, J COMP NEUR IN PRESS; Kubke MF, 2002, J NEUROSCI, V22, P7671; Kubke MF, 1998, MICROSC RES TECHNIQ, V41, P176; Kuenzel T, 2007, EUR J NEUROSCI, V25, P974, DOI 10.1111/j.1460-9568.2007.05343.x; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Kulesza RJ, 2011, BRAIN RES, V1367, P360, DOI 10.1016/j.brainres.2010.10.015; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lin JC, 2001, J NEUROSCI, V21, P159, DOI 10.1523/JNEUROSCI.21-01-00159.2001; LIPPE WR, 1980, BRAIN RES, V196, P43, DOI 10.1016/0006-8993(80)90715-5; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Lohmann C, 2005, NAT NEUROSCI, V8, P305, DOI 10.1038/nn1406; Lordkipanidze T, 2005, GLIA, V51, P229, DOI 10.1002/glia.20200; Lukose R, 2011, BRAIN RES, V1398, P102, DOI 10.1016/j.brainres.2011.05.013; LURIE DI, 1994, J COMP NEUROL, V346, P276, DOI 10.1002/cne.903460207; Lurie DI, 2000, J COMP NEUROL, V421, P199; Morrison ME, 1998, J NEUROSCI, V18, P3563; MURAI KK, 2011, GLIA; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; OVERHOLT EM, 1992, J NEUROSCI, V12, P1698; Parameshwaran S, 2001, J NEUROSCI, V21, P485, DOI 10.1523/JNEUROSCI.21-02-00485.2001; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; PARKS TN, 1987, J COMP NEUROL, V260, P312, DOI 10.1002/cne.902600211; PARKS TN, 1981, J COMP NEUROL, V202, P47, DOI 10.1002/cne.902020105; PARKS TN, 1979, J COMP NEUROL, V183, P665, DOI 10.1002/cne.901830313; Perney TM, 1997, J COMP NEUROL, V386, P178; Person AL, 2004, J NEUROBIOL, V60, P28, DOI 10.1002/neu.10330; Procko C, 2010, CURR OPIN CELL BIOL, V22, P560, DOI 10.1016/j.ceb.2010.07.005; RAKIC P, 1972, J COMP NEUROL, V146, P335, DOI 10.1002/cne.901460304; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; RUBEL EW, 1981, J COMP NEUROL, V202, P397, DOI 10.1002/cne.902020309; Sanchez JT, 2011, JOVE-J VIS EXP, DOI 10.3791/2527; Sanchez JT, 2010, J NEUROPHYSIOL, V104, P1774, DOI 10.1152/jn.00468.2010; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Seidl AH, 2010, MICROSC RES TECHNIQ, V73, P37, DOI 10.1002/jemt.20750; Seidl AH, 2010, J NEUROSCI, V30, P70, DOI 10.1523/JNEUROSCI.3464-09.2010; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; SMITH ZDJ, 1981, J COMP NEUROL, V203, P309, DOI 10.1002/cne.902030302; Sorensen SA, 2006, J NEUROSCI, V26, P1539, DOI 10.1523/JNEUROSCI.3807-05.2006; Sorensen SA, 2011, J COMP NEUROL, V519, P2838, DOI 10.1002/cne.22656; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; Tanaka M, 2009, NEUROCHEM RES, V34, P2078, DOI 10.1007/s11064-009-0073-y; Tang YZ, 2004, HEARING RES, V191, P79, DOI 10.1016/j.heares.2004.01.007; TAVOSANIS G, 2011, DEV NEUROBIOL; Taylor AR, 2007, NAT PROTOC, V2, P1499, DOI 10.1038/nprot.2007.208; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wang Y, 2008, NEUROSCIENCE, V154, P381, DOI 10.1016/j.neuroscience.2008.02.032; Yanni PA, 2002, GLIA, V38, P292, DOI 10.1002/glia.10071; YOUNG SR, 1983, J NEUROSCI, V3, P1373	85	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27383	10.1371/journal.pone.0027383	http://dx.doi.org/10.1371/journal.pone.0027383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087304	Green Published, gold			2022-12-27	WOS:000297347700047
J	Li, C; Mi, K; Wen, TF; Yan, LN; Li, B; Yang, JY; Xu, MQ; Wang, WT; Wei, YG				Li, Chuan; Mi, Kai; Wen, Tian Fu; Yan, Lu Nan; Li, Bo; Yang, Jia Ying; Xu, Ming Qing; Wang, Wen Tao; Wei, Yong Gang			Outcomes of Patients with Benign Liver Diseases Undergoing Living Donor versus Deceased Donor Liver Transplantation	PLOS ONE			English	Article							SINGLE-CENTER EXPERIENCE; SURGICAL COMPLICATIONS; VASCULAR COMPLICATIONS; BILIARY COMPLICATIONS; HEPATIC-ARTERY; WAITING-LIST; RISK-FACTORS; EMERGENCY; GRAFT; DONATION	Background/Aims: The number of people undergoing living donor liver transplantation (LDLT) has increased rapidly in many transplant centres. Patients considering LDLT need to know whether LDLT is riskier than deceased donor liver transplantation (DDLT). The aim of this study was to compare the outcomes of patients undergoing LDLT versus DDLT. Methods: A total of 349 patients with benign liver diseases were recruited from 2005 to 2011 for this study. LDLT was performed in 128 patients, and DDLT was performed in 221 patients. Pre- and intra-operative variables for the two groups were compared. Statistically analysed post-operative outcomes include the postoperative incidence of complication, biliary and vascular complication, hepatitis B virus (HBV) recurrence, long-term survival rate and outcomes of emergency transplantation. Results: The waiting times were 22.10 +/- 15.31 days for the patients undergoing LDLT versus 35.81 +/- 29.18 days for the patients undergoing DDLT. The cold ischemia time (CIT) was 119.34 +/- 19.75 minutes for the LDLT group and 346 +/- 154.18 for DDLT group. LDLT group had higher intraoperative blood loss, but red blood cell (RBC) transfusion was not different. Similar >= Clavien III complications, vascular complications, hepatitis B virus (HBV) recurrence and long-term survival rates were noted. LDLT patients suffered a higher incidence of biliary complications in the early postoperative days. However, during the long-term follow-up period, biliary complication rates were similar between the two groups. The long-term survival rate of patients undergoing emergency transplantation was lower than of patients undergoing elective transplantation. However, no significant difference was observed between emergency LDLT and emergency DDLT. Conclusions: Patients undergoing LDLT achieved similar outcomes to patients undergoing DDLT. Although LDLT patients may suffer a higher incidence of early biliary complications, the total biliary complication rate was similar during the long-term follow-up period.	[Li, Chuan; Mi, Kai; Wen, Tian Fu; Yan, Lu Nan; Li, Bo; Yang, Jia Ying; Xu, Ming Qing; Wang, Wen Tao; Wei, Yong Gang] Sichuan Univ, Div Liver Transplantat, W China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Li, C (corresponding author), Sichuan Univ, Div Liver Transplantat, W China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	ccwentianfu@sohu.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888	National Science and Technology Major Project of China [2008ZX10002-026]	National Science and Technology Major Project of China	This work was supported by a grant from the National Science and Technology Major Project of China (2008ZX10002-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MT, 2005, ARCH SURG-CHICAGO, V140, P465, DOI 10.1001/archsurg.140.5.465; Barr ML, 2006, TRANSPLANTATION, V81, P1373, DOI 10.1097/01.tp.0000216825.56841.cd; Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012; Berrocal T, 2006, RADIOGRAPHICS, V26, P1187, DOI 10.1148/rg.264055081; Bhangui P, 2011, HEPATOLOGY, V53, P1570, DOI 10.1002/hep.24231; Brown RS, 1997, ARCH SURG-CHICAGO, V132, P1098; Chok KSH, 2011, LIVER TRANSPLANT, V17, P47, DOI 10.1002/lt.22188; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; de Vera ME, 2009, AM J TRANSPLANT, V9, P773, DOI 10.1111/j.1600-6143.2009.02560.x; Deutsch M, 2007, J HEPATOL, V47, P728, DOI 10.1016/j.jhep.2007.08.003; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Duailibi DF, 2010, TRANSPL P, V42, P517, DOI 10.1016/j.transproceed.2010.01.017; Duffy JP, 2009, J AM COLL SURGEONS, V208, P896, DOI 10.1016/j.jamcollsurg.2008.12.032; Eguchi S, 2008, SURG TODAY, V38, P795, DOI 10.1007/s00595-007-3729-8; Foley DP, 2011, ANN SURG, V253, P817, DOI 10.1097/SLA.0b013e3182104784; Foxton MR, 2010, LIVER TRANSPLANT, V16, P668, DOI 10.1002/lt.22027; Frasco PE, 2005, ANESTH ANALG, V101, P30, DOI 10.1213/01.ANE.0000155288.57914.0D; Freise CE, 2008, AM J TRANSPLANT, V8, P2569, DOI 10.1111/j.1600-6143.2008.02440.x; Gallardo ML, 2004, LIVER TRANSPLANT, V10, P1379, DOI 10.1002/lt.20215; Guba M, 2010, AM J TRANSPLANT, V10, P612, DOI 10.1111/j.1600-6143.2009.02979.x; Heidenhain C, 2010, TRANSPL INT, V23, P14, DOI 10.1111/j.1432-2277.2009.00947.x; Jiang L, 2002, CHINESE MED J-PEKING, V115, P1679; Kashyap R, 2009, J GASTROINTEST SURG, V13, P1480, DOI 10.1007/s11605-009-0898-3; Khalaf H, 2010, TRANSPL P, V42, P865, DOI 10.1016/j.transproceed.2010.02.037; Lee SG, 2009, SURG TODAY, V39, P367, DOI 10.1007/s00595-008-3917-1; Li C, 2011, J GASTROINTEST SURG, V15, P982, DOI 10.1007/s11605-011-1474-1; Lim S. G., 2006, SMJ Singapore Medical Journal, V47, P599; Liu LU, 2005, TRANSPLANTATION, V80, P1072, DOI 10.1097/01.tp.0000176483.52769.5a; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lu Jin-Shan, 2005, Zhonghua Yi Xue Za Zhi, V85, P657; Mack CL, 2001, LIVER TRANSPLANT, V7, P890, DOI 10.1053/jlts.2001.27963; Maluf DG, 2005, AM J TRANSPLANT, V5, P149, DOI 10.1111/j.1600-6143.2004.00654.x; Markiewicz M, 2003, TRANSPL P, V35, P2318, DOI 10.1016/S0041-1345(03)00784-X; Marsh JW, 2009, J HEPATOL, V51, P715, DOI 10.1016/j.jhep.2009.04.023; Massicotte L, 2004, ANESTH ANALG, V98, P1245, DOI 10.1213/01.ANE.0000111184.21278.07; Park SJ, 2010, HEPATOLOGY, V51, P903, DOI 10.1002/hep.23369; Perrakis A, 2010, TRANSPL P, V42, P4154, DOI 10.1016/j.transproceed.2010.09.045; Porrett PM, 2009, LIVER TRANSPLANT, V15, pS12, DOI 10.1002/lt.21893; Prakoso E, 2010, INTERN MED J, V40, P619, DOI 10.1111/j.1445-5994.2010.02277.x; Sanchez-Bueno F, 2005, TRANSPL P, V37, P3878, DOI 10.1016/j.transproceed.2005.09.131; SOMEDA H, 1995, J HEPATOL, V22, P623, DOI 10.1016/0168-8278(95)80218-5; Stewart ZA, 2009, LIVER TRANSPLANT, V15, P1688, DOI 10.1002/lt.21946; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Thuluvath PJ, 2004, LIVER TRANSPLANT, V10, P1263, DOI 10.1002/lt.20254; Toso C, 2007, TRANSPL INT, V20, P675, DOI 10.1111/j.1432-2277.2007.00492.x; Toyoki Y, 2002, PEDIATR TRANSPLANT, V6, P301, DOI 10.1034/j.1399-3046.2002.02013.x; Tran Tram T, 2009, Cleve Clin J Med, V76 Suppl 3, pS10, DOI 10.3949/ccjm.76.s3.03; Wang Wei-lin, 2005, Zhonghua Yi Xue Za Zhi, V85, P3460; Welling TH, 2008, LIVER TRANSPLANT, V14, P73, DOI 10.1002/lt.21354; Wojcicki M, 2007, TRANSPL P, V39, P2781, DOI 10.1016/j.transproceed.2007.08.066; Xu X, 2011, LIVER INT, V31, P1477, DOI 10.1111/j.1478-3231.2011.02500.x; Yan LN, 2008, J SURG RES, V146, P172, DOI 10.1016/j.jss.2007.05.017; Yan LN, 2007, HEPATOL RES, V37, P305, DOI 10.1111/j.1872-034X.2007.00009.x; Yang Y, 2010, WORLD J GASTROENTERO, V16, P2682, DOI 10.3748/wjg.v16.i21.2682	54	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27366	10.1371/journal.pone.0027366	http://dx.doi.org/10.1371/journal.pone.0027366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087299	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700045
J	Littel, M; Franken, IHA				Littel, Marianne; Franken, Ingmar H. A.			Intentional Modulation of the Late Positive Potential in Response to Smoking Cues by Cognitive Strategies in Smokers	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ATTENTIONAL BIAS MODIFICATION; EMOTION REGULATION; BRAIN POTENTIALS; DRUG CUES; ELECTROPHYSIOLOGICAL EVIDENCE; EXPERIMENTAL MANIPULATION; NICOTINE DEPENDENCE; FAGERSTROM TEST; HEAVY DRINKERS	Attentional bias is considered an important concept in addiction since it has been found to correlate with subjective craving and is strongly associated with relapse after periods of abstinence. Hence, investigating in ways to regulate attention for drug cues would be of major clinical relevance. The present study examined deliberate, cognitive modulation of motivated attention for smoking cues in smokers. The effects of three different reappraisal strategies on an electrophysiological measure of attentive processing were investigated. Early and late LPP components in response to passively viewed neutral and smoking pictures were compared with LPPs in response to smoking pictures that were reappraised with three different reappraisal strategies. Results show that when smokers actively imagine how pleasant it would be to smoke (pleasant condition), their early LPP in response to smoking cues increases, but when smokers actively focus on an alternative stimulus (distraction condition) or think of a rational, uninvolved interpretation of the situation (rational condition), smoking-related late LPP amplitude decreases to the processing level of neutral stimuli. Present results are the first to indicate that smoking cue-elicited LPP amplitudes can be modulated by cognitive strategies, suggesting that attentive processing of smoking cues can be intentionally regulated by smokers with various levels of dependence. Although cognitive strategies can lead to enhanced processing of smoking cues, it is not completely clear whether cognitive strategies are also successful in reducing smoking-related motivated attention. Although findings do point in this direction, present study is best considered preliminary and a starting point for other research on this topic. A focus on the distraction strategy is proposed, as there are indications that this strategy is more successful than the rational strategy in decreasing LPP amplitude.	[Littel, Marianne; Franken, Ingmar H. A.] Erasmus Univ, Inst Psychol, Rotterdam, Netherlands	Erasmus University Rotterdam	Littel, M (corresponding author), Erasmus Univ, Inst Psychol, Rotterdam, Netherlands.	littel@fsw.eur.nl	Franken, Ingmar/C-2382-2008; Franken, Ingmar/AAB-7562-2019	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Littel, Marianne/0000-0002-3741-6005	Netherlands Organization for Scientific Research (NOW) [016.08.322]; VIDI	Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO)); VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported by a VIDI grant funded by the Netherlands Organization for Scientific Research (NOW; grant number 016.08.322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood AS, 2008, ADDICTION, V103, P1875, DOI 10.1111/j.1360-0443.2008.02335.x; Bradley BP, 2003, PSYCHOL ADDICT BEHAV, V17, P66, DOI 10.1037/0893-164X.17.1.66; Carpenter KM, 2006, ADDICT BEHAV, V31, P174, DOI 10.1016/j.addbeh.2005.04.012; Coggins CRE, 2009, PSYCHOPHARMACOLOGY, V207, P343, DOI 10.1007/s00213-009-1675-4; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Cox WM, 2007, PSYCHOPHARMACOLOGY, V192, P499, DOI 10.1007/s00213-007-0736-9; Cox WM, 2002, DRUG ALCOHOL DEPEN, V68, P237, DOI 10.1016/S0376-8716(02)00219-3; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Dillon DG, 2005, BEHAV NEUROSCI, V119, P1118, DOI 10.1037/0735-7044.119.4.1118; Dunning JP, 2011, EUR J NEUROSCI, V33, P1716, DOI 10.1111/j.1460-9568.2011.07663.x; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Field M, 2005, PSYCHOPHARMACOLOGY, V183, P350, DOI 10.1007/s00213-005-0202-5; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Field M, 2007, PSYCHOPHARMACOLOGY, V192, P593, DOI 10.1007/s00213-007-0760-9; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Field M, 2009, NICOTINE TOB RES, V11, P812, DOI 10.1093/ntr/ntp067; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Franken IHA, 2004, J PSYCHOPHARMACOL, V18, P544, DOI 10.1177/0269881104047282; Franken IHA, 2003, PSYCHOPHARMACOLOGY, V170, P205, DOI 10.1007/s00213-003-1542-7; Franken IHA, 2008, ADDICT BIOL, V13, P386, DOI 10.1111/j.1369-1600.2008.00100.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Handy T. C., 2005, EVENT RELATED POTENT, P57; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Herrmann MJ, 2000, ALCOHOL CLIN EXP RES, V24, P1724, DOI 10.1111/j.1530-0277.2000.tb01974.x; Herrmann MJ, 2001, ALCOHOL ALCOHOLISM, V36, P588, DOI 10.1093/alcalc/36.6.588; Hogarth LC, 2003, BEHAV PHARMACOL, V14, P153, DOI 10.1097/00008877-200303000-00007; Jackson DC, 2000, PSYCHOPHYSIOLOGY, V37, P515, DOI 10.1111/1469-8986.3740515; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Kober H, 2010, DRUG ALCOHOL DEPEN, V106, P52, DOI 10.1016/j.drugalcdep.2009.07.017; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Littel M, 2011, NETH J PSYCHOL, V66, P44; Littel M, 2007, J PSYCHOPHARMACOL, V21, P873, DOI 10.1177/0269881107078494; Littel M, 2011, J PSYCHOPHARMACOL, V25, P503, DOI 10.1177/0269881110379284; Lubman DI, 2008, J PSYCHOPHARMACOL, V22, P836, DOI 10.1177/0269881107083846; Lubman DI, 2007, PSYCHOL MED, V37, P1203, DOI 10.1017/S0033291707009932; MacNamara A, 2010, SOC COGN AFFECT NEUR; MacNamara A, 2009, EMOTION, V9, P531, DOI 10.1037/a0016251; Marissen MAE, 2006, ADDICTION, V101, P1306, DOI 10.1111/j.1360-0443.2006.01498.x; McCrady BS, 2001, BEHAV THER, V32, P309, DOI 10.1016/S0005-7894(01)80007-1; McDonough BE, 2001, PSYCHOPHARMACOLOGY, V154, P282; McHugh RK, 2010, NICOTINE TOB RES, V12, P1261, DOI 10.1093/ntr/ntq171; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Munafo M, 2003, J PSYCHOPHARMACOL, V17, P310, DOI 10.1177/02698811030173013; Namkoong K, 2004, ALCOHOL CLIN EXP RES, V28, P1317, DOI 10.1097/01.ALC.0000139828.78099.69; O'Connell KA, 2007, HEALTH PSYCHOL, V26, P77, DOI 10.1037/0278-6133.26.1.77; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sayette MA, 2001, ADDICTION, V96, P1419, DOI 10.1046/j.1360-0443.2001.961014196.x; Schoenmakers T, 2007, ADDICTION, V102, P399, DOI 10.1111/j.1360-0443.2006.01718.x; Schoenmakers TM, 2010, DRUG ALCOHOL DEPEN, V109, P30, DOI 10.1016/j.drugalcdep.2009.11.022; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; SHIFFMAN S, 1995, HEALTH PSYCHOL, V14, P301, DOI 10.1037/0278-6133.14.4.301; Shiffman S, 1994, J Subst Abuse, V6, P21, DOI 10.1016/S0899-3289(94)90052-3; Shiffman S, 1996, J CONSULT CLIN PSYCH, V64, P366, DOI 10.1037/0022-006X.64.2.366; Shiftman S, 1994, EXP CLIN PSYCHOPHARM, V2, P126, DOI 10.1037/1064-1297.2.2.126; Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465; TIFFANY ST, 1991, BRIT J ADDICT, V86, P1467, DOI 10.1111/j.1360-0443.1991.tb01732.x; van de Laar MC, 2004, PSYCHOPHARMACOLOGY, V177, P121, DOI 10.1007/s00213-004-1928-1; Vink JM, 2005, ADDICT BEHAV, V30, P575, DOI 10.1016/j.addbeh.2004.05.023; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Warren CA, 1999, CLIN NEUROPHYSIOL, V110, P1570, DOI 10.1016/S1388-2457(99)00089-9; Waters AJ, 2000, PSYCHOL ADDICT BEHAV, V14, P111, DOI 10.1037/0893-164X.14.2.111; Waters AJ, 2003, HEALTH PSYCHOL, V22, P378, DOI 10.1037/0278-6133.22.4.378; Wolfling K, 2008, EUR J NEUROSCI, V27, P976, DOI 10.1111/j.1460-9568.2008.06051.x	76	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27519	10.1371/journal.pone.0027519	http://dx.doi.org/10.1371/journal.pone.0027519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HH	22087333	Green Published, Green Submitted, gold			2022-12-27	WOS:000297347700062
J	Xu, HT; Li, XX; Zhang, ZZ; Qiu, MG; Mu, QW; Wu, Y; Tan, LW; Zhang, SX; Zhang, XM				Xu, Haotong; Li, Xiaoxiao; Zhang, Zhengzhi; Qiu, Mingguo; Mu, Qiwen; Wu, Yi; Tan, Liwen; Zhang, Shaoxiang; Zhang, Xiaoming			Visualization of the Left Extraperitoneal Space and Spatial Relationships to Its Related Spaces by the Visible Human Project	PLOS ONE			English	Article							PERITONEAL REFLECTIONS; SURGICAL-TREATMENT; SECTIONAL ANATOMY; ADRENAL-GLAND; CT	Background: The major hindrance to multidetector CT imaging of the left extraperitoneal space (LES), and the detailed spatial relationships to its related spaces, is that there is no obvious density difference between them. Traditional gross anatomy and thick-slice sectional anatomy imagery are also insufficient to show the anatomic features of this narrow space in three-dimensions (3D). To overcome these obstacles, we used a new method to visualize the anatomic features of the LES and its spatial associations with related spaces, in random sections and in 3D. Methods: In conjunction with Mimics (R) and Amira (R) software, we used thin-slice cross-sectional images of the upper abdomen, retrieved from the Chinese and American Visible Human dataset and the Chinese Virtual Human dataset, to display anatomic features of the LES and spatial relationships of the LES to its related spaces, especially the gastric bare area. The anatomic location of the LES was presented on 3D sections reconstructed from CVH2 images and CT images. Principal Findings: What calls for special attention of our results is the LES consists of the left sub-diaphragmatic fat space and gastric bare area. The appearance of the fat pad at the cardiac notch contributes to converting the shape of the anteroexternal surface of the LES from triangular to trapezoidal. Moreover, the LES is adjacent to the lesser omentum and the hepatic bare area in the anterointernal and right rear direction, respectively. Conclusion: The LES and its related spaces were imaged in 3D using visualization technique for the first time. This technique is a promising new method for exploring detailed communication relationships among other abdominal spaces, and will promote research on the dynamic extension of abdominal diseases, such as acute pancreatitis and intra-abdominal carcinomatosis.	[Xu, Haotong; Zhang, Zhengzhi; Wu, Yi; Tan, Liwen; Zhang, Shaoxiang] Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China; [Xu, Haotong; Mu, Qiwen] N Sichuan Med Coll, Nanchong Cent Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Li, Xiaoxiao] Third Mil Med Univ, Coll High Altitude Mil Med, Dept Hlth Serv, Chongqing, Peoples R China; [Qiu, Mingguo] Third Mil Med Univ, Coll Bioengn & Med Imaging, Chongqing, Peoples R China; [Mu, Qiwen] Med Univ S Carolina, Ctr Adv Imaging Res, Charleston, SC 29425 USA; [Zhang, Xiaoming] N Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China	Army Medical University; North Sichuan Medical University; Army Medical University; Army Medical University; Medical University of South Carolina; North Sichuan Medical University	Xu, HT (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China.	zhangsx1021@yahoo.com; cjr.zhxm@vip.163.com		Xu, Haotong/0000-0001-6416-9970; Xu, Hao-tong/0000-0003-0352-1795	National Science Foundation of China [60871099]; Study on Key Science and Technology Program of Nanchong [N2008-ZC027]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Study on Key Science and Technology Program of Nanchong	This work was supported by the National Science Foundation of China (No. 60871099) URL: http://www.nsfc.gov.cn/Portal0/default124.htm. This work was also supported by the Study on Key Science and Technology Program of Nanchong (No. N2008-ZC027) URL: http://www.v86.org/unitsite/index.asp?unit_id=46532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Chen R, 2009, SURG RADIOL ANAT, V31, P129, DOI 10.1007/s00276-008-0417-3; CHEN Y, 2001, SICHUAN J ANATOMY, V9, P26; Congdon ED, 1941, ANAT REC, V80, P289, DOI 10.1002/ar.1090800303; DING GF, 1991, CHIN J CLIN ANAT, V9, P26; Henderson JM, 2000, BEST PRACT RES CL GA, V14, P911, DOI 10.1053/bega.2000.0138; Ikramuddin S, 2007, J GASTROINTEST SURG, V11, P217, DOI 10.1007/s11605-006-0028-4; [蒋穗斌 Jiang Suibin], 2008, [解剖学杂志, Chinese Journal of Anatomy], V31, P235; [李幼琼 LI Youqiong], 2007, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V33, P464; Lim JH, 1998, BRIT J RADIOL, V71, P450, DOI 10.1259/bjr.71.844.9659142; Liu ZY, 2008, EUR RADIOL, V18, P1611, DOI 10.1007/s00330-008-0935-8; LU QY, 2009, SHANGHAI MED IMAGING, V18, P139; Lyass S, 2005, AM SURGEON, V71, P738; Ma G, 2008, SURG RADIOL ANAT, V30, P271, DOI 10.1007/s00276-008-0308-7; MCCORT JJ, 1981, ABDOMINAL RADIOLOGY, P192; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; MEYERS MA, 2010, DYNAMIC RADIOLOGY AB; [闵鹏秋 Min Pengqiu], 2003, [中国医学影像学杂志, Chinese Journal of Medical Imaging], V11, P161; MIN PQ, 1992, RADIOLOGY, V182, P553, DOI 10.1148/radiology.182.2.1732980; Monig SP, 2001, HEPATO-GASTROENTEROL, V48, P1231; Parikh MS, 2005, SURG ENDOSC, V19, P1631, DOI 10.1007/s00464-005-0302-7; Raptopoulos V, 1997, RADIOLOGY, V205, P777, DOI 10.1148/radiology.205.3.9393535; Rowe PM, 1999, LANCET, V353, P46, DOI 10.1016/S0140-6736(05)74857-1; Sadat Umar, 2007, J Med Case Rep, V1, P12, DOI 10.1186/1752-1947-1-12; Spitzer VM, 1998, ANAT RECORD, V253, P49, DOI 10.1002/(SICI)1097-0185(199804)253:2<49::AID-AR8>3.0.CO;2-9; SPITZER VM, 1995, VISIBLE HUMAN PROJEC; Tonelli P., 1999, Annali Italiani di Chirurgia, V70, P405; TONELLI P, 1999, ANN ITAL CHIR, V70, P419; WALD H, 1983, ANN SURG, V197, P389, DOI 10.1097/00000658-198304000-00002; Wu B, 2007, ABDOM IMAGING, V32, P284, DOI 10.1007/s00261-006-9058-3; Wu Y, 2010, SURG RADIOL ANAT, V32, P629, DOI 10.1007/s00276-010-0625-5; XIA CL, 2007, J JILIN U MED EDITIO, V33, P898; Yepes H, 2010, J BONE JOINT SURG AM, V92A, P1215, DOI 10.2106/JBJS.I.00743; [张俐 Zhang L], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P8193; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; Zhang SX, 2006, CLIN ANAT, V19, P204, DOI 10.1002/ca.20273; Zhao ZM, 2005, J COMPUT ASSIST TOMO, V29, P430, DOI 10.1097/01.rct.0000164259.91057.af	37	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27166	10.1371/journal.pone.0027166	http://dx.doi.org/10.1371/journal.pone.0027166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087259	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700023
J	Mo, WK; Nicolson, T				Mo, Weike; Nicolson, Teresa			Both Pre- and Postsynaptic Activity of Nsf Prevents Degeneration of Hair-Cell Synapses	PLOS ONE			English	Article							LATERAL-LINE SYSTEM; NEUROTROPHIC FACTOR; SNARE-COMPLEX; BRAIN; ALPHA; BDNF; ORGANIZATION; POTENTIATION; REQUIREMENT; MAINTENANCE	Vesicle fusion contributes to the maintenance of synapses in the nervous system by mediating synaptic transmission, release of neurotrophic factors, and trafficking of membrane receptors. N-ethylmaleimide-sensitive factor (NSF) is indispensible for dissociation of the SNARE-complex following vesicle fusion. Although NSF function has been characterized extensively in vitro, the in vivo role of NSF in vertebrate synaptogenesis is relatively unexplored. Zebrafish possess two nsf genes, nsf and nsfb. Here, we examine the function of either Nsf or Nsfb in the pre- and postsynaptic cells of the zebrafish lateral line organ and demonstrate that Nsf, but not Nsfb, is required for maintenance of afferent synapses in hair cells. In addition to peripheral defects in nsf mutants, neurodegeneration of glutamatergic synapses in the central nervous system also occurs in the absence of Nsf function. Expression of an nsf transgene in a null background indicates that stabilization of synapses requires Nsf function in both hair cells and afferent neurons. To identify potential targets of Nsf-mediated fusion, we examined the expression of genes implicated in stabilizing synapses and found that transcripts for multiple genes including brain-derived neurotrophic factor (bdnf) were significantly reduced in nsf mutants. With regard to trafficking of BDNF, we observed a striking accumulation of BDNF in the neurites of nsf mutant afferent neurons. In addition, injection of recombinant BDNF protein partially rescued the degeneration of afferent synapses in nsf mutants. These results establish a role for Nsf in the maintenance of synaptic contacts between hair cells and afferent neurons, mediated in part via the secretion of trophic signaling factors.	[Mo, Weike] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Mo, WK (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	Nicolson@ohsu.edu	Mo, Weike/K-2066-2014		NIH [DC 006880]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported in part by NIH DC 006880 and by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, METHOD CELL BIOL, V77, P3; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; Becker T, 2001, MECH DEVELOP, V109, P37, DOI 10.1016/S0925-4773(01)00504-4; Berliocchi L, 2005, J CELL BIOL, V168, P607, DOI 10.1083/jcb.200406126; Burgoyne RD, 2011, NAT CELL BIOL, V13, P8, DOI 10.1038/ncb0111-8; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Germana A, 2010, CELL MOL NEUROBIOL, V30, P787, DOI 10.1007/s10571-010-9506-z; Golby JA, 2001, GENETICS, V158, P265; Gorski JA, 2003, J NEUROSCI, V23, P6856; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Henshall TL, 2009, HUM MOL GENET, V18, P4830, DOI 10.1093/hmg/ddp455; KNUSEL B, 1992, J NEUROSCI, V12, P4391; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Kurrasch DM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-22; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nouvian R, 2011, NAT NEUROSCI, V14, P411, DOI 10.1038/nn.2774; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Sanyal S, 2001, NEUROREPORT, V12, P1363, DOI 10.1097/00001756-200105250-00015; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; WEBB JF, 1989, BRAIN BEHAV EVOLUT, V33, P34, DOI 10.1159/000115896; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Williamson LC, 1998, J NEUROSCI RES, V52, P569, DOI 10.1002/(SICI)1097-4547(19980601)52:5<569::AID-JNR9>3.0.CO;2-A; Woods IG, 2006, CURR BIOL, V16, P636, DOI 10.1016/j.cub.2006.02.067; Wright MA, 2010, J NEUROSCI, V30, P14513, DOI 10.1523/JNEUROSCI.4025-10.2010; Wu CL, 2010, ANN NY ACAD SCI, V1201, P8, DOI 10.1111/j.1749-6632.2010.05628.x; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27146	10.1371/journal.pone.0027146	http://dx.doi.org/10.1371/journal.pone.0027146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073277	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000029
J	Andersen, JV; Nowak, A; Rotundo, G; Parrott, L; Martinez, S				Andersen, Jorgen Vitting; Nowak, Andrzej; Rotundo, Giulia; Parrott, Lael; Martinez, Sebastian			"Price-Quakes'' Shaking the World's Stock Exchanges	PLOS ONE			English	Article							MODEL	Background: Systemic risk has received much more awareness after the excessive risk taking by major financial instituations pushed the world's financial system into what many considered a state of near systemic failure in 2008. The IMF for example in its yearly 2009 Global Financial Stability Report acknowledged the lack of proper tools and research on the topic. Understanding how disruptions can propagate across financial markets is therefore of utmost importance. Methodology/Principal Findings: Here, we use empirical data to show that the world's markets have a non-linear threshold response to events, consistent with the hypothesis that traders exhibit change blindness. Change blindness is the tendency of humans to ignore small changes and to react disproportionately to large events. As we show, this may be responsible for generating cascading events-pricequakes-in the world's markets. We propose a network model of the world's stock exchanges that predicts how an individual stock exchange should be priced in terms of the performance of the global market of exchanges, but with change blindness included in the pricing. The model has a direct correspondence to models of earth tectonic plate movements developed in physics to describe the slip-stick movement of blocks linked via spring forces. Conclusions/Significance: We have shown how the price dynamics of the world's stock exchanges follows a dynamics of build-up and release of stress, similar to earthquakes. The nonlinear response allows us to classify price movements of a given stock index as either being generated internally, due to specific economic news for the country in question, or externally, by the ensemble of the world's stock exchanges reacting together like a complex system. The model may provide new insight into the origins and thereby also prevent systemic risks in the global financial network.	[Andersen, Jorgen Vitting] Inst Non Lineaire Nice, CNRS, Valbonne, France; [Nowak, Andrzej] Warsaw Univ, Dept Psychol, Warsaw, Poland; [Rotundo, Giulia] Univ Tuscia, Dept Econ, Viterbo, Italy; [Parrott, Lael] Univ Montreal, Complex Syst Lab, Dept Geog, Quebec City, PQ, Canada; [Martinez, Sebastian] Univ Los Andes, CRA Dept Math 1 18a 12, Bogota, Colombia	Centre National de la Recherche Scientifique (CNRS); University of Warsaw; Tuscia University; Universite de Montreal; Universidad de los Andes (Colombia)	Andersen, JV (corresponding author), Inst Non Lineaire Nice, CNRS, Valbonne, France.	vitting@unice.fr	Rotundo, Giulia/I-5665-2012; Nowak, Andrzej/ABC-5414-2020; Rotundo, Giulia/A-4948-2012	Nowak, Andrzej K/0000-0001-9965-0684	College Interdisciplinaire de la Finance	College Interdisciplinaire de la Finance	J.V.A. and S.M. would like to thank the College Interdisciplinaire de la Finance for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2003, REV FINANC STUD, V16, P717, DOI 10.1093/rfs/hhg012; Bak P., 1966, NATURE WORKS SCI SEL; Billio M, 2010, 477410 MIT SSRN; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; Cizeau P, 2001, QUANT FINANC, V1, P217, DOI [10.1088/1469-7688/1/2/303, 10.1080/713665669]; De Bandt O, 2000, 35 SSRN; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Gagnon L, 2006, WORKING PAPER SERIES; Grimes J., 1996, PERCEPTION, P89; Hou K, 2006, WORKING PAPER SERIES; IMF (Int. Monet. Fund), 2021, REP; JONES RH, 1969, PSYCHOL BULL, V71, P352, DOI 10.1037/h0027225; Kenett DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019378; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Korajczyk R.A., 1961, ASSET PRICING PORTFO, P15; Kritzman M, 2010, 477410 MIT; Leung KT, 1997, J PHYS I, V7, P423, DOI 10.1051/jp1:1997101; Lewin TD, 2000, VISION, V7, P397; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; LONGIN F, 1995, J INT MONEY FINANC, V14, P3, DOI 10.1016/0261-5606(94)00001-H; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; OLAMI Z, 1992, PHYS REV LETT, V68, P1244, DOI 10.1103/PhysRevLett.68.1244; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Shapira Y, 2009, EUR PHYS J B, V72, P657, DOI 10.1140/epjb/e2009-00384-y; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Simons DJ, 2002, CONSCIOUS COGN, V11, P78, DOI 10.1006/ccog.2001.0533; Vitting Andersen J, 2009, ENCY COMPLEXITY SYST, V5, P4971, DOI [10.1007/978-0-387-30440-3-296, DOI 10.1007/978-0-387-30440-3-296]; Vitting Andersen J, IN PRESS	32	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26472	10.1371/journal.pone.0026472	http://dx.doi.org/10.1371/journal.pone.0026472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073168	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900021
J	Eastburn, A; Scherzer, R; Zolopa, AR; Benson, C; Tracy, R; Do, T; Bacchetti, P; Shlipak, M; Grunfeld, C; Tien, PC				Eastburn, Abigail; Scherzer, Rebecca; Zolopa, Andrew R.; Benson, Constance; Tracy, Russell; Do, Tri; Bacchetti, Peter; Shlipak, Michael; Grunfeld, Carl; Tien, Phyllis C.			Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ANTIRETROVIRAL THERAPY; FAT REDISTRIBUTION; METABOLIC-CHANGE; MARKERS; FRAM	Background: Whether HIV viremia, particularly at low levels is associated with inflammation, increased coagulation, and all-cause mortality is unclear. Methods: The associations of HIV RNA level with C-reactive protein (CRP), fibrinogen, interleukin (IL)-6 and mortality were evaluated in 1116 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV infection. HIV RNA level was categorized as undetectable (i.e., "target not detected"), 1-19, 20-399, 400-9999, and >= 10,000 copies/ml. Covariates included demographics, lifestyle, adipose tissue, and HIV-related factors. Results: HIV RNA level had little association with CRP. Categories of HIV RNA below 10,000 copies/ml had similar levels of IL-6 compared with an undetectable HIV RNA level, while HIV RNA >= 10,000 copies/ml was associated with 89% higher IL-6 (p<0.001). This association was attenuated by similar to 50% after adjustment for CD4+ cell count. Higher HIV RNA was associated with higher fibrinogen. Compared to an undetectable HIV RNA level, fibrinogen was 0.6%, 1.9%, 4.5%, 4.6%, and 9.4% higher across HIV RNA categories, respectively, and statistically significant at the highest level (p = 0.0002 for HIV RNA >= 10,000 copies/ml). Higher HIV RNA was associated with mortality during follow-up in unadjusted analysis, but showed little association after adjustment for CD4+ cell count and inflammation. Conclusion: HIV RNA >= 10,000 copies/ml was associated with higher IL-6 and fibrinogen, but lower levels of viremia appeared similar, and there was little association with CRP. The relationship of HIV RNA with IL-6 was strongly affected by CD4 cell depletion. After adjustment for CD4+ cell count and inflammation, viremia did not appear to be substantially associated with mortality risk over 5 years.	[Eastburn, Abigail; Scherzer, Rebecca; Do, Tri; Bacchetti, Peter; Shlipak, Michael; Grunfeld, Carl; Tien, Phyllis C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Scherzer, Rebecca; Shlipak, Michael; Grunfeld, Carl; Tien, Phyllis C.] Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Zolopa, Andrew R.] Stanford Univ, Stanford, CA 94305 USA; [Benson, Constance] Univ Calif San Diego, San Diego, CA 92103 USA; [Tracy, Russell] Univ Vermont, Burlington, VT USA; [Do, Tri] Roche Mol Diagnost, Pleasanton, CA USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Diego; University of Vermont; Roche Holding	Eastburn, A (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ptien@ucsf.edu			NIH [R01-DK57508, HL74814, HL53359, K23-AI66943, DK080645]; NIH center [M01-RR00036, RR00051, RR00052, RR00054, RR00083, RR0636, RR00865, UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054, M01RR000865, M01RR000036, M01RR000083, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053359, R01HL074814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI066943, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057508, K23DK080645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIH grants R01-DK57508, HL74814, and HL53359; K23-AI66943 and DK080645, and NIH center grants M01-RR00036, RR00051, RR00052, RR00054, RR00083, RR0636, RR00865, and UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HIV RNA testing of stored samples was supported by Roche Molecular Diagnostics.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Choi A, 2010, AM J KIDNEY DIS, V56, P872, DOI 10.1053/j.ajkd.2010.05.019; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Cockerham L, 2010, JAIDS-J ACQ IMM DEF, V53, P102, DOI 10.1097/QAI.0b013e3181b79d22; FRAM Study Investigators, J ACQUIR IMMUNE DEFI, V40, P121; Gilks WR, 1996, MARKOV CHAIN MONTE C; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hunt PW, 2011, CLIN INFECT DIS, V52, P681, DOI 10.1093/cid/ciq202; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Madden E, 2008, AIDS, V22, P707, DOI 10.1097/QAD.0b013e3282f560d9; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Reingold JS, 2008, JAIDS-J ACQ IMM DEF, V48, P142, DOI 10.1097/QAI.0b013e3181685727; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Tien PC, 2006, AM J EPIDEMIOL, V163, P860, DOI 10.1093/aje/kwj111; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Zhang S, 2010, ANTIVIR THER, V15, P555, DOI 10.3851/IMP1564	21	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26320	10.1371/journal.pone.0026320	http://dx.doi.org/10.1371/journal.pone.0026320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073156	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900017
J	Schecklmann, M; Volberg, G; Frank, G; Hadersdorfer, J; Steffens, T; Weisz, N; Landgrebe, M; Hajak, G; Greenlee, M; Classen, J; Langguth, B				Schecklmann, Martin; Volberg, Gregor; Frank, Gabriele; Hadersdorfer, Julia; Steffens, Thomas; Weisz, Nathan; Landgrebe, Michael; Hajak, Goeran; Greenlee, Mark; Classen, Joseph; Langguth, Berthold			Paired Associative Stimulation of the Auditory System: A Proof-Of-Principle Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; EVOKED-POTENTIALS; SOMATOSENSORY CORTEX; CORTICAL PLASTICITY; EXCITABILITY; TINNITUS; RTMS; COMPONENT; EFFICACY	Background: Paired associative stimulation (PAS) consisting of repeated application of transcranial magnetic stimulation (TMS) pulses and contingent exteroceptive stimuli has been shown to induce neuroplastic effects in the motor and somatosensory system. The objective was to investigate whether the auditory system can be modulated by PAS. Methods: Acoustic stimuli (4 kHz) were paired with TMS of the auditory cortex with intervals of either 45 ms (PAS(45 ms)) or 10 ms (PAS(10 ms)). Two-hundred paired stimuli were applied at 0.1 Hz and effects were compared with low frequency repetitive TMS (rTMS) at 0.1 Hz (200 stimuli) and 1 Hz (1000 stimuli) in eleven healthy students. Auditory cortex excitability was measured before and after the interventions by long latency auditory evoked potentials (AEPs) for the tone (4 kHz) used in the pairing, and a control tone (1 kHz) in a within subjects design. Results: Amplitudes of the N1-P2 complex were reduced for the 4 kHz tone after both PAS(45 ms) and PAS(10 ms), but not after the 0.1 Hz and 1 Hz rTMS protocols with more pronounced effects for PAS(45 ms). Similar, but less pronounced effects were observed for the 1 kHz control tone. Conclusion: These findings indicate that paired associative stimulation may induce tonotopically specific and also tone unspecific human auditory cortex plasticity.	[Schecklmann, Martin; Landgrebe, Michael; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Frank, Gabriele] Univ Munich, Dept Neurol, D-8000 Munich, Germany; [Steffens, Thomas] Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany; [Weisz, Nathan] Univ Konstanz, Dept Psychol, Constance, Germany; [Hajak, Goeran] Hosp Bamberg, Dept Psychiat Psychosomat & Psychotherapy, Bamberg, Germany; [Classen, Joseph] Univ Leipzig, Dept Neurol, Leipzig, Germany	University of Regensburg; University of Munich; University of Regensburg; University of Konstanz; Leipzig University	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany.	martin.schecklmann@medbo.de	Weisz, Nathan/K-3325-2015; Langguth, Berthold/AAP-2638-2021	Weisz, Nathan/0000-0001-7816-0037; Volberg, Gregor/0000-0002-4427-2409; Classen, Joseph/0000-0001-7182-6967	Tinnitus Research Initiative	Tinnitus Research Initiative	This work was supported by the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER AT, 1985, LANCET, V1, P1106; CACACE AT, 1990, ELECTROEN CLIN NEURO, V77, P6, DOI 10.1016/0168-5597(90)90012-3; Classen Joseph, 2004, Suppl Clin Neurophysiol, V57, P563; DEIBER MP, 1988, ELECTROEN CLIN NEURO, V71, P187, DOI 10.1016/0168-5597(88)90004-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Frank G, 2010, EUR J NEUROL, V17, P951, DOI 10.1111/j.1468-1331.2010.02956.x; Gilmore CS, 2009, INT J PSYCHOPHYSIOL, V73, P326, DOI 10.1016/j.ijpsycho.2009.05.005; Heide G, 2006, EXP BRAIN RES, V171, P26, DOI 10.1007/s00221-005-0262-0; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Hoffman RE, 2002, AM J PSYCHIAT, V159, P1093, DOI 10.1176/appi.ajp.159.7.1093; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Kennedy NC, 2008, NEUROSCI LETT, V445, P7, DOI 10.1016/j.neulet.2008.08.064; Kleinjung Tobias, 2009, Int Tinnitus J, V15, P154; Kujirai K, 2006, J NEUROPHYSIOL, V96, P1337, DOI 10.1152/jn.01140.2005; Langguth B, 2010, NEUROPHYSIOL CLIN, V40, P45, DOI 10.1016/j.neucli.2009.03.001; Langguth B, 2006, BRAIN TOPOGR, V18, P241, DOI 10.1007/s10548-006-0002-1; Langguth B, 2008, BRAIN STIMUL, V1, P192, DOI 10.1016/j.brs.2008.06.003; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; Lorenz I, 2010, J NEUROPHYSIOL, V104, P1497, DOI 10.1152/jn.00370.2010; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Murakami T, 2008, EXP BRAIN RES, V184, P339, DOI 10.1007/s00221-007-1103-0; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pellicciari MC, 2009, NEUROSCIENCE, V163, P266, DOI 10.1016/j.neuroscience.2009.06.013; Plewnia C, 2011, CNS NEUROSCI THER, V17, P449, DOI 10.1111/j.1755-5949.2010.00169.x; Pridmore S, 1998, J ECT, V14, P25; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Weise D, 2006, BRAIN, V129, P2709, DOI 10.1093/brain/awl221; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; WOODS DL, 1995, HEARING RES, V85, P69, DOI 10.1016/0378-5955(95)00035-3; Yoshiura T, 1995, BRAIN RES, V703, P139, DOI 10.1016/0006-8993(95)01075-0; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009	38	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27088	10.1371/journal.pone.0027088	http://dx.doi.org/10.1371/journal.pone.0027088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073259	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900073
J	Jain, M; Zhang, LS; Patterson, EE; Kebebew, E				Jain, Meenu; Zhang, Lisa; Patterson, Erin E.; Kebebew, Electron			KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer	PLOS ONE			English	Article							PCNA-ASSOCIATED FACTOR; ADRENOCORTICAL TUMORS; HEPATOCELLULAR-CARCINOMA; EXPRESSION; GENE; MALIGNANCY; P15(PAF); PREDICTS; CELLS	Background: KIAA0101 is a proliferating cell nuclear antigen-associated factor that is overexpressed in some human malignancies. Adrenocortical neoplasm is one of the most common human neoplasms for which the molecular causes are poorly understood. Moreover, it is difficult to distinguish between localized benign and malignant adrenocortical tumors. For these reasons, we studied the expression, function and possible mechanism of dysregulation of KIAA0101 in human adrenocortical neoplasm. Methodology/Principal Findings: KIAA0101 mRNA and protein expression levels were determined in 112 adrenocortical tissue samples (21 normal adrenal cortex, 80 benign adrenocortical tumors, and 11 adrenocortical carcinoma (ACC). SiRNA knockdown was used to determine the functional role of KIAA0101 on cell proliferation, cell cycle, apoptosis, soft agar anchorage independent growth and invasion in the ACC cell line, NCI-H295R. In addition, we explored the mechanism of KIAA0101 dysregulation by examining the mutational status. KIAA0101 mRNA (9.7 fold) and protein expression were significantly higher in ACC (p<0.0001). KIAA0101 had sparse protein expression in only a few normal adrenal cortex samples, which was confined to adrenocortical progenitor cells. KIAA0101 expression levels were 84% accurate for distinguishing between ACC and normal and benign adrenocortical tumor samples. Knockdown of KIAA0101 gene expression significantly decreased anchorage independent growth by 80% and invasion by 60% (p = 0.001; p = 0.006). We found no mutations in KIAA0101 in ACC. Conclusions/Significance: KIAA0101 is overexpressed in ACC. Our data supports that KIAA0101 is a marker of cellular proliferation, promotes growth and invasion, and is a good diagnostic marker for distinguishing benign from malignant adrenocortical neoplasm.	[Jain, Meenu; Zhang, Lisa; Patterson, Erin E.; Kebebew, Electron] NCI, Endocrine Oncol Sect, Surg Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jain, M (corresponding author), NCI, Endocrine Oncol Sect, Surg Branch, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov			Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Collado M, 2007, CLIN CHEM, V53, P1860, DOI 10.1373/clinchem.2007.089201; Dunn JCY, 2009, J SURG RES, V156, P317, DOI 10.1016/j.jss.2009.04.021; Favia G, 1995, Minerva Endocrinol, V20, P95; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Guo ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-109; Hosokawa M, 2007, CANCER RES, V67, P2568, DOI 10.1158/0008-5472.CAN-06-4356; Icard P, 2001, ANN CHIR, V126, P249, DOI 10.1016/S0003-3944(01)00497-7; Kais Z, 2011, MOL CANC RES; KATO T, 2011, LUNG CANC; Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; Kjellman M, 1996, CANCER RES, V56, P4219; KLOOS RT, 1995, ENDOCR REV, V16, P460, DOI 10.1210/er.16.4.460; Lombardi CP, 2006, BIOMED PHARMACOTHER, V60, P186, DOI 10.1016/j.biopha.2006.03.006; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Mizutani K, 2005, CANCER-AM CANCER SOC, V103, P1785, DOI 10.1002/cncr.20988; Simpson F, 2006, EXP CELL RES, V312, P73, DOI 10.1016/j.yexcr.2005.09.020; Slater EP, 2006, EUR J ENDOCRINOL, V154, P587, DOI 10.1530/eje.1.02116; TURCHI L, 2009, CELL DEATH DIFFER; van Bueren KL, 2007, GENE EXPR PATTERNS, V7, P47, DOI 10.1016/j.modgep.2006.05.006; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W; Yu PW, 2001, ONCOGENE, V20, P484, DOI 10.1038/sj.onc.1204113; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113	30	44	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26866	10.1371/journal.pone.0026866	http://dx.doi.org/10.1371/journal.pone.0026866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096502	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900012
J	Kim, J; Dabiri, S; Seeley, ES				Kim, Jinah; Dabiri, Salma; Seeley, E. Scott			Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma	PLOS ONE			English	Article							HISTOPATHOLOGIC DIAGNOSIS; MELANOCYTIC LESIONS; CELLS; CANCER; IMMUNOREACTIVITY; MICROTUBULES; DISCORDANCE; EPITHELIA; FAMILIES; BENIGN	Cutaneous melanoma is a lethal malignancy that arises spontaneously or via in situ precursor neoplasms. While melanoma in situ and locally invasive malignant melanoma can be cured surgically, these lesions can sometimes be difficult to distinguish from melanocytic nevi. Thus, the identification of histolopathologic or molecular features that distinguish these biologically distinct lesions would represent an important advance. To this end, we determined the abundance of melanocytic primary cilia in a series of 62 cases composed of typical cutaneous melanocytic nevi, melanoma in situ, invasive melanoma, and metastatic melanoma. Primary cilia are sensory organelles that modulate developmental and adaptive signaling and notably, are substantially depleted from the neoplastic epithelium of pancreatic carcinoma at a stage equivalent to melanoma in situ. In this series, we find that while nearly all melanocytes in 22 melanocytic nevi possessed a primary cilium, a near-complete loss of this organelle was observed in 16 cases of melanoma in situ, in 16 unequivocal primary invasive melanomas, and in 8 metastatic tumors, each associated with a cutaneous primary lesion. These findings suggest that the primary cilium may be used to segregate cutaneous invasive melanoma and melanoma in situ from melanocytic nevi. Moreover, they place the loss of an organelle known to regulate oncogenic signaling at an early stage of melanoma development.	[Kim, Jinah; Dabiri, Salma; Seeley, E. Scott] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Kim, Jinah] Stanford Univ, Med Ctr, Dept Dermatol, Stanford, CA 94305 USA	Stanford University; Stanford University	Kim, J (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	seeley@stanford.edu			Stanford Department of Pathology	Stanford Department of Pathology	This study was supported by funding made available by the Stanford Department of Pathology (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bartsch DK, 2010, CLIN GENET, V77, P333, DOI 10.1111/j.1399-0004.2009.01352.x; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; DAVIES H, 2002, MUTATIONS BRAF; de Snoo FA, 2008, CLIN CANCER RES, V14, P7151, DOI 10.1158/1078-0432.CCR-08-0403; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; HAN YGG, 2009, NAT MED; Li LXL, 2000, AM J DERMATOPATH, V22, P489, DOI 10.1097/00000372-200012000-00002; Lodha S, 2008, J CUTAN PATHOL, V35, P349, DOI 10.1111/j.1600-0560.2007.00970.x; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nasr MR, 2008, AM J DERMATOPATH, V30, P117, DOI 10.1097/DAD.0b013e3181624054; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Ramos-Herberth FI, 2010, J CUTAN PATHOL, V37, P944, DOI 10.1111/j.1600-0560.2010.01568.x; ROTH KE, 1988, J CELL SCI, V89, P457; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seeley ES, 2009, METHOD CELL BIOL, V94, P299, DOI 10.1016/S0091-679X(08)94015-2; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; SHIDA T, 2010, P NATL ACAD SCI US; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; WARFVINGE K, 1988, CELL TISSUE RES, V251, P237, DOI 10.1007/BF00215830; Warfvinge K, 1995, ACTA DERM-VENEREOL, V75, P446; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; WONG SY, 2009, NAT MED	28	63	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27410	10.1371/journal.pone.0027410	http://dx.doi.org/10.1371/journal.pone.0027410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096570	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900042
J	Francis, CD; Ortega, CP; Cruz, A				Francis, Clinton D.; Ortega, Catherine P.; Cruz, Alexander			Noise Pollution Filters Bird Communities Based on Vocal Frequency	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; ACOUSTIC COMMUNICATION; TRAFFIC NOISE; URBAN NOISE; BODY-MASS; IMPACT; SONG; ROADS; CONSEQUENCES; ADJUSTMENT	Background: Human-generated noise pollution now permeates natural habitats worldwide, presenting evolutionarily novel acoustic conditions unprecedented to most landscapes. These acoustics not only harm humans, but threaten wildlife, and especially birds, via changes to species densities, foraging behavior, reproductive success, and predator-prey interactions. Explanations for negative effects of noise on birds include disruption of acoustic communication through energetic masking, potentially forcing species that rely upon acoustic communication to abandon otherwise suitable areas. However, this hypothesis has not been adequately tested because confounding stimuli often co-vary with noise and are difficult to separate from noise exposure. Methodology/Principal Findings: Using a natural experiment that controls for confounding stimuli, we evaluate whether species vocal features or urban-tolerance classifications explain their responses to noise measured through habitat use. Two data sets representing nesting and abundance responses reveal that noise filters bird communities nonrandomly. Signal duration and urban tolerance failed to explain species-specific responses, but birds with low-frequency signals that are more susceptible to masking from noise avoided noisy areas and birds with higher frequency vocalizations remained. Signal frequency was also negatively correlated with body mass, suggesting that larger birds may be more sensitive to noise due to the link between body size and vocal frequency. Conclusions/Significance: Our findings suggest that acoustic masking by noise may be a strong selective force shaping the ecology of birds worldwide. Larger birds with lower frequency signals may be excluded from noisy areas, whereas smaller species persist via transmission of higher frequency signals. We discuss our findings as they relate to interspecific relationships among body size, vocal amplitude and frequency and suggest that they are immediately relevant to the global problem of increases in noise by providing critical insight as to which species traits influence tolerance of these novel acoustics.	[Francis, Clinton D.; Cruz, Alexander] Univ Colorado, Boulder, CO 80309 USA; [Ortega, Catherine P.] Ft Lewis Coll, San Juan Inst Nat & Cultural Resources, Durango, CO 81301 USA	University of Colorado System; University of Colorado Boulder	Francis, CD (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	clinton.francis@nescent.org	Vazquez-Dominguez, Guillermo GVD/L-7818-2014		National Science Foundation (NSF) [IOS 0910092]; United States Bureau of Land Management; ConocoPhillips; Williams Energy; U. Colorado Department of Ecology and Evolutionary Biology; the Animal Behavior Society; Southwestern Association of Naturalists; Colorado Field Ornithologists; Edna Bailey Sussman Foundation; Mountain Studies Institute; Wells Fargo Foundation; National Evolutionary Synthesis Center (NESCent) [NSF EF-0905606]	National Science Foundation (NSF)(National Science Foundation (NSF)); United States Bureau of Land Management; ConocoPhillips; Williams Energy; U. Colorado Department of Ecology and Evolutionary Biology; the Animal Behavior Society; Southwestern Association of Naturalists; Colorado Field Ornithologists; Edna Bailey Sussman Foundation; Mountain Studies Institute; Wells Fargo Foundation; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was primarily supported by the National Science Foundation (NSF) Doctoral Dissertation Improvement Grants (DDIG) (# IOS 0910092), United States Bureau of Land Management, ConocoPhillips, Williams Energy, and U. Colorado Department of Ecology and Evolutionary Biology, plus the Animal Behavior Society, Southwestern Association of Naturalists, Colorado Field Ornithologists, Edna Bailey Sussman Foundation, Mountain Studies Institute, and an Ariel Appleton Research Fellowship with support from the Wells Fargo Foundation. Dr. Francis was supported by the National Evolutionary Synthesis Center (NESCent; NSF EF-0905606). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babisch W, 2003, Noise Health, V5, P1; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Bertelli S, 2002, BIOL J LINN SOC, V77, P423, DOI 10.1046/j.1095-8312.2002.00112.x; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cardoso GC, 2010, J EVOLUTION BIOL, V23, P212, DOI 10.1111/j.1420-9101.2009.01883.x; Charif RA, 2010, RAVEN PRO 1 4 USERS; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Francis CD, 2011, BIOL LETTERS, V7, P850, DOI 10.1098/rsbl.2011.0359; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gillooly JF, 2010, P ROY SOC B-BIOL SCI, V277, P1325, DOI 10.1098/rspb.2009.2134; Goodwin SE, 2011, CONSERV BIOL, V25, P406, DOI 10.1111/j.1523-1739.2010.01602.x; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Ortega CP, ORNITHOLOGI IN PRESS; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Podos Jeffrey, 2004, P318, DOI 10.1016/B978-012473070-0/50014-1; Poole A, BIRDS N AM ONLINE; R Core Development Team, 2010, R LANG ENV STAT COMP; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; Tubaro PL, 1998, CONDOR, V100, P54, DOI 10.2307/1369896; VANDERZANDE AN, 1980, BIOL CONSERV, V18, P299, DOI 10.1016/0006-3207(80)90006-3; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6	40	75	78	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27052	10.1371/journal.pone.0027052	http://dx.doi.org/10.1371/journal.pone.0027052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096517	Green Published, Green Submitted, gold			2022-12-27	WOS:000297350800024
J	Ma, XQ; Yang, LF; Xiao, LB; Tang, M; Liu, LY; Li, ZJ; Deng, MY; Sun, LQ; Cao, Y				Ma, Xiaoqian; Yang, Lifang; Xiao, Lanbo; Tang, Min; Liu, Liyu; Li, Zijian; Deng, Mengyao; Sun, Lunquan; Cao, Ya			Down-Regulation of EBV-LMP1 Radio-Sensitizes Nasal Pharyngeal Carcinoma Cells via NF-kappa B Regulated ATM Expression	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; ENCODED LATENT MEMBRANE-PROTEIN-1; ATAXIA-TELANGIECTASIA CELLS; DNA-DAMAGE RESPONSE; NASOPHARYNGEAL CARCINOMA; IONIZING-RADIATION; BREAST-CANCER; C-JUN; PATHWAY; ALPHA	Background: The latent membrane protein 1 (LMP1) encoded by EBV is expressed in the majority of EBV-associated human malignancies and has been suggested to be one of the major oncogenic factors in EBV-mediated carcinogenesis. In previous studies we experimentally demonstrated that down-regulation of LMP1 expression by DNAzymes could increase radiosensitivity both in cells and in a xenograft NPC model in mice. Results: In this study we explored the molecular mechanisms underlying the radiosensitization caused by the down-regulation of LMP1 in nasopharyngeal carcinoma. It was confirmed that LMP1 could up-regulate ATM expression in NPCs. Bioinformatic analysis of the ATM ptomoter region revealed three tentative binding sites for NF-kappa B. By using a specific inhibitor of NF-kB signaling and the dominant negative mutant of IkappaB, it was shown that the ATM expression in CNE1-LMP1 cells could be efficiently suppressed. Inhibition of LMP1 expression by the DNAzyme led to attenuation of the NF-kappa B DNA binding activity. We further showed that the silence of ATM expression by ATM-targeted siRNA could enhance the radiosensitivity in LMP1 positive NPC cells. Conclusions: Together, our results indicate that ATM expression can be regulated by LMP1 via the NF-kappa B pathways through direct promoter binding, which resulted in the change of radiosensitivity in NPCs.	[Ma, Xiaoqian; Yang, Lifang; Xiao, Lanbo; Tang, Min; Liu, Liyu; Li, Zijian; Deng, Mengyao; Cao, Ya] Cent S Univ, Canc Res Inst, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Yang, Lifang; Sun, Lunquan] Cent S Univ, Ctr Mol Med, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Cao, Ya] Minist Hlth, Key Lab Carcinogenesis & Invas, Minist Educ, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Sun, Lunquan; Cao, Ya] Cent S Univ, Ctr Mol Imaging, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Ma, XQ (corresponding author), Cent S Univ, Cell Transplantat & Gene Therapy Inst, Xiangya Hosp 3, Changsha, Hunan, Peoples R China.	Lq-sun@hotmail.com; ycao98@vip.sina.com	Li, Zi-Jian/O-7703-2019	Li, Zi-Jian/0000-0002-6796-4176	National Natural Science Foundation of China [30873010, 81072220]; National High Technology Research and Development Program of China [2006AA02Z481, 2009AA02Z403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30873010, No. 81072220) and National High Technology Research and Development Program of China (2006AA02Z481 and 2009AA02Z403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim B, 2003, ONCOGENE, V22, P2260, DOI 10.1038/sj.onc.1206402; Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Allio T, 2000, MUTAT RES-FUND MOL M, V453, P5, DOI 10.1016/S0027-5107(00)00030-0; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Benimetskaya L, 1998, NUCLEIC ACIDS RES, V26, P5310, DOI 10.1093/nar/26.23.5310; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; De Siervi A, 2009, CELL CYCLE, V8, P2093, DOI 10.4161/cc.8.13.8926; Deng L, 2003, CELL RES, V13, P187, DOI 10.1038/sj.cr.7290163; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; Dudziak D, 2003, J VIROL, V77, P8290, DOI 10.1128/JVI.77.15.8290-8298.2003; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Gueven N, 2001, J BIOL CHEM, V276, P8884, DOI 10.1074/jbc.M006190200; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; Hatzivassiliou E, 2002, FRONT BIOSCI, V7, pD319, DOI 10.2741/hatziva; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; JUNG M, 1995, SCIENCE, V268, P1619, DOI 10.1126/science.7777860; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Li ZK, 2001, RADIAT RES, V155, P543, DOI 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; Lu ZX, 2008, CANCER LETT, V265, P226, DOI 10.1016/j.canlet.2008.02.019; Lu ZX, 2005, CANCER GENE THER, V12, P647, DOI 10.1038/sj.cgt.7700833; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Pandita Tej K, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006318; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; Shiloh Y, 2001, BIOCHEM SOC T, V29, P661, DOI 10.1042/0300-5127:0290661; Sommer SS, 2003, CANCER GENET CYTOGEN, V145, P115, DOI 10.1016/S0165-4608(03)00119-5; Song X, 2004, CELL SIGNAL, V16, P1153, DOI 10.1016/j.cellsig.2004.03.014; Truman JP, 2005, J BIOL CHEM, V280, P23262, DOI 10.1074/jbc.M503701200; Wu BY, 1997, J VIROL, V71, P3161, DOI 10.1128/JVI.71.4.3161-3167.1997; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yin LQ, 2001, CHINESE MED J-PEKING, V114, P718; Zhao Y, 2004, INT J BIOCHEM CELL B, V36, P1473, DOI 10.1016/j.biocel.2003.10.024	45	35	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e24647	10.1371/journal.pone.0024647	http://dx.doi.org/10.1371/journal.pone.0024647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096476	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800001
J	Porter, MY; Routledge, KE; Radford, SE; Hewitt, EW				Porter, Morwenna Y.; Routledge, Katy E.; Radford, Sheena E.; Hewitt, Eric W.			Characterization of the Response of Primary Cells Relevant to Dialysis-Related Amyloidosis to beta(2)-Microglobulin Monomer and Fibrils	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; NEUTRAL PH; IN-VITRO; OSTEOCLAST DIFFERENTIATION; CHRONIC-HEMODIALYSIS; BETA-2-MICROGLOBULIN; MACROPHAGES; PROTEIN; COLLAGEN; PATHOGENESIS	The formation of insoluble amyloid fibrils is associated with an array of devastating human diseases. Dialysis-related amyloidosis (DRA) is a severe complication of hemodialysis that results in the progressive destruction of the bones and joints. Elevated concentrations of beta(2)-microglobulin (beta(2)m) in the serum of subjects on hemodialysis promote the formation of amyloid fibrils in the osteoarticular tissues, but the cellular basis for the destruction of these tissues in DRA is poorly understood. In this study we performed a systematic analysis of the interaction of monomeric and fibrillar beta(2)m with primary human cells of the types present in the synovial joints of subjects with DRA. Building upon observations that macrophages infiltrate beta(2)m amyloid deposits in vivo we demonstrate that monocytes, the precursors of macrophages, cannot degrade beta(2)m fibrils, and that both monomeric beta(2)m and fibrillar beta(2)m are cytotoxic to these cells. beta(2)m fibrils also impair the formation of bone resorbing osteoclasts from monocytes and reduce the viability of osteoblasts, the cell type that produces bone. As a consequence, we predict that beta(2)m amyloid will disrupt the remodelling of the bone, which is critical for the maintenance of this tissue. Moreover, we show that beta(2)m fibrils reduce the viability of chondrocytes, rationalizing the loss of cartilage in DRA. Together, our observations demonstrate that beta(2)m cytotoxicity has multiple cellular targets in the osteoarticular tissues and is likely to be a key factor in the bone and joint destruction characteristic of DRA.	[Porter, Morwenna Y.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Porter, MY (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	e.w.hewitt@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Hewitt, Eric/0000-0002-6238-6303	Yorkshire Kidney Research Fund	Yorkshire Kidney Research Fund	This work was funded by the Yorkshire Kidney Research Fund (http://www.ykrf.co.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGILES A, 1994, NEPHROL DIAL TRANSPL, V9, P662, DOI 10.1093/ndt/9.6.662; Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Corlin DB, 2005, CLIN CHEM, V51, P1177, DOI 10.1373/clinchem.2005.049544; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; de Koning EJP, 1998, AMYLOID, V5, P247, DOI 10.3109/13506129809007297; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Drueke TB, 2009, SEMIN DIALYSIS, V22, P378, DOI 10.1111/j.1525-139X.2009.00584.x; EFSTRATIADIS T, 1985, ENZYME, V34, P140, DOI 10.1159/000469376; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Floege J, 1996, NEPHRON, V72, P9, DOI 10.1159/000188801; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gargar C, 1999, KIDNEY INT, V55, P1983, DOI 10.1046/j.1523-1755.1999.00430.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Giorgetti S, 2009, NEPHROL DIAL TRANSPL, V24, P1176, DOI 10.1093/ndt/gfn623; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GOREVIC PD, 1985, J CLIN INVEST, V76, P2425, DOI 10.1172/JCI112257; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; INOUE H, 1995, NEPHROL DIAL TRANSPL, V10, P2077; Inoue S, 1997, KIDNEY INT, V52, P1543, DOI 10.1038/ki.1997.484; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazama JJ, 2006, J BONE MINER METAB, V24, P182, DOI 10.1007/s00774-005-0669-5; Kazama JJ, 2001, AM J KIDNEY DIS, V38, pS156, DOI 10.1053/ajkd.2001.27427; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Malluche HH, 2011, J BONE MINER RES, V26, P1368, DOI 10.1002/jbmr.309; Menaa C, 2008, KIDNEY INT, V73, P1275, DOI 10.1038/ki.2008.100; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; NISHI S, 1990, NEPHRON, V56, P357, DOI 10.1159/000186175; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ohashi K, 2001, PATHOL INT, V51, P1, DOI 10.1046/j.1440-1827.2001.01156.x; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Schonland SO, 2008, HAEMATOLOGICA, V93, P955, DOI 10.3324/haematol.12497; Shiraishi M, 1997, SCAND J RHEUMATOL, V26, P61, DOI 10.3109/03009749709065667; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	59	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27353	10.1371/journal.pone.0027353	http://dx.doi.org/10.1371/journal.pone.0027353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096558	Green Published, gold			2022-12-27	WOS:000297350800048
J	Daniels, CS; Rubinsky, B				Daniels, Charlotte S.; Rubinsky, Boris			Cryosurgery with Pulsed Electric Fields	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; ABLATION; CANCER; TISSUE; ELECTROCHEMOTHERAPY; MODEL	This study explores the hypothesis that combining the minimally invasive surgical techniques of cryosurgery and pulsed electric fields will eliminate some of the major disadvantages of these techniques while retaining their advantages. Cryosurgery, tissue ablation by freezing, is a well-established minimally invasive surgical technique. One disadvantage of cryosurgery concerns the mechanism of cell death; cells at high subzero temperature on the outer rim of the frozen lesion can survive. Pulsed electric fields (PEF) are another minimally invasive surgical technique in which high strength and very rapid electric pulses are delivered across cells to permeabilize the cell membrane for applications such as gene delivery, electrochemotherapy and irreversible electroporation. The very short time scale of the electric pulses is disadvantageous because it does not facilitate real time control over the procedure. We hypothesize that applying the electric pulses during the cryosurgical procedure in such a way that the electric field vector is parallel to the heat flux vector will have the effect of confining the electric fields to the frozen/cold region of tissue, thereby ablating the cells that survive freezing while facilitating controlled use of the PEF in the cold confined region. A finite element analysis of the electric field and heat conduction equations during simultaneous tissue treatment with cryosurgery and PEF (cryosurgery/PEF) was used to study the effect of tissue freezing on electric fields. The study yielded motivating results. Because of decreased electrical conductivity in the frozen/cooled tissue, it experienced temperature induced magnified electric fields in comparison to PEF delivered to the unfrozen tissue control. This suggests that freezing/cooling confines and magnifies the electric fields to those regions; a targeting capability unattainable in traditional PEF. This analysis shows how temperature induced magnified and focused PEFs could be used to ablate cells in the high subzero freezing region of a cryosurgical lesion.	[Daniels, Charlotte S.; Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Daniels, CS (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	daniels.charlotte@gmail.com			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	CD was supported by National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARPS JJ, 1953, T AM I MIN MET ENG, V198, P327; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Baust JG, 2007, TECHNOL CANCER RES T, V6, P97, DOI 10.1177/153303460700600206; Baust JG, 2005, BJU INT, V95, P1187, DOI 10.1111/j.1464-410X.2005.05502.x; BISCHOF J, 1993, CRYOBIOLOGY, V30, P482, DOI 10.1006/cryo.1993.1049; Daniels CS, 2011, PLOS ONE, P6; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Diaz-Rivera RE, 2006, BIOMED MICRODEVICES, V8, P25, DOI 10.1007/s10544-006-6379-5; DIAZRIVERA R, 2000, THESIS UC BERKELEY; EDD JF, 2008, PHYSL MEASUREMENT, V29; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Fuchs KH, 2002, ENDOSCOPY, V34, P154, DOI 10.1055/s-2002-19857; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Gallo SA, 2002, BIOPHYS J, V82, P109, DOI 10.1016/S0006-3495(02)75378-2; Gilbert J, 1984, IEEE T BIOMEDICAL EN, P563; Ingebritsen SE, 1998, GEOL MAG, V136, P697, DOI [10.1017/S0016756899363329, DOI 10.1017/S0016756899363329]; Jaroszeski MJ, 1999, ADV DRUG DELIVER REV, V35, P131, DOI 10.1016/S0169-409X(98)00068-4; Jiang J, 2010, CRYOBIOLOGY, V61, P280, DOI 10.1016/j.cryobiol.2010.09.006; KAATZE U, 1989, J CHEM ENG DATA, V34, P371, DOI 10.1021/je00058a001; Kanduser Masa, 2008, P1, DOI 10.1007/978-0-387-79374-0_1; Koushafar H, 1997, UROLOGY, V49, P421, DOI 10.1016/S0090-4295(96)00572-9; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; MAZZOLENI AP, 1986, BIOELECTROMAGNETICS, V7, P95, DOI 10.1002/bem.2250070111; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 2002, BRIT J CANCER, V86, P1658, DOI 10.1038/sj.bjc.6600306; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; OKINO M, 1987, JPN J CANCER RES, V78, P1319; ONIK G, 1984, CRYOBIOLOGY, V21, P321, DOI 10.1016/0011-2240(84)90327-4; ONIK G, 1991, CANCER, V67, P901, DOI 10.1002/1097-0142(19910215)67:4<901::AID-CNCR2820670408>3.0.CO;2-Z; Onik G, 2007, TECHNOLOGY CANC RES, P6; Pakhomov AG, 2010, ADV ELECTROPORATION; Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157; RUBINSKY B, 1990, CRYOBIOLOGY, V27, P85, DOI 10.1016/0011-2240(90)90055-9; Rubinsky B, 1988, P ROYAL SOC LONDON, P234; Rubinsky B, 1976, J HEAT TRANSFER, P98; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Somiari S, 2000, MOL THER, V2, P178, DOI 10.1006/mthe.2000.0124; Tatsutani K, 1996, UROLOGY, V48, P441, DOI 10.1016/S0090-4295(96)00199-9; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; WJ Minkowycz, 2006, HDB NUMERICAL HEAT T	42	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26219	10.1371/journal.pone.0026219	http://dx.doi.org/10.1371/journal.pone.0026219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087224	gold, Green Published			2022-12-27	WOS:000297347700004
J	Nischalke, HD; Berger, C; Luda, C; Berg, T; Muller, T; Grunhage, F; Lammert, F; Coenen, M; Kramer, B; Korner, C; Vidovic, N; Oldenburg, J; Nattermann, J; Sauerbruch, T; Spengler, U				Nischalke, Hans Dieter; Berger, Cordula; Luda, Carolin; Berg, Thomas; Mueller, Tobias; Gruenhage, Frank; Lammert, Frank; Coenen, Martin; Kraemer, Benjamin; Koerner, Christian; Vidovic, Natascha; Oldenburg, Johannes; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich			The PNPLA3 rs738409 148M/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C Cirrhosis	PLOS ONE			English	Article							DOMAIN-CONTAINING 3; HEPATOCELLULAR-CARCINOMA; GENE VARIANT; DISEASE; I148M; ADIPONUTRIN; SEVERITY; FIBROSIS; CHILDREN; TRENDS	Background: An isoleucine. methionine mutation at position 148 in the PNPLA3 gene (p. I148M, rs738409) has recently been identified as a susceptibility factor for liver damage in steatohepatitis. Here, we studied whether the PNPLA3 rs738409 polymorphism also affects predisposition to hepatocellular carcinoma (HCC). Methods: We compared distributions of PNPLA3 genotypes in 80 and 81 Caucasian patients with alcoholic and hepatitis C virus (HCV)-associated HCC to 80 and 81 age- and sex-matched patients with alcohol-related and HCV-related cirrhosis without HCC, respectively. PNPLA3 genotypes in 190 healthy individuals from the same population served as reference. Potential confounders obesity, diabetes, HCV genotype and HBV co-infection were controlled by univariate and multivariate logistic regression with forward variable selection. Results: PNPLA3 genotypes were in Hardy-Weinberg equilibrium for all study groups. The frequency of the 148M allele was significantly (p<0.001) increased in alcoholic cirrhosis with (53.7%) and without HCC (36.2%) but was not different between healthy controls (22.9%) and patients with cirrhosis (25.3%; p = 0.545) and HCC (30.2%; p = 0.071) due to hepatitis C. HCC risk was highest in 148M/M homozygous patients with alcoholic liver disease (odds ratio (OR) 16.8 versus healthy controls; 95% confidence interval (CI) 6.68-42.43, p<0.001). Finally, multivariate regression confirmed 148M/M homozygosity (OR 2.8; 95%-CI: 1.24-6.42; p = 0.013) as HCC risk factor in alcoholic cirrhosis. In HCV-related cirrhosis only HCV genotype 1 was confirmed as a HCC risk factor (OR 4.2; 95%-CI: 1.50-11.52; p = 0.006). Conclusion: The PNPLA3 148M variant is a prominent risk factor for HCC in patients with alcoholic cirrhosis, while its effects are negligible in patients with cirrhosis due to HCV. This polymorphism provides an useful tool to identify individuals with particularly high HCC risk in patients with alcoholic liver disease that should be taken into account in future HCC prevention studies.	[Nischalke, Hans Dieter; Berger, Cordula; Luda, Carolin; Coenen, Martin; Kraemer, Benjamin; Koerner, Christian; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany; [Berg, Thomas] Univ Hosp Leipzig, Dept Gastroenterol, Leipzig, Germany; [Mueller, Tobias] Med Univ Charite Campus, Virchow Klinikum Berlin, Med Clin Hepatol & Gastroenterol, Berlin, Germany; [Gruenhage, Frank; Lammert, Frank] Saarland Univ Hosp, Dept Internal Med 2, Homburg, Germany; [Vidovic, Natascha; Oldenburg, Johannes] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany	University of Bonn; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universitatsklinikum des Saarlandes; University of Bonn	Nischalke, HD (corresponding author), Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany.	ulrich.spengler@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020; Körner, Christian/ABB-8335-2020; Krämer, Benjamin/AAC-9618-2019	Körner, Christian/0000-0002-3431-7319; Krämer, Benjamin/0000-0002-1385-9709; Mueller, Tobias/0000-0003-3426-5421; Oldenburg, Johannes/0000-0002-1585-4100; Nischalke, Hans Dieter/0000-0002-3457-0023; Berg, Thomas/0000-0003-0003-6241	Deutsche Krebshilfe [107865]; Deutsche Forschungsgemeinschaft [SFB TR57 TP01, TP12]; BMBF Network [01KI0792]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF Network(Federal Ministry of Education & Research (BMBF))	This work was funded by the Deutsche Krebshilfe (grant 107865 to HDN and US, http://www.krebshilfe.de/english.html) and the SFB TR57 TP01 & TP12 of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to FL, JN and US. CK was supported by a grant of the BMBF Network "Susceptbility and Resistance to Hepatitis C" to US and JN (grant 01KI0792, http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Browning JD, 2010, HEPATOLOGY, V52, P1189, DOI 10.1002/hep.23946; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Corradini SG, 2011, HEPATOLOGY, V53, P1776, DOI 10.1002/hep.24244; Falleti E, 2011, LIVER INT       0419; Goran MI, 2010, DIABETES, V59, P3127, DOI 10.2337/db10-0554; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Petit JM, 2010, J CLIN ENDOCR METAB, V95, pE430, DOI 10.1210/jc.2010-0814; Rae-Whitcombe SM, 2010, BIOCHEM BIOPH RES CO, V402, P767, DOI 10.1016/j.bbrc.2010.10.106; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Sanyal AJ, 2005, ALIMENT PHARM THER, V22, P48, DOI 10.1111/j.1365-2036.2005.02596.x; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, J HEPATOL       0218; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Yang JD, NAT REV GASTROENTERO, V7, P448	28	87	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27087	10.1371/journal.pone.0027087	http://dx.doi.org/10.1371/journal.pone.0027087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087248	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700016
J	Chang, LR; Lin, YH; Kuo, TBJ; Chang, HCW; Liu, CM; Liu, CC; Hwu, HG; Yang, CCH				Chang, Li-Ren; Lin, Yu-Hsuan; Kuo, Terry B. J.; Chang, Hung-Chieh Wu; Liu, Chih-Min; Liu, Chen-Chung; Hwu, Hai-Gwo; Yang, Cheryl C. H.			Autonomic Modulation and Health-Related Quality of Life among Schizophrenic Patients Treated with Non-Intensive Case Management	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; NONLINEAR COMPLEXITY; NERVOUS-SYSTEM; QT VARIABILITY; RATE DYNAMICS; EQ-5D; VALIDATION; DEPRESSION; COMMUNITY; SEVERITY	Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population.	[Chang, Li-Ren; Lin, Yu-Hsuan; Chang, Hung-Chieh Wu; Liu, Chih-Min] Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Yunlin, Taiwan; [Lin, Yu-Hsuan; Liu, Chih-Min; Liu, Chen-Chung; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Kuo, Terry B. J.] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Liu, Chih-Min; Liu, Chen-Chung; Hwu, Hai-Gwo] Natl Taiwan Univ, Dept Psychiat, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University; National Taiwan University	Chang, LR (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Yunlin, Taiwan.	cchyang@ym.edu.tw		HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHEN-CHUNG/0000-0002-9290-110X; CHANG, LI-REN/0000-0003-0853-3904; LIU, CHIH-MIN/0000-0001-7016-8990	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL.99N015]; National Science Council (Taiwan) [NSC 99-2911-I-008-100]; Ministry of Education [100AC-B3]	National Taiwan University Hospital, Yun-Lin Branch; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Education	This study was supported by a Grant (NTUHYL.99N015) from the National Taiwan University Hospital, Yun-Lin Branch, and a grant (NSC 99-2911-I-008-100) from the National Science Council (Taiwan) and by a grant (100AC-B3) from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bar KB, 2008, J CLIN PSYCHOPHARM, V28, P694, DOI 10.1097/JCP.0b013e31818a6d25; Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bar KJ, 2008, PSYCHIAT RES, V157, P255, DOI 10.1016/j.psychres.2007.04.021; Bar KJ, 2007, SCHIZOPHR RES, V95, P115, DOI 10.1016/j.schres.2007.05.034; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bar KJ, 2007, J APPL PHYSIOL, V102, P1051, DOI 10.1152/japplphysiol.00811.2006; Bar KJ, 2005, J PSYCHIATR RES, V39, P519, DOI 10.1016/j.jpsychires.2004.12.007; Beck AT, 2013, SCHIZOPHRENIA BULL, V39, P43, DOI 10.1093/schbul/sbr040; Bobes J, 2005, EUR PSYCHIAT, V20, pS313, DOI 10.1016/S0924-9338(05)80182-8; Bobes J, 1997, QUALITY OF LIFE IN MENTAL DISORDERS, P165; Boettger S, 2006, CLIN NEUROPHYSIOL, V117, P2715, DOI 10.1016/j.clinph.2006.08.009; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Camm AJ, 1996, CIRCULATION, V93, P1043; Castro MN, 2008, SCHIZOPHR RES, V99, P294, DOI 10.1016/j.schres.2007.08.025; Chang JS, 2010, PROG NEURO-PSYCHOPH, V34, P924, DOI 10.1016/j.pnpbp.2010.04.017; Chang JS, 2009, PROG NEURO-PSYCHOPH, V33, P991, DOI 10.1016/j.pnpbp.2009.05.004; Chang TJ, 2007, J FORMOS MED ASSOC, V106, P1023, DOI 10.1016/S0929-6646(08)60078-9; Dieterich M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub2; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Fujibayashi M, 2009, PSYCHIAT CLIN NEUROS, V63, P538, DOI 10.1111/j.1440-1819.2009.01983.x; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Goldsmith RL, 2000, CORONARY ARTERY DIS, V11, P129, DOI 10.1097/00019501-200003000-00007; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; Isaac M, 2007, BRIT J PSYCHIAT, V191, pS71, DOI 10.1192/bjp.191.50.s71; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kemp AH, 2011, BIOL PSYCHIAT, V69, pE25, DOI 10.1016/j.biopsych.2010.10.035; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kim DH, 2006, J AM GERIATR SOC, V54, P1751, DOI 10.1111/j.1532-5415.2006.00940.x; Kim JH, 2004, PROG NEURO-PSYCHOPH, V28, P371, DOI 10.1016/j.pnpbp.2003.11.007; Konig HH, 2007, EUR PSYCHIAT, V22, P177, DOI 10.1016/j.eurpsy.2006.08.004; Koponen H, 2008, NORD J PSYCHIAT, V62, P342, DOI 10.1080/08039480801959323; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; Kuo TBJ, 2005, J CARDIOVASC ELECTR, V16, P864, DOI 10.1111/j.1540-8167.2005.40656.x; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lempp H, 2009, QUAL LIFE RES, V18, P699, DOI 10.1007/s11136-009-9486-y; Licht Carmilla M M, 2011, Biol Psychiatry, V69, pe3, DOI 10.1016/j.biopsych.2010.06.034; Licht CMM, 2010, BIOL PSYCHIAT, V68, P861, DOI 10.1016/j.biopsych.2010.06.032; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Okada T, 2003, J CLIN PSYCHOPHARM, V23, P441, DOI 10.1097/01.jcp.0000088901.24613.b8; Penttila J, 2005, EUR J CLIN PHARMACOL, V61, P559, DOI 10.1007/s00228-005-0953-2; Prieto L, 2004, CURR MED RES OPIN, V20, P827, DOI 10.1185/030079904125003674; Prieto L, 2003, ACTA PSYCHIAT SCAND, V107, P24, DOI 10.1034/j.1600-0447.107.s416.6.x; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rachow T, 2011, PSYCHOPHYSIOLOGY, V48, P1323, DOI 10.1111/j.1469-8986.2011.01210.x; Shinagawa M, 2002, BLOOD PRESS MONIT, V7, P69, DOI 10.1097/00126097-200202000-00015; Silke B, 2002, J PSYCHOPHARMACOL, V16, P355, DOI 10.1177/026988110201600410; So SH, 2010, PSYCHOSOM MED, V72, P681, DOI 10.1097/PSY.0b013e3181e7cca6; Sowden GL, 2009, INT J CARDIOL, V132, P30, DOI 10.1016/j.ijcard.2008.10.002; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thornicroft G, 2004, BRIT J PSYCHIAT, V185, P283, DOI 10.1192/bjp.185.4.283; Toichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147, DOI 10.1016/S0167-8760(98)00047-6; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; van Gestel AJR, 2011, RESPIROLOGY, V16, P939, DOI 10.1111/j.1440-1843.2011.01992.x; Voss A, 2011, PROG NEURO-PSYCHOPH, V35, P1131, DOI 10.1016/j.pnpbp.2011.03.015; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323	65	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26378	10.1371/journal.pone.0026378	http://dx.doi.org/10.1371/journal.pone.0026378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073161	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200008
J	Qidwai, W; Rauf, MUA; Sakina, S; Hamid, A; Ishaque, S; Ashfaq, T				Qidwai, Waris; Rauf, Mohammad Uzair Abdul; Sakina, Seema; Hamid, Ayesha; Ishaque, Sidra; Ashfaq, Tabinda			Frequency and Associated Factors for Care Giving among Elderly Patients Visiting a Teaching Hospital in Karachi, Pakistan	PLOS ONE			English	Article							FAMILY; CAREGIVERS; WOMEN	Objective: To study frequency and associated factors for care giving among elderly patients visiting a teaching hospital in Karachi, Pakistan. Methodology: A cross sectional questionnaire-based study was conducted at the Community Health Centre (CHC), Aga Khan University Hospital (AKUH) Karachi, Pakistan from September to November 2009. All individuals, visiting the CHC and aged 65 years or above were interviewed after taking written informed consent. Results: A total of 400 elderly completed the interview. Majority were females, 65-69 years age, More than half of the individuals ie: 227 (85%) had received Care Giver experience for assistance and among these 195(72%) had care provided by an immediate family member. A large proportion of them stated that their Care Givers managed to provide less than four hours in a day for care giving. Around 37% showed substantial improvement in their relationship with the care givers. About 70% of the respondents stated that the care provided by the Care Giver improved their quality of life. Conclusion: Elderly care is provided by majority of the family members resulting in increased satisfaction level, however small number still not satisfied due to unfulfilled need of these older people. This demands that efforts should be made to strengthen the family support by increasing awareness regarding elderly care and arranging support system by the government.	[Qidwai, Waris; Sakina, Seema; Ishaque, Sidra; Ashfaq, Tabinda] Aga Khan Univ, Dept Family Med, Karachi, Pakistan; [Rauf, Mohammad Uzair Abdul] Dow Univ, Karachi, Pakistan; [Hamid, Ayesha] Ziauddin Univ, Karachi, Pakistan	Aga Khan University; Dow University of Health Sciences; Ziauddin University	Qidwai, W (corresponding author), Aga Khan Univ, Dept Family Med, Karachi, Pakistan.	tabindaashfaq@gmail.com						[Anonymous], 2010, NUTR WELL BEING A Z; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; BRODY EM, 1981, GERONTOLOGIST, V21, P471, DOI 10.1093/geront/21.5.471; Centers for Disease Control and Prevention, 2007, STAT AG HLTH AM 2007; Cummings SM, 2009, AGING MENT HEALTH, V13, P619, DOI 10.1080/13607860902774451; Gibson MJ, 1984, INNOVATIVE AGING PRO, P159; Grunfeld E, 1997, CAN MED ASSOC J, V157, P1101; Gupta R, 2000, INT J AGING HUM DEV, V51, P295, DOI 10.2190/J9XY-V3E0-NP1B-UNA5; Itrat Ahmed, 2007, JPMA Journal of the Pakistan Medical Association, V57, P106; Laubunjong C., 2008, ABAC J, V28, P64; Lopez J, 2005, ARCH GERONTOL GERIAT, V41, P81, DOI 10.1016/j.archger.2004.12.001; Maas ML, 2004, NURS RES, V53, P76, DOI 10.1097/00006199-200403000-00003; National Institute on Aging, 2010, HEARTS ART HLTH OLD; Onishi C, 2010, J MED INVESTIG, V57, P69, DOI 10.2152/jmi.57.69; Population Reference Bureau, 2006, 2006 WORLD HLTH DAT; Saleem T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-205; Wang YC, 2004, J FORMOS MED ASSOC, V103, P533; WHO, 1999, AG EXPL MYTHS; World Health Organization, 1997, WORLD HLTH REP 1997; Yousafzai AW, 2008, J POSTGRAD MED INS, V22, P62; Zafar Syed Nabeel, 2006, J Pak Med Assoc, V56, P470	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e25873	10.1371/journal.pone.0025873	http://dx.doi.org/10.1371/journal.pone.0025873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073142	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200003
J	Kus, V; Flachs, P; Kuda, O; Bardova, K; Janovska, P; Svobodova, M; Jilkova, ZM; Rossmeisl, M; Wang-Sattler, R; Yu, ZH; Illig, T; Kopecky, J				Kus, Vladimir; Flachs, Pavel; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Svobodova, Michaela; Jilkova, Zuzana Macek; Rossmeisl, Martin; Wang-Sattler, Rui; Yu, Zhonghao; Illig, Thomas; Kopecky, Jan			Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet	PLOS ONE			English	Article							HEPATIC INSULIN SENSITIVITY; IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; MARINE ORIGIN; GLYCOGEN-SYNTHESIS; LIPID CATABOLISM; INDUCED OBESITY; RECEPTOR	Combining pharmacological treatments and life style interventions is necessary for effective therapy of major diseases associated with obesity, which are clustered in the metabolic syndrome. Acting via multiple mechanisms, combination treatments may reduce dose requirements and, therefore, lower the risk of adverse side effects, which are usually associated with long-term pharmacological interventions. Our previous study in mice fed high-fat diet indicated additivity in preservation of insulin sensitivity and in amelioration of major metabolic syndrome phenotypes by the combination treatment using n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and rosiglitazone, i.e. an anti-diabetic drug of the thiazolidinedione (TZD) family. We investigated here whether pioglitazone, a TZD-drug in clinical use, could elicit the additive beneficial effects when combined with n-3 LC-PUFA. Adult male mice (C57BL/6N) were fed an obesogenic corn oil-based high-fat diet (cHF) for 8 weeks, or randomly assigned to various dietary treatments (i) cHF+F, cHF with n-3 LC-PUFA concentrate replacing 15% of dietary lipids; (ii) cHF+ROSI, cHF with 10 mg rosiglitazone/kg diet; (iii) cHF+F+ROSI; (iv) cHF+PIO, cHF with 50 mg pioglitazone/kg diet; and (v) cHF+F+PIO, or chow-fed. Plasma concentrations of 163 metabolites were evaluated using a targeted metabolomics approach. Both TZDs preserved glucose homeostasis and normal plasma lipid levels while inducing adiponectin, with pioglitazone showing better effectiveness. The beneficial effects of TZDs were further augmented by the combination treatments. cHF+F+ROSI but not cHF+F+PIO counteracted development of obesity, in correlation with inducibility of fatty acid beta-oxidation, as revealed by the metabolomic analysis. By contrast, only cHF+F+PIO eliminated hepatic steatosis and this treatment also reversed insulin resistance in dietary obese mice. Our results reveal differential effects of rosiglitazone and pioglitazone, unmasked in the combination treatment with n-3 LC-PUFA, and support the notion that n-3 LC-PUFA could be used as add-on treatment to TZDs in order to improve diabetic patient's therapy.	[Kus, Vladimir; Flachs, Pavel; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Svobodova, Michaela; Jilkova, Zuzana Macek; Rossmeisl, Martin; Kopecky, Jan] Acad Sci Czech Republ Vvi, Dept Adipose Tissue Biol, Inst Physiol, Prague, Czech Republic; [Wang-Sattler, Rui; Yu, Zhonghao; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kus, V (corresponding author), Acad Sci Czech Republ Vvi, Dept Adipose Tissue Biol, Inst Physiol, Prague, Czech Republic.	kopecky@biomed.cas.cz	Flachs, Pavel/A-5341-2012; Kuda, Ondrej/B-7990-2012; Svobodova, Michaela/F-7783-2016; Janovska, Petra/E-7160-2013; Rossmeisl, Martin/C-1892-2012; Macek Jílková, Zuzana/N-4051-2014; Bardova, Kristina/C-3493-2015; Kopecky, Jan/B-8244-2012; Rossmeisl, Martin/CAF-0060-2022; Wang-Sattler, Rui/B-5354-2014	Kuda, Ondrej/0000-0001-7034-4536; Janovska, Petra/0000-0002-6154-2175; Rossmeisl, Martin/0000-0001-8534-4002; Macek Jílková, Zuzana/0000-0002-2553-5971; Bardova, Kristina/0000-0002-2297-5066; Kopecky, Jan/0000-0001-8072-2035; Rossmeisl, Martin/0000-0001-8534-4002; Wang-Sattler, Rui/0000-0002-8794-8229	Internal Grant Agency of the Ministry of Health of the Czech Republic [NS/10528-3]; European Union [244995]; EPAX AS (Norway); EFSD	Internal Grant Agency of the Ministry of Health of the Czech Republic; European Union(European Commission); EPAX AS (Norway); EFSD	The research leading to these results has received funding from the Internal Grant Agency of the Ministry of Health of the Czech Republic (NS/10528-3), the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS), EPAX AS (Norway), and the EFSD New Horizons research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, END SOC STAT PROV SU; Bays HE, 2010, CURR MED RES OPIN, V26, P907, DOI 10.1185/03007991003645318; Bell DSH, 2011, DIABETES OBES METAB, V13, P313, DOI 10.1111/j.1463-1326.2010.01342.x; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Djaouti L, 2010, DIABETES-METAB RES, V26, P297, DOI 10.1002/dmrr.1081; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; FASCHING P, 1991, DIABETES, V40, P583, DOI 10.2337/diabetes.40.5.583; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Higashi Y, 2010, J BIOL CHEM, V285, P36361, DOI 10.1074/jbc.M110.137661; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kim H, 2004, DIABETOLOGIA, V47, P2215, DOI 10.1007/s00125-004-1581-6; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kuda O, 2009, J PHYSIOL PHARMACOL, V60, P135; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Lankinen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005258; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Libby P, 2007, AM J CARDIOL, V99, p27B, DOI 10.1016/j.amjcard.2006.11.004; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; PELIKANOVA T, 1993, ANN NY ACAD SCI, V683, P272; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Rabol R, 2010, DIABETES OBES METAB, V12, P806, DOI 10.1111/j.1463-1326.2010.01237.x; Reyes-Soffer G, 2011, EXPERT OPIN PHARMACO, V12, P1429, DOI 10.1517/14656566.2011.563506; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Ruxton CH, 2007, J HUM NUTR DIET, V17, P449; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Serhan CN, 2005, PHARMACOL THERAPEUT, V105, P7, DOI 10.1016/j.pharmthera.2004.09.002; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; van Schothorst EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-110; Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0; Whitehead JP, 2011, INT J BIOCHEM CELL B, V43, P1071, DOI 10.1016/j.biocel.2011.04.017; Wilmsen HM, 2003, AM J PHYSIOL-ENDOC M, V285, pE354, DOI 10.1152/ajpendo.00491.2001; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yang KJ, 2010, LIFE SCI, V87, P405, DOI 10.1016/j.lfs.2010.08.002; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	61	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27126	10.1371/journal.pone.0027126	http://dx.doi.org/10.1371/journal.pone.0027126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073272	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000028
J	Liu, YC; Hsu, DH; Huang, CL; Liu, YL; Liu, GY; Hung, HC				Liu, Yen-Chin; Hsu, Den-Hua; Huang, Chi-Liang; Liu, Yi-Liang; Liu, Guang-Yaw; Hung, Hui-Chih			Determinants of the Differential Antizyme-Binding Affinity of Ornithine Decarboxylase	PLOS ONE			English	Article							METHOTREXATE-INDUCED APOPTOSIS; POLYAMINE METABOLISM; INTRACELLULAR DEGRADATION; CELL-GROWTH; ANALYTICAL ULTRACENTRIFUGATION; ODC ANTIZYME; C-MYC; PROTEIN; TARGET; EXPRESSION	Ornithine decarboxylase (ODC) is a ubiquitous enzyme that is conserved in all species from bacteria to humans. Mammalian ODC is degraded by the proteasome in a ubiquitin-independent manner by direct binding to the antizyme (AZ). In contrast, Trypanosoma brucei ODC has a low binding affinity toward AZ. In this study, we identified key amino acid residues that govern the differential AZ binding affinity of human and Trypanosoma brucei ODC. Multiple sequence alignments of the ODC putative AZ-binding site highlights several key amino acid residues that are different between the human and Trypanosoma brucei ODC protein sequences, including residue 119, 124,125, 129, 136, 137 and 140 (the numbers is for human ODC). We generated a septuple human ODC mutant protein where these seven bases were mutated to match the Trypanosoma brucei ODC protein sequence. The septuple mutant protein was much less sensitive to AZ inhibition compared to the WT protein, suggesting that these amino acid residues play a role in human ODC-AZ binding. Additional experiments with sextuple mutants suggest that residue 137 plays a direct role in AZ binding, and residues 119 and 140 play secondary roles in AZ binding. The dissociation constants were also calculated to quantify the affinity of the ODC-AZ binding interaction. The K-d value for the wild type ODC protein-AZ heterodimer ([ODC_WT]-AZ) is approximately 0.22 mu M, while the K-d value for the septuple mutant-AZ heterodimer ([ODC_7M]-AZ) is approximately 12.4 mu M. The greater than 50-fold increase in [ODC_7M]-AZ binding affinity shows that the ODC-7M enzyme has a much lower binding affinity toward AZ. For the mutant proteins ODC_7M(-Q119H) and ODC_7M(-V137D), the K-d was 1.4 and 1.2 mu M, respectively. These affinities are 6-fold higher than the WT_ODC K-d, which suggests that residues 119 and 137 play a role in AZ binding.	[Liu, Yen-Chin; Hsu, Den-Hua; Huang, Chi-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yen-Chin; Hsu, Den-Hua; Huang, Chi-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Liu, YC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, Republic of China [NSC-99-2113-M-005-010]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	The authors acknowledge support of this work by the National Science Council, Republic of China (NSC-99-2113-M-005-010) and in part by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Burns MR, 2009, J MED CHEM, V52, P1983, DOI 10.1021/jm801580w; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Coffino P, 1998, UBIQUITIN BIOL CELL, P411; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Feith DJ, 2006, CARCINOGENESIS, V27, P1090, DOI 10.1093/carcin/bgi343; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1992, MOL CELL BIOL, V12, P2178, DOI 10.1128/MCB.12.5.2178; GHODA L, 1990, J BIOL CHEM, V265, P11823; Hoffman DW, 2005, BIOCHEMISTRY-US, V44, P11777, DOI 10.1021/bi051081k; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019253; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; Morrison LD, 1998, J NEUROCHEM, V71, P288; MOSHIER JA, 1993, CANCER RES, V53, P2618; MURAKAMI Y, 1994, BIOCHEM J, V304, P183, DOI 10.1042/bj3040183; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; OBrien TG, 1997, CANCER RES, V57, P2630; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Seiler N, 1998, INT J ONCOL, V13, P993; Smithson DC, 2010, J BIOL CHEM, V285, P16771, DOI 10.1074/jbc.M109.081588; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; VANNIEUWENHOVE S, 1985, T ROY SOC TROP MED H, V79, P692, DOI 10.1016/0035-9203(85)90195-6; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26835	10.1371/journal.pone.0026835	http://dx.doi.org/10.1371/journal.pone.0026835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073206	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000014
J	Klinke, DJ				Klinke, David J., II			Age-Corrected Beta Cell Mass Following Onset of Type 1 Diabetes Mellitus Correlates with Plasma C-Peptide in Humans	PLOS ONE			English	Article							ORAL INSULIN; PANCREAS; RESERVE; TRIALS; COST	Background: The inability to produce insulin endogenously precipitates the clinical symptoms of type 1 diabetes mellitus. However, the dynamic trajectory of beta cell destruction following onset remains unclear. Using model-based inference, the severity of beta cell destruction at onset decreases with age where, on average, a 40% reduction in beta cell mass was sufficient to precipitate clinical symptoms at 20 years of age. While plasma C-peptide provides a surrogate measure of endogenous insulin production post-onset, it is unclear as to whether plasma C-peptide represents changes in beta cell mass or beta cell function. The objective of this paper was to determine the relationship between beta cell mass and endogenous insulin production post-onset. Methods and Findings: Model-based inference was used to compare direct measures of beta cell mass in 102 patients against contemporary measures of plasma C-peptide obtained from three studies that collectively followed 834 patients post-onset of clinical symptoms. An empirical Bayesian approach was used to establish the level of confidence associated with the model prediction. Age-corrected estimates of beta cell mass that were inferred from a series of landmark pancreatic autopsy studies significantly correlate (p>0.9995) with contemporary measures of plasma C-peptide levels following onset. Conclusions: Given the correlation between beta cell mass and plasma C-peptide following onset, plasma C-peptide may provide a surrogate measure of beta cell mass in humans. The clinical relevance of this study is that therapeutic strategies that provide an increase in plasma C-peptide over the predicted value for an individual may actually improve beta cell mass. The model predictions may establish a standard historical "control" group - a prior in a Bayesian context - for clinical trials.	[Klinke, David J., II] W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA; [Klinke, David J., II] W Virginia Univ, Dept Immunol Microbiol & Cell Biol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Klinke, DJ (corresponding author), W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA.	david.klinke@mail.wvu.edu		Klinke, David/0000-0003-3299-4938	National Science Foundation [1053490]; National Cancer Institute [R15CA132124]; National Institute of Allergy and Infectious Diseases [R56AI076221]; NATIONAL CANCER INSTITUTE [R15CA132124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076221] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Science Foundation CAREER 1053490, the National Cancer Institute R15CA132124, and the National Institute of Allergy and Infectious Diseases R56AI076221. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Science Foundation, the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for the Advancement of Science, 1990, SCI ALL AM; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2011, DIABETES, V60, P361, DOI 10.2337/db10-1506; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Daaboul J, 2003, REV ENDOCR METAB DIS, V4, P317, DOI 10.1023/A:1027308310837; FOULIS AK, 1987, DIABETOLOGIA, V30, P333, DOI 10.1007/BF00299027; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Frayn K., 2003, METABOLIC REGULATION; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Goke B, 2010, CURR PHARM DESIGN, V16, P1547, DOI 10.2174/138161210791164081; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kahn R, 2004, DIABETES CARE, V27, P2262; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Klinke DJ, 2008, BIOPHYS J, V94, P4249, DOI 10.1529/biophysj.107.120451; Klinke DJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-371; Komulainen J, 1997, DIABETIC MED, V14, P532, DOI 10.1002/(SICI)1096-9136(199707)14:7<532::AID-DIA403>3.0.CO;2-6; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Larsen MO, 2006, AM J PHYSIOL-ENDOC M, V290, pE670, DOI 10.1152/ajpendo.00251.2005; MCCULLOCH DK, 1991, DIABETES, V40, P673, DOI 10.2337/diabetes.40.6.673; Meier JJ, 2009, DIABETES, V58, P1595, DOI 10.2337/db08-1611; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Teuscher AU, 1998, DIABETES, V47, P324, DOI 10.2337/diabetes.47.3.324; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	31	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26873	10.1371/journal.pone.0026873	http://dx.doi.org/10.1371/journal.pone.0026873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073210	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900047
J	Soyiri, IN; Reidpath, DD; Sarran, C				Soyiri, Ireneous N.; Reidpath, Daniel D.; Sarran, Christophe			Asthma Length of Stay in Hospitals in London 2001-2006: Demographic, Diagnostic and Temporal Factors	PLOS ONE			English	Article							PATIENT SAFETY; ADMISSION; ATTENDANCE; MORTALITY; BURDEN; ADULTS; COST; CARE; NHS	Asthma is a condition of significant public health concern associated with morbidity, mortality and healthcare utilisation. This study identifies key determinants of length of stay (LOS) associated with asthma-related hospital admissions in London, and further explores their effects on individuals. Subjects were primarily diagnosed and admitted for asthma in London between 1(st) January 2001 and 31(st) December 2006. All repeated admissions were treated uniquely as independent cases. Negative binomial regression was used to model the effect(s) of demographic, temporal and diagnostic factors on the LOS, taking into account the cluster effect of each patient's hospital attendance in London. The median and mean asthma LOS over the period of study were 2 and 3 days respectively. Admissions increased over the years from 8,308 (2001) to 10,554 (2006), but LOS consistently declined within the same period. Younger individuals were more likely to be admitted than the elderly, but the latter significantly had higher LOS (p<0.001). Respiratory related secondary diagnoses, age, and gender of the patient as well as day of the week and year of admission were important predictors of LOS. Asthma LOS can be predicted by socio-demographic factors, temporal and clinical factors using count models on hospital admission data. The procedure can be a useful tool for planning and resource allocation in health service provision.	[Soyiri, Ireneous N.] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, Clayton, Vic 3800, Australia; [Sarran, Christophe] Met Off, Exeter, Devon, England	University of Ghana; Monash University; Met Office - UK	Soyiri, IN (corresponding author), Univ Ghana, Sch Publ Hlth, Accra, Ghana.	soyiriin@yahoo.com	Soyiri, Ireneous N./H-4594-2011; Soyiri, Ireneous/AAE-7617-2019	Soyiri, Ireneous N./0000-0003-4697-5156; Soyiri, Ireneous/0000-0003-4697-5156; Reidpath, Daniel/0000-0002-8796-0420				ALT JE, 2000, POLITICAL ANAL, V0009; Arnold DH, 2011, EMERGENCY MED J; Arnold DH, 2008, AM J EMERG MED, V26, P473, DOI 10.1016/j.ajem.2007.05.026; Asthma-UK, 2010, KEY FACTS STAT ASTHM; Asthma-UK, 2007, ASTHM DIV IN EM CAR; Atienza N, 2008, STAT MED, V27, P1403, DOI 10.1002/sim.3029; Burg JG, 2001, MED VET ENTOMOL, V15, P413, DOI 10.1046/j.0269-283x.2001.00329.x; Callery P, 2010, ARCH DIS CHILD, V95, P341, DOI 10.1136/adc.2009.163261; Cameron AC, 2007, ESSENTIALS COUNT DAT, P331; DiSantostefano RL, 2011, AM J RESP CRIT CARE, V183; Gerrish K, 2000, J ADV NURS, V31, P918, DOI 10.1046/j.1365-2648.2000.01357.x; [GLA Demography-Team], 2011, MIDY POP EST; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Gray B, 2009, ENVIRON ECOL STAT, V17, P573; HES, 2008, HES US HLTH SOC CAR; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hodder R, 2010, CAN MED ASSOC J, V182, pE55, DOI 10.1503/cmaj.080072; Holgate ST, 1995, ASTHM OUTD AIR POLL; Kuan V, 2010, THORAX, V65, pA6, DOI 10.1136/thx.2010.150912.7; Long J. S., 2003, REGRESSION MODELS CA; Long JS, 2001, STATA J, V1, P51, DOI 10.1177/1536867X0100100103; Lyratzopoulos G, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-4; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Moloney ED, 2006, EMERG MED J, V23, P363, DOI 10.1136/emj.2005.028944; Morrison DS, 2001, THORAX, V56, P687, DOI 10.1136/thorax.56.9.687; Mulla ZD, 2007, EPIDEMIOL INFECT, V135, P868, DOI 10.1017/S0950268806007448; Paradis AR, 2009, AM J MED QUAL, V24, P53, DOI 10.1177/1062860608327610; Poulos Leanne M, 2005, Paediatr Respir Rev, V6, P20, DOI 10.1016/j.prrv.2004.11.004; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Rowe, 2010, ADMISSIONS CANADIAN; Schenkel S, 2000, ACAD EMERG MED, V7, P1204, DOI 10.1111/j.1553-2712.2000.tb00466.x; Scott IA, 2010, AUST HEALTH REV, V34, P317, DOI 10.1071/AH09821; Singh CH, 2010, EUR J HEALTH ECON, V11, P119, DOI 10.1007/s10198-009-0153-6; Sobota A, 2010, AM J HEMATOL, V85, P24, DOI 10.1002/ajh.21565; Stewart B, 2006, EMERG MED J, V23, P911, DOI 10.1136/emj.2006.039339; Watson L, 2007, INT J CLIN PRACT, V61, P1884, DOI 10.1111/j.1742-1241.2007.01559.x; Watson L, 2007, RESP MED, V101, P1659, DOI 10.1016/j.rmed.2007.03.006; Xiao J, 1999, SOCIOECONOMIC PLANNI, V33, P39, DOI DOI 10.1016/S0038-0121(98)00006-8	38	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27184	10.1371/journal.pone.0027184	http://dx.doi.org/10.1371/journal.pone.0027184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073282	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900086
J	Tirok, K; Bauer, B; Wirtz, K; Gaedke, U				Tirok, Katrin; Bauer, Barbara; Wirtz, Kai; Gaedke, Ursula			Predator-Prey Dynamics Driven by Feedback between Functionally Diverse Trophic Levels	PLOS ONE			English	Article							TRADE-OFFS; FOOD WEBS; COMMUNITY ECOLOGY; PHYTOPLANKTON SUCCESSION; RESOURCE COMPETITION; LAKE CONSTANCE; MODEL; BIODIVERSITY; SIZE; PLANKTON	Neglecting the naturally existing functional diversity of communities and the resulting potential to respond to altered conditions may strongly reduce the realism and predictive power of ecological models. We therefore propose and study a predator-prey model that describes mutual feedback via species shifts in both predator and prey, using a dynamic trait approach. Species compositions of the two trophic levels were described by mean functional traits-prey edibility and predator food-selectivity- and functional diversities by the variances. Altered edibility triggered shifts in food-selectivity so that consumers continuously respond to the present prey composition, and vice versa. This trait-mediated feedback mechanism resulted in a complex dynamic behavior with ongoing oscillations in the mean trait values, reflecting continuous reorganization of the trophic levels. The feedback was only possible if sufficient functional diversity was present in both trophic levels. Functional diversity was internally maintained on the prey level as no niche existed in our system, which was ideal under any composition of the predator level due to the trade-offs between edibility, growth and carrying capacity. The predators were only subject to one trade-off between food-selectivity and grazing ability and in the absence of immigration, one predator type became abundant, i.e., functional diversity declined to zero. In the lack of functional diversity the system showed the same dynamics as conventional models of predator-prey interactions ignoring the potential for shifts in species composition. This way, our study identified the crucial role of trade-offs and their shape in physiological and ecological traits for preserving diversity.	[Tirok, Katrin; Bauer, Barbara; Gaedke, Ursula] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Tirok, Katrin; Wirtz, Kai] Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany; [Tirok, Katrin] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Potsdam; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Kwazulu Natal	Tirok, K (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	katrintirok@gmail.com	Bauer, Barbara/AAH-2454-2019; Wirtz, Kai/GRY-5339-2022; Bauer, Barbara/ABD-8980-2020		German Research Foundation (DFG) [1162, GA 401/7-1, 7-2]; European Union [MTKD-CT-2006-042261]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union(European Commission)	KT and BB were funded by the German Research Foundation (DFG, http://www.dfg.de) within the Priority Program 1162 "The impact of climate variability on aquatic ecosystems (AQUASHIFT)" (GA 401/7-1, 7-2). UG acknowledges support from the European Union through the Marie Curie Transfer of Knowledge Project FEMMES (MTKD-CT-2006-042261) (http://ec.europa.eu/research/fp6/mariecurie-actions/action/knowledge_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOL ECOL, V11, P1, DOI 10.1023/A:1018445517101; ABRAMS PA, 1993, EVOL ECOL, V7, P465, DOI 10.1007/BF01237642; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Abrams PA, 2009, J THEOR BIOL, V261, P294, DOI 10.1016/j.jtbi.2009.07.026; Armstrong RA, 2003, DEEP-SEA RES PT II, V50, P2895, DOI 10.1016/j.dsr2.2003.07.003; BARETTABEKKER JG, 1995, NETH J SEA RES, V33, P363, DOI 10.1016/0077-7579(95)90053-5; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; Begon M., 2009, ECOLOGY INDIVIDUALS; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Brodie ED, 1999, EVOLUTION, V53, P626, DOI 10.1111/j.1558-5646.1999.tb03798.x; BRUGGEMAN J, 2009, THESIS VRIJE U AMSTE; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fuchs HL, 2010, MAR ECOL PROG SER, V413, P1, DOI 10.3354/meps08716; GAEDEKE A, 1986, OECOLOGIA, V71, P25, DOI 10.1007/BF00377315; Gaedke U, 2002, ECOL MONOGR, V72, P251, DOI 10.1890/0012-9615(2002)072[0251:IBELAN]2.0.CO;2; Geritz Stefan A.H., 2004, P54; Grover J. P., 1997, RESOURCE COMPETITION; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; GROVER JP, 1989, J PHYCOL, V25, P402, DOI 10.1111/j.1529-8817.1989.tb00138.x; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Lampert W., 2007, LIMNOECOLOGY ECOLOGY, V2; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Merico A, 2009, ECOL MODEL, V220, P3001, DOI 10.1016/j.ecolmodel.2009.05.005; MOLONEY CL, 1991, J PLANKTON RES, V13, P1003, DOI 10.1093/plankt/13.5.1003; MULLER H, 1991, MICROB ECOL, V21, P119, DOI 10.1007/BF02539148; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; ROTHHAUPT KO, 1990, ARCH HYDROBIOL, V118, P1; Savage VM, 2007, J THEOR BIOL, V247, P213, DOI 10.1016/j.jtbi.2007.03.007; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SHUTER BJ, 1978, LIMNOL OCEANOGR, V23, P1248, DOI 10.4319/lo.1978.23.6.1248; SMITH SL, 2011, LIMNOLOGY OCEA UNPUB; Sommer U, 2001, ECOL LETT, V4, P545, DOI 10.1046/j.1461-0248.2001.00263.x; SOMMER U, 1988, LIMNOL OCEANOGR, V33, P1037, DOI 10.4319/lo.1988.33.5.1037; Thebault E, 2006, ECOL RES, V21, P17, DOI 10.1007/s11284-005-0127-9; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Tirok K, 2007, AQUAT MICROB ECOL, V49, P87, DOI 10.3354/ame01127; Tirok K, 2010, ECOLOGY, V91, P1748, DOI 10.1890/09-1052.1; Uchida S, 2007, ECOL MODEL, V206, P263, DOI 10.1016/j.ecolmodel.2007.03.035; Vincent TLS, 1996, J THEOR BIOL, V180, P111, DOI 10.1006/jtbi.1996.0086; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wirtz KW, 2003, TREE PHYSIOL, V23, P181, DOI 10.1093/treephys/23.3.181; Wirtz KW, 2002, J BIOTECHNOL, V97, P147, DOI 10.1016/S0168-1656(02)00064-0; Wirtz KW, 1996, ECOL MODEL, V92, P33, DOI 10.1016/0304-3800(95)00196-4; WIRTZ KW, 2011, MARINE ECOLOGY PROGR; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; Zhou M, 2010, J PLANKTON RES, V32, P1147, DOI 10.1093/plankt/fbq054	61	32	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27357	10.1371/journal.pone.0027357	http://dx.doi.org/10.1371/journal.pone.0027357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096560	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900036
J	Wermuth, PJ; Addya, S; Jimenez, SA				Wermuth, Peter J.; Addya, Sankar; Jimenez, Sergio A.			Effect of Protein Kinase C delta (PKC-delta) Inhibition on the Transcriptome of Normal and Systemic Sclerosis Human Dermal Fibroblasts In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; GROWTH-FACTOR; CYTOKINE; CLASSIFICATION; LOCALIZATION; STIMULATION; FIBRONECTIN; SIGNATURES; ROTTLERIN	Previous studies demonstrated that protein kinase C-delta (PKC-delta) inhibition with the selective inhibitor, rottlerin, resulted in potent downregulation of type I collagen expression and production in normal human dermal fibroblasts and abrogated the exaggerated type I collagen production and expression in fibroblasts cultured from affected skin from patients with the fibrosing disorder systemic sclerosis (SSc). To elucidate the mechanisms involved in the ability of PKC-delta to regulate collagen production in fibroblasts, we examined the effects of PKC-delta inhibition on the transcriptome of normal and SSc human dermal fibroblasts. Normal and SSc human dermal fibroblasts were incubated with rottlerin (5 mu M), and their gene expression was analyzed by microarrays. Pathway analysis and gene ontology analysis of differentially expressed genes in each comparison were performed. Identification of significantly overrepresented transcriptional regulatory elements (TREs) was performed using the Promoter Analysis and Interaction Network Toolset (PAINT) program. PKC-delta activity was also inhibited using RNA interference (siRNA) and by treating fibroblasts with a specific PKC-delta inhibitory cell permeable peptide. Differential gene expression of 20 genes was confirmed using real time PCR. PKC-delta inhibition caused a profound change in the transcriptome of normal and SSc human dermal fibroblasts in vitro. Pathway and gene ontology analysis identified multiple cellular and organismal pathways affected by PKC-delta inhibition. Furthermore, both pathway and PAINT analyses indicated that the transcription factor NFkB played an important role in the transcriptome changes induced by PKC-delta inhibition. Multiple genes involved in the degradation of the extracellular matrix components were significantly reduced in SSc fibroblasts and their expression was increased by PKC-delta inhibition. These results indicate that isoform-specific inhibition of PKC-delta profibrotic effects may represent a novel therapeutic approach for SSc and other fibrotic diseases.	[Wermuth, Peter J.; Jimenez, Sergio A.] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; [Addya, Sankar] Thomas Jefferson Univ, Jefferson Med Coll, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Wermuth, PJ (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA.	sergio.jimenez@jefferson.edu		Wermuth, Peter/0000-0002-0242-7265; Jimenez, Sergio/0000-0001-5213-1203	National Institutes of Health (NIH) [RO1 AR-019616]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [T-32 AR007583-15]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR019616, T32AR007583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant RO1 AR-019616 to SAJ. PJW was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Training Grant T-32 AR007583-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; CARPENTER D, 1987, NATURE, V325, P107, DOI 10.1038/325107a0; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; ESMON NL, 1983, J BIOL CHEM, V258, P2238; Fruchtman S, 2005, AM J PHYSIOL-GASTR L, V289, pG342, DOI 10.1152/ajpgi.00413.2004; Fuzii HT, 2008, CLIN EXP RHEUMATOL, V26, P866; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Iwata Y, 2009, J RHEUMATOL, V36, P976, DOI 10.3899/jrheum.080343; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; KIKKAWA U, 1987, FEBS LETT, V223, P212, DOI 10.1016/0014-5793(87)80291-0; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; LEROY EC, 1988, J RHEUMATOL, V15, P202; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Mi ZB, 2000, MOL THER, V2, P339, DOI 10.1006/mthe.2000.0137; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Mochly-Rosen D, 1998, FASEB J, V12, P35; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; Newton Alexandra C, 2003, Methods Mol Biol, V233, P3; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Ryer EJ, 2006, ARTERIOSCL THROM VAS, V26, P780, DOI 10.1161/01.ATV.0000209517.00220.cd; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; SELLERS A, 1981, INT REV CONNECT TISS, V9, P151; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Tan FK, 2005, ARTHRITIS RHEUM-US, V52, P865, DOI 10.1002/art.20871; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Vallee S, 2004, EXP CELL RES, V297, P165, DOI 10.1016/j.yexcr.2004.03.007; VARGA J, 1987, BIOCHEM BIOPH RES CO, V147, P1282, DOI 10.1016/S0006-291X(87)80209-7; WANG N, 1994, J BIOL CHEM, V269, P29308; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Zhang YH, 2007, J IMMUNOL, V179, P3297, DOI 10.4049/jimmunol.179.5.3297; Zohlman A, 2008, FASEB J, V22	53	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27110	10.1371/journal.pone.0027110	http://dx.doi.org/10.1371/journal.pone.0027110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096525	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900022
J	Tebruegge, M; Pantazidou, A; Clifford, V; Gonis, G; Ritz, N; Connell, T; Curtis, N				Tebruegge, Marc; Pantazidou, Anastasia; Clifford, Vanessa; Gonis, Gena; Ritz, Nicole; Connell, Tom; Curtis, Nigel			The Age-Related Risk of Co-Existing Meningitis in Children with Urinary Tract Infection	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PLEOCYTOSIS; ACUTE BACTERIAL-MENINGITIS; YOUNG INFANTS; FEBRILE INFANTS; ASEPTIC-MENINGITIS; BACTEREMIA	Objective: The primary aim of this study was to determine age-stratified rates of co-existing bacterial meningitis in children with urinary tract infection (UTI). The secondary aims of this study were to determine the causative pathogens of UTI, and the clinical features and outcome of children with co-existing meningitis. Methods: Analysis of data collected over a nine-year period at a tertiary pediatric hospital in Australia. Study population: children below 16 years of age with culture-confirmed UTI and a paired CSF sample. Results: A total of 748 episodes in 735 cases were included in the final analysis. The commonest pathogens causing UTI were Escherichia coli (67.4%), Enterococcus faecalis (8.4%), Klebsiella oxytoca (3.5%) and Klebsiella pneumoniae (3.5%). Only two (1.2%; 95% CI: 0.15-4.36%) of 163 neonates (between 0 and 28 days of age) with UTI had co-existing meningitis. Both presented with pyrexia, irritability and lethargy, and recovered uneventfully with antibiotic treatment. There were no cases of co-existing meningitis among 499 infants (between 29 days and 12 months of age) with UTI (95% CI: 0.00-0.74%), or any of the 86 children aged 12 months or over (95% CI: 0.00-4.20%). Conclusions: These findings indicate that clinicians should have a low threshold to perform a lumbar puncture in neonates with UTI, as the risk of co-existing meningitis is not insignificant in this age group. In contrast, beyond the neonatal period, the risk is small and a more selective approach is warranted.	[Tebruegge, Marc; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Tebruegge, Marc; Pantazidou, Anastasia; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Dept Gen Med, Parkville, Vic, Australia; [Tebruegge, Marc; Clifford, Vanessa; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Clifford, Vanessa; Gonis, Gena] Royal Childrens Hosp Melbourne, Dept Microbiol, Parkville, Vic, Australia	University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Tebruegge, M (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	marc.tebruegge@rch.org.au	Ritz, Nicole/L-1452-2019; Curtis, Nigel/B-3491-2012; Ritz, Nicole/G-2924-2015	Ritz, Nicole/0000-0002-1498-1685; Curtis, Nigel/0000-0003-3446-4594; Ritz, Nicole/0000-0002-1498-1685; Clifford, Vanessa/0000-0001-9758-867X	European Society for Paediatric Infectious Diseases; University of Melbourne; National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	European Society for Paediatric Infectious Diseases; University of Melbourne(University of Melbourne); National Institute for Health Research(National Institute for Health Research (NIHR))	No external funding was received for this study. MT and NR were supported by Fellowship awards from the European Society for Paediatric Infectious Diseases and International Research Scholarships provided by the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Shohet FC, 2003, PEDIATR INFECT DIS J, V22, P1039, DOI 10.1097/01.inf.0000100576.99266.07; [Anonymous], 2004, Paediatr Child Health, V9, P377; BACHUR R, 1995, PEDIATR EMERG CARE, V11, P280, DOI 10.1097/00006565-199510000-00004; BATNITZKY S, 1977, JAMA-J AM MED ASSOC, V237, P148, DOI 10.1001/jama.237.2.148; Bergman DA, 1999, PEDIATRICS, V103, P843; BERGSTRO.T, 1972, J PEDIATR-US, V80, P858; Bonsu Bema K, 2007, BMC Pediatr, V7, P24, DOI 10.1186/1471-2431-7-24; Connell T, 2005, ADV EXP MED BIOL, V568, P199; Dayan PS, 2004, PEDIATR EMERG CARE, V20, P85, DOI 10.1097/01.pec.0000113876.10140.9b; DELOUVOIS J, 1994, J ANTIMICROB CHEMOTH, V34, P61, DOI 10.1093/jac/34.suppl_A.61; ERICKSON RC, 1989, DIAGN MICR INFEC DIS, V12, P235, DOI 10.1016/0732-8893(89)90020-5; Finkelstein Y, 2001, PEDIATR INFECT DIS J, V20, P630, DOI 10.1097/00006454-200106000-00019; GINSBURG CM, 1982, PEDIATRICS, V69, P409; Goldman Ran D, 2003, CJEM, V5, P394; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Heath PT, 2003, ARCH DIS CHILD-FETAL, V88, P173; Hoberman A, 1997, PEDIATR INFECT DIS J, V16, P11, DOI 10.1097/00006454-199701000-00004; Honkinen O, 2000, PEDIATR INFECT DIS J, V19, P630, DOI 10.1097/00006454-200007000-00009; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; Joffe Ari R, 2007, J Intensive Care Med, V22, P194, DOI 10.1177/0885066607299516; Kestenbaum LA, 2010, PEDIATRICS, V125, P257, DOI 10.1542/peds.2009-1181; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Lin DS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e20; Magin EC, 2007, PEDIATR EMERG CARE, V23, P83, DOI 10.1097/PEC.0b013e3180302c47; National Institute for Health and Clinical Excellence UK, 2007, CLIN GUID UR TRACT I; Schnadower D, 2010, PEDIATRICS, V126, P1074, DOI 10.1542/peds.2010-0479; Shah SS, 2008, J PEDIATR, V153, P290, DOI 10.1016/j.jpeds.2008.02.044; Syrogiannopoulos GA, 2001, PEDIATR INFECT DIS J, V20, P927, DOI 10.1097/00006454-200110000-00003; Tebruegge M, 2011, ARCH DIS CHILD, V96, DOI 10.1136/adc.2011.215277; TEELE DW, 1981, NEW ENGL J MED, V305, P1079, DOI 10.1056/NEJM198110293051810; Vuillermin PJ, 2007, EMERG MED AUSTRALAS, V19, P464, DOI 10.1111/j.1742-6723.2007.01001.x; Wang Sue-Fan, 1994, Acta Paediatrica Sinica, V35, P294; Yam AOW, 2009, J PAEDIATR CHILD H, V45, P364, DOI 10.1111/j.1440-1754.2009.01502.x	33	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26576	10.1371/journal.pone.0026576	http://dx.doi.org/10.1371/journal.pone.0026576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096488	Green Published, gold, Green Accepted			2022-12-27	WOS:000297350800009
J	Marfe, G; Tafani, M; Fiorito, F; Pagnini, U; Iovane, G; De Martino, L				Marfe, Gabriella; Tafani, Marco; Fiorito, Filomena; Pagnini, Ugo; Iovane, Giuseppe; De Martino, Luisa			Involvement of FOXO Transcription Factors, TRAIL-FasL/Fas, and Sirtuin Proteins Family in Canine Coronavirus Type II-Induced Apoptosis	PLOS ONE			English	Article							CALORIE RESTRICTION; TNF SUPERFAMILY; SIR2 HOMOLOG; CELL-DEATH; DEACETYLASE; BIM; MITOCHONDRIA; EXPRESSION; RECEPTORS; BAX	In our previous study, we have shown that canine coronavirus type II (CCoV-II) activates both extrinsic and intrinsic apoptotic pathway in a canine fibrosarcoma cell line (A-72 cells). Herein we investigated the role of Sirtuin and Forkhead box O (FOXO) families in this experimental model using Nortern Blot and Western Blot analysis. Our results demonstrated that mitochondrial SIRT3 and SIRT4 protein expression increased from 12 and 24 h post infection (p.i.) onwards, respectively, whereas the nuclear SIRT1 expression increased during the first 12 h p.i. followed by a decrease after 36 h p.i., reaching the same level of control at 48 h p.i. Sirtuins interact with/and regulate the activity of FOXO family proteins, and we herein observed that FOXO3A and FOXO1 expression increased significantly and stably from 12 h p.i. onwards. In addition, CCoV-II induces a remarkable increase in the expression of TNF-related apoptosis-inducing ligand (TRAIL), while we observed a slight up-regulation of FasL/Fas at 36 p.i. with a decrease of both proteins at the end of infection. Furthermore, we found that virus infection increased both bax translocation into mitochondria and decreased bcl-2 expression in cytosol in a time-dependent manner. These data suggest that FOXO transcription factors mediate pro-apoptotic effects of CCoV-II, in part due to activation of extrinsic apoptosis pathway, while some Sirtuin family members (such as SIRT3 and SIRT4) may be involved in intrinsic apoptotic pathway. Moreover, these results propose that TRAIL is an important mediator of cell death induced by CCoV-II during in vitro infection.	[Marfe, Gabriella] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Tafani, Marco] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy; [Fiorito, Filomena; Pagnini, Ugo; Iovane, Giuseppe; De Martino, Luisa] Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy	University of Rome Tor Vergata; IRCCS San Raffaele Pisana; University of Naples Federico II	Marfe, G (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy.	filomena.fiorito@unina.it	Fiorito, Filomena/O-2175-2016; Tafani, Marco/C-3275-2017; Tafani, Marco/U-7230-2019	Fiorito, Filomena/0000-0002-6658-7807; Tafani, Marco/0000-0001-7128-810X; Tafani, Marco/0000-0001-7128-810X	Ministry of Education, University and Research, Italy [2005071441_002]	Ministry of Education, University and Research, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants of Ministry of Education, University and Research, Italy (Prot. 2005071441_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; De Martino L, 2010, VET MICROBIOL, V141, P36, DOI 10.1016/j.vetmic.2009.09.001; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Law HKW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-35; Li W, 2003, AM J PHYSIOL-HEART C, V284, pH23, DOI 10.1152/ajpheart.00240.2002; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Pratelli A, 2004, J CLIN MICROBIOL, V42, P1797, DOI 10.1128/JCM.42.4.1797-1799.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ruggieri A, 2007, VET MICROBIOL, V121, P64, DOI 10.1016/j.vetmic.2006.12.016; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; WANG F, 2006, AGING CELL, V5, P630; Wendt J, 2005, ONCOGENE, V24, P4052, DOI 10.1038/sj.onc.1208580; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358	42	31	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27313	10.1371/journal.pone.0027313	http://dx.doi.org/10.1371/journal.pone.0027313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087287	Green Published, Green Submitted, gold			2022-12-27	WOS:000297349700030
J	Walshe, DP; Lehane, MJ; Haines, LR				Walshe, Deirdre P.; Lehane, Michael J.; Haines, Lee R.			Post Eclosion Age Predicts the Prevalence of Midgut Trypanosome Infections in Glossina	PLOS ONE			English	Article							MORSITANS-MORSITANS DIPTERA; TSETSE-FLIES; BRUCEI-RHODESIENSE; AFRICAN TRYPANOSOMES; PERITROPHIC MEMBRANE; CONGOLENSE; FLY; SUSCEPTIBILITY; FORMS; IDENTIFICATION	The teneral phenomenon, as observed in Glossina sp., refers to the increased susceptibility of the fly to trypanosome infection when the first bloodmeal taken is trypanosome-infected. In recent years, the term teneral has gradually become synonymous with unfed, and thus fails to consider the age of the newly emerged fly at the time the first bloodmeal is taken. Furthermore, conflicting evidence exists of the effect of the age of the teneral fly post eclosion when it is given the infected first bloodmeal in determining the infection prevalence. This study demonstrates that it is not the feeding history of the fly but rather the age (hours after eclosion of the fly from the puparium) of the fly when it takes the first (infective) bloodmeal that determines the level of fly susceptibility to trypanosome infection. We examine this phenomenon in male and female flies from two distinct tsetse clades (Glossina morsitans morsitans and Glossina palpalis palpalis) infected with two salivarian trypanosome species, Trypanosoma (Trypanozoon) brucei brucei and Trypanosoma (Nannomonas) congolense using Fisher's exact test to examine differences in infection rates. Teneral tsetse aged less than 24 hours post-eclosion (h. p. e.) are twice as susceptible to trypanosome infection as flies aged 48 h. p. e. This trend is conserved across sex, vector clade and parasite species. The life cycle stage of the parasite fed to the fly (mammalian versus insect form trypanosomes) does not alter this age-related bias in infection. Reducing the numbers of parasites fed to 48 h. p. e., but not to 24 h. p. e. flies, increases teneral refractoriness. The importance of this phenomenon in disease biology in the field as well as the necessity of employing flies of consistent age in laboratory-based infection studies is discussed.	[Walshe, Deirdre P.; Lehane, Michael J.; Haines, Lee R.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Walshe, DP (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	m.j.lehane@liv.ac.uk	Walshe, Deirdre/AAD-7716-2019; Haines, Lee/K-9264-2017	Walshe, Deirdre/0000-0001-5531-2368; Haines, Lee/0000-0001-8821-6479	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoda K, 2009, J MED ENTOMOL, V46, P1446, DOI 10.1603/033.046.0629; Akoda K, 2009, MED VET ENTOMOL, V23, P195, DOI 10.1111/j.1365-2915.2009.00799.x; ANDERSON M, 1973, J INSECT PHYSIOL, V19, P1989, DOI 10.1016/0022-1910(73)90193-5; BEECROFT RP, 1993, MOL BIOCHEM PARASIT, V61, P285, DOI 10.1016/0166-6851(93)90074-8; BRUN R, 1979, ACTA TROP, V36, P289; BURTT E, 1946, ANN TROP MED PARASIT, V40, P18, DOI 10.1080/00034983.1946.11685259; DISTELMANS W, 1982, ANN SOC BELG MED TR, V62, P41; ELLIS DS, 1977, NATURE, V267, P834, DOI 10.1038/267834a0; EVANS DA, 1979, J PROTOZOOL, V26, P425, DOI 10.1111/j.1550-7408.1979.tb04648.x; Fairbairn H., 1950, Acta Tropica, V7, P19; FERRANTE A, 1983, PARASITE IMMUNOL, V5, P491, DOI 10.1111/j.1365-3024.1983.tb00763.x; FISH WR, 1989, BIOCHEMISTRY-US, V28, P5415, DOI 10.1021/bi00439a015; GINGRICH JB, 1982, T ROY SOC TROP MED H, V76, P479, DOI 10.1016/0035-9203(82)90142-0; GINGRICH JB, 1982, J MED ENTOMOL, V19, P268, DOI 10.1093/jmedent/19.3.268; GINGRICH JB, 1985, AM J TROP MED HYG, V34, P73, DOI 10.4269/ajtmh.1985.34.73; Haddow JD, 2002, INSECT BIOCHEM MOLEC, V32, P1045, DOI 10.1016/S0965-1748(02)00042-5; Haddow JD, 2004, THESIS U VICTORIA VI; Hao ZG, 2002, INSECT BIOCHEM MOLEC, V32, P1663, DOI 10.1016/S0965-1748(02)00106-6; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; HARLEY JMB, 1966, B ENTOMOL RES, V56, P595, DOI 10.1017/S0007485300056613; HARLEY JMB, 1971, ANN TROP MED PARASIT, V65, P191, DOI 10.1080/00034983.1971.11686745; Hoof L.van, 1937, Annales de la Societe Belge de Medecine Tropicale, V17, P249; Hu YJ, 2005, INSECT BIOCHEM MOLEC, V35, P105, DOI 10.1016/j.ibmb.2004.10.007; JACKSON CHN, 1946, B ENTOMOL RES, V37, P291, DOI 10.1017/S0007485300022203; Kubi C, 2007, ONDERSTEPOORT J VET, V74, P223; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; LEHANE MJ, 1991, MED VET ENTOMOL, V5, P495, DOI 10.1111/j.1365-2915.1991.tb00578.x; MAKUMYAVIRI AM, 1984, ANN SOC BELG MED TR, V64, P365; Maudlin I., 1991, Advances in Disease Vector Research, V7, P117; MAUDLIN I, 1989, ANN TROP MED PARASIT, V83, P431, DOI 10.1080/00034983.1989.11812368; MOLOO SK, 1971, PARASITOLOGY, V63, P507, DOI 10.1017/S0031182000080021; MOLOO SK, 1994, MED VET ENTOMOL, V8, P225, DOI 10.1111/j.1365-2915.1994.tb00503.x; MOSSER DM, 1982, EXP PARASITOL, V54, P310, DOI 10.1016/0014-4894(82)90040-6; Msangi AR, 1998, ACTA TROP, V70, P143, DOI 10.1016/S0001-706X(98)00013-8; MWANGELWA MI, 1987, INSECT SCI APPL, V8, P33, DOI 10.1017/S1742758400006913; OTIENO LH, 1983, ACTA TROP, V40, P113; PAGE W A, 1972, Tropical Animal Health and Production, V4, P41, DOI 10.1007/BF02357093; PAINDAVOINE P, 1986, PARASITOLOGY, V92, P31, DOI 10.1017/S0031182000063435; Rio RVM, 2006, P ROY SOC B-BIOL SCI, V273, P805, DOI 10.1098/rspb.2005.3399; Robertson M, 1913, PHILOS T R SOC LON B, V203, P161, DOI 10.1098/rstb.1913.0005; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Walshe DP, 2009, ADV INSECT PHYSIOL, V37, P119, DOI 10.1016/S0065-2806(09)37003-4; WELBURN SC, 1992, ANN TROP MED PARASIT, V86, P529, DOI 10.1080/00034983.1992.11812703; Wijers D. J. B., 1960, Annals of Tropical Medicine and Parasitology, V54, P341; WIJERS D. J. B., 1958, ANN TROP MED AND PARASITOL, V52, P385; Woolhouse MEJ, 1998, PARASITOLOGY, V116, P149, DOI 10.1017/S0031182097002047; YOUNG CJ, 1983, ANN TROP MED PARASIT, V77, P467, DOI 10.1080/00034983.1983.11811740	49	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26984	10.1371/journal.pone.0026984	http://dx.doi.org/10.1371/journal.pone.0026984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087240	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000297349700012
J	Charu, V; Viboud, C; Simonsen, L; Sturm-Ramirez, K; Shinjoh, M; Chowell, G; Miller, M; Sugaya, N				Charu, Vivek; Viboud, Cecile; Simonsen, Lone; Sturm-Ramirez, Katharine; Shinjoh, Masayoshi; Chowell, Gerardo; Miller, Mark; Sugaya, Norio			Influenza-Related Mortality Trends in Japanese and American Seniors: Evidence for the Indirect Mortality Benefits of Vaccinating Schoolchildren	PLOS ONE			English	Article							CHILDREN; IMPACT; LIVE; IMMUNIZATION; POPULATION; PREVENTION; MORBIDITY; INFECTION; COMMUNITY; EFFICACY	Background: The historical Japanese influenza vaccination program targeted at schoolchildren provides a unique opportunity to evaluate the indirect benefits of vaccinating high-transmitter groups to mitigate disease burden among seniors. Here we characterize the indirect mortality benefits of vaccinating schoolchildren based on data from Japan and the US. Methods: We compared age-specific influenza-related excess mortality rates in Japanese seniors aged >= 65 years during the schoolchildren vaccination program (1978-1994) and after the program was discontinued (1995-2006). Indirect vaccine benefits were adjusted for demographic changes, socioeconomics and dominant influenza subtype; US mortality data were used as a control. Results: We estimate that the schoolchildren vaccination program conferred a 36% adjusted mortality reduction among Japanese seniors (95% CI: 17-51%), corresponding to similar to 1,000 senior deaths averted by vaccination annually (95% CI: 400-1,800). In contrast, influenza-related mortality did not change among US seniors, despite increasing vaccine coverage in this population. Conclusions: The Japanese schoolchildren vaccination program was associated with substantial indirect mortality benefits in seniors.	[Charu, Vivek; Viboud, Cecile; Simonsen, Lone; Sturm-Ramirez, Katharine; Chowell, Gerardo; Miller, Mark] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC USA; [Shinjoh, Masayoshi] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Chowell, Gerardo] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Sugaya, Norio] Keiyu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); George Washington University; Keio University; Arizona State University; Arizona State University-Tempe	Charu, V (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	vcharu@gmail.com	Chowell, Gerardo/F-5038-2012; Shinjoh, Masayoshi/ABF-3935-2021; Simonsen, Lone/K-4531-2014	Chowell, Gerardo/0000-0003-2194-2251; Simonsen, Lone/0000-0003-1535-8526; Shinjoh, Masayoshi/0000-0002-6291-7186	Division of International Epidemiology and Population Studies; Fogarty International Center; National Institutes of Health; International Influenza Unit; Office of Global Affairs; Office of the Secretary of the Department of Health and Human Services; Department of Homeland Security	Division of International Epidemiology and Population Studies; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Influenza Unit; Office of Global Affairs; Office of the Secretary of the Department of Health and Human Services; Department of Homeland Security(United States Department of Homeland Security (DHS))	Financial support provided by the Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health and International Influenza Unit, Office of Global Affairs, Office of the Secretary of the Department of Health and Human Services. LS acknowledges support by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADGER GF, 1953, AM J HYG, V58, P179, DOI 10.1093/oxfordjournals.aje.a119599; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; CDC-Seasonal Influenza, CDC SEAS INFL FLU FI; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; DOWDLE WR, 1980, J INFECT DIS, V141, P258, DOI 10.1093/infdis/141.2.258; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fukuda K, 2001, NEW ENGL J MED, V344, P1946; Ghendon YZ, 2006, EPIDEMIOL INFECT, V134, P71, DOI 10.1017/S0950268805005650; Glezen WP, 2008, PEDIATR INFECT DIS J, V27, pS104, DOI 10.1097/INF.0b013e318168b729; Glezen WP, 2010, J INFECT DIS, V202, P1626, DOI 10.1086/657089; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Glezen WP, 2008, NEW ENGL J MED, V359, P2579, DOI 10.1056/NEJMcp0807498; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Hirota Y, 2008, VACCINE, V26, P6451, DOI 10.1016/j.vaccine.2008.06.042; Inoue K, 1999, NAT MED, V5, P592, DOI 10.1038/9416; Inouye S, 2001, NEW ENGL J MED, V344, P1946; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Ministry of Health & Welfare White Paper, MIN HLTH WELF WHIT P; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; Pabst L. J., 2010, Morbidity and Mortality Weekly Report, V59, P1266; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Reichert Thomas A, 2002, Semin Pediatr Infect Dis, V13, P104, DOI 10.1053/spid.2002.122997; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Sasaki M, 2008, FAMILIES THEIR CHILD; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Sugaya N, 2005, CLIN INFECT DIS, V41, P939, DOI 10.1086/432938; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Ujike M, 2010, EMERG INFECT DIS; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; White T, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e73; Yamazaki T, 2001, NEW ENGL J MED, V344, P1947	45	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26282	10.1371/journal.pone.0026282	http://dx.doi.org/10.1371/journal.pone.0026282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087226	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700005
J	Fabregat-Andres, O; Tierrez, A; Mata, M; Estornell-Erill, J; Ridocci-Soriano, F; Monsalve, M				Fabregat-Andres, Oscar; Tierrez, Alberto; Mata, Manuel; Estornell-Erill, Jordi; Ridocci-Soriano, Francisco; Monsalve, Maria			Induction of PGC-1 alpha Expression Can Be Detected in Blood Samples of Patients with ST-Segment Elevation Acute Myocardial Infarction	PLOS ONE			English	Article							RECEPTOR-GAMMA AGONIST; MITOCHONDRIAL BIOGENESIS; HEART-FAILURE; PIOGLITAZONE; ACTIVATION; MECHANISMS; GUIDELINES; UPDATE; MICE	Following acute myocardial infarction (MI), cardiomyocyte survival depends on its mitochondrial oxidative capacity. Cell death is normally followed by activation of the immune system. Peroxisome proliferator activated receptor gamma-coactivator 1 alpha (PGC-1 alpha) is a transcriptional coactivator and a master regulator of cardiac oxidative metabolism. PGC-1 alpha is induced by hypoxia and facilitates the recovery of the contractile capacity of the cardiac muscle following an artery ligation procedure. We hypothesized that PGC-1 alpha activity could serve as a good molecular marker of cardiac recovery after a coronary event. The objective of the present study was to monitor the levels of PGC-1 alpha following an ST-segment elevation acute myocardial infarction (STEMI) episode in blood samples of the affected patients. Analysis of blood mononuclear cells from human patients following an STEMI showed that PGC-1 alpha expression was increased and the level of induction correlated with the infarct size. Infarct size was determined by LGE-CMR (late gadolinium enhancement on cardiac magnetic resonance), used to estimate the percentage of necrotic area. Cardiac markers, maximum creatine kinase (CK-MB) and Troponin I (TnI) levels, left ventricular ejection function (LVEF) and regional wall motion abnormalities (RWMA) as determined by echocardiography were also used to monitor cardiac injury. We also found that PGC-1 alpha is present and active in mouse lymphocytes where its expression is induced upon activation and can be detected in the nuclear fraction of blood samples. These results support the notion that induction of PGC-1 alpha expression can be part of the recovery response to an STEMI and could serve as a prognosis factor of cardiac recovery.	[Fabregat-Andres, Oscar; Ridocci-Soriano, Francisco] Consorcio Hosp Gen Univ Valencia, Serv Cardiol, Valencia, Spain; [Tierrez, Alberto; Monsalve, Maria] Fdn Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Mata, Manuel] Fdn Hosp Gen Valencia, Valencia, Spain; [Estornell-Erill, Jordi] Consorcio Hosp Gen Univ Valencia, Unidad TAC & RMN, Valencia, Spain; [Monsalve, Maria] CSIC, Inst Invest Biol Alberto Sols, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC)	Fabregat-Andres, O (corresponding author), Consorcio Hosp Gen Univ Valencia, Serv Cardiol, Valencia, Spain.	mpmonsalve@iib.uam.es	Morcillo, Esteban/I-1552-2015; Roig, Manuel Mata/G-4338-2015; Monsalve, Maria/K-4416-2014	Morcillo, Esteban/0000-0003-4373-9457; Roig, Manuel Mata/0000-0002-1506-7983; Monsalve, Maria/0000-0003-2796-1453	Spanish Ministry of Science and Innovation [SAF2009-07599, CSD 2007-00020]; Juan de la Cierva postdoctoral; Fundacion Investigacion CHGUV; Spanish Cardiology Society; Pro-CNIC Foundation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva postdoctoral; Fundacion Investigacion CHGUV; Spanish Cardiology Society; Pro-CNIC Foundation	This work was supported by the Spanish Ministry of Science and Innovation (http://www.micinn.es/) (grants SAF2009-07599 and CSD 2007-00020 to M.M.); a Juan de la Cierva postdoctoral contract to A.T.; two Intramural grants ("Beca de investigacion Intramural"), years 2008 and 2010, from the Fundacion Investigacion CHGUV (http://chguv.san.gva.es/Inicio/Paginas/default.aspx); and a "Beca para Proyecto de Investigacion Basica en Cardiologia, 2010" grant from the Spanish Cardiology Society (http://www.secardiologia.es/). The Centro Nacional de Investigaciones Cardiovasculares (CNIC) (http://www.cnic.es/es/index.php) is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bodi V, 2008, AM HEART J, V156, P1065, DOI 10.1016/j.ahj.2008.07.008; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Ding L, 2007, CELL BIOL INT, V31, P1002, DOI 10.1016/j.cellbi.2007.03.013; Ferrer MD, 2009, J SPORT SCI, V27, P49, DOI 10.1080/02640410802409683; Garcia C, 2010, DIABETES METAB, V36, P327, DOI 10.1016/j.diabet.2010.07.001; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Honda T, 2008, J MOL CELL CARDIOL, V44, P915, DOI 10.1016/j.yjmcc.2008.03.004; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ortolani P, 2008, EUR HEART J, V29, P1241, DOI 10.1093/eurheartj/ehm338; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Rohini A, PHARM RES, V61, P269; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; Shohet RV, 2007, J MOL MED, V85, P1309, DOI 10.1007/s00109-007-0279-x; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Sun CK, 2007, INT HEART J, V48, P533, DOI 10.1536/ihj.48.533; Swedberg K, 2005, REV ESP CARDIOL, V58, P1062, DOI 10.1157/13078554; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Van de Werf F, 2009, REV ESP CARDIOL, V62, P293, DOI 10.1016/S1885-5857(09)71559-2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yasuda S, 2009, CIRC J, V73, P2000, DOI 10.1253/circj.CJ-09-0655; Yue TL, 2001, CIRCULATION, V104, P2588, DOI 10.1161/hc4601.099403	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26913	10.1371/journal.pone.0026913	http://dx.doi.org/10.1371/journal.pone.0026913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087236	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700011
J	Gilchrist, CL; Darling, EM; Chen, J; Setton, LA				Gilchrist, Christopher L.; Darling, Eric M.; Chen, Jun; Setton, Lori A.			Extracellular Matrix Ligand and Stiffness Modulate Immature Nucleus Pulposus Cell-Cell Interactions	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; MAMMARY EPITHELIAL-CELLS; PROTEIN GENE-EXPRESSION; BASEMENT-MEMBRANE; NOTOCHORDAL CELLS; VISCOELASTIC PROPERTIES; PROTEOGLYCAN SYNTHESIS; STEM-CELLS; SUBSTRATE; DEGENERATION	The nucleus pulposus (NP) of the intervertebral disc functions to provide compressive load support in the spine, and contains cells that play a critical role in the generation and maintenance of this tissue. The NP cell population undergoes significant morphological and phenotypic changes during maturation and aging, transitioning from large, vacuolated immature cells arranged in cell clusters to a sparse population of smaller, isolated chondrocyte-like cells. These morphological and organizational changes appear to correlate with the first signs of degenerative changes within the intervertebral disc. The extracellular matrix of the immature NP is a soft, gelatinous material containing multiple laminin isoforms, features that are unique to the NP relative to other regions of the disc and that change with aging and degeneration. Based on this knowledge, we hypothesized that a soft, laminin-rich extracellular matrix environment would promote NP cell-cell interactions and phenotypes similar to those found in immature NP tissues. NP cells were isolated from porcine intervertebral discs and cultured in matrix environments of varying mechanical stiffness that were functionalized with various matrix ligands; cellular responses to periods of culture were assessed using quantitative measures of cell organization and phenotype. Results show that soft (<720 Pa), laminin-containing extracellular matrix substrates promote NP cell morphologies, cell-cell interactions, and proteoglycan production in vitro, and that this behavior is dependent upon both extracellular matrix ligand and substrate mechanical properties. These findings indicate that NP cell organization and phenotype may be highly sensitive to their surrounding extracellular matrix environment.	[Gilchrist, Christopher L.; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Darling, Eric M.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Darling, Eric M.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA; [Darling, Eric M.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Chen, Jun; Setton, Lori A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA	Duke University; Brown University; Brown University; Brown University; Duke University	Gilchrist, CL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	lori.setton@duke.edu	Darling, Eric/K-2529-2013	Darling, Eric/0000-0002-3932-8623; Setton, Lori/0000-0001-5992-4206	National Intitutes of Health (NIH) [AR054673, R01EB002263, R01AR047442, R01AR057410]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054673, R01AR057410, R01AR047442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002263] Funding Source: NIH RePORTER	National Intitutes of Health (NIH); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Intitutes of Health (NIH) (AR054673 (Dr. Darling), R01EB002263, R01AR047442, and R01AR057410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1966, J CELL BIOL, V28, P473, DOI 10.1083/jcb.28.3.473; Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; BASELGA J, 1987, MACROMOLECULES, V20, P3060, DOI 10.1021/ma00178a020; BAYLISS MT, 1988, SPINE, V13, P972, DOI 10.1097/00007632-198809000-00003; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Cao L, 2007, J ANAT, V211, P444, DOI 10.1111/j.1469-7580.2007.00784.x; Cappello R, 2006, SPINE, V31, P873, DOI 10.1097/01.brs.0000209302.00820.fd; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; CLOYD JM, 2007, EUR SPINE J; COTTEN A, 1994, SURG RADIOL ANAT, V16, P53, DOI 10.1007/BF01627921; Darling EM, 2005, TISSUE ENG, V11, P395, DOI 10.1089/ten.2005.11.395; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd; Evans ND, 2009, EUR CELLS MATER, V18, P1; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; GOTO S, 1986, ACTA ORTHOP SCAND, V57, P85, DOI 10.3109/17453678608993224; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Gudjonsson T, 2002, J CELL SCI, V115, P39; Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hayes AJ, 1999, DEV DYNAM, V215, P179, DOI 10.1002/(SICI)1097-0177(199907)215:3<179::AID-AJA1>3.3.CO;2-H; Hertz H., 1881, REINE ANGEW MATH, V171, P156; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Hunter CJ, 2003, J ANAT, V202, P279, DOI 10.1046/j.1469-7580.2003.00162.x; Hunter CJ, 2003, TISSUE ENG, V9, P667, DOI 10.1089/107632703768247368; Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009; Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Korecki CL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt18; LEHTONEN E, 1995, DIFFERENTIATION, V59, P43, DOI 10.1046/j.1432-0436.1995.5910043.x; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x; Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; RUFAI A, 1995, ANAT EMBRYOL, V192, P53; Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	64	74	74	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27170	10.1371/journal.pone.0027170	http://dx.doi.org/10.1371/journal.pone.0027170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087260	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700024
J	Enayetallah, AE; Ziemek, D; Leininger, MT; Randhawa, R; Yang, JX; Manion, TB; Mather, DE; Zavadoski, WJ; Kuhn, M; Treadway, JL; Etages, SAGD; Gibbs, EM; Greene, N; Steppan, CM				Enayetallah, Ahmed E.; Ziemek, Daniel; Leininger, Michael T.; Randhawa, Ranjit; Yang, Jianxin; Manion, Tara B.; Mather, Dawn E.; Zavadoski, William J.; Kuhn, Max; Treadway, Judith L.; Etages, Shelly Ann G. des; Gibbs, E. Michael; Greene, Nigel; Steppan, Claire M.			Modeling the Mechanism of Action of a DGAT1 Inhibitor Using a Causal Reasoning Platform	PLOS ONE			English	Article							GENE-EXPRESSION; DIACYLGLYCEROL ACYLTRANSFERASE-1; LEPTIN SENSITIVITY; INSULIN-RESISTANCE; FAT DIET; MICE; OBESITY; OVEREXPRESSION; IDENTIFICATION; DYSLIPIDEMIA	Triglyceride accumulation is associated with obesity and type 2 diabetes. Genetic disruption of diacylglycerol acyltransferase 1 (DGAT1), which catalyzes the final reaction of triglyceride synthesis, confers dramatic resistance to high-fat diet induced obesity. Hence, DGAT1 is considered a potential therapeutic target for treating obesity and related metabolic disorders. However, the molecular events shaping the mechanism of action of DGAT1 pharmacological inhibition have not been fully explored yet. Here, we investigate the metabolic molecular mechanisms induced in response to pharmacological inhibition of DGAT1 using a recently developed computational systems biology approach, the Causal Reasoning Engine (CRE). The CRE algorithm utilizes microarray transcriptomic data and causal statements derived from the biomedical literature to infer upstream molecular events driving these transcriptional changes. The inferred upstream events (also called hypotheses) are aggregated into biological models using a set of analytical tools that allow for evaluation and integration of the hypotheses in context of their supporting evidence. In comparison to gene ontology enrichment analysis which pointed to high-level changes in metabolic processes, the CRE results provide detailed molecular hypotheses to explain the measured transcriptional changes. CRE analysis of gene expression changes in high fat habituated rats treated with a potent and selective DGAT1 inhibitor demonstrate that the majority of transcriptomic changes support a metabolic network indicative of reversal of high fat diet effects that includes a number of molecular hypotheses such as PPARG, HNF4A and SREBPs. Finally, the CRE-generated molecular hypotheses from DGAT1 inhibitor treated rats were found to capture the major molecular characteristics of DGAT1 deficient mice, supporting a phenotype of decreased lipid and increased insulin sensitivity.	[Enayetallah, Ahmed E.; Greene, Nigel] Pfizer Inc, Compound Safety Predict Grp, Groton, CT 06340 USA; [Ziemek, Daniel; Randhawa, Ranjit] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA USA; [Leininger, Michael T.; Yang, Jianxin; Manion, Tara B.; Mather, Dawn E.; Zavadoski, William J.; Kuhn, Max; Treadway, Judith L.; Etages, Shelly Ann G. des; Gibbs, E. Michael; Steppan, Claire M.] Pfizer Inc, Cardiovasc Metab & Endocrine Dis Res Unit, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Enayetallah, AE (corresponding author), Pfizer Inc, Compound Safety Predict Grp, Groton, CT 06340 USA.	Ahmed.Enayetallah@pfizer.com	yang, jian/HIK-0188-2022	Randhawa, Ranjit/0000-0003-1516-7674; Kuhn, Max/0000-0003-2402-136X	Pfizer Inc.	Pfizer Inc.(Pfizer)	The authors have read the journal's policy and have the following conflicts: The work has been funded by Pfizer Inc. as part of DGAT1 therapeutic targeting program and the authors are/were paid employee of the funder, Pfizer Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; [Anonymous], 2010, R LANG ENV STAT COMP; Archer KJ, 2006, BIOSTATISTICS, V7, P198, DOI 10.1093/biostatistics/kxj001; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Becker W, 2004, J MOL ENDOCRINOL, V32, P195, DOI 10.1677/jme.0.0320195; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen HC, 2002, ENDOCRINOLOGY, V143, P2893, DOI 10.1210/en.143.8.2893; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hsieh J, 2008, ATHEROSCLEROSIS SUPP, V9, P7, DOI 10.1016/j.atherosclerosissup.2008.05.011; Jain AK., 1988, TECHNOMETRICS; Jia YZ, 2003, J BIOL CHEM, V278, P47232, DOI 10.1074/jbc.M306363200; Kawakami A, 2009, J ATHEROSCLER THROMB, V16, P6, DOI 10.5551/jat.E607; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Pollard Jack Jr, 2005, Diabetes Technol Ther, V7, P323, DOI 10.1089/dia.2005.7.323; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Sayers E.W., NUCL ACIDS RES; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Vallejo SJH, 2009, AM J PHYSIOL-GASTR L, V296, pG782, DOI 10.1152/ajpgi.90324.2008; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; [No title captured]; [No title captured]; [No title captured]	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27009	10.1371/journal.pone.0027009	http://dx.doi.org/10.1371/journal.pone.0027009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073239	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200028
J	Pechnick, RN; Zonis, S; Wawrowsky, K; Cosgayon, R; Farrokhi, C; Lacayo, L; Chesnokova, V				Pechnick, Robert N.; Zonis, Svetlana; Wawrowsky, Kolja; Cosgayon, Rosemarie; Farrokhi, Catherine; Lacayo, Liliana; Chesnokova, Vera			Antidepressants Stimulate Hippocampal Neurogenesis by Inhibiting p21 Expression in the Subgranular Zone of the Hipppocampus	PLOS ONE			English	Article							NEURAL STEM-CELLS; FORCED SWIMMING TEST; ANIMAL-MODEL; SYNAPTIC PLASTICITY; DENTATE GYRUS; FACTOR LIF; ADULT; DEPRESSION; APOPTOSIS; RAT	The relationships among hippocampal neurogenesis, depression and the mechanism of action of antidepressant drugs have generated a considerable amount of controversy. The cyclin-dependent kinase (Cdk) inhibitor p21(Cip1) (p21) plays a crucial role in restraining cellular proliferation and maintaining cellular quiescence. Using in vivo and in vitro approaches the present study shows that p21 is expressed in the subgranular zone of the dentate gyrus of the hippocampus in early neuronal progenitors and in immature neurons, but not in mature neurons or astroglia. In vitro, proliferation is higher in neuronal progenitor cells derived from p2-/- mice compared to cells derived from wild-type mice. Proliferation is increased in neuronal progenitor cells after suppression of p21 using lentivirus expressing short hairpin RNA against p21. In vivo, chronic treatment with the non-selective antidepressant imipramine as well as the norepinephrine-selective reuptake inhibitor desipramine or the serotonin-selective reuptake inhibitor fluoxetine all decrease p21 expression, and this was associated with increased neurogenesis. Chronic antidepressant treatment did not affect the expression of other Cdk inhibitors. Untreated p2-/- mice exhibit a higher degree of baseline neurogenesis and decreased immobility in the forced swim test. Although chronic imipramine treatment increased neurogenesis and reduced immobility in the forced swim test in wild-type mice, it reduced neurogenesis and increased immobility in p21/- mice. These results demonstrate the unique role of p21 in the control of neurogenesis, and support the hypothesis that different classes of reuptake inhibitor-type antidepressant drugs all stimulate hippocampal neurogenesis by inhibiting p21 expression.	[Pechnick, Robert N.; Farrokhi, Catherine; Lacayo, Liliana] Cedars Sinai Med Ctr, Dept Psychiat & Behav Neurosci, Los Angeles, CA 90048 USA; [Zonis, Svetlana; Wawrowsky, Kolja; Cosgayon, Rosemarie; Chesnokova, Vera] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol, Los Angeles, CA 90048 USA; [Pechnick, Robert N.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Pechnick, RN (corresponding author), Cedars Sinai Med Ctr, Dept Psychiat & Behav Neurosci, Los Angeles, CA 90048 USA.	chesnokovav@cshs.org	Chesnokova, Vera/AAI-4168-2020		National Institutes of Health [MH079988]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH079988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant MH079988 and NARSAD Independent Investigator Award (to V. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Benmansour S, 1999, J NEUROSCI, V19, P10494; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; CHESNOKOVA V, 2005, PITUITARY, V19, P2371; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dou Q. Ping, 1998, Frontiers in Bioscience, V3, pD419; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Frazer A, 2002, MOL PSYCHIATR, V7, pS23, DOI 10.1038/sj.mp.4001015; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gartel A L, 1998, Prog Mol Subcell Biol, V20, P43; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Krampert M, 2010, MOL CELL BIOL, V30, P3685, DOI 10.1128/MCB.00434-09; LI P, 2004, CELL, V116, P57; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Lucki I, 2001, PSYCHOPHARMACOLOGY, V153, P395, DOI 10.1007/s002130000561; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pechnick RN, 2006, PSYCHOPHARMACOLOGY, V185, P76, DOI 10.1007/s00213-005-0258-2; Pechnick RN, 2004, NEUROPSYCHOPHARMACOL, V29, P770, DOI 10.1038/sj.npp.1300402; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Piccotti JR, 2005, DRUG CHEM TOXICOL, V28, P117, DOI 10.1081/DCT-200039743; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Xia ZL, 1999, J BIOCHEM MOL TOXIC, V13, P338, DOI 10.1002/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.3.CO;2-Z; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	45	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27290	10.1371/journal.pone.0027290	http://dx.doi.org/10.1371/journal.pone.0027290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076148	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200062
J	Adam, E; Hussong, A; Bindics, J; Wust, F; Viczian, A; Essing, M; Medzihradszky, M; Kircher, S; Schafer, E; Nagy, F				Adam, Eva; Hussong, Andrea; Bindics, Janos; Wuest, Florian; Viczian, Andras; Essing, Marcus; Medzihradszky, Matyas; Kircher, Stefan; Schaefer, Eberhard; Nagy, Ferenc			Altered Dark- and Photoconversion of Phytochrome B Mediate Extreme Light Sensitivity and Loss of Photoreversibility of the phyB-401 Mutant	PLOS ONE			English	Article							PLANT PHOTORECEPTORS PHYTOCHROME; ARABIDOPSIS PHYTOCHROMES; DISTINCT FUNCTIONS; EID1; ELONGATION; DEPENDENCE; DYNAMICS; QUALITY; DOMAIN; GENE	The phyB-401 mutant is 10(3) fold more sensitive to red light than its wild-type analogue and shows loss of photoreversibility of hypocotyl growth inhibition. The phyB-401 photoreceptor displays normal spectral properties and shows almost no dark reversion when expressed in yeast cells. To gain insight into the molecular mechanism underlying this complex phenotype, we generated transgenic lines expressing the mutant and wild-type phyB in phyB-9 background. Analysis of these transgenic lines demonstrated that the mutant photoreceptor displays a reduced rate of dark-reversion but normal P-fr to P-r photoconversion in vivo and shows an altered pattern of association/dissociation with nuclear bodies compared to wild-type phyB. In addition we show (i) an enhanced responsiveness to far-red light for hypocotyl growth inhibition and CAB2 expression and (ii) that far-red light mediated photoreversibility of red light induced responses, including inhibition of hypocotyl growth, formation of nuclear bodies and induction of CAB2 expression is reduced in these transgenic lines. We hypothesize that the incomplete photoreversibility of signalling is due to the fact that far-red light induced photoconversion of the chromophore is at least partially uncoupled from the P-fr to P-r conformation change of the protein. It follows that the phyB-401 photoreceptor retains a P-fr-like structure (P-r*) for a few hours after the far-red light treatment. The greatly reduced rate of dark reversion and the formation of a biologically active P-r* conformer satisfactorily explain the complex phenotype of the phyB-401 mutant and suggest that amino acid residues surrounding the position 564 G play an important role in fine-tuning phyB signalling.	[Adam, Eva; Viczian, Andras; Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Hussong, Andrea; Bindics, Janos; Wuest, Florian; Essing, Marcus; Medzihradszky, Matyas; Kircher, Stefan; Schaefer, Eberhard] Univ Freiburg, Inst Biol Bot 2, Freiburg, Germany; [Schaefer, Eberhard] Univ Freiburg, Ctr Biol Signalling BIOSS, Freiburg, Germany; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Freiburg; University of Freiburg; University of Edinburgh	Adam, E (corresponding author), Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary.	nagyf@brc.hu	Viczián, András/D-3118-2015; Nagy, Ferenc/D-3532-2015	Viczián, András/0000-0003-2055-3430; Nagy, Ferenc/0000-0002-6157-9269; Kircher, Stefan/0000-0002-8351-567X; Wust, Florian/0000-0002-9941-5550	DFG [SFB592]; FRSYS; BIOSS; OTKA [81399]; SULSA	DFG(German Research Foundation (DFG)); FRSYS; BIOSS; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); SULSA	Work in Freiburg was supported by a grant of the DFG (SFB592) to ES, FN, and SK; and a grant from FRSYS and BIOSS to ES. Work in Szeged was supported by a grant from OTKA (81399) to FN, and work in Edinburgh was supported by a SULSA professorial grant to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Beggs CJ, 1994, PHOTOMORPHOGENESIS P, P733; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Buche C, 2000, PLANT CELL, V12, P547, DOI 10.1105/tpc.12.4.547; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Eichenberg K, 2000, PLANT CELL ENVIRON, V23, P311, DOI 10.1046/j.1365-3040.2000.00550.x; Eichenberg K, 1999, J BIOL CHEM, V274, P354, DOI 10.1074/jbc.274.1.354; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Furuya M, 1996, TRENDS PLANT SCI, V1, P301; Gross J, 1984, TECHNIQUES PHOTOMORP, P131; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hennig L, 1999, PLANTA, V208, P257, DOI 10.1007/s004250050557; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Hirschfeld M, 1998, GENETICS, V149, P523; Hu W, 2009, MOL PLANT, V2, P166, DOI 10.1093/mp/ssn086; JABBEN M, 1982, PHOTOCHEM PHOTOBIOL, V35, P709, DOI 10.1111/j.1751-1097.1982.tb02634.x; Khanna R, 2007, PLANT CELL, V19, P3915, DOI 10.1105/tpc.107.051508; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kretsch T, 2000, PLANT J, V22, P177, DOI 10.1046/j.1365-313x.2000.00715.x; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Livak KJ, 1997, USER B, P11; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Oka Y, 2004, PLANT CELL, V16, P2104, DOI 10.1105/tpc.104.022350; Oka Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000158; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rausenberger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010721; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; SCHAFER E, 1974, PLANTA, V116, P257, DOI 10.1007/BF00390231; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Zhou YC, 2002, PLANT PHYSIOL, V128, P1098, DOI 10.1104/pp.010811	43	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27250	10.1371/journal.pone.0027250	http://dx.doi.org/10.1371/journal.pone.0027250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073299	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000037
J	Matzdorff, AC; Arnold, G; Salama, A; Ostermann, H; Eberle, S; Hummler, S				Matzdorff, Axel C.; Arnold, Gabriele; Salama, Abdulgabar; Ostermann, Helmut; Eberle, Sonja; Hummler, Simone			Advances in ITP - Therapy and Quality of Life - A Patient Survey	PLOS ONE			English	Article							IMMUNE-THROMBOCYTOPENIC-PURPURA; NATURAL-HISTORY; DOUBLE-BLIND; ADULTS; SPLENECTOMY; MANAGEMENT; PREVALENCE; HEMORRHAGE; EFFICACY; CHILDREN	Background: Current guidelines recommend glucocorticoids and splenectomy as standard 1(st) and 2(nd) line treatments for chronic immune thrombocytopenia (ITP). We sought to find out how German ITP-patients are treated with respect to these guidelines. Methods: Members of a patient support association >= 18 years with a self-reported history of chronic ITP. 12 months were surveyed with a web-based questionnaire. Results: 122 questionnaires were evaluated. 70% of patients had chronic ITP for more than 5 years and 20% an average platelet count of <= 30.10(9)/L. 41% of the patients reported haematomas or petechiae more than once or twice and up to 12 times or more per year and 17% oropharyngeal and nasal bleeds. 11% had been admitted to hospital during the last 12 months. 88% had received or currently receive glucocorticoids, 27% were splenectomised. IVIG had been given to 55%, rituximab to 22%, anti-D to 12%, ciclosporin to 7%, while complementary and alternative medical treatments had been used by 36%. 50 women responded to questions concerning pregnancy. 14 (28%) had been advised not to become pregnant. 23 reported pregnancies and 10 (44%) required treatment for their ITP during pregnancy. Conclusion: Glucocorticoids are the most common therapy for chronic ITP but complementary and alternative treatments already come second and less than M of patients are splenectomised. This and the frequent use of complementary medicines suggests patients' dissatisfaction with conventional approaches. Many patients receive off-label therapies. There is a major need for adequate counselling and care for pregnant ITP-patients.	[Matzdorff, Axel C.] Caritasklin St Theresia, Dept Haematol, Saarbrucken, Germany; [Arnold, Gabriele] ITP Self Support Grp, Giessen, Germany; [Salama, Abdulgabar] Charite Univ Med Berlin, Inst Transfus Med, Berlin, Germany; [Ostermann, Helmut] Univ Munich Grosshadern Campus, Dept Haematol, Munich, Germany; [Eberle, Sonja] GlaxoSmithKline, Dept Biostat & Epidemiol, Munich, Germany; [Hummler, Simone] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Hummler, Simone] German Canc Res Ctr, D-6900 Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; GlaxoSmithKline; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Matzdorff, AC (corresponding author), Caritasklin St Theresia, Dept Haematol, Saarbrucken, Germany.	a.matzdorff@caritasklinik.de			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The set up of the web-based questionnaire was funded by GlaxoSmithKline (the content of the questionnaire was based on clinical literature, expert opinion and patients' experience). Sonja Eberle (employee at GlaxoSmithKline) was involved in the data analysis process. No other external funding was received.	ALEDORT LML, 2006, BLOOD, V108; BAILI LKM, 2009, BLOOD, V114; Berti D, 2008, CLIN THER, V30, P1540, DOI 10.1016/j.clinthera.2008.08.005; Buchanan GR, 2002, J PEDIATR-US, V141, P683, DOI 10.1067/mpd.2002.128547; Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Cohen YC, 2000, ARCH INTERN MED, V160, P1630, DOI 10.1001/archinte.160.11.1630; Djulbegovic B, 2001, BLOOD, V98, P2282, DOI 10.1182/blood.V98.7.2282; Feudjo-Tepie MA, 2008, J THROMB HAEMOST, V6, P711, DOI 10.1111/j.1538-7836.2008.02911.x; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; LACEY JV, 1977, SEMIN THROMB HEMOST, V3, P160; Love N, 2009, J CLIN ONCOL, V27; Mathias SD, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-13; Matzdorff A, 2007, EUR J HAEMATOL, V78, P381, DOI 10.1111/j.1600-0609.2007.00829.x; Matzdorff A, 2010, ONKOLOGIE, V33, P2, DOI 10.1159/000290758; McMillan R, 2004, BLOOD, V104, P956, DOI 10.1182/blood-2003-11-3908; Neunert CE, 2008, BLOOD, V112, P4003, DOI 10.1182/blood-2008-03-138487; Neylon AJ, 2003, BRIT J HAEMATOL, V122, P966, DOI 10.1046/j.1365-2141.2003.04547.x; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Psaila B, 2009, BLOOD, V114, P4777, DOI 10.1182/blood-2009-04-215525; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; Snyder CF, 2008, CURR MED RES OPIN, V24, P2767, DOI 10.1185/03007990802377461 ; STASI R, 1995, AM J MED, V98, P436, DOI 10.1016/S0002-9343(99)80342-8; Tarantino MD, 2010, CURR MED RES OPIN, V26, P319, DOI 10.1185/03007990903451298; Vesely SK, 2004, ANN INTERN MED, V140, P112, DOI 10.7326/0003-4819-140-3-200402030-00012	30	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27350	10.1371/journal.pone.0027350	http://dx.doi.org/10.1371/journal.pone.0027350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096556	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900034
J	Zhang, R; Zheng, LQ; Sun, ZQ; Zhang, XG; Li, J; Hu, DY; Sun, YX				Zhang, Rui; Zheng, Liqiang; Sun, Zhaoqing; Zhang, Xingang; Li, Jue; Hu, Dayi; Sun, Yingxian			Decreased Glomerular Filtration Rate Is Associated with Mortality and Cardiovascular Events in Patients with Hypertension: A Prospective Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; RISK-FACTOR; RENAL-INSUFFICIENCY; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; DYSFUNCTION; DEATH; ALBUMINURIA; POPULATION	Background: Few studies reported the associations between decreased glomerular filtration rate (GFR) and mortality, coronary heart disease (CHD), and stroke in hypertensive patients. We aim to assess the associations between GFR and mortality, CHD, and stroke in hypertensive patients and to evaluate whether low GFR can improve the prediction of these outcomes in addition to conventional cardiovascular risk factors. Methods and Findings: This is an observational prospective study and 3,711 eligible hypertensive patients aged >= 5 years from rural areas of China were used for the present analysis. The associations between eGFR and outcomes, followed by a median of 4.9 years, were evaluated using Cox proportional hazards models adjusting for other potential confounders. Low eGFR was independently associated with risk of all-cause mortality, cardiovascular mortality, and incident stroke [multivariable adjusted hazard ratios (95% confidence intervals) for eGFR,60 ml/min/1.73 m(2) relative to eGFR >= 90 ml/min/1.73 m(2) were 1.824 (1.047-3.365), 2.371 (1.109-5.068), and 2.493 (1.193-5.212), respectively]. We found no independent association between eGFR and the risk of CHD. For 4-year all-cause and cardiovascular mortality, integrated discrimination improvement (IDI) was positive when eGFR were added to traditional risk factors (1.51%, P = 0.016, and 1.99%, P = 0.017, respectively). For stroke and CHD events, net reclassification improvements (NRI) were 5.9% (P = 0.012) and 1.8% (P = 0.083) for eGFR, respectively. Conclusions: We have established an inversely independent association between eGFR and all-cause mortality, cardiovascular mortality, and stroke in hypertensive patients in rural areas of China. Further, addition of eGFR significantly improved the prediction of 4-year mortality and stroke over and above that of conventional risk factors. We recommend that eGFR be incorporated into prognostic assessment for patients with hypertension in rural areas of China. Limitations: We did not have sufficient information on atrial fibrillation to control for the potential covariate. These associations should be further confirmed in future.	[Zhang, Rui] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zheng, Liqiang] China Med Univ, Shengjing Hosp, Library, Shenyang, Peoples R China; [Sun, Zhaoqing] China Med Univ, Shengjing Hosp, Dept Cardiol, Shenyang, Peoples R China; [Zhang, Xingang; Sun, Yingxian] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Shenyang, Peoples R China; [Li, Jue; Hu, Dayi] Tongji Univ, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China	Peking University; China Medical University; China Medical University; China Medical University; Tongji University	Sun, YX (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Cardiol, 155 Nanjing N St, Shenyang 110001, Peoples R China.	sunyingxian12@yahoo.com.cn			Key Technology Research and Development Program of Liaoning Province [2003225003]	Key Technology Research and Development Program of Liaoning Province	This study was supported by grants from the Key Technology Research and Development Program of Liaoning Province (2003225003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax L, 2008, ATHEROSCLEROSIS, V200, P184, DOI 10.1016/j.atherosclerosis.2007.12.006; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Bouchi R, 2010, HYPERTENS RES, V33, P1298, DOI 10.1038/hr.2010.170; Bouchi R, 2009, HYPERTENS RES, V32, P381, DOI 10.1038/hr.2009.30; Brugts JJ, 2005, ARCH INTERN MED, V165, P2659, DOI 10.1001/archinte.165.22.2659; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; *DEP HLTH HUM SERV, 1989, INT CLASS DIS CLIN M; Ford I, 2009, PLOS MED, V6, P76, DOI 10.1371/journal.pmed.1000016; Fox CS, 2004, KIDNEY INT, V66, P2017, DOI 10.1111/j.1523-1755.2004.00973.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; McCullough PA, 2000, J AM COLL CARDIOL, V36, P679, DOI 10.1016/S0735-1097(00)00774-9; *NAT I ALC AB ALC, 2000, 10 SPEC REP US C ALC, V24, P5; Ovbiagele B, 2008, ARCH NEUROL-CHICAGO, V65, P934, DOI 10.1001/archneur.65.7.934; Rahman M, 2006, ANN INTERN MED, V144, P172, DOI 10.7326/0003-4819-144-3-200602070-00005; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; Viazzi F, 2010, J HYPERTENS, V28, P848, DOI 10.1097/HJH.0b013e328336ed09; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007; Zheng LQ, 2008, STROKE, V39, P1932, DOI 10.1161/STROKEAHA.107.510677	30	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27359	10.1371/journal.pone.0027359	http://dx.doi.org/10.1371/journal.pone.0027359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096561	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900037
J	Geng, W; Ng, KTP; Sun, CKW; Yau, WL; Liu, XB; Cheng, Q; Poon, RTP; Lo, CM; Man, K; Fan, ST				Geng, Wei; Ng, Kevin T. P.; Sun, Chris K. W.; Yau, Wing Lung; Liu, Xiao Bing; Cheng, Qiao; Poon, Ronnie T. P.; Lo, Chung Mau; Man, Kwan; Fan, Sheung Tat			The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; BREAST-CANCER CELL; LUNG-CANCER; TARGETED THERAPY; PROSTATE-CANCER; GROWTH-FACTOR; CHEMOTHERAPY; EXPRESSION; PATHWAY; PROLIFERATION	Aims: We previously demonstrated Proline rich tyrosine kinase 2 (Pyk2) plays important roles in regulating tumor progression, migration and invasion in hepatocellular carcinoma (HCC). In this study, we aimed to examine the role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in HCC and to explore its underlying molecular mechanism. Methodology/Principal Findings: Stable transfectants either overexpressing or suppressing Pyk2 were established in different HCC cell lines. MTT, colony formation and Annexin-V assays were employed to examine their in vitro responses to cisplatin. Xenograft ectopic and orthotopic nude mice models were generated to investigate the in vivo responses of them to cisplatin treatment. cDNA microarray was performed to identify Pyk2-induced genes which were further validated by quantitative real-time RT-PCR using clinical HCC samples. In vitro functional study demonstrated that Pyk2-overexpressing HCC transfectants exhibited relatively lower cytotoxicity, higher colony-forming ability and lower apoptosis to cisplatin compared with the control transfectants. Moreover, Pyk2 overexpressing HCC transfectants had a higher survival rate under cisplatin treatment by up-regulation of AKT phosphorylation. In vivo xenograft nude mice model demonstrated that Pyk2-overexpressing transfectants developed higher tolerance to cisplatin treatment together with less tumor necrosis and apoptosis. cDNA microarray analysis revealed that there were more than 4,000 genes differentially expressed upon overexpression of Pyk2. Several upregulated genes were found to be involved in drug resistance and invasion in cancers. Among them, the expression profiles of MDR1, GAGE1, STAT1 and MAP7 were significantly associated with the expression of Pyk2 in clinical HCC samples. Conclusions: Our results may suggest a new evidence of Pyk2 on promoting cisplatin resistance of HCC cells through preventing cell apoptosis, activation of AKT pathway and upregulation of drug resistant genes.	[Geng, Wei; Ng, Kevin T. P.; Sun, Chris K. W.; Yau, Wing Lung; Liu, Xiao Bing; Cheng, Qiao; Poon, Ronnie T. P.; Lo, Chung Mau; Man, Kwan; Fan, Sheung Tat] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Geng, W (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	kwanman@hkucc.hku.hk	NG, Kevin Tak-Pan/J-1510-2018	NG, Kevin Tak-Pan/0000-0001-9822-1335	Research Grant Council Hong Kong [7574/06M, HKU5/CRF/08]	Research Grant Council Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (7574/06M) and Collaborative Research Fund (HKU5/CRF/08) of the Research Grant Council Hong Kong. http://www.ugc.edu.hk/eng/ugc/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, MOL MECH HEPATOCELLU; Asechi H, 2010, INT J ONCOL, V37, P89, DOI 10.3892/ijo_00000656; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bagi CM, 2009, CANCER BIOL THER, V8, P856, DOI 10.4161/cbt.8.9.8246; Behmoaram E, 2008, AM J PATHOL, V173, P1540, DOI 10.2353/ajpath.2008.080292; Chou YY, 1997, J GASTROEN HEPATOL, V12, P569, DOI 10.1111/j.1440-1746.1997.tb00487.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503, DOI 10.14670/HH-24.503; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Inamura K, 2005, BBA-MOL CELL RES, V1745, P401, DOI 10.1016/j.bbamcr.2005.06.003; JANIK P, 1975, CANCER RES, V35, P3698; Johnson-Holiday C, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-46; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Kasuga C, 2008, J NEUROS-PEDIATR, V1, P305, DOI 10.3171/PED/2008/1/4/305; Kawano Y, 2009, EJSO-EUR J SURG ONC, V35, P174, DOI 10.1016/j.ejso.2008.01.027; Kerr SH, 2009, CANCER LETT, V286, P114, DOI 10.1016/j.canlet.2009.07.001; Langer R, 2004, VERH DEUT G, V88, P207; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luo Guorong, 2002, Cancer Immun, V2, P11; Man K, 2005, AM J TRANSPLANT, V5, P40, DOI 10.1111/j.1600-6143.2004.00642.x; Man K, 2010, ANN SURG, V251, P1154, DOI 10.1097/SLA.0b013e3181d96e3d; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Minemura M, 1999, INT J ONCOL, V15, P559; Okusaka Takuji, 2004, Gan To Kagaku Ryoho, V31, P2122; Pan JH, 2009, RESPIRATION, V78, P49, DOI 10.1159/000158454; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Picascia A, 2002, MOL CELL ENDOCRINOL, V186, P81, DOI 10.1016/S0303-7207(01)00667-0; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Shen X, 2010, CELL MOL LIFE SCI; Shiraga K, 2001, J GASTROEN HEPATOL, V16, P460, DOI 10.1046/j.1440-1746.2001.02457.x; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spangenberg HC, 2009, TARGETED THERAPY HEP; Stanzione R, 2001, LAB INVEST, V81, P51, DOI 10.1038/labinvest.3780211; Sun CK, 2007, BRIT J CANCER, V97, P50, DOI 10.1038/sj.bjc.6603827; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Sun CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018878; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Tsurutani J, 2005, CANCER RES, V65, P8423, DOI 10.1158/0008-5472.CAN-05-0058; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yau T, 2009, LIVER INT, V29, P10, DOI 10.1111/j.1478-3231.2008.01916.x; Zhang SY, 2008, LUNG CANCER, V62, P295, DOI 10.1016/j.lungcan.2008.05.008; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422	50	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27362	10.1371/journal.pone.0027362	http://dx.doi.org/10.1371/journal.pone.0027362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096562	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800049
J	Gilbert, RS; Kobayashi, R; Sekine, S; Fujihashi, K				Gilbert, Rebekah S.; Kobayashi, Ryoki; Sekine, Shinichi; Fujihashi, Kohtaro			Functional Transforming Growth Factor-beta Receptor Type II Expression by CD4(+) T Cells in Peyer's Patches Is Essential for Oral Tolerance Induction	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TGF-BETA; IMMUNE-RESPONSES; FOXP3 EXPRESSION; FOOD ALLERGY; CUTTING EDGE; ABSENCE; SUPPRESSION; MICE	Our previous studies have shown that Peyer's patches (PPs) play a key role in the induction of oral tolerance. Therefore, we hypothesized that PPs are an important site for Transforming Growth Factor (TGF)- beta signaling and sought to prove that this tissue is of importance in oral tolerance induction. We found that expression of TGF-beta type II receptor (TGF beta RII) by CD4(+) T cells increases and persists in the PPs of normal C57BL/6 mice after either high- or low-dose feeding of OVA when compared to mesenteric lymph nodes (MLNs) and spleen. Approximately one-third of these TGF beta RII+ CD4(+) T cells express the transcription factor Foxp3. Interestingly, the number of TGF beta RII+ CD4(+) T cells in PPs decreased when OVA-fed mice were orally challenged with OVA plus native cholera toxin (CT). In contrast, numbers of TGF beta RII+ CD4(+) T cells were increased in the intestinal lamina propria (iLP) of these challenged mice. Further, these PP CD4(+) TGF beta RII+ T cells upregulated Foxp3 within 2 hours after OVA plus CT challenge. Mice fed PBS and challenged with OVA plus CT did not reveal any changes in TGFbRII expression by CD4(+) T cells. In order to test the functional property of TGF beta RII in the induction of oral tolerance, CD4dnTGF beta RII transgenic mice, in which TGF beta RII signaling is abrogated from all CD4(+) T cells, were employed. Importantly, these mice could not develop oral tolerance to OVA. Our studies show a critical, dose-independent, role for TGF beta RII expression and function by CD4(+) T cells in the gut-associated lymphoid tissues, further underlining the vital role of PPs in oral tolerance.	[Gilbert, Rebekah S.; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA; [Kobayashi, Ryoki; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Pediat Dent, Immunobiol Vaccine Ctr, Birmingham, AL USA; [Sekine, Shinichi] Osaka Univ, Dept Prevent Dent, Suita, Osaka, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Osaka University	Gilbert, RS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA.	kohtarof@uab.edu		Kobayashi, Ryoki/0000-0002-7909-8981	U.S. Public Health Service [DE012242, AG 025873]; DART (Dental Academic Research Training) [T35 DE0176707]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012242, R29DE012242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025873] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); DART (Dental Academic Research Training); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by U.S. Public Health Service Grants DE012242 and AG 025873 as well as DART (Dental Academic Research Training) grant no T35 DE0176707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2010, J CLIN GASTROENTEROL, V44, P391, DOI 10.1097/MCG.0b013e3181d7760b; Amendt C, 1998, ONCOGENE, V17, P25, DOI 10.1038/sj.onc.1202161; Barron L, 2008, J IMMUNOL, V180, P2762, DOI 10.4049/jimmunol.180.5.2762; Bottinger EP, 1997, CANCER RES, V57, P5564; Broere F, 2009, MUCOSAL IMMUNOL, V2, P254, DOI 10.1038/mi.2009.2; Burks AW, 2008, J ALLERGY CLIN IMMUN, V121, P1344, DOI 10.1016/j.jaci.2008.02.037; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; du Pre MF, 2011, ALLERGY, V66, P478, DOI 10.1111/j.1398-9995.2010.02519.x; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Fujihashi K, 1999, INT IMMUNOL, V11, P1907, DOI 10.1093/intimm/11.12.1907; Fujihashi K, 1996, J EXP MED, V183, P1929, DOI 10.1084/jem.183.4.1929; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Fujihashi K, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P539, DOI 10.1016/B978-012491543-5/50032-2; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hauet-Broere F, 2003, EUR J IMMUNOL, V33, P2801, DOI 10.1002/eji.200324115; Huang XP, 2005, J IMMUNOL, V175, P4283, DOI 10.4049/jimmunol.175.7.4283; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kweon MN, 1998, J IMMUNOL, V160, P1687; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Maeda Y, 2001, IMMUNOBIOLOGY, V204, P442, DOI 10.1078/0171-2985-00054; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mestecky J, 2003, FUNDAMENTAL IMMUNOLO, P965; Mowat AM, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P487, DOI 10.1016/B978-012491543-5/50031-0; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Shiokawa A, 2009, IMMUNOL LETT, V125, P7, DOI 10.1016/j.imlet.2009.05.002; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P43, DOI [10.1016/j.jaci.2008.09.051, 10.1016/j.jaci.2008.12.1128]; Smith KM, 2000, AM J RESP CRIT CARE, V162, pS175, DOI 10.1164/ajrccm.162.supplement_3.15tac7; Song F, 2008, J AUTOIMMUN, V30, P230, DOI 10.1016/j.jaut.2007.10.002; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Spahn TW, 2001, EUR J IMMUNOL, V31, P1278, DOI 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Strober W, 2008, MUCOSAL IMMUNOL, V1, P92, DOI 10.1038/mi.2007.22; Strober W, 1998, J CLIN IMMUNOL, V18, P1, DOI 10.1023/A:1023222003039; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsuji NM, 2003, INT IMMUNOL, V15, P525, DOI 10.1093/intimm/dxg051; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Walton KLW, 2006, CLIN EXP IMMUNOL, V143, P503, DOI 10.1111/j.1365-2249.2006.03019.x; Wardrop RM, 1999, INFLAMM RES, V48, P106; WHITACRE CC, 1991, J IMMUNOL, V147, P2155; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	51	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27501	10.1371/journal.pone.0027501	http://dx.doi.org/10.1371/journal.pone.0027501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087328	Green Submitted, gold, Green Published			2022-12-27	WOS:000297347700060
J	Henriksen, K; Flores, C; Thomsen, JS; Bruel, AM; Thudium, CS; Neutzsky-Wulff, AV; Langenbach, GEJ; Sims, N; Askmyr, M; Martin, TJ; Everts, V; Karsdal, MA; Richter, J				Henriksen, Kim; Flores, Carmen; Thomsen, Jesper S.; Bruel, Anne-Marie; Thudium, Christian S.; Neutzsky-Wulff, Anita V.; Langenbach, Geerling E. J.; Sims, Natalie; Askmyr, Maria; Martin, Thomas J.; Everts, Vincent; Karsdal, Morten A.; Richter, Johan			Dissociation of Bone Resorption and Bone Formation in Adult Mice with a Non-Functional V-ATPase in Osteoclasts Leads to Increased Bone Strength	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; RESISTANT ACID-PHOSPHATASE; PARATHYROID-HORMONE; ANABOLIC ACTIONS; STRUCTURAL BASIS; GENE; CELLS; PHENOTYPE; GROWTH; ACIDIFICATION	Osteopetrosis caused by defective acid secretion by the osteoclast, is characterized by defective bone resorption, increased osteoclast numbers, while bone formation is normal or increased. In contrast the bones are of poor quality, despite this uncoupling of formation from resorption. To shed light on the effect of uncoupling in adult mice with respect to bone strength, we transplanted irradiated three-month old normal mice with hematopoietic stem cells from control or oc/oc mice, which have defective acid secretion, and followed them for 12 to 28 weeks. Engraftment levels were assessed by flow cytometry of peripheral blood. Serum samples were collected every six weeks for measurement of bone turnover markers. At termination bones were collected for mu CT and mechanical testing. An engraftment level of 98% was obtained. From week 6 until termination bone resorption was significantly reduced, while the osteoclast number was increased when comparing oc/oc to controls. Bone formation was elevated at week 6, normalized at week 12, and reduced onwards. mu CT and mechanical analyses of femurs and vertebrae showed increased bone volume and bone strength of cortical and trabecular bone. In conclusion, these data show that attenuation of acid secretion in adult mice leads to uncoupling and improves bone strength.	[Henriksen, Kim; Thudium, Christian S.; Neutzsky-Wulff, Anita V.; Karsdal, Morten A.] Nord Biosci AS, Herlev, Denmark; [Flores, Carmen; Askmyr, Maria; Richter, Johan] Lund Univ, Lund, Sweden; [Thomsen, Jesper S.; Bruel, Anne-Marie] Univ Aarhus, Inst Anat, Aarhus, Denmark; [Langenbach, Geerling E. J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Funct Anat, Amsterdam, Netherlands; [Langenbach, Geerling E. J.; Everts, Vincent] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands; [Sims, Natalie; Martin, Thomas J.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Everts, Vincent] Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands	Nordic Bioscience; Lund University; Aarhus University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; St. Vincent's Institute of Medical Research; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Henriksen, K (corresponding author), Nord Biosci AS, Herlev, Denmark.	kh@nordicbioscience.com	Sims, Natalie Ann/A-7192-2012; Bruel, Annemarie/AAT-2310-2020	Sims, Natalie Ann/0000-0003-1421-8468; Karsdal, Morten/0000-0001-5026-8740; Bruel, Annemarie/0000-0003-4833-0888; Flores Bjurstrom, Carmen/0000-0002-8673-9142; Neutzsky-Wulff, Anita Vibsig/0000-0002-0577-3374; Thomsen, Jesper Skovhus/0000-0001-9386-6679	Nordforsk; Danish Research Foundation; European Calcified Tissue Society; Swedish Childhood Cancer Foundation; Lund University Hospital; Magnus Bergvalls Foundation; Georg Danielsson Foundation; Foundations of Lund University Hospital; Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research	Nordforsk; Danish Research Foundation; European Calcified Tissue Society; Swedish Childhood Cancer Foundation(European Commission); Lund University Hospital; Magnus Bergvalls Foundation; Georg Danielsson Foundation; Foundations of Lund University Hospital; Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research	CST received funding from Nordforsk, AVNW received funding from the Danish Research Foundation, CF is supported by a PhD fellowship from European Calcified Tissue Society. JR was supported by grants from The Swedish Childhood Cancer Foundation, a Clinical Research Award from Lund University Hospital, Magnus Bergvalls Foundation, the Georg Danielsson Foundation and The Foundations of Lund University Hospital. The Lund Stem Cell Center is supported by a Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo SL, 2004, CLIN CHEM, V50, P883, DOI 10.1373/clinchem.2003.029355; Askmyr M, 2009, EXP HEMATOL, V37, P302, DOI 10.1016/j.exphem.2008.10.010; Blin-Wakkach C, 2004, LEUKEMIA, V18, P1505, DOI 10.1038/sj.leu.2403449; BOLLERSLEV J, 1993, BONE, V14, P865, DOI 10.1016/8756-3282(93)90316-3; BOLLERSLEV J, 1989, ENDOCR REV, V10, P45, DOI 10.1210/edrv-10-1-45; BOLLERSLEV J, 1989, BONE, V10, P19, DOI 10.1016/8756-3282(89)90142-7; Chavassieux P, 2007, ENDOCR REV, V28, P151, DOI 10.1210/er.2006-0029; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Fuller K, 2008, BONE, V42, P200, DOI 10.1016/j.bone.2007.09.044; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; GRAM J, 1991, CALCIFIED TISSUE INT, V48, P438, DOI 10.1007/BF02556458; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Jansen IDC, 2009, FASEB J, V23, P3470, DOI 10.1096/fj.08-122598; Johansson MK, 2007, BLOOD, V109, P5178, DOI 10.1182/blood-2006-12-061382; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Leeming DJ, 2009, OSTEOPOROSIS INT, V20, P1461, DOI 10.1007/s00198-009-0904-3; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mosekilde L, 1999, BONE, V24, P71, DOI 10.1016/S8756-3282(98)00169-0; Nazarian A, 2009, J BIOMECH, V42, P82, DOI 10.1016/j.jbiomech.2008.09.037; Neutzsky-Wulff AV, 2010, DEV BIOL, V344, P1001, DOI 10.1016/j.ydbio.2010.06.018; Neutzsky-Wulff AV, 2008, CALCIFIED TISSUE INT, V83, P425, DOI 10.1007/s00223-008-9185-7; Nielsen RH, 2007, BIOCHEM BIOPH RES CO, V360, P834, DOI 10.1016/j.bbrc.2007.06.145; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; Pennypacker B, J BONE MINER RES S1, V24; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Scott K, 2009, J BONE MINER RES S1, V24; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Segovia-Silvestre T, 2009, HUM GENET, V124, P561, DOI 10.1007/s00439-008-0583-8; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613; TAKAHASHI H, 1964, Surg Forum, V15, P437; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tondelli B, 2009, AM J PATHOL, V174, P727, DOI 10.2353/ajpath.2009.080688; Waguespack SG, 2002, J CLIN ENDOCR METAB, V87, P2212, DOI 10.1210/jc.87.5.2212; Waguespack SG, 2007, J CLIN ENDOCR METAB, V92, P771, DOI 10.1210/jc.2006-1986; WALKER DG, 1975, J EXP MED, V142, P651, DOI 10.1084/jem.142.3.651; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; WALKER DG, 1975, SCIENCE, V190, P785, DOI 10.1126/science.1198094; WIKTORJEDRZEJCZAK W, 1986, EXP HEMATOL, V14, P819; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Yuan FL, 2010, MOL BIOL REP, V37, P3561, DOI 10.1007/s11033-010-0004-7; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	70	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27482	10.1371/journal.pone.0027482	http://dx.doi.org/10.1371/journal.pone.0027482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087326	Green Published, gold			2022-12-27	WOS:000297347700058
J	Pardo, R; Enguix, N; Lasheras, J; Feliu, JE; Kralli, A; Villena, JA				Pardo, Rosario; Enguix, Natalia; Lasheras, Jaime; Feliu, Juan E.; Kralli, Anastasia; Villena, Josep A.			Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor gamma Coactivator-1 alpha	PLOS ONE			English	Article							INSULIN-RESISTANCE; PPAR-GAMMA; INDUCIBLE COACTIVATOR; BROWN ADIPOCYTES; SKELETAL-MUSCLE; MICE; FAT; PGC-1-ALPHA; PGC-1-BETA; METABOLISM	Background: Thiazolidinediones, a family of insulin-sensitizing drugs commonly used to treat type 2 diabetes, are thought to exert their effects in part by promoting mitochondrial biogenesis in white adipose tissue through the transcriptional coactivator PGC-1 alpha (Peroxisome Proliferator-Activated Receptor gamma Coactivator-1 alpha). Methodology/Principal Findings: To assess the role of PGC-1 alpha in the control of rosiglitazone-induced mitochondrial biogenesis, we have generated a mouse model that lacks expression of PGC-1 alpha specifically in adipose tissues (PGC-1 alpha-FAT-KO mice). We found that expression of genes encoding for mitochondrial proteins involved in oxidative phosphorylation, tricarboxylic acid cycle or fatty acid oxidation, was similar in white adipose tissue of wild type and PGC-1 alpha-FAT-KO mice. Furthermore, the absence of PGC-1 alpha did not prevent the positive effect of rosiglitazone on mitochondrial gene expression or biogenesis, but it precluded the induction by rosiglitazone of UCP1 and other brown fat-specific genes in white adipose tissue. Consistent with the in vivo findings, basal and rosiglitazone-induced mitochondrial gene expression in 3T3-L1 adipocytes was unaffected by the knockdown of PGC-1 alpha but it was impaired when PGC-1 beta expression was knockdown by the use of specific siRNA. Conclusions/Significance: These results indicate that in white adipose tissue PGC-1 alpha is dispensable for basal and rosiglitazone-induced mitochondrial biogenesis but required for the rosiglitazone-induced expression of UCP1 and other brown adipocyte-specific markers. Our study suggests that PGC-1 alpha is important for the appearance of brown adipocytes in white adipose tissue. Our findings also provide evidence that PGC-1 beta and not PGC-1 alpha regulates basal and rosiglitazone-induced mitochondrial gene expression in white adipocytes.	[Pardo, Rosario; Enguix, Natalia; Lasheras, Jaime; Feliu, Juan E.; Villena, Josep A.] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Unit Diabet & Metab, Lab Metab & Obes, E-08193 Barcelona, Spain; [Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Scripps Research Institute	Pardo, R (corresponding author), Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Unit Diabet & Metab, Lab Metab & Obes, E-08193 Barcelona, Spain.	josep.villena@vhir.org	Villena, Josep A/H-1597-2015	Enguix, Natalia/0000-0002-7873-902X; Villena, Josep A/0000-0002-2200-2985	Ministerio de Ciencia e Innovacion (MICINN), Spain [SAF2008-03644, RYC-2006-002622, DK064951, BES-2009-013411]; Fundacio La Marato de TV3 [082610]	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3	This work was supported by grants SAF2008-03644 and RYC-2006-002622 from Ministerio de Ciencia e Innovacion (MICINN), Spain, to J.A.V. and DK064951 to A.K. J.A.V. is a researcher of the "Ramon y Cajal" program (MICINN), Spain. N.E. is a FPI predoctoral fellow (BES-2009-013411) from the MICINN. J.L. is supported by a grant from the "Fundacio La Marato de TV3" (082610) to J.A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; COUSIN B, 1992, J CELL SCI, V103, P931; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; DESAUTELS M, 1985, AM J PHYSIOL, V249, pE99, DOI 10.1152/ajpendo.1985.249.1.E99; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Toseland CDN, 2001, DIABETES OBES METAB, V3, P163, DOI 10.1046/j.1463-1326.2001.00117.x; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752	67	70	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26989	10.1371/journal.pone.0026989	http://dx.doi.org/10.1371/journal.pone.0026989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087241	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700014
J	Kuhn, BF; Werdelin, L; Hartstone-Rose, A; Lacruz, RS; Berger, LR				Kuhn, Brian F.; Werdelin, Lars; Hartstone-Rose, Adam; Lacruz, Rodrigo S.; Berger, Lee R.			Carnivoran Remains from the Malapa Hominin Site, South Africa	PLOS ONE			English	Article							AUSTRALOPITHECUS-SEDIBA; DEPOSITS; GENUS; MACHAIRODONTINAE; REVISION; PLIOCENE; MAMMALIA; GAUTENG; KENYA; HOMO	Recent discoveries at the new hominin-bearing deposits of Malapa, South Africa, have yielded a rich faunal assemblage associated with the newly described hominin taxon Australopithecus sediba. Dating of this deposit using U-Pb and palaeomagnetic methods has provided an age of 1.977 Ma, being one of the most accurately dated, time constrained deposits in the Plio-Pleistocene of southern Africa. To date, 81 carnivoran specimens have been identified at this site including members of the families Canidae, Viverridae, Herpestidae, Hyaenidae and Felidae. Of note is the presence of the extinct taxon Dinofelis cf. D. barlowi that may represent the last appearance date for this species. Extant large carnivores are represented by specimens of leopard (Panthera pardus) and brown hyaena (Parahyaena brunnea). Smaller carnivores are also represented, and include the genera Atilax and Genetta, as well as Vulpes cf. V. chama. Malapa may also represent the first appearance date for Felis nigripes (Black-footed cat). The geochronological age of Malapa and the associated hominin taxa and carnivoran remains provide a window of research into mammalian evolution during a relatively unknown period in South Africa and elsewhere. In particular, the fauna represented at Malapa has the potential to elucidate aspects of the evolution of Dinofelis and may help resolve competing hypotheses about faunal exchange between East and Southern Africa during the late Pliocene or early Pleistocene.	[Kuhn, Brian F.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Kuhn, Brian F.; Berger, Lee R.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa; [Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Hartstone-Rose, Adam] Penn State Univ Altoona, Altoona, PA USA; [Lacruz, Rodrigo S.] Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Witwatersrand; University of Witwatersrand; Swedish Museum of Natural History; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Southern California	Kuhn, BF (corresponding author), Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa.	brian.kuhn@wits.ac.za	Hartstone-Rose, Adam/I-3503-2016; Lacruz, Rodrigo/AGY-8090-2022; Hartstone-Rose, Adam/AAU-3332-2020; Berger, Lee Rogers/AAC-3484-2020	Hartstone-Rose, Adam/0000-0001-5307-5573; Berger, Lee Rogers/0000-0002-0367-7629; LACRUZ, RODRIGO/0000-0002-0776-6143	Swedish Research Council; Pennsylvania State University; South African Department of Science and Technology; South African National Research Foundation; Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; Africa Array Program; Duke University; Texas AM University; University of Zurich; Nash family	Swedish Research Council(Swedish Research CouncilEuropean Commission); Pennsylvania State University; South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; Africa Array Program; Duke University; Texas AM University; University of Zurich; Nash family	Research by LW is funded by the Swedish Research Council. AHR is supported by the Pennsylvania State University. The South African Department of Science and Technology, the South African National Research Foundation, the Palaeontological Scientific Trust (PAST), the Andrew W. Mellon Foundation, the Africa Array Program, the United States Diplomatic Mission to South Africa, Duke University, the Ray A. Rothrock Fellowship of Texas A&M University, the Texas A&M Program to Enhance Scholarly and Creative Activities, the University of Zurich 2009 Field School, and Sir Richard Branson all provided substantial funding for the excavations and research conducted at Malapa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bernhard Zipfel for access to materials curated at the IHE and BPI at the University of the Witwatersrand. Stephany Potze for access to material housed at the Ditsong Museum, Pretoria. Job Kibii, Christine Steininger and Bonita de Klerk for aid in the early identification and sorting of specimens. Celeste Yates, Meshack Kgasi and Roseberry Languza for preparing the specimens. The South African Heritage Resource agency for the permits to work on the Malapa site and the Nash family for granting access to the Malapa site and continued support of research on their reserve.	ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bamford M. K., 2010, Palaeontologia Africana, V45, P23; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Berger LR, 2003, S AFR J SCI, V99, P279; Broom R., 1937, S AFR J SCI, V33, P750; BROOM ROBERT, 1948, ANN TRANSVAAL MUS, V21, P1; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; COLLINS K, 2010, P 16 C PAL SOC SO AF; COOKE H B S, 1991, Palaeontologia Africana, V28, P9; de Ruiter DJ, 2009, J HUM EVOL, V56, P497, DOI 10.1016/j.jhevol.2009.01.009; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Ditchfield P, 1999, J HUM EVOL, V36, P123, DOI 10.1006/jhev.1998.0255; ESTES RD, 1991, BEHAV GUIDE AFRICAN; EWER R. F., 1956, PROC ZOOL SOC LONDON, V126, P97; EWER R. F., 1956, PROC ZOOL SOC LONDON, V126, P259; EWER R. F., 1955, PROC ZOOL SOC LONDON, V125, P587; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Gommery D., 2008, Annals of the Transvaal Museum, V45, P67; Hartstone-Rose A, 2010, J PALEONTOL, V84, P299, DOI 10.1666/09-124.1; HENDEY Q B, 1974, Annals of the Transvaal Museum, V29, P27; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; Keyser AW, 2000, S AFR J SCI, V96, P193; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Lacruz Rodrigo, 2006, Annals of the Transvaal Museum, V43, P89; Leakey M.G., 1976, P302; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Macdonald David W., 2010, P3; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; MILLS MGL, 1976, P S END WILDL 1976 E, P36; Mills MGL, 1990, KALAHARI HYAENAS COM; O'Regan HJ, 2009, GEOBIOS-LYON, V42, P329, DOI 10.1016/j.geobios.2009.03.001; OREGAN HJ, 2009, J HUM EVOL, P212; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Savage R.J.G., 1978, P249; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Sliwa A, 2004, MAMM BIOL, V69, P96, DOI 10.1078/1616-5047-00124; Thackeray JF, 2002, S AFR J SCI, V98, P537; Turner A., 1997, Palaeontologia Africana, V34, P115; TURNER A, 1993, PRETORIA TRANSVAAL M, V7, P151; Von den Driesch A., 1976, ARCHAEOLOGY PEABODY, V1; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Werdelin L, 2001, ZOOL J LINN SOC-LOND, V132, P147, DOI 10.1006/zjls.2000.0260; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; WERDELIN L, 2008, CARNIVORA KOOBI FORA, V7; WERDELIN L, 2011, PALAEONTOLOGIA AFRIC, V28, P9; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	50	17	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26940	10.1371/journal.pone.0026940	http://dx.doi.org/10.1371/journal.pone.0026940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073222	gold, Green Published			2022-12-27	WOS:000297197000017
J	Xia, XM; Wang, FY; Zhou, J; Hu, KF; Li, SW; Zou, BB				Xia, Xian-Ming; Wang, Fang-Yu; Zhou, Ju; Hu, Kai-Feng; Li, Su-Wen; Zou, Bing-Bing			CXCR4 Antagonist AMD3100 Modulates Claudin Expression and Intestinal Barrier Function in Experimental Colitis	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; EPITHELIAL BARRIER; CHARGE SELECTIVITY; IN-VITRO; ALPHA; CELLS; PERMEABILITY; RECEPTOR; MODEL; LOCALIZATION	Ulcerative colitis is a gastrointestinal disorder characterized by local inflammation and impaired epithelial barrier. Previous studies demonstrated that CXC chemokine receptor 4 (CXCR4) antagonists could reduce colonic inflammation and mucosal damage in dextran sulfate sodium (DSS)-induced colitis. Whether CXCR4 antagonist has action on intestinal barrier and the possible mechanism, is largely undefined. In the present study, the experimental colitis was induced by administration of 5% DSS for 7 days, and CXCR4 antagonist AMD3100 was administered intraperitoneally once daily during the study period. For in vitro study, HT-29/B6 colonic cells were treated with cytokines or AMD3100 for 24 h until assay. DSS-induced colitis was characterized by morphologic changes in mice. In AMD3100-treated mice, epithelial destruction, inflammatory infiltration, and submucosal edema were markedly reduced, and the disease activity index was also significantly decreased. Increased intestinal permeability in DSS-induced colitis was also significantly reduced by AMD3100. The expressions of colonic claudin-1, claudin-3, claudin-5, claudin-7 and claudin-8 were markedly decreased after DSS administration, whereas colonic claudin-2 expression was significantly decreased. Treatment with AMD3100 prevented all these changes. However, AMD3100 had no influence on claudin-3, claudin-5, claudin-7 and claudin-8 expression in HT-29/B6 cells. Cytokines as TNF-alpha, IL-6, and IFN-gamma increased apoptosis and monolayer permeability, inhibited the wound-healing and the claudin-3, claudin-7 and claudin-8 expression in HT-29/B6 cells. We suggest that AMD3100 acted on colonic claudin expression and intestinal barrier function, at least partly, in a cytokine-dependent pathway.	[Xia, Xian-Ming; Zhou, Ju; Hu, Kai-Feng; Li, Su-Wen] Anhui Med Univ, Affiliated Hosp 4, Dept Gastroenterol & Hepatol, Hefei, Anhui, Peoples R China; [Wang, Fang-Yu] Jinling Hosp, Dept Gastroenterol & Hepatol, Nanjing, Jiangsu, Peoples R China; [Zou, Bing-Bing] Anhui Med Univ, Affiliated Hosp 4, Dept Gen Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Xia, XM (corresponding author), Anhui Med Univ, Affiliated Hosp 4, Dept Gastroenterol & Hepatol, Hefei, Anhui, Peoples R China.	xiaxm2000@hotmail.com			Postdoctoral Science Foundation of China [20090451573]; Postdoctoral Science Foundation of Jiangsu Province [0902061C]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation)	This work was funded by projects from the Postdoctoral Science Foundation of China (grant no. 20090451573) and the Postdoctoral Science Foundation of Jiangsu Province (grant no. 0902061C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoghaibi MA, 2008, J DIGEST DIS, V9, P144, DOI 10.1111/j.1751-2980.2008.00336.x; Amasheh M, 2009, SCAND J GASTROENTERO, V44, P1226, DOI 10.1080/00365520903131973; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bernasconi E, 2010, INFLAMM BOWEL DIS, V16, P428, DOI 10.1002/ibd.21072; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Ding ZQ, 2006, CRIT CARE MED, V34, P3011, DOI 10.1097/01.CCM.0000247719.37793.43; Dotan I, 2010, INFLAMM BOWEL DIS, V16, P583, DOI 10.1002/ibd.21106; Fernandez AL, 2007, ALCOHOL, V41, P371, DOI 10.1016/j.alcohol.2007.04.010; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Haas CS, 2005, ARTHRITIS RHEUM-US, V52, P3718, DOI 10.1002/art.21476; Han XN, 2003, SHOCK, V19, P229, DOI 10.1097/00024382-200303000-00006; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Li QR, 2008, FEBS J, V275, P411, DOI 10.1111/j.1742-4658.2007.06210.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Mazzon E, 2008, AM J PHYSIOL-GASTR L, V294, pG1268, DOI 10.1152/ajpgi.00014.2008; Mazzon E, 2007, SHOCK, V28, P192, DOI 10.1097/shk.0b013e318033eb29; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Menconi MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG1007, DOI 10.1152/ajpgi.1997.272.5.G1007; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nakase H, 2009, INFLAMM BOWEL DIS, V15, P963, DOI 10.1002/ibd.20755; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Qin XF, 2008, SHOCK, V29, P372, DOI 10.1097/shk.0b013e3181453f4e; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shichijo K, 2008, DIGEST DIS SCI, V53, P2443, DOI 10.1007/s10620-007-0160-3; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Soriano FG, 2001, CRIT CARE MED, V29, P703, DOI 10.1097/00003246-200104000-00001; Suzuki K, 2007, PATHOL INT, V57, P413, DOI 10.1111/j.1440-1827.2007.02117.x; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; Wu JH, 2010, WORLD J GASTROENTERO, V16, P3911, DOI 10.3748/wjg.v16.i31.3911; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2994, DOI 10.3748/wjg.v16.i24.2994; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2873, DOI 10.3748/wjg.v16.i23.2873; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007	48	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27282	10.1371/journal.pone.0027282	http://dx.doi.org/10.1371/journal.pone.0027282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073304	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000040
J	Hua, J; Liang, SW; Ma, X; Webb, TJ; Potter, JP; Li, ZP				Hua, Jing; Liang, Shuwen; Ma, Xiong; Webb, Tonya J.; Potter, James P.; Li, Zhiping			The Interaction between Regulatory T Cells and NKT Cells in the Liver: A CD1d Bridge Links Innate and Adaptive Immunity	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; HIGH-FAT DIET; VIRUS-INFECTION; TOLERANCE; HEPATITIS; TRANSPLANTATION; LYMPHOCYTES; ACTIVATION; BIOLOGY; DISEASE	Background/Aims: Regulatory T cells (Tregs) and natural killer T (NKT) cells are two distinct lymphocyte subsets that independently regulate hepatic adaptive and innate immunity, respectively. In the current study, we examine the interaction between Tregs and NKT cells to understand the mechanisms of cross immune regulation by these cells. Methods: The frequency and function of Tregs were evaluated in wild type and NKT cell deficient (CD1dko) mice. In vitro lymphocyte proliferation and apoptosis assays were performed with NKT cells co-cultured with Tregs. The ability of Tregs to inhibit NKT cells in vivo was examined by adoptive transfer of Tregs in a model of NKT cell mediated hepatitis. Results: CD1dko mice have a significant reduction in hepatic Tregs. Although, the Tregs from CD1dko mice remain functional and can suppress conventional T cells, their ability to suppress activation induced NKT cell proliferation and to promote NKT cell apoptosis is greatly diminished. These effects are CD1d dependent and require cell to cell contact. Adoptive transfer of Tregs inhibits NKT cell-mediated liver injury. Conclusions: NKT cells promote Tregs, and Tregs inhibit NKT cells in a CD1d dependent manner requiring cell to cell contact. These cross-talk immune regulations provide a linkage between innate and adaptive immunity.	[Hua, Jing; Liang, Shuwen; Ma, Xiong; Potter, James P.; Li, Zhiping] Jiaotong Univ, Shanghai Renji Hosp, Sch Med, Shanghai Inst Digest Dis, Shanghai, Peoples R China; [Hua, Jing; Liang, Shuwen; Ma, Xiong; Potter, James P.; Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Webb, Tonya J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Shanghai Jiao Tong University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Hua, J (corresponding author), Jiaotong Univ, Shanghai Renji Hosp, Sch Med, Shanghai Inst Digest Dis, Shanghai, Peoples R China.	zhipingli@jhmi.edu		Webb, Tonya/0000-0003-3086-6414; Ma, Xiong/0000-0001-9616-4672	NIH/NIDDK [R01DK075990]; Program of Shanghai Innovative Research Team in Immunity of Non-viral Liver Diseases; NATIONAL CANCER INSTITUTE [R21CA162273, R21CA162277, K01CA131487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, R01DK075990] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Program of Shanghai Innovative Research Team in Immunity of Non-viral Liver Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from NIH/NIDDK R01DK075990 (ZL) and the Program of Shanghai Innovative Research Team in Immunity of Non-viral Liver Diseases (XM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2003, CANCER RES, V63, P4516; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Demirkiran A, 2006, LIVER TRANSPLANT, V12, P277, DOI 10.1002/lt.20612; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hallett WHD, 2008, BIOL BLOOD MARROW TR, V14, P1088, DOI 10.1016/j.bbmt.2008.08.001; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jiang SP, 2005, EUR J IMMUNOL, V35, P1193, DOI 10.1002/eji.200425899; Jiang SP, 2003, AM J TRANSPLANT, V3, P516, DOI 10.1034/j.1600-6143.2003.00124.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Klugewitz K, 2004, TRENDS IMMUNOL, V25, P590, DOI 10.1016/j.it.2004.09.006; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; La Cava A, 2006, TRENDS IMMUNOL, V27, P322, DOI 10.1016/j.it.2006.05.003; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Li WP, 2008, ACTA BIOCH BIOPH SIN, V40, P381, DOI 10.1111/j.1745-7270.2008.00410.x; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Nador RG, 2010, AM J TRANSPLANT, V10, P262, DOI 10.1111/j.1600-6143.2009.02942.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pillai AB, 2009, BLOOD, V113, P4458, DOI 10.1182/blood-2008-06-165506; QIAN SW, 1994, HEPATOLOGY, V19, P916, DOI 10.1002/hep.1840190418; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tupin E, 2006, METHOD ENZYMOL, V417, P185, DOI 10.1016/S0076-6879(06)17014-7; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; VELAOJEDA J, 2010, STEM CELLS DEV; Yang SQ, 2001, AM J PHYSIOL-GASTR L, V281, pG382, DOI 10.1152/ajpgi.2001.281.2.G382; YASSER O, 2000, J IMMUNOL, V30, P1919; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27038	10.1371/journal.pone.0027038	http://dx.doi.org/10.1371/journal.pone.0027038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073248	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900068
J	Wang, YJ; Zhang, Q; Chen, HQ; Li, X; Mai, WJ; Chen, KP; Zhang, SF; Lee, EYC; Lee, MYWT; Zhou, YJ				Wang, Yujue; Zhang, Qian; Chen, Huiqing; Li, Xiao; Mai, Weijun; Chen, Keping; Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.; Zhou, Yajing			P50, the Small Subunit of DNA Polymerase Delta, Is Required for Mediation of the Interaction of Polymerase Delta Subassemblies with PCNA	PLOS ONE			English	Article							EUKARYOTIC REPLICATION FORK; CELL NUCLEAR ANTIGEN; SCHIZOSACCHAROMYCES-POMBE; CALF THYMUS; DAMAGE RESPONSE; P12 SUBUNIT; PROTEIN; REPAIR; IDENTIFICATION; CHROMATOGRAPHY	Mammalian DNA polymerase delta (pol delta), a four-subunit enzyme, plays a crucial and versatile role in DNA replication and various DNA repair processes. Its function as a chromosomal DNA polymerase is dependent on the association with proliferating cell nuclear antigen (PCNA) which functions as a molecular sliding clamp. All four of the pol delta subunits (p125, p50, p68, and p12) have been reported to bind to PCNA. However, the identity of the subunit of pol delta that directly interacts with PCNA and is therefore primarily responsible for the processivity of the enzyme still remains controversial. Previous model for the network of protein-protein interactions of the pol delta-PCNA complex showed that pol delta might be able to interact with a single molecule of PCNA homotrimer through its three subunits, p125, p68, and p12 in which the p50 was not included in. Here, we have confirmed that the small subunit p50 of human pol delta truthfully interacts with PCNA by the use of far-Western analysis, quantitative ELISA assay, and subcellular co-localization. P50 is required for mediation of the interaction between pol delta subassemblies and PCNA homotrimer. Thus, pol delta interacts with PCNA via its four subunits.	[Wang, Yujue; Zhang, Qian; Chen, Huiqing; Li, Xiao; Mai, Weijun; Chen, Keping; Zhou, Yajing] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY USA	Jiangsu University; New York Medical College	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	yajingzhou@ujs.edu.cn	Wang, Yujue/HHN-4296-2022	Zhang, Sufang/0000-0003-3883-023X; Weijun, Mai/0000-0003-2636-9028	National Natural Science Foundation of China [30970612]; Jiangsu University for Advanced Professionals [09JDG002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University for Advanced Professionals; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Natural Science Foundation of China (30970612) and Startup Scientific Research Fund from Jiangsu University for Advanced Professionals (09JDG002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cardoso MC, 1999, J CELL BIOCHEM, P15; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Harlow E., 1988, ANTIBODIES LAB MANUA; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; JIANG YQ, 1995, ARCH BIOCHEM BIOPHYS, V320, P297, DOI 10.1016/0003-9861(95)90013-6; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee M Y, 1981, Prog Nucleic Acid Res Mol Biol, V26, P83; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; Leonhardt H, 1998, J CELL BIOCHEM, P243, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<243::AID-JCB30>3.0.CO;2-6; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Lu XQ, 2002, J BIOL CHEM, V277, P24340, DOI 10.1074/jbc.M200065200; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Pohler JRG, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-17; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shikata K, 2001, J BIOCHEM-TOKYO, V129, P699, DOI 10.1093/oxfordjournals.jbchem.a002909; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; TAN CK, 1986, J BIOL CHEM, V261, P2310; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	42	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27092	10.1371/journal.pone.0027092	http://dx.doi.org/10.1371/journal.pone.0027092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073260	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900074
J	Hewlett, L; Zupancic, G; Mashanov, G; Knipe, L; Ogden, D; Hannah, MJ; Carter, T				Hewlett, Lindsay; Zupancic, Gregor; Mashanov, Gregory; Knipe, Laura; Ogden, David; Hannah, Matthew J.; Carter, Tom			Temperature-Dependence of Weibel-Palade Body Exocytosis and Cell Surface Dispersal of von Willebrand Factor and Its Propolypeptide	PLOS ONE			English	Article							HUMAN-ENDOTHELIAL-CELLS; VONWILLEBRAND-FACTOR; BODIES; RELEASE; PROTEIN; SECRETION; MOLECULES; MECHANISM; STORAGE	Background: Weibel-Palade bodies (WPB) are endothelial cell (EC) specific secretory organelles containing Von Willebrand factor (VWF). The temperature-dependence of Ca2+-driven WPB exocytosis is not known, although indirect evidence suggests that WPB exocytosis may occur at very low temperatures. Here we quantitatively analyse the temperature-dependence of Ca2+-driven WPB exocytosis and release of secreted VWF from the cell surface of ECs using fluorescence microscopy of cultured human ECs containing fluorescent WPBs. Principal Findings: Ca2+-driven WPB exocytosis occurred at all temperatures studied (7-37 degrees C). The kinetics and extent of WPB exocytosis were strongly temperature-dependent: Delays in exocytosis increased from 0.92 s at 37 degrees C to 134.2 s at 7 degrees C, the maximum rate of WPB fusion decreased from 10.0 +/- 2.2 s(-1) (37 degrees C) to 0.80 +/- 0.14 s(-1) (7 degrees C) and the fractional extent of degranulation of WPBs in each cell from 67 +/- 3% (37 degrees C) to 3.6 +/- 1.3% (7 degrees C). A discrepancy was found between the reduction in Ca2+-driven VWF secretion and WPB exocytosis at reduced temperature; at 17 degrees C VWF secretion was reduced by 95% but WPB exocytosis by 75-80%. This discrepancy arises because VWF dispersal from sites of WPB exocytosis is largely prevented at low temperature. In contrast VWF-propolypeptide (proregion) dispersal from WPBs, although slowed, was complete within 60-120 s. Novel antibodies to the cleaved and processed proregion were characterised and used to show that secreted proregion more accurately reports the secretion of WPBs at sub-physiological temperatures than assay of VWF itself. Conclusions: We report the first quantitative analysis of the temperature-dependence of WPB exocytosis. We provide evidence; by comparison of biochemical data for VWF or proregion secretion with direct analysis of WPB exocytosis at reduced temperature, that proregion is a more reliable marker for WPB exocytosis at reduced temperature, where VWF-EC adhesion is increased.	[Hewlett, Lindsay; Mashanov, Gregory; Knipe, Laura; Hannah, Matthew J.; Carter, Tom] Med Res Councils Natl Inst Med Res, Div Phys Biochem, London, England; [Zupancic, Gregor] Univ Ljubljana, Dept Biol, Ljubljana, Slovenia; [Ogden, David] Univ Paris 05, Brain Physiol Lab, Paris, France	MRC National Institute for Medical Research; University of Ljubljana; UDICE-French Research Universities; Universite Paris Cite	Hewlett, L (corresponding author), Med Res Councils Natl Inst Med Res, Div Phys Biochem, London, England.	tcarter@nimr.mrc.ac.uk	Carter, Tom/E-5035-2016	Carter, Tom/0000-0002-6248-7278	United Kingdom Medical Research Council [U117573808, U117570589]; MRC [MC_U117573808] Funding Source: UKRI; Medical Research Council [U117512659, MC_U117573808] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the United Kingdom Medical Research Council (reference codes U117573808 and U117570589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Babich V, 2009, J BIOL CHEM, V284, P12459, DOI 10.1074/jbc.M809235200; Berriman JA, 2009, P NATL ACAD SCI USA, V106, P17407, DOI 10.1073/pnas.0902977106; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; BONFANTI R, 1989, BLOOD, V73, P1109; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; CROWE JH, 1989, CRYOBIOLOGY, V26, P76, DOI 10.1016/0011-2240(89)90035-7; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; FREARSON JA, 1995, BIOCHEM J, V309, P473, DOI 10.1042/bj3090473; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; Hannah MJ, 2003, J CELL SCI, V116, P3939, DOI 10.1242/jcs.00711; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kiskin NI, 2010, J CELL SCI, V123, P2964, DOI 10.1242/jcs.073593; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; REINDERS JH, 1984, BIOCHIM BIOPHYS ACTA, V804, P361, DOI 10.1016/0167-4889(84)90140-X; ROARKE MC, 1989, EUR J CELL BIOL, V48, P337; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217	23	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27314	10.1371/journal.pone.0027314	http://dx.doi.org/10.1371/journal.pone.0027314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096550	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000297553900032
J	Le Port, A; Watier, L; Cottrell, G; Ouedraogo, S; Dechavanne, C; Pierrat, C; Rachas, A; Bouscaillou, J; Bouraima, A; Massougbodji, A; Fayomi, B; Thiebaut, A; Chandre, F; Migot-Nabias, F; Martin-Prevel, Y; Garcia, A; Cot, M				Le Port, Agnes; Watier, Laurence; Cottrell, Gilles; Ouedraogo, Smaila; Dechavanne, Celia; Pierrat, Charlotte; Rachas, Antoine; Bouscaillou, Julie; Bouraima, Aziz; Massougbodji, Achille; Fayomi, Benjamin; Thiebaut, Anne; Chandre, Fabrice; Migot-Nabias, Florence; Martin-Prevel, Yves; Garcia, Andre; Cot, Michel			Infections in Infants during the First 12 Months of Life: Role of Placental Malaria and Environmental Factors	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; GAMBIAN CHILDREN; TRANSMISSION; VARIABILITY; MORBIDITY; DISTRICT; VECTORS; ALLELES; RISK	Background: The association between placental malaria (PM) and first peripheral parasitaemias in early infancy was assessed in Tori Bossito, a rural area of Benin with a careful attention on transmission factors at an individual level. Methodology: Statistical analysis was performed on 550 infants followed weekly from birth to 12 months. Malaria transmission was assessed by anopheles human landing catches every 6 weeks in 36 sampling houses and season defined by rainfall. Each child was located by GPS and assigned to the closest anopheles sampling house. Data were analysed by survival Cox models, stratified on the possession of insecticide-treated mosquito nets (ITNs) at enrolment. Principal Findings: Among infants sleeping in a house with an ITN, PM was found to be highly associated to first malaria infections, after adjusting on season, number of anopheles, antenatal care (ANC) visits and maternal severe anaemia. Infants born from a malaria infected placenta had a 2.13 fold increased risk to present a first malaria infection than those born from a non infected placenta ([1.24-3.67], p<0.01) when sleeping in a house with an ITN. The risk to present a first malaria infection was increased by 3.2 to 6.5, according to the level of anopheles exposure (moderate or high levels, compared to the absence of anopheles). Conclusions: First malaria infections in early childhood can be attributed simultaneously to both PM and high levels of exposure to infected anopheles. Protective measures as Intermittent Preventive Treatment during pregnancy (IPTp) and ITNs, targeted on both mothers and infants should be reinforced, as well as the research on new drugs and insecticides. In parallel, investigations on placental malaria have to be strengthened to better understand the mechanisms involved, and thus to protect adequately the infants high risk group.	[Le Port, Agnes; Dechavanne, Celia; Pierrat, Charlotte; Rachas, Antoine; Bouscaillou, Julie; Migot-Nabias, Florence; Garcia, Andre; Cot, Michel] IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Le Port, Agnes; Cottrell, Gilles; Ouedraogo, Smaila; Dechavanne, Celia; Pierrat, Charlotte; Rachas, Antoine; Bouscaillou, Julie; Migot-Nabias, Florence; Garcia, Andre; Cot, Michel] Univ Paris 05, Fac Pharm, Paris, France; [Watier, Laurence; Thiebaut, Anne] INSERM, U657, Garches, France; [Watier, Laurence; Thiebaut, Anne] UVSQ, EA4499, Garches, France; [Watier, Laurence; Thiebaut, Anne] Inst Pasteur, PhEMI, Garches, France; [Cottrell, Gilles; Ouedraogo, Smaila] IRD, Mere & Enfant Face Infect Trop UMR216, Cotonou, Benin; [Bouraima, Aziz; Fayomi, Benjamin] ISBA, Cotonou, Benin; [Massougbodji, Achille] FSS, Cotonou, Benin; [Chandre, Fabrice] IRD, Caracterisat & Controle Populat Vecteurs UR016, Montpellier, France; [Martin-Prevel, Yves] IRD, Prevent Malnutr & Pathol Associees NUTRIPASS UMR2, Montpellier, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Le Port, A (corresponding author), IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France.	agnesleport@yahoo.fr	Garcia, Andre/S-2959-2016; , Watier/K-8213-2013; Cot, Michel/E-7633-2011; Chandre, Fabrice/Q-3429-2019; Thiébaut, Anne C.M./O-1788-2018; Garcia, Andre/ABA-1820-2020; Martin-Prevel, Yves/E-7637-2011	Garcia, Andre/0000-0002-1808-472X; , Watier/0000-0002-4057-1102; Cot, Michel/0000-0003-3014-4294; Chandre, Fabrice/0000-0002-1994-9705; Thiébaut, Anne C.M./0000-0003-2651-2795; Garcia, Andre/0000-0002-1808-472X; Martin-Prevel, Yves/0000-0002-4689-7867; Migot-Nabias, Florence/0000-0001-9982-594X; Dechavanne, Celia/0000-0001-8439-9976; Cottrell, Gilles/0000-0002-7964-8963; Le Port, Agnes/0000-0002-8337-6569	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche (ANR); Ministere de la Recherche et des Technologies, France; Fondation de France; Fondation Merieux	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de la Recherche et des Technologies, France; Fondation de France(Fondation de France); Fondation Merieux	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche (ANR); Ministere de la Recherche et des Technologies, France; Fondation de France; Fondation Merieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; [Anonymous], 2004, COCHRANE DB SYST REV; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Cairns M, 2009, CLIN INFECT DIS, V48, P497, DOI 10.1086/596548; Cano J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-21; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; *INSAE, 2007, ANN STAT SAN 2006; Jafari-Guemouri S, 2005, J CLIN MICROBIOL, V43, P2980, DOI 10.1128/JCM.43.6.2980-2983.2005; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2005, J CLIN MICROBIOL, V43, P3630, DOI 10.1128/JCM.43.8.3630-3635.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Mwangoka GW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-117; RANTALA AM, MALAR J, V9, P269; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8; Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2; *WHO, 2000, AB DECL PLAN ACT; World Health Organization, 1995, PHYS STAT US INT ANT; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	25	55	55	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27516	10.1371/journal.pone.0027516	http://dx.doi.org/10.1371/journal.pone.0027516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096588	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900056
J	Garbuz, DG; Astakhova, LN; Zatsepina, OG; Arkhipova, IR; Nudler, E; Evgen'ev, MB				Garbuz, David G.; Astakhova, Lubov N.; Zatsepina, Olga G.; Arkhipova, Irina R.; Nudler, Eugene; Evgen'ev, Michael B.			Functional Organization of hsp70 Cluster in Camel (Camelus dromedarius) and Other Mammals	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; MOLECULAR CHAPERONES; STRESS-RESPONSE; GENES; ADAPTATION; EVOLUTION; PROTEINS; DIFFER; CELLS	Heat shock protein 70 (Hsp70) is a molecular chaperone providing tolerance to heat and other challenges at the cellular and organismal levels. We sequenced a genomic cluster containing three hsp70 family genes linked with major histocompatibility complex (MHC) class III region from an extremely heat tolerant animal, camel (Camelus dromedarius). Two hsp70 family genes comprising the cluster contain heat shock elements (HSEs), while the third gene lacks HSEs and should not be induced by heat shock. Comparison of the camel hsp70 cluster with the corresponding regions from several mammalian species revealed similar organization of genes forming the cluster. Specifically, the two heat inducible hsp70 genes are arranged in tandem, while the third constitutively expressed hsp70 family member is present in inverted orientation. Comparison of regulatory regions of hsp70 genes from camel and other mammals demonstrates that transcription factor matches with highest significance are located in the highly conserved 250-bp upstream region and correspond to HSEs followed by NF-Y and Sp1 binding sites. The high degree of sequence conservation leaves little room for putative camel-specific regulatory elements. Surprisingly, RT-PCR and 5'/3'-RACE analysis demonstrated that all three hsp70 genes are expressed in camel's muscle and blood cells not only after heat shock, but under normal physiological conditions as well, and may account for tolerance of camel cells to extreme environmental conditions. A high degree of evolutionary conservation observed for the hsp70 cluster always linked with MHC locus in mammals suggests an important role of such organization for coordinated functioning of these vital genes.	[Garbuz, David G.; Astakhova, Lubov N.; Zatsepina, Olga G.; Evgen'ev, Michael B.] RAS, Engelhardt Inst Mol Biol, Moscow 117901, Russia; [Arkhipova, Irina R.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Nudler, Eugene] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Evgen'ev, Michael B.] RAS, Inst Cell Biophys, Pushchino, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Marine Biological Laboratory - Woods Hole; New York University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Garbuz, DG (corresponding author), RAS, Engelhardt Inst Mol Biol, Moscow 117901, Russia.	misha572001@yahoo.com	Garbuz, David/Q-7522-2016	Nudler, Evgeny/0000-0002-8811-3071; Arkhipova, Irina/0000-0002-4805-1339	Russian Foundation for Basic Research [09-04-00643, 09-04-00660]; "Genofond dynamics" program; Molecular and Cellular Biology RAN; Ministry of Education and Science of Russian Federation [14.740.11.0757]; Russia President Grant [MK-1418.2010.4]; Ministry of Education and Science [N16.552.11.7034]; Direct For Biological Sciences [0821956] Funding Source: National Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); "Genofond dynamics" program; Molecular and Cellular Biology RAN; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russia President Grant; Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Russian Foundation for Basic Research, project 09-04-00643 and 09-04-00660, project from "Genofond dynamics" program, and Grant of the Program of Molecular and Cellular Biology RAN to Dr. Evgen'ev; and by the Ministry of Education and Science of Russian Federation (State contract 14.740.11.0757 and Russia President Grant to young scientists MK-1418.2010.4. The research was supported by State Contract N16.552.11.7034 of Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Swailem AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010720; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Evgen'ev MB, 2007, J BIOSCIENCES, V32, P489, DOI 10.1007/s12038-007-0048-6; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Freeman BC, 2000, METH MOL B, V99, P393; Garbuz DG, 2008, MOL ECOL, V17, P4763, DOI 10.1111/j.1365-294X.2008.03947.x; Garbuz DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-74; GLINSKI W, 1976, J CLIN INVEST, V57, P604, DOI 10.1172/JCI108316; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HUNT CR, 1993, GENOMICS, V16, P193, DOI 10.1006/geno.1993.1158; Jensen ON, 1999, METH MOL B, V112, P513; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LYASHKO VN, 1994, P NATL ACAD SCI USA, V91, P12492, DOI 10.1073/pnas.91.26.12492; Margulis B, HEAT SHOCK PROTEINS, P305; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rozhkova E, 2010, ANN NY ACAD SCI, V1197, P94, DOI 10.1111/j.1749-6632.2009.05375.x; SALTERCID L, 1994, IMMUNOGENETICS, V39, P1; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Schmidt-Nilsen K, 1972, ANIMALS DESERTS; Thayyullathil F, 2008, ANN NY ACAD SCI, V1138, P376, DOI 10.1196/annals.1414.039; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; ULMASOV HA, 1993, COMP BIOCHEM PHYS B, V106, P867, DOI 10.1016/0305-0491(93)90043-5; ULMASOV KA, 1992, P NATL ACAD SCI USA, V89, P1666, DOI 10.1073/pnas.89.5.1666; WALTER L, 1994, IMMUNOGENETICS, V40, P325, DOI 10.1007/BF01246673; Zatsepina OG, 2000, J EXP BIOL, V203, P1017	29	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27205	10.1371/journal.pone.0027205	http://dx.doi.org/10.1371/journal.pone.0027205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096537	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800037
J	Thomsen, MS; El-Sayed, M; Mikkelsen, JD				Thomsen, Morten S.; El-Sayed, Mona; Mikkelsen, Jens D.			Differential Immediate and Sustained Memory Enhancing Effects of Alpha7 Nicotinic Receptor Agonists and Allosteric Modulators in Rats	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; COGNITIVE IMPROVEMENT; IN-VITRO; ACTIVATION; DESENSITIZATION; SCHIZOPHRENIA; PERFORMANCE; EXPRESSION; DEFICITS; GTS-21	The alpha 7 nicotinic acetylcholine receptor (nAChR) is a potential target for the treatment of cognitive deficits in patients with schizophrenia, ADHD and Alzheimer's disease. Here we test the hypothesis that upregulation of alpha 7 nAChR levels underlies the enhanced and sustained procognitive effect of repeated administration of alpha 7 nAChR agonists. We further compare the effect of agonists to that of alpha 7 nAChR positive allosteric modulators (PAMs), which do not induce upregulation of the alpha 7 nAChR. Using the social discrimination test as a measure of short-term memory, we show that the alpha 7 nAChR agonist A582941 improves short-term memory immediately after repeated (76daily), but not a single administration. The alpha 7 nAChR PAMs PNU-120596 and AVL-3288 do not affect short-term memory immediately after a single or repeated administration. This demonstrates a fundamental difference in the behavioral effects of agonists and PAMs that may be relevant for clinical development. Importantly, A-582941 and AVL-3288 increase short-term memory 24 hrs after repeated, but not a single, administration, suggesting that repeated administration of both agonists and PAMs may produce sustained effects on cognitive performance. Subsequent [I-125]-bungarotoxin autoradiography revealed no direct correlation between alpha 7 nAChR levels in frontal cortical or hippocampal brain regions and short-term memory with either compound. Additionally, repeated treatment with A-582941 did not affect mRNA expression of RIC-3 or the lynx-like gene products lynx1, lynx2, PSCA, or Ly6H, which are known to affect nAChR function. In conclusion, both alpha 7 nAChR agonists and PAMs exhibit sustained pro-cognitive effects after repeated administration, and altered levels of the alpha 7 nAChR per se, or that of endogenous regulators of nAChR function, are likely not the major cause of this effect.	[Thomsen, Morten S.; El-Sayed, Mona; Mikkelsen, Jens D.] Univ Copenhagen Hosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark; [Mikkelsen, Jens D.] Neurosearch AS, Ballerup, Denmark	University of Copenhagen	Thomsen, MS (corresponding author), Univ Copenhagen Hosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark.	morten.s.thomsen@nru.dk	Hervig, Mona El-Sayed/E-4791-2019; Hervig, Mona El-Sayed/Q-3970-2019	Hervig, Mona El-Sayed/0000-0003-0969-1250; Hervig, Mona El-Sayed/0000-0003-0969-1250	Danish Medical Research Council; NOVO Nordisk Foundation; Lundbeck Foundation; Danish Ministry of Science, Technology and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Science, Technology and Innovation	This work was supported by the Danish Medical Research Council, the NOVO Nordisk Foundation, the Lundbeck Foundation, and the Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla FA, 1996, PSYCHOPHARMACOLOGY, V124, P323, DOI 10.1007/BF02247437; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Bjugstad KB, 1996, DRUG DEVELOP RES, V39, P19; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Castner SA, 2011, BIOL PSYCHIAT, V69, P12, DOI 10.1016/j.biopsych.2010.08.006; Christensen DZ, 2010, J NEUROCHEM, V114, P1205, DOI 10.1111/j.1471-4159.2010.06845.x; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Deutsch SI, 2008, CLIN NEUROPHARMACOL, V31, P34, DOI [10.1097/WNF.0B013E31806462BA, 10.1097/wnf.0b013e31806462ba]; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Dunlop J, 2009, J PHARMACOL EXP THER, V328, P766, DOI 10.1124/jpet.108.146514; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; Faghih R, 2008, J MED CHEM, V51, P701, DOI 10.1021/jm070256g; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hauser TA, 2009, BIOCHEM PHARMACOL, V78, P803, DOI 10.1016/j.bcp.2009.05.030; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Keller JJ, 2005, BEHAV BRAIN RES, V162, P143, DOI 10.1016/j.bbr.2005.03.004; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Li JG, 2008, NEUROPSYCHOPHARMACOL, V33, P2820, DOI 10.1038/npp.2008.1; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Pei Q, 2003, NEUROSCIENCE, V121, P975, DOI 10.1016/S0306-4522(03)00504-9; Pepeu G, 2004, LEARN MEMORY, V11, P21, DOI 10.1101/lm.68104; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Reymond J-L, 2011, BIOCH PHARM IN PRESS; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Thomsen MS, 2011, CURR DRUG T IN PRESS; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Treinin Millet, 2008, Biotechnology Journal, V3, P1539, DOI 10.1002/biot.200800179; Werkheiser JL, 2011, NEUROSCIENCE, V186, P76, DOI 10.1016/j.neuroscience.2011.04.033; Woldbye DPD, 1996, BRAIN RES, V720, P111, DOI 10.1016/0006-8993(96)00158-8; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008	40	43	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27014	10.1371/journal.pone.0027014	http://dx.doi.org/10.1371/journal.pone.0027014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096516	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800023
J	Hajage, D; de Rycke, Y; Bollet, M; Savignoni, A; Caly, M; Pierga, JY; Horlings, HM; Van de Vijver, MJ; Vincent-Salomon, A; Sigal-Zafrani, B; Senechal, C; Asselain, B; Sastre, X; Reyal, F				Hajage, David; de Rycke, Yann; Bollet, Marc; Savignoni, Alexia; Caly, Martial; Pierga, Jean-Yves; Horlings, Hugo M.; Van de Vijver, Marc J.; Vincent-Salomon, Anne; Sigal-Zafrani, Brigitte; Senechal, Claire; Asselain, Bernard; Sastre, Xavier; Reyal, Fabien			External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement	PLOS ONE			English	Article							COMPUTER-PROGRAM; ST-GALLEN; INDEX; PROLIFERATION; DECISIONS; THERAPY; ASSIST; CHEMOTHERAPY; PREDICTION; SIGNATURE	Background: Adjuvant! Online is a web-based application designed to provide 10 years survival probability of patients with breast cancer. Several predictors have not been assessed in the original Adjuvant! Online study. We provide the validation of Adjuvant! Online algorithm on two breast cancer datasets, and we determined whether the accuracy of Adjuvant! Online is improved with other well-known prognostic factors. Patients and Methods: The French data set is composed of 456 women with early breast cancer. The Dutch data set is composed of 295 women less than 52 years of age. Agreement between observation and Adjuvant! Online prediction was checked, and logistic models were performed to estimate the prognostic information added by risk factors to Adjuvant! Online prediction. Results: Adjuvant! Online prediction was overall well-calibrated in the French data set but failed in some subgroups of such high grade and HER2 positive patients. HER2 status, Mitotic Index and Ki67 added significant information to Adjuvant! Online prediction. In the Dutch data set, the overall 10-year survival was overestimated by Adjuvant! Online, particularly in patients less than 40 years old. Conclusion: Adjuvant! Online needs to be updated to adjust overoptimistic results in young and high grade patients, and should consider new predictors such as Ki67, HER2 and Mitotic Index.	[Hajage, David; de Rycke, Yann; Savignoni, Alexia; Asselain, Bernard] Inst Curie, Dept Biostat, Paris, France; [Bollet, Marc] Inst Curie, Dept Radiotherapy, Paris, France; [Caly, Martial; Vincent-Salomon, Anne; Sigal-Zafrani, Brigitte; Sastre, Xavier] Inst Curie, Dept Tumour Biol, Paris, France; [Pierga, Jean-Yves] Inst Curie, Dept Med Oncol, Paris, France; [Horlings, Hugo M.; Van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Senechal, Claire; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Hajage, D (corresponding author), Inst Curie, Dept Biostat, Paris, France.	Fabien.reyal@curie.net	Hajage, David/D-5226-2014	Hajage, David/0000-0002-8475-4090; van de Vijver, Marc/0000-0002-0385-4787	Netherlands Cancer Institute; Institut Curie	Netherlands Cancer Institute; Institut Curie	This work was supported by grants from the Institut Curie and the Netherlands Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 1998, LANCET, V352, P930; Agarwal V, 2011, CLIN ONCOL-UK, V23, P159, DOI 10.1016/j.clon.2010.11.004; Balakrishnan A, 2011, ANN ONCOL, V22, P1461, DOI 10.1093/annonc/mdr152; Bedard PL, 2011, NAT REV CLIN ONCOL, V8, P272, DOI 10.1038/nrclinonc.2011.19; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; BLAMEY RW, 1979, CLIN ONCOL-US, V5, P227; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Campbell HE, 2009, BRIT J CANCER, V101, P1074, DOI 10.1038/sj.bjc.6605283; Clarke M, 1998, LANCET, V351, P1451; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Geffen DB, 2011, ANN ONCOL; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Lende TH, 2011, J CLIN ONCOL, V29, P852, DOI 10.1200/JCO.2009.25.0407; Mook S, 2009, LANCET ONCOL, V10, P1070, DOI 10.1016/S1470-2045(09)70254-2; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Penault-Llorca F, 2008, ONCOLOGIST, V13, P1235, DOI 10.1634/theoncologist.2008-0073; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Ravdin PM, 1995, B CANCER, V82, pS561; Ravdin PM, 1996, SEMIN ONCOL, V23, P43; Retel VP, 2010, EUR J CANCER, V46, P1382, DOI 10.1016/j.ejca.2010.02.035; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Schemper M, 2003, STAT MED, V22, P2299, DOI 10.1002/sim.1486; Schmidt M, 2009, ANN ONCOL, V20, P258, DOI 10.1093/annonc/mdn590; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; TODD JH, 1987, BRIT J CANCER, V56, P489, DOI 10.1038/bjc.1987.230; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Weigelt B, 2011, NAT REV CLIN ONCOL; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	34	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27446	10.1371/journal.pone.0027446	http://dx.doi.org/10.1371/journal.pone.0027446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087319	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700047
J	Huang, T; Sun, LG; Stark, J; Wang, YH; Cheng, ZQ; Yang, QC; Sun, S				Huang, Tao; Sun, Liguang; Stark, John; Wang, Yuhong; Cheng, Zhongqi; Yang, Qichao; Sun, Song			Relative Changes in Krill Abundance Inferred from Antarctic Fur Seal	PLOS ONE			English	Article							STABLE-ISOTOPES; SOUTHERN-OCEAN; MIGRATION PATTERNS; MARINE ECOSYSTEMS; LAKE-SEDIMENTS; TROPHIC LEVELS; CLIMATE-CHANGE; ICE EXTENT; FOOD-WEB; DIET	Antarctic krill Euphausia superba is a predominant species in the Southern Ocean, it is very sensitive to climate change, and it supports large stocks of fishes, seabirds, seals and whales in Antarctic marine ecosystems. Modern krill stocks have been estimated directly by net hauls and acoustic surveys; the historical krill density especially the long-term one in the Southern Ocean, however, is unknown. Here we inferred the relative krill population changes along the West Antarctic Peninsula (WAP) over the 20th century from the trophic level change of Antarctic fur seal Arctocephalus gazella using stable carbon (delta C-13) and nitrogen (delta N-15) isotopes of archival seal hairs. Since Antarctic fur seals feed preferentially on krill, the variation of delta N-15 in seal hair indicates a change in the proportion of krill in the seal's diets and thus the krill availability in local seawater. For the past century, enriching fur seal delta N-15 values indicated decreasing krill availability. This is agreement with direct observation for the past similar to 30 years and suggests that the recently documented decline in krill populations began in the early parts of the 20th century. This novel method makes it possible to infer past krill population changes from ancient tissues of krill predators.	[Huang, Tao; Sun, Liguang; Wang, Yuhong; Yang, Qichao] Univ Sci & Technol China, Inst Polar Environm, Sch Earth & Space Sci, Hefei 230026, Peoples R China; [Stark, John] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Stark, John] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Wang, Yuhong; Sun, Song] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Cheng, Zhongqi] CUNY Brooklyn Coll, Brooklyn, NY 11210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Chinese Academy of Sciences; Institute of Oceanology, CAS; City University of New York (CUNY) System; Brooklyn College (CUNY)	Huang, T (corresponding author), Univ Sci & Technol China, Inst Polar Environm, Sch Earth & Space Sci, Hefei 230026, Peoples R China.	slg@ustc.edu.cn	Cheng, Zhongqi/K-4148-2018	Cheng, Zhongqi/0000-0002-2486-9662; Huang, Tao/0000-0001-5035-1632	National Natural Science Foundation of China [40730107, 41106162]; Chinese Arctic and Antarctic Administration; Polar Research Institute of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Arctic and Antarctic Administration; Polar Research Institute of China	Funding for this work was provided by the National Natural Science Foundation of China (No. 40730107 and No. 41106162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Chinese Arctic and Antarctic Administration and Polar Research Institute of China for support in field, and all the people who provided help in field.	Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; APPLEBY PG, 1995, J PALEOLIMNOL, V13, P179, DOI 10.1007/BF00678106; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Casaux R, 1998, POLAR BIOL, V20, P424, DOI 10.1007/s003000050324; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Crosta X, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000565; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hodgson DA, 1997, NATURE, V387, P30, DOI 10.1038/387030a0; Hofmann EE, 2004, ANTARCT SCI, V16, P487, DOI 10.1017/S0954102004002275; Liu XD, 2004, PROG NAT SCI-MATER, V14, P786, DOI 10.1080/10020070412331344331; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; Miller DG, 1989, BIOMASS SCI SER, V9, P1; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reid K, 1999, MAR ECOL PROG SER, V177, P103, DOI 10.3354/meps177103; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Sun LG, 2000, NATURE, V407, P858, DOI 10.1038/35038163; Sun LG, 2004, POLAR BIOL, V27, P495, DOI 10.1007/s00300-004-0608-2; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; Yang QC, 2010, CHINESE SCI BULL, V55, P1084, DOI 10.1007/s11434-009-0581-9	29	21	29	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27331	10.1371/journal.pone.0027331	http://dx.doi.org/10.1371/journal.pone.0027331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087294	Green Published, gold			2022-12-27	WOS:000297347700042
J	Rosani, U; Varotto, L; Rossi, A; Roch, P; Novoa, B; Figueras, A; Pallavicini, A; Venier, P				Rosani, Umberto; Varotto, Laura; Rossi, Alberta; Roch, Philippe; Novoa, Beatriz; Figueras, Antonio; Pallavicini, Alberto; Venier, Paola			Massively Parallel Amplicon Sequencing Reveals Isotype-Specific Variability of Antimicrobial Peptide Transcripts in Mytilus galloprovincialis	PLOS ONE			English	Article							INNATE IMMUNITY; COPY NUMBER; MUSSELS; EXPRESSION; DEFENSE; INVOLVEMENT; MYTICIN; DNA; RESISTANCE; HEMOCYTES	Background: Effective innate responses against potential pathogens are essential in the living world and possibly contributed to the evolutionary success of invertebrates. Taken together, antimicrobial peptide (AMP) precursors of defensin, mytilin, myticin and mytimycin can represent about 40% of the hemocyte transcriptome in mussels injected with viral-like and bacterial preparations, and unique profiles of myticin C variants are expressed in single mussels. Based on amplicon pyrosequencing, we have ascertained and compared the natural and Vibrio-induced diversity of AMP transcripts in mussel hemocytes from three European regions. Methodology/Principal Findings: Hemolymph was collected from mussels farmed in the coastal regions of Palavas (France), Vigo (Spain) and Venice (Italy). To represent the AMP families known in M. galloprovincialis, nine transcript sequences have been selected, amplified from hemocyte RNA and subjected to pyrosequencing. Hemolymph from farmed (offshore) and wild (lagoon) Venice mussels, both injected with 10 7 Vibrio cells, were similarly processed. Amplicon pyrosequencing emphasized the AMP transcript diversity, with Single Nucleotide Changes (SNC) minimal for mytilin B/C and maximal for arthropod-like defensin and myticin C. Ratio of non-synonymous vs. synonymous changes also greatly differed between AMP isotypes. Overall, each amplicon revealed similar levels of nucleotidic variation across geographical regions, with two main sequence patterns confirmed for mytimycin and no substantial changes after immunostimulation. Conclusions/Significance: Barcoding and bidirectional pyrosequencing allowed us to map and compare the transcript diversity of known mussel AMPs. Though most of the genuine cds variation was common to the analyzed samples we could estimate from 9 to 106 peptide variants in hemolymph pools representing 100 mussels, depending on the AMP isoform and sampling site. In this study, no prevailing SNC patterns related to geographical origin or Vibrio injection emerged. Whether or not the contact with potential pathogens can increase the amount of AMP transcript variants in mussels requires additional study.	[Rosani, Umberto; Varotto, Laura; Rossi, Alberta; Venier, Paola] Univ Padua, Dept Biol, Padua, Italy; [Roch, Philippe] Univ Montpellier 2, CNRS, IRD, Montpellier, France; [Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain; [Pallavicini, Alberto] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Padua; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Trieste	Rosani, U (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	umberto.rosani@unipd.it; paola.venier@unipd.it	Venier, Paola/J-6302-2019; Pallavicini, Alberto/H-9281-2019; Figueras, Antonio/AAB-8921-2019; Pallavicini, Alberto/J-4158-2012; Figueras, Antonio/B-5133-2015; rosani, umbero/I-6007-2019; Novoa, Beatriz/K-3785-2014	Venier, Paola/0000-0001-9634-3662; Pallavicini, Alberto/0000-0001-7174-4603; Figueras, Antonio/0000-0002-0617-0030; Pallavicini, Alberto/0000-0001-7174-4603; Figueras, Antonio/0000-0002-0617-0030; rosani, umbero/0000-0003-0685-1618; Novoa, Beatriz/0000-0003-4888-8419	 [FOOD-CT-2005-007103];  [20084BEJ9F-PRIN08]	; 	This study was funded by the European project FOOD-CT-2005-007103 (http://imaquanim.dfvf.dk/info) and, in part, by the Italian Project 20084BEJ9F-PRIN08 (http://prin.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, MAR GENOM, V4, P61, DOI 10.1016/j.margen.2011.01.001; Akaishi FM, 2007, AQUAT TOXICOL, V82, P1, DOI 10.1016/j.aquatox.2007.01.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babarro JMF, 2008, COMP BIOCHEM PHYS A, V151, P108, DOI 10.1016/j.cbpa.2008.06.006; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Benaglio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013071; BERKOWITZ BA, 1990, BIOCHEM PHARMACOL, V39, P625, DOI 10.1016/0006-2952(90)90138-B; Bers AV, 2006, BIOFOULING, V22, P251, DOI 10.1080/08927010600901112; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; Cellura C, 2007, FISH SHELLFISH IMMUN, V22, P340, DOI 10.1016/j.fsi.2006.06.007; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Chen QX, 2010, ANESTHESIOLOGY, V112, P1428, DOI 10.1097/ALN.0b013e3181d968eb; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Francisco CJ, 2010, J PARASITOL, V96, P200, DOI 10.1645/GE-2064.1; Galler S, 2008, J MUSCLE RES CELL M, V29, P73, DOI 10.1007/s10974-008-9149-6; Gao B, 2010, DEV COMP IMMUNOL, V34, P659, DOI 10.1016/j.dci.2010.01.012; Gerard K, 2008, MOL PHYLOGENET EVOL, V49, P84, DOI 10.1016/j.ympev.2008.07.006; Gilg MR, 2003, EVOLUTION, V57, P1061, DOI 10.1111/j.0014-3820.2003.tb00316.x; Gomez DK, 2008, J INVERTEBR PATHOL, V97, P197, DOI 10.1016/j.jip.2007.10.012; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Hamilton CE, 2010, RNA BIOL, V7, P220, DOI 10.4161/rna.7.2.11344; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Lazzaro BP, 2011, SCIENCE, V332, P43, DOI 10.1126/science.1200486; Li H, 2010, FISH SHELLFISH IMMUN, V28, P640, DOI 10.1016/j.fsi.2009.12.022; Li H, 2009, DEV COMP IMMUNOL, V33, P974, DOI 10.1016/j.dci.2009.04.002; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f; Mitta G, 2000, J BIOL CHEM, V275, P12954, DOI 10.1074/jbc.275.17.12954; Mitta G, 2000, J CELL SCI, V113, P2759; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Pantzartzi C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000847; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Parisi MG, 2009, MOL IMMUNOL, V46, P384, DOI 10.1016/j.molimm.2008.10.009; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Rayyan A, 2006, DIS AQUAT ORGAN, V70, P251, DOI 10.3354/dao070251; Roch P, 2008, DEV COMP IMMUNOL, V32, P227, DOI 10.1016/j.dci.2007.05.006; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Rozen S, 2000, Methods Mol Biol, V132, P365; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Smith LC, 2010, DIS MODEL MECH, V3, P1; Sonthi M, 2011, MAR BIOTECHNOL, V13, P857, DOI 10.1007/s10126-010-9345-4; Sperstad SV, 2011, BIOTECHNOL IN PRESS; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P954, DOI 10.1016/j.fsi.2011.01.031	64	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26680	10.1371/journal.pone.0026680	http://dx.doi.org/10.1371/journal.pone.0026680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087233	gold, Green Published			2022-12-27	WOS:000297347700008
J	Al-Alwan, M; Olabi, S; Ghebeh, H; Barhoush, E; Tulbah, A; Al-Tweigeri, T; Ajarim, D; Adra, C				Al-Alwan, Monther; Olabi, Safiah; Ghebeh, Hazem; Barhoush, Eman; Tulbah, Asma; Al-Tweigeri, Taher; Ajarim, Dahish; Adra, Chaker			Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules	PLOS ONE			English	Article							NF-KAPPA-B; MYOEPITHELIAL CELL LINEAGES; BUNDLING PROTEIN; GENE-EXPRESSION; CARCINOMA METASTASIS; ESTROGEN-RECEPTOR; PLASMINOGEN-ACTIVATOR; RELA/P65 SUBUNIT; TUMOR-METASTASIS; DENDRITIC CELLS	The actin-bundling protein, fascin, is a member of the cytoskeletal protein family that has restricted expression in specialized normal cells. However, many studies have reported the induction of this protein in various transformed cells including breast cancer cells. While the role of fascin in the regulation of breast cancer cell migration has been previously shown, the underlying molecular mechanism remained poorly defined. We have used variety of immunological and functional assays to study whether fascin regulates breast cancer metastasis-associated molecules. In this report we found a direct relationship between fascin expression in breast cancer patients and; metastasis and shorter disease-free survival. Most importantly, in vitro interference with fascin expression by loss or gain of function demonstrates a central role for this protein in regulating the cell morphology, migration and invasion potential. Our results show that fascin regulation of invasion is mediated via modulating several metastasis-associated genes. We show for the first time that fascin down-regulates the expression and nuclear translocation of a key metastasis suppressor protein known as breast cancer metastasis suppressor-1 (BRMS1). In addition, fascin up-regulates NF-kappa B activity, which is essential for metastasis. Importantly, fascin up-regulates other proteins that are known to be critical for the execution of metastasis such as urokinase-type plasminogen activator (uPA) and the matrix metalloproteases (MMP)-2 and MMP-9. This study demonstrates that fascin expression in breast cancer cells establishes a gene expression profile consistent with metastatic tumors and offers a potential therapeutic intervention in metastatic breast cancer treatment through fascin targeting.	[Al-Alwan, Monther; Olabi, Safiah; Ghebeh, Hazem; Barhoush, Eman; Adra, Chaker] King Faisal Specialist Hosp & Res Ctr, Stem Cell Therapy Program, Riyadh 11211, Saudi Arabia; [Tulbah, Asma] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Al-Tweigeri, Taher; Ajarim, Dahish] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia; [Adra, Chaker] Harvard Univ, Brigham & Womens Hosp, Sch Med, TRC, Boston, MA 02115 USA; [Adra, Chaker] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Al-Alwan, M (corresponding author), King Faisal Specialist Hosp & Res Ctr, Stem Cell Therapy Program, Riyadh 11211, Saudi Arabia.	MAlwan@kfshrc.edu.sa	Olabi, Safaih/AAG-8956-2020; Ghebeh, Hazem/AAR-1453-2021	Olabi, Safaih/0000-0002-2850-0475; Ghebeh, Hazem/0000-0002-3297-3996; Al-Alwan, Monther/0000-0003-2150-5297	Research Advisory Council, King Faisal Specialist Hospital and Research Centre [2060 016]	Research Advisory Council, King Faisal Specialist Hospital and Research Centre	This work was supported by the Research Advisory Council (proposal grant 2060 016), King Faisal Specialist Hospital and Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Al-Alwan MM, 2001, J IMMUNOL, V166, P338, DOI 10.4049/jimmunol.166.1.338; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Bashyam MD, 2002, CANCER, V94, P1821, DOI 10.1002/cncr.10362; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Boecker W, 2003, CELL PROLIFERAT, V36, P73, DOI 10.1046/j.1365-2184.36.s.1.7.x; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DUH FM, 1994, DNA CELL BIOL, V13, P821, DOI 10.1089/dna.1994.13.821; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Frolova N, 2009, TUMOR BIOL, V30, P148, DOI 10.1159/000228908; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Gordon LA, 2003, INT J CANCER, V106, P8, DOI 10.1002/ijc.11172; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; JIANG P, 2009, CANC LETT; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Mosialos G, 1996, AM J PATHOL, V148, P593; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Naffar-Abu-Amara S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001457; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Onodera M, 2009, LAB INVEST, V89, P1261, DOI 10.1038/labinvest.2009.89; Pinkus GS, 1997, AM J PATHOL, V150, P543; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Saaristo A, 2000, ONCOGENE, V19, P6122, DOI 10.1038/sj.onc.1203969; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Seraj MJ, 2000, CANCER RES, V60, P2764; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Tran J, 2007, MOL THER, V15, P1331, DOI 10.1038/sj.mt.6300184; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	53	79	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27339	10.1371/journal.pone.0027339	http://dx.doi.org/10.1371/journal.pone.0027339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076152	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200066
J	Radpour, R; Barekati, Z; Kohler, C; Schumacher, MM; Grussenmeyer, T; Jenoe, P; Hartmann, N; Moes, S; Letzkus, M; Bitzer, J; Lefkovits, I; Staedtler, F; Zhong, XY				Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Schumacher, Martin M.; Grussenmeyer, Thomas; Jenoe, Paul; Hartmann, Nicole; Moes, Suzette; Letzkus, Martin; Bitzer, Johannes; Lefkovits, Ivan; Staedtler, Frank; Zhong, Xiao Yan			Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation Treatment	PLOS ONE			English	Article							DNA METHYLATION; TUMOR-SUPPRESSOR; MYELODYSPLASTIC SYNDROMES; POOR-PROGNOSIS; LUNG-CANCER; CELL-LINES; PHASE-III; IN-VIVO; EXPRESSION; METASTASIS	Background: The contribution of aberrant DNA methylation in silencing of tumor suppressor genes (TSGs) and microRNAs has been investigated. Since these epigenetic alterations are reversible, it became of interest to determine the effects of the 5-aza-2'-deoxycytidine (DAC) demethylation therapy in breast cancer at different molecular levels. Methods and Findings: Here we investigate a synoptic model to predict complete DAC treatment effects at the level of genes, microRNAs and proteins for several human breast cancer lines. The present study assessed an effective treatment dosage based on the cell viability, cytotoxicity, apoptosis and methylation assays for the investigated cell lines. A highly aggressive and a non-aggressive cell line were investigated using omics approaches such as MALDI-TOF MS, mRNA- and microRNA expression arrays, 2-D gel electrophoresis and LC-MS-MS. Complete molecular profiles including the biological interaction and possible early and late systematic stable or transient effects of the methylation inhibition were determined. Beside the activation of several epigenetically suppressed TSGs, we also showed significant dysregulation of some important oncogenes, oncomiRs and oncosuppressors miRNAs as well as drug tolerance genes/miRNAs/proteins. Conclusions: In the present study, the results denote some new molecular DAC targets and pathways based on the chemical modification of DNA methylation in breast cancer. The outlined approach might prove to be useful as an epigenetic treatment model also for other human solid tumors in the management of cancer patients.	[Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Zhong, Xiao Yan] Univ Basel, Lab Gynecol Oncol, Womens Hosp, Dept Biomed, Basel, Switzerland; [Schumacher, Martin M.; Hartmann, Nicole; Letzkus, Martin; Staedtler, Frank] Novartis Pharma AG, Biomarker Dev, Novartis Inst BioMed Res, Basel, Switzerland; [Grussenmeyer, Thomas; Lefkovits, Ivan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Grussenmeyer, Thomas; Lefkovits, Ivan] Univ Basel Hosp, Dept Cardiac Surg, CH-4031 Basel, Switzerland; [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, Basel, Switzerland; [Bitzer, Johannes] Univ Basel, Dept Obstet & Gynecol, Womens Hosp, Basel, Switzerland	University of Basel; Novartis; University of Basel; University of Basel; University of Basel; University of Basel	Radpour, R (corresponding author), Univ Basel, Lab Gynecol Oncol, Womens Hosp, Dept Biomed, Basel, Switzerland.	ivan.lefkovits@unibas.ch; frank.staedtler@novartis.com; zhongx@uhbs.ch	Lefkovits, Ivan/B-9777-2009; Radpour, Ramin/J-4949-2014	Lefkovits, Ivan/0000-0003-1783-8881; Radpour, Ramin/0000-0002-5632-7833; Schumacher, Martin/0000-0001-9538-8682	Swiss National Science Foundation Basel, Switzerland [320000-119722/1, 320030_124958/1]	Swiss National Science Foundation Basel, Switzerland	This work was supported in part by Swiss National Science Foundation (320000-119722/1 and 320030_124958/1) Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; Barekati Z, 2010, HUM MOL GENET, V19, P2936, DOI 10.1093/hmg/ddq199; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita T, 2006, CYTOKINE, V34, P271, DOI 10.1016/j.cyto.2006.06.002; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Issa Jean-Pierre, 2003, Current Opinion in Oncology, V15, P446, DOI 10.1097/00001622-200311000-00007; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Li JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-354; Li Min, 2005, Archives of Gynecology and Obstetrics, V272, P48, DOI 10.1007/s00404-004-0708-9; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Moggs JG, 2004, TOXICOL APPL PHARM, V196, P422, DOI 10.1016/j.taap.2004.01.009; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; MUSGROVE EA, 1995, INT J CANCER, V63, P584, DOI 10.1002/ijc.2910630420; Plante I., 2010, ONCOGENE; POLLACK MS, 1981, J NATL CANCER I, V66, P1003, DOI 10.1093/jnci/66.6.1003; Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149; Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016080; Radpour R, 2009, J PROTEOME RES, V8, P5264, DOI 10.1021/pr900591w; Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Rivenbark AG, 2007, EXP MOL PATHOL, V83, P188, DOI 10.1016/j.yexmp.2007.03.008; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; SMITH HS, 1979, J NATL CANCER I, V62, P225; Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	70	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27355	10.1371/journal.pone.0027355	http://dx.doi.org/10.1371/journal.pone.0027355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076154	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200068
J	Ryman, SG; Gasparovic, C; Bedrick, EJ; Flores, RA; Marshall, AN; Jung, RE				Ryman, Sephira G.; Gasparovic, Chuck; Bedrick, Edward J.; Flores, Ranee A.; Marshall, Alison N.; Jung, Rex E.			Brain Biochemistry and Personality: A Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							N-ACETYLASPARTATE LEVELS; MAJOR DEPRESSION; CINGULATE CORTEX; INTELLIGENCE; EXTROVERSION; ANATOMY; NETWORK; MARKERS	To investigate the biochemical correlates of normal personality we utilized proton magnetic resonance spectroscopy (H-1-MRS). Our sample consisted of 60 subjects ranging in age from 18 to 32 (27 females). Personality was assessed with the NEO Five-Factor Inventory (NEO-FFI). We measured brain biochemistry within the precuneus, the cingulate cortex, and underlying white matter. We hypothesized that brain biochemistry within these regions would predict individual differences across major domains of personality functioning. Biochemical models were fit for all personality domains including Neuroticism, Extraversion, Openness, Agreeableness, and Conscientiousness. Our findings involved differing concentrations of Choline (Cho), Creatine (Cre), and N-acetylaspartate (NAA) in regions both within (i.e., posterior cingulate cortex) and white matter underlying (i.e., precuneus) the Default Mode Network (DMN). These results add to an emerging literature regarding personality neuroscience, and implicate biochemical integrity within the default mode network as constraining major personality domains within normal human subjects.	[Ryman, Sephira G.; Gasparovic, Chuck; Flores, Ranee A.; Marshall, Alison N.; Jung, Rex E.] Univ New Mexico, Hlth Sci Ctr, MRN, Albuquerque, NM 87131 USA; [Bedrick, Edward J.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; [Marshall, Alison N.; Jung, Rex E.] Univ New Mexico, Hlth Sci Ctr, Dept Neurosurg, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Ryman, SG (corresponding author), Univ New Mexico, Hlth Sci Ctr, MRN, Albuquerque, NM 87131 USA.	rex.jung@gmail.com		Jung, Rex/0000-0003-3718-0597	John Templeton Foundation [22156]	John Templeton Foundation	This research was funded by grant number 22156 from the John Templeton Foundation entitled "The Neuroscience of Scientific Creativity." http://www.templeton.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; DeYoung C, CAMBRIDGE HDB INTELL; DeYoung CG, 2010, EUR J PERSONALITY, V24, P404; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dinzeo TJ, 2007, J NERV MENT DIS, V195, P421, DOI 10.1097/01.nmd.0000253795.69089.ec; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gjedde A, 1999, ADV EXP MED BIOL, V471, P67; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; Jung RE, 2005, NEUROIMAGE, V26, P965, DOI 10.1016/j.neuroimage.2005.02.039; Jung RE, 2002, BIOL PSYCHIAT, V51, P224, DOI 10.1016/S0006-3223(01)01224-0; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; Jung RE, 2009, INTELLIGENCE, V37, P192, DOI 10.1016/j.intell.2008.10.009; Jung RE, 2009, J NEUROSCI, V29, P5319, DOI 10.1523/JNEUROSCI.0588-09.2009; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; McCrae R.R., 1993, IMAGIN COGN PERS, V13, P39, DOI [10.2190/H8H6-QYKR-KEU8-GAQ0, DOI 10.2190/H8H6-QYKR-KEU8-GAQ0]; Moore Gregory J, 2002, Psychopharmacol Bull, V36, P5; Moutafi J, 2006, PERS INDIV DIFFER, V40, P587, DOI 10.1016/j.paid.2005.08.004; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Pfleiderer B, 2004, NEUROSCIENCE, V123, P1053, DOI 10.1016/j.neuroscience.2003.11.008; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rae C, 1996, P ROY SOC B-BIOL SCI, V263, P1061, DOI 10.1098/rspb.1996.0156; Rae C, 2003, DEV NEUROSCI-BASEL, V25, P324, DOI 10.1159/000073509; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sundberg R, 2002, ENCY ENV; Valenzuela MJ, 2000, NEUROIMAGE, V12, P747, DOI 10.1006/nimg.2000.0629; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WIDIGER TA, 1994, J ABNORM PSYCHOL, V103, P78, DOI 10.1037/0021-843X.103.1.78; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	41	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26758	10.1371/journal.pone.0026758	http://dx.doi.org/10.1371/journal.pone.0026758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073190	Green Published, Green Submitted, gold			2022-12-27	WOS:000297197000012
J	Soria, A; Guerini, FR; Bandera, A; Bolognesi, E; Uglietti, A; Fusco, C; Zucchi, P; Maserati, R; Rizzardini, G; Clerici, M; Gori, A				Soria, Alessandro; Guerini, Franca Rosa; Bandera, Alessandra; Bolognesi, Elisabetta; Uglietti, Alessia; Fusco, Caterina; Zucchi, Patrizia; Maserati, Renato; Rizzardini, Giuliano; Clerici, Mario; Gori, Andrea			KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy	PLOS ONE			English	Article							COUNT RECOVERY; CELL RECOVERY; RECEPTOR; PROGRESSION; SUBTYPES; AIDS	Background: In HIV-infected individuals, mechanisms underlying unsatisfactory immune recovery during effective combination antiretroviral therapy (cART) have yet to be fully understood. We investigated whether polymorphism of genes encoding immune-regulating molecules, such as killer immunoglobulin-like receptors (KIR) and their ligands class I human leukocyte antigen (HLA), could influence immunological response to cART. Methods: KIR and HLA frequencies were analyzed in 154 HIV-infected and cART-treated patients with undetectable viral load divided into two groups: 'immunological non responders' (INR, N = 50, CD4(+) T-cell count <200/mm(3)) and full responders (FR, N = 104, CD4(+) T-cell count >350/mm(3)). Molecular KIR were typed using polymerase chain reaction-based genotyping. Comparisons were adjusted for baseline patient characteristics. Results: The frequency of KIR2DL3 allele was significantly higher in FR than in INR (83.7% vs. 62%, P = 0.005). The functional compound genotype HLA-C1(+)/KIR2DL3(+), even at multivariable analysis, when adjusted for nadir CD4(+) T-cell count, was associated with reduced risk of INR status: odds ratio (95% Confidence Intervals) 0.34 (0.13-0.88), P = 0.03. Conclusions: Reduced presence of the inhibitory KIR2DL3 genotype detected in INR might provoke an imbalance in NK function, possibly leading to increased immune activation, impaired killing of latently infected cells, and higher proviral burden. These factors would hinder full immune recovery during therapy.	[Soria, Alessandro; Bandera, Alessandra; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Guerini, Franca Rosa; Bolognesi, Elisabetta; Clerici, Mario] Don C Gnocchi Fdn IRCCS, Lab Mol Med & Biotechnol, Milan, Italy; [Uglietti, Alessia; Maserati, Renato] Fdn IRCCS San Matteo Hosp, Dept Infect Dis, Pavia, Italy; [Fusco, Caterina] AORN A Cardarelli, Immunohematol & Transfus Serv, Naples, Italy; [Zucchi, Patrizia; Rizzardini, Giuliano] Luigi Sacco Hosp, Div Infect Dis, Milan, Italy; [Clerici, Mario] Univ Milan, Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Fondazione San Matteo; University of Milan; Luigi Sacco Hospital; University of Milan	Soria, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	a.soria@hsgerardo.org	Guerini, Franca R./G-8055-2012; Gori, Andrea/AAC-6078-2022; Zucchi, Patrizia/AFQ-5312-2022; Bandera, Alessandra/AAC-6081-2022; Bolognesi, Elisabetta/AAC-1629-2022; Bandera, Alessandra/D-6255-2015	Guerini, Franca R./0000-0001-9461-5927; SORIA, Alessandro/0000-0002-4447-2574; Clerici, Mario/0000-0001-5920-6191; Bolognesi, Elisabetta/0000-0001-5554-1697; Fusco, Caterina/0000-0001-8124-6376; BANDERA, ALESSANDRA/0000-0001-9440-4601; Bandera, Alessandra/0000-0003-1626-0328	Cariplo Foundation [2006.0687/10.4877]; "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Cariplo Foundation(Fondazione Cariplo); "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	This work was supported by a grant from Cariplo Foundation (2006.0687/10.4877), "Ermenegildo Zegna" Foundation, Italy, and Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Boyton RJ, 2006, AM J RESP CRIT CARE, V173, P327, DOI 10.1164/rccm.200501-124OC; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferraris L, 2008, CLIN INFECT DIS, V46, P149, DOI 10.1086/524087; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; KLATT N, 2010, 17 C RETR OPP INF SA; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Wong AHW, 2010, AIDS RES HUM RETROV, V26, P459, DOI 10.1089/aid.2009.0176	24	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27349	10.1371/journal.pone.0027349	http://dx.doi.org/10.1371/journal.pone.0027349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073315	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000048
J	Vaknin, I; Kunis, G; Miller, O; Butovsky, O; Bukshpan, S; Beers, DR; Henkel, JS; Yoles, E; Appel, SH; Schwartz, M				Vaknin, Ilan; Kunis, Gilad; Miller, Omer; Butovsky, Oleg; Bukshpan, Shay; Beers, David R.; Henkel, Jenny S.; Yoles, Eti; Appel, Stanley H.; Schwartz, Michal			Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPPRESSOR-CELLS; IMMUNE-SYSTEM; INHERITED ALS; MOTOR-NEURONS; DISEASE; CANCER; MODEL; IMMUNOSUPPRESSION; NEUROPROTECTION	Background: Circulating immune cells including autoreactive T cells and monocytes have been documented as key players in maintaining, protecting and repairing the central nervous system (CNS) in health and disease. Here, we hypothesized that neurodegenerative diseases might be associated, similarly to tumors, with increased levels of circulating peripheral myeloid derived suppressor cells (MDSCs), representing a subset of suppressor cells that often expand under pathological conditions and inhibit possible recruitment of helper T cells needed for fighting off the disease. Methods and Findings: We tested this working hypothesis in amyotrophic lateral sclerosis (ALS) and its mouse model, which are characterized by a rapid progression once clinical symptoms are evident. Adaptive transfer of alternatively activated myeloid (M2) cells, which homed to the spleen and exhibited immune suppressive activity in G93A mutant superoxide dismutase-1 (mSOD1) mice at a stage before emergence of disease symptoms, resulted in earlier appearance of disease symptoms and shorter life expectancy. The same protocol mitigated the inflammation-induced disease model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), which requires circulating T cells for disease induction. Analysis of whole peripheral blood samples obtained from 28 patients suffering from sporadic ALS (sALS), revealed a two-fold increase in the percentage of circulating MDSCs (LIN(-/Low)HLA-DR(-)CD33(+)) compared to controls. Conclusions: Taken together, these results emphasize the distinct requirements for fighting the inflammatory neurodegenerative disease, multiple sclerosis, and the neurodegenerative disease, ALS, though both share a local inflammatory component. Moreover, the increased levels of circulating MDSCs in ALS patients indicates the operation of systemic mechanisms that might lead to an impairment of T cell reactivity needed to overcome the disease conditions within the CNS. This high level of suppressive immune cells might represent a risk factor and a novel target for therapeutic intervention in ALS at least at the early stage.	[Vaknin, Ilan; Kunis, Gilad; Miller, Omer; Butovsky, Oleg; Bukshpan, Shay; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Beers, David R.; Henkel, Jenny S.; Appel, Stanley H.] Methodist Hosp, Res Inst, Methodist Neurol Inst, Dept Neurol, Houston, TX 77030 USA; [Yoles, Eti] NeuroQuest Ltd, Misgav Venture Accelerator, Misgav, Israel	Weizmann Institute of Science; The Methodist Hospital System; The Methodist Hospital - Houston	Vaknin, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	sappel@tmhs.org; michal.schwartz@weizmann.ac.il	Butovsky, Oleg/ABG-9086-2020	Butovsky, Oleg/0000-0003-0186-8867	Israel Science Foundation (ISF) [710312020]; IsrA.L.S Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088137] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); IsrA.L.S Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Israel Science Foundation (ISF)-Legacy-Bio-Med program, grant No. 710312020, and was also supported by the IsrA.L.S Research Fund. The funders had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; nor the preparation, review, or approval of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Finkelstein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022374; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Katchar K, 2001, SCAND J IMMUNOL, V54, P220, DOI 10.1046/j.1365-3083.2001.00923.x; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Moline-Velazquez V, 2011, BRAIN PATHOL, V21, P678, DOI 10.1111/j.1750-3639.2011.00495.x; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SEKSENYAN A, 2009, J CELL MOL MED; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009	30	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26921	10.1371/journal.pone.0026921	http://dx.doi.org/10.1371/journal.pone.0026921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073221	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000016
J	Zhang, Z; Tao, LM; Chen, Z; Zhou, DZ; Kan, MY; Zhang, D; Li, C; He, L; Liu, Y				Zhang, Zhou; Tao, Liming; Chen, Zhuo; Zhou, Daizhan; Kan, Mengyuan; Zhang, Di; Li, Can; He, Lin; Liu, Yun			Association of Genetic Loci with Blood Lipids in the Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-DISEASE; RISK; CHOLESTEROL; TRIGLYCERIDES; POLYMORPHISM	Background: Recent genome-wide association (GWA) studies have identified a number of novel genetic determinants of blood lipid concentrations in Europeans. However, it is still unclear whether these loci identified in the Caucasian GWA studies also exert the same effect on lipid concentrations in the Chinese population. Methods and Results: We conducted a replication study assessing associations between SNPs at 15 loci and blood lipid and lipoprotein concentrations in two Chinese cohorts, comprising 2533 and 2105 individuals respectively. SNPs in APO(A1/C3/A4/A5), TIMD4-HAVCR1, DOCK7, TRIB1, ABCA1, and TOMM40-APOE showed strong associations with at least one lipids trait, and rs174546 in FADS1/2/3 showed modest association with triglyceride in the Chinese population. Conclusions: We successfully replicated 7 loci associated plasma lipid concentrations in the Chinese population. Our study confirmed the implication of APO(A1/C3/A4/A5), TOMM40-APOE, ABCA1, DOCK7, TIMD4-HAVCR1, TRIB1 and FADS1/2 in plasma lipid and lipoprotein concentrations in Chinese population.	[Zhang, Zhou; Tao, Liming; Chen, Zhuo; Zhou, Daizhan; Kan, Mengyuan; Zhang, Di] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Zhang, Zhou; He, Lin; Liu, Yun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Can; He, Lin] Shanghai Jiao Tong Univ, Key Lab Dev Genet & Neuropsychiat Dis, Minist Educ, Bio X Ctr, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Shanghai Jiao Tong University	Zhang, Z (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China.	helin@bio-x.cn; superliuyun@gmail.com	liming, tao/D-7969-2013; chen, zhuo/E-7041-2012		973 Program [2010CB529600, 2007CB947300, 2006CB910601]; 863 Program [2006AA02A407, 2009AA022701]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; National Key Project for Investigational New Drug [2008ZX09312-003]; Shanghai Leading Academic Discipline Project [B205]; National Natural Science Foundation of China [909190492, 30972529]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Shanghai Municipal Commission of Science and Technology Program; National Key Project for Investigational New Drug; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 Program (2010CB529600, 2007CB947300, 2006CB910601), the 863 Program (2006AA02A407, 2009AA022701), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the National Key Project for Investigational New Drug 2008ZX09312-003, and the Shanghai Leading Academic Discipline Project (B205), and the National Natural Science Foundation of China (No. 909190492, 30972529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Delgado-Lista J, 2010, J LIPID RES, V51, P63, DOI 10.1194/jlr.M800527-JLR200; Gomez P, 2010, J NUTR, V140, P773, DOI 10.3945/jn.109.115964; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Pan LA, 2009, CARDIOLOGY, V114, P174, DOI 10.1159/000226610; Park MH, 2011, J MED GENET, V48, P10, DOI 10.1136/jmg.2010.081000; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	22	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27305	10.1371/journal.pone.0027305	http://dx.doi.org/10.1371/journal.pone.0027305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073310	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000045
J	Coude, G; Ferrari, PF; Roda, F; Maranesi, M; Borelli, E; Veroni, V; Monti, F; Rozzi, S; Fogassi, L				Coude, Gino; Ferrari, Pier Francesco; Roda, Francesca; Maranesi, Monica; Borelli, Eleonora; Veroni, Vania; Monti, Fabio; Rozzi, Stefano; Fogassi, Leonardo			Neurons Controlling Voluntary Vocalization in the Macaque Ventral Premotor Cortex	PLOS ONE			English	Article							LEARNED VOCAL COMMUNICATION; TRAINED TONGUE-PROTRUSION; FACE MOTOR CORTEX; MIRROR NEURONS; RHESUS-MONKEYS; REVERSIBLE INACTIVATION; FUNCTIONAL-PROPERTIES; CORTICAL CONNECTIONS; PREFRONTAL CORTEX; NONHUMAN PRIMATE	The voluntary control of phonation is a crucial achievement in the evolution of speech. In humans, ventral premotor cortex (PMv) and Broca's area are known to be involved in voluntary phonation. In contrast, no neurophysiological data are available about the role of the oro-facial sector of nonhuman primates PMv in this function. In order to address this issue, we recorded PMv neurons from two monkeys trained to emit coo-calls. Results showed that a population of motor neurons specifically fire during vocalization. About two thirds of them discharged before sound onset, while the remaining were time-locked with it. The response of vocalization-selective neurons was present only during conditioned (voluntary) but not spontaneous (emotional) sound emission. These data suggest that the control of vocal production exerted by PMv neurons constitutes a newly emerging property in the monkey lineage, shedding light on the evolution of phonation-based communication from a nonhuman primate species.	[Coude, Gino; Ferrari, Pier Francesco; Roda, Francesca; Maranesi, Monica; Borelli, Eleonora; Veroni, Vania; Monti, Fabio; Rozzi, Stefano; Fogassi, Leonardo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Ferrari, Pier Francesco] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy; [Fogassi, Leonardo] Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; [Coude, Gino; Ferrari, Pier Francesco; Roda, Francesca; Maranesi, Monica; Rozzi, Stefano; Fogassi, Leonardo] Ist Italiano Tecnol, Parma, Italy	University of Parma; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT	Coude, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	gino.coude@nemo.unipr.it	Ferrari, Pier Francesco/G-5547-2017; Borelli, Eleonora/AAU-9973-2021; Rozzi, Stefano/F-9915-2019; FOGASSI, Leonardo/K-3541-2018	Rozzi, Stefano/0000-0002-6147-1530; Borelli, Eleonora/0000-0002-3391-4437; FOGASSI, Leonardo/0000-0003-3348-039X; Maranesi, Monica/0000-0002-8090-3300; Roda', Francesca/0000-0003-4740-8743	European Program Neurocom [12738]; Italian Ministry of Education, Universities and Research [2004057380]	European Program Neurocom; Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by European Program Neurocom no. 12738 2005-2008 and by the Italian Ministry of Education, Universities and Research (Cofin) no. 2004057380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1979, BRAIN LANG, V8, P227, DOI 10.1016/0093-934X(79)90051-8; AITKEN PG, 1981, BRAIN LANG, V13, P171, DOI 10.1016/0093-934X(81)90137-1; Belmalih A, 2009, J COMP NEUROL, V512, P183, DOI 10.1002/cne.21892; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Buch ER, 2006, EXP BRAIN RES, V169, P69, DOI 10.1007/s00221-005-0130-y; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; Egnor SER, 2006, AM J PRIMATOL, V68, P1183, DOI 10.1002/ajp.20317; Fant G., 1960, ACOUSTIC THEORY SPEE; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Fogassi L, 2007, CURR DIR PSYCHOL SCI, V16, P136, DOI 10.1111/j.1467-8721.2007.00491.x; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2008, CURR BIOL, V18, pR457, DOI 10.1016/j.cub.2008.03.030; Gil-Da-Costa R, 2006, NAT NEUROSCI, V9, P1064, DOI 10.1038/nn1741; HAKE DF, 1979, J EXP ANAL BEHAV, V32, P305, DOI 10.1901/jeab.1979.32-305; HAST MH, 1974, BRAIN RES, V73, P229, DOI 10.1016/0006-8993(74)91046-4; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hihara S, 2003, NEUROSCI RES, V45, P383, DOI 10.1016/S0168-0102(03)00011-7; HUANG CS, 1988, J NEUROPHYSIOL, V59, P796, DOI 10.1152/jn.1988.59.3.796; Izumi A, 2001, COGN AFFECT BEHAV NE, V1, P266, DOI 10.3758/CABN.1.3.266; JURGENS U, 1970, EXP BRAIN RES, V10, P532; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lal H., 1967, PSYCHON SCI, V8, P35; Lieberman P, 1998, BEHAV BRAIN SCI, V21, P520, DOI 10.1017/S0140525X98341266; LOUBOUNGOU M, 1987, PRIMATES, V28, P367, DOI 10.1007/BF02381019; MCGUINNESS E, 1980, J COMP NEUROL, V193, P591, DOI 10.1002/cne.901930302; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; MOLLIVER ME, 1963, J EXP ANAL BEHAV, V6, P197, DOI 10.1901/jeab.1963.6-197; Moran A, 2006, MOVEMENT DISORD, V21, P1425, DOI 10.1002/mds.20995; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; MURRAY GM, 1992, J NEUROPHYSIOL, V67, P775, DOI 10.1152/jn.1992.67.3.775; MURRAY GM, 1991, J NEUROPHYSIOL, V65, P511, DOI 10.1152/jn.1991.65.3.511; MYERS RE, 1976, ANN NY ACAD SCI, V280, P745, DOI 10.1111/j.1749-6632.1976.tb25537.x; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Pardo-Vazquez JL, 2008, J NEUROSCI, V28, P12396, DOI 10.1523/JNEUROSCI.3396-08.2008; PENFIELD WILDER, 1950; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; PIERCE J D JR, 1985, Primates, V26, P202, DOI 10.1007/BF02382019; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Rasmussen T., 1975, CEREBRAL LOCALIZATIO, P238, DOI DOI 10.1007/978-3-642-66204-1.J9; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P427; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; SALZINGER K, 1962, J EXP ANAL BEHAV, V5, P383, DOI 10.1901/jeab.1962.5-383; Seyfarth RM, 1997, ANIM LEARN BEHAV, V25, P249, DOI 10.3758/BF03199083; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Simoes CS, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00123; Simonyan K, 2003, BRAIN RES, V974, P43, DOI 10.1016/S0006-8993(03)02548-4; SINNOTT JM, 1975, J ACOUST SOC AM, V58, P412, DOI 10.1121/1.380685; SMITH WK, 1945, J NEUROPHYSIOL, V8, P241, DOI 10.1152/jn.1945.8.4.241; SUTTON D, 1973, BRAIN RES, V52, P225, DOI 10.1016/0006-8993(73)90660-4; SUTTON D, 1974, BRAIN RES, V71, P61, DOI 10.1016/0006-8993(74)90191-7; WEST RA, 1995, J NEUROPHYSIOL, V74, P1856, DOI 10.1152/jn.1995.74.5.1856; Yamaguchi C, 2008, ORIGINS LANGUAGE UNR; YAMAGUCHI SI, 1972, BRAIN RES, V37, P109, DOI 10.1016/0006-8993(72)90350-2; Yoshino K, 1998, NEUROSCI RES, V30, P321, DOI 10.1016/S0168-0102(98)00014-5	71	103	103	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26822	10.1371/journal.pone.0026822	http://dx.doi.org/10.1371/journal.pone.0026822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073201	Green Published, gold			2022-12-27	WOS:000297154900041
J	Dejean, A; Cereghino, R; Carpenter, JM; Corbara, B; Herault, B; Rossi, V; Leponce, M; Orivel, J; Bonal, D				Dejean, Alain; Cereghino, Regis; Carpenter, James M.; Corbara, Bruno; Herault, Bruno; Rossi, Vivien; Leponce, Maurice; Orivel, Jerome; Bonal, Damien			Climate Change Impact on Neotropical Social Wasps	PLOS ONE			English	Article							EL-NINO; AMPHIBIAN EXTINCTIONS; DROUGHT; ECOLOGY; FOREST; SEASONALITY; RESPONSES; VESPIDAE; PRODUCTIVITY; TERRESTRIAL	Establishing a direct link between climate change and fluctuations in animal populations through long-term monitoring is difficult given the paucity of baseline data. We hypothesized that social wasps are sensitive to climatic variations, and thus studied the impact of ENSO events on social wasp populations in French Guiana. We noted that during the 2000 La Nina year there was a 77.1% decrease in their nest abundance along ca. 5 km of forest edges, and that 70.5% of the species were no longer present. Two simultaneous 13-year surveys (1997-2009) confirmed the decrease in social wasps during La Nina years (2000 and 2006), while an increase occurred during the 2009 El Nino year. A 30-year weather survey showed that these phenomena corresponded to particularly high levels of rainfall, and that temperature, humidity and global solar radiation were correlated with rainfall. Using the Self-Organizing Map algorithm, we show that heavy rainfall during an entire rainy season has a negative impact on social wasps. Strong contrasts in rainfall between the dry season and the short rainy season exacerbate this effect. Social wasp populations never recovered to their pre-2000 levels. This is probably because these conditions occurred over four years; heavy rainfall during the major rainy seasons during four other years also had a detrimental effect. On the contrary, low levels of rainfall during the major rainy season in 2009 spurred an increase in social wasp populations. We conclude that recent climatic changes have likely resulted in fewer social wasp colonies because they have lowered the wasps' resistance to parasitoids and pathogens. These results imply that Neotropical social wasps can be regarded as bio-indicators because they highlight the impact of climatic changes not yet perceptible in plants and other animals.	[Dejean, Alain; Orivel, Jerome] CNRS, UMR 8172, Campus Agron,BP 709, Kourou, France; [Dejean, Alain; Cereghino, Regis] Univ Toulouse 3, F-31062 Toulouse, France; [Dejean, Alain; Cereghino, Regis] Univ Toulouse, Toulouse, France; [Cereghino, Regis] CNRS, UMR 5245, Lab Ecol Fonct & Environm EcoLab, Toulouse, France; [Carpenter, James M.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Corbara, Bruno] Univ Blaise Pascal, CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Corbara, Bruno] Univ Blaise Pascal, Clermont Univ, F-63000 Clermont Ferrand, France; [Herault, Bruno] Ecol Forets Guyane UMR UAG 43, Kourou, France; [Herault, Bruno] Univ Antilles Guyane, Kourou, France; [Rossi, Vivien] CIRAD, Kourou, France; [Rossi, Vivien] Ecol Forets Guyane UMR CIRAD 93, Kourou, France; [Leponce, Maurice] Royal Belgian Inst Nat Sci, Biol Evaluat Sect, Brussels, Belgium; [Bonal, Damien] INRA Nancy, UMR EEF, Nancy, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Royal Belgian Institute of Natural Sciences; INRAE; Universite de Lorraine	Dejean, A (corresponding author), CNRS, UMR 8172, Campus Agron,BP 709, Kourou, France.	alain.dejean@wanadoo.fr	CEREGHINO, Regis/G-9500-2011; Hérault, Bruno/B-2765-2011; Rossi, Vivien/C-9721-2009	Hérault, Bruno/0000-0002-6950-7286; Rossi, Vivien/0000-0001-5458-1523; Orivel, Jerome/0000-0002-5636-3228; Cereghino, Regis/0000-0003-3981-3159; Dejean, Alain/0000-0002-3561-2248; Carpenter, James/0000-0001-6754-8028; CORBARA, Bruno/0000-0003-4232-8234	French Centre National de la Recherche Scientifique [2ID]; European Community	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Bouwma AM, 2005, BEHAV ECOL SOCIOBIOL, V59, P222, DOI 10.1007/s00265-005-0028-5; Bouwma AM, 2007, BIOTROPICA, V39, P719, DOI 10.1111/j.1744-7429.2007.00321.x; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Collins M, 2005, CLIM DYNAM, V24, P89, DOI 10.1007/s00382-004-0478-x; Colwell RK, ESTIMATES STAT ESTIM; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corbara B, 2009, CR BIOL, V332, P470, DOI 10.1016/j.crvi.2009.01.003; Cowling SA, 2004, PHILOS T R SOC B, V359, P539, DOI 10.1098/rstb.2003.1427; Dejean A, 1998, INSECT SOC, V45, P33, DOI 10.1007/s000400050066; Dejean A, 2010, CR BIOL, V333, P35, DOI 10.1016/j.crvi.2009.10.007; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diniz IR, 1998, REV BIOL TROP, V46, P109; Fonty E, 2009, GLOBAL CHANGE BIOL, V15, P2360, DOI 10.1111/j.1365-2486.2009.01923.x; Gaston AJ, 2005, AVIAN CONSERV ECOL, V1; Gergis J.L., 2006, ADV GEOSCI, V6, P173, DOI [10.5194/adgeo-6-173-2006, DOI 10.5194/ADGEO-6-173-2006, DOI 10.5194/ADGE0-6-173-2006]; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Grant PR, 2000, ECOLOGY, V81, P2442, DOI 10.2307/177466; Harrison RD, 2000, P ROY SOC B-BIOL SCI, V267, P911, DOI 10.1098/rspb.2000.1089; Harrison RD, 2001, POPUL ECOL, V43, P63, DOI 10.1007/PL00012017; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heinrich B., 1996, THERMAL WARRIORS STR; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Howard KJ, 2004, INSECT SOC, V51, P179, DOI 10.1007/s00040-004-0730-8; Hunt JH, 1999, BIOTROPICA, V31, P192; Hunt JH, 2001, ANN ENTOMOL SOC AM, V94, P555, DOI 10.1603/0013-8746(2001)094[0555:OOTNSF]2.0.CO;2; IPCC, 2007, CLIM CHANG 2007 PHYS; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Jeanne RL, 1996, BEHAV ECOL, V7, P43, DOI 10.1093/beheco/7.1.43; JEANNE RL, 1975, Q REV BIOL, V50, P267, DOI 10.1086/408564; Kayano MT, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006142; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Kumar A, 2009, BIOTROPICA, V41, P338, DOI 10.1111/j.1744-7429.2008.00483.x; Laurance WF, 2008, AUSTRAL ECOL, V33, P1, DOI 10.1111/j.1442-9993.2007.01812.x; Li WH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006355; London KB, 1998, J KANSAS ENTOMOL SOC, V71, P175; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Meisel JE, 2006, ECOL APPL, V16, P913, DOI 10.1890/1051-0761(2006)016[0913:TEOTNA]2.0.CO;2; O'Donnell S, 2001, BIOTROPICA, V33, P727, DOI 10.1646/0006-3606(2001)033[0727:SACCIA]2.0.CO;2; ODONNELL S, 1990, J TROP ECOL, V6, P507, DOI 10.1017/S0266467400004958; Parks D, 2011, CLIMATE CHANGE CATER; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011325; Payne CD, 1986, GEN LINEAR INTERACTI; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Santos GMD, 2009, ENVIRON ENTOMOL, V38, P1613, DOI 10.1603/022.038.0613; Santos GMDM, 2007, NEOTROP ENTOMOL, V36, P180, DOI 10.1590/S1519-566X2007000200002; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Todd MC, 2002, J APPL ECOL, V39, P31, DOI 10.1046/j.1365-2664.2002.00691.x; Tsonis AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022875; Van Bael SA, 2004, J TROP ECOL, V20, P625, DOI 10.1017/S0266467404001725; Vargas G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028812; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	62	30	31	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27004	10.1371/journal.pone.0027004	http://dx.doi.org/10.1371/journal.pone.0027004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073236	Green Published, gold			2022-12-27	WOS:000297154900061
J	Jain, S; Chang, TT; Hamilton, JP; Lin, SY; Lin, YJ; Evans, AA; Selaru, FM; Lin, PW; Chen, SH; Block, TM; Hu, CT; Song, W; Meltzer, SJ; Su, YH				Jain, Surbhi; Chang, Ting-Tsung; Hamilton, James P.; Lin, Selena Y.; Lin, Yih-Jyh; Evans, Alison A.; Selaru, Florin M.; Lin, Pin-Wen; Chen, Shun-Hua; Block, Timothy M.; Hu, Chi-Tan; Song, Wei; Meltzer, Stephen J.; Su, Ying-Hsiu			Methylation of the CpG Sites Only on the Sense Strand of the APC Gene Is Specific for Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; LUNG-CANCER PATIENTS; ISLAND HYPERMETHYLATION; PROMOTER METHYLATION; COLORECTAL-CANCER; ABERRANT METHYLATION; BREAST-CANCER; DNA; MARKERS; LIVER	Hypermethylation of the promoter of the tumor suppressor gene, adenomatous polyposis coli (APC), occurs in various malignancies, including hepatocellular carcinoma (HCC). However, reports on the specificity of the methylation of the APC gene for HCC have varied. To gain insight into how these variations occur, bisulfite PCR sequencing was performed to analyze the methylation status of both sense and antisense strands of the APC gene in samples of HCC tissue, matched adjacent non-HCC liver tissue, hepatitis, cirrhosis, and normal liver tissues. DNA derived from fetal liver and 12 nonhepatic normal tissue was also examined. These experiments revealed liver-specific, antisense strand-biased CpG methylation of the APC gene and suggested that, although methylation of the antisense strand of the APC gene exists in normal liver and other non-HCC disease liver tissue, methylation of the sense strand of the APC gene occurs predominantly in HCC. To determine the effect of the DNA strand on the specificity of the methylated APC gene as a biomarker for HCC detection, quantitative methylation-specific PCR assays for sense and antisense strand DNA were developed and performed on DNA isolated from HCC (n = 58), matched adjacent non-HCC (n = 58), cirrhosis (n = 41), and hepatitis (n = 39). Receiver operating characteristic curves were constructed. With the cutoff value set at the limit of detection, the specificity of sense and antisense strand methylation was 84% and 43%, respectively, and sensitivity was 67.2% and 72.4%, respectively. This result demonstrated that the identity of the methylated DNA strand impacted the specificity of APC for HCC detection. Interestingly, methylation of the sense strand of APC occurred in 40% of HCCs from patients with serum AFP levels less than 20 ng/mL, suggesting a potential role for APC as a biomarker to complement AFP in HCC screening.	[Jain, Surbhi; Lin, Selena Y.; Block, Timothy M.; Su, Ying-Hsiu] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Dept Med, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Hamilton, James P.; Selaru, Florin M.; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Meltzer, Stephen J.] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA; [Lin, Yih-Jyh; Lin, Pin-Wen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Evans, Alison A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Chen, Shun-Hua] Natl Cheng Kung Univ, Coll Med, Dept Microbiol, Tainan 70101, Taiwan; [Hu, Chi-Tan] Buddhist Tzu Chi Gen Hosp, Dept Gen Med, Hualien, Taiwan; [Song, Wei] JBS Sci Inc, Philadelphia, PA USA	Drexel University; National Cheng Kung University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National Cheng Kung University; National Cheng Kung University Hospital; Drexel University; National Cheng Kung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Jain, S (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	Ying-hsiu.Su@drexelmed.edu	Evans, Alison/I-4970-2013	Selaru, Florin/0000-0001-7990-8238	National Institutes of Health [R01 CA125642, CA146799, CA133012, CA085069, DK087454, K08]; Johns Hopkins University School of Medicine; Prevent Cancer Foundation; Early Detection Research Network of The National Cancer Institute; Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA125642, U01CA085069, R01CA136607, R01CA133012, R01CA146799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454, K08DK090154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine(Johns Hopkins University); Prevent Cancer Foundation; Early Detection Research Network of The National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 CA125642 (Y-HS), CA146799(SM), CA133012 (SM), CA085069 (SM), DK087454 (SM), and K08 (JH); a Clinician-Scientist Award from Johns Hopkins University School of Medicine (JH); Prevent Cancer Foundation Postdoctoral Fellowship Award (SJ); The Early Detection Research Network grant of The National Cancer Institute (TB); The Hepatitis B Foundation of America (TB); and an appropriation from The Commonwealth of Pennsylvania (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2010, CANC FACTS FIG; An Q, 2002, CANCER LETT, V188, P109, DOI 10.1016/S0304-3835(02)00496-2; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chan AOO, 2003, AM J PATHOL, V163, P370, DOI 10.1016/S0002-9440(10)63663-2; Chang H, 2008, EXP MOL PATHOL, V85, P96, DOI 10.1016/j.yexmp.2008.07.001; Clement G, 2004, CANCER RES, V64, P6867, DOI 10.1158/0008-5472.CAN-03-2503; Csepregi A, 2008, J CANCER RES CLIN, V134, P579, DOI 10.1007/s00432-007-0321-y; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Esteller M, 2000, CANCER RES, V60, P4366; Esteller M, 1999, CANCER RES, V59, P67; Esteller M, 2001, CANCER RES, V61, P3225; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142; Harder J, 2008, INT J CANCER, V122, P2800, DOI 10.1002/ijc.23433; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Iyer P, EXPT MOL PATHOLOGY, V88, P107; Iyer P, 2010, EXP MOL PATHOL, V88, P107, DOI 10.1016/j.yexmp.2009.09.012; Jain S, 2010, AM J TRANSL RES, V2, P105; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Katoh H, 2006, GENE CHROMOSOME CANC, V45, P1050, DOI 10.1002/gcc.20362; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lee TL, 2002, CLIN CANCER RES, V8, P1761; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Lou C, 2009, CANCER SCI, V100, P996, DOI 10.1111/j.1349-7006.2009.01138.x; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; Pao MM, 2001, HUM MOL GENET, V10, P903, DOI 10.1093/hmg/10.9.903; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Qu ZX, 2010, J BIOL CHEM, V285, P11786, DOI 10.1074/jbc.M109.086561; Ronneberg JA, 2008, CANCER RES, V68, P5562, DOI 10.1158/0008-5472.CAN-07-5828; Tsuchiya T, 2000, ONCOGENE, V19, P3642, DOI 10.1038/sj.onc.1203704; Uhlmann K, 2002, EVALUATION POTENTIAL, P4072; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Veeck J, 2010, J CLIN ONCOL, V28, pE563, DOI 10.1200/JCO.2010.30.1010; Wong IHN, 1999, CANCER RES, V59, P71; Wright LA, 2007, CANCER DETECT PREV, V31, P35, DOI 10.1016/j.cdp.2006.11.003; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4	46	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26799	10.1371/journal.pone.0026799	http://dx.doi.org/10.1371/journal.pone.0026799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073196	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900038
J	Landmann, C; Landi, SM; Grafton, ST; Della-Maggiore, V				Landmann, Claire; Landi, Sofia M.; Grafton, Scott T.; Della-Maggiore, Valeria			fMRI Supports the Sensorimotor Theory of Motor Resonance	PLOS ONE			English	Article							DORSAL PREMOTOR CORTEX; MOVEMENT; PARIETAL; AREAS; RESPONSES; MODULATION; ACTIVATION; EXECUTION; REGIONS; EVENTS	The neural mechanisms mediating the activation of the motor system during action observation, also known as motor resonance, are of major interest to the field of motor control. It has been proposed that motor resonance develops in infants through Hebbian plasticity of pathways connecting sensory and motor regions that fire simultaneously during imitation or self movement observation. A fundamental problem when testing this theory in adults is that most experimental paradigms involve actions that have been overpracticed throughout life. Here, we directly tested the sensorimotor theory of motor resonance by creating new visuomotor representations using abstract stimuli (motor symbols) and identifying the neural networks recruited through fMRI. We predicted that the network recruited during action observation and execution would overlap with that recruited during observation of new motor symbols. Our results indicate that a network consisting of premotor and posterior parietal cortex, the supplementary motor area, the inferior frontal gyrus and cerebellum was activated both by new motor symbols and by direct observation of the corresponding action. This tight spatial overlap underscores the importance of sensorimotor learning for motor resonance and further indicates that the physical characteristics of the perceived stimulus are irrelevant to the evoked response in the observer.	[Landmann, Claire; Landi, Sofia M.; Della-Maggiore, Valeria] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Buenos Aires, DF, Argentina; [Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	University of Buenos Aires; University of California System; University of California Santa Barbara	Landmann, C (corresponding author), Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Buenos Aires, DF, Argentina.	vdellamaggiore@fmed.uba.ar		Della-Maggiore, Valeria/0000-0001-9586-4255	National Institutes of Health [RO3 TW007815-01A1]; National Agency for the Promotion of Science and Technology [PICT 34312]; FOGARTY INTERNATIONAL CENTER [R03TW007815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Agency for the Promotion of Science and Technology(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the National Institutes of Health grant "Fogarty International Research Collaboration Award" (STG and VDM, RO3 TW007815-01A1, http://www.fic.nih.gov/programs/pages/research-collaboration.aspx) and by the National Agency for the Promotion of Science and Technology (VDM, PICT 34312, http://www.agencia.gov.ar/spip.php?article28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Buch ER, 2006, EXP BRAIN RES, V169, P69, DOI 10.1007/s00221-005-0130-y; Caggiano V, 2011, CURR BIOL, V21, P144, DOI 10.1016/j.cub.2010.12.022; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Engel A, 2008, SOC NEUROSCI, V3, P368, DOI 10.1080/17470910701612793; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PASSINGHAM RE, 1988, EXP BRAIN RES, V70, P590; PASSINGHAM RE, 1985, BEHAV BRAIN RES, V18, P175, DOI 10.1016/0166-4328(85)90073-7; PASSINGHAM RE, 1985, NEUROPSYCHOLOGIA, V23, P453, DOI 10.1016/0028-3932(85)90001-6; PASSINGHAM RE, 1989, BRAIN BEHAV EVOLUT, V33, P189, DOI 10.1159/000115927; Petroni A, 2010, J NEUROPHYSIOL, V104, P1867, DOI 10.1152/jn.00386.2010; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rothwell J. C, 2008, OXFORD HDB TRANSCRAN, P171; Sakreida K, 2005, J NEUROSCI, V25, P1335, DOI 10.1523/JNEUROSCI.4170-04.2005; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; Talairach J., 1988, COPLANAR STEREOTAXIC; Thoenissen D, 2002, J NEUROSCI, V22, P9024; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Toni I, 2002, J COGNITIVE NEUROSCI, V14, P769, DOI 10.1162/08989290260138663; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8	45	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26859	10.1371/journal.pone.0026859	http://dx.doi.org/10.1371/journal.pone.0026859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073209	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900046
J	Zheng, BX; Tan, LL; Mo, XJ; Yu, WM; Wang, Y; Tucker-Kellogg, L; Welsch, RE; So, PTC; Yu, HR				Zheng, Baixue; Tan, Looling; Mo, Xuejun; Yu, Weimiao; Wang, Yan; Tucker-Kellogg, Lisa; Welsch, Roy E.; So, Peter T. C.; Yu, Hanry			Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; INDUCED LIVER FIBROSIS; CARBON-TETRACHLORIDE; TGF-BETA; SIGNALING PATHWAY; CONTROLLED TRIAL; RATS; CIRRHOSIS; INHIBITION; EXPRESSION	Background/Aims: Many anti-fibrotic drugs with high in vitro efficacies fail to produce significant effects in vivo. The aim of this work is to use a statistical approach to design a numerical predictor that correlates better with in vivo outcomes. Methods: High-content analysis (HCA) was performed with 49 drugs on hepatic stellate cells (HSCs) LX-2 stained with 10 fibrotic markers. similar to 0.3 billion feature values from all cells in >150,000 images were quantified to reflect the drug effects. A systematic literature search on the in vivo effects of all 49 drugs on hepatofibrotic rats yields 28 papers with histological scores. The in vivo and in vitro datasets were used to compute a single efficacy predictor (E-predict). Results: We used in vivo data from one context (CCl4 rats with drug treatments) to optimize the computation of E-predict. This optimized relationship was independently validated using in vivo data from two different contexts (treatment of DMN rats and prevention of CCl4 induction). A linear in vitro-in vivo correlation was consistently observed in all the three contexts. We used Epredict values to cluster drugs according to efficacy; and found that high-efficacy drugs tended to target proliferation, apoptosis and contractility of HSCs. Conclusions: The E-predict statistic, based on a prioritized combination of in vitro features, provides a better correlation between in vitro and in vivo drug response than any of the traditional in vitro markers considered.	[Zheng, Baixue; Tucker-Kellogg, Lisa; Welsch, Roy E.; So, Peter T. C.; Yu, Hanry] Natl Univ Singapore, Computat & Syst Biol Program, Singapore MIT Alliance, Singapore 117548, Singapore; [Zheng, Baixue; Tan, Looling; Mo, Xuejun; Wang, Yan; Yu, Hanry] ASTAR, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Zheng, Baixue; Tucker-Kellogg, Lisa; Yu, Hanry] Natl Univ Singapore, Inst Mechanobiol, Singapore 117548, Singapore; [So, Peter T. C.; Yu, Hanry] BioSyM, Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Yu, Hanry] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Mo, Xuejun] Natl Univ Singapore, Fac Sci, Dept Chem, Singapore 117548, Singapore; [Yu, Hanry] Natl Univ Singapore, NUS Grad Sch Integrat Sci, Singapore 117548, Singapore; [Yu, Hanry] Natl Univ Singapore, NUS Tissue Engn Programme, Singapore 117548, Singapore; [Yu, Weimiao] ASTAR, Bioinformat Inst, Imaging Informat Div, Singapore, Singapore; [Wang, Yan] So Med Univ, Affiliated Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Yu, Weimiao] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [So, Peter T. C.; Yu, Hanry] MIT, Dept Mech Engn & Biol Engn, Cambridge, MA 02139 USA; [Welsch, Roy E.] MIT, Sloan Sch Management, Engn Syst Div, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Southern Medical University - China; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Zheng, BX (corresponding author), Natl Univ Singapore, Computat & Syst Biol Program, Singapore MIT Alliance, Singapore 117548, Singapore.	hanry_yu@nuhs.edu.sg	Tucker-Kellogg, Lisa/G-3376-2012; Yu, Hanry/C-1031-2013; Tucker-Kellogg, Lisa/AAD-9265-2022; Yu, Hanry/L-6050-2019; Yu, Weimiao/AAN-4790-2020; Yu, Hanry/C-7375-2011	Tucker-Kellogg, Lisa/0000-0002-1301-7069; Yu, Hanry/0000-0002-0339-3685; Yu, Hanry/0000-0002-0339-3685; 	Institute of Bioengineering and Nanotechnology, BMRC, A*STAR; Singapore-MIT Alliance for Research and Technology Centre [C-185-000-033-531]; Janssen Cilag Singapore [R-185-000-182-592]; Singapore-MIT Alliance [C-382-641-001-091]; Mechanobiology Institute [R-714-001-003-271]	Institute of Bioengineering and Nanotechnology, BMRC, A*STAR(Agency for Science Technology & Research (A*STAR)); Singapore-MIT Alliance for Research and Technology Centre(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Janssen Cilag Singapore(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Mechanobiology Institute	This work is supported by funding from the Institute of Bioengineering and Nanotechnology, BMRC, A*STAR; the Singapore-MIT Alliance for Research and Technology Centre (C-185-000-033-531); Janssen Cilag Singapore (R-185-000-182-592); Singapore-MIT Alliance Computational and Systems Biology Flagship Project funding (C-382-641-001-091); and Mechanobiology Institute (R-714-001-003-271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; BACHEM MG, 1992, J CLIN INVEST, V89, P19, DOI 10.1172/JCI115561; BONKOWSKY HL, 1978, LANCET, V1, P1016; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Chong LW, 2006, J BIOMED SCI, V13, P403, DOI 10.1007/s11373-006-9079-5; Conover W. J., PRACTICAL NONPARAMET; Dai L, 2010, ACTA PHARMACOL SIN, V31, P27, DOI 10.1038/aps.2009.170; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; Deng ZY, 2009, CHINESE MED J-PEKING, V122, P1449, DOI 10.3760/cma.j.issn.0366-6999.2009.12.018; DUMONT JM, 1986, J HEPATOL, V3, P260, DOI 10.1016/S0168-8278(86)80036-8; FERENCI P, 1989, J HEPATOL, V9, P105, DOI 10.1016/0168-8278(89)90083-4; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Hashem MA, 2008, MOL CELLS, V26, P625; Hong RT, 2009, WORLD J GASTROENTERO, V15, P1452, DOI 10.3748/wjg.15.1452; Hsu YC, 2007, J GASTROEN HEPATOL, V22, P99, DOI 10.1111/j.1440-1746.2006.04361.x; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Jeong DH, 2005, WORLD J GASTROENTERO, V11, P1141, DOI 10.3748/wjg.v11.i8.1141; JONKER AM, 1994, HEPATOLOGY, V19, P775, DOI 10.1002/hep.1840190334; KERSHENOBICH D, 1988, NEW ENGL J MED, V318, P1709, DOI 10.1056/NEJM198806303182602; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Langguth P, 2010, J PHARM SCI, V99, P4427; Lee MK, 2009, J ENZYM INHIB MED CH, V24, P1276, DOI 10.3109/14756360902829709; Lee SJ, 2004, CHEM-BIOL INTERACT, V147, P9, DOI 10.1016/j.cbi.2003.10.005; Li GS, 2010, PHYTOMEDICINE, V17, P282, DOI 10.1016/j.phymed.2009.05.002; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; Marek CJ, 2005, BIOCHEM J, V387, P601, DOI 10.1042/BJ20041598; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MION F, 1991, GUT, V32, P715, DOI 10.1136/gut.32.6.715; Morgan TR, 2005, GASTROENTEROLOGY, V128, P882, DOI 10.1053/j.gastro.2005.01.057; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Pares A, 1998, J HEPATOL, V28, P615, DOI 10.1016/S0168-8278(98)80285-7; Raetsch C, 2002, GUT, V50, P241, DOI 10.1136/gut.50.2.241; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockey DC, 2008, CLIN LIVER DIS, V12, P939, DOI 10.1016/j.cld.2008.07.011; Sale S, 2009, EUR J CANCER, V45, P2731, DOI 10.1016/j.ejca.2009.07.004; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Soma J, 2002, NEPHRON, V92, P693, DOI 10.1159/000064071; Tasci I, 2008, WORLD J GASTROENTERO, V14, P4897, DOI 10.3748/wjg.14.4897; Tasci I, 2007, WORLD J GASTROENTERO, V13, P3237, DOI 10.3748/wjg.v13.i23.3237; Uchida K, 2011, J ANTIMICROB CHEMOTH, V66, P626, DOI 10.1093/jac/dkq475; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wu XL, 2008, WORLD J GASTROENTERO, V14, P2100, DOI 10.3748/wjg.14.2100; Xu QH, 2007, AM J PHYSIOL-RENAL, V293, pF631, DOI 10.1152/ajprenal.00379.2006; Yu WM, 2010, CYTOM PART A, V77A, P379, DOI 10.1002/cyto.a.20876; Yuan GJ, 2004, WORLD J GASTROENTERO, V10, P1047; Zhao XY, 2008, PATHOL INT, V58, P580, DOI 10.1111/j.1440-1827.2008.02274.x; Zhen MC, 2007, J NUTR BIOCHEM, V18, P795, DOI 10.1016/j.jnutbio.2006.12.016	50	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26230	10.1371/journal.pone.0026230	http://dx.doi.org/10.1371/journal.pone.0026230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073152	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900006
J	Rhodes, G; Lie, HC; Thevaraja, N; Taylor, L; Iredell, N; Curran, C; Tan, SQC; Carnemolla, P; Simmons, LW				Rhodes, Gillian; Lie, Hanne C.; Thevaraja, Nishta; Taylor, Libby; Iredell, Natasha; Curran, Christine; Tan, Shi Qin Claire; Carnemolla, Pia; Simmons, Leigh W.			Facial Attractiveness Ratings from Video-Clips and Static Images Tell the Same Story	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; MATING SUCCESS; HUMAN FACES; PREFERENCES; FEMALE	Most of what we know about what makes a face attractive and why we have the preferences we do is based on attractiveness ratings of static images of faces, usually photographs. However, several reports that such ratings fail to correlate significantly with ratings made to dynamic video clips, which provide richer samples of appearance, challenge the validity of this literature. Here, we tested the validity of attractiveness ratings made to static images, using a substantial sample of male faces. We found that these ratings agreed very strongly with ratings made to videos of these men, despite the presence of much more information in the videos (multiple views, neutral and smiling expressions and speech-related movements). Not surprisingly, given this high agreement, the components of video-attractiveness were also very similar to those reported previously for static-attractiveness. Specifically, averageness, symmetry and masculinity were all significant components of attractiveness rated from videos. Finally, regression analyses yielded very similar effects of attractiveness on success in obtaining sexual partners, whether attractiveness was rated from videos or static images. These results validate the widespread use of attractiveness ratings made to static images in evolutionary and social psychological research. We speculate that this validity may stem from our tendency to make rapid and robust judgements of attractiveness.	[Rhodes, Gillian; Taylor, Libby; Simmons, Leigh W.] Univ Western Australia, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia; [Rhodes, Gillian; Lie, Hanne C.; Thevaraja, Nishta; Taylor, Libby; Iredell, Natasha; Curran, Christine; Tan, Shi Qin Claire; Carnemolla, Pia; Simmons, Leigh W.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Rhodes, G (corresponding author), Univ Western Australia, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia.	gillian.rhodes@uwa.edu.au	Lie, Hanne Cathrine/AAL-8227-2020; Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518; Lie, Hanne Cathrine/0000-0002-8370-5422	Australian Research Council [DP0877379]; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	This work was supported by the Australian Research Council (DP0877379) and the Australian Research Council Centre of Excellence for Cognition and its Disorders (CE110001021. URL http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins DC, 2007, J FAM PSYCHOL, V21, P726, DOI 10.1037/0893-3200.21.4.726; BROWN TA, 1986, J SOC PSYCHOL, V126, P305, DOI 10.1080/00224545.1986.9713590; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; DUNTEMAN GH, 2005, GEN LINEAR MODELS IN; Lander K, 2008, ANIM BEHAV, V75, P817, DOI 10.1016/j.anbehav.2007.07.001; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Lie HC, 2010, ANIM BEHAV, V79, P903, DOI 10.1016/j.anbehav.2009.12.040; Little A. C., 2011, SCI SOCIAL VISION, P164; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Morrison ER, 2010, ETHOLOGY, V116, P1234, DOI 10.1111/j.1439-0310.2010.01839.x; Olson IR, 2005, EMOTION, V5, P498, DOI 10.1037/1528-3542.5.4.498; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Penton-Voak I, 2008, J EVOLUTIONARY PSYCH, V6, P89, DOI DOI 10.1556/JEP.2008.1011; PENTONVOAK IS, 2011, OXFORD HDB FACE PERC, P653; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; REIS HT, 1990, EUR J SOC PSYCHOL, V20, P259, DOI 10.1002/ejsp.2420200307; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Roberts SC, 2009, ETHOLOGY, V115, P588, DOI 10.1111/j.1439-0310.2009.01640.x; Rubenstein AJ, 2005, PSYCHOL SCI, V16, P759, DOI 10.1111/j.1467-9280.2005.01610.x; Simmons LW, 2004, BEHAV ECOL, V15, P864, DOI 10.1093/beheco/arh099; TRACY JL, 2011, HAPPY GUYS FINISH LA; Valenzano DR, 2006, VISION RES, V46, P1282, DOI 10.1016/j.visres.2005.10.024; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zebrowitz L.A., 2011, OXFORD HDB FACE PERC, P31, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0003	26	35	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26653	10.1371/journal.pone.0026653	http://dx.doi.org/10.1371/journal.pone.0026653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HG	22096491	gold, Green Submitted, Green Published			2022-12-27	WOS:000297553900006
J	Williams, R; Krkosek, M; Ashe, E; Branch, TA; Clark, S; Hammond, PS; Hoyt, E; Noren, DP; Rosen, D; Winship, A				Williams, Rob; Krkosek, Martin; Ashe, Erin; Branch, Trevor A.; Clark, Steve; Hammond, Philip S.; Hoyt, Erich; Noren, Dawn P.; Rosen, David; Winship, Arliss			Competing Conservation Objectives for Predators and Prey: Estimating Killer Whale Prey Requirements for Chinook Salmon	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; ORCINUS-ORCA; PACIFIC SALMON; FISHERIES; ABUNDANCE; SEA; POPULATIONS; FISH; DIET	Ecosystem-based management (EBM) of marine resources attempts to conserve interacting species. In contrast to single-species fisheries management, EBM aims to identify and resolve conflicting objectives for different species. Such a conflict may be emerging in the northeastern Pacific for southern resident killer whales (Orcinus orca) and their primary prey, Chinook salmon (Oncorhynchus tshawytscha). Both species have at-risk conservation status and transboundary (Canada-US) ranges. We modeled individual killer whale prey requirements from feeding and growth records of captive killer whales and morphometric data from historic live-capture fishery and whaling records worldwide. The models, combined with caloric value of salmon, and demographic and diet data for wild killer whales, allow us to predict salmon quantities needed to maintain and recover this killer whale population, which numbered 87 individuals in 2009. Our analyses provide new information on cost of lactation and new parameter estimates for other killer whale populations globally. Prey requirements of southern resident killer whales are difficult to reconcile with fisheries and conservation objectives for Chinook salmon, because the number of fish required is large relative to annual returns and fishery catches. For instance, a U. S. recovery goal (2.3% annual population growth of killer whales over 28 years) implies a 75% increase in energetic requirements. Reducing salmon fisheries may serve as a temporary mitigation measure to allow time for management actions to improve salmon productivity to take effect. As ecosystem-based fishery management becomes more prevalent, trade-offs between conservation objectives for predators and prey will become increasingly necessary. Our approach offers scenarios to compare relative influence of various sources of uncertainty on the resulting consumption estimates to prioritise future research efforts, and a general approach for assessing the extent of conflict between conservation objectives for threatened or protected wildlife where the interaction between affected species can be quantified.	[Williams, Rob; Hammond, Philip S.] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Rosen, David] Univ British Columbia, Dept Zool, Marine Mammal Res Unit, Fisheries Ctr, Vancouver, BC, Canada; [Krkosek, Martin] Univ Otago, Dept Zool, Dunedin, New Zealand; [Ashe, Erin] Oceans Initiat, Pearse Isl, BC, Canada; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Clark, Steve] SeaWorld, Orlando, FL USA; [Hoyt, Erich] Whale & Dolphin Conservat Soc, North Berwick, Scotland; [Noren, Dawn P.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Marine Mammal & Seabird Program, Seattle, WA USA; [Winship, Arliss] Dalhousie Univ, Dept Biol, Life Sci Ctr, Halifax, NS, Canada	University of St Andrews; University of British Columbia; University of Otago; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University	Williams, R (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	rmcw@st-andrews.ac.uk	Williams, Rob/C-5882-2011; Branch, Trevor/A-5691-2009	Williams, Rob/0000-0001-7496-453X; Ashe, Erin/0000-0001-9918-1419; Hoyt, Erich/0000-0001-6946-4055; Noren, Dawn/0000-0002-9544-4530; Hammond, Philip/0000-0002-2381-8302	University of Washington; Russell Family Foundation; British Columbia Marine Planning Fund; SeaWorld-Busch Gardens Conservation Fund; Natural Sciences and Engineering Research Council of Canada; Natural Environment Research Council [smru10001] Funding Source: researchfish	University of Washington(University of Washington); Russell Family Foundation; British Columbia Marine Planning Fund; SeaWorld-Busch Gardens Conservation Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Canada-United States Fulbright program (RW) at University of Washington, The Russell Family Foundation, the British Columbia Marine Planning Fund and SeaWorld-Busch Gardens Conservation Fund, and a Natural Sciences and Engineering Research Council of Canada Post Doctoral Fellowship (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Arkema KK, 2006, FRONT ECOL ENVIRON, V4, P525, DOI 10.1890/1540-9295(2006)4[525:MEMFCT]2.0.CO;2; Bax NJ, 1998, ICES J MAR SCI, V55, P997, DOI 10.1006/jmsc.1998.0350; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Boersma PD, 2001, BIOSCIENCE, V51, P643; Boyd IL, 2002, AQUAT CONSERV, V12, P119, DOI 10.1002/aqc.481; Brewer JF, 2011, ECOL SOC, V16; Clark ST, 1999, J MAMMAL, V80, P777, DOI 10.2307/1383247; Corkeron PJ, 2006, CONSERV BIOL, V20, P617, DOI 10.1111/j.1523-1739.2006.00436.x; Durban JW, 2006, MAR MAMMAL SCI, V22, P735, DOI 10.1111/j.1748-7692.2006.00068.x; Fearnbach Holly, 2011, Endangered Species Research, V13, P173, DOI 10.3354/esr00330; Fisheries and Oceans Canada (FOC), 2002, CAN OC STRAT; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2010, 2009101 DFO CAN SCI; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Grellier K, 2006, MF0319 DEP ENV FOOD; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; HARWOOD J, 1988, MAR MAMMAL SCI, V4, P13, DOI 10.1111/j.1748-7692.1988.tb00179.x; HARWOOD J, 1987, P ROY SOC EDINB B, V93, P535; Hauser DDW, 2007, MAR ECOL PROG SER, V351, P301, DOI 10.3354/meps07117; Healey M.C., 1991, P311; HOYT E, 1990, ORCA WHALE CALLED KI; ICES, 2008, REP ICES ADV COMM 20, P326; JONSGARD A, 1970, Nytt Magasin for Zoologi (Oslo), V18, P41; Kriete B., 1995, THESIS U BRIT COLUMB; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Lackey R.T., 2006, SALMON 2100 FUTURE W, P13; Larkin PA, 1996, REV FISH BIOL FISHER, V6, P139; Leaper Russell, 2007, Journal of Cetacean Research and Management, V9, P179; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Logerwell Elizabeth A., 2005, Aquatic Mammals, V31, P62, DOI 10.1578/AM.31.1.2005.62; Lusseau D, 2004, ECOL LETT, V7, P1068, DOI 10.1111/j.1461-0248.2004.00669.x; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Mooers AO, 2007, CONSERV BIOL, V21, P572, DOI 10.1111/j.1523-1739.2007.00689.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Myers J, 1998, NOAA TECH MEMO, P443; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; NMFS, 2008, REC PLAN SO RES KILL; NMFS (National Marine Fisheries Service), 1999, EC BAS FISH MAN REP; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; Noren DP, 2011, MAR MAMMAL SCI, V27, P60, DOI 10.1111/j.1748-7692.2010.00386.x; Northcote T.G., 1997, P199; Osborne RW, 1999, THESIS U VICTORIA VI, P262; Pacific Salmon Commission, 2009, ANN REP CATCH ESC PA; Pacific Salmon Commission, 2004, TCCHINOOK0404 PAC SA, P04; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinheiro J, MIXED EFFECTS MODELS; POC, 2003, AM LIV OC CHART COUR; Raymond B, 2011, J APPL ECOL, V48, P181, DOI 10.1111/j.1365-2664.2010.01916.x; Reynolds John E. III, 2009, Endangered Species Research, V7, P23, DOI 10.3354/esr00179; RICKER WE, 1976, J FISH RES BOARD CAN, V33, P1483, DOI 10.1139/f76-191; Roni P, 2002, N AM J FISH MANAGE, V22, P1, DOI 10.1577/1548-8675(2002)022&lt;0001:AROSRT&gt;2.0.CO;2; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Sharples RJ, 2009, MAR ECOL PROG SER, V390, P265, DOI 10.3354/meps08232; Sigler MF, 2006, J FISH BIOL, V69, P392, DOI 10.1111/j.1095-8649.2006.01096.x; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Southwell C, 2008, J APPL ECOL, V45, P622, DOI 10.1111/j.1365-2664.2007.01399.x; STEPHENSON RL, 1995, CAN J FISH AQUAT SCI, V52, P2051, DOI 10.1139/f95-796; Taylor BL, 2004, NMFSNWFSC62 NOAA; US Commission on Ocean Policy (USCOP), 2004, OC BLUEPR 21 CENT WA; Walters Carl, 1997, Conservation Ecology, V1, pUnpaginated; Waples R.S., 1991, MAR FISH REV, V53, P11; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Winship AJ, 2001, J MAMMAL, V82, P500, DOI 10.1644/1545-1542(2001)082<0500:GIBSOT>2.0.CO;2; Womble JN, 2006, MAR ECOL PROG SER, V325, P281, DOI 10.3354/meps325281	72	60	61	3	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26738	10.1371/journal.pone.0026738	http://dx.doi.org/10.1371/journal.pone.0026738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096495	Green Published, gold			2022-12-27	WOS:000297350800012
J	Belete, HA; Hubmayr, RD; Wang, SH; Singh, RD				Belete, Hewan A.; Hubmayr, Rolf D.; Wang, Shaohua; Singh, Raman-Deep			The Role of Purinergic Signaling on Deformation Induced Injury and Repair Responses of Alveolar Epithelial Cells	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; INDUCED LIPID TRAFFICKING; MEMBRANE STRESS FAILURE; PLASMA-MEMBRANE; ATP RELEASE; CYCLIC STRETCH; NUCLEOTIDE RECEPTORS; MOLECULAR-MECHANISMS; EXTRACELLULAR ATP	Cell wounding is an important driver of the innate immune response of ventilator-injured lungs. We had previously shown that the majority of wounded alveolus resident cells repair and survive deformation induced insults. This is important insofar as wounded and repaired cells may contribute to injurious deformation responses commonly referred to as biotrauma. The central hypothesis of this communication states that extracellular adenosine-5' triphosphate (ATP) promotes the repair of wounded alveolus resident cells by a P2Y2-Receptor dependent mechanism. Using primary type 1 alveolar epithelial rat cell models subjected to micropuncture injury and/or deforming stress we show that 1) stretch causes a dose dependent increase in cell injury and ATP media concentrations; 2) enzymatic depletion of extracellular ATP reduces the probability of stretch induced wound repair; 3) enriching extracellular ATP concentrations facilitates wound repair; 4) purinergic effects on cell repair are mediated by ATP and not by one of its metabolites; and 5) ATP mediated cell salvage depends at least in part on P2Y2-R activation. While rescuing cells from wounding induced death may seem appealing, it is possible that survivors of membrane wounding become governors of a sustained pro-inflammatory state and thereby perpetuate and worsen organ function in the early stages of lung injury syndromes. Means to uncouple P2Y2-R mediated cytoprotection from P2Y2-R mediated inflammation and to test the preclinical efficacy of such an undertaking deserve to be explored.	[Belete, Hewan A.; Hubmayr, Rolf D.; Wang, Shaohua; Singh, Raman-Deep] Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Belete, HA (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA.	rhubmayr@mayo.edu	Takhter, Ramandeep/AAG-8977-2019	Takhter, Ramandeep/0000-0002-1441-2722	National Institutes of Health [HL 63178]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL 63178) and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Adriaensen D, 2004, CURR OPIN PHARMACOL, V4, P207, DOI 10.1016/j.coph.2004.01.010; Ahmad S, 2005, FREE RADICAL BIO MED, V39, P213, DOI 10.1016/j.freeradbiomed.2005.03.009; Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Beigi RD, 2000, J IMMUNOL, V165, P7189, DOI 10.4049/jimmunol.165.12.7189; Belete HA, 2010, CELL PHYSIOL BIOCHEM, V25, P71, DOI 10.1159/000272052; Boitano S, 2004, AM J PHYSIOL-LUNG C, V287, pL455, DOI 10.1152/ajplung.00172.2004; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; da Cruz CM, 2006, BRIT J PHARMACOL, V147, P324, DOI 10.1038/sj.bjp.0706559; dos Santos CC, 2006, ANNU REV PHYSIOL, V68, P585, DOI 10.1146/annurev.physiol.68.072304.113443; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; Douillet CD, 2005, AM J RESP CELL MOL, V32, P52, DOI 10.1165/rcmb.2004-0177OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Gattinoni L, 2011, CURR OPIN CRIT CARE, V17, P18, DOI 10.1097/MCC.0b013e32834272d8; GODIN LM, 2011, AM J PHYSL LUNG CELL; Goding JW, 2000, J LEUKOCYTE BIOL, V67, P285, DOI 10.1002/jlb.67.3.285; Gozal E, 2001, FREE RADICAL BIO MED, V31, P679, DOI 10.1016/S0891-5849(01)00630-X; Green AS, 2004, J BIOMECH, V37, P661, DOI 10.1016/j.jbiomech.2003.09.024; Grembowicz KP, 1999, MOL BIOL CELL, V10, P1247, DOI 10.1091/mbc.10.4.1247; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; Jung SR, 2004, AM J PHYSIOL-CELL PH, V286, pC573, DOI 10.1152/ajpcell.00350.2003; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; LEONARD RT, 1978, PLANT PHYSIOL, V61, P175, DOI 10.1104/pp.61.2.175; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu GJ, 2005, EUR J NEUROSCI, V21, P151, DOI 10.1111/j.1460-9568.2004.03831.x; Matsuyama H, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-79; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2002, J CELL SCI, V115, P873; Nieuwenhuizen L, 2009, EUR J HAEMATOL, V82, P413, DOI 10.1111/j.1600-0609.2009.01238.x; Oeckler RA, 2007, CRIT CARE, V11, DOI 10.1186/cc6160; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Orihuela PA, 2006, J ENDOCRINOL, V188, P579, DOI 10.1677/joe.1.06448; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; RICE WR, 1995, AM J RESP CELL MOL, V12, P27, DOI 10.1165/ajrcmb.12.1.7811468; Rossi AH, 2007, AM J PHYSIOL-LUNG C, V292, pL92, DOI 10.1152/ajplung.00081.2006; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Stroetz RW, 2001, J APPL PHYSIOL, V90, P2361, DOI 10.1152/jappl.2001.90.6.2361; Sugamoto Yoshiharu, 1999, Journal of Medical and Dental Sciences, V46, P83; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Vlahakis NE, 2005, AM J RESP CRIT CARE, V171, P1328, DOI 10.1164/rccm.200408-1036SO; Vlahakis NE, 2002, AM J RESP CRIT CARE, V166, P1282, DOI 10.1164/rccm.200203-207OC; Vlahakis NE, 2001, AM J PHYSIOL-LUNG C, V280, pL938, DOI 10.1152/ajplung.2001.280.5.L938; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; WANG S, 2011, AM J RESP CELL MOL B; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weisman GA, 2005, MOL NEUROBIOL, V31, P169, DOI 10.1385/MN:31:1-3:169; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	70	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27469	10.1371/journal.pone.0027469	http://dx.doi.org/10.1371/journal.pone.0027469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087324	Green Published, gold, Green Submitted			2022-12-27	WOS:000297349700050
J	Hsu, SC; Endow, JK; Ruppel, NJ; Roston, RL; Baldwin, AJ; Inoue, K				Hsu, Shih-Chi; Endow, Joshua K.; Ruppel, Nicholas J.; Roston, Rebecca L.; Baldwin, Amy J.; Inoue, Kentaro			Functional Diversification of Thylakoidal Processing Peptidases in Arabidopsis thaliana	PLOS ONE			English	Article							I SIGNAL PEPTIDASE; LEADER PEPTIDASE; OUTER ENVELOPE; PROTEIN-IMPORT; REACTION SPECIFICITIES; POLYGLYCINE STRETCH; COMPLETE MATURATION; GENOME SEQUENCE; TRANSIT PEPTIDE; TRANSPORT	Thylakoidal processing peptidase (TPP) is responsible for removing amino-terminal thylakoid-transfer signals from several proteins in the thylakoid lumen. Three TPP isoforms are encoded by the nuclear genome of Arabidopsis thaliana. Previous studies showed that one of them termed plastidic type I signal peptidase 1 (Plsp1) was necessary for processing three thylakoidal proteins and one protein in the chloroplast envelope in vivo. The lack of Plsp1 resulted in seedling lethality, apparently due to disruption of proper thylakoid development. The physiological roles of the other two TPP homologs remain unknown. Here we show that the three A. thaliana TPP isoforms evolved to acquire diverse functions. Phylogenetic analysis revealed that TPP may have originated before the endosymbiotic event, and that there are two groups of TPP in seed plants: one includes Plsp1 and another comprises the other two A. thaliana TPP homologs, which are named as Plsp2A and Plsp2B in this study. The duplication leading to the two groups predates the gymnosperm-angiosperm divergence, and the separation of Plsp2A and Plsp2B occurred after the Malvaceae-Brassicaceae diversification. Quantitative reverse transcription-PCR assay revealed that the two PLSP2 genes were co-expressed in both photosynthetic tissues and roots, whereas the PLSP1 transcript accumulated predominantly in photosynthetic tissues. Both PLSP2 genes were expressed in the aerial parts of the plsp1-null mutant at levels comparable to those in wild-type plants. The seedling-lethal phenotype of the plsp1-null mutant could be rescued by a constitutive expression of Plsp1 cDNA but not by that of Plsp2A or Plsp2B. These results indicate that Plsp1 and Plsp2 evolved to function differently, and that neither of the Plsp2 isoforms is necessary for proper thylakoid development in photosynthetic tissues.	[Hsu, Shih-Chi; Endow, Joshua K.; Ruppel, Nicholas J.; Roston, Rebecca L.; Baldwin, Amy J.; Inoue, Kentaro] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Hsu, SC (corresponding author), Boyce Thompson Inst Plant Res, Itacha, NY USA.	kinoue@ucdavis.edu	Roston, Rebecca/AAQ-5309-2020	Baldwin, Amy/0000-0002-2162-3771; Roston, Rebecca/0000-0002-3063-5002; Endow-Monteiro, Joshua/0000-0002-5845-0077	United States of America Department of Energy [DE-FG02-08ER15963]	United States of America Department of Energy	This work was supported by the Energy Biosciences Program at the United States of America Department of Energy DE-FG02-08ER15963 to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Baldwin AJ, 2006, FEBS J, V273, P1547, DOI 10.1111/j.1742-4658.2006.05175.x; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlos JL, 2000, J BIOL CHEM, V275, P38813, DOI 10.1074/jbc.M007093200; Chaal BK, 2003, PLANT MOL BIOL, V52, P463, DOI 10.1023/A:1023900100803; Chaal BK, 1998, J BIOL CHEM, V273, P689, DOI 10.1074/jbc.273.2.689; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coate JE, 2011, PLANT PHYSIOL, V155, P2081, DOI 10.1104/pp.110.169599; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; DATE T, 1983, J BACTERIOL, V154, P76, DOI 10.1128/JB.154.1.76-83.1983; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Endow JK, 2010, PLANT SIGNAL BEHAV, V5, P721, DOI 10.4161/psb.5.6.11662; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Firlej-Kwoka E, 2008, PLANT MOL BIOL, V68, P505, DOI 10.1007/s11103-008-9387-4; Green N, 2001, CO POSTTRANSLATIONAL, VXXII, P57; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; HALPIN C, 1989, EMBO J, V8, P3917, DOI 10.1002/j.1460-2075.1989.tb08572.x; Howe C. J., 2001, CO POSTTRANSLATIONAL, VXXII, P101; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KIRWIN PM, 1987, J BIOL CHEM, V262, P16386; KIRWIN PM, 1988, J BIOL CHEM, V263, P18128; Lang D, 2005, PLANT BIOLOGY, V7, P238, DOI 10.1055/s-2005-837578; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mould RM, 1997, PLANT J, V11, P1051, DOI 10.1046/j.1365-313X.1997.11051051.x; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Nohara T, 1996, BIOCHEM BIOPH RES CO, V224, P474, DOI 10.1006/bbrc.1996.1051; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Richter S, 2005, PHYSIOL PLANTARUM, V123, P362, DOI 10.1111/j.1399-3054.2005.00476.x; Robinson C, 2005, ANNU PLANT REV, V13, P180; Rodrigues RAO, 2011, PLANT J, V65, P600, DOI 10.1111/j.1365-313X.2010.04448.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnell DJ, 1997, TRENDS CELL BIOL, V7, P303, DOI 10.1016/S0962-8924(97)01111-2; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Schunemann D, 2007, BIOL CHEM, V388, P907, DOI 10.1515/BC.2007.111; SHACKLETON JB, 1991, J BIOL CHEM, V266, P12152; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Skalitzky CA, 2011, PLANT PHYSIOL, V155, P354, DOI 10.1104/pp.110.166546; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; Strittmatter P, 2010, METHODS MOL BIOL, V619, P307, DOI 10.1007/978-1-60327-412-8_18; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; WALLACE TP, 1990, FEBS LETT, V272, P141, DOI 10.1016/0014-5793(90)80468-X; WHATLEY JM, 1983, NEW PHYTOL, V94, P381, DOI 10.1111/j.1469-8137.1983.tb03452.x; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zhang YB, 1997, GENE, V194, P249, DOI 10.1016/S0378-1119(97)00198-4; Zhbanko M, 2005, J BACTERIOL, V187, P3071, DOI 10.1128/JB.187.9.3071-3078.2005	69	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27258	10.1371/journal.pone.0027258	http://dx.doi.org/10.1371/journal.pone.0027258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087276	Green Published, Green Accepted, gold			2022-12-27	WOS:000297347700032
J	Jakob, C; Aust, DE; Liebscher, B; Baretton, GB; Datta, K; Muders, MH				Jakob, Christiane; Aust, Daniela E.; Liebscher, Birgit; Baretton, Gustavo B.; Datta, Kaustubh; Muders, Michael H.			Lymphangiogenesis in Regional Lymph Nodes Is an Independent Prognostic Marker in Rectal Cancer Patients after Neoadjuvant Treatment	PLOS ONE			English	Article							COLORECTAL-CANCER; TUMOR-REGRESSION; VESSEL DENSITY; PREOPERATIVE CHEMORADIOTHERAPY; CHEMORADIATION THERAPY; MICROVESSEL DENSITY; BREAST-CARCINOMA; VEGF-C; METASTASIS; PREDICTOR	One of the major prognostic factors in rectal cancer is lymph node metastasis. The formation of lymph node metastases is dependent on the existence of a premetastatic niche. An important factor preceding metastasis are lymph vessels which are located in the lymph node. Accordingly, the occurrence of intranodal lymphangiogenesis is thought to indicate distant metastasis and worse prognosis. To evaluate the significance of lymph node lymphangiogenesis, we studied formalin fixed, paraffin embedded adenocarcinomas and regional lymph nodes of 203 rectal cancer patients who were treated with neoadjuvant radiochemotherapy and consecutive curative surgery with cancer free surgical margins (R0). Regional lymph node lymph vessels were detected by immunohistochemistry for podoplanin (D2-40). Our results show that the presence of lymphatic vessels in regional lymph nodes significantly affects the disease-free survival in univariate and multivariate analyses. In contrast, there was no correlation between peritumoral or intratumoral lymph vessel density and prognosis. Indeed, our study demonstrates the importance of lymphangiogenesis in regional lymph nodes after neoadjuvant radiochemotherapy and consecutive surgery as an independent prognostic marker. Staining for intranodal lymphangiogenesis and methods of intravital imaging of lymphangiogenesis and lymphatic flow may be a useful strategy to predict long-term outcome in rectal cancer patients. Furthermore, addition of VEGF-blocking agents to standardized neoadjuvant treatment schemes might be indicated in advanced rectal cancer.	[Jakob, Christiane; Aust, Daniela E.; Liebscher, Birgit; Baretton, Gustavo B.; Datta, Kaustubh; Muders, Michael H.] Tech Univ Dresden, Inst Pathol, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany; [Datta, Kaustubh] Univ Nebraska Med Ctr, Dept Biochem, Omaha, NE USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Nebraska System; University of Nebraska Medical Center	Jakob, C (corresponding author), Tech Univ Dresden, Inst Pathol, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany.	kaustubh.datta@unmc.edu; michael.muders@uniklinikum-dresden.de	Muders, Michael/AAU-6443-2020		Wilhelm Sander Stiftung fur Krebsforschung; KD [R01-NIH, CA140432]; NATIONAL CANCER INSTITUTE [R01CA140432] Funding Source: NIH RePORTER	Wilhelm Sander Stiftung fur Krebsforschung; KD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	No current external sources fund this specific study. Generally, the work of the researchers was supported by grants to MHM (Wilhelm Sander Stiftung fur Krebsforschung) and KD (R01-NIH, CA140432).	Alabi AA, 2009, INT J COLORECTAL DIS, V24, P269, DOI 10.1007/s00384-008-0622-x; Caricato M, 2007, EJSO-EUR J SURG ONC, V33, P724, DOI 10.1016/j.ejso.2007.01.023; Chang GJ, 2009, CANCER, V115, P5432, DOI 10.1002/cncr.24622; Duff SE, 2007, COLORECTAL DIS, V9, P793, DOI 10.1111/j.1463-1318.2006.01199.x; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Gao J, 2009, DIGEST LIVER DIS, V41, P116, DOI 10.1016/j.dld.2008.07.315; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hirakawa S, 2009, AM J PATHOL, V175, P2235, DOI 10.2353/ajpath.2009.090420; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Jakob C, 2006, AM J SURG PATHOL, V30, P1169; Kaneko I, 2007, DIS COLON RECTUM, V50, P13, DOI 10.1007/s10350-006-0745-5; Klos CL, 2010, AM J SURG, V200, P440, DOI 10.1016/j.amjsurg.2010.03.013; Kurahara H, 2010, J SURG ONCOL, V102, P809, DOI 10.1002/jso.21744; Longatto A, 2008, VIRCHOWS ARCH, V452, P133, DOI 10.1007/s00428-007-0550-0; Matsumoto K, 2007, DIS COLON RECTUM, V50, P308, DOI 10.1007/s10350-006-0792-y; Muders MH, 2009, CANCER RES, V69, P6042, DOI 10.1158/0008-5472.CAN-09-0552; Omachi T, 2007, CANCER LETT, V246, P167, DOI 10.1016/j.canlet.2006.02.013; Perez RO, 2005, INT J COLORECTAL DIS, V20, P434, DOI 10.1007/s00384-004-0712-3; Rinaldo F, 2007, ONCOGENE, V26, P1731, DOI 10.1038/sj.onc.1209971; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Royston D, 2009, J PATHOL, V217, P608, DOI 10.1002/path.2517; Sauer R, 2003, Colorectal Dis, V5, P406; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Van den Eynden GG, 2007, CLIN CANCER RES, V13, P5391, DOI 10.1158/1078-0432.CCR-07-1230; Van der Auwera I, 2005, CLIN CANCER RES, V11, P7637, DOI 10.1158/1078-0432.CCR-05-1142; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yeo SG, 2010, ANN SURG, V252, P998, DOI 10.1097/SLA.0b013e3181f3f1b1	29	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27402	10.1371/journal.pone.0027402	http://dx.doi.org/10.1371/journal.pone.0027402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087309	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700048
J	Liu, L; Zhong, R; Wei, S; Yin, JY; Xiang, H; Zou, L; Chen, W; Chen, JG; Zheng, XW; Huang, LJ; Zhu, BB; Chen, Q; Duan, SY; Rui, R; Yang, BF; Sun, JW; Xie, DS; Xu, YH; Miao, XP; Nie, SF				Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jie-Yun; Xiang, Hao; Zou, Li; Chen, Wei; Chen, Ji-Gui; Zheng, Xia-Wen; Huang, Li-Juan; Zhu, Bei-Bei; Chen, Quan; Duan, Sheng-Yu; Rui, Rui; Yang, Bei-Fang; Sun, Jing-Wen; Xie, Duo-Shuang; Xu, Yi-Hua; Miao, Xiao-Ping; Nie, Shao-Fa			Interactions between Genetic Variants in the Adiponectin, Adiponectin Receptor 1 and Environmental Factors on the Risk of Colorectal Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; PLASMA ADIPONECTIN; CIRCULATING ADIPONECTIN; CELL-PROLIFERATION; SERUM ADIPONECTIN; OBESITY; ASSOCIATION; COLON; INSULIN; ADIPOQ	Background: Metabolic syndrome traits play an important role in the development of colorectal cancer. Adipokines, key metabolic syndrome cellular mediators, when abnormal, may induce carcinogenesis. Methodology/Principal Findings: To investigate whether polymorphisms of important adipokines, adiponectin (ADIPOQ) and its receptors, either alone or in combination with environmental factors, are implicated in colorectal cancer, a two-stage case-control study was conducted. In the first stage, we evaluated 24 tag single nucleotide polymorphisms (tag SNPs) across ADIPOQ ligand and two ADIPOQ receptors (ADIPOR1 and ADIPOR2) among 470 cases and 458 controls. One SNP with promising association was then analyzed in stage 2 among 314 cases and 355 controls. In our study, ADIPOQ rs1063538 was consistently associated with increased colorectal cancer risk, with an odds ratio (OR) of 1.94 (95% CI: 1.48-2.54) for CC genotype compared with TT genotype. In two-factor gene-environment interaction analyses, rs1063538 presented significant interactions with smoking status, family history of cancer and alcohol use, with ORs of 4.52 (95% CI: 2.78-7.34), 3.18 (95% CI: 1.73-5.82) and 1.97 (95% CI: 1.27-3.04) for smokers, individuals with family history of cancer or drinkers with CC genotype compared with non-smokers, individuals without family history of cancer or non-drinkers with TT genotype, respectively. Multifactor gene-environment interactions analysis revealed significant interactions between ADIPOQ rs1063538, ADIPOR1 rs1539355, smoking status and BMI. Individuals carrying one, two and at least three risk factors presented 1.18-fold (95% CI: 0.89-fold to 1.58-fold), 1.87-fold (95% CI: 1.38-fold to2.54-fold) and 4.39-fold (95% CI: 2.75-fold to 7.01-fold) increased colorectal cancer risk compared with those who without risk factor, respectively (P-trend <0.0001). Conclusions/Significance: Our results suggest that variants in ADIPOQ may contribute to increased colorectal cancer risk in Chinese and this contribution may be modified by environmental factors, such as smoking status, family history of cancer and BMI.	[Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jie-Yun; Zou, Li; Chen, Wei; Zheng, Xia-Wen; Huang, Li-Juan; Zhu, Bei-Bei; Chen, Quan; Duan, Sheng-Yu; Rui, Rui; Yang, Bei-Fang; Sun, Jing-Wen; Xie, Duo-Shuang; Xu, Yi-Hua; Miao, Xiao-Ping; Nie, Shao-Fa] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jie-Yun; Zou, Li; Chen, Wei; Zheng, Xia-Wen; Huang, Li-Juan; Zhu, Bei-Bei; Chen, Quan; Duan, Sheng-Yu; Rui, Rui; Yang, Bei-Fang; Sun, Jing-Wen; Xie, Duo-Shuang; Xu, Yi-Hua; Miao, Xiao-Ping; Nie, Shao-Fa] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xiang, Hao] Wuhan Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China; [Chen, Ji-Gui] Eighth Hosp Wuhan, Dept Surg, Wuhan, Hubei, Peoples R China; [Xie, Duo-Shuang] Taihe Hosp, Dept Infect Control, Yunyang Med Coll, Shiyan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Liu, L (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	miaoxp@mail.hust.edu.cn; sf_nie@mails.tjmu.edu.cn	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; chen, quan/0000-0002-8019-0857	National Natural Science Foundation of China [NSFC-30972534, NSFC-81001275, 81171878]; Program for New Century Excellent Talents in University [NCET-10-0388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China [NSFC-30972534 to N. S., NSFC-81001275 and 81171878 to M. X. http://www.nsfc.gov.cn/Portal0/default124.htm] and Program for New Century Excellent Talents in University [NCET-10-0388 to M. X. http://www.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DIABETIC MED, V25, P400, DOI 10.1111/j.1464-5491.2008.02396.x; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bluher M, 2006, J CLIN ENDOCR METAB, V91, P2310, DOI 10.1210/jc.2005-2556; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Bray MS, 2001, HUM MUTAT, V17, P296, DOI 10.1002/humu.27; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Fenton JI, 2010, MOL CARCINOGEN, V49, P700, DOI 10.1002/mc.20644; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedland SJ, 2005, J UROLOGY, V174, P1266, DOI 10.1097/01.ju.0000173093.89897.97; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; Gonullu G, 2010, INT J COLORECTAL DIS, V25, P205, DOI 10.1007/s00384-009-0828-6; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Holmes MD, 2004, AM J EPIDEMIOL, V159, P732, DOI 10.1093/aje/kwh112; Inoue K, 2011, INTERNAL MED, V50, P707, DOI 10.2169/internalmedicine.50.4600; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jurinke C, 2001, Methods Mol Biol, V170, P103; Kaklamani V, 2011, METABOLISM, V60, P1234, DOI 10.1016/j.metabol.2011.01.005; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; LeMarchand L, 1997, CANCER RES, V57, P4787; Li HJ, 2010, CLIN CHEM, V56, P34, DOI 10.1373/clinchem.2009.133272; Lin J, 2004, CANCER CAUSE CONTROL, V15, P581, DOI 10.1023/B:CACO.0000036168.23351.f1; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Loos RJF, 2007, AM J CLIN NUTR, V85, P26, DOI 10.1093/ajcn/85.1.26; Lukanova A, 2006, INT J CANCER, V118, P458, DOI 10.1002/ijc.21354; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Meilleur KG, 2010, J CLIN ENDOCR METAB, V95, P3517, DOI 10.1210/jc.2009-2765; Mutoh M, 2011, GASTROENTEROLOGY, V140, p[2000, e2]; Nagel G, 2009, EUR HEART J, V30, P1885, DOI 10.1093/eurheartj/ehp180; Ong KL, 2010, EUR J ENDOCRINOL, V163, P251, DOI 10.1530/EJE-10-0251; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Otsuka F, 2009, J CARDIOL, V53, P219, DOI 10.1016/j.jjcc.2008.11.004; Petridou E, 2003, J CLIN ENDOCR METAB, V88, P993, DOI 10.1210/jc.2002-021209; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Russo A, 1998, INT J CANCER, V78, P161, DOI 10.1002/(SICI)1097-0215(19981005)78:2&lt;161::AID-IJC7&gt;3.0.CO;2-X; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Sun YT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011987; Tang HW, 2011, CANCER EPIDEM BIOMAR, V20, P779, DOI 10.1158/1055-9965.EPI-10-0845; Wan De-Sen, 2009, Ai Zheng, V28, P897; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Williams CJ, 2008, ENDOCR-RELAT CANCER, V15, P289, DOI 10.1677/ERC-07-0197; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705	55	56	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27301	10.1371/journal.pone.0027301	http://dx.doi.org/10.1371/journal.pone.0027301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087284	gold, Green Published, Green Submitted			2022-12-27	WOS:000297347700037
J	Anez, G; Morales-Betoulle, ME; Rios, M				Anez, German; Morales-Betoulle, Maria E.; Rios, Maria			Circulation of Different Lineages of Dengue Virus Type 2 in Central America, Their Evolutionary Time-Scale and Selection Pressure Analysis	PLOS ONE			English	Article							MOLECULAR EVOLUTION; PHYLOGENETIC-RELATIONSHIPS; PUERTO-RICO; NICARAGUA; MICROEVOLUTION; GENOTYPE; BIOLOGY; MEXICO; PCR	Dengue is caused by any of the four serotypes of dengue virus (DENV-1 to 4). Each serotype is genetically distant from the others, and each has been subdivided into different genotypes based on phylogenetic analysis. The study of dengue evolution in endemic regions is important since the diagnosis is often made by nucleic acid amplification tests, which depends upon recognition of the viral genome target, and natural occurring mutations can affect the performance of these assays. Here we report for the first time a detailed study of the phylogenetic relationships of DENV-2 from Central America, and report the first fully sequenced DENV-2 strain from Guatemala. Our analysis of the envelope (E) protein and of the open reading frame of strains from Central American countries, between 1999 and 2009, revealed that at least two lineages of the American/Asian genotype of DENV-2 have recently circulated in that region. In occasions the co-circulation of these lineages may have occurred and that has been suggested to play a role in the observed increased severity of clinical cases. Our time-scale analysis indicated that the most recent common ancestor for Central American DENV-2 of the American/Asian genotype existed about 19 years ago. Finally, we report positive selection in DENV-2 from Central America in codons of the genes encoding for C, E, NS2A, NS3, and NS5 proteins. Some of these identified codons are novel findings, described for the first time for any of the DENV-2 genotypes.	[Anez, German; Rios, Maria] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Morales-Betoulle, Maria E.] US Naval Med Res Unit 3 NAMRU 3, Cairo, Egypt	US Food & Drug Administration (FDA); Egyptian Knowledge Bank (EKB); Cairo University	Anez, G (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	German.Anez@fda.hhs.gov; Maria.Rios@fda.hhs.gov	Añez, Germán/H-4912-2019	Añez, Germán/0000-0001-5361-3001; Rios, Maria/0000-0001-5092-8403	Office of Blood Research and Review/Center for Biologics Evaluation and Research/Food and Drug Administration	Office of Blood Research and Review/Center for Biologics Evaluation and Research/Food and Drug Administration	This study was funded by Office of Blood Research and Review/Center for Biologics Evaluation and Research/Food and Drug Administration Internal Operational Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bennett SN, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P157; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Centers for Disease Control and Prevention (CDC), 1995, MMWR, V44, P21; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Droll D, 2001, TIMELINE DENGUE AM D; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lorono-Pino MA, 2004, AM J TROP MED HYG, V71, P485; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; PAHO, 2011, DENG REG INF NUMB CA; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reyes M, 2010, AM J TROP MED HYG, V83, P683, DOI 10.4269/ajtmh.2010.10-0023; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633; Tamura K, 2011, MOL BIOL EV IN PRESS; Tang Y, 2011, VIRUS GENES; TRENT DW, 1989, VIROLOGY, V172, P523, DOI 10.1016/0042-6822(89)90195-5; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Uzcategui NY, 2001, J GEN VIROL, V82, P2945, DOI 10.1099/0022-1317-82-12-2945; Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06; Vasilakis N, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P183; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0	44	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27459	10.1371/journal.pone.0027459	http://dx.doi.org/10.1371/journal.pone.0027459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076162	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200076
J	Mendez-Bravo, A; Calderon-Vazquez, C; Ibarra-Laclette, E; Raya-Gonzalez, J; Ramirez-Chavez, E; Molina-Torres, J; Guevara-Garcia, AA; Lopez-Bucio, J; Herrera-Estrella, L				Mendez-Bravo, Alfonso; Calderon-Vazquez, Carlos; Ibarra-Laclette, Enrique; Raya-Gonzalez, Javier; Ramirez-Chavez, Enrique; Molina-Torres, Jorge; Guevara-Garcia, Angel A.; Lopez-Bucio, Jose; Herrera-Estrella, Luis			Alkamides Activate Jasmonic Acid Biosynthesis and Signaling Pathways and Confer Resistance to Botrytis cinerea in Arabidopsis thaliana	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; N-ACYLETHANOLAMINES; SALICYLIC-ACID; NITRIC-OXIDE; GENE-EXPRESSION; HOMOSERINE-LACTONE; DEFENSE RESPONSES; PROTEIN; TRANSDUCTION; LIPOXYGENASE	Alkamides are fatty acid amides of wide distribution in plants, structurally related to N-acyl-L-homoserine lactones (AHLs) from Gram-negative bacteria and to N-acylethanolamines (NAEs) from plants and mammals. Global analysis of gene expression changes in Arabidopsis thaliana in response to N-isobutyl decanamide, the most highly active alkamide identified to date, revealed an overrepresentation of defense-responsive transcriptional networks. In particular, genes encoding enzymes for jasmonic acid (JA) biosynthesis increased their expression, which occurred in parallel with JA, nitric oxide (NO) and H2O2 accumulation. The activity of the alkamide to confer resistance against the necrotizing fungus Botrytis cinerea was tested by inoculating Arabidopsis detached leaves with conidiospores and evaluating disease symptoms and fungal proliferation. N-isobutyl decanamide application significantly reduced necrosis caused by the pathogen and inhibited fungal proliferation. Arabidopsis mutants jar1 and coi1 altered in JA signaling and a MAP kinase mutant (mpk6), unlike salicylic acid-(SA) related mutant eds16/sid2-1, were unable to defend from fungal attack even when N-isobutyl decanamide was supplied, indicating that alkamides could modulate some necrotrophic-associated defense responses through JA-dependent and MPK6-regulated signaling pathways. Our results suggest a role of alkamides in plant immunity induction.	[Mendez-Bravo, Alfonso; Raya-Gonzalez, Javier; Lopez-Bucio, Jose] Univ Michoacana, Inst Invest Quim Biol, Morelia, Michoacan, Mexico; [Mendez-Bravo, Alfonso; Calderon-Vazquez, Carlos; Ibarra-Laclette, Enrique; Herrera-Estrella, Luis] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Ramirez-Chavez, Enrique; Molina-Torres, Jorge] CINVESTAV, Dept Biotecnol & Bioquim, Unidad Irapuato, Guanajuato, Mexico; [Guevara-Garcia, Angel A.] UNAM, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Calderon-Vazquez, Carlos] IPN, Ctr Interdisciplinario Invest Desarrollo Integral, Guasave, Sinaloa, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Mendez-Bravo, A (corresponding author), Univ Michoacana, Inst Invest Quim Biol, Morelia, Michoacan, Mexico.	jbucio@umich.mx; lherrera@ira.cinvestav.mx	Calderon-Vazquez, Carlos/R-3601-2018; Herrera-Estrella, Luis/AAL-2472-2020; Torres, Jorge Molina/B-9325-2019; Herrera-Estrella, Luis/ABC-7431-2020; Estrella, Luis R Herrera/G-7351-2011	Calderon-Vazquez, Carlos/0000-0002-6674-2504; Herrera-Estrella, Luis/0000-0001-7936-3856; Estrella, Luis R Herrera/0000-0001-7936-3856; Mendez-Bravo, Alfonso/0000-0002-0991-5464; Molina Torres, Jorge/0000-0003-2371-0307; Ramirez-Chavez, Enrique/0000-0003-1689-7759	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [C02-43978/330, 106725]; Coordinacion de la Investigacion Cientifica-UMSNH [CIC 2.26]; Consejo Estatal de Ciencia y Tecnologia (COECYT); DGAPA-UNAM [IN-217698]; Howard Hughes Medical Institute [Nbr55003677]; European Commission [ICA-4-CT2000-30017]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Coordinacion de la Investigacion Cientifica-UMSNH; Consejo Estatal de Ciencia y Tecnologia (COECYT); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Consejo Nacional de Ciencia y Tecnologia (CONACYT C02-43978/330 and 106725), the Coordinacion de la Investigacion Cientifica-UMSNH (CIC 2.26), the Consejo Estatal de Ciencia y Tecnologia (COECYT), the DGAPA-UNAM (IN-217698), the Howard Hughes Medical Institute (grant no. Nbr55003677), and the European Commission (grant no. ICA-4-CT2000-30017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2002, PLANTA, V214, P497, DOI 10.1007/s00425-001-0688-y; Binns SE, 2001, PHYTOCHEMISTRY, V57, P417, DOI 10.1016/S0031-9422(00)00444-1; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Bush SM, 2007, J EXP BOT, V58, P2181, DOI 10.1093/jxb/erm092; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chapman KD, 1999, PLANT PHYSIOL, V120, P1157, DOI 10.1104/pp.120.4.1157; Chapman KD, 1998, PLANT PHYSIOL, V116, P1163, DOI 10.1104/pp.116.3.1163; Chehab EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001904; Dangl J.L., 2000, BIOCH MOL BIOL PLANT, P1044; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Dudler R, 2006, CURR OPIN BIOTECH, V17, P1; Gibson G., 2004, GENETIC ANAL COMPLEX, P251; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Goel V, 2002, INT IMMUNOPHARMACOL, V2, P381, DOI 10.1016/S1567-5769(01)00163-1; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hu XY, 2009, PLANT SIGNAL BEHAV, V4, P696, DOI 10.4161/psb.4.8.9181; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Keereetaweep J, 2010, FEBS LETT, V584, P3215, DOI 10.1016/j.febslet.2010.06.008; Kim SC, 2010, PLANT SCI, V178, P411, DOI 10.1016/j.plantsci.2010.02.017; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Kunos G, 2000, CHEM PHYS LIPIDS, V108, P159, DOI 10.1016/S0009-3084(00)00194-8; Lait CG, 2003, P NATL ACAD SCI USA, V100, P7027, DOI 10.1073/pnas.1232474100; Laluk K, 2011, PLANT J, V68, P480, DOI 10.1111/j.1365-313X.2011.04702.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bucio J, 2007, PLANT PHYSIOL, V145, P1703, DOI 10.1104/pp.107.107953; Lopez-Bucio J, 2006, CURR OPIN PLANT BIOL, V9, P523, DOI 10.1016/j.pbi.2006.07.002; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Mendez-Bravo A, 2010, PLANT CELL PHYSIOL, V51, P1612, DOI 10.1093/pcp/pcq117; Molina-Torres J, 2004, J AGR FOOD CHEM, V52, P4700, DOI 10.1021/jf034374y; Morquecho-Contreras A, 2010, PLANT PHYSIOL, V152, P1659, DOI 10.1104/pp.109.149989; MORQUECHOCONTRE.A, 2007, INT J PLANT DEV BIOL, V1, P34; Ortiz-Castro R, 2008, PLANT CELL ENVIRON, V31, P1497, DOI 10.1111/j.1365-3040.2008.01863.x; Paria BC, 2000, CHEM PHYS LIPIDS, V108, P211, DOI 10.1016/S0009-3084(00)00197-3; Pluskota WE, 2007, J EXP BOT, V58, P4071, DOI 10.1093/jxb/erm263; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ramirez-Chavez E, 2004, PLANT PHYSIOL, V134, P1058, DOI 10.1104/pp.103.034553; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Rios-Chavez P, 2003, IN VITRO CELL DEV-PL, V39, P37, DOI 10.1079/IVP2002354; Romero FR, 2009, IN VITRO CELL DEV-PL, V45, P599, DOI 10.1007/s11627-008-9187-1; Rosario SL, 1996, PLANTA MED, V62, P376, DOI 10.1055/s-2006-957913; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schuhegger R, 2006, PLANT CELL ENVIRON, V29, P909, DOI 10.1111/j.1365-3040.2005.01471.x; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tripathy S, 1999, PLANT PHYSIOL, V121, P1299, DOI 10.1104/pp.121.4.1299; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; von Rad U, 2008, PLANTA, V229, P73, DOI 10.1007/s00425-008-0811-4; Wendehenne D, 2006, PLANT CELL MONOGR, P35; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Woo HR, 2002, PLANT J, V31, P331, DOI 10.1046/j.1365-313X.2002.01355.x; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zimmerli L, 2001, PLANT PHYSIOL, V126, P517, DOI 10.1104/pp.126.2.517	88	39	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27251	10.1371/journal.pone.0027251	http://dx.doi.org/10.1371/journal.pone.0027251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076141	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200055
J	Marquez, CMS; Ceux, T; Wenderoth, N				Marquez, Cinthia M. Saucedo; Ceux, Tanja; Wenderoth, Nicole			Attentional Demands of Movement Observation as Tested by a Dual Task Approach	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; MOTOR CORTEX EXCITABILITY; MAGNETIC STIMULATION; PREMOTOR CORTEX; AUTOMATIC IMITATION; CONTROLLED-TRIAL; MENTAL PRACTICE; CHRONIC STROKE; HUMAN BRAIN; BOTTOM-UP	Movement observation (MO) has been shown to activate the motor cortex of the observer as indicated by an increase of corticomotor excitability for muscles involved in the observed actions. Moreover, behavioral work has strongly suggested that this process occurs in a near-automatic manner. Here we further tested this proposal by applying transcranial magnetic stimulation (TMS) when subjects observed how an actor lifted objects of different weights as a single or a dual task. The secondary task was either an auditory discrimination task (experiment 1) or a visual discrimination task (experiment 2). In experiment 1, we found that corticomotor excitability reflected the force requirements indicated in the observed movies (i.e. higher responses when the actor had to apply higher forces). Interestingly, this effect was found irrespective of whether MO was performed as a single or a dual task. By contrast, no such systematic modulations of corticomotor excitability were observed in experiment 2 when visual distracters were present. We conclude that interference effects might arise when MO is performed while competing visual stimuli are present. However, when a secondary task is situated in a different modality, neural responses are in line with the notion that the observers motor system responds in a near-automatic manner. This suggests that MO is a task with very low cognitive demands which might be a valuable supplement for rehabilitation training, particularly, in the acute phase after the incident or in patients suffering from attention deficits. However, it is important to keep in mind that visual distracters might interfere with the neural response in M1.	[Marquez, Cinthia M. Saucedo; Ceux, Tanja; Wenderoth, Nicole] Katholieke Univ Leuven, Res Ctr Motor Control & Neuroplast, Dept Biomed Kinesiol, Grp Biomed Sci, Heverlee, Belgium	KU Leuven	Marquez, CMS (corresponding author), Katholieke Univ Leuven, Res Ctr Motor Control & Neuroplast, Dept Biomed Kinesiol, Grp Biomed Sci, Heverlee, Belgium.	nici.wenderoth@faber.kuleuven.be	Wenderoth, Nicole/D-7262-2015	Wenderoth, Nicole/0000-0002-3246-9386	Flanders Fund for Scientific Research [G.0749.09]	Flanders Fund for Scientific Research(FWO)	Support for this study was provided through a grant from the Flanders Fund for Scientific Research (G.0749.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2012, PSYCHOL RES-PSYCH FO, V76, P503, DOI 10.1007/s00426-011-0380-1; Alaerts K, 2010, NEUROPSYCHOLOGIA, V48, P2082, DOI 10.1016/j.neuropsychologia.2010.03.029; Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P2593, DOI 10.1016/j.neuropsychologia.2009.05.006; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Andres M, 2007, J COGNITIVE NEUROSCI, V19, P563, DOI 10.1162/jocn.2007.19.4.563; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Candidi M, 2010, EUR J NEUROSCI, V32, P677, DOI 10.1111/j.1460-9568.2010.07305.x; Celnik P, 2008, STROKE, V39, P1814, DOI 10.1161/STROKEAHA.107.508184; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Engel A, 2008, SOC NEUROSCI, V3, P368, DOI 10.1080/17470910701612793; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Gazes Y, 2010, BEHAV BRAIN RES, V210, P229, DOI 10.1016/j.bbr.2010.02.036; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Goodale MA, 1998, NOVART FDN SYMP, V218, P21; Gowen E, 2010, BRAIN COGNITION, V74, P288, DOI 10.1016/j.bandc.2010.08.010; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Hiraga CY, 2009, BEHAV BRAIN RES, V205, P10, DOI 10.1016/j.bbr.2009.07.019; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Jonas M, 2007, EXP BRAIN RES, V177, P255, DOI 10.1007/s00221-006-0660-y; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Langguth B, 2009, NEUROSCI LETT, V460, P32, DOI 10.1016/j.neulet.2009.05.034; Leon-Sarmiento FE, 2005, NEUROSCI LETT, V389, P17, DOI 10.1016/j.neulet.2005.06.061; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Muthukumaraswamy SD, 2008, PSYCHOPHYSIOLOGY, V45, P896, DOI 10.1111/j.1469-8986.2008.00711.x; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Press C, 2006, EUR J NEUROSCI, V24, P2415, DOI 10.1111/j.1460-9568.2006.05115.x; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2005, CURR OPIN NEUROBIOL, V15, P623, DOI 10.1016/j.conb.2005.10.018; RIZZOLATTI G, 1987, EXP BRAIN RES, V67, P220, DOI 10.1007/BF00269468; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; van Leeuwen ML, 2009, NEUROPSYCHOLOGIA, V47, P3265, DOI 10.1016/j.neuropsychologia.2009.06.005; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Wolfe P, 2001, BRAIN MATTERS TRANSL, P151	75	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27292	10.1371/journal.pone.0027292	http://dx.doi.org/10.1371/journal.pone.0027292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073307	Green Submitted, Green Published, gold			2022-12-27	WOS:000297197000043
J	Polito, A; Sonneville, R; Guidoux, C; Barrett, L; Viltart, O; Mattot, V; Siami, S; de la Grandmaison, GL; Chretien, F; Singer, M; Gray, F; Annane, D; Brouland, JP; Sharshar, T				Polito, Andrea; Sonneville, Romain; Guidoux, Celine; Barrett, Lucinda; Viltart, Odile; Mattot, Virginie; Siami, Shidasp; de la Grandmaison, Geoffroy Lorin; Chretien, Fabrice; Singer, Mervyn; Gray, Francoise; Annane, Djillali; Brouland, Jean-Philippe; Sharshar, Tarek			Changes in CRH and ACTH Synthesis during Experimental and Human Septic Shock	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; CECAL LIGATION; NITRIC-OXIDE; HYDROCORTISONE THERAPY; CORTISOL-LEVELS; VASOPRESSIN; SEPSIS; SECRETION; STRESS	Context: The mechanisms of septic shock-associated adrenal insufficiency remain unclear. This study aimed at investigating the synthesis of corticotropin-releasing hormone (CRH) and vasopressin (AVP) by parvocellular neurons and the antehypophyseal expression of ACTH in human septic shock and in an experimental model of sepsis. Objective: To test the hypothesis that ACTH secretion is decreased secondarily to alteration of CRH or AVP synthesis, we undertook a neuropathological study of the antehypophyseal system in patients who had died from septic shock and rats with experimental faecal peritonitis. Methods: Brains obtained in 9 septic shock patients were compared to 10 nonseptic patients (controls). Parvocellular expression of AVP and CRH mRNA were evaluated by in situ hybridization. Antehypophyseal expression of ACTH, vasopressin V1b and CRH R1 receptors and parvocellular expression of iNOS in the PVN were evaluated by immunohistochemistry. The same experiments were carried out in a fecal peritonitis-induced model of sepsis. Data from septic rats with (n = 6) or without (n = 10) early death were compared to sham-operated (n = 8) animals. Results: In patients and rats, septic shock was associated with a decreased expression of ACTH, unchanged expression of V1B receptor, CRHR1 and AVP mRNA, and increased expression of parvocellular iNOS compared to controls. Septic shock was also characterized by an increased expression of CRH mRNA in rats but not in patients, who notably had a greater duration of septic shock. Conclusion: The present study suggests that in humans and in rats, septic shock is associated with decreased ACTH synthesis that is not compensated by its two natural secretagogues, AVP and CRH. One underlying mechanism might be increased expression of iNOS in hypothalamic parvocellular neurons.	[Polito, Andrea; Siami, Shidasp; Annane, Djillali; Sharshar, Tarek] Hop Raymond Poincare, Dept Intens Care, Garches, France; [Polito, Andrea; Siami, Shidasp; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin Yvelines, Virginie EA4342, Lab Neuroendocrin Response Sepsis, Garches, France; [Sonneville, Romain; Guidoux, Celine; Gray, Francoise; Brouland, Jean-Philippe] Lariboisiere Hosp, Dept Pathol, Paris, France; [Sonneville, Romain; Chretien, Fabrice] Inst Pasteur, Dept Infect & Epidemiol, HISTO Human HiSTOpathol & Anim Models, Paris, France; [Barrett, Lucinda] UCL, Dept Intens Care, London, England; [Viltart, Odile] Inst Pasteur, CNRS, Dept Biol, UMR8161, F-59019 Lille, France; [Mattot, Virginie] Univ Nord France, INSERM, Dept Plast Postnatal Brain, U837, Lille, France; [de la Grandmaison, Geoffroy Lorin] Hop Raymond Poincare, Dept Pathol, Garches, France; [Singer, Mervyn] UCL, Dept Med, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; University of London; University College London	Polito, A (corresponding author), Hop Raymond Poincare, Dept Intens Care, Garches, France.	djillali.annane@rpc.aphp.fr	Singer, Mervyn/J-4425-2012; Chretien, fabrice B/D-4035-2018; Sharshar, Tarek/ABF-4117-2021; Singer, Mervyn/Q-6142-2019; Sonneville, Romain/AAE-7039-2020; Annane, Djillali/R-7947-2019	Singer, Mervyn/0000-0002-1042-6350; Chretien, fabrice B/0000-0002-2794-1383; Singer, Mervyn/0000-0002-1042-6350; Sonneville, Romain/0000-0003-0245-309X; Brouland, Jean Philippe/0000-0003-3475-0101	Fondation Garches; CORTICUS [NCT00147004]	Fondation Garches; CORTICUS	This study was funded by a grant from the Fondation Garches and also by CORTICUS (NCT00147004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bugajski J, 1999, BRAIN RES, V817, P220, DOI 10.1016/S0006-8993(98)01209-8; Carlson DE, 2006, CRIT CARE MED, V34, P1178, DOI 10.1097/01.CCM.0000207340.24290.3C; Carlson DE, 2007, EXP NEUROL, V205, P485, DOI 10.1016/j.expneurol.2007.03.015; DALLMAN MF, 1987, RECENT PROG HORM RES, V43, P113; DOHANICS J, 1990, PEPTIDES, V11, P51, DOI 10.1016/0196-9781(90)90109-I; FLESHNER M, 1995, BRAIN RES BULL, V37, P605, DOI 10.1016/0361-9230(95)00051-F; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Guzman JA, 2007, J CRIT CARE, V22, P319, DOI 10.1016/j.jcrc.2007.05.003; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Heuer JG, 2004, J SURG RES, V121, P178, DOI 10.1016/j.jss.2004.04.018; HOLMES MC, 1986, NATURE, V319, P326, DOI 10.1038/319326a0; Hsieh CH, 2010, NEUROSCIENCE, V165, P1191, DOI 10.1016/j.neuroscience.2009.12.003; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; IRVINE CHG, 1989, ENDOCRINOLOGY, V124, P3102, DOI 10.1210/endo-124-6-3102; Kapcala LP, 1995, ANN NY ACAD SCI, V771, P419, DOI 10.1111/j.1749-6632.1995.tb44699.x; LIGHTMAN SL, 1988, J PHYSIOL-LONDON, V403, P511, DOI 10.1113/jphysiol.1988.sp017261; Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533; Lolait SJ, 2007, ENDOCRINOLOGY, V148, P849, DOI 10.1210/en.2006-1309; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathiak G, 2000, BRIT J PHARMACOL, V131, P383, DOI 10.1038/sj.bjp.0703629; Medina E, 2010, METHODS MOL BIOL, V602, P411, DOI 10.1007/978-1-60761-058-8_23; Muller MB, 2001, ENDOCRINOLOGY, V142, P4150, DOI 10.1210/en.142.9.4150; Oliveira-Pelegrin GR, 2010, J NEUROIMMUNOL, V227, P80, DOI 10.1016/j.jneuroim.2010.06.019; Oliveira-Pelegrin GR, 2009, NEUROIMMUNOMODULAT, V16, P45, DOI 10.1159/000179666; Oppert M, 2000, INTENS CARE MED, V26, P1747, DOI 10.1007/s001340000685; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Polito A, 2011, CRIT CARE, V15, DOI 10.1186/cc10244; Rivier C, 2003, ANN NY ACAD SCI, V992, P72, DOI 10.1111/j.1749-6632.2003.tb03139.x; Rivier C, 1998, NEUROIMMUNOMODULAT, V5, P203, DOI 10.1159/000026338; Schroeder S, 2001, CRIT CARE MED, V29, P310, DOI 10.1097/00003246-200102000-00017; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Sharshar T, 2010, INTENS CARE MED, V36, P1318, DOI 10.1007/s00134-010-1840-6; Sonneville R, 2010, BRAIN PATHOL, V20, P613, DOI 10.1111/j.1750-3639.2009.00355.x; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Pancoto JAT, 2008, AUTON NEUROSCI-BASIC, V138, P57, DOI 10.1016/j.autneu.2007.10.006; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	41	33	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e25905	10.1371/journal.pone.0025905	http://dx.doi.org/10.1371/journal.pone.0025905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073145	gold, Green Published, Green Submitted			2022-12-27	WOS:000297197000006
J	Yamazaki, Y; Matsubara, T; Takahashi, T; Kurashige, T; Dohi, E; Hiji, M; Nagano, Y; Yamawaki, T; Matsumoto, M				Yamazaki, Yuu; Matsubara, Tomoyasu; Takahashi, Tetsuya; Kurashige, Takashi; Dohi, Eisuke; Hiji, Masanori; Nagano, Yoshito; Yamawaki, Takemori; Matsumoto, Masayasu			Granulovacuolar Degenerations Appear in Relation to Hippocampal Phosphorylated Tau Accumulation in Various Neurodegenerative Disorders	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE HIPPOCAMPUS; NEUROFIBRILLARY TANGLES; SENILE PLAQUES; PICKS-DISEASE; CORTICOBASAL DEGENERATION; TDP-43 IMMUNOREACTIVITY; PRECURSOR PROTEIN; DEMENTED PATIENTS; ALPHA-SYNUCLEIN	Background: Granulovacuolar degeneration (GVD) is one of the pathological hallmarks of Alzheimer's disease (AD), and it is defined as electron-dense granules within double membrane-bound cytoplasmic vacuoles. Several lines of evidence have suggested that GVDs appear within hippocampal pyramidal neurons in AD when phosphorylated tau begins to aggregate into early-stage neurofibrillary tangles. The aim of this study is to investigate the association of GVDs with phosphorylated tau pathology to determine whether GVDs and phosphorylated tau coexist among different non-AD neurodegenerative disorders. Methods: An autopsied series of 28 patients with a variety of neurodegenerative disorders and 9 control patients were evaluated. Standard histological stains along with immunohistochemistry using protein markers for GVD and confocal microscopy were utilized. Results: The number of neurons with GVDs significantly increased with the level of phosphorylated tau accumulation in the hippocampal regions in non-AD neurodegenerative disorders. At the cellular level, diffuse staining for phosphorylated tau was detected in neurons with GVDs. Conclusions: Our data suggest that GVDs appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders, while the presence of phosphorylated tau in GVD-harbouring neurons in non-AD neurodegenerative disorders was indistinguishable from age-related accumulation of phosphorylated tau. Although GVDs in non-AD neurodegenerative disorders have not been studied thoroughly, our results suggest that they are not incidental findings, but rather they appear in relation to phosphorylated tau accumulation, further highlighting the role of GVD in the process of phosphorylated tau accumulation.	[Yamazaki, Yuu; Takahashi, Tetsuya; Kurashige, Takashi; Dohi, Eisuke; Hiji, Masanori; Nagano, Yoshito; Yamawaki, Takemori; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Matsubara, Tomoyasu] Aso Iizuka Hosp, Dept Gen Internal Med, Iizuka, Fukuoka, Japan; [Hiji, Masanori] Mifukai Viha Ra Hananosato Hosp, Dept Neurol, Miyoshi, Japan	Hiroshima University	Yamazaki, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	yyamazak@hiroshima-u.ac.jp	Kurashige, Takashi/N-1767-2014; Dohi, Eisuke/I-7197-2019; Takahashi, Tetsuya/ABG-8566-2021; Matsubara, Tomoyasu/AAB-4925-2021	Kurashige, Takashi/0000-0002-5206-5979; Takahashi, Tetsuya/0000-0001-6891-0842; Matsubara, Tomoyasu/0000-0002-7559-8284; Yamazaki, Yu/0000-0002-0806-4960; NAGANO, YOSHITO/0000-0002-7974-4824	Ministry of Education, Culture, Sports, Science and Technology (MEXT);  [21591085]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT: http://www.mext.go.jp/english/) and Grant-in-Aid for Scientific Research (C) (#21591085; Principle Investigator, Tetsuya Takahashi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; BALL MJ, 1978, ACTA NEUROPATHOL, V42, P73, DOI 10.1007/BF00690970; BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; BONDAREFF W, 1991, AM J PATHOL, V139, P641; BONDAREFF W, 1989, NEUROBIOL AGING, V10, P709, DOI 10.1016/0197-4580(89)90007-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; Cohen J, 1988, STAT POWER ANAL BEHA, Vxxi; DICKSON DW, 1987, ACTA NEUROPATHOL, V73, P254, DOI 10.1007/BF00686619; EIDELBERG D, 1987, BRAIN, V110, P993, DOI 10.1093/brain/110.4.993; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; FLAMENT S, 1990, BRAIN RES, V516, P15, DOI 10.1016/0006-8993(90)90891-E; FUNK KE, 2010, NEUROPATHOL APPL NEU; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gertz HJ, 1996, EUR ARCH PSY CLIN N, V246, P132, DOI 10.1007/BF02189114; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Ghanevati M, 2005, J MOL NEUROSCI, V25, P79, DOI 10.1385/JMN:25:1:079; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; GIBB WRG, 1989, BRAIN, V112, P1171, DOI 10.1093/brain/112.5.1171; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; HOF PR, 1992, ACTA NEUROPATHOL, V84, P45, DOI 10.1007/BF00427214; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; HOF PR, 1992, NEUROSCI LETT, V139, P10, DOI 10.1016/0304-3940(92)90846-Y; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4; Ikegami K, 1996, PSYCHIAT CLIN NEUROS, V50, P137, DOI 10.1111/j.1440-1819.1996.tb01678.x; Ishizawa T, 2003, AM J PATHOL, V163, P1057, DOI 10.1016/S0002-9440(10)63465-7; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Kadokura A, 2009, NEUROSCI LETT, V463, P87, DOI 10.1016/j.neulet.2009.06.024; Kannanayakal TJ, 2006, ACTA NEUROPATHOL, V111, P413, DOI 10.1007/s00401-006-0049-9; KIUCHI A, 1991, ACTA NEUROPATHOL, V82, P1, DOI 10.1007/BF00310916; Lagalwar S, 2007, ACTA NEUROPATHOL, V113, P63, DOI 10.1007/s00401-006-0159-4; Lagalwar S, 2006, J NEUROPATH EXP NEUR, V65, P455, DOI 10.1097/01.jnen.0000229236.98124.d8; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Lieberman AP, 1998, ANN NEUROL, V43, P259, DOI 10.1002/ana.410430218; LOVE S, 1988, J NEUROPATH EXP NEUR, V47, P393, DOI 10.1097/00005072-198807000-00001; Mena R, 1992, J Geriatr Psychiatry Neurol, V5, P132; MOLSA PK, 1987, ACTA NEUROL SCAND, V75, P376; OKAMOTO K, 1991, ACTA NEUROPATHOL, V82, P340, DOI 10.1007/BF00296544; SCHERRER VB, 1996, ACTA NEUROPATHOL, V91, P351; Schmidt ML, 1996, J NEUROPATH EXP NEUR, V55, P534, DOI 10.1097/00005072-199605000-00006; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Spillantini MG, 1999, ACTA NEUROPATHOL, V97, P585, DOI 10.1007/s004010051034; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Su JH, 2002, ACTA NEUROPATHOL, V104, P1, DOI 10.1007/s00401-002-0548-2; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; TOWFIGHI J, 1972, ACTA NEUROPATHOL, V21, P224, DOI 10.1007/BF00688501; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; VERMERSCH P, 1993, ANN NEUROL, V33, P445, DOI 10.1002/ana.410330506; WOODARD JS, 1962, J NEUROPATH EXP NEUR, V21, P85, DOI 10.1097/00005072-196201000-00007; XU M, 1992, ACTA NEUROPATHOL, V85, P1, DOI 10.1007/BF00304627; Yamazaki Y, 2010, NEUROSCI LETT, V477, P86, DOI 10.1016/j.neulet.2010.04.038	61	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26996	10.1371/journal.pone.0026996	http://dx.doi.org/10.1371/journal.pone.0026996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073234	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000020
J	Connelly, JT; Mishra, A; Gautrot, JE; Watt, FM				Connelly, John T.; Mishra, Ajay; Gautrot, Julien E.; Watt, Fiona M.			Shape-Induced Terminal Differentiation of Human Epidermal Stem Cells Requires p38 and Is Regulated by Histone Acetylation	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSIT-AMPLIFYING CELLS; MAP KINASE; GENE-EXPRESSION; ACTIVATION; ACTIN; SRF; SURFACE; ROLES; HDAC1	Engineered model substrates are powerful tools for examining interactions between stem cells and their microenvironment. Using this approach, we have previously shown that restricted cell adhesion promotes terminal differentiation of human epidermal stem cells via activation of serum response factor (SRF) and transcription of AP-1 genes. Here we investigate the roles of p38 MAPK and histone acetylation. Inhibition of p38 activity impaired SRF transcriptional activity and shape-induced terminal differentiation of human keratinocytes. In addition, inhibiting p38 reduced histone H3 acetylation at the promoters of SRF target genes, FOS and JUNB. Although histone acetylation correlated with SRF transcriptional activity and target gene expression, treatment with the histone de-acetylase inhibitor, trichostatin A (TSA) blocked terminal differentiation on micro-patterned substrates and in suspension. TSA treatment simultaneously maintained expression of LRIG1, TP63, and ITGB1. Therefore, global histone de-acetylation represses stem cell maintenance genes independent of SRF. Our studies establish a novel role for extrinsic physical cues in the regulation of chromatin remodeling, transcription, and differentiation of human epidermal stem cells.	[Connelly, John T.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Mishra, Ajay; Watt, Fiona M.] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Gautrot, Julien E.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England	University of London; Queen Mary University London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; Queen Mary University London; University of Cambridge	Connelly, JT (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	j.connelly@qmul.ac.uk	Watt, Fiona/AHB-0226-2022; Gautrot, Julien/S-7920-2016	Watt, Fiona/0000-0001-9151-5154; Gautrot, Julien/0000-0002-1614-2578; mishra, ajay/0000-0001-8201-4067; Connelly, John/0000-0002-5955-8848	Wellcome Trust; Medical Research Council; Cancer Research UK; European Union; Barts and the London Charity; National Institutes of Health	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union(European Commission); Barts and the London Charity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Wellcome Trust, Medical Research Council, Cancer Research UK, the European Union Framework 7, and Barts and the London Charity. JTC was the recipient of a National Institutes of Health postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; Chen WX, 2000, MOL CARCINOGEN, V28, P196, DOI 10.1002/1098-2744(200008)28:4<196::AID-MC2>3.0.CO;2-C; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Murai K, 2002, MOL CELL BIOL, V22, P7083, DOI 10.1128/MCB.22.20.7083-7092.2002; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	39	43	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27259	10.1371/journal.pone.0027259	http://dx.doi.org/10.1371/journal.pone.0027259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073300	Green Published, gold			2022-12-27	WOS:000297154900095
J	Klemuk, SA; Riede, T; Walsh, EJ; Titze, IR				Klemuk, Sarah A.; Riede, Tobias; Walsh, Edward J.; Titze, Ingo R.			Adapted to Roar: Functional Morphology of Tiger and Lion Vocal Folds	PLOS ONE			English	Article							PHONATION THRESHOLD PRESSURE; FINITE-ELEMENT MODEL; VISCOELASTIC PROPERTIES; LAMINA PROPRIA; FUNDAMENTAL-FREQUENCY; STRESS-RELAXATION; ELASTICITY; TISSUE; BIOMATERIALS; GEOMETRY	Vocal production requires active control of the respiratory system, larynx and vocal tract. Vocal sounds in mammals are produced by flow-induced vocal fold oscillation, which requires vocal fold tissue that can sustain the mechanical stress during phonation. Our understanding of the relationship between morphology and vocal function of vocal folds is very limited. Here we tested the hypothesis that vocal fold morphology and viscoelastic properties allow a prediction of fundamental frequency range of sounds that can be produced, and minimal lung pressure necessary to initiate phonation. We tested the hypothesis in lions and tigers who are well-known for producing low frequency and very loud roaring sounds that expose vocal folds to large stresses. In histological sections, we found that the Panthera vocal fold lamina propria consists of a lateral region with adipocytes embedded in a network of collagen and elastin fibers and hyaluronan. There is also a medial region that contains only fibrous proteins and hyaluronan but no fat cells. Young's moduli range between 10 and 2000 kPa for strains up to 60%. Shear moduli ranged between 0.1 and 2 kPa and differed between layers. Biomechanical and morphological data were used to make predictions of fundamental frequency and subglottal pressure ranges. Such predictions agreed well with measurements from natural phonation and phonation of excised larynges, respectively. We assume that fat shapes Panthera vocal folds into an advantageous geometry for phonation and it protects vocal folds. Its primary function is probably not to increase vocal fold mass as suggested previously. The large square-shaped Panthera vocal fold eases phonation onset and thereby extends the dynamic range of the voice.	[Klemuk, Sarah A.; Titze, Ingo R.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Riede, Tobias] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Riede, Tobias; Titze, Ingo R.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Walsh, Edward J.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	University of Iowa; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Boys Town National Research Hospital	Klemuk, SA (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA.	u0629893@utah.edu	Riede, Tobias/J-9092-2012	Riede, Tobias/0000-0001-6875-0017; Walsh, Edward/0000-0002-6846-2872; Riede, Tobias/0000-0001-9606-0742	National Institutes of Health (NIH) [R01 DC008612, R01 DC04390, 1R01 DC010275]; National Science Foundation (NSF) [0823417]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010275, R01DC008612, R01DC004390] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this work was provided in part by National Institutes of Health (NIH) Grants R01 DC008612, R01 DC04390, and 1R01 DC010275, and National Science Foundation (NSF) Grant 0823417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour F, 2000, J ACOUST SOC AM, V108, P3003, DOI 10.1121/1.1324678; Alipour F, 2011, J VOICE, V25, P130, DOI 10.1016/j.jvoice.2009.09.002; Alipoura F, 2008, J ACOUST SOC AM, V123, P4572, DOI 10.1121/1.2908289; Bevington PR., 2002, DATA REDUCTION ERROR; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Chan RW, 2006, J ACOUST SOC AM, V119, P2351, DOI 10.1121/1.2173516; Chan RW, 2003, ANN BIOMED ENG, V31, P482, DOI 10.1114/1.1561287; Chan RW, 1998, LARYNGOSCOPE, V108, P725, DOI 10.1097/00005537-199805000-00019; CICERO VL, 2008, CELL PROLIFERAT, V41, P460; *COMM LOW FREQ MAR, 1994, LOW FREQ SOUND MAR M; Geerligs M, 2008, BIORHEOLOGY, V45, P677, DOI 10.3233/BIR-2008-0517; Goemmel Andreas, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P377, DOI 10.1080/10255840701550923; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Hahn MS, 2008, ANN OTO RHINOL LARYN, V117, P371, DOI 10.1177/000348940811700508; Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607; Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022; HAST MH, 1989, J ANAT, V163, P117; Hirano S, 2004, ANN OTO RHINOL LARYN, V113, P777, DOI 10.1177/000348940411301002; HOLBROOK KA, 1974, J INVEST DERMATOL, V62, P415, DOI 10.1111/1523-1747.ep12701670; Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006; Ishizaka K., 1968, J ACOUST SOC JPN, V24, P311, DOI [10.20697/jasj.24.5_311, DOI 10.20697/JASJ.24.5_311]; JIANG JJQ, 1994, J VOICE, V8, P132, DOI 10.1016/S0892-1997(05)80305-4; Klemuk SA, 2004, LARYNGOSCOPE, V114, P1597, DOI 10.1097/00005537-200409000-00018; Klemuk SA, 2010, LARYNGOSCOPE, V120, P995, DOI 10.1002/lary.20877; Kurita S., 1983, VOCAL FOLD PHYSL CON, P3; Larom D, 1997, J EXP BIOL, V200, P421; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; MIN YB, 1995, ANN OTO RHINOL LARYN, V104, P563, DOI 10.1177/000348949510400711; Peters G., 1978, SPIXIANA, V1, P1; Peters G, 2011, MAMMAL REV, V41, P54, DOI 10.1111/j.1365-2907.2010.00169.x; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; Riede T, 2008, J EXP BIOL, V211, P2144, DOI 10.1242/jeb.017004; Riede T, 2011, J BIOMECH, V44, P1936, DOI 10.1016/j.jbiomech.2011.04.024; Riede T, 2010, J EXP BIOL, V213, P2924, DOI 10.1242/jeb.044404; Riede T, 2010, J MORPHOL, V271, P1, DOI 10.1002/jmor.10774; Schaller G. B., 1972, SERENGETI LION; SCHRAG JL, 1977, T SOC RHEOL, V21, P399, DOI 10.1122/1.549445; Selbie WS, 1998, J ACOUST SOC AM, V103, P1115, DOI 10.1121/1.421223; Tayama N, 2002, ANN OTO RHINOL LARYN, V111, P83, DOI 10.1177/000348940211100114; Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299; Titze IR, 2011, J SPEECH LANG HEAR R, V54, P520, DOI 10.1044/1092-4388(2010/09-0284); Titze IR, 2010, J EXP BIOL, V213, P3866, DOI 10.1242/jeb.044982; Titze IR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000897; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; WALSH EJ, 2011, 3 INT S AC COMM AN, P173; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	47	26	26	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27029	10.1371/journal.pone.0027029	http://dx.doi.org/10.1371/journal.pone.0027029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073246	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900066
J	Moore, TJ; Furberg, CD; Glenmullen, J; Maltsberger, JT; Singh, S				Moore, Thomas J.; Furberg, Curt D.; Glenmullen, Joseph; Maltsberger, John T.; Singh, Sonal			Suicidal Behavior and Depression in Smoking Cessation Treatments	PLOS ONE			English	Article							PSYCHIATRIC ADVERSE EVENTS; CONTROLLED CLINICAL-TRIALS; VARENICLINE; TOBACCO; RISK; METAANALYSIS; SYMPTOMS; COHORT	Background: Two treatments for smoking cessation-varenicline and bupropion-carry Boxed Warnings from the U. S. Food and Drug Administration (FDA) about suicidal/self-injurious behavior and depression. However, some epidemiological studies report an increased risk in smoking or smoking cessation independent of treatment, and differences between drugs are unknown. Methodology: From the FDA's Adverse Event Reporting System (AERS) database from 1998 through September 2010 we selected domestic, serious case reports for varenicline (n = 9,575), bupropion for smoking cessation (n = 1,751), and nicotine replacement products (n = 1,917). A composite endpoint of suicidal/self-injurious behavior or depression was defined as a case with one or more Preferred Terms in Standardized MedDRA Query (SMQ) for those adverse effects. The main outcome measure was the ratio of reported suicide/self-injury or depression cases for each drug compared to all other serious events for that drug. Results: Overall we identified 3,249 reported cases of suicidal/self-injurious behavior or depression, 2,925 (90%) for varenicline, 229 (7%) for bupropion, and 95 (3%) for nicotine replacement. Compared to nicotine replacement, the disproportionality results (OR (95% CI)) were varenicline 8.4 (6.8-10.4), and bupropion 2.9 (2.3-3.7). The disproportionality persisted after excluding reports indicating concomitant therapy with any of 58 drugs with suicidal behavior warnings or precautions in the prescribing information. An additional antibiotic comparison group showed that adverse event reports of suicidal/self-injurious behavior or depression were otherwise rare in a healthy population receiving short-term drug treatment. Conclusions: Varenicline shows a substantial, statistically significant increased risk of reported depression and suicidal/self-injurious behavior. Bupropion for smoking cessation had smaller increased risks. The findings for varenicline, combined with other problems with its safety profile, render it unsuitable for first-line use in smoking cessation.	[Moore, Thomas J.] Inst Safe Medicat Practices, Alexandria, VA USA; [Furberg, Curt D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA; [Glenmullen, Joseph] Harvard Univ, Sch Med, Dept Psychiat, Cambridge Hosp, Cambridge, MA 02138 USA; [Maltsberger, John T.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; [Singh, Sonal] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; McLean Hospital; Johns Hopkins University	Moore, TJ (corresponding author), Inst Safe Medicat Practices, Alexandria, VA USA.	tmoore@ismp.org	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X; Moore, Thomas/0000-0003-0994-836X				American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P328, DOI 10.1001/archpsyc.62.3.328; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Greenland S, 1998, DRUG SAFETY, V18, P297, DOI 10.2165/00002018-199818040-00005; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Harrison-Woolrych M, 2011, DRUG SAFETY, V34, P763, DOI 10.2165/11594450-000000000-00000; HATSUKAMI DK, 1988, PSYCHOPHARMACOLOGY, V94, P242; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Hughes JR, 2007, NICOTINE TOB RES, V9, P443, DOI 10.1080/14622200701243185; Josefberg H, 2006, CLIN SAFETY REV APPL; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Leistikow B N, 2000, Inj Prev, V6, P277, DOI 10.1136/ip.6.4.277; Levenson M., 2008, STAT REV EVALUATION; MedDRA Maintenance and Support Services Organization, 2010, INTR GUID MEDDRA VER; MedDRA Maintenance and Support Services Organization, 2010, INTR GUID STAND MEDD; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Moore TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015337; Moore TJ, 2010, ANN PHARMACOTHER, V44, P1389, DOI 10.1345/aph.1P172; Moore TJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4964; Moore TJ, 2011, SIGNALS VARENICLINE; Mosholder AD, 2006, J CHILD ADOL PSYCHOP, V16, P25, DOI 10.1089/cap.2006.16.25; National Cancer Institute Centers for Disease Control and Prevention, 2009, NAT CANC I CTR DIS C; National Center for Chronic Disease Prevention and Health Promotion; Office on Smoking and Health (U.S.), 2010, TOB SMOK CAUS DIS BI; National Library of Medicine, 2010, UN MED LANG SYST UML; Pfizer Inc, 2010, CHANTIX VAR TARTR TA; Pollock M, 2008, SUICIDALITY VARENICL; Rouve N, 2011, EUR J CLIN IN PRESS; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; United States Department of Veterans Affairs Pharmacy Benefits Management Services, 2011, CLIN GUID VAR CRIT P; United States Food and Drug Administration, 2009, CHANT ZYB GET BOX WA; United States Food and Drug Administration, 2011, CHANT QUARTERWATCH A; United States Food and Drug Administration, 2010, ADV EV REP SYST AERS; Wallerstedt SM, 2009, PHARMACOEPIDEM DR S, V18, P858, DOI 10.1002/pds.1794; Winchell C, 2006, SUPERVISORY REV NDA	40	116	119	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27016	10.1371/journal.pone.0027016	http://dx.doi.org/10.1371/journal.pone.0027016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073240	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900064
J	Wicherts, JM; Bakker, M; Molenaar, D				Wicherts, Jelte M.; Bakker, Marjan; Molenaar, Dylan			Willingness to Share Research Data Is Related to the Strength of the Evidence and the Quality of Reporting of Statistical Results	PLOS ONE			English	Article							P-VALUES; MEDICAL-RESEARCH; PSYCHOLOGY; JOURNALS	Background: The widespread reluctance to share published research data is often hypothesized to be due to the authors' fear that reanalysis may expose errors in their work or may produce conclusions that contradict their own. However, these hypotheses have not previously been studied systematically. Methods and Findings: We related the reluctance to share research data for reanalysis to 1148 statistically significant results reported in 49 papers published in two major psychology journals. We found the reluctance to share data to be associated with weaker evidence (against the null hypothesis of no effect) and a higher prevalence of apparent errors in the reporting of statistical results. The unwillingness to share data was particularly clear when reporting errors had a bearing on statistical significance. Conclusions: Our findings on the basis of psychological papers suggest that statistical results are particularly hard to verify when reanalysis is more likely to lead to contrasting conclusions. This highlights the importance of establishing mandatory data archiving policies.	[Wicherts, Jelte M.; Bakker, Marjan; Molenaar, Dylan] Univ Amsterdam, Dept Psychol, Fac Social & Behav Sci, Amsterdam, Netherlands	University of Amsterdam	Wicherts, JM (corresponding author), Univ Amsterdam, Dept Psychol, Fac Social & Behav Sci, Amsterdam, Netherlands.	j.m.wicherts@uva.nl	Bakker, Marjan/O-5864-2019; Wicherts, Jelte M./A-2664-2008	Bakker, Marjan/0000-0001-9024-337X; Wicherts, Jelte M./0000-0003-2415-2933	Netherlands Organization for Scientific Research (NWO) [021-001-124, 451-07-016, 400-08-214]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The preparation of this article was supported by three grants (021-001-124, 451-07-016, and 400-08-214) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS ONE; [Anonymous], 2011, NATURE, V470, P305; APA (American Psychological Association), 2010, PUBL MAN AM PSYCH AS; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Barber T.X., 1976, PITFALLS HUMAN RES 1; Berle D, 2007, INT J METH PSYCH RES, V16, P202, DOI 10.1002/mpr.225; Blanton H, 2009, J APPL PSYCHOL, V94, P567, DOI 10.1037/a0014665; Board on Life Sciences National Research Council, 2003, SHAR PUBL DAT MAT RE; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; CECI SJ, 1983, AM PSYCHOL, V38, P414, DOI 10.1037/0003-066X.38.4.414; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Firebaugh G, 2007, SOCIOL METHOD RES, V36, P200, DOI 10.1177/0049124107306663; Fisher R.A., 1958, STAT METHODS RES WOR; Freese J, 2007, SOCIOL METHOD RES, V36, P153, DOI 10.1177/0049124107306659; Friedlander F, 1964, AM PSYCHOL, V19, P198; Garcia-Berthou Emili, 2004, BMC Med Res Methodol, V4, P13, DOI 10.1186/1471-2288-4-13; Hoekstra R, 2006, PSYCHON B REV, V13, P1033, DOI 10.3758/BF03213921; Hubbard R, 2000, EDUC PSYCHOL MEAS, V60, P661, DOI 10.1177/0013164400605001; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jubb M., 2008, SHARE NOT SHARE PUBL; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Mahoney M.J., 1976, SCI SUBJECT PSYCHOL; Mahoney M.J., 1977, COGNITIVE THER RES, V1, P161, DOI [10.1007/BF01173636, DOI 10.1007/BF01173636]; McCullough BD, 2006, J MONEY CREDIT BANK, V38, P1093, DOI 10.1353/mcb.2006.0061; McCullough BD, 2003, AM ECON REV, V93, P873, DOI 10.1257/000282803322157133; Murphy JR, 2004, J ALLERGY CLIN IMMUN, V114, P1259, DOI 10.1016/j.jaci.2004.09.023; Nature, 2006, NATURE, V444, P653; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; ROSENTHAL R, 1963, J PSYCHOL, V55, P33, DOI 10.1080/00223980.1963.9916596; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sellke T, 2001, AM STAT, V55, P62, DOI 10.1198/000313001300339950; Strasak AM, 2007, AM STAT, V61, P47, DOI 10.1198/000313007X170242; Voorbrood C, 2010, ARCHIVERING BESCHIKB; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wicherts J, 2009, NATURE, V461, P1053, DOI 10.1038/4611053c; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; WOLINS L, 1962, AM PSYCHOL, V17, P657, DOI 10.1037/h0038819	40	200	200	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26828	10.1371/journal.pone.0026828	http://dx.doi.org/10.1371/journal.pone.0026828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073203	Green Published, gold			2022-12-27	WOS:000297154900042
J	Dickerson, JE; Zhu, A; Robertson, DL; Hentges, KE				Dickerson, Jonathan E.; Zhu, Ana; Robertson, David L.; Hentges, Kathryn E.			Defining the Role of Essential Genes in Human Disease	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; OF-FUNCTION MUTATIONS; GENOME DATABASE MGD; HOUSEKEEPING GENES; NETWORK PROPERTIES; MOUSE; IDENTIFICATION; MALFORMATIONS; TUMORIGENESIS; CYTOSCAPE	A greater understanding of the causes of human disease can come from identifying characteristics that are specific to disease genes. However, a full understanding of the contribution of essential genes to human disease is lacking, due to the premise that these genes tend to cause developmental abnormalities rather than adult disease. We tested the hypothesis that human orthologs of mouse essential genes are associated with a variety of human diseases, rather than only those related to miscarriage and birth defects. We segregated human disease genes according to whether the knockout phenotype of their mouse ortholog was lethal or viable, defining those with orthologs producing lethal knockouts as essential disease genes. We show that the human orthologs of mouse essential genes are associated with a wide spectrum of diseases affecting diverse physiological systems. Notably, human disease genes with essential mouse orthologs are over-represented among disease genes associated with cancer, suggesting links between adult cellular abnormalities and developmental functions. The proteins encoded by essential genes are highly connected in protein-protein interaction networks, which we find correlates with an over-representation of nuclear proteins amongst essential disease genes. Disease genes associated with essential orthologs also are more likely than those with non-essential orthologs to contribute to disease through an autosomal dominant inheritance pattern, suggesting that these diseases may actually result from semi-dominant mutant alleles. Overall, we have described attributes found in disease genes according to the essentiality status of their mouse orthologs. These findings demonstrate that disease genes do occupy highly connected positions in protein-protein interaction networks, and that due to the complexity of disease-associated alleles, essential genes cannot be ignored as candidates for causing diverse human diseases.	[Dickerson, Jonathan E.; Zhu, Ana; Robertson, David L.; Hentges, Kathryn E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Dickerson, JE (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	kathryn.hentges@manchester.ac.uk		Chen, Wei-Hua/0000-0003-2168-6147; Hentges, Kathryn/0000-0001-8917-3765	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	AZ, DLR, and KEH had no external funding sources for this study. JED was supported by a Wellcome Trust studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; DICKERSON JE, 2011, MOL BIOL EVOL; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Furney SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn482; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Karkera JD, 2007, AM J HUM GENET, V81, P987, DOI 10.1086/522890; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Kondrashov FA, 2004, NUCLEIC ACIDS RES, V32, P1731, DOI 10.1093/nar/gkh330; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Ma YL, 2010, J CELL MOL MED, V14, P2697, DOI 10.1111/j.1582-4934.2010.01191.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; McKusick V.A., 1998, MENDELIAN INHERITANC; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; R Core Team, 2020, R LANG ENV STAT COMP; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith NGC, 2003, GENE, V318, P169, DOI 10.1016/S0378-1119(03)00772-8; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vaiserman A, 2011, EXP GERONTOL, V46, P189, DOI 10.1016/j.exger.2010.08.031; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Veugelers M, 2000, HUM MOL GENET, V9, P1321, DOI 10.1093/hmg/9.9.1321; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	53	62	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27368	10.1371/journal.pone.0027368	http://dx.doi.org/10.1371/journal.pone.0027368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096564	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000297553900038
J	Sun, Y; Dandekar, RD; Mao, YTS; Yin, HL; Wulfing, C				Sun, Yi; Dandekar, Radhika D.; Mao, Yuntao S.; Yin, Helen L.; Wuelfing, Christoph			Phosphatidylinositol (4,5) Bisphosphate Controls T Cell Activation by Regulating T Cell Rigidity and Organization	PLOS ONE			English	Article							PLASMA-MEMBRANE; IMMUNOLOGICAL SYNAPSE; CDC42 ACTIVITY; ERM PROTEINS; PIP KINASE; RECEPTOR; CYTOSKELETON; HYDROLYSIS; MOVEMENT; ADHESION	Here we investigate the role of Phosphatidylinositol (4,5) bisphosphate (PIP(2)) in the physiological activation of primary murine T cells by antigen presenting cells (APC) by addressing two principal challenges in PIP(2) biology. First, PIP(2) is a regulator of cytoskeletal dynamics and a substrate for second messenger generation. The relative importance of these two processes needs to be determined. Second, PIP(2) is turned over by multiple biosynthetic and metabolizing enzymes. The joint effect of these enzymes on PIP(2) distributions needs to be determined with resolution in time and space. We found that T cells express four isoforms of the principal PIP(2)-generating enzyme phosphatidylinositol 4-phosphate 5-kinase (PIP5K) with distinct spatial and temporal characteristics. In the context of a larger systems analysis of T cell signaling, these data identify the T cell/APC interface and the T cell distal pole as sites of differential PIP(2) turnover. Overexpression of different PIP5K isoforms, as corroborated by knock down and PIP(2) blockade, yielded an increase in PIP(2) levels combined with isoform-specific changes in the spatiotemporal distributions of accessible PIP(2). It rigidified the T cell, likely by impairing the inactivation of Ezrin Moesin Radixin, delayed and diminished the clustering of the T cell receptor at the cellular interface, reduced the efficiency of T cell proximal signaling and IL-2 secretion. These effects were consistently more severe for distal PIP5K isoforms. Thus spatially constrained cytoskeletal roles of PIP(2) in the control of T cell rigidity and spatiotemporal organization dominate the effects of PIP(2) on T cell activation.	[Sun, Yi; Dandekar, Radhika D.; Wuelfing, Christoph] UT SW Med Ctr, Dept Immunol, Dallas, TX USA; [Mao, Yuntao S.; Yin, Helen L.] UT SW Med Ctr, Dept Physiol, Dallas, TX USA; [Wuelfing, Christoph] UT SW Med Ctr, Dept Cell Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, Y (corresponding author), UT SW Med Ctr, Dept Immunol, Dallas, TX USA.	Christoph.Wuelfing@UTSouthwestern.edu	Mao, Yuntao/E-9168-2012	Wuelfing, Christoph/0000-0002-6156-9861	National Institutes of Health [R01 CA96733, P50-GM21681]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to C.W. (R01 CA96733) and H.L.Y. (P50-GM21681) and a Robert A. Welch Foundation grant to H.L.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Chao WT, 2010, J CELL BIOL, V190, P247, DOI 10.1083/jcb.200911110; Corbett-Nelson EF, 2006, J CELL BIOL, V174, P255, DOI 10.1083/jcb.200605044; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; INOKUCHI S, 1990, J BIOL CHEM, V265, P5983; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shaw AS, 2001, IMMUNITY, V15, P683, DOI 10.1016/S1074-7613(01)00237-0; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Tskvitaria-Fuller I, 2007, J IMMUNOL METHODS, V319, P64, DOI 10.1016/j.jim.2006.10.017; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wernimont SA, 2010, J IMMUNOL, V185, P4714, DOI 10.4049/jimmunol.1001445; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yonemura S, 2002, J CELL SCI, V115, P2569; Zaru R, 2001, EUR J IMMUNOL, V31, P2438, DOI 10.1002/1521-4141(200108)31:8<2438::AID-IMMU2438>3.0.CO;2-P	41	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27227	10.1371/journal.pone.0027227	http://dx.doi.org/10.1371/journal.pone.0027227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096541	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900027
J	Janebodin, K; Horst, OV; Ieronimakis, N; Balasundaram, G; Reesukumal, K; Pratumvinit, B; Reyes, M				Janebodin, Kajohnkiart; Horst, Orapin V.; Ieronimakis, Nicholas; Balasundaram, Gayathri; Reesukumal, Kanit; Pratumvinit, Busadee; Reyes, Morayma			Isolation and Characterization of Neural Crest-Derived Stem Cells from Dental Pulp of Neonatal Mice	PLOS ONE			English	Article							HUMAN BONE-MARROW; IN-VITRO CHONDROGENESIS; ADULT PROGENITOR CELLS; ADIPOCYTE DIFFERENTIATION; SELF-RENEWAL; MOUSE; EXPRESSION; GENE; MUSCLE; ACTIVATION	Dental pulp stem cells (DPSCs) are shown to reside within the tooth and play an important role in dentin regeneration. DPSCs were first isolated and characterized from human teeth and most studies have focused on using this adult stem cell for clinical applications. However, mouse DPSCs have not been well characterized and their origin(s) have not yet been elucidated. Herein we examined if murine DPSCs are neural crest derived and determined their in vitro and in vivo capacity. DPSCs from neonatal murine tooth pulp expressed embryonic stem cell and neural crest related genes, but lacked expression of mesodermal genes. Cells isolated from the Wnt1-Cre/R26R-LacZ model, a reporter of neural crest-derived tissues, indicated that DPSCs were Wnt1-marked and therefore of neural crest origin. Clonal DPSCs showed multi-differentiation in neural crest lineage for odontoblasts, chondrocytes, adipocytes, neurons, and smooth muscles. Following in vivo subcutaneous transplantation with hydroxyapatite/tricalcium phosphate, based on tissue/cell morphology and specific antibody staining, the clones differentiated into odontoblast-like cells and produced dentin-like structure. Conversely, bone marrow stromal cells (BMSCs) gave rise to osteoblast-like cells and generated bone-like structure. Interestingly, the capillary distribution in the DPSC transplants showed close proximity to odontoblasts whereas in the BMSC transplants bone condensations were distant to capillaries resembling dentinogenesis in the former vs. osteogenesis in the latter. Thus we demonstrate the existence of neural crest-derived DPSCs with differentiation capacity into cranial mesenchymal tissues and other neural crest-derived tissues. In turn, DPSCs hold promise as a source for regenerating cranial mesenchyme and other neural crest derived tissues.	[Janebodin, Kajohnkiart; Reyes, Morayma] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Horst, Orapin V.] Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Seattle, WA 98195 USA; [Horst, Orapin V.] Univ Washington, Sch Dent, Dept Endodont, Seattle, WA 98195 USA; [Ieronimakis, Nicholas; Balasundaram, Gayathri; Reyes, Morayma] Univ Washington, Sch Med, Dept Pathol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Janebodin, Kajohnkiart] Mahidol Univ, Dept Anat, Fac Dent, Bangkok 10700, Thailand; [Pratumvinit, Busadee] Mahidol Univ, Dept Clin Pathol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mahidol University; Mahidol University	Janebodin, K (corresponding author), Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	morayma@uw.edu	Janebodin, Kajohnkiart/AFG-5639-2022	Pratumvinit, Busadee/0000-0002-5220-0552	National Institutes of Health [5R03AR054955]; Department of Pathology and Laboratory Medicine, University of Washington; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE022377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Laboratory Medicine, University of Washington(University of Washington); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by funding from National Institutes of Health grant 5R03AR054955 to MR, and the Department of Pathology and Laboratory Medicine, University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Alliot-Licht B, 2001, ARCH ORAL BIOL, V46, P221, DOI 10.1016/S0003-9969(00)00115-1; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Balic A, BONE; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braut A, 2003, INT J DEV BIOL, V47, P281; Breyer A, 2006, EXP HEMATOL, V34, P1596, DOI 10.1016/j.exphem.2006.07.013; Carlile MJ, 2000, HISTOCHEM J, V32, P239, DOI 10.1023/A:1004055118334; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Conway SJ, 1997, DEVELOPMENT, V124, P505; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; Duband JL, 1995, ACTA ANAT, V154, P63; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; GAUNT SJ, 1993, DEVELOPMENT, V117, P769; Grabski AD, 2009, ARTERIOSCL THROM VAS, V29, P1644, DOI 10.1161/ATVBAHA.109.191965; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Hara-Kaonga B, 2006, TRANSGENIC RES, V15, P101, DOI 10.1007/s11248-005-2541-8; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Huang GTJ, 2006, J ENDODONT, V32, P1066, DOI 10.1016/j.joen.2006.05.009; Hunt DP, 2010, STEM CELLS DEV, V19, P1055, DOI 10.1089/scd.2009.0371; Ji XH, 2000, J BONE MINER METAB, V18, P132, DOI 10.1007/s007740050103; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kiernan JA., 2009, HISTOLOGICAL HISTOCH, V4; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Lovschall H, 2005, EUR J ORAL SCI, V113, P312, DOI 10.1111/j.1600-0722.2005.00221.x; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Marchionni C, 2009, INT J IMMUNOPATH PH, V22, P699, DOI 10.1177/039463200902200315; Meulemans D, 2005, J EXP ZOOL PART B, V304B, P298, DOI 10.1002/jez.b.21047; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; Pavlov MI, 2003, BIOL CELL, V95, P75, DOI 10.1016/S0248-4900(03)00008-X; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; RASHBASS P, 1991, NATURE, V353, P348, DOI 10.1038/353348a0; Reyes M, 2005, BLOOD, V106, P3646, DOI 10.1182/blood-2004-12-4603; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Satomura K, 2000, J CELL BIOCHEM, V78, P391; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Sieber-Blum M, 2008, STEM CELL REV, V4, P256, DOI 10.1007/s12015-008-9042-0; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Sloan AJ, 2009, INT J PAEDIATR DENT, V19, P61, DOI 10.1111/j.1365-263X.2008.00964.x; Sommer B, 1996, BONE, V19, P371, DOI 10.1016/S8756-3282(96)00218-9; Stevens A, 2008, STEM CELLS DEV, V17, P1175, DOI 10.1089/scd.2008.0012; Stokowski A, 2007, STEM CELLS, V25, P156, DOI 10.1634/stemcells.2006-0373; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; THOMPSON TJ, 1989, J ANAT, V166, P55; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torreggiani E, 2011, J CELL MOL MED; Trowbridge Henry O, 2003, Aust Endod J, V29, P5; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; Wang WG, 2003, TISSUE CELL, V35, P69, DOI 10.1016/S0040-8166(02)00106-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x; Yoshida S, 1996, ANAT RECORD, V245, P313; Yu JH, 2007, BIOL CELL, V99, P465, DOI 10.1042/BC20070013; Zhang JP, 2006, BIOL CELL, V98, P567, DOI 10.1042/BC20060012; Zhang P, J BIOL CHEM, V285, P9180; Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357	85	101	107	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27526	10.1371/journal.pone.0027526	http://dx.doi.org/10.1371/journal.pone.0027526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087335	Green Published, gold, Green Submitted			2022-12-27	WOS:000297349700057
J	Shen, MY; Liu, YJ; Don, MJ; Liu, HY; Chen, ZW; Mettling, C; Corbeau, P; Chiang, CK; Jang, YS; Li, TH; Young, P; Chang, CLT; Lin, YL; Yang, WC				Shen, Ming-Yi; Liu, Yan-Jun; Don, Ming-Jaw; Liu, Hsien-Yueh; Chen, Zeng-Weng; Mettling, Clement; Corbeau, Pierre; Chiang, Chih-Kang; Jang, Yu-Song; Li, Tzu-Hsuan; Young, Paul; Chang, Cicero L. T.; Lin, Yea-Lih; Yang, Wen-Chin			Combined Phytochemistry and Chemotaxis Assays for Identification and Mechanistic Analysis of Anti-Inflammatory Phytochemicals in Fallopia japonica	PLOS ONE			English	Article							POLYGONUM-CUSPIDATUM; CHEMOKINE RECEPTORS; KINASE INHIBITORS; EMODIN; INFLAMMATION; RESVERATROL; EXTRACT; ANGIOGENESIS; SEPARATION; STILBENES	Plants provide a rich source of lead compounds for a variety of diseases. A novel approach combining phytochemistry and chemotaxis assays was developed and used to identify and study the mechanisms of action of the active compounds in F. japonica, a medicinal herb traditionally used to treat inflammation. Based on a bioactivity-guided purification strategy, two anthranoids, emodin and physcion, were identified from F. japonica. Spectroscopic techniques were used to characterize its crude extract, fractions and phytochemicals. The crude extract, chloroform fraction, and anthranoids of F. japonica significantly inhibited CXCR4-mediated chemotaxis. Mechanistic studies showed that emodin and physcion inhibited chemotaxis via inactivating the MEK/ERK pathway. Moreover, the crude extract and emodin could prevent or treat type 1 diabetes in non-obese diabetic (NOD) mice. This study illustrates the applicability of a combinational approach for the study of anti-inflammatory medicine and shows the potential of F. japonica and its anthranoids for anti-inflammatory therapy.	[Shen, Ming-Yi; Liu, Yan-Jun; Chen, Zeng-Weng; Jang, Yu-Song; Li, Tzu-Hsuan; Young, Paul; Yang, Wen-Chin] Acad Sinica, Biotechnol Res Ctr, Taipei 115, Taiwan; [Liu, Yan-Jun; Yang, Wen-Chin] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Don, Ming-Jaw] Natl Res Inst Chinese Med, Taipei, Taiwan; [Liu, Hsien-Yueh; Chang, Cicero L. T.; Yang, Wen-Chin] Natl Chung Hsing Univ, Dept Vet Med, Dept Life Sci, Taichung 40227, Taiwan; [Mettling, Clement; Corbeau, Pierre; Lin, Yea-Lih] Inst Genet Humaine CNRS UPR 1142, Montpellier, France; [Chiang, Chih-Kang] Buddist Tzu Chi Gen Hosp, Dept Chinese Med, Hualien, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; National Chung Hsing University; Centre National de la Recherche Scientifique (CNRS); Buddhist Tzu Chi General Hospital	Shen, MY (corresponding author), Acad Sinica, Biotechnol Res Ctr, Taipei 115, Taiwan.	ltchang@nchu.edu.tw; ylin@igh.cnrs.fr; wcyang@gate.sinica.edu.tw	刘, 严君/GZL-5764-2022; Yang, Wen-Chin/D-3441-2015; liu, yan/HCI-5542-2022; Shen, Ming-Yi/L-6861-2019	Yang, Wen-Chin/0000-0001-6410-2581; Mettling, Clement/0000-0002-4963-2928; Shen, Ming-Yi/0000-0002-9351-1912; CHIANG, CHIH-KANG/0000-0001-9021-4616	Development Program of Industrialization for Agricultural Biotechnology (DPAB) [099S0030093-AA]	Development Program of Industrialization for Agricultural Biotechnology (DPAB)	This work was supported by the Development Program of Industrialization for Agricultural Biotechnology (DPAB 099S0030093-AA). M.Y. Shen is an Academia Sinica postdoc fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 2002, J CLIN INVEST, V110, P1611, DOI 10.1172/JCI200217311; Bachmann M, 1992, J Environ Pathol Toxicol Oncol, V11, P49; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; BOSCH R, 1987, MUTAT RES, V188, P161, DOI 10.1016/0165-1218(87)90085-1; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Chang CLT, 2005, J BIOMED SCI, V12, P79, DOI 10.1007/s11373-004-8172-x; Chang LC, 1999, BIOCHEM PHARMACOL, V58, P49, DOI 10.1016/S0006-2952(99)00075-1; China PCoPsRo ed, 2000, PHARM PEOPL REP CHIN, P950; Chong BF, 2009, EXPERT OPIN THER TAR, V13, P1147, DOI 10.1517/14728220903196761; Chu X, 2005, J CHROMATOGR A, V1097, P33, DOI 10.1016/j.chroma.2005.08.008; Cui XR, 2008, CHEM PHARM BULL, V56, P497, DOI 10.1248/cpb.56.497; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Della Ragione F, 1998, BIOCHEM BIOPH RES CO, V250, P53, DOI 10.1006/bbrc.1998.9263; Ding Y, 2008, EUR J PHARMACOL, V590, P377, DOI 10.1016/j.ejphar.2008.06.044; Emmelkamp JM, 2007, EUR J MED RES, V12, P409; Fan PH, 2009, J SEP SCI, V32, P2979, DOI 10.1002/jssc.200900057; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; Ghanim H, 2011, J CLIN ENDOCR METAB, V96, P1409, DOI 10.1210/jc.2010-1812; Hegde VR, 2004, BIOORG MED CHEM LETT, V14, P2275, DOI 10.1016/j.bmcl.2004.02.006; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; JAYASURIYA H, 1992, J NAT PROD, V55, P696, DOI 10.1021/np50083a026; JAYATILAKE GS, 1993, J NAT PROD, V56, P1805, DOI 10.1021/np50100a021; Kaneshiro T, 2006, EUR J PHARMACOL, V553, P46, DOI 10.1016/j.ejphar.2006.09.026; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kucia M, 2004, J MOL HISTOL, V35, P233; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Kwak HJ, 2006, INT J CANCER, V118, P2711, DOI 10.1002/ijc.21641; LEMLI J, 1988, PHARMACOLOGY, V36, P126, DOI 10.1159/000138431; Leu YL, 2008, PHYTOTHER RES, V22, P552, DOI 10.1002/ptr.2324; Lin SY, 2009, ANTICANCER RES, V29, P327; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; MANNILA E, 1993, PHYTOCHEMISTRY, V33, P813, DOI 10.1016/0031-9422(93)85280-5; Martin-Blondel G, 2009, AIDS, V23, P2545, DOI 10.1097/QAD.0b013e32833365f4; Matsuda H, 2001, BIOORG MED CHEM LETT, V11, P1839, DOI 10.1016/S0960-894X(01)00318-3; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; Murdoch C, 2000, BLOOD, V95, P3032; Park CS, 2004, VASC PHARMACOL, V40, P279, DOI 10.1016/j.vph.2004.01.003; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Vastano BC, 2000, J AGR FOOD CHEM, V48, P253, DOI 10.1021/jf9909196; Xiao K, 2002, CHEM PHARM BULL, V50, P605, DOI 10.1248/cpb.50.605; Yang CLH, 2009, J MED CHEM, V52, P6707, DOI 10.1021/jm9006164; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Zhang CN, 2009, PHYTOTHER RES, V23, P740, DOI 10.1002/ptr.2619; Zhang LS, 1998, ONCOGENE, V16, P2855, DOI 10.1038/sj.onc.1201813	45	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27480	10.1371/journal.pone.0027480	http://dx.doi.org/10.1371/journal.pone.0027480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087325	Green Published, gold			2022-12-27	WOS:000297349700051
J	Gorlatova, N; Chao, KL; Pal, LR; Araj, RH; Galkin, A; Turko, I; Moult, J; Herzberg, O				Gorlatova, Natalia; Chao, Kinlin; Pal, Lipika R.; Araj, Rawan Hanna; Galkin, Andrey; Turko, Illarion; Moult, John; Herzberg, Osnat			Protein Characterization of a Candidate Mechanism SNP for Crohn's Disease: The Macrophage Stimulating Protein R689C Substitution	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; BETA-CHAIN; FACTOR/SCATTER FACTOR; CRYSTAL-STRUCTURE; SEMA DOMAIN; STABILITY; RECEPTOR; GENE; RON	High throughput genome wide associations studies (GWAS) are now identifying a large number of genome loci related to risk of common human disease. Each such locus presents a challenge in identifying the relevant underlying mechanism. Here we report the experimental characterization of a proposed causal single nucleotide polymorphism (SNP) in a locus related to risk of Crohn's disease and ulcerative colitis. The SNP lies in the MST1 gene encoding Macrophage Stimulating Protein (MSP), and results in an R689C amino acid substitution within the beta-chain of MSP (MSP beta). MSP binding to the RON receptor tyrosine kinase activates signaling pathways involved in the inflammatory response. We have purified wild-type and mutant MSP beta proteins and compared biochemical and biophysical properties that might impact the MSP/RON signaling pathway. Surface plasmon resonance (SPR) binding studies showed that MSP beta R689C affinity to RON is approximately 10-fold lower than that of the wild-type MSP beta and differential scanning fluorimetry (DSF) showed that the thermal stability of the mutant MSP beta was slightly lower than that of wild-type MSP beta, by 1.6 K. The substitution was found not to impair the specific Arg483-Val484 peptide bond cleavage by matriptase-1, required for MSP activation, and mass spectrometry of tryptic fragments of the mutated protein showed that the free thiol introduced by the R689C mutation did not form an aberrant disulfide bond. Together, the studies indicate that the missense SNP impairs MSP function by reducing its affinity to RON and perhaps through a secondary effect on in vivo concentration arising from reduced thermodynamic stability, resulting in down-regulation of the MSP/RON signaling pathway.	[Gorlatova, Natalia; Chao, Kinlin; Pal, Lipika R.; Araj, Rawan Hanna; Galkin, Andrey; Turko, Illarion; Moult, John; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Turko, Illarion] NIST, Gaithersburg, MD 20899 USA; [Moult, John] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Gorlatova, N (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	jmoult@umd.edu; osnat@umd.edu	Ray, Lipika/N-1245-2019	Ray, Lipika/0000-0002-3390-110X; Moult, John/0000-0002-3012-2282; Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health (NIH) [R21-DA027024, R01-GM087922, R01LM007174]; HHMI (Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027024] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI (Howard Hughes Medical Institute)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health (NIH) grants R21-DA027024, R01-GM087922, R01LM007174 (URL: http://grants.nih.gov/grants/oer.htm). RHA was a recipient of an HHMI (Howard Hughes Medical Institute) undergraduate student award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Angeloni D, 2004, J BIOL CHEM, V279, P3726, DOI 10.1074/jbc.M309342200; Axe DD, 1999, J MOL BIOL, V286, P1471, DOI 10.1006/jmbi.1999.2569; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Beckly JB, 2008, INFLAMM BOWEL DIS, V14, P500, DOI 10.1002/ibd.20365; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carafoli F, 2005, FEBS J, V272, P5799, DOI 10.1111/j.1742-4658.2005.04968.x; Danilkovitch A, 1999, J BIOL CHEM, V274, P29937, DOI 10.1074/jbc.274.42.29937; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; KELLEY RF, 1989, BIOCHEMISTRY-US, V28, P4047, DOI 10.1021/bi00435a062; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kretschmann KL, 2010, CURR DRUG TARGETS, V11, P1157; Lehr RV, 2000, PROTEIN EXPRES PURIF, V19, P362, DOI 10.1006/prep.2000.1258; Loo T, 2002, PROTEIN EXPRES PURIF, V24, P90, DOI 10.1006/prep.2001.1555; Ma Q, 2010, INT J ONCOL, V36, P1551, DOI 10.3892/ijo_00000642; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; PANTOLIANO MW, 1989, BIOCHEMISTRY-US, V28, P7205, DOI 10.1021/bi00444a012; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	37	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27269	10.1371/journal.pone.0027269	http://dx.doi.org/10.1371/journal.pone.0027269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087277	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700033
J	Lu, MP; Chen, RX; Wang, ML; Zhu, XJ; Zhu, LP; Yin, M; Zhang, ZD; Cheng, L				Lu, Mei-Ping; Chen, Ruo-Xi; Wang, Mei-Lin; Zhu, Xin-Jie; Zhu, Lu-Ping; Yin, Min; Zhang, Zheng-Dong; Cheng, Lei			Association Study on IL4, IL13 and IL4RA Polymorphisms in Mite-Sensitized Persistent Allergic Rhinitis in a Chinese Population	PLOS ONE			English	Article							IL-4 RECEPTOR-ALPHA; SERUM IGE LEVELS; INTERLEUKIN-4 RECEPTOR; CEDAR POLLINOSIS; DUTCH POPULATION; BIRTH COHORT; ASTHMA; ATOPY; GENE; VARIANT	Background: The IL4, IL13, and IL4 receptor a chain (IL4RA) genes are candidate genes for atopic diseases. We hypothesized that the polymorphisms in these genes are associated with persistent allergic rhinitis (PER). Objective: To investigate the association of the potential functional polymorphisms in IL4, IL13, and IL4RA with PER induced by house dust mites in a Chinese population. Methods: Using the TaqMan method, we genotyped six single nucleotide polymorphisms (SNPs) including C-590T in IL4, C-1055T and Arg130Gln in IL13, and Ile50Val, Ser478Pro and Gln551Arg in IL4RA, in a case-control study of 265 patients with PER and 275 healthy controls. Results: We found that the CT/CC genotypes in IL4 C-590T were associated with a significantly decreased risk of mite-sensitized PER [adjusted odds ratio (OR) = 0.64, 95% confidence interval (CI) 0.45-0.92], compared to the TT genotype. Furthermore, PER patients with CT/CC genotypes had significantly lower serum levels of total IgE than those with TT genotype (P = 0.001). However, there was no significant association of the IL13 and IL4RA polymorphisms with mite-sensitized PER (P>0.05). Conclusions: Our results suggest that the C-590T polymorphism in IL4 may contribute to the susceptibility to mite-sensitized PER in a Chinese population.	[Lu, Mei-Ping; Chen, Ruo-Xi; Zhu, Xin-Jie; Zhu, Lu-Ping; Yin, Min; Cheng, Lei] Nanjing Med Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Nanjing, Peoples R China; [Wang, Mei-Lin; Zhang, Zheng-Dong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, Nanjing, Peoples R China; [Yin, Min; Cheng, Lei] Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Lu, MP (corresponding author), Nanjing Med Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Nanjing, Peoples R China.	zdzhang@njmu.edu.cn; jspent@126.com	zhang, zheng/HCH-9684-2022; Cheng, Lei/AAT-2690-2021	Cheng, Lei/0000-0001-6541-7702	Jiangsu Higher Education Institutions [PAPD 2010-2013]; Innovative Research Project of Jiangsu Province [CX10B_341Z]; Health Promotion Project of Jiangsu Province [XK200719, RC2007065, RC2011]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS), Ministry of Education, the People's Republic of China [2008-890]	Jiangsu Higher Education Institutions; Innovative Research Project of Jiangsu Province; Health Promotion Project of Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS), Ministry of Education, the People's Republic of China	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Innovative Research Project (CX10B_341Z) and the Health Promotion Project (XK200719, RC2007065 and RC2011) of Jiangsu Province, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS 2008-890), Ministry of Education, the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; Black S, 2009, ALLERGY, V64, P1172, DOI 10.1111/j.1398-9995.2009.01988.x; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Celedon JC, 2002, CLIN EXP ALLERGY, V32, P387, DOI 10.1046/j.1365-2222.2002.01348.x; Cheng L, 2006, INT ARCH ALLERGY IMM, V139, P25, DOI 10.1159/000089519; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Huebner M, 2008, J ALLERGY CLIN IMMUN, V121, P408, DOI 10.1016/j.jaci.2007.09.020; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kim JJ, 2007, EUR ARCH OTO-RHINO-L, V264, P395, DOI 10.1007/s00405-006-0204-x; Kruse S, 2002, RESP RES, V3, DOI 10.1186/rr174; Liu X, 2004, J ALLERGY CLIN IMMUN, V113, P489, DOI 10.1016/j.jaci.2003.12.037; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakamura H, 2003, J ALLERGY CLIN IMMUN, V112, P1127, DOI 10.1016/j.jaci.2003.08.051; Nguyen DP, 2004, OBSTET GYNECOL, V104, P293, DOI 10.1097/01.AOG.0000133486.85400.5e; Noguchi E, 1998, CLIN EXP ALLERGY, V28, P449; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Peden DB, 2002, TOXICOLOGY, V181, P323, DOI 10.1016/S0300-483X(02)00301-3; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Settipane Russell A, 2007, Clin Allergy Immunol, V19, P23; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Toda M, 2002, IMMUNOLOGY, V106, P1, DOI 10.1046/j.1365-2567.2002.01407.x; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Walley AJ, 1996, J MED GENET, V33, P689, DOI 10.1136/jmg.33.8.689; Wang M, 2003, HUM GENET, V113, P387, DOI 10.1007/s00439-003-1001-x; Yabiku K, 2007, CLIN EXP IMMUNOL, V148, P425, DOI 10.1111/j.1365-2249.2007.03366.x; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	39	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27363	10.1371/journal.pone.0027363	http://dx.doi.org/10.1371/journal.pone.0027363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087298	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700044
J	Pell, MD; Kotz, SA				Pell, Marc D.; Kotz, Sonja A.			On the Time Course of Vocal Emotion Recognition	PLOS ONE			English	Article							UNIVERSAL FACIAL EXPRESSIONS; CATEGORICAL PERCEPTION; SPEECH-PERCEPTION; BRAIN POTENTIALS; PROSODY; ATTENTION; LANGUAGE; CUES; COMMUNICATION; JUDGMENTS	How quickly do listeners recognize emotions from a speaker's voice, and does the time course for recognition vary by emotion type? To address these questions, we adapted the auditory gating paradigm to estimate how much vocal information is needed for listeners to categorize five basic emotions (anger, disgust, fear, sadness, happiness) and neutral utterances produced by male and female speakers of English. Semantically-anomalous pseudo-utterances (e. g., The rivix jolled the silling) conveying each emotion were divided into seven gate intervals according to the number of syllables that listeners heard from sentence onset. Participants (n = 48) judged the emotional meaning of stimuli presented at each gate duration interval, in a successive, blocked presentation format. Analyses looked at how recognition of each emotion evolves as an utterance unfolds and estimated the "identification point" for each emotion. Results showed that anger, sadness, fear, and neutral expressions are recognized more accurately at short gate intervals than happiness, and particularly disgust; however, as speech unfolds, recognition of happiness improves significantly towards the end of the utterance (and fear is recognized more accurately than other emotions). When the gate associated with the emotion identification point of each stimulus was calculated, data indicated that fear (M = 517 ms), sadness (M = 576 ms), and neutral (M = 510 ms) expressions were identified from shorter acoustic events than the other emotions. These data reveal differences in the underlying time course for conscious recognition of basic emotions from vocal expressions, which should be accounted for in studies of emotional speech processing.	[Pell, Marc D.] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Neurocognit Rhythm Commun, Leipzig, Germany	McGill University; Max Planck Society	Pell, MD (corresponding author), McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada.	marc.pell@mcgill.ca	Pell, Marc D./AAL-3121-2021	Pell, Marc D./0000-0002-9947-1552	Natural Sciences and Engineering Research Council of Canada [RGPIN/203708-2006]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was financed by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN/203708-2006 to M. D. Pell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Audibert N, 2007, P ICPHS, P2137; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; BOROD JC, 1990, J COMMUN DISORD, V23, P247, DOI 10.1016/0021-9924(90)90003-H; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; BOWER GH, 1987, BEHAV RES THER, V25, P443, DOI 10.1016/0005-7967(87)90052-0; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Brosch T, 2009, J COGNITIVE NEUROSCI, V21, P1670, DOI 10.1162/jocn.2009.21110; Calder AJ, 2004, BRAIN, V127, P1958, DOI 10.1093/brain/awh214; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Charash M, 2002, J ANXIETY DISORD, V16, P529, DOI 10.1016/S0887-6185(02)00171-8; Cisler JM, 2009, COGNITION EMOTION, V23, P675, DOI 10.1080/02699930802051599; Coles M. G. H., 1987, ADV PSYCHOPHYSIOLOGY, V2, P79; Cornew L, 2010, COGNITION EMOTION, V24, P1133, DOI 10.1080/02699930903247492; COSMIDES L, 1983, J EXP PSYCHOL HUMAN, V9, P864, DOI 10.1037/0096-1523.9.6.864; Cowie R, 2003, SPEECH COMMUN, V40, P5, DOI 10.1016/S0167-6393(02)00071-7; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; FRICK RW, 1986, AGGRESSIVE BEHAV, V12, P121, DOI 10.1002/1098-2337(1986)12:2<121::AID-AB2480120206>3.0.CO;2-F; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Greasley P, 2000, LANG SPEECH, V43, P355, DOI 10.1177/00238309000430040201; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; GROSJEAN F, 1985, PERCEPT PSYCHOPHYS, V38, P299, DOI 10.3758/BF03207159; Grosjean F, 1996, LANG COGNITIVE PROC, V11, P597, DOI 10.1080/016909696386999; Harnmerschmidt K, 2007, J VOICE, V21, P531, DOI 10.1016/j.jvoice.2006.03.002; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hot P, 2006, BRAIN RES, V1122, P171, DOI 10.1016/j.brainres.2006.09.020; Ishii K, 2003, PSYCHOL SCI, V14, P39, DOI 10.1111/1467-9280.01416; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Jaywant A, SPEECH COMMUNICATION, V54, P1; JOHNSON WF, 1986, ARCH GEN PSYCHIAT, V43, P280; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; KRAMER E, 1964, J ABNORM SOC PSYCH, V68, P390, DOI 10.1037/h0042473; Kreifelts B, 2009, NEUROPSYCHOLOGIA, V47, P3059, DOI 10.1016/j.neuropsychologia.2009.07.001; Laukka P, 2005, EMOTION, V5, P277, DOI 10.1037/1528-3542.5.3.277; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Levitt E, 1964, COMMUNICATION EMOTIO, P87; MATSUMOTO D, 1992, J NONVERBAL BEHAV, V16, P85, DOI 10.1007/BF00990324; Mozziconacci SJL, 2001, USER MODEL USER-ADAP, V11, P297, DOI 10.1023/A:1011800417621; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; Niedenthal P.M., 1994, HEARTS EYE EMOTIONAL, P87, DOI [10.1016/B978-0-12-410560-7.50011-9, DOI 10.1016/B978-0-12-410560-7.50011-9]; Oatley K., 1987, COGNITION EMOTION, V1, P29, DOI [10.1080/02699938708408362, DOI 10.1080/02699938708408362]; OHALA JJ, 1983, PHONETICA, V40, P1, DOI 10.1159/000261678; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2012, SPEECH COMMUN, V54, P92, DOI 10.1016/j.specom.2011.07.004; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2009, NEUROREPORT, V20, P1603, DOI 10.1097/WNR.0b013e3283320e3f; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Pell MD, 2008, SPEECH COMMUN, V50, P519, DOI 10.1016/j.specom.2008.03.006; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 2009, J NONVERBAL BEHAV, V33, P107, DOI 10.1007/s10919-008-0065-7; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Pell MD, 2005, J NONVERBAL BEHAV, V29, P45, DOI 10.1007/s10919-004-0889-8; Pell MD, 2001, J ACOUST SOC AM, V109, P1668, DOI 10.1121/1.1352088; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; POLLACK I, 1960, LANG SPEECH, V3, P121, DOI 10.1177/002383096000300301; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; SALASOO A, 1985, J MEM LANG, V24, P210, DOI 10.1016/0749-596X(85)90025-7; Sauter DA, 2007, MOTIV EMOTION, V31, P192, DOI 10.1007/s11031-007-9065-x; Scherer KR, 2009, PHILOS T R SOC B, V364, P3459, DOI 10.1098/rstb.2009.0141; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048; Simon-Thomas ER, 2009, EMOTION, V9, P838, DOI 10.1037/a0017810; Sobin C, 1999, J PSYCHOLINGUIST RES, V28, P347, DOI 10.1023/A:1023237014909; Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003; Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017; Tracy JL, 2008, EMOTION, V8, P81, DOI 10.1037/1528-3542.8.1.81; TYLER LK, 1985, PERCEPT PSYCHOPHYS, V38, P217, DOI 10.3758/BF03207148; VANBEZOOIJEN R, 1983, J CROSS CULT PSYCHOL, V14, P387, DOI 10.1177/0022002183014004001; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; WARREN P, 1987, PERCEPT PSYCHOPHYS, V41, P262, DOI 10.3758/BF03208224; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Williams CE, 1981, SPEECH EVALUATION PS, P221; Wurm LH, 2001, COGNITION EMOTION, V15, P831, DOI 10.1080/02699930143000086; ZUCKERMAN M, 1975, J PERS SOC PSYCHOL, V32, P1068, DOI 10.1037/0022-3514.32.6.1068	99	84	89	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27256	10.1371/journal.pone.0027256	http://dx.doi.org/10.1371/journal.pone.0027256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HH	22087275	Green Published, gold			2022-12-27	WOS:000297347700031
J	Rokholm, B; Silventoinen, K; Tynelius, P; Gamborg, M; Sorensen, TIA; Rasmussen, F				Rokholm, Benjamin; Silventoinen, Karri; Tynelius, Per; Gamborg, Michael; Sorensen, Thorkild I. A.; Rasmussen, Finn			Increasing Genetic Variance of Body Mass Index during the Swedish Obesity Epidemic	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEX-DIFFERENCES; RISK-FACTORS; TWIN; HERITABILITY; RESOURCE; SWEDEN; SHIFT; BMI	Background and Objectives: There is no doubt that the dramatic worldwide increase in obesity prevalence is due to changes in environmental factors. However, twin and family studies suggest that genetic differences are responsible for the major part of the variation in adiposity within populations. Recent studies show that the genetic effects on body mass index (BMI) may be stronger when combined with presumed risk factors for obesity. We tested the hypothesis that the genetic variance of BMI has increased during the obesity epidemic. Methods: The data comprised height and weight measurements of 1,474,065 Swedish conscripts at age 18-19 y born between 1951 and 1983. The data were linked to the Swedish Multi-Generation Register and the Swedish Twin Register from which 264,796 full-brother pairs, 1,736 monozygotic (MZ) and 1,961 dizygotic (DZ) twin pairs were identified. The twin pairs were analysed to identify the most parsimonious model for the genetic and environmental contribution to BMI variance. The full-brother pairs were subsequently divided into subgroups by year of birth to investigate trends in the genetic variance of BMI. Results: The twin analysis showed that BMI variation could be explained by additive genetic and environmental factors not shared by co-twins. On the basis of the analyses of the full-siblings, the additive genetic variance of BMI increased from 4.3 [95% CI 4.04-4.53] to 7.9 [95% CI 7.28-8.54] within the study period, as did the unique environmental variance, which increased from 1.4 [95% CI 1.32-1.48] to 2.0 [95% CI 1.89-2.22]. The BMI heritability increased from 75% to 78.8%. Conclusion: The results confirm the hypothesis that the additive genetic variance of BMI has increased strongly during the obesity epidemic. This suggests that the obesogenic environment has enhanced the influence of adiposity related genes.	[Rokholm, Benjamin; Gamborg, Michael; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of Copenhagen; University of Helsinki; Karolinska Institutet	Rokholm, B (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	br@ipm.regionh.dk		Silventoinen, Karri/0000-0003-1759-3079; Rasmussen, Finn/0000-0001-7915-7809; Tynelius, Per/0000-0001-8155-7406	Danish Research Counsil (the Ministry of Science, Technology and Innovation)	Danish Research Counsil (the Ministry of Science, Technology and Innovation)	Funding was provided by the Danish Research Counsil (the Ministry of Science, Technology and Innovation; http://www.fi.dk/raad-og-udvalg/det-frieforskningsraad). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Beyerlein A, 2010, INT J OBESITY, V34, P642, DOI 10.1038/ijo.2009.301; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; Clement K, 2008, OBESITY GENOMICS POS; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Freathy RM, 2011, INT J EPIDEMIOL; Hebebrand J, 2000, INT J OBESITY, V24, P345, DOI 10.1038/sj.ijo.0801135; Heitmann BL, 1997, AM J CLIN NUTR, V66, P672, DOI 10.1093/ajcn/66.3.672; Johnson W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016290; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Karnehed N, 2006, PUBLIC HEALTH NUTR, V9, P851, DOI 10.1017/PHN2005926; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Neale M. C, 2003, MX STAT MODELING, V6th; NEALE MC, 2006, METHODOLOGY GENETIC; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Rasmussen F, 2006, TWIN RES HUM GENET, V9, P883, DOI 10.1375/183242706779462741; Richardson K, 2005, BRIT J EDUC PSYCHOL, V75, P339, DOI 10.1348/000709904X24690; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020816; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Silventoinen K, 2009, INT J OBES LOND; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Silventoinen K, 2009, AM J CLIN NUTR, V90, P1096, DOI 10.3945/ajcn.2009.27689; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Staub K, 2010, EUR J CLIN NUTR, V64, P335, DOI 10.1038/ejcn.2010.7; Sundquist J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-119; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; World Health Organization, 2000, OBESITY PREVENTING M	33	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27135	10.1371/journal.pone.0027135	http://dx.doi.org/10.1371/journal.pone.0027135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087252	Green Published, gold, Green Submitted			2022-12-27	WOS:000297347700018
J	Farre, M; Bosch, M; Lopez-Giraldez, F; Ponsa, M; Ruiz-Herrera, A				Farre, Marta; Bosch, Montserrat; Lopez-Giraldez, Francesc; Ponsa, Montserrat; Ruiz-Herrera, Aurora			Assessing the Role of Tandem Repeats in Shaping the Genomic Architecture of Great Apes	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; PRIMATE CHROMOSOMES; EVOLUTION; MOUSE; DNA; KARYOTYPE; INVERSION; MICROSATELLITES; REARRANGEMENTS; MECHANISMS	Background: Ancestral reconstructions of mammalian genomes have revealed that evolutionary breakpoint regions are clustered in regions that are more prone to break and reorganize. What is still unclear to evolutionary biologists is whether these regions are physically unstable due solely to sequence composition and/or genome organization, or do they represent genomic areas where the selection against breakpoints is minimal. Methodology and Principal Findings: Here we present a comprehensive study of the distribution of tandem repeats in great apes. We analyzed the distribution of tandem repeats in relation to the localization of evolutionary breakpoint regions in the human, chimpanzee, orangutan and macaque genomes. We observed an accumulation of tandem repeats in the genomic regions implicated in chromosomal reorganizations. In the case of the human genome our analyses revealed that evolutionary breakpoint regions contained more base pairs implicated in tandem repeats compared to synteny blocks, being the AAAT motif the most frequently involved in evolutionary regions. We found that those AAAT repeats located in evolutionary regions were preferentially associated with Alu elements. Significance: Our observations provide evidence for the role of tandem repeats in shaping mammalian genome architecture. We hypothesize that an accumulation of specific tandem repeats in evolutionary regions can promote genome instability by altering the state of the chromatin conformation or by promoting the insertion of transposable elements.	[Farre, Marta; Ponsa, Montserrat; Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, Dept Biol Cel Lular Fisiol & Immunol, Cerdanyola Del Valles, Spain; [Lopez-Giraldez, Francesc] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Bosch, Montserrat] IRTA, Cabrils, Spain; [Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, IBB, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Yale University; IRTA; Autonomous University of Barcelona	Farre, M (corresponding author), Univ Autonoma Barcelona, Dept Biol Cel Lular Fisiol & Immunol, Cerdanyola Del Valles, Spain.	aurora.ruizherrera@uab.cat	Ruiz-Herrera, Aurora/K-3728-2012; López-Giráldez, Francesc/A-5251-2011; Farré, Marta/L-7791-2019	Ruiz-Herrera, Aurora/0000-0003-3868-6151; López-Giráldez, Francesc/0000-0001-7476-9822; Farré, Marta/0000-0001-9170-5767; Ponsa, Montserrat/0000-0002-7688-1049	Ministerio de Ciencia y Tecnologia [BFU2004-03422, CGL-2010-20170]; Universitat Autonoma de Barcelona	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universitat Autonoma de Barcelona	Financial support from Ministerio de Ciencia y Tecnologia (BFU2004-03422 and CGL-2010-20170) and the Universitat Autonoma de Barcelona (PhD fellowship to Marta Farre) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusan G, 2006, J MOL EVOL, V63, P484, DOI 10.1007/s00239-005-0275-0; Armour JAL, 2006, MUTAT RES-FUND MOL M, V598, P6, DOI 10.1016/j.mrfmmm.2006.01.013; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carbone L, 2006, PLOS GENET, V2, P2162, DOI 10.1371/journal.pgen.0020223; Carbone L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000538; CLEMENTE IC, 1990, HUM GENET, V84, P493; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Delprat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007883; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Froenicke L, 2006, GENOME RES, V16, P306, DOI 10.1101/gr.3955206; Froenicke L, 2005, CYTOGENET GENOME RES, V108, P122, DOI 10.1159/000080810; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Goidts V, 2004, HUM GENET, V115, P116, DOI 10.1007/s00439-004-1120-z; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Graphodatsky AS, 2008, CHROMOSOME RES, V16, P261, DOI 10.1007/s10577-007-1191-5; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kehrer-Sawatzki H, 2005, GENOMICS, V85, P542, DOI 10.1016/j.ygeno.2005.01.012; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Kolb J, 2009, CHROMOSOME RES, V17, P469, DOI 10.1007/s10577-009-9039-9; Kvikstad EM, 2010, GENOME RES, V20, P600, DOI 10.1101/gr.099044.109; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Lee JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001639; Lemaitre C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-335; Longo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-334; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Muller S, 2001, HUM GENET, V109, P85; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naslund K, 2005, GENOMICS, V85, P24, DOI 10.1016/j.ygeno.2004.10.009; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson TJ, 2008, CHROMOSOME RES, V16, P1133, DOI 10.1007/s10577-008-1264-0; Ruiz-Herrera A, 2005, CYTOGENET GENOME RES, V108, P161, DOI 10.1159/000080812; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sankoff David, 2009, Journal of Biology (London), V8, P66, DOI 10.1186/jbiol162; SHEN MR, 1991, J MOL EVOL, V33, P311; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wienberg J, 1997, CURR OPIN GENET DEV, V7, P784, DOI 10.1016/S0959-437X(97)80041-X; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zhao H, 2009, GENOME RES, V19, P934, DOI 10.1101/gr.086009.108; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304	62	28	28	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27239	10.1371/journal.pone.0027239	http://dx.doi.org/10.1371/journal.pone.0027239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076140	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000297198200054
J	Johnstone, CP; Lill, A; Reina, RD				Johnstone, Christopher P.; Lill, Alan; Reina, Richard D.			Response of the Agile Antechinus to Habitat Edge, Configuration and Condition in Fragmented Forest	PLOS ONE			English	Article							YELLOW-FOOTED ANTECHINUS; STUARTII MARSUPIALIA; SEXUAL SEGREGATION; SMALL MAMMALS; PHYSIOLOGICAL STRESS; PATERNITY SUCCESS; FIELD POPULATION; MICROHABITAT USE; BLOOD PARASITES; PREDATION RISK	Habitat fragmentation and degradation seriously threaten native animal communities. We studied the response of a small marsupial, the agile antechinus Antechinus agilis, to several environmental variables in anthropogenically fragmented Eucalyptus forest in south-east Australia. Agile antechinus were captured more in microhabitats dominated by woody debris than in other microhabitats. Relative abundances of both sexes were positively correlated with fragment core area. Male and female mass-size residuals were smaller in larger fragments. A health status indicator, haemoglobin-haematocrit residuals (HHR), did not vary as a function of any environmental variable in females, but male HHR indicated better health where sites' microhabitats were dominated by shrubs, woody debris and trees other than Eucalyptus. Females were trapped less often in edge than interior fragment habitat and their physiological stress level, indicated by the neutrophil/lymphocyte ratio in peripheral blood, was higher where fragments had a greater proportion of edge habitat. The latter trend was potentially due to lymphopoenia resulting from stress hormone-mediated leukocyte trafficking. Using multiple indicators of population condition and health status facilitates a comprehensive examination of the effects of anthropogenic disturbances, such as habitat fragmentation and degradation, on native vertebrates. Male agile antechinus' health responded negatively to habitat degradation, whilst females responded negatively to the proportion of edge habitat. The health and condition indicators used could be employed to identify conservation strategies that would make habitat fragments less stressful for this or similar native, small mammals.	[Johnstone, Christopher P.; Lill, Alan; Reina, Richard D.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University	Johnstone, CP (corresponding author), Monash Univ, Sch Biol Sci, Clayton Campus, Clayton, Vic 3800, Australia.	christopher.johnstone@monash.edu; alan.lill@monash.edu; richard.reina@monash.edu	Reina, Richard/AAC-7017-2019		Holsworth Wildlife Research [HOLSWOGB08]	Holsworth Wildlife Research	The research was partly funded by Holsworth Wildlife Research grant scheme for post-graduate studies (ANZ Philanthropy Partners), Fund scheme code: HOLSWOGB08 (website: http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/). All other funds were provided by Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ATCHLEY WR, 1976, SYST ZOOL, V25, P137, DOI 10.2307/2412740; Banks PB, 2000, CAN J ZOOL, V78, P1775, DOI 10.1139/cjz-78-10-1775; Banks SC, 2005, BIOL CONSERV, V122, P581, DOI 10.1016/j.biocon.2004.09.013; BENNETT AF, 1990, AUST WILDLIFE RES, V17, P325, DOI 10.1071/WR9900325; BENNETT AF, 1993, WILDLIFE RES, V20, P267, DOI 10.1071/WR9930267; Berry L, 2002, WILDLIFE RES, V29, P341, DOI 10.1071/WR01022; Binckley CA, 2005, BIOL LETTERS, V1, P370, DOI 10.1098/rsbl.2005.0310; Blackwell GL, 2006, J MAMMAL, V87, P216, DOI 10.1644/05-MAMM-A-215R1.1; Bradbury J.W., 1981, P138; BRAITHWAITE RW, 1979, AM NAT, V113, P151, DOI 10.1086/283372; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; CATLING PC, 1988, AUST WILDLIFE RES, V15, P307, DOI 10.1071/WR9880307; CAUGHLEY G, 1988, J ANIM ECOL, V57, P771, DOI 10.2307/5092; CHEAL PD, 1976, AUST J ZOOL, V24, P299, DOI 10.1071/ZO9760299; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; COCKBURN A, 1992, J ZOOL, V226, P657, DOI 10.1111/j.1469-7998.1992.tb07508.x; Colombelli-Negrel D, 2008, AUST J ZOOL, V56, P117, DOI 10.1071/ZO07072; Cox MP, 2004, BIOL CONSERV, V115, P175, DOI 10.1016/S0006-3207(03)00105-8; Crawley M.J., 2007, R BOOK; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Delehanty B, 2009, GEN COMP ENDOCR, V160, P176, DOI 10.1016/j.ygcen.2008.11.011; DHABHAR FS, 1994, BRAIN BEHAV IMMUN, V8, P66, DOI 10.1006/brbi.1994.1006; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; DIAMOND J M, 1987, Conservation Biology, V1, P132, DOI 10.1111/j.1523-1739.1987.tb00022.x; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; DICKMAN CR, 1983, OECOLOGIA, V60, P127, DOI 10.1007/BF00379332; Dickman CR, 1998, AUST J ZOOL, V46, P1, DOI 10.1071/ZO97036; DICKMAN CR, 1989, AUST J ECOL, V14, P387, DOI 10.1111/j.1442-9993.1989.tb01449.x; DUFVA R, 1995, FUNCT ECOL, V9, P785, DOI 10.2307/2390253; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Figuerola J, 1999, FUNCT ECOL, V13, P594, DOI 10.1046/j.1365-2435.1999.00354.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FISHER JW, 1962, BLOOD, V19, P557, DOI 10.1182/blood.V19.5.557.557; Fletcher QE, 2006, J ZOOL, V270, P473, DOI 10.1111/j.1469-7998.2006.00153.x; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GILPIN ME, 1976, P NATL ACAD SCI USA, V73, P4130, DOI 10.1073/pnas.73.11.4130; Holland GJ, 2009, BIODIVERS CONSERV, V18, P2997, DOI 10.1007/s10531-009-9621-7; Jaeger JAG, 2000, LANDSCAPE ECOL, V15, P115, DOI 10.1023/A:1008129329289; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P139, DOI 10.1007/s00360-011-0598-7; Johnstone CP, 2010, J MAMMAL, V91, P1332, DOI 10.1644/10-MAMM-A-034.1; Jorgensen EE, 2004, J MAMMAL, V85, P531, DOI 10.1644/BER-019; Kelly LT, 2008, WILDLIFE RES, V35, P128, DOI 10.1071/WR07088; Knight EH, 2000, AUST J ZOOL, V48, P577, DOI 10.1071/ZO00018; Kraaijeveld-Smit FJL, 2003, MOL ECOL, V12, P475, DOI 10.1046/j.1365-294X.2003.01745.x; Kraaijeveld-Smit FJL, 2002, AUST J ZOOL, V50, P325, DOI 10.1071/ZO02010; Kraaijeveld-Smit FJL, 2002, J EVOLUTION BIOL, V15, P100, DOI 10.1046/j.1420-9101.2002.00367.x; Kraaijeveld-Smit FJL, 2002, BEHAV ECOL SOCIOBIOL, V52, P84, DOI 10.1007/s00265-002-0485-z; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; LAZENBYCOHEN KA, 1988, BEHAV ECOL SOCIOBIOL, V22, P195, DOI 10.1007/BF00300569; LAZENBYCOHEN KA, 1991, AUST J ECOL, V16, P301, DOI 10.1111/j.1442-9993.1991.tb01058.x; Lee AK., 1985, EVOL ECOL; Lewis S, 2006, DACIE LEWIS PRACTICA, V10th; Lidicker WZ, 1999, LANDSCAPE ECOL, V14, P333, DOI 10.1023/A:1008056817939; Lomolino MV, 2000, ECOLOGY, V81, P1517, DOI 10.2307/177303; Lunney D, 2001, WILDLIFE RES, V28, P459, DOI 10.1071/WR00015; MAC ARTHUR ROBERT H., 1967; Mac Nally R., 2002, Animal Biodiversity and Conservation, V25, P41; Mac Nally R, 1996, AUST J ECOL, V21, P224; Marchesan D, 2008, LANDSCAPE ECOL, V23, P741, DOI 10.1007/s10980-008-9234-7; MARLOW B. J., 1961, AUSTRALIAN JOUR ZOOL, V9, P203, DOI 10.1071/ZO9610203; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Masello JF, 2009, COMP BIOCHEM PHYS A, V152, P176, DOI 10.1016/j.cbpa.2008.09.018; May SA, 1996, WILDLIFE RES, V23, P387, DOI 10.1071/WR9960387; Menkhorst P., 2004, FIELD GUIDE MAMMALS; Naylor R, 2008, J COMP PHYSIOL B, V178, P545, DOI 10.1007/s00360-007-0250-8; Oishi K, 1999, ACTA PHYSIOL SCAND, V165, P65; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Shimmin GA, 1999, BIOL REPROD, V60, P1353, DOI 10.1095/biolreprod60.6.1353; Shnberloff D.S., 1974, Annual Rev Ecol Syst, V5, P161; SIEGEL HS, 1980, BIOSCIENCE, V30, P529, DOI 10.2307/1307973; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Stokes VL, 2004, BIOL CONSERV, V117, P331, DOI 10.1016/j.biocon.2003.12.012; Sutherland DR, 1999, AUST J ZOOL, V47, P1, DOI 10.1071/ZO98037; Teague CR, 2007, J PROTEOME RES, V6, P2080, DOI 10.1021/pr060412s; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Tyler RD, 1996, COMP HAEMATOL INT, V6, P1, DOI 10.1007/BF00368096; WOOD D H, 1970, Australian Journal of Zoology, V18, P185, DOI 10.1071/ZO9700185; WOOLLARD P, 1971, Australian Journal of Zoology, V19, P347, DOI 10.1071/ZO9710347; Zanette L, 2003, P ROY SOC B-BIOL SCI, V270, P799, DOI 10.1098/rspb.2002.2311; Zuur Alain F., 2009, P1	96	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27158	10.1371/journal.pone.0027158	http://dx.doi.org/10.1371/journal.pone.0027158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076129	gold, Green Published, Green Submitted			2022-12-27	WOS:000297198200041
J	Teng, CT; Li, Y; Stockton, P; Foley, J				Teng, Christina T.; Li, Yin; Stockton, Pat; Foley, Julie			Fasting Induces the Expression of PGC-1 alpha and ERR Isoforms in the Outer Stripe of the Outer Medulla (OSOM) of the Mouse Kidney	PLOS ONE			English	Article							ERYTHROPOIETIN-PRODUCING CELLS; HORMONE RESPONSE ELEMENT; ALPHA GENE-EXPRESSION; RECEPTOR-GAMMA; COACTIVATOR-1-ALPHA PGC-1-ALPHA; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; JUXTAMEDULLARY CORTEX; ESTROGEN-RECEPTOR; METABOLIC-CONTROL	Background: Peroxisome proliferator-activated receptor-gamma co-activator-1 alpha (PGC-1 alpha) is a member of the transcriptional coactivator family that plays a central role in the regulation of cellular energy metabolism under various physiological stimuli. During fasting, PGC-1 alpha is induced in the liver and together with estrogen-related receptor a and gamma (ERR alpha and ERR gamma, orphan nuclear receptors with no known endogenous ligand, regulate sets of genes that participate in the energy balance program. We found that PGC-1 alpha, ERR alpha and ERR gamma was highly expressed in human kidney HK2 cells and that PGC-1 alpha induced dynamic protein interactions on the ERR alpha chromatin. However, the effect of fasting on the expression of endogenous PG-C1 alpha, ERR alpha and ERR gamma in the kidney is not known. Methodology/Principal Findings: In this study, we demonstrated by qPCR that the expression of PGC-1 alpha, ERR alpha and ERR gamma was increased in the mouse kidney after fasting. By using immunohistochemistry (IHC), we showed these three proteins are co-localized in the outer stripe of the outer medulla (OSOM) of the mouse kidney. We were able to collect this region from the kidney using the Laser Capture Microdissection (LCM) technique. The qPCR data showed significant increase of PGC-1 alpha, ERR alpha and ERR gamma mRNA in the LCM samples after fasting for 24 hours. Furthermore, the known ERR alpha target genes, mitochondrial oxidative phosphorylation gene COX8H and the tricarboxylic acid (TCA) cycle gene IDH3A also showed an increase. Taken together, our data suggest that fasting activates the energy balance program in the OSOM of the kidney.	[Teng, Christina T.] NIEHS, Biomol Screening Branch, NIH, Res Triangle Pk, NC 27709 USA; [Li, Yin] NIEHS, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA; [Li, Yin] NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Stockton, Pat; Foley, Julie] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Teng, CT (corresponding author), NIEHS, Biomol Screening Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	teng1@niehs.nih.gov			National Institutes of Health; National Institute of Environmental Health Sciences [Z01-ES 070067]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the Intramural Research Program of the National Institutes of Health and by the National Institute of Environmental Health Sciences Project Z01-ES 070067 to C.T.T. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Araki M, 2006, FEBS J, V273, P1669, DOI 10.1111/j.1742-4658.2006.05183.x; ARNALL DA, 1988, AM J PHYSIOL, V254, pC560, DOI 10.1152/ajpcell.1988.254.4.C560; Blantz RC, 1998, KIDNEY INT, V53, P512, DOI 10.1046/j.1523-1755.2003_t01-1-00784.x; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; COMMITTEE NRN, 1999, CELL, V97, P161; Couchepin C, 2008, DIABETES CARE, V31, P1254, DOI 10.2337/dc07-2001; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Grasfeder LL, 2009, MOL ENDOCRINOL, V23, P1171, DOI 10.1210/me.2009-0024; GUYTON AC, 1964, CIRC RES, V15, P187; GUYTON AC, 1992, HYPERTENSION, V19, pI2, DOI 10.1161/01.HYP.19.1_Suppl.I2; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Iversen BM, 1998, AM J PHYSIOL-RENAL, V274, pF365, DOI 10.1152/ajprenal.1998.274.2.F365; Jelinsky SA, 2003, ENDOCRINOLOGY, V144, P701, DOI 10.1210/en.2002-220728; Johkura K, 1998, J HISTOCHEM CYTOCHEM, V46, P1161, DOI 10.1177/002215549804601008; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V281, pE1333, DOI 10.1152/ajpendo.2001.281.6.E1333; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; OLSON JL, 1986, KIDNEY INT, V29, P849, DOI 10.1038/ki.1986.76; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ranhotra HS, 2009, MOL CELL BIOCHEM, V332, P59, DOI 10.1007/s11010-009-0174-6; Roald AB, 2002, AM J PHYSIOL-RENAL, V282, pF506, DOI 10.1152/ajprenal.00199.2001; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rohman MS, 2005, KIDNEY INT, V67, P1410, DOI 10.1111/j.1523-1755.2005.00218.x; RUNDLE SE, 1989, ENDOCRINOLOGY, V125, P1700, DOI 10.1210/endo-125-3-1700; SCHREIBER SN, 2003, J BIOL CHEM; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shigeta H, 1997, J MOL ENDOCRINOL, V19, P299, DOI 10.1677/jme.0.0190299; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Taketani Y, 1998, J BIOL CHEM, V273, P14575, DOI 10.1074/jbc.273.23.14575; Teng CT, 2002, MOL HUM REPROD, V8, P58, DOI 10.1093/molehr/8.1.58; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; TUCKER BJ, 1977, AM J PHYSIOL, V232, pF477, DOI 10.1152/ajprenal.1977.232.6.F477; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang LL, 2008, BIOCHEM J, V416, P407, DOI 10.1042/BJ20081085; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26961	10.1371/journal.pone.0026961	http://dx.doi.org/10.1371/journal.pone.0026961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073226	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200026
J	Yi, QY; Zhao, XY; Huang, Y; Ma, TL; Zhang, YY; Hou, HL; Cooke, HJ; Yang, DQ; Wu, MA; Shi, QH				Yi, Qiyi; Zhao, Xiaoyu; Huang, Yun; Ma, Tieliang; Zhang, Yingyin; Hou, Heli; Cooke, Howard J.; Yang, Da-Qing; Wu, Mian; Shi, Qinghua			p53 Dependent Centrosome Clustering Prevents Multipolar Mitosis in Tetraploid Cells	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; NUCLEOTIDE EXCHANGE FACTOR; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR GENE; RHO-ASSOCIATED KINASE; CANCER-CELLS; CHROMOSOMAL INSTABILITY; CYTOKINESIS FAILURE; GENOMIC INSTABILITY; ACTIN CYTOSKELETON	Background: p53 abnormality and aneuploidy often coexist in human tumors, and tetraploidy is considered as an intermediate between normal diploidy and aneuploidy. The purpose of this study was to investigate whether and how p53 influences the transformation from tetraploidy to aneuploidy. Principal Findings: Live cell imaging was performed to determine the fates and mitotic behaviors of several human and mouse tetraploid cells with different p53 status, and centrosome and spindle immunostaining was used to investigate centrosome behaviors. We found that p53 dominant-negative mutation, point mutation, or knockout led to a 2 similar to 33-fold increase of multipolar mitosis in N/TERT1, 3T3 and mouse embryonic fibroblasts (MEFs), while mitotic entry and cell death were not significantly affected. In p53(-/-) tetraploid MEFs, the ability of centrosome clustering was compromised, while centrosome inactivation was not affected. Suppression of RhoA/ROCK activity by specific inhibitors in p53(-/-) tetraploid MEFs enhanced centrosome clustering, decreased multipolar mitosis from 38% to 20% and 16% for RhoA and ROCK, respectively, while expression of constitutively active RhoA in p53(+/+) tetraploid 3T3 cells increased the frequency of multipolar mitosis from 15% to 35%. Conclusions: p53 could not prevent tetraploid cells entering mitosis or induce tetraploid cell death. However, p53 abnormality impaired centrosome clustering and lead to multipolar mitosis in tetraploid cells by modulating the RhoA/ROCK signaling pathway.	[Yi, Qiyi; Zhao, Xiaoyu; Huang, Yun; Ma, Tieliang; Zhang, Yingyin; Hou, Heli; Cooke, Howard J.; Wu, Mian; Shi, Qinghua] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Yi, Qiyi; Zhao, Xiaoyu; Huang, Yun; Ma, Tieliang; Zhang, Yingyin; Hou, Heli; Cooke, Howard J.; Wu, Mian; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Yang, Da-Qing] Univ S Dakota, Sioux Falls, SD USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Edinburgh; University of Edinburgh; University of South Dakota	Yi, QY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013; Huang, Yun/AGX-8953-2022	Huang, Yun/0000-0001-5987-1319; Wu, Mian/0000-0002-2714-0500; Yi, Qiyi/0000-0001-5143-8828	National Natural Science Foundation of China [30571030, 30671168, 30725013]; National High Technology Research and Development Program of China [2006AA02Z4B4]; Ministry of Education of China [20070358022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from National Natural Science Foundation of China (Grants 30571030, 30671168 and 30725013), National High Technology Research and Development Program of China (2006AA02Z4B4), and Doctoral Fund of Ministry of Education of China (20070358022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Andreassen PR, 2003, MUTAT RES-FUND MOL M, V532, P245, DOI 10.1016/j.mrfmmm.2003.08.020; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Boveri T, 1929, ORIGIN MALIGNANT TUM; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Brown N, 2009, CELL CYCLE, V8, P1997, DOI 10.4161/cc.8.13.8987; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; del Peso L, 1997, ONCOGENE, V15, P3047; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Eda M, 2001, J CELL SCI, V114, P3273; EYFJORD JE, 1995, CANCER RES, V55, P646; Fichter CD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-13; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gisselsson D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001871; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; HARVEY M, 1993, ONCOGENE, V8, P2457; Ho CC, 2010, ONCOTARGET, V1, P583; Ianzini F, 2009, CANCER RES, V69, P2296, DOI 10.1158/0008-5472.CAN-08-3364; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Lozano G, 2000, NATURE, V404, P24, DOI 10.1038/35003670; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; MOSCOW JA, 1994, ONCOGENE, V9, P189; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Nakamoto M, 2001, INT J ONCOL, V19, P971; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rihet S, 2001, J CANCER RES CLIN, V127, P733; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Schmidt S, 2010, CELL CYCLE, V9, P4469, DOI 10.4161/cc.9.22.13684; Scoumanne A, 2006, CANCER RES, V66, P6271, DOI 10.1158/0008-5472.CAN-06-0121; Senovilla L, 2009, CELL CYCLE, V8, P1380, DOI 10.4161/cc.8.9.8305; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sigurdsson S, 2000, CANCER GENET CYTOGEN, V121, P150, DOI 10.1016/S0165-4608(00)00260-0; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Song YH, 2000, J CELL BIOCHEM, V80, P229; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; Vitale I, 2010, CELL CYCLE, V9, P2823, DOI 10.4161/cc.9.14.12254; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wadhwa R, 1999, CELL RES, V9, P261, DOI 10.1038/sj.cr.7290025; Wang WQ, 2008, J CELL SCI, V121, P1334, DOI 10.1242/jcs.018176; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208	85	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27304	10.1371/journal.pone.0027304	http://dx.doi.org/10.1371/journal.pone.0027304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076149	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200063
J	Bakkali, M				Bakkali, Mohammed			Microevolution of cis-Regulatory Elements: An Example from the Pair-Rule Segmentation Gene fushi tarazu in the Drosophila melanogaster Subgroup	PLOS ONE			English	Article							PHYLOGENETIC FOOTPRINTING REVEALS; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; HAPLOTYPE RECONSTRUCTION; CONCERTED EVOLUTION; FUNCTIONAL-ANALYSIS; ENHANCER EVOLUTION; ADAPTIVE EVOLUTION; SEQUENCE ALIGNMENT; STATISTICAL-METHOD	The importance of non-coding DNAs that control transcription is ever noticeable, but the characterization and analysis of the evolution of such DNAs presents challenges not found in the analysis of coding sequences. In this study of the cis-regulatory elements of the pair rule segmentation gene fushi tarazu (ftz) I report the DNA sequences of ftz's zebra element (promoter) and a region containing the proximal enhancer from a total of 45 fly lines belonging to several populations of the species Drosophila melanogaster, D. simulans, D. sechellia, D. mauritiana, D. yakuba, D. teissieri, D. orena and D. erecta. Both elements evolve at slower rate than ftz synonymous sites, thus reflecting their functional importance. The promoter evolves more slowly than the average for ftz's coding sequence while, on average, the enhancer evolves more rapidly, suggesting more functional constraint and effective purifying selection on the former. Comparative analysis of the number and nature of base substitutions failed to detect significant evidence for positive/adaptive selection in transcription-factor-binding sites. These seem to evolve at similar rates to regions not known to bind transcription factors. Although this result reflects the evolutionary flexibility of the transcription factor binding sites, it also suggests a complex and still not completely understood nature of even the characterized cis-regulatory sequences. The latter seem to contain more functional parts than those currently identified, some of which probably transcription factor binding. This study illustrates ways in which functional assignments of sequences within cis-acting sequences can be used in the search for adaptive evolution, but also highlights difficulties in how such functional assignment and analysis can be carried out.	Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain	University of Granada	Bakkali, M (corresponding author), Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain.	mbakkali@ugr.es	Bakkali, Mohammed/M-1267-2014	Bakkali, Mohammed/0000-0002-9079-8452	Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [G19219] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Andolfatto P, 2011, GENOME BIOL EVOL, V3, P114, DOI 10.1093/gbe/evq086; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bakkali M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000741; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-42; Borok MJ, 2010, DEVELOPMENT, V137, P5, DOI 10.1242/dev.036160; Bretschneider N, 2008, MOL ONCOL, V2, P182, DOI 10.1016/j.molonc.2008.05.004; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Caracristi G, 2003, MOL BIOL EVOL, V20, P792, DOI 10.1093/molbev/msg091; Carey M, 2000, TRANSCRIPTIONAL REGU, P539; CVEKL A, 1992, GENE, V110, P225, DOI 10.1016/0378-1119(92)90652-6; DAVID JR, 1982, BIOCHEM GENET, V20, P747, DOI 10.1007/BF00483971; DEAROLF CR, 1990, BIOESSAYS, V12, P109, DOI 10.1002/bies.950120303; DEAROLF CR, 1989, GENE DEV, V3, P384, DOI 10.1101/gad.3.3.384; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER G, 1994, CURR BIOL, V4, P1165, DOI 10.1016/S0960-9822(00)00265-7; DOVER GA, 1993, METHOD ENZYMOL, V224, P525, DOI 10.1016/0076-6879(93)24039-W; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FU YX, 1993, GENETICS, V133, P693; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Ganley Austen R. D., 2007, V395, P367; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2008, BIOL LETTERS, V4, P438, DOI 10.1098/rsbl.2008.0174; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAN W, 1993, MOL CELL BIOL, V13, P5549, DOI 10.1128/MCB.13.9.5549; Han W, 1998, MOL CELL BIOL, V18, P3384, DOI 10.1128/MCB.18.6.3384; Hancock JM, 1999, MOL BIOL EVOL, V16, P253, DOI 10.1093/oxfordjournals.molbev.a026107; Heffer A, 2010, P NATL ACAD SCI USA, V107, P18040, DOI 10.1073/pnas.1010746107; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Ho MCW, 2009, INT J DEV BIOL, V53, P459, DOI 10.1387/ijdb.082647mh; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; INGHAM P, 1988, DEVELOPMENT, V104, P51; JEFFS PS, 1994, MOL BIOL EVOL, V11, P287; JENKINS DL, 1995, P ROY SOC B-BIOL SCI, V261, P203, DOI 10.1098/rspb.1995.0137; Jiao K, 2002, YEAST, V19, P99, DOI 10.1002/yea.800; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kauer M, 2002, GENETICS, V160, P247; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lemos B, 2004, GENOMICS, V84, P511, DOI 10.1016/j.ygeno.2004.05.009; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; LIN KC, 1995, J BIOCHEM BIOPH METH, V30, P85, DOI 10.1016/0165-022X(94)00066-M; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nasiadka A, 1999, DEVELOPMENT, V126, P1515; Nei M., 1987, MOL EVOLUTIONARY GEN; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Phinchongsakuldit J, 2004, MOL BIOL EVOL, V21, P348, DOI 10.1093/molbev/msh025; PICK L, 1990, GENE DEV, V4, P1224, DOI 10.1101/gad.4.7.1224; Potokina E, 2008, PLANT J, V56, P287, DOI 10.1111/j.1365-313X.2008.03601.x; POWELL JR, 1991, MOL BIOL EVOL, V8, P892; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Skaer N, 2000, DEV BIOL, V221, P148, DOI 10.1006/dbio.1999.9661; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stern David L, 2007, Novartis Found Symp, V284, P191; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Su NF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-150; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOPOL J, 1991, GENE DEV, V5, P855, DOI 10.1101/gad.5.5.855; Tran DA, 2010, DNA CELL BIOL, V29, P499, DOI 10.1089/dna.2009.0994; TSAI CC, 1995, DEVELOPMENT, V121, P453; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wingender E, 1996, PACIFIC SYMPOSIUM ON BIOCOMPUTING '97, P477; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wratten NS, 2006, EVOL DEV, V8, P6, DOI 10.1111/j.1525-142X.2006.05070.x; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200	93	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27376	10.1371/journal.pone.0027376	http://dx.doi.org/10.1371/journal.pone.0027376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073317	Green Published, gold, Green Submitted			2022-12-27	WOS:000297197000049
J	Taylor, PD; Mackenzie, SA; Thurber, BG; Calvert, AM; Mills, AM; McGuire, LP; Guglielmo, CG				Taylor, Philip D.; Mackenzie, Stuart A.; Thurber, Bethany G.; Calvert, Anna M.; Mills, Alex M.; McGuire, Liam P.; Guglielmo, Christopher G.			Landscape Movements of Migratory Birds and Bats Reveal an Expanded Scale of Stopover	PLOS ONE			English	Article							NOCTURNAL PASSERINE MIGRANTS; SPRING MIGRATION; EUROPEAN ROBINS; NEW-WORLD; ORIENTATION; AUTUMN; FLIGHT; SANDPIPERS; DEPARTURE; DURATION	Many species of birds and bats undertake seasonal migrations between breeding and over-wintering sites. En-route, migrants alternate periods of flight with time spent at stopover - the time and space where individuals rest and refuel for subsequent flights. We assessed the spatial scale of movements made by migrants during stopover by using an array of automated telemetry receivers with multiple antennae to track the daily location of individuals over a geographic area similar to 20x40 km. We tracked the movements of 322 individuals of seven migratory vertebrate species (5 passerines, 1 owl and 1 bat) during spring and fall migratory stopover on and adjacent to a large lake peninsula. Our results show that many individuals leaving their capture site relocate within the same landscape at some point during stopover, moving as much as 30 km distant from their site of initial capture. We show that many apparent nocturnal departures from stopover sites are not a resumption of migration in the strictest sense, but are instead relocations that represent continued stopover at a broader spatial scale.	[Taylor, Philip D.; Calvert, Anna M.; Mills, Alex M.] Acadia Univ, Wolfville, NS B0P 1X0, Canada; [Taylor, Philip D.; Mackenzie, Stuart A.; Thurber, Bethany G.; Calvert, Anna M.; Mills, Alex M.] Bird Studies Canada, Port Rowan, ON, Canada; [Mackenzie, Stuart A.; Thurber, Bethany G.; McGuire, Liam P.; Guglielmo, Christopher G.] Univ Western Ontario, London, ON, Canada	Acadia University; Western University (University of Western Ontario)	Taylor, PD (corresponding author), Acadia Univ, Wolfville, NS B0P 1X0, Canada.	Philip.taylor@acadiau.ca	McGuire, Liam/CAE-8434-2022		National Sciences and Engineering Research Council; Environment Canada; Ontario Ministry of Natural Resources	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Ontario Ministry of Natural Resources	Funding for the study was provided by grants from the National Sciences and Engineering Research Council (Discovery Grants to PDT, CGG; Scholarships to SAM, BGT, LPM), Environment Canada (PDT) and the Ontario Ministry of Natural Resources (CGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 1996, BEHAV ECOL SOCIOBIOL, V38, P293, DOI 10.1007/s002650050245; Akesson S, 1996, J AVIAN BIOL, V27, P95, DOI 10.2307/3677138; Akesson S, 1999, ARDEA, V87, P129; ALERSTAM T, 1978, OIKOS, V30, P405, DOI 10.2307/3543491; Amelon Sybill K., 2009, P57; Bachler E, 2007, CONDOR, V109, P142, DOI 10.1650/0010-5422(2007)109[142:TEOPLE]2.0.CO;2; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Butler RW, 2002, WILSON BULL, V114, P485, DOI 10.1676/0043-5643(2002)114[0485:SFALMO]2.0.CO;2; Chernetsov N, 2006, J ORNITHOL, V147, P185, DOI 10.1007/s10336-006-0064-6; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Chernetsov Nikita, 2000, Avian Ecology and Behaviour, V5, P27; Cochran William W., 2005, P274; ELLEGREN H, 1993, ORNIS SCAND, V24, P220, DOI 10.2307/3676737; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fair J., 2010, ORNITHOLOGICAL COUNC; Farmer AH, 1997, CONDOR, V99, P698, DOI 10.2307/1370481; Goymann W, 2010, BIOL LETTERS, V6, P478, DOI 10.1098/rsbl.2009.1028; Holberton Rebecca L., 2005, P290; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; Mills AM, 2011, CONDOR, V113, P597, DOI 10.1525/cond.2011.100186; Moore FR, 1996, AUK, V113, P949, DOI 10.2307/4088878; Moore Frank R., 1995, P121; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Richardson W.J., 1990, P78; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Sandberg R, 1996, BEHAV ECOL SOCIOBIOL, V39, P1, DOI 10.1007/s002650050261; Schaub M, 2008, BEHAV ECOL, V19, P657, DOI 10.1093/beheco/arn023; Schmaljohann H, 2011, J ORNITHOL, V152, P439, DOI 10.1007/s10336-010-0604-y; Sprague AJ, 2008, AVIAN CONSERV ECOL, V3; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tsvey A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1665, DOI 10.1007/s00265-007-0397-z; WIEDNER DS, 1992, AUK, V109, P500; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Zehnder Susanna, 2002, Avian Science, V2, P103	39	98	102	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27054	10.1371/journal.pone.0027054	http://dx.doi.org/10.1371/journal.pone.0027054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073253	Green Submitted, Green Published, gold			2022-12-27	WOS:000297197000026
J	Ahn, JH; Keum, JW; Kim, DM				Ahn, Jin-Ho; Keum, Jung-Won; Kim, Dong-Myung			Expression Screening of Fusion Partners from an E. coli Genome for Soluble Expression of Recombinant Proteins in a Cell-Free Protein Synthesis System	PLOS ONE			English	Article							ESCHERICHIA-COLI; INITIATION CODON; HIGH-THROUGHPUT; TRANSLATION INITIATION; STEP PURIFICATION; GENE-EXPRESSION; AGGREGATION; EFFICIENCY; ENHANCEMENT; DOWNSTREAM	While access to soluble recombinant proteins is essential for a number of proteome studies, preparation of purified functional proteins is often limited by the protein solubility. In this study, potent solubility-enhancing fusion partners were screened from the repertoire of endogenous E. coli proteins. Based on the presumed correlation between the intracellular abundance and folding efficiency of proteins, PCR-amplified ORFs of a series of highly abundant E. coli proteins were fused with aggregation-prone heterologous proteins and then directly expressed for quantitative estimation of the expression efficiency of soluble translation products. Through two-step screening procedures involving the expression of 552 fusion constructs targeted against a series of cytokine proteins, we were able to discover a number of endogenous E. coli proteins that dramatically enhanced the soluble expression of the target proteins. This strategy of cell-free expression screening can be extended to quantitative, global analysis of genomic resources for various purposes.	[Ahn, Jin-Ho; Kim, Dong-Myung] Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Taejon, South Korea; [Keum, Jung-Won] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Chungnam National University; Seoul National University (SNU)	Ahn, JH (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	dmkim@cnu.ac.kr		Kim, Dong-Myung/0000-0001-7875-0694	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011K000841, 2011-0027901]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was financially supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant numbers 2011K000841 and 2011-0027901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2005, BIOCHEM BIOPH RES CO, V337, P325, DOI 10.1016/j.bbrc.2005.09.061; Ahn JH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl917; Ahn JH, 2008, J PROTEOME RES, V7, P2107, DOI 10.1021/pr700856s; Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Bi Y, 2006, PROTEIN EXPRES PURIF, V47, P234, DOI 10.1016/j.pep.2005.10.023; Braun P, 2004, DRUG DISCOV TODAY, V9, pS1; Castillo V, 2011, BIOTECHNOL J, V6, P752, DOI 10.1002/biot.201100014; Chambers S, 2008, J BIOMOL SCREEN, V13, P719; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; de Groot NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009383; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; ECKER DJ, 1989, J BIOL CHEM, V264, P7715; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Etchegaray JP, 1999, J BIOL CHEM, V274, P10079, DOI 10.1074/jbc.274.15.10079; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x; Kwon YC, 2010, APPL ENVIRON MICROB, V76, P6295, DOI 10.1128/AEM.00029-10; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Ottosson J, 2006, MOL CELL PROTEOMICS, V5, pS40; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Son JM, 2006, ANAL BIOCHEM, V351, P187, DOI 10.1016/j.ab.2005.11.047; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V32, P252, DOI 10.1016/j.pep.2003.07.001; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; Swartz J, 2006, J IND MICROBIOL BIOT, V33, P476, DOI 10.1007/s10295-006-0127-y; Zhang G, 2009, PLOS ONE	39	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26875	10.1371/journal.pone.0026875	http://dx.doi.org/10.1371/journal.pone.0026875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073212	Green Submitted, Green Published, gold			2022-12-27	WOS:000297154900049
J	Dutra, RC; Claudino, RF; Bento, AF; Marcon, R; Schmidt, EC; Bouzon, ZL; Pianowski, LF; Calixto, JB				Dutra, Rafael C.; Claudino, Rafaela F.; Bento, Allisson F.; Marcon, Rodrigo; Schmidt, Eder C.; Bouzon, Zenilda L.; Pianowski, Luiz F.; Calixto, Joao B.			Preventive and Therapeutic Euphol Treatment Attenuates Experimental Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ENDOTHELIAL-CELL-ADHESION; SODIUM-INDUCED COLITIS; NF-KAPPA-B; P-SELECTIN; ULCERATIVE-COLITIS; NITRIC-OXIDE; INTESTINAL INFLAMMATION; PLANT-EXTRACTS; DEFICIENT MICE	Background: The tetracyclic triterpene euphol is the main constituent found in the sap of Euphorbia tirucalli. This plant is widely known in Brazilian traditional medicine for its use in the treatment of several kinds of cancer, including leukaemia, prostate and breast cancers. Here, we investigated the effect of euphol on experimental models of colitis and the underlying mechanisms involved in its action. Methodology/Principal Findings: Colitis was induced in mice either with dextran sulfate sodium (DSS) or with 2,4,6-trinitrobenzene sulfonic acid (TNBS), and the effect of euphol (3, 10 and 30 mg/kg) on colonic injury was assessed. Pro-inflammatory mediators and cytokines were measured by immunohistochemistry, enzyme-Linked immunoabsorbent assay (ELISA), real time-polymerase chain reaction (RT-PCR) and flow cytometry. Preventive and therapeutic oral administration of euphol attenuated both DSS- and TNBS-induced acute colitis as observed by a significant reduction of the disease activity index (DAI), histological/microscopic damage score and myeloperoxidase (MPO) activity in colonic tissue. Likewise, euphol treatment also inhibited colon tissue levels and expression of IL-1 beta, CXCL1/KC, MCP-1, MIP-2, TNF-alpha and IL-6, while reducing NOS2, VEGF and Ki67 expression in colonic tissue. This action seems to be likely associated with inhibition of activation of nuclear factor-kappa B (NF-kappa B). In addition, euphol decreased LPS-induced MCP-1, TNF-alpha, IL-6 and IFN-gamma, but increased IL-10 secretion from bone marrow-derived macrophages in vitro. Of note, euphol, at the same schedule of treatment, markedly inhibited both selectin (P- and E-selectin) and integrin (ICAM-1, VCAM-1 and LFA-1) expression in colonic tissue. Conclusions/Significance: Together, these results clearly demonstrated that orally-administered euphol, both preventive or therapeutic treatment were effective in reducing the severity of colitis in two models of chemically-induced mouse colitis and suggest this plant-derived compound might be a potential molecule in the management of inflammatory bowel diseases.	[Dutra, Rafael C.; Claudino, Rafaela F.; Bento, Allisson F.; Marcon, Rodrigo; Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil; [Schmidt, Eder C.; Bouzon, Zenilda L.] Univ Fed Santa Catarina, Dept Cell Biol Embryol & Genet, Cent Lab Elect Microscopy, Florianopolis, SC, Brazil; [Pianowski, Luiz F.] Pianowski & Pianowski Ltda, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Dutra, RC (corresponding author), Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil.	calixto@farmaco.ufsc.br	Bento, Allisson/F-5603-2013; Dutra, Rafael C/F-8452-2012; Ibrahim, Essam Hassan/G-1960-2018; bouzon, zenilda/I-6673-2012	Dutra, Rafael C/0000-0002-6938-2161; Ibrahim, Essam Hassan/0000-0003-0130-2257; calixto, joao Batista/0000-0003-4041-7153	Amazonia Fitomedicamentos Ltda.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Programa de Apoio aos Nucleos de Excelencia; Fundacao de Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina; Amazonia Fitomedicamentos	Amazonia Fitomedicamentos Ltda.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia; Fundacao de Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina; Amazonia Fitomedicamentos	This work was supported by grants from the Amazonia Fitomedicamentos Ltda., Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Programa de Apoio aos Nucleos de Excelencia and the Fundacao de Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina, all of Brazil. R. C. D., A. F. B., R. M. and E. C. S. are Ph.D. students and receiving grants from CNPq. R. F. C. holds a postdoctoral fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Luiz Francisco Pianowski is proprietor of the contract research organization Pianowski & Pianowski Ltda. He has received consulting fees from Amazonia Fitomedicamentos. In addition, Luiz F. Pianowski performed previous chemical characterization of euphol and provided it for this study. Luiz Francisco Pianowski and Joao Batista Calixto are assigned in the patent on the analgesic action of euphol as inventors. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Arulampalam V, 2002, GUT, V50, P446, DOI 10.1136/gut.50.4.446; Baert F, 2004, ACTA CLIN BELG, V59, P304, DOI 10.1179/acb.2004.045; Bani S, 2007, J ETHNOPHARMACOL, V110, P92, DOI 10.1016/j.jep.2006.09.021; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Betancur-Galvis LA, 2002, MEM I OSWALDO CRUZ, V97, P541, DOI 10.1590/S0074-02762002000400017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Chavakis T, 2002, BIOCHEM SOC T, V30, P168, DOI 10.1042/BST0300168; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COOPER HS, 1993, LAB INVEST, V69, P238; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; Cuzzocrea Salvatore, 2003, Expert Opin Emerg Drugs, V8, P339, DOI 10.1517/14728214.8.2.339; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; De Paula ML, 2008, INT IMMUNOPHARMACOL, V8, P1291, DOI 10.1016/j.intimp.2008.05.002; Dharmani Poonam, 2008, Curr Mol Pharmacol, V1, P195; Dutra R, 2011, BR J PHARM, P19; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; Frenette P S, 1996, Immunol Today, V17, P205; FRIEDMAN S, 2001, HARRISONS PRINCIPLES, P1679; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; GERDES J, 1984, J IMMUNOL, V133, P1710; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hanauer Stephen B, 2003, Rev Gastroenterol Disord, V3, P81; HECKER E, 1968, CANCER RES, V28, P2338; Hokari R, 2001, FREE RADICAL BIO MED, V31, P153, DOI 10.1016/S0891-5849(01)00565-2; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kang SY, 2008, J PHARM PHARMACOL, V60, P1347, DOI 10.1211/jpp/60.10.0011; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kimball ES, 2004, NEUROGASTROENT MOTIL, V16, P811, DOI 10.1111/j.1365-2982.2004.00549.x; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Kumar A, 2010, ECOTOX ENVIRON SAFE, V73, P1671, DOI 10.1016/j.ecoenv.2010.08.003; LEY K, 1991, BLOOD, V77, P2553; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu M, 2008, INT IMMUNOPHARMACOL, V8, P1561, DOI 10.1016/j.intimp.2008.06.011; Lucas R, 1997, J LEUKOCYTE BIOL, V61, P551, DOI 10.1002/jlb.61.5.551; Ma XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013489; Martin R, 2010, BIOCHEM PHARMACOL, V79, P198, DOI 10.1016/j.bcp.2009.08.002; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; NOLTE D, 1994, AM J PHYSIOL-HEART C, V267, pH1637, DOI 10.1152/ajpheart.1994.267.4.H1637; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Peterson CGB, 2007, SCAND J CLIN LAB INV, V67, P810, DOI 10.1080/00365510701452838; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; SANDERS WE, 1992, BLOOD, V80, P795; Sandor Z, 2006, BIOCHEM BIOPH RES CO, V350, P147, DOI 10.1016/j.bbrc.2006.09.021; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Soriano A, 2000, LAB INVEST, V80, P1541, DOI 10.1038/labinvest.3780164; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Stanley E R, 1997, Methods Mol Biol, V75, P301; Stocker CJ, 2000, J IMMUNOL, V164, P3309, DOI 10.4049/jimmunol.164.6.3309; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vestweber D, 1992, Semin Cell Biol, V3, P211; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Vitor CE, 2009, BRIT J PHARMACOL, V157, P1034, DOI 10.1111/j.1476-5381.2009.00271.x; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wallace JL, 1998, AM J PHYSIOL-GASTR L, V274, pG802, DOI 10.1152/ajpgi.1998.274.5.G802; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; WELLER A, 1992, J BIOL CHEM, V267, P15176; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Yue G, 2001, J PHARMACOL EXP THER, V297, P915; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	75	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27122	10.1371/journal.pone.0027122	http://dx.doi.org/10.1371/journal.pone.0027122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073270	Green Submitted, gold, Green Published			2022-12-27	WOS:000297154900081
J	Kawai, K; Larson, BJ; Ishise, H; Carre, AL; Nishimoto, S; Longaker, M; Lorenz, HP				Kawai, Kenichiro; Larson, Barrett J.; Ishise, Hisako; Carre, Antoine Lyonel; Nishimoto, Soh; Longaker, Michael; Lorenz, H. Peter			Calcium-Based Nanoparticles Accelerate Skin Wound Healing	PLOS ONE			English	Article							PUTATIVE NANOBACTERIA; SERUM; COMPLEXES; DIFFERENTIATION; ARTERIES; CULTURE; CANCER	Introduction: Nanoparticles (NPs) are small entities that consist of a hydroxyapatite core, which can bind ions, proteins, and other organic molecules from the surrounding environment. These small conglomerations can influence environmental calcium levels and have the potential to modulate calcium homeostasis in vivo. Nanoparticles have been associated with various calcium-mediated disease processes, such as atherosclerosis and kidney stone formation. We hypothesized that nanoparticles could have an effect on other calcium-regulated processes, such as wound healing. In the present study, we synthesized pH-sensitive calcium-based nanoparticles and investigated their ability to enhance cutaneous wound repair. Methods: Different populations of nanoparticles were synthesized on collagen-coated plates under various growth conditions. Bilateral dorsal cutaneous wounds were made on 8-week-old female Balb/c mice. Nanoparticles were then either administered intravenously or applied topically to the wound bed. The rate of wound closure was quantified. Intravenously injected nanoparticles were tracked using a FLAG detection system. The effect of nanoparticles on fibroblast contraction and proliferation was assessed. Results: A population of pH-sensitive calcium-based nanoparticles was identified. When intravenously administered, these nanoparticles acutely increased the rate of wound healing. Intravenously administered nanoparticles were localized to the wound site, as evidenced by FLAG staining. Nanoparticles increased fibroblast calcium uptake in vitro and caused contracture of a fibroblast populated collagen lattice in a dose-dependent manner. Nanoparticles also increased the rate of fibroblast proliferation. Conclusion: Intravenously administered, calcium-based nanoparticles can acutely decrease open wound size via contracture. We hypothesize that their contraction effect is mediated by the release of ionized calcium into the wound bed, which occurs when the pH-sensitive nanoparticles disintegrate in the acidic wound microenvironment. This is the first study to demonstrate that calcium-based nanoparticles can have a therapeutic benefit, which has important implications for the treatment of wounds.	[Kawai, Kenichiro; Larson, Barrett J.; Carre, Antoine Lyonel; Longaker, Michael; Lorenz, H. Peter] Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Kawai, Kenichiro; Ishise, Hisako; Nishimoto, Soh] Hyogo Coll Med, Dept Plast & Reconstruct Surg, Hyogo, Japan	Stanford University; Hyogo College of Medicine	Kawai, K (corresponding author), Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.	plorenz@stanford.edu			Oak Foundation; Plastic Surgery Education Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIGMS [R01 GM087609]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087609] Funding Source: NIH RePORTER	Oak Foundation; Plastic Surgery Education Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Oak Foundation; Plastic Surgery Education Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIGMS: R01 GM087609 (HPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altundag K, 2006, BREAST J, V12, P287, DOI 10.1111/j.1075-122X.2006.00264.x; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Featherstone JD, 1982, CARIES RES, V15, P377; Folk R L, 1992, GEOL SOC AM ANN M, V24, P104; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Huang JS, 1999, EUR J BIOCHEM, V266, P943, DOI 10.1046/j.1432-1327.1999.00932.x; Jadali A, 2010, J BIOL CHEM, V285, P23385, DOI 10.1074/jbc.M110.105619; Jelic TM, 2007, J HEART VALVE DIS, V16, P101; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; KAJANDER EO, 1997, SPIE P, V3111, P420; Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x; Limova Marketa, 2003, Ostomy Wound Manage, V49, P26; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Martel J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010343; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Motta G J, 1989, Ostomy Wound Manage, V25, P52; O'Donoghue J M, 1997, Acta Chir Plast, V39, P53; Peng HH, 2011, NANOMEDICINE-UK, V6, P643, DOI [10.2217/NNM.11.24, 10.2217/nnm.11.24]; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2010, SURGERY, V147, P181, DOI 10.1016/j.surg.2009.07.009; Schwartz MK, 2008, FASEB J, V924, P17; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Wainwright M, 1999, MICROBIOL-SGM, V145, P2623, DOI 10.1099/00221287-145-10-2623; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417	32	75	77	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27106	10.1371/journal.pone.0027106	http://dx.doi.org/10.1371/journal.pone.0027106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073267	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900079
J	Kipson, S; Fourt, M; Teixido, N; Cebrian, E; Casas, E; Ballesteros, E; Zabala, M; Garrabou, J				Kipson, Silvija; Fourt, Maia; Teixido, Nuria; Cebrian, Emma; Casas, Edgar; Ballesteros, Enric; Zabala, Mikel; Garrabou, Joaquim			Rapid Biodiversity Assessment and Monitoring Method for Highly Diverse Benthic Communities: A Case Study of Mediterranean Coralligenous Outcrops	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIP; MASS MORTALITY EVENT; MULTIVARIATE-ANALYSIS; PERMUTATION TESTS; LIGURIAN SEA; HUMAN IMPACT; ASSEMBLAGES; PATTERNS; VARIABILITY; SIMILARITY	Increasing anthropogenic pressures urge enhanced knowledge and understanding of the current state of marine biodiversity. This baseline information is pivotal to explore present trends, detect future modifications and propose adequate management actions for marine ecosystems. Coralligenous outcrops are a highly diverse and structurally complex deep-water habitat faced with major threats in the Mediterranean Sea. Despite its ecological, aesthetic and economic value, coralligenous biodiversity patterns are still poorly understood. There is currently no single sampling method that has been demonstrated to be sufficiently representative to ensure adequate community assessment and monitoring in this habitat. Therefore, we propose a rapid non-destructive protocol for biodiversity assessment and monitoring of coralligenous outcrops providing good estimates of its structure and species composition, based on photographic sampling and the determination of presence/absence of macrobenthic species. We used an extensive photographic survey, covering several spatial scales (100s of m to 100s of km) within the NW Mediterranean and including 2 different coralligenous assemblages: Paramuricea clavata (PCA) and Corallium rubrum assemblage (CRA). This approach allowed us to determine the minimal sampling area for each assemblage (5000 cm(2) for PCA and 2500 cm(2) for CRA). In addition, we conclude that 3 replicates provide an optimal sampling effort in order to maximize the species number and to assess the main biodiversity patterns of studied assemblages in variability studies requiring replicates. We contend that the proposed sampling approach provides a valuable tool for management and conservation planning, monitoring and research programs focused on coralligenous outcrops, potentially also applicable in other benthic ecosystems.	[Kipson, Silvija; Teixido, Nuria; Casas, Edgar; Garrabou, Joaquim] Inst Ciencies Mar ICM CSIC, Barcelona, Catalonia, Spain; [Fourt, Maia; Garrabou, Joaquim] Univ Aix Marseille 2, Ctr Oceanol Marseille, DIMAR CNRS, Stn Marine Endoume,UMR 6540, Marseille, France; [Kipson, Silvija] Univ Zagreb, Fac Sci, Div Biol, Zagreb 41000, Croatia; [Cebrian, Emma] Univ Girona, Dept Ciencies Ambientals, Fac Ciencies, Girona, Catalonia, Spain; [Ballesteros, Enric] Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Catalonia, Spain; [Teixido, Nuria; Zabala, Mikel] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Aix-Marseille Universite; University of Zagreb; Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Kipson, S (corresponding author), Inst Ciencies Mar ICM CSIC, Barcelona, Catalonia, Spain.	silvija.kipson@zg.htnet.hr	Fourt, Maïa/ACD-7367-2022; Cebrian, Emma/J-9640-2012; Ballesteros, Enric/K-6497-2012	Cebrian, Emma/0000-0001-7588-0135; Teixido, Nuria/0000-0001-9286-2852	Spanish International Cooperation Agency for Development (AECID); French Government (Service de cooperation et d'action culturelle); Spanish Ministry of Science and Innovation [CTM2009-08045]; Parc National de Port-Cros; French Agence Nationale pour la Recherche (ANR); Total Foundation	Spanish International Cooperation Agency for Development (AECID); French Government (Service de cooperation et d'action culturelle); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Parc National de Port-Cros; French Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Total Foundation(Total SA)	The research was funded by the Spanish International Cooperation Agency for Development (AECID) (S. Kipson, Research Fellowship 2009-11), the French Government (Service de cooperation et d'action culturelle) (S. Kipson, Fellowship 2007), the Spanish Ministry of Science and Innovation (E. Casas, Doctoral Fellowship), Parc National de Port-Cros, French Agence Nationale pour la Recherche (ANR) (MEDCHANGE Project), the Total Foundation (MedDiversa Project) and the Spanish Ministry of Science and Innovation (Biorock project ref. CTM2009-08045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunto S., 2001, BIOL MARINA MEDITERR, V8, P191; AGARDY T, 2005, MILLENNIUM ECOSYSTEM, P513; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Ballesteros E., 1986, OECOL AQUATICA, V8, P117; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bianchi C.N., 2004, BIOL MAR MEDITERR, V11, P185; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; BOHNSACK JA, 1979, B MAR SCI, V29, P242; BOUDOURESQUE C-F, 1971, Tethys, V3, P79; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CAIN STANLEY A., 1938, AMER MIDI NAT, V19, P573, DOI 10.2307/2420468; Casellato S, 2008, MAR ECOL-EVOL PERSP, V29, P321, DOI 10.1111/j.1439-0485.2008.00236.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cocito S, 2002, SCI MAR, V66, P175, DOI 10.3989/scimar.2002.66n2175; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; Ferdeghini F, 2000, HYDROBIOLOGIA, V440, P27, DOI 10.1023/A:1004124423718; Flos J, 1985, W MEDITERRANEAN, P60; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; GILI JM, 1985, PSZNI MAR ECOL, V6, P219, DOI 10.1111/j.1439-0485.1985.tb00323.x; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gili JM, 1984, ARXIUS SECCIO CIENCI, V73, P677; Gili Josep-Maria, 1992, Oecologia Aquatica, V10, P243; Giuliani S, 2005, SCI TOTAL ENVIRON, V353, P340, DOI 10.1016/j.scitotenv.2005.09.023; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Gorley C.K., 2006, GETTING STARTED PRIM; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HAWKINS SJ, 1980, ESTUAR COAST MAR SCI, V10, P201, DOI 10.1016/S0302-3524(80)80058-2; Hong J.-S., 1983, Bulletin of the Korean Fisheries Society, V16, P273; Hong J.-S., 1982, BULLETIN OF KOREA OCEAN RESEARCH & DEVELOPMENT INSTITUTE, V4, P27; Hong JS, 1980, THESIS U AIX MARSEIL; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KRONBERG I, 1987, MAR BIOL, V96, P555, DOI 10.1007/BF00397974; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA, P93; LABOREL J, 1961, STAT MAR ENDOUME REC, V23, P37; Laubier L, 1966, ANN I OCEANOGRAPHIQU, V43, P139; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; MARTIN D, 1993, ESTUAR COAST SHELF S, V36, P47, DOI 10.1006/ecss.1993.1004; Muxika I, 2007, J EXP MAR BIOL ECOL, V349, P323, DOI 10.1016/j.jembe.2007.05.026; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NIELL FX, 1977, INVEST PESQ, V41, P509; Parravicini V, 2009, ESTUAR COAST SHELF S, V81, P359, DOI 10.1016/j.ecss.2008.11.007; Parravicini V, 2010, J EXP MAR BIOL ECOL, V395, P21, DOI 10.1016/j.jembe.2010.08.005; Piazzi L, 2004, BOT MAR, V47, P105, DOI 10.1515/BOT.2004.010; Piazzi L, 2010, J NAT HIST, V44, P1, DOI 10.1080/00222930903377547; Rocchini D, 2010, J ENVIRON MONITOR, V12, P825, DOI 10.1039/b921835a; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Steinitz O, 2006, J BIOGEOGR, V33, P1044, DOI 10.1111/j.1365-2699.2006.01473.x; Teixido N, 2011, MAR ECOL PROG SER, V431, P45, DOI 10.3354/meps09127; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; True MA, 1970, B I OCEANOGR MONACO, V60, P1; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT, P21; Virgilio M, 2006, CORAL REEFS, V25, P265, DOI 10.1007/s00338-006-0100-2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEINBERG S, 1978, MAR BIOL, V49, P33, DOI 10.1007/BF00390728; ZABALA M, 1989, Scientia Marina, V53, P3	69	54	55	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27103	10.1371/journal.pone.0027103	http://dx.doi.org/10.1371/journal.pone.0027103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073264	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900078
J	Niu, R; Skliar, M				Niu, Ran; Skliar, Mikhail			Identification of Controlled-Complexity Thermal Therapy Models Derived from Magnetic Resonance Thermometry Images	PLOS ONE			English	Article							PROPER ORTHOGONAL DECOMPOSITION; KARHUNEN-LOEVE DECOMPOSITION; IN-VIVO; FOCUSED ULTRASOUND; MR THERMOMETRY; ABLATION; PHANTOM; SHIFT	Medical imaging provides information valuable in diagnosis, planning, and control of therapies. In this paper, we develop a method that uses a specific type of imaging-the magnetic resonance thermometry-to identify accurate and computationally efficient site and patient-specific computer models for thermal therapies, such as focused ultrasound surgery, hyperthermia, and thermally triggered targeted drug delivery. The developed method uses a sequence of acquired MR thermometry images to identify a treatment model describing the deposition and dissipation of thermal energy in tissues. The proper orthogonal decomposition of thermal images is first used to identify a set of empirical eigenfunctions, which captures spatial correlations in the thermal response of tissues. Using the reduced subset of eigenfunction as a functional basis, low-dimensional thermal response and the ultrasound specific absorption rate models are then identified. Once identified, the treatment models can be used to plan, optimize, and control the treatment. The developed approach is validated experimentally using the results of MR thermal imaging of a tissue phantom during focused ultrasound sonication. The validation demonstrates that our approach produces accurate low-dimensional treatment models and provides a convenient tool for balancing the accuracy of model predictions and the computational complexity of the treatment models.	[Niu, Ran; Skliar, Mikhail] Univ Utah, Dept Chem Engn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Niu, R (corresponding author), GE Global Res, Real Time Controls & Instrumentat Lab, Shanghai, Peoples R China.	mikhail.skliar@utah.edu			National Institute of Health (NIH); National Science Foundation (NSF) [RO1-CA87785, CTS 0117300]; NATIONAL CANCER INSTITUTE [R01CA087785] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the National Institute of Health (NIH) and the National Science Foundation (NSF) grants RO1-CA87785 and CTS 0117300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora D, 2006, INT J HYPERTHER, V22, P29, DOI 10.1080/02656730500412411; Arora D, 2005, PHYS MED BIOL, V50, P1919, DOI 10.1088/0031-9155/50/8/019; Chato JC, 1998, ANN NY ACAD SCI, V858, P1, DOI 10.1111/j.1749-6632.1998.tb10135.x; Holmes P., 1996, TURBULENCE COHERENT; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Ljung L., 1999, SYSTEM IDENTIFICATIO; Madsen EL, 1998, ULTRASOUND MED BIOL, V24, P535, DOI 10.1016/S0301-5629(98)00013-1; Niu R, 2005, P AMER CONTR CONF, P3241, DOI 10.1109/ACC.2005.1470471; Niu R., IEEE T MED IMA UNPUB; Palussiere J, 2003, MAGNET RESON MED, V49, P89, DOI 10.1002/mrm.10328; Park HM, 1996, CHEM ENG SCI, V51, P81, DOI 10.1016/0009-2509(95)00230-8; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Peters RD, 1998, MAGNET RESON MED, V40, P454, DOI 10.1002/mrm.1910400316; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Sirovich L, 1991, NEW PERSPECTIVES TUR; Smith NB, 2001, INT J HYPERTHER, V17, P271, DOI 10.1080/02656730010025841; Uenohara M, 1997, IEEE T PATTERN ANAL, V19, P891, DOI 10.1109/34.608291; Weidensteiner C, 2003, MAGNET RESON MED, V50, P322, DOI 10.1002/mrm.10521	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26830	10.1371/journal.pone.0026830	http://dx.doi.org/10.1371/journal.pone.0026830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073204	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900043
J	Sanguinetti-Scheck, JI; Pedraja, EF; Cilleruelo, E; Migliaro, A; Aguilera, P; Caputi, AA; Budelli, R				Ignacio Sanguinetti-Scheck, Juan; Federico Pedraja, Eduardo; Cilleruelo, Esteban; Migliaro, Adriana; Aguilera, Pedro; Ariel Caputi, Angel; Budelli, Ruben			Fish Geometry and Electric Organ Discharge Determine Functional Organization of the Electrosensory Epithelium	PLOS ONE			English	Article							GYMNOTUS-CARAPO; GNATHONEMUS-PETERSII; WAVE-FORM; APTERONOTUS-LEPTORHYNCHUS; ACTIVE ELECTROLOCATION; OBJECTS; IMAGE; ELECTRORECEPTION; DISTANCE; PERCEPTION	Active electroreception in Gymnotus omarorum is a sensory modality that perceives the changes that nearby objects cause in a self generated electric field. The field is emitted as repetitive stereotyped pulses that stimulate skin electroreceptors. Differently from mormyriformes electric fish, gymnotiformes have an electric organ distributed along a large portion of the body, which fires sequentially. As a consequence shape and amplitude of both, the electric field generated and the image of objects, change during the electric pulse. To study how G. omarorum constructs a perceptual representation, we developed a computational model that allows the determination of the self-generated field and the electric image. We verify and use the model as a tool to explore image formation in diverse experimental circumstances. We show how the electric images of objects change in shape as a function of time and position, relative to the fish's body. We propose a theoretical framework about the organization of the different perceptive tasks made by electroreception: 1) At the head region, where the electrosensory mosaic presents an electric fovea, the field polarizing nearby objects is coherent and collimated. This favors the high resolution sampling of images of small objects and perception of electric color. Besides, the high sensitivity of the fovea allows the detection and tracking of large faraway objects in rostral regions. 2) In the trunk and tail region a multiplicity of sources illuminate different regions of the object, allowing the characterization of the shape and position of a large object. In this region, electroreceptors are of a unique type and capacitive detection should be based in the pattern of the afferents response. 3) Far from the fish, active electroreception is not possible but the collimated field is suitable to be used for electrocommunication and detection of large objects at the sides and caudally.	[Ignacio Sanguinetti-Scheck, Juan; Federico Pedraja, Eduardo; Migliaro, Adriana; Budelli, Ruben] Univ Republica, Dept Biol Celular & Mol, Fac Ciencias, Montevideo, Uruguay; [Cilleruelo, Esteban; Aguilera, Pedro; Ariel Caputi, Angel] Inst Invest Biol Clemente Estable, Dept Neurociencias Integrat, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Sanguinetti-Scheck, JI (corresponding author), Univ Republica, Dept Biol Celular & Mol, Fac Ciencias, Montevideo, Uruguay.	rbudelli@gmail.com	Pedraja, Federico/GMX-0979-2022	Sanguinetti-Scheck, Juan Ignacio/0000-0002-2511-208X	European Union; CSIC (Universidad de la Republica Oriental del Uruguay); Dinacyt (Uruguay)	European Union(European Commission); CSIC (Universidad de la Republica Oriental del Uruguay); Dinacyt (Uruguay)	We received grants from the 7th Frame Program of the European Union (to Ruben Budelli and Angel Caputi) as a part of ANGELS project (http://www.theangelsproject.eu), CSIC (Universidad de la Republica Oriental del Uruguay, to Ruben Budelli) and the Dinacyt (Uruguay, to Ruben Budelli). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; ASSAD C, 1997, ELECT FIELD MAPS BOU; Babineau D, 2007, PLOS COMPUT BIOL, V3, P402, DOI 10.1371/journal.pcbi.0030038; Babineau D, 2006, J EXP BIOL, V209, P3636, DOI 10.1242/jeb.02403; Budelli R, 2000, J EXP BIOL, V203, P481; Budelli R, 2002, J PHYSIOLOGY-PARIS, V96, P421, DOI 10.1016/S0928-4257(03)00020-2; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; CAPUTI A, 1993, J COMP PHYSIOL A, V173, P227; CAPUTI A, 1994, BRAIN BEHAV EVOLUT, V44, P166, DOI 10.1159/000113588; Caputi AA, 2006, J COMP PHYSIOL A, V192, P587, DOI 10.1007/s00359-006-0100-2; Caputi AA, 1998, J EXP BIOL, V201, P2115; Caputi AA, 2008, J PHYSIOL-PARIS, V102, P256, DOI 10.1016/j.jphysparis.2008.10.005; Castello ME, 2000, J EXP BIOL, V203, P3279; Einthoven W, 1912, LANCET, V1, P853; HEILIGENBERG W, 1973, J COMP PHYSL, V87; Hopkins CD, 1995, CURR OPIN NEUROBIOL, V5, P769, DOI 10.1016/0959-4388(95)80105-7; LISSMANN HW, 1958, J EXP BIOL, V35, P457; Migliaro A, 2005, PLOS COMPUT BIOL, V1, P123, DOI 10.1371/journal.pcbi.0010016; PEREIRA AC, INTERDISCIP SCI, V2, P291; Rasnow B, 1996, J COMP PHYSIOL A, V178, P383; RASNOW B, 1993, J COMP PHYSIOL A, V172, P481, DOI 10.1007/BF00213530; Rasnow B, 1996, J COMP PHYSIOL A, V178, P397; Rodriguez-Cattaneo A, 2009, J EXP BIOL, V212, P3478, DOI 10.1242/jeb.033217; Rother D, 2003, BIOSYSTEMS, V71, P169, DOI 10.1016/S0303-2647(03)00124-2; von der Emde G, 2004, J PHYSIOLOGY-PARIS, V98, P67, DOI 10.1016/j.jphysparis.2004.03.013; von der Emde G, 2002, J PHYSIOLOGY-PARIS, V96, P431, DOI 10.1016/S0928-4257(03)00021-4; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; von der Emde G, 2007, J EXP BIOL, V210, P3082, DOI 10.1242/jeb.005694; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576; WATSON D, 1979, J COMP PHYSIOL, V134, P191, DOI 10.1007/BF00610394	30	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27470	10.1371/journal.pone.0027470	http://dx.doi.org/10.1371/journal.pone.0027470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096578	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900048
J	Le Marechal, C; Seyffert, N; Jardin, J; Hernandez, D; Jan, G; Rault, L; Azevedo, V; Francois, P; Schrenzel, J; van de Guchte, M; Even, S; Berkova, N; Thiery, R; Fitzgerald, JR; Vautor, E; Le Loir, Y				Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Hernandez, David; Jan, Gwenael; Rault, Lucie; Azevedo, Vasco; Francois, Patrice; Schrenzel, Jacques; van de Guchte, Maarten; Even, Sergine; Berkova, Nadia; Thiery, Richard; Fitzgerald, J. Ross; Vautor, Eric; Le Loir, Yves			Molecular Basis of Virulence in Staphylococcus aureus Mastitis	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; HORIZONTAL GENE-TRANSFER; ANTIBODY-RESPONSE; STAPHOPAIN-B; ALPHA-TOXINS; BETA-TOXINS; METHICILLIN; IDENTIFICATION; EXPRESSION; COMMUNITY	Background: S. aureus is one of the main pathogens involved in ruminant mastitis worldwide. The severity of staphylococcal infection is highly variable, ranging from subclinical to gangrenous mastitis. This work represents an in-depth characterization of S. aureus mastitis isolates to identify bacterial factors involved in severity of mastitis infection. Methodology/Principal Findings: We employed genomic, transcriptomic and proteomic approaches to comprehensively compare two clonally related S. aureus strains that reproducibly induce severe (strain O11) and milder (strain O46) mastitis in ewes. Variation in the content of mobile genetic elements, iron acquisition and metabolism, transcriptional regulation and exoprotein production was observed. In particular, O11 produced relatively high levels of exoproteins, including toxins and proteases known to be important in virulence. A characteristic we observed in other S. aureus strains isolated from clinical mastitis cases. Conclusions/Significance: Our data are consistent with a dose-dependant role of some staphylococcal factors in the hypervirulence of strains isolated from severemastitis. Mobile genetic elements, transcriptional regulators, exoproteins and iron acquisition pathways constitute good targets for further research to define the underlying mechanisms of mastitis severity.	[Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Jan, Gwenael; Rault, Lucie; Even, Sergine; Berkova, Nadia; Le Loir, Yves] INRA, UMR1253, F-35042 Rennes, France; [Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Jan, Gwenael; Rault, Lucie; Even, Sergine; Berkova, Nadia; Le Loir, Yves] I CEuf, Rennes, France; [Le Marechal, Caroline; Seyffert, Nubia; Jardin, Julien; Jan, Gwenael; Rault, Lucie; Even, Sergine; Berkova, Nadia; Le Loir, Yves] AGROCAMPUS OUEST, UMR1253, Rennes, France; [Le Marechal, Caroline; Thiery, Richard; Vautor, Eric] ANSES, Lab Sophia Antipolis, Unite Pathol Ruminants, Sophia Antipolis, France; [Seyffert, Nubia; Azevedo, Vasco] Univ Fed Minas Gerais UFMG, Inst Ciencias Biol ICB, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Hernandez, David; Francois, Patrice; Schrenzel, Jacques] Univ Geneva Hosp HUG, Genom Res Lab, Infect Dis Serv, Geneva, Switzerland; [van de Guchte, Maarten] INRA, MICALIS, UMR1319, Jouy En Josas, France; [Fitzgerald, J. Ross] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Fitzgerald, J. Ross] Univ Edinburgh, Royal Dick Sch Vet Studies, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland	INRAE; Institut Agro; Agrocampus Ouest; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sophia-Antipolis; Universidade Federal de Minas Gerais; University of Geneva; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Le Marechal, C (corresponding author), INRA, UMR1253, F-35042 Rennes, France.	Yves.LeLoir@rennes.inra.fr	Schrenzel, Jacques/P-8525-2017; Jan, Gwenael/K-6767-2014; LE LOIR, Yves/AAD-1879-2021; Schrenzel, Jacques/AAC-5685-2021; Seyffert, Nubia/N-6410-2014; JARDIN, Julien/A-3241-2012; Azevedo, Vasco A.C/F-4315-2011; francois, patrice/AAL-5583-2020; Azevedo, Vasco/B-1556-2019; Thiery, Richard/GRR-1496-2022	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Seyffert, Nubia/0000-0002-2193-6508; JARDIN, Julien/0000-0003-0520-9391; Azevedo, Vasco A.C/0000-0002-4775-2280; Azevedo, Vasco/0000-0002-4775-2280; francois, patrice/0000-0002-0540-750X; Le Loir, Yves/0000-0002-0355-1065; Berkova, Nadia/0000-0001-6246-5549; Thiery, Richard/0000-0003-2049-918X	Biotechnology and Biological Sciences Research Council [BB/D521222/1] Funding Source: Medline; BBSRC [BB/D521222/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ADLAM C, 1977, INFECT IMMUN, V17, P250, DOI 10.1128/IAI.17.2.250-256.1977; Attia AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000802; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diarra MS, 2002, J DAIRY SCI, V85, P2141, DOI 10.3168/jds.S0022-0302(02)74292-6; Dorrell N, 2005, CURR OPIN MICROBIOL, V8, P620, DOI 10.1016/j.mib.2005.08.012; Dumas E, 2008, APPL ENVIRON MICROB, V74, P7399, DOI 10.1128/AEM.00594-08; Duquenne M, 2010, APPL ENVIRON MICROB, V76, P1367, DOI 10.1128/AEM.01736-09; Even S, 2010, INT J FOOD MICROBIOL, V139, P87, DOI 10.1016/j.ijfoodmicro.2010.02.019; Even S, 2009, APPL ENVIRON MICROB, V75, P4459, DOI 10.1128/AEM.02388-08; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Goji N, 2004, VET MICROBIOL, V99, P269, DOI 10.1016/j.vetmic.2003.12.009; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Grumann D, 2008, J IMMUNOL, V181, P5054, DOI 10.4049/jimmunol.181.7.5054; Guinane CM, 2008, J INFECT DIS, V197, P205, DOI 10.1086/524689; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Halasa T, 2009, LIVEST SCI, V124, P295, DOI 10.1016/j.livsci.2009.02.019; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; JETT M, 1990, INFECT IMMUN, V58, P3494, DOI 10.1128/IAI.58.11.3494-3499.1990; JONES TO, 1986, VET REC, V119, P435, DOI 10.1136/vr.119.17.435; JONSSON P, 1985, INFECT IMMUN, V49, P765, DOI 10.1128/IAI.49.3.765-769.1985; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le Marechal C, 2009, J MICROBIOL METH, V79, P131, DOI 10.1016/j.mimet.2009.08.017; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Le Marechal C, 2011, J BACTERIOL, V193, P2353, DOI 10.1128/JB.00045-11; Le Marechal C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-35; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; LELOIR Y, 1994, J BACTERIOL, V176, P5135, DOI 10.1128/jb.176.16.5135-5139.1994; Lorenz U, 2000, FEMS IMMUNOL MED MIC, V29, P145, DOI 10.1111/j.1574-695X.2000.tb01517.x; MATSUNAGA T, 1993, J VET MED SCI, V55, P297, DOI 10.1292/jvms.55.297; Nickerson NN, 2007, J BIOL CHEM, V282, P34129, DOI 10.1074/jbc.M705672200; Nimmo GR, 2006, MED J AUSTRALIA, V184, P384, DOI 10.5694/j.1326-5377.2006.tb00287.x; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Oscarsson J, 2006, INT J MED MICROBIOL, V296, P365, DOI 10.1016/j.ijmm.2006.02.019; Park SA, 2006, PROTEOMICS, V6, P1319, DOI 10.1002/pmic.200500293; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Rainard P, 2007, VET RES, V38, P685, DOI 10.1051/vetres:2007026; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Shevchenko Anna, 2003, Methods Mol Biol, V211, P221; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smagur J, 2009, J INNATE IMMUN, V1, P98, DOI 10.1159/000181014; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Stenz L, 2008, FEMS MICROBIOL LETT, V287, P149, DOI 10.1111/j.1574-6968.2008.01316.x; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; Trivier D, 1996, FEMS MICROBIOL LETT, V141, P117, DOI 10.1111/j.1574-6968.1996.tb08373.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vautor E, 2003, VET MICROBIOL, V96, P69, DOI 10.1016/S0378-1135(03)00207-4; Vautor E, 2009, VET MICROBIOL, V133, P105, DOI 10.1016/j.vetmic.2008.06.006; Vautor E, 2009, VET RES, V40, DOI 10.1051/vetres/2009039; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; WARD PD, 1979, J COMP PATHOL, V89, P169, DOI 10.1016/0021-9975(79)90056-2; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313; Zollner TM, 2000, CLIN EXP ALLERGY, V30, P994	72	55	56	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27354	10.1371/journal.pone.0027354	http://dx.doi.org/10.1371/journal.pone.0027354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096559	Green Submitted, Green Published, gold			2022-12-27	WOS:000297553900035
J	Liu, SB; Qiao, LP; He, HL; Zhang, Q; Chen, XL; Zhou, WZ; Zhou, BC; Zhang, YZ				Liu, Sheng-Bo; Qiao, Li-Ping; He, Hai-Lun; Zhang, Qian; Chen, Xiu-Lan; Zhou, Wei-Zhi; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Optimization of Fermentation Conditions and Rheological Properties of Exopolysaccharide Produced by Deep-Sea Bacterium Zunongwangia profunda SM-A87	PLOS ONE			English	Article							HYDROTHERMAL VENTS; GUM; ENVIRONMENTS; GROWTH; CARBON; ICE; EPS	Zunongwangia profunda SM-A87 isolated from deep-sea sediment can secrete large quantity of exopolysaccharide (EPS). Response surface methodology was applied to optimize the culture conditions for EPS production. Single-factor experiment showed that lactose was the best carbon source. Based on the Plackett-Burman design, lactose, peptone and temperature were selected as significant variables, which were further optimized by the steepest ascent (descent) method and central composite design. The optimal culture conditions for EPS production and broth viscosity were determined as 32.21 g/L lactose, 8.87 g/L peptone and an incubation temperature of 9.8 degrees C. Under these conditions, the maximum EPS yield and broth viscosity were 8.90 g/L and 6551 mPa.s, respectively, which is the first report of such high yield of EPS from a marine bacterium. The aqueous solution of the EPS displayed high viscosity, interesting shearing thinning property and great tolerance to high temperature, a wide range of pH, and high salinity.	[Liu, Sheng-Bo; Qiao, Li-Ping; He, Hai-Lun; Zhang, Qian; Chen, Xiu-Lan; Zhou, Wei-Zhi; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Liu, SB (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn			National Natural Science Foundation of China [31025001, 40876072, 31070061]; Hi-Tech Research and Development program of China [2011AA090703]; Natural Science Foundation of Shandong Province, China [JQ200910, ZR2009DZ002]; Foundation for Young Excellent Scientists in Shandong Province, China [2007BS07007, BS2010SW015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Foundation for Young Excellent Scientists in Shandong Province, China	The work was supported by National Natural Science Foundation of China (31025001, 40876072, 31070061), Hi-Tech Research and Development program of China (2011AA090703), Natural Science Foundation of Shandong Province, China (JQ200910, ZR2009DZ002), Foundation for Young Excellent Scientists in Shandong Province, China (2007BS07007, BS2010SW015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achi OK, 2004, INT J FOOD SCI TECH, V39, P431, DOI 10.1111/j.1365-2621.2004.00801.x; Bramhachari PV, 2007, J MICROBIOL BIOTECHN, V17, P44; CONTI E, 1994, MICROBIOL-UK, V140, P1125, DOI 10.1099/13500872-140-5-1125; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; DREVETON E, 1994, J FERMENT BIOENG, V77, P642, DOI 10.1016/0922-338X(94)90147-3; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ENRIQUEZ LG, 1989, FOOD EMULSIFIERS CHE, P335; Guezennec J, 2002, J IND MICROBIOL BIOT, V29, P204, DOI 10.1038/sj.jim.7000298; Gutierrez T, 2009, BIOTECHNOL BIOENG, V103, P207, DOI 10.1002/bit.22218; JANNASCH HW, 1984, ANNU REV MICROBIOL, V38, P487, DOI 10.1146/annurev.mi.38.100184.002415; Katzbauer B, 1998, POLYM DEGRAD STABIL, V59, P81, DOI 10.1016/S0141-3910(97)00180-8; KOJIC M, 1992, APPL ENVIRON MICROB, V58, P4086, DOI 10.1128/AEM.58.12.4086-4088.1992; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Lampitt RS, 1997, DEEP-SEA RES PT I, V44, P1377, DOI 10.1016/S0967-0637(97)00020-4; Li HP, 2011, CARBOHYD POLYM, V84, P1117, DOI 10.1016/j.carbpol.2010.12.072; Li X, 2008, BIORESOURCE TECHNOL, V99, P5391, DOI 10.1016/j.biortech.2007.11.017; Lopez MJ, 2004, J FOOD ENG, V63, P111, DOI 10.1016/S0260-8774(03)00289-9; Maugeri TL, 2002, BIOTECHNOL LETT, V24, P515, DOI 10.1023/A:1014891431233; Miqueleto AP, 2010, BIORESOURCE TECHNOL, V101, P1324, DOI 10.1016/j.biortech.2009.09.026; Moriello VS, 2003, J IND MICROBIOL BIOT, V30, P95, DOI 10.1007/s10295-002-0019-8; MORIN A, 1998, POLYSACCHARIDES STRU, P275; Muralidhar RV, 2001, BIOCHEM ENG J, V9, P17, DOI 10.1016/S1369-703X(01)00117-6; Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2; Nichols CM, 2005, APPL ENVIRON MICROB, V71, P3519, DOI 10.1128/AEM.71.7.3519-3523.2005; Nicolaus B, 2002, SYST APPL MICROBIOL, V25, P319, DOI 10.1078/0723-2020-00128; Papinutti L, 2010, BIORESOURCE TECHNOL, V101, P1941, DOI 10.1016/j.biortech.2009.09.076; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; Qin QL, 2007, FEMS MICROBIOL LETT, V271, P53, DOI 10.1111/j.1574-6968.2007.00694.x; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; QIN QL, 2010, ISME J; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Sahan T, 2010, BIORESOURCE TECHNOL, V101, P4520, DOI 10.1016/j.biortech.2010.01.105; Saravanan P, 2008, LETT APPL MICROBIOL, V46, P1, DOI 10.1111/j.1472-765X.2007.02215.x; Satpute SK, 2010, BIOTECHNOL ADV, V28, P436, DOI 10.1016/j.biotechadv.2010.02.006; Song XY, 2007, J BIOTECHNOL, V131, P209, DOI 10.1016/j.jbiotec.2007.06.012; STAUDT AK, 2011, ARCH MICROB IN PRESS; Sutherland I W, 1972, Adv Microb Physiol, V8, P143, DOI 10.1016/S0065-2911(08)60190-3; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; Turley CM, 2002, DEEP-SEA RES PT I, V49, P815, DOI 10.1016/S0967-0637(01)00080-2; Velasco SE, 2009, J AGR FOOD CHEM, V57, P1827, DOI 10.1021/jf803065w; VINCENT P, 1994, APPL ENVIRON MICROB, V60, P4134, DOI 10.1128/AEM.60.11.4134-4141.1994; Wang X, 2007, J BIOTECHNOL, V128, P403, DOI 10.1016/j.jbiotec.2006.09.019; Wang X, 2006, APPL ENVIRON MICROB, V72, P3367, DOI 10.1128/AEM.72.5.3367-3374.2006; Xu H, 2008, BIOCHEM ENG J, V39, P66, DOI 10.1016/j.bej.2007.08.013; Zakaria MB, 1996, CARBOHYD POLYM, V29, P25, DOI 10.1016/0144-8617(95)00132-8; Zhao Y, 2006, J APPL POLYM SCI, V102, P2616, DOI 10.1002/app.23991; Zhou WZ, 2009, COLLOID SURFACE B, V72, P295, DOI 10.1016/j.colsurfb.2009.04.018; Zhou WW, 2010, BIOPROC BIOSYST ENG, V33, P657, DOI 10.1007/s00449-009-0330-0	49	41	44	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26825	10.1371/journal.pone.0026825	http://dx.doi.org/10.1371/journal.pone.0026825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096500	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900010
J	Lottaz, D; Maurer, CA; Noel, A; Blacher, S; Huguenin, M; Nievergelt, A; Niggli, V; Kern, A; Muller, S; Seibold, F; Friess, H; Becker-Pauly, C; Stocker, W; Sterchi, EE				Lottaz, Daniel; Maurer, Christoph A.; Noel, Agnes; Blacher, Silvia; Huguenin, Maya; Nievergelt, Alexandra; Niggli, Verena; Kern, Alexander; Mueller, Stefan; Seibold, Frank; Friess, Helmut; Becker-Pauly, Christoph; Stoecker, Walter; Sterchi, Erwin E.			Enhanced Activity of Meprin-alpha, a Pro-Migratory and Pro-Angiogenic Protease, in Colorectal Cancer	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; HYDROLASE HUMAN MEPRIN; METALLOPROTEASE MEPRIN; BETA-SUBUNITS; MATRIX METALLOPROTEINASES; RECEPTOR EXPRESSION; EPITHELIAL-CELLS; PABA PEPTIDE; IN-VITRO; UROKINASE	Meprin-alpha is a metalloprotease overexpressed in cancer cells, leading to the accumulation of this protease in a subset of colorectal tumors. The impact of increased Meprin-alpha levels on tumor progression is not known. We investigated the effect of this protease on cell migration and angiogenesis in vitro and studied the expression of Meprin-alpha mRNA, protein and proteolytic activity in primary tumors at progressive stages and in liver metastases of patients with colorectal cancer, as well as inhibitory activity towards Meprin-alpha in sera of cancer patient as compared to healthy controls. We found that the hepatocyte growth factor (HGF)-induced migratory response of meprin-transfected epithelial cells was increased compared to wild-type cells in the presence of plasminogen, and that the angiogenic response in organ-cultured rat aortic explants was enhanced in the presence of exogenous human Meprin-alpha. In patients, Meprin-alpha mRNA was expressed in colonic adenomas, primary tumors UICC (International Union Against Cancer) stage I, II, III and IV, as well as in liver metastases. In contrast, the corresponding protein accumulated only in primary tumors and liver metastases, but not in adenomas. However, liver metastases lacked Meprin-alpha activity despite increased expression of the corresponding protein, which correlated with inefficient zymogen activation. Sera from cancer patients exhibited reduced Meprin-alpha inhibition compared to healthy controls. In conclusion, Meprin-alpha activity is regulated differently in primary tumors and metastases, leading to high proteolytic activity in primary tumors and low activity in liver metastases. By virtue of its pro-migratory and pro-angiogenic activity, Meprin-alpha may promote tumor progression in colorectal cancer.	[Lottaz, Daniel] Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Huguenin, Maya; Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Maurer, Christoph A.] Kantonsspital Liestal, Dept Surg, CH-4410 Liestal, Switzerland; [Noel, Agnes; Blacher, Silvia] Univ Liege, Lab Biol Tumor & Dev, Grp Interdisciplinaire Genoprote Appl Rech GIGA C, Liege, Belgium; [Nievergelt, Alexandra; Niggli, Verena] Univ Bern, Inst Pathol, Bern, Switzerland; [Kern, Alexander] Tech Univ Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Mueller, Stefan; Seibold, Frank] Univ Bern, Dept Gastroenterol, Bern, Switzerland; [Friess, Helmut] Tech Univ Munich, Dept Surg, Munich, Germany; [Becker-Pauly, Christoph] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany	University of Bern; University Hospital of Bern; University of Bern; Kantonsspital Baselland; University of Liege; University of Bern; Technische Universitat Dresden; University of Bern; Technical University of Munich; Johannes Gutenberg University of Mainz	Lottaz, D (corresponding author), Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland.	daniel.lottaz@insel.ch; erwin.sterchi@ibmm.unibe.ch	Becker-Pauly, Christoph/B-7569-2011; Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994; Noel, Agnes/0000-0002-7670-6179	Swiss National Foundation [3100A0-100772]; Bernese Cancer League; Deutsche Forschungsgemeinschaft (DFG) [BE 4086/1-1]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Bernese Cancer League; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Swiss National Foundation (www.snf.ch, grant #3100A0-100772 to EES), the Bernese Cancer League (www.bernischekrebsliga.ch, grant to DL) and the Deutsche Forschungsgemeinschaft (www.dfg.de, DFG BE 4086/1-1 to CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; DELBALDO C, 1995, CANCER RES, V55, P4688; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Hahn D, 2000, BIOCHEM J, V346, P83, DOI 10.1042/0264-6021:3460083; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Hirano M, 2005, J IMMUNOL, V175, P3177, DOI 10.4049/jimmunol.175.5.3177; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Illemann M, 2006, MOL CANCER RES, V4, P293, DOI 10.1158/1541-7786.MCR-06-0003; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; JEFFERSON T, 2011, J BIOL CHEM; Jiang WP, 2000, GENE, V248, P77, DOI 10.1016/S0378-1119(00)00143-8; KAUSHAL GP, 1994, J CELL BIOL, V126, P1319, DOI 10.1083/jcb.126.5.1319; Keller HU, 2000, INT J CANCER, V88, P195, DOI 10.1002/1097-0215(20001015)88:2<195::AID-IJC8>3.0.CO;2-W; Khan KMF, 2002, J BIOL CHEM, V277, P13778, DOI 10.1074/jbc.M111290200; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; MULCAHY HE, 1994, LANCET, V344, P583, DOI 10.1016/S0140-6736(94)91968-2; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; PEPPER MS, 1992, J BIOL CHEM, V267, P20493; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; SIER CFM, 1991, GASTROENTEROLOGY, V101, P1522, DOI 10.1016/0016-5085(91)90387-Z; SIER CFM, 1994, GASTROENTEROLOGY, V107, P1449, DOI 10.1016/0016-5085(94)90549-5; STERCHI EE, 1983, J PEDIATR GASTR NUTR, V2, P539, DOI 10.1097/00005176-198302030-00024; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Tait CR, 2004, J PATHOL, V203, P515, DOI 10.1002/path.1544; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	45	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26450	10.1371/journal.pone.0026450	http://dx.doi.org/10.1371/journal.pone.0026450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096485	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900004
J	Beyers, RL; Hart, JA; Sinclair, ARE; Grossmann, F; Klinkenberg, B; Dino, S				Beyers, Rene L.; Hart, John A.; Sinclair, Anthony R. E.; Grossmann, Falk; Klinkenberg, Brian; Dino, Simeon			Resource Wars and Conflict Ivory: The Impact of Civil Conflict on Elephants in the Democratic Republic of Congo - The Case of the Okapi Reserve	PLOS ONE			English	Article							FOREST ELEPHANT; LOXODONTA-AFRICANA; WILDLIFE; CONSERVATION; DETERMINES; MOVEMENTS; STRIFE	Human conflict generally has substantial negative impacts on wildlife and conservation. The recent civil war (1995-2006) in the Democratic Republic of Congo (DRC) resulted in a significant loss of wildlife, including elephants, due to institutional collapse, lawlessness and unbridled exploitation of natural resources such as minerals, wood, ivory and bushmeat. We used data from distance sampling surveys conducted before and after the war in a protected forest, the Okapi Faunal Reserve, to document changes in elephant abundance and distribution. We employed Generalized Additive Models to relate changes in elephant distribution to human and environmental factors. Populations declined by nearly fifty percent coinciding with a major increase in elephant poaching as indicated by reports of ivory trade during the war. Our results suggest that humans influenced elephant distribution far more than habitat, both before and after the war, but post-war models explained more of the variation. Elephant abundance declined more, closer to the park boundary and to areas of intense human activity. After the war, elephant densities were relatively higher in the centre of the park where they were better protected, suggesting that this area may have acted as a refuge. In other sites in Eastern DRC, where no protection was provided, elephants were even more decimated. Post-war dynamics, such as weakened institutions, human movements and availability of weapons, continue to affect elephants. Survival of remaining populations and recovery will be determined by these persistent factors and by new threats associated with growing human populations and exploitation of natural resources. Prioritizing wildlife protection, curbing illegal trade in ivory and bushmeat, and strengthening national institutions and organizations in charge of conservation will be crucial to counter these threats.	[Beyers, Rene L.; Sinclair, Anthony R. E.] Univ British Columbia, Beatty Biodivers Ctr, Vancouver, BC V5Z 1M9, Canada; [Hart, John A.; Dino, Simeon] Tshuapa Lomami Lualaba Project TL2, Kinshasa, DEM REP CONGO; [Grossmann, Falk] Wildlife Conservat Soc, Africa Programs, New York, NY USA; [Klinkenberg, Brian] Univ British Columbia, Dept Geog, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Wildlife Conservation Society; University of British Columbia	Beyers, RL (corresponding author), Univ British Columbia, Beatty Biodivers Ctr, Vancouver, BC V5Z 1M9, Canada.	beyers@zoology.ubc.ca			United States Fish and Wildlife Service (USFWS); United States Agency for International Development; United Nations Educational, Scientific and Cultural Organization (UNESCO); Institut Congolais pour la Conservation de la Nature (ICCN); Wildlife Conservation Society (WCS)	United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); United States Agency for International Development(United States Agency for International Development (USAID)); United Nations Educational, Scientific and Cultural Organization (UNESCO); Institut Congolais pour la Conservation de la Nature (ICCN); Wildlife Conservation Society (WCS)	This work was funded by the United States Fish and Wildlife Service (USFWS), the United States Agency for International Development, Central African Regional Program (USAID/CARPE), the United Nations Educational, Scientific and Cultural Organization (UNESCO), the Institut Congolais pour la Conservation de la Nature (ICCN) and the Wildlife Conservation Society (WCS). The views expressed here do not necessarily represent those of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALERS MPT, 1992, AFR J ECOL, V30, P279, DOI 10.1111/j.1365-2028.1992.tb00504.x; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; BARNES RFW, 1995, J TROP ECOL, V11, P27, DOI 10.1017/S0266467400008361; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; BLANC JJ, 2007, 33 IUCN SPEC SURV CO; Blom A, 2004, AFR J ECOL, V42, P23, DOI 10.1111/j.0141-6707.2004.00441.x; BRAECKMAN C, 2009, MONDE DIPLOMATIQ SEP, P11; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; de Merode E, 2007, BIOL LETTERS, V3, P299, DOI 10.1098/rsbl.2007.0010; DEWEERDT S, 2008, WORLD WATCH MAGAZINE; Donovan D., 2007, Extreme conflict and tropical forests, P1; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Dudley JP, 2002, CONSERV BIOL, V16, P319, DOI 10.1046/j.1523-1739.2002.00306.x; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Hall JS, 1997, AFR J ECOL, V35, P213, DOI 10.1111/j.1365-2028.1997.088-89088.x; Hanson T, 2009, CONSERV BIOL, V23, P578, DOI 10.1111/j.1523-1739.2009.01166.x; Hart JA, 1996, CONSERV BIOL, V10, P316, DOI 10.1046/j.1523-1739.1996.10020316.x; Hart T, 1997, CONSERV BIOL, V11, P308, DOI 10.1046/j.1523-1739.1997.011002308.x; Hart T., 2001, ARMED CONFLICT BIODI; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; HART TB, 1994, BIODIVERSITY AFRICAN; HASTIE T. J., 1990, MONOGRAPHS STAT APPL, V43; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hunter Nigel, 2004, Pachyderm, V36, P116; Johnston K., 2001, USING ARCGIS GEOSTAT; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; McNeely J. A., 2007, Extreme conflict and tropical forests, P159; Mubalama Leonard, 2001, Pachyderm, V31, P36; Nchanji AC, 2001, AFR J ECOL, V39, P24, DOI 10.1046/j.1365-2028.2001.00265.x; Plumptre A, 2000, SCIENCE, V288, P617; PLUMPTRE A, 2001, IMPACT GUERRE CIVILE; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; TCHAMBA MN, 1992, MAMMALIA, V56, P155; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; White L.J.T., 2000, CONSERVATION RES AFR; WILKIE DS, 1988, ECOL MODEL, V41, P307, DOI 10.1016/0304-3800(88)90034-8; Wilkie DS, 1998, ORYX, V32, P131, DOI 10.1017/S0030605300029872; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980	46	51	52	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27129	10.1371/journal.pone.0027129	http://dx.doi.org/10.1371/journal.pone.0027129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096529	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800030
J	De Neys, W; Novitskiy, N; Geeraerts, L; Ramautar, J; Wagemans, J				De Neys, Wim; Novitskiy, Nikolay; Geeraerts, Leen; Ramautar, Jennifer; Wagemans, Johan			Cognitive Control and Individual Differences in Economic Ultimatum Decision-Making	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PREFRONTAL CORTEX; WORKING-MEMORY; GO/NOGO TASK; GAME; INHIBITION; UNFAIRNESS; FAIRNESS; STIMULATION; COMPONENTS	Much publicity has been given to the fact that people's economic decisions often deviate from the rational predictions of standard economic models. In the classic ultimatum game, for example, most people turn down financial gains by rejecting unequal monetary splits. The present study points to neglected individual differences in this debate. After participants played the ultimatum game we tested for individual differences in cognitive control capacity of the most and least economic responders. The key finding was that people who were higher in cognitive control, as measured by behavioral (Go/No-Go performance) and neural (No-Go N2 amplitude) markers, did tend to behave more in line with the standard models and showed increased acceptance of unequal splits. Hence, the cognitively highest scoring decision-makers were more likely to maximize their monetary payoffs and adhere to the standard economic predictions. Findings question popular claims with respect to the rejection of standard economic models and the irrationality of human economic decision-making.	[Novitskiy, Nikolay; Wagemans, Johan] Univ Leuven, Expt Psychol Lab, Louvain, Belgium; [De Neys, Wim] Univ Toulouse, CNRS, Toulouse, France; [Geeraerts, Leen] Univ Leuven, Dept Econ & Appl Econ, Louvain, Belgium; [Ramautar, Jennifer] Netherlands Inst Neurosci, Amsterdam, Netherlands	KU Leuven; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; KU Leuven; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	De Neys, W (corresponding author), Univ Toulouse, CNRS, Toulouse, France.	Wim.Deneys@univ-tlse2.fr	Novitskiy, Nikolay/G-8703-2015; Novitskiy, Nikolay/ABF-3029-2020; Wagemans, Johan/M-3878-2019	Novitskiy, Nikolay/0000-0002-4039-5209; Novitskiy, Nikolay/0000-0002-4039-5209; Wagemans, Johan/0000-0002-7970-1541; Lauwereyns, Jan/0000-0003-0551-2550	Research Council of the University of Leuven [IDO 05/010 EEG-fMRI]; Flemish Government [METH/08/02]	Research Council of the University of Leuven(KU Leuven); Flemish Government(European Commission)	This research was supported by grants to Johan Wagemans from the Research Council of the University of Leuven (IDO 05/010 EEG-fMRI; www.kuleuven.be) and a Methusalem grant to Johan Wagemans by the Flemish Government (METH/08/02; www.vlaanderen.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Burnham TC, 2009, J ECON BEHAV ORGAN, V72, P171, DOI 10.1016/j.jebo.2009.05.015; Camerer CF, 2003, SCIENCE, V300, P1673, DOI 10.1126/science.1086215; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; de Neys W, 2006, PSYCHOL SCI, V17, P428, DOI 10.1111/j.1467-9280.2006.01723.x; De Neys W, 2006, EXP PSYCHOL, V53, P123, DOI 10.1027/1618-3169.53.1.123; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Houde O, 2007, THINK REASONING, V13, P81, DOI 10.1080/13546780500450599; Iannello P., 2008, INT REV EC, V55, P167, DOI [https://doi.org/10.1007/s12232-007-0031-4, DOI 10.1007/s12232-007-0031-4]; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Kaiser S, 2003, PSYCHIAT RES-NEUROIM, V122, P169, DOI 10.1016/S0925-4927(03)00004-0; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Koenigs M, 2010, NEUROPSYCHOLOGIA, V48, P2198, DOI 10.1016/j.neuropsychologia.2010.04.012; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Mennes M, 2010, PSYCHOPHYSIOLOGY, V47, P1142, DOI 10.1111/j.1469-8986.2010.01015.x; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Prox V, 2007, NEUROSCI LETT, V419, P236, DOI 10.1016/j.neulet.2007.04.011; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scheres Anouk, 2006, Behav Brain Funct, V2, P35, DOI 10.1186/1744-9081-2-35; Sevenants A, 2011, THINK REASONING, V17, P213, DOI 10.1080/13546783.2011.569153; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Veerman E, 2007, EC AAP CHIMPANSEES B	40	22	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27107	10.1371/journal.pone.0027107	http://dx.doi.org/10.1371/journal.pone.0027107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852II	22096522	gold, Green Published			2022-12-27	WOS:000297350800026
J	Du, WW; Yang, BB; Yang, BL; Deng, ZQ; Fang, L; Shan, SW; Jeyapalan, Z; Zhang, YU; Seth, A; Yee, AJ				Du, William Weidong; Yang, Burton B.; Yang, Bing L.; Deng, Zhaoqun; Fang, Ling; Shan, Sze Wan; Jeyapalan, Zina; Zhang, Yaou; Seth, Arun; Yee, Albert J.			Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; PG-M/VERSICAN; PRODUCT SECRETION; GLYCOSAMINOGLYCAN MODIFICATION; DRUG-RESISTANCE; MAMMARY-TUMOR; IN-VIVO; EXPRESSION	Overexpression of EGFR and versican has been reported in association with breast cancers. Considered oncogenic, these molecules may be attractive therapeutic targets. Possessing anti-apoptotic and drug resistant properties, overexpression of these molecules is accompanied by selective sensitization to the process of apoptosis. In this study, we exogenously expressed a versican G3 construct in breast cancer cell lines and analyzed the effects of G3 on cell viability in fetal bovine serum free conditioned media and evaluated the effects of apoptotic agent C2-ceramide, and chemotherapeutic agents including Docetaxel, Doxorubicin, and Epirubicin. Versican G3 domain enhanced tumor cell resistance to apoptosis when cultured in serum free medium, Doxorubicin, or Epirubicin by up-regulating pERK and GSK-3 beta (S9P). However, it could be prevented by selective EGFR inhibitor AG 1478 and selective MEK inhibitor PD 98059. Both AG 1478 and PD 98059 enhanced expression of pSAPK/JNK, while selective JNK inhibitor SP 600125 enhanced expression of GSK-3 beta (S9P). Versican G3 promoted cell apoptosis induced by C2-ceramide or Docetaxel by enhancing expression of pSAPK/JNK and decreasing expression of GSK-3 beta (S9P), an observation blocked by AG 1478 or SP 6000125. Inhibition of endogenous versican expression by siRNA or reduction of versican G3's expression by linking G3 with 3'UTR prevented G3 modulated cell apoptosis. The dual roles of G3 in modulating breast cancer cell resistance to chemotherapeutic agents may in part explain a potential mechanism for breast cancer cell resistance to chemotherapy and EGFR therapy. The apoptotic effects of chemotherapeutics depend upon the activation and balance of down stream signals in the EGFR pathway. GSK-3 beta (S9P) appears to function as a key checkpoint in this balance of apoptosis and anti-apoptosis. Investigation and potential consideration of targeting GSK-3 beta (S9P) merits further study.	[Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Ctr Study Bone Metastasis, Odette Canc Ctr, Toronto, ON, Canada; [Du, William Weidong; Yang, Burton B.; Yang, Bing L.; Deng, Zhaoqun; Fang, Ling; Shan, Sze Wan; Jeyapalan, Zina; Seth, Arun] Sunnybrook Res Inst, Toronto, ON, Canada; [Yang, Burton B.; Deng, Zhaoqun; Fang, Ling; Shan, Sze Wan; Jeyapalan, Zina; Seth, Arun] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Yaou] Tsinghua Univ, Div Life Sci, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Du, WW (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada.	albert.yee@sunnybrook.ca	Xie, Huangming/B-2260-2012	SHAN, SW/0000-0001-6876-9914	National Sciences and Engineering Research Council of Canada [227937-01]; Heart and Stroke Foundation of Ontario [CI5958]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a grant from National Sciences and Engineering Research Council of Canada (227937-01) to Dr. Yang who is the recipient of a Career Investigator Award (CI5958) from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Arteaga CL, 2004, CANCER CELL, V5, P525, DOI 10.1016/j.ccr.2004.05.028; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Brock N, 1996, CANCER, V78, P542; Brown LF, 1999, CLIN CANCER RES, V5, P1041; BUICK RN, 1990, PROG CLIN BIOL RES, V354, P179; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Chen LW, 2002, J BIOL CHEM, V277, P2657, DOI 10.1074/jbc.M101153200; Ciardiello FTT, 2005, PHASE 2 TRIAL GEFITI; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Flowers M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005342; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graham DL, 2005, PHASE 2 STUDY ERLOTI; Gu L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006220; Hambly RJ, 1997, BREAST CANCER RES TR, V43, P247, DOI 10.1023/A:1005756632293; HORWITZ KB, 1975, STEROIDS, V26, P785, DOI 10.1016/0039-128X(75)90110-5; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kaufmann SH, 1998, BBA-GENE STRUCT EXPR, V1400, P195, DOI 10.1016/S0167-4781(98)00136-5; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; Kim HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005933; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lyseng-Williamson KA, 2005, DRUGS, V65, P2513, DOI 10.2165/00003495-200565170-00007; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nahta R, 2003, ONCOLOGIST, V8, P5, DOI 10.1634/theoncologist.8-1-5; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; Navolanic PM, 2003, INT J ONCOL, V22, P237; Nitta M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010767; Polychronis ASH, 2005, ANTIPROLIFERATIVE MO; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Pusztai L, 1999, CANCER TREAT REV, V25, P271, DOI 10.1053/ctrv.1999.0132; Recchia I, 2004, BONE, V34, P65, DOI 10.1016/j.bone.2003.06.004; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; SCHABEL FM, 1977, CANCER, V39, P2875, DOI 10.1002/1097-0142(197706)39:6<2875::AID-CNCR2820390675>3.0.CO;2-7; Schaller G, 1999, J CANCER RES CLIN, V125, P520, DOI 10.1007/s004320050311; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Shimizu-Hirota R, 2001, J AM SOC NEPHROL, V12, P2609, DOI 10.1681/ASN.V12122609; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Syrokou A, 1999, BIOCHIMIE, V81, P733, DOI 10.1016/S0300-9084(99)80131-X; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; WALKERNASIR E, 1982, JNCI-J NATL CANCER I, V69, P371; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Wu YJ, 2001, J BIOL CHEM, V276, P14178, DOI 10.1074/jbc.M100618200; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zheng PS, 2004, J CELL SCI, V117, P5887, DOI 10.1242/jcs.01516; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	72	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26396	10.1371/journal.pone.0026396	http://dx.doi.org/10.1371/journal.pone.0026396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096483	Green Published, gold, Green Submitted			2022-12-27	WOS:000297350800006
J	Guimera, R; Sales-Pardo, M				Guimera, Roger; Sales-Pardo, Marta			Justice Blocks and Predictability of US Supreme Court Votes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; IDEOLOGICAL VALUES; NETWORK ANALYSIS; BLOCKMODELS	Successful attempts to predict judges' votes shed light into how legal decisions are made and, ultimately, into the behavior and evolution of the judiciary. Here, we investigate to what extent it is possible to make predictions of a justice's vote based on the other justices' votes in the same case. For our predictions, we use models and methods that have been developed to uncover hidden associations between actors in complex social networks. We show that these methods are more accurate at predicting justice's votes than forecasts made by legal experts and by algorithms that take into consideration the content of the cases. We argue that, within our framework, high predictability is a quantitative proxy for stable justice (and case) blocks, which probably reflect stable a priori attitudes toward the law. We find that U. S. Supreme Court justice votes are more predictable than one would expect from an ideal court composed of perfectly independent justices. Deviations from ideal behavior are most apparent in divided 5-4 decisions, where justice blocks seem to be most stable. Moreover, we find evidence that justice predictability decreased during the 50-year period spanning from the Warren Court to the Rehnquist Court, and that aggregate court predictability has been significantly lower during Democratic presidencies. More broadly, our results show that it is possible to use methods developed for the analysis of complex social networks to quantitatively investigate historical questions related to political decision-making.	[Guimera, Roger] ICREA, Barcelona, Catalonia, Spain; [Guimera, Roger; Sales-Pardo, Marta] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Catalonia, Spain	ICREA; Universitat Rovira i Virgili	Guimera, R (corresponding author), ICREA, Barcelona, Catalonia, Spain.	roger.guimera@urv.cat; marta.sales@urv.cat	Guimera, Roger/C-1727-2008; Guimera, Roger/M-9808-2019; Sales-Pardo, Marta/O-9797-2019; Sales-Pardo, Marta/C-1725-2008	Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310; Sales-Pardo, Marta/0000-0002-8140-6525; Sales-Pardo, Marta/0000-0002-8140-6525	Spanish Ministerio de Ciencia e Innovacion (MICINN) [FIS2010-18639]; James S. McDonnell Foundation; European Union [PIRG-GA-2010-277166, PIRG-GA-2010-268342]; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); James S. McDonnell Foundation; European Union(European Commission); ICREA(ICREA)	This work was supported by Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant FIS2010-18639, James S. McDonnell Foundation Research Award, European Union Grant PIRG-GA-2010-277166 (to R.G.), and European Union Grant PIRG-GA-2010-268342 (to M.S.-P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Brams SJ, 2011, COALITION FORMATION; Camerer CF, 2004, ROUNDTABLE SER BEHAV, P374; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Epstein Lee, 1998, CHOICES JUSTICES MAK; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Guthrie C, 2007, CORNELL LAW REV, V93, P1; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Kim P.T., 2004, PERSP POL, V2, P761, DOI DOI 10.1017/S1537592704040502; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moreira AA, 2004, P NATL ACAD SCI USA, V101, P12085, DOI 10.1073/pnas.0400672101; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Pomeranz K, 2011, CLIO DYNAMICS, V2, P1; POOLE KT, 1985, AM J POLIT SCI, V29, P357, DOI 10.2307/2111172; Porter MA, 2005, P NATL ACAD SCI USA, V102, P7057, DOI 10.1073/pnas.0500191102; Porter MA, 2007, PHYSICA A, V386, P414, DOI 10.1016/j.physa.2007.07.039; Posner R.A., 2010, JUDGES THINK; Ruger TW, 2004, COLUMBIA LAW REV, V104, P1150, DOI 10.2307/4099370; Schauer F, 1998, BOSTON U LAW REV, V78, P773; Scott J., 2000, SOCIAL STRUCTURE, V2nd; SEGAL JA, 1989, AM POLIT SCI REV, V83, P557, DOI 10.2307/1962405; SEGAL JA, 1995, J POLIT, V57, P812, DOI 10.2307/2960194; Sirovich L, 2003, P NATL ACAD SCI USA, V100, P7432, DOI 10.1073/pnas.1132164100; Turchin P, 2008, NATURE, V454, P34, DOI 10.1038/454034a; WHITE HC, 1976, AM J SOCIOL, V81, P730, DOI 10.1086/226141	27	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27188	10.1371/journal.pone.0027188	http://dx.doi.org/10.1371/journal.pone.0027188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852II	22096533	gold, Green Submitted, Green Published			2022-12-27	WOS:000297350800033
J	Xiong, AS; Peng, RH; Zhuang, J; Chen, JM; Zhang, B; Zhang, J; Yao, QH				Xiong, Ai-Sheng; Peng, Ri-He; Zhuang, Jing; Chen, Jian-Min; Zhang, Bin; Zhang, Jian; Yao, Quan-Hong			A Thermostable beta-Glucuronidase Obtained by Directed Evolution as a Reporter Gene in Transgenic Plants	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VITRO; MOLECULAR EVOLUTION; FIREFLY LUCIFERASE; RAPID EVOLUTION; GUS; EXPRESSION; ENZYMES; ARABIDOPSIS; UTILITY	A beta-glucuronidase variant, GUS-TR3337, that was obtained by directed evolution exhibited higher thermostability than the wild-type enzyme, GUS-WT. In this study, the utility of GUS-TR337 as an improved reporter was evaluated. The corresponding gus-tr3337 and gus-wt genes were independently cloned in a plant expression vector and introduced into Arabidopsis thaliana. With 4-MUG as a substrate, plants containing the gus-wt gene showed no detectable b-glucuronidase activity after exposure to 60 degrees C for 10 min, while those hosting the gus-tr3337 gene retained 70% or 50% activity after exposure to 80 degrees C for 10 min or 30 min, respectively. Similarly, in vivo b-glucuronidase activity could be demonstrated by using X-GLUC as a substrate in transgenic Arabidopsis plants hosting the gus-tr3337 gene that were exposed to 80 degrees C for up to 30 min. Thus, the thermostability of GUS-TR3337 can be exploited to distinguish between endogenous and transgenic beta-glucuronidase activity, which is a welcome improvement in its use as a reporter.	[Xiong, Ai-Sheng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Hort, Nanjing, Peoples R China; [Peng, Ri-He; Zhang, Bin; Yao, Quan-Hong] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China; [Zhuang, Jing; Zhang, Jian] Alberta Innovates Technol Futures, Vegreville, AB, Canada; [Chen, Jian-Min] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China	Nanjing Agricultural University; Shanghai Academy of Agricultural Sciences; Alberta Innovates; Yangzhou University	Xiong, AS (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Hort, Nanjing, Peoples R China.	Jian.Zhang@albertainnovates.ca; yaoquanhong@saas.sh.cn	ZHANG, JIAN/AAD-2686-2021	ZHANG, JIAN/0000-0003-1507-4718; Xiong, Ai-Sheng/0000-0002-7900-5001	Priority Academic Program Development of Jiangsu Higher Education Institutions; National key Project of Transgenic Crops of China [2009ZX08002-011B]; International Scientific and Technological Cooperation [2010DFA62320]	Priority Academic Program Development of Jiangsu Higher Education Institutions; National key Project of Transgenic Crops of China; International Scientific and Technological Cooperation	The research is supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions; National key Project of Transgenic Crops of China (2009ZX08002-011B); International Scientific and Technological Cooperation (2010DFA62320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva M, 2003, ORG BIOMOL CHEM, V1, P4133, DOI 10.1039/b311055a; Alwen Anna, 1992, Transgenic Research, V1, P63, DOI 10.1007/BF02513023; ANHALT S, 1992, PLANTA, V187, P83, DOI 10.1007/BF00201627; Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; BEKKAOUI F, 1988, PLANT CELL REP, V7, P481, DOI 10.1007/BF00272736; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chartrain M, 2000, CURR OPIN BIOTECH, V11, P209, DOI 10.1016/S0958-1669(00)00081-1; Chirumamilla RR, 2001, MOL CELL BIOCHEM, V224, P159, DOI 10.1023/A:1011904405002; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dixon DP, 2003, J BIOL CHEM, V278, P23930, DOI 10.1074/jbc.M303620200; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Fior S, 2009, PLANT SCI, V176, P130, DOI 10.1016/j.plantsci.2008.10.001; Fior S, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-19; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; Geddie ML, 2004, J BIOL CHEM, V279, P26462, DOI 10.1074/jbc.M401447200; Gilissen LJW, 1998, TRANSGENIC RES, V7, P157, DOI 10.1023/A:1008832711805; Haseloff J, 2006, METHOD BIOCHEM ANAL, V47, P259; Hastings JW, 2006, METHOD BIOCHEM ANAL, V47, P15; HAWKSWORTH G, 1971, J MED MICROBIOL, V4, P451, DOI 10.1099/00222615-4-4-451; HODAL L, 1992, PLANT SCI, V87, P115, DOI 10.1016/0168-9452(92)90199-V; HU CY, 1990, PLANT CELL REP, V9, P1, DOI 10.1007/BF00232123; JEFFERSON RA, 1987, EMBO J, V6, P3901; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; LANGLEY SD, 1983, J BIOL CHEM, V258, P7416; Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Leeuwen W. van, 2000, Plant Molecular Biology Reporter, V18, P143, DOI 10.1007/BF02824024; LEVVY GA, 1959, ADV CARBOHYD CHEM, V14, P381; Lewy GA, 1954, BIOCHEM J, V56, P462; Locher CP, 2005, DNA CELL BIOL, V24, P256, DOI 10.1089/dna.2005.24.256; Mantis J, 2000, PLANT MOL BIOL REP, V18, P319, DOI 10.1007/BF02825059; Martin T., 1992, GUS protocols: using the GUS gene as a reporter of gene expression., P23; Martin T, 1992, PLANT MOL BIOL REP, V10, P37, DOI 10.1007/BF02669263; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Matsumura I, 1999, NAT BIOTECHNOL, V17, P696, DOI 10.1038/10910; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Millar AJ, 1992, PLANT MOL BIOL REP, V10, P324, DOI 10.1007/BF02668909; Muhitch MJ, 1998, PHYSIOL PLANTARUM, V104, P423, DOI 10.1034/j.1399-3054.1998.1040318.x; Nam SH, 2003, PROTEIN ENG, V16, P1099, DOI 10.1093/protein/gzg146; Otten LG, 2005, BIOMOL ENG, V22, P1, DOI 10.1016/j.bioeng.2005.02.002; PLEGT L, 1989, MOL GEN GENET, V216, P321, DOI 10.1007/BF00334371; Rowe LA, 2003, J MOL BIOL, V332, P851, DOI 10.1016/S0022-2836(03)00972-0; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki K, 2000, J BIOL CHEM, V275, P27466; SEBASTIANO M, 1986, GENETICS, V112, P459; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stewart CN, 2001, PLANT CELL REP, V20, P376, DOI 10.1007/s002990100346; Sudan C, 2006, PLANTA, V224, P853, DOI 10.1007/s00425-006-0276-2; Taylor CB, 1997, PLANT CELL, V9, P273, DOI 10.1105/tpc.9.3.273; Tian YS, 2010, WORLD J MICROB BIOT, V26, P903, DOI 10.1007/s11274-009-0251-8; Verhees J, 2002, PLANT MOL BIOL, V50, P653, DOI 10.1023/A:1019922329081; Whalen RG, 2001, CURR OPIN MOL THER, V3, P31; WOZNIAK CA, 1994, PHYSIOL PLANTARUM, V90, P763, DOI 10.1111/j.1399-3054.1994.tb02535.x; Xiong AS, 2007, PROTEIN ENG DES SEL, V20, P319, DOI 10.1093/protein/gzm023; Xiong AS, 2007, APPL MICROBIOL BIOT, V74, P160, DOI 10.1007/s00253-006-0659-0; Xiong AS, 2010, IN VITRO MUTAGENESIS; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao HM, 2002, CURR OPIN BIOTECH, V13, P104, DOI 10.1016/S0958-1669(02)00291-4; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577	62	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26773	10.1371/journal.pone.0026773	http://dx.doi.org/10.1371/journal.pone.0026773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096498	gold, Green Published, Green Submitted			2022-12-27	WOS:000297350800014
J	Stewart, AD; Anand, RR; Laird, JS; Verrall, M; Ryan, CG; de Jonge, MD; Paterson, D; Howard, DL				Stewart, Aaron D.; Anand, Ravi R.; Laird, Jamie S.; Verrall, Michael; Ryan, Chris G.; de Jonge, Martin D.; Paterson, David; Howard, Daryl L.			Distribution of Metals in the Termite Tumulitermes tumuli (Froggatt): Two Types of Malpighian Tubule Concretion Host Zn and Ca Mutually Exclusively	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; BEETLE CHRYSOLINA-PARDALINA; GEMOC NUCLEAR MICROPROBE; GOLD EXPLORATION; TRACE-ELEMENTS; ACCUMULATION PATTERNS; ZINC DISTRIBUTION; DRYWOOD TERMITES; BERKHEYA-CODDII; PIXE	The aim of this study was to determine specific distribution of metals in the termite Tumulitermes tumuli (Froggatt) and identify specific organs within the termite that host elevated metals and therefore play an important role in the regulation and transfer of these back into the environment. Like other insects, termites bio-accumulate essential metals to reinforce cuticular structures and utilize storage detoxification for other metals including Ca, P, Mg and K. Previously, Mn and Zn have been found concentrated in mandible tips and are associated with increased hardness whereas Ca, P, Mg and K are accumulated in Malpighian tubules. Using high resolution Particle Induced X-Ray Emission (PIXE) mapping of whole termites and Scanning Electron Microscope (SEM) Energy Dispersive X-ray (EDX) spot analysis, localised accumulations of metals in the termite T. tumuli were identified. Tumulitermes tumuli was found to have proportionally high Mn concentrations in mandible tips. Malpighian tubules had significant enrichment of Zn (1.6%), Mg (4.9%), P (6.8%), Ca (2.7%) and K (2.4%). Synchrotron scanning X-ray Fluorescence Microprobe (XFM) mapping demonstrated two different concretion types defined by the mutually exclusive presence of Ca and Zn. In-situ SEM EDX realisation of these concretions is problematic due to the excitation volume caused by operating conditions required to detect minor amounts of Zn in the presence of significant amounts of Na. For this reason, previous researchers have not demonstrated this surprising finding.	[Stewart, Aaron D.; Anand, Ravi R.; Verrall, Michael] CSIRO Earth Sci & Resource Engn, Perth, WA, Australia; [Laird, Jamie S.; Ryan, Chris G.] Univ Melbourne, Sch Phys, CSIRO Earth Sci & Resource Engn, Melbourne, Vic, Australia; [Laird, Jamie S.; Ryan, Chris G.] Univ Tasmania, Ctr Excellence Ore Deposits CODES, Hobart, Tas, Australia; [de Jonge, Martin D.; Paterson, David; Howard, Daryl L.] Australian Synchrotron, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; University of Tasmania	Stewart, AD (corresponding author), CSIRO Earth Sci & Resource Engn, Perth, WA, Australia.	Aaron.Stewart@csiro.au	Laird, Jamie/A-7683-2011; Ryan, Chris G/A-6032-2011; de Jonge, Martin D/C-3400-2011; Laird, Jamie/AAG-3250-2021; Stewart, Aaron/C-3209-2009; Howard, Daryl/E-9107-2013	Ryan, Chris G/0000-0003-2891-3912; de Jonge, Martin D/0000-0001-7731-6175; laird, jamie/0000-0002-4981-975X; Stewart, Aaron/0000-0002-6195-4516; verrall, michael/0000-0001-8287-2504; Howard, Daryl/0000-0001-6071-2382	CSIRO OCE	CSIRO OCE(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was funded by an CSIRO OCE Postdoctoral Fellowship (http://www.csiro.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhin E, 2010, GEOCHEM-EXPLOR ENV A, V10, P401, DOI 10.1144/1467-7873/09-004; Augustyniak M, 2008, X-RAY SPECTROM, V37, P142, DOI 10.1002/xrs.1037; Augustyniak M, 2006, COMP BIOCHEM PHYS C, V144, P242, DOI 10.1016/j.cbpc.2006.09.003; Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; BROWN BE, 1982, BIOL REV, V57, P621, DOI 10.1111/j.1469-185X.1982.tb00375.x; COVENTRY RJ, 1988, AUST J SOIL RES, V26, P375, DOI 10.1071/SR9880375; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P433, DOI 10.1007/s00114-008-0346-3; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; Dallinger R., 1991, ECOTOXICOLOGY METALS, P245; DEBRUYN LAL, 1995, AUST J SOIL RES, V33, P179, DOI 10.1071/SR9950179; DESHMUKH I, 1989, SOCIOBIOLOGY, V15, P155; Fassil Kebede, 2005, Journal of African Earth Sciences, V40, P101; GLEESON CF, 1989, J GEOCHEM EXPLOR, V31, P253, DOI 10.1016/0375-6742(89)90105-2; Grzes IM, 2010, EUR J SOIL BIOL, V46, P350, DOI 10.1016/j.ejsobi.2010.09.004; JANSSEN MPM, 1991, ARCH ENVIRON CON TOX, V20, P305, DOI 10.1007/BF01064395; Judd TM, 2007, ANN ENTOMOL SOC AM, V100, P893, DOI 10.1603/0013-8746(2007)100[893:DOMISI]2.0.CO;2; Kramarz P, 1999, B ENVIRON CONTAM TOX, V63, P531, DOI 10.1007/s001289901013; Laker M.C., 1982, Fort Hare Papers, V7, P275; LEVY R, 1979, J NEMATOL, V11, P100; LEVY R, 1979, FLA ENTOMOL, V62, P260, DOI 10.2307/3494064; Mesjasz-Przybylowicz J, 2002, FRESEN ENVIRON BULL, V11, P78; Migula P, 2007, PLANT SOIL, V293, P197, DOI 10.1007/s11104-007-9231-7; Ohmura W, 2007, SOCIOBIOLOGY, V50, P1035; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; PRASAD EAV, 1984, CURR SCI INDIA, V53, P649; PRASAD EAV, 1987, CURR SCI INDIA, V56, P1219; Przybylowicz WJ, 2003, NUCL INSTRUM METH B, V210, P343, DOI 10.1016/S0168-583X(03)01029-2; RABITSCH WB, 1995, ENVIRON POLLUT, V90, P221, DOI 10.1016/0269-7491(94)00082-O; Rabitsch WB, 1997, ARCH ENVIRON CON TOX, V32, P172, DOI 10.1007/s002449900171; Rabitsch WB, 1997, J APPL ECOL, V34, P1455, DOI 10.2307/2405261; RUGGIERO RG, 1994, AFR J ECOL, V32, P222, DOI 10.1111/j.1365-2028.1994.tb00573.x; Ryan CG, 2002, NUCL INSTRUM METH B, V189, P400, DOI 10.1016/S0168-583X(01)01098-9; Ryan CG, 2001, NUCL INSTRUM METH B, V181, P12, DOI 10.1016/S0168-583X(01)00548-1; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; RYAN CG, 1995, NUCL INSTRUM METH B, V104, P157, DOI 10.1016/0168-583X(95)00404-1; Sako A, 2009, GEODERMA, V153, P217, DOI 10.1016/j.geoderma.2009.08.011; Scheifler R, 2002, CHEMOSPHERE, V48, P571, DOI 10.1016/S0045-6535(02)00116-9; Schofield RMS, 1997, J EXP BIOL, V200, P3235; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; Sileshi GW, 2010, J VEG SCI, V21, P923, DOI 10.1111/j.1654-1103.2010.01197.x; Silva AFD, 2006, SOCIOBIOLOGY, V47, P293; SOHAL RS, 1976, TISSUE CELL, V8, P447, DOI 10.1016/0040-8166(76)90005-7; Tylko G, 2006, MICROCHIM ACTA, V155, P301, DOI 10.1007/s00604-006-0560-7; WATERHOUSE DF, 1950, AUST J SCI RES SER B, V3, P76, DOI 10.1071/BI9500076; WATSON J. P., 1970, Trans. Instn Min. Metall. Sect. B., V79, P53; WESSING A, 1992, J INSECT PHYSIOL, V38, P543, DOI 10.1016/0022-1910(92)90080-W; WESSING A, 1992, J INSECT PHYSIOL, V38, P623, DOI 10.1016/0022-1910(92)90114-S; Wood T.G., 1978, International Biological Programme, P245; Yoshimura T, 2002, NUCL INSTRUM METH B, V189, P450, DOI 10.1016/S0168-583X(01)01123-5; Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m	51	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27578	10.1371/journal.pone.0027578	http://dx.doi.org/10.1371/journal.pone.0027578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087339	gold, Green Published			2022-12-27	WOS:000297349700061
J	Boesby, L; Elung-Jensen, T; Klausen, TW; Strandgaard, S; Kamper, AL				Boesby, Lene; Elung-Jensen, Thomas; Klausen, Tobias Wirenfeldt; Strandgaard, Svend; Kamper, Anne-Lise			Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITOR; ACUTE MYOCARDIAL-INFARCTION; CHRONIC RENAL-DISEASE; II RECEPTOR BLOCKER; DIABETIC-NEPHROPATHY; HEART-FAILURE; BENEFICIAL IMPACT; CONTROLLED-TRIAL; PODOCYTE INJURY; SPIRONOLACTONE	Background: Reduction of proteinuria and blood pressure (BP) with blockers of the renin-angiotensin system (RAS) impairs the progression of chronic kidney disease (CKD). The aldosterone antagonist spironolactone has an antiproteinuric effect, but its use is limited by side effects. The present study evaluated the short-term antiproteinuric effect and safety of the selective aldosterone antagonist eplerenone in non-diabetic CKD. Study Design: Open randomized cross-over trial. Setting and Participants: Forty patients with non-diabetic CKD and urinary albumin excretion greater than 300 mg/24 hours. Intervention: Eight weeks of once-daily administration of add-on 25-50 mg eplerenone to stable standard antihypertensive treatment including RAS-blockade. Outcomes & Measurements: 24 hour urinary albumin excretion, BP, p-potassium, and creatinine clearance. Results: The mean urinary albumin excretion was 22% [CI: 14,28], P<0.001, lower during treatment with eplerenone. Mean systolic BP was 4 mmHg [CI: 2,6], P = 0.002, diastolic BP was 2 mmHg [CI: 0,4], P = 0.02, creatinine clearance was 5% [CI: 2,8], P = 0.005, lower during eplerenone treatment. After correction for BP and creatinine clearance differences between the study periods, the mean urinary albumin excretion was 14% [CI: 4,24], P = 0.008 lower during treatment. Mean p-potassium was 0.1 mEq/L [CI: 0.1,0.2] higher during eplerenone treatment, P<0.001. Eplerenone was thus well tolerated and no patients were withdrawn due to hyperkalaemia. Limitations: Open label, no wash-out period and a moderate sample size. Conclusions: In non-diabetic CKD patients, the addition of eplerenone to standard antihypertensive treatment including RAS-blockade caused a moderate BP independent fall in albuminuria, a minor fall in creatinine clearance and a 0.1 mEq/L increase in p-potassium.	[Boesby, Lene; Strandgaard, Svend] Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark; [Elung-Jensen, Thomas; Kamper, Anne-Lise] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Klausen, Tobias Wirenfeldt] Univ Copenhagen, Herlev Hosp, Dept Haematol, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Boesby, L (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark.	lenboe03@heh.regionh.dk		Kamper, Anne-Lise/0000-0001-7523-6569	Danish Cardiovascular Research Academy; Danish Kidney Association; Danish Society of Nephrology; Foundation of Aase Bay; Helen and Ejnar Bjornow Foundation; Research Council; Copenhagen University Hospital at Herlev; Jacob and Olga Madsen's Fund; Eva and Robert Voss Hansen's Fund; Danish Hypertension Society	Danish Cardiovascular Research Academy; Danish Kidney Association; Danish Society of Nephrology; Foundation of Aase Bay; Helen and Ejnar Bjornow Foundation; Research Council; Copenhagen University Hospital at Herlev; Jacob and Olga Madsen's Fund; Eva and Robert Voss Hansen's Fund; Danish Hypertension Society	The authors express their gratitude for the funding of this study by grants from the Danish Cardiovascular Research Academy, the Danish Kidney Association, the Danish Society of Nephrology, the Foundation of Aase Bay, the Helen and Ejnar Bjornow Foundation, the Research Council, Copenhagen University Hospital at Herlev, Director Jacob and Olga Madsen's Fund, Eva and Robert Voss Hansen's Fund and The Danish Hypertension Society LeoPharma scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima S, 2006, J STEROID BIOCHEM, V102, P170, DOI 10.1016/j.jsbmb.2006.09.018; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Bianchi S, 2006, KIDNEY INT, V70, P2116, DOI 10.1038/sj.ki.5001854; Chrysostomou A, 2006, CLIN J AM SOC NEPHRO, V1, P256, DOI 10.2215/CJN.01040905; Cravedi P, 2010, PHARMACEUTICALS, V3, P1, DOI 10.3390/ph3010001; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; Furumatsu Y, 2008, HYPERTENS RES, V31, P59, DOI 10.1291/hypres.31.59; Hostetter TH, 2001, SEMIN NEPHROL, V21, P573, DOI 10.1053/snep.2001.26797; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; KAMPER AL, 1992, AM J HYPERTENS, V5, P423, DOI 10.1093/ajh/5.7.423; Kanno Y, 2006, CLIN J AM SOC NEPHRO, V1, P730, DOI 10.2215/CJN.01110905; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Michea L, 2005, ENDOCRINOLOGY, V146, P973, DOI 10.1210/en.2004-1130; Nagase M, 2008, CLIN EXP NEPHROL, V12, P233, DOI 10.1007/s10157-008-0034-9; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2001, CARDIOVASC DRUG THER, V15, P79, DOI 10.1023/A:1011119003788; Pitt B, 2008, CIRCULATION, V118, P1643, DOI 10.1161/CIRCULATIONAHA.108.778811; Rudolph AE, 2004, MOL CELL ENDOCRINOL, V217, P229, DOI 10.1016/j.mce.2003.10.047; Ruggenenti P, 2003, KIDNEY INT, V63, P2254, DOI 10.1046/j.1523-1755.2003.00033.x; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Sato A, 2005, AM J HYPERTENS, V18, P44, DOI 10.1016/j.amjhyper.2004.06.029; Schjoedt KJ, 2006, KIDNEY INT, V70, P536, DOI 10.1038/sj.ki.5001580; Schjoedt KJ, 2005, KIDNEY INT, V68, P2829, DOI 10.1111/j.1523-1755.2005.00756.x; Schmidt BMW, 2008, STEROIDS, V73, P961, DOI 10.1016/j.steroids.2007.12.010; Struthers A, 2008, CLIN CARDIOL, V31, P153, DOI 10.1002/clc.20324; Tylicki L, 2008, AM J KIDNEY DIS, V52, P486, DOI 10.1053/j.ajkd.2008.02.297; Uhrenholt TR, 2003, CIRC RES, V93, P1258, DOI 10.1161/01.RES.0000106135.02935.E1; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA	33	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26904	10.1371/journal.pone.0026904	http://dx.doi.org/10.1371/journal.pone.0026904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073219	Green Published, Green Submitted, gold			2022-12-27	WOS:000297198200023
J	Ghosh, A; Zhao, HM; Price, ND				Ghosh, Amit; Zhao, Huimin; Price, Nathan D.			Genome-Scale Consequences of Cofactor Balancing in Engineered Pentose Utilization Pathways in Saccharomyces cerevisiae	PLOS ONE			English	Article							XYLOSE ISOMERASE PATHWAYS; METABOLIC NETWORK; XYLITOL DEHYDROGENASE; ESCHERICHIA-COLI; SYSTEMS BIOLOGY; PICHIA-STIPITIS; FERMENTATION; ETHANOL; ARABINOSE; REDUCTASE	Biofuels derived from lignocellulosic biomass offer promising alternative renewable energy sources for transportation fuels. Significant effort has been made to engineer Saccharomyces cerevisiae to efficiently ferment pentose sugars such as Dxylose and L-arabinose into biofuels such as ethanol through heterologous expression of the fungal D-xylose and L-arabinose pathways. However, one of the major bottlenecks in these fungal pathways is that the cofactors are not balanced, which contributes to inefficient utilization of pentose sugars. We utilized a genome-scale model of S. cerevisiae to predict the maximal achievable growth rate for cofactor balanced and imbalanced D-xylose and L-arabinose utilization pathways. Dynamic flux balance analysis (DFBA) was used to simulate batch fermentation of glucose, D-xylose, and L-arabinose. The dynamic models and experimental results are in good agreement for the wild type and for the engineered D-xylose utilization pathway. Cofactor balancing the engineered D-xylose and L-arabinose utilization pathways simulated an increase in ethanol batch production of 24.7% while simultaneously reducing the predicted substrate utilization time by 70%. Furthermore, the effects of cofactor balancing the engineered pentose utilization pathways were evaluated throughout the genome-scale metabolic network. This work not only provides new insights to the global network effects of cofactor balancing but also provides useful guidelines for engineering a recombinant yeast strain with cofactor balanced engineered pathways that efficiently co-utilizes pentose and hexose sugars for biofuels production. Experimental switching of cofactor usage in enzymes has been demonstrated, but is a time-consuming effort. Therefore, systems biology models that can predict the likely outcome of such strain engineering efforts are highly useful for motivating which efforts are likely to be worth the significant time investment.	[Ghosh, Amit; Zhao, Huimin; Price, Nathan D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL USA; [Zhao, Huimin; Price, Nathan D.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Ghosh, Amit; Price, Nathan D.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ghosh, A (corresponding author), Inst Syst Biol, Seattle, WA USA.	zhao5@illinois.edu; nprice@systemsbiology.org	Ghosh, Amit/AAA-3490-2021	Ghosh, Amit/0000-0003-3514-885X; Price, Nathan/0000-0002-4157-0267	Energy Biosciences Institute (EBI); Beyond Petroleum	Energy Biosciences Institute (EBI); Beyond Petroleum	This work was supported by a grant from the Energy Biosciences Institute (EBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding received from Energy Biosciences Institute (EBI), funded by Beyond Petroleum (a commercial company), is not accompanied by any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products and does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barrett CL, 2006, CURR OPIN BIOTECH, V17, P488, DOI 10.1016/j.copbio.2006.08.001; Becker J, 2003, APPL ENVIRON MICROB, V69, P4144, DOI 10.1128/AEM.69.7.4144-4150.2003; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bengtsson O, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-9; Bertilsson M, 2008, BIOPROC BIOSYST ENG, V31, P369, DOI 10.1007/s00449-007-0169-1; Bettiga M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-40; Bettiga M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-16; BRUINENBERG PM, 1983, EUR J APPL MICROBIOL, V18, P287, DOI 10.1007/BF00500493; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; dos Santos MM, 2004, METAB ENG, V6, P352, DOI 10.1016/j.ymben.2004.06.002; Duarte NC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-63; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Galafassi S, 2010, J IND MICROBIOL BIOT; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hahn-Hagerdal B, 2001, Adv Biochem Eng Biotechnol, V73, P53; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776, DOI 10.1007/BF00167144; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; Lee KH, 2007, BRAIN RES, V1171, P1, DOI 10.1016/j.brainres.2007.07.053; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Matsushika A, 2008, J BIOSCI BIOENG, V105, P296, DOI 10.1263/jbb.105.296; Milne Caroline B., 2009, Biotechnology Journal, V4, P1653, DOI 10.1002/biot.200900234; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Price ND, 2006, BIOPHYS J, V90, P3919, DOI 10.1529/biophysj.105.072645; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Tyo KEJ, 2010, CURR OPIN MICROBIOL, V13, P255, DOI 10.1016/j.mib.2010.02.001; Wahlbom CF, 2003, FEMS YEAST RES, V3, P319, DOI 10.1016/S1567-1356(02)00206-4; Watanabe S, 2007, J BIOTECHNOL, V130, P316, DOI 10.1016/j.jbiotec.2007.04.019	44	40	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27316	10.1371/journal.pone.0027316	http://dx.doi.org/10.1371/journal.pone.0027316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076150	Green Published, gold			2022-12-27	WOS:000297198200064
J	Lewis, SN; Nsoesie, E; Weeks, C; Qiao, D; Zhang, LQ				Lewis, Stephanie N.; Nsoesie, Elaine; Weeks, Charles; Qiao, Dan; Zhang, Liqing			Prediction of Disease and Phenotype Associations from Genome-Wide Association Studies	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; INSULIN-RESISTANCE; OBESITY	Background: Genome wide association studies (GWAS) have proven useful as a method for identifying genetic variations associated with diseases. In this study, we analyzed GWAS data for 61 diseases and phenotypes to elucidate common associations based on single nucleotide polymorphisms (SNP). The study was an expansion on a previous study on identifying disease associations via data from a single GWAS on seven diseases. Methodology/Principal Findings: Adjustments to the originally reported study included expansion of the SNP dataset using Linkage Disequilibrium (LD) and refinement of the four levels of analysis to encompass SNP, SNP block, gene, and pathway level comparisons. A pair-wise comparison between diseases and phenotypes was performed at each level and the Jaccard similarity index was used to measure the degree of association between two diseases/phenotypes. Disease relatedness networks (DRNs) were used to visualize our results. We saw predominant relatedness between Multiple Sclerosis, type 1 diabetes, and rheumatoid arthritis for the first three levels of analysis. Expected relatedness was also seen between lipid-and blood-related traits. Conclusions/Significance: The predominant associations between Multiple Sclerosis, type 1 diabetes, and rheumatoid arthritis can be validated by clinical studies. The diseases have been proposed to share a systemic inflammation phenotype that can result in progression of additional diseases in patients with one of these three diseases. We also noticed unexpected relationships between metabolic and neurological diseases at the pathway comparison level. The less significant relationships found between diseases require a more detailed literature review to determine validity of the predictions. The results from this study serve as a first step towards a better understanding of seemingly unrelated diseases and phenotypes with similar symptoms or modes of treatment.	[Lewis, Stephanie N.; Nsoesie, Elaine; Weeks, Charles; Zhang, Liqing] Virginia Tech, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA; [Lewis, Stephanie N.] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Qiao, Dan; Zhang, Liqing] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lewis, SN (corresponding author), Virginia Tech, Genet Bioinformat & Computat Biol Program, Blacksburg, VA 24061 USA.	lzhang@systemsbiology.org		Lewis, Stephanie/0000-0001-8724-2069; Nsoesie, Elaine/0000-0001-9170-8714	National Science Foundation [IIS-0710945]	National Science Foundation(National Science Foundation (NSF))	This work was partially supported by National Science Foundation grant IIS-0710945. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2010, R LANG ENV STAT COMP; Beckman R, 2008, 07043 VIRG TECH; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Doran M, 2007, J RHEUMATOL, V34, P460; Dorman JS, 2003, DIABETES CARE, V26, P3192, DOI 10.2337/diacare.26.11.3192; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gong YF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-56; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang W, 2009, BMC BIOINFORMATICS, V10, P1; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kanehisa M, 2000, NUCL ACIDS RES, V28; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lasher CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015247; Lewis SN, 2011, METAANALYSIS GENOME; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Nielsen NM, 2006, ARCH NEUROL-CHICAGO, V63, P1001, DOI 10.1001/archneur.63.7.1001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simon-Sanchez J, 2008, NEUROLOGY, P2067; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Toussirot E, 2006, J RHEUMATOL, V33, P1027; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visscher PM, 2009, JAMA-J AM MED ASSOC, V302, P2028, DOI 10.1001/jama.2009.1643; Wall L., 2000, PROGRAMMING PERL	33	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27175	10.1371/journal.pone.0027175	http://dx.doi.org/10.1371/journal.pone.0027175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076134	Green Submitted, Green Published			2022-12-27	WOS:000297198200046
J	Mateus, AM; Arias, AM				Mateus, Ana Margarida; Arias, Alfonso Martinez			Patterned Cell Adhesion Associated with Tissue Deformations during Dorsal Closure in Drosophila	PLOS ONE			English	Article							MORPHOGENESIS; INTEGRIN	Cell shape changes within epithelia require the regulation of adhesive molecules that maintain tissue integrity. How remodelling of cell contacts is achieved while tissue integrity is maintained remains a fundamental question in morphogenesis. Dorsal Closure is a good system to study the dynamics of DE-Cadherin during morphogenesis. It relies on concerted cell shape changes of two epithelial sheets: amnioserosa cell contraction and epidermal cell elongation. To investigate the modulation of DE-Cadherin we performed antibody uptake experiments in live embryos during Dorsal Closure. We found that some antibodies access certain epitopes of the extracellular domain of native DE-Cadherin only in the amnioserosa and epidermal cells attached to the amnioserosa, which has never been observed in fixed DE-Cadherin in Drosophila embryos. These differences correlate with the different cell behaviour of these regions and therefore we suggest that DE-Cadherin exists in different forms that confer different adhesive strengths. We propose this to be a widespread mechanism for the differential modulation of adhesion during morphogenesis.	[Mateus, Ana Margarida; Arias, Alfonso Martinez] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Mateus, Ana Margarida] Gulbenkian PhD Programme Biomed, Oeiras, Portugal	University of Cambridge	Mateus, AM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	ama11@hermes.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010; Tsai, Yu-Chen/B-5852-2008		Fundacao para a Ciencia e Tecnologia from Portugal; Wellcome Trust	Fundacao para a Ciencia e Tecnologia from Portugal(Portuguese Foundation for Science and Technology); Wellcome Trust(Wellcome Trust)	This work was funded by Fundacao para a Ciencia e Tecnologia from Portugal (AMM) and the Wellcome Trust (AMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; BROADIE K, 1992, ROUX ARCH DEV BIOL, V201, P364, DOI 10.1007/BF00365124; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Duband JL, 1995, ACTA ANAT, V154, P63; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fung S, 2008, J COMP NEUROL, V506, P469, DOI 10.1002/cne.21539; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Haag TA, 1999, DEV BIOL, V208, P56, DOI 10.1006/dbio.1998.9188; Hendersen DS, 2004, METHODS MOL BIOL; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Kasza KE, 2010, CURR OPIN CELL BIOL; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; MARSH EW, 1995, J CELL BIOL, V129, P1509, DOI 10.1083/jcb.129.6.1509; MARTINEZ ARIAS A., 1993, DEV PATTERNING LARVA; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Oda H, 2001, J CELL SCI, V114, P493; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Sanders PGT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000169; Simone RP, 2010, DEVELOPMENT, V137, P1385, DOI 10.1242/dev.048520; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27159	10.1371/journal.pone.0027159	http://dx.doi.org/10.1371/journal.pone.0027159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076130	Green Submitted, Green Published, gold			2022-12-27	WOS:000297198200042
J	Gane, L; Power, S; Kushki, A; Chau, T				Gane, Luke; Power, Sarah; Kushki, Azadeh; Chau, Tom			Thermal Imaging of the Periorbital Regions during the Presentation of an Auditory Startle Stimulus	PLOS ONE			English	Article							LOCKED-IN SYNDROME	Infrared thermal imaging of the inner canthi of the periorbital regions of the face can potentially serve as an input signal modality for an alternative access system for individuals with conditions that preclude speech or voluntary movement, such as total locked-in syndrome. However, it is unknown if the temperature of these regions is affected by the human startle response, as changes in the facial temperature of the periorbital regions manifested during the startle response could generate false positives in a thermography-based access system. This study presents an examination of the temperature characteristics of the periorbital regions of 11 able-bodied adult participants before and after a 102 dB auditory startle stimulus. The results indicate that the startle response has no substantial effect on the mean temperature of the periorbital regions. This indicates that thermography-based access solutions would be insensitive to startle reactions in their user, an important advantage over other modalities being considered in the context of access solutions for individuals with a severe motor disability.	[Gane, Luke; Power, Sarah; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Gane, Luke; Power, Sarah; Kushki, Azadeh; Chau, Tom] Bloorview Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto	Gane, L (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	tom.chau@utoronto.ca	Chau, Tom TK/C-8426-2009; Power, Sarah/AAU-9422-2020	Chau, Tom TK/0000-0002-7486-0316; Power, Sarah/0000-0001-5132-2753	Bloorview Research Institute	Bloorview Research Institute	Some funding was provided by the Bloorview Research Institute Graduate Student Scholarship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bakker MJ, 2009, CLIN NEUROPHYSIOL, V120, P424, DOI 10.1016/j.clinph.2008.11.014; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Blain S, 2008, OPEN REHABILITATION, V1, P27, DOI DOI 10.2174/1874943700801010027; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bruno MA, 2009, PEDIATR NEUROL, V41, P237, DOI 10.1016/j.pediatrneurol.2009.05.001; DRUMMOND PD, 1987, BRAIN, V110, P793, DOI 10.1093/brain/110.3.793; Eder DN, 2009, INT J PSYCHOPHYSIOL, V71, P149, DOI 10.1016/j.ijpsycho.2008.09.001; Falk TH, 2011, IEEE T NEUR SYS REH, V19, P136, DOI 10.1109/TNSRE.2010.2078516; Falk TH, 2010, INT CONF ACOUST SPEE, P517, DOI 10.1109/ICASSP.2010.5495643; GHANBARI M, 1990, IEEE T COMMUN, V38, P950, DOI 10.1109/26.57512; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Gray H, 1973, GRAYS ANATOMY; Gros DF, 2009, INT J PSYCHOPHYSIOL, V73, P207, DOI 10.1016/j.ijpsycho.2009.03.001; Jones BF, 2002, IEEE ENG MED BIOL, V21, P41, DOI 10.1109/MEMB.2002.1175137; Jones BF, 1998, IEEE T MED IMAGING, V17, P1019, DOI 10.1109/42.746635; Memarian N, 2011, DISABIL REHABIL-ASSI, V6, P179, DOI 10.3109/17483107.2010.498075; Memarian N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-38; Memarian N, 2009, J NEUROENG REHABIL, V6, DOI [10.1186/1743-0003-6-1, 10.1186/1743-0003-6-11]; Nhan BR, 2009, PHYSIOL MEAS, V30, pN23, DOI 10.1088/0967-3334/30/4/N01; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Palmieri RL, 2009, NURSING, V39, P29; Pavlidis I, 2002, IEEE ENG MED BIOL, V21, P56, DOI 10.1109/MEMB.2002.1175139; Pavlidis I, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P315, DOI 10.1109/ICIP.2001.958491; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Reilly T, 2009, J THERM BIOL, V34, pCP1, DOI 10.1016/j.jtherbio.2009.01.005; Schmajuk NA, 2009, BEHAV BRAIN RES, V197, P251, DOI 10.1016/j.bbr.2008.08.030; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sherwood L, 2009, HUMAN PHYSL CELLS SY; Tsiamyrtzis P, 2007, INT J COMPUT VISION, V71, P197, DOI 10.1007/s11263-006-6106-y; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861	32	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27268	10.1371/journal.pone.0027268	http://dx.doi.org/10.1371/journal.pone.0027268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073302	gold, Green Submitted, Green Published			2022-12-27	WOS:000297197000039
J	Abrahamczyk, S; Kluge, J; Gareca, Y; Reichle, S; Kessler, M				Abrahamczyk, Stefan; Kluge, Juergen; Gareca, Yuvinka; Reichle, Steffen; Kessler, Michael			The Influence of Climatic Seasonality on the Diversity of Different Tropical Pollinator Groups	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; PLANT-COMMUNITIES; SPECIES RICHNESS; FOREST; BUTTERFLIES; LEPIDOPTERA; PATTERNS; BIODIVERSITY; HYMENOPTERA; PHENOLOGY	Tropical South America is rich in different groups of pollinators, but the biotic and abiotic factors determining the geographical distribution of their species richness are poorly understood. We analyzed the species richness of three groups of pollinators (bees and wasps, butterflies, hummingbirds) in six tropical forests in the Bolivian lowlands along a gradient of climatic seasonality and precipitation ranging from 410 mm to 6250 mm. At each site, we sampled the three pollinator groups and their food plants twice for 16 days in both the dry and rainy seasons. The richness of the pollinator groups was related to climatic factors by linear regressions. Differences in species numbers between pollinator groups were analyzed by Wilcoxon tests for matched pairs and the proportion in species numbers between pollinator groups by correlation analyses. Species richness of hummingbirds was most closely correlated to the continuous availability of food, that of bees and wasps to the number of food plant species and flowers, and that of butterflies to air temperature. Only the species number of butterflies differed significantly between seasons. We were not able to find shifts in the proportion of species numbers of the different groups of pollinators along the study gradient. Thus, we conclude that the diversity of pollinator guilds is determined by group-specific factors and that the constant proportions in species numbers of the different pollinator groups constitute a general pattern.	[Abrahamczyk, Stefan; Kluge, Juergen; Kessler, Michael] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Kluge, Juergen] Univ Marburg, Fac Geog, Marburg, Germany; [Gareca, Yuvinka] Museo Hist Nat Alcide Orbigny, Cochabamba, Bolivia; [Reichle, Steffen] Torre B Multictr, Nat Conservancy, Bolivia Off, La Paz, Bolivia	University of Zurich; Philipps University Marburg	Abrahamczyk, S (corresponding author), Univ Zurich, Inst Systemat Bot, Zurich, Switzerland.	stefan.abrahamczyk@systbot.uzh.ch	Abrahamczyk, Stefan/D-7316-2011; Kluge, Jurgen/D-6200-2011; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Kessler, Michael/A-3605-2009	Kessler, Michael/0000-0003-4612-9937	Konrad-Adenauer-Stiftung; DFG (Deutsche Forschungsgemeinschaft); University of Zurich; National Herbarium at La Paz; Museo de Historia Natural Noel Kempff Mercado at Santa Cruz; Ministry of the Environment of Bolivia	Konrad-Adenauer-Stiftung; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Zurich; National Herbarium at La Paz; Museo de Historia Natural Noel Kempff Mercado at Santa Cruz; Ministry of the Environment of Bolivia	This study was funded by the Konrad-Adenauer-Stiftung, the DFG (Deutsche Forschungsgemeinschaft) and the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank T. Delhotal for assistance in the field, A. Schmidt-Lebuhn, B. Bembe and G. Gerlach for information during field work preparation, C. Hamel, S. K. Herzog, D.N. Karger, C. Bomblat, V. Sandoval and J.Q. Vidoz for their support and advice during field work as well as D. Cicuzza for their help during data analysis, M. Schwerdtfeger for providing odour baits, B. Steudel for his help with organization, S. Willinghofer, S. Stiegel, M. C. Vargas Karger, P. Buschhorn, P. Gottleuber for identifying and preparing euglossine bees, C. Taylor, M. H. Nee, R. Vasquez, and J.R.I. Wood for their support with plant identification, O. Mielke, K. Willmott, R. K. Robbins for the identification of butterflies, and R. W. Soria-Auza for providing the climatic data and the precipitation map. We are grateful to the Botanical Garden in Santa Cruz, the University of Cochabamba, Prometa, the municipal governments of Villa Tunari and Rio Seco, and R. Clarke Gemuseus for the permission to work on their land, and to the National Herbarium at La Paz, the Museo de Historia Natural Noel Kempff Mercado at Santa Cruz, as well as the Ministry of the Environment of Bolivia for supporting our study.	Abrahamczyk S, 2011, BIODIVERS CONSERV, V20, P2981, DOI 10.1007/s10531-011-0105-1; Abrahamczyk S, 2010, ENTOMOL EXP APPL, V137, P262, DOI 10.1111/j.1570-7458.2010.01063.x; Abrahamczyk S, 2010, J ORNITHOL, V151, P615, DOI 10.1007/s10336-010-0496-x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Araujo AC, 2003, FLORA, V198, P427, DOI 10.1078/0367-2530-00116; Azerefegne F, 2001, J ANIM ECOL, V70, P1032, DOI 10.1046/j.0021-8790.2001.00556.x; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; BECCALONI GW, 1995, BIOL CONSERV, V71, P77, DOI 10.1016/0006-3207(94)00023-J; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cotton PA, 1998, IBIS, V140, P512, DOI 10.1111/j.1474-919X.1998.tb04613.x; Cotton PA, 2007, IBIS, V149, P135; DAILY GC, 1995, BIODIVERS CONSERV, V4, P35, DOI 10.1007/BF00115313; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; des Granges J.-L., 1979, Living Bird, V17, P199; Devoto M, 2009, AUSTRAL ECOL, V34, P848, DOI 10.1111/j.1442-9993.2009.01987.x; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Devy MS, 2003, AM J BOT, V90, P650, DOI 10.3732/ajb.90.4.650; Diniz IR, 1998, REV BIOL TROP, V46, P109; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Eriksen W, 1986, BEITRAGE PHYSISCHEN, P1; Erwin TL., 2009, INSECT BIODIVERSITY; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hennessey A. B., 2003, LISTA ANOTADA AVES B; Herrera MMP, 2005, THESIS U COCHABAMBA; Hickman JM, 1996, J ECON ENTOMOL, V89, P832, DOI 10.1093/jee/89.4.832; Hill C. J., 1992, Journal of the Lepidopterists' Society, V46, P173; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; JONES RE, 1987, BIOTROPICA, V19, P7, DOI 10.2307/2388454; KEIGHERY GJ, 1980, PLANT SYST EVOL, V135, P171, DOI 10.1007/BF00983185; Kessler M, 2000, PLANT BIOLOGY, V2, P659, DOI 10.1055/s-2000-16642; Kevan Peter G., 2003, Biodiversity (Ottawa), V4, P3; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Gonzalez AMM, 2009, J TROP ECOL, V25, P493, DOI 10.1017/S0266467409990034; Mata JR, 2006, BIRDS S AM NONPASSER; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; MICHENER DC, 2000, BEES WORLD; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Neild EFA, 1996, BUTTERFLIES VENEZUEL; Nemesio A, 2009, ZOOTAXA, P1; Nicholls CI, 2001, LANDSCAPE ECOL, V16, P133, DOI 10.1023/A:1011128222867; Ollerton J, 2002, OIKOS, V98, P340, DOI 10.1034/j.1600-0706.2002.980215.x; Orr AG, 1996, MONOG BIOL, V74, P125; Owen D.F., 1971, TROPICAL BUTTERFLIES; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips RD, 2010, PHILOS T R SOC B, V365, P517, DOI 10.1098/rstb.2009.0238; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pozo C, 2008, FLA ENTOMOL, V91, P407, DOI 10.1653/0015-4040(2008)91[407:SAPOTB]2.0.CO;2; Proctor M, 1996, NATURAL STORY POLLIN; R Development Core Team, 2007, R LANG ENV STAT COMP; Rahbek C, 2000, P ROY SOC B-BIOL SCI, V267, P2259, DOI 10.1098/rspb.2000.1277; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Roback PJ, 2005, CONSERV BIOL, V19, P261, DOI 10.1111/j.1523-1739.2005.00269.x; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Salvatierra Mercado LM, 2003, THESIS U SANTA CRUZ; Schneider C, 2003, ECOL ENTOMOL, V28, P219, DOI 10.1046/j.1365-2311.2003.00494.x; Shahabuddin G, 1999, J TROP ECOL, V15, P703, DOI 10.1017/S0266467499001121; Shapiro AM, 1975, DIAMAND ECOLOGY EVOL; Shapiro AM, 1986, WEST N AM NATURALIST, V46, P112; SMITH PARDO ALLAN, 2007, Acta biol.Colomb., V12, P43; Soria-Auza RW, 2010, ECOL MODEL, V221, P1221, DOI 10.1016/j.ecolmodel.2010.01.004; Srygley RB, 2010, GLOBAL CHANGE BIOL, V16, P936, DOI 10.1111/j.1365-2486.2009.01986.x; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; TEPEDINO VJ, 1981, OIKOS, V36, P35, DOI 10.2307/3544376; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Tschapka M, 2004, J ZOOL, V263, P7, DOI 10.1017/S0952836903004734; Tudor O, 2004, BIOL CONSERV, V119, P397, DOI 10.1016/j.biocon.2004.01.002; Tylianakis JM, 2008, ECOL LETT, V9, P278; van Dulmen A, 2001, PLANT ECOL, V153, P73, DOI 10.1023/A:1017577305193; Williams MR, 2008, ENVIRON ENTOMOL, V37, P1313, DOI 10.1603/0046-225X(2008)37[1313:ADODLI]2.0.CO;2; Williams PH, 2007, BIOL CONSERV, V138, P493, DOI 10.1016/j.biocon.2007.06.001; [No title captured]	82	34	37	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27115	10.1371/journal.pone.0027115	http://dx.doi.org/10.1371/journal.pone.0027115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073268	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000297154900080
J	Coriat, R; Leconte, M; Kavian, N; Bedda, S; Nicco, C; Chereau, C; Goulvestre, C; Weill, B; Laurent, A; Batteux, F				Coriat, Romain; Leconte, Mahaut; Kavian, Niloufar; Bedda, Sassia; Nicco, Carole; Chereau, Christiane; Goulvestre, Claire; Weill, Bernard; Laurent, Alexis; Batteux, Federic			Mangafodipir Protects against Hepatic Ischemia-Reperfusion Injury in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; SUPEROXIDE-DISMUTASE; REACTIVE OXYGEN; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; LIVER RESECTION; PRECONDITIONING PROTECTS; INFLOW OCCLUSION; FREE-RADICALS; MURINE LIVER	Introduction and Aim: Mangafodipir is a contrast agent used in magnetic resonance imaging that concentrates in the liver and displays pleiotropic antioxidant properties. Since reactive oxygen species are involved in ischemia-reperfusion damages, we hypothesized that the use of mangafodipir could prevent liver lesions in a mouse model of hepatic ischemia reperfusion injury. Mangafodipir (MnDPDP) was compared to ischemic preconditioning and intermittent inflow occlusion for the prevention of hepatic ischemia-reperfusion injury in the mouse. Methods: Mice were subjected to 70% hepatic ischemia (continuous ischemia) for 90 min. Thirty minutes before the ischemic period, either mangafodipir (10 mg/kg) or saline was injected intraperitoneally. Those experimental groups were compared with one group of mice preconditioned by 10 minutes' ischemia followed by 15 minutes' reperfusion, and one group with intermittent inflow occlusion. Hepatic ischemia-reperfusion injury was evaluated by measurement of serum levels of aspartate aminotransferase (ASAT) activity, histologic analysis of the livers, and determination of hepatocyte apoptosis (cytochrome c release, caspase 3 activity). The effect of mangafodipir on the survival rate of mice was studied in a model of total hepatic ischemia. Results: Mangafodipir prevented experimental hepatic ischemia-reperfusion injuries in the mouse as indicated by a reduction in serum ASAT activity (P<0.01), in liver tissue damages, in markers of apoptosis (P<0.01), and by higher rates of survival in treated than in untreated animals (P<0.001). The level of protection by mangafodipir was similar to that observed following intermittent inflow occlusion and higher than after ischemic preconditioning. Conclusions: Mangafodipir is a potential new preventive treatment for hepatic ischemia-reperfusion injury.	[Coriat, Romain; Leconte, Mahaut; Kavian, Niloufar; Bedda, Sassia; Nicco, Carole; Chereau, Christiane; Goulvestre, Claire; Weill, Bernard; Laurent, Alexis; Batteux, Federic] Univ Paris 05, EA1833, Immunol Lab, Fac Med,Hop Cochin,AP HP, Paris, France; [Coriat, Romain] Univ Paris 05, Serv Hepatogastroenterol, Fac Med, Hop Cochin,AP HP, Paris, France; [Leconte, Mahaut] Univ Paris 05, Serv Chirurg Digest, Fac Med, Hop Cochin,AP HP, Paris, France; [Kavian, Niloufar; Goulvestre, Claire; Batteux, Federic] Univ Paris 05, Lab Immunol Biol, Fac Med, Hop Cochin,AP HP, Paris, France; [Laurent, Alexis] Univ Paris 12, Hop Henri Mondor, Serv Chirurg Digest, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Coriat, R (corresponding author), Univ Paris 05, EA1833, Immunol Lab, Fac Med,Hop Cochin,AP HP, Paris, France.	frederic.batteux@cch.aphp.fr	Nicco, Carole/O-8169-2017; Batteux, Frederic/O-7889-2017; Nicco, Carole/X-6726-2019; Coriat, Romain/O-7902-2017; Laurent, Alexis/O-3657-2016	Nicco, Carole/0000-0001-8211-2556; Batteux, Frederic/0000-0002-1265-7996; Nicco, Carole/0000-0001-8211-2556; Laurent, Alexis/0000-0003-1372-0843	French Ministry for Research; Association pour la Recherche sur le Cancer (ARC); National Agency for Valorization of Research (ANVAR); Association Transhepate; Association Benoit Malassagne; Paris-Biotech	French Ministry for Research(Ministry of Research, France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); National Agency for Valorization of Research (ANVAR); Association Transhepate; Association Benoit Malassagne; Paris-Biotech	This work was supported by grants from: French Ministry for Research, Association pour la Recherche sur le Cancer (ARC), National Agency for Valorization of Research (ANVAR), Association Transhepate, Association Benoit Malassagne, and Paris-Biotech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2006, J NATL CANCER I, V98, P236, DOI 10.1093/jnci/djj049; ALI BH, 1993, GEN PHARMACOL, V24, P1279, DOI 10.1016/0306-3623(93)90381-7; ATALLA SL, 1985, TRANSPLANTATION, V40, P584, DOI 10.1097/00007890-198512000-00002; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Bedda S, 2003, J HEPATOL, V39, P765, DOI 10.1016/S0168-8278(03)00325-8; Belghiti J, 1999, ANN SURG, V229, P369, DOI 10.1097/00000658-199903000-00010; Calabrese V, 1996, DRUG EXP CLIN RES, V22, P17; Calabrese V, 1998, DRUG EXP CLIN RES, V24, P85; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; ELIZONDO G, 1991, RADIOLOGY, V178, P73, DOI 10.1148/radiology.178.1.1898538; EZAKI T, 1992, BRIT J SURG, V79, P224, DOI 10.1002/bjs.1800790311; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; GOZZETTI G, 1995, BRIT J SURG, V82, P1105, DOI 10.1002/bjs.1800820833; Hassan-Khabbar S, 2010, BIOCHIMIE, V92, P405, DOI 10.1016/j.biochi.2009.12.009; Hirakawa A, 2003, J SURG RES, V111, P240, DOI 10.1016/S0022-4804(03)00091-X; JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K; KOO A, 1992, HEPATOLOGY, V15, P507, DOI 10.1002/hep.1840150325; Llacuna L, 2009, AM J PATHOL, V174, P1776, DOI 10.2353/ajpath.2009.080857; MAKUUCHI M, 1987, SURG GYNECOL OBSTET, V164, P155; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; MATSUMATA T, 1993, CANCER, V72, P1866, DOI 10.1002/1097-0142(19930915)72:6<1866::AID-CNCR2820720613>3.0.CO;2-F; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; NAGASUE N, 1995, EUR J SURG, V161, P181; Nguyen WD, 1999, CRIT CARE, V3, P127, DOI 10.1186/cc358; Nieuwenhuijs VB, 2006, DIGEST DIS SCI, V51, P1087, DOI 10.1007/s10620-006-8014-y; Peralta C, 2002, TRANSPLANTATION, V73, P1203, DOI 10.1097/00007890-200204270-00004; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rudiger HA, 2003, J HEPATOL, V39, P972, DOI 10.1016/S0168-8278(03)00415-X; Rudiger HA, 2002, ANN SURG, V235, P400; Sasaki H, 1998, TRANSPLANT P, V30, P2958, DOI 10.1016/S0041-1345(98)00887-2; Schauer RJ, 2004, ANN SURG, V239, P220, DOI 10.1097/01.sla.0000110321.64275.95; Sindram D, 2002, J HEPATOL, V36, P78, DOI 10.1016/S0168-8278(01)00229-X; Skjold A, 2004, J MAGN RESON IMAGING, V20, P948, DOI 10.1002/jmri.20200; STEIN HJ, 1991, J SURG RES, V50, P398, DOI 10.1016/0022-4804(91)90209-5; Tejima K, 2004, GASTROENTEROLOGY, V127, P1488, DOI 10.1053/j.gastro.2004.07.023; Yabe Y, 2001, J PHARMACOL EXP THER, V298, P894; Yadav SS, 1998, TRANSPLANTATION, V65, P1433, DOI 10.1097/00007890-199806150-00004; Yuan GJ, 2005, WORLD J GASTROENTERO, V11, P1825; Zhou LZH, 2001, FREE RADICAL BIO MED, V31, P1405, DOI 10.1016/S0891-5849(01)00719-5	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27005	10.1371/journal.pone.0027005	http://dx.doi.org/10.1371/journal.pone.0027005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073237	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900062
J	Quiros, S; Roos, WP; Kaina, B				Quiros, Steve; Roos, Wynand Paul; Kaina, Bernd			Rad51 and BRCA2-New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; MISMATCH REPAIR; TEMOZOLOMIDE; APOPTOSIS; METHYLTRANSFERASE; DAMAGE; MGMT; O-6-METHYLGUANINE	First line chemotherapeutics for brain tumors (malignant gliomas) are alkylating agents such as temozolomide and nimustine. Despite growing knowledge of how these agents work, patients suffering from this malignancy still face a dismal prognosis. Alkylating agents target DNA, forming the killing lesion O-6-alkylguanine, which is converted into DNA double-strand breaks (DSBs) that trigger apoptosis. Here we assessed whether inhibiting repair of DSBs by homologous recombination (HR) or non-homologous end joining (NHEJ) is a reasonable strategy for sensitizing glioma cells to alkylating agents. For down-regulation of HR in glioma cells, we used an interference RNA (iRNA) approach targeting Rad51 and BRCA2, and for NHEJ we employed the DNA-PK inhibitor NU7026. We also assessed whether inhibition of poly(ADP) ribosyltransferase (PARP) by olaparib would enhance the killing effect. The data show that knockdown of Rad51 or BRCA2 greatly sensitizes cells to DSBs and the induction of cell death following temozolomide and nimustine (ACNU). It did not sensitize to ionizing radiation (IR). The expression of O-6-methylguanine-DNA methyltransferase (MGMT) abolished all these effects, indicating that O-6-alkylguanine induced by these drugs is the primary lesion responsible for the formation of DSBs and increased sensitivity of glioma cells following knockdown of Rad51 and BRCA2. Inhibition of DNA-PK only slightly sensitized to temozolomide whereas a significant effect was observed with IR. A triple strategy including siRNA and the PARP inhibitor olaparib further improved the killing effect of temozolomide. The data provides evidence that down-regulation of Rad51 or BRCA2 is a reasonable strategy for sensitizing glioma cells to killing by O-6-alkylating anti-cancer drugs. The data also provide proof of principle that a triple strategy involving down-regulation of HR, PARP inhibition and MGMT depletion may greatly enhance the therapeutic effect of temozolomide.	[Quiros, Steve; Roos, Wynand Paul; Kaina, Bernd] Johannes Gutenberg Univ Mainz, Inst Toxicol, Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz	Quiros, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Toxicol, Med Ctr, D-6500 Mainz, Germany.	kaina@uni-mainz.de	Roos, Wynand/B-4846-2008; Quiros, Steve/A-2969-2015; Kaina, Bernd/AAE-4692-2020	Roos, Wynand/0000-0002-0474-7414; Quiros, Steve/0000-0002-9377-0199; 	Deutsche Forschungsgemeinschaft; German Cancer Research Fund; Deutscher Akademischer Austauschdienst [A/06/05736]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Fund; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	The Deutsche Forschungsgemeinschaft and German Cancer Research Fund supported this work. SQ was supported by the Deutscher Akademischer Austauschdienst (grant A/06/05736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista LFZ, 2007, CANCER RES, V67, P11886, DOI 10.1158/0008-5472.CAN-07-2964; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Boudreau RL, 2010, BRAIN RES, V1338, P112, DOI 10.1016/j.brainres.2010.03.038; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Christmann M, 2010, INT J CANCER, V127, P2106, DOI 10.1002/ijc.25229; CITRON M, 1995, ONCOL RES, V7, P49; Fan S, 2006, BRIT J CANCER, V94, P407, DOI 10.1038/sj.bjc.6602935; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kaina B, 2010, CELL MOL LIFE SCI, V67, P3663, DOI 10.1007/s00018-010-0491-7; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Koch D, 2007, J NEURO-ONCOL, V82, P85, DOI 10.1007/s11060-006-9244-8; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Nikolova T, 2010, DNA REPAIR, V9, P1050, DOI 10.1016/j.dnarep.2010.07.005; Ochs K, 2000, CANCER RES, V60, P5815; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Shao CJ, 2008, J NEURO-ONCOL, V89, P27, DOI 10.1007/s11060-008-9592-7; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Weller M, 1998, INT J CANCER, V79, P640; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527	34	76	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27183	10.1371/journal.pone.0027183	http://dx.doi.org/10.1371/journal.pone.0027183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073281	Green Published, Green Submitted, gold			2022-12-27	WOS:000297154900085
J	Sachs, JL; Russell, JE; Hollowell, AC				Sachs, Joel L.; Russell, James E.; Hollowell, Amanda C.			Evolutionary Instability of Symbiotic Function in Bradyrhizobium japonicum	PLOS ONE			English	Article							RHIZOBIUM-LEGUMINOSARUM; GENETIC-STRUCTURE; TRANSMISSION; MUTUALISM; ISLAND; HOST; SOIL; ASSOCIATION; TRANSITIONS; SYSTEMATICS	Bacterial mutualists are often acquired from the environment by eukaryotic hosts. However, both theory and empirical work suggest that this bacterial lifestyle is evolutionarily unstable. Bacterial evolution outside of the host is predicted to favor traits that promote an independent lifestyle in the environment at a cost to symbiotic function. Consistent with these predictions, environmentally-acquired bacterial mutualists often lose symbiotic function over evolutionary time. Here, we investigate the evolutionary erosion of symbiotic traits in Bradyrhizobium japonicum, a nodulating root symbiont of legumes. Building on a previous published phylogeny we infer loss events of nodulation capability in a natural population of Bradyrhizobium, potentially driven by mutation or deletion of symbiosis loci. Subsequently, we experimentally evolved representative strains from the symbiont population under host-free in vitro conditions to examine potential drivers of these loss events. Among Bradyrhizobium genotypes that evolved significant increases in fitness in vitro, two exhibited reduced symbiotic quality, but no experimentally evolved strain lost nodulation capability or evolved any fixed changes at six sequenced loci. Our results are consistent with trade-offs between symbiotic quality and fitness in a host free environment. However, the drivers of loss-of-nodulation events in natural Bradyrhizobium populations remain unknown.	[Sachs, Joel L.; Russell, James E.; Hollowell, Amanda C.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Sachs, Joel L.; Hollowell, Amanda C.] Univ Calif Riverside, Inst Integrat Genom Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Sachs, JL (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	joels@ucr.edu	Sachs, Joel/AAB-9348-2019	Sachs, Joel/0000-0002-0221-9247	NSF [DEB-0816663]	NSF(National Science Foundation (NSF))	JLS and JER were supported by NSF DEB-0816663 to JLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR BU; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI [10.1111/j.1574-6968.2004.tb09695.x, 10.1016/j.femsle.2004.07.013]; DJORDJEVIC MA, 1982, J BACTERIOL, V151, P560, DOI 10.1128/JB.151.2.560-568.1982; Holland JN, 2009, ECOL LETT, V12, P1357, DOI 10.1111/j.1461-0248.2009.01390.x; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUSSDANELL K, 1986, PLANT SOIL, V90, P407, DOI 10.1007/BF02277412; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Keeler K.H., 1985, P100; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; LAGUERRE G, 1993, CAN J MICROBIOL, V39, P1142, DOI 10.1139/m93-172; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Maddison WP, 2011, MESQUITE MODULAR SYS; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Mueller UG, 2010, ANTON LEEUW INT J G, V98, P195, DOI 10.1007/s10482-010-9427-3; Nishiguchi MK, 2003, INT J SYST EVOL MICR, V53, P2019, DOI 10.1099/ijs.0.02792-0; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Parker MA, 2000, SYST APPL MICROBIOL, V23, P585, DOI 10.1016/S0723-2020(00)80034-X; Pongsilp N, 2002, SYMBIOSIS, V33, P39; RAO JR, 1994, SOIL BIOL BIOCHEM, V26, P339, DOI 10.1016/0038-0717(94)90283-6; Sachs JL, 2006, J EVOLUTION BIOL, V19, P1415, DOI 10.1111/j.1420-9101.2006.01152.x; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1075, DOI 10.1111/j.1420-9101.2010.01980.x; Sachs JL, 2009, APPL ENVIRON MICROB, V75, P4727, DOI 10.1128/AEM.00667-09; Sachs JL, 2008, OIKOS, V117, P961, DOI 10.1111/j.0030-1299.2008.16606.x; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sawada H, 2003, J GEN APPL MICROBIOL, V49, P155, DOI 10.2323/jgam.49.155; SEGOVIA L, 1991, APPL ENVIRON MICROB, V57, P426, DOI 10.1128/AEM.57.2.426-433.1991; SPRENT JI, 1987, PHILOS T R SOC B, V317, P111, DOI 10.1098/rstb.1987.0051; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P98, DOI 10.1093/oxfordjournals.molbev.a026041; ZURKOWSKI W, 1979, ARCH MICROBIOL, V123, P195, DOI 10.1007/BF00446820	49	41	44	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26370	10.1371/journal.pone.0026370	http://dx.doi.org/10.1371/journal.pone.0026370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073160	gold, Green Submitted, Green Published			2022-12-27	WOS:000297154900020
J	Wibisono, HT; Linkie, M; Guillera-Arroita, G; Smith, JA; Sunarto; Pusparini, W; Asriadi; Baroto, P; Brickle, N; Dinata, Y; Gemita, E; Gunaryadi, D; Haidir, IA; Herwansyah; Karina, I; Kiswayadi, D; Kristiantono, D; Kurniawan, H; Lahoz-Monfort, JJ; Leader-Williams, N; Maddox, T; Martyr, DJ; Maryati; Nugroho, A; Parakkasi, K; Priatna, D; Ramadiyanta, E; Ramono, WS; Reddy, GV; Rood, EJJ; Saputra, DY; Sarimudi, A; Salampessy, A; Septayuda, E; Suhartono, T; Sumantri, A; Susilo; Tanjung, I; Tarmizi; Yulianto, K; Yunus, M; Zulfahmi				Wibisono, Hariyo T.; Linkie, Matthew; Guillera-Arroita, Gurutzeta; Smith, Joseph A.; Sunarto; Pusparini, Wulan; Asriadi; Baroto, Pandu; Brickle, Nick; Dinata, Yoan; Gemita, Elva; Gunaryadi, Donny; Haidir, Iding A.; Herwansyah; Karina, Indri; Kiswayadi, Dedy; Kristiantono, Decki; Kurniawan, Harry; Lahoz-Monfort, Jose J.; Leader-Williams, Nigel; Maddox, Tom; Martyr, Deborah J.; Maryati; Nugroho, Agung; Parakkasi, Karmila; Priatna, Dolly; Ramadiyanta, Eka; Ramono, Widodo S.; Reddy, Goddilla V.; Rood, Ente J. J.; Saputra, Doddy Y.; Sarimudi, Ahmad; Salampessy, Adnun; Septayuda, Eka; Suhartono, Tonny; Sumantri, Ade; Susilo; Tanjung, Iswandri; Tarmizi; Yulianto, Koko; Yunus, Mohammad; Zulfahmi			Population Status of a Cryptic Top Predator: An Island-Wide Assessment of Tigers in Sumatran Rainforests	PLOS ONE			English	Article							MODELS	Large carnivores living in tropical rainforests are under immense pressure from the rapid conversion of their habitat. In response, millions of dollars are spent on conserving these species. However, the cost-effectiveness of such investments is poorly understood and this is largely because the requisite population estimates are difficult to achieve at appropriate spatial scales for these secretive species. Here, we apply a robust detection/non-detection sampling technique to produce the first reliable population metric (occupancy) for a critically endangered large carnivore; the Sumatran tiger (Panthera tigris sumatrae). From 2007-2009, seven landscapes were surveyed through 13,511 km of transects in 394 grid cells (17617 km). Tiger sign was detected in 206 cells, producing a naive estimate of 0.52. However, after controlling for an unequal detection probability (where p = 0.13 +/- 0.017; +/- S.E.), the estimated tiger occupancy was 0.72 +/- 0.048. Whilst the Sumatra-wide survey results gives cause for optimism, a significant negative correlation between occupancy and recent deforestation was found. For example, the Northern Riau landscape had an average deforestation rate of 9.8%/yr and by far the lowest occupancy (0.33 +/- 0.055). Our results highlight the key tiger areas in need of protection and have led to one area (Leuser-Ulu Masen) being upgraded as a 'global priority' for wild tiger conservation. However, Sumatra has one of the highest global deforestation rates and the two largest tiger landscapes identified in this study will become highly fragmented if their respective proposed roads networks are approved. Thus, it is vital that the Indonesian government tackles these threats, e. g. through improved land-use planning, if it is to succeed in meeting its ambitious National Tiger Recovery Plan targets of doubling the number of Sumatran tigers by 2022.	[Wibisono, Hariyo T.; Pusparini, Wulan; Baroto, Pandu; Brickle, Nick; Gunaryadi, Donny; Kristiantono, Decki; Salampessy, Adnun; Sumantri, Ade; Susilo; Tanjung, Iswandri] Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia; [Wibisono, Hariyo T.; Sunarto; Pusparini, Wulan; Baroto, Pandu; Dinata, Yoan; Gemita, Elva; Haidir, Iding A.; Herwansyah; Karina, Indri; Kiswayadi, Dedy; Kristiantono, Decki; Kurniawan, Harry; Martyr, Deborah J.; Maryati; Nugroho, Agung; Parakkasi, Karmila; Priatna, Dolly; Ramadiyanta, Eka; Salampessy, Adnun; Septayuda, Eka; Susilo; Tanjung, Iswandri; Tarmizi; Yunus, Mohammad] Forum HarimauKita, Bogor, Indonesia; [Linkie, Matthew; Dinata, Yoan; Gemita, Elva; Martyr, Deborah J.] Fauna & Flora Int, Cambridge, England; [Linkie, Matthew; Leader-Williams, Nigel] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Guillera-Arroita, Gurutzeta; Lahoz-Monfort, Jose J.] Univ Kent, Sch Math Stat & Actuarial Sci, Natl Ctr Stat Ecol, Canterbury CT2 7NZ, Kent, England; [Smith, Joseph A.; Gemita, Elva; Maddox, Tom; Priatna, Dolly; Salampessy, Adnun] Zool Soc London Indonesia Programme, Bogor, Indonesia; [Smith, Joseph A.] Panthera, New York, NY USA; [Sunarto; Kurniawan, Harry; Parakkasi, Karmila; Septayuda, Eka; Yulianto, Koko; Zulfahmi] World Wide Fund Nat Indonesia, Jakarta, Indonesia; [Sunarto] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Kiswayadi, Dedy; Maryati; Nugroho, Agung; Rood, Ente J. J.; Saputra, Doddy Y.] Fauna & Flora Int Indonesia Programme, Jakarta, Indonesia; [Haidir, Iding A.; Suhartono, Tonny] Indonesian Minist Forestry, Jakarta, Indonesia; [Ramadiyanta, Eka; Reddy, Goddilla V.; Sarimudi, Ahmad; Tarmizi] Leuser Int Fdn, Medan, Indonesia; [Leader-Williams, Nigel] Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; [Ramono, Widodo S.] Rhino Fdn Indonesia, Bogor, Indonesia; [Yunus, Mohammad] Sumatran Tiger Conservat Program, Lampung, Indonesia	Wildlife Conservation Society - Indonesia; University of Kent; University of Kent; Virginia Polytechnic Institute & State University; Ministry of Environment & Forestry; University of Cambridge	Wibisono, HT (corresponding author), Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia.	matthew.linkie@fauna-flora.org	Guillera-Arroita, Gurutzeta/F-7461-2015; Wibisono, Hariyo T/I-7511-2019; Lahoz-Monfort, José J/O-3546-2017	Guillera-Arroita, Gurutzeta/0000-0002-8387-5739; Wibisono, Hariyo T/0000-0002-0311-3700; Lahoz-Monfort, José J/0000-0002-0845-7035; Pusparini, Wulan/0000-0001-9909-0920; Dinata, Yoan/0000-0001-5507-3379	United States Fish and Wildlife Service; National Fish and Wildlife Foundation; 21st Century Tiger; Multi-Donor trust Fund for Aceh and Nias Island; Rufford Small Grants; People's Trust for Endangered Species; Panthera; International Rhino Foundation; Darwin Initiative; World Wildlife Fund Networks; Critical Ecosystem Partnership Fund; Virginia Tech; Hurvis Family and Zoo Atlanta; Engineering and Physical Sciences Research Council/National Centre; EPSRC [EP/I000917/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000917/1] Funding Source: researchfish	United States Fish and Wildlife Service(US Fish & Wildlife Service); National Fish and Wildlife Foundation; 21st Century Tiger; Multi-Donor trust Fund for Aceh and Nias Island; Rufford Small Grants; People's Trust for Endangered Species; Panthera; International Rhino Foundation; Darwin Initiative; World Wildlife Fund Networks; Critical Ecosystem Partnership Fund; Virginia Tech; Hurvis Family and Zoo Atlanta; Engineering and Physical Sciences Research Council/National Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was provided by United States Fish and Wildlife Service, National Fish and Wildlife Foundation/Save the Tiger Fund, 21st Century Tiger, Multi-Donor trust Fund for Aceh and Nias Island, Rufford Small Grants, the People's Trust for Endangered Species, Panthera, International Rhino Foundation, Darwin Initiative, World Wildlife Fund Networks, Critical Ecosystem Partnership Fund, Virginia Tech, the Hurvis Family and Zoo Atlanta. The work of GG-A was supported by an Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATBC, 2011, RES OPP ROAD CONSTR; Clements GR, 2010, CONSERV BIOL, V24, P1437, DOI 10.1111/j.1523-1739.2010.01584.x; Government of Aceh, 2007, LOGG MOR TEMP CESS L; Government of Indonesia, 2008, KES BERS SEL GUB SUM; GTI, 2010, GLOB TIG IN NA UNPUB; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Karanth KU, 2011, J APPL ECOL IN PRESS; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Linkie M, 2010, INTEGR ZOOL, V5, P342, DOI 10.1111/j.1749-4877.2010.00215.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Ministry of Forestry of Indonesia, 2010, NAT TIG REC PROGR RO; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Seidensticker J, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P295, DOI 10.1016/B978-0-8155-1570-8.00022-0; Sunquist M. E., 1981, SMITHSONIAN CONTRIB, V336, P1, DOI DOI 10.5479/SI.00810282.336; TILSON RL, 1994, SUMATRAN TIGER POPUL; Wibisono HT, 2010, INTEGR ZOOL, V5, P313, DOI 10.1111/j.1749-4877.2010.00219.x; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; WWF-Indonesia, 2010, SUM FOR THEIR UNPUB	22	51	52	0	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25931	10.1371/journal.pone.0025931	http://dx.doi.org/10.1371/journal.pone.0025931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22087218	Green Published, gold			2022-12-27	WOS:000297154900004
J	Becker, PM; Tran, TS; Delannoy, MJ; He, CX; Shannon, JM; McGrath-Morrow, S				Becker, Patrice M.; Tran, Tracy S.; Delannoy, Michael J.; He, Chaoxia; Shannon, John M.; McGrath-Morrow, Sharon			Semaphorin 3A Contributes to Distal Pulmonary Epithelial Cell Differentiation and Lung Morphogenesis	PLOS ONE			English	Article							AXON GUIDANCE; BRANCHING MORPHOGENESIS; CIGARETTE-SMOKE; GENE-EXPRESSION; NEONATAL MICE; C/EBP-ALPHA; GROWTH; NEUROPILIN; EMPHYSEMA; APOPTOSIS	Rationale: Semaphorin 3A (Sema3A) is a neural guidance cue that also mediates cell migration, proliferation and apoptosis, and inhibits branching morphogenesis. Because we have shown that genetic deletion of neuropilin-1, which encodes an obligatory Sema3A co-receptor, influences airspace remodeling in the smoke-exposed adult lung, we sought to determine whether genetic deletion of Sema3A altered distal lung structure. Methods: To determine whether loss of Sema3A signaling influenced distal lung morphology, we compared pulmonary histology, distal epithelial cell morphology and maturation, and the balance between lung cell proliferation and death, in lungs from mice with a targeted genetic deletion of Sema3A (Sema3A(-/-)) and wild-type (Sema3A(+/+)) littermate controls. Results: Genetic deletion of Sema3A resulted in significant perinatal lethality. At E17.5, lungs from Sema3A(-/-) mice had thickened septae and reduced airspace size. Distal lung epithelial cells had increased intracellular glycogen pools and small multivesicular and lamellar bodies with atypical ultrastructure, as well as reduced expression of type I alveolar epithelial cell markers. Alveolarization was markedly attenuated in lungs from the rare Sema3A(-/-) mice that survived the immediate perinatal period. Furthermore, Sema3A deletion was linked with enhanced postnatal alveolar septal cell death. Conclusions: These data suggest that Sema3A modulates distal pulmonary epithelial cell development and alveolar septation. Defining how Sema3A influences structural plasticity of the developing lung is a critical first step for determining if this pathway can be exploited to develop innovative strategies for repair after acute or chronic lung injury.	[Becker, Patrice M.; He, Chaoxia] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Tran, Tracy S.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Delannoy, Michael J.] Johns Hopkins Univ, Sch Med, Cell Biol Imaging Facil, Baltimore, MD 21205 USA; [McGrath-Morrow, Sharon] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Pulm Med, Baltimore, MD 21205 USA; [Shannon, John M.] Childrens Hosp, Dept Pediat, Med Ctr, Cincinnati, OH 45229 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cincinnati Children's Hospital Medical Center	Becker, PM (corresponding author), Questcor Pharmaceut Inc, Ellicott City, MD USA.	Patrice.Becker@questcor.com	Tran, Tracy/M-2173-2019	Tran, Tracy/0000-0002-2179-5725	National Institutes of Health [RO1HL083286, RO1HL098319]; Flight Attendant Medical Research Institute [CIA 052365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098319, R01HL083286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1HL083286 (PMB), RO1HL098319 (JMS), and Flight Attendant Medical Research Institute CIA 052365 (PMB). No authors have any financial interests related to this work, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Bates D, 2003, DEV BIOL, V255, P77, DOI 10.1016/S0012-1606(02)00045-3; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chen H, 1998, NAT NEUROSCI, V1, P436, DOI 10.1038/2154; Chung L, 2007, DEVELOPMENT, V134, P2935, DOI 10.1242/dev.005066; Cimato T, 2009, CIRCULATION, V119, P2170, DOI 10.1161/CIRCULATIONAHA.109.849596; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Gagliardini V, 1999, MOL CELL NEUROSCI, V14, P301, DOI 10.1006/mcne.1999.0787; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Kagoshima M, 2001, GENES CELLS, V6, P559, DOI 10.1046/j.1365-2443.2001.00441.x; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Le A, 2009, AM J RESP CRIT CARE, V180, P396, DOI 10.1164/rccm.200809-1483OC; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; MASON RJ, 1976, J LIPID RES, V17, P281; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Metzger DE, 2008, DEV BIOL, V320, P149, DOI 10.1016/j.ydbio.2008.04.038; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Reidy KJ, 2009, DEVELOPMENT, V136, P3979, DOI 10.1242/dev.037267; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; Shoji W, 2003, DEVELOPMENT, V130, P3227, DOI 10.1242/dev.00516; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Taraseviciene-Stewart L, 2005, AM J RESP CRIT CARE, V171, P734, DOI 10.1164/rccm.200409-1275OC; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tufro A, 2008, MECH DEVELOP, V125, P558, DOI 10.1016/j.mod.2007.12.003; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC	51	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27449	10.1371/journal.pone.0027449	http://dx.doi.org/10.1371/journal.pone.0027449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096573	Green Submitted, gold, Green Published			2022-12-27	WOS:000297553900045
J	Gendoo, DMA; Harrison, PM				Gendoo, Deena M. A.; Harrison, Paul M.			Origins and Evolution of the HET-s Prion-Forming Protein: Searching for Other Amyloid-Forming Solenoids	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; WD-REPEAT; BETA; ORGANIZATION; SUPERFAMILY; ANNOTATIONS; HOMOLOGY; FIBRILS	The HET-s prion-forming domain from the filamentous fungus Podospora anserina is gaining considerable interest since it yielded the first well-defined atomic structure of a functional amyloid fibril. This structure has been identified as a left-handed beta solenoid with a triangular hydrophobic core. To delineate the origins of the HET-s prion-forming protein and to discover other amyloid-forming proteins, we searched for all homologs of the HET-s protein in a database of protein domains and fungal genomes, using a combined application of HMM, psi-blast and pGenThreader techniques, and performed a comparative evolutionary analysis of the N-terminal alpha-helical domain and the C-terminal prion-forming domain of HET-s. By assessing the tandem evolution of both domains, we observed that the prion-forming domain is restricted to Sordariomycetes, with a marginal additional sequence homolog in Arthroderma otae as a likely case of horizontal transfer. This suggests innovation and rapid evolution of the solenoid fold in the Sordariomycetes clade. In contrast, the N-terminal domain evolves at a slower rate (in Sordariomycetes) and spans many diverse clades of fungi. We performed a full three-dimensional protein threading analysis on all identified HET-s homologs against the HET-s solenoid fold, and present detailed structural annotations for identified structural homologs to the prion-forming domain. An analysis of the physicochemical characteristics in our set of structural models indicates that the HET-s solenoid shape can be readily adopted in these homologs, but that they are all less optimized for fibril formation than the P. anserina HET-s sequence itself, due chiefly to the presence of fewer asparagine ladders and salt bridges. Our combined structural and evolutionary analysis suggests that the HET-s shape has "limited scope" for amyloidosis across the wider protein universe, compared to the 'generic' left-handed beta helix. We discuss the implications of our findings on future identification of amyloid-forming proteins sharing the solenoid fold.	[Gendoo, Deena M. A.; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Gendoo, Deena M. A.; Harrison, Paul M.] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Gendoo, DMA (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca		Gendoo, Deena/0000-0001-8891-4138	PrioNet Canada Network of Centres of Excellence; CIHR McGill University	PrioNet Canada Network of Centres of Excellence; CIHR McGill University(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the PrioNet Canada Network of Centres of Excellence to PMH, and by a CIHR McGill University Systems Biology Training Program to DMAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Choi JH, 2008, PROTEINS, V73, P150, DOI 10.1002/prot.22051; Choi JH, 2009, BIOPHYS J, V97, P3187, DOI 10.1016/j.bpj.2009.09.042; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Cuomo CA, 2010, METHOD ENZYMOL, V470, P833, DOI 10.1016/S0076-6879(10)70034-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dobson CM, 2005, NATURE, V435, P747, DOI 10.1038/435747a; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar N., 2002, CURRENT PROTOCOLS BI; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Greenwald J, 2010, MOL CELL, V38, P889, DOI 10.1016/j.molcel.2010.05.019; Guo JT, 2004, PROTEINS, V57, P357, DOI 10.1002/prot.20222; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P1, DOI 10.1016/S0065-3233(06)73001-7; KAJAVA AV, 2004, SCIENCES, V101, P7885; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; SAUPE SJ, 2011, SEMINARS CE IN PRESS; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Zanuy D, 2006, J MOL BIOL, V358, P330, DOI 10.1016/j.jmb.2006.01.070	51	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27342	10.1371/journal.pone.0027342	http://dx.doi.org/10.1371/journal.pone.0027342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096554	Green Published, Green Submitted, gold			2022-12-27	WOS:000297553900033
J	Burn, CC				Burn, Charlotte C.			A Vicious Cycle: A Cross-Sectional Study of Canine Tail-Chasing and Human Responses to It, Using a Free Video-Sharing Website	PLOS ONE			English	Article							COMPULSIVE DISORDERS; YOUTUBE; DOGS; BEHAVIOR; INFORMATION; DIAGNOSIS	Tail-chasing is widely celebrated as normal canine behaviour in cultural references. However, all previous scientific studies of tail-chasing or 'spinning' have comprised small clinical populations of dogs with neurological, compulsive or other pathological conditions; most were ultimately euthanased. Thus, there is great disparity between scientific and public information on tail-chasing. I gathered data on the first large (n = 400), non-clinical tail-chasing population, made possible through a vast, free, online video repository, YouTube (TM). The demographics of this online population are described and discussed. Approximately one third of tail-chasing dogs showed clinical signs, including habitual (daily or 'all the time') or perseverative (difficult to distract) performance of the behaviour. These signs were observed across diverse breeds. Clinical signs appeared virtually unrecognised by the video owners and commenting viewers; laughter was recorded in 55% of videos, encouragement in 43%, and the commonest viewer descriptors were that the behaviour was 'funny' (46%) or 'cute' (42%). Habitual tail-chasers had 6.5+/-2.3 times the odds of being described as 'Stupid' than other dogs, and perseverative dogs were 6.8+/-2.1 times more frequently described as 'Funny' than distractible ones were. Compared with breed-and age-matched control videos, tail-chasing videos were significantly more often indoors and with a computer/television screen switched on. These findings highlight that tail-chasing is sometimes pathological, but can remain untreated, or even be encouraged, because of an assumption that it is 'normal' dog behaviour. The enormous viewing figures that YouTube (TM) attracts (mean+/-s.e. = 863+/-197 viewings per tail-chasing video) suggest that this perception will be further reinforced, without effective intervention.	Univ London Royal Vet Coll, N Mymms, Herts, England	University of London; University of London Royal Veterinary College	Burn, CC (corresponding author), Univ London Royal Vet Coll, N Mymms, Herts, England.	cburn@rvc.ac.uk	Burn, Charlotte/A-2843-2013	Burn, Charlotte/0000-0002-8734-8610	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The current study was carried out while the author was supported by a Wellcome Trust 'Value in People' Award (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Bauman AE, 2001, MED J AUSTRALIA, V175, P632, DOI 10.5694/j.1326-5377.2001.tb143757.x; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BLACKSHAW JK, 1994, CANINE PRACT, V19, P7; Bowen J., 2005, BEHAV PROBLEMS SMALL; Burn CC, 2010, DOG TAIL CHASING BEH, P165; Burn CC, 2011, VET J, V188, P166, DOI 10.1016/j.tvjl.2010.04.021; Cheng X, 2007, ARXIV07073670V1; Freeman B, 2007, TOB CONTROL, V16, P207, DOI 10.1136/tc.2007.020024; GROSS TL, 1990, VET PATHOL, V27, P61, DOI 10.1177/030098589002700110; HALNAN CRE, 1976, J SMALL ANIM PRACT, V17, P527, DOI 10.1111/j.1748-5827.1976.tb06996.x; Hartigan PJ, 2000, IRISH VET J, V53, P261; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hoehler FK, 2000, J CLIN EPIDEMIOL, V53, P499, DOI 10.1016/S0895-4356(99)00174-2; Hossler EW, 2008, ARCH DERMATOL, V144, P1395, DOI 10.1001/archderm.144.10.1395; Irimajiri M, 2009, JAVMA-J AM VET MED A, V235, P705, DOI 10.2460/javma.235.6.705; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Lindsay SR, 2001, HDB APPL DOG BEHAV T, V2, P131; Linkletter M, 2010, CLIN PEDIATR, V49, P274, DOI 10.1177/0009922809339203; Luescher AU, 2004, CLIN TECH SMALL AN P, V19, P233, DOI 10.1053/j.ctsap.2004.10.005; Lynch M, 2010, APPETITE, V54, P591, DOI 10.1016/j.appet.2010.02.006; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Moon-Fanelli AA, 1998, J AM VET MED ASSOC, V212, P1252; Packer RMA, 2011, UFAW INT AN WELF S; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Pereira J.T., 2010, J VET BEHAV, V5, P165; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Rowling JK, 2003, HARRY POTTER ORDER P; Schneider BM, 2009, J VET BEHAV, V4, P118, DOI 10.1016/j.jveb.2008.10.008; Small A, 1994, WORLDS GREATEST CLAS; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; Yalcin E, 2010, TIERAERZTL PRAX K H, V38, P295; Yalcin E, 2009, J SMALL ANIM PRACT, V50, P133, DOI 10.1111/j.1748-5827.2008.00704.x	37	36	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26553	10.1371/journal.pone.0026553	http://dx.doi.org/10.1371/journal.pone.0026553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096487	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800008
J	Lei, XH; Ning, LN; Cao, YJ; Liu, S; Zhang, SB; Qiu, ZF; Hu, HM; Zhang, HS; Liu, S; Duan, EK				Lei, Xiao-hua; Ning, Li-na; Cao, Yu-jing; Liu, Shuang; Zhang, Shou-bing; Qiu, Zhi-fang; Hu, Hui-min; Zhang, Hui-shan; Liu, Shu; Duan, En-kui			NASA-Approved Rotary Bioreactor Enhances Proliferation of Human Epidermal Stem Cells and Supports Formation of 3D Epidermis-Like Structure	PLOS ONE			English	Article							MODELED MICROGRAVITY; DIFFERENTIATION; CULTURE; KERATINOCYTE; MICROCARRIERS	The skin is susceptible to different injuries and diseases. One major obstacle in skin tissue engineering is how to develop functional three-dimensional (3D) substitute for damaged skin. Previous studies have proved a 3D dynamic simulated microgravity (SMG) culture system as a "stimulatory'' environment for the proliferation and differentiation of stem cells. Here, we employed the NASA-approved rotary bioreactor to investigate the proliferation and differentiation of human epidermal stem cells (hEpSCs). hEpSCs were isolated from children foreskins and enriched by collecting epidermal stem cell colonies. Cytodex-3 micro-carriers and hEpSCs were co-cultured in the rotary bioreactor and 6-well dish for 15 days. The result showed that hEpSCs cultured in rotary bioreactor exhibited enhanced proliferation and viability surpassing those cultured in static conditions. Additionally, immunostaining analysis confirmed higher percentage of ki67 positive cells in rotary bioreactor compared with the static culture. In contrast, comparing with static culture, cells in the rotary bioreactor displayed a low expression of involucrin at day 10. Histological analysis revealed that cells cultured in rotary bioreactor aggregated on the micro-carriers and formed multilayer 3D epidermis structures. In conclusion, our research suggests that NASA-approved rotary bioreactor can support the proliferation of hEpSCs and provide a strategy to form multilayer epidermis structure.	[Lei, Xiao-hua; Ning, Li-na; Cao, Yu-jing; Liu, Shuang; Zhang, Shou-bing; Qiu, Zhi-fang; Hu, Hui-min; Zhang, Hui-shan; Liu, Shu; Duan, En-kui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Liu, Shuang; Zhang, Shou-bing; Hu, Hui-min; Zhang, Hui-shan; Liu, Shu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lei, XH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	duane@ioz.ac.cn	Qiu, Zhifang/P-8313-2014; Lei, Xiaohua/J-7020-2019	Lei, Xiaohua/0000-0001-8095-9008; Qiu, Zhifang/0000-0001-9196-032X	National Basic Research Program of China [2011CB710905]; Chinese Academy of Sciences [XDA01010202, KSCX2-YW-R-228, KJCX2-YW-L08]; National Natural Science Foundation of China [30971671]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China Grant (2011CB710905), Strategic Priority Research Program of the Chinese Academy of Sciences Grant (XDA01010202), National Natural Science Foundation of China Grants (30971671), and Chinese Academy of Sciences Knowledge Innovation Program Grant (KSCX2-YW-R-228) and (KJCX2-YW-L08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Charruyer A, 2009, SKIN PHARMACOL PHYS, V22, P55, DOI 10.1159/000178864; Chen JS, 2007, ARTIF ORGANS, V31, P722, DOI 10.1111/j.1525-1594.2007.00440.x; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Duray P H, 1997, Sci Med (Phila), V4, P46; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Egberts F, 2004, J CELL SCI, V117, P2295, DOI 10.1242/jcs.01075; Facer SR, 2005, J DENT RES, V84, P542, DOI 10.1177/154405910508400611; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Jia LW, 2008, BIOCHEM BIOPH RES CO, V368, P483, DOI 10.1016/j.bbrc.2008.01.097; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; LEWIS ML, 1993, J CELL BIOCHEM, V51, P265, DOI 10.1002/jcb.240510305; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371; Meuli M, 1997, PEDIATR SURG INT, V12, P471, DOI 10.1007/BF01258705; Navran S, 2008, BIOTECHNOL ANN REV, V14, P275, DOI 10.1016/S1387-2656(08)00011-2; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Qiu Q, 1998, TISSUE ENG, V4, P19, DOI 10.1089/ten.1998.4.19; Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Voigt M, 1999, TISSUE ENG, V5, P563, DOI 10.1089/ten.1999.5.563; Watt FM, 2002, J DERMATOL SCI, V28, P173, DOI 10.1016/S0923-1811(02)00003-8; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Yuge L, 2011, STEM CELLS DEV, V20, P893, DOI 10.1089/scd.2010.0294	37	59	65	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26603	10.1371/journal.pone.0026603	http://dx.doi.org/10.1371/journal.pone.0026603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096490	Green Submitted, Green Published, gold			2022-12-27	WOS:000297350800010
J	Schue, M; Fekete, A; Ortet, P; Brutesco, C; Heulin, T; Schmitt-Kopplin, P; Achouak, W; Santaella, C				Schue, Mathieu; Fekete, Agnes; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Schmitt-Kopplin, Philippe; Achouak, Wafa; Santaella, Catherine			Modulation of Metabolism and Switching to Biofilm Prevail over Exopolysaccharide Production in the Response of Rhizobium alamii to Cadmium	PLOS ONE			English	Article							HEAVY-METAL RESISTANCE; LEGUMINOSARUM BV VICIAE; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; BRASSICA-NAPUS; GLUTATHIONE; MECHANISMS; STRAIN; SEQUESTRATION; NICKEL	Heavy metals such as cadmium (Cd2+) affect microbial metabolic processes. Consequently, bacteria adapt by adjusting their cellular machinery. We have investigated the dose-dependent growth effects of Cd2+ on Rhizobium alamii, an exopolysaccharide (EPS)-producing bacterium that forms a biofilm on plant roots. Adsorption isotherms show that the EPS of R. alamii binds cadmium in competition with calcium. A metabonomics approach based on ion cyclotron resonance Fourier transform mass spectrometry has showed that cadmium alters mainly the bacterial metabolism in pathways implying sugars, purine, phosphate, calcium signalling and cell respiration. We determined the influence of EPS on the bacterium response to cadmium, using a mutant of R. alamii impaired in EPS production (MS Delta GT). Cadmium dose-dependent effects on the bacterial growth were not significantly different between the R. alamii wild type (wt) and MSDGT strains. Although cadmium did not modify the quantity of EPS isolated from R. alamii, it triggered the formation of biofilm vs planktonic cells, both by R. alamii wt and by MS Delta GT. Thus, it appears that cadmium toxicity could be managed by switching to a biofilm way of life, rather than producing EPS. We conclude that modulations of the bacterial metabolism and switching to biofilms prevails in the adaptation of R. alamii to cadmium. These results are original with regard to the conventional role attributed to EPS in a biofilm matrix, and the bacterial response to cadmium.	[Schue, Mathieu; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Achouak, Wafa; Santaella, Catherine] CEA, Lab Ecol Microbienne Rhizosphere & Environm Extre, iBEB, DSV, St Paul Les Durance, France; [Schue, Mathieu; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Achouak, Wafa; Santaella, Catherine] CNRS, Unite Mixte Rech Biol Vegetale & Microbiol Enviro, UMR 6191, St Paul Les Durance, France; [Schue, Mathieu; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Achouak, Wafa; Santaella, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Fekete, Agnes; Schmitt-Kopplin, Philippe] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Ecol Chem, Dept BioGeochem & Anal, Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Dept Chem, Tech Anal Res Ctr Weihenstephan Brewing & Food Qu, D-8050 Freising Weihenstephan, Germany	CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Schue, M (corresponding author), CNRS, UPR 9025, Lab Enzymol Interfaciale & Physiol Lipolyse, Marseille, France.	catherine.santaella@cea.fr	, HEULIN/C-1689-2010; Schmitt-Kopplin, Philippe/H-6271-2011; SANTAELLA, Catherine/J-7967-2016; Achouak, Wafa/AAX-8916-2021; Fekete, Agnes/C-8048-2019; ORTET, Philippe/T-8172-2018	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; SANTAELLA, Catherine/0000-0003-3878-2733; Achouak, Wafa/0000-0003-4297-6661; Fekete, Agnes/0000-0003-3058-7570; ORTET, Philippe/0000-0002-2648-8978	French inter organism program "Toxicologie Nucleaire Environnementale''	French inter organism program "Toxicologie Nucleaire Environnementale''	This work was supported by the French inter organism program "Toxicologie Nucleaire Environnementale'' (Environmental Nuclear Toxicology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKING H, 1984, APPL ENVIRON MICROB, V47, P374, DOI 10.1128/AEM.47.2.374-377.1984; Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; Pereira SIA, 2006, MICROB ECOL, V52, P176, DOI 10.1007/s00248-006-9057-5; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; BLAKE RC, 1993, ENVIRON TOXICOL CHEM, V12, P1365, DOI 10.1002/etc.5620120806; Bouchelaghem W, 2006, ACTA CRYSTALLOGR E, V62, pI99, DOI 10.1107/S1600536806008397; CHEN JH, 1995, ENVIRON HEALTH PERSP, V103, P53, DOI 10.2307/3432013; Czajka DR, 1997, WATER RES, V31, P2827, DOI 10.1016/S0043-1354(97)00129-2; Dedieu K, 2006, ENVIRON CHEM, V3, P424, DOI 10.1071/EN06063; Figueira EMDP, 2005, CAN J MICROBIOL, V51, P7, DOI [10.1139/w04-101, 10.1139/W04-101]; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FOSTER TJ, 1983, MICROBIOL REV, V47, P361, DOI 10.1128/MMBR.47.3.361-409.1983; Fujishige NA, 2006, BOT J LINN SOC, V150, P79, DOI 10.1111/j.1095-8339.2006.00492.x; Gracy RW, 1999, MUTAT RES-FUND MOL M, V428, P17, DOI 10.1016/S1383-5742(99)00027-7; Lima AIG, 2006, ENZYME MICROB TECH, V39, P763, DOI 10.1016/j.enzmictec.2005.12.009; HEBBAR KP, 1992, APPL MICROBIOL BIOT, V38, P248, DOI 10.1007/BF00174477; HIGHAM DP, 1984, SCIENCE, V225, P1043, DOI 10.1126/science.225.4666.1043; Holmes JD, 1997, MICROBIOL-UK, V143, P2521, DOI 10.1099/00221287-143-8-2521; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; Lamelas C, 2006, CHEMOSPHERE, V65, P1362, DOI 10.1016/j.chemosphere.2006.04.021; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MITRA RS, 1975, J BACTERIOL, V121, P1180, DOI 10.1128/JB.121.3.1180-1188.1975; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Morgante C, 2007, SOIL BIOL BIOCHEM, V39, P1222, DOI 10.1016/j.soilbio.2006.11.022; NELSON YM, 1995, WATER RES, V29, P1934, DOI 10.1016/0043-1354(94)00351-7; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pacheco CC, 2008, ARCH MICROBIOL, V189, P271, DOI 10.1007/s00203-007-0316-8; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Pages D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001539; Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Ron Eliora Z., 1992, Biodegradation, V3, P161, DOI 10.1007/BF00129081; Santaella C, 2008, ENVIRON MICROBIOL, V10, P2150, DOI 10.1111/j.1462-2920.2008.01650.x; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Slaveykova VI, 2010, ENVIRON POLLUT, V158, P2561, DOI 10.1016/j.envpol.2010.05.016; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003; TRINICK MJ, 1995, PLANT SOIL, V172, P207, DOI 10.1007/BF00011323; Vicre M, 2005, PLANT PHYSIOL, V138, P998, DOI 10.1104/pp.104.051813; Villain-Simonnet A, 2000, INT J BIOL MACROMOL, V27, P65, DOI 10.1016/S0141-8130(99)00120-8; VOLESKY B, 1987, TRENDS BIOTECHNOL, V5, P96, DOI 10.1016/0167-7799(87)90027-8; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Zhou WZ, 2009, COLLOID SURFACE B, V72, P295, DOI 10.1016/j.colsurfb.2009.04.018	47	20	24	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26771	10.1371/journal.pone.0026771	http://dx.doi.org/10.1371/journal.pone.0026771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096497	Green Submitted, gold, Green Published			2022-12-27	WOS:000297350800013
J	Lin, DCH; Zhang, J; Zhuang, R; Li, F; Nguyen, K; Chen, M; Tran, T; Lopez, E; Lu, JYL; Li, XYNN; Tang, L; Tonn, GR; Swaminath, G; Reagan, JD; Chen, JL; Tian, H; Lin, YJ; Houze, JB; Luo, J				Lin, Daniel C. -H.; Zhang, Jane; Zhuang, Run; Li, Frank; Kathy Nguyen; Chen, Michael; Thanhvien Tran; Lopez, Edwin; Lu, Jenny Ying Lin; Li, Xiaoyan Nina; Tang, Liang; Tonn, George R.; Swaminath, Gayathri; Reagan, Jeff D.; Chen, Jin-Long; Tian, Hui; Lin, Yi-Jyun; Houze, Jonathan B.; Luo, Jian			AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROTEIN-COUPLED RECEPTORS; FATTY-ACID STIMULATION; OBESE FA/FA RATS; DISCOVERY; GENE; TOLERANCE; RELEASE; POTENT; MICE	Agonists of GPR40 (FFA1) have been proposed as a means to treat type 2 diabetes. Through lead optimization of a high throughput screening hit, we have identified a novel GPR40 agonist called AMG 837. The objective of these studies was to understand the preclinical pharmacological properties of AMG 837. The activity of AMG 837 on GPR40 was characterized through GTP gamma S binding, inositol phosphate accumulation and Ca2+ flux assays. Activity of AMG 837 on insulin release was assessed on isolated primary mouse islets. To determine the anti-diabetic activity of AMG 837 in vivo, we tested AMG 837 using a glucose tolerance test in normal Sprague-Dawley rats and obese Zucker fatty rats. AMG 837 was a potent partial agonist in the calcium flux assay on the GPR40 receptor and potentiated glucose stimulated insulin secretion in vitro and in vivo. Acute administration of AMG 837 lowered glucose excursions and increased glucose stimulated insulin secretion during glucose tolerance tests in both normal and Zucker fatty rats. The improvement in glucose excursions persisted following daily dosing of AMG 837 for 21-days in Zucker fatty rats. Preclinical studies demonstrated that AMG 837 was a potent GPR40 partial agonist which lowered post-prandial glucose levels. These studies support the potential utility of AMG 837 for the treatment of type 2 diabetes.	[Lin, Daniel C. -H.; Zhang, Jane; Zhuang, Run; Li, Frank; Kathy Nguyen; Chen, Michael; Thanhvien Tran; Lopez, Edwin; Lu, Jenny Ying Lin; Li, Xiaoyan Nina; Swaminath, Gayathri; Reagan, Jeff D.; Chen, Jin-Long; Tian, Hui; Lin, Yi-Jyun; Luo, Jian] Amgen Inc, Metab Disorders, San Francisco, CA USA; [Houze, Jonathan B.] Amgen Inc, Chem Res & Discovery, San Francisco, CA USA; [Tang, Liang; Tonn, George R.] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA	Amgen; Amgen; Amgen	Lin, DCH (corresponding author), Amgen Inc, Metab Disorders, San Francisco, CA USA.	dclin@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	This study was supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Bharate SB, 2008, BIOORG MED CHEM LETT, V18, P6357, DOI 10.1016/j.bmcl.2008.10.085; Boneva NB, 2009, HIPPOCAMPUS; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Del Guerra S, 2010, NUTR METAB CARDIOVAS, V20, P22, DOI 10.1016/j.numecd.2009.02.008; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; IONESCU E, 1985, AM J PHYSIOL, V248, pE500, DOI 10.1152/ajpendo.1985.248.5.E500; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Madiraju SRM, 2007, ENDOCRINOLOGY, V148, P2598, DOI 10.1210/en.2007-0336; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Naik H., 2011, J CLIN PHARM; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Sasaki S, 2011, J MED CHEM, V54, P1365, DOI 10.1021/jm101405t; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; TERRETTAZ J, 1986, ENDOCRINOLOGY, V118, P674, DOI 10.1210/endo-118-2-674; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tomita T, 2005, BIOCHEM BIOPH RES CO, V338, P1788, DOI 10.1016/j.bbrc.2005.10.161; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Walker SD, 2011, ORG PROCESS RES DEV, V15, P570, DOI 10.1021/op1003055	37	64	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27270	10.1371/journal.pone.0027270	http://dx.doi.org/10.1371/journal.pone.0027270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087278	Green Published, gold, Green Submitted			2022-12-27	WOS:000297349700025
J	Neddens, J; Buonanno, A				Neddens, Joerg; Buonanno, Andres			Expression of the Neuregulin Receptor ErbB4 in the Brain of the Rhesus Monkey (Macaca mulatta)	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PARVALBUMIN-POSITIVE INTERNEURONS; CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; DIFFERENTIAL EXPRESSION; GABAERGIC INTERNEURONS; SEXUAL DEVELOPMENT; RETICULAR NUCLEUS; PREFRONTAL CORTEX; RAT HIPPOCAMPUS	We demonstrated recently that frontal cortical expression of the Neuregulin (NRG) receptor ErbB4 is restricted to interneurons in rodents, macaques, and humans. However, little is known about protein expression patterns in other areas of the brain. In situ hybridization studies have shown high ErbB4 mRNA levels in various subcortical areas, suggesting that ErbB4 is also expressed in cell types other than cortical interneurons. Here, using highly-specific monoclonal antibodies, we provide the first extensive report of ErbB4 protein expression throughout the cerebrum of primates. We show that ErbB4 immunoreactivity is high in association cortices, intermediate in sensory cortices, and relatively low in motor cortices. The overall immunoreactivity in the hippocampal formation is intermediate, but is high in a subset of interneurons. We detected the highest overall immunoreactivity in distinct locations of the ventral hypothalamus, medial habenula, intercalated nuclei of the amygdala and structures of the ventral forebrain, such as the islands of Calleja, olfactory tubercle and ventral pallidum, and medium expression in the reticular thalamic nucleus. While this pattern is generally consistent with ErbB4 mRNA expression data, further investigations are needed to identify the exact cellular and subcellular sources of mRNA and protein expression in these areas. In contrast to in situ hybridization in rodents, we detected only low levels of ErbB4-immunoreactivity in mesencephalic dopaminergic nuclei but a diffuse pattern of immunofluorescence that was medium in the dorsal striatum and high in the ventral forebrain, suggesting that most ErbB4 protein in dopaminergic neurons could be transported to axons. We conclude that the NRG-ErbB4 signaling pathway can potentially influence many functional systems throughout the brain of primates, and suggest that major sites of action are areas of the "corticolimbic" network. This interpretation is functionally consistent with the genetic association of NRG1 and ERBB4 with schizophrenia.	[Neddens, Joerg; Buonanno, Andres] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurobiol Sect, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Neddens, J (corresponding author), JSW Life Sci GmbH, Dept Histol, Grambach, Austria.	jneddens@jsw-lifesciences.com			Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institutes of Health. Neither institution had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Arabadzisz D, 1999, NEUROSCIENCE, V92, P27, DOI 10.1016/S0306-4522(98)00736-2; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bernstein HG, 2006, BRAIN RES BULL, V69, P546, DOI 10.1016/j.brainresbull.2006.02.017; Bin Kwon O, 2008, P NATL ACAD SCI USA, V105, P15587, DOI 10.1073/pnas.0805722105; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Burns LH, 1996, BEHAV NEUROSCI, V110, P60, DOI 10.1037/0735-7044.110.1.60; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chen XM, 1996, J BIOL CHEM, V271, P7620, DOI 10.1074/jbc.271.13.7620; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Coyle Joseph T, 2010, Dialogues Clin Neurosci, V12, P359; Csillik B, 2005, J CHEM NEUROANAT, V30, P17, DOI 10.1016/j.jchemneu.2005.03.010; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Disney AA, 2008, J COMP NEUROL, V507, P1748, DOI 10.1002/cne.21616; Elman I, 2006, NEUROPSYCHOPHARMACOL, V31, P2091, DOI [10.1038/sj.npp.1301141, 10.1038/sj.npp.1301051]; Faure A, 2008, J NEUROSCI, V28, P7184, DOI 10.1523/JNEUROSCI.4961-07.2008; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; Ganzel BL, 2010, PSYCHOL REV, V117, P134, DOI 10.1037/a0017773; Georgieva L, 2008, BIOL PSYCHIAT, V64, P419, DOI 10.1016/j.biopsych.2008.03.025; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Higo N, 2007, BRAIN RES, V1171, P30, DOI 10.1016/j.brainres.2007.07.054; Hou JW, 2002, ENDOCRINOLOGY, V143, P1901, DOI 10.1210/en.143.5.1901; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Krivosheya D, 2008, J BIOL CHEM; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Laviolette SR, 2007, SCHIZOPHRENIA BULL, V33, P971, DOI 10.1093/schbul/sbm048; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Logothetis NK, 2007, COMBINED MRI HISTOLO; Ma YJ, 1999, J NEUROSCI, V19, P9913; McMahon LL, 1998, J NEUROSCI, V18, P5640; Meyer D, 1997, DEVELOPMENT, V124, P3575; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Neddens J, 2011, BIOL PSYCHIAT, V70, P636, DOI 10.1016/j.biopsych.2011.04.016; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Nicodemus KK, 2010, ARCH GEN PSYCHIAT, V67, P991, DOI 10.1001/archgenpsychiatry.2010.117; PinkasKramarski R, 1997, ONCOGENE, V15, P2803, DOI 10.1038/sj.onc.1201466; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Prata DP, 2009, PSYCHIAT GENET, V19, P113, DOI 10.1097/YPG.0b013e32832a4f69; Prevot V, 2003, J NEUROSCI, V23, P230; Rosler TW, 2011, NEUROPHARMACOLOGY; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Sharif A, 2009, GLIA, V57, P362, DOI 10.1002/glia.20762; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Singec I, 2004, J COMP NEUROL, V479, P30, DOI 10.1002/cne.20302; SORIANO E, 1993, J COMP NEUROL, V333, P435, DOI 10.1002/cne.903330309; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; Swerdlow NR, 2010, CURR TOP BEHAV NEURO, V4, P555, DOI 10.1007/7854_2010_48; Thompson M, 2007, BRAIN RES, V1139, P95, DOI 10.1016/j.brainres.2006.11.047; Thuret S, 2004, J NEUROCHEM, V91, P1302, DOI 10.1111/j.1471-4159.2004.02809.x; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	69	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27337	10.1371/journal.pone.0027337	http://dx.doi.org/10.1371/journal.pone.0027337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087295	gold, Green Published, Green Submitted			2022-12-27	WOS:000297349700033
J	Bhattacharjee, M; Sillanpaa, MJ				Bhattacharjee, Madhuchhanda; Sillanpaa, Mikko J.			A Bayesian Mixed Regression Based Prediction of Quantitative Traits from Molecular Marker and Gene Expression Data	PLOS ONE			English	Article							VARIABLE SELECTION; GENOMIC SELECTION; CROSS-VALIDATION; LASSO; MODELS	Both molecular marker and gene expression data were considered alone as well as jointly to serve as additive predictors for two pathogen-activity-phenotypes in real recombinant inbred lines of soybean. For unobserved phenotype prediction, we used a Bayesian hierarchical regression modeling, where the number of possible predictors in the model was controlled by different selection strategies tested. Our initial findings were submitted for DREAM5 (the 5th Dialogue on Reverse Engineering Assessment and Methods challenge) and were judged to be the best in sub-challenge B3 wherein both functional genomic and genetic data were used to predict the phenotypes. In this work we further improve upon this previous work by considering various predictor selection strategies and cross-validation was used to measure accuracy of in-data and out-data predictions. The results from various model choices indicate that for this data use of both data types (namely functional genomic and genetic) simultaneously improves out-data prediction accuracy. Adequate goodness-of-fit can be easily achieved with more complex models for both phenotypes, since the number of potential predictors is large and the sample size is not small. We also further studied gene-set enrichment (for continuous phenotype) in the biological process in question and chromosomal enrichment of the gene set. The methodological contribution of this paper is in exploration of variable selection techniques to alleviate the problem of over-fitting. Different strategies based on the nature of covariates were explored and all methods were implemented under the Bayesian hierarchical modeling framework with indicator-based covariate selection. All the models based in careful variable selection procedure were found to produce significant results based on permutation test.	[Bhattacharjee, Madhuchhanda] Univ Pune, Dept Stat, Pune, Maharashtra, India; [Sillanpaa, Mikko J.] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Sillanpaa, Mikko J.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Biol, Oulu, Finland	Savitribai Phule Pune University; University of Helsinki; University of Helsinki; University of Oulu; University of Oulu	Bhattacharjee, M (corresponding author), Univ Pune, Dept Stat, Pune, Maharashtra, India.	chhanda.bhatta@gmail.com	Bhattacharjee, Madhuchhanda/ABI-3732-2020	Bhattacharjee, Madhuchhanda/0000-0002-8700-376X; Sillanpaa, Mikko J./0000-0003-2808-2768	Academy of Finland; University of Helsinki	Academy of Finland(Academy of Finland); University of Helsinki	This work was supported by a research grant from the Academy of Finland and the University of Helsinki's research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bhattacharjee M, 2004, BIOINFORMATICS, V20, P2943, DOI 10.1093/bioinformatics/bth338; Bhattacharjee M, 2008, GENOMICS, V92, P384, DOI 10.1016/j.ygeno.2008.06.006; Bhattacharjee M, 2009, METHODS MICROARRAY D, P15; Caruana R., 2003, Journal of Machine Learning Research, V3, P1245, DOI 10.1162/153244303322753652; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang LC, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-81; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Lee E, 2009, GENOMICS, V94, P269, DOI 10.1016/j.ygeno.2009.06.002; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Lee SH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-22; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Mackay Trudy F C, 2009, J Biol, V8, P23, DOI 10.1186/jbiol133; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Paul D, 2008, ANN STAT, V36, P1595, DOI 10.1214/009053607000000578; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Sillanpaa MJ, 2005, GENETICS, V169, P427, DOI 10.1534/genetics.104.032680; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; West M, 2006, GENOME RES, V16, P559, DOI 10.1101/gr.3851306; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26959	10.1371/journal.pone.0026959	http://dx.doi.org/10.1371/journal.pone.0026959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087238	Green Submitted, Green Published, gold			2022-12-27	WOS:000297347700013
J	Prakash, R; Raja, SB; Devaraj, H; Devaraj, SN				Prakash, Radhakrishnan; Raja, Subramaniya Bharathi; Devaraj, Halagowder; Devaraj, Sivasitambaram Niranjali			Up-Regulation of MUC2 and IL-1 beta Expression in Human Colonic Epithelial Cells by Shigella and Its Interaction with Mucins	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENTEROPATHOGENIC ESCHERICHIA-COLI; GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA; IN-VITRO; PROINFLAMMATORY CYTOKINES; YERSINIA-ENTEROCOLITICA; HELICOBACTER-PYLORI; ADHESIVE PROPERTIES; INTESTINAL MUCINS	Background: The entire gastrointestinal tract is protected by a mucous layer, which contains complex glycoproteins called mucins. MUC2 is one such mucin that protects the colonic mucosa from invading microbes. The initial interaction between microbes and mucins is an important step for microbial pathogenesis. Hence, it was of interest to investigate the relationship between host (mucin) and pathogen interaction, including Shigella induced expression of MUC2 and IL-1 beta during shigellosis. Methods: The mucin-Shigella interaction was revealed by an in vitro mucin-binding assay. Invasion of Shigella dysenteriae into HT-29 cells was analyzed by Transmission electron microscopy. Shigella induced mucin and IL-1 beta expression were analyzed by RT-PCR and Immunofluorescence. Results: The clinical isolates of Shigella were found to be virulent by a congo-red binding assay. The in vitro mucin-binding assay revealed both Shigella dysenteriae and Shigella flexneri have binding affinity in the increasing order of: guinea pig small intestinal mucin, guinea pig colonic mucin, Human colonic mucin. Invasion of Shigella dysenteriae into HT-29 cells occurs within 2 hours. Interestingly, in Shigella dysenteriae infected conditions, significant increases in mRNA expression of MUC2 and IL-1 beta were observed in a time dependent manner. Further, immunofluorescence analysis of MUC2 shows more positive cells in Shigella dysenteriae treated cells than untreated cells. Conclusions: Our study concludes that the Shigella species specifically binds to guinea pig colonic mucin, but not to guinea pig small intestinal mucin. The guinea pig colonic mucin showed a greater binding parameter (R), and more saturable binding, suggesting the presence of a finite number of receptor binding sites in the colonic mucin of the host. In addition, modification of mucins with TFMS and sodium metaperiodate significantly reduced mucin-bacterial binding; suggesting that the mucin-Shigella interaction occurs through carbohydrate epitopes on the mucin backbones. Overproduction of MUC2 may alter adherence and invasion of Shigella dysenteriae into human colonic epithelial cells.	[Prakash, Radhakrishnan; Raja, Subramaniya Bharathi; Devaraj, Sivasitambaram Niranjali] Univ Madras, Dept Biochem, Madras, Tamil Nadu, India; [Devaraj, Halagowder] Univ Madras, Dept Zool, Biochem Unit, Madras, Tamil Nadu, India	University of Madras; University of Madras	Prakash, R (corresponding author), Univ Madras, Dept Biochem, Guindy Campus, Madras, Tamil Nadu, India.	niranjali@yahoo.com	Subramaniya, Bharathi raja/A-7024-2012	S, BHARATHIRAJA/0000-0002-5680-7036	University Grants Commission (UGC), New Delhi, India	University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	This work was supported by the University Grants Commission (UGC), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BUYSSE JM, 1987, J BACTERIOL, V169, P2561, DOI 10.1128/jb.169.6.2561-2569.1987; Dabbagh K, 1999, J IMMUNOL, V162, P6233; DAVIES J, 1995, INFECT IMMUN, V63, P2485, DOI 10.1128/IAI.63.7.2485-2492.1995; DEVARAJ H, 1993, ARCH BIOCHEM BIOPHYS, V302, P285, DOI 10.1006/abbi.1993.1212; DEVARAJ N, 1994, GLYCOBIOLOGY, V4, P307, DOI 10.1093/glycob/4.3.307; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113; Duguid JP, 1980, BACTERIAL ADHERENC B, V6, P184; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; EMBAYE H, 1989, GASTROENTEROLOGY, V96, P1079, DOI 10.1016/0016-5085(89)91626-0; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; FORMAL SB, 1991, J INFECT DIS, V164, P533, DOI 10.1093/infdis/164.3.533; FORSTNER JF, 1978, DIGESTION, V17, P234, DOI 10.1159/000198115; FRETER R, 1976, INFECT IMMUN, V14, P246, DOI 10.1128/IAI.14.1.246-256.1976; Guthrie RD, 1962, METHODS CARBOHYDRATE, V1, P432; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kim YD, 2002, MOL PHARMACOL, V62, P1112, DOI 10.1124/mol.62.5.1112; Kim YD, 2000, BIOCHEM BIOPH RES CO, V274, P112, DOI 10.1006/bbrc.2000.3107; KNUTTON S, 1987, INFECT IMMUN, V55, P78, DOI 10.1128/IAI.55.1.78-85.1987; KRIVAN HC, 1988, ARCH BIOCHEM BIOPHYS, V260, P493, DOI 10.1016/0003-9861(88)90473-0; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Lin JH, 2000, J INFECT DIS, V182, P882, DOI 10.1086/315767; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; MANTLE M, 1994, INFECT IMMUN, V62, P1219, DOI 10.1128/IAI.62.4.1219-1227.1994; MANTLE M, 1989, INFECT IMMUN, V57, P3292, DOI 10.1128/IAI.57.11.3292-3299.1989; MOURICOUT MA, 1987, INFECT IMMUN, V55, P1216, DOI 10.1128/IAI.55.5.1216-1223.1987; Nutten S, 2002, MICROBES INFECT, V4, P1121, DOI 10.1016/S1286-4579(02)01636-2; PAL T, 1989, INFECT IMMUN, V57, P2580; Parsot C, 1996, CURR TOP MICROBIOL, V209, P25; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Radhakrishnan P, 2007, BBA-GEN SUBJECTS, V1770, P884, DOI 10.1016/j.bbagen.2007.01.019; RAMPHAL R, 1983, INFECT IMMUN, V41, P339, DOI 10.1128/IAI.41.1.339-344.1983; RINGLER NJ, 1987, BIOCHEMISTRY-US, V26, P5322, DOI 10.1021/bi00391a016; SANFORD BA, 1989, INFECT IMMUN, V57, P3735, DOI 10.1128/IAI.57.12.3735-3742.1989; SASAKAWA C, 1986, INFECT IMMUN, V54, P32, DOI 10.1128/IAI.54.1.32-36.1986; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; Shuter J, 1996, INFECT IMMUN, V64, P310, DOI 10.1128/IAI.64.1.310-318.1996; Smirnova MG, 2001, EUR CYTOKINE NETW, V12, P119; Sudha PS, 2001, CURR MICROBIOL, V42, P381; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TZOUVELEKIS LS, 1991, INFECT IMMUN, V59, P4252, DOI 10.1128/IAI.59.11.4252-4254.1991; Udhayakumar G, 2007, MOL CARCINOGEN, V46, P807, DOI 10.1002/mc.20311; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; VISHWANATH S, 1985, INFECT IMMUN, V48, P331, DOI 10.1128/IAI.48.2.331-335.1985; Weiss AA, 1996, J HISTOCHEM CYTOCHEM, V44, P1161, DOI 10.1177/44.10.8813081; WELLS CL, 1988, REV INFECT DIS, V10, P958; Woodward H, 1982, BIOCHEMISTRY-US, V21, P4905; Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9; ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452	57	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27046	10.1371/journal.pone.0027046	http://dx.doi.org/10.1371/journal.pone.0027046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073249	Green Published, gold, Green Submitted			2022-12-27	WOS:000297198200030
J	Ramdarshan, A; Alloing-Seguier, T; Merceron, G; Marivaux, L				Ramdarshan, Anusha; Alloing-Seguier, Thomas; Merceron, Gildas; Marivaux, Laurent			The Primate Community of Cachoeira (Brazilian Amazonia): A Model to Decipher Ecological Partitioning among Extinct Species	PLOS ONE			English	Article							DENTAL MICROWEAR ANALYSIS; MOLAR MICROWEAR; LATE MIOCENE; IMAGE-ANALYSIS; HOWLER MONKEY; DIET; SURINAM; EXTANT; HABITAT; CANOPY	Dental microwear analysis is conducted on a community of platyrrhine primates from South America. This analysis focuses on the primate community of Cachoeira Porteira (Para, Brazil), in which seven sympatric species occur: Alouatta seniculus, Ateles paniscus, Cebus apella, Chiropotes satanas, Pithecia Pithecia, Saguinus midas, and Saimiri sciureus. Shearing quotients are also calculated for each taxon of this primate community. Dental microwear results indicate significant differences between taxa, but are somewhat insufficient when it comes to discriminating between ecologically similar taxa. The primates of Cachoeira Porteira all incorporate a certain amount of fruit in their diet, entailing a definite amount of interspecific competition as they must share food resources. Alouatta is the most folivorous taxon of this community, which is corroborated by dental microwear analysis. Ateles, although of a similar size to Alouatta, limits inter-specific competition by incorporating more fruit in its diet. Cebus has a very diverse omnivorous diet, which is highlighted in this study, as it compares to both fruit and leaf eating taxa. In some cases, microwear results need to be supplemented by other methods. For example, dental microwear seems insufficient to distinguish between Pithecia and Chiropotes, which eat foods with similar physical properties. However, other methods (i.e. shearing quotients and body mass) provide enough complimentary information to be able to highlight differences between the two taxa. On the other hand, dental microwear can highlight differences between primates which have similar diets, such as Saimiri and Saguinus. In this case, differences could be due to other exogenous factors.	[Ramdarshan, Anusha; Alloing-Seguier, Thomas; Marivaux, Laurent] Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, UMR CNRS 5554, Montpellier, France; [Merceron, Gildas] Univ Lyon 1, CNRS, ENS, Lab Geol Lyon Terre,UMR 5276, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ramdarshan, A (corresponding author), Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, UMR CNRS 5554, Cc 064, Montpellier, France.	Anusha.Ramdarshan@univ-montp2.fr	Habe, Neusa K/D-6316-2011; Merceron, Gildas/C-8648-2012	Merceron, Gildas/0000-0001-5777-7126	ANR- PALASIAFRICA [ANR-08-JCJC-0017]	ANR- PALASIAFRICA(French National Research Agency (ANR))	This study was funded by the ANR- PALASIAFRICA Program (ANR-08-JCJC-0017, ANR, ERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; AYRES JM, 1989, J HUM EVOL, V18, P697, DOI 10.1016/0047-2484(89)90101-2; Bearder S. K., 2007, PRIMATES PERSPECTIVE; BOURLIERE F, 1985, INT J PRIMATOL, V6, P1, DOI 10.1007/BF02693694; Butler P.M., 2000, P201, DOI 10.1017/CBO9780511542626.014; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; Calandra I, 2010, PALAEONTOL Z, V84, P205, DOI 10.1007/s12542-010-0054-0; CANNON CH, 1994, AM J PHYS ANTHROPOL, V93, P505, DOI 10.1002/ajpa.1330930409; Chivers DJ, 1984, FOOD ACQUISITION PRO; DAHL JF, 1988, AM J PHYS ANTHROPOL, V75, P201; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1245, DOI 10.1023/A:1008972901159; DUCKE A., 1953, ANAIS ACAD BRASIL CIENC, V25, P1; FLEAGLE JG, 1980, AM J PHYS ANTHROPOL, V52, P301, DOI 10.1002/ajpa.1330520302; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Ganzhorn Jorg U., 1999, P141, DOI 10.1017/CBO9780511542381.009; GANZHORN JU, 1988, OECOLOGIA, V75, P436, DOI 10.1007/BF00376949; Garber Paul A., 1993, P273; GINGERICH P D, 1980, Zeitschrift fuer Morphologie und Anthropologie, V71, P135; Glander K.E., 1975, P37; GRINE FE, 1988, NATURE, V333, P765, DOI 10.1038/333765a0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; IZAWA K, 1979, Primates, V20, P57, DOI 10.1007/BF02373828; IZAWA K, 1978, Primates, V19, P633, DOI 10.1007/BF02373631; JANSON CH, 1988, BEHAVIOUR, V105, P165, DOI 10.1163/156853988X00502; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; JUNGERS WL, 1984, J PHYS, V27, P73; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay R.F., 1984, FOOD ACQUISITION PRO, P467, DOI DOI 10.1007/978-1-4757-5244-1_21; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KAYRF, 1977, J PHYS, V46, P327; King T, 1999, J HUM EVOL, V36, P3, DOI 10.1006/jhev.1998.0258; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; Kirk EC, 2001, J HUM EVOL, V40, P203, DOI 10.1006/jhev.2000.0450; Krueger KL, 2008, AM J PHYS ANTHROPOL, V137, P485, DOI 10.1002/ajpa.20928; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Lima EM, 2003, FOLIA PRIMATOL, V74, P150, DOI 10.1159/000070648; LUCAS PW, 1994, P 12 C INT PRIM SOC, P125; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2007, GEODIVERSITAS, V29, P421; Merceron G, 2009, J HUM EVOL, V57, P732, DOI 10.1016/j.jhevol.2009.06.009; MITTERMEIER RA, 1981, FOLIA PRIMATOL, V36, P1, DOI 10.1159/000156007; Novello A, 2010, CR PALEVOL, V9, P471, DOI 10.1016/j.crpv.2010.10.001; Pack KS, 1999, FOLIA PRIMATOL, V70, P1, DOI 10.1159/000021668; Power Michael L., 1999, P225; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; ROSENBERGER AL, 1992, J HUM EVOL, V88, P525; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sokal R.R., 1995, BIOMETRY PRINCIPAL P; STRAIT SG, 1993, AM J PHYS ANTHROPOL, V92, P63, DOI 10.1002/ajpa.1330920106; Strait Suzanne G., 1997, Evolutionary Anthropology, V5, P199, DOI 10.1002/(SICI)1520-6505(1997)5:6<199::AID-EVAN2>3.0.CO;2-8; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; TEAFORD MF, 1985, AM J PHYS ANTHROPOL, V66, P363, DOI 10.1002/ajpa.1330660403; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; VISCHER NOE, 1994, BINARY-COMPUT MICROB, V6, P160; WRIGHT PC, 1989, J HUM EVOL, V18, P635, DOI 10.1016/0047-2484(89)90098-5	68	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27392	10.1371/journal.pone.0027392	http://dx.doi.org/10.1371/journal.pone.0027392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076156	gold, Green Published			2022-12-27	WOS:000297198200070
J	Piccardi, C				Piccardi, Carlo			Finding and Testing Network Communities by Lumped Markov Chains	PLOS ONE			English	Article							COMPLEX NETWORKS; GRAPH; WEB	Identifying communities (or clusters), namely groups of nodes with comparatively strong internal connectivity, is a fundamental task for deeply understanding the structure and function of a network. Yet, there is a lack of formal criteria for defining communities and for testing their significance. We propose a sharp definition that is based on a quality threshold. By means of a lumped Markov chain model of a random walker, a quality measure called "persistence probability" is associated to a cluster, which is then defined as an "alpha-community" if such a probability is not smaller than alpha. Consistently, a partition composed of alpha-communities is an "alpha-partition." These definitions turn out to be very effective for finding and testing communities. If a set of candidate partitions is available, setting the desired alpha-level allows one to immediately select the alpha-partition with the finest decomposition. Simultaneously, the persistence probabilities quantify the quality of each single community. Given its ability in individually assessing each single cluster, this approach can also disclose single well-defined communities even in networks that overall do not possess a definite clusterized structure.	Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy	Polytechnic University of Milan	Piccardi, C (corresponding author), Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy.	carlo.piccardi@polimi.it		Piccardi, Carlo/0000-0002-8373-539X				[Anonymous], 2009, ENCY COMPLEXITY SYST; Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BUCHHOLZ P, 1994, J APPL PROBAB, V31, P59, DOI 10.2307/3215235; Cafieri S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056105; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Everitt BS, 2011, CLUSTER ANAL, DOI [10.1002/9780470977811, DOI 10.1002/9780470977811]; Fagiolo G, 2008, PHYSICA A, V387, P3868, DOI 10.1016/j.physa.2008.01.050; Fenn DJ, 2009, CHAOS, V19, DOI 10.1063/1.3184538; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198701; Hoffmann KH, 2009, APPL MATH LETT, V22, P1471, DOI 10.1016/j.aml.2009.03.016; HOLGERSSON M, 1978, PATTERN RECOGN, V10, P287, DOI 10.1016/0031-3203(78)90038-9; Hu YQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066106; Hu YQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026121; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Kannan R, 2004, J ACM, V51, P497, DOI 10.1145/990308.990313; Kemeny J.G., 1976, MARKOV CHAINS, V6; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Meyer CD., 2000, MATRIX ANAL APPL LIN, DOI [10.1137/1.9780898719512, DOI 10.1137/1.9780898719512]; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Piccardi C, 2010, PHYSICA A, V389, P5247, DOI 10.1016/j.physa.2010.06.038; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Reichardt J, 2006, PHYSICA D, V224, P20, DOI 10.1016/j.physd.2006.09.009; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Sima J, 2006, LECT NOTES COMPUT SC, V3831, P530; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Subelj L, 2011, PHYSICA A, V390, P2968, DOI 10.1016/j.physa.2011.03.036; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Weinan E, 2008, P NATL ACAD SCI USA, V105, P7907, DOI 10.1073/pnas.0707563105; Zhou HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061901	55	39	39	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27028	10.1371/journal.pone.0027028	http://dx.doi.org/10.1371/journal.pone.0027028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073245	gold, Green Submitted, Green Published			2022-12-27	WOS:000297197000024
J	Andreatta, M; Schafer-Nielsen, C; Lund, O; Buus, S; Nielsen, M				Andreatta, Massimo; Schafer-Nielsen, Claus; Lund, Ole; Buus, Soren; Nielsen, Morten			NNAlign: A Web-Based Prediction Method Allowing Non-Expert End-User Discovery of Sequence Motifs in Quantitative Peptide Data	PLOS ONE			English	Article							BINDING PREDICTIONS; SIGNAL PEPTIDES; CLASS-I; HLA-DR; MICROARRAYS; EPITOPE; IDENTIFICATION; GENERATION; AFFINITY; DNA	Recent advances in high-throughput technologies have made it possible to generate both gene and protein sequence data at an unprecedented rate and scale thereby enabling entirely new "omics"-based approaches towards the analysis of complex biological processes. However, the amount and complexity of data that even a single experiment can produce seriously challenges researchers with limited bioinformatics expertise, who need to handle, analyze and interpret the data before it can be understood in a biological context. Thus, there is an unmet need for tools allowing non-bioinformatics users to interpret large data sets. We have recently developed a method, NNAlign, which is generally applicable to any biological problem where quantitative peptide data is available. This method efficiently identifies underlying sequence patterns by simultaneously aligning peptide sequences and identifying motifs associated with quantitative readouts. Here, we provide a web-based implementation of NNAlign allowing non-expert end-users to submit their data (optionally adjusting method parameters), and in return receive a trained method (including a visual representation of the identified motif) that subsequently can be used as prediction method and applied to unknown proteins/peptides. We have successfully applied this method to several different data sets including peptide microarray-derived sets containing more than 100,000 data points. NNAlign is available online at http://www.cbs.dtu.dk/services/NNAlign.	[Andreatta, Massimo; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Schafer-Nielsen, Claus] Schafer N, Copenhagen, Denmark; [Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Andreatta, M (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	massimo@cbs.dtu.dk	Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014; Andreatta, Massimo/AAA-4061-2020	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Andreatta, Massimo/0000-0002-8036-2647; Buus, Soren/0000-0001-8363-1999	European Union [222773]; National Institute of Allergy and Infectious Diseases [HHSN 272 2009 00045C]	European Union(European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research leading to these results received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement n<SUP>o</SUP> 222773, and from the National Institute of Allergy and Infectious Diseases under contract n<SUP>o</SUP> HHSN 272 2009 00045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhasin M, 2004, BIOINFORMATICS, V20, P421, DOI 10.1093/bioinformatics/btg424; Bhushan KR, 2003, TETRAHEDRON LETT, V44, P8585, DOI 10.1016/j.tetlet.2003.09.155; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x; Christensen JK, 2003, NEURAL COMPUT, V15, P2931, DOI 10.1162/089976603322518803; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Halperin RF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000786; Han XM, 2009, J BIOMOL SCREEN, V14, P256, DOI 10.1177/1087057108329348; Hasan A, 1997, TETRAHEDRON, V53, P4247, DOI 10.1016/S0040-4020(97)00154-3; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hoppe-Seyler F, 2004, CURR MOL MED, V4, P529, DOI 10.2174/1566524043360519; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; James William, 2001, Current Opinion in Pharmacology, V1, P540, DOI 10.1016/S1471-4892(01)00093-5; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Lathe W., 2008, NAT ED, V1; Lin J, 2009, J ALLERGY CLIN IMMUN, V124, P315, DOI 10.1016/j.jaci.2009.05.024; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Lundegaard C, 2010, IMMUNOLOGY, V130, P309, DOI 10.1111/j.1365-2567.2010.03300.x; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Petersen TN, 2000, PROTEINS, V41, P17, DOI 10.1002/1097-0134(20001001)41:1<17::AID-PROT40>3.0.CO;2-F; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schutkowski M, 2005, CHEMBIOCHEM, V6, P513, DOI 10.1002/cbic.200400314; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Sompuram SR, 2006, AM J CLIN PATHOL, V125, P82, DOI 10.1309/6H0ARQF7K3Y608EH; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Uttamchandani M, 2008, CURR PHARM DESIGN, V14, P2428, DOI 10.2174/138161208785777450; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568	49	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26781	10.1371/journal.pone.0026781	http://dx.doi.org/10.1371/journal.pone.0026781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073191	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900034
J	Graham, JF; Kurian, D; Agarwal, S; Toovey, L; Hunt, L; Kirby, L; Pinheiro, TJT; Banner, SJ; Gill, AC				Graham, James F.; Kurian, Dominic; Agarwal, Sonya; Toovey, Lorna; Hunt, Lawrence; Kirby, Louise; Pinheiro, Teresa J. T.; Banner, Steven J.; Gill, Andrew C.			Na+/K+-ATPase Is Present in Scrapie-Associated Fibrils, Modulates PrP Misfolding In Vitro and Links PrP Function and Dysfunction	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; SIGNAL-TRANSDUCTION; RECOMBINANT PRP; FREE CONVERSION; BRAIN; IDENTIFICATION; NA,K-ATPASE; MOLECULES; STRAIN; MODEL	Transmissible spongiform encephalopathies are characterised by widespread deposition of fibrillar and/or plaque-like forms of the prion protein. These aggregated forms are produced by misfolding of the normal prion protein, PrPC, to the disease-associated form, PrPSc, through mechanisms that remain elusive but which require either direct or indirect interaction between PrPC and PrPSc isoforms. A wealth of evidence implicates other non-PrP molecules as active participants in the misfolding process, to catalyse and direct the conformational conversion of PrPC or to provide a scaffold ensuring correct alignment of PrPC and PrPSc during conversion. Such molecules may be specific to different scrapie strains to facilitate differential prion protein misfolding. Since molecular cofactors may become integrated into the growing protein fibril during prion conversion, we have investigated the proteins contained in prion disease-specific deposits by shotgun proteomics of scrapie-associated fibrils (SAF) from mice infected with 3 different strains of mouse-passaged scrapie. Concomitant use of negative control preparations allowed us to identify and discount proteins that are enriched non-specifically by the SAF isolation protocol. We found several proteins that co-purified specifically with SAF from infected brains but none of these were reproducibly and demonstrably specific for particular scrapie strains. The alpha-chain of Na+/K+-ATPase was common to SAF from all 3 strains and we tested the ability of this protein to modulate in vitro misfolding of recombinant PrP. Na+/K+-ATPase enhanced the efficiency of disease-specific conversion of recombinant PrP suggesting that it may act as a molecular cofactor. Consistent with previous results, the same protein inhibited fibrillisation kinetics of recombinant PrP. Since functional interactions between PrPC and Na+/K+-ATPase have previously been reported in astrocytes, our data highlight this molecule as a key link between PrP function, dysfunction and misfolding.	[Graham, James F.; Agarwal, Sonya; Toovey, Lorna; Kirby, Louise; Banner, Steven J.; Gill, Andrew C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Graham, James F.; Agarwal, Sonya; Toovey, Lorna; Kirby, Louise; Banner, Steven J.; Gill, Andrew C.] Univ Edinburgh, RD SVS, Neuropathogenesis Div, Edinburgh, Midlothian, Scotland; [Kurian, Dominic; Hunt, Lawrence] Inst Anim Hlth, Newbury, Berks, England; [Pinheiro, Teresa J. T.] Univ Warwick, Sch Biol Sci, Coventry CV4 7AL, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Warwick	Graham, JF (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	andrew.gill@roslin.ed.ac.uk	Gill, Andrew C/A-5219-2009; Gill, ANdrew/GRO-1248-2022	Gill, Andrew C/0000-0001-5201-9473; Kurian, Dominic/0000-0002-5924-665X; Banner, Steve/0000-0002-7852-9284	Biotechnology and Biological Sciences Research Council, UK; Institute Strategic Programme Grants; BBSRC [BB/C506356/1, BB/C506356/2, BB/C506356/3, BBS/E/D/05241338] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241338, BB/C506356/2, BB/C506356/1, BB/C506356/3] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme Grants; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (www.bbsrc.ac.uk) through a doctoral training account to JFG and Institute Strategic Programme Grants to RI and IAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Baumann MH, 1996, BIOCHEM BIOPH RES CO, V219, P238, DOI 10.1006/bbrc.1996.0211; Bergemalm D, 2010, J NEUROCHEM, V114, P408, DOI 10.1111/j.1471-4159.2010.06753.x; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Breydo Leonid, 2008, V459, P105, DOI 10.1007/978-1-59745-234-2_8; Brimacombe DB, 1999, BIOCHEM J, V342, P605, DOI 10.1042/0264-6021:3420605; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; CALANDRIELLO L, 1995, MED HYPOTHESES, V44, P173, DOI 10.1016/0306-9877(95)90132-9; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dumpitak C, 2005, BIOL CHEM, V386, P1149, DOI 10.1515/BC.2005.131; Fasano C, 2006, J MOL NEUROSCI, V29, P195, DOI 10.1385/JMN:29:3:195; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Gill AC, 2010, PRION, V4, P235, DOI 10.4161/pri.4.4.13394; Giorgi A, 2009, PROTEOMICS, V9, P3802, DOI 10.1002/pmic.200900085; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Hasan MR, 2006, EXP CELL RES, V312, P1950, DOI 10.1016/j.yexcr.2006.02.023; Hnasko R, 2010, PRION, V4, P94, DOI 10.4161/pri.4.2.12622; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Kirby L, 2006, J GEN VIROL, V87, P3747, DOI 10.1099/vir.0.82086-0; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Kleene R, 2007, J NEUROSCI, V27, P12331, DOI 10.1523/JNEUROSCI.1358-07.2007; Kralovicova S, 2009, MOL CELL NEUROSCI, V41, P135, DOI 10.1016/j.mcn.2009.02.002; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Kurup RK, 2003, INT J NEUROSCI, V113, P971, DOI 10.1080/00207450390220312; Lazzari C, 2011, J NEUROCHEM, V116, P881, DOI 10.1111/j.1471-4159.2010.07015.x; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Liao LJ, 2009, NEURON, V63, P12, DOI 10.1016/j.neuron.2009.06.011; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Moore RA, 2010, PROTEOMICS; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nieznanski K, 2010, CELL MOL NEUROBIOL, V30, P653, DOI 10.1007/s10571-009-9491-2; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Petrakis S, 2008, EUR J NEUROSCI, V27, P612, DOI 10.1111/j.1460-9568.2008.06037.x; Petrakis S, 2009, J PROTEOMICS, V72, P690, DOI 10.1016/j.jprot.2009.01.025; Petrakis S, 2006, PROTEOMICS, V6, P6476, DOI 10.1002/pmic.200600103; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sanghera N, 2008, BBA-PROTEINS PROTEOM, V1784, P873, DOI 10.1016/j.bbapap.2008.02.017; Sanghera N, 2009, BBA-BIOMEMBRANES, V1788, P2245, DOI 10.1016/j.bbamem.2009.08.005; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Somerville RA, 2005, J GEN VIROL, V86, P241, DOI 10.1099/vir.0.80251-0; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; Sproul Adrian, 2009, P53, DOI 10.1007/978-1-60327-579-8_4; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Tomasi Vittorio, 2010, Immun Ageing, V7 Suppl 1, pS5, DOI 10.1186/1742-4933-7-S1-S5; Walker SG, 1996, J CHROMATOGR B, V680, P91, DOI 10.1016/0378-4347(95)00452-1; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Watt NT, 2007, FREE RADICAL BIO MED, V43, P959, DOI 10.1016/j.freeradbiomed.2007.06.004; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x	78	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26813	10.1371/journal.pone.0026813	http://dx.doi.org/10.1371/journal.pone.0026813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073199	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000297154900040
J	Kunik, D; Dion, C; Ozaki, T; Levin, LA; Costantino, S				Kunik, Dario; Dion, Carolyne; Ozaki, Tsuneyuki; Levin, Leonard A.; Costantino, Santiago			Laser-Based Single-Axon Transection for High-Content Axon Injury and Regeneration Studies	PLOS ONE			English	Article							DEGENERATION; CELL; MECHANISMS; WLD(S); MICROSURGERY; ABLATION	The investigation of the regenerative response of the neurons to axonal injury is essential to the development of new axoprotective therapies. Here we study the retinal neuronal RGC-5 cell line after laser transection, demonstrating that the ability of these cells to initiate a regenerative response correlates with axon length and cell motility after injury. We show that low energy picosecond laser pulses can achieve transection of unlabeled single axons in vitro and precisely induce damage with micron precision. We established the conditions to achieve axon transection, and characterized RGC-5 axon regeneration and cell body response using time-lapse microscopy. We developed an algorithm to analyze cell trajectories and established correlations between cell motility after injury, axon length, and the initiation of the regeneration response. The characterization of the motile response of axotomized RGC-5 cells showed that cells that were capable of repair or regrowth of damaged axons migrated more slowly than cells that could not. Moreover, we established that RGC-5 cells with long axons could not recover their injured axons, and such cells were much more motile. The platform we describe allows highly controlled axonal damage with subcellular resolution and the performance of high-content screening in cell cultures.	[Kunik, Dario; Dion, Carolyne; Ozaki, Tsuneyuki; Levin, Leonard A.; Costantino, Santiago] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Kunik, Dario; Costantino, Santiago] Univ Montreal, Inst Genie Biomed, Montreal, PQ, Canada; [Dion, Carolyne; Ozaki, Tsuneyuki] Inst Natl Rech Sci, Quebec City, PQ, Canada; [Levin, Leonard A.; Costantino, Santiago] Univ Montreal, Dept Ophtalmol, Montreal, PQ, Canada; [Levin, Leonard A.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison	Kunik, D (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada.	santiago.costantino@umontreal.ca	Ozaki, Tsuneyuki/B-3283-2012; Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635; Ozaki, Tsuneyuki/0000-0001-8857-3900	Fondation de l'Hopital Maisonneuve-Rosemont; National Sciences and Engineering Research Council (NSERC); Fonds Qubebecois de la Recherche sur la Nature et les Technologies (FQRNT); Canadian Institutes of Health Research (CIHR); National Institutes of Health (NIH) [R21 EY017970]; HMR; NSERCf; NATIONAL EYE INSTITUTE [R21EY017970] Funding Source: NIH RePORTER	Fondation de l'Hopital Maisonneuve-Rosemont; National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Qubebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HMR; NSERCf; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grants from the Fondation de l'Hopital Maisonneuve-Rosemont to SC, the National Sciences and Engineering Research Council (NSERC) and the Fonds Qubebecois de la Recherche sur la Nature et les Technologies (FQRNT) grants to SC and TO, the Canadian Institutes of Health Research (CIHR) to LAL and SC, and the National Institutes of Health (NIH) R21 EY017970 to LAL. DK is a recipient of a HMR postdoctoral fellowships and CD of a NSERCf postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra Mascaro Anna Letizia, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00021; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Beirowski B, 2008, EUR J NEUROSCI, V28, P1166, DOI 10.1111/j.1460-9568.2008.06426.x; Belisle JM, 2009, LAB CHIP, V9, P3580, DOI 10.1039/b911967a; Belisle JM, 2008, LAB CHIP, V8, P2164, DOI 10.1039/b813897d; Berns MW, 2007, METHOD CELL BIOL, V82, P3, DOI 10.1016/S0091-679X(06)82001-7; BERNS MW, 1981, SCIENCE, V213, P505, DOI 10.1126/science.7017933; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Bourgeois F, 2007, OPT EXPRESS, V15, P8521, DOI 10.1364/OE.15.008521; Chang WC, 2010, WIRES NANOMED NANOBI, V2, P151, DOI 10.1002/wnan.76; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hellman AN, 2010, LAB CHIP, V10, P2083, DOI 10.1039/b927153h; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Jia HQ, 2007, NEUROSCI LETT, V413, P46, DOI 10.1016/j.neulet.2006.11.067; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; Magidson V, 2007, METHOD CELL BIOL, V82, P239, DOI 10.1016/S0091-679(06)82007-8; Mandolesi G, 2004, FASEB J; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Schwartz M, 1999, MOL MED TODAY, V5, P470, DOI 10.1016/S1357-4310(99)01592-0; Steinmeyer JD, 2010, NAT PROTOC, V5, P395, DOI 10.1038/nprot.2010.4; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Vogel A, 2007, BIOPHYS J, V93, P4481, DOI 10.1529/biophysj.106.102277; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wu T, 2012, J R SOC INTERFACE, V9, P535, DOI 10.1098/rsif.2011.0351; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26832	10.1371/journal.pone.0026832	http://dx.doi.org/10.1371/journal.pone.0026832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073205	Green Published, gold, Green Submitted			2022-12-27	WOS:000297154900044
J	Loponen, H; Ylikoski, J; Albrecht, JH; Pirvola, U				Loponen, Heidi; Ylikoski, Jukka; Albrecht, Jeffrey H.; Pirvola, Ulla			Restrictions in Cell Cycle Progression of Adult Vestibular Supporting Cells in Response to Ectopic Cyclin D1 Expression	PLOS ONE			English	Article							MOUSE INNER-EAR; HAIR-CELLS; DNA-DAMAGE; IN-VIVO; CARDIOMYOCYTE PROLIFERATION; CENTROSOME AMPLIFICATION; CHROMOSOME CONDENSATION; RETINOBLASTOMA PROTEIN; BALANCE EPITHELIA; POSTMITOTIC STATE	Sensory hair cells and supporting cells of the mammalian inner ear are quiescent cells, which do not regenerate. In contrast, non-mammalian supporting cells have the ability to re-enter the cell cycle and produce replacement hair cells. Earlier studies have demonstrated cyclin D1 expression in the developing mouse supporting cells and its downregulation along maturation. In explant cultures of the mouse utricle, we have here focused on the cell cycle control mechanisms and proliferative potential of adult supporting cells. These cells were forced into the cell cycle through adenoviral-mediated cyclin D1 overexpression. Ectopic cyclin D1 triggered robust cell cycle re-entry of supporting cells, accompanied by changes in p27(Kip1) and p21(Cip1) expressions. Main part of cell cycle reactivated supporting cells were DNA damaged and arrested at the G2/M boundary. Only small numbers of mitotic supporting cells and rare cells with signs of two successive replications were found. Ectopic cyclin D1-triggered cell cycle reactivation did not lead to hyperplasia of the sensory epithelium. In addition, a part of ectopic cyclin D1 was sequestered in the cytoplasm, reflecting its ineffective nuclear import. Combined, our data reveal intrinsic barriers that limit proliferative capacity of utricular supporting cells.	[Loponen, Heidi; Pirvola, Ulla] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Ylikoski, Jukka] Helsinki Ear Inst, Helsinki, Finland; [Albrecht, Jeffrey H.] Hennepin Cty Med Ctr, Div Gastroenterol, Minneapolis, MN 55415 USA	University of Helsinki; Hennepin County Medical Center	Loponen, H (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	ulla.pirvola@helsinki.fi		Pirvola, Ulla/0000-0001-5285-4225	Academy of Finland; NIH [DK54921]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054921] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Academy of Finland (U.P.) and by the NIH grant DK54921 (J.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bourgo RJ, 2011, MOL BIOL CELL, V22, P931, DOI 10.1091/mbc.E10-11-0895; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 1999, DEVELOPMENT, V126, P1581; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Gu RD, 2007, EUR J NEUROSCI, V25, P1363, DOI 10.1111/j.1460-9568.2007.05414.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Hume CR, 2003, JARO-J ASSOC RES OTO, V4, P422, DOI 10.1007/s10162-002-3008-8; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Iovino F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-38; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu ZJ, 2008, DEV NEUROBIOL, V68, P1059, DOI 10.1002/dneu.20635; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Montcouquiol M, 2001, J NEUROSCI, V21, P570, DOI 10.1523/JNEUROSCI.21-02-00570.2001; Montcouquiol M, 2001, J NEUROSCI, V21, P974, DOI 10.1523/JNEUROSCI.21-03-00974.2001; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Nelsen CJ, 2001, CANCER RES, V61, P8564; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Ono K, 2009, MOL CELL NEUROSCI, V42, P391, DOI 10.1016/j.mcn.2009.08.011; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Quint E, 1998, HEARING RES, V118, P157, DOI 10.1016/S0378-5955(98)00026-4; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Sulg M, 2010, J NEUROCHEM, V112, P1513, DOI 10.1111/j.1471-4159.2009.06563.x; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Van Hooser A, 1998, J CELL SCI, V111, P3497; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Weber T, 2008, P NATL ACAD SCI USA, V105, P781, DOI 10.1073/pnas.0708061105; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wilkinson DG, 1991, POSTIMPLANTATION MAM, P447; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zheng JL, 1997, J NEUROSCI, V17, P216, DOI 10.1523/JNEUROSCI.17-01-00216.1997	55	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27360	10.1371/journal.pone.0027360	http://dx.doi.org/10.1371/journal.pone.0027360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073316	gold, Green Published, Green Submitted			2022-12-27	WOS:000297154900100
J	Lu, R; Zhang, XC; Huang, DP; Huang, B; Gao, N; Wang, ZC; Ge, J				Lu, Rong; Zhang, Xinchun; Huang, Danping; Huang, Bing; Gao, Nan; Wang, Zhichong; Ge, Jian			Conjunctival Reconstruction with Progenitor Cell-Derived Autologous Epidermal Sheets in Rhesus Monkey	PLOS ONE			English	Article							AMNIOTIC MEMBRANE TRANSPLANTATION; MUCIN GENE-EXPRESSION; STEM-CELLS; OCULAR SURFACE; EPITHELIAL EQUIVALENT; CORNEAL EPITHELIUM; IN-VITRO; SKIN; IDENTIFICATION; CULTURE	Severe ocular surface diseases are some of the most challenging problems that the clinician faces today. Conventional management is generally unsatisfactory, and the long-term ocular consequences of these conditions are devastating. It is significantly important to find a substitute for conjunctival epithelial cells. This study was to explore the possibility of progenitor cell-derived epidermal sheets on denuded amniotic membrane to reconstruct ocular surface of conjunctiva damaged monkeys. We isolated epidermal progenitor cells of rhesus monkeys by type IV collagen adhesion, and then expanded progenitor cell-derived epidermal sheets on denuded amniotic membrane ex vivo. At 3 weeks after the conjunctiva injury, the damaged ocular surface of four monkeys was surgically reconstructed by transplanting the autologous cultivated epidermal progenitor cells. At 2 weeks after surgery, transplants were removed and examined with Hematoxylin-eosin staining, Periodic acid Schiff staining, immunofluorescent staining, scanning and transmission electron microscopy. Histological examination of transplanted sheets revealed that the cell sheets were healthy alive, adhered well to the denuded amniotic membrane, and had several layers of epithelial cells. Electron microscopy showed that the epithelial cells were very similar in appearance to those of normal conjunctival epithelium, even without goblet cell detected. Epithelial cells of transplants had numerous desmosomal junctions and were attached to the amniotic membrane with hemidesmosomes. Immunohistochemistry confirmed the presence of the conjunctival specific markers, mucin 4 and keratin 4, in the transplanted epidermal progenitor cells. In conclusion, our present study successfully reconstructed conjunctiva with autologous transplantation of progenitor cell-derived epidermal sheets on denuded AM in conjunctival damaged monkeys, which is the first step toward assessing the use of autologous transplantation of progenitor cells of nonocular surface origin. Epidermal progenitor cells could be provided as a new substitute for conjunctival epithelial cells to overcome the problems of autologous conjunctiva shortage.	[Lu, Rong; Huang, Danping; Huang, Bing; Gao, Nan; Wang, Zhichong; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xinchun] Sun Yat Sen Univ, Guanghua Coll Stomatol, Hosp Stomatol, Dept Prosthodont, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Lu, R (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	gejian@mail.sysu.edu.cn		Schmidtko, Achim/0000-0001-7270-5075	National Natural Science Foundation of China [30901634]; Natural Science Foundation of Guangdong Province [9151008901000210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Natural Science Foundation of China (30901634) and the Natural Science Foundation of Guangdong Province (9151008901000210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Ang LPK, 2004, INVEST OPHTH VIS SCI, V45, P1789, DOI 10.1167/iovs.03-1361; Arora R, 2005, EYE, V19, P273, DOI 10.1038/sj.eye.6701490; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Berry M, 1996, INVEST OPHTH VIS SCI, V37, P2559; Bickenbach J R, 2000, Adv Dermatol, V16, P159; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Burman Sanghamitra, 2004, Cell and Tissue Banking, V5, P161, DOI 10.1023/B:CATB.0000046067.25057.0a; Chiou AGY, 1998, SURV OPHTHALMOL, V43, P19, DOI 10.1016/S0039-6257(98)00005-8; Corrales RM, 2003, Arch Soc Esp Oftalmol, V78, P375; Corrales RM, 2003, CURR EYE RES, V27, P323, DOI 10.1076/ceyr.27.5.323.17221; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013; Gao N, 2007, SCI CHINA SER C, V50, P101, DOI 10.1007/s11427-007-0006-4; GIPSON IK, 1992, INVEST OPHTH VIS SCI, V33, P218; Gonnering R S, 1987, Ophthalmic Plast Reconstr Surg, V3, P99, DOI 10.1097/00002341-198703020-00009; Grinnell KL, 2007, CELL PROLIFERAT, V40, P685, DOI 10.1111/j.1365-2184.2007.00464.x; Gunduz K, 2006, EYE, V20, P351, DOI 10.1038/sj.eye.6701890; Huang Bing, 2004, Zhonghua Yi Xue Za Zhi, V84, P838; Islam MS, 2007, EUR J DERMATOL, V17, P302, DOI 10.1684/ejd.2007.0204; Janes SM, 2002, J PATHOL, V197, P479, DOI 10.1002/path.1156; Jones PH, 1996, CLIN SCI, V91, P141, DOI 10.1042/cs0910141; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Krenzer KL, 1997, INVEST OPHTH VIS SCI, V38, P142; KRUSE FE, 1998, OPHTHALMOLOGY, V122; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Li W, 2006, INVEST OPHTH VIS SCI, V47, P2381, DOI 10.1167/iovs.05-1491; Liu YC, 2008, INT J DERMATOL, V47, P551, DOI 10.1111/j.1365-4632.2008.03647.x; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Lu Rong, 2005, Zhonghua Yi Xue Za Zhi, V85, P2554; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Pflugfelder SC, 2007, CURR OPIN ALLERGY CL, V7, P450, DOI 10.1097/ACI.0b013e3282ef69e3; Reiisi S, 2010, IN VITRO CELL DEV-AN, V46, P54, DOI 10.1007/s11626-009-9245-y; Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235; SHORE JW, 1992, OPHTHALMOLOGY, V99, P383; Tan DTH, 2004, TRANSPLANTATION, V77, P1729, DOI 10.1097/01.TP.0000127593.65888.A6; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; Tseng SCG, 2001, BIOSCIENCE REP, V21, P481, DOI 10.1023/A:1017995810755; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; WEISE RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1736, DOI 10.1001/archopht.1985.01050110132041; Yu CJ, 1996, ONCOLOGY, V53, P118; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zhou JX, 2004, CELL BIOL INT, V28, P523, DOI 10.1016/j.cellbi.2004.04.007	51	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e25713	10.1371/journal.pone.0025713	http://dx.doi.org/10.1371/journal.pone.0025713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096478	Green Published, gold, Green Submitted			2022-12-27	WOS:000297553900001
J	Chan, DSM; Lau, R; Aune, D; Vieira, R; Greenwood, DC; Kampman, E; Norat, T				Chan, Doris S. M.; Lau, Rosa; Aune, Dagfinn; Vieira, Rui; Greenwood, Darren C.; Kampman, Ellen; Norat, Teresa			Red and Processed Meat and Colorectal Cancer Incidence: Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							DOSE-RESPONSE DATA; COLON-CANCER; RISK-FACTORS; PROSPECTIVE COHORT; RECTAL-CANCER; UNITED-STATES; NAT2 POLYMORPHISMS; NETHERLANDS COHORT; DIETARY PATTERNS; WOMENS HEALTH	Background: The evidence that red and processed meat influences colorectal carcinogenesis was judged convincing in the 2007 World Cancer Research Fund/American Institute of Cancer Research report. Since then, ten prospective studies have published new results. Here we update the evidence from prospective studies and explore whether there is a non-linear association of red and processed meats with colorectal cancer risk. Methods and Findings: Relevant prospective studies were identified in PubMed until March 2011. For each study, relative risks and 95% confidence intervals (CI) were extracted and pooled with a random-effects model, weighting for the inverse of the variance, in highest versus lowest intake comparison, and dose-response meta-analyses. Red and processed meats intake was associated with increased colorectal cancer risk. The summary relative risk (RR) of colorectal cancer for the highest versus the lowest intake was 1.22 (95% CI = 1.11-1.34) and the RR for every 100 g/day increase was 1.14 (95% CI = 1.04-1.24). Non-linear dose-response meta-analyses revealed that colorectal cancer risk increases approximately linearly with increasing intake of red and processed meats up to approximately 140 g/day, where the curve approaches its plateau. The associations were similar for colon and rectal cancer risk. When analyzed separately, colorectal cancer risk was related to intake of fresh red meat (RR (for 100 g/day increase) = 1.17, 95% CI = 1.05-1.31) and processed meat (RR (for 50 g/day increase) = 1.18, 95% CI = 1.10-1.28). Similar results were observed for colon cancer, but for rectal cancer, no significant associations were observed. Conclusions: High intake of red and processed meat is associated with significant increased risk of colorectal, colon and rectal cancers. The overall evidence of prospective studies supports limiting red and processed meat consumption as one of the dietary recommendations for the prevention of colorectal cancer.	[Chan, Doris S. M.; Lau, Rosa; Aune, Dagfinn; Vieira, Rui; Norat, Teresa] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Greenwood, Darren C.] Univ Leeds, Biostat Unit, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Kampman, Ellen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Imperial College London; University of Leeds; Wageningen University & Research	Chan, DSM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	t.norat@imperial.ac.uk	Greenwood, Darren C/C-3220-2008; Kampman, E./H-8057-2014	Greenwood, Darren C/0000-0001-7035-3096; 	World Cancer Research Fund International [2007/SP01]	World Cancer Research Fund International(World Cancer Research Fund International (WCRF))	Funding: This work was funded by the World Cancer Research Fund International (Grant number: 2007/SP01) (http://www.wcrf-uk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this review are the opinions of the authors. They may not represent the views of WCRF International/AICR and may differ from those in their future updates of the evidence related to food, nutrition, physical activity and cancer risk.	Alexander DD, 2011, OBES REV, V12, pe472, DOI 10.1111/j.1467-789X.2010.00785.x; Alexander DD, 2010, EUR J CANCER PREV, V19, P328, DOI 10.1097/CEJ.0b013e32833b48fa; *AM I CANC RES WOR, 2003, FOOD NUTR PHYS ACT P; *AM I CANC RES WOR, 2009, POL ACT CANC PREV FO; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Bagnardi V, 2004, AM J EPIDEMIOL, V159, P1077, DOI 10.1093/aje/kwh142; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005; Berndt SI, 2006, CANCER EPIDEM BIOMAR, V15, P2263, DOI 10.1158/1055-9965.EPI-06-0449; Bingham SA, 2002, J NUTR, V132, p3522S, DOI 10.1093/jn/132.11.3522S; Bingham SA, 1999, P NUTR SOC, V58, P243, DOI 10.1017/S0029665199000336; BONNETT R, 1975, J CHEM SOC CHEM COMM, P884, DOI 10.1039/c39750000884; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Brink M, 2005, BRIT J CANCER, V92, P1310, DOI 10.1038/sj.bjc.6602491; Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chan AT, 2005, INT J CANCER, V115, P648, DOI 10.1002/ijc.20890; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Chen J, 1998, CANCER RES, V58, P3307; Chen K, 2003, WORLD J GASTROENTERO, V9, P99, DOI 10.3748/wjg.v9.i1.99; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2003, CANCER RES, V63, P2358; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flood A, 2003, AM J EPIDEMIOL, V158, P59, DOI 10.1093/aje/kwg099; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Gaard M, 1996, EUR J CANCER PREV, V5, P445; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOHM RA, 1994, CANCER RES, V54, P718; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jarvinen R, 2001, BRIT J CANCER, V85, P357, DOI 10.1054/bjoc.2001.1906; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Joosen AMCP, 2009, CARCINOGENESIS, V30, P1402, DOI 10.1093/carcin/bgp130; Kabat GC, 2007, BRIT J CANCER, V97, P118, DOI 10.1038/sj.bjc.6603837; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; KNEKT P, 1994, INT J CANCER, V59, P756, DOI 10.1002/ijc.2910590608; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SA, 2009, NUTR CANCER, V61, P194, DOI 10.1080/01635580802419780; Lin J, 2004, AM J EPIDEMIOL, V160, P1011, DOI 10.1093/aje/kwh319; Luchtenborg M, 2005, CANCER CAUSE CONTROL, V16, P1041, DOI 10.1007/s10552-005-0239-0; Ma J, 2001, J NATL CANCER I, V93, P1330, DOI 10.1093/jnci/93.17.1330; Nothlings U, 2009, CANCER EPIDEM BIOMAR, V18, P2098, DOI 10.1158/1055-9965.EPI-08-1218; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Norat T, 2001, NUTR REV, V59, P37, DOI 10.1111/j.1753-4887.2001.tb06974.x; Oba S, 2006, CANCER LETT, V244, P260, DOI 10.1016/j.canlet.2005.12.037; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Parkin DM, 2009, EUR J CANCER PREV, V18, P179, DOI 10.1097/CEJ.0b013e32830c8d83; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Sato Y, 2006, EUR J CANCER PREV, V15, P211, DOI 10.1097/01.cej.0000197455.87356.05; Sellers TA, 1998, CANCER CAUSE CONTROL, V9, P357; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; SINHA R, 1994, CANCER RES, V54, P6154; Sorensen M, 2008, CANCER LETT, V266, P186, DOI 10.1016/j.canlet.2008.02.046; Spencer EA, 2010, CANCER CAUSE CONTROL, V21, P1417, DOI 10.1007/s10552-010-9569-7; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; Wu K, 2004, CANCER CAUSE CONTROL, V15, P853, DOI 10.1007/s10552-004-1809-2	72	547	563	2	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20456	10.1371/journal.pone.0020456	http://dx.doi.org/10.1371/journal.pone.0020456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674008	Green Published, gold			2022-12-27	WOS:000291356400005
J	Li, JS; Bi, YT; Dong, C; Yang, JF; Liang, WD				Li, Jin-song; Bi, Yun-tian; Dong, Cheng; Yang, Ji-feng; Liang, Wan-dong			Transcriptome Analysis of Adaptive Heat Shock Response of Streptococcus thermophilus	PLOS ONE			English	Article							GROWTH TEMPERATURE; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; CLPL; METABOLISM; BULGARICUS; REGULATORS; TOLERANCE; BACTERIA; SYSTEMS	Streptococcus thermophilus, a gram-positive facultative anaerobe, is one of the most important lactic acid bacteria widely used in the dairy fermentation industry. In this study, we have analyzed the global transcriptional profiling of S. thermophilus upon temperature change. During a temperature shift from 42 degrees C to 50 degrees C, it is found that 196 (10.4%) genes show differential expression with 102 up-regulated and 94 down-regulated at 50 degrees C. In particular, 1) Heat shock genes, such as DnaK, GroESL and clpL, are identified to be elevated at 50 degrees C; 2) Transcriptional regulators, such as HrcA, CtsR, Fur, MarR and MerR family, are differentially expressed, indicating the complex molecular mechanisms of S. thermophilus adapting to heat shock; 3) Genes associated with signal transduction, cell wall genes, iron homeostasis, ABC transporters and restriction-modification system were induced; 4) A large number of the differentially expressed genes are hypothetical genes of unknown function, indicating that much remains to be investigated about the heat shock response of S. thermophilus. Experimental investigation of selected heat shock gene ClpL shows that it plays an important role in the physiology of S. thermophilus at high temperature and meanwhile we confirmed ClpL as a member of the CtsR regulon. Overall, this study has contributed to the underlying adaptive molecular mechanisms of S. thermophilus upon temperature change and provides a basis for future in-depth functional studies.	[Li, Jin-song; Yang, Ji-feng; Liang, Wan-dong] Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Bi, Yun-tian] Wenzhou Med Coll, Sch Basic Med Sci, Wenzhou, Peoples R China; [Dong, Cheng] Harbin Med Univ, Hosp 4, Harbin, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Harbin Medical University	Li, JS (corresponding author), Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	liliang2011@yahoo.com	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	Natural Science Foundation of Zhejiang Province [Y2090642]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Natural Science Foundation of Zhejiang Province (Y2090642), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizoglu RO, 2009, APPL ENVIRON MICROB, V75, P5315, DOI 10.1128/AEM.00458-09; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Herve-Jimenez L, 2009, APPL ENVIRON MICROB, V75, P2062, DOI 10.1128/AEM.01984-08; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novak L, 1997, APPL ENVIRON MICROB, V63, P2665, DOI 10.1128/AEM.63.7.2665-2670.1997; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; Pysz MA, 2004, EXTREMOPHILES, V8, P209, DOI 10.1007/s00792-004-0379-2; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suokko A, 2008, PROTEOMICS, V8, P1029, DOI 10.1002/pmic.200700925; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Varcamonti M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-6; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zotta T, 2009, INT J FOOD MICROBIOL, V129, P211, DOI 10.1016/j.ijfoodmicro.2008.11.024; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	28	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25777	10.1371/journal.pone.0025777	http://dx.doi.org/10.1371/journal.pone.0025777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194926	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600030
J	Li, J; Ding, ZY; Wang, ZX; Lu, JF; Maity, SN; Navone, NM; Logothetis, CJ; Mills, GB; Kim, J				Li, Jin; Ding, Zhiyong; Wang, Zhengxin; Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Mills, Gordon B.; Kim, Jeri			Androgen Regulation of 5 alpha-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; DEPENDENT INHIBITION; SERUM TESTOSTERONE; GENE-EXPRESSION; MESSENGER-RNA; ADULT-RAT; FINASTERIDE; RECEPTOR; DUTASTERIDE; TYPE-1	The enzyme 5 alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5 alpha-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigated mechanisms underlying androgen regulation of 5 alpha-reductase isoenzyme expression in human prostate cells. We found that androgen regulates the mRNA level of 5 alpha-reductase isoenzymes in a cell type-specific manner, that such regulation occurs at the transcriptional level, and that AR is necessary for this regulation. In addition, our results suggest that AR is recruited to a negative androgen response element (nARE) on the promoter of SRD5A3 in vivo and directly binds to the nARE in vitro. The different expression levels of 5 alpha-reductase isoenzymes may confer response or resistance to 5 alpha-reductase inhibitors and thus may have importance in prostate cancer prevention.	[Li, Jin; Ding, Zhiyong; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, J (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	jekim@mdanderson.org	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Prostate Cancer Research Program at MD Anderson Cancer Center and supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant, CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Fitzpatrick JM, 2009, BJU INT, V103, P864, DOI 10.1111/j.1464-410X.2008.08206.x; George FW, 1997, ENDOCRINOLOGY, V138, P871, DOI 10.1210/en.138.3.871; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Makridakis N, 2005, J MOL ENDOCRINOL, V34, P617, DOI 10.1677/jme.1.01725; Makridakis NM, 2000, PHARMACOGENETICS, V10, P407, DOI 10.1097/00008571-200007000-00004; Melcangi RC, 1998, J STEROID BIOCHEM, V65, P295, DOI 10.1016/S0960-0760(98)00030-2; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Noss KR, 2002, GENE, V285, P247, DOI 10.1016/S0378-1119(02)00397-9; Parsons JK, 2005, CANCER EPIDEM BIOMAR, V14, P2257, DOI 10.1158/1055-9965.EPI-04-0715; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pratis K, 2003, J ENDOCRINOL, V176, P393, DOI 10.1677/joe.0.1760393; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Reddy G Kesava, 2004, Clin Prostate Cancer, V2, P209; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Rittmaster R, 2008, UROLOGY, V72, P808, DOI 10.1016/j.urology.2008.06.032; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Schatzl G, 2001, PROSTATE, V47, P52; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SILVER RI, 1994, J UROLOGY, V152, P433, DOI 10.1016/S0022-5347(17)32757-X; Steiner JF, 1996, CLIN PHARMACOKINET, V30, P16, DOI 10.2165/00003088-199630010-00002; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; TIAN GC, 1995, BIOCHEMISTRY-US, V34, P13453, DOI 10.1021/bi00041a024; TITUS MA, 2009, 5ALPHA REDUCTASE I 2, P175; Torres JM, 2003, FASEB J, V17, P1428, DOI 10.1096/fj.02-1119com; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; WILBERT DM, 1983, J CLIN ENDOCR METAB, V56, P113, DOI 10.1210/jcem-56-1-113; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wilson JD, 1996, PROSTATE, P88; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Yamana K, 2010, HORM MOL BIOL CLIN I, V2, P293, DOI 10.1515/HMBCI.2010.035; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhou ZF, 1999, MOL GENET METAB, V68, P410, DOI 10.1006/mgme.1999.2898; Zhu YS, 2009, ANN NY ACAD SCI, V1155, P43, DOI 10.1111/j.1749-6632.2009.04115.x	49	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28840	10.1371/journal.pone.0028840	http://dx.doi.org/10.1371/journal.pone.0028840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194926	Green Published, Green Submitted, gold			2022-12-27	WOS:000298369100109
